PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Doritchamou, J; Sossou-tchatcha, S; Cottrell, G; Moussiliou, A; Houngbeme, CH; Massougbodji, A; Deloron, P; Ndam, NT				Doritchamou, Justin; Sossou-tchatcha, Sylvain; Cottrell, Gilles; Moussiliou, Azizath; Houngbeme, Christophe Hounton; Massougbodji, Achille; Deloron, Philippe; Ndam, Nicaise Tuikue			Dynamics in the Cytoadherence Phenotypes of Plasmodium falciparum Infected Erythrocytes Isolated during Pregnancy	PLOS ONE			English	Article							CHONDROITIN SULFATE-A; INTERCELLULAR-ADHESION MOLECULE-1; PLACENTAL MALARIA; VAR GENE; ANTIGENIC PROPERTIES; PARASITE ADHESION; ANALYSIS REVEALS; IMMUNOGLOBULIN-G; VAR2CSA PROTEIN; ANTIBODIES	Pregnant women become susceptible to malaria infection despite their acquired immunity to this disease from childhood. The placental sequestration of Plasmodium falciparum infected erythrocytes (IE) is the major feature of malaria during pregnancy, due to ability of these parasites to bind chondroitin sulfate A (CSA) in the placenta through the VAR2CSA protein that parasites express on the surface of IE. We collected parasites at different times of pregnancy and investigated the adhesion pattern of freshly collected isolates on the three well described host receptors (CSPG, CD36 and ICAM-1). Var genes transcription profile and VAR2CSA surface-expression were assessed in these isolates. Although adhesion of IE to CD36 and ICAM-1 was observed in some isolates, CSA-adhesion was the predominant binding feature in all isolates analyzed. Co-existence in the peripheral blood of several adhesion phenotypes in early pregnancy isolates was observed, a diversity that gradually tightens with gestational age in favour of the CSA-adhesion phenotype. Infections occurring in primigravidae were often by parasites that adhered more to CSA than those from multigravidae. Data from this study further emphasize the specificity of CSA adhesion and VAR2CSA expression by parasites responsible for pregnancy malaria, while drawing attention to the phenotypic complexity of infections occurring early in pregnancy as well as in multigravidae.	[Doritchamou, Justin; Cottrell, Gilles; Deloron, Philippe; Ndam, Nicaise Tuikue] Univ Paris 05, PRES Sorbonne Paris Cite, Fac Pharm, Paris, France; [Doritchamou, Justin; Cottrell, Gilles; Moussiliou, Azizath; Deloron, Philippe; Ndam, Nicaise Tuikue] Inst Rech Dev, Mere & Enfant Face Infect Trop UMR216, Paris, France; [Doritchamou, Justin; Sossou-tchatcha, Sylvain; Massougbodji, Achille; Ndam, Nicaise Tuikue] Univ Abomey Calavi, Ctr Etud & Rech Paludisme Associe Grossesse & Enf, Cotonou, Benin; [Moussiliou, Azizath] Univ Paris 06, ED Physiol Physiopathol & Therapeut Sorbone Univ, Paris, France; [Houngbeme, Christophe Hounton] Hop Zone Suru Lere, Cotonou, Benin	UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; University of Abomey Calavi; UDICE-French Research Universities; Sorbonne Universite	Ndam, NT (corresponding author), Univ Paris 05, PRES Sorbonne Paris Cite, Fac Pharm, Paris, France.	nicaise.ndam@ird.fr	Doritchamou, Justin/T-5671-2017; Deloron, Philippe/G-6305-2010	Doritchamou, Justin/0000-0002-4589-7216; Deloron, Philippe/0000-0003-4705-2484; Cottrell, Gilles/0000-0002-7964-8963; Tuikue Ndam, Nicaise/0000-0003-2646-2513	DVS-Maturation-IRD grant [DVS-2011]; Agence Inter-etablissements de Recherche pour le Developement; Universite Paris Descartes [BDMU 2013]	DVS-Maturation-IRD grant; Agence Inter-etablissements de Recherche pour le Developement; Universite Paris Descartes	This work received funding from DVS-Maturation-IRD grant DVS-2011 and J. D was supported by PhD studentships from Agence Inter-etablissements de Recherche pour le Developement and mobility grant (BDMU 2013) from Universite Paris Descartes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achur RN, 2000, J BIOL CHEM, V275, P40344, DOI 10.1074/jbc.M006398200; Andrews KT, 2002, PARASITOL RES, V88, P715, DOI 10.1007/s00436-002-0624-5; Beeson JG, 1999, J INFECT DIS, V180, P464, DOI 10.1086/314899; Beeson JG, 2000, NAT MED, V6, P86, DOI 10.1038/71582; Brabin BJ, 2004, ANN TROP PAEDIATR, V24, P311, DOI 10.1179/027249304225019136; BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005; Clausen TM, 2012, J BIOL CHEM, V287, P23332, DOI 10.1074/jbc.M112.348839; Dahlback M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191510; Doritchamou J, 2013, VACCINE, V31, P4516, DOI 10.1016/j.vaccine.2013.07.072; Doritchamou J, 2012, J INFECT DIS, V206, P1911, DOI 10.1093/infdis/jis629; Duffy MF, 2005, MOL MICROBIOL, V56, P774, DOI 10.1111/j.1365-2958.2005.04577.x; Duffy MF, 2006, INFECT IMMUN, V74, P4875, DOI 10.1128/IAI.01978-05; Duffy PE, 2003, INFECT IMMUN, V71, P6620, DOI 10.1128/IAI.71.11.6620-6623.2003; Duffy PE, 2003, CURR OPIN MICROBIOL, V6, P371, DOI 10.1016/S1369-5274(03)00090-0; Flick K, 2001, SCIENCE, V293, P2098, DOI 10.1126/science.1062891; Francis SE, 2007, INFECT IMMUN, V75, P4838, DOI 10.1128/IAI.00635-07; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Janes JH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002032; Khunrae P, 2010, J MOL BIOL, V397, P826, DOI 10.1016/j.jmb.2010.01.040; Lavstsen T, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-27; Magistrado PA, 2011, VACCINE, V29, P437, DOI 10.1016/j.vaccine.2010.10.080; Maubert B, 1997, INFECT IMMUN, V65, P1251, DOI 10.1128/IAI.65.4.1251-1257.1997; Maubert B, 2000, PARASITE IMMUNOL, V22, P191, DOI 10.1046/j.1365-3024.2000.00292.x; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Ndam NGT, 2006, J INFECT DIS, V193, P713, DOI 10.1086/500146; Ndam NGT, 2005, J INFECT DIS, V192, P331, DOI 10.1086/430933; Ndam NGT, 2004, J INFECT DIS, V190, P2001, DOI 10.1086/425521; Ndam NT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001855; Newbold C, 1997, AM J TROP MED HYG, V57, P389, DOI 10.4269/ajtmh.1997.57.389; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; Rogerson SJ, 2007, AM J TROP MED HYG, V77, P14; Rottmann M, 2006, INFECT IMMUN, V74, P3904, DOI 10.1128/IAI.02073-05; Rowe JA, 2002, J INFECT DIS, V185, P1207, DOI 10.1086/339684; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Sartelet H, 2000, HISTOPATHOLOGY, V36, P62, DOI 10.1046/j.1365-2559.2000.00742.x; Staalsoe T, 2004, INFECT IMMUN, V72, P5027, DOI 10.1128/IAI.72.9.5027-5030.2004; Staalsoe T, 2004, LANCET, V363, P283, DOI 10.1016/S0140-6736(03)15386-X; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; TURNER GDH, 1994, AM J PATHOL, V145, P1057; Viebig NK, 2005, EMBO REP, V6, P775, DOI 10.1038/sj.embor.7400466	44	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98577	10.1371/journal.pone.0098577	http://dx.doi.org/10.1371/journal.pone.0098577			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905223	Green Published, Green Submitted, gold			2022-12-27	WOS:000341869000041
J	Karamanidis, K; Oberlander, KD; Niehoff, A; Epro, G; Bruggemann, GP				Karamanidis, Kiros; Oberlaender, Kai Daniel; Niehoff, Anja; Epro, Gaspar; Brueggemann, Gert-Peter			Effect of Exercise-Induced Enhancement of the Leg-Extensor Muscle-Tendon Unit Capacities on Ambulatory Mechanics and Knee Osteoarthritis Markers in the Elderly	PLOS ONE			English	Article							MATRIX PROTEIN COMP; HUMAN GASTROCNEMIUS-MUSCLE; ADDUCTION MOMENT; ACHILLES-TENDON; MORPHOLOGICAL PROPERTIES; RESULTANT JOINT; ANKLE; CARTILAGE; WALKING; FORCE	Objective: Leg-extensor muscle weakness could be a key component in knee joint degeneration in the elderly because it may result in altered muscular control during locomotion influencing the mechanical environment within the joint. This work aimed to examine whether an exercise-induced enhancement of the triceps surae (TS) and quadriceps femoris (QF) muscle-tendon unit (MTU) capacities would affect mechanical and biological markers for knee osteoarthritis in the elderly. Methods: Twelve older women completed a 14-week TS and OF MTU exercise intervention, which had already been established as increasing muscle strength and tendon stiffness. Locomotion mechanics and serum cartilage oligomeric matrix protein (COMP) levels were examined during incline walking. MTU mechanical properties were assessed using simultaneously ultrasonography and dynamometry. Results: Post exercise intervention, the elderly had higher TS and QF contractile strength and tendon-aponeurosis stiffness. Regarding the incline gait task, the subjects demonstrated a lower external knee adduction moment and lower knee adduction angular impulse during the stance phase post-intervention. Furthermore, post-intervention compared to pre-intervention, the elderly showed lower external hip adduction moment, but revealed higher plantarflexion pushoff moment. The changes in the external knee adduction moment were significantly correlated with the improvement in ankle pushoff function. Serum COMP concentration increased in response to the 0.5-h incline walking exercise with no differences in the magnitude of increment between pre- and post-intervention. Conclusions: This work emphasizes the important role played by the ankle pushoff function in knee joint mechanical loading during locomotion, and may justify the inclusion of the TS MTU in prevention programs aiming to positively influence specific mechanical markers for knee osteoarthritis in the elderly. However, the study was unable to show that COMP is amenable to change in the elderly following a 14-week exercise intervention and, therefore, the physiological benefit of improved muscle function for knee cartilage requires further investigation.	[Karamanidis, Kiros; Oberlaender, Kai Daniel; Niehoff, Anja; Epro, Gaspar; Brueggemann, Gert-Peter] German Sport Univ Cologne, Inst Biomech & Orthopaed, Cologne, Germany; [Karamanidis, Kiros] Univ Appl Sci Koblenz, Dept Math & Technol, Koblenz, Germany; [Oberlaender, Kai Daniel] German Sport Univ Cologne, Inst Movement & Sport Gerontol, Cologne, Germany; [Niehoff, Anja; Brueggemann, Gert-Peter] Univ Cologne, Fac Med, Cologne Ctr Musculoskeletal Biomech, D-50931 Cologne, Germany	German Sport University Cologne; German Sport University Cologne; University of Cologne	Karamanidis, K (corresponding author), German Sport Univ Cologne, Inst Biomech & Orthopaed, Cologne, Germany.	Karamanidis@dshs-koeln.de	Niehoff, Anja/K-6626-2015; Epro, Gaspar/AAC-1452-2020	Epro, Gaspar/0000-0002-7241-1533; Niehoff, Anja/0000-0002-4165-0929; Karamanidis, Kiros/0000-0002-1839-6643				Amin S, 2004, ARTHRIT RHEUM-ARTHR, V51, P371, DOI 10.1002/art.20396; AnaMar Medical AB, COMP ELISA ENZYME IM, P3; Andriacchi TP, 2004, ANN BIOMED ENG, V32, P447, DOI 10.1023/B:ABME.0000017541.82498.37; Arampatzis A, 2005, J BIOMECH, V38, P885, DOI 10.1016/j.jbiomech.2004.04.027; Arampatzis A, 2005, J BIOMECH, V38, P833, DOI 10.1016/j.jbiomech.2004.04.031; Arampatzis A, 2004, CLIN BIOMECH, V19, P277, DOI 10.1016/j.clinbiomech.2003.11.011; Arampatzis A, 2007, J EXP BIOL, V210, P2743, DOI 10.1242/jeb.003814; Baliunas AJ, 2002, OSTEOARTHR CARTILAGE, V10, P573, DOI 10.1053/joca.2002.0797; Bennell KL, 2008, RHEUM DIS CLIN N AM, V34, P731, DOI 10.1016/j.rdc.2008.05.005; Cohen J.E., 1988, STAT POWER ANAL BEHA; De Monte G, 2006, J ELECTROMYOGR KINES, V16, P413, DOI 10.1016/j.jelekin.2005.10.001; Erhart-Hledik JC, 2012, OSTEOARTHR CARTILAGE, V20, P1309, DOI 10.1016/j.joca.2012.07.018; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Henriksen M, 2009, J BIOMECH, V42, P1236, DOI 10.1016/j.jbiomech.2009.03.021; HERZOG W, 1993, J ANAT, V182, P213; HOF AL, 1992, J BIOMECH, V25, P1209, DOI 10.1016/0021-9290(92)90076-D; Jenkyn TR, 2008, J BIOMECH, V41, P276, DOI 10.1016/j.jbiomech.2007.09.015; Karamanidis K, 2005, J EXP BIOL, V208, P3907, DOI 10.1242/jeb.01830; Karamanidis K, 2006, J BIOMECH, V39, P406, DOI 10.1016/j.jbiomech.2004.12.017; Karamanidis K, 2009, ANN BIOMED ENG, V37, P467, DOI 10.1007/s10439-008-9624-7; Lewis CL, 2008, J BIOMECH, V41, P2082, DOI 10.1016/j.jbiomech.2008.05.013; Lichtwark GA, 2006, J EXP BIOL, V209, P4379, DOI 10.1242/jeb.02434; Lindqvist E, 2005, ANN RHEUM DIS, V64, P196, DOI 10.1136/ard.2003.019992; Liu MQ, 2006, J BIOMECH, V39, P2623, DOI 10.1016/j.jbiomech.2005.08.017; Mademli L, 2004, J ELECTROMYOGR KINES, V14, P591, DOI 10.1016/j.jelekin.2004.03.006; Maganaris CN, 1998, J PHYSIOL-LONDON, V510, P977, DOI 10.1111/j.1469-7793.1998.977bj.x; Miyazaki T, 2002, ANN RHEUM DIS, V61, P617, DOI 10.1136/ard.61.7.617; Mundermann A, 2005, OSTEOARTHR CARTILAGE, V13, P34, DOI 10.1016/j.joca.2004.09.007; Muramatsu T, 2001, J APPL PHYSIOL, V90, P1671, DOI 10.1152/jappl.2001.90.5.1671; Niehoff A, 2011, OSTEOARTHR CARTILAGE, V19, P1003, DOI 10.1016/j.joca.2011.04.012; Niehoff A, 2010, EUR J APPL PHYSIOL, V110, P651, DOI 10.1007/s00421-010-1529-0; Oberlander KD, 2012, J BIOMECH, V45, P1387, DOI 10.1016/j.jbiomech.2012.02.029; Pandy MG, 2010, ANNU REV BIOMED ENG, V12, P401, DOI 10.1146/annurev-bioeng-070909-105259; Reeves ND, 2003, J PHYSIOL-LONDON, V548, P971, DOI 10.1113/jphysiol.2002.035576; Riener R, 1999, J BIOMECH, V32, P539, DOI 10.1016/S0021-9290(99)00009-3; Shelburne KB, 2006, J ORTHOP RES, V24, P1983, DOI 10.1002/jor.20255; SODERKVIST I, 1993, J BIOMECH, V26, P1473, DOI 10.1016/0021-9290(93)90098-Y; Sritharan P, 2012, J ORTHOP RES, V30, P1586, DOI 10.1002/jor.22082; Zatsiorsky V., 1983, BIOMECHANICS 8 B, V56, P1152; Zhao D, 2007, J ORTHOP RES, V25, P789, DOI 10.1002/jor.20379	40	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99330	10.1371/journal.pone.0099330	http://dx.doi.org/10.1371/journal.pone.0099330			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905024	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000341869000116
J	Bai, LC; Chen, JF; McEachern, D; Liu, L; Zhou, HB; Aguilar, A; Wang, SM				Bai, Longchuan; Chen, Jianfang; McEachern, Donna; Liu, Liu; Zhou, Haibin; Aguilar, Angelo; Wang, Shaomeng			BM-1197: A Novel and Specific Bcl-2/Bcl-xL Inhibitor Inducing Complete and Long-Lasting Tumor Regression In Vivo	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; SMALL-MOLECULE INHIBITORS; BH3 MIMETIC ABT-737; BCL-X-L; FAMILY; MCL-1; APOPTOSIS; POTENT; PROTEINS; ABT-263	Bcl-2 and Bcl-xL are critical regulators of apoptosis that are overexpressed in a variety of human cancers and pharmacological inhibition of Bcl-2 and Bcl-xL represents a promising strategy for cancer treatment. Using a structure-based design approach, we have designed BM-1197 as a potent and efficacious dual inhibitor of Bcl-2 and Bcl-xL. BM-1197 binds to Bcl-2 and Bcl-xL proteins with K-i values less than 1 nM and shows >1,000-fold selectivity over Mcl-1. Mechanistic studies performed in the Mcl-1 knockout mouse embryonic fibroblast (MEF) cells revealed that BM-1197 potently disassociates the heterodimeric interactions between anti-apoptotic and pro-apoptotic Bcl-2 family proteins, concomitant with conformational changes in Bax protein, loss of mitochondrial membrane potential and subsequent cytochrome c release to the cytosol, leading to activation of the caspase cascade and apoptosis. BM-1197 exerts potent growth-inhibitory activity in 7 of 12 small cell lung cancer cell lines tested and induces mechanism-based apoptotic cell death. When intravenously administered at daily or weekly in H146 and H1963 small-cell lung cancer xenograft models, it achieves complete and long-term tumor regression. Consistent with its targeting of Bcl-xL, BM-1197 causes transit platelet reduction in mice. Collectively, our data indicate that BM-1197 is a promising dual Bcl-2/Bcl-xL inhibitor which warrants further investigation as a new anticancer drug.	[Bai, Longchuan; Chen, Jianfang; McEachern, Donna; Liu, Liu; Zhou, Haibin; Aguilar, Angelo; Wang, Shaomeng] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Bai, Longchuan; Chen, Jianfang; McEachern, Donna; Liu, Liu; Zhou, Haibin; Aguilar, Angelo; Wang, Shaomeng] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Wang, Shaomeng] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Wang, Shaomeng] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Wang, SM (corresponding author), Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA.	shaomeng@umich.edu	liu, liu/GXF-0906-2022; liu, li/HGC-0900-2022; zhou, haibin/N-4597-2014	zhou, haibin/0000-0003-0879-790X; Wang, Shaomeng/0000-0002-8782-6950	National Cancer Institute, National Institutes of Health [U19CA113317]; University of Michigan Comprehensive Cancer Center Core grant [P30 CA046592]; Ascentage; NATIONAL CANCER INSTITUTE [P30CA046592, U19CA113317] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Michigan Comprehensive Cancer Center Core grant; Ascentage; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by funding from the National Cancer Institute, National Institutes of Health (U19CA113317), the University of Michigan Comprehensive Cancer Center Core grant (P30 CA046592), and Ascentage. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Aguilar A, 2013, J MED CHEM, V56, P3048, DOI 10.1021/jm4001105; Al-Harbi S, 2011, BLOOD, V118, P3579, DOI 10.1182/blood-2011-03-340364; Bai LC, 2012, CANCER RES, V72, P1229, DOI 10.1158/0008-5472.CAN-11-2428; Bruncko M, 2007, J MED CHEM, V50, P641, DOI 10.1021/jm061152t; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen JF, 2012, J MED CHEM, V55, P8502, DOI 10.1021/jm3010306; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Deng J, 2007, CANCER CELL, V12, P171, DOI 10.1016/j.ccr.2007.07.001; Friberg A, 2013, J MED CHEM, V56, P15, DOI 10.1021/jm301448p; Gandhi L, 2011, J CLIN ONCOL, V29, P909, DOI 10.1200/JCO.2010.31.6208; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hann CL, 2008, CANCER RES, V68, P2321, DOI 10.1158/0008-5472.CAN-07-5031; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Keuling AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006651; Kirkin V, 2004, BBA-MOL CELL RES, V1644, P229, DOI 10.1016/j.bbamcr.2003.08.009; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Lessene G, 2013, NAT CHEM BIOL, V9, P390, DOI [10.1038/NCHEMBIO.1246, 10.1038/nchembio.1246]; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Lu JF, 2008, CANCER RES, V68, P9384, DOI 10.1158/0008-5472.CAN-08-2655; Lucas KM, 2012, CLIN CANCER RES, V18, P783, DOI 10.1158/1078-0432.CCR-11-1166; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Merino D, 2012, BLOOD, V119, P5807, DOI 10.1182/blood-2011-12-400929; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Morales AA, 2011, BLOOD, V118, P1329, DOI 10.1182/blood-2011-01-327197; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Park D, 2013, CANCER RES, V73, P5485, DOI 10.1158/0008-5472.CAN-12-2272; Parsons MJ, 2010, ESSAYS BIOCHEM, V47, P99, DOI [10.1042/BSE0470099, 10.1042/bse0470099]; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Roberts AW, 2012, J CLIN ONCOL, V30, P488, DOI 10.1200/JCO.2011.34.7898; Rudin CM, 2012, CLIN CANCER RES, V18, P3163, DOI 10.1158/1078-0432.CCR-11-3090; Shoemaker AR, 2008, CLIN CANCER RES, V14, P3268, DOI 10.1158/1078-0432.CCR-07-4622; Shore GC, 2008, CELL, V135, P1004, DOI 10.1016/j.cell.2008.11.029; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Tromp JM, 2012, CLIN CANCER RES, V18, P487, DOI 10.1158/1078-0432.CCR-11-1440; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Verhaegen M, 2006, CANCER RES, V66, P11348, DOI 10.1158/0008-5472.CAN-06-1748; Vogler M, 2010, CLIN CANCER RES, V16, P4217, DOI 10.1158/1078-0432.CCR-10-0777; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wilson WH, 2010, LANCET ONCOL, V11, P1149, DOI 10.1016/S1470-2045(10)70261-8; Yecies D, 2010, BLOOD, V115, P3304, DOI 10.1182/blood-2009-07-233304; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zheng CH, 2012, BIOORG MED CHEM LETT, V22, P39, DOI 10.1016/j.bmcl.2011.11.101; Zhou HB, 2012, J MED CHEM, V55, P4664, DOI 10.1021/jm300178u	47	57	63	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99404	10.1371/journal.pone.0099404	http://dx.doi.org/10.1371/journal.pone.0099404			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901320	Green Submitted, Green Published, gold			2022-12-27	WOS:000336841400126
J	Takahashi, R; Ishimaru, Y; Shimo, H; Bashir, K; Senoura, T; Sugimoto, K; Ono, K; Suzui, N; Kawachi, N; Ishii, S; Yin, YG; Fujimaki, S; Yano, M; Nishizawa, NK; Nakanishi, H				Takahashi, Ryuichi; Ishimaru, Yasuhiro; Shimo, Hugo; Bashir, Khurram; Senoura, Takeshi; Sugimoto, Kazuhiko; Ono, Kazuko; Suzui, Nobuo; Kawachi, Naoki; Ishii, Satomi; Yin, Yong-Gen; Fujimaki, Shu; Yano, Masahiro; Nishizawa, Naoko K.; Nakanishi, Hiromi			From Laboratory to Field: OsNRAMP5-Knockdown Rice Is a Promising Candidate for Cd Phytoremediation in Paddy Fields	PLOS ONE			English	Article							CADMIUM UPTAKE; TRANSPORTER GENES; IRON TRANSPORTER; MANGANESE UPTAKE; TRANSLOCATION; ACCUMULATION; PLANT; NRAMP; ARABIDOPSIS; ATNRAMP3	Previously, we reported that OsNRAMP5 functions as a manganese, iron, and cadmium (Cd) transporter. The shoot Cd content in OsNRAMP5 RNAi plants was higher than that in wild-type (WT) plants, whereas the total Cd content (roots plus shoots) was lower. For efficient Cd phytoremediation, we produced OsNRAMP5 RNAi plants using the natural high Cd-accumulating cultivar Anjana Dhan (A5i). Using a positron-emitting tracer imaging system, we assessed the time-course of Cd absorption and accumulation in A5i plants. Enhanced Cd-107 translocation from the roots to the shoots was observed in A5i plants. To evaluate the phytoremediation capability of A5i plants, we performed a field experiment in a Cd-contaminated paddy field. The biomass of the A5i plants was unchanged by the suppression of OsNRAMP5 expression; the A5i plants accumulated twice as much Cd in their shoots as WT plants. Thus, A5i plants could be used for rapid Cd extraction and the efficient phytoremediation of Cd from paddy fields, leading to safer food production.	[Takahashi, Ryuichi; Ishimaru, Yasuhiro; Shimo, Hugo; Bashir, Khurram; Senoura, Takeshi; Nishizawa, Naoko K.; Nakanishi, Hiromi] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan; [Ishimaru, Yasuhiro] Tohoku Univ, Grad Sch Sci, Aoba Ku, Sendai, Miyagi 980, Japan; [Sugimoto, Kazuhiko; Ono, Kazuko; Yano, Masahiro] Natl Inst Agrobiol Sci, Agrogen Res Ctr, Tsukuba, Ibaraki, Japan; [Suzui, Nobuo; Kawachi, Naoki; Ishii, Satomi; Yin, Yong-Gen; Fujimaki, Shu] Japan Atom Energy Agcy, Quantum Beam Sci Directorate, Takasaki, Gunma, Japan; [Nishizawa, Naoko K.] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa, Japan	University of Tokyo; Tohoku University; National Institute of Agrobiological Sciences - Japan; Japan Atomic Energy Agency; Ishikawa Prefecture University	Nakanishi, H (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan.	ahnaka@mail.ecc.u-tokyo.ac.jp	ISHIMARU, Yasuhiro/AAS-5947-2020; Suzui, Nobuo/C-5855-2013; Bashir, Khurram/Z-5650-2019; Bashir, Khurram/C-6870-2011; Yano, Masahiro/AAC-5441-2019; Nakanishi, Hiromi/C-6461-2015	ISHIMARU, Yasuhiro/0000-0003-4723-8844; Suzui, Nobuo/0000-0003-1081-7578; Bashir, Khurram/0000-0001-7123-8380; Bashir, Khurram/0000-0001-7123-8380; Yin, Yong-Gen/0000-0002-2930-0141; Kawachi, Naoki/0000-0002-3991-5035; Nakanishi, Hiromi/0000-0001-5556-5058	Program for Promotion of Basic Research Activities for Innovative Biosciences; Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics for Agricultural Innovation) [GMB0001]; Grants-in-Aid for Scientific Research [23248011] Funding Source: KAKEN	Program for Promotion of Basic Research Activities for Innovative Biosciences; Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics for Agricultural Innovation)(Ministry of Agriculture Forestry & Fisheries - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Program for Promotion of Basic Research Activities for Innovative Biosciences and by a grant from the Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics for Agricultural Innovation, GMB0001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bereczky Z, 2003, J BIOL CHEM, V278, P24697, DOI 10.1074/jbc.M301365200; Cailliatte R, 2010, PLANT CELL, V22, P904, DOI 10.1105/tpc.109.073023; Cailliatte R, 2009, BIOCHEM J, V422, P217, DOI 10.1042/BJ20090655; Cheng FM, 2006, SCI TOTAL ENVIRON, V359, P156, DOI 10.1016/j.scitotenv.2005.05.005; Cheng LJ, 2007, PLANT PHYSIOL, V145, P1647, DOI 10.1104/pp.107.107912; Curie C, 2000, BIOCHEM J, V347, P749, DOI 10.1042/0264-6021:3470749; Fujimaki S, 2010, PLANT PHYSIOL, V152, P1796, DOI 10.1104/pp.109.151035; Ibaraki T, 2009, SOIL SCI PLANT NUTR, V55, P421, DOI 10.1111/j.1747-0765.2009.00367.x; Ishikawa S, 2006, SOIL SCI PLANT NUTR, V52, P32, DOI 10.1111/j.1747-0765.2006.00008.x; Ishikawa S, 2005, SOIL SCI PLANT NUTR, V51, P101, DOI 10.1111/j.1747-0765.2005.tb00012.x; Ishikawa S, 2012, P NATL ACAD SCI USA, V109, P19166, DOI 10.1073/pnas.1211132109; Ishikawa S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-172; Ishimaru Y, 2006, PLANT J, V45, P335, DOI 10.1111/j.1365-313X.2005.02624.x; Ishimaru Y, 2007, P NATL ACAD SCI USA, V104, P7373, DOI 10.1073/pnas.0610555104; Ishimaru Y, 2012, PLANT SIGNAL BEHAV, V7, P763, DOI 10.4161/psb.20510; Ishimaru Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00286; Kaiser BN, 2003, PLANT J, V35, P295, DOI 10.1046/j.1365-313X.2003.01802.x; Lanquar V, 2005, EMBO J, V24, P4041, DOI 10.1038/sj.emboj.7600864; Lanquar V, 2010, PLANT PHYSIOL, V152, P1986, DOI 10.1104/pp.109.150946; Mizuno T, 2005, PLANT PHYSIOL BIOCH, V43, P793, DOI 10.1016/j.plaphy.2005.07.006; Moon CS, 2003, INT ARCH OCC ENV HEA, V76, P282, DOI 10.1007/s00420-002-0415-4; Nakamura S, 2013, J EXP BOT, V64, P1073, DOI 10.1093/jxb/ers388; Nakanishi H, 2006, SOIL SCI PLANT NUTR, V52, P464, DOI 10.1111/j.1747-0765.2006.00055.x; Nevo Y, 2006, BBA-MOL CELL RES, V1763, P609, DOI 10.1016/j.bbamcr.2006.05.007; Okumura M, 2012, PLANT SIGNAL BEHAV, V7, P979, DOI 10.4161/psb.20936; Oomen RJFJ, 2009, NEW PHYTOL, V181, P637, DOI 10.1111/j.1469-8137.2008.02694.x; Sasaki A, 2012, PLANT CELL, V24, P2155, DOI 10.1105/tpc.112.096925; Suzuki M, 2008, PLANT MOL BIOL, V66, P609, DOI 10.1007/s11103-008-9292-x; Suzuki M, 2006, PLANT J, V48, P85, DOI 10.1111/j.1365-313X.2006.02853.x; Takahashi R, 2012, PLANT CELL ENVIRON, V35, P1948, DOI 10.1111/j.1365-3040.2012.02527.x; Takahashi R, 2011, PLANT SIGNAL BEHAV, V6, P1813, DOI 10.4161/psb.6.11.17587; Takahashi R, 2011, J EXP BOT, V62, P4843, DOI 10.1093/jxb/err136; Thomine S, 2003, PLANT J, V34, P685, DOI 10.1046/j.1365-313X.2003.01760.x; Thomine S, 2000, P NATL ACAD SCI USA, V97, P4991, DOI 10.1073/pnas.97.9.4991; Tsukamoto T, 2009, PLANT CELL PHYSIOL, V50, P48, DOI 10.1093/pcp/pcn192; Tsukamoto T, 2006, SOIL SCI PLANT NUTR, V52, P717, DOI 10.1111/j.1747-0765.2006.00096.x; Uraguchi S, 2009, J EXP BOT, V60, P2677, DOI 10.1093/jxb/erp119; Watanabe T, 2004, SCI TOTAL ENVIRON, V329, P17, DOI 10.1016/j.scitotenv.2004.03.010; World Health Organization (WHO) International Agency for Research on Cancer (IARC), 2012, MON EV CARC RISKS HU; Xia JX, 2010, P NATL ACAD SCI USA, V107, P18381, DOI 10.1073/pnas.1004949107; Xiao HH, 2008, ANN BOT-LONDON, V102, P881, DOI 10.1093/aob/mcn178	44	44	48	2	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98816	10.1371/journal.pone.0098816	http://dx.doi.org/10.1371/journal.pone.0098816			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901230	Green Published, gold, Green Submitted			2022-12-27	WOS:000336841400055
J	Barber, AG; Castillo-Martin, M; Bonal, DM; Rybicki, BA; Christiano, AM; Cordon-Cardo, C				Barber, Alison G.; Castillo-Martin, Mireia; Bonal, Dennis M.; Rybicki, Benjamin A.; Christiano, Angela M.; Cordon-Cardo, Carlos			Characterization of Desmoglein Expression in the Normal Prostatic Gland. Desmoglein 2 Is an Independent Prognostic Factor for Aggressive Prostate Cancer	PLOS ONE			English	Article							RIGHT-VENTRICULAR CARDIOMYOPATHY; AUTOSOMAL RECESSIVE HYPOTRICHOSIS; STRIATE PALMOPLANTAR KERATODERMA; SQUAMOUS-CELL CARCINOMA; DESMOSOMAL CADHERIN; HAIR FOLLICLE; MUTATIONS; GENE; MONILETHRIX; ADHESION	Purpose: The expression of desmogleins (DSGs), which are known to be crucial for establishing and maintaining the cell-cell adhesion required for tissue integrity, has been well characterized in the epidermis and hair follicle; however, their expression in other epithelial tissues such as prostate is poorly understood. Although downregulation of classical cadherins, such as E-cadherin, has been described in prostate cancer tissue samples, the expression of desmogleins has only been previously reported in prostate cancer cell lines. In this study we characterized desmoglein expression in normal prostate tissues, and further investigated whether Desmoglein 2 (DSG2) expression specifically can serve as a potential clinical prognostic factor for patients diagnosed with primary prostate cancer. Experimental Design: We utilized immunofluorescence to examine DSG2 expression in normal prostate (n = 50) and in a clinically well-characterized cohort of prostate cancer patients (n = 414). Correlation of DSG2 expression with clinicopathological characteristics and biochemical recurrence was analyzed to assess its clinical significance. Results: These studies revealed that DSG2 and DSG4 were specifically expressed in prostatic luminal cells, whereas basal cells lack their expression. In contrast, DSG1 and DSG3 were not expressed in normal prostate epithelium. Further analyses of DSG2 expression in prostate cancer revealed that reduced levels of this biomarker were a significant independent marker of poor clinical outcome. Conclusion: Here we report for the first time that a low DSG2 expression phenotype is a useful prognostic biomarker of tumor aggressiveness and may serve as an aid in identifying patients with clinically significant prostate cancer.	[Barber, Alison G.; Christiano, Angela M.] Columbia Univ, Dept Genet & Dev, New York, NY USA; [Christiano, Angela M.] Columbia Univ, Dept Dermatol, New York, NY 10027 USA; [Cordon-Cardo, Carlos] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Cordon-Cardo, Carlos] Columbia Univ, Dept Urol, New York, NY USA; [Cordon-Cardo, Carlos] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY USA; [Rybicki, Benjamin A.] Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI USA; [Castillo-Martin, Mireia; Bonal, Dennis M.; Cordon-Cardo, Carlos] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Henry Ford Health System; Henry Ford Hospital; Icahn School of Medicine at Mount Sinai	Castillo-Martin, M (corresponding author), Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA.	mireia.castillo-martin@mssm.edu; carlos.cordon-cardo@mssm.edu	Castillo-Martin, Mireia/H-6152-2013; Rybicki, Benjamin/L-4614-2019	Rybicki, Benjamin/0000-0003-3190-3467	National Institutes of Health [P01-CA087497, R01-ES11126]; NATIONAL CANCER INSTITUTE [P01CA087497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been partially supported by National Institutes of Health grants P01-CA087497 (CCC and MCM) and R01-ES11126 (BAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Amagai M, 1999, J DERMATOL SCI, V20, P92, DOI 10.1016/S0923-1811(99)00016-X; Awad MM, 2006, AM J HUM GENET, V79, P136, DOI 10.1086/504393; Barber AG, 2007, J DERMATOL SCI, V45, P161, DOI 10.1016/j.jdermsci.2006.11.013; Baron S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050024; Bazzi H, 2006, DIFFERENTIATION, V74, P129, DOI 10.1111/j.1432-0436.2006.00061.x; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Biedermann K, 2005, J PATHOL, V207, P199, DOI 10.1002/path.1821; Bonkhoff H, 1996, PROSTATE, V28, P98; Chen YJ, 2007, ONCOGENE, V26, P467, DOI 10.1038/sj.onc.1209802; Davies G, 2000, J UROLOGY, V163, P985, DOI 10.1016/S0022-5347(05)67869-X; Delva E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002543; Domingo-Domenech J, 2006, CLIN CANCER RES, V12, P5578, DOI 10.1158/1078-0432.CCR-05-2767; Getsios S, 2004, NAT REV MOL CELL BIO, V5, P271, DOI 10.1038/nrm1356; HAYWARD SW, 1995, IN VITRO CELL DEV-AN, V31, P14; Heuser A, 2006, AM J HUM GENET, V79, P1081, DOI 10.1086/509044; Horoszewicz J S, 1980, Prog Clin Biol Res, V37, P115; KAIGHN ME, 1979, INVEST UROL, V17, P16; Karkera JD, 2000, CLIN CANCER RES, V6, P3565; Karni-Schmidt O, 2011, AM J PATHOL, V178, P1350, DOI 10.1016/j.ajpath.2010.11.061; Kljuic A, 2003, CELL, V113, P249, DOI 10.1016/S0092-8674(03)00273-3; Kurzen H, 2003, J CUTAN PATHOL, V30, P621, DOI 10.1034/j.1600-0560.2003.00122.x; Lang SH, 2002, PROSTATE, V52, P253, DOI 10.1002/pros.10088; Lang SH, 2001, BRIT J CANCER, V85, P590, DOI 10.1054/bjoc.2001.1967; Pilichou K, 2006, CIRCULATION, V113, P1171, DOI 10.1161/CIRCULATIONAHA.105.583674; Ramani VC, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-373; Rickman L, 1999, HUM MOL GENET, V8, P971, DOI 10.1093/hmg/8.6.971; Rubin MA, 2001, HUM PATHOL, V32, P690, DOI 10.1053/hupa.2001.25902; Rybicki BA, 2006, CANCER DETECT PREV, V30, P412, DOI 10.1016/j.cdp.2006.09.004; Schafer S, 1996, DIFFERENTIATION, V60, P99, DOI 10.1046/j.1432-0436.1996.6020099.x; Schaffer JV, 2006, J INVEST DERMATOL, V126, P1286, DOI 10.1038/sj.jid.5700237; Schweizer J, 2006, J INVEST DERMATOL, V126, P1216, DOI 10.1038/sj.jid.5700266; Shimomura Y, 2006, J INVEST DERMATOL, V126, P1281, DOI 10.1038/sj.jid.5700113; Simpson MA, 2009, CARDIOLOGY, V113, P28, DOI 10.1159/000165696; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Syrris P, 2007, EUR HEART J, V28, P581, DOI 10.1093/eurheartj/hl380; Takebayashi S, 2000, CANCER RES, V60, P3397; Trojan L, 2005, ANTICANCER RES, V25, P183; Tselepis C, 1998, P NATL ACAD SCI USA, V95, P8064, DOI 10.1073/pnas.95.14.8064; Wahl JK, 2002, HYBRIDOMA HYBRIDOM, V21, P37, DOI 10.1089/15368590252917629; Whittock NV, 2003, J INVEST DERMATOL, V120, P523, DOI 10.1046/j.1523-1747.2003.12113.x; Yashiro M, 2006, EUR J CANCER, V42, P2397, DOI 10.1016/j.ejca.2006.03.024; Zlotogorski A, 2006, J INVEST DERMATOL, V126, P1292, DOI 10.1038/sj.jid.5700251	43	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98786	10.1371/journal.pone.0098786	http://dx.doi.org/10.1371/journal.pone.0098786			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896103	Green Submitted, Green Published, gold			2022-12-27	WOS:000338430700077
J	Oboshi, Y; Kikuchi, M; Shimizu, Y; Yoshimura, Y; Hiraishi, H; Okada, H; Magata, Y; Ouchi, Y				Oboshi, Yumi; Kikuchi, Mitsuru; Shimizu, Yoshiyuki; Yoshimura, Yuko; Hiraishi, Hirotoshi; Okada, Hiroyuki; Magata, Yasuhiro; Ouchi, Yasuomi			Pre-Task Prefrontal Activation during Cognitive Processes in Aging: A Near-Infrared Spectroscopy Study	PLOS ONE			English	Article							CORTEX AREA-10; FUNCTIONAL SPECIALIZATION; PROSPECTIVE MEMORY; BRAIN; AGE; METAANALYSIS; INVOLVEMENT; ATTENTION; WORKING; FUTURE	Purpose: Cognitive processing generally deteriorates as people age. Recent neuroimaging studies have shown that the prefrontal cortex (PFC) is involved in human-specific behavior, such as preparing for future actions and prospective memory; hence, the PFC may be voluntarily activated even during the "resting'' condition that precedes task execution. The purpose of the present study was to investigate changes in voluntary pre-task activation as a result of aging using a paradigm that includes a longer intertrial interval (e.g., 30 sec) than has been used in previous studies. Methods: A total of 120 cognitively normal adults (young: 60, old: 60) participated in this near-infrared spectroscopy (NIRS) study. All subjects performed 6 repetitions of the working memory task, which included a 30 sec resting period and a 28.8 sec task period. The resting period was divided into baseline and pre-task (preT) periods, and the task period was divided into early easy task (eT) and late difficult task (dT) periods. We then normalized the data, analyzed the magnitude of task-related NIRS responses in each period and compared the results between groups using an analysis of variance test. Results: Statistical analyses revealed a significant interaction between group x optode location x period, in which hemodynamic responses in the PFC during the preT period were smaller in the elderly in than young adults. By contrast, during the task period, the hemodynamic responses were higher in the lateral PFC in the elderly than in young adults. Spearman's rank correlation analysis showed a positive correlation between hemodynamic changes during the preT period in the PFC and correct answer ratios in both groups. Conclusions: These findings suggest that more pre-task activation in the anterior PFC is related to better cognitive performance in humans. Thus, a reduction in this activation might partly explain cognitive decline in the elderly.	[Oboshi, Yumi; Shimizu, Yoshiyuki; Okada, Hiroyuki; Ouchi, Yasuomi] Hamamatsu Univ Sch Med, Dept Biofunct Imaging, Med Photon Res Ctr, Hamamatsu, Shizuoka 4313192, Japan; [Oboshi, Yumi] Tokoha Univ, Fac Hlth & Med Sci, Dept Occupat Therapy, Hamamatsu, Shizuoka, Japan; [Kikuchi, Mitsuru; Yoshimura, Yuko; Hiraishi, Hirotoshi] Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa, Japan; [Shimizu, Yoshiyuki; Okada, Hiroyuki] Hamamatsu Photon KK, Cent Res Lab, Hamamatsu, Shizuoka, Japan; [Magata, Yasuhiro] Hamamatsu Univ Sch Med, Dept Mol Imaging, Med Photon Res Ctr, Hamamatsu, Shizuoka 4313192, Japan	Hamamatsu University School of Medicine; Kanazawa University; Hamamatsu Photonics; Hamamatsu University School of Medicine	Ouchi, Y (corresponding author), Hamamatsu Univ Sch Med, Dept Biofunct Imaging, Med Photon Res Ctr, Hamamatsu, Shizuoka 4313192, Japan.	ouchi@hama-med.ac.jp			New Energy and Industrial Technology Development Organization (NEDO); Japanese Ministry of Education, Culture, Sports, Science and Technology; Takeda Science Foundation; Japan Health Foundation; Ishikawa High-Tech Sensing Cluster	New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Health Foundation(Japan Health Foundation); Ishikawa High-Tech Sensing Cluster	This work was supported by the grants from Ishikawa High-Tech Sensing Cluster, from New Energy and Industrial Technology Development Organization (NEDO), from the Japanese Ministry of Education, Culture, Sports, Science and Technology, from the Takeda Science Foundation and from the Japan Health Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badre D, 2009, NAT REV NEUROSCI, V10, P659, DOI 10.1038/nrn2667; Benoit RG, 2012, CEREB CORTEX, V22, P1876, DOI 10.1093/cercor/bhr264; Berchicci M, 2013, J GERONTOL A-BIOL, V68, P1337, DOI 10.1093/gerona/glt094; Berchicci M, 2012, NEUROIMAGE, V62, P1750, DOI 10.1016/j.neuroimage.2012.06.031; Browning M, 2012, NEUROIMAGE, V59, P1942, DOI 10.1016/j.neuroimage.2011.09.007; Burgess PW, 2007, TRENDS COGN SCI, V11, P290, DOI 10.1016/j.tics.2007.05.004; Burgess PW, 2007, PHILOS T R SOC B, V362, P887, DOI 10.1098/rstb.2007.2095; Burgess PW, 2011, NEUROPSYCHOLOGIA, V49, P2246, DOI 10.1016/j.neuropsychologia.2011.02.014; Dreher JC, 2002, NEUROIMAGE, V17, P95, DOI 10.1006/nimg.2002.1169; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Gilbert SJ, 2006, CEREB CORTEX, V16, P1783, DOI 10.1093/cercor/bhj113; Gilbert SJ, 2010, NEUROIMAGE, V53, P1359, DOI 10.1016/j.neuroimage.2010.07.032; Gilbert SJ, 2010, J NEUROSCI, V30, P1233, DOI 10.1523/JNEUROSCI.3220-09.2010; Gilbert SJ, 2005, EUR J NEUROSCI, V21, P1423, DOI 10.1111/j.1460-9568.2005.03981.x; HENNIGHAUSEN E, 1993, ELECTROEN CLIN NEURO, V86, P199, DOI 10.1016/0013-4694(93)90008-J; Henseler I, 2011, NEUROIMAGE, V56, P1666, DOI 10.1016/j.neuroimage.2011.02.056; Jimura K, 2010, CEREB CORTEX, V20, P1420, DOI 10.1093/cercor/bhp206; Kikuchi M, 2011, J NEUROSCI, V31, P11193, DOI 10.1523/JNEUROSCI.2535-11.2011; Koechlin E, 2000, P NATL ACAD SCI USA, V97, P7651, DOI 10.1073/pnas.130177397; Kopp B, 2014, BRAIN COGNITION, V85, P209, DOI 10.1016/j.bandc.2013.12.008; Koshino H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022909; Maki A, 1995, MED PHYS, V22, P1997, DOI 10.1118/1.597496; Makizako H, 2013, ARCH GERONTOL GERIAT, V56, P118, DOI 10.1016/j.archger.2012.08.017; Ohmae E, 2006, NEUROIMAGE, V29, P697, DOI 10.1016/j.neuroimage.2005.08.008; Okuda J, 2003, NEUROIMAGE, V19, P1369, DOI 10.1016/S1053-8119(03)00179-4; Okuda J, 2007, INT J PSYCHOPHYSIOL, V64, P233, DOI 10.1016/j.ijpsycho.2006.09.009; Paxton JL, 2008, CEREB CORTEX, V18, P1010, DOI 10.1093/cercor/bhm135; Rajah MN, 2005, BRAIN, V128, P1964, DOI 10.1093/brain/awh608; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Sakai K, 2006, J NEUROSCI, V26, P1211, DOI 10.1523/JNEUROSCI.3887-05.2006; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; Sakai K, 2008, CEREB CORTEX, V31, P219; Schoofs D, 2012, BEHAV BRAIN RES; Schoofs D, 2008, PSYCHONEUROENDOCRINO, V33, P643, DOI 10.1016/j.psyneuen.2008.02.004; Soon CS, 2008, NAT NEUROSCI, V11, P543, DOI 10.1038/nn.2112; Straube T, 2010, HUM BRAIN MAPP, V31, P36, DOI 10.1002/hbm.20843; Volle E, 2011, NEUROPSYCHOLOGIA, V49, P2185, DOI 10.1016/j.neuropsychologia.2011.02.045	37	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98779	10.1371/journal.pone.0098779	http://dx.doi.org/10.1371/journal.pone.0098779			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897305	Green Submitted, gold, Green Published			2022-12-27	WOS:000338430700075
J	Brojatsch, J; Lima, H; Kar, AK; Jacobson, LS; Muehlbauer, SM; Chandran, K; Diaz-Griffero, F				Brojatsch, Juergen; Lima, Heriberto, Jr.; Kar, Alak K.; Jacobson, Lee S.; Muehlbauer, Stefan M.; Chandran, Kartik; Diaz-Griffero, Felipe			A Proteolytic Cascade Controls Lysosome Rupture and Necrotic Cell Death Mediated by Lysosome-Destabilizing Adjuvants	PLOS ONE			English	Article							DIPEPTIDYL PEPTIDASE-I; LEUCINE METHYL-ESTER; CYTOTOXIC LYMPHOCYTES; PROTEASOME INHIBITORS; CATHEPSIN-B; URIC-ACID; NECROSIS; INFLAMMASOME; ACTIVATE; DISRUPTION	Recent studies have linked necrotic cell death and proteolysis of inflammatory proteins to the adaptive immune response mediated by the lysosome-destabilizing adjuvants, alum and Leu-Leu-OMe (LLOMe). However, the mechanism by which lysosome-destabilizing agents trigger necrosis and proteolysis of inflammatory proteins is poorly understood. The proteasome is a cellular complex that has been shown to regulate both necrotic cell death and proteolysis of inflammatory proteins. We found that the peptide aldehyde proteasome inhibitors, MG115 and MG132, block lysosome rupture, degradation of inflammatory proteins and necrotic cell death mediated by the lysosome-destabilizing peptide LLOMe. However, non-aldehyde proteasome inhibitors failed to prevent LLOMe-induced cell death suggesting that aldehyde proteasome inhibitors triggered a pleotropic effect. We have previously shown that cathepsin C controls lysosome rupture, necrotic cell death and the adaptive immune response mediated by LLOMe. Using recombinant cathepsin C, we found that aldehyde proteasome inhibitors directly block cathepsin C, which presumably prevents LLOMe toxicity. The cathepsin B inhibitor CA-074-Me also blocks lysosome rupture and necrotic cell death mediated by a wide range of necrosis inducers, including LLOMe. Using cathepsin-deficient cells and recombinant cathepsins, we demonstrate that the cathepsins B and C are not required for the CA-074-Me block of necrotic cell death. Taken together, our findings demonstrate that lysosome-destabilizing adjuvants trigger an early proteolytic cascade, involving cathepsin C and a CA-074-Me-dependent protease. Identification of these early events leading to lysosome rupture will be crucial in our understanding of processes controlling necrotic cell death and immune responses mediated by lysosome-destabilizing adjuvants.	[Brojatsch, Juergen; Lima, Heriberto, Jr.; Kar, Alak K.; Jacobson, Lee S.; Muehlbauer, Stefan M.; Chandran, Kartik; Diaz-Griffero, Felipe] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Brojatsch, J (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.	jurgen.brojatsch@einstein.yu.edu		brojatsch, jurgen/0000-0002-7424-365X	National Institutes of Health [1R56AI092497-01A1, 5R01AI088027-02, R01 AI087390]; Martin Turkish Foundation; M-O'Connor-Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI092497, R01AI087390, R01AI088027] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Martin Turkish Foundation; M-O'Connor-Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	HL, LSJ, SMM, and JB were funded by the National Institutes of Health grants 1R56AI092497-01A1 (to HL, LSJ, SMM, and JB), 5R01AI088027-02 (to KC), and R01 AI087390 (to AK and FD-G), and by the Martin Turkish Foundation and the M-O'Connor-Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alileche A, 2006, CELL CYCLE, V5, P100, DOI 10.4161/cc.5.1.2283; Basu S, 2000, CELL STRESS CHAPERON, V5, P373; Brennan MA, 2000, MOL MICROBIOL, V38, P31, DOI 10.1046/j.1365-2958.2000.02103.x; Brojatsch Jurgen, 2014, Front Biosci (Elite Ed), V6, P139; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Diaz-Griffero F, 2002, J VIROL, V76, P12866, DOI 10.1128/JVI.76.24.12866-12876.2002; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Guicciardi ME, 2013, CELL CYCLE, V12, P1995, DOI 10.4161/cc.25317; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; Hentze H, 2003, CELL DEATH DIFFER, V10, P956, DOI 10.1038/sj.cdd.4401264; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Jacobson LS, 2013, J BIOL CHEM, V288, P7481, DOI 10.1074/jbc.M112.400655; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Kroemer G, 2005, CELL DEATH DIFFER, V12, P1463, DOI 10.1038/sj.cdd.4401724; Li HF, 2009, J IMMUNOL, V183, P1528, DOI 10.4049/jimmunol.0901080; Lima H, 2013, CELL CYCLE, V12, P1868, DOI 10.4161/cc.24903; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Muehlbauer SM, 2007, CELL CYCLE, V6, P758, DOI 10.4161/cc.6.6.3991; Muehlbauer SM, 2010, AM J PATHOL, V177, P735, DOI 10.2353/ajpath.2010.090828; Newman Z, 2009, INFECT IMMUN, P1; Newman ZL, 2009, INFECT IMMUN, V77, P4327, DOI 10.1128/IAI.00730-09; Nour AM, 2009, INFECT IMMUN, V77, P1262, DOI 10.1128/IAI.01032-08; Orlowski RZ, 1999, CELL DEATH DIFFER, V6, P303, DOI 10.1038/sj.cdd.4400505; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Reinheckel T, 2013, CELL CYCLE, V12, P1994, DOI 10.4161/cc.25316; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; Rovere-Querini P, 2004, EMBO REP, V5, P825, DOI 10.1038/sj.embor.7400205; Squires RC, 2007, J BIOL CHEM, V282, P34260, DOI 10.1074/jbc.M705687200; THIELE DL, 1990, J EXP MED, V172, P183, DOI 10.1084/jem.172.1.183; THIELE DL, 1990, P NATL ACAD SCI USA, V87, P83, DOI 10.1073/pnas.87.1.83; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Turk BE, 2007, BIOCHEM J, V402, P405, DOI 10.1042/BJ20061891; Vanden Berghe T, 2010, CELL DEATH DIFFER, V17, P922, DOI 10.1038/cdd.2009.184; Wang F, 2011, MOL BIOCHEM PARASIT, V175, P10, DOI 10.1016/j.molbiopara.2010.08.004	44	23	25	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e95032	10.1371/journal.pone.0095032	http://dx.doi.org/10.1371/journal.pone.0095032			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893007	Green Published, gold, Green Submitted			2022-12-27	WOS:000336911400003
J	Gonzalez-Vallinas, M; Molina, S; Vicente, G; Zarza, V; Martin-Hernandez, R; Garcia-Risco, MR; Fornari, T; Reglero, G; de Molina, AR				Gonzalez-Vallinas, Margarita; Molina, Susana; Vicente, Gonzalo; Zarza, Virginia; Martin-Hernandez, Roberto; Garcia-Risco, Monica R.; Fornari, Tiziana; Reglero, Guillermo; Ramirez de Molina, Ana			Expression of MicroRNA-15b and the Glycosyltransferase GCNT3 Correlates with Antitumor Efficacy of Rosemary Diterpenes in Colon and Pancreatic Cancer	PLOS ONE			English	Article							ROSMARINUS-OFFICINALIS; CARNOSIC ACID; ANTIOXIDANT; EXTRACTS; INHIBITION; ANTICANCER; GROWTH	Colorectal and pancreatic cancers remain important contributors to cancer mortality burden and, therefore, new therapeutic approaches are urgently needed. Rosemary (Rosmarinus officinalis L.) extracts and its components have been reported as natural potent antiproliferative agents against cancer cells. However, to potentially apply rosemary as a complementary approach for cancer therapy, additional information regarding the most effective composition, its antitumor effect in vivo and its main molecular mediators is still needed. In this work, five carnosic acid-rich supercritical rosemary extracts with different chemical compositions have been assayed for their antitumor activity both in vivo (in nude mice) and in vitro against colon and pancreatic cancer cells. We found that the antitumor effect of carnosic acid together with carnosol was higher than the sum of their effects separately, which supports the use of the rosemary extract as a whole. In addition, gene and microRNA expression analyses have been performed to ascertain its antitumor mechanism, revealing that up-regulation of the metabolic-related gene GCNT3 and down-regulation of its potential epigenetic modulator miR-15b correlate with the antitumor effect of rosemary. Moreover, plasmatic miR-15b down-regulation was detected after in vivo treatment with rosemary. Our results support the use of carnosic acid-rich rosemary extract as a complementary approach in colon and pancreatic cancer and indicate that GCNT3 expression may be involved in its antitumor mechanism and that miR-15b might be used as a non-invasive biomarker to monitor rosemary anticancer effect.	[Gonzalez-Vallinas, Margarita; Molina, Susana; Zarza, Virginia; Martin-Hernandez, Roberto; Reglero, Guillermo; Ramirez de Molina, Ana] Madrid Inst Adv Studies Food IMDEA Food, Unit Mol Oncol & Nutr Genom Canc, Madrid, Spain; [Vicente, Gonzalo; Garcia-Risco, Monica R.; Fornari, Tiziana; Reglero, Guillermo] Inst Food Sci Res CIAL, Dept Prod & Characterizat Novel Foods, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UAM - Instituto de Investigacion en Ciencias de la Alimentacion (CIAL)	de Molina, AR (corresponding author), Madrid Inst Adv Studies Food IMDEA Food, Unit Mol Oncol & Nutr Genom Canc, Campus Int Excellence UAM CSIC, Madrid, Spain.	ana.ramirez@imdea.org	de Molina, Ana Ramirez/AAA-3848-2019; Molina, Susana/M-8969-2014; Rodríguez, Mónica/AAA-7138-2019; González-Vallinas, Margarita/K-3506-2016; MARTIN-HERNANDEZ, ROBERTO/M-8161-2014; Reglero, Guillermo/K-6658-2014	Molina, Susana/0000-0001-7737-5562; González-Vallinas, Margarita/0000-0003-4968-6675; MARTIN-HERNANDEZ, ROBERTO/0000-0002-2723-6289; Reglero, Guillermo/0000-0002-7730-3486; Rodriguez Garcia-Risco, Monica/0000-0002-1384-6342; Djaoud, Kahina/0000-0002-6736-367X	Spanish Ministry of Science and Innovation (Plan Nacional I+D+i) [AGL2010-21565, RyC 2008-03734, IPT-2011-1248-060000]; Comunidad de Madrid (ALIBIRD) [S2009/AGR-1469]; European Union	Spanish Ministry of Science and Innovation (Plan Nacional I+D+i)(Spanish Government); Comunidad de Madrid (ALIBIRD)(Comunidad de Madrid); European Union(European Commission)	This work was supported by the Spanish Ministry of Science and Innovation (Plan Nacional I+D+i AGL2010-21565, RyC 2008-03734; IPT-2011-1248-060000); Comunidad de Madrid (ALIBIRD, S2009/AGR-1469); and European Union Structural Funds. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bai NS, 2010, J AGR FOOD CHEM, V58, P5363, DOI 10.1021/jf100332w; Chen CC, 2011, ACTA PHARMACOL SIN, V32, P62, DOI 10.1038/aps.2010.181; Cheung S, 2007, ONCOL REP, V17, P1525; Giraldez MD, 2012, CLIN GASTROENTEROLOG; Gonzalez-Vallinas M, 2013, PHARMACOL RES, V72, P61, DOI 10.1016/j.phrs.2013.03.010; Hernando E, 2009, ONCOGENE, V28, P2425, DOI 10.1038/onc.2009.91; Huang MC, 2006, ONCOGENE, V25, P3267, DOI 10.1038/sj.onc.1209350; HUANG MT, 1994, CANCER RES, V54, P701; Ibanez C, 2012, J CHROMATOGR A, V1248, P139, DOI 10.1016/j.chroma.2012.06.008; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jordan MJ, 2012, J AGR FOOD CHEM, V60, P9603, DOI 10.1021/jf302881t; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Mothana RAA, 2011, PHARM BIOL, V49, P200, DOI 10.3109/13880209.2010.512295; Palanca V, 2006, NUTR HOSP, V21, P199; Peng CH, 2007, BIOSCI BIOTECH BIOCH, V71, P2223, DOI 10.1271/bbb.70199; Posadas SJ, 2009, EXP GERONTOL, V44, P383, DOI 10.1016/j.exger.2009.02.015; Sharabani H, 2006, INT J CANCER, V118, P3012, DOI 10.1002/ijc.21736; Singletary K, 1996, CANCER LETT, V104, P43, DOI 10.1016/0304-3835(96)04227-9; Singletary KW, 1997, PLANT FOOD HUM NUTR, V50, P47, DOI 10.1007/BF02436042; Slamenova D, 2002, CANCER LETT, V177, P145, DOI 10.1016/S0304-3835(01)00784-4; Tai J, 2012, PHYTOMEDICINE, V19, P436, DOI 10.1016/j.phymed.2011.12.012; Tu Z, 2013, J AGR FOOD CHEM; Valdes A, 2013, GENES NUTR, V8, P43, DOI 10.1007/s12263-012-0311-9; Vicente G, 2013, J SUPERCRIT FLUID, V79, P101, DOI 10.1016/j.supflu.2012.07.006; Wang W, 2012, MOLECULES, V17, P2704, DOI 10.3390/molecules17032704; Yeo TP, 2012, CANCER J, V18, P477, DOI 10.1097/PPO.0b013e3182756803; Yesil-Celiktas O, 2010, PLANT FOOD HUM NUTR, V65, P158, DOI 10.1007/s11130-010-0166-4; Yi WG, 2011, J SCI FOOD AGR, V91, P1849, DOI 10.1002/jsfa.4394	29	58	62	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98556	10.1371/journal.pone.0098556	http://dx.doi.org/10.1371/journal.pone.0098556			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892299	Green Published, Green Submitted, gold			2022-12-27	WOS:000336911400065
J	Kerac, M; Bunn, J; Chagaluka, G; Bahwere, P; Tomkins, A; Collins, S; Seal, A				Kerac, Marko; Bunn, James; Chagaluka, George; Bahwere, Paluku; Tomkins, Andrew; Collins, Steve; Seal, Andrew			Follow-Up of Post-Discharge Growth and Mortality after Treatment for Severe Acute Malnutrition (FuSAM Study): A Prospective Cohort Study	PLOS ONE			English	Article							NUTRITION REHABILITATION; MALNOURISHED CHILDREN; HIV PREVALENCE; EFFICACY; MALAWI; MANAGEMENT; SURVIVAL; OUTCOMES; TIME	Background: Management of Severe Acute Malnutrition (SAM) plays a vital role in achieving global child survival targets. Effective treatment programmes are available but little is known about longer term outcomes following programme discharge. Methods: From July 2006 to March 2007, 1024 children (median age 21.5 months, IQR 15-32) contributed 1187 admission episodes to an inpatient-based SAM treatment centre in Blantyre, Malawi. Long term outcomes, were determined in a longitudinal cohort study, a year or more after initial programme discharge. We found information on 88%(899/1024). Results: In total, 42%(427/1024) children died during or after treatment. 25%(105/427) of deaths occurred after normal programme discharge, >90 days after admission. Mortality was greatest among HIV seropositive children: 62%(274/445). Other risk factors included age,12 months; severity of malnutrition at admission; and disability. In survivors, weight-for-height and weight-for-age improved but height-for-age remained low, mean -22.97 z-scores (SD 1.3). Conclusions: Although SAM mortality in this setting was unacceptably high, our findings offer important lessons for future programming, policy and research. First is the need for improved programme evaluation: most routine reporting systems would have missed late deaths and underestimated total mortality due to SAM. Second, a more holistic view of SAM is needed: while treatment will always focus on nutritional interventions, it is vital to also identify and manage underlying clinical conditions such as HIV and disability. Finally early identification and treatment of SAM should be emphasised: our results suggest that this could improve longer term as well as short term outcomes. As international policy and programming becomes increasingly focused on stunting and post-malnutrition chronic disease outcomes, SAM should not be forgotten. Proactive prevention and treatment services are essential, not only to reduce mortality in the short term but also because they have potential to impact on longer term morbidity, growth and development of survivors.	[Kerac, Marko; Bahwere, Paluku; Collins, Steve] Valid Int, Oxford, England; [Kerac, Marko; Bunn, James; Chagaluka, George] Coll Med, Dept Paediat & Child Hlth, Blantyre, Malawi; [Kerac, Marko; Tomkins, Andrew; Seal, Andrew] UCL, Inst Global Hlth, London, England; [Kerac, Marko] UCL, Leonard Cheshire Disabil & Inclus Dev Ctr, London, England; [Bunn, James] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Bahwere, Paluku] Univ Libre Brussels, Ctr Res Epidemiol Biostat & Clin Res, Brussels, Belgium	University of Malawi; University of London; University College London; University of London; University College London; Liverpool School of Tropical Medicine; University of Liverpool; Universite Libre de Bruxelles	Kerac, M (corresponding author), Valid Int, Oxford, England.	marko.kerac@gmail.com	Kerac, Marko/GQR-1136-2022; Kerac, Marko/G-1777-2010; Seal, Andrew/C-8550-2014	Kerac, Marko/0000-0002-3745-7317; Seal, Andrew/0000-0003-3656-4054	UNICEF Malawi; NIHR; National Institute for Health Research [CL-2012-18-005, ACF-2008-18-010] Funding Source: researchfish	UNICEF Malawi; NIHR(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	UNICEF Malawi funded this study. Valid International provided support in the form of salaries for authors MK (from end 2005 to Jan 2008 only - the 'baseline' period of this study) PB, and SC but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. MK gratefully acknowledges NIHR for funding his current UCL Academic Clinical Lecturer post.	[Anonymous], 2009, WHO CHILD GROWTH STA; Bahwere P., 2012, Journal of Public Health and Epidemiology, V4, P215; Bahwere P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-106; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Collins S, 2003, LANCET, V362, P249, DOI 10.1016/S0140-6736(03)13926-8; Collins S, 2001, LANCET, V358, P498, DOI 10.1016/S0140-6736(01)05630-6; Collins S, 2007, ARCH DIS CHILD, V92, P453, DOI 10.1136/adc.2006.098327; Collins S, 2006, FOOD NUTR BULL, V27, pS49, DOI 10.1177/15648265060273S304; de Onis M, 2009, ARCH PEDIATRIE, V16, P47, DOI 10.1016/j.arcped.2008.10.010; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27; Dulloo AG, 2008, BEST PRACT RES CL EN, V22, P155, DOI 10.1016/j.beem.2007.08.001; Fergusson P, 2009, INT HEALTH, V1, P10, DOI 10.1016/j.inhe.2009.03.001; Fergusson P, 2009, T ROY SOC TROP MED H, V103, P541, DOI 10.1016/j.trstmh.2008.10.029; Gillespie SHL, 2003, IFPRI REPORT; *GOV MAL, 2007, INT GUID MAN AC MALN; Grobler-Tanner C, 2004, 8 FANTA; Groce NE, 2013, LANCET GLOB HEALTH, V1, pE180, DOI 10.1016/S2214-109X(13)70056-1; HENNART P, 1987, J TROP PEDIATRICS, V33, P10, DOI 10.1093/tropej/33.1.10; Kerac M, 2011, THESIS UCL; Kerac M, 2009, LANCET, V374, P136, DOI 10.1016/S0140-6736(09)60884-9; PECOUL B, 1992, ANN TROP PAEDIATR, V12, P47, DOI 10.1080/02724936.1992.11747546; PERRA A, 1995, EUR J CLIN NUTR, V49, P353; Pocock SJ, 2002, LANCET, V359, P1686, DOI 10.1016/S0140-6736(02)08594-X; Sadler K, 2008, J TROP PEDIATRICS, V54, P364, DOI 10.1093/tropej/fmn029; SPHERE, 2011, SPHER PROJ HUM CHART; Stettler N, 2010, CURR OPIN CLIN NUTR, V13, P294, DOI 10.1097/MCO.0b013e328337d7b9; Thurstans S, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-22; UNICEF, 2013, UNICEF GLOB PARTN CH; VANROOSMALENWIEBENGA MW, 1987, J TROP PEDIATRICS, V33, P24, DOI 10.1093/tropej/33.1.24; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; *WHO WFP UNSCN UNI, 2007, COMM BAS MAN SEV AC; World Health Organization, 2006, WHO CAS DEF HIV SURV	32	108	109	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e96030	10.1371/journal.pone.0096030	http://dx.doi.org/10.1371/journal.pone.0096030			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892281	Green Published, gold, Green Accepted			2022-12-27	WOS:000336911400005
J	LaPensee, CR; Lin, G; Dent, AL; Schwartz, J				LaPensee, Christopher R.; Lin, Grace; Dent, Alexander L.; Schwartz, Jessica			Deficiency of the Transcriptional Repressor B Cell Lymphoma 6 (Bcl6) Is Accompanied by Dysregulated Lipid Metabolism	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; GERMINAL CENTER FORMATION; ACID SYNTHASE PROMOTER; GROWTH-HORMONE; GENE-EXPRESSION; PPAR-ALPHA; REGULATED TRANSCRIPTION; ADIPOCYTE DIFFERENTIATION; INSULIN-RESISTANCE; HEPATIC STEATOSIS	The transcriptional repressor B-cell Lymphoma 6 (Bcl6) was recently identified in a profile of genes regulated in adipocytes, suggesting a relationship between Bcl6 and metabolic regulation. As a representative target gene repressed by Bcl6, Suppressor of Cytokine Signaling (Socs) 2 expression was elevated in Bcl6 deficient (KO) mice, including metabolic tissues liver, adipose tissue and muscle, as well as in spleen and thymus. Bcl6 occupied the Socs2 promoter in wild-type, but not Bcl6 KO mice, suggesting direct regulation of Socs2 by Bcl6 in vivo. Mice deficient in Bcl6 were found to exhibit multiple features of dysregulated lipid metabolism. Adipose tissue mass was dramatically reduced or absent in Bcl6 KO mice. Further, hepatic and serum triglycerides were low. Bcl6 deficiency was accompanied by decreased hepatic expression of Stearoyl-CoA desaturase 1 (Scd1) and Fatty acid synthase (Fasn) genes which encode lipogenic enzymes. Expression of the gene for the transcription factor Carbohydrate-Responsive Element Binding Protein (Chrebp), which regulates expression of lipogenic genes, was also reduced in liver of Bcl6 KO mice. Bcl6 deficiency disrupted fasting-induced increases in hepatic triglyceride deposition, but not decreases in lipogenic gene expression. Taken together, these findings suggest that in addition to its well-recognized roles in immune regulation, Bcl6 plays a role in regulatory events of lipid metabolism, and that in the absence of Bcl6, lipid metabolism in liver and adipose tissue is dysregulated.	[LaPensee, Christopher R.; Schwartz, Jessica] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Lin, Grace; Schwartz, Jessica] Univ Michigan, Grad Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA; [Dent, Alexander L.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Indiana University System; Indiana University Bloomington	Schwartz, J (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	jeschwar@umich.edu			American Diabetes Association [7-09-BS-168]; NIH [R01DK46072, T32 GM07315]; NIAID [R21AI079349, R21AI090150, R21AI092212]; Center for Organogenesis at the University of Michigan [NIH T32 HD007505]; Univ Michigan Cancer Center; Rackham Predoctoral Fellowship, Univ Michigan; MIP [R25 DK088752]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R25DK088752, R01DK046072, P60DK020572, P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322, T32GM007315] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center for Organogenesis at the University of Michigan; Univ Michigan Cancer Center; Rackham Predoctoral Fellowship, Univ Michigan; MIP; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant 7-09-BS-168 from the American Diabetes Association and Grant R01DK46072 from NIH (to JS) and NIAID grants R21AI079349, R21AI090150 and R21AI092212 to ALD. CRL was supported by a postdoctoral fellowship from the Center for Organogenesis (NIH T32 HD007505) at the University of Michigan. GL was supported by NIH T32 GM07315, Director's and Loeb Fellowships from Univ Michigan Cancer Center and by a Rackham Predoctoral Fellowship, Univ Michigan. Aaron Taylor, recipient of a MIP summer fellowship (R25 DK088752) assisted with MSC preparation. Serum analysis was performed by the Chemistry Core of the Michigan Diabetes Research Center (NIH5P30 DK20572) at the University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad KF, 2003, MOL CELL, V12, P1551, DOI 10.1016/S1097-2765(03)00454-4; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Basso K, 2012, IMMUNOL REV, V247, P172, DOI 10.1111/j.1600-065X.2012.01112.x; Basso K, 2010, ADV IMMUNOL, V105, P193, DOI 10.1016/S0065-2776(10)05007-8; Berryman DE, 2004, GROWTH HORM IGF RES, V14, P309, DOI 10.1016/j.ghir.2004.02.005; Bhatt AP, 2012, P NATL ACAD SCI USA, V109, P11818, DOI 10.1073/pnas.1205995109; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Chen YL, 2009, ENDOCRINOLOGY, V150, P3645, DOI 10.1210/en.2009-0212; Chia DJ, 2010, MOL ENDOCRINOL, V24, P2038, DOI 10.1210/me.2010-0234; Ci WM, 2009, BLOOD, V113, P5536, DOI 10.1182/blood-2008-12-193037; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Cui TX, 2005, MOL ENDOCRINOL, V19, P2175, DOI 10.1210/me.2004-0502; DAVIDSON MB, 1987, ENDOCR REV, V8, P115, DOI 10.1210/edrv-8-2-115; DAVIS CG, 1987, NATURE, V326, P760, DOI 10.1038/326760a0; Dent AL, 1998, P NATL ACAD SCI USA, V95, P13823, DOI 10.1073/pnas.95.23.13823; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Flores-Morales A, 2006, MOL ENDOCRINOL, V20, P241, DOI 10.1210/me.2005-0170; Frederiksen KS, 2004, J LIPID RES, V45, P592, DOI 10.1194/jlr.M300239-JLR200; Fukuda T, 1997, J EXP MED, V186, P439, DOI 10.1084/jem.186.3.439; Glauser DA, 2009, J RECEPT SIGNAL TRAN; Goodman HM, 1974, HDB PHYSL, P211; Greenhalgh CJ, 2005, J CLIN INVEST, V115, P397, DOI 10.1172/JCI200522710; Hatzi K, 2013, CELL REP, V4, P578, DOI 10.1016/j.celrep.2013.06.016; Hollister K, 2013, J IMMUNOL, V191, P3705, DOI 10.4049/jimmunol.1300378; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Huang JF, 2013, BBA-MOL CELL BIOL L, V1831, P1555, DOI 10.1016/j.bbalip.2013.04.012; Huynh KD, 2000, GENE DEV, V14, P1810; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Ishii S, 2004, P NATL ACAD SCI USA, V101, P15597, DOI 10.1073/pnas.0405238101; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Kojima S, 2001, DEVELOPMENT, V128, P57; Krebs CJ, 2009, PHYSIOL GENOMICS, V38, P16, DOI 10.1152/physiolgenomics.90391.2008; LaPensee CR, 2006, ENDOCRINOLOGY, V147, P4638, DOI 10.1210/en.2006-0487; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Liao J, 1999, J BIOL CHEM, V274, P31597, DOI 10.1074/jbc.274.44.31597; Magana MM, 1996, J BIOL CHEM, V271, P32689, DOI 10.1074/jbc.271.51.32689; Mendez LM, 2008, MOL CELL BIOL, V28, P2175, DOI 10.1128/MCB.01400-07; Metcalf D, 2000, NATURE, V405, P1069, DOI 10.1038/35016611; Meyer RD, 2009, MOL ENDOCRINOL, V23, P1914, DOI 10.1210/me.2009-0242; Miyazaki M, 2004, J BIOL CHEM, V279, P35017, DOI 10.1074/jbc.M405327200; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Mori H, 2012, J CLIN INVEST, V122, P2405, DOI 10.1172/JCI63604; Muoio DM, 2002, J BIOL CHEM, V277, P26089, DOI 10.1074/jbc.M203997200; Nelson EA, 2013, MOL CELL BIOL; New EP, 2003, J BIOL CHEM, V278, P51664; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Oliphant CJ, 2011, IMMUNOLOGY, V134, P378, DOI 10.1111/j.1365-2567.2011.03499.x; Roder K, 2007, FEBS LETT, V581, P2715, DOI 10.1016/j.febslet.2007.05.022; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Schebesta M, 2002, CURR OPIN IMMUNOL, V14, P216, DOI 10.1016/S0952-7915(02)00324-2; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Staudt L M, 1999, Int Rev Immunol, V18, P381, DOI 10.3109/08830189909088490; Tabor DE, 1999, J BIOL CHEM, V274, P20603, DOI 10.1074/jbc.274.29.20603; Toney LM, 2000, NAT IMMUNOL, V1, P214, DOI 10.1038/79749; Tyagi S, 2011, J ADV PHARM TECHNOL, V2, P236, DOI 10.4103/2231-4040.90879; Vidal OM, 2007, MOL ENDOCRINOL, V21, P293, DOI 10.1210/me.2006-0096; Walker SR, 2007, ONCOGENE, V26, P224, DOI 10.1038/sj.onc.1209775; Wang X, 2002, P NATL ACAD SCI USA, V99, P15018, DOI 10.1073/pnas.232581199; Wei F, 2009, MOL CELL BIOL, V29, P4612, DOI 10.1128/MCB.00234-09; White UA, 2009, MOL CELL ENDOCRINOL; Yang HL, 2013, MOL BIOL REP, V40, P2319, DOI 10.1007/s11033-012-2313-5; Zadjali F, 2012, FASEB J, V26, P3282, DOI 10.1096/fj.12-205583; Zhang YJ, 2012, MOL CELL BIOL, V32, P880, DOI 10.1128/MCB.06312-11	72	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e97090	10.1371/journal.pone.0097090	http://dx.doi.org/10.1371/journal.pone.0097090			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892698	Green Published, Green Submitted, gold			2022-12-27	WOS:000336911400009
J	Libertus, ME; Marschik, PB; Einspieler, C				Libertus, Melissa E.; Marschik, Peter B.; Einspieler, Christa			Number Word Use in Toddlerhood Is Associated with Number Recall Performance at Seven Years of Age	PLOS ONE			English	Article							SHORT-TERM-MEMORY; VOCABULARY DEVELOPMENT; PHONOLOGICAL MEMORY; WORKING-MEMORY; LANGUAGE; ACQUISITION; CHILDREN	Previous studies have shown that verbal working memory and vocabulary acquisition are linked in early childhood. However, it is unclear whether acquisition of a narrow range of words during toddlerhood may be particularly related to recall of the same words later in life. Here we asked whether vocabulary acquisition of number words, location and quantifier terms over the first three years of life are associated with verbal and visuospatial working memory at seven years. Our results demonstrate that children who produced more number words between 20-26 months and started to produce the number words 1-10 earlier showed greater number recall at 7 years of age. This link was specific to numbers and neither extended to quantifier and location terms nor verbal and visuospatial working memory performance with other stimuli. These findings suggest a category-specific link between the mental lexicon of number words and working memory for numbers at an early age.	[Libertus, Melissa E.] Univ Pittsburgh, Dept Psychol, Learning Res & Dev Ctr, Pittsburgh, PA 15260 USA; [Marschik, Peter B.; Einspieler, Christa] Med Univ Graz, Ctr Physiol Med, Inst Physiol Dev Physiol & Dev Neurosci, Graz, Austria	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Medical University of Graz	Libertus, ME (corresponding author), Univ Pittsburgh, Dept Psychol, Learning Res & Dev Ctr, Pittsburgh, PA 15260 USA.	libertus@pitt.edu	Marschik, Peter/F-8195-2011; Einspieler, Christa/HHS-6481-2022; Libertus, Melissa/M-6516-2014	Marschik, Peter/0000-0001-8932-0980; 	Austrian Science Fund-FWF [P16984, P25241]; Franz-Lanyar Foundation [P337]; state of Styria; Austrian Science Fund (FWF) [P 25241] Funding Source: researchfish	Austrian Science Fund-FWF(Austrian Science Fund (FWF)); Franz-Lanyar Foundation; state of Styria; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by the Austrian Science Fund-FWF project numbers P16984 and P25241, the Franz-Lanyar Foundation (P337) and the state of Styria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins PWB, 1998, APPL PSYCHOLINGUIST, V19, P537, DOI 10.1017/S0142716400010353; Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; BADDELEY A, 1988, J MEM LANG, V27, P586, DOI 10.1016/0749-596X(88)90028-9; Bayley N, 1993, BAYLEY SCALES INFANT; Briars D.J., 1988, CHILDRENS COUNTING C, P63; CARROLL JB, 1973, Q J EXP PSYCHOL, V25, P85, DOI 10.1080/14640747308400325; DALE PS, 1989, J CHILD LANG, V16, P239, DOI 10.1017/S0305000900010394; Dunn L.M., 1982, BRIT PICTURE VOCABUL; FENSON L, 1994, MONOGR SOC RES CHILD, V59, pR5; GATHERCOLE SE, 1992, DEV PSYCHOL, V28, P887, DOI 10.1037//0012-1649.28.5.887; Gathercole SE, 1999, APPL COGNITIVE PSYCH, V13, P65, DOI 10.1002/(SICI)1099-0720(199902)13:1<65::AID-ACP548>3.0.CO;2-O; GATHERCOLE SE, 1989, J MEM LANG, V28, P200, DOI 10.1016/0749-596X(89)90044-2; GATHERCOLE SE, 1990, BRIT J PSYCHOL, V81, P439, DOI 10.1111/j.2044-8295.1990.tb02371.x; JARROLD C, 2004, J MEMORY LANGUAGE, V50; MARSCHIK PB, 2004, AUSTRIAN COMMUNICATI, V2; Marschik PB, 2007, EARLY HUM DEV, V83, P107, DOI 10.1016/j.earlhumdev.2006.05.009; Melchers P., 2003, K ABC KAUFMAN ASSESS, V6; MICHAS IC, 1994, BRIT J DEV PSYCHOL, V12, P147, DOI 10.1111/j.2044-835X.1994.tb00625.x; Miles C, 1996, CURR PSYCHOL, V15, P53, DOI 10.1007/BF02686934; PAPAGNO C, 1991, J MEM LANG, V30, P331, DOI 10.1016/0749-596X(91)90040-Q; Pickering SJ, 2001, Q J EXP PSYCHOL-A, V54, P397, DOI 10.1080/02724980042000174; Rescorla L, 2001, J SPEECH LANG HEAR R, V44, P434, DOI 10.1044/1092-4388(2001/035); REZNICK JS, 1989, J CHILD LANG, V16, P91, DOI 10.1017/S0305000900013453; Ring ED, 2000, FIRST LANG, V20, P141, DOI DOI 10.1177/014272370002005902; WYNN K, 1992, COGNITIVE PSYCHOL, V24, P220, DOI 10.1016/0010-0285(92)90008-P	25	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98573	10.1371/journal.pone.0098573	http://dx.doi.org/10.1371/journal.pone.0098573			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5ML	24892835	Green Published, Green Submitted, gold			2022-12-27	WOS:000336911400070
J	Hortal, M; Estevan, M; Meny, M; Iraola, I; Laurani, H				Hortal, Maria; Estevan, Miguel; Meny, Miguel; Iraola, Ines; Laurani, Hilda			Impact of Pneumococcal Conjugate Vaccines on the Incidence of Pneumonia in Hospitalized Children after Five Years of Its Introduction in Uruguay	PLOS ONE			English	Article							VACCINATION; INFECTIONS; PROGRAM; DISEASE; BURDEN	Background: Data on the burden of pneumococcal disease and the most frequent serotypes demonstrated that invasive disease and pneumonia were important manifestations affecting children under 5 years of age. Therefore, pneumococcal diseases prevention became a public health priority. Uruguay was the first Latin American country to incorporate PCV7 into its National Immunization Program. The aim of this study is to compare the incidence rates for hospitalized pneumonia in children from the pre PCV introduction period and the following five years of PCVs application in Uruguay. Methods and Findings: Population-based surveillance of pneumonia hospitalization rates, in children, less than 14 years of age, had been performed prior pneumococcal vaccination, and continued following PCV7 introduction and PCV13 replacement, using the same methodology. Hospitalized children with pneumonia were enrolled from January 1, 2009 through December 31 st, 2012. The study was carried out in an area with a population of 238,002 inhabitants of whom 18, 055 were under five years of age. Patients with acute lower respiratory infections for whom a chest radiograph was performed on admission were eligible. Digitalized radiographs were interpreted by a reference radiologist, using WHO criteria. Pneumonia was confirmed in 2,697 patients, 1,267 with consolidated and 1,430 with non consolidated pneumonia of which incidence decrease, between 2009 and 2012, was 27.3% and 46.4% respectively. 2001-2004 and 2009-2012 comparison showed a significant difference of 20.4% for consolidated pneumonia hospitalizations. A significant incidence decline was recorded among children 6 to 35 months of age. Conclusions: An overall significant reduction in pneumonia hospitalizations was observed following the introduction of PCV7 and furthermore following the change to PCV13.	[Hortal, Maria] Natl Univ, Montevideo, Uruguay; [Estevan, Miguel] Childrens Hosp, Dept Radiol, Minist Hlth, Montevideo, Uruguay; [Meny, Miguel] Montevideo Municipal, Dept Stat, Montevideo, Uruguay; [Iraola, Ines] Social Secur, Dept Pediat, Montevideo, Uruguay; [Laurani, Hilda] CHLAP, Immunizat Dept, Montevideo, Uruguay		Hortal, M (corresponding author), Natl Univ, Montevideo, Uruguay.	marujahortal@gmail.com			Pfizer inc.	Pfizer inc.(Pfizer)	Study supported by an irrestrictive grant of Pfizer inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Pirez MC, 2011, PEDIATR INFECT DIS J, V30, P669, DOI 10.1097/INF.0b013e3182152bf1; CDC, 2000, RECOMMENDATIONS COMM; Dagan R, 2001, PEDIATR INFECT DIS J, V20, P951, DOI 10.1097/00006454-200110000-00008; De Wals P, 2008, PEDIATR INFECT DIS J, V27, P963, DOI 10.1097/INF.0b013e31817cf76f; Fitzwater SP, 2012, PEDIATR INFECT DIS J, V31, P501, DOI 10.1097/INF.0b013e31824de9f6; Griffin MR, 2013, NEW ENGL J MED, V369, P155, DOI 10.1056/NEJMoa1209165; Hortal M, 2007, PEDIATR INFECT DIS J, V26, P1; Hortal M, 2007, INT J INFECT DIS, V11, P273, DOI 10.1016/j.ijid.2006.05.006; Hortal M, 2012, VACCINE, V30, P4934, DOI 10.1016/j.vaccine.2012.05.054; IRAOLA INéS, 2005, Arch. Pediatr. Urug., V76, P196; Madhi SA, 2004, NAT MED, V10, P811, DOI 10.1038/nm1077; Magnus MC, 2012, PEDIATR INFECT DIS J, V31, P951, DOI 10.1097/INF.0b013e31825d2f76; Pan American Health Organization, 2012, SIREVIA 2 REP 2012; Ruocco G, 1999, Rev Panam Salud Publica, V5, P197, DOI 10.1590/S1020-49891999000300021; Valenzuela MT, 2009, REV PANAM SALUD PUBL, V25, P270, DOI 10.1590/S1020-49892009000300011; Verani JR, 2014, PNEUMONIA, V3, P278; World Health Organization, 2001, STAND INT CHEST RAD; 2009, MMWR, V58, P1	18	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98567	10.1371/journal.pone.0098567	http://dx.doi.org/10.1371/journal.pone.0098567			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905093	Green Published, Green Submitted, gold			2022-12-27	WOS:000341869000040
J	Svishcheva, GR; Belonogova, NM; Axenovich, TI				Svishcheva, Gulnara R.; Belonogova, Nadezhda M.; Axenovich, Tatiana I.			FFBSKAT: Fast Family-Based Sequence Kernel Association Test	PLOS ONE			English	Article							GENETIC PATHWAY; RARE VARIANTS; REGRESSION; MODEL	The kernel machine-based regression is an efficient approach to region-based association analysis aimed at Identification of rare genetic variants. However, this method is computationally complex. The running time of kernel-based association analysis becomes especially long for samples with genetic (sub) structure h increasing the need to develop new and effective methods, algorithms, and software packages. We have developed a new R-package called fast family-based sequence kernel association test (FFBSKAT) for analysis of quantitative traits in samples of related individuals. This software implements a score-based variance component test to assess he association of a given set of single nucleotide polymorphisrns with a continuous phenotype. We compared the performance of our software with that of two existing software for family-based sequence kernel association testing, namely, ASKAT and farnSKAT, using the Genetic Analysis Workshop 17 family sample. Results demonstrate that FFBSKAT is several times faster than other available programs In addition, the calculations of the three-compared software were similarly accurate. With respect to the available analysis modes, we combined the advantages of both ASKAT and farnSKAT and added new options to empower FFBSKAT users. The FFBSIKAT package is fast, user-friendly, and provides an easy-to-use method to perform whole-exome kernel machine-based regression association analysis of quantitative traits in samples of related individuals. The FFBSKAT package, along with its manual, is available for free download at http://mga.bionet.nsc.rui/soft/FFBSKAT/.	[Svishcheva, Gulnara R.; Belonogova, Nadezhda M.; Axenovich, Tatiana I.] Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia; [Axenovich, Tatiana I.] Novosibirsk State Univ, Novosibirsk 630090, Russia	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Novosibirsk State University	Axenovich, TI (corresponding author), Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia.	aks@bionet.nsc.ru	Svishcheva, Gulnara/AAD-2881-2022; Axenovich, Tatiana I/AAD-2595-2022; Svishcheva, Gulnara/L-4010-2015	Svishcheva, Gulnara/0000-0001-9478-267X; Axenovich, Tatiana I/0000-0002-4318-4458; 	Russian Foundation for Basic Research [13-04-00272, 14-04-00126]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by grants from the Russian Foundation for Basic Research (13-04-00272, 14-04-00126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy Laura, 2011, BMC Proc, V5 Suppl 9, pS2, DOI 10.1186/1753-6561-5-S9-S2; Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; Belonogova NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065395; Beyene J, 2009, GENET EPIDEMIOL, V33, pS105, DOI 10.1002/gepi.20481; Chen H, 2013, GENET EPIDEMIOL, V37, P196, DOI 10.1002/gepi.21703; Davies RB, 1980, J ROYAL STAT SOC C, V29, P323, DOI DOI 10.2307/2346911; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kuonen D, 1999, BIOMETRIKA, V86, P929, DOI 10.1093/biomet/86.4.929; Kwee LC, 2008, AM J HUM GENET, V82, P386, DOI 10.1016/j.ajhg.2007.10.010; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Leutenegger AL, 2003, AM J HUM GENET, V73, P516, DOI 10.1086/378207; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li Lun, 2011, BMC Proc, V5 Suppl 9, pS117, DOI 10.1186/1753-6561-5-S9-S117; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/nmeth.1681, 10.1038/NMETH.1681]; Liu D, 2007, BIOMETRICS, V63, P1079, DOI 10.1111/j.1541-0420.2007.00799.x; Liu DW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-292; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Oualkacha K, 2013, GENET EPIDEMIOL, V37, P366, DOI 10.1002/gepi.21725; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Rhudy Matthew, 2011, International Journal of Navigation and Observation, DOI 10.1155/2011/416828; Schifano ED, 2012, GENET EPIDEMIOL, V36, P797, DOI 10.1002/gepi.21676; Svishcheva GR, 2012, NAT GENET, V44, P1166, DOI 10.1038/ng.2410; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Yang HC, 2008, GENETICS, V179, P1057, DOI 10.1534/genetics.107.084616; Zhang Qunyuan, 2011, BMC Proc, V5 Suppl 9, pS35, DOI 10.1186/1753-6561-5-S9-S35; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	30	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99407	10.1371/journal.pone.0099407	http://dx.doi.org/10.1371/journal.pone.0099407			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905468	Green Published, Green Submitted, gold			2022-12-27	WOS:000341869000120
J	Castano-Rodriguez, N; Kaakoush, NO; Goh, KL; Fock, KM; Mitchell, HM				Castano-Rodriguez, Natalia; Kaakoush, Nadeem O.; Goh, Khean-Lee; Fock, Kwong Ming; Mitchell, Hazel M.			The NOD-Like Receptor Signalling Pathway in Helicobacter pylori Infection and Related Gastric Cancer: A Case-Control Study and Gene Expression Analyses	PLOS ONE			English	Article							NF-KAPPA-B; COLON INFLAMMATION; PROTEIN; ACTIVATION; SUSCEPTIBILITY; IMMUNITY; CARD8; IL-1-BETA; INDUCTION; CASPASE-1	Background: Currently, it is well established that cancer arises in chronically inflamed tissue. A number of NOD-like receptors (NLRs) form inflammasomes, intracellular multiprotein complexes critical for generating mature pro-inflammatory cytokines (IL-1 beta and IL-18). As chronic inflammation of the gastric mucosa is a consequence of Helicobacter pylori infection, we investigated the role of genetic polymorphisms and expression of genes involved in the NLR signalling pathway in H. pylori infection and related gastric cancer (GC). Materials and Methods: Fifty-one genetic polymorphisms were genotyped in 310 ethnic Chinese (87 non-cardia GC cases and 223 controls with functional dyspepsia). In addition, gene expression of 84 molecules involved in the NLR signalling pathway was assessed in THP-1 cells challenged with two H. pylori strains, GC026 (GC) and 26695 (gastritis). Results: CARD8-rs11672725, NLRP3-rs10754558, NLRP3-rs4612666, NLRP12-rs199475867 and NLRX1-rs10790286 showed significant associations with GC. On multivariate analysis, CARD8-rs11672725 remained a risk factor (OR: 4.80, 95% CI: 1.39-16.58). Further, NLRP12-rs2866112 increased the risk of H. pylori infection (OR: 2.13, 95% CI: 1.22-3.71). Statistical analyses assessing the joint effect of H. pylori infection and the selected polymorphisms revealed strong associations with GC (CARD8, NLRP3, CASP1 and NLRP12 polymorphisms). In gene expression analyses, five genes encoding NLRs were significantly regulated in H. pylori-challenged cells (NLRC4, NLRC5, NLRP9, NLRP12 and NLRX1). Interestingly, persistent up-regulation of NFKB1 with simultaneous down-regulation of NLRP12 and NLRX1 was observed in H. pylori GC026-challenged cells. Further, NF-kappa B target genes encoding pro-inflammatory cytokines, chemokines and molecules involved in carcinogenesis were markedly up-regulated in H. pylori GC026-challenged cells. Conclusions: Novel associations between polymorphisms in the NLR signalling pathway (CARD8, NLRP3, NLRP12, NLRX1, and CASP1) and GC were identified in Chinese individuals. Our genetic polymorphisms and gene expression results highlight the relevance of the NLR signalling pathway in gastric carcinogenesis and its close interaction with NF-kappa B.	[Castano-Rodriguez, Natalia; Kaakoush, Nadeem O.; Mitchell, Hazel M.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Goh, Khean-Lee] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia; [Fock, Kwong Ming] Changi Gen Hosp, Div Gastroenterol, Dept Med, Singapore, Singapore	University of New South Wales Sydney; Universiti Malaya; Changi General Hospital	Mitchell, HM (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	h.mitchell@unsw.edu.au	Kaakoush, Nadeem/ABG-9499-2020; Goh, Khean-Lee/B-6404-2009	Goh, Khean-Lee/0000-0002-9965-1561; Castano-Rodriguez, Natalia/0000-0001-8819-8872; Kaakoush, Nadeem Omar/0000-0003-4017-1077	Cancer Council of New South Wales, Australia [66/04]; National Health and Medical Research Council, Australia	Cancer Council of New South Wales, Australia(Cancer Council New South Wales); National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by The Cancer Council of New South Wales, Australia (Grant no.66/04). N.O. Kaakoush is supported by an Early Career fellowship from the National Health and Medical Research Council, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; AKOPYANTS NS, 1995, INFECT IMMUN, V63, P116, DOI 10.1128/IAI.63.1.116-121.1995; Allen IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060842; Allen IC, 2012, IMMUNITY, V36, P742, DOI 10.1016/j.immuni.2012.03.012; Allen IC, 2011, IMMUNITY, V34, P854, DOI 10.1016/j.immuni.2011.03.026; Basak C, 2005, J BIOL CHEM, V280, P4279, DOI 10.1074/jbc.M412820200; Bouchier-Hayes L, 2001, J BIOL CHEM, V276, P44069, DOI 10.1074/jbc.M107373200; Coffelt SB, 2010, AM J PATHOL, V176, P1564, DOI 10.2353/ajpath.2010.090786; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Day TG, 2008, ARTHRITIS RHEUM-US, V58, P2142, DOI 10.1002/art.23604; De Palma M, 2007, TRENDS IMMUNOL, V28, P519, DOI 10.1016/j.it.2007.09.004; DeNardo D, 2010, CANCER METAST REV, V29, P309, DOI 10.1007/s10555-010-9223-6; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Faure E, 2014, AM J RESP CRIT CARE; Fehlings M, 2012, INFECT IMMUN, V80, P2724, DOI 10.1128/IAI.00381-12; Ferlay J SI, 2013, IARC CANCERBASE; Gonzalez CA, 2002, INT J CANCER, V100, P249, DOI 10.1002/ijc.10466; Gunaletchumy SP, 2012, J BACTERIOL, V194, P5695, DOI 10.1128/JB.01278-12; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hitzler I, 2012, J IMMUNOL, V188, P3594, DOI 10.4049/jimmunol.1103212; Johansson M, 2008, IMMUNOL REV, V222, P145, DOI 10.1111/j.1600-065X.2008.00600.x; Jurinke Christian, 2002, Adv Biochem Eng Biotechnol, V77, P57; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kim DJ, 2013, EUR J IMMUNOL, V43, P2650, DOI 10.1002/eji.201243281; Lavender NA, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-11; Li ZS, 2011, CANCER LETT, V313, P192, DOI 10.1016/j.canlet.2011.09.007; Lich JD, 2007, J IMMUNOL, V178, P1256, DOI 10.4049/jimmunol.178.3.1256; Macarthur M, 2004, AM J PHYSIOL-GASTR L, V286, pG515, DOI 10.1152/ajpgi.00475.2003; Maeda S, 2002, GUT, V50, P771, DOI 10.1136/gut.50.6.771; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mitchell H, 2008, ALIMENT PHARM THER, V28, P903, DOI 10.1111/j.1365-2036.2008.03792.x; Mockelmann N, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-79; Oeth PB M, 2005, IPLEX ASSAY INCREASE, P12; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pathan N, 2001, J BIOL CHEM, V276, P32220, DOI 10.1074/jbc.M100433200; Roberts RL, 2010, GENES IMMUN, V11, P351, DOI 10.1038/gene.2010.11; Schmausser B, 2004, INFECT IMMUN, V72, P6773, DOI 10.1128/IAI.72.12.6773-6779.2004; Schmidt HMA, 2010, EUR J CLIN MICROBIOL, V29, P439, DOI 10.1007/s10096-010-0881-7; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shimada M, 2008, EUR J GASTROEN HEPAT, V20, P1144, DOI 10.1097/MEG.0b013e32830edb15; Silveira TN, 2010, INFECT IMMUN, V78, P1403, DOI 10.1128/IAI.00905-09; Slatkin M, 1996, HEREDITY, V76, P377, DOI 10.1038/hdy.1996.55; Tadaki H, 2011, J HUM GENET, V56, P343, DOI 10.1038/jhg.2011.16; Talley NJ, 1999, GUT, V45, P37; Tamm I, 2000, CLIN CANCER RES, V6, P1796; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Vladimer GI, 2012, IMMUNITY, V37, P96, DOI 10.1016/j.immuni.2012.07.006; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Wen SC, 2004, J IMMUNOL, V172, P2595, DOI 10.4049/jimmunol.172.4.2595; Williams KL, 2005, J BIOL CHEM, V280, P39914, DOI 10.1074/jbc.M502820200; Wu WKK, 2010, CANCER LETT, V295, P7, DOI 10.1016/j.canlet.2010.03.015; Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022; Yamaoka Y, 1997, GUT, V41, P442, DOI 10.1136/gut.41.4.442; Yang JC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/248585; Yang SK, 2011, J HUM GENET, V56, P217, DOI 10.1038/jhg.2010.170; Yao Y, 2012, CELL RES, V22, P836, DOI 10.1038/cr.2012.56; Zaki MH, 2014, P NATL ACAD SCI USA, V111, P385, DOI 10.1073/pnas.1317643111; Zaki MH, 2011, CANCER CELL, V20, P649, DOI 10.1016/j.ccr.2011.10.022; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003	61	61	63	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98899	10.1371/journal.pone.0098899	http://dx.doi.org/10.1371/journal.pone.0098899			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901306	Green Published, Green Submitted, gold			2022-12-27	WOS:000336841400070
J	Dave, LA; Montoya, CA; Rutherfurd, SM; Moughan, PJ				Dave, Lakshmi A.; Montoya, Carlos A.; Rutherfurd, Shane M.; Moughan, Paul J.			Gastrointestinal Endogenous Proteins as a Source of Bioactive Peptides - An In Silico Study	PLOS ONE			English	Article							ACTIVE PEPTIDES; FOOD PROTEINS; SERUM-ALBUMIN; PIGS; DIGESTIBILITY; PRECURSORS; DATABASE; DIGESTA; MOTIFS; TRACT	Dietary proteins are known to contain bioactive peptides that are released during digestion. Endogenous proteins secreted into the gastrointestinal tract represent a quantitatively greater supply of protein to the gut lumen than those of dietary origin. Many of these endogenous proteins are digested in the gastrointestinal tract but the possibility that these are also a source of bioactive peptides has not been considered. An in silico prediction method was used to test if bioactive peptides could be derived from the gastrointestinal digestion of gut endogenous proteins. Twenty six gut endogenous proteins and seven dietary proteins were evaluated. The peptides present after gastric and intestinal digestion were predicted based on the amino acid sequence of the proteins and the known specificities of the major gastrointestinal proteases. The predicted resultant peptides possessing amino acid sequences identical to those of known bioactive peptides were identified. After gastrointestinal digestion (based on the in silico simulation), the total number of bioactive peptides predicted to be released ranged from 1 (gliadin) to 55 (myosin) for the selected dietary proteins and from 1 (secretin) to 39 (mucin-5AC) for the selected gut endogenous proteins. Within the intact proteins and after simulated gastrointestinal digestion, angiotensin converting enzyme (ACE)-inhibitory peptide sequences were the most frequently observed in both the dietary and endogenous proteins. Among the dietary proteins, after in silico simulated gastrointestinal digestion, myosin was found to have the highest number of ACE-inhibitory peptide sequences (49 peptides), while for the gut endogenous proteins, mucin-5AC had the greatest number of ACE-inhibitory peptide sequences (38 peptides). Gut endogenous proteins may be an important source of bioactive peptides in the gut particularly since gut endogenous proteins represent a quantitatively large and consistent source of protein.	[Dave, Lakshmi A.; Montoya, Carlos A.; Rutherfurd, Shane M.; Moughan, Paul J.] Massey Univ, Riddet Inst, Palmerston North, New Zealand	Massey University	Rutherfurd, SM (corresponding author), Massey Univ, Riddet Inst, Palmerston North, New Zealand.	S.M.Rutherfurd@massey.ac.nz	Rutherfurd, Shane M/D-8254-2011	Montoya, Carlos A./0000-0001-6953-8624; Dave, Lakshmi/0000-0003-0271-4296	Centre of Research Excellence fund from the Tertiary Education Commission; Ministry of Education, New Zealand	Centre of Research Excellence fund from the Tertiary Education Commission; Ministry of Education, New Zealand	The authors acknowledge the financial support provided by the Centre of Research Excellence fund from the Tertiary Education Commission and the Ministry of Education, New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, 14719827 FAO, V14719827, P421; Boutrou R, 2013, AM J CLIN NUTR, V97, P1314, DOI 10.3945/ajcn.112.055202; BRASSINNE A, 1974, GUT, V15, P194, DOI 10.1136/gut.15.3.194; Chair of Food Biochemistry University of Warmia and Mazury in Olsztyn Poland, 2012, BIOPEP; Cheung IWY, 2009, J AGR FOOD CHEM, V57, P9234, DOI 10.1021/jf9018245; Dziuba J, 1999, NAHRUNG, V43, P190, DOI [10.1002/(SICI)1521-3803(19990601)43:3&lt;190::AID-FOOD190&gt;3.0.CO;2-A, 10.1002/(SICI)1521-3803(19990601)43:3<190::AID-FOOD190>3.3.CO;2-1]; Erdmann K, 2008, J NUTR BIOCHEM, V19, P643, DOI 10.1016/j.jnutbio.2007.11.010; ERICKSON RH, 1990, ANNU REV MED, V41, P133; Fuller MF, 1998, ANNU REV NUTR, V18, P385, DOI 10.1146/annurev.nutr.18.1.385; HERCZEG B, 1975, ACTA CHIR HUNG, V16, P13; Iwaniak A, 2011, FOOD TECHNOL BIOTECH, V49, P118; Iwaniak A, 2009, FOOD TECHNOL BIOTECH, V47, P441; Iwaniak A, 2009, ACTA SCI POLON-TECHN, V8, P59; Keil B., 1992, SPECIFICITY PROTEOLY, V331, P201, DOI DOI 10.1007/978-3-642-48380-6; Martinez-Maqueda D, 2012, FOOD FUNCT, V3, P350, DOI 10.1039/c2fo10192k; Meisel H, 1997, LIVEST PROD SCI, V50, P125, DOI 10.1016/S0301-6226(97)00083-3; Meisel H., 1990, Trends in Food Science & Technology, V1, P41, DOI 10.1016/0924-2244(90)90029-X; Miner-Williams W, 2012, AM J CLIN NUTR, V96, P508, DOI 10.3945/ajcn.111.033472; Miner-Williams W, 2009, J AGR FOOD CHEM, V57, P2072, DOI 10.1021/jf8023886; Minkiewicz P, 2011, FOOD SCI TECHNOL INT, V17, P39, DOI 10.1177/1082013210368461; Minkiewicz P, 2008, J AOAC INT, V91, P965; Moller NP, 2008, EUR J NUTR, V47, P171, DOI 10.1007/s00394-008-0710-2; Moughan PJ, 2012, AMINO ACIDS IN HUMAN NUTRITION AND HEALTH, P245, DOI 10.1079/9781845937980.0245; Moughan P. J., 2013, NUTR RES REV, P1; Moughan PJ, 2007, INT J SPORT NUTR EXE, V17, pS5, DOI 10.1123/ijsnem.17.s1.s5; Moughan PJ, 2012, BRIT J NUTR, V108, pS258, DOI 10.1017/S0007114512002474; Urista CM, 2011, FOOD SCI TECHNOL INT, V17, P293, DOI 10.1177/1082013211398801; NAKAMURA Y, 1995, J DAIRY SCI, V78, P777, DOI 10.3168/jds.S0022-0302(95)76689-9; Nutrient Data Laboratory, REL 25 NAT NUTR DAT; Nyachoti CM, 1997, CAN J ANIM SCI, V77, P149, DOI 10.4141/A96-044; Ohsawa K, 2008, J AGR FOOD CHEM, V56, P854, DOI 10.1021/jf072671n; Rutherfurd-Markwick KJ, 2005, J AOAC INT, V88, P955; Ryan JT, 2011, NUTRIENTS, V3, P765, DOI 10.3390/nu3090765; Segura-Campos M, 2011, FOOD REV INT, V27, P213, DOI 10.1080/87559129.2011.563395; Shahidi F, 2008, J AOAC INT, V91, P914; SOUFFRANT WB, 1993, REPROD NUTR DEV, V33, P373, DOI 10.1051/rnd:19930406; Terashima M, 2010, J AGR FOOD CHEM, V58, P7432, DOI 10.1021/jf100977z; The UniProt Consortium, 2012, PEPTIDECUTTER; The UniProt Consortium, 2012, UNIPROTKB; Vercruysse L, 2009, PEPTIDES, V30, P575, DOI 10.1016/j.peptides.2008.06.027; WHO, 2007, WHO TECH REP SER, V935, P1; Wilkins MR, 1999, METH MOL B, V112, P531	42	20	20	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98922	10.1371/journal.pone.0098922	http://dx.doi.org/10.1371/journal.pone.0098922			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901416	Green Published, Green Submitted, gold			2022-12-27	WOS:000336841400071
J	Hao, CL; Huang, S; Deng, ZX; Zhao, CM; Yu, Y				Hao, Chunlin; Huang, Sheng; Deng, Zixin; Zhao, Changming; Yu, Yi			Mining of the Pyrrolamide Antibiotics Analogs in Streptomyces netropsis Reveals the Amidohydrolase-Dependent ``Iterative Strategy'' Underlying the Pyrrole Polymerization	PLOS ONE			English	Article							NATURAL-PRODUCT EXTRACTS; MINOR-GROOVE BINDERS; BIOSYNTHETIC PATHWAYS; ALKYLATING-AGENTS; DISTAMYCIN-A; DEREPLICATION; CONGOCIDINE	In biosynthesis of natural products, potential intermediates or analogs of a particular compound in the crude extracts are commonly overlooked in routine assays due to their low concentration, limited structural information, or because of their insignificant bio-activities. This may lead into an incomplete and even an incorrect biosynthetic pathway for the target molecule. Here we applied multiple compound mining approaches, including genome scanning and precursor ion scan-directed mass spectrometry, to identify potential pyrrolamide compounds in the fermentation culture of Streptomyces netropsis. Several novel congocidine and distamycin analogs were thus detected and characterized. A more reasonable route for the biosynthesis of pyrrolamides was proposed based on the structures of these newly discovered compounds, as well as the functional characterization of several key biosynthetic genes of pyrrolamides. Collectively, our results implied an unusual ``iterative strategy'' underlying the pyrrole polymerization in the biosynthesis of pyrrolamide antibiotics.	[Hao, Chunlin; Huang, Sheng; Deng, Zixin; Zhao, Changming; Yu, Yi] Wuhan Univ, Sch Pharmaceut Sci, Minist Educ, Key Lab Combinatory Biosynth & Drug Discovery, Wuhan 430072, Peoples R China; [Yu, Yi] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China; [Deng, Zixin] Wuhan Inst Biotechnol, Hubei Engn Lab Synthet Microbiol, Wuhan, Peoples R China	Wuhan University; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS	Zhao, CM (corresponding author), Wuhan Univ, Sch Pharmaceut Sci, Minist Educ, Key Lab Combinatory Biosynth & Drug Discovery, Wuhan 430072, Peoples R China.	cmzhao03@whu.edu.cn; yu_yi@whu.edu.cn		Hao, Chunlin/0000-0002-5818-1954	Ministry of Science and Technology of the People's Republic of China ("973" Program) [2013CB734003, 2012CB721006]; Ministry of Science and Technology of the People's Republic of China ("863" Program) [2012AA02A701]; National Natural Science Foundation of China [81102357, 81273411, 31200037]; Open Fund of the State Key Laboratory of Bio-Organic and Natural Products Chemistry	Ministry of Science and Technology of the People's Republic of China ("973" Program)(National Basic Research Program of China); Ministry of Science and Technology of the People's Republic of China ("863" Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Fund of the State Key Laboratory of Bio-Organic and Natural Products Chemistry	This work was financially supported in part by grants from Ministry of Science and Technology of the People's Republic of China ("973" Program 2013CB734003 and 2012CB721006, "863" Program 2012AA02A701), National Natural Science Foundation of China (81102357, 81273411 and 31200037), and the Open Fund of the State Key Laboratory of Bio-Organic and Natural Products Chemistry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai A, 2000, J ANTIBIOT, V53, P66, DOI 10.7164/antibiotics.53.66; Baker DD, 2007, NAT PROD REP, V24, P1225, DOI 10.1039/b602241n; Baraldi PG, 2004, CURR TOP MED CHEM, V4, P231, DOI 10.2174/1568026043451474; Barrett MP, 2013, PHARMACOL THERAPEUT, V139, P12, DOI 10.1016/j.pharmthera.2013.03.002; Bode HB, 2002, CHEMBIOCHEM, V3, P619, DOI 10.1002/1439-7633(20020703)3:7<619::AID-CBIC619>3.0.CO;2-9; Bumpus SB, 2009, NAT BIOTECHNOL, V27, P951, DOI 10.1038/nbt.1565; Cane DE, 2012, ACCOUNTS CHEM RES, V45, P463, DOI 10.1021/ar200198d; Challis GL, 2008, MICROBIOL-SGM, V154, P1555, DOI 10.1099/mic.0.2008/018523-0; Cordell GA, 1999, PURE APPL CHEM, V71, P1089, DOI 10.1351/pac199971061089; Corre C, 2009, NAT PROD REP, V26, P977, DOI 10.1039/b713024b; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; Nguyen DD, 2013, P NATL ACAD SCI USA, V110, pE2611, DOI 10.1073/pnas.1303471110; Fuchs JE, 2011, J CHEM INF MODEL, V51, P2223, DOI 10.1021/ci200237c; Hertweck C, 2009, NAT CHEM BIOL, V5, P450, DOI 10.1038/nchembio0709-450; Hur GH, 2012, NAT PROD REP, V29, P1074, DOI 10.1039/c2np20025b; Iyer P, 2013, CHEM RES TOXICOL, V26, P156, DOI 10.1021/tx300437x; Juguet M, 2009, CHEM BIOL, V16, P421, DOI 10.1016/j.chembiol.2009.03.010; Kersten RD, 2011, NAT CHEM BIOL, V7, P794, DOI 10.1038/nchembio.684; Lang G, 2008, J NAT PROD, V71, P1595, DOI 10.1021/np8002222; Lautru S, 2012, ANGEW CHEM INT EDIT, V51, P7454, DOI 10.1002/anie.201201445; Matteoli B, 2008, INTERVIROLOGY, V51, P166, DOI 10.1159/000148199; Menzella HG, 2007, CURR OPIN MICROBIOL, V10, P238, DOI 10.1016/j.mib.2007.05.005; Neidle S, 2001, NAT PROD REP, V18, P291, DOI 10.1039/a705982e; Nett M, 2009, NAT PROD REP, V26, P1362, DOI 10.1039/b817069j; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Qu XD, 2011, ANGEW CHEM INT EDIT, V50, P9651, DOI 10.1002/anie.201103085; Rose TM, 2003, NUCLEIC ACIDS RES, V31, P3763, DOI 10.1093/nar/gkg524; Shanna Sudha, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P183; Uria-Nickelsen M, 2013, INT J ANTIMICROB AG, V41, P28, DOI 10.1016/j.ijantimicag.2012.08.017; Wilkinson B, 2007, NAT CHEM BIOL, V3, P379, DOI 10.1038/nchembio.2007.7; Yamanaka K, 2008, NAT CHEM BIOL, V4, P766, DOI 10.1038/nchembio.125; Yamanaka K, 2010, APPL ENVIRON MICROB, V76, P5669, DOI 10.1128/AEM.00853-10; Yu Y, 2009, ACS CHEM BIOL, V4, P855, DOI 10.1021/cb900133x	33	11	12	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99077	10.1371/journal.pone.0099077	http://dx.doi.org/10.1371/journal.pone.0099077			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901640	Green Submitted, Green Published, gold			2022-12-27	WOS:000336841400093
J	Doedee, AMCM; Boland, GJ; Pennings, JLA; de Klerk, A; Berbers, GAM; van der Klis, FRM; de Melker, HE; van Loveren, H; Janssen, R				Doedee, Anne M. C. M.; Boland, Greet J.; Pennings, Jeroen L. A.; de Klerk, Arja; Berbers, Guy A. M.; van der Klis, Fiona R. M.; de Melker, Hester E.; van Loveren, Henk; Janssen, Riny			Effects of Prophylactic and Therapeutic Paracetamol Treatment during Vaccination on Hepatitis B Antibody Levels in Adults: Two Open-Label, Randomized Controlled Trials	PLOS ONE			English	Article							PRENATAL EXPOSURE; POLYCHLORINATED-BIPHENYLS; EARLY-CHILDHOOD; ACETAMINOPHEN; ASTHMA; IBUPROFEN; RESPONSES; CHILDREN; PREVENTION; VACCINES	Worldwide, paracetamol is administered as a remedy for complaints that occur after vaccination. Recently published results indicate that paracetamol inhibits the vaccination response in infants when given prior to vaccination. The goal of this study was to establish whether paracetamol exerts similar effects in young adults. In addition, the effect of timing of paracetamol intake was investigated. In two randomized, controlled, open-label studies 496 healthy young adults were randomly assigned to three groups. The study groups received paracetamol for 24 hours starting at the time of (prophylactic use) - or 6 hours after (therapeutic use) the primary (0 month) and first booster (1 month) hepatitis B vaccination. The control group received no paracetamol. None of the participants used paracetamol around the second booster (6 months) vaccination. Anti-HBs levels were measured prior to and one month after the second booster vaccination on ADVIA Centaur XP. One month after the second booster vaccination, the anti-HBs level in the prophylactic paracetamol group was significantly lower (p = 0.048) than the level in the control group (4257 mIU/mL vs. 5768 mIU/mL). The anti-HBs level in the therapeutic paracetamol group (4958 mIU/mL) was not different (p = 0.34) from the level in the control group. Only prophylactic paracetamol treatment, and not therapeutic treatment, during vaccination has a negative influence on the antibody concentration after hepatitis B vaccination in adults. These findings prompt to consider therapeutic instead of prophylactic treatment to ensure maximal vaccination efficacy and retain the possibility to treat pain and fever after vaccination.	[Doedee, Anne M. C. M.; Pennings, Jeroen L. A.; de Klerk, Arja; van Loveren, Henk; Janssen, Riny] Natl Inst Publ Hlth & Environm, Ctr Hlth Protect, NL-3720 BA Bilthoven, Netherlands; [Doedee, Anne M. C. M.; van Loveren, Henk] Maastricht Univ, Med Ctr, Dept Toxicogen, Maastricht, Netherlands; [Boland, Greet J.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Berbers, Guy A. M.; van der Klis, Fiona R. M.; de Melker, Hester E.] Natl Inst Publ Hlth & Environm, Ctr Immunol Infect Dis & Vaccines, NL-3720 BA Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment; Maastricht University; Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment	Doedee, AMCM (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Hlth Protect, NL-3720 BA Bilthoven, Netherlands.	Anne.Doedee@rivm.nl		Pennings, Jeroen L.A./0000-0002-9188-6358	National Institute for Public Health and the Environment [S340002/010/AA]	National Institute for Public Health and the Environment	This work was supported by the National Institute for Public Health and the Environment [S340002/010/AA]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baken KA, 2008, TOXICOL APPL PHARM, V226, P46, DOI 10.1016/j.taap.2007.08.026; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Coffman RL, 2010, SCIENCE, V328, P1116, DOI 10.1126/science.1192009; David S, 2008, VACCINE, V26, P5883, DOI 10.1016/j.vaccine.2008.07.105; Dimova S, 2005, INT J BIOCHEM CELL B, V37, P1727, DOI 10.1016/j.biocel.2005.03.005; DORAN TF, 1989, J PEDIATR-US, V114, P1045, DOI 10.1016/S0022-3476(89)80461-5; DROGE W, 1986, IMMUNOBIOLOGY, V172, P151; Farquhar H, 2009, J ALLERGY CLIN IMMUN, V124, P649, DOI 10.1016/j.jaci.2009.07.037; Graham GG, 2005, DRUG SAFETY, V28, P227, DOI 10.2165/00002018-200528030-00004; GRAHAM NMH, 1990, J INFECT DIS, V162, P1277, DOI 10.1093/infdis/162.6.1277; Granum B, 2013, J IMMUNOTOXICOL, V10, P373, DOI 10.3109/1547691X.2012.755580; GROSS PA, 1994, CLIN DIAGN LAB IMMUN, V1, P134, DOI 10.1128/CDLI.1.2.134-138.1994; Jackson LA, 2006, PEDIATRICS, V117, P620, DOI 10.1542/peds.2005-1217; Kimman TG, 2007, COMMUNITY GENET, V10, P201, DOI 10.1159/000106559; Koniman R, 2007, PEDIAT ALLERG IMM-UK, V18, P128, DOI 10.1111/j.1399-3038.2006.00484.x; Manley J, 2007, ANN PHARMACOTHER, V41, P1227, DOI 10.1345/aph.1H647; Perricone C, 2009, AUTOIMMUN REV, V8, P697, DOI 10.1016/j.autrev.2009.02.020; Prymula R, 2009, LANCET, V374, P1339, DOI 10.1016/S0140-6736(09)61208-3; Rebordosa C, 2008, INT J EPIDEMIOL, V37, P583, DOI 10.1093/ije/dyn070; RIVM, 2013, DUTCH IMM HDB; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Shaheen SO, 2000, THORAX, V55, P266, DOI 10.1136/thorax.55.4.266; Stolevik SB, 2013, FOOD CHEM TOXICOL, V51, P165, DOI 10.1016/j.fct.2012.09.027; Toma T, 2000, BRIT MED J, V321, P1178; Ueno K, 2000, RES COMMUN MOL PATH, V108, P237; Van Loveren H, 2001, ENVIRON HEALTH PERSP, V109, P757, DOI 10.2307/3454816; Weisglas-Kuperus N, 2000, ENVIRON HEALTH PERSP, V108, P1203, DOI 10.2307/3434834; World Health Organization website, GLOB AL REP HEP B; Yamaura K, 2002, BIOL PHARM BULL, V25, P201, DOI 10.1248/bpb.25.201	29	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98175	10.1371/journal.pone.0098175	http://dx.doi.org/10.1371/journal.pone.0098175			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897504	Green Published, Green Submitted, gold			2022-12-27	WOS:000338430700028
J	Nayak, S; Doerfler, PA; Porvasnik, SL; Cloutier, DD; Khanna, R; Valenzano, KJ; Herzog, RW; Byrne, BJ				Nayak, Sushrusha; Doerfler, Phillip A.; Porvasnik, Stacy L.; Cloutier, Denise D.; Khanna, Richie; Valenzano, Ken J.; Herzog, Roland W.; Byrne, Barry J.			Immune Responses and Hypercoagulation in ERT for Pompe Disease Are Mutation and rhGAA Dose Dependent	PLOS ONE			English	Article							ACID ALPHA-GLUCOSIDASE; ENZYME REPLACEMENT THERAPY; FACTOR-IX; TOLERANCE INDUCTION; GENE-THERAPY; GLYCOGEN; ANAPHYLAXIS; CHAPERONES; CLEARANCE; EFFICACY	Enzyme replacement therapy (ERT) with recombinant human acid-a-glucosidase (rhGAA) is the only FDA approved therapy for Pompe disease. Without ERT, severely affected individuals (early onset) succumb to the disease within 2 years of life. A spectrum of disease severity and progression exists depending upon the type of mutation in the GAA gene (GAA), which in turn determines the amount of defective protein produced and its enzymatic activity. A large percent of the early onset patients are also cross reactive immunological material negative (CRIM-) and develop high titer immune responses to ERT with rhGAA. New insights from our studies in pre-clinical murine models reveal that the type of Gaa mutation has a profound effect on the immune responses mounted against ERT and the associated toxicities, including activation of clotting factors and disseminated intravascular coagulation (DIC). Additionally, the mouse strain affects outcomes, suggesting the influence of additional genetic components or modifiers. High doses of rhGAA (20 mg/kg) are currently required to achieve therapeutic benefit. Our studies indicate that lower enzyme doses reduce the antibody responses to rhGAA, reduce the incidence of immune toxicity and avoid ERT-associated anaphylaxis. Therefore, development of rhGAA with increased efficacy is warranted to limit immunotoxicities.	[Nayak, Sushrusha; Doerfler, Phillip A.; Porvasnik, Stacy L.; Cloutier, Denise D.; Byrne, Barry J.] Univ Florida, Dept Pediat, Powell Gene Therapy Ctr, Gainesville, FL 32611 USA; [Nayak, Sushrusha] Karolinska Inst, Dept Med, Ctr Infect Med, Stockholm, Sweden; [Khanna, Richie; Valenzano, Ken J.] Amicus Therapeut Inc, Cranbury, NJ USA; [Herzog, Roland W.] Univ Florida, Dept Pediat Cellular & Mol Therapy, Gainesville, FL USA	State University System of Florida; University of Florida; Karolinska Institutet; State University System of Florida; University of Florida	Nayak, S (corresponding author), Univ Florida, Dept Pediat, Powell Gene Therapy Ctr, Gainesville, FL 32611 USA.	sushrusha.nayak@ki.se; bbyrne@ufl.edu		Byrne, Barry J./0000-0002-7302-1756; Doerfler, Phillip/0000-0001-7566-9073; nayak, sushrusha/0000-0003-1243-5792	NIH [P01 HL59412, P01 DK58327, R01 HL107904]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD043730] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059412, R01HL107904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058327] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by NIH grants P01 HL59412 and P01 DK58327 to BJ Byrne and R01 HL107904 to RW Herzog. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banugaria SG, 2012, GENETICS MED OFFICIA; Banugaria S, 2011, MOL GENET METAB, V102, pS6, DOI 10.1016/j.ymgme.2010.11.020; Byrne BJ, 2011, HUM MOL GENET, V20, pR61, DOI 10.1093/hmg/ddr174; Byrne BJ, 2011, MOL GENET METAB, V103, P1, DOI 10.1016/j.ymgme.2011.02.004; Cao O, 2009, MOL THER, V17, P1733, DOI 10.1038/mt.2009.159; Cardone Monica, 2008, Pathogenetics, V1, P6, DOI 10.1186/1755-8417-1-6; Cousens LP, 2012, HUM VACC IMMUNOTHER, V8, P1459, DOI 10.4161/hv.21405; de Vries JM, 2010, MOL GENET METAB, V101, P338, DOI 10.1016/j.ymgme.2010.08.009; Elder ME, 2013, J PEDIATR-US, V163, P847, DOI 10.1016/j.jpeds.2013.03.002; ElMallah MK, 2014, MOL THER, V22, P702, DOI 10.1038/mt.2013.282; Erickson JJ, 2012, J CLIN INVEST, V122, P2967, DOI 10.1172/JCI62860; FELIX SB, 1990, RES EXP MED, V190, P239, DOI 10.1007/BF00000029; Franco LM, 2005, MOL THER, V12, P876, DOI 10.1016/j.ymthe.2005.04.024; Hughes DA, 2013, MOL GENET METAB, V109, P269, DOI 10.1016/j.ymgme.2013.04.015; Khanna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040776; Kishnani PS, 2006, J PEDIATR-US, V148, P671, DOI 10.1016/j.jpeds.2005.11.033; Kishnani PS, 2010, MOL GENET METAB, V99, P26, DOI 10.1016/j.ymgme.2009.08.003; Korpela MP, 2009, MUSCLE NERVE, V40, P143, DOI 10.1002/mus.21291; Lacana E, 2012, AM J MED GENET C, V160C, P30, DOI [10.1002/ajmc.31316, 10.1002/ajmg.c.31316]; Maga JA, 2013, J BIOL CHEM, V288, P1428, DOI 10.1074/jbc.M112.438663; Markusic DM, 2013, EMBO MOL MED, V5, P1698, DOI 10.1002/emmm.201302859; Messinger YH, 2012, GENET MED, V14, P135, DOI 10.1038/gim.2011.4; Nayak S, 2012, MOL GENET METAB, V106, P189, DOI 10.1016/j.ymgme.2012.03.009; Nemeth N, 2009, BIORHEOLOGY, V46, P155, DOI 10.3233/BIR-2009-0533; Ohashi T, 2011, MOL GENET METAB, V103, P98, DOI 10.1016/j.ymgme.2011.01.009; Okumiya T, 2007, MOL GENET METAB, V90, P49, DOI 10.1016/j.ymgme.2006.09.010; Olivera A, 2010, J CLIN INVEST, V120, P1429, DOI 10.1172/JCI40659; Poorthuis BJHM, 1999, HUM GENET, V105, P151, DOI 10.1007/s004390051078; Raben N, 2000, NEUROMUSCULAR DISORD, V10, P283, DOI 10.1016/S0960-8966(99)00117-0; Regnery C, 2012, J INHERITED METABOLI; Stokes KL, 2011, J VIROL, V85, P5782, DOI 10.1128/JVI.01693-10; Sun BD, 2010, MOL THER, V18, P353, DOI 10.1038/mt.2009.195; Valenzano KJ, 2011, ASSAY DRUG DEV TECHN, V9, P213, DOI 10.1089/adt.2011.0370; van den Hout HMP, 2003, PEDIATRICS, V112, P332, DOI 10.1542/peds.112.2.332; van Gelder CM, 2014, J INHERITED METABOLI; Verma D, 2010, P NATL ACAD SCI USA, V107, P7101, DOI 10.1073/pnas.0912181107; Weinreb NJ, 2013, J INHERIT METAB DIS, V36, P543, DOI 10.1007/s10545-012-9528-4; Zhu YX, 2004, J BIOL CHEM, V279, P50336, DOI 10.1074/jbc.M409676200	38	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98336	10.1371/journal.pone.0098336	http://dx.doi.org/10.1371/journal.pone.0098336			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897114	Green Published, Green Submitted, gold			2022-12-27	WOS:000338430700033
J	Vergun, AA; Martirosyan, IA; Semyenova, SK; Omelchenko, AV; Petrosyan, VG				Vergun, A. A.; Martirosyan, I. A.; Semyenova, S. K.; Omelchenko, A., V; Petrosyan, V. G.			Clonal Diversity and Clone Formation in the Parthenogenetic Caucasian Rock Lizard Darevskia dahli (vol 9, e91674, 2014)	PLOS ONE			English	Correction													Omelchenko, Andrey V/E-8887-2014; Petrosyan, Varos/F-9681-2013; Lazebny, Oleg/R-9208-2016; Vergun, Andrey/I-4829-2016; Ryskov, Alexey/F-1179-2016; Korchagin, Vitaly/B-8635-2011	Omelchenko, Andrey V/0000-0003-4512-4413; Petrosyan, Varos/0000-0002-7483-5102; Lazebny, Oleg/0000-0003-3136-0415; Vergun, Andrey/0000-0001-5255-7802; Ryskov, Alexey/0000-0002-4159-0671; Korchagin, Vitaly/0000-0003-2264-6294				Vergun AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091674	1	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e100067	10.1371/journal.pone.0100067	http://dx.doi.org/10.1371/journal.pone.0100067			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896777	Green Submitted, Green Published, gold			2022-12-27	WOS:000338430700143
J	de Vries, EA; Caljouw, SR; Coppens, MJM; Postema, K; Verkerke, GJ; Lamoth, CJC				de Vries, Elisabeth A.; Caljouw, Simone R.; Coppens, Milou J. M.; Postema, Klaas; Verkerke, Gijsbertus J.; Lamoth, Claudine J. C.			Differences between Young and Older Adults in the Control of Weight Shifting within the Surface of Support	PLOS ONE			English	Article							ANTICIPATORY POSTURAL ADJUSTMENTS; AGE; BALANCE; STABILITY; FALLS; SPEED; INFORMATION; MOVEMENTS; COMMUNITY; ACCURACY	An important reason for falling in elderly is incorrect weight-shifting. In many daily life activities quick and accurate weight-shifting is needed to maintain balance and to prevent from falling. The present study aims to gain more insight in age-related differences in the control of weight-shifting. Nine healthy older adults (70.3 +/- 6.9 years) and twelve young adults (20.9 +/- 0.5 years) participated in the study. They performed a weight shifting task by moving the body's center of pressure, represented by a red dot on a screen, in different directions, towards targets of different sizes and at different distances projected on a screen. Movement time, fluency and accuracy of the movement were determined. Accuracy was quantified by the number of times the cursor hit the goal target before a target switch was realized (counts on goal) and by the time required to realize a target switch after the goal target was hit by the cursor for the first time (dwelling time). Fluency was expressed by the maximal deviation of the performed path with respect to the ideal path and the number of peaks, or inflections in the performed path. Significant main effects of target size, target distance and age on all outcome measures were found. With decreasing target size, increasing target distance and increasing age, movement time significantly increased and fluency and accuracy significantly decreased (i.e. increased number of peaks, maximal deviation, number of times on the goal target and longer dwelling time around the goal target). In addition, significant interaction effects of size*age and distance*age were found. Older adults needed more time to perform the weight-shifting task and their movements were less fluent and accurate compared to younger adults, especially with increasing task difficulty. This indicates that elderly might have difficulties with executing an adequate adaptation to a perturbation in daily life.	[de Vries, Elisabeth A.; Caljouw, Simone R.; Coppens, Milou J. M.; Lamoth, Claudine J. C.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [Postema, Klaas; Verkerke, Gijsbertus J.] Univ Groningen, Univ Med Ctr Groningen, Ctr Rehabil, Dept Rehabil Med, Groningen, Netherlands; [Verkerke, Gijsbertus J.] Univ Twente, Dept Biomech Engn, NL-7500 AE Enschede, Netherlands	University of Groningen; University of Groningen; University of Twente	de Vries, EA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	e.a.de.vries@umcg.nl	Coppens, Milou JM/F-7810-2016; Lamoth, Claudine JC/N-4325-2013	Coppens, Milou JM/0000-0002-6115-5271; Lamoth, Claudine JC/0000-0002-6495-2823; Caljouw, Simone R./0000-0002-3004-9900; Verkerke, Bart/0000-0003-3533-2446	Center of Research Excellence SPRINT	Center of Research Excellence SPRINT	Center of Research Excellence SPRINT (www.imdi-sprint.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleuse S, 2006, GAIT POSTURE, V24, P203, DOI 10.1016/j.gaitpost.2005.09.001; Bouisset S, 2008, NEUROPHYSIOL CLIN, V38, P345, DOI 10.1016/j.neucli.2008.10.001; Chapman GJ, 2010, EXP BRAIN RES, V201, P467, DOI 10.1007/s00221-009-2058-0; Cheng KC, 2012, J GERONTOL A-BIOL, V67, P1238, DOI 10.1093/gerona/gls116; Danion F, 1999, NEUROSCI LETT, V277, P131, DOI 10.1016/S0304-3940(99)00842-3; Duarte M, 2005, MOTOR CONTROL, V9, P180, DOI 10.1123/mcj.9.2.180; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Hernandez ME, 2012, HUM MOVEMENT SCI, V31, P1213, DOI 10.1016/j.humov.2011.11.002; Hernandez ME, 2012, CLIN BIOMECH, V27, P910, DOI 10.1016/j.clinbiomech.2012.06.007; HORAK FB, 1989, NEUROBIOL AGING, V10, P727, DOI 10.1016/0197-4580(89)90010-9; Huang MH, 2013, GAIT POSTURE, V38, P837, DOI 10.1016/j.gaitpost.2013.04.004; Jongman V, 2012, STUD HEALTH TECHNOL, V181, P93, DOI 10.3233/978-1-61499-121-2-93; Kanekar N, 2014, AGE, V36, P1067, DOI 10.1007/s11357-014-9621-8; Kanekar N, 2014, EXP BRAIN RES, V232, P1127, DOI 10.1007/s00221-014-3822-3; Ketcham CJ, 2002, J GERONTOL B-PSYCHOL, V57, pP54, DOI 10.1093/geronb/57.1.P54; Kosse NM., 2011, J CYBER THERAPY REHA, V4, P399; Lamoth CJC, 2011, STUD HEALTH TECHNOL, V167, P159, DOI 10.3233/978-1-60750-766-6-159; Laughton CA, 2003, GAIT POSTURE, V18, P101, DOI 10.1016/S0966-6362(02)00200-X; Prado JM, 2011, GAIT POSTURE, V33, P93, DOI 10.1016/j.gaitpost.2010.10.003; Robinovitch SN, 2013, LANCET, V381, P47, DOI 10.1016/S0140-6736(12)61263-X; Sihvonen SE, 2004, GERONTOLOGY, V50, P87, DOI 10.1159/000075559; Spreitzer L, 2013, AM J PHYS MED REHAB, V92, P36, DOI 10.1097/PHM.0b013e318269d8f9; Stalenhoef PA, 1997, EUR J PUBLIC HEALTH, V7, P328, DOI 10.1093/eurpub/7.3.328; Stapley P, 1998, NEUROREPORT, V9, P395, DOI 10.1097/00001756-199802160-00007; Thelen DG, 1996, J GERONTOL A-BIOL, V51, pM226, DOI 10.1093/gerona/51A.5.M226; Toledo DR, 2010, BRAZ J PHYS THER, V14, P267, DOI 10.1590/S1413-35552010000300004; Tucker MG, 2010, ARCH PHYS MED REHAB, V91, P750, DOI 10.1016/j.apmr.2010.01.004; Tucker MG, 2009, CLIN BIOMECH, V24, P597, DOI 10.1016/j.clinbiomech.2009.06.002; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Young WR, 2012, GAIT POSTURE, V36, P477, DOI 10.1016/j.gaitpost.2012.04.009	30	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98494	10.1371/journal.pone.0098494	http://dx.doi.org/10.1371/journal.pone.0098494			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5ML	24892646	Green Submitted, Green Published, gold			2022-12-27	WOS:000336911400058
J	Luo, YB; Mitrpant, C; Adams, AM; Johnsen, RD; Fletcher, S; Mastaglia, FL; Wilton, SD				Luo, Yue-Bei; Mitrpant, Chalermchai; Adams, Abbie M.; Johnsen, Russell D.; Fletcher, Sue; Mastaglia, Frank L.; Wilton, Steve D.			Antisense Oligonucleotide Induction of Progerin in Human Myogenic Cells	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; LAMIN-A; NUCLEAR-ENVELOPE; RESTRICTIVE DERMOPATHY; OXIDATIVE STRESS; PREMESSENGER RNA; MDX MOUSE; GENE; MUTATIONS; MUSCLE	We sought to use splice-switching antisense oligonucleotides to produce a model of accelerated ageing by enhancing expression of progerin, translated from a mis-spliced lamin A gene (LMNA) transcript in human myogenic cells. The progerin transcript (LMNA Delta 150) lacks the last 150 bases of exon 11, and is translated into a truncated protein associated with the severe premature ageing disease, Hutchinson-Gilford progeria syndrome (HGPS). HGPS arises from de novo mutations that activate a cryptic splice site in exon 11 of LMNA and result in progerin accumulation in tissues of mesodermal origin. Progerin has also been proposed to play a role in the 'natural' ageing process in tissues. We sought to test this hypothesis by producing a model of accelerated muscle ageing in human myogenic cells. A panel of splice-switching antisense oligonucleotides were designed to anneal across exon 11 of the LMNA pre-mRNA, and these compounds were transfected into primary human myogenic cells. RT-PCR showed that the majority of oligonucleotides were able to modify LMNA transcript processing. Oligonucleotides that annealed within the 150 base region of exon 11 that is missing in the progerin transcript, as well as those that targeted the normal exon 11 donor site induced the LMNA Delta 150 transcript, but most oligonucleotides also generated variable levels of LMNA transcript missing the entire exon 11. Upon evaluation of different oligomer chemistries, the morpholino phosphorodiamidate oligonucleotides were found to be more efficient than the equivalent sequences prepared as oligonucleotides with 2'-O-methyl modified bases on a phosphorothioate backbone. The morpholino oligonucleotides induced nuclear localised progerin, demonstrated by immunostaining, and morphological nuclear changes typical of HGPS cells. We show that it is possible to induce progerin expression in myogenic cells using splice-switching oligonucleotides to redirect splicing of LMNA. This may offer a model to investigate the role of progerin in premature muscle ageing.	[Luo, Yue-Bei; Mitrpant, Chalermchai; Adams, Abbie M.; Johnsen, Russell D.; Fletcher, Sue; Mastaglia, Frank L.; Wilton, Steve D.] Univ Western Australia, Australian Neuromuscular Res Inst, Ctr Neuromuscular & Neurol Disorders, Perth, WA 6009, Australia; [Luo, Yue-Bei] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China; [Mitrpant, Chalermchai] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Biochem, Bangkok 10700, Thailand; [Adams, Abbie M.; Johnsen, Russell D.; Fletcher, Sue; Wilton, Steve D.] Murdoch Univ, Ctr Comparat Genom, Perth, WA, Australia; [Mastaglia, Frank L.] Murdoch Univ, Inst Immunol & Infect Dis, Perth, WA, Australia	University of Western Australia; Central South University; Mahidol University; Murdoch University; Murdoch University	Wilton, SD (corresponding author), Univ Western Australia, Australian Neuromuscular Res Inst, Ctr Neuromuscular & Neurol Disorders, Perth, WA 6009, Australia.	swilton@ccg.murdoch.edu.au	Mitrpant, Chalermchai/HDN-9842-2022; Mitrpant, Chalermchai/AAX-6699-2021; L, YB/AAF-9728-2021	Mitrpant, Chalermchai/0000-0001-9311-7977; Wilton, Steve/0000-0002-9400-893X; Fletcher, Sue/0000-0002-8632-641X; Adams, Abbie/0000-0003-3445-7052	Neuromuscular Foundation of Western Australia; China Scholarship Council-University of Western Australia; Chalermphrakiat grant, Faculty of Medicine, Siriraj Hospital, Mahidol University	Neuromuscular Foundation of Western Australia; China Scholarship Council-University of Western Australia; Chalermphrakiat grant, Faculty of Medicine, Siriraj Hospital, Mahidol University	This work was supported by the Neuromuscular Foundation of Western Australia. Yue-Bei Luo was supported by a China Scholarship Council-University of Western Australia joint PhD scholarship. Chalermchai Mitrpant was partly supported by a Chalermphrakiat grant, Faculty of Medicine, Siriraj Hospital, Mahidol University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Carmeli E, 2002, EXP GERONTOL, V37, P477, DOI 10.1016/S0531-5565(01)00220-0; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Clark DJ, 2012, J GERONTOL A-BIOL, V67, P41, DOI 10.1093/gerona/glr041; Cooper ST, 2003, NEUROLOGY, V61, P93, DOI 10.1212/01.WNL.0000069460.53438.38; Crooke RM, 2005, J LIPID RES, V46, P872, DOI 10.1194/jlr.M400492-JLR200; De Sandre-Giovannoli A, 2002, AM J HUM GENET, V70, P726, DOI 10.1086/339274; Dechat T, 2007, P NATL ACAD SCI USA, V104, P4955, DOI 10.1073/pnas.0700854104; DOMINSKI Z, 1993, P NATL ACAD SCI USA, V90, P8673, DOI 10.1073/pnas.90.18.8673; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; FISHER DZ, 1986, P NATL ACAD SCI USA, V83, P6450, DOI 10.1073/pnas.83.17.6450; Fletcher S, 2006, J GENE MED, V8, P207, DOI 10.1002/jgm.838; Fletcher S, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.40; Fong LG, 2009, HUM MOL GENET, V18, P2462, DOI 10.1093/hmg/ddp184; Frock RL, 2006, GENE DEV, V20, P486, DOI 10.1101/gad.1364906; Genschel J, 2000, HUM MUTAT, V16, P451, DOI 10.1002/1098-1004(200012)16:6<451::AID-HUMU1>3.0.CO;2-9; Gleave M, 2005, ANN NY ACAD SCI, V1058, P1, DOI 10.1196/annals.1359.001; Guo SL, 2013, J CLIN INVEST, V123, P1531, DOI 10.1172/JCI66969; Harding PL, 2007, MOL THER, V15, P157, DOI 10.1038/sj.mt.6300006; Heemskerk HA, 2009, J GENE MED, V11, P257, DOI 10.1002/jgm.1288; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Kumaran RI, 2002, J CELL BIOL, V159, P783, DOI 10.1083/jcb.200204149; Lahoute C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003910; Lee HC, 2001, BIOGERONTOLOGY, V2, P231, DOI 10.1023/A:1013270512172; Liu YY, 2006, J CELL SCI, V119, P4644, DOI 10.1242/jcs.03263; Lopez-Bigas N, 2005, FEBS LETT, V579, P1900, DOI 10.1016/j.febslet.2005.02.047; Lopez-Mejia IC, 2011, HUM MOL GENET, V20, P4540, DOI 10.1093/hmg/ddr385; Luo YB, 2011, NEUROMUSCULAR DISORD, V21, P734, DOI 10.1016/j.nmd.2011.06.1063; Luo YB, 2013, INT J CLIN EXP PATHO, V6, P1723; Machiels BM, 1996, J BIOL CHEM, V271, P9249, DOI 10.1074/jbc.271.16.9249; Mann CJ, 2002, J GENE MED, V4, P644, DOI 10.1002/jgm.295; Mattioli E, 2011, CELL DEATH DIFFER, V18, P1305, DOI 10.1038/cdd.2010.183; McClintock D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001269; McClorey G, 2006, GENE THER, V13, P1373, DOI 10.1038/sj.gt.3302800; Mendell JR, 2013, ANN NEUROL, V74, P637, DOI 10.1002/ana.23982; Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006; Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036; Navarro CL, 2004, HUM MOL GENET, V13, P2493, DOI 10.1093/hmg/ddh265; Navarro CL, 2005, HUM MOL GENET, V14, P1503, DOI 10.1093/hmg/ddi159; Olins AL, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-30; Pereira S, 2008, MECH AGEING DEV, V129, P449, DOI 10.1016/j.mad.2008.04.003; Porensky PN, 2012, HUM MOL GENET, V21, P1625, DOI 10.1093/hmg/ddr600; Ragnauth CD, 2010, CIRCULATION, V121, P2200, DOI 10.1161/CIRCULATIONAHA.109.902056; Sazani P, 2003, J CLIN INVEST, V112, P481, DOI 10.1172/JCI200319547; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708; Schaap LA, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.049; Serdaroglu P, 2007, HDB CLIN NEUROLOGY, P357; Shimi T, 2012, CURR OPIN CELL BIOL, V24, P71, DOI 10.1016/j.ceb.2011.11.007; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Toth JI, 2005, P NATL ACAD SCI USA, V102, P12873, DOI 10.1073/pnas.0505767102; Wilton SD, 2005, CURR GENE THER, V5, P467, DOI 10.2174/156652305774329249; Wilton SD, 2007, MOL THER, V15, P1288, DOI 10.1038/sj.mt.6300095; Zhang QP, 2005, J CELL SCI, V118, P673, DOI 10.1242/jcs.01642	57	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98306	10.1371/journal.pone.0098306	http://dx.doi.org/10.1371/journal.pone.0098306			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892300	Green Published, gold, Green Submitted			2022-12-27	WOS:000336911400045
J	Picard-Meyer, E; Robardet, E; Arthur, L; Larcher, G; Harbusch, C; Servat, A; Cliquet, F				Picard-Meyer, Evelyne; Robardet, Emmanuelle; Arthur, Laurent; Larcher, Gerald; Harbusch, Christine; Servat, Alexandre; Cliquet, Florence			Bat Rabies in France: A 24-Year Retrospective Epidemiological Study	PLOS ONE			English	Article							SEROTINE BATS; VIRUS-INFECTION; NATTERERS BAT; LYSSAVIRUS; SURVEILLANCE; ECOLOGY; SEASONALITY; DYNAMICS; HOST	Since bat rabies surveillance was first implemented in France in 1989, 48 autochthonous rabies cases without human contamination have been reported using routine diagnosis methods. In this retrospective study, data on bats submitted for rabies testing were analysed in order to better understand the epidemiology of EBLV-1 in bats in France and to investigate some epidemiological trends. Of the 3176 bats submitted for rabies diagnosis from 1989 to 2013, 1.96% (48/2447 analysed) were diagnosed positive. Among the twelve recognised virus species within the Lyssavirus genus, two species were isolated in France. 47 positive bats were morphologically identified as Eptesicus serotinus and were shown to be infected by both the EBLV-1a and the EBLV-1b lineages. Isolation of BBLV in Myotis nattereri was reported once in the north-east of France in 2012. The phylogenetic characterisation of all 47 French EBLV-1 isolates sampled between 1989 and 2013 and the French BBLV sample against 21 referenced partial nucleoprotein sequences confirmed the low genetic diversity of EBLV-1 despite its extensive geographical range. Statistical analysis performed on the serotine bat data collected from 1989 to 2013 showed seasonal variation of rabies occurrence with a significantly higher proportion of positive samples detected during the autumn compared to the spring and the summer period (34% of positive bats detected in autumn, 15% in summer, 13% in spring and 12% in winter). In this study, we have provided the details of the geographical distribution of EBLV-1a in the south-west of France and the north-south division of EBLV-1b with its subdivisions into three phylogenetic groups: group B1 in the north-west, group B2 in the centre and group B3 in the north-east of France.	[Picard-Meyer, Evelyne; Robardet, Emmanuelle; Servat, Alexandre; Cliquet, Florence] French Agcy Food Environm & Occupat Hlth & Safety, Nancy Lab Rabies & Wildlife, European Union Reference Lab Rabies Serol, European Union Reference Lab Rabies,OIE Reference, Malzeville, France; [Arthur, Laurent] Museum Hist Nat Bourges, Bourges, France; [Larcher, Gerald] Museum Hist Nat Bourges, SFEPM Chiroptera Grp, Bourges, France; [Harbusch, Christine] Nat & Biodivers Conservat Union, Perl Kesslingen, Germany	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Technopole Agricole et Veterinaire	Picard-Meyer, E (corresponding author), French Agcy Food Environm & Occupat Hlth & Safety, Nancy Lab Rabies & Wildlife, European Union Reference Lab Rabies Serol, European Union Reference Lab Rabies,OIE Reference, Malzeville, France.	evelyne.picard-meyer@anses.fr	Servat, Alexandre/J-1804-2019	Servat, Alexandre/0000-0003-4753-6614; Picard-Meyer, Evelyne/0000-0001-9122-9027; CLIQUET, Florence/0000-0003-2237-1243				Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Ceballos NA, 2013, EMERG INFECT DIS, V19, P793, DOI 10.3201/eid1905.121071; Arthur Laurent, 2012, Symbioses, V28, P23; Baker ML, 2013, ZOONOSES PUBLIC HLTH, V60, P104, DOI 10.1111/j.1863-2378.2012.01528.x; Banyard AC, 2011, ADV VIRUS RES, V79, P239, DOI 10.1016/B978-0-12-387040-7.00012-3; Bourhy H, 2011, EPIDEMIOLOGIE RAGE H; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Cliquet F, 2010, DEV HARMONISED SCHEM; Dacheux L, 2009, EMERG INFECT DIS, V15, P280, DOI 10.3201/eid1502.080637; Davis PL, 2005, J VIROL, V79, P10487, DOI 10.1128/JVI.79.16.10487-10497.2005; Dean D. J., 1996, LAB TECHNIQUES RABIE; Dietz C, 2004, ILLUSTRATED IDENTIFI; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fenton MB, 2010, CURR ZOOL, V56, P454, DOI 10.1093/czoolo/56.4.454; Franka R, 2008, J GEN VIROL, V89, P1998, DOI 10.1099/vir.0.83688-0; Freuling C, 2009, J GEN VIROL, V90, P2493, DOI 10.1099/vir.0.011510-0; Freuling CM, 2011, EMERG INFECT DIS, V17, P1519, DOI 10.3201/eid1708.110201; Georgea DB, 2011, P NATL ACAD SCI USA, V108, P10208, DOI 10.1073/pnas.1010875108; Godineau F, 2007, PLAN RESTAURATION CH; Harbusch C, 2002, ASPECTS ECOLOGY SERO; Hayman DTS, 2013, ZOONOSES PUBLIC HLTH, V60, P2, DOI 10.1111/zph.12000; Hayman DTS, 2011, J VIROL METHODS, V177, P87, DOI 10.1016/j.jviromet.2011.07.002; ICTV, 2012, VERT; Jackson FR, 2008, J WILDLIFE DIS, V44, P612, DOI 10.7589/0090-3558-44.3.612; KAPLAN MM, 1969, NATURE, V221, P421, DOI 10.1038/221421a0; Kappeler A., 1989, Rabies Bulletin Europe, V13, P12; King A. A., 2004, Historical perspective of rabies in Europe and the Mediterranean Basin: a testament to rabies by Dr Arthur A. King, P221; Marston DA, 2012, EMERG INFECT DIS, V18, P664, DOI 10.3201/eid1804.111553; McElhinney LM, 2013, ZOONOSES PUBLIC HLTH, V60, P35, DOI 10.1111/zph.12003; Meslin FX, 1996, LAB TECHNIQUES RABIE; Muller T, 2007, ARCH VIROL, V152, P273, DOI 10.1007/s00705-006-0853-5; Patyk K, 2012, VECTOR-BORNE ZOONOT, V12, P666, DOI 10.1089/vbz.2011.0839; Picard-Meyer E, 2004, VET REC, V155, P774; Picard-Meyer E, 2004, VACCINE, V22, P1921, DOI 10.1016/j.vaccine.2003.11.015; Picard-Meyer E, 2013, B EPIDEMIOLOGIQUE SA, V60, P12; Picard-Meyer E, 2013, ARCH VIROL, V158, P2333, DOI 10.1007/s00705-013-1747-y; Picard-Meyer E, 2011, VET MICROBIOL, V151, P390, DOI 10.1016/j.vetmic.2011.03.034; Salicini I, 2011, MOL PHYLOGENET EVOL, V61, P888, DOI 10.1016/j.ympev.2011.08.010; Schatz J, 2013, ZOONOSES PUBLIC HLTH, V60, P22, DOI 10.1111/zph.12002; Scherrer B, 1984, BIOSTATISTIQUE; Serra-Cobo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064467; Servat A, 2012, BIOLOGICALS, V40, P61, DOI 10.1016/j.biologicals.2011.12.011; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Turmelle AS, 2010, J GEN VIROL, V91, P2360, DOI 10.1099/vir.0.020073-0; Turmelle AS, 2010, VECTOR-BORNE ZOONOT, V10, P165, DOI 10.1089/vbz.2008.0163; Van der Poel WHM, 2005, EMERG INFECT DIS, V11, P1854, DOI 10.3201/eid1112.041200; Vazquez-Moron S, 2008, DEV BIOLOGICALS, V131, P311; Vazquez-Moron S, 2008, EMERG INFECT DIS, V14, P1263, DOI [10.3201/eid1408.080068, 10.3201/1408.080068]	49	22	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98622	10.1371/journal.pone.0098622	http://dx.doi.org/10.1371/journal.pone.0098622			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892287	Green Published, gold			2022-12-27	WOS:000336911400075
J	Rodrigues, ASB; Silva, SE; Marabuto, E; Silva, DN; Wilson, MR; Thompson, V; Yurtsever, S; Halkka, A; Borges, PAV; Quartau, JA; Paulo, OS; Seabra, SG				Rodrigues, Ana S. B.; Silva, Sara E.; Marabuto, Eduardo; Silva, Diogo N.; Wilson, Mike R.; Thompson, Vinton; Yurtsever, Selcuk; Halkka, Antti; Borges, Paulo A. V.; Quartau, Jose A.; Paulo, Octavio S.; Seabra, Sofia G.			New Mitochondrial and Nuclear Evidences Support Recent Demographic Expansion and an Atypical Phylogeographic Pattern in the Spittlebug Philaenus spumarius (Hemiptera, Aphrophoridae)	PLOS ONE			English	Article							POPULATION-STRUCTURE; PHYLOGENETIC ANALYSIS; GENETIC-VARIATION; DNA-SEQUENCES; REFUGIA; COLONIZATION; EVOLUTION; SOFTWARE; GROWTH; POLYMORPHISM	Philaenus spumarius is a widespread insect species in the Holarctic region. Here, by focusing on the mtDNA gene COI but also using the COII and Cyt b genes and the nuclear gene EF-1 alpha, we tried to explain how and when its current biogeographic pattern evolved by providing time estimates of the main demographic and evolutionary events and investigating its colonization patterns in and out of Eurasia. Evidence of recent divergence and expansion events at less than 0.5 Ma ago indicate that climate fluctuations in the Mid-Late Pleistocene were important in shaping the current phylogeographic pattern of the species. Data support a first split and differentiation of P. spumarius into two main mitochondrial lineages: the "western", in the Mediterranean region and the "eastern", in Anatolia/Caucasus. It also supports a following differentiation of the "western" lineage into two sub-lineages: the "western-Mediterranean", in Iberia and the "eastern-Mediterranean" in the Balkans. The recent pattern seems to result from postglacial range expansion from Iberia and Caucasus/Anatolia, thus not following one of the four common paradigms. Unexpected patterns of recent gene-flow events between Mediterranean peninsulas, a close relationship between Iberia and North Africa, as well as high levels of genetic diversity being maintained in northern Europe were found. The mitochondrial pattern does not exactly match to the nuclear pattern suggesting that the current biogeographic pattern of P. spumarius may be the result of both secondary admixture and incomplete lineage sorting. The hypothesis of recent colonization of North America from both western and northern Europe is corroborated by our data and probably resulted from accidental human translocations. A probable British origin for the populations of the Azores and New Zealand was revealed, however, for the Azores the distribution of populations in high altitude native forests is somewhat puzzling and may imply a natural colonization of the archipelago.	[Rodrigues, Ana S. B.; Silva, Sara E.; Marabuto, Eduardo; Silva, Diogo N.; Quartau, Jose A.; Paulo, Octavio S.; Seabra, Sofia G.] Univ Lisbon, Fac Ciencias, Dept Biol Anim Platform Enhancing Ecol Res & Sust, Computat Biol & Populat Genom Grp,Ctr Biol Ambien, Lisbon, Portugal; [Wilson, Mike R.] Natl Museum Wales, Dept Nat Sci, Cardiff CF1 3NP, S Glam, Wales; [Thompson, Vinton] Metropolitan Coll New York, New York, NY USA; [Yurtsever, Selcuk] Trakya Univ, Fac Sci, Dept Biol, Edirne, Turkey; [Halkka, Antti] Univ Helsinki, Dept Biol & Environm Sci, Helsinki, Finland; [Borges, Paulo A. V.] Univ Acores, Dept Ciencias Agr, Ctr Invest & Tecnol Agr Acores, Azorean Biodivers Grp, Angra Do Heroismo, Terceira, Portugal; [Borges, Paulo A. V.] Univ Acores, Dept Ciencias Agr, Angra Do Heroismo, Terceira, Portugal	Universidade de Lisboa; Trakya University; University of Helsinki; Universidade dos Acores; Universidade dos Acores	Rodrigues, ASB (corresponding author), Univ Lisbon, Fac Ciencias, Dept Biol Anim Platform Enhancing Ecol Res & Sust, Computat Biol & Populat Genom Grp,Ctr Biol Ambien, Lisbon, Portugal.	asorodrigues@fc.ul.pt	Borges, Paulo/H-5153-2019; Borges, Paulo/B-2780-2008; Silva, Sara Ema/M-9608-2013; Marabuto, Eduardo/B-7284-2013; Paulo, Octávio/D-9921-2011; Seabra, Sofia G/B-3808-2013	Borges, Paulo/0000-0002-8448-7623; Borges, Paulo/0000-0002-8448-7623; Silva, Sara Ema/0000-0001-8766-8131; Marabuto, Eduardo/0000-0001-7017-8451; Paulo, Octávio/0000-0001-5408-5212; Seabra, Sofia G/0000-0003-1413-2349; Rodrigues, Ana Sofia/0000-0003-4887-3823; Silva, Diogo/0000-0002-6827-2673	FCT, Portugal [SFRH/BPD/26365/2006, SFRH/BD/73879/2010, PTDC/BIA-BEC/098783/2008]	FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission)	Financial support: FCT, Portugal (Grant SFRH/BPD/26365/2006; Grant SFRH/BD/73879/2010; Project PTDC/BIA-BEC/098783/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arensburger P, 2004, J BIOGEOGR, V31, P557, DOI 10.1046/j.1365-2699.2003.01012.x; Assing V, 2010, LIST TERRESTRIAL MAR; Besold J, 2008, J BIOGEOGR, V35, P2090, DOI 10.1111/j.1365-2699.2008.01939.x; Bhagwat SA, 2008, J BIOGEOGR, V35, P464, DOI 10.1111/j.1365-2699.2007.01861.x; Downie DA, 2004, SYST ENTOMOL, V29, P238, DOI 10.1111/j.0307-6970.2004.00241.x; DROSOPOULOS S, 2002, ZOOTAXA, V68, P1, DOI DOI 10.11646/ZOOTAXA.68.1.1; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Flot JF, 2007, MOL ECOL NOTES, V7, P974, DOI 10.1111/j.1471-8286.2007.01857.x; Franck P, 2001, HEREDITY, V86, P420, DOI 10.1046/j.1365-2540.2001.00842.x; Fu YX, 1997, GENETICS, V147, P915; Gibbard PL, 2010, J QUATERNARY SCI, V25, P96, DOI 10.1002/jqs.1338; Graur D, 2004, TRENDS GENET, V20, P80, DOI 10.1016/j.tig.2003.12.003; Habel JC, 2005, J BIOGEOGR, V32, P1489, DOI 10.1111/j.1365-2699.2005.01273.x; HALKKA O, 1990, EVOL BIOL, V24, P149; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HAMILTON KGA, 1979, CAN ENTOMOL, V111, P127, DOI 10.4039/Ent111127-2; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; HARPENDING HC, 1994, HUM BIOL, V66, P591; Heads M, 2005, CLADISTICS, V21, P62, DOI 10.1111/j.1096-0031.2005.00052.x; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hewitt GM, 2001, MOL ECOL, V10, P537, DOI 10.1046/j.1365-294x.2001.01202.x; Hewitt Godfrey M., 2011, P123; Hewitt GM, 2011, GENETICA, V139, P617, DOI 10.1007/s10709-011-9547-3; Horn A, 2006, MOL ECOL, V15, P1603, DOI 10.1111/j.1365-294X.2006.02872.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ibrahim KM, 1996, HEREDITY, V77, P282, DOI 10.1038/hdy.1996.142; Karban R, 2004, ECOL ENTOMOL, V29, P251, DOI 10.1111/j.1365-2311.2004.00576.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maryanska-Nadachowska A, 2012, SYST ENTOMOL, V37, P55, DOI 10.1111/j.1365-3113.2011.00592.x; Nardi F, 2005, MOL ECOL, V14, P2729, DOI 10.1111/j.1365-294X.2005.02610.x; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Pina-Martins F, 2008, MOL ECOL RESOUR, V8, P1254, DOI 10.1111/j.1755-0998.2008.02164.x; Pinto-Juma GA, 2008, B ENTOMOL RES, V98, P15, DOI 10.1017/S0007485307005573; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Quartau J, 1992, ACTAS C IBERICO ENTO, V1, P129; Quartau J. A., 1997, Miscellania Zoologica (Barcelona), V20, P19; Rambaut A., 2007, TRACER V1 4; Ribera I, 2004, MOL ECOL, V13, P179, DOI 10.1046/j.1365-294X.2003.02035.x; Rodriguez-Sanchez F, 2008, QUATERNARY SCI REV, V27, P2100, DOI 10.1016/j.quascirev.2008.08.006; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Schmitt T, 2005, BIOL J LINN SOC, V85, P419, DOI 10.1111/j.1095-8312.2005.00504.x; Schmitt T, 2001, J BIOGEOGR, V28, P1129, DOI 10.1046/j.1365-2699.2001.00621.x; Schmitt T, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-22; Schneider S, 1999, GENETICS, V152, P1079; Seabra SG, 2010, MOL PHYLOGENET EVOL, V56, P462, DOI 10.1016/j.ympev.2010.03.023; Seabra SG, 2009, BIOL J LINN SOC, V96, P249, DOI 10.1111/j.1095-8312.2008.01116.x; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON V, 1984, NEW ZEAL ENTOMOL, V8, P86, DOI 10.1080/00779962.1984.9722475; Weaver C., 1954, RES B, V741, P1; Yurtsever Selcuk, 2000, Turkish Journal of Zoology, V24, P447; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	62	15	16	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98375	10.1371/journal.pone.0098375	http://dx.doi.org/10.1371/journal.pone.0098375			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892429	Green Published, gold, Green Submitted			2022-12-27	WOS:000336911400046
J	Zhen, XE; Zong, M; Gao, SN; Cao, YG; Jiang, L; Chen, SX; Wang, K; Sun, SQ; Peng, HS; Bai, YH; Li, S				Zhen, Xi-E; Zong, Ming; Gao, Sai-Nan; Cao, Yong-Gang; Jiang, Lei; Chen, Shu-Xin; Wang, Kuan; Sun, Shi-Qin; Peng, Hai-Sheng; Bai, Yu-Hua; Li, Sen			Preparation and Characterization of a Novel Aspirin Derivative with Anti-Thrombotic and Gastric Mucosal Protection Properties	PLOS ONE			English	Article							NITRIC-OXIDE; PROSTAGLANDINS	The use of acetylsalicylic acid (ASP) is limited by its adverse effects, especially the effect on the gastric mucosa. To address this problem, we synthesized a derivative form of ASP, prepared by modification of ASP with nano-hydroxyapatite (a kind of inorganic particle containing Ca2+). The derivative was named Ca-ASP. Structural study showed that Ca-ASP was a kind of carboxylate containing intramolecular hydrogen bonds. Rats given a high dose of Ca-ASP (5 mmol per kg body weight) showed similar anti-thrombotic activity as those given the same dose of ASP, but had much lower gastric mucosal damage than ASP (UI: 2 versus UI: 12.5). These rats also showed reduced expression of COX-2, but their COX-1 expression was similar to that of control rats, but significantly higher than that of ASP-administered rats. Furthermore, the level of prostaglandin E2 (PGE2) was up-regulated in Ca-ASP-administered rats compared to ASP-administered rats. Taken together, the results showed that Ca-ASP possessed similar antithrombotic activity as ASP but without the side effect associated with ASP, and the underlying mechanism may center on inhibiting COX-2 without inhibiting COX-1, and thus favouring the production of PGE2, the prostaglandin that plays a vital role in the suppression of platelet aggregation and thrombosis, as well as in the repair of gastric damage.	[Zhen, Xi-E; Zong, Ming; Gao, Sai-Nan; Cao, Yong-Gang; Jiang, Lei; Chen, Shu-Xin; Wang, Kuan; Sun, Shi-Qin; Peng, Hai-Sheng; Bai, Yu-Hua; Li, Sen] Harbin Med Univ, Dept Pharmaceut, Daqing Branch, Daqing, Peoples R China	Harbin Medical University	Li, S (corresponding author), Harbin Med Univ, Dept Pharmaceut, Daqing Branch, Daqing, Peoples R China.	tiande0405@sina.com			Heilongjiang Young Scientists Fund of Natural Science Foundation [QC2011C099]; Post-Doctoral Scientific Research Startup Fund [LBH-Q13131]; Postgraduate Innovation Scientific Research Fund [YJSCX2012-212HLJ]	Heilongjiang Young Scientists Fund of Natural Science Foundation; Post-Doctoral Scientific Research Startup Fund; Postgraduate Innovation Scientific Research Fund	This work was financially supported by the Heilongjiang Young Scientists Fund of Natural Science Foundation (QC2011C099), Post-Doctoral Scientific Research Startup Fund (LBH-Q13131), and Postgraduate Innovation Scientific Research Fund YJSCX2012-212HLJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amagase K, 2013, J PHYSIOL PHARMACOL, V64, P65; Bai BL, 2007, NEW J CHEM, V31, P401, DOI 10.1039/b614444f; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Ballhausen CJ, 1996, INORG CHEM, V111; Etcheverry SB, 2002, BIOMETALS, V15, P37, DOI 10.1023/A:1013183910203; GUTH PH, 1979, GASTROENTEROLOGY, V76, P88; Harrison P, 2008, PLATELETS, V19, P119, DOI 10.1080/09537100701771736; Have LWJ, 2013, PEDIATR BLOOD CANCER, V60, P1198, DOI 10.1002/pbc.24484; Jian Cheng H, 1989, POLYCRYSTAL STRUCTUR, P153; Jonsson F, 2013, BRIT J CANCER, V109, P1921, DOI 10.1038/bjc.2013.411; Lin-Vien D., 1991, HDB INFRARED RAMAN C; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Luo T, 2012, BREAST CANCER RES TR, V131, P581, DOI 10.1007/s10549-011-1747-0; Matsuura K, 2009, HEART VESSELS, V24, P169, DOI 10.1007/s00380-008-1105-2; Morais TC, 2010, CHEM-BIOL INTERACT, V183, P264, DOI 10.1016/j.cbi.2009.10.008; Morgan MP, 2001, MOL CARCINOGEN, V32, P111, DOI 10.1002/mc.1070; Nakamoto K., 1997, INFRARED RAMAN SPE B; Pathi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048208; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Rolando B, 2013, CHEMMEDCHEM, V8, P1199, DOI 10.1002/cmdc.201300105; Rubner G, 2011, ARCH PHARM, V344, P684, DOI 10.1002/ardp.201000382; Smyth EM, 2009, J LIPID RES, V50, pS423, DOI 10.1194/jlr.R800094-JLR200; Tarnawski A, 2013, CURR PHARM DESIGN, V19, P126; Do TNT, 2012, THER DELIV, V3, P623, DOI 10.4155/TDE.12.39; Wallace JL, 2000, GASTROENTEROLOGY, V119, P512, DOI 10.1053/gast.2000.9304; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Wang Xiao, 2000, The ways of making medicines with no or low gastrointestinal system poisonous side effect, Patent No. [CN99107973.6, 991079736]; Wang XY, 2011, CHINESE J PHARM, V7, P266; Zhang P, 2010, LANGMUIR, V26, P10183, DOI 10.1021/la100325c	29	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98513	10.1371/journal.pone.0098513	http://dx.doi.org/10.1371/journal.pone.0098513			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892779	Green Published, gold			2022-12-27	WOS:000336911400060
J	aan het Rot, M; Hogenelst, K				aan het Rot, Marije; Hogenelst, Koen			The Influence of Affective Empathy and Autism Spectrum Traits on Empathic Accuracy	PLOS ONE			English	Article							HIGH-FUNCTIONING ADULTS; EMOTIONAL EXPRESSIVITY; ASPERGER-SYNDROME; QUOTIENT AQ; FACETS; ALEXITHYMIA; COGNITION; OXYTOCIN; DEFICITS; OTHERS	Autism spectrum disorder is characterized by interpersonal deficits and has been associated with limited cognitive empathy, which includes perspective taking, theory of mind, and empathic accuracy (EA). The capacity for affective empathy may also be impaired. In the present study we aimed to determine if EA in normally developing individuals with varying levels of autism spectrum traits is moderated by trait affective empathy. Fifty male and fifty female participants ('perceivers') completed the Autism-Spectrum Quotient and the Balanced Emotional Empathy Scale to assess autism spectrum traits and trait affective empathy, respectively. EA was assessed using a Dutch-language version of a previously developed task and involved rating the feelings of others ('targets') verbally recounting autobiographical emotional events. Targets varied in trait emotional expressivity, assessed using the Berkeley Expressivity Questionnaire. Perceivers with more autism spectrum traits performed worse on the EA task, particularly when their trait affective empathy was relatively low. Interpersonal deficits in autism spectrum disorder may be partially explained by low cognitive empathy. Further, they might be aggravated by a limited capacity for affective empathy.	[aan het Rot, Marije] Univ Groningen, Dept Psychol, NL-9712 TS Groningen, Netherlands; Univ Groningen, Sch Behav & Cognit Neurosci, Groningen, Netherlands	University of Groningen; University of Groningen	aan het Rot, M (corresponding author), Univ Groningen, Dept Psychol, Grote Kruisstr 2-1, NL-9712 TS Groningen, Netherlands.	m.aan.het.rot@rug.nl	Rot, Marije aan het/H-8708-2019	Rot, Marije aan het/0000-0001-6761-7513	Innovational Research Incentives Scheme Veni from the Netherlands Organisation for Scientific Research (NWO, Veni) [451-09-013]	Innovational Research Incentives Scheme Veni from the Netherlands Organisation for Scientific Research (NWO, Veni)	The work was supported by the Innovational Research Incentives Scheme Veni from the Netherlands Organisation for Scientific Research (NWO, Veni grant 451-09-013 awarded to Dr. aan het Rot). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L. S., 1991, MULTIPLE REGRESSION; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; Bartz JA, 2010, PSYCHOL SCI, V21, P1426, DOI 10.1177/0956797610383439; Batson D. C., HDB IMAGINATION MENT, P267, DOI DOI 10.4324/9780203809846.CH18; Bellebaum C, 2014, COGN NEUROPSYCHIATRY, V19, P205, DOI 10.1080/13546805.2013.823860; Blair RJR, 2005, CONSCIOUS COGN, V14, P698, DOI 10.1016/j.concog.2005.06.004; Bons D, 2013, J ABNORM CHILD PSYCH, V41, P425, DOI 10.1007/s10802-012-9689-5; Cook R, 2013, PSYCHOL SCI, V24, P723, DOI 10.1177/0956797612463582; Courtright KE, 2005, J CRIM JUSTICE EDUC, V16, P125, DOI 10.1080/1051125042000333514; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Decety J, 2010, DEV NEUROSCI-BASEL, V32, P257, DOI 10.1159/000317771; Demurie E, 2011, RES AUTISM SPECT DIS, V5, P126, DOI 10.1016/j.rasd.2010.03.002; Dziobek I, 2008, J AUTISM DEV DISORD, V38, P464, DOI 10.1007/s10803-007-0486-x; Gadassi R, 2011, PSYCHOL SCI, V22, P1033, DOI 10.1177/0956797611414728; Groen Y, 2013, NEUROPSYCHOLOGIA, V51, P142, DOI 10.1016/j.neuropsychologia.2012.11.012; GROSS JJ, 1995, PERS INDIV DIFFER, V19, P555, DOI 10.1016/0191-8869(95)00055-B; Gross JJ, 1997, J PERS SOC PSYCHOL, V72, P435, DOI 10.1037/0022-3514.72.2.435; Hadjikhani N, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.113; Hoekstra RA, 2008, J AUTISM DEV DISORD, V38, P1555, DOI 10.1007/s10803-008-0538-x; Ickes W.J., 1997, EMPATHIC ACCURACY; KASARI C, 1990, J AUTISM DEV DISORD, V20, P87, DOI 10.1007/BF02206859; Leiberg S, 2006, PROG BRAIN RES, V156, P419, DOI 10.1016/S0079-6123(06)56023-6; Lombardo MV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000883; Mathersul D, 2013, INT J PSYCHOPHYSIOL, V89, P475, DOI 10.1016/j.ijpsycho.2013.04.014; Mathersul D, 2013, J CLIN EXP NEUROPSYC, V35, P655, DOI 10.1080/13803395.2013.809700; McIntosh DN, 2006, DEVELOPMENTAL SCI, V9, P295, DOI 10.1111/j.1467-7687.2006.00492.x; Mehrabian A, 1997, AGGRESSIVE BEHAV, V23, P433, DOI 10.1002/(SICI)1098-2337(1997)23:6<433::AID-AB3>3.0.CO;2-H; Minio-Paluello I, 2009, BIOL PSYCHIAT, V65, P55, DOI 10.1016/j.biopsych.2008.08.006; Newton BW, 2008, ACAD MED, V83, P244, DOI 10.1097/ACM.0b013e3181637837; Roeyers H, 2010, EUR J DEV PSYCHOL, V7, P123, DOI 10.1080/17405620903425924; Rogers K, 2007, J AUTISM DEV DISORD, V37, P709, DOI 10.1007/s10803-006-0197-8; Schwenck C, 2012, J CHILD PSYCHOL PSYC, V53, P651, DOI 10.1111/j.1469-7610.2011.02499.x; Shamay-Tsoory SG, 2002, NEUROCASE, V8, P245; Shamay-Tsoory SG, 2011, NEUROSCIENTIST, V17, P18, DOI 10.1177/1073858410379268; SIGMAN MD, 1992, CHILD DEV, V63, P796, DOI 10.2307/1131234; Striepens N, 2011, FRONT NEUROENDOCRIN, V32, P426, DOI 10.1016/j.yfrne.2011.07.001; Swart M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005751; Theodoridou A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00197; YIRMIYA N, 1992, CHILD DEV, V63, P150, DOI 10.1111/j.1467-8624.1992.tb03603.x; Young KA, 2011, FRONT NEUROENDOCRIN, V32, P53, DOI 10.1016/j.yfrne.2010.07.006; Zaki J, 2008, PSYCHOL SCI, V19, P399, DOI 10.1111/j.1467-9280.2008.02099.x	43	23	23	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98436	10.1371/journal.pone.0098436	http://dx.doi.org/10.1371/journal.pone.0098436			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP1YS	24905105	Green Submitted, Green Published, gold			2022-12-27	WOS:000341869000029
J	Ji, LL; Ma, YB; Wang, ZY; Cai, ZX; Pang, C; Wang, ZT				Ji, Lili; Ma, Yibo; Wang, Zaiyong; Cai, Zhunxiu; Pang, Chun; Wang, Zhengtao			Quercetin Prevents Pyrrolizidine Alkaloid Clivorine-Induced Liver Injury in Mice by Elevating Body Defense Capacity	PLOS ONE			English	Article							METABOLIC-ACTIVATION; MEDICINAL-PLANTS; GLUTATHIONE; HEPATOTOXICITY; INVOLVEMENT; MECHANISMS; METHIONINE; APOPTOSIS; PATHWAY; STRESS	Quercetin is a plant-derived flavonoid that is widely distributed in nature. The present study is designed to analyze the underlying mechanism in the protection of quercetin against pyrrolizidine alkaloid clivorine-induced acute liver injury in vivo. Serum transaminases, total bilirubin analysis, and liver histological evaluation demonstrated the protection of quercetin against clivorine-induced liver injury. Terminal dUTP nick end-labeling assay demonstrated that quercetin reduced the increased amount of liver apoptotic cells induced by clivorine. Western-blot analysis of caspase-3 showed that quercetin inhibited the cleaved activation of caspase-3 induced by clivorine. Results also showed that quercetin reduced the increase in liver glutathione and lipid peroxidative product malondialdehyde induced by clivorine. Quercetin reduced the enhanced liver immunohistochemical staining for 4-hydroxynonenal induced by clivorine. Results of the Mouse Stress and Toxicity PathwayFinder RT2 Profiler PCR Array demonstrated that the expression of genes related with oxidative or metabolic stress and heat shock was obviously altered after quercetin treatment. Some of the alterations were confirmed by real-time PCR. Our results demonstrated that quercetin prevents clivorine-induced acute liver injury in vivo by inhibiting apoptotic cell death and ameliorating oxidative stress injury. This protection may be caused by the elevation of the body defense capacity induced by quercetin.	[Ji, Lili; Ma, Yibo; Cai, Zhunxiu; Pang, Chun; Wang, Zhengtao] Shanghai Univ Tradit Chinese Med, SATCM Key Lab New Resources & Qual Evaluat Chines, MOE Key Lab Standardizat Chinese Med, Shanghai, Peoples R China; [Ji, Lili; Ma, Yibo; Cai, Zhunxiu; Pang, Chun; Wang, Zhengtao] Shanghai Univ Tradit Chinese Med, Inst Chinese Mat Med, Shanghai Key Lab Complex Prescript, Shanghai, Peoples R China; [Ji, Lili; Wang, Zaiyong; Wang, Zhengtao] Shanghai R&D Ctr Standardizat Chinese Med, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine	Ji, LL (corresponding author), Shanghai Univ Tradit Chinese Med, SATCM Key Lab New Resources & Qual Evaluat Chines, MOE Key Lab Standardizat Chinese Med, Shanghai, Peoples R China.	lichenyue1307@126.com	Wang, Zhengtao/AAH-7360-2019	Wang, Zhengtao/0000-0003-2797-4625	National Natural Science Foundation of China [81322053]; Program for New Century Excellent Talents in University [NCET-11-1054]; Program for Changjiang Scholars and Innovative Research Team in University [PCSIRT-IRT1071]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was financially supported by National Natural Science Foundation of China (81322053), the Program for New Century Excellent Talents in University (NCET-11-1054), and partially supported by Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT-IRT1071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amacher DE, 2012, EXPERT OPIN DRUG MET, V8, P335, DOI 10.1517/17425255.2012.658041; Chen Y, 2013, FOOD CHEM TOXICOL, V60, P38, DOI 10.1016/j.fct.2013.07.008; de David C, 2011, TOXICOL PATHOL, V39, P949, DOI 10.1177/0192623311418680; de Groot H, 1998, FUND CLIN PHARMACOL, V12, P249; Domitrovic R, 2012, ACTA PHARMACOL SIN, V33, P1260, DOI 10.1038/aps.2012.62; Fretland AJ, 2000, CHEM-BIOL INTERACT, V129, P41, DOI 10.1016/S0009-2797(00)00197-6; Fu PP, 2004, DRUG METAB REV, V36, P1, DOI 10.1081/DMR-120028426; HOGBERG J, 1974, BIOCHEM BIOPH RES CO, V56, P836, DOI 10.1016/0006-291X(74)90681-0; Jaeschke H, 2004, LIVER INT, V24, P85, DOI 10.1111/j.1478-3231.2004.0906.x; Jaeschke H, 2012, DRUG METAB REV, V44, P88, DOI 10.3109/03602532.2011.602688; Ji LL, 2008, EXP TOXICOL PATHOL, V60, P87, DOI 10.1016/j.etp.2007.11.010; Ji LL, 2008, ENVIRON TOXICOL PHAR, V26, P331, DOI 10.1016/j.etap.2008.06.007; Ji LL, 2008, TOXICOL APPL PHARM, V231, P393, DOI 10.1016/j.taap.2008.05.015; Ji LL, 2010, HUM EXP TOXICOL, V29, P303, DOI 10.1177/0960327110361757; Ji LL, 2009, J CELL BIOCHEM, V108, P424, DOI 10.1002/jcb.22269; Ji LL, 2002, TOXICON, V40, P1685, DOI 10.1016/S0041-0101(02)00184-8; Jiang J., 2008, PHARM CLIN RES, V16, P178; Jie QF, 2013, ALCOHOL, V47, P141, DOI 10.1016/j.alcohol.2012.10.006; Krause RJ, 2006, CHEM RES TOXICOL, V19, P1643, DOI 10.1021/tx0601915; KUHARA K, 1980, CANCER LETT, V10, P117, DOI 10.1016/0304-3835(80)90034-8; Laverty HG, 2010, EUR J CLIN PHARMACOL, V66, P961, DOI 10.1007/s00228-010-0862-x; Li N, 2011, CURR DRUG METAB, V12, P823, DOI 10.2174/138920011797470119; Liang QN, 2011, ARCH TOXICOL, V85, P1267, DOI 10.1007/s00204-011-0664-7; Lin G, 2007, DRUG METAB DISPOS, V35, P607, DOI 10.1124/dmd.106.014100; Lin G, 2011, J HEPATOL, V54, P666, DOI 10.1016/j.jhep.2010.07.031; Ma Hong-Yan, 2009, Chinese Journal of Natural Medicines, V7, P28, DOI 10.3724/SP.J.1009.2009.00028; Ma Hongyan, 2011, Zhongguo Zhong Yao Za Zhi, V36, P166; Mancuso C, 2009, CURR DRUG METAB, V10, P579, DOI 10.2174/138920009789375405; MIRANDA CL, 1991, CARCINOGENESIS, V12, P515, DOI 10.1093/carcin/12.3.515; Miriyala S, 2012, BBA-MOL BASIS DIS, V1822, P794, DOI 10.1016/j.bbadis.2011.12.002; Naumann C, 2002, P NATL ACAD SCI USA, V99, P6085, DOI 10.1073/pnas.082674499; Roeder E, 2000, PHARMAZIE, V55, P711; ROEDER E, 1995, PHARMAZIE, V50, P83; Wang JF, 2013, J BIOGEOGR, V40, P1741, DOI 10.1111/jbi.12114; Wang YP, 2005, CANCER LETT, V226, P27, DOI 10.1016/j.canlet.2004.11.039; Yamamoto Y, 1998, RECENT RES CANCER, V147, P157; Yousef MI, 2010, FOOD CHEM TOXICOL, V48, P3246, DOI 10.1016/j.fct.2010.08.034; Yuan LY, 2009, MOL ASPECTS MED, V30, P29, DOI 10.1016/j.mam.2008.08.003	38	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98970	10.1371/journal.pone.0098970	http://dx.doi.org/10.1371/journal.pone.0098970			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905073	Green Submitted, Green Published, gold			2022-12-27	WOS:000341869000084
J	Liang, XD; Dai, YC; Li, ZY; Gan, MF; Zhang, SR; Yin-Pan; Lu, HS; Cao, XQ; Zheng, BJ; Bao, LF; Wang, DD; Zhang, LM; Ma, SL				Liang, Xiao-Dong; Dai, Yue-Chu; Li, Zhao-Yun; Gan, Mei-Fu; Zhang, Shi-Rong; Yin-Pan; Lu, Hong-Sheng; Cao, Xue-Quan; Zheng, Bei-jia; Bao, Ling-Fen; Wang, Dan-Dan; Zhang, Li-Ming; Ma, Sheng-Lin			Expression and Function Analysis of Mitotic Checkpoint Genes Identifies TTK as a Potential Therapeutic Target for Human Hepatocellular Carcinoma	PLOS ONE			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; PROTEIN PHOSPHATASE; CANCER-CELLS; SORAFENIB; GLIOBLASTOMA; MITOSIS; GROWTH; INHIBITION; ANEUPLOIDY; MUTATIONS	The mitotic spindle checkpoint (SAC) genes have been considered targets of anticancer therapies. Here, we sought to identify the attractive mitotic spindle checkpoint genes appropriate for human hepatocellular carcinoma (HCC) therapies. Through expression profile analysis of 137 selected mitotic spindle checkpoint genes in the publicly available microarray datasets, we showed that 13 genes were dramatically up-regulated in HCC tissues compared to normal livers and adjacent non-tumor tissues. A role of the 13 genes in proliferation was evaluated by knocking them down via small interfering RNA (siRNA) in HCC cells. As a result, several mitotic spindle checkpoint genes were required for maintaining the proliferation of HCC cells, demonstrated by cell viability assay and soft agar colony formation assay. Then we established sorafenib-resistant sublines of HCC cell lines Huh7 and HepG2. Intriguingly, increased TTK expression was significantly associated with acquired sorafenib-resistance in Huh7, HepG2 cells. More importantly, TTK was observably up-regulated in 46 (86.8%) of 53 HCC specimens. A series of in vitro and in vivo functional experiment assays showed that TTK overexpression promoted cell proliferation, anchor-dependent colony formation and resistance to sorafenib of HCC cells; TTK knockdown restrained cell growth, soft agar colony formation and resistance to sorafenib of HCC cells. Collectively, TTK plays an important role in proliferation and sorafenib resistance and could act as a potential therapeutic target for human hepatocellular carcinoma.	[Liang, Xiao-Dong; Zhang, Shi-Rong; Ma, Sheng-Lin] Nanjing Med Univ, Affiliated Hangzhou Hosp, Peoples Hosp 1, Hangzhou, Zhejiang, Peoples R China; [Dai, Yue-Chu; Li, Zhao-Yun; Yin-Pan; Lu, Hong-Sheng; Cao, Xue-Quan; Zheng, Bei-jia; Bao, Ling-Fen; Wang, Dan-Dan; Zhang, Li-Ming] Cent Hosp Taizhou City, Taizhou, Zhejiang, Peoples R China; [Gan, Mei-Fu] Wenzhou Med Univ Linhai, Taizhou Hosp, Linhai, Zhejiang, Peoples R China	Nanjing Medical University	Ma, SL (corresponding author), Nanjing Med Univ, Affiliated Hangzhou Hosp, Peoples Hosp 1, Hangzhou, Zhejiang, Peoples R China.	mashenglinhz@163.com	Zhang, Li/GWM-7501-2022; Liang, Xiaodong/S-7749-2019	Liang, xiaodong/0000-0001-9479-0936	Zhejiang Natural Science Foundation [Z13H160012]; Medical Science and Technology Fund of Zhejiang Provincial Health Department [2010KYA186]; Science Project of Taizhou City [141KY15-6]	Zhejiang Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Medical Science and Technology Fund of Zhejiang Provincial Health Department; Science Project of Taizhou City	This work was supported by grants from Zhejiang Natural Science Foundation (Z13H160012), Medical Science and Technology Fund of Zhejiang Provincial Health Department (2010KYA186), and Science Project of Taizhou City (141KY15-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blivet-Van Eggelpoel MJ, 2012, J HEPATOL, V57, P108, DOI 10.1016/j.jhep.2012.02.019; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Carr BI, 2013, J CELL PHYSIOL, V228, P1344, DOI 10.1002/jcp.24291; Chang YS, 2007, CANCER CHEMOTH PHARM, V59, P561, DOI 10.1007/s00280-006-0393-4; Chen KF, 2011, J PHARMACOL EXP THER, V337, P155, DOI 10.1124/jpet.110.175786; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Chiou JF, 2010, ANN SURG ONCOL, V17, P603, DOI 10.1245/s10434-009-0718-8; Cormier JN, 2006, J GASTROINTEST SURG, V10, P761, DOI 10.1016/j.gassur.2005.10.006; Daniel J, 2011, P NATL ACAD SCI USA, V108, P5384, DOI 10.1073/pnas.1007645108; Fisk HA, 2004, CELL CYCLE, V3, P439; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Ito Y, 2000, ONCOLOGY-BASEL, V59, P68, DOI 10.1159/000012140; Janssen Aniek, 2011, Hormones & Cancer, V2, P113, DOI 10.1007/s12672-010-0059-x; Kaposi-Novak P, 2009, CANCER RES, V69, P2775, DOI 10.1158/0008-5472.CAN-08-3357; Kim HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043223; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Li KKW, 2002, LIVER, V22, P259, DOI 10.1046/j.0106-9543.2002.01629.x; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; Liu LL, 2013, ONCOGENE; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Maciejowski J, 2010, J CELL BIOL, V190, P89, DOI 10.1083/jcb.201001050; Maire V, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063712, 10.1371/journal.pone.0077372]; Manchado E, 2012, CELL DEATH DIFFER, V19, P369, DOI 10.1038/cdd.2011.197; Masuzaki Ryota, 2008, Indian J Gastroenterol, V27, P113; Mir SE, 2010, CANCER CELL, V18, P244, DOI 10.1016/j.ccr.2010.08.011; Musacchio A, 2012, NAT STRUCT MOL BIOL, V19, P1059, DOI 10.1038/nsmb.2429; Musacchio A, 2011, PHILOS T R SOC B, V366, P3595, DOI 10.1098/rstb.2011.0072; Nakagawa H., 2012, CANC LETT; Niittymaki I, 2011, CARCINOGENESIS, V32, P305, DOI 10.1093/carcin/bgq272; Nishida N, 2013, ONCOLOGY-BASEL, V84, P93, DOI 10.1159/000345897; Palmer DH, 2013, BRIT J CANCER, V109, P888, DOI 10.1038/bjc.2013.410; Qin X, 2013, SCAND J GASTROENTERO; Saeki A, 2002, CANCER-AM CANCER SOC, V94, P2047, DOI 10.1002/cncr.10448; Tannous BA, 2013, JNCI-J NATL CANCER I, V105, P1322, DOI 10.1093/jnci/djt168; Tighe A, 2008, J CELL BIOL, V181, P893, DOI 10.1083/jcb.200712028; Uchibori K, 2012, INT J ONCOL, V40, P1005, DOI 10.3892/ijo.2011.1300; Wang XH, 2009, CELL CYCLE, V8, P1567, DOI 10.4161/cc.8.10.8489; Xin H, 2009, CANCER RES, V69, P2506, DOI 10.1158/0008-5472.CAN-08-4323; Yeh CT, 2000, CANCER RES, V60, P4697; Yu Y, 2007, CANCER RES, V67, P130, DOI 10.1158/0008-5472.CAN-06-2478; Zhai B, 2013, WORLD J HEPATOL, V5, P345, DOI 10.4254/wjh.v5.i7.345; Zhang L, 2013, CANCER LETT, V337, P125, DOI 10.1016/j.canlet.2013.05.029	43	33	33	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e97739	10.1371/journal.pone.0097739	http://dx.doi.org/10.1371/journal.pone.0097739			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905462	gold, Green Submitted, Green Published			2022-12-27	WOS:000341869000010
J	Shlyakhtenko, LS; Lushnikov, AJ; Li, M; Harris, RS; Lyubchenko, YL				Shlyakhtenko, Luda S.; Lushnikov, Alexander J.; Li, Ming; Harris, Reuben S.; Lyubchenko, Yuri L.			Interaction of APOBEC3A with DNA Assessed by Atomic Force Microscopy	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; CYTIDINE DEAMINASE; HIV-1 RESTRICTION; VIRUS TYPE-1; FOREIGN DNA; PROTEINS; VIF; BINDING	The APOBEC3 family of DNA cytosine deaminases functions block the spread of endogenous retroelements and retroviruses including HIV-1. Potency varies among family members depending on the type of parasitic substrate. APOBEC3A (A3A) is unique among the human enzymes in that it is expressed predominantly in myeloid lineage cell types, it strongly induced by innate immune agonists such as type 1 interferon, and it has the capacity to accommodate both normal and 5-methyl cytosine nucleobases Here we apply atomic force microscopy (AFM) to characterize the interaction between A3A and single- and double-stranded DNA using a hybrid DNA approach in which a single-stranded region is flanked by defined length duplexes. AFM image analyses reveal A3A binding to single-stranded DNA, and that this interaction becomes most evident (similar to 80% complex yield) at high protein-to-DNA ratios (at least 100:1). A3A is predominantly monomeric when bound to single-stranded DNA, and it is also monomeric in solution at concentrations as high as 50 nM. These properties agree well with recent, biochemical, biophysical, and structural studies. However, these characteristics contrast with those of the related enzyme APOBEC3G, which in similar assays can exist as a monomer but tends to form oligomers in a concentration-dependent manner. These AFM data indicate that A3A has intrinsic biophysical differences that distinguish it from APOBEC3G. The potential relationships between these properties and biological functions in innate immunity are discussed.	[Shlyakhtenko, Luda S.; Lushnikov, Alexander J.; Lyubchenko, Yuri L.] Univ Nebraska Med Ctr, Coll Pharm, Dept Pharmaceut Sci, Omaha, NE 68198 USA; [Li, Ming; Harris, Reuben S.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Inst Mol Virol, Ctr Genome Engn,Masonic Canc Ctr, Minneapolis, MN USA	University of Nebraska System; University of Nebraska Medical Center; University of Minnesota System; University of Minnesota Twin Cities	Lyubchenko, YL (corresponding author), Univ Nebraska Med Ctr, Coll Pharm, Dept Pharmaceut Sci, Omaha, NE 68198 USA.	ylyubchenko@unmc.edu			National Institutes of Health [1P01 GM091743-02, 5R01 GM096039-02]; National Science Foundation [EPS - 1004094]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM091743, R01GM096039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by grants from National Institutes of Health (1P01 GM091743-02, 5R01 GM096039-02), and National Science Foundation (EPS - 1004094). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albin JS, 2010, J BIOL CHEM, V285, P40785, DOI 10.1074/jbc.M110.173161; Albin JS, 2010, J VIROL, V84, P10209, DOI 10.1128/JVI.00632-10; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bulliard Y, 2011, J VIROL, V85, P1765, DOI 10.1128/JVI.01651-10; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Byeon IJL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2883; Carpenter MA, 2012, J BIOL CHEM, V287, P34801, DOI 10.1074/jbc.M112.385161; Chelico L, 2010, J BIOL CHEM, V285, P16195, DOI 10.1074/jbc.M110.107987; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Desimmie BA, 2013, J MOL BIOL; Harjes E, 2009, J MOL BIOL, V389, P819, DOI 10.1016/j.jmb.2009.04.031; Harris RS, 2006, NAT STRUCT MOL BIOL, V13, P380, DOI 10.1038/nsmb0506-380; Henry M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030036; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Holmes RK, 2007, J BIOL CHEM, V282, P2587, DOI 10.1074/jbc.M607298200; Hultquist JF, 2011, J VIROL, V85, P11220, DOI 10.1128/JVI.05238-11; Imahashi M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00250; Kitamura S, 2012, NAT STRUCT MOL BIOL, V19, P1005, DOI 10.1038/nsmb.2378; Kitamura S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00258; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; Li JH, 2014, J MOL BIOL, V426, P1296, DOI 10.1016/j.jmb.2013.12.014; Li M, 2012, ACS CHEM BIOL, V7, P506, DOI 10.1021/cb200440y; Love RP, 2012, J BIOL CHEM, V287, P30812, DOI 10.1074/jbc.M112.393181; Mbisa JL, 2010, J VIROL, V84, P5250, DOI 10.1128/JVI.02358-09; McDougall WM, 2011, BIOCHEM BIOPH RES CO, V412, P612, DOI 10.1016/j.bbrc.2011.08.009; McDougall WM, 2011, J BIOL CHEM; Miyagi E, 2010, J VIROL, V84, P11067, DOI 10.1128/JVI.01249-10; Narvaiza I, 2012, CELL CYCLE, V11, P33, DOI 10.4161/cc.11.1.18706; Narvaiza I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000439; Niewiadomska AM, 2007, J VIROL, V81, P9577, DOI 10.1128/JVI.02800-06; Ooms M, 2012, J VIROL, V86, P6097, DOI 10.1128/JVI.06570-11; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Senavirathne G, 2012, J BIOL CHEM, V287, P15826, DOI 10.1074/jbc.M112.342790; Shandilya SMD, 2010, STRUCTURE, V18, P28, DOI 10.1016/j.str.2009.10.016; Shlyakhtenko LS, 2007, BIOCHEMISTRY-US, V46, P11128, DOI 10.1021/bi701123u; Shlyakhtenko LS, 2013, J STRUCT BIOL, V184, P217, DOI 10.1016/j.jsb.2013.09.008; Shlyakhtenko Luda S, 2013, Methods Mol Biol, V931, P295, DOI 10.1007/978-1-62703-056-4_14; Shlyakhtenko LS, 2012, BIOCHEMISTRY-US, V51, P6432, DOI 10.1021/bi300733d; Shlyakhtenko LS, 2012, BIOCHEMISTRY-US, V51, P1500, DOI 10.1021/bi201863z; Shlyakhtenko LS, 2011, J BIOL CHEM, V286, P3387, DOI 10.1074/jbc.M110.195685; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; Thielen BK, 2007, PLOS PATHOG, V3, P1320, DOI 10.1371/journal.ppat.0030135; Wiegand HL, 2007, J VIROL, V81, P13694, DOI 10.1128/JVI.01646-07; Wijesinghe P, 2012, NUCLEIC ACIDS RES, V40, P9206, DOI 10.1093/nar/gks685	46	18	18	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99354	10.1371/journal.pone.0099354	http://dx.doi.org/10.1371/journal.pone.0099354			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905100	gold, Green Submitted, Green Published			2022-12-27	WOS:000341869000117
J	An, GP; Du, ZQ; Meng, X; Guo, T; Shang, R; Li, JF; An, FS; Li, WJ; Zhang, C				An, Guipeng; Du, Zhongqi; Meng, Xiao; Guo, Tao; Shang, Rui; Li, Jifu; An, Fengshuang; Li, Wenjing; Zhang, Cheng			Association between Low Serum Magnesium Level and Major Adverse Cardiac Events in Patients Treated with Drug-Eluting Stents for Acute Myocardial Infarction	PLOS ONE			English	Article							PLATELET-DEPENDENT THROMBOSIS; SMOOTH-MUSCLE; HEART-DISEASE; HYPOMAGNESEMIA; METAANALYSIS; MECHANISMS; MODEL; RISK	Objectives: We investigated the association of serum magnesium (Mg) levels and major adverse cardiac events (MACEs) after drug-eluting stent (DES) implantation. Background: Mg depletion plays a key role in the pathphysiologic features of diabetes mellitus, hypertension, thrombosis, arrhythmias and coronary artery disease. Whether the depletion is related to the long-term prognosis of DES implantation is not known. Methods: From 2008 to 2011, we enrolled 414 consecutive patients,50 years old who underwent DES implantation for acute coronary syndrome. Serum Mg level was analyzed and patients were followed up for a median of 24 months (interquartile range 14-32 months) for the occurrence of MACEs defined as death, myocardial infarction, stroke, and any revascularization. Results: For patients with unstable angina, no significant association between serum Mg level and MACEs was found in the multivariate model. For patients with myocardial infarction, after adjusting for age, positive family history, smoking status, hypertension, hypercholesterolemia, and diabetes at baseline, the risk was 8.11-fold higher for patients with quartile 1 than 4 Mg level (95% confidence interval 1.7-38.75; P< 0.01). In addition, when tested as a continuous variable, serum magnesium was a significant predictor for MACEs of acute myocardial infarction (HR [per 0.1 mM increase], 0.35 [95% CI, 0.19-0.63], p< 0.01), after adjustment for other confounders. Conclusions: Low serum level of Mg may be an important predictor of MACEs with DES implantation for acute myocardial infarction. Further research into the effectiveness of Mg supplementation for these patients is warranted.	[An, Guipeng; Du, Zhongqi; Meng, Xiao; Guo, Tao; Shang, Rui; Li, Jifu; An, Fengshuang; Zhang, Cheng] Shandong Univ, Qilu Hosp, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan, Shandong, Peoples R China; [An, Guipeng; Du, Zhongqi; Meng, Xiao; Guo, Tao; Shang, Rui; Li, Jifu; An, Fengshuang; Zhang, Cheng] Shandong Univ, Qilu Hosp, Chinese Minist Hlth, Jinan, Shandong, Peoples R China; [An, Guipeng; Du, Zhongqi; Meng, Xiao; Guo, Tao; Shang, Rui; Li, Jifu; An, Fengshuang; Zhang, Cheng] Shandong Univ, Qilu Hosp, Dept Cardiol, Jinan, Shandong, Peoples R China; [Li, Wenjing] Shandong Univ, Fine Arts Sch, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University	Li, WJ (corresponding author), Shandong Univ, Fine Arts Sch, Jinan, Shandong, Peoples R China.	tianya_79@163.com; zhangc@sdu.edu.cn			National Natural Science Foundation of China [81000125]; Specialized Research Fund for the Doctoral Program of Higher Education [20100131120057]; Promotive Research Fund for Young and Middle-aged Scientisits of Shandong Province [BS2012YY017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Promotive Research Fund for Young and Middle-aged Scientisits of Shandong Province	This study was supported by the National Natural Science Foundation of China (No. 81000125), Specialized Research Fund for the Doctoral Program of Higher Education (20100131120057) and Promotive Research Fund for Young and Middle-aged Scientisits of Shandong Province (BS2012YY017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amighi J, 2004, STROKE, V35, P22, DOI 10.1161/01.STR.0000105928.95124.1F; Chakraborti S, 2002, MOL CELL BIOCHEM, V238, P163, DOI 10.1023/A:1019998702946; Cojocaru Inimioara Mihaela, 2007, Rom J Intern Med, V45, P269; Dasgupta Arundhati, 2012, Indian J Endocrinol Metab, V16, P1000, DOI 10.4103/2230-8210.103020; Dong JY, 2011, DIABETES CARE, V34, P2116, DOI 10.2337/dc11-0518; Fiset C, 1996, J AM COLL CARDIOL, V27, P1771, DOI 10.1016/0735-1097(96)00089-7; Ford ES, 1999, INT J EPIDEMIOL, V28, P645, DOI 10.1093/ije/28.4.645; GARTSIDE PS, 1995, J AM COLL NUTR, V14, P71; Ishikawa K, 2012, J INVASIVE CARDIOL, V24, P178; Khan AM, 2013, CIRCULATION, V127, P33, DOI 10.1161/CIRCULATIONAHA.111.082511; Kirtane AJ, 2009, CIRCULATION, V119, P3198, DOI 10.1161/CIRCULATIONAHA.108.826479; Lima MD, 2009, DIABETES RES CLIN PR, V83, P257, DOI 10.1016/j.diabres.2008.11.019; Luscher TF, 2007, CIRCULATION, V115, P1051, DOI 10.1161/CIRCULATIONAHA.106.675934; Morrill GA, 1997, FEBS LETT, V408, P191, DOI 10.1016/S0014-5793(97)00420-1; Peacock JM, 2010, AM HEART J, V160, P464, DOI 10.1016/j.ahj.2010.06.012; Pollak A, 2004, EUR HEART J, V25, P240, DOI 10.1016/j.ehj.2003.10.028; Qin SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072710; RASMUSSEN HS, 1986, ARCH INTERN MED, V146, P872, DOI 10.1001/archinte.146.5.872; Ravn HB, 1996, BLOOD COAGUL FIBRIN, V7, P241, DOI 10.1097/00001721-199603000-00033; Reffelmann T, 2011, ATHEROSCLEROSIS, V219, P280, DOI 10.1016/j.atherosclerosis.2011.05.038; ROTH A, 1994, NEW STATESMAN SOC, V7, P9; Roukoz H, 2009, AM J MED, V122, DOI 10.1016/j.amjmed.2008.12.019; Shechter M, 2000, AM HEART J, V140, P212, DOI 10.1067/mhj.2000.107553; Shechter M, 1999, AM J CARDIOL, V84, P152, DOI 10.1016/S0002-9149(99)00225-8; Shechter M, 2000, CIRCULATION, V102, P2353, DOI 10.1161/01.CIR.102.19.2353; Sherer Y, 2001, MAGNESIUM RES, V14, P173; Shivakumar K, 2001, MED HYPOTHESES, V56, P110, DOI 10.1054/mehy.2000.1123; Sternberg K, 2012, J BIOMED MATER RES B, V100B, P41, DOI 10.1002/jbm.b.31918; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058	29	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98971	10.1371/journal.pone.0098971	http://dx.doi.org/10.1371/journal.pone.0098971			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901943	Green Published, Green Submitted, gold			2022-12-27	WOS:000336841400081
J	Coumailleau, F; Schweisguth, F				Coumailleau, Franck; Schweisguth, Francois			Insensible Is a Novel Nuclear Inhibitor of Notch Activity in Drosophila	PLOS ONE			English	Article							ORGAN PRECURSOR CELL; SPLIT COMPLEX GENES; HAIRLESS; SUPPRESSOR; BINDING; PROTEIN; COREPRESSOR; ACTIVATION; REPRESSION; FATE	Notch signalling regulates a wide range of developmental processes. In the Drosophila peripheral nervous system, Notch regulates a series of binary fate decisions that lead to the formation of regularly spaced sensory organs. Each sensory organ is generated by single sensory organ precursor cell (SOP) via a series of asymmetric cell divisions. Starting from a SOP-specific Cis-Regulatory Module (CRM), we identified insensible (insb), a.k.a CG6520, as a SOP/neuron-specific gene encoding a nuclear factor that inhibits Notch signalling activity. First, over-expression of Insb led to the transcriptional repression of a Notch reporter and to phenotypes associated with the inhibition of Notch. Second, while the complete loss of insb activity had no significant phenotype, it enhanced the bristle phenotype associated with reduced levels of Hairless, a nuclear protein acting as a co-repressor for Suppressor of Hairless. In conclusion, our work identified Insb as a novel SOP/neuron-specific nuclear inhibitor of Notch activity in Drosophila.	[Coumailleau, Franck; Schweisguth, Francois] Inst Pasteur, Dev & Stem Cell Biol Dept, Paris, France; [Coumailleau, Franck; Schweisguth, Francois] CNRS, URA2578, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Schweisguth, F (corresponding author), Inst Pasteur, Dev & Stem Cell Biol Dept, Paris, France.	fschweis@pasteur.fr		COUMAILLEAU, Franck/0000-0002-1392-5665	CNRS; Institut Pasteur	CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut Pasteur(European Commission)	This work was funded by the CNRS and Institut Pasteur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; BANG AG, 1991, DEVELOPMENT, V111, P89; Bang AG, 1995, DEV BIOL, V172, P479, DOI 10.1006/dbio.1995.8033; BANG AG, 1992, GENE DEV, V6, P1752, DOI 10.1101/gad.6.9.1752; BROU C, 1994, GENE DEV, V8, P2491, DOI 10.1101/gad.8.20.2491; Castel D, 2013, GENE DEV, V27, P1059, DOI 10.1101/gad.211912.112; Castro B, 2005, DEVELOPMENT, V132, P3333, DOI 10.1242/dev.01920; Dai Q, 2013, DEVELOPMENT, V140, P1892, DOI 10.1242/dev.087502; DOU SB, 1994, MOL CELL BIOL, V14, P3310, DOI 10.1128/MCB.14.5.3310; Duan H, 2011, EMBO J, V30, P3120, DOI 10.1038/emboj.2011.218; Furriols M, 2001, CURR BIOL, V11, P60, DOI 10.1016/S0960-9822(00)00044-0; Furriols M, 2000, DEV BIOL, V227, P520, DOI 10.1006/dbio.2000.9923; Gho M, 1999, DEVELOPMENT, V126, P3573; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; Housden B, 2012, G3-GENES GENOM GENET, V2, P79, DOI 10.1534/g3.111.001321; Hsieh JJD, 1999, P NATL ACAD SCI USA, V96, P23, DOI 10.1073/pnas.96.1.23; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Koelzer S, 2003, DEVELOPMENT, V130, P1973, DOI 10.1242/dev.00426; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Krejci A, 2007, GENE DEV, V21, P1322, DOI 10.1101/gad.424607; LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598; Micchelli CA, 1997, DEVELOPMENT, V124, P1485; Morel V, 2000, GENE DEV, V14, P377; Morel V, 2001, CURR BIOL, V11, P789, DOI 10.1016/S0960-9822(01)00224-X; Mulligan P, 2011, MOL CELL, V42, P689, DOI 10.1016/j.molcel.2011.04.020; Nagel AC, 2005, MOL CELL BIOL, V25, P10433, DOI 10.1128/MCB.25.23.10433-10441.2005; Oswald F, 2005, MOL CELL BIOL, V25, P10379, DOI 10.1128/MCB.25.23.10379-10390.2005; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Rouault H, 2010, P NATL ACAD SCI USA, V107, P14615, DOI 10.1073/pnas.1002876107; Schweisguth F, 1998, DEV GENES EVOL, V208, P19, DOI 10.1007/s004270050149; SCHWEISGUTH F, 1992, CELL, V69, P1199, DOI 10.1016/0092-8674(92)90641-O; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Venken KJT, 2009, NAT METHODS, V6, P431, DOI [10.1038/NMETH.1331, 10.1038/nmeth.1331]; Yatim A, 2012, MOL CELL, V48, P445, DOI 10.1016/j.molcel.2012.08.022; Zheng L, 2008, MECH DEVELOP, V125, P18, DOI 10.1016/j.mod.2007.10.007	37	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98213	10.1371/journal.pone.0098213	http://dx.doi.org/10.1371/journal.pone.0098213			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24902027	Green Published, Green Submitted, gold			2022-12-27	WOS:000336841400019
J	Frei, ER; Ghazoul, J; Pluess, AR				Frei, Esther R.; Ghazoul, Jaboury; Pluess, Andrea R.			Plastic Responses to Elevated Temperature in Low and High Elevation Populations of Three Grassland Species	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; CLIMATE-CHANGE; LOCAL ADAPTATION; MATURATION TEMPERATURE; PHENOLOGICAL RESPONSE; HABITAT FRAGMENTATION; ALTITUDINAL GRADIENT; ADAPTIVE PLASTICITY; PLANT-RESPONSES; RAPID EVOLUTION	Local persistence of plant species in the face of climate change is largely mediated by genetic adaptation and phenotypic plasticity. In species with a wide altitudinal range, population responses to global warming are likely to differ at contrasting elevations. In controlled climate chambers, we investigated the responses of low and high elevation populations (1200 and 1800 m a.s.l.) of three nutrient-poor grassland species, Trifolium montanum, Ranunculus bulbosus, and Briza media, to ambient and elevated temperature. We measured growth-related, reproductive and phenological traits, evaluated differences in trait plasticity and examined whether trait values or plasticities were positively related to approximate fitness and thus under selection. Elevated temperature induced plastic responses in several growth-related traits of all three species. Although flowering phenology was advanced in T. montanum and R. bulbosus, number of flowers and reproductive allocation were not increased under elevated temperature. Plasticity differed between low and high elevation populations only in leaf traits of T. montanum and B. media. Some growth-related and phenological traits were under selection. Moreover, plasticities were not correlated with approximate fitness indicating selectively neutral plastic responses to elevated temperature. The observed plasticity in growth-related and phenological traits, albeit variable among species, suggests that plasticity is an important mechanism in mediating plant responses to elevated temperature. However, the capacity of species to respond to climate change through phenotypic plasticity is limited suggesting that the species additionally need evolutionary adaptation to adjust to climate change. The observed selection on several growth-related and phenological traits indicates that the study species have the potential for future evolution in the context of a warming climate.	[Frei, Esther R.; Ghazoul, Jaboury; Pluess, Andrea R.] ETH, Dept Environm Syst Sci, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Frei, ER (corresponding author), WSL Inst Snow & Avalanche Res SLF, Davos, Switzerland.	esther.frei@slf.ch	Ghazoul, Jaboury/B-2121-2018	Frei, Esther R./0000-0003-1910-7900	Swiss National Science Foundation [3100A0-116277]; Competence Center Environment and Sustainability (CCES) BioChange; Basler Stiftung fur biologische Forschung	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Competence Center Environment and Sustainability (CCES) BioChange; Basler Stiftung fur biologische Forschung	This study was funded by the Swiss National Science Foundation No. 3100A0-116277 (www.snf.ch) to J.G. and A. R. P., the Competence Center Environment and Sustainability (CCES) BioChange (http://www.cces.ethz.ch/projects/clench/BioChange) to J.G., and the Basler Stiftung fur biologische Forschung to E. R. F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeschimann D, 2004, FLORA ALPINA; Arft AM, 1999, ECOL MONOGR, V69, P491, DOI 10.1890/0012-9615(1999)069[0491:ROTPTE]2.0.CO;2; Atkin OK, 2006, J EXP BOT, V57, P267, DOI 10.1093/jxb/erj029; BARLING DM, 1955, J ECOL, V43, P207, DOI 10.2307/2257130; Becker U, 2006, OECOLOGIA, V150, P506, DOI 10.1007/s00442-006-0534-9; Begert M, 2003, HOMOGENISIERUNG KLIM; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; BURGER R, 1995, EVOLUTION, V49, P151, DOI 10.1111/j.1558-5646.1995.tb05967.x; Byars SG, 2007, EVOLUTION, V61, P2925, DOI 10.1111/j.1558-5646.2007.00248.x; Bylesjo M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-82; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; COLEMAN JS, 1994, TRENDS ECOL EVOL, V9, P187, DOI 10.1016/0169-5347(94)90087-6; COLES S M, 1973, Watsonia, V9, P207; Collingham YC, 2000, ECOL APPL, V10, P131, DOI 10.1890/1051-0761(2000)010[0131:IOHFAP]2.0.CO;2; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Davis MB, 2005, ECOLOGY, V86, P1704, DOI 10.1890/03-0788; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; De Frenne P, 2011, GLOBAL CHANGE BIOL, V17, P3240, DOI 10.1111/j.1365-2486.2011.02449.x; De Valpine P, 2001, ECOLOGY, V82, P637, DOI 10.1890/0012-9658(2001)082[0637:PRTEWI]2.0.CO;2; Didiano TJ, 2014, J ECOL, V102, P584, DOI 10.1111/1365-2745.12227; Diggle PK, 1997, AM J BOT, V84, P154, DOI 10.2307/2446077; Dixon JM, 2002, J ECOL, V90, P737, DOI 10.1046/j.1365-2745.2002.00684.x; Donnelly A, 2012, CLIM RES, V53, P245, DOI 10.3354/cr01102; Draghi JA, 2012, EVOLUTION, V66, P2891, DOI 10.1111/j.1558-5646.2012.01649.x; Dudley SA, 1996, AM NAT, V147, P445, DOI 10.1086/285860; Edenhofer O., 2014, CONTRIBUTION WORKING; Elmendorf SC, 2012, ECOL LETT, V15, P164, DOI 10.1111/j.1461-0248.2011.01716.x; Engler R, 2011, GLOBAL CHANGE BIOL, V17, P2330, DOI 10.1111/j.1365-2486.2010.02393.x; Etterson JR, 2001, SCIENCE, V294, P151, DOI 10.1126/science.1063656; Etterson JR, 2004, EVOLUTION, V58, P1446, DOI 10.1111/j.0014-3820.2004.tb01726.x; Faraway J.J., 2005, LINEAR MODELS R; Fischer SF, 1996, J APPL ECOL, V33, P1206, DOI 10.2307/2404699; Franks SJ, 2007, P NATL ACAD SCI USA, V104, P1278, DOI 10.1073/pnas.0608379104; Frei E, 2010, BOT HELV, V120, P117, DOI 10.1007/s00035-010-0076-y; Frei ER, 2014, GLOBAL CHANGE BIOL, V20, P441, DOI 10.1111/gcb.12403; Funk JL, 2008, J ECOL, V96, P1162, DOI 10.1111/j.1365-2745.2008.01435.x; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Gianoli E, 2005, EVOL ECOL, V19, P603, DOI 10.1007/s10682-005-2220-5; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; GOLDSTEIN G, 1985, OECOLOGIA, V68, P147, DOI 10.1007/BF00379487; Gonzalo-Turpin H, 2009, J ECOL, V97, P742, DOI 10.1111/j.1365-2745.2009.01509.x; Gottfried M, 2012, NAT CLIM CHANGE, V2, P111, DOI [10.1038/nclimate1329, 10.1038/NCLIMATE1329]; Grime J P, 1986, Symp Soc Exp Biol, V40, P5; Hahn MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050284; Hahn T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041608; Hegland SJ, 2009, ECOL LETT, V12, P184, DOI 10.1111/j.1461-0248.2008.01269.x; Heschel MS, 2004, INT J PLANT SCI, V165, P817, DOI 10.1086/421477; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Honnay O, 2002, ECOL LETT, V5, P525, DOI 10.1046/j.1461-0248.2002.00346.x; HOPKINS W. G., 2008, INTRO PLANT PHYSL, VFourth; HUNTLEY B, 1991, ANN BOT-LONDON, V67, P15, DOI 10.1093/oxfordjournals.aob.a088205; Inouye DW, 2008, ECOLOGY, V89, P353, DOI 10.1890/06-2128.1; Joshi J, 2001, ECOL LETT, V4, P536, DOI 10.1046/j.1461-0248.2001.00262.x; Jump AS, 2005, ECOL LETT, V8, P1010, DOI 10.1111/j.1461-0248.2005.00796.x; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; Kingsolver JG, 2007, BIOSCIENCE, V57, P561, DOI 10.1641/B570706; Kochanek J, 2010, AUSTRAL ECOL, V35, P837, DOI 10.1111/j.1442-9993.2010.02118.x; Korner C., 2003, ALPINE PLANT LIFE FU, V2nd ed.; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; Lande R, 2009, J EVOLUTION BIOL, V22, P1435, DOI 10.1111/j.1420-9101.2009.01754.x; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lesica P, 2004, J VEG SCI, V15, P679, DOI 10.1111/j.1654-1103.2004.tb02310.x; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; Macel M, 2007, ECOLOGY, V88, P424, DOI 10.1890/0012-9658(2007)88[424:CVSFIL]2.0.CO;2; Matesanz S, 2010, ANN NY ACAD SCI, V1206, P35, DOI 10.1111/j.1749-6632.2010.05704.x; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Menzel A, 2003, CLIMATIC CHANGE, V57, P243, DOI 10.1023/A:1022880418362; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Molau U, 1997, GLOB CHANGE BIOL, V3, P97, DOI 10.1111/j.1365-2486.1997.gcb138.x; Nicotra AB, 2010, TRENDS PLANT SCI, V15, P684, DOI 10.1016/j.tplants.2010.09.008; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; PARSONS AN, 1995, OIKOS, V72, P61, DOI 10.2307/3546038; POLLOCK CJ, 1990, J AGR SCI, V115, P1, DOI 10.1017/S0021859600073834; Pratt JD, 2013, GLOBAL CHANGE BIOL, V19, P2454, DOI 10.1111/gcb.12199; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; Pulido F, 2004, ADV ECOL RES, V35, P151, DOI 10.1016/S0065-2504(04)35008-7; Qaderi MM, 2006, CAN J BOT, V84, P28, DOI [10.1139/B05-139, 10.1139/b05-139]; R Core Team, 2021, R LANGUAGE ENV STAT; RAUSHER MD, 1992, EVOLUTION, V46, P616, DOI 10.1111/j.1558-5646.1992.tb02070.x; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; ROUGHLEY RJ, 1970, J EXP BOT, V21, P776, DOI 10.1093/jxb/21.3.776; SARUKHAN J, 1973, J ECOL, V61, P675, DOI 10.2307/2258643; Schleuning M, 2009, BASIC APPL ECOL, V10, P61, DOI 10.1016/j.baae.2007.12.002; Springate DA, 2014, GLOBAL CHANGE BIOL, V20, P456, DOI 10.1111/gcb.12430; Steadman KJ, 2004, AUST J AGR RES, V55, P1047, DOI 10.1071/AR04083; STEINBACH K, 1994, PHYTON-ANN REI BOT A, V34, P203; Sultan SE, 2002, AM NAT, V160, P271, DOI 10.1086/341015; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomson JD, 2010, PHILOS T R SOC B, V365, P3187, DOI 10.1098/rstb.2010.0115; Valladares F, 2006, J ECOL, V94, P1103, DOI 10.1111/j.1365-2745.2006.01176.x; van Kleunen M, 2007, J EVOLUTION BIOL, V20, P2126, DOI 10.1111/j.1420-9101.2007.01431.x; Van Kleunen M, 2001, ECOLOGY, V82, P3309, DOI 10.1890/0012-9658(2001)082[3309:AEOPFR]2.0.CO;2; van Kleunen M, 2005, NEW PHYTOL, V166, P49, DOI 10.1111/j.1469-8137.2004.01296.x; van Vliet AJH, 2003, INT J BIOMETEOROL, V47, P202, DOI 10.1007/s00484-003-0174-2; VIA S, 1985, EVOLUTION, V39, P505, DOI [10.2307/2408649, 10.1111/j.1558-5646.1985.tb00391.x]; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Vitasse Y, 2014, FUNCT ECOL, V28, P243, DOI 10.1111/1365-2435.12161; Vitasse Y, 2013, OECOLOGIA, V171, P663, DOI 10.1007/s00442-012-2580-9; Walker MD, 2006, P NATL ACAD SCI USA, V103, P1342, DOI 10.1073/pnas.0503198103; Walther GR, 2005, J VEG SCI, V16, P541, DOI 10.1111/j.1654-1103.2005.tb02394.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warwick KR, 1998, GLOB CHANGE BIOL, V4, P375, DOI 10.1046/j.1365-2486.1998.00159.x; Weiner J., 1988, Plant reproductive ecology: patterns and strategies, P228; Weiner J, 1997, J ECOL, V85, P133, DOI 10.2307/2960645; Welker JM, 1997, GLOB CHANGE BIOL, V3, P61, DOI 10.1111/j.1365-2486.1997.gcb143.x; Whitney KD, 2008, DIVERS DISTRIB, V14, P569, DOI 10.1111/j.1472-4642.2008.00473.x; Wilczek AM, 2009, SCIENCE, V323, P930, DOI 10.1126/science.1165826; Wolfe DW, 2005, INT J BIOMETEOROL, V49, P303, DOI 10.1007/s00484-004-0248-9	113	22	23	2	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98677	10.1371/journal.pone.0098677	http://dx.doi.org/10.1371/journal.pone.0098677			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901500	Green Submitted, Green Published, gold			2022-12-27	WOS:000336841400044
J	Ghouila, A; Florent, I; Guerfali, FZ; Terrapon, N; Laouini, D; Ben Yahia, S; Gascuel, O; Brehelin, L				Ghouila, Amel; Florent, Isabelle; Guerfali, Fatma Zahra; Terrapon, Nicolas; Laouini, Dhafer; Ben Yahia, Sadok; Gascuel, Olivier; Brehelin, Laurent			Identification of Divergent Protein Domains by Combining HMM-HMM Comparisons and Co-Occurrence Detection	PLOS ONE			English	Article							HIDDEN MARKOV-MODELS; PARASITE PLASMODIUM-FALCIPARUM; RNA-POLYMERASE-II; COMPARATIVE GENOMICS; TRANSCRIPTION FACTORS; SHIKIMATE PATHWAY; CRYSTAL-STRUCTURE; HOST-CELL; SEQUENCE; BINDING	Identification of protein domains is a key step for understanding protein function. Hidden Markov Models (HMMs) have proved to be a powerful tool for this task. The Pfam database notably provides a large collection of HMMs which are widely used for the annotation of proteins in sequenced organisms. This is done via sequence/HMM comparisons. However, this approach may lack sensitivity when searching for domains in divergent species. Recently, methods for HMM/HMM comparisons have been proposed and proved to be more sensitive than sequence/HMM approaches in certain cases. However, these approaches are usually not used for protein domain discovery at a genome scale, and the benefit that could be expected from their utilization for this problem has not been investigated. Using proteins of P. falciparum and L. major as examples, we investigate the extent to which HMM/HMM comparisons can identify new domain occurrences not already identified by sequence/HMM approaches. We show that although HMM/HMM comparisons are much more sensitive than sequence/HMM comparisons, they are not sufficiently accurate to be used as a standalone complement of sequence/HMM approaches at the genome scale. Hence, we propose to use domain co-occurrence - the general domain tendency to preferentially appear along with some favorite domains in the proteins - to improve the accuracy of the approach. We show that the combination of HMM/HMM comparisons and co-occurrence domain detection boosts protein annotations. At an estimated False Discovery Rate of 5%, it revealed 901 and 1098 new domains in Plasmodium and Leishmania proteins, respectively. Manual inspection of part of these predictions shows that it contains several domain families that were missing in the two organisms. All new domain occurrences have been integrated in the EuPathDomains database, along with the GO annotations that can be deduced.	[Ghouila, Amel; Gascuel, Olivier; Brehelin, Laurent] Univ Montpellier 2, CNRS, LIRMM, Inst Biol Computat, Montpellier, France; [Ghouila, Amel; Ben Yahia, Sadok] Fac Sci Tunis, Dept Comp Sci, Tunis 1060, Tunisia; [Florent, Isabelle] Museum Natl Hist Nat, CNRS, Mol Commun & Adaptat Microorganismes UMR7245, Paris, France; [Guerfali, Fatma Zahra; Laouini, Dhafer] Inst Pasteur Tunis, LR11IPT02, LTCII, Tunis, Tunisia; [Guerfali, Fatma Zahra; Laouini, Dhafer] Univ Tunis El Manar, Tunis, Tunisia; [Terrapon, Nicolas] Aix Marseille Univ, CNRS, UMR 7257, AFMB, Marseille, France	Centre National de la Recherche Scientifique (CNRS); Universite Paul-Valery; Universite Perpignan Via Domitia; Universite de Montpellier; Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Tunis-El-Manar; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Brehelin, L (corresponding author), Univ Montpellier 2, CNRS, LIRMM, Inst Biol Computat, Montpellier, France.	brehelin@lirmm.fr	Terrapon, Nicolas/AAA-9033-2019; Florent, Isabelle/M-6838-2019; Guerfali, Fatma/S-8626-2019; BEN YAHIA, Sadok/C-8239-2019; Terrapon, Nicolas/O-3630-2014; Laouini, Dhafer/Q-6535-2019	Terrapon, Nicolas/0000-0002-3693-6017; Florent, Isabelle/0000-0002-7140-6417; BEN YAHIA, Sadok/0000-0001-8939-8948; Terrapon, Nicolas/0000-0002-3693-6017; Laouini, Dhafer/0000-0003-1222-4880; Guerfali, Fatma/0000-0002-6973-2870	French National Research Agency: PlasmoExpress project (ANR JCJC)	French National Research Agency: PlasmoExpress project (ANR JCJC)(French National Research Agency (ANR))	This research work was supported by the French National Research Agency: PlasmoExpress project (ANR JCJC2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apic G, 2001, J MOL BIOL, V310, P311, DOI 10.1006/jmbi.2001.4776; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Battey JND, 2007, PROTEINS, V69, P68, DOI 10.1002/prot.21761; Baxt LA, 2008, GENE DEV, V22, P1636, DOI 10.1101/gad.1667708; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Besteiro S, 2007, INT J PARASITOL, V37, P1063, DOI 10.1016/j.ijpara.2007.03.008; Bonin I, 2004, BIOCHEM J, V383, P419, DOI 10.1042/BJ20040889; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Bourbon HM, 2004, MOL CELL, V14, P553, DOI 10.1016/j.molcel.2004.05.011; Brehelin L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-35; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Cohen G, 2007, BMC GENOMICS, V8; DEJONG J, 1995, P NATL ACAD SCI USA, V92, P3313, DOI 10.1073/pnas.92.8.3313; Dlakic M, 2009, BIOINFORMATICS, V25, P3071, DOI 10.1093/bioinformatics/btp555; Durbin R., 1998, BIOL SEQUENCE ANAL P; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Eddy SR, 1996, CURR OPIN STRUC BIOL, V6, P361, DOI 10.1016/S0959-440X(96)80056-X; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Forslund K, 2008, BIOINFORMATICS, V24, P1681, DOI 10.1093/bioinformatics/btn312; Friedrich N, 2010, J BIOL CHEM, V285, P2064, DOI 10.1074/jbc.M109.060988; Ghouila A, 2011, INFECT GENET EVOL, V11, P698, DOI 10.1016/j.meegid.2010.09.008; Gopal B, 2000, NAT STRUCT BIOL, V7, P475; Hager KM, 2008, TRENDS PARASITOL, V24, P51, DOI 10.1016/j.pt.2007.10.008; Hegyi H, 2001, GENOME RES, V11, P1632, DOI 10.1101/gr. 183801; Horrocks P, 2009, MOL BIOCHEM PARASIT, V164, P9, DOI 10.1016/j.molbiopara.2008.11.010; Iyer LM, 2008, INT J PARASITOL, V38, P1, DOI 10.1016/j.ijpara.2007.07.018; JORIS B, 1992, FEMS MICROBIOL LETT, V91, P257; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; McConkey GA, 2004, TRENDS PARASITOL, V20, P60, DOI 10.1016/j.pt.2003.11.001; Nunes MC, 2007, MOL MICROBIOL, V63, P391, DOI 10.1111/j.1365-2958.2006.05521.x; Ochoa A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-90; Pan GH, 1997, J BIOL CHEM, V272, P24563, DOI 10.1074/jbc.272.39.24563; Pasek Sophie, 2007, V396, P17; Passos-Silva DG, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/840768; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Richards TA, 2006, EUKARYOT CELL, V5, P1517, DOI 10.1128/EC.00106-06; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Santos JM, 2012, MOL BIOCHEM PARASIT, V182, P27, DOI 10.1016/j.molbiopara.2011.11.010; Sato Y, 2001, GENES GENET SYST, V76, P373, DOI 10.1266/ggs.76.373; SELBY CP, 1995, J BIOL CHEM, V270, P4882, DOI 10.1074/jbc.270.9.4882; Severinov K, 1996, J BIOL CHEM, V271, P27969, DOI 10.1074/jbc.271.44.27969; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Soding J, 2011, CURR OPIN STRUC BIOL, V21, P404, DOI 10.1016/j.sbi.2011.03.005; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Tan S, 1996, NATURE, V381, P127, DOI 10.1038/381127a0; Terrapon N, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-67; Terrapon N, 2009, BIOINFORMATICS, V25, P3077, DOI 10.1093/bioinformatics/btp560; Thompson J, 2007, CELL MICROBIOL, V9, P1466, DOI 10.1111/j.1462-5822.2006.00885.x; Tian WD, 2003, J MOL BIOL, V333, P863, DOI 10.1016/j.jmb.2003.08.057; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Weisberg RA, 1999, J BACTERIOL, V181, P359, DOI 10.1128/JB.181.2.359-367.1999; Wilson RJM, 1996, J MOL BIOL, V261, P155, DOI 10.1006/jmbi.1996.0449	57	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e95275	10.1371/journal.pone.0095275	http://dx.doi.org/10.1371/journal.pone.0095275			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901648	Green Submitted, Green Published, gold			2022-12-27	WOS:000336841400003
J	Liu, ZX; Wu, YC; Guo, ZR; Liu, Y; Shen, YJ; Zhou, P; Lu, X				Liu, Zhengxia; Wu, Yucheng; Guo, Zhirui; Liu, Ying; Shen, Yujie; Zhou, Ping; Lu, Xiang			Effects of Internalized Gold Nanoparticles with Respect to Cytotoxicity and Invasion Activity in Lung Cancer Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MATRIX METALLOPROTEINASES; INHIBITION; RISK; SIZE; CHEMOTHERAPY; PROGRESSION; MOLECULES; THERAPY	The effect of gold nanoparticles on lung cancer cells is not yet clear. In this study, we investigated the cytotoxicity and cell invasion activity of lung cancer cells after treatment with gold nanoparticles and showed that small gold nanoparticles can be endocytosed by lung cancer cells and that they facilitate cell invasion. The growth of A549 cells was inhibited after treatment with 5-nm gold nanoparticles, but cell invasion increased. Endocytosed gold nanoparticles (size, 10 nm) notably promoted the invasion activity of 95D cells. All these effects of gold nanoparticles were not seen after treatment with larger particles (20 and 40 nm). The enhanced invasion activity may be associated with the increased expression of matrix metalloproteinase 9 and intercellular adhesion molecule-1. In this study, we obtained evidence for the effect of gold nanoparticles on lung cancer cell invasion activity in vitro. Moreover, matrix metalloproteinase 9 and intercellular adhesion molecule-1, key modulators of cell invasion, were found to be regulated by gold nanoparticles. These data also demonstrate that the responses of the A549 and 95D cells to gold nanoparticles have a remarkable relationship with their unique size-dependent physiochemical properties. Therefore, this study provides a new perspective for cell biology research in nanomedicine.	[Liu, Zhengxia; Wu, Yucheng; Guo, Zhirui; Liu, Ying; Shen, Yujie; Zhou, Ping; Lu, Xiang] Nanjing Med Univ, Affiliated Hosp 2, Dept Geriatr, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Lu, X (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Dept Geriatr, Nanjing, Jiangsu, Peoples R China.	luxiang66@njmu.edu.cn			National Science Foundation of China [81270428, 81300999]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by grants from the National Science Foundation of China(No.81270428 and 81300999). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkilany AM, 2010, J NANOPART RES, V12, P2313, DOI 10.1007/s11051-010-9911-8; Arvizo R, 2010, EXPERT OPIN DRUG DEL, V7, P753, DOI 10.1517/17425241003777010; Arvizo RR, 2011, NANOMED-NANOTECHNOL, V7, P580, DOI 10.1016/j.nano.2011.01.011; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Connor EE, 2005, SMALL, V1, P325, DOI 10.1002/smll.200400093; Coulter JA, 2012, INT J NANOMED, V7, P2673, DOI 10.2147/IJN.S31751; Dowlati A, 2008, CLIN CANCER RES, V14, P1407, DOI 10.1158/1078-0432.CCR-07-1154; Dreaden EC, 2012, CHEM SOC REV, V41, P2740, DOI 10.1039/c1cs15237h; Dreaden EC, 2011, CHEM SOC REV, V40, P3391, DOI 10.1039/c0cs00180e; Eccles SA, 2005, BIOTECHNOL ANN REV, V11, P391, DOI 10.1016/S1387-2656(05)11013-8; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; El-Sayed IH, 2005, NANO LETT, V5, P829, DOI 10.1021/nl050074e; Fajersztajn L, 2013, NAT REV CANCER, V13, P674, DOI 10.1038/nrc3572; FRENS G, 1973, NATURE-PHYS SCI, V241, P20, DOI 10.1038/physci241020a0; Giljohann DA, 2010, ANGEW CHEM INT EDIT, V49, P3280, DOI 10.1002/anie.200904359; Guo CB, 2007, MOL DIAGN THER, V11, P183, DOI 10.1007/BF03256240; Hamano Y, 2003, CANCER CELL, V3, P589, DOI 10.1016/S1535-6108(03)00133-8; Han SW, 2006, J BIOL CHEM, V281, P29614, DOI 10.1074/jbc.M604013200; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huang XH, 2007, NANOMEDICINE-UK, V2, P681, DOI 10.2217/17435889.2.5.681; Hung WC, 2010, CANCER LETT, V288, P156, DOI 10.1016/j.canlet.2009.06.032; Ju DW, 2012, MED ONCOL, V29, P91, DOI 10.1007/s12032-010-9780-0; Li Y, 2012, EXP THER MED, V3, P673, DOI 10.3892/etm.2012.453; Lin SS, 2009, CANCER LETT, V285, P127, DOI 10.1016/j.canlet.2009.04.037; Lin YC, 2006, CLIN CANCER RES, V12, P7165, DOI 10.1158/1078-0432.CCR-06-1393; Longmire M, 2008, NANOMEDICINE-UK, V3, P703, DOI 10.2217/17435889.3.5.703; Manegold C, 2001, LUNG CANCER, V34, pS165, DOI 10.1016/S0169-5002(01)00363-4; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Mukherjee P, 2005, CLIN CANCER RES, V11, P3530, DOI 10.1158/1078-0432.CCR-04-2482; Pan Y, 2009, SMALL, V5, P2067, DOI 10.1002/smll.200900466; Patra HK, 2007, NANOMED-NANOTECHNOL, V3, P111, DOI 10.1016/j.nano.2007.03.005; Pritchard SC, 2001, ONCOL REP, V8, P421; Rosette C, 2005, CARCINOGENESIS, V26, P943, DOI 10.1093/carcin/bgi070; Shukla R, 2005, LANGMUIR, V21, P10644, DOI 10.1021/la0513712; SLOT JW, 1985, EUR J CELL BIOL, V38, P87; Tsai SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076545; Veiseh O, 2009, SMALL, V5, P256, DOI 10.1002/smll.200800646; Weissleder R, 2006, SCIENCE, V312, P1168, DOI 10.1126/science.1125949	38	64	65	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99175	10.1371/journal.pone.0099175	http://dx.doi.org/10.1371/journal.pone.0099175			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901215	Green Submitted, gold, Green Published			2022-12-27	WOS:000336841400104
J	Abou Chakra, CN; Pepin, J; Sirard, S; Valiquette, L				Abou Chakra, Claire Nour; Pepin, Jacques; Sirard, Stephanie; Valiquette, Louis			Risk Factors for Recurrence, Complications and Mortality in Clostridium difficile Infection: A Systematic Review	PLOS ONE			English	Article							PROTON PUMP INHIBITORS; EMERGENCY COLECTOMY; 1ST RECURRENCE; COLITIS; DISEASE; PREDICTORS; OUTCOMES; EPIDEMIOLOGY; DIARRHEA; FAILURE	Background: Clostridium difficile infection (CDI) can lead to complications, recurrence, and death. Numerous studies have assessed risk factors for these unfavourable outcomes, but systematic reviews or meta-analyses published so far were limited in scope or in quality. Methods: A systematic review was completed according to PRISMA guidelines. An electronic search in five databases was performed. Studies published until October 2013 were included if risk factors for at least one CDI outcome were assessed with multivariate analyses. Results: 68 studies were included: 24 assessed risk factors for recurrence, 18 for complicated CDI, 8 for treatment failure, and 30 for mortality. Most studies accounted for mortality in the definition of complicated CDI. Important variables were inconsistently reported, such as previous episodes and use of antibiotics. Substantial heterogeneity and methodological limitations were noted, mainly in the sample size, the definition of the outcomes and periods of follow-up, precluding a meta-analysis. Older age, use of antibiotics after diagnosis, use of proton pump inhibitors, and strain type were the most frequent risk factors for recurrence. Older age, leucocytosis, renal failure and co-morbidities were frequent risk factors for complicated CDI. When considered alone, mortality was associated with age, co-morbidities, hypo-albuminemia, leucocytosis, acute renal failure, and infection with ribotype 027. Conclusion: Laboratory parameters currently used in European and American guidelines to define patients at risk of a complicated CDI are adequate. Strategies for the management of CDI should be tailored according to the age of the patient, biological markers of severity, and underlying co-morbidities.	[Abou Chakra, Claire Nour; Pepin, Jacques; Sirard, Stephanie; Valiquette, Louis] Univ Sherbrooke, Dept Microbiol & Infect Dis, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Valiquette, L (corresponding author), Univ Sherbrooke, Dept Microbiol & Infect Dis, Sherbrooke, PQ J1K 2R1, Canada.	Louis.Valiquette@USherbrooke.ca						Abou Chakra CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030258; Andrews CN, 2003, CAN J GASTROENTEROL, V17, P369, DOI 10.1155/2003/723471; Aslam S, 2005, LANCET INFECT DIS, V5, P549, DOI 10.1016/S1473-3099(05)70215-2; Bauer MP, 2009, CLIN MICROBIOL INFEC, V15, P1067, DOI 10.1111/j.1469-0691.2009.03099.x; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; Bavishi C, 2011, ALIMENT PHARM THER, V34, P1269, DOI 10.1111/j.1365-2036.2011.04874.x; Bishara J, 2008, J HOSP INFECT, V68, P308, DOI 10.1016/j.jhin.2008.01.033; Bloomfield MG, 2012, J HOSP INFECT, V82, P1, DOI 10.1016/j.jhin.2012.05.008; Byrn JC, 2008, ARCH SURG-CHICAGO, V143, P150, DOI 10.1001/archsurg.2007.46; Cadena J, 2010, AM J MED SCI, V339, P350, DOI 10.1097/MAJ.0b013e3181d3cdaa; Choi HK, 2011, J KOREAN MED SCI, V26, P859, DOI 10.3346/jkms.2011.26.7.859; Cloud J, 2009, CLIN GASTROENTEROL H, V7, P868, DOI 10.1016/j.cgh.2009.05.018; Cober ED, 2009, J AM GERIATR SOC, V57, P659, DOI 10.1111/j.1532-5415.2009.02182.x; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Das R, 2010, AM J GASTROENTEROL, V105, P2040, DOI 10.1038/ajg.2010.142; de Isusi AM, 2003, MED CLIN-BARCELONA, V121, P331, DOI 10.1157/13050841; de Jong E, 2012, EUR J CLIN MICROBIOL, V31, P2219, DOI 10.1007/s10096-012-1558-1; Do AN, 1998, CLIN INFECT DIS, V26, P954, DOI 10.1086/513952; Drekonja DM, 2011, ANN INTERN MED, V155, P839, DOI 10.7326/0003-4819-155-12-201112200-00007; Drekonja DM, 2011, AM J MED, V124, DOI 10.1016/j.amjmed.2011.05.032; Egger M, 1998, BRIT MED J, V316, P140; Eyre DW, 2012, CLIN INFECT DIS, V55, pS77, DOI 10.1093/cid/cis356; Fekety R, 1997, CLIN INFECT DIS, V24, P324, DOI 10.1093/clinids/24.3.324; Fernandez A, 2004, J CLIN GASTROENTEROL, V38, P414, DOI 10.1097/00004836-200405000-00005; Freedberg DE, 2013, AM J GASTROENTEROL, V108, P1794, DOI 10.1038/ajg.2013.333; Garey KW, 2008, J HOSP INFECT, V70, P298, DOI 10.1016/j.jhin.2008.08.012; Garey KW, 2010, CLIN INFECT DIS, V51, P1406, DOI 10.1086/657398; Gasperino J, 2010, J CRIT CARE, V25, P282, DOI 10.1016/j.jcrc.2009.04.002; Goorhuis A, 2011, CLIN INFECT DIS, V53, P860, DOI 10.1093/cid/cir549; Greenstein AJ, 2008, SURGERY, V143, P623, DOI 10.1016/j.surg.2007.12.008; Gujja D, 2009, ALIMENT PHARM THER, V29, P635, DOI 10.1111/j.1365-2036.2008.03914.x; Halabi WJ, 2013, J AM COLL SURGEONS, V217, P802, DOI 10.1016/j.jamcollsurg.2013.05.028; Hall JF, 2008, AM J SURG, V196, P384, DOI 10.1016/j.amjsurg.2007.11.017; Hardt C, 2008, WORLD J GASTROENTERO, V14, P4338, DOI 10.3748/wjg.14.4338; Henrich TJ, 2009, EMERG INFECT DIS, V15, P415, DOI 10.3201/eid1503.080312; Hensgens MPM, 2012, J ANTIMICROB CHEMOTH, V67, P742, DOI 10.1093/jac/dkr508; Herbison P, 2006, J CLIN EPIDEMIOL, V59, P1249, DOI 10.1016/j.jclinepi.2006.03.008; Hu MY, 2008, CLIN GASTROENTEROL H, V6, P1354, DOI 10.1016/j.cgh.2008.06.024; Huttunen R, 2012, INT J INFECT DIS, V16, pE532, DOI 10.1016/j.ijid.2012.02.019; Inns T, 2013, J HOSP INFECT, V84, P235, DOI 10.1016/j.jhin.2013.04.008; Jansen A, 2010, Z GASTROENTEROL, V48, P1120, DOI 10.1055/s-0029-1245269; Jung KS, 2010, GUT LIVER, V4, P332, DOI 10.5009/gnl.2010.4.3.332; Karas JA, 2010, J INFECTION, V61, P1, DOI 10.1016/j.jinf.2010.03.025; Kenneally C, 2007, CHEST, V132, P418, DOI 10.1378/chest.07-0202; Khan FY, 2012, TRAVEL MED INFECT DI, V10, P179, DOI 10.1016/j.tmaid.2012.06.004; Khanna S, 2012, MAYO CLIN PROC, V87, P636, DOI 10.1016/j.mayocp.2011.12.021; Kim ES, 2013, HEPATO-GASTROENTEROL, V60, P543; Kim JW, 2010, WORLD J GASTROENTERO, V16, P3573, DOI 10.3748/wjg.v16.i28.3573; Kim YG, 2012, J CLIN GASTROENTEROL, V46, P397, DOI 10.1097/MCG.0b013e3182431d78; Kuijper EJ, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01580.x; Kyne L, 2001, LANCET, V357, P189, DOI 10.1016/S0140-6736(00)03592-3; Kyne L, 1999, AGE AGEING, V28, P107, DOI 10.1093/ageing/28.2.107; Labbe AC, 2008, ANTIMICROB AGENTS CH, V52, P3180, DOI 10.1128/AAC.00146-08; Lamontagne F, 2007, ANN SURG, V245, P267, DOI 10.1097/01.sla.0000236628.79550.e5; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; Lavergne V, 2013, J INFECTION, V66, P129, DOI 10.1016/j.jinf.2012.11.001; Linsky A, 2010, ARCH INTERN MED, V170, P772, DOI 10.1001/archinternmed.2010.73; Longtin Y, 2013, CLIN INFECT DIS, V56, P67, DOI 10.1093/cid/cis840; Louie TJ, 2013, J AM GERIATR SOC, V61, P222, DOI 10.1111/jgs.12090; Louie TJ, 2011, NEW ENGL J MED, V364, P422, DOI 10.1056/NEJMoa0910812; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; Manek K, 2011, CAN J GASTROENTEROL, V25, P368, DOI 10.1155/2011/153020; Markelov A, 2011, AM SURGEON, V77, P977; Marra AR, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-42; Marsh JW, 2012, J CLIN MICROBIOL, V50, P4078, DOI 10.1128/JCM.02291-12; McDonald LC, 2007, INFECT CONT HOSP EP, V28, P140, DOI 10.1086/511798; McFarland LV, 1999, INFECT CONT HOSP EP, V20, P43, DOI 10.1086/501553; McFarland LV, 2009, CURR OPIN GASTROEN, V25, P24, DOI 10.1097/MOG.0b013e32831da7c4; Mitchell BG, 2012, ANTIMICROB RESIST IN, V1, DOI 10.1186/2047-2994-1-20; Moher David, 2009, Open Med, V3, pe123; Morrison RH, 2011, CLIN INFECT DIS, V53, P1173, DOI 10.1093/cid/cir668; Nelson RL, 2011, COCHRANE DB SYST REV, V9; O'Horo JC, 2014, INFECTION, V42, P43, DOI 10.1007/s15010-013-0496-x; Pant C, 2010, J INVEST MED, V58, P43, DOI 10.2310/JIM.0b013e3181bca525; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pepin J, 2006, CLIN INFECT DIS, V42, P758, DOI 10.1086/501126; Pepin J, 2005, CLIN INFECT DIS, V40, P1591, DOI 10.1086/430315; Pepin J, 2004, CAN MED ASSOC J, V171, P466, DOI 10.1503/cmaj.1041104; Pepin J, 2009, DIS COLON RECTUM, V52, P400, DOI 10.1007/DCR.0b013e31819a69aa; Perera AD, 2010, AM SURGEON, V76, P418; Petrella LA, 2012, CLIN INFECT DIS, V55, P351, DOI 10.1093/cid/cis430; Planche T, 2008, LANCET INFECT DIS, V8, P777, DOI 10.1016/S1473-3099(08)70233-0; Rao K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058265; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Sailhamer EA, 2009, ARCH SURG-CHICAGO, V144, P433, DOI 10.1001/archsurg.2009.51; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Seder CW, 2009, AM J SURG, V197, P302, DOI 10.1016/j.amjsurg.2008.11.001; Shakov R, 2011, AM J INFECT CONTROL, V39, P194, DOI 10.1016/j.ajic.2010.08.017; Shamliyan T, 2010, J CLIN EPIDEMIOL, V63, P1061, DOI 10.1016/j.jclinepi.2010.04.014; Soes LM, 2012, EUR J CLIN MICROBIOL, V31, P185, DOI 10.1007/s10096-011-1292-0; Solomon K, 2013, J MED MICROBIOL, V62, P1453, DOI 10.1099/jmm.0.058479-0; Stanley JD, 2013, CURR PROB SURG, V50, P302, DOI 10.1067/j.cpsurg.2013.02.004; Stevens V, 2011, PHARMACOEPIDEM DR S, V20, P1035, DOI 10.1002/pds.2198; Stewart DB, 2013, J GASTROINTEST SURG, V17, P118, DOI 10.1007/s11605-012-2056-6; Stewart DB, 2011, J GASTROINTEST SURG, V15, P1548, DOI 10.1007/s11605-011-1615-6; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; Thomas C, 2003, J ANTIMICROB CHEMOTH, V51, P1339, DOI 10.1093/jac/dkg254; van der Wilden GM, 2014, J PARENTER ENTERAL N, V9; Venugopal AA, 2012, SCAND J INFECT DIS, V44, P243, DOI 10.3109/00365548.2011.631029; Walk ST, 2012, CLIN INFECT DIS, V55, P1661, DOI 10.1093/cid/cis786; Walker AS, 2013, CLIN INFECT DIS, V56, P1589, DOI 10.1093/cid/cit127; Wang WJ, 2014, THER ADV GASTROENTER, V7, P14, DOI 10.1177/1756283X13502838; Wenisch JM, 2012, EUR J CLIN MICROBIOL, V31, P1923, DOI 10.1007/s10096-011-1522-5; Wilson V, 2010, CLIN INFECT DIS, V50, pE77, DOI 10.1086/653012	104	204	208	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98400	10.1371/journal.pone.0098400	http://dx.doi.org/10.1371/journal.pone.0098400			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897375	Green Submitted, Green Published, gold			2022-12-27	WOS:000338430700041
J	Chung, WC; Chen, CC; Ho, JM; Lin, CY; Hsu, WL; Wang, YC; Lee, DT; Lai, FP; Huang, CW; Chang, YJ				Chung, Wei-Chun; Chen, Chien-Chih; Ho, Jan-Ming; Lin, Chung-Yen; Hsu, Wen-Lian; Wang, Yu-Chun; Lee, D. T.; Lai, Feipei; Huang, Chih-Wei; Chang, Yu-Jung			CloudDOE: A User-Friendly Tool for Deploying Hadoop Clouds and Analyzing High-Throughput Sequencing Data with MapReduce	PLOS ONE			English	Article							FRAMEWORK	Background: Explosive growth of next-generation sequencing data has resulted in ultra-large-scale data sets and ensuing computational problems. Cloud computing provides an on-demand and scalable environment for large-scale data analysis. Using a MapReduce framework, data and workload can be distributed via a network to computers in the cloud to substantially reduce computational latency. Hadoop/MapReduce has been successfully adopted in bioinformatics for genome assembly, mapping reads to genomes, and finding single nucleotide polymorphisms. Major cloud providers offer Hadoop cloud services to their users. However, it remains technically challenging to deploy a Hadoop cloud for those who prefer to run MapReduce programs in a cluster without built-in Hadoop/MapReduce. Results: We present CloudDOE, a platform-independent software package implemented in Java. CloudDOE encapsulates technical details behind a user-friendly graphical interface, thus liberating scientists from having to perform complicated operational procedures. Users are guided through the user interface to deploy a Hadoop cloud within in-house computing environments and to run applications specifically targeted for bioinformatics, including CloudBurst, CloudBrush, and CloudRS. One may also use CloudDOE on top of a public cloud. CloudDOE consists of three wizards, i.e., Deploy, Operate, and Extend wizards. Deploy wizard is designed to aid the system administrator to deploy a Hadoop cloud. It installs Java runtime environment version 1.6 and Hadoop version 0.20.203, and initiates the service automatically. Operate wizard allows the user to run a MapReduce application on the dashboard list. To extend the dashboard list, the administrator may install a new MapReduce application using Extend wizard. Conclusions: CloudDOE is a user-friendly tool for deploying a Hadoop cloud. Its smart wizards substantially reduce the complexity and costs of deployment, execution, enhancement, and management. Interested users may collaborate to improve the source code of CloudDOE to further incorporate more MapReduce bioinformatics tools into CloudDOE and support next-generation big data open source tools, e.g., Hadoop BigTop and Spark. Availability: CloudDOE is distributed under Apache License 2.0 and is freely available at http://clouddoe.iis.sinica.edu.tw/.	[Chung, Wei-Chun; Chen, Chien-Chih; Ho, Jan-Ming; Lin, Chung-Yen; Hsu, Wen-Lian; Wang, Yu-Chun; Lee, D. T.; Huang, Chih-Wei; Chang, Yu-Jung] Acad Sinica, Inst Informat Sci, Taipei, Taiwan; [Chung, Wei-Chun; Chen, Chien-Chih; Lee, D. T.; Lai, Feipei] Natl Taiwan Univ, Dept Comp Sci & Informat Engn, Taipei 10764, Taiwan; [Chung, Wei-Chun; Ho, Jan-Ming] Acad Sinica, Res Ctr Informat Technol Innovat, Taipei 115, Taiwan; [Lee, D. T.] Natl Chung Hsing Univ, Dept Comp Sci & Informat Engn, Taichung 40227, Taiwan	Academia Sinica - Taiwan; National Taiwan University; Academia Sinica - Taiwan; National Chung Hsing University	Chang, YJ (corresponding author), Acad Sinica, Inst Informat Sci, Taipei, Taiwan.	yjchang@iis.sinica.edu.tw	Lin, Chung-Yen/AAQ-3833-2021; Huang, James/ADK-6342-2022; Hsu, Wen-Lian/ABB-2851-2020	Lin, Chung-Yen/0000-0002-4733-9488; Hsu, Wen-Lian/0000-0001-7061-3513	Digital Culture Center, Academia Sinica; National Science Council, Taiwan [102-2221-E-001-013-MY3]; Chunghwa Telecom Co.; Networked Communications Program of Taiwan; Microsoft Co.; National Science Council of Taiwan	Digital Culture Center, Academia Sinica; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Chunghwa Telecom Co.; Networked Communications Program of Taiwan; Microsoft Co.(Microsoft); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This research is partially supported by Digital Culture Center, Academia Sinica (http://www.sinica.edu.tw/main_e.shtml) under the project "System Management and Content Retrieval Technologies for Supporting Cloud-based Digital Archive Systems and Services,'' and National Science Council (http://web1.nsc.gov.tw/mp.aspx?mp=7), Taiwan, under 102-2221-E-001-013-MY3 dubbed as "Next Generation Content Delivery Network: Cloud and Mobile Internet.'' The hicloud CaaS computing resources are supported by Chunghwa Telecom Co. and Networked Communications Program of Taiwan under the project "A CloudBased DNA Analysis Platform.'' The Microsoft Azure computing resources are supported by Microsoft Co. and National Science Council of Taiwan under the project "World Cloud Research Collaboration Project hosted by Microsoft Research: Electronic Laboratory Notebook (Elegance) for Biomedical Research Community on Sharing, Co-working and Inspiriting in the Cloud'' to Chung-Yen Lin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang YP, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-96; Chen CC, 2013, CLOUDRS ERROR CORREC, P717; Dean J, 2008, COMMUN ACM, V51, P107, DOI 10.1145/1327452.1327492; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Jourdren L, 2012, BIOINFORMATICS, V28, P1542, DOI 10.1093/bioinformatics/bts165; Krampis K, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-42; Langmead B, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r83; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r134; Nordberg H, 2013, BIOINFORMATICS, V29, P3014, DOI 10.1093/bioinformatics/btt528; Schatz MC, 2010, NAT BIOTECHNOL, V28, P691, DOI 10.1038/nbt0710-691; Schatz MC, 2009, BIOINFORMATICS, V25, P1363, DOI 10.1093/bioinformatics/btp236; Schumacher A, 2014, BIOINFORMATICS, V30, P119, DOI 10.1093/bioinformatics/btt601; Taylor RC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S12-S1; Zaharia M., 2012, P 9 USENIX S NETW SY, P15, DOI DOI 10.1111/J.1095-8649.2005.00662.X; Zou Q., 2013, BRIEF BIOINFORM	15	7	7	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98146	10.1371/journal.pone.0098146	http://dx.doi.org/10.1371/journal.pone.0098146			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897343	gold, Green Published, Green Submitted			2022-12-27	WOS:000338430700027
J	Eykelbosh, AJ; Johnson, MS; de Queiroz, ES; Dalmagro, HJ; Couto, EG				Eykelbosh, Angela Joy; Johnson, Mark S.; de Queiroz, Edmar Santos; Dalmagro, Higo Jose; Couto, Eduardo Guimaraes			Biochar from Sugarcane Filtercake Reduces Soil CO2 Emissions Relative to Raw Residue and Improves Water Retention and Nutrient Availability in a Highly-Weathered Tropical Soil	PLOS ONE			English	Article							BLACK CARBON; ORGANIC-CARBON; PARTICLE-SIZE; PYROLYSIS; NITROGEN; IMPACT; AGRICULTURE; MANAGEMENT; INCREASES; SORPTION	In Brazil, the degradation of nutrient-poor Ferralsols limits productivity and drives agricultural expansion into pristine areas. However, returning agricultural residues to the soil in a stabilized form may offer opportunities for maintaining or improving soil quality, even under conditions that typically promote carbon loss. We examined the use of biochar made from filtercake (a byproduct of sugarcane processing) on the physicochemical properties of a cultivated tropical soil. Filtercake was pyrolyzed at 575 degrees C for 3 h yielding a biochar with increased surface area and porosity compared to the raw filtercake. Filtercake biochar was primarily composed of aromatic carbon, with some residual cellulose and hemicellulose. In a three-week laboratory incubation, CO2 effluxes from a highly weathered Ferralsol soil amended with 5% biochar (dry weight, d.w.) were roughly four-fold higher than the soil-only control, but 23-fold lower than CO2 effluxes from soil amended with 5% (d.w.) raw filtercake. We also applied vinasse, a carbon-rich liquid waste from bioethanol production typically utilized as a fertilizer on sugarcane soils, to filtercake- and biochar-amended soils. Total CO2 efflux from the biochar-amended soil in response to vinasse application was only 5% of the efflux when vinasse was applied to soil amended with raw filtercake. Furthermore, mixtures of 5 or 10% biochar (d.w.) in this highly weathered tropical soil significantly increased water retention within the plant-available range and also improved nutrient availability. Accordingly, application of sugarcane filtercake as biochar, with or without vinasse application, may better satisfy soil management objectives than filtercake applied to soils in its raw form, and may help to build soil carbon stocks in sugarcane-cultivating regions.	[Eykelbosh, Angela Joy; Johnson, Mark S.] Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC V5Z 1M9, Canada; [Johnson, Mark S.] Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC V5Z 1M9, Canada; [de Queiroz, Edmar Santos; Couto, Eduardo Guimaraes] Univ Fed Mato Grosso, Fac Agron Med Vet & Zootecnia FAMEV, Cuiabaa, Mato Grosso, Brazil; [Dalmagro, Higo Jose] Univ Fed Mato Grosso, Inst Fis, Cuiaba, Mato Grosso, Brazil	University of British Columbia; University of British Columbia; Universidade Federal de Mato Grosso; Universidade Federal de Mato Grosso	Eykelbosh, AJ (corresponding author), Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC V5Z 1M9, Canada.	a.eykelbosh@alumni.ubc.ca	Couto, Eduardo Guimarães/E-4240-2010; Couto, Eduardo Guimarães/AAF-5790-2019; Johnson, Mark S./B-4445-2008	Couto, Eduardo Guimarães/0000-0002-5271-9709; Couto, Eduardo Guimarães/0000-0002-5271-9709; Johnson, Mark S./0000-0001-5070-7539; Eykelbosh, Angela/0000-0003-3880-9019	UBC Bridge Program; National Sciences and Engineering Research Council (NSERC) of Canada; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) of Brazil	UBC Bridge Program; National Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) of Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding was obtained from the UBC Bridge Program and the National Sciences and Engineering Research Council (NSERC) of Canada (awarded to AJE), and from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) of Brazil (awarded to AJE, MSJ, and EGC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2013, GEODERMA, V202, P183, DOI 10.1016/j.geoderma.2013.03.003; Abiven S, 2014, NAT GEOSCI, V7, P326, DOI 10.1038/ngeo2154; Anderson-Teixeira KJ, 2009, GCB BIOENERGY, V1, P75, DOI 10.1111/j.1757-1707.2008.01001.x; ArsÃ¨ne Marie-Ange, 2013, Mat. Res., V16, P903; Asadullah M, 2010, BIORESOURCE TECHNOL, V101, P7935, DOI 10.1016/j.biortech.2010.05.048; Basso Andres S., 2013, GCB Bioenergy, V5, P132, DOI 10.1111/gcbb.12026; de Vasconcelos RFB, 2010, REV BRAS CIENC SOLO, V34, P309, DOI 10.1590/S0100-06832010000200004; Brewer CE, 2009, ENVIRON PROG SUSTAIN, V28, P386, DOI 10.1002/ep.10378; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Cagnon Benoit, 2009, Bioresour Technol, V100, P292, DOI 10.1016/j.biortech.2008.06.009; Chen Y, 2010, AUST J SOIL RES, V48, P526, DOI 10.1071/SR10011; Cornelissen G, 2005, ENVIRON SCI TECHNOL, V39, P6881, DOI 10.1021/es050191b; Cross A, 2011, SOIL BIOL BIOCHEM, V43, P2127, DOI 10.1016/j.soilbio.2011.06.016; Czimczik CI, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002798; de Oliveira BG, 2013, GEODERMA, V200, P77, DOI 10.1016/j.geoderma.2013.02.005; de Resende AS, 2006, PLANT SOIL, V281, P339, DOI 10.1007/s11104-005-4640-y; Demirbas A, 2004, J ANAL APPL PYROL, V72, P243, DOI 10.1016/j.jaap.2004.07.003; do Carmo JB, 2013, GCB BIOENERGY, V5, P267, DOI 10.1111/j.1757-1707.2012.01199.x; Elsayed MT, 2008, BIORESOURCE TECHNOL, V99, P4164, DOI 10.1016/j.biortech.2007.08.079; EMBRAPA, 2009, MAN AN QUI MIC SOL P; Fox J, 2005, J BEHAV EDUC, V14, P1, DOI 10.1007/s10864-005-0957-0; Fuertes AB, 2010, AUST J SOIL RES, V48, P618, DOI 10.1071/SR10010; Gaunt JL, 2008, ENVIRON SCI TECHNOL, V42, P4152, DOI 10.1021/es071361i; George PAO, 2010, WASTE BIOMASS VALORI, V1, P407, DOI 10.1007/s12649-010-9046-2; Glaser B, 2001, NATURWISSENSCHAFTEN, V88, P37, DOI 10.1007/s001140000193; GOEDERT WJ, 1983, J SOIL SCI, V34, P405, DOI 10.1111/j.1365-2389.1983.tb01045.x; HAMBLIN AP, 1985, ADV AGRON, V38, P95, DOI 10.1016/S0065-2113(08)60674-4; Hoffmann WA, 2000, J CLIMATE, V13, P1593, DOI 10.1175/1520-0442(2000)013<1593:VCFITC>2.0.CO;2; Huntley SK, 2003, J AGR FOOD CHEM, V51, P6178, DOI 10.1021/jf034320o; Inyang M, 2010, BIORESOURCE TECHNOL, V101, P8868, DOI 10.1016/j.biortech.2010.06.088; Jones DL, 2011, SOIL BIOL BIOCHEM, V43, P1723, DOI 10.1016/j.soilbio.2011.04.018; Joseph S, 2009, BIOCHR ENG MANAGE SC, V1, P107; Kameyama K, 2012, J ENVIRON QUAL, V41, P1131, DOI 10.2134/jeq2010.0453; Kasozi GN, 2010, ENVIRON SCI TECHNOL, V44, P6189, DOI 10.1021/es1014423; Khalil MI, 2005, SOIL BIOL BIOCHEM, V37, P1507, DOI 10.1016/j.soilbio.2005.01.014; Kim P, 2011, ENERG FUEL, V25, P4693, DOI 10.1021/ef200915s; Klink CA, 2005, CONSERV BIOL, V19, P707, DOI 10.1111/j.1523-1739.2005.00702.x; Kuzyakov Y, 2010, SOIL BIOL BIOCHEM, V42, P1363, DOI 10.1016/j.soilbio.2010.04.003; Lee Y, 2013, BIORESOURCE TECHNOL, V148, P196, DOI 10.1016/j.biortech.2013.08.135; Liang B, 2006, SOIL SCI SOC AM J, V70, P1719, DOI 10.2136/sssaj2005.0383; Liang BQ, 2010, ORG GEOCHEM, V41, P206, DOI 10.1016/j.orggeochem.2009.09.007; Liska AJ, 2014, NAT CLIM CHANGE, V4, P398, DOI [10.1038/NCLIMATE2187, 10.1038/nclimate2187]; Machado PLOD, 2001, NUTR CYCL AGROECOSYS, V61, P119, DOI 10.1023/A:1013331805519; Major J, 2012, J ENVIRON QUAL, V41, P1076, DOI 10.2134/jeq2011.0128; Martinelli LA, 2010, CURR OPIN ENV SUST, V2, P431, DOI 10.1016/j.cosust.2010.09.008; Mathews JA, 2008, ENERG POLICY, V36, P940, DOI 10.1016/j.enpol.2007.11.029; McCown RL, 1996, AGR SYST, V50, P255, DOI 10.1016/0308-521X(94)00055-V; Oliveira VS, 2010, REV BRAS ENG AGR AMB, V14, P907, DOI 10.1590/S1415-43662010000900001; Prado R.M., 2013, APPL ENVIRON SOIL SC, V2013, P1, DOI [DOI 10.1155/2013/581984, 10.1155/2013/581984]; R Core Team, 2021, R LANGUAGE ENV STAT; Roscoe R, 2001, GEODERMA, V104, P185, DOI 10.1016/S0016-7061(01)00080-5; Sparovek G, 2007, SCI AGR, V64, P77, DOI 10.1590/S0103-90162007000100012; Spokas K. A., 2009, Annals of Environmental Science, V3, P179; Steinbeiss S, 2009, SOIL BIOL BIOCHEM, V41, P1301, DOI 10.1016/j.soilbio.2009.03.016; Steiner C, 2007, PLANT SOIL, V291, P275, DOI 10.1007/s11104-007-9193-9; Ulyett J, 2014, EUR J SOIL SCI, V65, P96, DOI 10.1111/ejss.12081; Yao Y, 2012, CHEMOSPHERE, V89, P1467, DOI 10.1016/j.chemosphere.2012.06.002; Zimmerman AR, 2011, SOIL BIOL BIOCHEM, V43, P1169, DOI 10.1016/j.soilbio.2011.02.005; Zimmerman AR, 2010, ENVIRON SCI TECHNOL, V44, P1295, DOI 10.1021/es903140c	59	25	26	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98523	10.1371/journal.pone.0098523	http://dx.doi.org/10.1371/journal.pone.0098523			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897522	Green Published, gold, Green Submitted			2022-12-27	WOS:000338430700048
J	Hu, WD; Liu, Y; Zhou, WH; Si, LL; Ren, L				Hu, Weidong; Liu, Yue; Zhou, Wenhui; Si, Lianlian; Ren, Liang			CXCL16 and CXCR6 Are Coexpressed in Human Lung Cancer In Vivo and Mediate the Invasion of Lung Cancer Cell Lines In Vitro	PLOS ONE			English	Article							DECIDUAL STROMAL CELLS; CHEMOKINE CXCL16; SCAVENGER RECEPTOR; EXPRESSION; INFLAMMATION; MIGRATION; LYMPHOCYTES; PROGRESSION; LIGAND-16; PROMOTES	Despite advances in early diagnosis and multimodality therapy for cancers, most of lung cancer patients have been locally advanced or metastatic at the time of diagnosis, suggesting the highly progressive characteristic of lung cancer cells. The mechanisms underling invasiveness and metastasis of lung cancer are yet to be elucidated. In the present study, immunohistochemistry was performed to detect the expression of CXCL16-CXCR6 in human lung cancer tissues. It was demonstrated that similar to CXCL12 and CXCR4, CXCL16 and CXCR6 were also coexpressed in human primary lung cancer tissues. After confirming the functional existence of CXCL16 and CXCR6 protein in A549, 95D and H292 cells by ELSA and flow cytometry analysis, we further explored the significance of CXCL16-CXCR6 axis in the biological functions of lung cancer cell lines in vitro. It was found that CXCL16 had no effects on the PCNA (proliferating cell nuclear antigen) expression of A549, 95D and H292 cells. However, both exogenous CXCL16 and CM (conditioned medium from A549, 95D or H292) significantly improved the in vitro viability and invasion of three lung cancer cell lines. The neutralizing antibody to CXCL16 or down-regulation of CXCR6 was able to inhibit the increased viability and invasiveness of A549, 95D and H292 cells stimulated by CXCL16 or CM. Our results imply that CXCL16-CXCR6 axis is involved in the regulation of viability and invasion rather than PCNA expression of lung caner cells, which opens the door for better understanding the mechanisms of lung tumor progression and metastasis.	[Hu, Weidong; Liu, Yue; Si, Lianlian] Wuhan Univ, Zhongnan Hosp, Dept Thorac Oncol, Wuhan 430072, Peoples R China; [Hu, Weidong] Hubei Canc Clin Study Ctr, Wuhan, Peoples R China; [Hu, Weidong] Hubei Key Lab Tumor Biol Behav, Wuhan, Peoples R China; [Zhou, Wenhui] Capital Med Univ, Beijing Chao Yang Hosp, Reprod Med Ctr, Beijing, Peoples R China; [Ren, Liang] Wuhan Univ, Zhongnan Hosp, Reprod Med Ctr, Wuhan 430072, Peoples R China	Wuhan University; Capital Medical University; Wuhan University	Hu, WD (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Thorac Oncol, Wuhan 430072, Peoples R China.	weidhu@aliyun.com; 77305875@qq.com			National Natural Science Foundation of China [81270753]; Wuhan Science and Technology [2013060602010249]; Natural Science Foundation of Science and Technology Ministry of Hubei Province [2010CDB05502]; Personnel Training Plan of The Health Care System of Beijing [2013-3-021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wuhan Science and Technology; Natural Science Foundation of Science and Technology Ministry of Hubei Province; Personnel Training Plan of The Health Care System of Beijing	This work is supported by National Natural Science Foundation of China 81270753 (to W.-H.Z.), Wuhan Science and Technology Project 2013060602010249 (to W.-D.H.), Natural Science Foundation of Science and Technology Ministry of Hubei Province 2010CDB05502 (to W.-D.H.) and Personnel Training Plan of The Health Care System of Beijing 2013-3-021 (to W.-H.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Darash-Yahana M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006695; Day C, 2009, EXP LUNG RES, V35, P272, DOI 10.1080/01902140802635517; Deng L, 2010, BBA-REV CANCER, V1806, P42, DOI 10.1016/j.bbcan.2010.01.004; Fahham D, 2012, J THORAC CARDIOV SUR, V144, P1167, DOI 10.1016/j.jtcvs.2012.07.031; Guo P, 2012, ANN ONCOL, V23, P2755, DOI 10.1093/annonc/mds069; Hara T, 2006, INT IMMUNOL, V18, P301, DOI 10.1093/intimm/dxh369; Hattermann K, 2008, MOL CELL NEUROSCI, V39, P133, DOI 10.1016/j.mcn.2008.03.009; Hattermann K, 2013, ANN ANAT, V195, P103, DOI 10.1016/j.aanat.2012.10.013; Hojo S, 2007, CANCER RES, V67, P4725, DOI 10.1158/0008-5472.CAN-06-3424; Hu WD, 2008, CANCER SCI, V99, P1362, DOI 10.1111/j.1349-7006.2008.00833.x; Huang Y, 2006, HUM REPROD, V21, P1083, DOI 10.1093/humrep/dei436; Kamp DW, 2011, ONCOLOGY-NY, V25, P400; Keeley EC, 2010, ADV CANCER RES, V106, P91, DOI 10.1016/S0065-230X(10)06003-3; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; Lee LN, 2011, INFECT IMMUN, V79, P3328, DOI 10.1128/IAI.01133-10; Mantovani A, 2010, CYTOKINE GROWTH F R, V21, P27, DOI 10.1016/j.cytogfr.2009.11.007; Matloubian M, 2000, NAT IMMUNOL, V1, P298, DOI 10.1038/79738; Oldham KA, 2012, EUR UROL, V61, P385, DOI 10.1016/j.eururo.2011.10.035; Otsuka S, 2008, J THORAC ONCOL, V3, P1379, DOI 10.1097/JTO.0b013e31818dda9d; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Raynaud CM, 2010, CLIN LUNG CANCER, V11, P187, DOI 10.3816/CLC.2010.n.024; Ren L, 2012, HUM REPROD, V27, P366, DOI 10.1093/humrep/der395; Shimaoka T, 2000, J BIOL CHEM, V275, P40663, DOI 10.1074/jbc.C000761200; Shimaoka T, 2004, J LEUKOCYTE BIOL, V75, P267, DOI 10.1189/jlb.1003465; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Wald O, 2013, THERANOSTICS, V3, P26, DOI 10.7150/thno.4922; Wang JH, 2008, CANCER RES, V68, P10367, DOI 10.1158/0008-5472.CAN-08-2780; Wilbanks A, 2001, J IMMUNOL, V166, P5145, DOI 10.4049/jimmunol.166.8.5145; Zhang LP, 2009, AM J PATHOL, V175, P2518, DOI 10.2353/ajpath.2009.090275; Zhou WH, 2008, HUM REPROD, V23, P2669, DOI 10.1093/humrep/den308; Zhou WH, 1998, ZHONGHUA WEI SHENG W, V31, P1076	32	33	34	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99056	10.1371/journal.pone.0099056	http://dx.doi.org/10.1371/journal.pone.0099056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897301	Green Published, Green Submitted, gold			2022-12-27	WOS:000338430700110
J	Huang, Q; Sparatore, A; Del Soldato, P; Wu, LY; Desai, K				Huang, Qian; Sparatore, Anna; Del Soldato, Piero; Wu, Lingyun; Desai, Kaushik			Hydrogen Sulfide Releasing Aspirin, ACS14, Attenuates High Glucose-Induced Increased Methylglyoxal and Oxidative Stress in Cultured Vascular Smooth Muscle Cells	PLOS ONE			English	Article							GLYOXALASE SYSTEM; PEROXYNITRITE PRODUCTION; ENDOTHELIAL DYSFUNCTION; DIABETIC COMPLICATIONS; NITRIC-OXIDE; IN-VITRO; TISSUES; RATS; HYPERTENSION; INFLAMMATION	Hydrogen sulfide is a gasotransmitter with vasodilatory and anti-inflammatory properties. Aspirin is an irreversible cyclooxygenase inhibitor anti-inflammatory drug. ACS14 is a novel synthetic hydrogen sulfide releasing aspirin which inhibits cyclooxygenase and has antioxidant effects. Methylglyoxal is a chemically active metabolite of glucose and fructose, and a major precursor of advanced glycation end products formation. Methylglyoxal is harmful when produced in excess. Plasma methylglyoxal levels are significantly elevated in diabetic patients. Our aim was to investigate the effects of ACS14 on methylglyoxal levels in cultured rat aortic vascular smooth muscle cells. We used cultured rat aortic vascular smooth muscle cells for the study. Methylglyoxal was measured by HPLC after derivatization, and nitrite+nitrate with an assay kit. Western blotting was used to determine NADPH oxidase 4 (NOX4) and inducible nitric oxide synthase (iNOS) protein expression. Dicholorofluorescein assay was used to measure oxidative stress. ACS14 significantly attenuated elevation of intracellular methylglyoxal levels caused by incubating cultured vascular smooth muscle cells with methylglyoxal (30 mu M) and high glucose (25 mM). ACS14, but not aspirin, caused a significant attenuation of increase in nitrite+nitrate levels caused by methylglyoxal or high glucose. ACS14, aspirin, and sodium hydrogen sulfide (NaHS, a hydrogen sulfide donor), all attenuated the increase in oxidative stress caused by methylglyoxal and high glucose in cultured cells. ACS14 prevented the increase in NOX4 expression caused by incubating the cultured VSMCs with MG (30 mu M). ACS14, aspirin and NaHS attenuated the increase in iNOS expression caused by high glucose (25 mM). In conclusion, ACS14 has the novel ability to attenuate an increase in methylglyoxal levels which in turn can reduce oxidative stress, decrease the formation of advanced glycation end products and prevent many of the known deleterious effects of elevated methylglyoxal. Thus, ACS14 has the potential to be especially beneficial for diabetic patients pending further in vivo studies.	[Huang, Qian; Desai, Kaushik] Univ Saskatchewan, Dept Pharmacol, Coll Med, Saskatoon, SK S7N 0W0, Canada; [Huang, Qian] Shanghai Jiao Tong Univ, Kings Lab, Sch Pharm, Shanghai 200030, Peoples R China; [Sparatore, Anna] Univ Milan, Dipartimento Sci Farmaceut, Milan, Italy; [Del Soldato, Piero] CTG Pharma, Milan, Italy; [Wu, Lingyun] Lakehead Univ, Dept Hlth Sci, Thunder Bay, ON P7B 5E1, Canada; [Wu, Lingyun] Thunder Bay Reg Res Inst, Thunder Bay, ON, Canada	University of Saskatchewan; Shanghai Jiao Tong University; University of Milan; Lakehead University; Northern Ontario School of Medicine	Wu, LY (corresponding author), Lakehead Univ, Dept Hlth Sci, Thunder Bay, ON P7B 5E1, Canada.	lwu@lakeheadu.ca; k.desai@usask.ca	Sparatore, Anna/J-8634-2015	Sparatore, Anna/0000-0003-2135-2649; Desai, Kaushik/0000-0001-9355-4528	CTG Pharma; Heart and Stroke Foundation of Saskatchewan; Canadian Institutes of Health Research grant [MOP-68938]	CTG Pharma; Heart and Stroke Foundation of Saskatchewan; Canadian Institutes of Health Research grant(Canadian Institutes of Health Research (CIHR))	Professor Anna Sparatore received a grant from CTG Pharma. This work was supported by a Grant-In-Aid from the Heart and Stroke Foundation of Saskatchewan to Dr. Kaushik Desai and Dr. Lingyun Wu, and the Canadian Institutes of Health Research grant # MOP-68938 to Dr. Lingyun Wu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MU, 1997, BIOCHEM J, V324, P565, DOI 10.1042/bj3240565; Ahmed N, 2003, BBA-MOL BASIS DIS, V1639, P121, DOI 10.1016/j.bbadis.2003.08.002; Chang TJ, 2005, FREE RADICAL BIO MED, V38, P286, DOI 10.1016/j.freeradbiomed.2004.10.034; Chang TJ, 2010, ANTIOXID REDOX SIGN, V12, P1093, DOI 10.1089/ars.2009.2918; Desai Kaushik M., 2008, Drug Metabolism and Drug Interactions, V23, P151; Dhar A, 2008, METABOLISM, V57, P1211, DOI 10.1016/j.metabol.2008.04.014; Dhar A, 2011, DIABETES, V60, P899, DOI 10.2337/db10-0627; Dhar A, 2010, BRIT J PHARMACOL, V161, P1843, DOI 10.1111/j.1476-5381.2010.01017.x; Dhar A, 2009, J CHROMATOGR B, V877, P1093, DOI 10.1016/j.jchromb.2009.02.055; Dhar I, 2012, J PHARMACOL EXP THER, V342, P196, DOI 10.1124/jpet.112.192112; Gill R, 2010, FREE RADICAL BIO MED, V48, P1121, DOI 10.1016/j.freeradbiomed.2010.01.006; Giustarini D, 2010, FREE RADICAL BIO MED, V48, P1263, DOI 10.1016/j.freeradbiomed.2010.02.014; Hulsmans M, 2010, J CELL MOL MED, V14, P70, DOI 10.1111/j.1582-4934.2009.00978.x; Jia XM, 2007, MOL CELL BIOCHEM, V306, P133, DOI 10.1007/s11010-007-9563-x; Jia XM, 2006, FASEB J, V20, P1555, DOI 10.1096/fj.05-5478fje; Kilhovd BK, 2003, METABOLISM, V52, P163, DOI 10.1053/meta.2003.50035; Lassegue B, 2001, CIRC RES, V88, P888, DOI 10.1161/hh0901.090299; Lee M, 2010, GLIA, V58, P103, DOI 10.1002/glia.20905; Liu JH, 2011, CARDIOVASC RES, V92, P494, DOI 10.1093/cvr/cvr239; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; MCLELLAN AC, 1994, CLIN SCI, V87, P21, DOI 10.1042/cs0870021; PATRONO C, 1994, NEW ENGL J MED, V330, P1287; Pircher J, 2012, ARTERIOSCL THROM VAS, V32, P2884, DOI 10.1161/ATVBAHA.112.300627; RAO GN, 1985, BIOCHEM BIOPH RES CO, V128, P1125, DOI 10.1016/0006-291X(85)91057-5; Sparatore A, 2009, FREE RADICAL BIO MED, V46, P586, DOI 10.1016/j.freeradbiomed.2008.11.013; THORNALLEY PJ, 1993, MOL ASPECTS MED, V14, P287, DOI 10.1016/0098-2997(93)90002-U; THORNALLEY PJ, 1988, BIOCHEM J, V254, P751, DOI 10.1042/bj2540751; Thornalley PJ, 1996, GEN PHARMACOL-VASC S, V27, P565, DOI 10.1016/0306-3623(95)02054-3; Vander Jagt DL, 2003, CHEM-BIOL INTERACT, V143, P341, DOI 10.1016/S0009-2797(02)00212-0; Wang H, 2007, CLIN BIOCHEM, V40, P1232, DOI 10.1016/j.clinbiochem.2007.07.016; Wang H, 2006, LIFE SCI, V79, P2448, DOI 10.1016/j.lfs.2006.08.009; Wang R, 2010, ANTIOXID REDOX SIGN, V12, P1061, DOI 10.1089/ars.2009.2938; Wang XX, 2008, J HYPERTENS, V26, P765, DOI 10.1097/HJH.0b013e3282f4a13c; Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026; Wu LY, 2002, HYPERTENSION, V39, P809, DOI 10.1161/hy0302.105207; Xi G, 2012, DIABETES, V61, P104, DOI 10.2337/db11-0990; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667	37	19	20	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e97315	10.1371/journal.pone.0097315	http://dx.doi.org/10.1371/journal.pone.0097315			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896242	Green Submitted, Green Published, gold			2022-12-27	WOS:000338430700009
J	Kok, VC; Horng, JT; Chang, WS; Hong, YF; Chang, TH				Kok, Victor C.; Horng, Jorng-Tzong; Chang, Wan-Shan; Hong, Ya-Fang; Chang, Tzu-Hao			Allopurinol Therapy in Gout Patients Does Not Associate with Beneficial Cardiovascular Outcomes: A Population-Based Matched-Cohort Study	PLOS ONE			English	Article							HIGH-DOSE ALLOPURINOL; IMPROVES ENDOTHELIAL FUNCTION; CHRONIC HEART-FAILURE; URIC-ACID; NATIONAL-HEALTH; RISK; DISEASE; MORTALITY; HYPERURICEMIA; PROGRESSION	Introduction: Previous studies have shown an association between gout and/or hyperuricemia and a subsequent increase in cardiovascular disease (CVD) outcomes. Allopurinol reduces vascular oxidative stress, ameliorates inflammatory state, improves endothelial function, and prevents atherosclerosis progression. Accordingly, we tested the hypothesis that a positive association between allopurinol therapy in gout patients and future cardiovascular outcomes is present using a population-based matched-cohort study design. Methods: Patients aged >= 40 years with newly diagnosed gout having no pre-existing severe form of CVD were separated into allopurinol (n = 2483) and non-allopurinol (n = 2483) groups after matching for age, gender, index date, diabetes mellitus, hypertension, hyperlipidemia, and atrial fibrillation. The two groups were also balanced in terms of uric acid nephrolithiasis, acute kidney injury, hepatitis, and Charlson comorbidity index. Results: With a median follow-up time of 5.25 years, the allopurinol group had a modest increase in cardiovascular risk [relative risk, 1.20; 95% confidence interval (CI), 1.08-1.34]. A Cox proportional hazard model adjusted for chronic kidney disease, uremia, and gastric ulcer gave a hazard ratio (HR) for cardiovascular outcomes of 1.25 (95% CI, 1.10-1.41) in gout patients receiving allopurinol compared with the non-allopurinol group. In further analysis of patients receiving urate-lowering therapy, the uricosuric agent group (n = 1713) had an adjusted HR of 0.83 (0.73-0.95) for cardiovascular events compared with the allopurinol group. Conclusions: The current population-based matched-cohort study did not support the association between allopurinol therapy in gout patients with normal risk for cardiovascular sequels and beneficial future cardiovascular outcomes. Several important risk factors for cardiovascular disease, such as smoking, alcohol consumption, body mass index, blood pressure were not obtainable in the current retrospective cohort study, thus could potentially bias the effect estimate.	[Kok, Victor C.; Horng, Jorng-Tzong] Asia Univ, Dept Biomed Informat, Publ Hlth & Clin Informat Res Grp, Taichung, Taiwan; [Kok, Victor C.] Kuang Tien Gen Hosp, Dept Internal Med, Taichung, Taiwan; [Horng, Jorng-Tzong; Chang, Wan-Shan] Natl Cent Univ, Dept Comp Sci & Informat Engn, Taoyuan, Taiwan; [Hong, Ya-Fang] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Chang, Tzu-Hao] Taipei Med Univ, Grad Inst Biomed Informat, Taipei, Taiwan	Asia University Taiwan; National Central University; Academia Sinica - Taiwan; Taipei Medical University	Kok, VC (corresponding author), Asia Univ, Dept Biomed Informat, Publ Hlth & Clin Informat Res Grp, Taichung, Taiwan.	doctorkok@hotmail.com; horng@db.csie.ncu.edu.tw	Kok, Victor C/C-1437-2013	Kok, Victor C/0000-0003-3440-8154	National Science Council of the Republic of China [NSC 101-2221-E-008-125-MY3]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	This work was partially supported by the National Science Council of the Republic of China under contract no. NSC 101-2221-E-008-125-MY3. There are no other funders to support the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhansing KJ, 2010, NETH J MED, V68, P352; Chang CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050729; Erdogan D, 2012, CAN J CARDIOL, V28, P721, DOI 10.1016/j.cjca.2012.04.005; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Ford ES, 2011, DIABETES RES CLIN PR, V93, pE84, DOI 10.1016/j.diabres.2011.05.012; George J, 2006, CIRCULATION, V114, P2508, DOI 10.1161/CIRCULATIONAHA.106.651117; Goicoechea M, 2010, CLIN J AM SOC NEPHRO, V5, P1388, DOI 10.2215/CJN.01580210; Gotsman I, 2012, J CARD FAIL, V18, P694, DOI 10.1016/j.cardfail.2012.06.528; Kanbay M, 2011, NEPHROL DIAL TRANSPL, V26, P430, DOI 10.1093/ndt/gfq635; Kok VC, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-108; Krishnan E, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3322; Kuo CF, 2010, RHEUMATOLOGY, V49, P141, DOI 10.1093/rheumatology/kep364; Muir SW, 2008, STROKE, V39, P3303, DOI 10.1161/STROKEAHA.108.519793; Needham DM, 2005, J CRIT CARE, V20, P12, DOI 10.1016/j.jcrc.2004.09.007; Noman A, 2010, LANCET, V375, P2161, DOI 10.1016/S0140-6736(10)60391-1; Puddu P, 2012, J CARDIOL, V59, P235, DOI 10.1016/j.jjcc.2012.01.013; Rajendra NS, 2011, J AM COLL CARDIOL, V58, P820, DOI 10.1016/j.jacc.2010.12.052; Rekhraj S, 2013, J AM COLL CARDIOL, V61, P926, DOI 10.1016/j.jacc.2012.09.066; Schneeweiss S, 2000, INT J EPIDEMIOL, V29, P891, DOI 10.1093/ije/29.5.891; Siu YP, 2006, AM J KIDNEY DIS, V47, P51, DOI 10.1053/j.ajkd.2005.10.006; Stone PH, 2011, J AM COLL CARDIOL, V58, P829, DOI 10.1016/j.jacc.2011.02.072; Struthers AD, 2002, HEART, V87, P229, DOI 10.1136/heart.87.3.229; Thanassoulis G, 2010, ARCH INTERN MED, V170, P1358, DOI 10.1001/archinternmed.2010.198; Wang YP, 2012, CAN MED ASSOC J, V184, pE804, DOI 10.1503/cmaj.120518; Wei L, 2011, BRIT J CLIN PHARMACO, V71, P600, DOI 10.1111/j.1365-2125.2010.03887.x; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Yiginer O, 2008, CLIN RES CARDIOL, V97, P334, DOI 10.1007/s00392-007-0636-3; Zhu YY, 2011, ARTHRITIS RHEUM-US, V63, P3136, DOI 10.1002/art.30520	28	58	58	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99102	10.1371/journal.pone.0099102	http://dx.doi.org/10.1371/journal.pone.0099102			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897240	Green Published, gold, Green Submitted			2022-12-27	WOS:000338430700117
J	Liu, J; Li, M; Li, Z; Zuo, XL; Li, CQ; Dong, YY; Zhou, CJ; Li, YQ				Liu, Jing; Li, Ming; Li, Zhen; Zuo, Xiu-Li; Li, Chang-Qing; Dong, Yan-Yan; Zhou, Cheng-Jun; Li, Yan-Qing			Learning Curve and Interobserver Agreement of Confocal Laser Endomicroscopy for Detecting Precancerous or Early-Stage Esophageal Squamous Cancer	PLOS ONE			English	Article							DIAGNOSTIC-ACCURACY; DYSPLASIA	Background: Confocal laser endomicroscopy (CLE) can provide in vivo subcellular resolution images of esophageal lesions. However, the learning curve in interpreting CLE images of precancerous or early-stage esophageal squamous cancer is unknown. The goal of this study is to evaluate the diagnostic accuracy and inter-observer agreement for differentiating esophageal lesions in CLE images among experienced and inexperienced observers and to assess the learning curve. Method: After a short training, 8 experienced and 14 inexperienced endoscopists evaluated in sequence 4 sets of high-quality CLE images. Their diagnoses were corrected and discussed after each set. For each image, the diagnostic results, confidence in diagnosis, quality and time to evaluate were recorded. Results: Overall, diagnostic accuracy was greater for the second, third, fourth set of images as compared with the initial set (odds ratio [OR] 2.01, 95% CI 1.22-3.31; 7.95, 3.74-16.87; and 6.45, 3.14-13.27), respectively, with no difference between the third and fourth sets in accuracy (p = 0.67). Previous experience affected the diagnostic accuracy only in the first set of images (OR 3.70, 1.87-7.29, p < 0.001). Inter-observer agreement was higher for experienced than inexperienced endoscopists (0.732 vs. 0.666, p < 0.01) Conclusion: CLE is a promising technology that can be quickly learned after a short training period; previous experience is associated with diagnostic accuracy only at the initial stage of learning.	[Liu, Jing; Li, Ming; Li, Zhen; Zuo, Xiu-Li; Li, Chang-Qing; Dong, Yan-Yan; Li, Yan-Qing] Shandong Univ, Qilu Hosp, Dept Gastroenterol, Jinan 250100, Peoples R China; [Liu, Jing] Shandong Univ, Qilu Hosp, Dept Anesthesiol, Jinan 250100, Peoples R China; [Zhou, Cheng-Jun] Shandong Univ, Affiliated Hosp 2, Dept Pathol, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University	Li, YQ (corresponding author), Shandong Univ, Qilu Hosp, Dept Gastroenterol, Jinan 250100, Peoples R China.	Liyanqing@sdu.edu.cn	Li, Zhen/AFK-5293-2022; Li, Zhen/AAH-2515-2022; Li, Zhen/HHM-3328-2022	Li, Zhen/0000-0002-9783-169X; Li, Chang-Qing/0000-0003-4380-2284; Liu, Jing/0000-0001-9149-7339				Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Buchner AM, 2011, GASTROINTEST ENDOSC, V73, P556, DOI 10.1016/j.gie.2011.01.002; DAWSEY SM, 1993, GASTROENTEROLOGY, V105, P1333, DOI 10.1016/0016-5085(93)90137-2; Gaddam S, 2011, AM J GASTROENTEROL, V106, P1961, DOI 10.1038/ajg.2011.294; Hayat MJ, 2007, ONCOLOGIST, V12, P20, DOI 10.1634/theoncologist.12-1-20; Jemal A, 2004, CANCER-AM CANCER SOC, V101, P3, DOI 10.1002/cncr.20288; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeon SR, 2011, GASTROINTEST ENDOSC, V74, P772, DOI 10.1016/j.gie.2011.05.005; Koh CE, 2011, SURG ENDOSC, V25, P947, DOI 10.1007/s00464-010-1259-8; Kuiper T, 2012, GASTROINTEST ENDOSC, V75, P1211, DOI 10.1016/j.gie.2012.01.040; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Li M, 2012, GUT; Li WB, 2011, GUT, V60, P299, DOI 10.1136/gut.2010.223586; Lim LG, 2011, GASTROINTEST ENDOSC, V73, P1141, DOI 10.1016/j.gie.2011.01.068; Liu H, 2009, ENDOSCOPY, V41, P99, DOI 10.1055/s-0028-1119492; Pech O, 2008, CLIN GASTROENTEROL H, V6, P89, DOI 10.1016/j.cgh.2007.10.013; Polglase AL, 2006, EXPERT REV MED DEVIC, V3, P549, DOI 10.1586/17434440.3.5.549; Polglase AL, 2005, GASTROINTEST ENDOSC, V62, P686, DOI 10.1016/j.gie.2005.05.021; Rispo A, 2012, WORLD J GASTRO ENDOS, V4, P414, DOI 10.4253/wjge.v4.i9.414; Shahid MW, 2012, ENDOSCOPY, V44, P343, DOI 10.1055/s-0031-1291589; Stolte M, 2003, VIRCHOWS ARCH, V442, P99, DOI 10.1007/s00428-002-0680-3; Su P, 2013, COLORECTAL DIS, V15, pE1, DOI 10.1111/codi.12033; Ussui VM, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/545679	23	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99089	10.1371/journal.pone.0099089	http://dx.doi.org/10.1371/journal.pone.0099089			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897112	gold, Green Published, Green Submitted			2022-12-27	WOS:000338430700116
J	Cheung, KSC; Sposito, N; Stumpf, PS; Wilson, DI; Sanchez-Elsner, T; Oreffo, ROC				Cheung, Kelvin S. C.; Sposito, Nunzia; Stumpf, Patrick S.; Wilson, David I.; Sanchez-Elsner, Tilman; Oreffo, Richard O. C.			MicroRNA-146a Regulates Human Foetal Femur Derived Skeletal Stem Cell Differentiation by Down-Regulating SMAD2 and SMAD3	PLOS ONE			English	Article							CHONDROGENESIS; OSTEOBLAST; TISSUE; SKELETOGENESIS; EXPRESSION; CARTILAGE; LEVEL; RNA	MicroRNAs (miRs) play a pivotal role in a variety of biological processes including stem cell differentiation and function. Human foetal femur derived skeletal stem cells (SSCs) display enhanced proliferation and multipotential capacity indicating excellent potential as candidates for tissue engineering applications. This study has examined the expression and role of miRs in human foetal femur derived SSC differentiation along chondrogenic and osteogenic lineages. Cells isolated from the epiphyseal region of the foetal femur expressed higher levels of genes associated with chondrogenesis while cells from the foetal femur diaphyseal region expressed higher levels of genes associated with osteogenic differentiation. In addition to the difference in osteogenic and chondrogenic gene expression, epiphyseal and diaphyseal cells displayed distinct miRs expression profiles. miR-146a was found to be expressed by human foetal femur diaphyseal cells at a significantly enhanced level compared to epiphyseal populations and was predicted to target various components of the TGF-beta pathway. Examination of miR-146a function in foetal femur cells confirmed regulation of protein translation of SMAD2 and SMAD3, important TGF-b and activin ligands signal transducers following transient overexpression in epiphyseal cells. The down-regulation of SMAD2 and SMAD3 following overexpression of miR-146a resulted in an up-regulation of the osteogenesis related gene RUNX2 and down-regulation of the chondrogenesis related gene SOX9. The current findings indicate miR-146a plays an important role in skeletogenesis through attenuation of SMAD2 and SMAD3 function and provide further insight into the role of miRs in human skeletal stem cell differentiation modulation with implications therein for bone reparation.	[Cheung, Kelvin S. C.; Sposito, Nunzia; Stumpf, Patrick S.; Oreffo, Richard O. C.] Southampton Gen Hosp, Inst Dev Sci, Bone & Joint Res Grp, Southampton SO9 4XY, Hants, England; [Cheung, Kelvin S. C.; Sposito, Nunzia; Stumpf, Patrick S.; Wilson, David I.; Oreffo, Richard O. C.] Univ Southampton, Ctr Human Dev Stem Cells & Regenerat, Southampton, Hants, England; [Sanchez-Elsner, Tilman] Univ Southampton, Southampton, Hants, England	University of Southampton; University of Southampton; University of Southampton	Oreffo, ROC (corresponding author), Southampton Gen Hosp, Inst Dev Sci, Bone & Joint Res Grp, Southampton SO9 4XY, Hants, England.	richard.oreffo@soton.ac.uk	Oreffo, Richard OC/A-4615-2011; Cheung, Kelvin Sin Chi/AID-4386-2022; Wilson, David/A-6264-2010; Stumpf, Patrick/AAK-1895-2020	Oreffo, Richard OC/0000-0001-5995-6726; Cheung, Kelvin Sin Chi/0000-0002-1562-8883; Wilson, David/0000-0001-8779-2060; Stumpf, Patrick/0000-0003-0862-0290; Sanchez-Elsner, Tilman/0000-0003-1915-2410	Biotechnology and Biological Sciences Research Council UK [BB/G010579/1]; BBSRC [BB/G010579/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G010579/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work carried out in this manuscript was supported by a strategic longer and larger grant (sLOLA) from the Biotechnology and Biological Sciences Research Council UK (BB/G010579/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Baek Wook-Young, 2011, Front Biosci (Schol Ed), V3, P126, DOI 10.2741/s138; Compston J, 2009, MATURITAS, V62, P105, DOI 10.1016/j.maturitas.2008.11.022; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Developmental plasticity of human foetal femur-derived cells in pellet culture: self assembly of an osteoid shell around a cartilaginous core, 2011, EUR CELL MAT, V21, P558; Dong SW, 2012, BIOCHEM BIOPH RES CO, V418, P587, DOI 10.1016/j.bbrc.2012.01.075; Eberhart JK, 2008, NAT GENET, V40, P290, DOI 10.1038/ng.82; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Eskildsen T, 2011, P NATL ACAD SCI USA, V108, P6139, DOI 10.1073/pnas.1016758108; Furumatsu T, 2005, J BIOL CHEM, V280, P8343, DOI 10.1074/jbc.M413913200; Gao W, 2010, BIOMED PHARMACOTHER, V64, P399, DOI 10.1016/j.biopha.2010.01.018; Guo L, 2011, EXP HEMATOL, V39, P608, DOI 10.1016/j.exphem.2011.01.011; Hellingman CA, 2011, TISSUE ENG PT A, V17, P1157, DOI [10.1089/ten.TEA.2010.0043, 10.1089/ten.tea.2010.0043]; Inose H, 2009, P NATL ACAD SCI USA, V106, P20794, DOI 10.1073/pnas.0909311106; Ivanovska I, 2008, CELL CYCLE, V7, P3137, DOI 10.4161/cc.7.20.6923; Jones SW, 2009, OSTEOARTHR CARTILAGE, V17, P464, DOI 10.1016/j.joca.2008.09.012; Karsenty G, 1998, DEV GENET, V22, P301, DOI 10.1002/(SICI)1520-6408(1998)22:4&lt;301::AID-DVG1&gt;3.0.CO;2-A; Khraiwesh B, 2010, CELL, V140, P111, DOI 10.1016/j.cell.2009.12.023; Klebanov L, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-9; Lewis BP, TARGETSCANHUMAN; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; Liu XD, 2009, BIOCHEM BIOPH RES CO, V380, P177, DOI 10.1016/j.bbrc.2009.01.066; Liu Z, 2012, ARCH DERMATOL RES, V304, P195, DOI 10.1007/s00403-011-1178-0; Mar JC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-110; Michigami Toshimi, 2014, Clin Pediatr Endocrinol, V23, P1, DOI 10.1292/cpe.23.1; Mirmalek-Sani SH, 2006, STEM CELLS, V24, P1042, DOI 10.1634/stemcells.2005-0368; Miyaki S, 2009, ARTHRITIS RHEUM-US, V60, P2723, DOI 10.1002/art.24745; Mizuno Y, 2009, FEBS LETT, V583, P2263, DOI 10.1016/j.febslet.2009.06.006; Moustakas A, 2001, J CELL SCI, V114, P4359; Pais H, 2010, RNA, V16, P489, DOI 10.1261/rna.1701210; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Pratap J, 2003, CANCER RES, V63, P5357; Song B, 2009, CYTOKINE GROWTH F R, V20, P379, DOI 10.1016/j.cytogfr.2009.10.010; Suomi S, 2008, GENE REGUL SYST BIO, V2, P177; Swingler TE, 2012, ARTHRITIS RHEUM-US, V64, P1909, DOI 10.1002/art.34314; TUCH B, 1988, HASTINGS CENT REP, V18, P44, DOI 10.2307/3563238; Tuddenham L, 2006, FEBS LETT, V580, P4214, DOI 10.1016/j.febslet.2006.06.080; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021679; Yang L, 2012, J BONE MINER RES, V27, P1598, DOI 10.1002/jbmr.1621; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Zhong H, 2010, INT J HEMATOL, V92, P129, DOI 10.1007/s12185-010-0626-5; Zhou SH, 2011, J CELL BIOCHEM, V112, P1651, DOI 10.1002/jcb.23079; Zimmermann P, 2008, ARTHRITIS RHEUM, V58, P2743, DOI 10.1002/art.23736	45	38	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98063	10.1371/journal.pone.0098063	http://dx.doi.org/10.1371/journal.pone.0098063			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892945	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000336911400032
J	Shenkin, SD; Watson, R; Laidlaw, K; Starr, JM; Deary, IJ				Shenkin, Susan D.; Watson, Roger; Laidlaw, Ken; Starr, John M.; Deary, Ian J.			The Attitudes to Ageing Questionnaire: Mokken Scaling Analysis	PLOS ONE			English	Article							QUALITY-OF-LIFE; OLDER-ADULTS; RELIABILITY; VALIDITY; PEOPLE; SAMPLE; AAQ; IRT	Background: Hierarchical scales are useful in understanding the structure of underlying latent traits in many questionnaires. The Attitudes to Ageing Questionnaire (AAQ) explored the attitudes to ageing of older people themselves, and originally described three distinct subscales: (1) Psychosocial Loss (2) Physical Change and (3) Psychological Growth. This study aimed to use Mokken analysis, a method of Item Response Theory, to test for hierarchies within the AAQ and to explore how these relate to underlying latent traits. Methods: Participants in a longitudinal cohort study, the Lothian Birth Cohort 1936, completed a cross-sectional postal survey. Data from 802 participants were analysed using Mokken Scaling analysis. These results were compared with factor analysis using exploratory structural equation modelling. Results: Participants were 51.6% male, mean age 74.0 years (SD 0.28). Three scales were identified from 18 of the 24 items: two weak Mokken scales and one moderate Mokken scale. (1) 'Vitality' contained a combination of items from all three previously determined factors of the AAQ, with a hierarchy from physical to psychosocial; (2) 'Legacy' contained items exclusively from the Psychological Growth scale, with a hierarchy from individual contributions to passing things on; (3) 'Exclusion' contained items from the Psychosocial Loss scale, with a hierarchy from general to specific instances. All of the scales were reliable and statistically significant with 'Legacy' showing invariant item ordering. The scales correlate as expected with personality, anxiety and depression. Exploratory SEM mostly confirmed the original factor structure. Conclusions: The concurrent use of factor analysis and Mokken scaling provides additional information about the AAQ. The previously-described factor structure is mostly confirmed. Mokken scaling identifies a new factor relating to vitality, and a hierarchy of responses within three separate scales, referring to vitality, legacy and exclusion. This shows what older people themselves consider important regarding their own ageing.	[Shenkin, Susan D.; Starr, John M.] Univ Edinburgh, Dept Geriatr Med, Edinburgh, Midlothian, Scotland; [Shenkin, Susan D.; Starr, John M.; Deary, Ian J.] Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Watson, Roger] Univ Hull, Fac Hlth & Social Care, Kingston Upon Hull HU6 7RX, N Humberside, England; [Laidlaw, Ken] Univ E Anglia, Dept Clin Psychol, Norwich NR4 7TJ, Norfolk, England; [Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Hull; University of East Anglia; University of Edinburgh	Shenkin, SD (corresponding author), Univ Edinburgh, Dept Geriatr Med, Edinburgh, Midlothian, Scotland.	susan.shenkin@ed.ac.uk	Deary, Ian J/C-6297-2009; Shenkin, Susan/GWZ-3174-2022; Watson, Roger/A-2969-2009	Deary, Ian J/0000-0002-1733-263X; Watson, Roger/0000-0001-8040-7625; Shenkin, Susan/0000-0001-7375-4776	British Geriatrics Society Scottish Branch; BBSRC; EPSRC; MRC; Medical Research Council [MR/K026992/1, G0700704] Funding Source: researchfish; MRC [G0700704] Funding Source: UKRI	British Geriatrics Society Scottish Branch; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a start up grant from the British Geriatrics Society Scottish Branch. The University of Edinburgh Centre for Cognitive Aging and Cognitive Epidemiology is part of the cross council Lifelong Health and Wellbeing Initiative (G0700704/84698). Funding from the BBSRC, EPSRC, ESRC and MRC is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedford A, 2011, PERS INDIV DIFFER, V50, P38, DOI 10.1016/j.paid.2010.08.017; Bryant C, 2012, INT PSYCHOGERIATR, V24, P1674, DOI 10.1017/S1041610212000774; Byrne B. M., 2001, STRUCTURAL EQUATION; Chachamovich E, 2008, GERONTOLOGIST, V48, P593, DOI 10.1093/geront/48.5.593; Deary IJ, 2012, INT J EPIDEMIOL, V41, P1576, DOI 10.1093/ije/dyr197; Deary Ian J, 2007, BMC Geriatr, V7, P28, DOI 10.1186/1471-2318-7-28; DEGRUIJTER DNM, 1994, APPL PSYCH MEAS, V18, P27, DOI 10.1177/014662169401800103; Diehl MK, 2010, J GERONTOL B, V65B, DOI 10.1093/geronb/gbp110; Fry PS, 2000, INT J AGING HUM DEV, V50, P361, DOI 10.2190/DD41-W8F4-W6LK-FY8Q; H.M.S.O, 1956, CENSUS 1951 CLASSIFI; Hempker BT, 1995, APPL PSYCH MEAS, V19, P337; House of Lords Select Committee on Public Service and Demographic Change, 2013, 140 HL; Kalfoss MH, 2010, SCAND J CARING SCI, V24, P75, DOI 10.1111/j.1471-6712.2010.00786.x; KOGAN N, 1961, J ABNORM SOC PSYCH, V62, P616, DOI 10.1037/h0048356; Kuijpers RE, 2013, SOCIOL METHODOL, V43, P42, DOI 10.1177/0081175013481958; Laidlaw K, 2007, INT J GERIATR PSYCH, V22, P367, DOI 10.1002/gps.1683; LAWTON MP, 1975, J GERONTOL, V30, P85, DOI 10.1093/geronj/30.1.85; Levy BR, 2003, J GERONTOL B-PSYCHOL, V58, pP203, DOI 10.1093/geronb/58.4.P203; Lucas-Carrasco R, 2013, INT PSYCHOGERIATR, V25, P490, DOI 10.1017/S1041610212001809; Meijer RR, 2012, EDUC PSYCHOL MEAS, V72, P589, DOI 10.1177/0013164411429344; MEIJER RR, 1990, APPL PSYCH MEAS, V14, P283, DOI 10.1177/014662169001400306; Meijer RR, 2001, PSYCHOL METHODS, V9, P351; Molenaar I. W., 2000, MSP5 WINDOWS PROGRAM; Mooij T, 2012, J PSYCHOEDUC ASSESS, V30, P496, DOI 10.1177/0734282912439387; Nader IW, 2012, ARCH SUICIDE RES, V16, P226, DOI 10.1080/13811118.2012.695271; Office for National Statistics, 2011, NAT POP PROJ 2010 BA; R Foundation for Statistical Computing, 2012, LANG ENV STAT COMP; Scheibe S, 2010, J GERONTOL B-PSYCHOL, V65, P135, DOI 10.1093/geronb/gbp132; Shenkin SD, 2014, INT PSYCHOGERIATR, V26, P1417, DOI 10.1017/S1041610214000301; Sijtsma K, 1996, BRIT J MATH STAT PSY, V49, P79, DOI 10.1111/j.2044-8317.1996.tb01076.x; Sijtsma K, 2011, PERS INDIV DIFFER, V50, P31, DOI 10.1016/j.paid.2010.08.016; Stuart-Hamilton I, 2000, EDUC GERONTOL, V26, P37, DOI 10.1080/036012700267385; United Nations Department of Economic and Social Affairs Population Division, 2011, WORLD POP PROSP 2010, VII; van der Ark L. A., 2007, J STAT SOFTW, V20, P1, DOI DOI 10.18637/JSS.V020.I11; van Schuur WH, 2003, POLIT ANAL, V11, P139, DOI 10.1093/pan/mpg002; Watson R, 2008, PSYCHOL MED, V38, P575, DOI 10.1017/S003329170800281X; Watson R, 2014, PERS INDIV DIFFER, V66, P74, DOI 10.1016/j.paid.2014.03.017; Watson R, 2012, J CLIN NURS, V21, P2736, DOI 10.1111/j.1365-2702.2011.03893.x	39	11	11	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e99100	10.1371/journal.pone.0099100	http://dx.doi.org/10.1371/journal.pone.0099100			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5ML	24892302	Green Published, Green Submitted, gold			2022-12-27	WOS:000336911400125
J	Kuzilek, J; Kremen, V; Soucek, F; Lhotska, L				Kuzilek, Jakub; Kremen, Vaclav; Soucek, Filip; Lhotska, Lenka			Independent Component Analysis and Decision Trees for ECG Holter Recording De-Noising	PLOS ONE			English	Article							REMOVING ARTIFACTS; REDUCTION; DATABASE; ELECTROCARDIOGRAMS; DYNAMICS; PCA	We have developed a method focusing on ECG signal de-noising using Independent component analysis (ICA). This approach combines JADE source separation and binary decision tree for identification and subsequent ECG noise removal. In order to to test the efficiency of this method comparison to standard filtering a wavelet-based de-noising method was used. Freely data available at Physionet medical data storage were evaluated. Evaluation criteria was root mean square error (RMSE) between original ECG and filtered data contaminated with artificial noise. Proposed algorithm achieved comparable result in terms of standard noises (power line interference, base line wander, EMG), but noticeably significantly better results were achieved when uncommon noise (electrode cable movement artefact) were compared.	[Kuzilek, Jakub; Kremen, Vaclav; Lhotska, Lenka] Czech Tech Univ, FEE, Dept Cybernet, Prague, Czech Republic; [Kremen, Vaclav] Czech Tech Univ, Czech Inst Informat Robot & Cybernet, Prague, Czech Republic; [Soucek, Filip] St Annes Hosp Brno, ICRC, Dept Cardiovasc Dis, Brno, Czech Republic	Czech Technical University Prague; Czech Technical University Prague; St Anne's University Hospital Brno (FNUSA-ICRC)	Kuzilek, J (corresponding author), Czech Tech Univ, FEE, Dept Cybernet, Prague, Czech Republic.	jakub.kuzilek@fel.cvut.cz	Kremen, Vaclav/G-7612-2017; Kuzilek, Jakub/M-4316-2019; Lhotska, Lenka/X-1866-2019; Kuzilek, Jakub/G-6733-2012	Kremen, Vaclav/0000-0001-9844-7617; Kuzilek, Jakub/0000-0002-8656-0599; Lhotska, Lenka/0000-0003-0742-5645; Kuzilek, Jakub/0000-0002-8656-0599	Czech Science Foundation GACR [P103/11/P106]; CTU [SGS13/203/OHK3/3T/13]	Czech Science Foundation GACR(Grant Agency of the Czech Republic); CTU	This work was supported by post doctoral research project by Czech Science Foundation GACR #P103/11/P106 and by the CTU Grant SGS13/203/OHK3/3T/13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya A, 2010, IEEE ENG MED BIO, P1142, DOI 10.1109/IEMBS.2010.5627133; Agrawal G, 2008, J SCI IND RES INDIA, V67, P43; Albrecht P., 1983, ST SEGMENT CHARACTER; Barros AK, 1998, NEUROCOMPUTING, V22, P173, DOI 10.1016/S0925-2312(98)00056-3; Breiman L., 2017, CLASSIFICATION REGRE; BROOMHEAD DS, 1986, PHYSICA D, V20, P217, DOI 10.1016/0167-2789(86)90031-X; Castells F, 2007, BIOMED TECH, V52, P18, DOI 10.1515/BMT.2007.005; Chawla MPS, 2008, INT J CARDIOL, V129, P278, DOI 10.1016/j.ijcard.2007.06.037; Chawla MPS, 2011, APPL SOFT COMPUT, V11, P2216, DOI 10.1016/j.asoc.2010.08.001; Comon P, 2010, HANDBOOK OF BLIND SOURCE SEPARATION: INDEPENDENT COMPONENT ANALYSIS AND APPLICATIONS, P1; DiPietroPaolo D, 2006, MED BIOL ENG COMPUT, V44, P489, DOI 10.1007/s11517-006-0055-z; DONOHO DL, 1995, IEEE T INFORM THEORY, V41, P613, DOI 10.1109/18.382009; FRIESEN GM, 1990, IEEE T BIO-MED ENG, V37, P85, DOI 10.1109/10.43620; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; He TG, 2006, NEURAL COMPUT APPL, V15, P105, DOI 10.1007/s00521-005-0013-y; HIRANO K, 1974, IEEE T COMMUN, VCO22, P964, DOI 10.1109/TCOM.1974.1092311; Hong X., 2009, 2009 9 INT C INFORM, P1, DOI [10.1109/ITAB.2009.5394306, DOI 10.1109/ITAB.2009.5394306]; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Jager F, 2003, MED BIOL ENG COMPUT, V41, P172, DOI 10.1007/BF02344885; Jimenez-Gonzalez A, 2008, COMPUTERS IN CARDIOLOGY 2008, VOLS 1 AND 2, P949, DOI 10.1109/CIC.2008.4749200; Keralapura Mallika, 2011, IAENG International Journal of Computer Science, V38, P38; Kiviniemi V, 2003, NEUROIMAGE, V19, P253, DOI 10.1016/S1053-8119(03)00097-1; Kuzilek J, 2013, THESIS CZECH TU; Liu YD, 2008, IEEE J-STSP, V2, P870, DOI 10.1109/JSTSP.2008.2008495; Mallat S, 1999, WAVELT TOUR SIGNAL P; Milanesi M, 2008, MED BIOL ENG COMPUT, V46, P251, DOI 10.1007/s11517-007-0293-8; Milanesi M, 2006, 2006 28 ANN INT C IE; Moody GA, 2001, IEEE ENG MED BIOL, V20, P45, DOI 10.1109/51.932724; Oster J, 2009, PHYSIOL MEAS, V30, P1381, DOI 10.1088/0967-3334/30/12/007; PAN J, 1985, IEEE T BIO-MED ENG, V32, P230, DOI 10.1109/TBME.1985.325532; Patil P.B., 2012, INT C PATTERN RECOGN, P278, DOI [DOI 10.1109/ICPRIME.2012.6208358, 10.1109/ICPREIME.2012.6208358, DOI 10.1109/ICPREIME.2012.6208358]; Romero I, 2011, COMPUT CARDIOL CONF, V38, P613; TADDEI A, 1992, EUR HEART J, V13, P1164, DOI 10.1093/oxfordjournals.eurheartj.a060332; Thomas CG, 2002, NEUROIMAGE, V17, P1521, DOI 10.1006/nimg.2002.1200; Tu YW, 2012, ANN BIOMED ENG, V40, P1917, DOI 10.1007/s10439-012-0551-2; WIDROW B, 1975, P IEEE, V63, P1692, DOI 10.1109/PROC.1975.10036; Wisbeck J.O., 1998, APPL ICA SEPARATION	38	21	21	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98450	10.1371/journal.pone.0098450	http://dx.doi.org/10.1371/journal.pone.0098450			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905359	gold, Green Published, Green Submitted			2022-12-27	WOS:000341869000031
J	Villanueva, A; Vlachos, P; Priya, S				Villanueva, Alex; Vlachos, Pavlos; Priya, Shashank			Flexible Margin Kinematics and Vortex Formation of Aurelia aurita and Robojelly	PLOS ONE			English	Article							SWIMMING PERFORMANCE; FLOW PATTERNS; JELLYFISH; MORPHOLOGY; RINGS	The development of a rowing jellyfish biomimetic robot termed as "Robojelly'', has led to the discovery of a passive flexible flap located between the flexion point and bell margin on the Aurelia aurita. A comparative analysis of biomimetic robots showed that the presence of a passive flexible flap results in a significant increase in the swimming performance. In this work we further investigate this concept by developing varying flap geometries and comparing their kinematics with A. aurita. It was shown that the animal flap kinematics can be replicated with high fidelity using a passive structure and a flap with curved and tapered geometry gave the most biomimetic performance. A method for identifying the flap location was established by utilizing the bell curvature and the variation of curvature as a function of time. Flaps of constant cross-section and varying lengths were incorporated on the Robojelly to conduct a systematic study of the starting vortex circulation. Circulation was quantified using velocity field measurements obtained from planar Time Resolved Digital Particle Image Velocimetry (TRDPIV). The starting vortex circulation was scaled using a varying orifice model and a pitching panel model. The varying orifice model which has been traditionally considered as the better representation of jellyfish propulsion did not appear to capture the scaling of the starting vortex. In contrast, the pitching panel representation appeared to better scale the governing flow physics and revealed a strong dependence on the flap kinematics and geometry. The results suggest that an alternative description should be considered for rowing jellyfish propulsion, using a pitching panel method instead of the traditional varying orifice model. Finally, the results show the importance of incorporating the entire bell geometry as a function of time in modeling rowing jellyfish propulsion.	[Villanueva, Alex; Priya, Shashank] Virginia Polytech Inst & State Univ, Dept Mech Engn, BMDL, CEHMS, Blacksburg, VA 24061 USA; [Vlachos, Pavlos] Purdue Univ, Dept Mech Engn, W Lafayette, IN 47907 USA	Virginia Polytechnic Institute & State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Villanueva, A (corresponding author), Virginia Polytech Inst & State Univ, Dept Mech Engn, BMDL, CEHMS, Blacksburg, VA 24061 USA.	alexv@vt.edu	Priya, S/GQH-7176-2022; Vlachos, Pavlos P/G-3779-2010	Priya, Shashank/0000-0003-1367-3434; Vlachos, Pavlos P/0000-0002-8040-9257	Office of Naval Research [N00014-08-1-0654]	Office of Naval Research(Office of Naval Research)	The authors gratefully acknowledge the financial support from the Office of Naval Research through grant #N00014-08-1-0654. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JJ, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1921949; Buchholz JHJ, 2008, J FLUID MECH, V603, P331, DOI 10.1017/S0022112008000906; Buchholz JHJ, 2011, J FLUID MECH, V688, P591, DOI 10.1017/jfm.2011.408; Chakraborty P, 2005, J FLUID MECH, V535, P189, DOI 10.1017/S0022112005004726; Chapman DM, 1999, CAN J ZOOL, V77, P34, DOI 10.1139/cjz-77-1-34; Charonko JJ, 2013, MEAS SCI TECHNOL, V24, DOI 10.1088/0957-0233/24/6/065301; Colin SP, 2002, J EXP BIOL, V205, P427; COSTELLO JH, 1994, MAR BIOL, V121, P327, DOI 10.1007/BF00346741; Dabiri JO, 2010, J EXP BIOL, V213, P1217, DOI 10.1242/jeb.034660; Dabiri JO, 2005, J FLUID MECH, V538, P111, DOI 10.1017/S002211200500515X; Dabiri JO, 2005, J EXP BIOL, V208, P1257, DOI 10.1242/jeb.01519; Dabiri JO, 2007, J EXP BIOL, V210, P1868, DOI 10.1242/jeb.003772; DANIEL TL, 1983, CAN J ZOOL, V61, P1406, DOI 10.1139/z83-190; DIDDEN N, 1979, Z ANGEW MATH PHYS, V30, P101, DOI 10.1007/BF01597484; DOLIGALSKI TL, 1994, ANNU REV FLUID MECH, V26, P573, DOI 10.1146/annurev.fl.26.010194.003041; Eckstein A, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/5/055401; Eckstein A, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/7/075402; Eckstein AC, 2008, EXP FLUIDS, V45, P485, DOI 10.1007/s00348-008-0492-6; Gemmell BJ, 2013, PNAS, V110, P44; GLADFELTER WB, 1972, HELGOLAND WISS MEER, V23, P38, DOI 10.1007/BF01616310; GLADFELTER WB, 1972, MAR BIOL, V14, P150, DOI 10.1007/BF00373214; Green MA, 2008, J FLUID MECH, V615, P211, DOI 10.1017/S0022112008003583; Holden D, 2011, THESIS VIRGINIA POLY; Jiang M, 2002, P IEEE TCVG, V217; Joshi K, 2013, INTEGR FERROELECTR, V148, P53, DOI 10.1080/10584587.2013.851591; KRAMP PL, 1961, J MAR BIOL ASSOC UK, V40, P7, DOI 10.1017/S0025315400007347; LARSON RJ, 1987, CAN J ZOOL, V65, P2690, DOI 10.1139/z87-408; Mayor AG, 1910, MEDUSAE WORLD; McHenry MJ, 2003, J EXP BIOL, V206, P4125, DOI 10.1242/jeb.00649; Megill WM, 2005, J EXP BIOL, V208, P3819, DOI 10.1242/jeb.01765; Sahin M, 2009, J EXP BIOL, V212, P2656, DOI 10.1242/jeb.025536; Satterlie RA, 2005, BIOL BULL-US, V209, P154, DOI 10.2307/3593133; Scarano F, 2002, MEAS SCI TECHNOL, V13, pR1, DOI 10.1088/0957-0233/13/1/201; SIROVICH L, 1987, Q APPL MATH, V45, P561, DOI 10.1090/qam/910462; Smith C, 2011, SMART MATER STRUCT, V20, DOI 10.1088/0964-1726/20/1/012001; Timmins BH, 2012, EXP FLUIDS, V53, P1133, DOI 10.1007/s00348-012-1341-1; Villanueva AA, 2010, SMART MATER STRUCT, V19, DOI 10.1088/0964-1726/19/2/025013; Wilson MM, 2011, INT J NONLIN MECH, V46, P557, DOI 10.1016/j.ijnonlinmec.2010.12.005; Zhou J, 1999, J FLUID MECH, V387, P353, DOI 10.1017/S002211209900467X	40	8	8	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98310	10.1371/journal.pone.0098310	http://dx.doi.org/10.1371/journal.pone.0098310			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905025	Green Submitted, Green Published, gold			2022-12-27	WOS:000341869000028
J	FitzGerald, J; Murillo, LS; O'Brien, G; O'Connell, E; O'Connor, A; Wu, K; Wang, GN; Rainey, MD; Natoni, A; Healy, S; O'Dwyer, M; Santocanale, C				FitzGerald, Jennifer; Murillo, Laura S.; O'Brien, Gemma; O'Connell, Enda; O'Connor, Aisling; Wu, Kevin; Wang, Guan-Nan; Rainey, Michael D.; Natoni, Alessandro; Healy, Sandra; O'Dwyer, Michael; Santocanale, Corrado			A High Through-Put Screen for Small Molecules Modulating MCM2 Phosphorylation Identifies Ryuvidine as an Inducer of the DNA Damage Response	PLOS ONE			English	Article							CDC7 KINASE INHIBITORS; CELL-CYCLE REGULATION; DOUBLE-STRAND BREAKS; S-PHASE; TOPOISOMERASE-II; CANCER-THERAPY; IONIZING-RADIATION; REPLICATION STRESS; ANTITUMOR-ACTIVITY; PROTEIN	DNA replication is an essential process for cell division and as such it is a process that is directly targeted by several anticancer drugs. CDC7 plays an essential role in the activation of replication origins and has recently been proposed as a novel target for drug discovery. The MCM DNA helicase complex (MCM2-7) is a key target of the CDC7 kinase, and MCM phosphorylation status at specific sites is a reliable biomarker of CDC7 cellular activity. In this work we describe a cell-based assay that utilizes the "In Cell Western Technique'' (ICW) to identify compounds that affect cellular CDC7 activity. By screening a library of approved drugs and kinase inhibitors we found several compounds that can affect CDC7-dependent phosphorylation of MCM2 in HeLa cells. Among these, Mitoxantrone, a topoisomerase inhibitor, and Ryuvidine, previously described as a CDK4 inhibitor, cause a reduction in phosphorylated MCM2 levels and a sudden blockade of DNA synthesis that is accompanied by an ATM-dependent checkpoint response. This study sheds light on the previously observed cytotoxity of Ryuvidine, strongly suggesting that it is related to its effect of causing DNA damage.	[FitzGerald, Jennifer; Murillo, Laura S.; O'Brien, Gemma; O'Connor, Aisling; Wu, Kevin; Wang, Guan-Nan; Rainey, Michael D.; Natoni, Alessandro; Healy, Sandra; Santocanale, Corrado] Natl Univ Ireland Galway, Sch Nat Sci, Ctr Chromosome Biol, Galway, Ireland; [FitzGerald, Jennifer; Murillo, Laura S.; O'Brien, Gemma; O'Connor, Aisling; Wu, Kevin; Wang, Guan-Nan; Rainey, Michael D.; Natoni, Alessandro; Healy, Sandra; Santocanale, Corrado] Natl Univ Ireland Galway, Sch Nat Sci, Natl Ctr Biomed Engn Sci, Galway, Ireland; [Murillo, Laura S.; Natoni, Alessandro; O'Dwyer, Michael] Natl Univ Ireland Galway, Sch Med, Galway, Ireland; [O'Connell, Enda] Natl Univ Ireland Galway, Natl Ctr Biomed Engn Sci, Screening Core, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Santocanale, C (corresponding author), Natl Univ Ireland Galway, Sch Nat Sci, Ctr Chromosome Biol, Galway, Ireland.	corrado.santocanale@nuigalway.ie		Wu, Kevin/0000-0003-3597-8714; Natoni, Alessandro/0000-0003-4321-9005; O'Connell, Enda/0000-0001-7441-0262; Murillo, Laura/0000-0002-2493-8584; o'dwyer, michael/0000-0002-6173-7140; Santocanale, Corrado/0000-0003-1337-5656; Rainey, Michael/0000-0001-9777-873X	Science Foundation Ireland [08/IN.1/B2064]; Irish Health Research Board [HRA/2009/89]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Health Research Board	This work was partially supported by Science Foundation Ireland (http://www.sfi.ie http://www.sfi.ie) grant 08/IN.1/B2064 and the Irish Health Research Board (http://www.hrb.ie http://www.hrb.ie) grant HRA/2009/89. Screening Core and Flow Cytomerty facilities are supported by HEA (www.hea.ie http://www.hea.ie) PRTLI5 Advancing Medicine through Discovery programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed K, 2012, EXPERT OPIN INV DRUG, V21, P619, DOI 10.1517/13543784.2012.676043; Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Barkley LR, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.20; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; BEGLEITER A, 1984, CANCER RES, V44, P78; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; Bryan MC, 2013, BIOORG MED CHEM LETT, V23, P2056, DOI 10.1016/j.bmcl.2013.02.007; Chauvier D, 2007, CELL DEATH DIFFER, V14, P387, DOI 10.1038/sj.cdd.4402044; Cho WH, 2006, P NATL ACAD SCI USA, V103, P11521, DOI 10.1073/pnas.0604990103; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; Chong CR, 2006, NAT CHEM BIOL, V2, P415, DOI 10.1038/nchembio806; Chuang LC, 2009, MOL CELL, V35, P206, DOI 10.1016/j.molcel.2009.06.014; Cicenas J, 2011, J CANCER RES CLIN, V137, P1409, DOI 10.1007/s00432-011-1039-4; Collins FS, 2011, NAT REV DRUG DISCOV, V10, P397, DOI 10.1038/nrd3461; Day TA, 2010, J CELL BIOL, V191, P953, DOI 10.1083/jcb.201006043; Diaz-Moralli S, 2013, PHARMACOL THERAPEUT, V138, P255, DOI 10.1016/j.pharmthera.2013.01.011; Dodson H, 2007, CELL CYCLE, V6, P364, DOI 10.4161/cc.6.3.3834; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Gatei M, 2003, J BIOL CHEM, V278, P14806, DOI 10.1074/jbc.M210862200; Hande KR, 1998, BBA-GENE STRUCT EXPR, V1400, P173, DOI 10.1016/S0167-4781(98)00134-1; Harrington PE, 2013, BIOORG MED CHEM LETT, V23, P6396, DOI 10.1016/j.bmcl.2013.09.055; Hiraga S, 2014, GENE DEV, V28, P372, DOI 10.1101/gad.231258.113; Hoffman GR, 2010, ASSAY DRUG DEV TECHN, V8, P186, DOI 10.1089/adt.2009.0213; Huang X, 2003, CELL CYCLE, V2, P614, DOI 10.4161/cc.2.6.565; Ito S, 2008, DRUG NEWS PERSPECT, V21, P481, DOI 10.1358/dnp.2008.21.9.1290818; Jiang W, 1999, EMBO J, V18, P5703, DOI 10.1093/emboj/18.20.5703; Kim JM, 2008, ONCOGENE, V27, P3475, DOI 10.1038/sj.onc.1210994; Koltun ES, 2012, BIOORG MED CHEM LETT, V22, P3727, DOI 10.1016/j.bmcl.2012.04.024; Kurose A, 2005, CYTOM PART A, V68A, P1, DOI 10.1002/cyto.a.20186; Menichincheri M, 2010, J MED CHEM, V53, P7296, DOI 10.1021/jm100504d; Menichincheri M, 2009, J MED CHEM, V52, P293, DOI 10.1021/jm800977q; Montagnoli A, 2002, EMBO J, V21, P3171, DOI 10.1093/emboj/cdf290; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Montagnoli A, 2008, NAT CHEM BIOL, V4, P357, DOI 10.1038/nchembio.90; Montagnoli A, 2010, CLIN CANCER RES, V16, P4503, DOI 10.1158/1078-0432.CCR-10-0185; Natoni A, 2011, MOL CANCER THER, V10, P1624, DOI 10.1158/1535-7163.MCT-10-1119; Paul SM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004452; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Pommier Y, 2013, ACS CHEM BIOL, V8, P82, DOI 10.1021/cb300648v; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Rainey MD, 2008, CANCER RES, V68, P7466, DOI 10.1158/0008-5472.CAN-08-0763; Rainey MD, 2013, CELL CYCLE, V12, P1560, DOI 10.4161/cc.24675; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Ryu CK, 2000, BIOORG MED CHEM LETT, V10, P461, DOI 10.1016/S0960-894X(00)00014-7; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Singh M, 2013, ANTICANCER AGENTS ME; Smart DJ, 2008, MUTAT RES-FUND MOL M, V641, P43, DOI 10.1016/j.mrfmmm.2008.03.005; Suzuki T, 2012, J BIOL CHEM, V287, P40256, DOI 10.1074/jbc.M112.353805; Swords R, 2010, EUR J CANCER, V46, P33, DOI 10.1016/j.ejca.2009.09.020; Tenca P, 2007, J BIOL CHEM, V282, P208, DOI 10.1074/jbc.M604457200; Vanotti E, 2008, J MED CHEM, V51, P487, DOI 10.1021/jm700956r; Wan XB, 2013, J MED CHEM, V56, P2619, DOI 10.1021/jm400045y; Poh WT, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130138; Wu X, 2002, ONCOGENE, V21, P7786, DOI 10.1038/sj.onc.1205914; Yamada M, 2013, GENE DEV, V27, P2459, DOI 10.1101/gad.224568.113; Yin RC, 2013, SCI REP-UK, V3, DOI 10.1038/srep01269; Yoshizawa-Sugata N, 2005, J BIOL CHEM, V280, P13062, DOI 10.1074/jbc.M411653200; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao CL, 2009, BIOORG MED CHEM LETT, V19, P319, DOI 10.1016/j.bmcl.2008.11.093; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou BBS, 2000, J BIOL CHEM, V275, P10342, DOI 10.1074/jbc.275.14.10342	64	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98891	10.1371/journal.pone.0098891	http://dx.doi.org/10.1371/journal.pone.0098891			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24902048	gold, Green Published, Green Submitted			2022-12-27	WOS:000336841400068
J	Luzwick, JW; Nam, EA; Zhao, RX; Cortez, D				Luzwick, Jessica W.; Nam, Edward A.; Zhao, Runxiang; Cortez, David			Mutation of Serine 1333 in the ATR HEAT Repeats Creates a Hyperactive Kinase	PLOS ONE			English	Article							EARLY EMBRYONIC LETHALITY; PIK-RELATED KINASES; DNA-DAMAGE; ATAXIA-TELANGIECTASIA; GENOME MAINTENANCE; PROTEIN; DOMAIN; PHOSPHORYLATION; REPLICATION; AUTOPHOSPHORYLATION	Subcellular localization, protein interactions, and post-translational modifications regulate the DNA damage response kinases ATR, ATM, and DNA-PK. During an analysis of putative ATR phosphorylation sites, we found that a single mutation at S1333 creates a hyperactive kinase. In vitro and in cells, mutation of S1333 to alanine (S1333A-ATR) causes elevated levels of kinase activity with and without the addition of the protein activator TOPBP1. S1333 mutations to glycine, arginine, or lysine also create a hyperactive kinase, while mutation to aspartic acid decreases ATR activity. S1333A-ATR maintains the G(2) checkpoint and promotes completion of DNA replication after transient exposure to replication stress but the less active kinase, S1333D-ATR, has modest defects in both of these functions. While we find no evidence that S1333 is phosphorylated in cultured cells, our data indicate that small changes in the HEAT repeats can have large effects on kinase activity. These mutants may serve as useful tools for future studies of the ATR pathway.	[Luzwick, Jessica W.; Nam, Edward A.; Zhao, Runxiang; Cortez, David] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA	Vanderbilt University	Cortez, D (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA.	david.cortez@vanderbilt.edu			NIH [CA102792, S10RR027714]; Vanderbilt Ingram Cancer Center [P30CA06485]; NATIONAL CANCER INSTITUTE [R01CA102792, R01CA102729] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027714] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Ingram Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was funded by NIH grant CA102792 to D.C. Additional funds for mass spectrometry were obtained from NIH grant S10RR027714 and the Vanderbilt Ingram Cancer Center support grant P30CA06485. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Ball HL, 2007, MOL CELL BIOL, V27, P3367, DOI 10.1128/MCB.02238-06; Ball HL, 2005, MOL BIOL CELL, V16, P2372, DOI 10.1091/mbc.e04-11-1006; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; Brown EJ, 2000, GENE DEV, V14, P397; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Chen XP, 2007, EXP CELL RES, V313, P1667, DOI 10.1016/j.yexcr.2007.02.015; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; de Klein A, 2000, CURR BIOL, V10, P479, DOI 10.1016/S0960-9822(00)00447-4; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu SZ, 2011, MOL CELL, V43, P192, DOI 10.1016/j.molcel.2011.06.019; Lovejoy CA, 2009, P NATL ACAD SCI USA, V106, P19304, DOI 10.1073/pnas.0909345106; Mordes DA, 2008, CELL CYCLE, V7, P2809, DOI 10.4161/cc.7.18.6689; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Myers JS, 2007, CANCER RES, V67, P6685, DOI 10.1158/0008-5472.CAN-07-0495; Nam EA, 2011, J BIOL CHEM, V286, P37320, DOI 10.1074/jbc.M111.276113; Nam EA, 2011, J BIOL CHEM, V286, P28707, DOI 10.1074/jbc.M111.248914; Nam EA, 2011, BIOCHEM J, V436, P527, DOI 10.1042/BJ20102162; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; Reaper PM, 2011, NAT CHEM BIOL, V7, P428, DOI [10.1038/NCHEMBIO.573, 10.1038/nchembio.573]; Rubinson EH, 2010, NATURE, V468, P406, DOI 10.1038/nature09428; Schoppy DW, 2012, J CLIN INVEST, V122, P241, DOI 10.1172/JCI58928; Shechter D, 2004, DNA REPAIR, V3, P901, DOI 10.1016/j.dnarep.2004.03.020; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; Sirbu B. M., 2013, COLD SPRING HARBOR P, V5; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	35	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99397	10.1371/journal.pone.0099397	http://dx.doi.org/10.1371/journal.pone.0099397			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901225	gold, Green Published, Green Submitted			2022-12-27	WOS:000336841400125
J	Sun, LP; Liu, JW; Yuan, Q; Xing, CZ; Yuan, Y				Sun, Liping; Liu, Jingwei; Yuan, Quan; Xing, Chengzhong; Yuan, Yuan			Association between PTEN Gene IVS4 Polymorphism and Risk of Cancer: A Meta-Analysis	PLOS ONE			English	Article							GERMLINE MUTATIONS; TUMOR-SUPPRESSOR; PATHWAY	Background: Phosphatase and tensin homolog (PTEN) is a well established tumor suppressor gene. Recently, increasing studies investigated the association between PTEN IVS4 polymorphism (rs3830675) and risk of various types of cancer. However, the results from the individual studies were controversial. The aim of this meta-analysis was to elucidate whether PTEN IVS4 polymorphism was associated with cancer risk. Methods: Databases including PubMed, Web of knowledge and Chinese National Knowledge Infrastructure (CNKI) were systematically searched to identify potentially eligible literatures. Odds ratios (OR) and their 95% confidence interval (CI) were used to assess the strength of association between PTEN IVS4 polymorphism and cancer risk. Results: A total of seven case-control studies were finally included in this meta-analysis. The pooled analysis suggested that individuals with PTEN IVS4 (-/-) genotype were significantly associated with increased risk of cancer (OR = 1.45, 95% CI = 1.19-1.76, P<0.001) and subgroup of digestive tract cancer (OR = 1.67, 95% CI = 1.28-2.18, P<0.001) compared with (+/+) genotype. The allele analysis revealed that (-) allele was significantly associated with increased risk of cancer (OR = 1.30, 95% CI = 1.12-1.50, P = 0.001) and subgroup of digestive tract cancer (OR = 1.42, 95% CI = 1.16-1.74, P = 0.001) compared with (+) allele. No significant association was observed between PTEN IVS4 (+/-) genotype and risk of cancer. Conclusion: PTEN IVS4 (-/-) genotype was significantly associated with increased risk of cancer especially for digestive tract cancer compared with (+/+) genotype. The (-) allele of PTEN IVS4 (rs3830675) polymorphism was significantly associated with increased risk of cancer especially for digestive tract cancer compared with (+) allele. The recessive effect model and dominant effect model also demonstrated significant association between PTEN IVS4 (rs3830675) polymorphism and increased cancer risk especially for digestive tract cancer. Further large-scale and well-designed studies regarding different ethnicities are still required to confirm the results of our meta-analysis.	[Xing, Chengzhong] China Med Univ, Affiliated Hosp 1, Tumor Etiol & Screening Dept Canc Inst & Gen Surg, Shenyang, Peoples R China; China Med Univ, Liaoning Prov Educ Dept, Key Lab Canc Etiol & Prevent, Shenyang, Peoples R China	China Medical University; China Medical University	Xing, CZ (corresponding author), China Med Univ, Affiliated Hosp 1, Tumor Etiol & Screening Dept Canc Inst & Gen Surg, Shenyang, Peoples R China.	xcz1966@126.com; yyuan@mail.cmu.edu.cn	yuan, quan/GZM-5597-2022		National Basic Research Program of China (973 Program) [2010CB529304]; Science and Technology Project of Liaoning province [2011225002, 2012225016]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Science and Technology Project of Liaoning province	This study is supported by grants from National Basic Research Program of China (973 Program Ref No. 2010CB529304), the grants of the Science and Technology Project of Liaoning province (Ref No. 2011225002) and the grants of the Science and Technology Project of Liaoning province (Ref No. 2012225016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Canbay E, 2013, GENET TEST MOL BIOMA, V17, P249, DOI 10.1089/gtmb.2012.0306; Canbay E, 2013, EXPERT OPIN THER TAR, V17, P1, DOI 10.1517/14728222.2013.727398; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ge H, 2008, DIS ESOPHAGUS, V21, P409, DOI 10.1111/j.1442-2050.2007.00786.x; [葛晖 Ge Hui], 2007, [中国肿瘤临床, Chinese Journal of Clinical Oncology], V34, P1261; George DJ, 2001, CANCER EPIDEM BIOMAR, V10, P411; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; Mills GB, 2001, SEMIN ONCOL, V28, P125, DOI 10.1053/sonc.2001.28554; Nelen MR, 1997, HUM MOL GENET, V6, P1383, DOI 10.1093/hmg/6.8.1383; Ortega-Molina A, 2013, TRENDS ENDOCRIN MET, V24, P184, DOI 10.1016/j.tem.2012.11.002; Pesche S, 1998, ONCOGENE, V16, P2879, DOI 10.1038/sj.onc.1202081; Rearick D, 2011, NUCLEIC ACIDS RES, V39, P2357, DOI 10.1093/nar/gkq1080; Risinger JI, 1997, CANCER RES, V57, P4736; Rose AB, 2008, CURR TOP MICROBIOL, V326, P277; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Wang XJ, 2008, CELL RES, V18, P807, DOI 10.1038/cr.2008.83; Yang JL, 2010, J CANCER RES CLIN, V136, P1303, DOI 10.1007/s00432-010-0781-3; Yin Y, 2008, ONCOGENE, V27, P5443, DOI 10.1038/onc.2008.241; Ying Shao-Yao, 2009, V487, P387, DOI 10.1007/978-1-60327-547-7_19; Zaridze DG, 2008, BIOCHEMISTRY-MOSCOW+, V73, P532, DOI 10.1134/S0006297908050064; Zhao Z H, 2012, CHIN J CANC PREV TRE, V19, P743	29	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98851	10.1371/journal.pone.0098851	http://dx.doi.org/10.1371/journal.pone.0098851			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901890	gold, Green Submitted, Green Published			2022-12-27	WOS:000336841400060
J	Xie, QS; Chen, LH; Zhao, FQ; Zhou, XH; Huang, PF; Zhang, LF; Zhou, DK; Wei, JF; Wang, WL; Zheng, SS				Xie, Qingsong; Chen, Linghui; Zhao, Fengqing; Zhou, Xiaohu; Huang, Pengfei; Zhang, Lufei; Zhou, Dongkai; Wei, Jianfeng; Wang, Weilin; Zheng, Shusen			A Meta-Analysis of Randomized Controlled Trials of Low-Volume Polyethylene Glycol plus Ascorbic Acid versus Standard-Volume Polyethylene Glycol Solution as Bowel Preparations for Colonoscopy	PLOS ONE			English	Article							ORAL SODIUM-PHOSPHATE; GASTROINTESTINAL-ENDOSCOPY ASGE; RECTAL-SURGEONS ASCRS; COLORECTAL-CANCER; LAVAGE SOLUTION; CLEANSING PREPARATION; ELECTROLYTE-SOLUTION; CONSENSUS DOCUMENT; MAGNESIUM CITRATE; AMERICAN-SOCIETY	Background: Standard-volume polyethylene glycol (PEG) gut lavage solutions are safe and effective, but they require the consumption of large volumes of fluid. A new lower-volume solution of PEG plus ascorbic acid has been used recently as a preparation for colonoscopy. Aim: A meta-analysis was performed to compare the performance of low-volume PEG plus ascorbic acid with standard-volume PEG as bowel preparation for colonoscopy. Study: Electronic and manual searches were performed to identify randomized controlled trials (RCTs) that compared the performance of low-volume PEG plus ascorbic acid with standard-volume PEG as bowel preparation for colonoscopy. After a methodological quality assessment and data extraction, the pooled estimates of bowel preparation efficacy during bowel cleansing, compliance with preparation, willingness to repeat the same preparation, and the side effects were calculated. We calculated pooled estimates of odds ratios (OR) by fixed-and/or random-effects models. We also assessed heterogeneity among studies and the publication bias. Results: Eleven RCTs were identified for analysis. The pooled OR for preparation efficacy during bowel cleansing and for compliance with preparation for low-volume PEG plus ascorbic acid were 1.08 (95% CI = 0.98-1.28, P = 0.34) and 2.23 (95% CI = 1.67-2.98, P<0.00001), respectively, compared with those for standard-volume PEG. The side effects of vomiting and nausea for low-volume PEG plus ascorbic acid were reduced relative to standard-volume PEG. There was no significant publication bias, according to a funnel plot. Conclusions: Low-volume PEG plus ascorbic acid gut lavage achieved non-inferior efficacy for bowel cleansing, is more acceptable to patients, and has fewer side effects than standard-volume PEG as a bowel preparation method for colonoscopy.	[Xie, Qingsong; Chen, Linghui; Zhao, Fengqing; Zhou, Xiaohu; Huang, Pengfei; Zhang, Lufei; Zhou, Dongkai; Wei, Jianfeng; Wang, Weilin; Zheng, Shusen] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Div Hepatobilitary & Pancreat Surg,Dept Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Xie, Qingsong; Chen, Linghui; Zhao, Fengqing; Zhou, Xiaohu; Huang, Pengfei; Zhang, Lufei; Zhou, Dongkai; Wei, Jianfeng; Wang, Weilin; Zheng, Shusen] Minist Publ Hlth, Key Lab Combined Multiorgan Transplantat, Hangzhou, Zhejiang, Peoples R China; [Xie, Qingsong; Chen, Linghui; Zhao, Fengqing; Zhou, Xiaohu; Huang, Pengfei; Zhang, Lufei; Zhou, Dongkai; Wei, Jianfeng; Wang, Weilin; Zheng, Shusen] Key Lab Organ Transplantat, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Wang, WL (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Div Hepatobilitary & Pancreat Surg,Dept Surg, Hangzhou 310003, Zhejiang, Peoples R China.	wam@zju.edu.cn; shusenzheng@zju.edu.cn			National Natural Science Foundation of China [81172315/H1617]; research Special Fund For public welfare industry of health; translational research of early diagnosis and comprehensive treatment in pancreatic cancer [201202007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); research Special Fund For public welfare industry of health; translational research of early diagnosis and comprehensive treatment in pancreatic cancer	This work was supported by grants from the National Natural Science Foundation of China (No. 81172315/H1617), the research Special Fund For public welfare industry of health and the translational research of early diagnosis and comprehensive treatment in pancreatic cancer (201202007). The funders had a role in preparation of the manuscript and publication.	Arditi C, 2009, ENDOSCOPY, V41, P200, DOI 10.1055/s-0028-1119626; Aronchick CA, 2000, GASTROINTEST ENDOSC, V52, P346, DOI 10.1067/mge.2000.108480; Barclay RL, 2002, GASTROINTEST ENDOSC, V56, P633, DOI 10.1067/mge.2002.129221; Barkun A, 2006, CAN J GASTROENTEROL, V20, P699, DOI 10.1155/2006/915368; Belsey J, 2007, ALIMENT PHARM THER, V25, P373, DOI 10.1111/j.1365-2036.2006.03212.x; BENDICH A, 1995, J AM COLL NUTR, V14, P124; Bitoun A, 2006, ALIMENT PHARM THERAP, V24, P1631, DOI 10.1111/j.1365-2036.2006.03167.x; Blanchard J, 1997, AM J CLIN NUTR, V66, P1165, DOI 10.1093/ajcn/66.5.1165; Bond JH, 2006, AM J GASTROENTEROL, V101, P263, DOI 10.1111/j.1572-0241.2006.00426.x; Brenner H, 2011, ANN INTERN MED, V154, P22, DOI 10.7326/0003-4819-154-1-201101040-00004; Chokshi RV, 2012, GASTROINTEST ENDOSC, V75, P1197, DOI 10.1016/j.gie.2012.01.005; Clark L, 2007, GASTROINTEST ENDOSC, V65, pAB262, DOI 10.1016/j.gie.2007.03.617; Corporaal S, 2010, SCAND J GASTROENTERO, V45, P1380, DOI 10.3109/00365521003734158; DIFEBO G, 1990, ENDOSCOPY, V22, P214, DOI 10.1055/s-2007-1012851; Ell C, 2008, AM J GASTROENTEROL, V103, P883, DOI 10.1111/j.1572-0241.2007.01708.x; Froehlich F, 2005, GASTROINTEST ENDOSC, V61, P378, DOI 10.1016/S0016-5107(04)02776-2; Fujita I, 2000, RES COMMUN MOL PATH, V107, P219; Gentile Maurizio, 2013, Surg Laparosc Endosc Percutan Tech, V23, P276, DOI 10.1097/SLE.0b013e31828e389d; Godfrey JD, 2013, WORLD J META-ANAL, V1, P10, DOI 10.13105/wjma.v1.i1.10; Gonzalez-Mendez Y, 2011, GASTROINTEST ENDOSC, V73, pAB424, DOI 10.1016/j.gie.2011.03.976; Halphen M, 2013, GASTROINTEST ENDOSC, V78, P121, DOI 10.1016/j.gie.2013.02.009; Harewood GC, 2002, AM J GASTROENTEROL, V97, P3186, DOI 10.1111/j.1572-0241.2002.07129.x; Hsu CW, 1998, GASTROINTEST ENDOSC, V48, P276, DOI 10.1016/S0016-5107(98)70191-9; Huppertz-Hauss G, 2005, ENDOSCOPY, V37, P537, DOI 10.1055/s-2005-861315; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jansen SV, 2011, EUR J GASTROEN HEPAT, V23, P897, DOI 10.1097/MEG.0b013e32834a3444; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Lebwohl B, 2011, GASTROINTEST ENDOSC, V73, P1207, DOI 10.1016/j.gie.2011.01.051; Lee BC, 2008, GASTROINTEST ENDOSC, V67, pAB290, DOI 10.1016/j.gie.2008.03.836; Lichtenstein G, 2009, AM J HEALTH-SYST PH, V66, P27, DOI 10.2146/ajhp080084; Lieberman DA, 1996, GASTROINTEST ENDOSC, V43, P467; Markowitz GS, 2005, J AM SOC NEPHROL, V16, P3389, DOI 10.1681/ASN.2005050496; Markowitz GS, 2004, HUM PATHOL, V35, P675, DOI 10.1016/j.humpath.2003.12.005; Marmo R, 2010, GASTROINTEST ENDOSC, V72, P313, DOI 10.1016/j.gie.2010.02.048; Mathus-Vliegen EMH, 2006, ALIMENT PHARM THERAP, V23, P543, DOI 10.1111/j.1365-2036.2006.02777.x; Nelson RS, 2009, CURR ONCOL REP, V11, P482, DOI 10.1007/s11912-009-0065-8; Nyberg C, 2010, NAT REV GASTRO HEPAT, V7, P557, DOI 10.1038/nrgastro.2010.136; Pitcher DE, 1997, GASTROINTEST ENDOSC, V46, P266, DOI 10.1016/S0016-5107(97)70099-3; Ponchon T, 2013, DIGEST LIVER DIS, V45, P820, DOI 10.1016/j.dld.2013.04.009; Pontone S, 2011, WORLD J GASTROENTERO, V17, P4689, DOI 10.3748/wjg.v17.i42.4689; Radaelli F, 2005, AM J GASTROENTEROL, V100, P2674, DOI 10.1111/j.1572-0241.2005.00335.x; Rex DK, 2009, AM J GASTROENTEROL, V104, P739, DOI 10.1038/ajg.2009.104; Shaoul R, 2001, GASTROINTEST ENDOSC, V53, P650, DOI 10.1067/mge.2001.112712; Sharma VK, 1997, GASTROINTEST ENDOSC, V46, P541, DOI 10.1016/S0016-5107(97)70011-7; Sharma VK, 1998, GASTROINTEST ENDOSC, V47, P167, DOI 10.1016/S0016-5107(98)70351-7; Toledo TK, 2001, ALIMENT PHARM THERAP, V15, P605, DOI 10.1046/j.1365-2036.2001.00966.x; Tsikitis VL, 2009, J CLIN ONCOL, V27, P3671, DOI 10.1200/JCO.2008.20.7050; Valiante F, 2012, DIGEST LIVER DIS, V44, P224, DOI 10.1016/j.dld.2011.10.007; VANNER SJ, 1990, AM J GASTROENTEROL, V85, P422; Wexner SD, 2006, GASTROINTEST ENDOSC, V63, P894, DOI 10.1016/j.gie.2006.03.918; Wexner SD, 2006, DIS COLON RECTUM, V49, P792, DOI 10.1007/s10350-006-0536-z; Wilson JX, 2005, ANNU REV NUTR, V25, P105, DOI 10.1146/annurev.nutr.25.050304.092647; Young CJ, 2000, DIS COLON RECTUM, V43, P1568, DOI 10.1007/BF02236740; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370	55	12	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99092	10.1371/journal.pone.0099092	http://dx.doi.org/10.1371/journal.pone.0099092			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24902028	Green Published, Green Submitted, gold			2022-12-27	WOS:000336841400096
J	Daignan, JM; Chen, R; Mahmoud, KA; Ma, Y; Hill, IG; Kreplak, L				Daignan, Jean-Michel; Chen, Ran; Mahmoud, Khaled A.; Ma, Yuan; Hill, Ian G.; Kreplak, Laurent			Patterning of Nanocrystalline Cellulose Gel Phase by Electrodissolution of a Metallic Electrode	PLOS ONE			English	Article							SUSPENSIONS; SEPARATION; COPPER	At high concentration or in the presence of electrolytes and organic solvents, solutions of cellulose nanocrystals (CNCs) can form gels exhibiting optical properties similar to the ones of liquid crystal phases. In an attempt to pattern such a gel phase, we have studied the electrodissolution of a metallic electrode in a water suspension of carboxylated CNCs (cCNCs). Depending on the metal used, the electrodissolution process was observed at a different positive potential. In the case of copper the minimum potential at which we could observe optically the growth of the gel phase was 200 mV. The growth rate was current limited indicating that the process was controlled by the electrodissolution of the copper electrode. This hypothesis was confirmed by using circular and square copper patterns as positive electrodes. In both cases, the consumption of the electrode material was observed optically and correlated with the growth of the gel phase.	[Daignan, Jean-Michel; Hill, Ian G.; Kreplak, Laurent] Dalhousie Univ, Dept Phys & Atmospher Sci, Halifax, NS, Canada; [Chen, Ran; Ma, Yuan] Dalhousie Univ, Dept Elect & Comp Engn, Halifax, NS, Canada; [Mahmoud, Khaled A.] Qatar Fdn, QEERI, Doha, Qatar	Dalhousie University; Dalhousie University; Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; Qatar Environment & Energy Research Institute	Kreplak, L (corresponding author), Dalhousie Univ, Dept Phys & Atmospher Sci, Halifax, NS, Canada.	kreplak@dal.ca	Hill, Ian G/L-9743-2018	Hill, Ian G/0000-0001-6180-9311; kreplak, laurent/0000-0001-9370-9809; Mahmoud, Khaled/0000-0003-1246-4067	Biovision Technology (Nova Scotia, Canada)	Biovision Technology (Nova Scotia, Canada)	The authors would like to thank Biovision Technology (Nova Scotia, Canada) for support during the course of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck-Candanedo S, 2007, MACROMOLECULES, V40, P3429, DOI 10.1021/ma0704818; Beck-Candanedo S, 2006, LANGMUIR, V22, P8690, DOI 10.1021/la061310j; Beck-Candanedo S, 2006, CELLULOSE, V13, P629, DOI 10.1007/s10570-006-9084-x; Bordel D, 2006, LANGMUIR, V22, P4899, DOI 10.1021/la0600402; BRAUN M, 1979, J ELECTROCHEM SOC, V126, P1666, DOI 10.1149/1.2128773; CROUSIER J, 1988, CORROSION, V44, P768, DOI 10.5006/1.3584945; DEVRIES H, 1951, ACTA CRYSTALLOGR, V4, P219, DOI 10.1107/S0365110X51000751; Dong SP, 2007, J AM CHEM SOC, V129, P13810, DOI 10.1021/ja076196l; Dong XM, 1998, CELLULOSE, V5, P19, DOI 10.1023/A:1009260511939; Habibi Y, 2006, CELLULOSE, V13, P679, DOI 10.1007/s10570-006-9075-y; Habibi Y, 2010, CHEM REV, V110, P3479, DOI 10.1021/cr900339w; Heux L, 2000, LANGMUIR, V16, P8210, DOI 10.1021/la9913957; Jasmani L, 2013, NANOSCALE, V5, P10207, DOI 10.1039/c3nr03456a; Leung ACW, 2011, SMALL, V7, P302, DOI 10.1002/smll.201001715; Mahmoud KA, 2009, ACS APPL MATER INTER, V1, P1383, DOI 10.1021/am900331d; MARCHESSAULT RH, 1959, NATURE, V184, P632, DOI 10.1038/184632a0; ONDRISCRAWFORD R, 1991, J APPL PHYS, V69, P6380, DOI 10.1063/1.348840; RANBY BG, 1950, EXPERIENTIA, V6, P12, DOI 10.1007/BF02154044; RANBY BG, 1949, ACTA CHEM SCAND, V3, P649, DOI 10.3891/acta.chem.scand.03-0649; REVOL JF, 1994, LIQ CRYST, V16, P127, DOI 10.1080/02678299408036525; REVOL JF, 1992, INT J BIOL MACROMOL, V14, P170, DOI 10.1016/S0141-8130(05)80008-X; Roman M, 2009, ACS SYM SER, V1017, P81	22	0	0	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99202	10.1371/journal.pone.0099202	http://dx.doi.org/10.1371/journal.pone.0099202			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897116	Green Submitted, Green Published, gold			2022-12-27	WOS:000338430700123
J	Rohatgi, N; Nielsen, TK; Bjorn, SP; Axelsson, I; Paglia, G; Voldborg, BG; Palsson, BO; Rolfsson, O				Rohatgi, Neha; Nielsen, Tine Kragh; Bjorn, Sara Petersen; Axelsson, Ivar; Paglia, Giuseppe; Voldborg, Bjorn Gunnar; Palsson, Bernhard O.; Rolfsson, Ottar			Biochemical Characterization of Human Gluconokinase and the Proposed Metabolic Impact of Gluconic Acid as Determined by Constraint Based Metabolic Network Analysis	PLOS ONE			English	Article							PENTOSE-PHOSPHATE PATHWAY; CELL; RECONSTRUCTION; GENES; GNTK	The metabolism of gluconate is well characterized in prokaryotes where it is known to be degraded following phosphorylation by gluconokinase. Less is known of gluconate metabolism in humans. Human gluconokinase activity was recently identified proposing questions about the metabolic role of gluconate in humans. Here we report the recombinant expression, purification and biochemical characterization of isoform I of human gluconokinase alongside substrate specificity and kinetic assays of the enzyme catalyzed reaction. The enzyme, shown to be a dimer, had ATP dependent phosphorylation activity and strict specificity towards gluconate out of 122 substrates tested. In order to evaluate the metabolic impact of gluconate in humans we modeled gluconate metabolism using steady state metabolic network analysis. The results indicate that significant metabolic flux changes in anabolic pathways linked to the hexose monophosphate shunt (HMS) are induced through a small increase in gluconate concentration. We argue that the enzyme takes part in a context specific carbon flux route into the HMS that, in humans, remains incompletely explored. Apart from the biochemical description of human gluconokinase, the results highlight that little is known of the mechanism of gluconate metabolism in humans despite its widespread use in medicine and consumer products.	[Rohatgi, Neha; Axelsson, Ivar; Paglia, Giuseppe; Palsson, Bernhard O.; Rolfsson, Ottar] Univ Iceland, Ctr Syst Biol, Reykjavik, Iceland; [Rohatgi, Neha; Rolfsson, Ottar] Univ Iceland, Biomed Ctr, Reykjavik, Iceland; [Nielsen, Tine Kragh; Bjorn, Sara Petersen; Voldborg, Bjorn Gunnar] Univ Copenhagen, Fac Hlth Sci, Ctr Prot Res, Copenhagen, Denmark	University of Iceland; University of Iceland; University of Copenhagen	Rolfsson, O (corresponding author), Univ Iceland, Ctr Syst Biol, Reykjavik, Iceland.	ottarr@hi.is	Paglia, Giuseppe/H-2012-2018	Paglia, Giuseppe/0000-0003-4724-6801; Rohatgi, Neha/0000-0003-1103-0259; Palsson, Bernhard/0000-0003-2357-6785; Voldborg, Bjorn Gunnar/0000-0002-7005-1642; Rolfsson, Ottar/0000-0003-4258-6057	European Research Council [232816]	European Research Council(European Research Council (ERC)European Commission)	This work was supported by the European Research Council grant proposal no. 232816. The funders had no role in study design, data collection and analysis.	Agren R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002518; [Anonymous], 2004, UNEPREPORT; Behrends V, 2013, J BIOL CHEM, V288, P15098, DOI 10.1074/jbc.M112.442814; BIRNESSER H, 1973, DIABETOLOGIA, V9, P30, DOI 10.1007/BF01225997; BLOOM B, 1955, J BIOL CHEM, V212, P555; Bordbar A, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-180; Bordbar A, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-110; BUBLITZ C, 1988, J BIOL CHEM, V263, P12849; DAHL JL, 1974, ANNU REV BIOCHEM, V43, P327; Frank JE, 2005, AM FAM PHYSICIAN, V72, P1277; Gebauer J, 2012, FEBS J, V279, P3192, DOI 10.1111/j.1742-4658.2012.08700.x; Gille C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.62; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Handa S, 2009, BIOL PHARM BULL, V32, P1645, DOI 10.1248/bpb.32.1645; Hu ZP, 2012, J PROTEOME RES, V11, P5903, DOI 10.1021/pr300666p; Izu H, 1996, FEBS LETT, V394, P14, DOI 10.1016/0014-5793(96)00923-4; JOSHI A, 1990, J THEOR BIOL, V142, P41, DOI 10.1016/S0022-5193(05)80012-8; Karlstadt A, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-114; Kolodziejczyk J, 2011, J PHYSIOL BIOCHEM, V67, P175, DOI 10.1007/s13105-010-0061-3; Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103; Kraft L, 2002, J MOL BIOL, V318, P1057, DOI 10.1016/S0022-2836(02)00215-2; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; LEDER IG, 1957, J BIOL CHEM, V225, P125; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Mardinoglu A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.5; Oresic M, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.55; Palsson BO., 2006, SYSTEMS BIOL PROPERT; Peekhaus N, 1998, J BACTERIOL, V180, P3495, DOI 10.1128/JB.180.14.3495-3502.1998; Ramachandran S, 2006, FOOD TECHNOL BIOTECH, V44, P185; Riganti C, 2012, FREE RADICAL BIO MED, V53, P421, DOI 10.1016/j.freeradbiomed.2012.05.006; Rolfsson O, 2013, BIOCHEM J, V449, P427, DOI 10.1042/BJ20120980; Rolfsson O, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-155; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213; Senesi S, 2010, BIOL CHEM, V391, P1, DOI 10.1515/BC.2009.146; STETTEN MR, 1953, J BIOL CHEM, V203, P653; Sweetser DA, 2005, GENE CHROMOSOME CANC, V44, P279, DOI 10.1002/gcc.20236; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; Thornalley PJ, 1998, CELL MOL BIOL, V44, P1013; Tong SX, 1996, J BACTERIOL, V178, P3260, DOI 10.1128/jb.178.11.3260-3269.1996; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002318	44	23	24	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98760	10.1371/journal.pone.0098760	http://dx.doi.org/10.1371/journal.pone.0098760			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896608	Green Published, gold, Green Submitted			2022-12-27	WOS:000338430700072
J	Wallace, IJ; Demes, B; Mongle, C; Pearson, OM; Polk, JD; Lieberman, DE				Wallace, Ian J.; Demes, Brigitte; Mongle, Carrie; Pearson, Osbjorn M.; Polk, John D.; Lieberman, Daniel E.			Exercise-Induced Bone Formation Is Poorly Linked to Local Strain Magnitude in the Sheep Tibia	PLOS ONE			English	Article							GRADIENTS CORRELATE; LAW; PATTERNS; SKELETON; GROWTH; SITES; WOLFF	Functional interpretations of limb bone structure frequently assume that diaphyses adjust their shape by adding bone primarily across the plane in which they are habitually loaded in order to minimize loading-induced strains. Here, to test this hypothesis, we characterize the in vivo strain environment of the sheep tibial midshaft during treadmill exercise and examine whether this activity promotes bone formation disproportionately in the direction of loading in diaphyseal regions that experience the highest strains. It is shown that during treadmill exercise, sheep tibiae were bent in an anteroposterior direction, generating maximal tensile and compressive strains on the anterior and posterior shaft surfaces, respectively. Exercise led to significantly increased periosteal bone formation; however, rather than being biased toward areas of maximal strains across the anteroposterior axis, exercise-related osteogenesis occurred primarily around the medial half of the shaft circumference, in both high and low strain regions. Overall, the results of this study demonstrate that loading-induced bone growth is not closely linked to local strain magnitude in every instance. Therefore, caution is necessary when bone shaft shape is used to infer functional loading history in the absence of in vivo data on how bones are loaded and how they actually respond to loading.	[Wallace, Ian J.; Mongle, Carrie] SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA; [Demes, Brigitte] SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; [Pearson, Osbjorn M.] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA; [Polk, John D.] Univ Illinois, Dept Anthropol, Urbana, IL USA; [Lieberman, Daniel E.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of New Mexico; University of Illinois System; University of Illinois Urbana-Champaign; Harvard University	Wallace, IJ (corresponding author), SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA.	ian.wallace@stonybrook.edu		Pearson, Osbjorn/0000-0002-1814-7663; Mongle, Carrie/0000-0002-5474-0501	NSF [IBN 96-03833]	NSF(National Science Foundation (NSF))	This research was supported by NSF (www.nsf.gov) grant no. IBN 96-03833 to DEL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTRAM JEA, 1991, BIOL REV, V66, P245, DOI 10.1111/j.1469-185X.1991.tb01142.x; BIEWENER A A, 1992, P123; Carter DR, 2001, SKELETAL FUNCTION FO; Demes B, 2001, AM J PHYS ANTHROPOL, V116, P257, DOI 10.1002/ajpa.1122.abs; Demes B, 1998, AM J PHYS ANTHROPOL, V106, P87, DOI 10.1002/(SICI)1096-8644(199805)106:1<87::AID-AJPA6>3.0.CO;2-A; Garman R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000653; Gross TS, 1997, J BONE MINER RES, V12, P982, DOI 10.1359/jbmr.1997.12.6.982; Judex S, 1997, J BONE MINER RES, V12, P1737, DOI 10.1359/jbmr.1997.12.10.1737; Lanyon L.E., 1985, P1; Larsen C.S., 1997, BIOARCHAEOLOGY INTER; Lieberman DE, 2004, AM J PHYS ANTHROPOL, V123, P156, DOI 10.1002/ajpa.10316; Lieberman DE, 2003, J EXP BIOL, V206, P3125, DOI 10.1242/jeb.00514; Main RP, 2007, J ANAT, V210, P272, DOI 10.1111/j.1469-7580.2007.00696.x; Moore MK, 2013, RESEARCH METHODS IN HUMAN SKELETAL BIOLOGY, P397; Mosley JR, 1997, BONE, V20, P191, DOI 10.1016/S8756-3282(96)00385-7; OCONNOR JA, 1982, J BIOMECH, V15, P767, DOI 10.1016/0021-9290(82)90092-6; Pearson OM, 2004, YEARB PHYS ANTHROPOL, V47, P63, DOI 10.1002/ajpa.20155; Rubin C, 2001, NATURE, V412, P603, DOI 10.1038/35088122; Ruff C, 2006, AM J PHYS ANTHROPOL, V129, P484, DOI 10.1002/ajpa.20371; RUFF CB, 2008, BIOL ANTHR HUMAN SKE, P183, DOI DOI 10.1002/9780470245842.CH6; Thompson WR, 2012, GENE, V503, P179, DOI 10.1016/j.gene.2012.04.076; Wallace IJ, 2013, J MUSCULOSKEL NEURON, V13, P283; Warden S J, 2004, Eura Medicophys, V40, P223	23	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99108	10.1371/journal.pone.0099108	http://dx.doi.org/10.1371/journal.pone.0099108			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897411	Green Published, gold, Green Submitted			2022-12-27	WOS:000338430700118
J	Clausen, MP; Arnspang, EC; Ballou, B; Bear, JE; Lagerholm, BC				Clausen, Mathias P.; Arnspang, Eva C.; Ballou, Byron; Bear, James E.; Lagerholm, B. Christoffer			Simultaneous Multi-Species Tracking in Live Cells with Quantum Dot Conjugates	PLOS ONE			English	Article							UNDERGO HOP DIFFUSION; PLASMA-MEMBRANE; RECEPTOR CLUSTERS; SURFACE-PROTEINS; PARTICLE; CHOLESTEROL; CONFINEMENT; MONOVALENT; MOLECULES; TRANSPORT	Quantum dots are available in a range of spectrally separated emission colors and with a range of water-stabilizing surface coatings that offers great flexibility for enabling bio-specificity. In this study, we have taken advantage of this flexibility to demonstrate that it is possible to perform a simultaneous investigation of the lateral dynamics in the plasma membrane of i) the transmembrane epidermal growth factor receptor, ii) the glucosylphospatidylinositol-anchored protein CD59, and iii) ganglioside G(M1)-cholera toxin subunit B clusters in a single cell. We show that a large number of the trajectories are longer than 50 steps, which we by simulations show to be sufficient for robust single trajectory analysis. This analysis shows that the populations of the diffusion coefficients are heterogeneously distributed for all three species, but differ between the different species. We further show that the heterogeneity is decreased upon treating the cells with methyl-beta-cyclodextrin.	[Clausen, Mathias P.; Arnspang, Eva C.; Lagerholm, B. Christoffer] Univ Southern Denmark, MEMPHYS Ctr Biomembrane Phys, Odense M, Denmark; [Clausen, Mathias P.; Arnspang, Eva C.; Lagerholm, B. Christoffer] Univ Southern Denmark, Danish Mol Biomed Imaging Ctr DaMBIC, Odense M, Denmark; [Ballou, Byron] Carnegie Mellon Univ, MBIC, Mellon Inst, Pittsburgh, PA 15213 USA; [Bear, James E.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA; [Bear, James E.] Univ N Carolina, Dept Cell & Dev Biol, Howard Hughes Med Inst, Chapel Hill, NC USA	University of Southern Denmark; University of Southern Denmark; Carnegie Mellon University; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill	Lagerholm, BC (corresponding author), Univ Oxford, Weatherall Inst Mol Med, Oxford, England.	christoffer.lagerholm@imm.ox.ac.uk	Clausen, Mathias P./AAE-6487-2020; Arnspang, Eva C/Y-1132-2018	Clausen, Mathias P./0000-0003-1196-6241; Arnspang, Eva C/0000-0002-3095-4070; Lagerholm, Christoffer/0000-0003-4678-5168	VillumKann Rasmussen Foundation; Leo PharmaForskningsfond; Lundbeck Foundation; Novo Nordisk Foundation; Danish Natural Research Foundation; DaMBIC (Danish Molecular Biomedical Imaging Center); National Institutes of Health (NIH) [GM083035]; NIH [R01 EB000364]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083035] Funding Source: NIH RePORTER	VillumKann Rasmussen Foundation; Leo PharmaForskningsfond(LEO Pharma); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Natural Research Foundation(Danish Natural Science Research Council); DaMBIC (Danish Molecular Biomedical Imaging Center); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the VillumKann Rasmussen Foundation (to BioNET), Leo PharmaForskningsfond, the Lundbeck Foundation, the Novo Nordisk Foundation, and the Danish Natural Research Foundation (to MEMPHYS - Center for Biomembrane Physics) and DaMBIC (Danish Molecular Biomedical Imaging Center). J.E.B. was supported by National Institutes of Health (NIH) grant GM083035. B. B. was supported by NIH grant R01 EB000364. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews NL, 2008, NAT CELL BIOL, V10, P955, DOI 10.1038/ncb1755; Andrews NL, 2009, IMMUNITY, V31, P469, DOI 10.1016/j.immuni.2009.06.026; Arnspang EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048521; Bannai H, 2006, NAT PROTOC, V1, P2628, DOI 10.1038/nprot.2006.429; Bauer R, 1997, BBA-GEN SUBJECTS, V1334, P98, DOI 10.1016/S0304-4165(96)00078-5; Boggara M, 2013, BBA-BIOMEMBRANES, V1828, P419, DOI 10.1016/j.bbamem.2012.08.022; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Cai L, 2008, CELL, V134, P828, DOI 10.1016/j.cell.2008.06.054; Chakraborty SK, 2007, NANO LETT, V7, P2618, DOI 10.1021/nl0709930; Chen I, 2005, NAT METHODS, V2, P99, DOI 10.1038/NMETH735; Christensen EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044355; Clausen MP, 2013, NANO LETT, V13, P2332, DOI 10.1021/nl303151f; Clausen MP, 2011, CURR PROTEIN PEPT SC, V12, P699; Cutler PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064320; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; Day CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034923; Day CA, 2009, BBA-BIOMEMBRANES, V1788, P245, DOI 10.1016/j.bbamem.2008.10.024; Durisic N, 2007, BIOPHYS J, V93, P1338, DOI 10.1529/biophysj.107.106864; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994; Howarth M, 2005, P NATL ACAD SCI USA, V102, P7583, DOI 10.1073/pnas.0503125102; Howarth M, 2008, NAT PROTOC, V3, P534, DOI 10.1038/nprot.2008.20; Howarth M, 2008, NAT METHODS, V5, P397, DOI 10.1038/NMETH.1206; Kopriva-Altfahrt G, 2009, PERITON DIALYSIS INT, V29, P330; Lidke DS, 2005, J CELL BIOL, V170, P619, DOI 10.1083/jcb.200503140; Lidke DS, 2004, NAT BIOTECHNOL, V22, P198, DOI 10.1038/nbt929; Low-Nam ST, 2011, NAT STRUCT MOL BIOL, V18, P1244, DOI 10.1038/nsmb.2135; Mahammad S, 2008, BBA-BIOMEMBRANES, V1778, P1251, DOI 10.1016/j.bbamem.2008.02.010; Mascalchi P, 2012, SOFT MATTER, V8, P4462, DOI 10.1039/c2sm07018a; Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Mittal R, 2011, BIOCONJUGATE CHEM, V22, P362, DOI 10.1021/bc100321c; Orr G, 2005, BIOPHYS J, V89, P1362, DOI 10.1529/biophysj.104.056192; Petershans A, 2011, CHEM COMMUN, V47, P10671, DOI 10.1039/c1cc12874d; Pinaud F, 2010, NAT METHODS, V7, P275, DOI [10.1038/nmeth.1444, 10.1038/NMETH.1444]; Pinaud F, 2009, TRAFFIC, V10, P691, DOI 10.1111/j.1600-0854.2009.00902.x; Rosenthal SJ, 2011, CHEM BIOL, V18, P10, DOI 10.1016/j.chembiol.2010.11.013; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; SIMSON R, 1995, BIOPHYS J, V69, P989, DOI 10.1016/S0006-3495(95)79972-6; Sunbul M, 2008, CHEM COMMUN, P5927, DOI 10.1039/b812162a; Suzuki K, 2005, BIOPHYS J, V88, P3659, DOI 10.1529/biophysj.104.048538; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; Thompson AR, 2013, BIOPHYS J, V104, P2651, DOI 10.1016/j.bpj.2013.05.022; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tu RS, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.041914; Umemura YM, 2008, BIOPHYS J, V95, P435, DOI 10.1529/biophysj.107.123018; Wang S, 2013, B MATH BIOL; Wieser S, 2007, BIOPHYS J, V92, P3719, DOI 10.1529/biophysj.106.095398; Wieser S, 2008, METHODS, V46, P131, DOI 10.1016/j.ymeth.2008.06.010; Wu CY, 2012, CELL, V148, P973, DOI 10.1016/j.cell.2011.12.034; You CJ, 2010, ANGEW CHEM INT EDIT, V49, P4108, DOI 10.1002/anie.200907032	52	20	21	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e97671	10.1371/journal.pone.0097671	http://dx.doi.org/10.1371/journal.pone.0097671			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892555	Green Published, gold, Green Submitted			2022-12-27	WOS:000336911400017
J	Ladner-Keay, CL; Griffith, BJ; Wishart, DS				Ladner-Keay, Carol L.; Griffith, Bethany J.; Wishart, David S.			Shaking Alone Induces De Novo Conversion of Recombinant Prion Proteins to beta-Sheet Rich Oligomers and Fibrils	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; IN-VITRO; CONFORMATION; STRAINS; STATE	The formation of beta-sheet rich prion oligomers and fibrils from native prion protein (PrP) is thought to be a key step in the development of prion diseases. Many methods are available to convert recombinant prion protein into beta-sheet rich fibrils using various chemical denaturants (urea, SDS, GdnHCl), high temperature, phospholipids, or mildly acidic conditions (pH 4). Many of these methods also require shaking or another form of agitation to complete the conversion process. We have identified that shaking alone causes the conversion of recombinant PrP to beta-sheet rich oligomers and fibrils at near physiological pH (pH 5.5 to pH 6.2) and temperature. This conversion does not require any denaturant, detergent, or any other chemical cofactor. Interestingly, this conversion does not occur when the water-air interface is eliminated in the shaken sample. We have analyzed shaking-induced conversion using circular dichroism, resolution enhanced native acidic gel electrophoresis (RENAGE), electron microscopy, Fourier transform infrared spectroscopy, thioflavin T fluorescence and proteinase K resistance. Our results show that shaking causes the formation of beta-sheet rich oligomers with a population distribution ranging from octamers to dodecamers and that further shaking causes a transition to beta-sheet fibrils. In addition, we show that shaking-induced conversion occurs for a wide range of full-length and truncated constructs of mouse, hamster and cervid prion proteins. We propose that this method of conversion provides a robust, reproducible and easily accessible model for scrapie-like amyloid formation, allowing the generation of milligram quantities of physiologically stable beta-sheet rich oligomers and fibrils. These results may also have interesting implications regarding our understanding of prion conversion and propagation both within the brain and via techniques such as protein misfolding cyclic amplification (PMCA) and quaking induced conversion (QuIC).	[Ladner-Keay, Carol L.; Griffith, Bethany J.; Wishart, David S.] Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada; [Ladner-Keay, Carol L.; Wishart, David S.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Ladner-Keay, Carol L.; Griffith, Bethany J.; Wishart, David S.] Natl Inst Nanotechnol, Edmonton, AB, Canada	University of Alberta; University of Alberta; National Research Council Canada	Wishart, DS (corresponding author), Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada.	david.wishart@ualberta.ca	Wishart, David Scott/ABI-3181-2020	Wishart, David S/0000-0002-3207-2434; Ladner-Keay, Carol/0000-0003-0273-713X	Alberta Prion Research Institute (APRI); Alberta Meat and Livestock Agency (ALMA)	Alberta Prion Research Institute (APRI); Alberta Meat and Livestock Agency (ALMA)	This work was supported by grants awarded to DSW from the Alberta Prion Research Institute (APRI) and Alberta Meat and Livestock Agency (ALMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi R, 2008, NAT METHODS, V5, P211, DOI 10.1038/nmeth0308-211; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Atarashi R, 2011, NAT MED, V17, P175, DOI 10.1038/nm.2294; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bjorndahl TC, 2011, BIOCHEMISTRY-US, V50, P1162, DOI 10.1021/bi101435c; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Breydo L, 2005, ANAL BIOCHEM, V339, P165, DOI 10.1016/j.ab.2005.01.003; Caughey B, 2003, J VIROL, V77, P5499, DOI 10.1128/JVI.77.9.5499-5502.2003; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Cobb NJ, 2008, J BIOL CHEM, V283, P34704, DOI 10.1074/jbc.M806701200; Colby DW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000736; Colby DW, 2009, P NATL ACAD SCI USA, V106, P20417, DOI 10.1073/pnas.0910350106; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Di Stasio E, 2010, BIOPHYS CHEM, V153, P1, DOI 10.1016/j.bpc.2010.07.002; Eghiaian F, 2007, P NATL ACAD SCI USA, V104, P7414, DOI 10.1073/pnas.0607745104; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Feng BY, 2008, NAT CHEM BIOL, V4, P197, DOI 10.1038/nchembio.65; Gomes MPB, 2008, J BIOL CHEM, V283, P19616, DOI 10.1074/jbc.M802102200; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Ladner CL, 2012, ANAL BIOCHEM, V426, P54, DOI 10.1016/j.ab.2012.04.005; Loksztejn A, 2010, J MOL BIOL, V395, P643, DOI 10.1016/j.jmb.2009.10.065; McGuire LI, 2012, ANN NEUROL, V72, P278, DOI 10.1002/ana.23589; Morillas M, 2001, BIOCHEMISTRY-US, V40, P6982, DOI 10.1021/bi010232q; Murray AN, 2013, PROTEIN SCI, V22, P1531, DOI 10.1002/pro.2339; NEUHOFF V, 1985, ELECTROPHORESIS, V6, P427, DOI 10.1002/elps.1150060905; Orru CD, 2011, MBIO, V2, DOI 10.1128/mBio.00078-11; Ostapchenko VG, 2010, J MOL BIOL, V400, P908, DOI 10.1016/j.jmb.2010.05.051; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Saleem F, PRION IN PRESS; Sankaranarayanan K, 2012, J PHYS CHEM B, V116, P895, DOI 10.1021/jp2100733; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; SLUZKY V, 1991, P NATL ACAD SCI USA, V88, P9377, DOI 10.1073/pnas.88.21.9377; Spassov S, 2006, BBA-GEN SUBJECTS, V1760, P1138, DOI 10.1016/j.bbagen.2006.02.018; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Sreerama N, 2004, PROTEIN SCI, V13, P100, DOI 10.1110/ps.03258404; Stohr J, 2008, P NATL ACAD SCI USA, V105, P2409, DOI 10.1073/pnas.0712036105; Wang F, 2007, BIOCHEMISTRY-US, V46, P7045, DOI 10.1021/bi700299h; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Wong E, 2004, BIOCHEM J, V380, P273, DOI 10.1042/BJ20031767	45	23	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98753	10.1371/journal.pone.0098753	http://dx.doi.org/10.1371/journal.pone.0098753			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892647	Green Submitted, Green Published, gold			2022-12-27	WOS:000336911400088
J	Macaulay, S; Dunger, DB; Norris, SA				Macaulay, Shelley; Dunger, David B.; Norris, Shane A.			Gestational Diabetes Mellitus in Africa: A Systematic Review	PLOS ONE			English	Review							ORAL GLUCOSE-TOLERANCE; FETAL MACROSOMIA; OBESITY; PREVALENCE; PREGNANCY; WOMEN; HYPERGLYCEMIA; EPIDEMIOLOGY; ASSOCIATION; DIAGNOSIS	Background: Gestational diabetes mellitus (GDM) is any degree of impaired glucose tolerance first recognised during pregnancy. Most women with GDM revert to normal glucose metabolism after delivery of their babies; however, they are at risk of developing type 2 diabetes later in life as are their offspring. Determining a country's GDM prevalence can assist with policy guidelines regarding GDM screening and management, and can highlight areas requiring research. This systematic review assesses GDM prevalence in Africa. Methods and Findings: Three electronic databases were searched without language restrictions; PubMed, Scopus and the Cochrane Library. Thirty-one search terms were searched. Eligible articles defined GDM, stated what GDM screening approaches were employed and reported GDM prevalence. The reporting quality and risk of bias within each study was assessed. The PRISMA guidelines for systematic reviews were followed. The literature search identified 466 unique records. Sixty full text articles were reviewed of which 14 were included in the systematic review. One abstract, for which the full text article could not be obtained, was also included. Information regarding GDM classification, screening methods and prevalence was obtained for six African countries; Ethiopia (n = 1), Morocco (n = 1), Mozambique (n = 1), Nigeria (n = 6), South Africa (n = 4) and Tanzania (n = 1). Prevalence figures ranged from 0% (Tanzania) to 13.9% (Nigeria) with some studies focussing on women with GDM risk factors. Most studies utilised the two hour 75 g oral glucose tolerance test and applied the World Health Organization's diagnostic criteria. Conclusions: Six countries, equating to 11% of the African continent, were represented in this systematic review. This indicates how little is known about GDM in Africa and highlights the need for further research. Considering the increasing public health burden of obesity and type 2 diabetes, it is essential that the extent of GDM is understood in Africa to allow for effective intervention programmes.	[Macaulay, Shelley; Dunger, David B.; Norris, Shane A.] Univ Witwatersrand, Dept Paediat, MRC, Wits Dev Pathways Hlth Res Unit, Johannesburg, South Africa; [Dunger, David B.; Norris, Shane A.] Univ Cambridge, Dept Paediat, Cambridge, England	University of Witwatersrand; University of Cambridge	Macaulay, S (corresponding author), Univ Witwatersrand, Dept Paediat, MRC, Wits Dev Pathways Hlth Res Unit, Johannesburg, South Africa.	shelley.macaulay@wits.ac.za	Norris, Shane/C-4664-2014	Norris, Shane/0000-0001-7124-3788; Dunger, Professor David/0000-0002-2566-9304	UK Medical Research Council; Department of Development African Research Leader Scheme grant; National Institute for Health Research [NF-SI-0508-10274, NF-SI-0513-10012] Funding Source: researchfish; Wellbeing of Women [RG1644] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Development African Research Leader Scheme grant; National Institute for Health Research(National Institute for Health Research (NIHR)); Wellbeing of Women(Wellbeing of Women (WoW))	The authors acknowledge the funding support of the UK Medical Research Council and the Department of Development African Research Leader Scheme grant (Dunger and Norris). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbola O, 2008, West Afr J Med, V27, P139; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; [Anonymous], 1988, LANCET, V2, P1173; [Anonymous], 1985, World Health Organ Tech Rep Ser, V727, P1; Anzaku AS, 2013, ARCH GYNECOL OBSTET, V287, P859, DOI 10.1007/s00404-012-2649-z; Barker DJP, 2012, PUBLIC HEALTH, V126, P185, DOI 10.1016/j.puhe.2011.11.014; Basu JK, 2010, INT J GYNECOL OBSTET, V110, P101, DOI 10.1016/j.ijgo.2010.02.020; Ben-Haroush A, 2004, DIABETIC MED, V21, P103, DOI 10.1046/j.1464-5491.2003.00985.x; Bouhsain S, 2009, ANN BIOL CLIN-PARIS, V67, P159, DOI 10.1684/abc.2009.0309; Buchmann EJ, 1996, CHASA J COMPR HLTH, V7, P118; Buchmann EJ, 2013, COMMUNICATION; CARPENTER MW, 1982, AM J OBSTET GYNECOL, V144, P768, DOI 10.1016/0002-9378(82)90349-0; Challis K, 2002, ACTA OBSTET GYN SCAN, V81, P560, DOI 10.1034/j.1600-0412.2002.810615.x; Dabelea D, 2011, DIABETES, V60, P1849, DOI 10.2337/db11-0400; Dabelea D, 2007, DIABETES CARE, V30, pS169, DOI 10.2337/dc07-s211; Expert Committee, 2003, DIABETES CARE S1, V26, pS5, DOI DOI 10.2337/DIACARE.26.2007.S5; Ezegwui HU, 2011, NIGER J CLIN PRACT, V14, P322, DOI 10.4103/1119-3077.86777; Farrar D, 2012, COCHRANE DB SYST REV; Forsbach-Sanchez G, 2005, ARCH MED RES, V36, P291, DOI 10.1016/j.arcmed.2005.03.001; Hall V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-564; HARRIS M, 1979, DIABETES, V28, P1039; Herring SJ, 2011, CURR DIABETES REP, V11, P20, DOI 10.1007/s11892-010-0156-9; Hillier TA, 2007, DIABETES CARE, V30, P2287, DOI 10.2337/dc06-2361; Hirst JE, 2012, J DIABETOLOGY, V3, P1; Hoy D, 2012, J CLIN EPIDEMIOL, V65, P934, DOI 10.1016/j.jclinepi.2011.11.014; International Diabetes Federation, 2013, IDF DIAB ATL; International Diabetes Federation, 2006, DIAB DECL STRAT AFR; JACKSON WPU, 1979, S AFR MED J, V56, P921; Jiwani A, 2012, J MATERN-FETAL NEO M, V25, P600, DOI 10.3109/14767058.2011.587921; Kamanu CI, 2009, ARCH GYNECOL OBSTET, V279, P857, DOI 10.1007/s00404-008-0780-7; Kim SY, 2011, EXP DIABETES RES, DOI 10.1155/2011/541308; Kjos SL, 1999, NEW ENGL J MED, V341, P1749, DOI 10.1056/NEJM199912023412307; Koyanagi A, 2013, LANCET, V381, P476, DOI 10.1016/S0140-6736(12)61605-5; Kuti MA, 2011, J CLIN PATHOL, V64, P718, DOI 10.1136/jcp.2010.087098; Lindsay RS., 2009, BRIT J DIABETES VASC, V9, P27; Mamabolo RL, 2007, DIABETIC MED, V24, P233, DOI 10.1111/j.1464-5491.2006.02073.x; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nielsen KK, 2012, GLOB HLTH ACTION, V5; Olarinoye J K, 2004, West Afr J Med, V23, P198; Onyiriuka A N, 2006, Niger J Clin Pract, V9, P114; Ozumba BC, 2004, INT J GYNECOL OBSTET, V84, P114, DOI 10.1016/S0020-7292(03)00210-8; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; RANCHOD HA, 1991, S AFR MED J, V80, P14; Seshiah V, 2008, J Assoc Physicians India, V56, P329; Seyoum B, 1999, DIABETES RES CLIN PR, V46, P247, DOI 10.1016/S0168-8227(99)00101-1; Sierra GN, 2009, AFRICA HLTH, V32, P50; Statistics South Africa, 2013, MIDYEAR POPULATION E; SWAI ABM, 1991, DIABETIC MED, V8, P254, DOI 10.1111/j.1464-5491.1991.tb01581.x; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; World Health Organization, 1999, DEF DIAGN CLASS DI 1; World Health Organization, 2002, LAB DIAGN MON DIAB M; Yogev Y, 2009, SEMIN FETAL NEONAT M, V14, P94, DOI 10.1016/j.siny.2009.01.001	54	94	96	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e97871	10.1371/journal.pone.0097871	http://dx.doi.org/10.1371/journal.pone.0097871			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892280	Green Published, gold			2022-12-27	WOS:000336911400025
J	Ohlberger, J; Rogers, LA; Stenseth, NC				Ohlberger, Jan; Rogers, Lauren A.; Stenseth, Nils Chr			Stochasticity and Determinism: How Density-Independent and Density-Dependent Processes Affect Population Variability	PLOS ONE			English	Article							NORTHEAST ARCTIC COD; AT-AGE DATA; GADUS-MORHUA; CLASS STRENGTH; FISH RECRUITMENT; BARENTS SEA; TIME-SERIES; STOCK; MORTALITY; ABUNDANCE	A persistent debate in population ecology concerns the relative importance of environmental stochasticity and density dependence in determining variability in adult year-class strength, which contributes to future reproduction as well as potential yield in exploited populations. Apart from the strength of the processes, the timing of density regulation may affect how stochastic variation, for instance through climate, translates into changes in adult abundance. In this study, we develop a life-cycle model for the population dynamics of a large marine fish population, Northeast Arctic cod, to disentangle the effects of density-independent and density-dependent processes on early life-stages, and to quantify the strength of compensatory density dependence in the population. The model incorporates information from scientific surveys and commercial harvest, and dynamically links multiple effects of intrinsic and extrinsic factors on all life-stages, from eggs to spawners. Using a state-space approach we account for observation error and stochasticity in the population dynamics. Our findings highlight the importance of density-dependent survival in juveniles, indicating that this period of the life cycle largely determines the compensatory capacity of the population. Density regulation at the juvenile life-stage dampens the impact of stochastic processes operating earlier in life such as environmental impacts on the production of eggs and climate-dependent survival of larvae. The timing of stochastic versus regulatory processes thus plays a crucial role in determining variability in adult abundance. Quantifying the contribution of environmental stochasticity and compensatory mechanisms in determining population abundance is essential for assessing population responses to climate change and exploitation by humans.	[Ohlberger, Jan; Rogers, Lauren A.; Stenseth, Nils Chr] Univ Oslo, Dept Biosci, CEES, Oslo, Norway	University of Oslo	Ohlberger, J (corresponding author), Univ Oslo, Dept Biosci, CEES, Oslo, Norway.	jan.ohlberger@ibv.uio.no	Ohlberger, Jan/H-3262-2019; Stenseth, Nils Chr./G-5212-2016	Ohlberger, Jan/0000-0001-6795-240X; Stenseth, Nils Chr./0000-0002-1591-5399; Rogers, Lauren/0000-0003-3305-6441	VISTA; Statoil; Norwegian Academy of Science and Letters; Norden Top-Level Research Initiative through the Nordic Centre for Research on Marine Ecosystems and Resources under Climate Change (NorMER)	VISTA; Statoil; Norwegian Academy of Science and Letters; Norden Top-Level Research Initiative through the Nordic Centre for Research on Marine Ecosystems and Resources under Climate Change (NorMER)	JO was supported by VISTA (http://www.vista.no), a basic research program funded by Statoil and conducted in close collaboration with The Norwegian Academy of Science and Letters (http://english.dnva.no). LAR acknowledges support by the Norden Top-Level Research Initiative through the Nordic Centre for Research on Marine Ecosystems and Resources under Climate Change (NorMER, http://www.normer.uio.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanes S, 2007, CAN J FISH AQUAT SCI, V64, P1130, DOI 10.1139/F07-074; Andrewartha HG, 1954, THE DISTRIBUTION AND; BOGSTAD B, 1994, ICES MAR SC, V198, P576; Brinch CN, 2011, CAN J FISH AQUAT SCI, V68, P1717, DOI 10.1139/F2011-085; Brook BW, 2006, ECOLOGY, V87, P1445, DOI 10.1890/0012-9658(2006)87[1445:SOEFDD]2.0.CO;2; Ciannelli L, 2007, ECOLOGY, V88, P635, DOI 10.1890/05-2035; Dingsor GE, 2007, ECOLOGY, V88, P625, DOI 10.1890/05-1782; Eikeset AM, 2010, THE ECOLOGICAL AND E; ELLERTSEN B, 1989, RAP PROCES, V191, P209; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Geweke J., 1992, BAYESIAN STAT, V4, P169, DOI DOI 10.21034/SR.148; GUDMUNDSSON G, 1994, J R STAT SOC C-APPL, V43, P117; HANSKI I, 1990, PHILOS T R SOC B, V330, P141; Hixon MA, 2002, ECOLOGY, V83, P1490, DOI 10.2307/3071969; Hjermann DO, 2004, CAN J FISH AQUAT SCI, V61, P1747, DOI 10.1139/F04-115; Hjort J., 1914, RAPP P V REUN CONS I, V20, P1; Houde Edward D., 2009, Journal of Northwest Atlantic Fishery Science, V41, P53; Hylen A., 2002, ICES MARINE SCI S, V215, P543, DOI [10.1046/j.1467-2979.2003.00112.x, DOI 10.1046/J.1467-2979.2003.00112.X]; ICES, 2013, REPORT OF THE ARCTIC; ICES, 2007, REPORT OF THE ARCTIC; Jakobsen T, 1997, ICES CM 1997 Y 17; Keith DM, 2012, CAN J FISH AQUAT SCI, V69, P1150, DOI 10.1139/F2012-055; Korsbrekke K, 2001, ICES J MAR SCI, V58, P763, DOI 10.1006/jmsc.2001.1064; Langangen O, 2014, ICES J MAR SCI, V71, P1129, DOI 10.1093/icesjms/fst007; Marshall CT, 2006, CAN J FISH AQUAT SCI, V63, P980, DOI 10.1139/F05-270; Maunder MN, 2011, CAN J FISH AQUAT SCI, V68, P1285, DOI 10.1139/F2011-071; Michalsen K, 1998, ICES J MAR SCI, V55, P863, DOI 10.1006/jmsc.1998.0364; Millar RB, 2000, CAN J FISH AQUAT SCI, V57, P43, DOI 10.1139/f99-169; Mukhina NV, 2003, J SEA RES, V50, P57, DOI 10.1016/S1385-1101(03)00046-7; Mukhina NV, 1992, EKOLOGICHESKIE PROBL; MYERS RA, 1995, CAN J FISH AQUAT SCI, V52, P1265, DOI 10.1139/f95-123; Myers RA, 2001, ICES J MAR SCI, V58, P937, DOI 10.1006/jmsc.2001.1109; Myers RA, 1996, FISH B-NOAA, V94, P707; MYERS RA, 1993, CAN J FISH AQUAT SCI, V50, P1576, DOI 10.1139/f93-179; Olsen E, 2010, ICES J MAR SCI, V67, P87, DOI 10.1093/icesjms/fsp229; Ottersen G, 1995, FISH OCEANOGR, V4, P278, DOI 10.1111/j.1365-2419.1995.tb00073.x; Ottersen G, 2000, ICES J MAR SCI, V57, P339, DOI 10.1006/jmsc.1999.0529; Plummer M, 2003, PROC 3 INT WORK DIST, V3, P1; Quinn T.J., 1999, BIOL RES MANAG SER; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Raftery AE., 1992, BAYESIAN STAT, V4, P763; Rijnsdorp AD, 2009, ICES J MAR SCI, V66, P1570, DOI 10.1093/icesjms/fsp056; Rose KA, 2001, FISH FISH, V2, P293, DOI 10.1046/j.1467-2960.2001.00056.x; Rubin D. B., 2003, BAYESIAN DATA ANALYS; SHEPHERD JG, 1990, PHILOS T ROY SOC B, V330, P151, DOI 10.1098/rstb.1990.0189; Stige LC, 2013, MAR ECOL PROG SER, V480, P245, DOI 10.3354/meps10246; Stige LC, 2010, P ROY SOC B-BIOL SCI, V277, P3411, DOI 10.1098/rspb.2010.0602; Su Y-S, 2013, PACKAGE R2JAGS; SUNDBY S, 1989, RAP PROCES, V191, P351; Tereshchenko VV, 1996, ICES CM 1996 C 11; Walters C.J., 2004, FISHERIES ECOLOGY MA; Yaragina NA, 2009, MAR BIOL RES, V5, P75, DOI 10.1080/17451000802512739	52	27	27	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98940	10.1371/journal.pone.0098940	http://dx.doi.org/10.1371/journal.pone.0098940			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893001	Green Published, gold, Green Submitted			2022-12-27	WOS:000336911400112
J	Xu, J; Li, WL; Zhang, CH; Liu, W; Du, GZ				Xu, Jing; Li, Wenlong; Zhang, Chunhui; Liu, Wei; Du, Guozhen			Variation in Seed Germination of 134 Common Species on the Eastern Tibetan Plateau: Phylogenetic, Life History and Environmental Correlates	PLOS ONE			English	Article							COMMUNITY STRUCTURE; SIZE; DISPERSAL; ECOLOGY; SEEDLINGS; DORMANCY; CLIMATE; MASS	Seed germination is a crucial stage in the life history of a species because it represents the pathway from adult to offspring, and it can affect the distribution and abundance of species in communities. In this study, we examined the effects of phylogenetic, life history and environmental factors on seed germination of 134 common species from an alpine/subalpine meadow on the eastern Tibetan Plateau. In one-way ANOVAs, phylogenetic groups (at or above order) explained 13.0% and 25.9% of the variance in germination percentage and mean germination time, respectively; life history attributes, such as seed size, dispersal mode, explained 3.7%, 2.1% of the variance in germination percentage and 6.3%, 8.7% of the variance in mean germination time, respectively; the environmental factors temperature and habitat explained 4.7%, 1.0% of the variance in germination percentage and 13.5%, 1.7% of the variance in mean germination time, respectively. Our results demonstrated that elevated temperature would lead to a significant increase in germination percentage and an accelerated germination. Multi-factorial ANOVAs showed that the three major factors contributing to differences in germination percentage and mean germination time in this alpine/subalpine meadow were phylogenetic attributes, temperature and seed size (explained 10.5%, 4.7% and 1.4% of the variance in germination percentage independently, respectively; and explained 14.9%, 13.5% and 2.7% of the variance in mean germination time independently, respectively). In addition, there were strong associations between phylogenetic group and life history attributes, and between life history attributes and environmental factors. Therefore, germination variation are constrained mainly by phylogenetic inertia in a community, and seed germination variation correlated with phylogeny is also associated with life history attributes, suggesting a role of niche adaptation in the conservation of germination variation within lineages. Meanwhile, selection can maintain the association between germination behavior and the environmental conditions within a lineage.	[Xu, Jing; Zhang, Chunhui; Liu, Wei; Du, Guozhen] Lanzhou Univ, Sch Life Sci, State Key Lab Grassland & Agroecosyst, Lanzhou 730000, Peoples R China; [Li, Wenlong] Lanzhou Univ, Sch Pastoral Agr Sci & Technol, State Key Lab Grassland & Agroecosyst, Lanzhou 730000, Peoples R China	Lanzhou University; Lanzhou University	Du, GZ (corresponding author), Lanzhou Univ, Sch Life Sci, State Key Lab Grassland & Agroecosyst, Lanzhou 730000, Peoples R China.	guozhendu2013@gmail.com	Zhang, Chunhui/G-4663-2016	Zhang, Chunhui/0000-0002-1500-4114	National Natural Science Foundation of China [40930533, 41171214, 31170430]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Key Program of National Natural Science Foundation of China (Grant No. 40930533) and the National Natural Science Foundation of China (Grant No. 41171214 and No. 31170430). Funder's website: http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACIA, 2004, IMP WARM ARCT ARCT C; ARMSTRONG DP, 1993, ECOLOGY, V74, P1092, DOI 10.2307/1940479; BAKER HG, 1972, ECOLOGY, V53, P997, DOI 10.2307/1935413; Baskin C. C., 1998, Seeds: ecology, biogeography, and evolution of dormancy and germination.; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Beniston M, 2003, CLIMATIC CHANGE, V59, P5, DOI 10.1023/A:1024458411589; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Chen ZH, 2002, ACTA BOT SIN, V44, P1469; Ellis RH, 1978, SEED PRODUCTION, P605; Flora China Editing Group, 2004, FLORA REIPUBLICAE PO; GRIME JP, 1981, J ECOL, V69, P1017, DOI 10.2307/2259651; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; JOHNSON SD, 1993, J ECOL, V81, P567, DOI 10.2307/2261535; Jurado E, 2005, J VEG SCI, V16, P559, DOI 10.1111/j.1654-1103.2005.tb02396.x; KOCHMER JP, 1986, ECOL MONOGR, V56, P303, DOI 10.2307/1942549; KONIAK S, 1985, GREAT BASIN NAT, V45, P556; Lacey EP, 2003, ECOLOGY, V84, P2462, DOI 10.1890/02-0101; LEISHMAN MR, 1995, J ECOL, V83, P517, DOI 10.2307/2261604; LEISHMAN MR, 1994, J ECOL, V82, P249, DOI 10.2307/2261293; Leishman MR, 2001, OIKOS, V93, P294, DOI 10.1034/j.1600-0706.2001.930212.x; Levey DJ, 2005, SCIENCE, V309, P146, DOI 10.1126/science.1111479; Liu XD, 2000, INT J CLIMATOL, V20, P1729, DOI [10.1002/1097-0088(20001130)20:14<1729::AID-JOC556>3.0.CO;2-Y, 10.1002/1097-0088(20001130)20:14&lt;1729::AID-JOC556&gt;3.0.CO;2-Y]; Lopez-Castaneda C., 1996, Crop Science, V36, P1257, DOI 10.2135/cropsci1996.0011183X003600050031x; Luzuriaga AL, 2006, WEED RES, V46, P163, DOI 10.1111/j.1365-3180.2006.00496.x; MAZER SJ, 1989, ECOL MONOGR, V59, P153, DOI 10.2307/2937284; Milbau A, 2009, ANN BOT-LONDON, V104, P287, DOI 10.1093/aob/mcp117; MILES DB, 1993, ANNU REV ECOL SYST, V24, P587, DOI 10.1146/annurev.es.24.110193.003103; Moles AT, 2005, SCIENCE, V307, P576, DOI 10.1126/science.1104863; Moles AT, 2004, OIKOS, V106, P193, DOI 10.1111/j.0030-1299.2004.13101.x; Norden N, 2009, FUNCT ECOL, V23, P203, DOI 10.1111/j.1365-2435.2008.01477.x; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; Pearson RG, 2006, TRENDS ECOL EVOL, V21, P111, DOI 10.1016/j.tree.2005.11.022; Pearson TRH, 2002, ECOLOGY, V83, P2798, DOI 10.1890/0012-9658(2002)083[2798:GEONPI]2.0.CO;2; Rees M, 1996, PHILOS T R SOC B, V351, P1299, DOI 10.1098/rstb.1996.0113; REES M, 1994, AM NAT, V144, P43, DOI 10.1086/285660; Ruf M, 2003, TREE PHYSIOL, V23, P257, DOI 10.1093/treephys/23.4.257; Sadeghi H., 2011, Journal of Agricultural and Biological Science, V6, P5; Schippers P, 2001, OIKOS, V95, P198, DOI 10.1034/j.1600-0706.2001.950202.x; Smith SA, 2010, P NATL ACAD SCI USA, V107, P5897, DOI 10.1073/pnas.1001225107; Smith-Ramirez C, 1998, PLANT ECOL, V136, P119, DOI 10.1023/A:1009730810655; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Venable DL, 2007, ECOLOGY, V88, P1086, DOI 10.1890/06-1495; VENABLE DL, 1988, AM NAT, V131, P360, DOI 10.1086/284795; VENABLE DL, 1980, OECOLOGIA, V46, P272, DOI 10.1007/BF00540137; Verdu M, 2005, ECOLOGY, V86, P1385, DOI 10.1890/04-1647; Wang JH, 2009, EVOL ECOL, V23, P827, DOI 10.1007/s10682-008-9273-1; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; Zhang ST, 2004, FOLIA GEOBOT, V39, P129, DOI 10.1007/BF02805242; Ziello C, 2009, CLIM RES, V39, P227, DOI 10.3354/cr00822	52	17	18	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98601	10.1371/journal.pone.0098601	http://dx.doi.org/10.1371/journal.pone.0098601			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893308	gold, Green Published, Green Submitted			2022-12-27	WOS:000336911400074
J	Chen, H; Gurmesa, GA; Liu, L; Zhang, T; Fu, SL; Liu, ZF; Dong, SF; Ma, C; Mo, JM				Chen, Hao; Gurmesa, Geshere A.; Liu, Lei; Zhang, Tao; Fu, Shenglei; Liu, Zhanfeng; Dong, Shaofeng; Ma, Chuan; Mo, Jiangming			Effects of Litter Manipulation on Litter Decomposition in a Successional Gradients of Tropical Forests in Southern China	PLOS ONE			English	Article							SUBSTRATE UTILIZATION PATTERNS; NORTHERN HARDWOOD FORESTS; LEAF-LITTER; NITROGEN ADDITIONS; SUBTROPICAL CHINA; MICROBIAL BIOMASS; MATURE FORESTS; MOIST FOREST; SOIL; CARBON	Global changes such as increasing CO2, rising temperature, and land-use change are likely to drive shifts in litter inputs to forest floors, but the effects of such changes on litter decomposition remain largely unknown. We initiated a litter manipulation experiment to test the response of litter decomposition to litter removal/addition in three successional forests in southern China, namely masson pine forest (MPF), mixed coniferous and broadleaved forest (MF) and monsoon evergreen broadleaved forest (MEBF). Results showed that litter removal decreased litter decomposition rates by 27%, 10% and 8% and litter addition increased litter decomposition rates by 55%, 36% and 14% in MEBF, MF and MPF, respectively. The magnitudes of changes in litter decomposition were more significant in MEBF forest and less significant in MF, but not significant in MPF. Our results suggest that change in litter quantity can affect litter decomposition, and this impact may become stronger with forest succession in tropical forest ecosystem.	[Chen, Hao; Liu, Lei; Zhang, Tao; Fu, Shenglei; Liu, Zhanfeng; Dong, Shaofeng; Ma, Chuan; Mo, Jiangming] Chinese Acad Sci, Key Lab Vegetat Restorat & Management Degraded Ec, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Gurmesa, Geshere A.] Univ Copenhagen, Dept Geosci & Nat Resource Management, Copenhagen, Denmark; [Liu, Lei] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China; [Zhang, Tao] Zhanjiang Normal Univ, Inst Trop Pratacultural Sci, Zhanjiang, Peoples R China; [Chen, Hao; Gurmesa, Geshere A.] Univ Chinese Acad Sci, Beijing, Peoples R China; [Gurmesa, Geshere A.] Sino Danish Ctr Educ & Res, Aarhus, Denmark	Chinese Academy of Sciences; South China Botanical Garden, CAS; University of Copenhagen; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); LingNan Normal University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Mo, JM (corresponding author), Chinese Acad Sci, Key Lab Vegetat Restorat & Management Degraded Ec, South China Bot Garden, Guangzhou, Guangdong, Peoples R China.	mojm@scib.ac.cn	Gurmesa, Geshere Abdisa/GPX-2764-2022; Gurmesa, Geshere Abdisa/C-2126-2015; Liu, Zhanfeng/ABD-3933-2021; Chen, Hao/U-4752-2017; Fu, Shenglei/B-2729-2012; Lei, Liu/J-7929-2017	Gurmesa, Geshere Abdisa/0000-0002-2340-6076; Liu, Zhanfeng/0000-0002-6602-6196; Chen, Hao/0000-0003-3577-2345; Lei, Liu/0000-0002-8063-610X	National Key Basic Research 973 Programme [2011CB403204]	National Key Basic Research 973 Programme	This study was founded by National Key Basic Research 973 Programme (2011CB403204) and National Natural Science Foundation of China (No: 41273143). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhamd L, 2004, FOREST ECOL MANAG, V202, P1, DOI 10.1016/j.foreco.2004.02.062; Anderson J.M., 1989, TROPICAL SOIL BIOL F; [Anonymous], 1982, TROP SUBTROP ECOSYS; [Anonymous], [No title captured]; Barantal S, 2012, ECOSYSTEMS, V15, P1039, DOI 10.1007/s10021-012-9564-9; BINGEMAN CW, 1953, SOIL SCI SOC AM PRO, V17, P34, DOI 10.2136/sssaj1953.03615995001700010008x; Boberg J, 2008, SOIL BIOL BIOCHEM, V40, P995, DOI 10.1016/j.soilbio.2007.11.005; Bossio DA, 1998, MICROBIAL ECOL, V35, P265, DOI 10.1007/s002489900082; Chapin F.S., 2002, PRINCIPLES TERRESTRI, DOI 10.1007/978-1-4419-9504-9; Chen H, 2013, PLOS ONE IN PRESS; Chigineva NI, 2009, APPL SOIL ECOL, V42, P264, DOI 10.1016/j.apsoil.2009.05.001; Cleveland CC, 2006, ECOLOGY, V87, P492, DOI 10.1890/05-0525; Crow SE, 2009, FOREST ECOL MANAG, V258, P2224, DOI 10.1016/j.foreco.2009.01.014; Cusack DF, 2009, GLOBAL CHANGE BIOL, V15, P1339, DOI 10.1111/j.1365-2486.2008.01781.x; Dzwonko Z, 2002, BIOL CONSERV, V106, P389, DOI 10.1016/S0006-3207(01)00266-X; Fahey TJ, 1998, ECOL MONOGR, V68, P183, DOI 10.1890/0012-9615(1998)068[0183:ROESNH]2.0.CO;2; Fang H, 2007, PLANT SOIL, V297, P233, DOI 10.1007/s11104-007-9339-9; Fang YT, 2006, J ENVIRON SCI, V18, P752; Fisk MC, 2001, BIOGEOCHEMISTRY, V53, P201, DOI 10.1023/A:1010693614196; Fontaine S, 2004, ECOL LETT, V7, P314, DOI 10.1111/j.1461-0248.2004.00579.x; Gholz HL, 2000, GLOBAL CHANGE BIOL, V6, P751, DOI 10.1046/j.1365-2486.2000.00349.x; Hickler T, 2008, GLOBAL CHANGE BIOL, V14, P1531, DOI 10.1111/j.1365-2486.2008.01598.x; Hobbie SE, 2000, ECOLOGY, V81, P1867, DOI 10.1890/0012-9658(2000)081[1867:NLODIH]2.0.CO;2; Holmes KW, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002507; Huang WJ, 2012, ACTA OECOL, V44, P20, DOI 10.1016/j.actao.2011.06.005; Kranabetter JM, 1999, CAN J SOIL SCI, V79, P543, DOI 10.4141/S98-081; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; Kuzyakov Y, 2007, PLANT SOIL, V290, P293, DOI 10.1007/s11104-006-9162-8; Leff JW, 2012, GLOBAL CHANGE BIOL, V18, P2969, DOI 10.1111/j.1365-2486.2012.02749.x; Li YQ, 2004, SOIL BIOL BIOCHEM, V36, P2111, DOI 10.1016/j.soilbio.2004.06.003; Liu ZF, 2012, PEDOBIOLOGIA, V55, P7, DOI 10.1016/j.pedobi.2011.07.014; Loranger G, 2002, BIOL FERT SOILS, V35, P247, DOI 10.1007/s00374-002-0467-3; Matsushima M, 2007, PLANT SOIL, V292, P243, DOI 10.1007/s11104-007-9220-x; McGroddy ME, 2004, ECOSYSTEMS, V7, P172, DOI 10.1007/s10021-003-0208-y; MELILLO JM, 1982, ECOLOGY, V63, P621, DOI 10.2307/1936780; Mo HM, 2003, FOREST ECOL MANAG, V175, P573; Mo JM, 2006, PLANT SOIL, V282, P135, DOI 10.1007/s11104-005-5446-7; MO JM, 1995, BIOTROPICA, V27, P290, DOI 10.2307/2388915; Norby RJ, 2005, P NATL ACAD SCI USA, V102, P18052, DOI 10.1073/pnas.0509478102; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Ostertag R, 2003, ECOSYSTEMS, V6, P261, DOI 10.1007/PL00021512; Peng SL, 1993, J TROPICAL SUBTROPIC, V2, P34; PONGE JF, 1993, EUR J SOIL BIOL, V29, P141; Raich JW, 2006, ECOLOGY, V87, P76, DOI 10.1890/05-0023; Ruan HH, 2005, PEDOBIOLOGIA, V49, P529, DOI 10.1016/j.pedobi.2005.08.001; Sayer EJ, 2006, FOREST ECOL MANAG, V229, P285, DOI 10.1016/j.foreco.2006.04.007; Sayer EJ, 2006, BIOL REV, V81, P1, DOI 10.1017/S1464793105006846; Sayer EJ, 2011, NAT CLIM CHANGE, V1, P304, DOI 10.1038/NCLIMATE1190; Sullivan NH, 1999, BIOTROPICA, V31, P382, DOI 10.1111/j.1744-7429.1999.tb00380.x; Tang XL, 2006, GLOBAL CHANGE BIOL, V12, P546, DOI 10.1111/j.1365-2486.2006.01109.x; Villalobos-Vega R, 2011, PLANT SOIL, V346, P385, DOI 10.1007/s11104-011-0860-5; Wu JP, 2011, FUNCT ECOL, V25, P921, DOI 10.1111/j.1365-2435.2011.01845.x; Zhang D.Q., 2000, ACTA ECOL SIN, V20, P938; Zhou GY, 2007, PLANT ECOL, V188, P77, DOI 10.1007/s11258-006-9149-9	54	20	20	9	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99018	10.1371/journal.pone.0099018	http://dx.doi.org/10.1371/journal.pone.0099018			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901698	Green Published, gold, Green Submitted			2022-12-27	WOS:000336841400087
J	Cinkova, I; Policht, R				Cinkova, Ivana; Policht, Richard			Contact Calls of the Northern and Southern White Rhinoceros Allow for Individual and Species Identification	PLOS ONE			English	Article							CERATOTHERIUM-SIMUM-COTTONI; CAPTIVE SOUTHERN; VOCAL REPERTOIRE; RECOGNITION; COMMUNICATION; VOCALIZATIONS; IDENTITY; SEX; CONSPECIFICS; INFORMATION	Inter-individual relationships particularly in socially living mammals often require a well-developed communication system. Vocal and olfactory signals are the most important for the communication of rhinos, however, their vocal communication has been investigated to a very limited extent so far. White rhinos have the most developed social system out of all the rhinoceros species and vocal signals might therefore play an important role in their social interactions. We recorded repetitive contact pant calls from six captive northern white rhinos (Ceratotherium cottoni) and 14 captive and free-ranging southern white rhinos (Ceratotherium simum) and examined if they transmit information about individual identity, species, social context and age class. Discriminant analyses revealed that a high percentage of the pant calls of both species could be classified to a correct individual. We calculated signature information capacity of pant calls recorded from adult animals in isolation at 3.19 bits for the northern white rhinos and at 3.15 bits for the southern white rhinos, which can potentially allow for a vocal discrimination of nine individuals of both species. We found that pant calls varied by species. Northern white rhinos had longer calls and also differed from the southern white rhinos in several frequency parameters of their calls. We also analysed the pant calls of southern white rhinos for the differences between the age classes and between social contexts in which they were recorded. Our results show that pant calls carry information about individual, species, age class and context. The ability to recognize this information would allow rhinos, in addition to olfactory cues, to communicate with highly increased accuracy. A better understanding of communication of white rhinos has potential practical use in their management and conservation particularly because of the low breeding success of white rhinos in captivity.	[Cinkova, Ivana] Palacky Univ, Dept Zool, CR-77147 Olomouc, Czech Republic; [Cinkova, Ivana] Palacky Univ, Ornithol Lab, CR-77147 Olomouc, Czech Republic; [Policht, Richard] Inst Anim Sci, Dept Ethol, Prague, Czech Republic; [Policht, Richard] Czech Univ Life Sci Prague, Dept Game Management & Wildlife Biol, Fac Forestry & Wood Sci, Prague, Czech Republic	Palacky University Olomouc; Palacky University Olomouc; Czech Research Institute of Animal Science; Czech University of Life Sciences Prague	Cinkova, I (corresponding author), Palacky Univ, Dept Zool, CR-77147 Olomouc, Czech Republic.	ivanacinkova@centrum.cz	Policht, Richard/H-3039-2015; Cinkova, Ivana/L-5582-2019	Policht, Richard/0000-0002-8026-3964; Cinkova, Ivana/0000-0002-6653-0907	Internal Grant Agency of the Palacky University in Olomouc [PRF 2014-018]; Palacky University; Internal Grant Agency of the Faculty of Forestry and Wood Sciences, Czech University of Life Sciences Prague [20134363]; Internal Grant Agency of the Czech University of Life Sciences Prague CIGA [20115005 (51120/1313/3104)]	Internal Grant Agency of the Palacky University in Olomouc; Palacky University; Internal Grant Agency of the Faculty of Forestry and Wood Sciences, Czech University of Life Sciences Prague; Internal Grant Agency of the Czech University of Life Sciences Prague CIGA	The project was financially supported by the Internal Grant Agency of the Palacky University in Olomouc PRF 2014-018, by the mobility grants from the Palacky University to IC and by the Internal Grant Agency of the Faculty of Forestry and Wood Sciences, Czech University of Life Sciences Prague (no. 20134363). The participation of RP was supported by the Internal Grant Agency of the Czech University of Life Sciences Prague CIGA 20115005 (51120/1313/3104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold BD, 2011, BEHAV ECOL SOCIOBIOL, V65, P1581, DOI 10.1007/s00265-011-1168-4; Aubin T, 2002, J EXP BIOL, V205, P3793; BASKIN Y, 1991, SCIENCE, V252, P1256, DOI 10.1126/science.252.5010.1256; BEECHER MD, 1982, AM ZOOL, V22, P477; BEECHER MD, 1989, ANIM BEHAV, V38, P248, DOI 10.1016/S0003-3472(89)80087-9; Blumstein DT, 2012, CURR ZOOL, V58, P765, DOI 10.1093/czoolo/58.5.765; Blumstein DT, 2005, ANIM BEHAV, V69, P353, DOI 10.1016/j.anbehav.2004.10.001; Blumstein DT, 2004, ANIM BEHAV, V68, P1257, DOI 10.1016/j.anbehav.2003.12.024; Bouchet H, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00390; Boughman JW, 2002, TRENDS ECOL EVOL, V17, P571, DOI 10.1016/S0169-5347(02)02595-8; Budde C, 2003, MAMM BIOL, V68, P42, DOI 10.1078/1616-5047-00060; Carter GG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038791; Charlton BD, 2007, BIOL LETTERS, V3, P382, DOI 10.1098/rsbl.2007.0244; Charlton BD, 2009, J ACOUST SOC AM, V126, P2721, DOI 10.1121/1.3224720; Charrier I, 2001, NATURE, V412, P873, DOI 10.1038/35091136; Cinkova I, 2009, 7 INT C BEH PHYS GEN; Cinkova I, 2013, MAMM BIOL, V78, P50, DOI 10.1016/j.mambio.2012.09.007; COSENS SE, 1984, BEHAV ECOL SOCIOBIOL, V15, P161, DOI 10.1007/BF00292970; Crockford C, 2004, ETHOLOGY, V110, P221, DOI 10.1111/j.1439-0310.2004.00968.x; EMSLIE R, 2011, IUCN RED LIST THREAT; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; ESTES RD, 1991, BEHAV GUIDE AFRICAN; Ey E, 2007, PRIMATES, V48, P253, DOI 10.1007/s10329-006-0033-y; Fischer J, 2004, ANIM BEHAV, V67, P655, DOI 10.1016/j.anbehav.2003.08.006; Frommolt KH, 2003, ANIM BEHAV, V65, P509, DOI 10.1006/anbe.2003.2064; Goddard J., 1967, East African Wildlife Journal, V5, P133; Groves CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009703; Hammerschmidt K, 1998, PRIMATES, V39, P231, DOI 10.1007/BF02557735; Heller E., 1913, SMITHSONIAN MISCELLA, V61, P1; Hermes R, 2006, THERIOGENOLOGY, V65, P1492, DOI 10.1016/j.theriogenology.2005.09.002; Hermes R, 2005, THERIOGENOLOGY, V63, P219, DOI 10.1016/j.theriogenology.2004.04.007; Hillman-Smith K, 1987, PACHYDERM, V9, P19; Hillman-Smith K, 1982, WWF YB, V1982, P273; Illmann G, 2002, BEHAVIOUR, V139, P487, DOI 10.1163/15685390260135970; Insley SJ, 2012, J ACOUST SOC AM, V131, pEL35, DOI 10.1121/1.3665259; Knight M, 2011, PACHYDERM, P7; Kunes M, 2002, ACTA U PALACKI OLOMU, V39-40, P81; LAURIE A, 1982, J ZOOL, V196, P307; Lemasson A, 2009, ANIM COGN, V12, P693, DOI 10.1007/s10071-009-0229-9; McComb K, 2003, ANIM BEHAV, V65, P317, DOI 10.1006/anbe.2003.2047; Metrione LC, 2007, ZOO BIOL, V26, P487, DOI 10.1002/zoo.20143; Mikulica V., 1991, Zoologische Garten, V61, P365; Milliken T., 2012, S AFRICA VIET NAM RH; Mundry R, 2007, ANIM BEHAV, V74, P965, DOI 10.1016/j.anbehav.2006.12.028; O'Connor BP, 2000, BEHAV RES METH INS C, V32, P396, DOI 10.3758/BF03200807; OWEN-SMITH R N, 1975, Zeitschrift fuer Tierpsychologie, V38, P337; Owen-Smith RN, 1973, THESIS WISCONSIN U M; Penny M, 1987, RHINOS ENDANGERED SP; Pienaar D. J., 1993, Koedoe, V36, P79; Pienaar D. J., 1992, Koedoe, V35, P1; Policht R, 2008, BIOACOUSTICS, V18, P69, DOI 10.1080/09524622.2008.9753591; Policht R, 2011, AFR ZOOL, V46, P18, DOI 10.3377/004.046.0110; Pollard KA, 2011, CURR BIOL, V21, P413, DOI 10.1016/j.cub.2011.01.051; Proops L, 2009, P NATL ACAD SCI USA, V106, P947, DOI 10.1073/pnas.0809127105; Rookmaaker K, 2014, NILE RHINOCEROS SPEC; Rookmaaker K, 2011, PACHYDERM, P72; RUBENSTEIN DI, 1992, EVOL ECOL, V6, P254, DOI 10.1007/BF02214165; Ryan MJ, 2003, SPR HDB AUD, V16, P225; Schuchmann M, 2012, ACTA CHIROPTEROL, V14, P161, DOI 10.3161/150811012X654376; Sebe F, 2010, ANIM BEHAV, V79, P1055, DOI 10.1016/j.anbehav.2010.01.021; Shrader AM, 2002, BEHAV ECOL SOCIOBIOL, V52, P255, DOI 10.1007/s00265-002-0506-y; Soltis J, 2005, ANIM BEHAV, V70, P589, DOI 10.1016/j.anbehav.2004.11.016; Stoeger AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048907; Swaisgood Ronald R., 2004, P106; Swaisgood RR, 2006, BIOL CONSERV, V129, P468, DOI 10.1016/j.biocon.2005.11.015; Terry Andrew M.R., 2005, Frontiers in Zoology, V2, P1; VANGYSEGHEM R, 1984, Z SAUGETIERKD, V49, P348; Venables WN., 2002, MODERN APPL STAT S 4; von Muggenthaler E, 2003, ACOUST RES LETT ONL, V4, P83, DOI 10.1121/1.1588271; von Muggenthaler EK, 1993, INT RHIN C SAN DIEG; WILEY RH, 1978, BEHAV ECOL SOCIOBIOL, V3, P69, DOI 10.1007/BF00300047	71	21	21	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98475	10.1371/journal.pone.0098475	http://dx.doi.org/10.1371/journal.pone.0098475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901244	Green Submitted, gold, Green Published			2022-12-27	WOS:000336841400034
J	Freires, ID; Murata, RM; Furletti, VF; Sartoratto, A; de Alencar, SM; Figueira, GM; Rodrigues, JAD; Duarte, MCT; Rosalen, PL				Freires, Irlan de Almeida; Murata, Ramiro Mendonca; Furletti, Vivian Fernandes; Sartoratto, Adilson; de Alencar, Severino Matias; Figueira, Glyn Mara; de Oliveira Rodrigues, Janaina Aparecida; Teixeira Duarte, Marta Cristina; Rosalen, Pedro Luiz			Coriandrum sativum L. (Coriander) Essential Oil: Antifungal Activity and Mode of Action on Candida spp., and Molecular Targets Affected in Human Whole-Genome Expression	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; CHEMICAL-COMPOSITION; ALBICANS; ASSAY; IDENTIFICATION; PHOSPHOLIPASE; EPIDEMIOLOGY; SURVEILLANCE; INHIBITORS; VIRULENCE	candidiasis is an opportunistic fungal infection of the oral cavity with increasingly worldwide prevalence and incidence Novel specifically-targeted strategies to manage this ailment have been proposed using essential oils CEO) known to have antifungal properties. In this study, we aim to investigate the antifungal activity and mode of action of the EO from Coriandrum sativurn L (coriander) leaves on Candida spp. In addition detected the molecular targets affected in who genorne expression in human cells. The EO phytochernical profile indicates monoterpenes and sesquiterpenes as components, which are likely to negatively impact the viability of yeast cells. There seems to be a synergistic activity of EO chemical compounds as their isolation into fractions led to a decreased antimicrobial effect. C. sativum EO may bind membrane ergosterol, increasing ionic permeability and causing membrane damage leading to cell death, but it does not on cell wall biosynthesis-related pathways. This mode of action is illustrated by photomicrographs showing disruption in caused by the EO at varied concentrations. The EO also inhibited Candida biofilm adherence to polystyrene substrate at low concentrations, and decreased the proteolytic activity of Candida albicans at mini inhibitory concentration. Finally, the EO and its selected active fraction had low cytotoxicity on human cells, mechanisms affecting gene expression in pathways involving chernokines and MAP-kinase (proliferation/apoptosis), as adhesion proteins. These findings highlight the potential antifungal activity of the EO from C. sativum leaves and suggest avenues for future translational toxicological research.	[Freires, Irlan de Almeida; Rosalen, Pedro Luiz] Univ Estadual Campinas, Piracicaba Dent Sch, Dept Physiol Sci, Piracicaba, SP, Brazil; [Murata, Ramiro Mendonca] Univ So Calif, Ostrow Sch Dent, Div Periodontol Diagnost Sci & Dent Hyg, Los Angeles, CA USA; [Murata, Ramiro Mendonca] Univ So Calif, Ostrow Sch Dent, Div Biomed Sci, Los Angeles, CA USA; [Furletti, Vivian Fernandes; Sartoratto, Adilson; Figueira, Glyn Mara; Teixeira Duarte, Marta Cristina] Univ Estadual Campinas, Res Ctr Chem Biol & Agr, Campinas, SP, Brazil; [de Alencar, Severino Matias] Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Agri Food Ind Food & Nutr, Piracicaba, SP, Brazil; [de Oliveira Rodrigues, Janaina Aparecida] Univ Sao Paulo, Sch Engn Sao Carlos, Postgrad Program Interunits Bioengn, Sao Carlos, SP, Brazil	Universidade Estadual de Campinas; University of Southern California; University of Southern California; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade de Sao Paulo	Murata, RM (corresponding author), Univ So Calif, Ostrow Sch Dent, Div Periodontol Diagnost Sci & Dent Hyg, Los Angeles, CA USA.	ramiro.murata@usc.edu; rosalen@fop.unicamp.br	Rosalen, Pedro Luiz/I-3718-2012; Alencar, Severino Matias/B-7743-2012; Sartoratto, Adilson/C-4349-2012; Duarte, Marta CT/L-1401-2014; Freires, Irlan/M-9214-2014; Figueira, Glyn/C-9605-2017; Murata, Ramiro M/P-9052-2014	Rosalen, Pedro Luiz/0000-0003-0812-4027; Alencar, Severino Matias/0000-0002-6637-7973; Sartoratto, Adilson/0000-0002-1763-3715; Freires, Irlan/0000-0002-1079-6941; Figueira, Glyn/0000-0002-0159-9735; Murata, Ramiro M/0000-0002-8478-6981; Duarte, Marta Cristina Teixeira/0000-0001-7604-629X	Sao Paulo Research Foundation (FAPESP, Brazil) [2011/14757-0, 2011/15984-0, 2014/09742-2]; National Council for Scientific and Technological Development (CNPq, Brazil) [308644/2011-5]; National Center for Complementary and Alternative Medicine (NCCAM) of the National Institutes of Health (NIH, USA) [5R00AT00650704]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R00AT006507] Funding Source: NIH RePORTER	Sao Paulo Research Foundation (FAPESP, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Center for Complementary and Alternative Medicine (NCCAM) of the National Institutes of Health (NIH, USA); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	Research reported in this publication was supported by Sao Paulo Research Foundation (FAPESP, Brazil, grants #2011/14757-0, #2011/15984-0 and #2014/09742-2), National Council for Scientific and Technological Development (CNPq, Brazil, grant #308644/2011-5), and the National Center for Complementary and Alternative Medicine (NCCAM) of the National Institutes of Health (NIH, USA, award #5R00AT00650704). The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R.P., 2007, IDENTIFICATION ESSEN, V4th; [Anonymous], 2002, M27A2 NAT COMM CLIN, VSecond; Asgarpanah J, 2012, AFR J PHARM PHARMACO, V6, P2340, DOI 10.5897/AJPP12.901; Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Begnami AF, 2010, FOOD CHEM, V118, P74, DOI 10.1016/j.foodchem.2009.04.089; Berman J, 2002, NAT REV GENET, V3, P918, DOI 10.1038/nrg948; Bhuiyan MNI, 2009, J PHARM, V4, P150; Burdock GA, 2009, FOOD CHEM TOXICOL, V47, P22, DOI 10.1016/j.fct.2008.11.006; Cal K, 2006, PLANTA MED, V72, P311, DOI 10.1055/s-2005-916230; Choudhary V., 2012, J ACAD IND RES, V1, P215; Colombo AL, 2006, J CLIN MICROBIOL, V44, P2816, DOI 10.1128/JCM.00773-06; Duarte MCT, 2007, J ETHNOPHARMACOL, V111, P197, DOI 10.1016/j.jep.2006.11.034; Galvao LCD, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/751435; Delaquis PJ, 2002, INT J FOOD MICROBIOL, V74, P101, DOI 10.1016/S0168-1605(01)00734-6; Djordjevic D, 2002, APPL ENVIRON MICROB, V68, P2950, DOI 10.1128/AEM.68.6.2950-2958.2002; Drago L, 2000, INT J ANTIMICROB AG, V16, P545, DOI 10.1016/S0924-8579(00)00296-X; Escalante A, 2008, J NAT PROD, V71, P1720, DOI 10.1021/np070660i; Eyres G, 2005, J SEP SCI, V28, P1061, DOI 10.1002/jssc.200500012; FROST DJ, 1995, J ANTIBIOT, V48, P306, DOI 10.7164/antibiotics.48.306; Furletti VF, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/985832; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Ghoreyshi E, 2008, PHARM SCI, V3, P1; Guba R, 2001, INT J AROMATHER, V11, P76, DOI DOI 10.1016/s0962-4562(01)80021-7; Harsha SN, 2014, J FOOD SCI TECH MYS, V51, P1533, DOI 10.1007/s13197-012-0648-5; Hasan F, 2009, MICROBES INFECT, V11, P753, DOI 10.1016/j.micinf.2009.04.018; Hofling JF, 2011, MYCOPATHOLOGIA, V172, P117, DOI 10.1007/s11046-011-9404-z; Jeon JG, 2011, CARIES RES, V45, P243, DOI 10.1159/000327250; Kajfasz JK, 2010, J BACTERIOL, V192, P2546, DOI 10.1128/JB.00028-10; Kantarcioglu AS, 2002, MYCOSES, V45, P160, DOI 10.1046/j.1439-0507.2002.00727.x; Kuhn Duncan M, 2004, Curr Opin Investig Drugs, V5, P186; Lima IO, 2013, J ESSENT OIL RES, V25, P138, DOI 10.1080/10412905.2012.754728; Lopes G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072203; Matasyoh JC, 2009, FOOD CHEM, V113, P526, DOI 10.1016/j.foodchem.2008.07.097; Messer SA, 2009, J CLIN MICROBIOL, V47, P1942, DOI 10.1128/JCM.02434-08; Muller C, 2013, STEROIDS, V78, P483, DOI 10.1016/j.steroids.2013.02.006; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Ozbek H, 2006, EGE J MED, V45, P163; Pauli A, 2006, MED RES REV, V26, P223, DOI 10.1002/med.20050; Pfaller M, 2012, DIAGN MICR INFEC DIS, V74, P323, DOI 10.1016/j.diagmicrobio.2012.10.003; Pierce CG, 2013, CURR OPIN PHARMACOL, V13, P726, DOI 10.1016/j.coph.2013.08.008; Potter TL, 1996, J AGR FOOD CHEM, V44, P1824, DOI 10.1021/jf950814c; PRICE MF, 1982, SABOURAUDIA, V20, P7; Ramage G, 2005, EUKARYOT CELL, V4, P633, DOI 10.1128/EC.4.4.633-638.2005; Ramage Gordon, 2012, Int J Microbiol, V2012, P528521, DOI 10.1155/2012/528521; Ramage G, 2009, CRIT REV MICROBIOL, V35, P340, DOI 10.3109/10408410903241436; Rane HS, 2014, J ANTIMICROB CHEMOTH, V69, P428, DOI 10.1093/jac/dkt398; Rodrigues JADO, 2007, HYBRIDOMA, V26, P201, DOI 10.1089/hyb.2007.007; Sahib NG, 2013, PHYTOTHER RES, V27, P1439, DOI 10.1002/ptr.4897; Samaranayake LP, 2002, ORAL DIS, V8, P151, DOI 10.1034/j.1601-0825.8.s2.6.x; Siddiqui ZN, 2013, J SAUDI CHEM SOC, V17, P237, DOI 10.1016/j.jscs.2011.03.016; Silva F, 2011, PHYTOMEDICINE, V19, P42, DOI 10.1016/j.phymed.2011.06.033; Silva F, 2011, J MED MICROBIOL, V60, P1479, DOI 10.1099/jmm.0.034157-0; Skloot R, 2011, IMMORTAL LIFE HENRIE; Snigdha Chawla, 2013, Medicinal Plants - International Journal of Phytomedicines and Related Industries, V5, P59; Soares BV, 2012, MOLECULES, V17, P8439, DOI 10.3390/molecules17078439; Sreelatha S, 2009, FOOD CHEM TOXICOL, V47, P702, DOI 10.1016/j.fct.2008.12.022; Sun N, 2013, ANTIMICROB AGENTS CH, V57, P532, DOI 10.1128/AAC.01520-12; Vermelho AB, 1996, MEM I OSWALDO CRUZ, V91, P755, DOI 10.1590/S0074-02761996000600020; Wachtler B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036952	60	89	92	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99086	10.1371/journal.pone.0099086	http://dx.doi.org/10.1371/journal.pone.0099086			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901768	Green Published, Green Submitted, gold			2022-12-27	WOS:000336841400094
J	Green, KM; Greenley, AP; Starr, RM				Green, Kristen M.; Greenley, Ashley P.; Starr, Richard M.			Movements of Blue Rockfish (Sebastes mystinus) off Central California with Comparisons to Similar Species	PLOS ONE			English	Article							MARINE RESERVES; SANTA-BARBARA; HOME-RANGE; NORTHERN CALIFORNIA; KELP FORESTS; REEF FISHES; PATTERNS; POPULATIONS; HABITAT; LINGCOD	Olive (Sebastes serranoides), black (Sebastes melanops), and blue rockfish (Sebastes mystinus) are all common inhabitants of nearshore ecosystems on the West coast of North America and important components of the recreational fishery off California. Acoustic monitoring studies indicate that olive rockfish are highly residential and that black rockfish are capable of long migrations and have less site fidelity; yet little is known about the long-term movements of blue rockfish. External tag-recapture studies indicate that blue rockfish may have intermediate movements relative to these congener nearshore species. To better understand the site fidelity, and daily and seasonal movements of blue rockfish over long (>1-year) time scales, we placed acoustic transmitters into 21 adult blue rockfish (30-41 cm total length) in Carmel Bay, California. Blue rockfish displayed intermediate movement patterns and residency relative to other similar kelp forest rockfish species. Two-thirds of tagged blue rockfish (13 fish) exhibited high residency to the study area (>12 mo). When in residence, mean home range of blue rockfish was 0.23 km(2), however as many as 30% of tagged blue rockfish shifted their core home range area during the study. Most shifts in home range occurred during upwelling season, and tagged fish moved up to 3.1 km when in residence. Blue rockfish with short residence times were last detected in the study area in late winter and early spring. Blue rockfish were observed at shallower depths during day than night, likely indicative of diurnal feeding. However, over longer time scales, blue rockfish were detected at deeper depths during upwelling periods and with increased wave heights. Daily and seasonal vertical movements of blue rockfish may be influenced by upwelling conditions and local prey abundance.	[Green, Kristen M.] Alaska Dept Fish & Game, Sitka, AK 99835 USA; [Greenley, Ashley P.] Fishwise, Santa Cruz, CA USA; [Starr, Richard M.] Univ Calif, Sea Grant Extens Program, Moss Landing, CA USA	Alaska Department of Fish & Game	Green, KM (corresponding author), Alaska Dept Fish & Game, Sitka, AK 99835 USA.	kristen.green@alaska.gov		Green, Kristen/0000-0001-8684-0884	California Sea Grant College Program	California Sea Grant College Program	Funding for this study was provided by the California Sea Grant College Program (http://www-csgc.ucsd.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LG, 2006, ECOLOGY OF MARINE FISHES: CALIFORNIA AND ADJACENT WATERS, P1; CULVER BN, 1986, P INT ROCK FISH S AN, P231; EBELING AW, 1976, FISH B-NOAA, V74, P703; ECHEVERRIA TW, 1987, FISH B-NOAA, V85, P229; Freiwald J, 2012, CAN J FISH AQUAT SCI, V69, P1362, DOI 10.1139/F2012-068; GAINES SD, 1987, SCIENCE, V235, P479, DOI 10.1126/science.235.4787.479; GOTSHALL DANIEL W., 1965, CALIF FISH GAME, V51, P147; Green KM, 2011, MAR ECOL PROG SER, V436, P219, DOI 10.3354/meps09263; HALLACHER LE, 1985, ENVIRON BIOL FISH, V12, P91, DOI 10.1007/BF00002762; Heilprin DJ., 1992, THESIS SAN JOSE STAT THESIS SAN JOSE STAT; Hobson ES, 1996, CALIF FISH GAME, V82, P87; Hobson ES, 2001, FISH B-NOAA, V99, P292; HOBSON ES, 1988, FISH B-NOAA, V86, P715; Jorgensen SJ, 2006, MAR ECOL PROG SER, V327, P157, DOI 10.3354/meps327157; KATZ RW, 1988, J CLIMATOL, V8, P241, DOI 10.1002/joc.3370080303; Lea R.N., 1999, CALIF DEP FISH GAME, V177; Love M. S., 2002, ROCKFISHES NE PACIFI; LOVE MS, 1980, FISH B-NOAA, V77, P975; LOVE MS, 1978, FISH B-NOAA, V76, P257; Lowe CG, 2003, MAR ECOL PROG SER, V256, P205, DOI 10.3354/meps256205; Lowe CG, 2009, MAR COAST FISH, V1, P71, DOI 10.1577/C08-047.1; MATTHEWS KR, 1990, CAN J ZOOL, V68, P2243, DOI 10.1139/z90-312; Miller D. J., 1973, CALIF DEP FISH GAME, V158; Moffitt EA, 2011, BIOL CONSERV, V144, P306, DOI 10.1016/j.biocon.2010.09.008; Parker SJ, 2008, AQUAT BIOL, V2, P57, DOI 10.3354/ab00036; PEARCY WG, 1992, FISH B-NOAA, V90, P726; Schwing FB, 2000, CAL COOP OCEAN FISH, V41, P148; Simpfendorfer CA, 2002, CAN J FISH AQUAT SCI, V59, P23, DOI 10.1139/F01-191; Starr R.M., 2007, SPECIES COMPOSITION; Starr RM, 2004, CAN J FISH AQUAT SCI, V61, P1083, DOI 10.1139/F04-054; Starr RM, 2002, FISH B-NOAA, V100, P324; Stein J, 2000, THESIS CALIFORNIA PO; Tolimieri N, 2009, MAR ECOL PROG SER, V380, P229, DOI 10.3354/meps07930; Zeller DC, 1998, CAN J FISH AQUAT SCI, V55, P917, DOI 10.1139/cjfas-55-4-917	34	11	11	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98976	10.1371/journal.pone.0098976	http://dx.doi.org/10.1371/journal.pone.0098976			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24902049	Green Submitted, gold, Green Published			2022-12-27	WOS:000336841400082
J	Kalinski, T; Sel, S; Hutten, H; Ropke, M; Roessner, A; Nass, N				Kalinski, Thomas; Sel, Saadettin; Huetten, Heiko; Roepke, Martin; Roessner, Albert; Nass, Norbert			Curcumin Blocks Interleukin-1 Signaling in Chondrosarcoma Cells	PLOS ONE			English	Article							NF-KAPPA-B; HUMAN ARTICULAR CHONDROCYTES; TUMOR INVASIVENESS; EXPRESSION; CANCER; CARTILAGE; IL-1; ANGIOGENESIS; INFLAMMATION; METASTASIS	Interleukin (IL)-1 signaling plays an important role in inflammatory processes, but also in malignant processes. The essential downstream event in IL-1 signaling is the activation of nuclear factor (NF)-kappa B, which leads to the expression of several genes that are involved in cell proliferation, invasion, angiogenesis and metastasis, among them VEGF-A. As microenvironment-derived IL-1 beta is required for invasion and angiogenesis in malignant tumors, also in chondrosarcomas, we investigated IL-1 beta-induced signal transduction and VEGF-A expression in C3842 and SW1353 chondrosarcoma cells. We additionally performed in vitro angiogenesis assays and NF-kappa B-related gene expression analyses. Curcumin is a substance which inhibits IL-1 signaling very early by preventing the recruitment of IL-1 receptor associated kinase (IRAK) to the IL-1 receptor. We demonstrate that IL-1 signaling and VEGF-A expression are blocked by Curcumin in chondrosarcoma cells. We further show that Curcumin blocks IL-1 beta-induced angiogenesis and NF-kappa B-related gene expression. We suppose that IL-1 blockade is an additional treatment option in chondrosarcoma, either by Curcumin, its derivatives or other IL-1 blocking agents.	[Kalinski, Thomas; Roessner, Albert; Nass, Norbert] Univ Magdeburg, Dept Pathol, D-39106 Magdeburg, Germany; [Sel, Saadettin] Heidelberg Univ, Dept Ophthalmol, Heidelberg, Germany; [Huetten, Heiko] Klinikum Braunschweig, Dept Hematol & Oncol, Braunschweig, Germany; [Roepke, Martin] Univ Magdeburg, Dept Orthoped, D-39106 Magdeburg, Germany	Otto von Guericke University; Ruprecht Karls University Heidelberg; Otto von Guericke University	Kalinski, T (corresponding author), Univ Magdeburg, Dept Pathol, D-39106 Magdeburg, Germany.	kalinski@med.ovgu.de	Nass, Norbert/A-5592-2011	Nass, Norbert/0000-0003-2563-0386; Sel, Prof. Dr. med. Saadettin/0000-0003-3307-3305				Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Apte RN, 2006, EUR J CANCER, V42, P751, DOI 10.1016/j.ejca.2006.01.010; Apte RN, 2008, IMMUNOL REV, V222, P222, DOI 10.1111/j.1600-065X.2008.00615.x; Bharti AC, 2002, BIOCHEM PHARMACOL, V64, P883, DOI 10.1016/S0006-2952(02)01154-1; Bresnihan B, 2003, RHEUMATOLOGY, V42, P22, DOI 10.1093/rheumatology/keg329; Csaki C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2850; Dinarello CA, 2010, CANCER METAST REV, V29, P317, DOI 10.1007/s10555-010-9229-0; Fan Z, 2007, AM J PATHOL, V171, P938, DOI 10.2353/ajpath.2007.061083; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gebauer M, 2005, OSTEOARTHR CARTILAGE, V13, P697, DOI 10.1016/j.joca.2005.04.004; GRABSTEIN KH, 1986, SCIENCE, V232, P506, DOI 10.1126/science.3083507; Henrotin Y, 2010, OSTEOARTHR CARTILAGE, V18, P141, DOI 10.1016/j.joca.2009.10.002; Jurrmann N, 2005, J NUTR, V135, P1859, DOI 10.1093/jn/135.8.1859; Kalinski T, 2006, CANCER, V106, P2028, DOI 10.1002/cncr.21848; Kalinski T, 2005, VIRCHOWS ARCH, V446, P287, DOI 10.1007/s00428-004-1194-y; Kalinski T, 2007, HUM PATHOL, V38, P86, DOI 10.1016/j.humpath.2006.06.012; Kalinski T, 2009, PATHOL RES PRACT, V205, P339, DOI 10.1016/j.prp.2008.12.008; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Krelin Y, 2007, CANCER RES, V67, P1062, DOI 10.1158/0008-5472.CAN-06-2956; Kunnumakkara AB, 2008, CANCER LETT, V269, P199, DOI 10.1016/j.canlet.2008.03.009; Lavi G, 2007, J CONTROL RELEASE, V123, P123, DOI 10.1016/j.jconrel.2007.07.015; Lay E, 2012, J NUTR BIOCHEM, V23, P106, DOI 10.1016/j.jnutbio.2010.11.004; Lewis AM, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-48; Li TM, 2012, J CELL BIOCHEM, V113, P3353, DOI 10.1002/jcb.24211; Liu G, 2007, J IMMUNOL, V179, P4125, DOI 10.4049/jimmunol.179.6.4125; Martin MU, 2002, BBA-MOL CELL RES, V1592, P265, DOI 10.1016/S0167-4889(02)00320-8; Mosley CA, 2007, ADV EXP MED BIOL, V595, P77; Pan MH, 1999, DRUG METAB DISPOS, V27, P486; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Peschel D, 2007, J NUTR BIOCHEM, V18, P113, DOI 10.1016/j.jnutbio.2006.03.007; Ravindran J, 2009, AAPS J, V11, P495, DOI 10.1208/s12248-009-9128-x; Roomi MW, 2014, INT J ONCOL, V44, P27, DOI 10.3892/ijo.2013.2159; Schweizerhof M, 2009, NAT MED, V15, P802, DOI 10.1038/nm.1976; Shakibaei M, 2007, BIOCHEM PHARMACOL, V73, P1434, DOI 10.1016/j.bcp.2007.01.005; Song XP, 2003, J IMMUNOL, V171, P6448, DOI 10.4049/jimmunol.171.12.6448; Tang CH, 2012, BIOCHEM PHARMACOL, V83, P335, DOI 10.1016/j.bcp.2011.11.013; Vincenti MP, 2001, ARTHRITIS RES, V3, P381, DOI 10.1186/ar331; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100	39	12	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99296	10.1371/journal.pone.0099296	http://dx.doi.org/10.1371/journal.pone.0099296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901233	Green Published, Green Submitted, gold			2022-12-27	WOS:000336841400118
J	Liu, Q; Liu, N; Zang, SL; Liu, H; Wang, P; Ji, CY; Sun, XL				Liu, Qiang; Liu, Na; Zang, Shaolei; Liu, Heng; Wang, Pin; Ji, Chunyan; Sun, Xiulian			Tumor Suppressor DYRK1A Effects on Proliferation and Chemoresistance of AML Cells by Downregulating c-Myc	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; TRANSCRIPTION FACTOR; PROTEIN-KINASES; TRANSGENIC MICE; FAMILY KINASES; DNA-DAMAGE; CYCLE; PHOSPHORYLATION; EXPRESSION; SURVIVAL	Acute myeloid leukemia (AML), caused by abnormal proliferation and accumulation of hematopoietic progenitor cells, is one of the most common malignancies in adults. We reported here DYRK1A expression level was reduced in the bone marrow of adult AML patients, comparing to normal controls. Overexpression of DYRK1A inhibited the proliferation of AML cell lines by increasing the proportion of cells undergoing G0/G1 phase. We reasoned that the proliferative inhibition was due to downregulation of c-Myc by DYRK1A, through mediating its degradation. Moreover, overexpression of c-Myc markedly reversed AML cell growth inhibition induced by DYRK1A. DYRK1A also had significantly lower expression in relapsed/refractory AML patients, comparing to newly-diagnosed AML patients, which indicated the role of DYRK1A in chemoresistance of AML. Our study provided functional evidences for DYRK1A as a potential tumor suppressor in AML.	[Liu, Qiang; Liu, Heng; Wang, Pin; Sun, Xiulian] Shandong Univ, Qilu Hosp, Key Lab Otolaryngol, Jinan 250100, Peoples R China; [Liu, Na; Zang, Shaolei; Ji, Chunyan] Shandong Univ, Qilu Hosp, Dept Hematol, Jinan 250100, Peoples R China	Shandong University; Shandong University	Ji, CY (corresponding author), Shandong Univ, Qilu Hosp, Dept Hematol, Jinan 250100, Peoples R China.	jichunyan@sdu.edu.cn; xiulians@gmail.com			National Natural Science Foundation of China [81171030, 81370662, 81000223]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grant 81171030 (X. Sun), 81370662 (C. Ji), and 81000223 (S. Zang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Becker W, 1998, J BIOL CHEM, V273, P25893, DOI 10.1074/jbc.273.40.25893; Birger Y, 2012, J CLIN INVEST, V122, P807, DOI 10.1172/JCI62372; Chen JY, 2013, MOL CELL, V52, P87, DOI 10.1016/j.molcel.2013.09.009; DAKSIS JI, 1994, ONCOGENE, V9, P3635; de Wit NJW, 2002, MELANOMA RES, V12, P57, DOI 10.1097/00008390-200202000-00009; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Gregory MA, 2010, CANCER CELL, V18, P74, DOI 10.1016/j.ccr.2010.04.025; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Hammerle B, 2011, DEVELOPMENT, V138, P2543, DOI 10.1242/dev.066167; Hammerle B, 2002, DEV BIOL, V246, P259, DOI 10.1006/dbio.2002.0675; Jung MS, 2011, J BIOL CHEM, V286, P40401, DOI 10.1074/jbc.M111.253971; Jung P, 2008, P NATL ACAD SCI USA, V105, P15046, DOI 10.1073/pnas.0801773105; Kim MY, 2006, P NATL ACAD SCI USA, V103, P13074, DOI 10.1073/pnas.0601915103; Kurabayashi N, 2010, MOL CELL BIOL, V30, P1757, DOI 10.1128/MCB.01047-09; Lee Y, 2009, J BIOL CHEM, V284, P33343, DOI 10.1074/jbc.M109.042234; Licht Jonathan D, 2005, Hematology Am Soc Hematol Educ Program, P137; Litovchick L, 2011, GENE DEV, V25, P801, DOI 10.1101/gad.2034211; Lu M, 2011, J BIOL CHEM, V286, P10755, DOI 10.1074/jbc.M110.174540; Maenz B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-30; Malinge S, 2009, BLOOD, V113, P2619, DOI 10.1182/blood-2008-11-163501; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Oran B, 2012, HAEMATOL-HEMATOL J, V97, P1916, DOI 10.3324/haematol.2012.066100; Park J, 2010, J BIOL CHEM, V285, P31895, DOI 10.1074/jbc.M110.147520; Park J, 2009, CELL MOL LIFE SCI, V66, P3235, DOI 10.1007/s00018-009-0123-2; Pulte D, 2013, HAEMATOLOGICA, V98, P693, DOI 10.3324/haematol.2012.063602; Reavie L, 2013, CANCER CELL, V23, P362, DOI 10.1016/j.ccr.2013.01.025; Reddy BY, 2009, P NATL ACAD SCI USA, V106, P4408, DOI 10.1073/pnas.0809130106; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Satge D, 1998, CANCER RES, V58, P448; Scales TME, 2009, J CELL SCI, V122, P2424, DOI 10.1242/jcs.040162; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Strom DK, 1998, CELL GROWTH DIFFER, V9, P59; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; Teague TK, 1999, P NATL ACAD SCI USA, V96, P12691, DOI 10.1073/pnas.96.22.12691; Wagoner MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000979; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Xie RL, 2003, J BIOL CHEM, V278, P26589, DOI 10.1074/jbc.M301491200; Yiu GK, 2006, J BIOL CHEM, V281, P12210, DOI 10.1074/jbc.M600184200; Yoshida K, 2008, BIOCHEM PHARMACOL, V76, P1389, DOI 10.1016/j.bcp.2008.05.021; Zhang JR, 2012, ONCOL REP, V28, P1503, DOI 10.3892/or.2012.1943	46	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98853	10.1371/journal.pone.0098853	http://dx.doi.org/10.1371/journal.pone.0098853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901999	Green Submitted, Green Published, gold			2022-12-27	WOS:000336841400061
J	Lobo, L; Travieso, D; Barrientos, A; Jacobs, DM				Lobo, Lorena; Travieso, David; Barrientos, Antonio; Jacobs, David M.			Stepping on Obstacles with a Sensory Substitution Device on the Lower Leg: Practice without Vision Is More Beneficial than Practice with Vision	PLOS ONE			English	Article							AUDITORY SUBSTITUTION; SYSTEM; LOCALIZATION; PERCEPTION; ATTENTION; PERCEIVE; GUIDANCE	Practice is essential for an adapted use of sensory substitution devices. Understanding the learning process is therefore a fundamental issue in this field of research. This study presents a novel sensory substitution device worn on the lower leg and uses the device to study learning. The device includes 32 vibrotactile actuators that each vibrate as a function of the distance to the nearest surface in a particular direction. Participants wearing the device were asked to approach an object and to step on the object. Two 144-trial practice conditions were compared in a pretest-practice-posttest design. Participants in the first condition practiced with vibrotactile stimulation while blindfolded. Participants in the second condition practiced with vibrotactile stimulation along with normal vision. Performance was relatively successful, both types of practice led to improvements in performance, and practice without vision led to a larger reduction in the number of errors than practice with vision. These results indicate that distance-based sensory substitution is promising in addition to the more traditional light-intensity-based sensory substitution and that providing appropriate sensorimotor couplings is more important than applying the stimulation to highly sensitive body parts. The observed advantage of practice without vision over practice with vision is interpreted in terms of the guidance hypothesis of feedback and learning.	[Lobo, Lorena; Travieso, David; Jacobs, David M.] Univ Autonoma Madrid, Fac Psicol, Madrid, Spain; [Barrientos, Antonio] Univ Politecn Madrid, CSIC, Ctr Automat & Robot, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Politecnica de Madrid; CSIC-UPM - Centro de Automatica y Robotica	Jacobs, DM (corresponding author), Univ Autonoma Madrid, Fac Psicol, Madrid, Spain.	david.jacobs@uam.es	Lobo, Lorena/U-8397-2019; Barrientos, Antonio/B-4053-2013; Travieso, David/B-5321-2012; Jacobs, David M/C-5216-2011	Lobo, Lorena/0000-0002-2697-3244; Barrientos, Antonio/0000-0003-1691-3907; Travieso, David/0000-0002-5804-4212; Jacobs, David M/0000-0003-2954-5293	Spanish Ministry of Science and Innovation [FFI2009-13416-C02-02]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This material is based upon work supported by Grant FFI2009-13416-C02-02 of the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzamarski R, 2010, ATTEN PERCEPT PSYCHO, V72, P721, DOI 10.3758/APP.72.3.721; Auvray M, 2007, PERCEPTION, V36, P416, DOI 10.1068/p5631; Auvray M, 2009, COGNITIVE SCI, V33, P1036, DOI 10.1111/j.1551-6709.2009.01040.x; Bach-y-Rita P, 2003, TRENDS COGN SCI, V7, P541, DOI 10.1016/j.tics.2003.10.013; Cancar L, 2013, INT J ADV ROBOT SYST, V10, DOI 10.5772/56235; Cardin S, 2007, VISUAL COMPUT, V23, P109, DOI 10.1007/s00371-006-0032-4; Dakopoulos D, 2010, IEEE T SYST MAN CY C, V40, P25, DOI 10.1109/TSMCC.2009.2021255; Diaz A, 2011, STUDIES PERCEPTION A, P8; Diaz A, 2012, HUM MOVEMENT SCI, V31, P1571, DOI 10.1016/j.humov.2012.05.006; Durette B, 2008, WORKSH COMP VIS APPL, P1; EPSTEIN W, 1989, J EXP PSYCHOL HUMAN, V15, P28, DOI 10.1037/0096-1523.15.1.28; FLEURY M, 1995, BRAIN, V118, P1149, DOI 10.1093/brain/118.5.1149; Gibson J.J., 1986, ECOLOGICAL APPROACH; GUARNIER.G, 1974, PERCEPTION, V3, P101, DOI 10.1068/p030101; GUARNIERO G, 1977, J VISUAL IMPAIR BLIN, V71, P125; Huet M, 2011, J EXP PSYCHOL HUMAN, V37, P1841, DOI 10.1037/a0024386; Huet M, 2009, HUM MOVEMENT SCI, V28, P450, DOI 10.1016/j.humov.2008.12.004; Jacobs DM, 2009, ECOL PSYCHOL, V21, P245, DOI 10.1080/10407410903058302; Jacobs DM, 2001, J EXP PSYCHOL HUMAN, V27, P1019, DOI 10.1037/0096-1523.27.5.1019; JANSSON G, 1983, INT J NEUROSCI, V19, P37, DOI 10.3109/00207458309148644; Jones LA, 2008, HUM FACTORS, V50, P90, DOI 10.1518/001872008X250638; Kim JK, 2008, BRAIN RES, V1242, P263, DOI 10.1016/j.brainres.2008.06.038; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; Lenay C., 2003, TOUCHING KNOWING COG, P275, DOI [10.1075/aicr.53.22len, DOI 10.1075/AICR.53.22LEN]; MEIJER PBL, 1992, IEEE T BIO-MED ENG, V39, P112, DOI 10.1109/10.121642; Michaels CF, 2008, J EXP PSYCHOL HUMAN, V34, P944, DOI 10.1037/0096-1523.34.4.944; Michaels CF, 2011, ATTEN PERCEPT PSYCHO, V73, P160, DOI 10.3758/s13414-010-0024-3; Nagel SK, 2005, J NEURAL ENG, V2, pR13, DOI 10.1088/1741-2560/2/4/R02; O'Regan JK, 2001, BEHAV BRAIN SCI, V24, P939, DOI 10.1017/S0140525X01000115; Proulx MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001840; Rovira Katia, 2010, 2010 IEEE 9th International Conference on Development and Learning (ICDL 2010), P1, DOI 10.1109/DEVLRN.2010.5578875; SALMONI AW, 1984, PSYCHOL BULL, V95, P355, DOI 10.1037/0033-2909.95.3.355; Segond H, 2005, PERCEPTION, V34, P1231, DOI 10.1068/p3409; Smeeton NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079811; Turvey MT, 1996, AM PSYCHOL, V51, P1134, DOI 10.1037/0003-066X.51.11.1134; van Erp JBF, 2007, THESIS UTRECHT U; WARREN DH, 1984, PERCEPTION, V13, P331, DOI 10.1068/p130331	37	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98801	10.1371/journal.pone.0098801	http://dx.doi.org/10.1371/journal.pone.0098801			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4NF	24901843	Green Published, gold, Green Submitted			2022-12-27	WOS:000336841400053
J	Sun, W; Guo, J; Li, XY; Zhao, YQ; Chen, H; Wu, G				Sun, Wei; Guo, Jing; Li, Xiuyang; Zhao, Yongqi; Chen, Hui; Wu, Gang			The Routine Utilization of Dental Care during Pregnancy in Eastern China and the Key Underlying Factors: A Hangzhou City Study	PLOS ONE			English	Article							ORAL-HEALTH; SERVICES; WOMEN	Objectives: Oral diseases are associated with adverse pregnancy outcomes. The routine utilization of dental care (RUDC) during pregnancy is an effective way to improve pregnant women's oral health, and thus safeguard the health of their babies. As China has one fifth of the world's population, it is especially meaningful to encourage RUDC there. However, the status of RUDC in China and the key underlying factors are largely unknown. Methods: This cross-sectional survey investigated the current status of RUDC during pregnancy and the key underlying factors in Hangzhou City, Zhejiang Province, eastern China. We collected participants' demographics, individual oral-hygiene behaviors, individual lifestyle, oral-health conditions and attitudes, and also their RUDC during pregnancy. Binary Logistic Regression Analysis was used to analyze the key underlying factors. Results: Only 16.70% of the participants reported RUDC during pregnancy. The percentage of RUDC was significantly lower among pregnant women with the following characteristics: aged 30 or less, an annual household income under $8,000, brushing once a day or less, never flossing or rinsing the mouth, paying no attention to pregnancy-related oral-health knowledge, and being dissatisfied with one's individual dental hygiene behavior. Conclusions: RUDC during pregnancy is very low in eastern China and is greatly influenced not only by a woman's age, annual income, individual hygiene behavior, but also by her attention and attitudes to oral health. To improve this population's access to and use of dental care during pregnancy, appropriate programs and policies are urgently needed.	[Sun, Wei; Zhao, Yongqi; Chen, Hui] Zhejiang Univ, Dept Conservat Dent & Periodont, Affiliated Hosp Stomatol, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Guo, Jing] Vrije Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Res Inst MOVE, Dept Oral Cell Biol, Amsterdam, Netherlands; [Guo, Jing; Wu, Gang] Univ Amsterdam, Amsterdam, Netherlands; [Li, Xiuyang] Zhejiang Univ, Dept Epidemiol & Biostat, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Gang] Vrije Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Res Inst MOVE, Dept Oral Implantol & Prosthet Dent, Amsterdam, Netherlands	Zhejiang University; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Zhejiang University; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam	Chen, H (corresponding author), Zhejiang Univ, Dept Conservat Dent & Periodont, Affiliated Hosp Stomatol, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China.	huic66@hotmail.com; g.wu@acta.nl	wu, gang/C-5072-2012	wu, gang/0000-0001-8941-2500	Education Department of Zhejiang Province, China [Y200909830]	Education Department of Zhejiang Province, China	This study was supported by the grant of the Education Department of Zhejiang Province, China (Grant Number: Y200909830 to WS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Habashneh R, 2005, J CLIN PERIODONTOL, V32, P815, DOI 10.1111/j.1600-051X.2005.00739.x; Boggess KA, 2010, J AM DENT ASSOC, V141, P553, DOI 10.14219/jada.archive.2010.0228; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Desrosiers Tania A, 2012, N C Med J, V73, P136; Du MQ, 2000, INT DENT J, V50, P250, DOI 10.1111/j.1875-595X.2000.tb00561.x; Khader Y, 2009, ARCH GYNECOL OBSTET, V279, P165, DOI 10.1007/s00404-008-0696-2; Kushtagi P, 2008, INT J GYNECOL OBSTET, V101, P296, DOI 10.1016/j.ijgo.2008.01.010; Lo ECM, 2001, J DENT RES, V80, P1471, DOI 10.1177/00220345010800051701; LOE HARALD, 1963, ACTA ODONTOL SCAND, V21, P533, DOI 10.3109/00016356309011240; Lydon-Rochelle MT, 2004, AM J PUBLIC HEALTH, V94, P765, DOI 10.2105/AJPH.94.5.765; Milgrom P, 2008, J PUBLIC HEALTH DENT, V68, P170, DOI 10.1111/j.1752-7325.2007.00049.x; Radnai M, 2009, J DENT RES, V88, P280, DOI 10.1177/0022034508330229; Radnai M, 2006, J CLIN PERIODONTOL, V33, P791, DOI 10.1111/j.1600-051X.2006.00986.x; Straka M, 2011, NEUROENDOCRINOL LETT, V32, P34; Thomson WM, 2010, J DENT RES, V89, P307, DOI 10.1177/0022034509356779	15	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98780	10.1371/journal.pone.0098780	http://dx.doi.org/10.1371/journal.pone.0098780			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901520	Green Submitted, Green Published, gold			2022-12-27	WOS:000336841400051
J	Thierry, S; Tourterel, C; Le Fleche, P; Derzelle, S; Dekhil, N; Mendy, C; Colaneri, C; Vergnaud, G; Madani, N				Thierry, Simon; Tourterel, Christophe; Le Fleche, Philippe; Derzelle, Sylviane; Dekhil, Neira; Mendy, Christiane; Colaneri, Cecile; Vergnaud, Gilles; Madani, Nora			Genotyping of French Bacillus anthracis Strains Based on 31-Loci Multi Locus VNTR Analysis: Epidemiology, Marker Evaluation, and Update of the Internet Genotype Database	PLOS ONE			English	Article							NUMBER TANDEM REPEATS; MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; HIGH-RESOLUTION; IDENTIFICATION; EVOLUTION; OUTBREAK; FRANCE; MLVA	Background: Bacillus anthracis is known to have low genetic variability. In spite of this lack of diversity, multiple-locus variable-number tandem repeat (VNTR) analysis (MLVA) and single nucleotide polymorphisms (SNPs) including the canonical SNPs assay (canSNP) have proved to be highly effective to differentiate strains. Five different MLVA schemes based on a collection of 31 VNTR loci (MLVA8, MLVA15, MLVA20, MLVA25 and MLVA31) with increased resolving power have been described. Results: MLVA31 was applied to characterize the French National Reference Laboratory collection. The total collection of 130 strains is resolved in 35 genotypes. The 119 veterinary and environmental strains collection in France were resolved into 26 genotypes belonging to three canSNP lineages and four MLVA clonal complexes (CCs) with particular geographical clustering. A subset of seven loci (MLVA7) is proposed to constitute a first line assay. The loci are compatible with moderate resolution equipment such as agarose gel electrophoresis and show a good congruence value with MLVA31. The associated MLVA and SNP data was imported together with published genotyping data by taking advantage of major enhancements to the MLVAbank software and web site. Conclusions: The present report provides a wide coverage of the genetic diversity of naturally occurring B. anthracis strains in France as can be revealed by MLVA. The data obtained suggests that once such coverage is achieved, it becomes possible to devise optimized first-line MLVA assays comprising a sufficiently low number of loci to be typed either in one multiplex PCR or on agarose gels. Such a selection of seven loci is proposed here, and future similar investigations in additional countries will indicate to which extend the same selection can be used worldwide as a common minimum set. It is hoped that this approach will contribute to an efficient and low-cost routine surveillance of important pathogens for biosecurity such as B. anthracis.	[Thierry, Simon; Derzelle, Sylviane; Dekhil, Neira; Mendy, Christiane; Colaneri, Cecile; Madani, Nora] Univ Paris Est, Anses, Hlth Anim Lab, Bacterial Zoonosis Unit, Maisons Alfort, France; [Tourterel, Christophe; Le Fleche, Philippe; Vergnaud, Gilles] Univ Paris Sud, Inst Genet & Microbiol, UMR 8621, Orsay, France; [Tourterel, Christophe; Le Fleche, Philippe; Vergnaud, Gilles] CNRS, F-91405 Orsay, France; [Le Fleche, Philippe] DGA CBRN Def, Div Analyt Microbiol, Vert Le Petit, France; [Vergnaud, Gilles] DGA MRIS Mission Rech & Innovat Sci, Bagneux, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Madani, N (corresponding author), Univ Paris Est, Anses, Hlth Anim Lab, Bacterial Zoonosis Unit, Maisons Alfort, France.	nora.madani@anses.fr	Vergnaud, Gilles/AAC-1162-2020; Vergnaud, Gilles/P-1304-2015	Vergnaud, Gilles/0000-0003-0913-194X; Vergnaud, Gilles/0000-0003-0913-194X; Derzelle, Sylviane/0000-0002-2302-2291	DGA [REI2010 34 0003];  [ANR11ASTR007]	DGA; 	This work was made possible by ANR11ASTR007 grant Franthracis (SD, ST). CT is supported by DGA grant Brucella REI2010 34 0003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anaraki S, 2008, EURO SURVEILL, V13; Antwerpen M, 2011, EUR J CLIN MICROBIOL, V30, P923, DOI 10.1007/s10096-011-1177-2; Beyer W, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001534; Birdsell DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032866; Cheung DTL, 2005, J CLIN MICROBIOL, V43, P1992, DOI 10.1128/JCM.43.4.1992-1994.2005; Denoeud F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-4; Derzelle S, 2011, J CLIN MICROBIOL, V49, P4286, DOI 10.1128/JCM.05439-11; Drevet Christine, 2012, Methods Mol Biol, V905, P15, DOI 10.1007/978-1-61779-949-5_2; Durmaz R, 2012, EUR J CLIN MICROBIOL, V31, P2783, DOI 10.1007/s10096-012-1628-4; Fasanella A, 2005, J CLIN MICROBIOL, V43, P3398, DOI 10.1128/JCM.43.7.3398-3401.2005; Fouet AS, 2002, J CLIN MICROBIOL, V40, P4732, DOI 10.1128/JCM.40.12.4732-4734.2002; Gierczynski R, 2004, FEMS MICROBIOL LETT, V239, P235, DOI 10.1016/j.femsle.2004.08.038; Grissa I, 2008, BIOCHIMIE, V90, P660, DOI 10.1016/j.biochi.2007.07.014; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Hoffmaster AR, 2002, EMERG INFECT DIS, V8, P1111, DOI 10.3201/eid0810.020394; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Karlsson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085417; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Keim P, 2004, INFECT GENET EVOL, V4, P205, DOI 10.1016/j.meegid.2004.02.005; Keim P, 2009, MOL ASPECTS MED, V30, P397, DOI 10.1016/j.mam.2009.08.005; Kenefic LJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004813; Kilic S, 2011, J CLIN MICROBIOL, V49, P3276, DOI 10.1128/JCM.02538-10; Larkeryd A, 2014, BIOINFORMATICS; Le Fleche P, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-37; Leski TA, 2009, APPL ENVIRON MICROB, V75, P7163, DOI 10.1128/AEM.01069-09; Lista F, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-33; Madani N, 2010, B EPIDEMIOLOGIQUE HE; Maho A, 2006, J CLIN MICROBIOL, V44, P3422, DOI 10.1128/JCM.01269-06; Mayo L., 2010, Morbidity and Mortality Weekly Report, V59, P872; Merabishvili M, 2006, APPL ENVIRON MICROB, V72, P5631, DOI 10.1128/AEM.00440-06; O'Sullivan MVN, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-148; Okutani A, 2010, J VET MED SCI, V72, P93, DOI 10.1292/jvms.09-0213; Patra G, 1998, J CLIN MICROBIOL, V36, P3412, DOI 10.1128/JCM.36.11.3412-3414.1998; Pearson T, 2004, P NATL ACAD SCI USA, V101, P13536, DOI 10.1073/pnas.0403844101; Pilo P, 2008, APPL ENVIRON MICROB, V74, P2928, DOI 10.1128/AEM.02574-07; Ryu C, 2005, APPL ENVIRON MICROB, V71, P4664, DOI 10.1128/AEM.71.8.4664-4671.2005; Smith KL, 2000, J CLIN MICROBIOL, V38, P3780, DOI 10.1128/JCM.38.10.3780-3784.2000; Sobral D, 2012, EUR J CLIN MICROBIOL, V31, P2247, DOI 10.1007/s10096-012-1562-5; Sobral D, 2011, APPL ENVIRON MICROB, V77, P6899, DOI 10.1128/AEM.05556-11; Stratilo CW, 2012, APPL ENVIRON MICROB, V78, P6433, DOI 10.1128/AEM.01036-12; Stratilo CW, 2006, J CLIN MICROBIOL, V44, P777, DOI 10.1128/JCM.44.3.777-782.2006; Sue D, 2007, J CLIN MICROBIOL, V45, P1777, DOI 10.1128/JCM.02488-06; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Turnbull PCB, 2002, CURR TOP MICROBIOL, V271, P1; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; Visca P, 2011, MICROBIOLOGY	46	29	33	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e95131	10.1371/journal.pone.0095131	http://dx.doi.org/10.1371/journal.pone.0095131			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901417	Green Published, Green Submitted, gold			2022-12-27	WOS:000336841400001
J	Weinsaft, JW; Kochav, JD; Kim, J; Gurevich, S; Volo, SC; Afroz, A; Petashnick, M; Kim, A; Devereux, RB; Okin, PM				Weinsaft, Jonathan W.; Kochav, Jonathan D.; Kim, Jiwon; Gurevich, Sergey; Volo, Samuel C.; Afroz, Anika; Petashnick, Maya; Kim, Agnes; Devereux, Richard B.; Okin, Peter M.			P Wave Area for Quantitative Electrocardiographic Assessment of Left Atrial Remodeling	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; CARDIOVASCULAR MAGNETIC-RESONANCE; CONGESTIVE-HEART-FAILURE; ECHOCARDIOGRAPHIC PREDICTORS; FIBRILLATION RECURRENCE; ENLARGEMENT; CRITERIA; STROKE; RISK; SIZE	Background: Left atrial (LA) dilation provides a substrate for mitral regurgitation (MR) and atrial arrhythmias. ECG can screen for LA dilation but standard approaches do not assess LA geometry as a continuum, as does non-invasive imaging. This study tested ECG-quantified P wave area as an index of LA geometry. Methods and Results: 342 patients with CAD underwent ECG and CMR within 7 (0.1 +/- 1.4) days. LA area on CMR correlated best with P wave area in ECG lead V1 (r = 0.42, p < 0.001), with lesser correlations for P wave amplitude and duration. P wave area increased stepwise in relation to CMR-evidenced MR severity (p < 0.001), with similar results for MR on echocardiography (performed in 86% of patients). Pulmonary arterial (PA) pressure on echo was increased by 50% among patients in the highest (45 +/- 14 mmHg) vs. the lowest (31 +/- 9 mmHg) P wave area quartile of the population. In multivariate regression, CMR and echo-specific models demonstrated P wave area to be independently associated with LA size after controlling for MR, as well as echo-evidenced PA pressure. Clinical follow-up (mean 2.4 +/- 1.9 years) demonstrated ECG and CMR to yield similar results for stratification of arrhythmic risk, with a 2.6-fold increase in risk for atrial fibrillation/flutter among patients in the top P wave area quartile of the population (CI 1.1-5.9, p = 0.02), and a 3.2-fold increase among patients in the top LA area quartile (CI 1.4-7.0, p = 0.005). Conclusions: ECG-quantified P wave area provides an index of LA remodeling that parallels CMR-evidenced LA chamber geometry, and provides similar predictive value for stratification of atrial arrhythmic risk.	[Weinsaft, Jonathan W.; Kochav, Jonathan D.; Kim, Jiwon; Gurevich, Sergey; Volo, Samuel C.; Afroz, Anika; Petashnick, Maya; Kim, Agnes; Devereux, Richard B.; Okin, Peter M.] Weill Cornell Med Coll, Dept Med, Greenberg Cardiol Div, New York, NY 10021 USA; [Weinsaft, Jonathan W.] Weill Cornell Med Coll, Dept Radiol, New York, NY USA; [Weinsaft, Jonathan W.; Kim, Jiwon] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Kochav, Jonathan D.] Duke Univ, Sch Med, Durham, NC USA	Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Duke University	Weinsaft, JW (corresponding author), Weill Cornell Med Coll, Dept Med, Greenberg Cardiol Div, New York, NY 10021 USA.	jww2001@med.cornell.edu	Kim, Agnes/ABD-2784-2020		United States National Institutes of Health [K23 HL102249-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL102249] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was conducted with salary support as provided by the United States National Institutes of Health (grant number K23 HL102249-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMIN EJ, 1995, CIRCULATION, V92, P835, DOI 10.1161/01.CIR.92.4.835; Berruezo A, 2007, EUR HEART J, V28, P836, DOI 10.1093/eurheartj/ehm027; CHIRIFE R, 1975, BRIT HEART J, V37, P1281; Gardin JM, 2001, AM J CARDIOL, V87, P1051, DOI 10.1016/S0002-9149(01)01460-6; Gerdts E, 2002, HYPERTENSION, V39, P739, DOI 10.1161/hy0302.105683; Grothues F, 2002, AM J CARDIOL, V90, P29, DOI 10.1016/S0002-9149(02)02381-0; Heitner J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040491; John B, 2008, EUR HEART J, V29, P2234, DOI 10.1093/eurheartj/ehn329; John B, 2010, J AM COLL CARDIOL, V55, P1217, DOI 10.1016/j.jacc.2009.10.046; Jones EC, 2001, AM J CARDIOL, V87, P298, DOI 10.1016/S0002-9149(00)01362-X; Kochav JD, 2013, AM J CARDIOL, V112, P174, DOI 10.1016/j.amjcard.2013.03.013; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lauren A, 2013, J CARDIOVASCULAR MAG, V2013; Lewis T, 1911, Proc R Soc Med, V4, P81; Li DS, 1999, CIRCULATION, V100, P87, DOI 10.1161/01.CIR.100.1.87; Maceira AM, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-65; Magnani JW, 2011, AM J CARDIOL, V107, P917, DOI 10.1016/j.amjcard.2010.10.075; Maunganidze F, 2013, J HYPERTENS, V31, P377, DOI 10.1097/HJH.0b013e32835b8daa; MILLER DH, 1983, J ELECTROCARDIOL, V16, P15, DOI 10.1016/S0022-0736(83)80154-X; MORRIS JJ, 1964, CIRCULATION, V29, P242, DOI 10.1161/01.CIR.29.2.242; MUNUSWAMY K, 1984, AM J CARDIOL, V53, P829, DOI 10.1016/0002-9149(84)90413-2; Nasir JM, 2012, J ELECTROCARDIOL, V45, P646, DOI 10.1016/j.jelectrocard.2012.07.022; Oakes RS, 2009, CIRCULATION, V119, P1758, DOI 10.1161/CIRCULATIONAHA.108.811877; Okin PM, 1998, HYPERTENSION, V31, P937, DOI 10.1161/01.HYP.31.4.937; Olshansky B, 2005, J AM COLL CARDIOL, V45, P2026, DOI 10.1016/j.jacc.2005.03.020; Roberts-Thomson KC, 2009, HEART RHYTHM, V6, P1000, DOI 10.1016/j.hrthm.2009.03.050; Sanders P, 2003, CIRCULATION, V108, P1461, DOI 10.1161/01.CIR.0000090688.49283.67; Soliman EZ, 2009, STROKE, V40, P1204, DOI 10.1161/STROKEAHA.108.534735; TERMINI BA, 1975, SOUTHERN MED J, V68, P161, DOI 10.1097/00007611-197502000-00010; Tsang TSM, 2002, AM J CARDIOL, V90, P1284, DOI 10.1016/S0002-9149(02)02864-3; Tsao CW, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-7; VAZIRI SM, 1994, CIRCULATION, V89, P724, DOI 10.1161/01.CIR.89.2.724; WAGGONER AD, 1976, CIRCULATION, V54, P553, DOI 10.1161/01.CIR.54.4.553; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	34	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99178	10.1371/journal.pone.0099178	http://dx.doi.org/10.1371/journal.pone.0099178			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901435	Green Published, gold, Green Submitted			2022-12-27	WOS:000336841400106
J	Carle, T; Yamawaki, Y; Watanabe, H; Yokohari, F				Carle, Thomas; Yamawaki, Yoshifumi; Watanabe, Hidehiro; Yokohari, Fumio			Antennal Development in the Praying Mantis (Tenodera aridifolia) Highlights Multitudinous Processes in Hemimetabolous Insect Species	PLOS ONE			English	Article							SEX ATTRACTANT SPECIFICITY; SENSE-ORGANS; POSTEMBRYONIC DEVELOPMENT; PERIPLANETA-AMERICANA; GENUS PERIPLANETA; JUVENILE-HORMONE; MATE LOCATION; DIMORPHISM; MORPHOLOGY; DROSOPHILA	Insects possess antennae equipped with a large number of segments (flagellomeres) on which sensory organs (sensilla) are located. Hemimetabolous insects grow by molting until they reach adulthood. In these species, the sensory structures develop and mature during each stage of development; new flagellomeres are generated at each molt elongating the antennae, and new sensilla appear. The praying mantis (Tenodera aridifolia) is a hemimetabolous insect with 7 different instars before it reaches adulthood. Because their antennae are provided with an atypical sensillar distribution, we previously suggested that their antennae develop with a different mechanism to other hemimetaboulous insect species. In the present study, we measured the number, length and width of flagellomeres along the antennae in nymph and adult mantis Tenodera aridifolia. For this study, we developed a new and innovative methodology to reconstruct the antennal development based on the length of flagellomeres. We observed and confirmed that the antennae of mantises develop with the addition of new segments at two distinct sites. In addition, we constructed a complete database of the features of the flagellum for each stage of development. From our data, we found that sexual dimorphism appears from the 6 instar (larger number and wider flagellomeres in males) in accordance with the appearance of their genital apparatus. The antennal sexual dimorphism completes at adulthood with longer flagellomeres and the emergence of a huge number of grooved peg sensilla in males during the last molting, which suggests once again their function as sex-pheromone receptive sensilla.	[Carle, Thomas; Watanabe, Hidehiro; Yokohari, Fumio] Fukuoka Univ, Fac Sci, Div Biol, Dept Earth Syst Sci, Fukuoka 81401, Japan; [Yamawaki, Yoshifumi] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan	Fukuoka University; Kyushu University	Carle, T (corresponding author), Fukuoka Univ, Fac Sci, Div Biol, Dept Earth Syst Sci, Fukuoka 81401, Japan.	th.carle@gmail.com			Fyssen Foundation; Japan Society for the Promotion of Science [PE12038]; Mishima Kaiun Memorial Foundation	Fyssen Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation)	This work was supported by a postdoctoral fellowship from the Fyssen Foundation and the Japan Society for the Promotion of Science (PE12038) (TC), as well as a grant from the Mishima Kaiun Memorial Foundation. Fyssen foundation: http://www. fondationfyssen. fr/Japan Society for the Promotion of Science: http://www. jsps. go. jp/Kaiun Memorial Foundation: http://www. mishima-kaiun. or. jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LE, 2012, AUST J ENTOMOL, V51, P133, DOI 10.1111/j.1440-6055.2011.00843.x; Brown V.K., 1975, International J Insect Morph Embryol, V4, P49, DOI 10.1016/0020-7322(75)90005-7; Campbell FL, 1969, ANN ENTOMOLOGICAL SO, V63, P81; Carle T, 2014, ARTHROPOD STRUCT DEV, V43, P103, DOI 10.1016/j.asd.2013.10.005; Chapman RF, 2002, J MORPHOL, V254, P186, DOI 10.1002/jmor.10026; Darwin C., 1860, ORIGIN SPECIES MEANS; De Loof Arnold, 2006, Insect Science, V13, P325, DOI 10.1111/j.1744-7917.2006.00101.x; De Loof A, 2013, GEN COMP ENDOCR, V188, P35, DOI 10.1016/j.ygcen.2013.02.004; FINLAYSON LH, 1956, Q J MICROSC SCI, V97, P215; Hansson B.S., 1999, INSECT OLFACTION; Hockman D, 2009, ARTHROPOD STRUCT DEV, V38, P125, DOI 10.1016/j.asd.2008.08.001; Holwell GI, 2007, BIOL J LINN SOC, V91, P307, DOI 10.1111/j.1095-8312.2007.00788.x; HUSTERT R, 1986, CELL TISSUE RES, V245, P615; Klass KD, 2002, SCIENCE, V296, P1456, DOI 10.1126/science.1069397; Kopp A, 2000, NATURE, V408, P553, DOI 10.1038/35046017; Kristensen N.P., 2003, LEPIDOPTERA MOTHS BU; Lelito JP, 2008, BEHAV ECOL SOCIOBIOL, V63, P313, DOI 10.1007/s00265-008-0663-8; Loudon C, 2009, ENCY INSECTS; MORRIS MR, 1992, COPEIA, P980, DOI 10.2307/1446627; PARTRIDGE L, 1983, ANIM BEHAV, V31, P871, DOI 10.1016/S0003-3472(83)80242-5; Prete F.R., 2004, COMPLEX WORLDS SIMPL; PRETE FR, 1992, BRAIN BEHAV EVOLUT, V39, P124, DOI 10.1159/000114110; RILLING SUSAN, 1959, BEHAVIOUR, V14, P164, DOI 10.1163/156853959X00063; Saito K, 1972, JPN J MED ENTMOL ZOO, V23, P181; Monteys VSI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029282; SCHAFER R, 1976, J MORPHOL, V149, P139, DOI 10.1002/jmor.1051490202; SCHAFER R, 1973, J COMP NEUROL, V149, P335, DOI 10.1002/cne.901490304; SCHAFER R, 1977, J EXP ZOOL, V199, P189, DOI 10.1002/jez.1401990204; SCHAFER R, 1973, J EXP ZOOL, V183, P353, DOI 10.1002/jez.1401830309; SCHALLER D, 1978, CELL TISSUE RES, V191, P121, DOI 10.1007/BF00223221; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; SLIFER EH, 1968, J MORPHOL, V124, P105, DOI 10.1002/jmor.1051240107; VOLLRATH F, 1992, NATURE, V360, P156, DOI 10.1038/360156a0; Wang W, 2011, P NATL ACAD SCI USA, V108, P11139, DOI 10.1073/pnas.1108431108; Yamawaki Y, 1998, J ETHOL, V16, P23, DOI 10.1007/BF02896350; Yamawaki Y, 2003, ZOOL SCI, V20, P819, DOI 10.2108/zsj.20.819; Yamawaki Yoshifumi, 2006, P147	37	7	7	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98324	10.1371/journal.pone.0098324	http://dx.doi.org/10.1371/journal.pone.0098324			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896610	gold, Green Submitted, Green Published			2022-12-27	WOS:000338430700031
J	Caruba, T; Katsahian, S; Schramm, C; Nelson, AC; Durieux, P; Begue, D; Juilliere, Y; Dubourg, O; Danchin, N; Sabatier, B				Caruba, Thibaut; Katsahian, Sandrine; Schramm, Catherine; Nelson, Anais Charles; Durieux, Pierre; Begue, Dominique; Juilliere, Yves; Dubourg, Olivier; Danchin, Nicolas; Sabatier, Brigitte			Treatment for Stable Coronary Artery Disease: A Network Meta-Analysis of Cost-Effectiveness Studies	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; SIROLIMUS-ELUTING STENTS; BARE METAL STENTS; QUALITY-OF-LIFE; BYPASS-SURGERY; CARDIAC-CATHETERIZATION; MEDICAL THERAPY; FOLLOW-UP; INTERVENTIONAL CARDIOLOGY; ECONOMIC EVALUATIONS	Introduction and Objectives: Numerous studies have assessed cost-effectiveness of different treatment modalities for stable angina. Direct comparisons, however, are uncommon. We therefore set out to compare the efficacy and mean cost per patient after 1 and 3 years of follow-up, of the following treatments as assessed in randomized controlled trials (RCT): medical therapy (MT), percutaneous coronary intervention (PCI) without stent (PTCA), with bare-metal stent (BMS), with drug-eluting stent (DES), and elective coronary artery bypass graft (CABG). Methods: RCT comparing at least two of the five treatments and reporting clinical and cost data were identified by a systematic search. Clinical end-points were mortality and myocardial infarction (MI). The costs described in the different trials were standardized and expressed in US $ 2008, based on purchasing power parity. A network meta-analysis was used to compare costs. Results: Fifteen RCT were selected. Mortality and MI rates were similar in the five treatment groups both for 1-year and 3-year follow-up. Weighted cost per patient however differed markedly for the five treatment modalities, at both one year and three years (P<0.0001). MT was the least expensive treatment modality: US $3069 and 13 864 after one and three years of follow-up, while CABG was the most costly: US $27 003 and 28 670 after one and three years. PCI, whether with plain balloon, BMS or DES came in between, but was closer to the costs of CABG. Conclusions: Appreciable savings in health expenditures can be achieved by using MT in the management of patients with stable angina.	[Caruba, Thibaut; Danchin, Nicolas; Sabatier, Brigitte] Hop Europe Georges Pompidou, APHP, Paris, France; [Katsahian, Sandrine; Schramm, Catherine; Nelson, Anais Charles] URC Hop Henri Mondor, APHP, Creteil, France; [Katsahian, Sandrine; Durieux, Pierre; Sabatier, Brigitte] INSERM, UMRS 762, Ctr Rech Cordeliers, Equipe 22, Paris, France; [Durieux, Pierre] Hop Europe Georges Pompidou, APHP, Dept Sante Publ & Informat, Paris, France; [Begue, Dominique] Univ Paris 05, Fac Pharm, Paris, France; [Juilliere, Yves] Inst Lorrain Coeur & Vaisseaux Louis Mathieu, Nancy, France; [Dubourg, Olivier] Hop Ambroise Pare, APHP, Boulogne Billancourt, France; [Dubourg, Olivier] Univ Versailles St Quentin, Montigny Le Bretonneux, France; [Danchin, Nicolas] Univ Paris 05, Fac Med, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU de Nancy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite	Caruba, T (corresponding author), Hop Europe Georges Pompidou, APHP, Paris, France.	thibaut.caruba@egp.aphp.fr	Danchin, Nicolas/AAN-8291-2020; Juillière, Yves/AAG-1038-2020; Schramm, Catherine/AAB-5104-2021	Juillière, Yves/0000-0002-6101-7530; Schramm, Catherine/0000-0002-1185-8809; Charles-Nelson, Anais/0000-0001-6437-7059; KATSAHIAN, Sandrine/0000-0002-7261-0671; Sabatier, Brigitte/0000-0003-1643-2070				Antioch K M, 2002, Eur J Health Econ, V3, P26, DOI 10.1007/s10198-001-0088-z; Bakhai A, 2006, J AM COLL CARDIOL, V48, P253, DOI 10.1016/j.jacc.2006.02.063; Bertoldi EG, 2013, INT J CARDIOL, V163, P309, DOI 10.1016/j.ijcard.2011.06.046; Cohen DJ, 2012, CATHETER CARDIO INTE, V79, P198, DOI 10.1002/ccd.23147; COHEN DJ, 1995, CIRCULATION, V92, P2480, DOI 10.1161/01.CIR.92.9.2480; Cohen DJ, 2004, CIRCULATION, V110, P508, DOI 10.1161/01.CIR.0000136821.99814.43; Dehmer GJ, 2012, J AM COLL CARDIOL, V60, P2017, DOI 10.1016/j.jacc.2012.08.966; Diaz JF, 2012, REV ESP CARDIOL, V65, P1106, DOI [10.1016/j.recesp.2012.07.021, 10.1016/j.rec.2012.07.013]; Eisenberg MJ, 2006, CIRCULATION, V114, P1745, DOI 10.1161/CIRCULATIONAHA.106.646190; Eisenstein EL, 2009, JACC-CARDIOVASC INTE, V2, P1178, DOI 10.1016/j.jcin.2009.10.011; Eisenstein EL, 2009, JACC-CARDIOVASC INTE, V2, P1199, DOI 10.1016/j.jcin.2009.10.009; Epstein AJ, 2011, JAMA-J AM MED ASSOC, V305, P1769, DOI 10.1001/jama.2011.551; Evers S, 2005, INT J TECHNOL ASSESS, V21, P240, DOI 10.1017/S0266462305050324; Favarato D, 2003, CIRCULATION, V108, P21, DOI 10.1161/01.cir.0000087381.98299.7b; Fihn SD, 2012, CIRCULATION, V126, P3097, DOI 10.1161/CIR.0b013e3182776f83; Gudnason T, 2013, INT J CARDIOL, V168, P1237, DOI 10.1016/j.ijcard.2012.11.054; Higgins JPT, 1996, STAT MED, V15, P2733, DOI 10.1002/(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO;2-0; Hill R A, 2007, Health Technol Assess, V11, pxi; Hlatky MA, 1997, NEW ENGL J MED, V336, P92, DOI 10.1056/NEJM199701093360203; Hlatky MA, 2013, ANN INTERN MED, V158, P727, DOI 10.7326/0003-4819-158-10-201305210-00639; Hlatky MA, 2009, CIRCULATION, V120, P2550, DOI 10.1161/CIRCULATIONAHA.109.912709; Hlatky MA, 2009, LANCET, V373, P1190, DOI 10.1016/S0140-6736(09)60552-3; Kinlay S, 1996, AUST NZ J MED, V26, P20, DOI 10.1111/j.1445-5994.1996.tb02902.x; Kirtane AJ, 2009, CIRCULATION, V119, P3198, DOI 10.1161/CIRCULATIONAHA.108.826479; Kuhr EM, 2011, VALUE HEALTH, V14, pS100, DOI 10.1016/j.jval.2011.05.006; Legrand VMG, 2004, CIRCULATION, V109, P1114, DOI 10.1161/01.CIR.0000118504.61212.4B; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lu G, 2007, STAT MED, V26, P3681, DOI 10.1002/sim.2831; Meredith I, 2005, ESC STOCKH; Meredith I, 2006, EUR PARIS; Pursnani S, 2012, CIRC-CARDIOVASC INTE, V5, P476, DOI 10.1161/CIRCINTERVENTIONS.112.970954; Puymirat E, 2013, AM J CARDIOL, V112, P336, DOI 10.1016/j.amjcard.2013.03.030; Reed SD, 2005, AM HEART J, V149, P434, DOI 10.1016/j.ahj.2004.11.001; Rodriguez A, 1996, J AM COLL CARDIOL, V27, P1178, DOI 10.1016/0735-1097(95)00592-7; RODRIGUEZ A, 1993, J AM COLL CARDIOL, V22, P1060, DOI 10.1016/0735-1097(93)90416-X; Schomig A, 2008, J AM COLL CARDIOL, V52, P894, DOI 10.1016/j.jacc.2008.05.051; Sculpher MJ, 2002, EUR HEART J, V23, P1291, DOI 10.1053/euhj.2001.3075; Serruys PW, 2001, NEW ENGL J MED, V344, P1117, DOI 10.1056/NEJM200104123441502; Serruys PW, 1998, LANCET, V352, P673, DOI 10.1016/S0140-6736(97)11128-X; Smith TC, 1995, STAT MED, V14, P2685, DOI 10.1002/sim.4780142408; Stergiopoulos K, 2012, ARCH INTERN MED, V172, P312, DOI 10.1001/archinternmed.2011.1484; van Hout BA, 2005, HEART, V91, P507, DOI 10.1136/hrt.2004.034454; Villanueva EV, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003334, 10.1002/14651858.CD003334., DOI 10.1002/14651858.CD003334]; Weintraub WS, 2008, CIRC-CARDIOVASC QUAL, V1, P12, DOI 10.1161/CIRCOUTCOMES.108.798462; WEINTRAUB WS, 1995, CIRCULATION, V92, P2831, DOI 10.1161/01.CIR.92.10.2831; Weintraub WS, 2004, HEART, V90, P782, DOI 10.1136/hrt.2003.015057; Woods BS, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-54; Zeiher A, 2007, EUR BARC	48	16	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98371	10.1371/journal.pone.0098371	http://dx.doi.org/10.1371/journal.pone.0098371			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896266	Green Published, Green Submitted, gold			2022-12-27	WOS:000338430700037
J	Casique-Arroyo, G; Martinez-Gallardo, N; de la Vara, LG; Delano-Frier, JP				Casique-Arroyo, Gabriela; Martinez-Gallardo, Norma; Gonzalez de la Vara, Luis; Delano-Frier, John P.			Betacyanin Biosynthetic Genes and Enzymes Are Differentially Induced by (a)biotic Stress in Amaranthus hypochondriacus	PLOS ONE			English	Article							GRAIN AMARANTH; CYCLO-DOPA; BACTERIAL INFILTRATION; BETALAIN BIOSYNTHESIS; SUSPENSION-CULTURES; POLYPHENOL OXIDASE; 4 OCLOCKS; RED; ACCUMULATION; EXPRESSION	An analysis of key genes and enzymes of the betacyanin biosynthetic pathway in Amaranthus hypochondriacus (Ah) was performed. Complete cDNA sequence of Ah genes coding for cyclo-DOPA 5-O glucosyltransferase (AhcDOPA5-GT), two 4, 5-DOPA-extradiol-dioxygenase isoforms (AhDODA-1 and AhDODA-2, respectively), and a betanidin 5-O-glucosyltransferase (AhB5-GT), plus the partial sequence of an orthologue of the cytochrome P-450 R gene (CYP76AD1) were obtained. With the exception AhDODA-2, which had a closer phylogenetic relationship to DODA-like genes in anthocyanin-synthesizing plants, all genes analyzed closely resembled those reported in related Caryophyllales species. The measurement of basal gene expression levels, in addition to the DOPA oxidase tyrosinase (DOT) activity, in different tissues of three Ah genotypes having contrasting pigmentation levels (green to red-purple) was determined. Additional analyses were performed in Ah plants subjected to salt and drought stress and to two different insect herbivory regimes. Basal pigmentation accumulation in leaves, stems and roots of betacyanic plants correlated with higher expression levels of AhDODA-1 and AhB5-GT, whereas DOT activity levels coincided with pigment accumulation in stems and roots and with the acyanic nature of green plants, respectively, but not with pigmentation in leaves. Although the abiotic stress treatments tested produced changes in pigment levels in different tissues, pigment accumulation was the highest in leaves and stems of drought stressed betacyanic plants, respectively. However, tissue pigment accumulation in stressed Ah plants did not always correlate with betacyanin biosynthetic gene expression levels and/or DOT activity. This effect was tissue- and genotype-dependent, and further suggested that other unexamined factors were influencing pigment content in stressed Ah. The results obtained from the insect herbivory assays, particularly in acyanic plants, also support the proposal that these genes could have functions other than betacyanin biosynthesis.	[Casique-Arroyo, Gabriela; Martinez-Gallardo, Norma; Gonzalez de la Vara, Luis; Delano-Frier, John P.] Ctr Invest & Estudios Avanzados Unidad Irapuato, Guanajuato, Mexico		Delano-Frier, JP (corresponding author), Ctr Invest & Estudios Avanzados Unidad Irapuato, Guanajuato, Mexico.	jdelano@ira.cinvestav.mx	Délano-Frier, John/B-5768-2015; Martínez Gallardo, Norma/B-6181-2015; de la Vara, Luis Gonzalez/J-9119-2012	Martínez Gallardo, Norma/0000-0001-5726-091X; de la Vara, Luis Gonzalez/0000-0003-0275-7202	European Commission; Mexico Tierra de Amaranto A. C.; Deborah Presser-Velder Foundation; National Council for Science and Technology (CONACyT, Mexico) [203537]; AMARANTH: FUTURE-FOOD [032263]	European Commission(European CommissionEuropean Commission Joint Research Centre); Mexico Tierra de Amaranto A. C.; Deborah Presser-Velder Foundation; National Council for Science and Technology (CONACyT, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); AMARANTH: FUTURE-FOOD	This work was largely supported financially by the European Commission 6th Framework Programme, AMARANTH: FUTURE-FOOD, Contract No. 032263. Financial support by Mexico Tierra de Amaranto A. C. and The Deborah Presser-Velder Foundation is also acknowledged. GCA was supported by a postgraduate scholarship (code 203537) granted by The National Council for Science and Technology (CONACyT, Mexico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Huerta-Ocampo JA, 2011, CURR NUTR FOOD SCI, V7, P1, DOI 10.2174/157340111794941076; Huerta-Ocampo JA, 2009, INT J PLANT SCI, V170, P990, DOI 10.1086/605119; Bahramnejad B, 2010, PLANT SCI, V178, P147, DOI 10.1016/j.plantsci.2009.10.007; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216; Bowles D, 2005, CURR OPIN PLANT BIOL, V8, P254, DOI 10.1016/j.pbi.2005.03.007; Bowles D, 2006, ANNU REV PLANT BIOL, V57, P567, DOI 10.1146/annurev.arplant.57.032905.105429; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brenner D. M., 2000, Plant Breeding Reviews, V19, P227, DOI 10.1002/9780470650172.ch7; Brockington SF, 2011, NEW PHYTOL, V190, P854, DOI 10.1111/j.1469-8137.2011.03687.x; Cai YZ, 2001, J AGR FOOD CHEM, V49, P1971; Cai YZ, 1998, J AGR FOOD CHEM, V46, P2063, DOI 10.1021/jf9709966; Cao SF, 2012, FOOD CHEM, V134, P1715, DOI 10.1016/j.foodchem.2012.03.129; Chang-Quan W, 2007, PLANT SCI, V173, P487, DOI 10.1016/j.plantsei.2007.07.010; Christinet L, 2004, PLANT PHYSIOL, V134, P265, DOI 10.1104/pp.103.031914; Das SS, 2013, PLANT SCI, V211, P61, DOI 10.1016/j.plantsci.2013.07.003; Delano-Frier JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-363; Edreva A, 2005, AGR ECOSYST ENVIRON, V106, P135, DOI 10.1016/j.agee.2004.10.002; Eichenseer H, 1999, ARCH INSECT BIOCHEM, V42, P99, DOI 10.1002/(SICI)1520-6327(199909)42:1&lt;99::AID-ARCH10&gt;3.0.CO;2-B; Furstenberg-Hagg J, 2013, INT J MOL SCI, V14, P10242, DOI 10.3390/ijms140510242; Gandia-Herrero F, 2004, J AGR FOOD CHEM, V52, P609, DOI 10.1021/jf034381m; Gandia-Herrero F, 2007, J AGR FOOD CHEM, V55, P1546, DOI 10.1021/jf062858z; Gandia-Herrero F, 2013, TRENDS PLANT SCI, V18, P334, DOI 10.1016/j.tplants.2013.01.003; Georgiev VG, 2010, PLANT FOOD HUM NUTR, V65, P105, DOI 10.1007/s11130-010-0156-6; Gins MS, 2002, APPL BIOCHEM MICRO+, V38, P474, DOI 10.1023/A:1019980821313; Han XH, 2009, AFR J BIOTECHNOL, V8, P6735; Hatlestad GJ, 2012, NAT GENET, V44, P816, DOI 10.1038/ng.2297; Hauptli H, 1977, P AM SEM; Hempel J, 1997, PHYTOCHEMISTRY, V44, P847, DOI 10.1016/S0031-9422(96)00633-4; HIRANO H, 1994, PHYSIOL PLANTARUM, V90, P239, DOI 10.1111/j.1399-3054.1994.tb00383.x; Huerta-Ocampo JA, 2011, PLANT BIOLOGY, V13, P472, DOI 10.1111/j.1438-8677.2010.00391.x; Ibdah M, 2002, PLANT CELL ENVIRON, V25, P1145, DOI 10.1046/j.1365-3040.2002.00895.x; Iwamoto K, 2001, PLANT J, V27, P275, DOI 10.1046/j.1365-313x.2001.01082.x; Johnson BL, 2002, AGRON J, V94, P1437, DOI 10.2134/agronj2002.1437; JOY RW, 1995, PLANT PHYSIOL, V107, P1083, DOI 10.1104/pp.107.4.1083; Kujala T, 2001, Z NATURFORSCH C, V56, P343; KUMON K, 1990, PLANT CELL PHYSIOL, V31, P233; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez-Parra J, 2001, J AGR FOOD CHEM, V49, P4064, DOI 10.1021/jf0013555; Massey B, 2012, THESIS U QUEENSLAND; Moreno Diego A., 2008, Phytochemistry Reviews, V7, P261, DOI 10.1007/s11101-007-9084-y; Mosco A, 2012, REV MEX BIODIVERS, V83, P413; Mueller LA, 1997, PLANTA, V203, P260, DOI 10.1007/s004250050190; Myers R. L., 1996, Progress in new crops: Proceedings of the Third National Symposium Indianapolis, Indiana, 22-25 October, 1996., P207; Omami EN, 2006, NEW ZEAL J CROP HORT, V34, P11, DOI 10.1080/01140671.2006.9514382; Pavokovic D, 2011, FOOD TECHNOL BIOTECH, V49, P145; PIATTELL.M, 1969, PHYTOCHEMISTRY, V8, P731, DOI 10.1016/S0031-9422(00)85844-6; Piattelli M., 1966, ANN CHIM-ROME, V56, P1060; PIHA MI, 1995, TROP AGRIC, V72, P7; Putnam D. H, 1990, P NATL AM S 4 MINN M, P151; SAKUTA M, 1986, J PLANT PHYSIOL, V125, P337, DOI 10.1016/S0176-1617(86)80155-9; Sasaki N, 2005, J PLANT RES, V118, P439, DOI 10.1007/s10265-005-0237-z; Sasaki N, 2005, PLANT CELL PHYSIOL, V46, P666, DOI 10.1093/pcp/pci064; Sasaki N, 2004, FEBS LETT, V568, P159, DOI 10.1016/j.febslet.2004.04.097; Sasaki N, 2009, PLANT CELL PHYSIOL, V50, P1012, DOI 10.1093/pcp/pcp053; Schliemann W, 1999, PLANT PHYSIOL, V119, P1217, DOI 10.1104/pp.119.4.1217; SCIUTO S, 1974, PHYTOCHEMISTRY, V13, P947, DOI 10.1016/S0031-9422(00)91427-4; Sepulveda-Jimenez G, 2005, J EXP BOT, V56, P605, DOI 10.1093/jxb/eri036; Sepulveda-Jimenez G, 2004, PHYSIOL MOL PLANT P, V64, P125, DOI 10.1016/j.pmpp.2004.08.003; Shao L, 2013, PAK J BOT, V45, P1905; Shao Ling, 2008, Plant Physiology Communications, V44, P923; Stagnari F, 2014, SCI HORTIC-AMSTERDAM, V165, P13, DOI 10.1016/j.scienta.2013.10.026; Steiner U, 1999, PLANTA, V208, P114, DOI 10.1007/s004250050541; Strack D, 2003, PHYTOCHEMISTRY, V62, P247, DOI 10.1016/S0031-9422(02)00564-2; Takahashi K, 2009, Z NATURFORSCH C, V64, P564; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Venskutonis PR, 2013, COMPR REV FOOD SCI F, V12, P381, DOI 10.1111/1541-4337.12021; Wang CQ, 2007, J INTEGR PLANT BIOL, V49, P1378, DOI 10.1111/j.1744-7909.2007.00489.x; Wang CQ, 2007, PLANT SCI, V172, P1, DOI 10.1016/j.plantsci.2006.06.015; Wang Chang-Quan, 2006, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V32, P195; Weber LE, 1990, AMARANTH GRAIN PRODU; WYLER H, 1984, HELV CHIM ACTA, V67, P1348, DOI 10.1002/hlca.19840670520; Yamamoto K, 2001, PLANT CELL PHYSIOL, V42, P969, DOI 10.1093/pcp/pce125; Yuan JS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S6; Zhao SZ, 2010, PLANT CELL TISS ORG, V102, P99, DOI 10.1007/s11240-010-9710-z	77	38	38	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99012	10.1371/journal.pone.0099012	http://dx.doi.org/10.1371/journal.pone.0099012			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896616	gold, Green Submitted, Green Published			2022-12-27	WOS:000338430700107
J	Turc, G; Aguettaz, P; Ponchelle-Dequatre, N; Henon, H; Naggara, O; Leclerc, X; Cordonnier, C; Leys, D; Mas, JL; Oppenheim, C				Turc, Guillaume; Aguettaz, Pierre; Ponchelle-Dequatre, Nelly; Henon, Hilde; Naggara, Olivier; Leclerc, Xavier; Cordonnier, Charlotte; Leys, Didier; Mas, Jean-Louis; Oppenheim, Catherine			External Validation of the MRI-DRAGON Score: Early Prediction of Stroke Outcome after Intravenous Thrombolysis	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; IV THROMBOLYSIS; REGRESSION; EVENTS; IMPACT	Background and Purpose: The aim of our study was to validate in an independent cohort the MRI-DRAGON score, an adaptation of the (CT-) DRAGON score to predict 3-month outcome in acute ischemic stroke patients undergoing MRI before intravenous thrombolysis (IV-tPA). Methods: We reviewed consecutive (2009-2013) anterior circulation stroke patients treated within 4.5 hours by IV-tPA in the Lille stroke unit (France), where MRI is the first-line pretherapeutic work-up. We assessed the discrimination and calibration of the MRI-DRAGON score to predict poor 3-month outcome, defined as modified Rankin Score >2, using c-statistic and the Hosmer-Lemeshow test, respectively. Results: We included 230 patients (mean +/- SD age 70.4 +/- 16.0 years, median [IQR] baseline NIHSS 8 [5-14]; poor outcome in 78(34%) patients). The c-statistic was 0.81 (95%CI 0.75-0.87), and the Hosmer-Lemeshow test was not significant (p = 0.54). Conclusions: The MRI-DRAGON score showed good prognostic performance in the external validation cohort. It could therefore be used to inform the patient's relatives about long-term prognosis and help to identify poor responders to IV-tPA alone, who may be candidates for additional therapeutic strategies, if they are otherwise eligible for such procedures based on the institutional criteria.	[Turc, Guillaume; Mas, Jean-Louis] Hop St Anne, Dept Neurol, F-75674 Paris, France; [Turc, Guillaume; Naggara, Olivier; Mas, Jean-Louis; Oppenheim, Catherine] Univ Paris 05, Sorbonne Paris Cite, INSERM UMR S894, Paris, France; [Naggara, Olivier; Oppenheim, Catherine] Hop St Anne, Dept Radiol, F-75674 Paris, France; [Ponchelle-Dequatre, Nelly; Henon, Hilde; Cordonnier, Charlotte; Leys, Didier] Lille Univ Hosp, Dept Neurol, Lille, France; [Aguettaz, Pierre; Ponchelle-Dequatre, Nelly; Henon, Hilde; Leclerc, Xavier; Cordonnier, Charlotte; Leys, Didier] Univ Lille Nord France, UDSL, EA 1046, Lille, France; [Aguettaz, Pierre; Leclerc, Xavier] Lille Univ Hosp, Dept Radiol, Lille, France	GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille	Turc, G (corresponding author), Hop St Anne, Dept Neurol, F-75674 Paris, France.	g.turc@ch-sainte-anne.fr	Cordonnier, Charlotte/O-3258-2017; LEYS, Didier/G-2955-2016; Oppenheim, Catherine/N-1635-2018; Naggara, Olivier/R-3939-2017	Cordonnier, Charlotte/0000-0002-5697-6892; LEYS, Didier/0000-0003-4408-4392; Turc, Guillaume/0000-0001-5059-4095; Oppenheim, Catherine/0000-0003-3410-0862; Naggara, Olivier/0000-0002-9544-379X				Aries MJH, 2009, J NEUROL SCI, V285, P114, DOI 10.1016/j.jns.2009.06.010; Barber PA, 2005, J NEUROL NEUROSUR PS, V76, P1528, DOI 10.1136/jnnp.2004.059261; de Margerie-Mellon C, 2013, STROKE, V44, P3565, DOI 10.1161/STROKEAHA.113.003047; Giralt-Steinhauer E, 2013, CEREBROVASC DIS, V36, P110, DOI 10.1159/000352061; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247; Nezu T, 2010, NEUROLOGY, V75, P555, DOI 10.1212/WNL.0b013e3181eccf78; Ovesen C, 2013, J CLIN NEUROSCI, V20, P1635, DOI 10.1016/j.jocn.2013.04.023; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Rha JH, 2007, STROKE, V38, P967, DOI 10.1161/01.STR.0000258112.14918.24; Strbian D, 2012, NEUROLOGY, V78, P427, DOI 10.1212/WNL.0b013e318245d2a9; Strbian D, 2013, STROKE, V44, P2718, DOI 10.1161/STROKEAHA.113.002033; Tei H, 2011, J NEUROL, V258, P559, DOI 10.1007/s00415-010-5787-x; Tei H, 2010, J NEUROL, V257, P767, DOI 10.1007/s00415-009-5406-x; Turc G, 2013, STROKE, V44, P1323, DOI 10.1161/STROKEAHA.111.000127; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Wahlgren N, 2008, LANCET, V372, P1303, DOI 10.1016/S0140-6736(08)61339-2	16	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99164	10.1371/journal.pone.0099164	http://dx.doi.org/10.1371/journal.pone.0099164			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896827	gold, Green Published, Green Submitted			2022-12-27	WOS:000338430700122
J	Vallur, R; Kalbacher, H; Feil, R				Vallur, Raghavan; Kalbacher, Hubert; Feil, Robert			Catalytic Activity of cGMP-Dependent Protein Kinase Type I in Intact Cells Is Independent of N-Terminal Autophosphorylation	PLOS ONE			English	Article							BINDING-SITES; SMOOTH-MUSCLE; BOVINE LUNG; CYCLIC-GMP; ACTIVATION; PHOSPHORYLATION; ACID; MICE; IDENTIFICATION; SEQUENCE	Although cGMP-dependent protein kinase type I (cGKI) is an important mediator of cGMP signaling and upcoming drug target, its in vivo-biochemistry is not well understood. Many studies showed that purified cGKI autophosphorylates multiple sites at its N-terminus. Autophosphorylation might be involved in kinase activation, but it is unclear whether this happens also in intact cells. To study cGKI autophosphorylation in vitro and in vivo, we have generated phospho-specific antisera against major in vitro-autophosphorylation sites of the cGKI isoforms, cGKI alpha and cGKI beta. These antisera detected specifically and with high sensitivity phospho-cGKI alpha (Thr58), phospho-cGKI alpha (Thr84), or phospho-cGKI beta (Thr56/Ser63/Ser79). Using these antisera, we show that ATP-induced autophosphorylation of cGKI in purified preparations and cell extracts did neither require nor induce an enzyme conformation capable of substrate heterophosphorylation; it was even inhibited by pre-incubation with cGMP. Interestingly, phospho-cGKI species were not detectable in intact murine cells and tissues, both under basal conditions and after induction of cGKI catalytic activity. We conclude that N-terminal phosphorylation, although readily induced in vitro, is not required for the catalytic activity of cGKI alpha and cGKI beta in vivo. These results will also inform screening strategies to identify novel cGKI modulators.	[Vallur, Raghavan; Kalbacher, Hubert; Feil, Robert] Univ Tubingen, Interfak Inst Biochem, Tubingen, Germany; [Vallur, Raghavan] German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany; [Vallur, Raghavan] Univ Tubingen, Grad Sch Cellular & Mol Neurosci, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen	Feil, R (corresponding author), Univ Tubingen, Interfak Inst Biochem, Tubingen, Germany.	robert.feil@uni-tuebingen.de	Feil, Robert/B-8918-2014	Feil, Robert/0000-0002-7335-4841	Deutsche Forschungsgemeinschaft; Tubingen University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tubingen University	We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tubingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN A, 1984, BIOCHIM BIOPHYS ACTA, V790, P219, DOI 10.1016/0167-4838(84)90025-6; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; DEJONGE HR, 1977, J BIOL CHEM, V252, P2780; Feil R, 2003, CIRC RES, V93, P907, DOI 10.1161/01.RES.0000100390.68771.CC; FEIL R, 1995, BIOCHEMISTRY-US, V34, P13152, DOI 10.1021/bi00040a029; Feil S, 2005, NEUROSCIENCE, V135, P863, DOI 10.1016/j.neuroscience.2005.06.051; FRANCIS SH, 1994, ANNU REV PHYSIOL, V56, P237, DOI 10.1146/annurev.ph.56.030194.001321; Francis SH, 1996, J BIOL CHEM, V271, P20748, DOI 10.1074/jbc.271.34.20748; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; Hofmann F, 2006, PHYSIOL REV, V86, P1, DOI 10.1152/physrev.00015.2005; HOFMANN F, 1983, FEBS LETT, V164, P350, DOI 10.1016/0014-5793(83)80315-9; Hou YL, 2003, J BIOL CHEM, V278, P16706, DOI 10.1074/jbc.M300045200; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Kemp-Harper B, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.19pe12; Kuhbandner S, 2000, GENESIS, V28, P15, DOI 10.1002/1526-968X(200009)28:1<15::AID-GENE20>3.0.CO;2-C; LINCOLN TM, 1978, J BIOL CHEM, V253, P6002; Lohmann SM, 2005, FRONT BIOSCI, V10, P1313, DOI 10.2741/1621; MONKEN CE, 1980, J BIOL CHEM, V255, P7067; Muller PM, 2012, FREE RADICAL BIO MED, V53, P1574, DOI 10.1016/j.freeradbiomed.2012.08.011; Mullershausen F, 2003, J CELL BIOL, V160, P719, DOI 10.1083/jcb.200211041; Pfeifer A, 1999, Rev Physiol Biochem Pharmacol, V135, P105, DOI 10.1007/BFb0033671; Pinkse MWH, 2004, J AM SOC MASS SPECTR, V15, P1392, DOI 10.1016/j.jasms.2004.06.015; Pinkse MWH, 2004, ANAL CHEM, V76, P3935, DOI 10.1021/ac0498617; Rasband W., 2006, IMAGEJ; Ruth P, 1997, J BIOL CHEM, V272, P10522; Samara P, 2013, J IMMUNOL METHODS, V395, P54, DOI 10.1016/j.jim.2013.06.011; Sellak H, 2013, CARDIOVASC RES, V97, P200, DOI 10.1093/cvr/cvs327; Smith JA, 1996, J BIOL CHEM, V271, P20756, DOI 10.1074/jbc.271.34.20756; Smith JK, 2000, J BIOL CHEM, V275, P154, DOI 10.1074/jbc.275.1.154; TAKIO K, 1983, J BIOL CHEM, V258, P5531; Thunemann M, 2013, CIRC RES, V113, P365, DOI 10.1161/CIRCRESAHA.113.301063; Valtcheva N, 2009, J BIOL CHEM, V284, P556, DOI 10.1074/jbc.M806161200; Waraich RS, 2008, BIOCHEM BIOPH RES CO, V376, P26, DOI 10.1016/j.bbrc.2008.08.053; Weber S, 2007, CIRC RES, V101, P1096, DOI 10.1161/CIRCRESAHA.107.154351; Wegener JW, 2002, CIRC RES, V90, P18, DOI 10.1161/hh0102.103222; Xue Y, 2005, NUCLEIC ACIDS RES, V33, pW184, DOI 10.1093/nar/gki393; Zaidi N, 2007, FEBS J, V274, P3138, DOI 10.1111/j.1742-4658.2007.05846.x	37	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98946	10.1371/journal.pone.0098946	http://dx.doi.org/10.1371/journal.pone.0098946			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897423	Green Published, Green Submitted, gold			2022-12-27	WOS:000338430700097
J	Vogel, I; van de Looij-Jansen, PM; Mieloo, CL; Burdorf, A; de Waart, F				Vogel, Ineke; van de Looij-Jansen, Petra M.; Mieloo, Cathelijne L.; Burdorf, Alex; de Waart, Frouwkje			Risky Music Listening, Permanent Tinnitus and Depression, Anxiety, Thoughts about Suicide and Adverse General Health	PLOS ONE			English	Article							INDUCED HEARING-LOSS; NOISE EXPOSURE; MENTAL-HEALTH; MP3 PLAYERS; ADOLESCENTS; CHILDREN; CONSERVATION; DISCOTHEQUES; PREVENTION; PEOPLE	Objective: To estimate the extent to which exposure to music through earphones or headphones with MP3 players or at discotheques and pop/rock concerts exceeded current occupational safety standards for noise exposure, to examine the extent to which temporary and permanent hearing-related symptoms were reported, and to examine whether the experience of permanent symptoms was associated with adverse perceived general and mental health, symptoms of depression, and thoughts about suicide. Methods: A total of 943 students in Dutch inner-city senior-secondary vocational schools completed questionnaires about their sociodemographics, music listening behaviors and health. Multiple logistic regression analyses were used to examine associations. Results: About 60% exceeded safety standards for occupational noise exposure; about one third as a result of listening to MP3 players. About 10% of the participants experienced permanent hearing-related symptoms. Temporary hearing symptoms that occurred after using an MP3 player or going to a discotheque or pop/rock concert were associated with exposure to high-volume music. However, compared to participants not experiencing permanent hearing-related symptoms, those experiencing permanent symptoms were less often exposed to high volume music. Furthermore, they reported at least two times more often symptoms of depression, thoughts about suicide and adverse self-assessed general and mental health. Conclusions: Risky music-listening behaviors continue up to at least the age of 25 years. Permanent hearing-related symptoms are associated with people's health and wellbeing. Participants experiencing such symptoms appeared to have changed their behavior to be less risky. In order to induce behavior change before permanent and irreversible hearing-related symptoms occur, preventive measurements concerning hearing health are needed.	[Vogel, Ineke; Burdorf, Alex] Erasmus MC Univ Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Vogel, Ineke; van de Looij-Jansen, Petra M.; Mieloo, Cathelijne L.; de Waart, Frouwkje] Municipal Publ Hlth Serv Rotterdam Area, Dept Youth Policy, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Vogel, I (corresponding author), Erasmus MC Univ Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands.	i.vogel@erasmusmc.nl	Burdorf, Alex/A-2226-2008	Burdorf, Alex/0000-0003-3129-2862				American Academy of Audiology, 2003, POS STAT PREV NOIS I; BERWICK DM, 1991, MED CARE, V29, P169, DOI 10.1097/00005650-199102000-00008; Blasing L, 2010, INT J AUDIOL, V49, P518, DOI 10.3109/14992021003724996; Boorsma M, 2012, AM J GERIAT PSYCHIAT, V20, P932, DOI 10.1097/JGP.0b013e31825d08ac; BROOKHOUSER PE, 1994, PREV MED, V23, P665, DOI 10.1006/pmed.1994.1111; Chung JH, 2005, PEDIATRICS, V115, P861, DOI 10.1542/peds.2004-0173; Dreschler WA, 2007, 20071 NHS; European Parliament and Council, 2003, OFFICIAL J EUROP UNI; Fausti SA, 2005, J REHABIL RES DEV, V42, P45, DOI 10.1682/JRRD.2005.02.0039; Gopinath B, 2009, J AM GERIATR SOC, V57, P1306, DOI 10.1111/j.1532-5415.2009.02317.x; Hogan A, 2009, J AGING HEALTH, V21, P1098, DOI 10.1177/0898264309347821; Holmes S, 2009, J CLIN NURS, V18, P2927, DOI 10.1111/j.1365-2702.2009.02909.x; Huang CQ, 2010, AGEING RES REV, V9, P131, DOI 10.1016/j.arr.2009.05.005; ISO, 1990, 19991990 ISO; Kelly MJ, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-10; Li CM, 2014, JAMA OTOLARYNGOL, V140, P293, DOI 10.1001/jamaoto.2014.42; MeyerBisch C, 1996, AUDIOLOGY, V35, P121; Niskar AS, 2001, PEDIATRICS, V108, P40, DOI 10.1542/peds.108.1.40; Portnuff CDF, 2006, SOUND OUTPUT LEVELS; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rasic D, 2013, DRUG ALCOHOL DEPEN, V129, P49, DOI 10.1016/j.drugalcdep.2012.09.009; Rawool V, 2011, NOISE HEALTH, V13, P356, DOI 10.4103/1463-1741.85508; Rothman K., 1998, MODERN EPIDEMIOLOGY; Rumpf HJ, 2001, PSYCHIAT RES, V105, P243, DOI 10.1016/S0165-1781(01)00329-8; Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR), 2008, POT HLTH RISKS EXP N; Seniors Research Group, 1999, CONSEQUENCES UNTREAT; Serra MR, 2005, INT J AUDIOL, V44, P65, DOI 10.1080/14992020400030010; Shetye A, 2010, ARCH DIS CHILD, V95, P645, DOI 10.1136/adc.2009.168252; *STAT NETH, 2007, STATLINE; Strasser H, 1999, NOISE CONTROL ENG, V47, P187, DOI 10.3397/1.599303; Theunissen SCPM, 2014, JAMA PEDIATR, V168, P170, DOI 10.1001/jamapediatrics.2013.3974; VERNON JA, 1987, AM J OTOL, V8, P201; Vogel I, 2008, J PEDIATR-US, V152, P400, DOI 10.1016/j.jpeds.2007.07.009; Vogel I, 2012, PEDIATRICS, V129, P1097, DOI 10.1542/peds.2011-1948; Vogel I, 2011, HEALTH EDUC RES, V26, P254, DOI 10.1093/her/cyq091; Vogel I, 2010, HEALTH EDUC RES, V25, P737, DOI 10.1093/her/cyq018; Vogel I, 2010, AM J PUBLIC HEALTH, V100, P1095, DOI 10.2105/AJPH.2009.168690; Vogel I, 2009, INT J AUDIOL, V48, P531, DOI 10.1080/14992020902845907; Vogel I, 2009, PEDIATRICS, V123, pE953, DOI 10.1542/peds.2008-3179; Ward WD, 1986, NOISE HEARING CONSER, P197; WHO, 2001, WORLD HLTH REPORT 20; World Health Organization WHO, 1997, PREV NOIS IND HEAR L; World Medical Association, 2008, DECL HELS ETH PRINC	43	25	25	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98912	10.1371/journal.pone.0098912	http://dx.doi.org/10.1371/journal.pone.0098912			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK4YO	24897078	Green Published, Green Submitted, gold			2022-12-27	WOS:000338430700095
J	Walther-Antonio, MRS; Jeraldo, P; Miller, MEB; Yeoman, CJ; Nelson, KE; Wilson, BA; White, BA; Chia, N; Creedon, DJ				Walther-Antonio, Marina R. S.; Jeraldo, Patricio; Miller, Margret E. Berg; Yeoman, Carl J.; Nelson, Karen E.; Wilson, Brenda A.; White, Bryan A.; Chia, Nicholas; Creedon, Douglas J.			Pregnancy's Stronghold on the Vaginal Microbiome	PLOS ONE			English	Article							BACTERIAL VAGINOSIS; PRETERM DELIVERY; WOMEN; BIRTH; IDENTIFICATION; COMMUNITIES; INFECTION; RISK	Objective: To assess the vaginal microbiome throughout full-term uncomplicated pregnancy. Methods: Vaginal swabs were obtained from twelve pregnant women at 8-week intervals throughout their uncomplicated pregnancies. Patients with symptoms of vaginal infection or with recent antibiotic use were excluded. Swabs were obtained from the posterior fornix and cervix at 8-12, 17-21, 27-31, and 36-38 weeks of gestation. The microbial community was profiled using hypervariable tag sequencing of the V3-V5 region of the 16S rRNA gene, producing approximately 8 million reads on the Illumina MiSeq. Results: Samples were dominated by a single genus, Lactobacillus, and exhibited low species diversity. For a majority of the patients (n = 8), the vaginal microbiome was dominated by Lactobacillus crispatus throughout pregnancy. Two patients showed Lactobacillus iners dominance during the course of pregnancy, and two showed a shift between the first and second trimester from L. crispatus to L. iners dominance. In all of the samples only these two species were identified, and were found at an abundance of higher than 1% in this study. Comparative analyses also showed that the vaginal microbiome during pregnancy is characterized by a marked dominance of Lactobacillus species in both Caucasian and African-American subjects. In addition, our Caucasian subject population clustered by trimester and progressed towards a common attractor while African-American women clustered by subject instead and did not progress towards a common attractor. Conclusion: Our analyses indicate normal pregnancy is characterized by a microbiome that has low diversity and high stability. While Lactobacillus species strongly dominate the vaginal environment during pregnancy across the two studied ethnicities, observed differences between the longitudinal dynamics of the analyzed populations may contribute to divergent risk for pregnancy complications. This helps establish a baseline for investigating the role of the microbiome in complications of pregnancy such as preterm labor and preterm delivery.	[Walther-Antonio, Marina R. S.; Jeraldo, Patricio; Chia, Nicholas] Mayo Clin, Dept Surg Res, Rochester, MN USA; [Jeraldo, Patricio; Miller, Margret E. Berg; Wilson, Brenda A.; White, Bryan A.; Chia, Nicholas] Univ Illinois, Inst Genom Biol, Urbana, IL USA; [Yeoman, Carl J.] Montana State Univ, Dept Anim & Range Sci, Bozeman, MT 59717 USA; [Nelson, Karen E.] J Craig Venter Inst, Genom Med Grp, Rockville, MD USA; [Wilson, Brenda A.] Univ Illinois, Dept Microbiol, Urbana, IL USA; [White, Bryan A.] Univ Illinois, Urbana, IL USA; [Chia, Nicholas] Mayo Coll, Dept Physiol & Biomed Engn, Rochester, MN USA; [Creedon, Douglas J.] Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic; University of Illinois System; University of Illinois Urbana-Champaign; Montana State University System; Montana State University Bozeman; J. Craig Venter Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Mayo Clinic; Mayo Clinic	Creedon, DJ (corresponding author), Mayo Clin, Rochester, MN 55905 USA.	creedon.douglas@mayo.edu	Yeoman, Carl/ABA-1906-2021; Jeraldo, Patricio/H-8178-2019	Yeoman, Carl/0000-0002-8775-7879; Jeraldo, Patricio/0000-0003-0282-4217; Chia, Nicholas/0000-0001-9652-691X; Walther-Antonio, Marina/0000-0002-5531-3712; Berg, Margret/0000-0002-0411-1619	National Institutes of Health (NIH) [R56 AI085096-01]; Center for Individualized Medicine; Mayo-Illinois Strategic Alliance for Technology-Based Healthcare; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI085096] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Individualized Medicine; Mayo-Illinois Strategic Alliance for Technology-Based Healthcare; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institutes of Health (NIH) grant R56 AI085096-01, the Center for Individualized Medicine, and the Mayo-Illinois Strategic Alliance for Technology-Based Healthcare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036466; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Donders GG, 2009, BJOG-INT J OBSTET GY, V116, P1315, DOI 10.1111/j.1471-0528.2009.02237.x; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hauth JC, 1995, NEW ENGL J MED, V333, P1732, DOI 10.1056/NEJM199512283332603; Hay PE, 1997, INT J STD AIDS, V8, P603, DOI 10.1258/0956462971918850; HAY PE, 1994, BRIT MED J, V308, P295, DOI 10.1136/bmj.308.6924.295; Huppertz B, 2003, PLACENTA, V24, P181, DOI 10.1053/plac.2002.0903; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jakobsson T, 2007, J CLIN MICROBIOL, V45, P3145, DOI 10.1128/JCM.00558-07; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Leitich H, 2003, AM J OBSTET GYNECOL, V189, P139, DOI 10.1067/mob.2003.339; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; MCDONALD HM, 1991, BRIT J OBSTET GYNAEC, V98, P427, DOI 10.1111/j.1471-0528.1991.tb10335.x; McGregor JA, 2000, OBSTET GYNECOL SURV, V55, pS1; Oakeshott P, 2002, BRIT MED J, V325, P1334, DOI 10.1136/bmj.325.7376.1334; Oakley BB, 2008, APPL ENVIRON MICROB, V74, P4898, DOI 10.1128/AEM.02884-07; PLATZCHRISTENSEN JJ, 1993, ACTA OBSTET GYN SCAN, V72, P99, DOI 10.3109/00016349309023420; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Relman DA, 2012, NUTR REV, V70, pS2, DOI 10.1111/j.1753-4887.2012.00489.x; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-4; Saito S, 2007, MOL ASPECTS MED, V28, P192, DOI 10.1016/j.mam.2007.02.006; Sipos M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015220; Ward DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039315; White BA, 2011, TRENDS ENDOCRIN MET, V22, P389, DOI 10.1016/j.tem.2011.06.001; Wilks M, 2004, J CLIN MICROBIOL, V42, P713, DOI 10.1128/JCM.42.2.713-717.2004; Ye YZ, 2010, IEEE INT C BIOINFORM, P153, DOI 10.1109/BIBM.2010.5706555; Yeoman CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056111; Zhou X, 2004, MICROBIOL-SGM, V150, P2565, DOI 10.1099/mic.0.26905-0; Zhou Xiaoping, 2007, U S Forest Service Pacific Northwest Research Station General Technical Report PNW-GTR, P1	35	111	121	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98514	10.1371/journal.pone.0098514	http://dx.doi.org/10.1371/journal.pone.0098514			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896831	Green Published, gold, Green Submitted			2022-12-27	WOS:000338430700045
J	Aoki, Y; Yoshida, K; Nishizawa, D; Kasai, S; Ichinohe, T; Ikeda, K; Fukuda, K				Aoki, Yoshinori; Yoshida, Kaori; Nishizawa, Daisuke; Kasai, Shinya; Ichinohe, Tatsuya; Ikeda, Kazutaka; Fukuda, Ken-ichi			Factors that Affect Intravenous Patient-Controlled Analgesia for Postoperative Pain Following Orthognathic Surgery for Mandibular Prognathism	PLOS ONE			English	Article							ASSOCIATION; GENE	The predictors of postoperative pain and analgesic consumption were previously found to include preoperative pain, anxiety, age, type of surgery, and genotype, but remaining unclear was whether intraoperative factors could predict postoperative pain. In the present study, we investigated the time-course of fentanyl consumption using intravenous patient-controlled analgesia records from patients who underwent orthognathic surgery for mandibular prognathism and analyzed the influence of anesthesia methods and surgical methods together with sex on the time course. A significant difference in the time course of fentanyl administration was found (P<0.001). No significant difference in the time course of fentanyl administration was found between males and females (P = 0.653), with no interaction between time course and sex (P = 0.567). No significant difference in the time course of fentanyl administration was found among anesthesia methods, such as fentanyl induction followed by fentanyl maintenance, fentanyl induction followed by remifentanil maintenance, and remifentanil induction followed by remifentanil maintenance (P = 0.512), but an interaction between time course and anesthesia method was observed (P = 0.004). A significant difference in the time course of fentanyl administration was found between surgical methods, such as bilateral mandibular sagittal split ramus osteotomy (BSSRO) and BSSRO combined with Le Fort I osteotomy (bimaxillary; P = 0.008), with no interaction between time course and surgical method (P = 0.535). Total postoperative 24 h consumption associated with the bimaxillary procedure was significantly higher than with BSSRO (P = 0.008). The present results indicate that administration patterns and total 24 h consumption were different among the three groups of anesthesia methods and between the two groups of surgical methods, respectively. Although more research on patient-controlled analgesia patterns and consumption is necessary, the present study will contribute to adequately relieving individual patients from postoperative pain.	[Aoki, Yoshinori; Yoshida, Kaori; Nishizawa, Daisuke; Kasai, Shinya; Ikeda, Kazutaka] Tokyo Metropolitan Inst Med Sci, Addict Subst Project, Tokyo 113, Japan; [Aoki, Yoshinori; Yoshida, Kaori; Ichinohe, Tatsuya; Fukuda, Ken-ichi] Tokyo Dent Coll, Dept Dent Anesthesiol, Tokyo, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Dental College	Ikeda, K (corresponding author), Tokyo Metropolitan Inst Med Sci, Addict Subst Project, Tokyo 113, Japan.	ikeda-kz@igakuken.or.jp		Ichinohe, Tatsuya/0000-0001-5793-3379	Ministry of Health, Labour and Welfare (MHLW) of Japan [H21-3jigan-ippan-011, H22-Iyaku-015, H25-Iyaku-020]; JSPS KAKENHI [20602020, 20390162, 23390377, 24790544, 24659549, 26293347]; MEXT KAKENHI [25116532]; Smoking Research Foundation; Naito Foundation; Astellas Foundation for Research on Metabolic Disorders; Grants-in-Aid for Scientific Research [25116532] Funding Source: KAKEN	Ministry of Health, Labour and Welfare (MHLW) of Japan(Ministry of Health, Labour and Welfare, Japan); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Smoking Research Foundation; Naito Foundation(Naito Memorial Foundation); Astellas Foundation for Research on Metabolic Disorders; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Health, Labour and Welfare (MHLW) of Japan (H21-3jigan-ippan-011, H22-Iyaku-015, and H25-Iyaku-020), JSPS KAKENHI grant no. 20602020, 20390162, 23390377, 24790544, 24659549, and 26293347, MEXT KAKENHI grant no. 25116532, the Smoking Research Foundation, the Naito Foundation, and the Astellas Foundation for Research on Metabolic Disorders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2013, NEUROSCI LETT, V542, P1, DOI 10.1016/j.neulet.2013.02.039; BELL WH, 1975, J ORAL SURG, V33, P412; Burkle H, 1996, ANESTH ANALG, V83, P646, DOI 10.1097/00000539-199609000-00038; Chegini Soudeh, 2012, Anesth Prog, V59, P69, DOI 10.2344/11-10.1; de Santana-Santos T, 2013, MED ORAL PATOL ORAL, V18, pE65, DOI 10.4317/medoral.18039; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fukuda K, 2009, PAIN, V147, P194, DOI 10.1016/j.pain.2009.09.004; Haerle F, 1997, ATLAS CRANIOMAXILLOF, p[90, 100]; Ip HYV, 2009, ANESTHESIOLOGY, V111, P657, DOI 10.1097/ALN.0b013e3181aae87a; Kehlet H, 2001, BRIT J ANAESTH, V87, P62, DOI 10.1093/bja/87.1.62; Nagatsuka C, 2000, Anesth Prog, V47, P119; Nishizawa D, 2014, MOL PSYCHIATR, V19, P55, DOI 10.1038/mp.2012.164; Nishizawa D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007060; OBWEGESER H, 1965, SSO Schweiz Monatsschr Zahnheilkd, V75, P365; TRAUNER R, 1957, Oral Surg Oral Med Oral Pathol, V10, P677, DOI 10.1016/S0030-4220(57)80063-2; United Nations, 2011, REP INT NARC CONTR B, P59; Warltier DC, 2000, ANESTHESIOLOGY, V92, P253, DOI 10.1097/00000542-200001000-00038; Wassmund M, 1935, LEHRBUCH PRAKTISCHEN, VI, P282; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8	19	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98548	10.1371/journal.pone.0098548	http://dx.doi.org/10.1371/journal.pone.0098548			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893040	gold, Green Published, Green Submitted			2022-12-27	WOS:000336911400063
J	Dash, CH; Gillanders, KR; Bobbitt, MES; Gascoigne, EW; Leach, SJ				Dash, Clive H.; Gillanders, Kate R.; Bobbitt, Margaret E. Stratford; Gascoigne, Ernie W.; Leach, Samantha J.			Safety and Efficacy of Gammaplex (R) in Idiopathic Thrombocytopenic Purpura (ClinicalTrials.gov-NCT00504075)	PLOS ONE			English	Article							INTRAVENOUS GAMMA-GLOBULIN; ADULTS; MANAGEMENT; CHILDREN; IMMUNOGLOBULIN; CHILDHOOD	Background and Objectives: This multicentre, open-label study investigated the safety and efficacy of Gammaplex, a 5% Intravenous Immunoglobulin (IVIg), in patients with idiopathic (immune) thrombocytopenic purpura (ITP). Materials and Methods: Patients were between the ages of 6 and 70 years; had ITP for at least six months and had a platelet count <= 20x10(9)/L. Eligible patients were dosed with 1 g/kg of Gammaplex on two consecutive days, followed by assessment of safety and efficacy on Days 3, 5, 9, 14, 21, 32 and 90. Response was defined as the increase in platelet count to a threshold of >= 50x10(9)/L on or before Day 9 after the first dose of Gammaplex. Results: All 35 patients received at least one infusion of Gammaplex. Twenty-nine (83%) patients responded to Gammaplex, similar to the historical control, with a 95% lower one-sided confidence interval of 68.9%. Median duration of response was 10.0 days, with an overall reduction in bleeding episodes. Gammaplex provided supranormal concentrations of total IgG; mean peak concentration (Cmax) of 45.3 g/L (4.53 g/dL), with a mean half-life of 28.5 days. Fifteen patients reported 63 Adverse Drug Reactions (ADRs); the most common were headache (10 patients), vomiting (6 patients) and pyrexia (5 patients). Five of these ADRs were considered serious, one patient had three concurrent Serious Adverse Events (SAEs); these were vomiting, dehydration and headache. Two other patients each had one SAE (headache). There were no unexpected Adverse Events (AEs) or thromboembolic episodes and no significant changes in vital signs, biochemical, haematological and virology results. Conclusion: Gammaplex achieved a very high concentration of serum IgG but was well-tolerated and effective in the treatment of ITP with a similar degree of efficacy to the pre-determined historical control group and the pre-set statistical criteria.	[Dash, Clive H.; Gillanders, Kate R.; Bobbitt, Margaret E. Stratford; Gascoigne, Ernie W.; Leach, Samantha J.] Bio Prod Lab Ltd Ltd, Dept Med, Elstree, Herts, England		Gascoigne, EW (corresponding author), Bio Prod Lab Ltd Ltd, Dept Med, Elstree, Herts, England.	ernie.gascoigne@bpl.co.uk			BPL	BPL	The clinical trial was funded by BPL. BPL was involved in the study design, data collection and analysis, decision to publish and the preparation of the manuscript. At the time the authors K. R. Gillanders and E.W. Gascoigne were employees of BPL. C. H. Dash, S.J. Leach and M. E. Stratford Bobbitt were contracted by BPL. All the authors were involved in the design and management of the trial and preparation of this manuscript.	Buchanan GR, 1997, BLOOD, V89, P1464, DOI 10.1182/blood.V89.4.1464; Bussel JB, 2004, THROMB HAEMOSTASIS, V91, P771, DOI 10.1160/TH03-10-0650; BUSSEL JB, 1987, VOX SANG, V52, P206, DOI 10.1111/j.1423-0410.1987.tb03029.x; BUSSEL JB, 1983, BLOOD, V62, P480; BUSSEL JB, 1983, J PEDIATR-US, V103, P651, DOI 10.1016/S0022-3476(83)80608-8; CARROLL RR, 1984, AM J MED, V76, P181, DOI 10.1016/0002-9343(84)90339-5; Cines DB, 2002, NEW ENGL J MED, V346, P995, DOI 10.1056/NEJMra010501; European Medicines Agency, 2010, COMM MED PROD HUM US; George JN, 1996, BLOOD, V88, P3, DOI 10.1182/blood.V88.1.3.3; IMBACH P, 1981, LANCET, V1, P1228; KURLANDER R, 1987, AM J MED, V83, P17, DOI 10.1016/0002-9343(87)90546-8; MANKARIOUS S, 1988, J LAB CLIN MED, V112, P634; Medicines and Healthcare products Regulatory Agency, 2009, SAF GUARD PUBL HLTH; ORAL A, 1984, AM J MED, V76, P187, DOI 10.1016/0002-9343(84)90340-1; Portielje JEA, 2001, BLOOD, V97, P2549, DOI 10.1182/blood.V97.9.2549; Provan D, 2003, BRIT J HAEMATOL, V120, P574; Provan D, 2010, BLOOD, V115, P168, DOI 10.1182/blood-2009-06-225565; Rodeghiero F, 2009, BLOOD, V113, P2386, DOI 10.1182/blood-2008-07-162503; SIMON R, 1982, CANCER TREAT REP, V66, P37; US.Department of Health and Human Services National Institutes of Health and National Cancer Institute, 2007, COMM TERM CRIT ADV E; WARRIER I, 1984, AM J MED, V76, P193, DOI 10.1016/0002-9343(84)90341-3; WOERNER SJ, 1981, PEDIATRICS, V67, P453; Zimmer J, 2004, CLIN LAB HAEMATOL, V26, P137, DOI 10.1111/j.1365-2257.2004.00591.x	23	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e96600	10.1371/journal.pone.0096600	http://dx.doi.org/10.1371/journal.pone.0096600			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892422	Green Published, Green Submitted, gold			2022-12-27	WOS:000336911400006
J	Horsley, A; Macleod, K; Gupta, R; Goddard, N; Bell, N				Horsley, Alex; Macleod, Kenneth; Gupta, Ruchi; Goddard, Nick; Bell, Nicholas			Enhanced Photoacoustic Gas Analyser Response Time and Impact on Accuracy at Fast Ventilation Rates during Multiple Breath Washout	PLOS ONE			English	Article							LUNG CLEARANCE INDEX; RISE-TIME; DISEASE; INDICATOR; CHILDREN; DELAY	Background: The Innocor device contains a highly sensitive photoacoustic gas analyser that has been used to perform multiple breath washout (MBW) measurements using very low concentrations of the tracer gas SF6. Use in smaller subjects has been restricted by the requirement for a gas analyser response time of <100 ms, in order to ensure accurate estimation of lung volumes at rapid ventilation rates. Methods: A series of previously reported and novel enhancements were made to the gas analyser to produce a clinically practical system with a reduced response time. An enhanced lung model system, capable of delivering highly accurate ventilation rates and volumes, was used to assess in vitro accuracy of functional residual capacity (FRC) volume calculation and the effects of flow and gas signal alignment on this. Results: 10-90% rise time was reduced from 154 to 88 ms. In an adult/child lung model, accuracy of volume calculation was -0.9 to 2.9% for all measurements, including those with ventilation rate of 30/min and FRC of 0.5 L; for the un-enhanced system, accuracy deteriorated at higher ventilation rates and smaller FRC. In a separate smaller lung model (ventilation rate 60/min, FRC 250 ml, tidal volume 100 ml), mean accuracy of FRC measurement for the enhanced system was minus 0.95% (range -3.8 to 2.0%). Error sensitivity to flow and gas signal alignment was increased by ventilation rate, smaller FRC and slower analyser response time. Conclusion: The Innocor analyser can be enhanced to reliably generate highly accurate FRC measurements down at volumes as low as those simulating infant lung settings. Signal alignment is a critical factor. With these enhancements, the Innocor analyser exceeds key technical component recommendations for MBW apparatus.	[Horsley, Alex] Univ Manchester, Inst Inflammat & Repair, Manchester, Lancs, England; [Horsley, Alex] Univ S Manchester Hosp, Manchester Adult Cyst Fibrosis Ctr, Manchester M20 8LR, Lancs, England; [Macleod, Kenneth] Great Ormond St Hosp Sick Children, Dept Resp Med, London, England; [Gupta, Ruchi; Goddard, Nick] Univ Manchester, Sch Chem Engn & Analyt Sci, Manchester, Lancs, England; [Bell, Nicholas] Univ Hosp Bristol NHS Fdn Trust, Dept Resp Med, Bristol Royal Infirm, Bristol, Avon, England	University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Manchester; Bristol Royal Infirmary; University of Bristol	Horsley, A (corresponding author), Univ Manchester, Inst Inflammat & Repair, Manchester, Lancs, England.	alexander.horsley@manchester.ac.uk	Gupta, Ruchi/B-5321-2018; MacLeod, Kenneth/GWU-8940-2022; Gupta, Ruchi/Q-7542-2019	Gupta, Ruchi/0000-0001-6456-8007; Gupta, Ruchi/0000-0001-6456-8007; Horsley, Alex/0000-0003-1828-0058	National Institute for Health Research Clinician Scientist award; National Institute for Health Research (NIHR); North West Lung Centre (Manchester, UK); National Institute for Health Research [NIHR-CS-012-013] Funding Source: researchfish	National Institute for Health Research Clinician Scientist award; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); North West Lung Centre (Manchester, UK); National Institute for Health Research(National Institute for Health Research (NIHR))	Dr Horsley is funded by a National Institute for Health Research Clinician Scientist award. This report presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. Part of this work was supported by an additional grant from the North West Lung Centre (Manchester, UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin R, 2011, EUR RESPIR J, V37, P806, DOI 10.1183/09031936.00072510; Arieli R, 2010, RESP PHYSIOL NEUROBI, V170, P183, DOI 10.1016/j.resp.2009.12.013; Aurora P, 2005, AM J RESP CRIT CARE, V171, P249, DOI 10.1164/rccm.200407-895OC; BECKLAKE MR, 1952, THORAX, V7, P111, DOI 10.1136/thx.7.1.111; Beydon N, 2007, AM J RESP CRIT CARE, V175, P1304, DOI 10.1164/rccm.200605-642ST; BRUNNER JX, 1985, J APPL PHYSIOL, V59, P1008, DOI 10.1152/jappl.1985.59.3.1008; BRUNNER JX, 1988, BRIT J ANAESTH, V61, P628, DOI 10.1093/bja/61.5.628; Cunningham S, 2012, THORAX, V67, P849, DOI 10.1136/thoraxjnl-2012-202465; Farmery AD, 2000, J APPL PHYSIOL, V89, P581, DOI 10.1152/jappl.2000.89.2.581; Frey U, 2000, EUR RESPIR J, V16, P731, DOI 10.1034/j.1399-3003.2000.16d28.x; Fuchs SI, 2006, PEDIATR PULM, V41, P1218, DOI 10.1002/ppul.20524; Gonem S, 2014, RESPIRATION; Gustafsson PM, 2003, EUR RESPIR J, V22, P972, DOI 10.1183/09031936.03.00049502; Hoo AF, 2012, THORAX, V67, P874, DOI 10.1136/thoraxjnl-2012-201747; Horsley AR, 2008, THORAX, V63, P135, DOI 10.1136/thx.2007.082628; Jensen R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056868; Kent L, 2013, J CYST FIBROS; Latzin P, 2008, THORAX, V63, P98, DOI 10.1136/thx.2007.085332; MACLEOD K, 2008, EUR RESP J S52, V32, pS691; Macleod KA, 2008, THORAX; Pittman JE, 2012, PEDIATR PULM, V47, P1242, DOI 10.1002/ppul.22531; Robinson P, 2013, EUROPEAN RESP J; Rowan SA, 2014, AM J RESP CRIT CARE, V189, P586, DOI 10.1164/rccm.201310-1747OC; SCHENA J, 1984, CRIT CARE MED, V12, P672, DOI 10.1097/00003246-198408000-00015; Schmidt A, 2014, PEDIAT PULMONOL; Singer F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036083; Tang YQ, 2005, PHYSIOL MEAS, V26, P1103, DOI 10.1088/0967-3334/26/6/019; Thompson EB, 2013, AM J RESP CRIT CARE, V187	28	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98487	10.1371/journal.pone.0098487	http://dx.doi.org/10.1371/journal.pone.0098487			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892522	Green Submitted, Green Published, gold			2022-12-27	WOS:000336911400057
J	Leu, HB; Chung, CM; Lin, SJ; Lu, TM; Yang, HC; Ho, HY; Ting, CT; Lin, TH; Sheu, SH; Tsai, WC; Chen, JH; Yin, WH; Chiu, TY; Chen, CL; Pan, WH; Chen, JW				Leu, Hsin-Bang; Chung, Chia-Min; Lin, Shing-Jong; Lu, Tse-Min; Yang, Hsin-Chou; Ho, Hung-Yun; Ting, Chih-Tai; Lin, Tsung-Hsien; Sheu, Sheng-Hsiung; Tsai, Wei-Chuan; Chen, Jyh-Hong; Yin, Wei-Hsian; Chiu, Ting-Yu; Chen, Chin-luan; Pan, Wen-Harn; Chen, Jaw-Wen			A Novel SNP Associated with Nighttime Pulse Pressure in Young-Onset Hypertension Patients Could Be a Genetic Prognostic Factor for Cardiovascular Events in a General Cohort in Taiwan	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; AMBULATORY BLOOD-PRESSURE; ISCHEMIC-STROKE; HEART-DISEASE; RISK-FACTORS; POPULATION; LINKAGE; HERITABILITY; PREDICTOR; NUTRITION	Background: Pulse pressure (PP) is a risk factor for cardiovascular disease. It has been reported that ambulatory blood pressure (BP) and nighttime BP parameters are heritable traits. However, the genetic association of pulse pressure and its clinical impact remain undetermined. Method and Results: We conducted a genome-wide association study of PP using ambulatory BP monitoring in young-onset hypertensive patients and found a significant association between nighttime PP and SNP rs897876 (p = 0.009) at chromosome 2p14, which contains the predicted gene FLJ16124. Young-onset hypertension patients carrying TT genotypes at rs897876 had higher nighttime PP than those with CT and CC genotypes (TT, 41.6+/-7.3 mm Hg; CT, 39.1+/-6.0 mm Hg; CC, 38.9+/-6.3 mm Hg; p<0.05,). The T risk allele resulted in a cumulative increase in nighttime PP (beta = 1.036 mm Hg, se. = 0.298, p<0.001 per T allele). An independent community-based cohort containing 3325 Taiwanese individuals (mean age, 50.2 years) was studied to investigate the genetic impact of rs897876 polymorphisms in determining future cardiovascular events. After an average 7.79+/-0.28 years of follow-up, the TT genotype of rs897876 was independently associated with an increased risk (in a recessive model) of coronary artery disease (HR, 2.20; 95% CI, 1.20-4.03; p = 0.01) and total cardiovascular events (HR, 1.99; 95% CI, 1.29-3.06; p = 0.002), suggesting that the TT genotype of rs897876C, which is associated with nighttime pulse pressure in young-onset hypertension patients, could be a genetic prognostic factor of cardiovascular events in the general cohort. Conclusion: The TT genotype of rs897876C at 2p14 identified in young-onset hypertensive had higher nighttime PP and could be a genetic prognostic factor of cardiovascular events in the general cohort in Taiwan.	[Leu, Hsin-Bang; Lin, Shing-Jong; Lu, Tse-Min; Chen, Jaw-Wen] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Leu, Hsin-Bang; Lin, Shing-Jong; Lu, Tse-Min; Chen, Jaw-Wen] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Leu, Hsin-Bang] Taipei Vet Gen Hosp, Heath Care & Management Ctr, Taipei, Taiwan; [Leu, Hsin-Bang; Lin, Shing-Jong; Lu, Tse-Min; Chen, Jaw-Wen] Taipei Vet Gen Hosp, Div Cardiol, Dept Med, Taipei, Taiwan; [Chen, Jaw-Wen] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan; [Chung, Chia-Min; Pan, Wen-Harn] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Yang, Hsin-Chou] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Ho, Hung-Yun; Ting, Chih-Tai] Taichung Vet Gen Hosp, Taichung, Taiwan; [Lin, Tsung-Hsien; Sheu, Sheng-Hsiung] Kaohsiung Med Univ, Chung Ho Mem Hosp, Kaohsiung, Taiwan; [Tsai, Wei-Chuan; Chen, Jyh-Hong] Natl Cheng Kung Univ Hosp, Tainan 70428, Taiwan; [Yin, Wei-Hsian] Cheng Hsin Rehabil Med Ctr, Taipei, Taiwan; [Chiu, Ting-Yu; Chen, Chin-luan] Min Sheng Gen Hosp, Taoyuan, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Taichung Veterans General Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Cheng Kung University; National Cheng Kung University Hospital	Pan, WH (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	pan@ibms.sinica.edu.tw; jwchen@vghtpe.gov.tw	Yang, Hsin-Chou/AAP-2547-2021; Pan, Wen-Harn/F-9972-2010	Yang, Hsin-Chou/0000-0001-6853-7881; Pan, Wen-Harn/0000-0001-9136-0658; Lin, Tsung-Hsien/0000-0002-7226-8730	Taipei Veterans General Hospital [V98B1-010, V99B1-023, V100B-004]; National Science Council [101-2314-B-075-071, 99-2628-B-010-015-MY3, 99-2314-B-075-042-MY2]	Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by project grants from the Taipei Veterans General Hospital (Grant No. V98B1-010, V99B1-023, V100B-004) and National Science Council (Grant No. 101-2314-B-075-071, 99-2628-B-010-015-MY3, 99-2314-B-075-042-MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bochud M, 2005, HYPERTENSION, V45, P445, DOI 10.1161/01.HYP.0000156538.59873.86; Brautbar A, 2009, CIRC-CARDIOVASC GENE, V2, P279, DOI 10.1161/CIRCGENETICS.108.817338; Chae CU, 1999, JAMA-J AM MED ASSOC, V281, P634, DOI 10.1001/jama.281.7.634; Chen HJ, 2006, STROKE, V37, P1060, DOI 10.1161/01.STR.0000206458.58142.f3; Chen JW, 2004, INT J CARDIOL, V96, P65, DOI 10.1016/j.ijcard.2003.07.010; Chuang SY, 2009, STROKE, V40, P1578, DOI 10.1161/STROKEAHA.108.540492; Domanski M, 2001, HYPERTENSION, V38, P793, DOI 10.1161/hy1001.092966; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Fagard RH, 2004, J HYPERTENS, V22, P1663, DOI 10.1097/00004872-200409000-00005; Fava C, 2005, AM J HYPERTENS, V18, P1402, DOI 10.1016/j.amjhyper.2005.05.011; Franklin SS, 1997, J HYPERTENS, V15, P1143, DOI 10.1097/00004872-199715100-00012; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Huang CC, 2008, J HUM HYPERTENS, V22, P329, DOI 10.1038/sj.jhh.1002330; HUNT SC, 1986, J CHRON DIS, V39, P809, DOI 10.1016/0021-9681(86)90083-4; Jiang WJ, 2012, TWIN RES HUM GENET, V15, P759, DOI 10.1017/thg.2012.58; Kao YT, 2011, J HUM HYPERTENS, V25, P444, DOI 10.1038/jhh.2010.80; Kikuya M, 2005, HYPERTENSION, V45, P240, DOI 10.1161/01.HYP.0000152079.04553.2c; Kobayashi S, 1996, CIRCULATION, V94, P3362, DOI 10.1161/01.CIR.94.12.3362; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Mitchell GF, 1997, CIRCULATION, V96, P4254; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; O'Keefe JH, 2009, MAYO CLIN PROC, V84, P741, DOI 10.1016/S0025-6196(11)60525-9; Palomaki GE, 2010, JAMA-J AM MED ASSOC, V303, P648, DOI 10.1001/jama.2010.118; Pan WH, 2001, J HUM HYPERTENS, V15, P793, DOI 10.1038/sj.jhh.1001268; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rice T, 2006, AM J HYPERTENS, V19, P270, DOI 10.1016/j.amjhyper.2005.09.006; Rice T, 2002, HYPERTENSION, V39, P1037, DOI 10.1161/01.HYP.0000018911.46067.6E; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Ullrich M, 2011, J BIOL CHEM, V286, P9477, DOI 10.1074/jbc.M110.171306; Vaccarino V, 2001, AM J CARDIOL, V88, P980, DOI 10.1016/S0002-9149(01)01974-9; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Wang XL, 2009, J HYPERTENS, V27, P2358, DOI 10.1097/HJH.0b013e328330e84d; Weng LC, 2008, STROKE, V39, P3152, DOI 10.1161/STROKEAHA.108.524934; Wu GY, 2001, CIRC RES, V89, P1130, DOI 10.1161/hh2401.100427; Yang HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005459	38	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e97919	10.1371/journal.pone.0097919	http://dx.doi.org/10.1371/journal.pone.0097919			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892410	gold, Green Submitted, Green Published			2022-12-27	WOS:000336911400026
J	Neuber, C; Uebeler, J; Schulze, T; Sotoud, H; El-Armouche, A; Eschenhagen, T				Neuber, Christiane; Uebeler, June; Schulze, Thomas; Sotoud, Hannieh; El-Armouche, Ali; Eschenhagen, Thomas			Guanabenz Interferes with ER Stress and Exerts Protective Effects in Cardiac Myocytes	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; INITIATION-FACTOR 2-ALPHA; CELL-DEATH; EIF2-ALPHA DEPHOSPHORYLATION; CARDIOVASCULAR-DISEASE; SELECTIVE-INHIBITION; BINDING-SITES; IN-VIVO; TRANSLATION	Endoplasmic reticulum (ER) stress has been implicated in a variety of cardiovascular diseases. During ER stress, disruption of the complex of protein phosphatase 1 regulatory subunit 15A and catalytic subunit of protein phosphatase 1 by the small molecule guanabenz (antihypertensive, alpha(2)-adrenoceptor agonist) and subsequent inhibition of stress-induced dephosphorylation of eukaryotic translation initiation factor 2 alpha (eIF2 alpha) results in prolonged eIF2 alpha phosphorylation, inhibition of protein synthesis and protection from ER stress. In this study we assessed whether guanabenz protects against ER stress in cardiac myocytes and affects the function of 3 dimensional engineered heart tissue (EHT). We utilized neonatal rat cardiac myocytes for the assessment of cell viability and activation of ER stress-signalling pathways and EHT for functional analysis. (i) Tunicamycin induced ER stress as measured by increased mRNA and protein levels of glucose-regulated protein 78 kDa, P-eIF2 alpha, activating transcription factor 4, C/EBP homologous protein, and cell death. (ii) Guanabenz had no measurable effect alone, but antagonized the effects of tunicamycin on ER stress markers. (iii) Tunicamycin and other known inducers of ER stress (hydrogen peroxide, doxorubicin, thapsigargin) induced cardiac myocyte death, and this was antagonized by guanabenz in a concentration-and time-dependent manner. (iv) ER stressors also induced acute or delayed contractile dysfunction in spontaneously beating EHTs and this was, with the notable exception of relaxation deficits under thapsigargin, not significantly affected by guanabenz. The data confirm that guanabenz interferes with ER stress-signalling and has protective effects on cell survival. Data show for the first time that this concept extends to cardiac myocytes. The modest protection in EHTs points to more complex mechanisms of force regulation in intact functional heart muscle.	[Neuber, Christiane; Uebeler, June; Schulze, Thomas; Sotoud, Hannieh; Eschenhagen, Thomas] Univ Med Ctr Hamburg Eppendorf, Dept Expt Pharmacol & Toxicol, Hamburg, Germany; [Neuber, Christiane; Uebeler, June; Schulze, Thomas; Sotoud, Hannieh; Eschenhagen, Thomas] DZHK German Ctr Cardiovasc Res, Hamburg, Germany; [El-Armouche, Ali] Univ Med Ctr Goettingen, Dept Pharmacol, Gottingen, Germany; [El-Armouche, Ali] DZHK German Ctr Cardiovasc Res, Gottingen, Germany; [El-Armouche, Ali] Tech Univ Dresden, Dept Pharmacol, Dresden, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; German Centre for Cardiovascular Research; University of Gottingen; German Centre for Cardiovascular Research; Technische Universitat Dresden	Eschenhagen, T (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Expt Pharmacol & Toxicol, Hamburg, Germany.	t.eschenhagen@uke.de	El-Armouche, Ali/H-3161-2018	El-Armouche, Ali/0000-0003-2514-9429	European Union	European Union(European Commission)	The study was supported by the European Union (FP7 Angioscaff). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbezier N, 2011, EMBO MOL MED, V3, P35, DOI 10.1002/emmm.201000109; BOGNAR IT, 1984, EUR J PHARMACOL, V103, P173, DOI 10.1016/0014-2999(84)90207-3; Boyce M, 2008, CELL DEATH DIFFER, V15, P589, DOI 10.1038/sj.cdd.4402296; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Chiellini G, 2007, FASEB J, V21, P1597, DOI 10.1096/fj.06-7474com; Cnop M, 2007, J BIOL CHEM, V282, P3989, DOI 10.1074/jbc.M607627200; Dan H, 2008, BIOCHEM BIOPH RES CO, V365, P777, DOI 10.1016/j.bbrc.2007.11.040; DeGracia DJ, 1997, J CEREBR BLOOD F MET, V17, P1291, DOI 10.1097/00004647-199712000-00004; El-Armouche A, 2003, FASEB J, V17, P437, DOI 10.1096/fj.02-0057fje; El-Armouche A, 2008, CARDIOVASC RES, V80, P396, DOI 10.1093/cvr/cvn208; ERNSBERGER P, 1987, EUR J PHARMACOL, V134, P1, DOI 10.1016/0014-2999(87)90125-7; Frascarelli S, 2008, EUR J PHARMACOL, V587, P231, DOI 10.1016/j.ejphar.2008.03.055; Frascarelli S, 2011, CARDIOVASC DRUG THER, V25, P307, DOI 10.1007/s10557-011-6320-x; Fu HY, 2010, CIRCULATION, V122, P361, DOI 10.1161/CIRCULATIONAHA.109.917914; Ghelardoni S, 2009, J CELL MOL MED, V13, P3082, DOI 10.1111/j.1582-4934.2009.00728.x; Hansen A, 2010, CIRC RES, V107, P35, DOI 10.1161/CIRCRESAHA.109.211458; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; HOLMES B, 1983, DRUGS, V26, P212, DOI 10.2165/00003495-198326030-00003; Hu LYA, 2009, BIOCHEM J, V424, P39, DOI 10.1042/BJ20090998; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kim I, 2009, J BIOL CHEM, V284, P1593, DOI 10.1074/jbc.M807308200; Kitakaze M, 2010, CIRC RES, V107, P15, DOI 10.1161/CIRCRESAHA.110.222919; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; LACHAUDPETTITI V, 1991, EUR J PHARM-MOLEC PH, V206, P23, DOI 10.1016/0922-4106(91)90142-5; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu LP, 2008, J BIOL CHEM, V283, P31153, DOI 10.1074/jbc.M805056200; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Matsukawa J, 2004, J BIOCHEM, V136, P261, DOI 10.1093/jb/mvh134; Minamino T, 2010, CIRC RES, V107, P1071, DOI 10.1161/CIRCRESAHA.110.227819; Minamino T, 2010, J MOL CELL CARDIOL, V48, P1105, DOI 10.1016/j.yjmcc.2009.10.026; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Norez C, 2008, EUR J PHARMACOL, V592, P33, DOI 10.1016/j.ejphar.2008.06.103; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Okada K, 2004, CIRCULATION, V110, P705, DOI 10.1161/01.CIR.0000137836.95625.D4; Ozaita A, 1997, BRIT J PHARMACOL, V121, P901, DOI 10.1038/sj.bjp.0701214; Ron D, 2008, CELL, V132, P24, DOI 10.1016/j.cell.2007.12.017; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Srivastava SP, 1998, J BIOL CHEM, V273, P2416, DOI 10.1074/jbc.273.4.2416; Tribouillard-Tanvier D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001981; Tsaytler P, 2013, FEBS J, V280, P766, DOI 10.1111/j.1742-4658.2012.08535.x; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Yamaguchi O, 2003, P NATL ACAD SCI USA, V100, P15883, DOI 10.1073/pnas.2136717100; Zhang YW, 2009, ARCH IMMUNOL THER EX, V57, P435, DOI 10.1007/s00005-009-0051-8; Zhang YM, 2011, FREE RADICAL BIO MED, V51, P2172, DOI 10.1016/j.freeradbiomed.2011.09.005	51	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98893	10.1371/journal.pone.0098893	http://dx.doi.org/10.1371/journal.pone.0098893			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892553	Green Published, Green Submitted, gold			2022-12-27	WOS:000336911400107
J	Chen, MM; Cao, HX; Peng, HS; Hu, HB; Wang, W; Zhang, XH				Chen, Mingmin; Cao, Hongxia; Peng, Huasong; Hu, Hongbo; Wang, Wei; Zhang, Xuehong			Reaction Kinetics for the Biocatalytic Conversion of Phenazine-1-Carboxylic Acid to 2-Hydroxyphenazine	PLOS ONE			English	Article							FLUORESCENT PSEUDOMONADS; PHENAZINE; BIOSYNTHESIS; GENES; METABOLITES; LACTONE; LOCUS	The phenazine derivative 2-hydroxyphenazine (2-OH-PHZ) plays an important role in the biocontrol of plant diseases, and exhibits stronger bacteriostatic and fungistatic activity than phenazine-1-carboxylic acid (PCA) toward some pathogens. PhzO has been shown to be responsible for the conversion of PCA to 2-OH-PHZ, however the kinetics of the reaction have not been systematically studied. Further, the yield of 2-OH-PHZ in fermentation culture is quite low and enhancement in our understanding of the reaction kinetics may contribute to improvements in large-scale, high-yield production of 2-OH-PHZ for biological control and other applications. In this study we confirmed previous reports that free PCA is converted to 2-hydroxy-phenazine-1-carboxylic acid (2-OH-PCA) by the action of a single enzyme PhzO, and particularly demonstrate that this reaction is dependent on NADP(H) and Fe3+. Fe3+ enhanced the conversion from PCA to 2-OH-PHZ and 28 degrees C was a optimum temperature for the conversion. However, PCA added in excess to the culture inhibited the production of 2-OH-PHZ. 2-OH-PCA was extracted and purified from the broth, and it was confirmed that the decarboxylation of 2-OH-PCA could occur without the involvement of any enzyme. A kinetic analysis of the conversion of 2-OH-PCA to 2-OH-PHZ in the absence of enzyme and under different temperatures and pHs in vitro, revealed that the conversion followed first-order reaction kinetics. In the fermentation, the concentration of 2-OH-PCA increased to about 90 mg/L within a red precipitate fraction, as compared to 37 mg/L within the supernatant. The results of this study elucidate the reaction kinetics involved in the biosynthesis of 2-OH-PHZ and provide insights into in vitro methods to enhance yields of 2-OH-PHZ.	[Chen, Mingmin; Cao, Hongxia; Peng, Huasong; Hu, Hongbo; Wang, Wei; Zhang, Xuehong] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Zhang, XH (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	xuehzhang@sjtu.edu.cn			National Key Basic Research Program of China [2012CB721005]; National Natural Science Foundation of China [31270084]; National High Technology Research and Development Program of China [2012AA022107]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This research was supported by the National Key Basic Research Program of China (No. 2012CB721005), the National Natural Science Foundation of China (No. 31270084), and the National High Technology Research and Development Program of China (No. 2012AA022107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumer C, 2000, MICROBIOL-SGM, V146, P2417, DOI 10.1099/00221287-146-10-2417; BUDZIKIEWICZ H, 1993, FEMS MICROBIOL LETT, V104, P209, DOI 10.1111/j.1574-6968.1993.tb05868.x; Chin-A-Woeng TFC, 2003, NEW PHYTOL, V157, P503, DOI 10.1046/j.1469-8137.2003.00686.x; Chin-A-Woeng TFC, 2001, MOL PLANT MICROBE IN, V14, P1006, DOI 10.1094/MPMI.2001.14.8.1006; Delaney SM, 2001, J BACTERIOL, V183, P318, DOI 10.1128/JB.183.1.318-327.2001; Du X, 2013, APPL MICROBIOL BIOTE; Dwivedi D, 2003, CURR SCI INDIA, V85, P1693; Huang L, 2011, APPL MICROBIOL BIOT, V89, P169, DOI 10.1007/s00253-010-2863-1; Hunter RC, 2013, MBIO, V4, DOI 10.1128/mBio.00557-13; KEEL C, 1989, PHYTOPATHOLOGY, V79, P584, DOI 10.1094/Phyto-79-584; Khan SR, 2007, APPL ENVIRON MICROB, V73, P7443, DOI 10.1128/AEM.01354-07; LEVITCH ME, 1966, BIOCHEMISTRY-US, V5, P689, DOI 10.1021/bi00866a040; Liu HM, 2007, CURR MICROBIOL, V54, P302, DOI 10.1007/s00284-006-0444-4; Maddula VSRK, 2008, J BACTERIOL, V190, P2759, DOI 10.1128/JB.01587-07; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Mavrodi DV, 1998, J BACTERIOL, V180, P2541, DOI 10.1128/JB.180.9.2541-2548.1998; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; MAZZOLA M, 1992, APPL ENVIRON MICROB, V58, P2616, DOI 10.1128/AEM.58.8.2616-2624.1992; Mehnaz S, 2009, J MICROBIOL BIOTECHN, V19, P1688, DOI 10.4014/jmb.0904.04022; Menezes SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037969; Park GK, 2012, J MICROBIOL BIOTECHN, V22, P326, DOI 10.4014/jmb.1106.06042; Park JY, 2011, LETT APPL MICROBIOL, V52, P532, DOI 10.1111/j.1472-765X.2011.03036.x; PIERSON LS, 1992, MOL PLANT MICROBE IN, V5, P330, DOI 10.1094/MPMI-5-330; PIERSON LS, 1995, FEMS MICROBIOL LETT, V134, P299, DOI 10.1111/j.1574-6968.1995.tb07954.x; Selin C, 2012, MICROBIOLOGY; Shen XM, 2012, J BACTERIOL, V194, P1269, DOI 10.1128/JB.06713-11; Tietze M, 2005, ORG LETT, V7, P1549, DOI 10.1021/ol050198y; TOOHEY JI, 1965, CAN J BOTANY, V43, P1151, DOI 10.1139/b65-128; TURNER JM, 1986, ADV MICROB PHYSIOL, V27, P211, DOI 10.1016/S0065-2911(08)60306-9; Zhang JF, 2010, PEST MANAG SCI, V66, P248, DOI 10.1002/ps.1856; Zhou Q, 2010, APPL MICROBIOL BIOT, V86, P1761, DOI 10.1007/s00253-010-2464-z	31	8	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98537	10.1371/journal.pone.0098537	http://dx.doi.org/10.1371/journal.pone.0098537			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905009	Green Submitted, Green Published, gold			2022-12-27	WOS:000341869000039
J	Banjare, P; Pradhan, J				Banjare, Pallavi; Pradhan, Jalandhar			Socio-Economic Inequalities in the Prevalence of Multi-Morbidity among the Rural Elderly in Bargarh District of Odisha (India)	PLOS ONE			English	Article							QUALITY-OF-LIFE; SMOKELESS TOBACCO; CHRONIC DISEASES; MULTIMORBIDITY; MORTALITY; PATTERNS; PEOPLE; POPULATION; DISABILITY; CARE	Background: Multi-morbidity among elderly is increasingly recognized as a major public health challenge in most of the developing countries. However, information on the size of population suffering from multi-morbidity and socio-economic differentials of multi-morbidity is scarce. The objectives of this paper are twofold; first, to assess the prevalence of various chronic conditions and morbidity among rural elderly and second, to examine the socio-economic and demographic factors that have a significant effect on the morbidity. Methods: A cross-sectional survey has been done using multi-stage random sampling procedure that was conducted among elderly (60+ years) in Bargarh District of Odisha during October 2011-February 2012. The survey was conducted among 310 respondents including 153 males and 157 females. Descriptive analyses were performed to assess the pattern of multi-morbidity. Logistic regression analyses were used to see the adjusted effect of various socio-economic and demographic covariates of multi-morbidity. Results: The overall prevalence of multi-morbidity is 57% among rural elderly in Bargarh District of Odisha. The most common diseases in rural areas are: Arthritis, Chronic Obstructive Pulmonary Disease (COPD), High Blood Pressure and Cataract. Results from the logistic regression analyses show that age, state of economic independence and life style indicators are the most important measured predictors of multi-morbidity. Unlike earlier studies, wealth index and education have a marginal impact on multi-morbidity rate. Moreover, the occurrence of multi-morbidity is higher for elderly males compared to their female counterparts, though the difference is not significant. Conclusion: The high prevalence of morbidity observed in the present study suggests that there is an urgent need to develop geriatric health care services in a developing country like India. Any effort to reorganize primary care for elderly people should also consider the high prevalence of multi-morbidity among rural elderly in India.	[Banjare, Pallavi; Pradhan, Jalandhar] Natl Inst Technol, Dept Humanities & Social Sci, Rourkela, Odisha, India	National Institute of Technology (NIT System); National Institute of Technology Rourkela	Pradhan, J (corresponding author), Natl Inst Technol, Dept Humanities & Social Sci, Rourkela, Odisha, India.	jpp_pradhan@yahoo.co.uk	Pradhan, Jalandhar/HIK-1917-2022; Pradhan, Jalandhar/N-1820-2017	Pradhan, Jalandhar/0000-0001-5998-0363				Accortt NA, 2002, AM J EPIDEMIOL, V156, P730, DOI 10.1093/aje/kwf106; Angra SK, 1997, INDIAN J MED RES, V106, P312; [Anonymous], 2008, AG FRIENDL PRIM HLTH; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bhattacharya P., 2005, LIV 100 S SPONS SOC; Boffetta P, 2008, LANCET ONCOL, V9, P667, DOI 10.1016/S1470-2045(08)70173-6; Britt HC, 2008, MED J AUSTRALIA, V189, P72, DOI 10.5694/j.1326-5377.2008.tb01919.x; By Yuvaraj, 2010, Indian J Community Med, V35, P138, DOI 10.4103/0970-0218.62578; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chinnakali P, 2012, N AM J MED SCI, V4, P558, DOI 10.4103/1947-2714.103314; DAVELUY C, 2000, ENQUETE SOCIALE SANT; Eachus J, 1996, BMJ-BRIT MED J, V312, P287; Fortin M, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-52; Fortin M, 2006, ANN FAM MED, V4, P417, DOI 10.1370/afm.528; Fuchs Z, 1998, J GERONTOL A-BIOL, V53, pM447, DOI 10.1093/gerona/53A.6.M447; Gijsen R, 2001, J CLIN EPIDEMIOL, V54, P661, DOI 10.1016/S0895-4356(00)00363-2; Guralnik JM, 1996, ANN EPIDEMIOL, V6, P376, DOI 10.1016/S1047-2797(96)00060-9; Hoffman C, 1996, JAMA-J AM MED ASSOC, V276, P1473, DOI 10.1001/jama.276.18.1473; Hudon C, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-304; Jindal S K, 2006, Indian J Chest Dis Allied Sci, V48, P23; Joshi K, 2003, INT J EPIDEMIOL, V32, P978, DOI 10.1093/ije/dyg204; Kadam UT, 2007, FAM PRACT, V24, P412, DOI 10.1093/fampra/cmm049; Khanam MA, 2011, J HEALTH POPUL NUTR, V29, P406, DOI 10.3329/jhpn.v29i4.8458; Khokhar A, 2001, Indian J Med Sci, V55, P609; Kiecolt-Glaser JK, 2001, PSYCHOL BULL, V127, P472, DOI 10.1037//0033-2909.127.4.472; Landi F, 2010, J CLIN EPIDEMIOL, V63, P752, DOI 10.1016/j.jclinepi.2009.09.007; Loza E, 2009, SEMIN ARTHRITIS RHEU, V38, P312, DOI 10.1016/j.semarthrit.2008.01.004; Lyon F, 2007, INT AGENCY RES CANC, V89, P55; Manzoli L, 2007, SOC SCI MED, V64, P77, DOI 10.1016/j.socscimed.2006.08.031; Maranetra Khun Nanta, 2002, Journal of the Medical Association of Thailand, V85, P1147; Marengoni A, 2008, AM J PUBLIC HEALTH, V98, P1198, DOI 10.2105/AJPH.2007.121137; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Mercer SW, 2007, ANN FAM MED, V5, P503, DOI 10.1370/afm.778; Ministry of Social Justice & Empowerment, 2008, INT PROGR OLD PERS C; Mohan M, 1992, NATL PROGRAMS ME CON, P80; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Palloni A., 2001, LIVING ARRANGE OLDER, V42, P54; Purty AJ, 2006, TURK J MED SCI, V36, P45; Rajan SI., 1995, HONG KONG J GERONTOL, V9, P20; Rajshree Bhatt, 2011, National Journal of Community Medicine, V2, P233; Rana AM, 2009, AGEING SOC, V29, P727, DOI 10.1017/S0144686X09008411; Rapoport John, 2004, Chronic Dis Can, V25, P13; Roland M, 2002, 3 INT C SMOK TOB STO; Salisbury C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X548929; Schafer A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014060; Schram MT, 2008, J CLIN EPIDEMIOL, V61, P1104, DOI 10.1016/j.jclinepi.2007.11.021; Shankar R, 2007, Indian J Public Health, V51, P56; Shraddha K., 2012, International Journal of Medicine and Biomedical Research, V1, P215; Solomons NW, 2001, J HLTH AGEING, V3, P3; Swami HM, 2002, BAHRAIN MED B, V24, P13; Uijen Annemarie A, 2008, Eur J Gen Pract, V14 Suppl 1, P28, DOI 10.1080/13814780802436093; van den Akker M, 1998, J CLIN EPIDEMIOL, V51, P367, DOI 10.1016/S0895-4356(97)00306-5; van den Akker M, 2000, SOC SCI MED, V50, P1679, DOI 10.1016/S0277-9536(99)00408-6; van den Akker M, 1996, EUR J GEN PRACT, V2, P65, DOI [DOI 10.3109/13814789609162146, 10.3109/13814789609162146]; Walker AE, 2007, CHRONIC ILLN, V3, P202, DOI 10.1177/1742395307081504; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; Wong SY, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-119; World Health Organization, 2004, AG FRIENDL PRIM HLTH	58	50	52	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e97832	10.1371/journal.pone.0097832	http://dx.doi.org/10.1371/journal.pone.0097832			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4NF	24902041	Green Published, Green Submitted, gold			2022-12-27	WOS:000336841400012
J	Gudex, B; Johnson, D; Singh, K				Gudex, Boyd; Johnson, David; Singh, Kuljeet			Prenatal Maternal and Possible Transgenerational Epigenetic Effects on Milk Production	PLOS ONE			English	Article							INHERITANCE; CONCEPTION; DISEASE	This study investigated whether the prenatal maternal environment in dairy cattle influences the postnatal milking performance of the resulting daughters and grand-daughters. Linear mixed models were used to analyse whole season milk production from similar to 46000 Jersey and similar to 123000 Holstein Friesian cows in their 1st and 2nd lactations. Variation in the prenatal environment was associated with a small but significant (P<0.05) proportion of the total phenotypic variation (0.010 to 0.015) in all traits in Holstein Friesian cows and in the first lactation milk volume (0.011) and milk protein (0.011), and the second lactation milk fat (0.015) in the Jersey breed. This indicates that the prenatal environment does influence the adult performance of the subsequent daughter. Associations between daughter performance and dam and grand-dam traits indicative of their prenatal environment were also estimated. A one litre increase in the dam's herd test milk volume was associated with a 7.5 litre increase in the daughters' whole season milk yield and a 1% increase in either the dams' herd test milk fat or protein percentage was associated with a reduction in daughter whole season milk volume (-49.6 and -45.0 litres for dam fat and protein, respectively). Similar results between the grand-dam herd test traits ansd the daughters' whole season milk production were observed with a 1% increase in either grand-dam milk fat or protein percentage associated with a reduction in daughter whole season milk yield (-34.7 and -9.7 litres for fat and protein, respectively). This study revealed that the prenatal environment of the dam and the grand-dam can influence milk production in the subsequent daughters, though the effects are small. The similarity of the results between the dam daughter and the grand-dam daughter analyses suggests that the majority of the prenatal maternal effects are mediated by epigenetic mechanisms.	[Gudex, Boyd; Johnson, David] Livestock Improvement Corp, Hamilton, New Zealand; [Gudex, Boyd] Univ New England, Armidale, NSW, Australia; [Singh, Kuljeet] AgResearch, Ruakura Res Ctr, Hamilton, New Zealand	Livestock Improvement Corporation; University of New England; AgResearch - New Zealand	Gudex, B (corresponding author), Livestock Improvement Corp, Hamilton, New Zealand.	bgudex@lic.co.nz			Ministry of Business, Innovation and Employment [C10X0702]	Ministry of Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE))	This work was funded by the Ministry of Business, Innovation and Employment (www.mbie.govt.nz) grant number C10X0702. Livestock Improvement Corporation (www.lic.co.nz) supplied the data that was analysed and together with AgResearch Limited (www.agresearch.co.nz) approved the publication of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banos G, 2007, J DAIRY SCI, V90, P3490, DOI 10.3168/jds.2006-809; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Berry DP, 2008, J DAIRY SCI, V91, P329, DOI 10.3168/jds.2007-0438; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; Erdman RA, 2009, J DAIRY SCI S1, V92, pi; Gilmour A. R., 2009, ASREML REFERENCE MAN; Gluckman PD, 2007, BIOESSAYS, V29, P145, DOI 10.1002/bies.20522; Gonzalez-Recio O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051816; Gonzalez-Recio Oscar, 2012, Frontiers in Genetics, V2, P106, DOI 10.3389/fgene.2011.00106; Gudex B. W., 2012, Proceedings of the New Zealand Society of Animal Production, V72, P19; Johnson D. L., 1996, Proceedings of the New Zealand Society of Animal Production, V56, P16; Park CS, 2005, FASEB J, V19, P1586, DOI 10.1096/fj.05-3816hyp; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Pryce JE, 2006, J DAIRY SCI, V89, P4424, DOI 10.3168/jds.S0022-0302(06)72490-0; Roche JR, 2006, J DAIRY SCI, V89, P2119, DOI 10.3168/jds.S0022-0302(06)72282-2; Singh K, 2012, ANIMAL, V6, P375, DOI 10.1017/S1751731111002564; Singh K, 2010, J MAMMARY GLAND BIOL, V15, P101, DOI 10.1007/s10911-010-9164-2; Veenendaal MVE, 2013, BJOG-INT J OBSTET GY, V120, P548, DOI 10.1111/1471-0528.12136	18	10	11	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98928	10.1371/journal.pone.0098928	http://dx.doi.org/10.1371/journal.pone.0098928			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901792	Green Published, Green Submitted, gold			2022-12-27	WOS:000336841400074
J	Maffei, R; Bulgarelli, J; Fiorcari, S; Martinelli, S; Castelli, I; Valenti, V; Rossi, D; Bonacorsi, G; Zucchini, P; Potenza, L; Vallisa, D; Gattei, V; Del Poeta, G; Forconi, F; Gaidano, G; Narni, F; Luppi, M; Marasca, R				Maffei, Rossana; Bulgarelli, Jenny; Fiorcari, Stefania; Martinelli, Silvia; Castelli, Ilaria; Valenti, Vanessa; Rossi, Davide; Bonacorsi, Goretta; Zucchini, Patrizia; Potenza, Leonardo; Vallisa, Daniele; Gattei, Valter; Del Poeta, Giovanni; Forconi, Francesco; Gaidano, Gianluca; Narni, Franco; Luppi, Mario; Marasca, Roberto			Endothelin-1 Promotes Survival and Chemoresistance in Chronic Lymphocytic Leukemia B Cells through ETA Receptor	PLOS ONE			English	Article							COLORECTAL-CANCER; INDUCED APOPTOSIS; PROGNOSTIC-FACTOR; SUBTYPE-B; PROLIFERATION; MICROENVIRONMENT; ACTIVATION; IDENTIFICATION; MACITENTAN; PACLITAXEL	The endothelin axis, comprising endothelins (ET-1, ET-2 and ET-3) and their receptors (ETAR and ETBR), has emerged as relevant player in tumor growth and metastasis. Here, we investigated the involvement of ET-1/ETAR axis in chronic lymphocytic leukemia (CLL). CLL cells expressed higher levels of ET-1 and ETA receptor as compared to normal B cells. ET-1 peptide stimulated phosphoinositide-3-kinase and mitogen-activated protein kinase signaling pathways, improved survival and promoted proliferation of leukemic cells throughout ETAR triggering. Moreover, the blockade of ETAR by the selective antagonist BQ-123 inhibited the survival advantage acquired by CLL cells in contact with endothelial layers. We also found that blocking ETAR via BQ-123 interferes with ERK phosphorylation and CLL pro-survival effect mediated by B-cell receptor (BCR) activation. The pro-apoptotic effect of phosphoinositide-3-kinase delta inhibitor idelalisib and mitogen-activated protein kinase inhibitor PD98059 was decreased by the addition of ET-1 peptide. Then, ET-1 also reduced the cytotoxic effect of fludarabine on CLL cells cultured alone or co-cultured on endothelial layers. ETAR blockade by BQ-123 inhibited the ET-1-mediated protection against drug-induced apoptosis. Lastly, higher plasma levels of big ET-1 were detected in patients (n = 151) with unfavourable prognostic factors and shorter time to first treatment. In conclusion, our data describe for the first time a role of ET-1/ETAR signaling in CLL pathobiology. ET-1 mediates survival, drug-resistance, and growth signals in CLL cells that can be blocked by ETAR inhibition.	[Maffei, Rossana; Bulgarelli, Jenny; Fiorcari, Stefania; Martinelli, Silvia; Castelli, Ilaria; Bonacorsi, Goretta; Zucchini, Patrizia; Potenza, Leonardo; Narni, Franco; Luppi, Mario; Marasca, Roberto] Univ Modena & Reggio Emilia, Div Hematol, Dept Med & Surg Sci, Modena, Italy; [Valenti, Vanessa; Vallisa, Daniele] Piacenza Hosp, Div Hematol, Piacenza, Italy; [Rossi, Davide; Gaidano, Gianluca] Amedeo Avogadro Univ Eastern Piedmont, Div Hematol, Dept Clin & Expt Med, Novara, Italy; [Gattei, Valter] IRCCS, Ctr Riferimento Oncol, Clin & Expt Oncohematol Unit, Aviano, PN, Italy; [Del Poeta, Giovanni] S Eugenio Hosp, Div Hematol, Rome, Italy; [Del Poeta, Giovanni] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Forconi, Francesco] Univ Southampton, CRUK Clin Ctr, Canc Sci Unit, Southampton, Hants, England; [Forconi, Francesco] Univ Siena, Div Hematol, Dept Clin Med & Immunol Sci, I-53100 Siena, Italy	Universita di Modena e Reggio Emilia; Ospedale di Piacenza; University of Eastern Piedmont Amedeo Avogadro; IRCCS Aviano (CRO); Sant'Eugenio Hospital; University of Rome Tor Vergata; University of Southampton; University of Siena	Marasca, R (corresponding author), Univ Modena & Reggio Emilia, Div Hematol, Dept Med & Surg Sci, Modena, Italy.	roberto.marasca@unimore.it	Luppi, Mario/J-3668-2016; Maffei, Rossana/O-4836-2016; Bulgarelli, Jenny/AAB-6083-2021; Gaidano, Gianluca/AAW-2773-2021; Martinelli, Silvia/J-9080-2016; Forconi, Francesco/AAO-2694-2021; Fiorcari, Stefania/I-7240-2018; Gattei, Valter/AAB-5048-2020; Potenza, Leonardo/P-9579-2016; Marasca, Roberto/I-8072-2013	Luppi, Mario/0000-0002-0373-1154; Maffei, Rossana/0000-0002-3518-2006; Bulgarelli, Jenny/0000-0002-6551-0189; Gaidano, Gianluca/0000-0002-4681-0151; Martinelli, Silvia/0000-0002-2856-6327; Forconi, Francesco/0000-0002-2211-1831; Fiorcari, Stefania/0000-0002-8582-4951; Gattei, Valter/0000-0001-5933-9680; Potenza, Leonardo/0000-0002-2738-6105; Marasca, Roberto/0000-0002-6431-6878; DEL POETA, GIOVANNI/0000-0003-2443-1422; NARNI, Franco/0000-0003-3994-9101; Vallisa, Daniele/0000-0002-3130-1979	Associazione Italiana per la Ricerca sul Cancro, Milan, Italy [AIRC IG14376-R.Mar.]; Programma di Ricerca di Interesse Nazionale (PRIN), Ministero dell'Universita e della Ricerca (MIUR), Rome, Italy	Associazione Italiana per la Ricerca sul Cancro, Milan, Italy(Fondazione AIRC per la ricerca sul cancro); Programma di Ricerca di Interesse Nazionale (PRIN), Ministero dell'Universita e della Ricerca (MIUR), Rome, Italy(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from: Associazione Italiana per la Ricerca sul Cancro (AIRC IG14376-R.Mar.), Milan, Italy; Programma di Ricerca di Interesse Nazionale (PRIN) 2008, Ministero dell'Universita e della Ricerca (MIUR), Rome, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apollonio B, 2013, BLOOD, V121, P3879, DOI 10.1182/blood-2012-12-474718; Arun C, 2004, INT J BIOL MARKER, V19, P262, DOI 10.1177/172460080401900402; Arun C, 2004, INT J BIOL MARKER, V19, P32, DOI 10.1177/172460080401900104; Asham E, 2001, BRIT J CANCER, V85, P1759, DOI 10.1054/bjoc.2001.2193; Badoux X, 2011, HUM PATHOL, V42, P1989, DOI 10.1016/j.humpath.2011.02.027; Bagnato A, 1997, CANCER RES, V57, P1306; Bagnato A, 2011, BRIT J PHARMACOL, V163, P220, DOI 10.1111/j.1476-5381.2011.01217.x; Bagnato A, 2001, AM J PATHOL, V158, P841, DOI 10.1016/S0002-9440(10)64032-1; Bagnato A, 2008, INT J BIOCHEM CELL B, V40, P1443, DOI 10.1016/j.biocel.2008.01.022; Barone F, 2002, FASEB J, V16, DOI 10.1096/fj.01-0749com; Bouallegue A, 2007, CURR VASC PHARMACOL, V5, P45, DOI 10.2174/157016107779317161; Brown JR, 2014, BLOOD, V124; Buggins AGS, 2010, CANCER RES, V70, P7523, DOI 10.1158/0008-5472.CAN-10-1634; Burger JA, 2012, CURR OPIN ONCOL, V24, P643, DOI 10.1097/CCO.0b013e3283589950; Burger JA, 2011, HEMATOL-AM SOC HEMAT, P96, DOI 10.1182/asheducation-2011.1.96; Byrd JC, 2013, NEW ENGL J MED, V369, P32, DOI 10.1056/NEJMoa1215637; Chiorazzi N, 2003, ANNU REV IMMUNOL, V21, P841, DOI 10.1146/annurev.immunol.21.120601.141018; Cols M, 2012, J IMMUNOL, V188, P6071, DOI 10.4049/jimmunol.1102066; Damle RN, 2010, BEST PRACT RES CL HA, V23, P33, DOI 10.1016/j.beha.2010.02.001; Del Bufalo D, 2002, MOL PHARMACOL, V61, P524, DOI 10.1124/mol.61.3.524; EHRENREICH H, 1990, J EXP MED, V172, P1741, DOI 10.1084/jem.172.6.1741; Evans NJ, 2008, CAN J PHYSIOL PHARM, V86, P526, DOI 10.1139/Y08-050; Furman RR, 2014, NEW ENGL J MED, V370, P997, DOI 10.1056/NEJMoa1315226; Gambara G, 2008, J CELL PHYSIOL, V216, P396, DOI 10.1002/jcp.21407; Grant K, 2007, BRIT J SURG, V94, P106, DOI 10.1002/bjs.5536; Guruli G, 2004, BLOOD, V104, P2107, DOI 10.1182/blood-2003-10-3559; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hamilton E, 2012, BRIT J HAEMATOL, V158, P589, DOI 10.1111/j.1365-2141.2012.09191.x; HEMSEN A, 1995, REGUL PEPTIDES, V55, P287, DOI 10.1016/0167-0115(94)00119-I; Herishanu Y, 2011, BLOOD, V117, P563, DOI 10.1182/blood-2010-05-284984; HIRATA Y, 1993, J CLIN INVEST, V91, P1367, DOI 10.1172/JCI116338; Jiao WJ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-334; Kalles V, 2012, TUMOR BIOL, V33, P1231, DOI 10.1007/s13277-012-0371-x; Kim SJ, 2012, TRANSL ONCOL, V5, P39, DOI 10.1593/tlo.11286; Kim SJ, 2011, NEOPLASIA, V13, P167, DOI 10.1593/neo.10806; KONDO M, 1992, BIOCHIM BIOPHYS ACTA, V1134, P242, DOI 10.1016/0167-4889(92)90182-B; KUSUHARA M, 1990, CANCER RES, V50, P3257; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Maffei R, 2013, HAEMATOLOGICA; Maffei R, 2012, HAEMATOL-HEMATOL J, V97, P952, DOI 10.3324/haematol.2011.054924; Maffei R, 2010, BLOOD, V116, P584, DOI 10.1182/blood-2009-11-252494; Mai HQ, 2006, CANCER-AM CANCER SOC, V106, P1548, DOI 10.1002/cncr.21790; NELSON JB, 1995, NAT MED, V1, P944, DOI 10.1038/nm0995-944; Rosano L, 2011, CLIN CANCER RES, V17, P2350, DOI 10.1158/1078-0432.CCR-10-2325; Stevenson FK, 2004, BLOOD, V103, P4389, DOI 10.1182/blood-2003-12-4312; Thai TL, 2009, AM J PHYSIOL-RENAL, V297, pF169, DOI 10.1152/ajprenal.00079.2009; Wang R, 2011, PHARMACOL RES, V63, P519, DOI 10.1016/j.phrs.2011.01.002; Woyach JA, 2012, BLOOD, V120, P1175, DOI 10.1182/blood-2012-02-362624; Yamaguchi E, 2007, J GASTROEN HEPATOL, V22, P1134, DOI 10.1111/j.1440-1746.2006.04822.x; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Zhang WM, 2008, LIFE SCI, V82, P764, DOI 10.1016/j.lfs.2008.01.008; Zhao YT, 2011, CLIN ORTHOP RELAT R, V469, P3190, DOI 10.1007/s11999-011-1939-2; Zwick C, 2013, BLOOD, V121, P4708, DOI 10.1182/blood-2012-08-447904	53	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98818	10.1371/journal.pone.0098818	http://dx.doi.org/10.1371/journal.pone.0098818			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901342	Green Published, gold, Green Submitted			2022-12-27	WOS:000336841400056
J	Mandel, DR; Omorogbe, P				Mandel, David R.; Omorogbe, Philip			Political Differences in Past, Present, and Future Life Satisfaction: Republicans Are More Sensitive than Democrats to Political Climate	PLOS ONE			English	Article							POSITIVE PSYCHOLOGY; CONSERVATIVES; HAPPIER; PARTISANSHIP; EXPERIENCE; ATTITUDES; IDEOLOGY; LIBERALS; VARY	Previous research finds that Republicans report being happier or more satisfied with their lives than Democrats. Using representative American samples from 2002, 2005, 2007, 2009, and 2010, we tested a Person x Situation interactionist account in which political affiliation (Democrat, Republican) and political climate (favorable when the president in office is of the same party) are proposed to affect past, present, and anticipated future life satisfaction. Meta-analyses of related tests of key hypotheses confirmed that (a) life satisfaction was greater when the political climate was favorable rather than unfavorable and (b) Republicans were more sensitive to political climate than Democrats. As predicted, Republicans also were more politically polarized than Democrats. Taken together, the findings indicate that, compared to Democrats, Republicans are more apt to self-identify in political terms, and core aspects of their subjective well-being are more easily affected by the outcome of political events.	[Mandel, David R.] Def Res & Dev Canada, Sociocognit Syst Sect, Toronto, ON, Canada; [Mandel, David R.] York Univ, Toronto, ON M3J 2R7, Canada; [Omorogbe, Philip] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada	Defence Research & Development Canada; York University - Canada; McMaster University	Mandel, DR (corresponding author), Def Res & Dev Canada, Sociocognit Syst Sect, Toronto, ON, Canada.	drmandel66@gmail.com		Mandel, David/0000-0003-1036-2286	Natural Sciences and Engineering Council of Canada (NSERC) [249537-07]; NSERC	Natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Research salary for PO was funded by Natural Sciences and Engineering Council of Canada (NSERC) Discovery Grant 249537-07 under the direction of DM and by an NSERC Undergraduate Student Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio DM, 2007, NAT NEUROSCI, V10, P1246, DOI 10.1038/nn1979; Bartels LM, 2000, AM J POLIT SCI, V44, P35, DOI 10.2307/2669291; Bless H, 2010, ADV EXP SOC PSYCHOL, V42, P319, DOI 10.1016/S0065-2601(10)42006-7; Bonaparte Y, 2012, AFA 2012 CHIC M; Cantril H., 1965, PATTERNS HUMAN; Carraro L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026456; Carroll J, 2007, MOST AM VERY SATISFI; Choma BL, 2012, PERS INDIV DIFFER, V53, P431, DOI 10.1016/j.paid.2012.04.012; Cohen J.E., 1988, STAT POWER ANAL BEHA; Critcher CR, 2009, SOC JUSTICE RES, V22, P181, DOI 10.1007/s11211-009-0096-1; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dodd MD, 2012, PHILOS T R SOC B, V367, P640, DOI 10.1098/rstb.2011.0268; Duckitt J, 2009, PSYCHOL INQ, V20, P98, DOI 10.1080/10478400903028540; ENDLER NS, 1976, PSYCHOL BULL, V83, P956, DOI 10.1037/0033-2909.83.5.956; Evans G, 2006, J POLIT, V68, P194, DOI 10.1111/j.1468-2508.2006.00380.x; Evans G, 2010, J POLIT, V72, P1236, DOI 10.1017/S0022381610000654; Gerber AS, 2010, AM J POLIT SCI, V54, P153, DOI 10.1111/j.1540-5907.2009.00424.x; Glass G. V., 1981, META ANALYSIS IN SOC; GRAHAM J, 2012, AM POETRY REV, V7, DOI DOI 10.1371/JOURNAL.PONE.0050092; Hays WL, 1963, STAT; Heller D, 2004, PSYCHOL BULL, V130, P574, DOI 10.1037/0033-2909.130.4.574; Holbrook AL, 2001, AM J POLIT SCI, V45, P930, DOI 10.2307/2669333; Inbar Y, 2009, COGNITION EMOTION, V23, P714, DOI 10.1080/02699930802110007; Janoff-Bulman R, 2008, J EXP SOC PSYCHOL, V44, P1091, DOI 10.1016/j.jesp.2007.11.003; Jetten J, 2013, SOC PSYCHOL PERS SCI, V4, P6, DOI 10.1177/1948550612439721; Joel S, 2014, J PERS, V82, P32, DOI 10.1111/jopy.12031; Johnston R, 2005, J ELECT PUBLIC OPIN, V15, P129, DOI 10.1080/13689880500064692; Jost JT, 2005, CURR DIR PSYCHOL SCI, V14, P260, DOI 10.1111/j.0963-7214.2005.00377.x; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Kifer Y, 2013, PSYCHOL SCI, V24, P280, DOI 10.1177/0956797612450891; Krizan Z, 2010, PSYCHOL SCI, V21, P140, DOI 10.1177/0956797609356421; MISCHEL W, 1995, PSYCHOL REV, V102, P246, DOI 10.1037/0033-295X.102.2.246; Myers DG, 2000, AM PSYCHOL, V55, P56, DOI 10.1037/0003-066X.55.1.56; Nam HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059837; Napier JL, 2008, PSYCHOL SCI, V19, P565, DOI 10.1111/j.1467-9280.2008.02124.x; Oxley DR, 2008, SCIENCE, V321, P1667, DOI 10.1126/science.1157627; Proto E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079358; RICE WR, 1994, BIOMETRICS, V50, P746, DOI 10.2307/2532788; Richardson JTE, 2011, EDUC RES REV-NETH, V6, P135, DOI 10.1016/j.edurev.2010.12.001; ROSENTHAL R, 1991, PSYCHOSOM MED, V53, P247, DOI 10.1097/00006842-199105000-00001; Ross L., 2011, PERSON SITUATION PER; Schlenker BR, 2012, J RES PERS, V46, P127, DOI 10.1016/j.jrp.2011.12.009; Schwarz N., 1999, WELL BEING FDN HEDON, P61, DOI DOI 10.7758/9781610443258; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.56.1.89; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Smith KB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025552; Taylor P., 2006, ARE WE HAPPY YET; TETLOCK PE, 1983, J PERS SOC PSYCHOL, V45, P118, DOI 10.1037/0022-3514.45.1.118; Vigil JM, 2010, GROUP PROCESS INTERG, V13, P547, DOI 10.1177/1368430209356930	50	9	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98854	10.1371/journal.pone.0098854	http://dx.doi.org/10.1371/journal.pone.0098854			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4NF	24901253	Green Published, gold, Green Submitted			2022-12-27	WOS:000336841400062
J	Xiao, QH; Cui, YY				Xiao, Qinghuan; Cui, Yuanyuan			Acidic Amino Acids in the First Intracellular Loop Contribute to Voltage- and Calcium- Dependent Gating of Anoctamin1/TMEM16A	PLOS ONE			English	Article							ACTIVATED CHLORIDE CHANNEL; CA2+-ACTIVATED CL-CHANNELS; SMOOTH-MUSCLE-CELLS; FAMILY-MEMBERS; ION-BINDING; TMEM16A; PROTEIN; EXPRESSION; CURRENTS; ANOCTAMINS	Anoctamin1 (Ano1, or TMEM16A) is a Ca2+-activated chloride channel that is gated by both voltage and Ca2+. We have previously identified that the first intracellular loop that contains a high density of acidic residues mediates voltage-and calcium-dependent gating of Ano1. Mutation of the four consecutive glutamates (444EEEE447) inhibits the voltage-dependent activation of Ano1, whereas deletion of these residues decreases apparent Ca2+ sensitivity. In the present study, we further found that deletion of (444)EEEEEAVKD(452) produced a more than 40-fold decrease in the apparent Ca2+ sensitivity with altered activation kinetics. We then systematically mutated each acidic residue into alanine, and analyzed the voltage-and calcium dependent activation of each mutation. Activation kinetics of wild type Ano1 consisted of a fast component (tau(fast)) that represented voltage-dependent mode, and a slow component (tau(slow)) that reflected the Ca2+-dependent modal gating. E444A, E445A, E446A, E447A, E448A, and E457A mutations showed a decrease in the tau(fast), significantly inhibited voltage-dependent activation of Ano1 in the absence of Ca2+, and greatly shifted the G-V curve to the right, suggesting that these glutamates are involved in voltage-gating of Ano1. Furthermore, D452A, E464A, E470A, and E475A mutations that did not alter voltage-dependent activation of the channel, significantly decreased Ca2+ dependence of G-V curve, exhibited an increase in the tau(slow), and produced a 2-3 fold decrease in the apparent Ca2+ sensitivity, suggesting that these acidic residues are involved in Ca2+-dependent gating of the channel. Our data show that acidic residues in the first intracellular loop are the important structural determinant that couples the voltage and calcium dependent gating of Ano1.	[Xiao, Qinghuan] China Med Univ, Sch Pharm, Dept Ion Channel Pharmacol, Shenyang, Peoples R China; [Cui, Yuanyuan] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA USA	China Medical University; Emory University	Xiao, QH (corresponding author), China Med Univ, Sch Pharm, Dept Ion Channel Pharmacol, Shenyang, Peoples R China.	qinghuanxiao@gmail.com	Xiao, Qinghuan/L-1114-2019		American Heart Association; National Natural Science Foundation of China [31371145]; NATIONAL EYE INSTITUTE [R01EY014852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060448] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by an American Heart Association postdoctoral fellowship, and a grant from the National Natural Science Foundation of China (No. 31371145) to QX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaca J, 2009, J BIOL CHEM, V284, P28571, DOI 10.1074/jbc.M109.010074; Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Cenedese V, 2012, J GEN PHYSIOL, V139, P285, DOI 10.1085/jgp.201110764; Das S, 2008, CANCER RES, V68, P6306, DOI 10.1158/0008-5472.CAN-08-0870; Duran C, 2011, ACTA PHARMACOL SIN, V32, P685, DOI 10.1038/aps.2011.48; FALKE JJ, 1994, Q REV BIOPHYS, V27, P219, DOI 10.1017/S0033583500003012; Ferrera L, 2011, BBA-BIOMEMBRANES, V1808, P2214, DOI 10.1016/j.bbamem.2011.05.017; Ferrera L, 2009, J BIOL CHEM, V284, P33360, DOI 10.1074/jbc.M109.046607; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Grubb S, 2013, J GEN PHYSIOL, V141, P585, DOI 10.1085/jgp.201210861; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; Huang F, 2012, P NATL ACAD SCI USA, V109, P16354, DOI 10.1073/pnas.1214596109; Huang F, 2012, PHARMACOL REV, V64, P1, DOI 10.1124/pr.111.005009; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Huang WC, 2012, NEURON, V74, P179, DOI 10.1016/j.neuron.2012.01.033; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; Jaiswal JK, 2001, J BIOSCIENCES, V26, P357, DOI 10.1007/BF02703745; Jung J, 2013, P NATL ACAD SCI USA, V110, P360, DOI 10.1073/pnas.1211594110; Kunzelmann K, 2011, PFLUG ARCH EUR J PHY, V462, P195, DOI 10.1007/s00424-011-0975-9; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; Malvezzi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3367; Manoury B, 2010, J PHYSIOL-LONDON, V588, P2305, DOI 10.1113/jphysiol.2010.189506; Perez-Cornejo P, 2004, J MEMBRANE BIOL, V198, P125, DOI 10.1007/s00232-004-0659-x; Perez-Cornejo P, 2012, P NATL ACAD SCI USA, V109, P10376, DOI 10.1073/pnas.1200174109; Qu ZQ, 2000, J GEN PHYSIOL, V116, P825, DOI 10.1085/jgp.116.6.825; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Saidu SP, 2013, J GEN PHYSIOL, V141, P691, DOI 10.1085/jgp.201210937; Schreiber R, 2010, J BIOL CHEM, V285, P7838, DOI 10.1074/jbc.M109.065367; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Scudieri P, 2013, BIOCHEM J, V452, P443, DOI 10.1042/BJ20130348; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Thomas-Gatewood C, 2011, AM J PHYSIOL-HEART C, V301, pH1819, DOI 10.1152/ajpheart.00404.2011; Tian YM, 2011, FASEB J, V25, P1058, DOI 10.1096/fj.10-166884; Wang M, 2012, CIRCULATION, V125, P697, DOI 10.1161/CIRCULATIONAHA.111.041806; Xiao QH, 2011, P NATL ACAD SCI USA, V108, P8891, DOI 10.1073/pnas.1102147108; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yu K, 2014, J GEN PHYSIOL, V143, P253, DOI 10.1085/jgp.201311047; Yu K, 2012, CIRC RES, V110, P990, DOI 10.1161/CIRCRESAHA.112.264440	42	21	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99376	10.1371/journal.pone.0099376	http://dx.doi.org/10.1371/journal.pone.0099376			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901998	Green Published, gold, Green Submitted			2022-12-27	WOS:000336841400124
J	Zhong, MG; Zheng, K; Chen, MY; Xiang, YF; Jin, FJ; Ma, KQ; Qiu, XX; Wang, QL; Peng, T; Kitazato, K; Wang, YF				Zhong, Meigong; Zheng, Kai; Chen, Maoyun; Xiang, Yangfei; Jin, Fujun; Ma, Kaiqi; Qiu, Xianxiu; Wang, Qiaoli; Peng, Tao; Kitazato, Kaio; Wang, Yifei			Heat-Shock Protein 90 Promotes Nuclear Transport of Herpes Simplex Virus 1 Capsid Protein by Interacting with Acetylated Tubulin	PLOS ONE			English	Article							CELLULAR CHAPERONE; VIRAL TRANSPORT; HSP90; LOCALIZATION; REORGANIZATION; IDENTIFICATION; STABILIZATION; REPLICATION; ACTIVATION; BINDING	Although it is known that inhibitors of heat shock protein 90 (Hsp90) can inhibit herpes simplex virus type 1 (HSV-1) infection, the role of Hsp90 in HSV-1 entry and the antiviral mechanisms of Hsp90 inhibitors remain unclear. In this study, we found that Hsp90 inhibitors have potent antiviral activity against standard or drug-resistant HSV-1 strains and viral gene and protein synthesis are inhibited in an early phase. More detailed studies demonstrated that Hsp90 is upregulated by virus entry and it interacts with virus. Hsp90 knockdown by siRNA or treatment with Hsp90 inhibitors significantly inhibited the nuclear transport of viral capsid protein (ICP5) at the early stage of HSV-1 infection. In contrast, overexpression of Hsp90 restored the nuclear transport that was prevented by the Hsp90 inhibitors, suggesting that Hsp90 is required for nuclear transport of viral capsid protein. Furthermore, HSV-1 infection enhanced acetylation of alpha-tubulin and Hsp90 interacted with the acetylated alpha-tubulin, which is suppressed by Hsp90 inhibition. These results demonstrate that Hsp90, by interacting with acetylated alpha-tubulin, plays a crucial role in viral capsid protein nuclear transport and may provide novel insight into the role of Hsp90 in HSV-1 infection and offer a promising strategy to overcome drug-resistance.	[Zhong, Meigong; Zheng, Kai; Chen, Maoyun; Xiang, Yangfei; Jin, Fujun; Ma, Kaiqi; Qiu, Xianxiu; Wang, Qiaoli; Wang, Yifei] Jinan Univ, Natl Engn Res Ctr Genet Med, Guangzhou Jinan Biomed Res & Dev Ctr, Guangzhou, Guangdong, Peoples R China; [Zhong, Meigong; Chen, Maoyun; Jin, Fujun; Qiu, Xianxiu] Jinan Univ, Coll Pharm, Guangzhou, Guangdong, Peoples R China; [Peng, Tao] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangzhou 510530, Guangdong, Peoples R China; [Kitazato, Kaio] Nagasaki Univ, Dept Mol Microbiol & Immunol, Div Mol Pharmacol Infect Agents, Grad Sch Biomed Sci, Nagasaki 852, Japan	Jinan University; Jinan University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State Key Laboratory of Respiratory Disease; Nagasaki University	Peng, T (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangzhou 510530, Guangdong, Peoples R China.	peng_tao@gibh.ac.cn; kkholi@nagasaki-u.ac.jp; twang-yf@163.com	Qiu, Xianxiu/AAN-1006-2020; Zheng, Kai/AAT-8994-2021	Zheng, Kai/0000-0001-9275-1239; Jin, Fujun/0000-0002-7314-0085; Peng, Tao/0000-0001-5260-7128	Twelfth Five-Year National Science and Technology Support Program [2012BAI29B06]; National Natural Science Foundation of China [81274170]; Foundation for High-level Talents in Higher Education of Guangdong, China [79]	Twelfth Five-Year National Science and Technology Support Program(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for High-level Talents in Higher Education of Guangdong, China	This work was supported by the Twelfth Five-Year National Science and Technology Support Program (2012BAI29B06), the National Natural Science Foundation of China (81274170, http://www.nsfc.gov.cn/), and the Foundation for High-level Talents in Higher Education of Guangdong, China ([2010]NO.79). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basta S, 2005, J IMMUNOL, V175, P796, DOI 10.4049/jimmunol.175.2.796; Boyault C, 2007, GENE DEV, V21, P2172, DOI 10.1101/gad.436407; Burch AD, 2005, J VIROL, V79, P10740, DOI 10.1128/JVI.79.16.10740-10749.2005; Burch AD, 2004, J VIROL, V78, P7175, DOI 10.1128/JVI.78.13.7175-7185.2004; Cheng HY, 2002, ANTIVIR RES, V55, P447, DOI 10.1016/S0166-3542(02)00077-3; Coen DM, 2003, NAT REV DRUG DISCOV, V2, P278, DOI 10.1038/nrd1065; Crevel G, 2001, J CELL SCI, V114, P2015; De Regge N, 2006, J CELL BIOL, V174, P267, DOI 10.1083/jcb.200510156; Diefenbach RJ, 2002, J VIROL, V76, P3282, DOI 10.1128/JVI.76.7.3282-3291.2002; Douglas MW, 2004, J BIOL CHEM, V279, P28522, DOI 10.1074/jbc.M311671200; Elliott G, 1998, J VIROL, V72, P6448, DOI 10.1128/JVI.72.8.6448-6455.1998; Garnier C, 1998, BIOCHEM BIOPH RES CO, V250, P414, DOI 10.1006/bbrc.1998.9319; Geller R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056762; Geller R, 2012, BBA-MOL CELL RES, V1823, P698, DOI 10.1016/j.bbamcr.2011.11.007; Giustiniani J, 2009, CELL SIGNAL, V21, P529, DOI 10.1016/j.cellsig.2008.12.004; Hino M, 2000, BIOCHEM BIOPH RES CO, V271, P164, DOI 10.1006/bbrc.2000.2553; Huang KH, 2009, J MED CHEM, V52, P4288, DOI 10.1021/jm900230j; Husain M, 2011, FEBS LETT, V585, P128, DOI 10.1016/j.febslet.2010.11.023; Jaeger V, 2010, J GEN VIROL, V91, P2152, DOI 10.1099/vir.0.021055-0; Ju HQ, 2011, BIOORG MED CHEM LETT, V21, P1675, DOI 10.1016/j.bmcl.2011.01.098; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Krtkova J, 2012, J PLANT PHYSIOL, V169, P1329, DOI 10.1016/j.jplph.2012.06.010; Lamberti C, 1998, J VIROL, V72, P2463, DOI 10.1128/JVI.72.3.2463-2473.1998; Li YH, 2004, ANTIMICROB AGENTS CH, V48, P867, DOI 10.1128/AAC.48.3.867-872.2004; Makhnevych T, 2012, BBA-MOL CELL RES, V1823, P674, DOI 10.1016/j.bbamcr.2011.09.001; Maloney A, 2002, EXPERT OPIN BIOL TH, V2, P3, DOI 10.1517/14712598.2.1.3; Martinez-Moreno M, 2003, FEBS LETT, V544, P262, DOI 10.1016/S0014-5793(03)00516-7; Mathew SS, 2009, J VIROL, V83, P9304, DOI 10.1128/JVI.01826-08; Momose F, 2002, J BIOL CHEM, V277, P45306, DOI 10.1074/jbc.M206822200; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Naito T, 2007, J VIROL, V81, P1339, DOI 10.1128/JVI.01917-06; Pei Y, 2011, ANTIVIR RES, V89, P98, DOI 10.1016/j.antiviral.2010.11.012; Piret J, 2011, ANTIMICROB AGENTS CH, V55, P459, DOI 10.1128/AAC.00615-10; Ploubidou A, 2001, CURR OPIN CELL BIOL, V13, P97, DOI 10.1016/S0955-0674(00)00180-0; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Reynolds AE, 2002, J VIROL, V76, P8939, DOI 10.1128/JVI.76.17.8939-8952.2002; SANCHEZ C, 1994, ARCH BIOCHEM BIOPHYS, V310, P428, DOI 10.1006/abbi.1994.1188; Sodeik B, 2000, TRENDS MICROBIOL, V8, P465, DOI 10.1016/S0966-842X(00)01824-2; Sodeik B, 1997, J CELL BIOL, V136, P1007, DOI 10.1083/jcb.136.5.1007; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; Wang Y, 2011, J CLIN VIROL, V52, P107, DOI 10.1016/j.jcv.2011.06.009; Weller SK, 2011, ALPHAHERPESVIRUSES: MOLECULAR VIROLOGY, P1; Xiang YF, 2012, BIOORG MED CHEM LETT, V22, P4703, DOI 10.1016/j.bmcl.2012.05.079; Yang K, 2006, MOL BIOL CELL, V17, P1461, DOI 10.1091/mbc.E05-09-0853; Zheng K, 2014, MBIO, V5, DOI [10.1128/mBio.00942-13, 10.1128/mBio.00958-13]	46	31	34	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99425	10.1371/journal.pone.0099425	http://dx.doi.org/10.1371/journal.pone.0099425			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901434	Green Submitted, Green Published, gold			2022-12-27	WOS:000336841400127
J	Toh, TC; Ng, CSL; Peh, JWK; Ben Toh, K; Chou, LM				Toh, Tai Chong; Ng, Chin Soon Lionel; Peh, Jia Wei Kassler; Ben Toh, Kok; Chou, Loke Ming			Augmenting the Post-Transplantation Growth and Survivorship of Juvenile Scleractinian Corals via Nutritional Enhancement	PLOS ONE			English	Article							POCILLOPORA-DAMICORNIS; PORITES-COMPRESSA; REEF; RESTORATION; RECRUITS; SIZE; TRANSPLANTATION; HETEROTROPHY; ZOOPLANKTON; STRATEGIES	Size-dependant mortality influences the recolonization success of juvenile corals transplanted for reef restoration and assisting juvenile corals attain a refuge size would thus improve post-transplantation survivorship. To explore colony size augmentation strategies, recruits of the scleractinian coral Pocillopora damicornis were fed with live Artemia salina nauplii twice a week for 24 weeks in an ex situ coral nursery. Fed recruits grew significantly faster than unfed ones, with corals in the 3600, 1800, 600 and 0 (control) nauplii/L groups exhibiting volumetric growth rates of 10.65 +/- 1.46, 4.69 +/- 0.9, 3.64 +/- 0.55 and 1.18 +/- 0.37 mm(3)/week, respectively. Corals supplied with the highest density of nauplii increased their ecological volume by more than 74 times their initial size, achieving a mean final volume of 248.38 +/- 33.44 mm(3). The benefits of feeding were apparent even after transplantation to the reef. The corals in the 3600, 1800, 600 and 0 nauplii/L groups grew to final sizes of 4875 +/- 260 mm(3), 203 +/- 6627 mm(3), 1066 +/- 70 mm 3 and 512 +/- 116 mm(3), respectively. The fed corals had significantly higher survival rates than the unfed ones after transplantation (63%, 59%, 56% and 38% for the 3600, 1800, 600 and 0 nauplii/L treatments respectively). Additionally, cost-effectiveness analysis revealed that the costs per unit volumetric growth were drastically reduced with increasing feed densities. Corals fed with the highest density of nauplii were the most cost-effective (US$ 0.02/mm(3)), and were more than 12 times cheaper than the controls. This study demonstrated that nutrition enhancement can augment coral growth and post-transplantation survival, and is a biologically and economically viable option that can be used to supplement existing coral mariculture procedures and enhance reef restoration outcomes.	[Toh, Tai Chong; Ng, Chin Soon Lionel; Peh, Jia Wei Kassler; Ben Toh, Kok; Chou, Loke Ming] Natl Univ Singapore, Dept Biol Sci, Reef Ecol Lab, Singapore 117548, Singapore	National University of Singapore	Toh, TC (corresponding author), Natl Univ Singapore, Dept Biol Sci, Reef Ecol Lab, Singapore 117548, Singapore.	taichong.toh@gmail.com	Toh, Kok Ben/D-7294-2014; Ng, Lionel/AAF-5117-2020; Chou, Loke/AAE-5266-2020	Ng, Lionel/0000-0003-2700-3474; Chou, Loke/0000-0001-6668-399X; Toh, Tai Chong/0000-0003-2961-4199; Toh, Kok Ben/0000-0003-1371-817X	Wildlife Reserves Singapore Conservation Fund; National University of Singapore Research Scholarship; SingHaiyi Scholarship	Wildlife Reserves Singapore Conservation Fund; National University of Singapore Research Scholarship(National University of Singapore); SingHaiyi Scholarship	Funding for the research was provided by Wildlife Reserves Singapore Conservation Fund awarded to TCT. TCT was supported by the National University of Singapore Research Scholarship and the SingHaiyi Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 1999, J EXP MAR BIOL ECOL, V232, P85, DOI 10.1016/S0022-0981(98)00099-9; BAK RPM, 1979, MAR BIOL, V54, P341, DOI 10.1007/BF00395440; Benijts F., 1976, P 10 EUR S MAR BIOL, V1, P1; Bridge TCL, 2013, NAT CLIM CHANGE, V3, P528, DOI 10.1038/nclimate1879; Chou L., 2012, CONTRIBUTIONS MARI S, V5, P81; Chou LM, 1993, P 7 INT COR REEF S, P500; Cumbo VR, 2012, CORAL REEFS, V31, P1155, DOI 10.1007/s00338-012-0940-x; Dikou A, 2006, MAR POLLUT BULL, V52, P1340, DOI 10.1016/j.marpolbul.2006.02.011; Edwards AJ, 1998, MAR POLLUT BULL, V37, P474; Edwards AJ, 2010, REEF REHABILITATION; Ferrier-Pages C, 2003, CORAL REEFS, V22, P229, DOI 10.1007/s00338-003-0312-7; Forsman ZH, 2006, AQUACULTURE, V261, P89, DOI 10.1016/j.aquaculture.2006.06.040; Graham NAJ, 2013, FRONT ECOL ENVIRON, V11, P541, DOI 10.1890/120305; Guest J., 2010, REEF REHABILITATION, P73; Harii S, 2002, MAR BIOL, V141, P39, DOI 10.1007/s00227-002-0812-y; Harriott V.J., 1983, Coral Reefs, V2, P151, DOI 10.1007/BF00336721; Heyward AJ, 2002, MAR ECOL PROG SER, V230, P113, DOI 10.3354/meps230113; Hii YS, 2009, AQUACULT INT, V17, P363, DOI 10.1007/s10499-008-9208-4; Houlbreque F, 2009, BIOL REV, V84, P1, DOI 10.1111/j.1469-185X.2008.00058.x; HUGHES TP, 1984, AM NAT, V123, P778, DOI 10.1086/284239; Levy G, 2010, ECOL ENG, V36, P560, DOI 10.1016/j.ecoleng.2009.12.003; Marubini F, 2001, MAR ECOL PROG SER, V220, P153, DOI 10.3354/meps220153; Nakamura R, 2011, MAR ECOL PROG SER, V436, P161, DOI 10.3354/meps09257; Ng C.S.L., 2012, CONTRIBUTIONS MARINE, P95; Omori M, 2008, CORAL REEFS, V27, P165, DOI 10.1007/s00338-007-0312-0; PANCER Z, 1995, BIOL BULL, V189, P106, DOI 10.2307/1542460; Petersen D, 2008, AQUACULTURE, V277, P174, DOI 10.1016/j.aquaculture.2008.02.034; Raymundo LJ, 2004, ECOL APPL, V14, P281, DOI 10.1890/02-5373; Rinkevich B, 1995, RESTOR ECOL, V3, P241, DOI 10.1111/j.1526-100X.1995.tb00091.x; RINKEVICH B, 1992, OIKOS, V63, P119, DOI 10.2307/3545520; Sebens KP, 1997, J EXP MAR BIOL ECOL, V211, P1, DOI 10.1016/S0022-0981(96)02636-6; Shafir S, 2006, MAR BIOL, V149, P679, DOI 10.1007/s00227-005-0236-6; Shaish L, 2010, ECOL ENG, V36, P1424, DOI 10.1016/j.ecoleng.2010.06.022; Shearer TL, 2009, CORAL REEFS, V28, P727, DOI 10.1007/s00338-009-0520-x; SOROKIN YI, 1973, LIMNOL OCEANOGR, V18, P380, DOI 10.4319/lo.1973.18.3.0380; Toh TC, 2013, AQUACULTURE, V414, P288, DOI 10.1016/j.aquaculture.2013.08.025; Toh TC, 2013, MAR FRESHW BEHAV PHY, V46, P313, DOI 10.1080/10236244.2013.832890; Toh TC, 2013, MAR BIODIVERS, V43, P177, DOI 10.1007/s12526-013-0156-5; VANMOORSEL GWNM, 1985, MAR ECOL PROG SER, V24, P99, DOI 10.3354/meps024099; Veron J.E.N., 2000, CORALS WORLD, V1-3; Villanueva RD, 2012, MAR BIOL RES, V8, P877, DOI 10.1080/17451000.2012.682582; Wallace CC, 1985, MAR BIOL, V88, P21; WOOD R, 1993, PALAIOS, V8, P526, DOI 10.2307/3515030; Yap HT, 1998, J EXP MAR BIOL ECOL, V229, P69, DOI 10.1016/S0022-0981(98)00041-0	45	30	30	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98529	10.1371/journal.pone.0098529	http://dx.doi.org/10.1371/journal.pone.0098529			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896085	Green Published, Green Submitted, gold			2022-12-27	WOS:000338430700049
J	Boerio, D; Bostock, H; Spescha, R; Z'Graggen, WJ				Boerio, Delphine; Bostock, Hugh; Spescha, Romana; Z'Graggen, Werner J.			Potassium and the Excitability Properties of Normal Human Motor Axons In Vivo	PLOS ONE			English	Article							STAGE KIDNEY-DISEASE; NERVE EXCITABILITY; MEMBRANE CURRENTS; MYELINATED NERVE; PERIPHERAL-NERVE; RANVIER NODE; CHANNELS; FIBERS; NEUROPATHY; HYPERKALEMIA	Hyperkalemia is an important cause of membrane depolarization in renal failure. A recent theoretical model of axonal excitability explains the effects of potassium on threshold electrotonus, but predicts changes in superexcitability in the opposite direction to those observed. To resolve this contradiction we assessed the relationship between serum potassium and motor axon excitability properties in 38 volunteers with normal potassium levels. Most threshold electrotonus measures were strongly correlated with potassium, and superexcitability decreased at higher potassium levels (P = 0.016), contrary to the existing model. Improved modelling of potassium effects was achieved by making the potassium currents obey the constant-field theory, and by making the potassium permeabilities proportional to external potassium, as has been observed in vitro. This new model also accounted well for the changes in superexcitability and other excitability measures previously reported in renal failure. These results demonstrate the importance of taking potassium levels into account when assessing axonal membrane dysfunction by excitability testing, and provide evidence that potassium currents are activated by external potassium in vivo.	[Boerio, Delphine; Bostock, Hugh; Spescha, Romana; Z'Graggen, Werner J.] Univ Hosp Bern, Inselspital, Dept Neurol, CH-3010 Bern, Switzerland; [Boerio, Delphine; Bostock, Hugh; Spescha, Romana; Z'Graggen, Werner J.] Univ Bern, Bern, Switzerland; [Bostock, Hugh] UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England; [Z'Graggen, Werner J.] Univ Hosp Bern, Inselspital, Dept Neurosurg, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of London; University College London; University of Bern; University Hospital of Bern	Bostock, H (corresponding author), Univ Hosp Bern, Inselspital, Dept Neurol, CH-3010 Bern, Switzerland.	H.Bostock@ucl.ac.uk	BOSTOCK, HUGH/AAD-8698-2019	Z'Graggen, Werner/0000-0002-5684-4419	Swiss National Science Foundation [320030_125160/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by a grant of the Swiss National Science Foundation (320030_125160/1) (http://www.snf.ch) to W.J.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold R, 2014, CLIN NEUROPHYSIOL, V125, P179, DOI 10.1016/j.clinph.2013.06.022; Arroyo EJ, 2000, HISTOCHEM CELL BIOL, V113, P1, DOI 10.1007/s004180050001; Bostock H, 2004, NEPHROL DIAL TRANSPL, V19, P1054, DOI 10.1093/ndt/gfh093; BOSTOCK H, 1991, J PHYSIOL-LONDON, V441, P537, DOI 10.1113/jphysiol.1991.sp018766; Bostock H, 1998, MUSCLE NERVE, V21, P137, DOI 10.1002/(SICI)1097-4598(199802)21:2<137::AID-MUS1>3.0.CO;2-C; BRISMAR T, 1980, J PHYSIOL-LONDON, V298, P171, DOI 10.1113/jphysiol.1980.sp013074; CHIU SY, 1981, J PHYSIOL-LONDON, V313, P415, DOI 10.1113/jphysiol.1981.sp013674; CHIU SY, 1979, J PHYSIOL-LONDON, V292, P149, DOI 10.1113/jphysiol.1979.sp012843; DUBOIS JM, 1977, PFLUG ARCH EUR J PHY, V370, P185, DOI 10.1007/BF00581693; DUBOIS JM, 1981, J PHYSIOL-LONDON, V318, P297; FRANKENHAEUSER B, 1964, J PHYSIOL-LONDON, V171, P302, DOI 10.1113/jphysiol.1964.sp007378; Howells J, 2012, J PHYSL, V500, P1625; Kanai K, 2012, J NEUROL NEUROSUR PS, V83, P734, DOI 10.1136/jnnp-2011-301782; Kiernan MC, 2005, ANN NEUROL, V57, P339, DOI 10.1002/ana.20395; Kiernan MC, 2000, MUSCLE NERVE, V23, P399, DOI 10.1002/(SICI)1097-4598(200003)23:3<399::AID-MUS12>3.0.CO;2-G; Kiernan MC, 2002, BRAIN, V125, P1366, DOI 10.1093/brain/awf123; Kiernan MC, 2001, BRAIN, V124, P816, DOI 10.1093/brain/124.4.816; Krarup C, 2009, CURR OPIN NEUROL, V22, P460, DOI 10.1097/WCO.0b013e3283304c9d; Krishnan AV, 2006, CLIN NEUROPHYSIOL, V117, P992, DOI 10.1016/j.clinph.2006.02.002; Krishnan AV, 2009, PROG NEUROBIOL, V89, P288, DOI 10.1016/j.pneurobio.2009.08.002; Krishnan AV, 2006, J NEUROL NEUROSUR PS, V77, P548, DOI 10.1136/jnnp.2005.079988; Krishnan AV, 2005, BRAIN, V128, P2164, DOI 10.1093/brain/awh558; Kuwabara S, 2002, MUSCLE NERVE, V26, P283, DOI 10.1002/mus.10169; Kuwabara S, 2007, CLIN NEUROPHYSIOL, V118, P278, DOI 10.1016/j.clinph.2006.10.009; Lin CSY, 2008, BRAIN, V131, P2510, DOI 10.1093/brain/awn152; Nodera H, 2006, CLIN NEUROPHYSIOL, V117, P1902, DOI 10.1016/j.clinph.2006.01.018; Park SB, 2012, JOVE-J VIS EXP, V62, P3439; ROPER J, 1989, J PHYSIOL-LONDON, V416, P93; RUTHERFORD WE, 1977, KIDNEY INT, V11, P62, DOI 10.1038/ki.1977.8; SAFRONOV BV, 1993, J PHYSIOL-LONDON, V460, P675, DOI 10.1113/jphysiol.1993.sp019493; SCHOLZ A, 1993, J NEUROPHYSIOL, V70, P1274, DOI 10.1152/jn.1993.70.3.1274; SCHWARZ JR, 1995, PFLUG ARCH EUR J PHY, V430, P283, DOI 10.1007/BF00374660; Z'Graggen WJ, 2006, BRAIN, V129, P2461, DOI 10.1093/brain/awl191	33	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98262	10.1371/journal.pone.0098262	http://dx.doi.org/10.1371/journal.pone.0098262			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893161	gold, Green Submitted, Green Published			2022-12-27	WOS:000336911400043
J	Lin, WC; Chen, PC; Wang, HC; Tsai, NW; Chou, KH; Chen, HL; Su, YJ; Lin, CP; Li, SH; Chang, WN; Lu, CH				Lin, Wei-Che; Chen, Pei-Chin; Wang, Hung-Chen; Tsai, Nai-Wen; Chou, Kun-Hsien; Chen, Hsiu-Ling; Su, Yu-Jih; Lin, Ching-Po; Li, Shau-Hsuan; Chang, Wen-Neng; Lu, Cheng-Hsien			Diffusion Tensor Imaging Study of White Matter Damage in Chronic Meningitis	PLOS ONE			English	Article							CRYPTOCOCCAL MENINGITIS; TUBERCULOUS MENINGITIS; PROGNOSTIC-FACTORS; WATER DIFFUSION; NERVOUS-SYSTEM; BASAL GANGLIA; MENINGOENCEPHALITIS; SCHIZOPHRENIA; HYDROCEPHALUS; DEGENERATION	Tuberculous meningitis (TBM) and cryptococcal meningitis (CM) are two of the most common types of chronic meningitis. This study aimed to assess whether chronic neuro-psychological sequelae are associated with micro-structure white matter (WM) damage in HIV-negative chronic meningitis. Nineteen HIV-negative TBM patients, 13 HIV-negative CM patients, and 32 sex-and age-matched healthy volunteers were evaluated and compared. The clinical relevance of WM integrity was studied using voxel-based diffusion tensor imaging (DTI) magnetic resonance imaging. All of the participants underwent complete medical and neurologic examinations, and neuro-psychological testing. Differences in DTI indices correlated with the presence of neuro-psychological rating scores and cerebrospinal fluid (CSF) analysis during the initial hospitalization. Patients with CM had more severe cognitive deficits than healthy subjects, especially in TBM. There were changes in WM integrity in several limbic regions, including the para-hippocampal gyrus and cingulate gyrus, and in the WM close to the globus pallidus. A decline in WM integrity close to the globus pallidus and anterior cingulate gyrus was associated with worse CSF analysis profiles. Poorer DTI parameters directly correlated with worse cognitive performance on follow-up. These correlations suggest that WM alterations may be involved in the psychopathology and pathophysiology of co-morbidities. Abnormalities in the limbic system and globus pallidus, with their close relationship to the CSF space, may be specific biomarkers for disease evaluation.	[Lin, Wei-Che; Chen, Pei-Chin; Chen, Hsiu-Ling] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Radiol, Kaohsiung, Taiwan; [Wang, Hung-Chen] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung, Taiwan; [Tsai, Nai-Wen; Chang, Wen-Neng; Lu, Cheng-Hsien] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Neurol, Kaohsiung, Taiwan; [Chou, Kun-Hsien; Lin, Ching-Po] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan; [Su, Yu-Jih; Li, Shau-Hsuan] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan; [Lu, Cheng-Hsien] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; Chang Gung University; National Sun Yat Sen University	Lu, CH (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Neurol, Kaohsiung, Taiwan.	chlu99@adm.cgmh.org.tw	Su, Yu-Jih/AGJ-4763-2022	Su, Yu-Jih/0000-0002-7274-3458	Chang Gung Memorial Hospital [CMRPG 870482, CMRPG 870991, CMRPG 890801]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was supported by Chang Gung Memorial Hospital (Chang Gung Medical Research Project Grant/CMRPG 870482 to WC Lin, CMRPG 870991 to CH Lu, and CMRPG 890801 to HL Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Cabronero J, 2010, BRAIN, V133, P529, DOI 10.1093/brain/awp257; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Bai YM, 2009, SCHIZOPHR RES, V109, P167, DOI 10.1016/j.schres.2009.02.003; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; BHATIA KP, 1994, BRAIN, V117, P859, DOI 10.1093/brain/117.4.859; Carter CS, 1997, AM J PSYCHIAT, V154, P1670, DOI 10.1176/ajp.154.12.1670; Catani M, 2006, CURR OPIN NEUROL, V19, P599, DOI 10.1097/01.wco.0000247610.44106.3f; Chang CC, 2008, EUR J NEUROL, V15, pE66, DOI 10.1111/j.1468-1331.2008.02151.x; Vieira MADES, 2013, REV SOC BRAS MED TRO, V46, P658, DOI 10.1590/0037-8682-0142-2013; Dammann O, 2000, J PEDIATR-US, V136, P433, DOI 10.1016/S0022-3476(00)90004-0; Del Bigio MR, 2003, ANN NEUROL, V53, P337, DOI 10.1002/ana.10453; DELBIGIO MR, 1993, ACTA NEUROPATHOL, V85, P573, DOI 10.1007/BF00334666; DIAMOND RD, 1974, ANN INTERN MED, V80, P176, DOI 10.7326/0003-4819-80-2-176; Girgis NI, 1998, AM J TROP MED HYG, V58, P28, DOI 10.4269/ajtmh.1998.58.28; Glass HC, 2008, PEDIATRICS, V122, P299, DOI 10.1542/peds.2007-2184; Gumbo T, 2002, PEDIATR INFECT DIS J, V21, P54, DOI 10.1097/00006454-200201000-00012; Hoffmann M, 2009, J ALZHEIMERS DIS, V16, P517, DOI 10.3233/JAD-2009-0985; Kuwahara H, 2014, NEUROPATHOLOGY, V34, P45, DOI 10.1111/neup.12046; Lan SH, 2001, QJM-MON J ASSOC PHYS, V94, P247, DOI 10.1093/qjmed/94.5.247; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lee SC, 1996, HUM PATHOL, V27, P839, DOI 10.1016/S0046-8177(96)90459-1; Liliang PC, 2003, CLIN INFECT DIS, V37, P673, DOI 10.1086/377208; Lim KO, 2002, NMR BIOMED, V15, P587, DOI 10.1002/nbm.789; Lin WC, 2009, AM J NEURORADIOL, V30, P1248, DOI 10.3174/ajnr.A1517; Lin WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033809; Lu CH, 2007, INFECTION, V35, P359, DOI 10.1007/s15010-007-6263-0; Lu CH, 2011, AM J NEURORADIOL, V32, P1333, DOI 10.3174/ajnr.A2489; Lu CH, 1999, J HOSP INFECT, V42, P313, DOI 10.1053/jhin.1998.0610; Malik GK, 2008, BRAIN DEV-JPN, V30, P334, DOI 10.1016/j.braindev.2007.10.002; Misra UK, 1996, J NEUROL SCI, V137, P57, DOI 10.1016/0022-510X(95)00334-X; Moseley M, 2002, NMR BIOMED, V15, P553, DOI 10.1002/nbm.785; MS G, 1997, HYDROCEPHALUS; Mukherjee P, 2000, RADIOLOGY, V215, P211, DOI 10.1148/radiology.215.1.r00ap29211; Nyhus E, 2009, BRAIN COGNITION, V71, P437, DOI 10.1016/j.bandc.2009.03.005; Rock RB, 2008, CLIN MICROBIOL REV, V21, P243, DOI 10.1128/CMR.00042-07; SAADAH MA, 1995, TROP GEOGR MED, V47, P224; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Szeszko PR, 2000, SCHIZOPHR RES, V43, P97, DOI 10.1016/S0920-9964(99)00155-3; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Thwaites GE, 2003, J INFECT DIS, V188, P1105, DOI 10.1086/378642; Trivedi R, 2007, NEURORADIOLOGY, V49, P767, DOI 10.1007/s00234-007-0246-9; Trivedi Richa, 2009, Indian J Radiol Imaging, V19, P256, DOI 10.4103/0971-3026.57205; Tung GA, 2003, AM J NEURORADIOL, V24, P1110; Volpe JJ., 2001, NEUROLOGY NEWBORN, V4; Wechsler D, 1981, WECHSLER ADAPT INTEL; Wojciulik E, 1999, NEURON, V23, P747, DOI 10.1016/S0896-6273(01)80033-7	48	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98210	10.1371/journal.pone.0098210	http://dx.doi.org/10.1371/journal.pone.0098210			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892826	gold, Green Published, Green Submitted			2022-12-27	WOS:000336911400040
J	Ruano-Fajardo, G; Rovito, SM; Ladle, RJ				Ruano-Fajardo, Gustavo; Rovito, Sean M.; Ladle, Richard J.			Bromeliad Selection by Two Salamander Species in a Harsh Environment	PLOS ONE			English	Article							ADAPTIVE RADIATION; PLETHODONTIDAE; ANURA; DIVERSIFICATION; MICROHABITAT; EVOLUTIONARY; AMPHIBIA; ECOLOGY; GENUS; PH	Bromeliad phytotelmata are frequently used by several Neotropical amphibian taxa, possibly due to their high humidity, microclimatic stability, and role as a refuge from predators. Indeed, the ability of phytotelmata to buffer against adverse environmental conditions may be instrumental in allowing some amphibian species to survive during periods of environmental change or to colonize sub-optimal habitats. Association between bromeliad traits and salamanders has not been studied at a fine scale, despite the intimate association of many salamander species with bromeliads. Here, we identify microhabitat characteristics of epiphytic bromeliads used by two species of the Bolitoglossa morio group (B. morio and B. pacaya) in forest disturbed by volcanic activity in Guatemala. Specifically, we measured multiple variables for bromeliads (height and position in tree, phytotelma water temperature and pH, canopy cover, phytotelma size, leaf size, and tree diameter at breast height), as well as salamander size. We employed a DNA barcoding approach to identify salamanders. We found that B. morio and B. pacaya occurred in microsympatry in bromeliads and that phytotelmata size and temperature of bromeliad microhabitat were the most important factors associated with the presence of salamanders. Moreover, phytotelmata with higher pH contained larger salamanders, suggesting that larger salamanders or aggregated individuals might modify pH. These results show that bromeliad selection is nonrandom with respect to microhabitat characteristics, and provide insight into the relationship between salamanders and this unique arboreal environment.	[Ruano-Fajardo, Gustavo] Univ San Carlos, Fac Ciencias Quim & Farm, Escuela Biol, Museo Hist Nat, Ciudad De Guatemala, Guatemala; [Rovito, Sean M.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Ruano-Fajardo, Gustavo; Ladle, Richard J.] Univ Fed Alagoas, Inst Ciencias Biol & Saude, Sect Diversidade Biol & Conservacao Trop, Maceio, Alagoas, Brazil; [Ladle, Richard J.] Univ Oxford, Sch Geog & Environm, Oxford, England	Universidad de San Carlos de Guatemala; University of California System; University of California Berkeley; Universidade Federal de Alagoas; University of Oxford	Ruano-Fajardo, G (corresponding author), Univ San Carlos, Fac Ciencias Quim & Farm, Escuela Biol, Museo Hist Nat, Ciudad De Guatemala, Guatemala.	ruano.gustavo@yahoo.com	Rovito, Sean/AAG-1143-2019; Ladle, Richard/E-4228-2014	Rovito, Sean/0000-0002-4713-9654; Ladle, Richard/0000-0003-3200-3946	Direccion General de Docencia (DIGED), Universidad San Carlos de Guatemala (USAC); U.S. National Science Foundation [DEB 1026396]; UC MEXUS-CONACyT postdoctoral fellowship	Direccion General de Docencia (DIGED), Universidad San Carlos de Guatemala (USAC); U.S. National Science Foundation(National Science Foundation (NSF)); UC MEXUS-CONACyT postdoctoral fellowship	G. Ruano-Fajardo was funded by the Direccion General de Docencia (DIGED), Universidad San Carlos de Guatemala (USAC) and S. Rovito was supported by a Biodiversity Survey and Inventory grant from the U.S. National Science Foundation (DEB 1026396) and a UC MEXUS-CONACyT postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AmphibiaWeb, 2013, AMPHIBIAWEB INF AMPH; Bandoni F, 2004, J HERPETOL, V38, P331; BENZING DH, 2000, BROMELIACEAE PROFILE; Blankers T, 2012, J EVOLUTION BIOL, V25, P634, DOI 10.1111/j.1420-9101.2012.02458.x; Buosi PRB, 2014, J EUKARYOT MICROBIOL, V61, P2, DOI 10.1111/jeu.12071; Campbell Jonathan A., 2010, MISCELLANEOUS PUBLICATIONS MUSEUM OF ZOOLOGY UNIVERSITY OF MICHIGAN, P1; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; FEDER ME, 1982, ECOLOGY, V63, P1665, DOI 10.2307/1940108; FRISBIE MP, 1992, ARCH ENVIRON CON TOX, V23, P64; Goncalves-Souza T, 2010, J ARACHNOL, V38, P270, DOI 10.1636/P09-58.1; Grinnell J., 1904, Auk, Vxxi, P364; Grippa CR, 2007, MYCORRHIZA, V17, P235, DOI 10.1007/s00572-006-0090-5; Heyer W. R., 1994, MEASURING MONITORING, P364; Kitching R. L., 2000, FOOD WEBS CONTAINER, P431; Lehtinen Richard M., 2004, Miscellaneous Publications Museum of Zoology University of Michigan, V193, P1; Leroy C, 2013, ANN BOT-LONDON, V112, P919, DOI 10.1093/aob/mct147; LYNCH JF, 1985, J HERPETOL, V19, P328, DOI 10.2307/1564262; Maguire Jr B, 1971, ANNU REV ECOL SYST, V2, P439, DOI [DOI 10.1146/ANNUREV.ES.02.110171.002255, 10.1146/annurev.es.02.110171.002255]; McLachlan A, 2001, BIOL REV, V76, P377, DOI 10.1017/S1464793101005723; MORITZ C, 1992, SYST BIOL, V41, P273, DOI 10.2307/2992567; Palumbi S. R., 1996, MOL SYSTEMATICS, V2, P205, DOI DOI 10.1080/17451000.2014.902536; Parra-Olea G, 2004, BIOL J LINN SOC, V81, P325, DOI 10.1111/j.1095-8312.2003.00303.x; Pederassi J, 2012, BRAZ J BIOL, V72, P229, DOI 10.1590/S1519-69842012000200001; Peixoto OL, 2003, HERPETOLOGICA, V59, P235, DOI 10.1655/0018-0831(2003)059[0235:TNSOPA]2.0.CO;2; Peixoto Oswaldo Luiz, 1995, Revista Universidade Rural Serie Ciencias da Vida, V17, P75; Peng CYJ, 2002, J EDUC RES, V96, P3, DOI 10.1080/00220670209598786; Poelman EH, 2013, EVOL ECOL, V27, P661, DOI 10.1007/s10682-013-9633-3; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Romero GQ, 2010, OECOLOGIA, V162, P941, DOI 10.1007/s00442-009-1533-4; Rovito SM, 2013, BIOL J LINN SOC, V109, P622, DOI 10.1111/bij.12083; Rovito SM, 2012, J BIOGEOGR, V39, P1251, DOI 10.1111/j.1365-2699.2012.02696.x; Sherman E, 2012, NORTHEAST NAT, V19, P111, DOI 10.1656/045.019.0109; Stuckert Adam M. M., 2009, Phyllomedusa, V8, P125; Wake D.B., 1976, NAT HIST MUS LOS ANG, V25, P1; Wake DB, 2009, ANNU REV ECOL EVOL S, V40, P333, DOI 10.1146/annurev.ecolsys.39.110707.173552; WAKE DB, 1987, ANN MO BOT GARD, V74, P242, DOI 10.2307/2399397; Woodley SK, 2014, GEN COMP ENDOCR, V201, P8, DOI 10.1016/j.ygcen.2014.03.019	37	8	10	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98474	10.1371/journal.pone.0098474	http://dx.doi.org/10.1371/journal.pone.0098474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892414	Green Published, Green Submitted, gold			2022-12-27	WOS:000336911400056
J	Wang, SL; Wu, B; Zhu, LA; Leng, L; Bucala, R; Lu, LJ				Wang, Su-li; Wu, Bin; Zhu, Li-an; Leng, Lin; Bucala, Richard; Lu, Liang-jing			Construct and Criterion Validity of the Euro Qol-5D in Patients with Systemic Lupus Erythematosus	PLOS ONE			English	Article							QUALITY-OF-LIFE; THE-LITERATURE; INDEX; COHORT	Objective: To investigate the construct and criterion validity of the Euro Qol-5D (EQ-5D), which allows quality-adjusted life-years to be calculated, in patients with systemic lupus erythematosus (SLE). Methods: Consecutive SLE patients who had been followed at the Renji Hospital, School of Medicine, Shanghai Jiao Tong University were recruited. Cross-sectional correlations of the EQ-5D with equivalent domains in disease-specific health-related quality of life (HRQoL), LupusQol, Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) measures, the Systemic Lupus International Collaborating Clinics Damage Index (SDI), and patient characteristics were tested. Discriminant validity to assess the ability to distinguish between patients of different disease severity was assessed. There also were evaluations of ceiling and floor effects. Results: 240 patients were recruited in total. The EQ-5D correlated moderately to strongly with all domains of the LupusQoL (r : 0.44-0.7) apart from intimate relationships (r = 0.25) and body image (r = 0.18). There was moderate negative correlation between EQ-5D and clinical assessment of disease, SLEDAI (r = -0.589) and SDI (r = -0.509). When compared with equivalent domains on LupusQoL, there was good construct validity in EQ-5D (r: 0.631-0.812). EQ-5D could also discriminate patients with varied disease severity (according SLEDAI and SDI). There was no floor effect in EQ-5D but the ceiling effect remains strong (34%). Conclusion: Our results provide sufficient evidence that the EQ-5D displays construct and criterion validity for use in SLE patients. Disease-specific measures of HRQoL used alongside may be a better choice.	[Wang, Su-li; Lu, Liang-jing] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Rheumatol, Shanghai 200030, Peoples R China; [Wu, Bin] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Clin Outcomes & Econ Grp,Dept Pharm, Shanghai 200030, Peoples R China; [Zhu, Li-an; Leng, Lin; Bucala, Richard] Yale Univ, Sch Med, Dept Med, Sect Rheumatol,Anlyan Ctr, New Haven, CT 06510 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Yale University	Lu, LJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Rheumatol, Shanghai 200030, Peoples R China.	lu_liangjing@medmail.com.cn		Leng, Lin/0000-0002-0605-358X; Lu, Liangjing/0000-0001-9116-6038	National Natural Sciences Foundation of China [81373209, 81072469, 30671946]; Shanghai Natural Sciences Foundation [09ZR1417600]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Sciences Foundation(Natural Science Foundation of Shanghai)	This work was supported by grants from the National Natural Sciences Foundation of China (No. 81373209; No. 81072469; No. 30671946) and Shanghai Natural Sciences Foundation (No. 09ZR1417600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aday LA, 1996, DESIGNING CONDUCTING; Alarcon GS, 2004, ARTHRIT RHEUM-ARTHR, V51, P465, DOI 10.1002/art.20409; [Anonymous], 2011, FDA APPROVES BENLYST; Cervera R, 2003, MEDICINE, V82, P299, DOI 10.1097/01.md.0000091181.93122.55; Dua AB, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0380-9; Gladman DD, 1997, ARTHRITIS RHEUM-US, V40, P809, DOI 10.1002/art.1780400506; Gladman DD, 2002, J RHEUMATOL, V29, P288; Grech P, 2013, LUPUS, V22, P978, DOI 10.1177/0961203313499417; Group EQ, 1990, HLTH POLICY, V16, P199, DOI DOI 10.1016/0168-8510(90)90421-9; Harrison MJ, 2012, J RHEUMATOL, V39, P735, DOI 10.3899/jrheum.110648; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Jolly M, 2005, J RHEUMATOL, V32, P1706; Jolly M, 2010, ANN RHEUM DIS, V69, P29, DOI 10.1136/ard.2008.094763; Kularatna S, 2013, VALUE HEALTH, V16, P1091, DOI 10.1016/j.jval.2013.05.006; Kuriya B, 2008, ARTHRIT RHEUM-ARTHR, V59, P181, DOI 10.1002/art.23339; McElhone K, 2007, ARTHRIT RHEUM-ARTHR, V57, P972, DOI 10.1002/art.22881; MCHORNEY CA, 1995, QUAL LIFE RES, V4, P293, DOI 10.1007/BF01593882; Mok CC, 2005, MEDICINE, V84, P218, DOI 10.1097/01.md.0000170022.44998.d1; Rudmik L, 2013, LARYNGOSCOPE, V123, P1341, DOI 10.1002/lary.23943; Sullivan PW, 2006, MED DECIS MAKING, V26, P410, DOI 10.1177/0272989X06290495; Veenhof C, 2006, ARTHRIT RHEUM-ARTHR, V55, P480, DOI 10.1002/art.22001; Waldheim E, 2013, LUPUS, V22, P1118, DOI 10.1177/0961203313502109; Wang SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063795; Whitehurst DGT, 2011, MED DECIS MAKING, V31, pE34, DOI 10.1177/0272989X11421529	24	20	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98883	10.1371/journal.pone.0098883	http://dx.doi.org/10.1371/journal.pone.0098883			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892282	Green Submitted, gold, Green Published			2022-12-27	WOS:000336911400105
J	Henneberg, A; Bender, K; Blaha, L; Giebner, S; Kuch, B; Kohler, HR; Maier, D; Oehlmann, J; Richter, D; Scheurer, M; Schulte-Oehlmann, U; Sieratowicz, A; Ziebart, S; Triebskorn, R				Henneberg, Anja; Bender, Katrin; Blaha, Ludek; Giebner, Sabrina; Kuch, Bertram; Koehler, Heinz-R.; Maier, Diana; Oehlmann, Joerg; Richter, Doreen; Scheurer, Marco; Schulte-Oehlmann, Ulrike; Sieratowicz, Agnes; Ziebart, Simone; Triebskorn, Rita			Are In Vitro Methods for the Detection of Endocrine Potentials in the Aquatic Environment Predictive for In Vivo Effects? Outcomes of the Projects SchussenAktiv and SchussenAktiv plus in the Lake Constance Area, Germany	PLOS ONE			English	Article							TREATMENT-PLANT EFFLUENTS; MUNICIPAL SEWAGE PLANT; UNITED-KINGDOM RIVERS; TROUT SALMO-TRUTTA; E-SCREEN ASSAY; POTAMOPYRGUS-ANTIPODARUM; ESTROGENIC ACTIVITY; WASTE-WATER; DISRUPTING CHEMICALS; BISPHENOL-A	Many studies about endocrine pollution in the aquatic environment reveal changes in the reproduction system of biota. We analysed endocrine activities in two rivers in Southern Germany using three approaches: (1) chemical analyses, (2) in vitro bioassays, and (3) in vivo investigations in fish and snails. Chemical analyses were based on gas chromatography coupled with mass spectrometry. For in vitro analyses of endocrine potentials in water, sediment, and waste water samples, we used the E-screen assay (human breast cancer cells MCF-7) and reporter gene assays (human cell line HeLa-9903 and MDA-kb2). In addition, we performed reproduction tests with the freshwater mudsnail Potamopyrgus antipodarum to analyse water and sediment samples. We exposed juvenile brown trout (Salmo trutta f. fario) to water downstream of a wastewater outfall (Schussen River) or to water from a reference site (Argen River) to investigate the vitellogenin production. Furthermore, two feral fish species, chub (Leuciscus cephalus) and spirlin (Alburnoides bipunctatus), were caught in both rivers to determine their gonadal maturity and the gonadosomatic index. Chemical analyses provided only little information about endocrine active substances, whereas the in vitro assays revealed endocrine potentials in most of the samples. In addition to endocrine potentials, we also observed toxic potentials (E-screen/reproduction test) in waste water samples, which could interfere with and camouflage endocrine effects. The results of our in vivo tests were mostly in line with the results of the in vitro assays and revealed a consistent reproduction-disrupting (reproduction tests) and an occasional endocrine action (vitellogenin levels) in both investigated rivers, with more pronounced effects for the Schussen river (e. g. a lower gonadosomatic index). We were able to show that biological in vitro assays for endocrine potentials in natural stream water reasonably reflect reproduction and endocrine disruption observed in snails and field-exposed fish, respectively.	[Henneberg, Anja; Koehler, Heinz-R.; Maier, Diana; Triebskorn, Rita] Univ Tubingen, Tubingen, Germany; [Blaha, Ludek] Masaryk Univ, Fac Sci, RECETOX, CS-61137 Brno, Czech Republic; [Bender, Katrin; Giebner, Sabrina; Oehlmann, Joerg; Schulte-Oehlmann, Ulrike; Sieratowicz, Agnes; Ziebart, Simone] Goethe Univ Frankfurt, Dept Aquat Ecotoxicol, D-60054 Frankfurt, Germany; [Kuch, Bertram] Univ Stuttgart, Inst Sanit Engn Water Qual & Solid Waste Manageme, D-70174 Stuttgart, Germany; [Richter, Doreen; Scheurer, Marco] Water Technol Ctr Karlsruhe, Karlsruhe, Germany	Eberhard Karls University of Tubingen; Masaryk University Brno; Goethe University Frankfurt; University of Stuttgart	Henneberg, A (corresponding author), Univ Tubingen, Tubingen, Germany.	anja.henneberg@uni-tuebingen.de	Schulte-Oehlmann, Ulrike/D-1339-2010; Köhler, Heinz-R./AAL-1350-2021; Blaha, Ludek/N-6343-2013; Oehlmann, Jörg/B-4565-2010	Blaha, Ludek/0000-0002-7314-7455; Oehlmann, Jörg/0000-0002-6075-2701	Ministerium fur Umwelt, Naturschutz und Verkehr Baden-Wurttemberg (UVM); foundation "Natur und Umwelt" of the Landesbank Baden-Wurttemberg (LBBW); Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of Tubingen University; Federal Ministry for Education and Research (BMBF); Jedele Partner GmbH; Okonsult GbR; city of Ravensburg; AZV Mariatal; AV Unteres Schussental; BMBF frame programme "Research for sustainable development FONA" [02WRS1281A]	Ministerium fur Umwelt, Naturschutz und Verkehr Baden-Wurttemberg (UVM); foundation "Natur und Umwelt" of the Landesbank Baden-Wurttemberg (LBBW); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Tubingen University; Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Jedele Partner GmbH; Okonsult GbR; city of Ravensburg; AZV Mariatal; AV Unteres Schussental; BMBF frame programme "Research for sustainable development FONA"	The project SchussenAktiv was funded by the Ministerium fur Umwelt, Naturschutz und Verkehr Baden-Wurttemberg (UVM), and the foundation "Natur und Umwelt" of the Landesbank Baden-Wurttemberg (LBBW). We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tubingen University. The project SchussenAktivplus is funded by the Federal Ministry for Education and Research (BMBF) and cofounded by the Ministry of Environment Baden-Wurttemberg. In addition, the city of Ravensburg, the AZV Mariatal and the AV Unteres Schussental financially contribute to the project. The commercial companies (Jedele & Partner GmbH and Okonsult GbR) provided funding to this study. This does not alter our adherence to PLOS ONE policies on sharing data and materials. SchussenAktivplus is connected to the BMBF action plan "Sustainable water management (NaWaM)" and is integrated in the BMBF frame programme "Research for sustainable development FONA". Contract period: 1/2012 to 12/2014, Funding number: 02WRS1281A. All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann GE, 2002, AQUAT TOXICOL, V60, P203, DOI 10.1016/S0166-445X(02)00003-6; Adams SM, 1999, ENVIRON TOXICOL CHEM, V18, P628, DOI 10.1002/etc.5620180407; ANDERSSON T, 1988, CAN J FISH AQUAT SCI, V45, P1525, DOI 10.1139/f88-181; Bernet D, 2003, BATTERY TECHNOLOGY H, P1; Bicchi C, 2009, SCI TOTAL ENVIRON, V407, P1842, DOI 10.1016/j.scitotenv.2008.11.039; Bjerregaard LB, 2006, ECOTOXICOLOGY, V15, P315, DOI 10.1007/s10646-006-0061-9; Bjerregaard P, 2008, ENVIRON TOXICOL CHEM, V27, P2387, DOI 10.1897/08-148.1; Bless R, 1996, ADV LIF SCI, P249; Bolong N, 2009, DESALINATION, V239, P229, DOI 10.1016/j.desal.2008.03.020; Brander SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074251; Brauch H-J, 2011, GWF WASSER ABWASSER, V12, P1206; Burki R, 2006, ENVIRON TOXICOL CHEM, V25, P2077, DOI 10.1897/05-545R.1; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; DICKSON RB, 1981, ENDOCRINOLOGY, V108, P1511, DOI 10.1210/endo-108-4-1511; Duft M, 2003, AQUAT TOXICOL, V64, P437, DOI 10.1016/S0166-445X(03)00102-4; Duft M, 2007, ECOTOXICOLOGY, V16, P169, DOI 10.1007/s10646-006-0106-0; ECONOMOU AN, 1991, J FISH BIOL, V39, P393, DOI 10.1111/j.1095-8649.1991.tb04371.x; Folmar LC, 2002, AQUAT TOXICOL, V60, P101, DOI 10.1016/S0166-445X(01)00276-4; Fretter V, 1994, J MAR BIOL ASSOC UK, V74, P985; Galluba S, 2012, J SOIL SEDIMENT, V12, P252, DOI 10.1007/s11368-011-0454-0; Giesy JP, 2000, ENVIRON TOXICOL CHEM, V19, P1368, DOI 10.1002/etc.5620190520; Grund S, 2011, ENVIRON SCI POLLUT R, V18, P446, DOI 10.1007/s11356-010-0390-3; Gutendorf B, 2001, TOXICOLOGY, V166, P79, DOI 10.1016/S0300-483X(01)00437-1; Harries JE, 1997, ENVIRON TOXICOL CHEM, V16, P534, DOI [10.1897/1551-5028(1997)016&lt;0534:EAIFUK&gt;2.3.CO;2, 10.1002/etc.5620160320]; Heinz B, 2009, ENVIRON GEOL, V57, P797, DOI 10.1007/s00254-008-1359-0; Hilscherova K, 2002, ARCH ENVIRON CON TOX, V43, P175, DOI 10.1007/s00244-002-1128-0; Hilscherova K, 2010, ENVIRON TOXICOL CHEM, V29, P522, DOI 10.1002/etc.83; Houtman CJ, 2006, CHEMOSPHERE, V65, P2244, DOI 10.1016/j.chemosphere.2006.05.043; Jacobsen R, 1997, FUNCT ECOL, V11, P260, DOI 10.1046/j.1365-2435.1997.00082.x; Janosek J, 2006, TOXICOL IN VITRO, V20, P18, DOI 10.1016/j.tiv.2005.06.001; Jarosova B, 2012, ENVIRON INT, V45, P22, DOI 10.1016/j.envint.2012.04.001; Jarosova B, 2014, ENVIRON INT, V64, P98, DOI 10.1016/j.envint.2013.12.009; Jeffries MKS, 2011, AQUAT TOXICOL, V105, P189, DOI 10.1016/j.aquatox.2011.04.008; Jobling S, 2004, AQUAT TOXICOL, V66, P205, DOI 10.1016/j.aquatox.2004.01.001; Jobling S, 2002, BIOL REPROD, V66, P272, DOI 10.1095/biolreprod66.2.272; Jobling S, 2006, ENVIRON HEALTH PERSP, V114, P7, DOI 10.1289/ehp.8046; Jobling S, 2009, ENVIRON HEALTH PERSP, V117, P797, DOI 10.1289/ehp.0800197; Kang IJ, 2008, AQUAT TOXICOL, V87, P37, DOI 10.1016/j.aquatox.2008.01.010; Kavlock RJ, 1996, RISK ANAL, V16, P731, DOI 10.1111/j.1539-6924.1996.tb00824.x; Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104; Kime DE, 1999, AQUACULTURE, V177, P345, DOI 10.1016/S0044-8486(99)00097-6; Kinani S, 2010, ENVIRON POLLUT, V158, P74, DOI 10.1016/j.envpol.2009.07.041; Kobler B, 2004, OKOLOGISCHE FISCHBIO; Koc HT, 2007, J APPL ICHTHYOL, V23, P19, DOI 10.1111/j.1439-0426.2006.00787.x; Kohler HR, 2013, SCIENCE, V341, P759, DOI 10.1126/science.1237591; Korner W, 1999, SCI TOTAL ENVIRON, V225, P33; Korner W, 2000, CHEMOSPHERE, V40, P1131, DOI 10.1016/S0045-6535(99)00362-8; Korner W., 2001, Journal of Aquatic Ecosystem Stress and Recovery, V8, P215, DOI 10.1023/A:1012976800922; Korner W, 1999, 95004 PUGU U TUB U W; Kortenkamp A, 2007, ENVIRON HEALTH PERSP, V115, P98, DOI 10.1289/ehp.9357; Loos R, 2013, WATER RES, V47, P6475, DOI 10.1016/j.watres.2013.08.024; Louiz I, 2008, SCI TOTAL ENVIRON, V402, P318, DOI 10.1016/j.scitotenv.2008.05.005; Mazurova E, 2008, BIOLOGIA, V63, P139, DOI 10.2478/s11756-008-0027-x; Mazurova E, 2010, J SOIL SEDIMENT, V10, P423, DOI 10.1007/s11368-009-0166-x; Mert R, 2011, AFYON KOCATEPE U J S, V6, P1; MUNKITTRICK KR, 1992, CAN J FISH AQUAT SCI, V49, P1560, DOI 10.1139/f92-173; Nagel R, 2004, RINGTEST VALIDIERUNG, V200, P411; Nilsen BM, 1998, MAR ENVIRON RES, V46, P153, DOI 10.1016/S0141-1136(98)00019-1; OECD, 2010, OECD SER TEST ASS, P182; Oehlmann J, 2000, ECOTOXICOLOGY, V9, P383, DOI 10.1023/A:1008972518019; Oehlmann J, 2006, ENVIRON HEALTH PERSP, V114, P127, DOI 10.1289/ehp.8065; Peck M, 2004, ENVIRON TOXICOL CHEM, V23, P945, DOI 10.1897/03-41; PONDER WF, 1988, J MOLLUS STUD, V54, P271, DOI 10.1093/mollus/54.3.271; Purdom C.E., 1994, Chemistry and Ecology, V8, P275, DOI 10.1080/02757549408038554; Runnalls TJ, 2010, HUM ECOL RISK ASSESS, V16, P1318, DOI 10.1080/10807039.2010.526503; Schmitt C, 2008, SOP TESTING CHEM R 3; Schmitt C, 2008, ENVIRON POLLUT, V152, P322, DOI 10.1016/j.envpol.2007.06.031; Schmitt C, 2010, CHEMOSPHERE, V80, P13, DOI 10.1016/j.chemosphere.2010.03.050; Schwarzenbach RP, 2006, SCIENCE, V313, P1072, DOI 10.1126/science.1127291; Sharpe RM, 2004, BMJ-BRIT MED J, V328, P447, DOI 10.1136/bmj.328.7437.447; Sieratowicz A, 2011, ENVIRON POLLUT, V159, P2766, DOI 10.1016/j.envpol.2011.05.012; SOTO AM, 1995, ENVIRON HEALTH PERSP, V103, P113, DOI 10.1289/ehp.95103s7113; Stalter D, 2010, WATER RES, V44, P439, DOI 10.1016/j.watres.2009.07.025; Stenseth N., 2004, MARINE ECOSYSTEMS CL; SUMPTER JP, 1995, ENVIRON HEALTH PERSP, V103, P173, DOI 10.2307/3432529; Thorpe KL, 2003, ENVIRON SCI TECHNOL, V37, P1142, DOI 10.1021/es0201348; Triebskorn Rita, 2013, Environmental Sciences Europe, V25, P2, DOI 10.1186/2190-4715-25-2; Triebskorn Rita, 2012, Environmental Sciences Europe, V24, P8, DOI 10.1186/2190-4715-24-8; Turkmen Mustafa, 1999, Turkish Journal of Zoology, V23, P355; Tyler CR, 1999, ENVIRON TOXICOL CHEM, V18, P337, DOI 10.1002/etc.5620180234; U. S. EPA, 2011, ESTR REC TRANSCR ACT; Urbatzka R, 2007, CHEMOSPHERE, V67, P1080, DOI 10.1016/j.chemosphere.2006.11.041; Vajda AM, 2008, ENVIRON SCI TECHNOL, V42, P3407, DOI 10.1021/es0720661; Van den Belt K, 2004, AQUAT TOXICOL, V66, P183, DOI 10.1016/j.aquatox.2003.09.004; Velasco-Santamaria YM, 2010, MAR ENVIRON RES, V69, pS67, DOI 10.1016/j.marenvres.2009.09.009; Vigano L, 2008, CHEMOSPHERE, V73, P1078, DOI 10.1016/j.chemosphere.2008.07.057; Villeneuve DL, 2000, ENVIRON TOXICOL CHEM, V19, P2835, DOI 10.1002/etc.5620191131; Vondracek J, 2001, ENVIRON TOXICOL CHEM, V20, P1499, DOI 10.1002/etc.5620200712; Wallace C, 1979, J MOLLUS STUD, V45, P383; Weltje L, 2005, HUM EXP TOXICOL, V24, P431, DOI 10.1191/0960327105ht551oa; Wilson VS, 2002, TOXICOL SCI, V66, P69, DOI 10.1093/toxsci/66.1.69; Zhang SC, 2011, INT J BIOCHEM CELL B, V43, P303, DOI 10.1016/j.biocel.2010.11.003; Zhao JL, 2011, ENVIRON TOXICOL CHEM, V30, P2208, DOI 10.1002/etc.625	93	28	28	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98307	10.1371/journal.pone.0098307	http://dx.doi.org/10.1371/journal.pone.0098307			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901835	Green Published, Green Submitted, gold			2022-12-27	WOS:000336841400025
J	Wang, SY; Zheng, G; Cheng, BR; Chen, FF; Wang, ZM; Chen, YY; Wang, Y; Xiong, B				Wang, Shuyi; Zheng, Gang; Cheng, Boran; Chen, Fangfang; Wang, Zhenmeng; Chen, Yuanyuan; Wang, You; Xiong, Bin			Circulating Tumor Cells (CTCs) Detected by RT-PCR and Its Prognostic Role in Gastric Cancer: A Meta-Analysis of Published Literature	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; BONE-MARROW MICROMETASTASIS; ANTIGEN MESSENGER-RNA; PERIPHERAL-BLOOD; MOLECULAR-DETECTION; CLINICAL-SIGNIFICANCE; PROGRESSION; METASTASIS; EXPRESSION; MARKER	Objective: The prognostic significance of circulating tumor cells (CTCs) is controversial in gastric cancer (GC). We performed a meta-analysis of available studies to assess its prognostic value detected by RT-PCR for patients diagnosed with GC. Methods: EMBase, PubMed, Ovid, Web of Science, Cochrane library and Google Scholar database search was conducted on all studies reporting the outcomes of interest. The studies were set up according to the inclusion/exclusion criteria. Meta-analysis was performed by using a random-effects model; hazard ratio (HR), risk ratio (RR) and their 95% confidence intervals (95% CIs) were set as effect measures. The information about trial design, results from the data was independently extracted. Heterogeneity of the studies was tested for each pooled analysis. Results: Nineteen studies published matched the selection criteria and were included in this meta-analysis. CTCs positivity was significantly associated with poor relapse free survival (RFS) (HR 2.42, 95% CI: [1.94-3.02]; P < 0.001) and poor overall survival (OS) (HR 2.42, 95% CI: [1.94-3.02]; P < 0.001). CTCs positivity were also significantly associated with regional lymph nodes (RLNs) metastasis (RR 1.42, 95% CI: [1.20-1.68]; p < 0.0001), depth of infiltration (RR 1.51, 95% CI: [1.27-1.79]; p < 0.0001), vascular invasion (RR = 1.43, 95% CI: [1.18-1.74], p = 0.0002) and TNM stage(I, II versus III) (RR 0.63, 95% CI [0.48-0.84]; p = 0.001). Conclusion: Preoperative CTCs positivity indicates poor prognosis in patients with gastric cancer, and associated with poor clinicopathological prognostic factors.	[Wang, Shuyi; Cheng, Boran; Chen, Fangfang; Wang, Zhenmeng; Chen, Yuanyuan; Wang, You; Xiong, Bin] Wuhan Univ, Hubei Key Lab Tumor Biol Behav, Hubei Canc Clin Study Ctr, Dept Oncol,Zhongnan Hosp, Wuhan 430072, Hubei, Peoples R China; [Zheng, Gang] 5th Hosp Wuhan, Dept Gen Surg, Wuhan, Hubei, Peoples R China	Wuhan University	Xiong, B (corresponding author), Wuhan Univ, Hubei Key Lab Tumor Biol Behav, Hubei Canc Clin Study Ctr, Dept Oncol,Zhongnan Hosp, Wuhan 430072, Hubei, Peoples R China.	Binxiong1961@gmail.com	Chen, Yuanyuan/GXG-2130-2022		National High Technology Research and Development Program of China [2012AA02A502, 2012AA02A506]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	The work was supported by National High Technology Research and Development Program of China (Grant No. 2012AA02A502, 2012AA02A506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix-Panabieres C, 2012, ANNU REV MED, V63, P199, DOI 10.1146/annurev-med-062310-094219; Arigami T, 2013, ONCOL REP, V30, P2838, DOI 10.3892/or.2013.2775; Arigami T, 2011, CANCER SCI, V102, P1019, DOI 10.1111/j.1349-7006.2011.01877.x; Ashworth TR, 1869, AUST MED J, V14; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Bertazza L, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-111; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Bidard FC, 2010, ANN ONCOL, V21, P729, DOI 10.1093/annonc/mdp391; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; Cao WG, 2011, J SURG ONCOL, V103, P110, DOI 10.1002/jso.21777; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; ENGELL H C, 1955, Acta Chir Scand Suppl, V201, P1; Ikeguchi M, 2005, SURG TODAY, V35, P436, DOI 10.1007/s00595-004-2978-z; Illert B, 2005, SCAND J GASTROENTERO, V40, P843, DOI 10.1080/00365520510015557; Kita Y, 2009, BRIT J CANCER, V100, P153, DOI 10.1038/sj.bjc.6604806; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Koga T, 2008, HEPATO-GASTROENTEROL, V55, P1131; Kosaka Y, 2007, BRIT J CANCER, V96, P1723, DOI 10.1038/sj.bjc.6603785; Liu MC, 2009, J CLIN ONCOL, V27, P5153, DOI 10.1200/JCO.2008.20.6664; Majima T, 2000, JPN J CLIN ONCOL, V30, P499, DOI 10.1093/jjco/hyd130; Miyazono F, 2001, ANN SURG, V233, P189, DOI 10.1097/00000658-200102000-00007; Nishida S, 2000, ANTICANCER RES, V20, P2155; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Pantel K, 2010, TRENDS MOL MED, V16, P398, DOI 10.1016/j.molmed.2010.07.001; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Pham B, 2005, J CLIN EPIDEMIOL, V58, P769, DOI 10.1016/j.jclinepi.2004.08.021; Qiu MZ, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-107; Rahbari NN, 2010, GASTROENTEROLOGY, V138, P1714, DOI 10.1053/j.gastro.2010.01.008; Seo JH, 2005, AM J CLIN ONCOL-CANC, V28, P24, DOI 10.1097/01.coc.0000139018.47930.a5; Shaffer DR, 2007, CLIN CANCER RES, V13, P2023, DOI 10.1158/1078-0432.CCR-06-2701; Shin JH, 2002, ALIMENT PHARM THERAP, V16, P137, DOI 10.1046/j.1365-2036.16.s2.33.x; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Sumikura S, 2003, CANCER LETT, V200, P77, DOI 10.1016/S0304-3835(03)00388-4; Uen YH, 2006, CLIN CHIM ACTA, V367, P55, DOI 10.1016/j.cca.2005.11.013; Vincent-Salomon A, 2008, J CLIN PATHOL, V61, P570, DOI 10.1136/jcp.2007.046649; Wicha MS, 2011, J CLIN ONCOL, V29, P1508, DOI 10.1200/JCO.2010.34.0026; Wu CH, 2006, DIS MARKERS, V22, P103, DOI 10.1155/2006/281315; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Yie SM, 2008, ANN SURG ONCOL, V15, P3073, DOI 10.1245/s10434-008-0069-x	42	32	32	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99259	10.1371/journal.pone.0099259	http://dx.doi.org/10.1371/journal.pone.0099259			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901848	gold, Green Submitted, Green Published			2022-12-27	WOS:000336841400116
J	Gao, R; Chen, J; Hu, YX; Li, ZY; Wang, SX; Shetty, S; Fu, J				Gao, Rong; Chen, Jiao; Hu, Yuxin; Li, Zhenyu; Wang, Shuxia; Shetty, Sreerama; Fu, Jian			Sirt1 Deletion Leads to Enhanced Inflammation and Aggravates Endotoxin-Induced Acute Kidney Injury	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; ADHESION MOLECULES; CELL APOPTOSIS; SEVERE SEPSIS; SEPTIC SHOCK; MOUSE MODELS; ACTIVATION; SURVIVAL; MICE; LIPOPOLYSACCHARIDE	Bacterial endotoxin has been known to induce excessive inflammatory responses and acute kidney injury. In the present study, we used a mouse model of endotoxemia to investigate the role of Sirt1 in inflammatory kidney injury. We examined molecular and cellular responses in inducible Sirt1 knockout (Sirt1(-/-)) mice and wild type littermates (Sirt1(+/+)) in lipopolysaccharide (LPS)-induced kidney injury. Our studies demonstrated that Sirt1 deletion caused aggravated kidney injury, which was associated with increased inflammatory responses including elevated pro-inflammatory cytokine production, and increased ICAM-1 and VCAM-1 expression. Inflammatory signaling such as STAT3/ERK phosphorylation and NF-kappa B activation was markedly elevated in kidney tissues of Sirt1 knockout mice after LPS challenge. The results indicate that Sirt1 is protective against LPS-induced acute kidney injury by suppressing kidney inflammation and down-regulating inflammatory signaling.	[Gao, Rong; Hu, Yuxin] Jilin Univ, Hosp 2, Changchun 130023, Jilin, Peoples R China; [Gao, Rong; Chen, Jiao; Hu, Yuxin; Fu, Jian] Univ Kentucky, Coll Med, Ctr Res Environm Dis, Lexington, KY 40506 USA; [Fu, Jian] Univ Kentucky, Grad Ctr Toxicol, Coll Med, Lexington, KY 40536 USA; [Li, Zhenyu] Univ Kentucky, Coll Med, Div Cardiovasc Med, Lexington, KY USA; [Wang, Shuxia] Univ Kentucky, Coll Med, Grad Ctr Nutr Sci, Lexington, KY USA; [Shetty, Sreerama] Univ Texas Hlth Sci Ctr Tyler, Ctr Biomed Res, Tyler, TX USA	Jilin University; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Fu, J (corresponding author), Univ Kentucky, Coll Med, Ctr Res Environm Dis, Lexington, KY 40506 USA.	jian.fu@uky.edu			National Institutes of Health [1R01GM099744]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported in part by the National Institutes of Health (http://www.nih.gov) grant (1R01GM099744) to JF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Masataka, 2005, Nihon Rinsho, V63, P45; Araujo M, 2013, INFLAMM RES; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Busch F, 2012, J BIOL CHEM, V287, P25770, DOI 10.1074/jbc.M112.355420; Chang HC, 2013, CELL, V153, P1448, DOI 10.1016/j.cell.2013.05.027; Chen SH, 2012, J LEUKOCYTE BIOL, V92, P851, DOI 10.1189/jlb.0212060; Chen T, 2013, EXP DERMATOL, V22, P453, DOI 10.1111/exd.12174; Coldewey S.M., 2013, KIDNEY INT; Cunningham PN, 2002, J IMMUNOL, V168, P5817, DOI 10.4049/jimmunol.168.11.5817; Danoff TM, 1998, KIDNEY INT, V53, P1807, DOI 10.1046/j.1523-1755.1998.00920.x; Dear JW, 2006, KIDNEY INT, V69, P832, DOI 10.1038/sj.ki.5000165; Doi K, 2008, KIDNEY INT, V73, P1266, DOI 10.1038/ki.2008.97; Fan H, 2013, KIDNEY INT, V83, P404, DOI 10.1038/ki.2012.394; Gautier EL, 2008, J IMMUNOL, V180, P6941, DOI 10.4049/jimmunol.180.10.6941; Gentile LF, 2012, J TRAUMA ACUTE CARE, V72, P1491, DOI 10.1097/TA.0b013e318256e000; Greenhill CJ, 2011, J IMMUNOL, V186, P1199, DOI 10.4049/jimmunol.1002971; Guarente L, 2005, MECH AGEING DEV, V126, P923, DOI 10.1016/j.mad.2005.03.013; Hao CM, 2010, J AM SOC NEPHROL, V21, P1620, DOI 10.1681/ASN.2010010046; He WJ, 2010, J CLIN INVEST, V120, P1056, DOI 10.1172/JCI41563; Heuer JG, 2005, J IMMUNOL, V174, P7141, DOI 10.4049/jimmunol.174.11.7141; Horky K, 1967, Cas Lek Cesk, V106, P105; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Hwang JW, 2010, ARCH BIOCHEM BIOPHYS, V500, P203, DOI 10.1016/j.abb.2010.05.013; Jeong SJ, 2013, CRIT CARE, V17, DOI 10.1186/cc12742; Jung J, 2012, IMMUNOLOGY, V137, P98, DOI 10.1111/j.1365-2567.2012.03618.x; Kasprzak A, 2013, J PERIODONTAL RES, V48, P1, DOI 10.1111/j.1600-0765.2012.01492.x; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kong SY, 2012, IMMUNOL CELL BIOL, V90, P6, DOI 10.1038/icb.2011.102; Lampinen M, 2008, INT J COLORECTAL DIS, V23, P939, DOI 10.1007/s00384-008-0509-x; Li HZ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1632; Lim JH, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/171383; Liu TF, 2012, J BIOL CHEM, V287, P25758, DOI 10.1074/jbc.M112.362343; Maddens B, 2012, CRIT CARE MED, V40, P2638, DOI 10.1097/CCM.0b013e3182591ebe; McCurdy TR, 2013, MICROCIRCULATION; Mihara M, 2012, CLIN SCI, V122, P143, DOI 10.1042/CS20110340; Miyaji T, 2003, KIDNEY INT, V64, P1620, DOI 10.1046/j.1523-1755.2003.00268.x; Mortuza R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054514; Nguyen HB, 2006, ANN EMERG MED, V48, P28, DOI 10.1016/j.annemergmed.2006.02.015; Peng XJ, 2013, EXP BIOL MED, V238, P960, DOI 10.1177/1535370213497176; Ranganathan P, 2013, AM J PHYSIOL-RENAL, V304, pF1054, DOI 10.1152/ajprenal.00650.2012; Ranganathan PV, 2013, KIDNEY INT, V83, P1087, DOI 10.1038/ki.2012.423; Sabbisetti VS, 2013, TOXICOL SCI, V131, P13, DOI 10.1093/toxsci/kfs268; Scott MJ, 2002, CLIN DIAGN LAB IMMUN, V9, P1153, DOI 10.1128/CDLI.9.6.1153-1159.2002; Singer M, 2013, CURR OPIN PULM MED, V19, P305, DOI 10.1097/MCP.0b013e32835f1b49; Suh SH, 2013, YONSEI MED J, V54, P965, DOI 10.3349/ymj.2013.54.4.965; Tu B, 2012, CANCER LETT, V325, P80, DOI 10.1016/j.canlet.2012.06.006; Uribarri J, 2013, AMINO ACIDS; Uribarri J, 2011, DIABETES CARE, V34, P1610, DOI 10.2337/dc11-0091; Van de Wiele C, 2012, EUR J NUCL MED MOL I, V39, P1646, DOI 10.1007/s00259-012-2189-6; Venkataraman R, 2013, ADV CHRONIC KIDNEY D, V20, P6, DOI 10.1053/j.ackd.2012.10.013; Wan L, 2008, CRIT CARE MED, V36, pS198, DOI 10.1097/CCM.0b013e318168ccd5; Wang SX, 2013, BBA-MOL BASIS DIS, V1832, P1582, DOI 10.1016/j.bbadis.2013.05.023; Wei Q, 2013, KIDNEY INT, V84, P138, DOI 10.1038/ki.2013.68; Winnik S, 2012, CURR VASC PHARMACOL, V10, P693, DOI 10.2174/157016112803520756; Wu Z, 2012, BLOOD, V119, P2422, DOI 10.1182/blood-2011-04-350413; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yin HQ, 2012, J BIOL CHEM, V287, P9817, DOI 10.1074/jbc.M111.333534; Zager RA, 2006, KIDNEY INT, V69, P1181, DOI 10.1038/sj.ki.5000022; Zhang DS, 2013, J PHARMACOL EXP THER, V345, P69, DOI 10.1124/jpet.112.202481	59	59	65	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98909	10.1371/journal.pone.0098909	http://dx.doi.org/10.1371/journal.pone.0098909			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896770	Green Published, Green Submitted, gold			2022-12-27	WOS:000338430700094
J	Li, L; Lian, BF; Li, C; Li, W; Li, J; Zhang, YN; He, XH; Li, YX; Xie, L				Li, Ling; Lian, Baofeng; Li, Chao; Li, Wei; Li, Jing; Zhang, Yuannv; He, Xianghuo; Li, Yixue; Xie, Lu			Integrative Analysis of Transcriptional Regulatory Network and Copy Number Variation in Intrahepatic Cholangiocarcinoma	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; PROTEIN-INTERACTION NETWORKS; HEPATITIS-C-VIRUS; HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; BREAST-CANCER; CELL-MIGRATION; IN-VIVO; B-VIRUS; METASTASIS	Background: Transcriptional regulatory network (TRN) is used to study conditional regulatory relationships between transcriptional factors and genes. However few studies have tried to integrate genomic variation information such as copy number variation (CNV) with TRN to find causal disturbances in a network. Intrahepatic cholangiocarcinoma (ICC) is the second most common hepatic carcinoma with high malignancy and poor prognosis. Research about ICC is relatively limited comparing to hepatocellular carcinoma, and there are no approved gene therapeutic targets yet. Method: We first constructed TRN of ICC (ICC-TRN) using forward-and-reverse combined engineering method, and then integrated copy number variation information with ICC-TRN to select CNV-related modules and constructed CNV-ICC-TRN. We also integrated CNV-ICC-TRN with KEGG signaling pathways to investigate how CNV genes disturb signaling pathways. At last, unsupervised clustering method was applied to classify samples into distinct classes. Result: We obtained CNV-ICC-TRN containing 33 modules which were enriched in ICC-related signaling pathways. Integrated analysis of the regulatory network and signaling pathways illustrated that CNV might interrupt signaling through locating on either genomic sites of nodes or regulators of nodes in a signaling pathway. In the end, expression profiles of nodes in CNV-ICC-TRN were used to cluster the ICC patients into two robust groups with distinct biological function features. Conclusion: Our work represents a primary effort to construct TRN in ICC, also a primary effort to try to identify key transcriptional modules based on their involvement of genetic variations shown by gene copy number variations (CNV). This kind of approach may bring the traditional studies of TRN based only on expression data one step further to genetic disturbance. Such kind of approach can easily be extended to other disease samples with appropriate data.	[Li, Ling; Li, Yixue] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Li, Ling; Lian, Baofeng; Li, Wei; Li, Jing; Xie, Lu] Shanghai Acad Sci & Technol, Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Lian, Baofeng; Li, Yixue] Shanghai Jiao Tong Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Li, Chao; Zhang, Yuannv; He, Xianghuo; Li, Yixue] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China	Tongji University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Li, YX (corresponding author), Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China.	yxli@sibs.ac.cn; xielu@scbit.org	He, Xianghuo/I-1497-2014	He, Xianghuo/0000-0001-8872-668X	Key Infectious Disease Project [2012ZX10002012-014]; National Natural Science Foundation of China [31070752]; National Hi-Tech program [2012AA020201]; National Key Basic Research Program [2010CB912702, 2011CB910204]	Key Infectious Disease Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Hi-Tech program; National Key Basic Research Program(National Basic Research Program of China)	This work was funded by Key Infectious Disease Project (2012ZX10002012-014), National Natural Science Foundation of China (31070752), National Hi-Tech program 2012AA020201, and National Key Basic Research Program 2010CB912702, 2011CB910204. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksamitiene E, 2012, CROSS TALK MITOGENIC; Baum B, 2004, ONCOGENE, V23, P8336, DOI 10.1038/sj.onc.1208009; Beckmann JS, 2007, NAT REV GENET, V8, P639, DOI 10.1038/nrg2149; Blais A, 2005, GENE DEV, V19, P1499, DOI 10.1101/gad.1325605; Blechacz B, 2011, NAT REV GASTRO HEPAT, V8, P512, DOI 10.1038/nrgastro.2011.131; Bunn AG, 2008, DENDROCHRONOLOGIA, V26, P115, DOI 10.1016/j.dendro.2008.01.002; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Demichelis F, 2012, P NATL ACAD SCI USA, V109, P6686, DOI 10.1073/pnas.1117405109; Devarajan K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000029; Dudeja V, 2009, GASTROENTEROLOGY, V136, P1772, DOI 10.1053/j.gastro.2009.01.070; Essaghir A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039666; Fritz G, 2006, CURR CANCER DRUG TAR, V6, P1, DOI 10.2174/156800906775471752; Gao H, 2012, CELL, V150, P764, DOI 10.1016/j.cell.2012.06.035; Geynisman DM, 2012, DISCOV MED, V14, P41; Gozdecka M, 2012, BIOCHEM SOC T, V40, P230, DOI 10.1042/BST20110630; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Hodgson PD, 2005, COMP FUNCT GENOM, V6, P244, DOI 10.1002/cfg.474; Homayounfar K, 2009, HUM PATHOL, V40, P834, DOI 10.1016/j.humpath.2008.11.005; Huang Q, 2012, ASIAN PAC J CANCER P, V13, P5161, DOI 10.7314/APJCP.2012.13.10.5161; Huang Tao, 2011, International Journal of Computational Biology and Drug Design, V4, P5, DOI 10.1504/IJCBDD.2011.038654; Kiesslich T, 2010, INT J ONCOL, V36, P49, DOI 10.3892/ijo_00000474; Ling Q, 2013, GENE, V522, P214, DOI 10.1016/j.gene.2013.03.089; Liu Q, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S11-S5; McCulley DJ, 2012, CURR TOP DEV BIOL, V100, P253, DOI 10.1016/B978-0-12-387786-4.00008-7; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Mudduluru G, 2010, MOL CANCER RES, V8, P159, DOI 10.1158/1541-7786.MCR-09-0326; Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059; Munker S, 2012, Z GASTROENTEROL, V50, p5_40; Nagayama S, 2009, CANCER SCI, V100, P405, DOI 10.1111/j.1349-7006.2008.01052.x; Narong S, 2011, ONCOL LETT, V2, P821, DOI 10.3892/ol.2011.333; Neph S, 2012, CELL, V150, P1274, DOI 10.1016/j.cell.2012.04.040; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pylkas K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002734; Rane MJ, 2010, AM J PHYSIOL-RENAL, V298, pF49, DOI 10.1152/ajprenal.00032.2009; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rodriguez-Molinero A, 2007, MED HYPOTHESES, V68, P1333, DOI 10.1016/j.mehy.2006.10.033; Sakurai H, 2012, TRENDS PHARMACOL SCI, V33, P522, DOI 10.1016/j.tips.2012.06.007; Sia D, 2013, ONCOGENE, V32, P4861, DOI 10.1038/onc.2012.617; Sia D, 2013, GASTROENTEROLOGY, V144, P829, DOI 10.1053/j.gastro.2013.01.001; Sirica AE, 2008, WORLD J GASTROENTERO, V14, P7033, DOI 10.3748/wjg.14.7033; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stone James C, 2011, Genes Cancer, V2, P320, DOI 10.1177/1947601911408082; Sun Q, 2007, CANCER BIOL THER, V6, P668, DOI 10.4161/cbt.6.5.3955; Tan FLS, 2010, INT J CANCER, V126, P2353, DOI 10.1002/ijc.24944; Uhm KO, 2005, CANCER GENET CYTOGEN, V157, P37, DOI 10.1016/j.cancergencyto.2004.05.007; Villard J, 2004, SWISS MED WKLY, V134, P571; WORKMAN C, 2002, GENOME BIOL, V0003; Xu HY, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S2-S7; Xu Y, 2012, MOL BIOL REP, V39, P1627, DOI 10.1007/s11033-011-0902-3; Yu H, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-61; Yuan WL, 2014, BBA-PROTEINS PROTEOM, V1844, P271, DOI 10.1016/j.bbapap.2013.06.002; Zaman N, 2013, CELL REP, V5, P216, DOI 10.1016/j.celrep.2013.08.028; Zeng LY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S14; Zhai Y, 2006, GASTROENTEROLOGY, V130, P2001, DOI 10.1053/j.gastro.2006.02.030; Zhang JD, 2009, BIOINFORMATICS, V25, P1470, DOI 10.1093/bioinformatics/btp167; Zhang KS, 2013, ONCOL REP, V30, P1430, DOI 10.3892/or.2013.2560	57	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98653	10.1371/journal.pone.0098653	http://dx.doi.org/10.1371/journal.pone.0098653			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897108	gold, Green Submitted, Green Published			2022-12-27	WOS:000338430700060
J	Maras, B; Angiolella, L; Mignogna, G; Vavala, E; Macone, A; Colone, M; Pitari, G; Stringaro, A; Dupre, S; Palamara, AT				Maras, Bruno; Angiolella, Letizia; Mignogna, Giuseppina; Vavala, Elisabetta; Macone, Alberto; Colone, Marisa; Pitari, Giuseppina; Stringaro, Annarita; Dupre, Silvestro; Palamara, Anna Teresa			Glutathione Metabolism in Candida albicans Resistant Strains to Fluconazole and Micafungin	PLOS ONE			English	Article							OXIDATIVE STRESS-RESPONSE; CELL-WALL; MECHANISMS	Currently available therapies for candidiasis are based on antifungal drugs belonging to azole and echinocandin families that interfere with different aspects of fungal metabolism. These drugs, beyond their specific effects, elicit also a cellular stress including an unbalance of redox state that is counteracted not only utilizing antioxidant species but also increasing the outcome export by transporters to detoxify the internal environment. These cellular actions are both based on the cytosolic concentration of reduced glutathione (GSH). In this paper we investigated the effects of two antifungal drugs fluconazole and micafungin on the redox state of the cell in C. albicans to understand if the resistance to these drugs is accompanied by variation of glutathione metabolism. Analyses of resistant strains showed a marked difference in glutathione contents in strains resistant to fluconazole (CO23RFLC) or micafungin (CO23RFK). In CO23RFLC, the total amount of glutathione was more than doubled with respect to CO23RFK thanks to the increased activity of gamma-glutamilcysteine synthetase, the key enzyme involved in GSH synthesis. We demonstrated that the GSH increase in CO23RFLC conferred to this strain a clear advantage in counteracting oxidative toxic agents while assignment of other roles, such as a more efficient elimination of the drug from the cell, should be considered more speculative. As far as MCFG resistance is concerned, from our data a role of glutathione metabolism in supporting this condition is not evident. Overall our data indicate that glutathione metabolism is differently affected in the two resistant strains and that glutathione system may play an important role in the global organization of C. albicans cells for resistance to fluconazole. Such scenario may pave the way to hypothesize the use of oxidant drugs or inhibitors able to deplete reduced glutathione level as a novel approach, for counteracting the resistance to this specific antifungal drug.	[Maras, Bruno; Mignogna, Giuseppina; Macone, Alberto; Dupre, Silvestro] Univ Roma La Sapienza, Dipartimento Sci Biochim A Rossi Fanelli, I-00185 Rome, Italy; [Angiolella, Letizia; Vavala, Elisabetta; Palamara, Anna Teresa] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, Dipartimento Sanita Pubbl & Malattie Infett, I-00185 Rome, Italy; [Colone, Marisa; Stringaro, Annarita] Ist Super Sanita, Dipartimento Tecnol & Salute, I-00161 Rome, Italy; [Pitari, Giuseppina] Univ Aquila, Dipartimento Biol Base & Applicata, I-67100 Laquila, Italy	Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; Istituto Superiore di Sanita (ISS); University of L'Aquila	Maras, B (corresponding author), Univ Roma La Sapienza, Dipartimento Sci Biochim A Rossi Fanelli, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	bruno.maras@uniroma1.it	COLONE, MARISA/E-9089-2015; STRINGARO, ANNARITA/E-9092-2015; Macone, Alberto/AAB-2570-2019; angiolella, letizia/P-3878-2015	COLONE, MARISA/0000-0002-7522-7483; STRINGARO, ANNARITA/0000-0002-0143-2978; Macone, Alberto/0000-0003-0455-1400; angiolella, letizia/0000-0002-0473-5587; Mignogna, Giuseppina/0000-0001-9238-132X; pitari, giuseppina/0000-0002-1244-6451; PALAMARA, ANNA TERESA/0000-0001-8330-4381	Sapienza University of Rome;  [PON 01_01802]	Sapienza University of Rome; 	This work was supported by funds from Sapienza University of Rome and partially by the Project PON 01_01802 (to ATP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins RA, 2005, MED MYCOL, V43, P285, DOI 10.1080/13693780500138971; Angiolella L, 2005, J CHEMOTHERAPY, V17, P409, DOI 10.1179/joc.2005.17.4.409; Angiolella L, 2009, INT J ANTIMICROB AG, V33, P143, DOI 10.1016/j.ijantimicag.2008.08.021; Angiolella L, 2008, ANTIMICROB AGENTS CH, V52, P927, DOI 10.1128/AAC.01223-07; Berruyer C, 2004, MOL CELL BIOL, V24, P7214, DOI 10.1128/MCB.24.16.7214-7224.2004; Calcabrini A, 2002, INT J CANCER, V99, P43, DOI 10.1002/ijc.10310; Calderone RA., 2002, CANDIDA CANDIDIASIS; Cannon RD, 2007, MICROBIOL-SGM, V153, P3211, DOI 10.1099/mic.0.2007/010405-0; Cannon RD, 2009, CLIN MICROBIOL REV, V22, P291, DOI 10.1128/CMR.00051-08; DELEVE LD, 1991, PHARMACOL THERAPEUT, V52, P287, DOI 10.1016/0163-7258(91)90029-L; Enjalbert B, 2006, MOL BIOL CELL, V17, P1018, DOI 10.1091/mbc.E05-06-0501; Enjalbert B, 2007, INFECT IMMUN, V75, P2143, DOI 10.1128/IAI.01680-06; Fortun J, 2012, J INFECTION, V65, P64, DOI 10.1016/j.jinf.2012.02.011; Franklin CC, 2009, MOL ASPECTS MED, V30, P86, DOI 10.1016/j.mam.2008.08.009; Gutierrez-Escobedo G, 2013, CURR GENET, V59, P91, DOI 10.1007/s00294-013-0390-1; Herrero E., 2007, BIOCHIM BIOPHYS ACTA, V1780, P1217; Kim J, 2011, J MICROBIOL, V49, P171, DOI 10.1007/s12275-011-1064-7; Morschhauser J, 2007, PLOS PATHOG, V3, P1603, DOI 10.1371/journal.ppat.0030164; Niimi K, 2006, ANTIMICROB AGENTS CH, V50, P1148, DOI 10.1128/AAC.50.4.1148-1155.2006; Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3; Perlroth J, 2007, MED MYCOL, V45, P321, DOI 10.1080/13693780701218689; Pocsi I, 2004, ADV MICROB PHYSIOL, V49, P1, DOI 10.1016/S0065-2911(04)49001-8; Sobhakumari A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048175; Vavala E, 2013, J CHEMOTHERAPY, V25, P332, DOI 10.1179/1973947813Y.0000000091; Yadav AK, 2011, MICROBIOL-SGM, V157, P484, DOI 10.1099/mic.0.045054-0; Zhu JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028830	26	15	15	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98387	10.1371/journal.pone.0098387	http://dx.doi.org/10.1371/journal.pone.0098387			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896636	Green Published, gold, Green Submitted			2022-12-27	WOS:000338430700038
J	Sahoo, DK; Dey, N; Maiti, IB				Sahoo, Dipak Kumar; Dey, Nrisingha; Maiti, Indu Bhushan			pSiM24 Is a Novel Versatile Gene Expression Vector for Transient Assays As Well As Stable Expression of Foreign Genes in Plants	PLOS ONE			English	Article							LENGTH TRANSCRIPT PROMOTER; FIGWORT-MOSAIC-VIRUS; AGROBACTERIUM-MEDIATED TRANSFORMATION; VEGETATIVE INSECTICIDAL PROTEIN; BINARY TI VECTOR; TRANSGENIC TOBACCO; DELETION ANALYSIS; CHIMERIC GENES; DNA; SYSTEM	We have constructed a small and highly efficient binary Ti vector pSiM24 for plant transformation with maximum efficacy. In the pSiM24 vector, the size of the backbone of the early binary vector pKYLXM24 (GenBank Accession No. HM036220; a derivative of pKYLX71) was reduced from 12.8 kb to 7.1 kb. The binary vector pSiM24 is composed of the following genetic elements: left and right T-DNA borders, a modified full-length transcript promoter (M24) of Mirabilis mosaic virus with duplicated enhancer domains, three multiple cloning sites, a 3'rbcsE9 terminator, replication functions for Escherichia coli (ColE1) and Agrobacterium tumefaciens (pRK2-OriV) and the replicase trfA gene, selectable marker genes for kanamycin resistance (nptII) and ampicillin resistance (bla). The pSiM24 plasmid offers a wide selection of cloning sites, high copy numbers in E. coli and a high cloning capacity for easily manipulating different genetic elements. It has been fully tested in transferring transgenes such as green fluorescent protein (GFP) and beta-glucuronidase (GUS) both transiently (agro-infiltration, protoplast electroporation and biolistic) and stably in plant systems (Arabidopsis and tobacco) using both agrobacterium-mediated transformation and biolistic procedures. Not only reporter genes, several other introduced genes were also effectively expressed using pSiM24 expression vector. Hence, the pSiM24 vector would be useful for various plant biotechnological applications. In addition, the pSiM24 plasmid can act as a platform for other applications, such as gene expression studies and different promoter expressional analyses.	[Sahoo, Dipak Kumar; Maiti, Indu Bhushan] Univ Kentucky, Coll Agr Food & Environm, KTRDC, Lexington, KY 40506 USA; [Dey, Nrisingha] Inst Life Sci, Dept Gene Funct & Regulat, Bhubaneswar, Odisha, India	University of Kentucky; Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS)	Sahoo, DK (corresponding author), Univ Kentucky, Coll Agr Food & Environm, KTRDC, Lexington, KY 40506 USA.	dipak_sahoo11@rediffmail.com; imaiti@uky.edu	Sahoo, Dipak Kumar/M-8818-2013	Sahoo, Dipak Kumar/0000-0003-3748-3395	KY state KTRDC [1235411320]	KY state KTRDC	This work was fully supported by the KY state KTRDC grant (no. 1235411320) to IBM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 2013, PLANTA; Ali MA, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-37; AN G, 1986, PLANT PHYSIOL, V81, P301, DOI 10.1104/pp.81.1.301; Banerjee J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079622; BEVAN M, 1984, NUCLEIC ACIDS RES, V12, P8711, DOI 10.1093/nar/12.22.8711; Bhattacharyya S, 2002, VIRUS RES, V90, P47, DOI 10.1016/S0166-0934(02)00146-5; Bhullar S, 2003, PLANT PHYSIOL, V132, P988, DOI 10.1104/pp.103.020602; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREYNE P, 1992, MOL GEN GENET, V235, P389, DOI 10.1007/BF00279385; Chakrabarty R, 2007, MOL PLANT MICROBE IN, V20, P740, DOI 10.1094/MPMI-20-7-0740; Chan V., 2002, J EXP MICROBIOL IMMU, V2, P207; Chatterjee A, 2010, IN VITRO CELL DEV-PL, V46, P198, DOI 10.1007/s11627-010-9283-x; Dey N, 1999, PLANT MOL BIOL, V40, P771, DOI 10.1023/A:1006285426523; Dey N, 1999, TRANSGENICS, V3, P61; Estruch JJ, 1996, P NATL ACAD SCI USA, V93, P5389, DOI 10.1073/pnas.93.11.5389; Filippi CM, 2008, J PATHOL, V214, P224, DOI 10.1002/path.2272; FLUHR R, 1986, EMBO J, V5, P2063, DOI 10.1002/j.1460-2075.1986.tb04467.x; FLUHR R, 1986, SCIENCE, V232, P1106, DOI 10.1126/science.232.4754.1106; FLUHR R, 1986, P NATL ACAD SCI USA, V83, P2358, DOI 10.1073/pnas.83.8.2358; Gelderblom H, 2007, AM J PATHOL, V170, P251, DOI 10.2353/ajpath.2007.060407; Goodin MM, 2002, PLANT J, V31, P375, DOI 10.1046/j.1365-313X.2002.01360.x; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Hellens R, 2000, TRENDS PLANT SCI, V5, P446, DOI 10.1016/S1360-1385(00)01740-4; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hiei Y, 2006, PLANT CELL TISS ORG, V85, P271, DOI 10.1007/s11240-005-9069-8; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; HOEKEMA A, 1983, NATURE, V303, P179, DOI 10.1038/303179a0; HOFGEN R, 1988, NUCLEIC ACIDS RES, V16, P9877, DOI 10.1093/nar/16.20.9877; Huang Z, 2009, BIOTECHNOL BIOENG, V103, P706, DOI 10.1002/bit.22299; Ishida Y, 1996, NAT BIOTECHNOL, V14, P745, DOI 10.1038/nbt0696-745; JEFFERSON RA, 1987, J MOL BIOL, V193, P41, DOI 10.1016/0022-2836(87)90624-3; JEFFERSON RA, 1987, EMBO J, V6, P3901; KLEE HJ, 1985, BIO-TECHNOL, V3, P637, DOI 10.1038/nbt0785-637; Komari T, 1996, PLANT J, V10, P165, DOI 10.1046/j.1365-313X.1996.10010165.x; Komari T, 2006, METH MOL B, V343, P15; Komori T, 2007, PLANT PHYSIOL, V145, P1155, DOI 10.1104/pp.107.105734; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Kroumova AB, 2007, PLANT PHYSIOL, V144, P1843, DOI 10.1104/pp.107.097584; Kroumova ABM, 2013, PLANT CELL REP, V32, P1771, DOI 10.1007/s00299-013-1490-6; Kumar D, 2012, GENE, V503, P36, DOI 10.1016/j.gene.2012.04.053; Kumar D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024627; Kusaba M, 1996, PLANT PHYSIOL, V111, P1161, DOI 10.1104/pp.111.4.1161; Lee S, 2012, PLANT SCI, V187, P49, DOI 10.1016/j.plantsci.2012.01.012; LEMOS ML, 1992, PLASMID, V27, P161, DOI 10.1016/0147-619X(92)90016-4; Li ZY, 2008, EUKARYOT CELL, V7, P1941, DOI 10.1128/EC.00249-08; Lindbo JA, 2007, PLANT PHYSIOL, V145, P1232, DOI 10.1104/pp.107.106377; Lu YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057171; Maiti IB, 1997, TRANSGENIC RES, V6, P143, DOI 10.1023/A:1018477705019; MAITI IB, 1993, P NATL ACAD SCI USA, V90, P6110, DOI 10.1073/pnas.90.13.6110; Minter RM, 2001, P NATL ACAD SCI USA, V98, P277, DOI 10.1073/pnas.250489297; Murai N., 2013, American Journal of Plant Sciences, V4, P932, DOI 10.4236/ajps.2013.44115; OW DW, 1986, SCIENCE, V234, P856, DOI 10.1126/science.234.4778.856; Pang SZ, 1996, PLANT PHYSIOL, V112, P893, DOI 10.1104/pp.112.3.893; PANSEGRAU W, 1994, J MOL BIOL, V239, P623, DOI 10.1006/jmbi.1994.1404; Patro S, 2013, J BIOTECHNOL, V163, P311, DOI 10.1016/j.jbiotec.2012.11.009; Pattanaik S, 2004, PLANT SCI, V167, P427, DOI 10.1016/j.plantsci.2004.04.011; Ranjan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031931; Ranjan R, 2011, J BIOTECHNOL, V152, P58, DOI 10.1016/j.jbiotec.2011.01.015; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Sahoo DK, 2014, SCI WORLD J, DOI 10.1155/2014/601314; Sahoo DK, 2013, PLANT BIOTECHNOL J, V11, P362, DOI 10.1111/pbi.12024; Sahoo DK, 2009, J VIROL METHODS, V161, P114, DOI 10.1016/j.jviromet.2009.06.011; Sahoo DK, 2014, ACTA BIOL HUNG, V65, P189, DOI 10.1556/ABiol.65.2014.2.7; Sainsbury F, 2009, PLANT BIOTECHNOL J, V7, P682, DOI 10.1111/j.1467-7652.2009.00434.x; SCHARDL CL, 1987, GENE, V61, P1, DOI 10.1016/0378-1119(87)90359-3; Selvapandiyan A, 2001, APPL ENVIRON MICROB, V67, P5855, DOI 10.1128/AEM.67.12.5855-5858.2001; Shah KH, 2013, PLANT MOL BIOL REP, V31, P1529, DOI 10.1007/s11105-013-0614-z; Shepherd RW, 2005, PLANT CELL, V17, P1851, DOI 10.1105/tpc.105.031559; Song F, 2014, IRISH J MED SCI, V183, P85, DOI 10.1007/s11845-013-0980-4; Stober CB, 2005, J IMMUNOL, V175, P2517, DOI 10.4049/jimmunol.175.4.2517; SVAB Z, 1990, P NATL ACAD SCI USA, V87, P8526, DOI 10.1073/pnas.87.21.8526; Takken FLW, 2004, CURR GENET, V45, P242, DOI 10.1007/s00294-003-0481-5; Thole V, 2007, PLANT PHYSIOL, V145, P1211, DOI 10.1104/pp.107.108563; TOLSON DL, 1994, INFECT IMMUN, V62, P4893, DOI 10.1128/IAI.62.11.4893-4899.1994; Untergasser A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047885; Vasil IK, 1996, NAT BIOTECHNOL, V14, P702, DOI 10.1038/nbt0696-702; Vaucheret H, 2001, TRENDS GENET, V17, P29, DOI 10.1016/S0168-9525(00)02166-1; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; Villalta SA, 2011, HUM MOL GENET, V20, P790, DOI 10.1093/hmg/ddq523; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wang C, 2013, PLOS ONE, V8; Xiang CB, 1999, PLANT MOL BIOL, V40, P711, DOI 10.1023/A:1006201910593; YADAV NS, 1982, P NATL ACAD SCI-BIOL, V79, P6322, DOI 10.1073/pnas.79.20.6322; ZAMBRYSKI P, 1983, EMBO J, V2, P2143, DOI 10.1002/j.1460-2075.1983.tb01715.x; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; ZUPAN JR, 1995, PLANT PHYSIOL, V107, P1041, DOI 10.1104/pp.107.4.1041	86	11	14	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98988	10.1371/journal.pone.0098988	http://dx.doi.org/10.1371/journal.pone.0098988			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897541	Green Published, gold, Green Submitted			2022-12-27	WOS:000338430700104
J	Spada, J; Sander, C; Burkhardt, R; Hantzsch, M; Mergl, R; Scholz, M; Hegerl, U; Hensch, T				Spada, Janek; Sander, Christian; Burkhardt, Ralph; Haentzsch, Madlen; Mergl, Roland; Scholz, Markus; Hegerl, Ulrich; Hensch, Tilman			Genetic Association of Objective Sleep Phenotypes with a Functional Polymorphism in the Neuropeptide S Receptor Gene	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; NEURONS; WAKEFULNESS; AROUSAL; DURATION; RHYTHMS; BRAIN; MODEL	Background: The neuropeptide S receptor (NPSR1) and its ligand neuropeptide S (NPS) have received increased attention in the last few years, as both establish a previously unknown system of neuromodulation. Animal research studies have suggested that NPS may be involved in arousal/wakefulness and may also have a crucial role in sleep regulation. The single nucleotide polymorphism (SNP) rs324981 in NPSR1 has begun to shed light on a function of the NPS-system in human sleep regulation. Due to an amino acid exchange, the T-allele leads to an increased sensitivity of the NPSR1. In the only genome-wide association study to date on circadian sleep parameters in humans, an association was found between rs324981 and regular bedtime. However, the sleep parameters in this study were only measured by self-rating. Therefore, our study aimed to replicate these findings using an objective measure of sleep. Methods: The study included n = 393 white subjects (62-79 years) who participated in an actigraphic assessment for determining sleep duration, rest duration, sleep onset, rest onset and sleep onset latency. Genotyping of the SNP rs324981 was performed using the TaqMan OpenArray System. Results: The genotype at rs324981 was not significantly associated with rest onset (bedtime) or sleep onset (p = .146 and p = .199, respectively). However, the SNP showed a significant effect on sleep- and rest duration (p = .007 and p = .003, respectively). Subjects that were homozygous for the minor T-allele had a significantly decreased sleep-and rest duration compared to A-allele carriers. Conclusion: The results of this study indicate that the sleep pattern in humans is influenced by the NPS-system. However, the previously reported association between bedtime and rs324981 could not be confirmed. The current finding of decreased sleep duration in T/T allele carriers is in accordance with studies in rodents reporting similar results after NPS application.	[Spada, Janek; Sander, Christian; Burkhardt, Ralph; Haentzsch, Madlen; Mergl, Roland; Scholz, Markus; Hegerl, Ulrich; Hensch, Tilman] Univ Leipzig, LIFE Leipzig Res Ctr Civilizat Dis, D-04109 Leipzig, Germany; [Spada, Janek; Sander, Christian; Mergl, Roland; Hegerl, Ulrich; Hensch, Tilman] Univ Leipzig, Dept Psychiat & Psychotherapy, D-04109 Leipzig, Germany; [Burkhardt, Ralph; Haentzsch, Madlen] Univ Hosp Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany; [Scholz, Markus] Univ Leipzig, IMISE, D-04109 Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University	Spada, J (corresponding author), Univ Leipzig, LIFE Leipzig Res Ctr Civilizat Dis, D-04109 Leipzig, Germany.	janek.spada@medizin.uni-leipzig.de	Sander, Christian/AAB-8674-2022	Sander, Christian/0000-0002-5402-6631; Burkhardt, Ralph/0000-0003-1924-1202; Hegerl, Ulrich/0000-0002-3039-7470; Hensch, Tilman/0000-0003-2696-6017	LIFE - Leipzig Research Center for Civilization Diseases, Universitat Leipzig; European Union; European Regional Development Fund (ERDF); Free State of Saxony within the framework of the excellence initiative; German Research Foundation (DFG); UniversitAt Leipzig within the program of Open Access Publishing	LIFE - Leipzig Research Center for Civilization Diseases, Universitat Leipzig; European Union(European Commission); European Regional Development Fund (ERDF)(European Commission); Free State of Saxony within the framework of the excellence initiative; German Research Foundation (DFG)(German Research Foundation (DFG)); UniversitAt Leipzig within the program of Open Access Publishing	This publication is supported by LIFE - Leipzig Research Center for Civilization Diseases, Universitat Leipzig. LIFE is funded by means of the European Union, by the European Regional Development Fund (ERDF) and by means of the Free State of Saxony within the framework of the excellence initiative. Moreover, the authors acknowledge support from the German Research Foundation (DFG) and UniversitAt Leipzig within the program of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Brown RE, 2012, PHYSIOL REV, V92, P1087, DOI 10.1152/physrev.00032.2011; BURBIDGE JB, 1988, J AM STAT ASSOC, V83, P123, DOI 10.2307/2288929; CAIRNS BE, 1995, J NEUROPHYSIOL, V73, P2486, DOI 10.1152/jn.1995.73.6.2486; Clark SD, 2011, J COMP NEUROL, V519, P1867, DOI 10.1002/cne.22606; De la Herran-Arita Alberto K, 2011, Front Neurol, V2, P26, DOI 10.3389/fneur.2011.00026; Domschke K, 2011, MOL PSYCHIATR, V16, P938, DOI 10.1038/mp.2010.81; Gibson G, 2009, NAT REV GENET, V10, P134, DOI 10.1038/nrg2502; Glotzbach-Schoon E, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00031; Gottlieb DJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S9; Hegerl U, 2012, NEUROSCI BI IN PRESS; Hegerl U, 2012, WORLD J BIOL PSYCHIA, V13, P436, DOI 10.3109/15622975.2011.579164; Hegerl U, 2010, CURR OPIN PSYCHIATR, V23, P1, DOI 10.1097/YCO.0b013e328331f694; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Jones BE, 2003, FRONT BIOSCI-LANDMRK, V8, pS438, DOI 10.2741/1074; Klauke B, 2014, WORLD J BIOL PSYCHIA, V15, P17, DOI 10.3109/15622975.2011.646302; Kohlmeier KA, 2006, EUR J NEUROSCI, V23, P3245, DOI 10.1111/j.1460-9568.2006.04875.x; Krishnan V, 2006, CURR OPIN PULM MED, V12, P383, DOI 10.1097/01.mcp.0000245705.69440.6a; Laas K, 2014, INT J NEUROPSYCHOPH, V17, P541, DOI 10.1017/S1461145713001478; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Lockley SW, 1999, J SLEEP RES, V8, P175, DOI 10.1046/j.1365-2869.1999.00155.x; Minelli C, 2005, INT J EPIDEMIOL, V34, P1319, DOI 10.1093/ije/dyi169; Moraes W, 2013, SLEEP MED, V14, P312, DOI 10.1016/j.sleep.2012.11.010; Pitti T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034046; Raymann RJEM, 2007, PHYSIOL BEHAV, V90, P257, DOI 10.1016/j.physbeh.2006.09.008; Reinscheid Rainer K., 2008, V46, P145, DOI 10.1007/400_2007_051; Reinscheid RK, 2005, J PHARMACOL EXP THER, V315, P1338, DOI 10.1124/jpet.105.093427; Roenneberg T, 2007, SLEEP MED REV, V11, P429, DOI 10.1016/j.smrv.2007.07.005; Sander C, 2010, CLIN NEUROPHYSIOL, V121, P1511, DOI 10.1016/j.clinph.2010.03.021; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Sato S, 2002, World Patent Application, Patent No. [WO 02/ 31145 A1, 0231145]; Sharif MM, 2013, ANN THORAC MED, V8, P53, DOI 10.4103/1817-1737.105720; Sutcliffe JG, 2002, NAT REV NEUROSCI, V3, P339, DOI 10.1038/nrn808; Thakkar MM, 2011, SLEEP MED REV, V15, P65, DOI 10.1016/j.smrv.2010.06.004; von Arb M, 2009, BIOPSYCHOSOC MED, V3, DOI 10.1186/1751-0759-3-11; Wang MY, 2011, J NURS RES, V19, P173, DOI 10.1097/JNR.0b013e318229c42f; Xu YL, 2007, J COMP NEUROL, V500, P84, DOI 10.1002/cne.21159; Xu YL, 2004, NEURON, V43, P487, DOI 10.1016/j.neuron.2004.08.005; Zhao P, 2012, NEUROSCIENCE, V207, P218, DOI 10.1016/j.neuroscience.2012.01.022	39	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98789	10.1371/journal.pone.0098789	http://dx.doi.org/10.1371/journal.pone.0098789			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896296	Green Published, Green Submitted, gold			2022-12-27	WOS:000338430700078
J	Yuan, DQ; Xu, YD; Hang, H; Liu, XY; Chen, X; Xie, P; Yuan, ST; Zhang, WW; Lin, XJ; Liu, QH				Yuan, Dongqing; Xu, Yidan; Hang, Hui; Liu, Xiaoyi; Chen, Xi; Xie, Ping; Yuan, Songtao; Zhang, Weiwei; Lin, Xiaojun; Liu, Qinghuai			Edaravone Protect against Retinal Damage in Streptozotocin-Induced Diabetic Mice	PLOS ONE			English	Article							FREE-RADICAL SCAVENGER; GANGLION-CELLS; OXIDATIVE STRESS; OPTIC-NERVE; APOPTOSIS; DEGENERATION; MODEL	Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a free radical scavenger, is used for the clinical treatment of retinal injury. In this study, we investigated the protective effects of edaravone against diabetic retinal damage in the mouse. Diabetic retinopathy in the mouse was induced by injection of streptozotocin. Edaravone was given once-daily and was intraperitoneally (i.p.) treated at a dose of 3 mg/kg from streptozotocin injection to 4 weeks after onset of diabetes. Retinal ganglion cells (RGCs) damage was evaluated by recording the pattern electroretinogram (ERG). RGCs damage was also detected by Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining, and the levels of reactive oxygen species (ROS) were determined fluorometrically. The expressions of phosporylated-ERK1/2, BDNF, and caspase-3 were determined by Western blot analysis. Retinal levels of ROS, phosphorylated ERK1/2, and cleaved caspase-3 were significantly increased, whereas the expression of BDNF was significantly decreased in the retinas of diabetic mice, compared to nondiabetic mice. Administration of edaravone significantly attenuated diabetes induced RGCs death, upregulation of ROS, ERK1/2 phosphorylation, and cleaved caspase-3 and downregulation of BDNF. These findings suggest that oxidative stress plays a pivotal role in diabetic retinal damage and that systemic administration of edaravone may slow the progression of retinal neuropathy induced by diabetes.	[Yuan, Dongqing; Xu, Yidan; Hang, Hui; Liu, Xiaoyi; Chen, Xi; Xie, Ping; Yuan, Songtao; Zhang, Weiwei; Lin, Xiaojun; Liu, Qinghuai] Nanjing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Liu, QH (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China.	liuqh@njmu.edu.cn		Liu, Qinghuai/0000-0003-1605-1964; Xie, Ping/0000-0003-4257-8970	National Basic Research Program of China (973 Program) [2012CB066300, 2011CB510200]; National Natural Science Fund [81170855, 81070743]; Research and Innovation Project for College Graduates of Jiangsu Province [CXZZ12_0586]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Research and Innovation Project for College Graduates of Jiangsu Province	This research project was supported by National Basic Research Program of China (973 Program, No. 2012CB066300 and No. 2011CB510200, http://www.973.gov.cn/AreaAppl.aspx), General Project of the National Natural Science Fund (No. 81170855 and No. 81070743, http://www.nsfc.gov.cn/Portal0/default152.htm) and Research and Innovation Project for College Graduates of Jiangsu Province (No. CXZZ12_0586). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizu Y, 2002, NEUROPATHOLOGY, V22, P161, DOI 10.1046/j.1440-1789.2002.00439.x; Amemiya S, 2005, EUR J PHARMACOL, V516, P125, DOI 10.1016/j.ejphar.2005.04.036; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Carmody RJ, 2000, CELL DEATH DIFFER, V7, P282, DOI 10.1038/sj.cdd.4400646; [程海霞 Cheng Haixia], 2012, [中华实验眼科杂志, Chinese Journal of Experimental Ophthalmology], V30, P50; El-Remessy AB, 2006, AM J PATHOL, V168, P235, DOI 10.2353/ajpath.2006.050500; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Imai S, 2010, EUR J PHARMACOL, V642, P77, DOI 10.1016/j.ejphar.2010.05.057; Inokuchi Y, 2009, J PHARMACOL EXP THER, V329, P687, DOI 10.1124/jpet.108.148676; Ji Y, 2011, INT J MOL SCI, V12, P4722, DOI 10.3390/ijms12074722; Kawasaki T, 2007, GLIA, V55, P1325, DOI 10.1002/glia.20541; Kowluru RA, 2007, EXP DIABETES RES, DOI 10.1155/2007/43603; Kusari J, 2007, INVEST OPHTH VIS SCI, V48, P5152, DOI 10.1167/iovs.07-0427; Lee BJ, 2010, BRAIN RES, V1307, P22, DOI 10.1016/j.brainres.2009.10.026; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Li GY, 2009, EXP EYE RES, V89, P581, DOI 10.1016/j.exer.2009.06.004; Li WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076025; Luo Y, 2006, J BIOL CHEM, V281, P16436, DOI 10.1074/jbc.M512430200; Martin KRG, 2003, INVEST OPHTH VIS SCI, V44, P4357, DOI 10.1167/iovs.02-1332; Miloso M, 2008, CURR MED CHEM, V15, P538, DOI 10.2174/092986708783769731; NISHI H, 1989, STROKE, V20, P1236, DOI 10.1161/01.STR.20.9.1236; Ola MS, 2012, J DIABETES COMPLICAT, V26, P56, DOI 10.1016/j.jdiacomp.2011.11.004; Qin YW, 2006, CURR EYE RES, V31, P967, DOI 10.1080/02713680600987674; Roh MI, 2011, INVEST OPHTH VIS SCI, V52, P3825, DOI 10.1167/iovs.10-6797; Sasaki M, 2010, DIABETOLOGIA, V53, P971, DOI 10.1007/s00125-009-1655-6; SCOTT TM, 1986, J ANAT, V144, P145; Seigel GM, 2006, J DIABETES COMPLICAT, V20, P196, DOI 10.1016/j.jdiacomp.2005.06.007; Seki M, 2003, INVEST OPHTH VIS SCI, V44, P3211, DOI 10.1167/iovs.02-1089; Shimazaki H, 2011, INVEST OPHTH VIS SCI, V52, P7289, DOI 10.1167/iovs.11-7983; Silva KC, 2009, DIABETES, V58, P1382, DOI 10.2337/db09-0166; SIMA AAF, 1992, DIABETOLOGIA, V35, P602, DOI 10.1007/BF00400249; Toyoda K, 2004, J NEUROL SCI, V221, P11, DOI 10.1016/j.jns.2004.03.002; Yang Y, 2012, MOL VIS, V18, P1411; Zeng XX, 2000, VISUAL NEUROSCI, V17, P463, DOI 10.1017/S0952523800173122; Zheng L, 2007, DIABETES, V56, P337, DOI 10.2337/db06-0789	35	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99219	10.1371/journal.pone.0099219	http://dx.doi.org/10.1371/journal.pone.0099219			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897298	Green Published, gold, Green Submitted			2022-12-27	WOS:000338430700124
J	Kuntner, M; Naparus, M; Li, DQ; Coddington, JA				Kuntner, Matjaz; Naparus, Magdalena; Li, Daiqin; Coddington, Jonathan A.			Phylogeny Predicts Future Habitat Shifts Due to Climate Change	PLOS ONE			English	Article							RANGE EXPANSION; IMPACTS; DRIVEN; DISTRIBUTIONS; BIODIVERSITY; EXTINCTIONS; EVOLUTION; PATTERNS; ARANEAE	Background: Taxa may respond differently to climatic changes, depending on phylogenetic or ecological effects, but studies that discern among these alternatives are scarce. Here, we use two species pairs from globally distributed spider clades, each pair representing two lifestyles (generalist, specialist) to test the relative importance of phylogeny versus ecology in predicted responses to climate change. Methodology: We used a recent phylogenetic hypothesis for nephilid spiders to select four species from two genera (Nephilingis and Nephilengys) that match the above criteria, are fully allopatric but combined occupy all subtropical-tropical regions. Based on their records, we modeled each species niche spaces and predicted their ecological shifts 20, 40, 60, and 80 years into the future using customized GIS tools and projected climatic changes. Conclusions: Phylogeny better predicts the species current ecological preferences than do lifestyles. By 2080 all species face dramatic reductions in suitable habitat (54.8-77.1%) and adapt by moving towards higher altitudes and latitudes, although at different tempos. Phylogeny and life style explain simulated habitat shifts in altitude, but phylogeny is the sole best predictor of latitudinal shifts. Models incorporating phylogenetic relatedness are an important additional tool to predict accurately biotic responses to global change.	[Kuntner, Matjaz] Slovenian Acad Sci & Arts, Inst Biol, Ctr Sci Res, Ljubljana, Slovenia; [Kuntner, Matjaz; Li, Daiqin] Hubei Univ, Coll Life Sci, Ctr Behav Ecol & Evolut, Wuhan, Hubei, Peoples R China; [Kuntner, Matjaz; Coddington, Jonathan A.] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA; [Naparus, Magdalena] Univ Bucharest, Ctr Landscape Terr Informat Syst CeLTIS, Bucharest, Romania; [Naparus, Magdalena] Tular Cave Lab, Kranj, Slovenia; [Li, Daiqin] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	National Institute of Biology - Slovenia; Slovenian Academy of Sciences & Arts (SASA); Hubei University; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Bucharest; National University of Singapore	Kuntner, M (corresponding author), Slovenian Acad Sci & Arts, Inst Biol, Ctr Sci Res, Ljubljana, Slovenia.	kuntner@gmail.com	Li, Daiqin/CAH-3746-2022; Kuntner, Matjaz/AAE-2195-2020; Aljancic, Magdalena/O-4801-2014; Li, Daiqin/D-6922-2013	Li, Daiqin/0000-0001-8269-7734; Li, Daiqin/0000-0001-8269-7734; Coddington, Jonathan A./0000-0001-6004-7730	Raffles Museum for Biodiversity Research (RMBR); Slovenian Research Agency [P10236, BI-US/09-12-016, MU-PROM/12-001]; NSFC [31272324]; Singapore Ministry of Education (MOE) AcRF [R-154-000-476-112]	Raffles Museum for Biodiversity Research (RMBR); Slovenian Research Agency(Slovenian Research Agency - Slovenia); NSFC(National Natural Science Foundation of China (NSFC)); Singapore Ministry of Education (MOE) AcRF(Ministry of Education, Singapore)	This research was supported in part by a Raffles Museum for Biodiversity Research (RMBR) Short-term Fellowship and the grants P10236, BI-US/09-12-016 and MU-PROM/12-001 from the Slovenian Research Agency to M. K. and by the NSFC grant (31272324) and Singapore Ministry of Education (MOE) AcRF grant (R-154-000-476-112) to D. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angert AL, 2011, ECOL LETT, V14, P677, DOI 10.1111/j.1461-0248.2011.01620.x; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Banfai DS, 2006, BIOL CONSERV, V131, P553, DOI 10.1016/j.biocon.2006.03.002; Barton BT, 2009, ECOL LETT, V12, P1317, DOI 10.1111/j.1461-0248.2009.01386.x; Beale CM, 2013, ECOL LETT, V16, P1061, DOI 10.1111/ele.12139; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Bennie J, 2013, ECOL LETT, V16, P921, DOI 10.1111/ele.12129; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Brierley AS, 2009, CURR BIOL, V19, pR602, DOI 10.1016/j.cub.2009.05.046; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Diamond SE, 2012, GLOBAL CHANGE BIOL, V18, P448, DOI 10.1111/j.1365-2486.2011.02542.x; Erwin DH, 2009, CURR BIOL, V19, pR575, DOI 10.1016/j.cub.2009.05.047; ESRI, 2010, ARCGIS 9 3 1; Flato GM, 2001, GEOPHYS RES LETT, V28, P195, DOI 10.1029/2000GL012121; Franco AMA, 2006, GLOBAL CHANGE BIOL, V12, P1545, DOI 10.1111/j.1365-2486.2006.01180.x; Gottfried M, 2012, NAT CLIM CHANGE, V2, P111, DOI [10.1038/nclimate1329, 10.1038/NCLIMATE1329]; Habel JC, 2011, GLOBAL CHANGE BIOL, V17, P194, DOI 10.1111/j.1365-2486.2010.02233.x; Hegland SJ, 2009, ECOL LETT, V12, P184, DOI 10.1111/j.1461-0248.2008.01269.x; Heino J, 2009, BIOL REV, V84, P39, DOI 10.1111/j.1469-185X.2008.00060.x; Heubes J, 2011, J BIOGEOGR, V38, P2248, DOI 10.1111/j.1365-2699.2011.02560.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hillebrand H, 2010, GLOBAL CHANGE BIOL, V16, P1181, DOI 10.1111/j.1365-2486.2009.02045.x; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Hof C, 2011, GLOBAL CHANGE BIOL, V17, P2987, DOI 10.1111/j.1365-2486.2011.02418.x; Intergovernmental Panel on Climate Change (IPCC), 2000, SPEC REP EM SCEN SUM; IPCC, 2007, REP WORK GROUP 1 INT; Jump AS, 2005, ECOL LETT, V8, P1010, DOI 10.1111/j.1461-0248.2005.00796.x; Kearney MR, 2013, ECOL LETT, V16, P1470, DOI 10.1111/ele.12192; Kuntner M, 2007, SYST ENTOMOL, V32, P95, DOI 10.1111/j.1365-3113.2006.00348.x; Kuntner M, 2013, MOL PHYLOGENET EVOL, V69, P961, DOI 10.1016/j.ympev.2013.06.008; Kuntner M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-119; Kuntner M, 2011, MOL PHYLOGENET EVOL, V59, P477, DOI 10.1016/j.ympev.2011.02.002; Lawler JJ, 2013, ECOL LETT, V16, P1014, DOI 10.1111/ele.12132; Munday PL, 2013, ECOL LETT, V16, P1488, DOI 10.1111/ele.12185; Naparus M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030047; Pau S, 2011, GLOBAL CHANGE BIOL, V17, P3633, DOI 10.1111/j.1365-2486.2011.02515.x; Pigot AL, 2013, ECOL LETT, V16, P330, DOI 10.1111/ele.12043; Post E, 2013, P ROYAL SOC B, V280; Quintero I, 2013, ECOL LETT, V16, P1095, DOI 10.1111/ele.12144; Ramirez-Villegas J, 2010, 1 CIAT; Randall DA., 2007, CLIMATE CHANGE 2007; Razgour O, 2013, ECOL LETT, V16, P1258, DOI 10.1111/ele.12158; Saikkonen K, 2012, NAT CLIM CHANGE, V2, P239, DOI [10.1038/NCLIMATE1430, 10.1038/nclimate1430]; Sandel B, 2011, SCIENCE, V334, P660, DOI 10.1126/science.1210173; Sandel B, 2012, GLOBAL CHANGE BIOL, V18, P277, DOI 10.1111/j.1365-2486.2011.02480.x; Scinocca JF, 2008, ATMOS CHEM PHYS, V8, P7055, DOI 10.5194/acp-8-7055-2008; Slatyer RA, 2013, ECOL LETT, V16, P1104, DOI 10.1111/ele.12140; Teixeira J, 2002, BIODIVERS CONSERV, V11, P2167, DOI 10.1023/A:1021342611769; Thuiller W, 2011, NATURE, V470, P531, DOI 10.1038/nature09705; Vink CJ, 2011, BIOL INVASIONS, V13, P1003, DOI 10.1007/s10530-010-9885-6; Willis CG, 2008, P NATL ACAD SCI USA, V105, P17029, DOI 10.1073/pnas.0806446105	52	11	11	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98907	10.1371/journal.pone.0098907	http://dx.doi.org/10.1371/journal.pone.0098907			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892737	Green Published, Green Submitted, gold			2022-12-27	WOS:000336911400109
J	Mahadevan, D; Morales, C; Cooke, LS; Manziello, A; Mount, DW; Persky, DO; Fisher, RI; Miller, TP; Qi, WQ				Mahadevan, Daruka; Morales, Carla; Cooke, Laurence S.; Manziello, Ann; Mount, David W.; Persky, Daniel O.; Fisher, Richard I.; Miller, Thomas P.; Qi, Wenqing			Alisertib Added to Rituximab and Vincristine Is Synthetic Lethal and Potentially Curative in Mice with Aggressive DLBCL Co-Overexpressing MYC and BCL2	PLOS ONE			English	Article							B-CELL LYMPHOMA; PLUS CYCLOPHOSPHAMIDE; AURORA; PROLIFERATION; DOXORUBICIN; EXPRESSION; INHIBITOR; SURVIVAL; THERAPY; MLN8237	Pearson correlation coefficient for expression analysis of the Lymphoma/Leukemia Molecular Profiling Project (LLMPP) demonstrated Aurora A and B are highly correlated with MYC in DLBCL and mantle cell lymphoma (MCL), while both Auroras correlate with BCL2 only in DLBCL. Auroras are up-regulated by MYC dysregulation with associated aneuploidy and resistance to microtubule targeted agents such as vincristine. Myc and Bcl2 are differentially expressed in U-2932, TMD-8, OCI-Ly10 and Granta-519, but only U-2932 cells over-express mutated p53. Alisertib [MLN8237 or M], a highly selective small molecule inhibitor of Aurora A kinase, was synergistic with vincristine [VCR] and rituximab [R] for inhibition of cell proliferation, abrogation of cell cycle checkpoints and enhanced apoptosis versus single agent or doublet therapy. A DLBCL (U-2932) mouse model showed tumor growth inhibition (TGI) of similar to 10-20% (p = 0.001) for M, VCR and M-VCR respectively, while R alone showed similar to 50% TGI (p = 0.001). M-R and VCR-R led to tumor regression [TR], but relapsed 10 days after discontinuing therapy. In contrast, M-VCR-R demonstrated TR with no relapse >40 days after stopping therapy with a Kaplan-Meier survival of 100%. Genes that are modulated by M-VCR-R (CENP-C, Auroras) play a role in centromere-kinetochore function in an attempt to maintain mitosis in the presence of synthetic lethality. Together, our data suggest that the interaction between alisertib plus VCR plus rituximab is synergistic and synthetic lethal in Myc and Bcl-2 co-expressing DLBCL. Alisertib plus vincristine plus rituximab [M-VCR-R] may represent a new strategy for DLBCL therapy.	[Mahadevan, Daruka; Morales, Carla; Cooke, Laurence S.; Qi, Wenqing] Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA; [Manziello, Ann; Mount, David W.; Persky, Daniel O.; Miller, Thomas P.] Univ Arizona, Dept Med, Ctr Canc, Tucson, AZ USA; [Fisher, Richard I.] Fox Chase Canc Ctr Temple Hlth, Dept Med, Philadelphia, PA USA	University of Tennessee System; University of Tennessee Health Science Center; University of Arizona	Mahadevan, D (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA.	dmahadevan@westclinic.com; wqi@uthsc.edu			Lymphoma SPORE [1 P5O CA B080501A1]	Lymphoma SPORE	This work was supported by Lymphoma SPORE (1 P5O CA B080501A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aukema SM, 2011, BLOOD, V117, P2319, DOI 10.1182/blood-2010-09-297879; Barrans S, 2010, J CLIN ONCOL, V28, P3360, DOI 10.1200/JCO.2009.26.3947; Cuccuini W, 2012, BLOOD, V119, P4619, DOI 10.1182/blood-2012-01-406033; den Hollander J, 2010, BLOOD, V116, P1498, DOI 10.1182/blood-2009-11-251074; Dunleavy K, 2011, ANN ONCOL, V22, P106; Friedberg JW, 2014, J CLIN ONCOL, V32, P44, DOI 10.1200/JCO.2012.46.8793; Friedberg JW, 2012, J CLIN ONCOL, V30, P3439, DOI 10.1200/JCO.2012.43.5800; Green TM, 2012, J CLIN ONCOL, V30, P3460, DOI 10.1200/JCO.2011.41.4342; Johnson NA, 2012, J CLIN ONCOL, V30, P3452, DOI 10.1200/JCO.2011.41.0985; Mahadevan D, 2012, CLIN CANCER RES, V18, P2210, DOI 10.1158/1078-0432.CCR-11-2413; Mead GM, 2008, BLOOD, V112, P2248, DOI 10.1182/blood-2008-03-145128; Pfreundschuh M, 2012, J CLIN ONCOL, V30, P3433, DOI 10.1200/JCO.2012.44.4729; Qi WQ, 2013, LEUKEMIA RES, V37, P434, DOI 10.1016/j.leukres.2012.10.017; Qi WQ, 2011, BIOCHEM PHARMACOL, V81, P881, DOI 10.1016/j.bcp.2011.01.017; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Rosenwald A, 2003, CANCER CELL, V3, P185, DOI 10.1016/S1535-6108(03)00028-X; Sasaki N, 2011, EXP HEMATOL, V39, P817, DOI 10.1016/j.exphem.2011.05.002; Savage KJ, 2009, BLOOD, V114, P3533, DOI 10.1182/blood-2009-05-220095	18	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e95184	10.1371/journal.pone.0095184	http://dx.doi.org/10.1371/journal.pone.0095184			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893165	Green Published, gold, Green Submitted			2022-12-27	WOS:000336911400004
J	Monnahan, CC; Branch, TA; Stafford, KM; Ivashchenko, YV; Oleson, EM				Monnahan, Cole C.; Branch, Trevor A.; Stafford, Kathleen M.; Ivashchenko, Yulia V.; Oleson, Erin M.			Estimating Historical Eastern North Pacific Blue Whale Catches Using Spatial Calling Patterns	PLOS ONE			English	Article							BALAENOPTERA-MUSCULUS; TROPICAL PACIFIC; CALIFORNIA; WATERS	Blue whales (Balaenoptera musculus) were exploited extensively around the world and remain endangered. In the North Pacific their population structure is unclear and current status unknown, with the exception of a well-studied eastern North Pacific (ENP) population. Despite existing abundance estimates for the ENP population, it is difficult to estimate pre-exploitation abundance levels and gauge their recovery because historical catches of the ENP population are difficult to separate from catches of other populations in the North Pacific. We collated previously unreported Soviet catches and combined these with known catches to form the most current estimates of North Pacific blue whale catches. We split these conflated catches using recorded acoustic calls from throughout the North Pacific, the knowledge that the ENP population produces a different call than blue whales in the western North Pacific (WNP). The catches were split by estimating spatiotemporal occurrence of blue whales with generalized additive models fitted to acoustic call patterns, which predict the probability a catch belonged to the ENP population based on the proportion of calls of each population recorded by latitude, longitude, and month. When applied to the conflated historical catches, which totaled 9,773, we estimate that ENP blue whale catches totaled 3,411 (95% range 2,593 to 4,114) from 1905-1971, and amounted to 35% (95% range 27% to 42%) of all catches in the North Pacific. Thus most catches in the North Pacific were for WNP blue whales, totaling 6,362 (95% range 5,659 to 7,180). The uncertainty in the acoustic data influence the results substantially more than uncertainty in catch locations and dates, but the results are fairly insensitive to the ecological assumptions made in the analysis. The results of this study provide information for future studies investigating the recovery of these populations and the impact of continuing and future sources of anthropogenic mortality.	[Monnahan, Cole C.] Univ Washington, Seattle, WA 98195 USA; [Branch, Trevor A.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Stafford, Kathleen M.] Univ Washington, Appl Phys Lab, Seattle, WA 98195 USA; [Ivashchenko, Yulia V.] Alaska Fisheries Sci Ctr, Natl Marine Mammal Lab, Seattle, WA USA; [Ivashchenko, Yulia V.] So Cross Univ, Sch Environm Sci & Management, Lismore, NSW 2480, Australia; [Oleson, Erin M.] Pacific Isl Fisheries Sci Ctr, Protected Species Div, Honolulu, HI USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA; Southern Cross University	Monnahan, CC (corresponding author), Univ Washington, Seattle, WA 98195 USA.	colemonnahan@gmail.com	Oleson, Erin/AAA-9681-2019	Oleson, Erin/0000-0002-4889-6059; Stafford, Kathleen/0000-0003-0039-5025	Joint Institute for the Study of the Atmosphere and Ocean (JISAO) under NOAA [NA10OAR4320148, 2151]	Joint Institute for the Study of the Atmosphere and Ocean (JISAO) under NOAA	This publication is funded by the Joint Institute for the Study of the Atmosphere and Ocean (JISAO) under NOAA Cooperative Agreement NA10OAR4320148, Contribution No. 2151. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison C, 2011, IWC SUMMARY CATCH DA; Allison C, 2011, IWC INDIVIDUAL CATCH; Bailey Helen, 2010, Endangered Species Research, V10, P93, DOI 10.3354/esr00239; Baker CS, 2004, TRENDS ECOL EVOL, V19, P365, DOI 10.1016/j.tree.2004.05.005; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calambokidis J, 2004, MAR MAMMAL SCI, V20, P63, DOI 10.1111/j.1748-7692.2004.tb01141.x; Calambokidis J., 2009, PHOTOGRAPHIC IDENTIF; Calambokidis J, 2009, MAR MAMMAL SCI, V25, P816, DOI 10.1111/j.1748-7692.2009.00298.x; Carretta JV, 2012, NOAATMNMFSSWFSC504; Costa-Urrutia P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058315; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Gilpatrick James W. Jr., 2008, Journal of Cetacean Research and Management, V10, P9; Goldbogen JA, 2011, J EXP BIOL, V214, P698, DOI 10.1242/jeb.054726; Gregr EJ, 2001, CAN J FISH AQUAT SCI, V58, P1265, DOI 10.1139/cjfas-58-7-1265; Ivashchenko Y. V., 2013, Journal of Cetacean Research and Management, V13, P59; McDonald MA, 1999, J ACOUST SOC AM, V105, P2643, DOI 10.1121/1.426880; McDonald Mark A., 2006, Journal of Cetacean Research and Management, V8, P55; Melcon ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032681; Oleson EM, 2007, ANIM BEHAV, V74, P881, DOI 10.1016/j.anbehav.2007.01.022; Oleson EM, 2007, MAR MAMMAL SCI, V23, P574, DOI 10.1111/j.1748-7692.2007.02303.x; Oleson EM, 2007, MAR ECOL PROG SER, V330, P269, DOI 10.3354/meps330269; R Core Team, 2012, R LANG ENV STAT COMP; Reeves RR, 1998, PUBLICATIONS AGENCES; Reilly SB, 2008, IUCN 2012 IUCN RED L; RICE DW, 1998, MARINE MAMMALS WORLD; Rigby RA, 2005, J R STAT SOC C-APPL, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; Rivers JA, 1997, MAR MAMMAL SCI, V13, P186, DOI 10.1111/j.1748-7692.1997.tb00626.x; Stafford Kathleen M., 2001, Journal of Cetacean Research and Management, V3, P65; Stafford KM, 2003, MAR MAMMAL SCI, V19, P682, DOI 10.1111/j.1748-7692.2003.tb01124.x; Stafford KM, 1999, MAR MAMMAL SCI, V15, P1258, DOI 10.1111/j.1748-7692.1999.tb00889.x; Stafford KM, 1999, J ACOUST SOC AM, V106, P3687, DOI 10.1121/1.428220; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; YABLOKOV AV, 1994, NATURE, V367, P108, DOI 10.1038/367108a0	33	17	19	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98974	10.1371/journal.pone.0098974	http://dx.doi.org/10.1371/journal.pone.0098974			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892427	Green Published, Green Submitted, gold			2022-12-27	WOS:000336911400116
J	Zeng, T; Zhang, CL; Song, FY; Zhao, XL; Xie, KQ				Zeng, Tao; Zhang, Cui-Li; Song, Fu-Yong; Zhao, Xiu-Lan; Xie, Ke-Qin			CMZ Reversed Chronic Ethanol-Induced Disturbance of PPAR-alpha Possibly by Suppressing Oxidative Stress and PGC-1 alpha Acetylation, and Activating the MAPK and GSK3 beta Pathway	PLOS ONE			English	Article							ALCOHOLIC LIVER-DISEASE; FATTY-ACID SYNTHESIS; MOLECULAR-MECHANISMS; RECEPTOR-ALPHA; GARLIC OIL; RAT-LIVER; HEPATIC STEATOSIS; OXIDANT STRESS; CYP2E1; CONTRIBUTES	Background: Cytochrome P4502E1 (CYP2E1) has been suggested to play critical roles in the pathogenesis of alcoholic fatty liver (AFL), but the underlying mechanisms remains unclear. The current study was designed to evaluate whether CYP2E1 suppression by chlormethiazole (CMZ) could suppress AFL in mice, and to explore the underlying mechanisms. Methods: Mice were treated with or without CMZ (50 mg/kg bw, i.p.) and subjected to liquid diet with or without ethanol (5%, w/v) for 4 weeks. Biochemical parameters were measured using commercial kits. The protein and mRNA levels were detected by western blot and qPCR, respectively. Histopathology and immunohistochemical assay were performed with routine methods. Results: CYP2E1 inhibition by CMZ completely blocked AFL in mice, shown as the decline of the hepatic and serum triglyceride levels, and the fewer fat droplets in the liver sections. Chronic ethanol exposure led to significant decrease of the mRNA and protein levels of peroxisome proliferator-activated receptor alpha (PPAR-alpha), which was blocked by CMZ co-treatment. CMZ co-treatment suppressed ethanol-induced oxidative stress, overproduction of tumor necrosis alpha (TNF-alpha), and decrease of protein levels of the PPAR-alpha co-activators including p300 and deacetylated PGC1-alpha. Furthermore, CMZ co-treatment led to the activation of AMP-activated protein kinase (AMPK), mitogen-activated protein kinase (MAPK), and PI3K/Akt/GSK3 beta pathway. However, chronic ethanol-induced decline of acyl-CoA carboxylase (ACC) and fatty acid synthase (FAS) protein levels was partially restored by CMZ, while the activation of autophagy appeared to be suppressed by CMZ. Conclusion: These results suggested that CMZ suppressed chronic ethanol-induced oxidative stress, TNF-alpha overproduction, decline of p300 protein level and deacetylation of PGC1-alpha, and activated AMPK, MAPK, and PI3K/Akt/GSK3 beta pathway, which might contribute to the activation of PPAR-alpha and account for the protection of CMZ against AFL.	[Zeng, Tao; Zhang, Cui-Li; Song, Fu-Yong; Zhao, Xiu-Lan; Xie, Ke-Qin] Shandong Univ, Sch Publ Hlth, Inst Toxicol, Jinan 250100, Shandong, Peoples R China	Shandong University	Xie, KQ (corresponding author), Shandong Univ, Sch Publ Hlth, Inst Toxicol, Jinan 250100, Shandong, Peoples R China.	keqinx@sdu.edu.cn	Zeng, T/CAJ-0684-2022	Zeng, T/0000-0002-1145-2059	National Science Foundation of China [81102153]; China Postdoctoral Science Foundation [201104626]; Postdoctoral Science Foundation funded Project of Shandong Province [201002020]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Postdoctoral Science Foundation funded Project of Shandong Province	This work was supported by the National Science Foundation of China (Grant No. 81102153), the Special Financial Grant from the China Postdoctoral Science Foundation (Grant No. 201104626), and Postdoctoral Science Foundation funded Project of Shandong Province (Grant No. 201002020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajmo JM, 2008, AM J PHYSIOL-GASTR L, V295, pG833, DOI 10.1152/ajpgi.90358.2008; Albano E, 2008, MOL ASPECTS MED, V29, P9, DOI 10.1016/j.mam.2007.09.004; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Beier K, 1997, FEBS LETT, V412, P385, DOI 10.1016/S0014-5793(97)00805-3; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Cederbaum AI, 2010, DIGEST DIS, V28, P802, DOI 10.1159/000324289; Cho K, 2009, J MED FOOD, V12, P1293, DOI 10.1089/jmf.2009.0085; Crabb David W., 1999, Keio Journal of Medicine, V48, P184; Crabb DW, 2004, ALCOHOL, V34, P35, DOI 10.1016/j.alcohol.2004.07.005; Day CP, 1998, HEPATOLOGY, V27, P1463, DOI 10.1002/hep.510270601; Ding WX, 2011, EXP BIOL MED, V236, P546, DOI 10.1258/ebm.2011.010360; Ding WX, 2010, GASTROENTEROLOGY, V139, P1740, DOI 10.1053/j.gastro.2010.07.041; Donohue TM, 2007, WORLD J GASTROENTERO, V13, P4974; Eid N, 2013, J MOL HISTOL, V44, P311, DOI 10.1007/s10735-013-9483-x; Gyamfi MA, 2010, EXP BIOL MED, V235, P547, DOI 10.1258/ebm.2009.009249; He L, 2007, MOL ENDOCRINOL, V21, P2541, DOI 10.1210/me.2007-0036; Ji C, 2006, J HEPATOL, V45, P717, DOI 10.1016/j.jhep.2006.05.009; Kang XQ, 2009, HEPATOLOGY, V50, P1241, DOI 10.1002/hep.23090; Ki SH, 2007, CHEM-BIOL INTERACT, V169, P80, DOI 10.1016/j.cbi.2007.05.008; Kong LB, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-246; Kono H, 1999, AM J PHYSIOL-GASTR L, V277, pG1259, DOI 10.1152/ajpgi.1999.277.6.G1259; LEEVY CM, 1962, MEDICINE, V41, P249, DOI 10.1097/00005792-196209000-00003; Leung TM, 2013, J HEPATOL, V58, P395, DOI 10.1016/j.jhep.2012.08.018; LIEBER CS, 1965, J CLIN INVEST, V44, P1009, DOI 10.1172/JCI105200; LIEBER CS, 1989, HEPATOLOGY, V10, P501, DOI 10.1002/hep.1840100417; Lu YK, 2008, HEPATOLOGY, V47, P1483, DOI 10.1002/hep.22222; Medina J, 2005, DRUGS, V65, P2445, DOI 10.2165/00003495-200565170-00003; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Nakajima T, 2004, HEPATOLOGY, V40, P972, DOI 10.1002/hep.20399; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; Ogita S, 2011, TARGET ONCOL, V6, P103, DOI 10.1007/s11523-011-0176-7; Pahan K, 1997, FREE RADICAL BIO MED, V23, P963, DOI 10.1016/S0891-5849(97)00017-8; Purohit V, 2009, ALCOHOL CLIN EXP RES, V33, P191, DOI 10.1111/j.1530-0277.2008.00827.x; Ramaiah SK, 2004, INT J TOXICOL, V23, P217, DOI 10.1080/10915810490502069; REINKE LA, 1987, P NATL ACAD SCI USA, V84, P9223, DOI 10.1073/pnas.84.24.9223; Sertznig P, 2008, AM J CLIN DERMATOL, V9, P15, DOI 10.2165/00128071-200809010-00002; Shearn CT, 2013, J NUTR BIOCHEM, V24, P1436, DOI 10.1016/j.jnutbio.2012.12.002; Shen Z., 2009, AM J PHYSL GASTROINT; SIMPSON KJ, 1994, CLIN SCI, V87, P441, DOI 10.1042/cs0870441; SORENSEN TIA, 1984, LANCET, V2, P241, DOI 10.1016/S0140-6736(84)90295-2; Sugden MC, 2010, J ENDOCRINOL, V204, P93, DOI 10.1677/JOE-09-0359; Wan YJY, 2001, HEPATOL RES, V19, P117, DOI 10.1016/S1386-6346(00)00089-9; Yin HQ, 2007, TOXICOL APPL PHARM, V223, P225, DOI 10.1016/j.taap.2007.06.018; You M, 2004, ALCOHOL, V34, P39, DOI 10.1016/j.alcohol.2004.07.004; You M, 2004, AM J PHYSIOL-GASTR L, V287, pG1, DOI 10.1152/ajpgi.00056.2004; You M, 2002, J BIOL CHEM, V277, P29342, DOI 10.1074/jbc.M202411200; Zeng T, 2013, BBA-GEN SUBJECTS, V1830, P4848, DOI 10.1016/j.bbagen.2013.06.028; Zeng T, 2012, TOXICOLOGY, V296, P56, DOI 10.1016/j.tox.2012.03.005; Zeng T, 2012, FOOD CHEM TOXICOL, V50, P485, DOI 10.1016/j.fct.2011.11.030; Zeng T, 2009, HUM EXP TOXICOL, V28, P777, DOI 10.1177/0960327109353057; Zeng T, 2009, ARCH TOXICOL, V83, P1075, DOI 10.1007/s00204-009-0457-4; Zhao ZW, 2011, ALCOHOL CLIN EXP RES, V35, P229, DOI 10.1111/j.1530-0277.2010.01338.x; Zhou ZX, 2003, AM J PATHOL, V163, P1137, DOI 10.1016/S0002-9440(10)63473-6; Zhu H, 2012, J DIGEST DIS, V13, P133, DOI 10.1111/j.1751-2980.2011.00569.x	55	35	41	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98658	10.1371/journal.pone.0098658	http://dx.doi.org/10.1371/journal.pone.0098658			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892905	Green Published, Green Submitted, gold			2022-12-27	WOS:000336911400081
J	Lopez-Guimera, G; Dashti, HS; Smith, CE; Sanchez-Carracedo, D; Ordovas, JM; Garaulet, M				Lopez-Guimera, Gemma; Dashti, Hassan S.; Smith, Caren E.; Sanchez-Carracedo, David; Ordovas, Jose M.; Garaulet, Marta			CLOCK 3111 T/C SNP Interacts with Emotional Eating Behavior for Weight-Loss in a Mediterranean Population	PLOS ONE			English	Article							FOOD-INTAKE; METABOLIC SYNDROME; LOSS MAINTENANCE; LIFE-STYLE; OBESITY; OVERWEIGHT; GENE; STRESS; PREDICTORS; WOMEN	Objective: The goals of this research was (1) to analyze the role of emotional eating behavior on weight-loss progression during a 30-week weight-loss program in 1,272 individuals from a large Mediterranean population and (2) to test for interaction between CLOCK 3111 T/C SNP and emotional eating behavior on the effectiveness of the weight-loss program. Design and Methods: A total of 1,272 overweight and obese participants (BMI: 31 +/- 5 kg/m(2)), aged 20 to 65 years, attending outpatient weight-loss clinics were recruited for this analysis. Emotional eating behavior was assessed by the Emotional Eating Questionnaire (EEQ), a questionnaire validated for overweight and obese Spanish subjects. Anthropometric measures, dietary intake and weight-loss progression were assessed and analyzed throughout the 30-week program. Multivariate analysis and linear regression models were performed to test for gene-environment interaction. Results: Weight-loss progression during the 30-week program differed significantly according to the degree of emotional eating behavior. Participants classified as 'very emotional eaters' experienced more irregular (P = 0.007) weight-loss, with a lower rate of weight decline (-0.002 vs. -0.003, P<0.05) in comparison with less emotional eaters. The percentage of weight-loss was also significantly higher in 'non-emotional eaters' (P = 0.009). Additionally, we identified a significant gene-environment interaction associated with weight-loss at the CLOCK 3111 T/C locus (P = 0.017). By dichotomizing the emotional eating behavior score, linear regression analysis indicated that minor C allele carriers with a high emotional score (> = 11), lost significantly less weight than those C carriers with a low emotional score (<11) (P = 0.005). Conclusions: Emotional eating behavior associates with weight-loss pattern, progression and total weight-loss. Additionally, CLOCK 3111 T/C SNP interacts with emotional eating behavior to modulate total weight loss. These results suggest that the assessment of this locus and emotional eating behavior could improve the development of effective, long-tern weight-management interventions.	[Lopez-Guimera, Gemma; Sanchez-Carracedo, David] Univ Autonoma Barcelona, Dept Clin & Hlth Psychol, E-08193 Barcelona, Spain; [Dashti, Hassan S.; Smith, Caren E.; Ordovas, Jose M.] Tufts Univ, Nutr & Genom Lab, Jean Mayer US Dept Agr, Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Garaulet, Marta] Univ Murcia, Dept Physiol, Murcia, Spain; [Ordovas, Jose M.] CNIC, Dept Epidemiol, Madrid, Spain; [Ordovas, Jose M.] Inst Madrileno Estudios Avanzados Alimentac IMDEA, Madrid, Spain	Autonomous University of Barcelona; Tufts University; United States Department of Agriculture (USDA); University of Murcia; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Garaulet, M (corresponding author), Univ Murcia, Dept Physiol, Murcia, Spain.	garaulet@um.es	Greiver, Michelle/N-8764-2015; Sánchez-Carracedo, David/A-4505-2009; Garaulet, Marta/K-6625-2014; Ordovas, Jose/B-8727-2013	Greiver, Michelle/0000-0001-8957-0285; Sánchez-Carracedo, David/0000-0002-3945-6940; Garaulet, Marta/0000-0002-4066-3509; Dashti, Hassan/0000-0002-1650-679X; Ordovas, Jose/0000-0002-7581-5680	NHLBI NIH HHS [HL-54776, K08 HL112845, R01 HL054776] Funding Source: Medline; NIDDK NIH HHS [DK075030, R01 DK075030] Funding Source: Medline; NIMHD NIH HHS [L60 MD003562] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054776, K08HL112845] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bacon L, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-9; Bandin C, 2013, INT J OBESITY, V37, P1044, DOI 10.1038/ijo.2012.180; Bandin C, 2014, INT J OBESITY, V38, P1083, DOI 10.1038/ijo.2013.211; Barte JCM, 2010, OBES REV, V11, P899, DOI 10.1111/j.1467-789X.2010.00740.x; Benedetti F, 2003, AM J MED GENET B, V123B, P23, DOI 10.1002/ajmg.b.20038; BLAIR AJ, 1990, APPETITE, V15, P151, DOI 10.1016/0195-6663(90)90047-C; Bond DS, 2009, INT J OBESITY, V33, P173, DOI 10.1038/ijo.2008.256; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Bryant EJ, 2008, OBES REV, V9, P409, DOI 10.1111/j.1467-789X.2007.00426.x; Carter FA, 2012, APPETITE, V58, P1063, DOI 10.1016/j.appet.2012.01.016; Corbalan-Tutau M.D., 2009, REV ESP OBES, V7, P144; Corbalan MD, 2009, NUTRITION, V25, P861, DOI 10.1016/j.nut.2009.02.013; Elfhag K, 2005, OBES REV, V6, P67, DOI 10.1111/j.1467-789X.2005.00170.x; Evers C, 2010, PERS SOC PSYCHOL B, V36, P792, DOI 10.1177/0146167210371383; Garaulet M, 2013, INT J OBESITY, V37, P604, DOI 10.1038/ijo.2012.229; Garaulet M, 2012, INT J OBESITY, V36, P1436, DOI 10.1038/ijo.2011.270; Garaulet M, 2012, NUTR HOSP, V27, P645, DOI [10.3305/nh.2012.27.2.5659, 10.1590/S0212-16112012000200043]; Garaulet M, 2010, INT J OBESITY, V34, P516, DOI 10.1038/ijo.2009.255; Garaulet M, 1999, J HUM NUTR DIET, V12, P219, DOI 10.1046/j.1365-277x.1999.00163.x; Garaulet M, 2010, J AM DIET ASSOC, V110, P917, DOI 10.1016/j.jada.2010.03.017; Garaulet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017435; Garaulet M, 2010, ADV DRUG DELIVER REV, V62, P967, DOI 10.1016/j.addr.2010.05.005; Garaulet M, 2010, EUR J HUM GENET, V18, P364, DOI 10.1038/ejhg.2009.176; Garaulet M, 2009, AM J CLIN NUTR, V90, P1466, DOI 10.3945/ajcn.2009.27536; Geliebter Allan, 2003, Eat Behav, V3, P341, DOI 10.1016/S1471-0153(02)00100-9; Gibson EL, 2006, PHYSIOL BEHAV, V89, P53, DOI 10.1016/j.physbeh.2006.01.024; GOLDSTEIN DJ, 1992, INT J OBESITY, V16, P397; Hainer V, 2008, DIABETES CARE, V31, pS269, DOI 10.2337/dc08-s265; Hays NP, 2008, OBESITY, V16, P52, DOI 10.1038/oby.2007.12; Jansen A, 2008, APPETITE, V51, P556, DOI 10.1016/j.appet.2008.04.009; KARLSSON J, 1994, APPETITE, V23, P15, DOI 10.1006/appe.1994.1031; Kissling C, 2008, AM J MED GENET B, V147B, P333, DOI 10.1002/ajmg.b.30602; Konttinen H, 2010, APPETITE, V54, P473, DOI 10.1016/j.appet.2010.01.014; Kripke Daniel F, 2009, J Circadian Rhythms, V7, P2, DOI 10.1186/1740-3391-7-2; LAVERY MA, 1993, J AM DIET ASSOC, V93, P1017, DOI 10.1016/0002-8223(93)92041-U; Leblanc V, 2012, CLIN NUTR, V31, P481, DOI 10.1016/j.clnu.2011.12.013; Macht M, 2003, PHYSIOL BEHAV, V80, P367, DOI 10.1016/j.physbeh.2003.08.012; Macht M, 2008, APPETITE, V50, P1, DOI 10.1016/j.appet.2007.07.002; Mann T, 2007, AM PSYCHOL, V62, P220, DOI 10.1037/0003-066X.62.3.220; Milagro FI, 2012, CHRONOBIOL INT, V29, P1180, DOI 10.3109/07420528.2012.719967; Nguyen-Michel ST, 2007, APPETITE, V49, P494, DOI 10.1016/j.appet.2007.03.005; Oliver G, 2000, PSYCHOSOM MED, V62, P853, DOI 10.1097/00006842-200011000-00016; Royal JD, 2010, PERS INDIV DIFFER, V49, P565, DOI 10.1016/j.paid.2010.04.022; Scott EM, 2008, INT J OBESITY, V32, P658, DOI 10.1038/sj.ijo.0803778; Serra-Majem L, 2001, PUBLIC HEALTH NUTR, V4, P1409, DOI 10.1079/PHN2001229; Serretti A, 2003, AM J MED GENET B, V121B, P35, DOI 10.1002/ajmg.b.20053; Sherwood NE, 1999, INT J OBESITY, V23, P485, DOI 10.1038/sj.ijo.0800846; Teixeira Pedro J, 2004, Int J Behav Nutr Phys Act, V1, P12; Teixeira PJ, 2010, OBESITY, V18, P725, DOI 10.1038/oby.2009.281; Teixeira PJ, 2005, OBES REV, V6, P43, DOI 10.1111/j.1467-789X.2005.00166.x; Teixeira PJ, 2002, J BEHAV MED, V25, P499, DOI 10.1023/A:1020687832448; Torres SJ, 2007, NUTRITION, V23, P887, DOI 10.1016/j.nut.2007.08.008; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Von Schantz M, 2008, J GENET, V87, P513, DOI 10.1007/s12041-008-0074-7; Wallis DJ, 2009, APPETITE, V52, P355, DOI 10.1016/j.appet.2008.11.007; Wallis DJ, 2004, APPETITE, V43, P39, DOI 10.1016/j.appet.2004.02.001; Wing RR, 2005, AM J CLIN NUTR, V82, p222S, DOI 10.1093/ajcn/82.1.222S	58	28	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99152	10.1371/journal.pone.0099152	http://dx.doi.org/10.1371/journal.pone.0099152			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905098	Green Published, gold, Green Submitted			2022-12-27	WOS:000341869000106
J	Meyer, PJ; Cogan, ES; Robinson, TE				Meyer, Paul J.; Cogan, Elizabeth S.; Robinson, Terry E.			The Form of a Conditioned Stimulus Can Influence the Degree to Which It Acquires Incentive Motivational Properties	PLOS ONE			English	Article							CUE-INDUCED REINSTATEMENT; COCAINE-SEEKING; SIGN-TRACKING; D-AMPHETAMINE; INDIVIDUAL-DIFFERENCES; PREFRONTAL CORTEX; DOPAMINE EFFLUX; ACCUMBENS CORE; GOAL-TRACKING; FOOD SEEKING	There is considerable individual variation in the extent to which food- and drug-associated cues (conditioned stimuli, CSs) acquire incentive salience, as indicated by whether they elicit approach towards them, and/or act as conditioned reinforcers. Here we asked whether this variation is influenced by properties of the CS itself. In rats, we assessed both the attractiveness and conditioned reinforcing properties of two CSs: a manipulable lever CS versus an auditory (tone) CS. There was considerable individual variation in the extent to which a lever CS acquired incentive motivational properties, as indicated by whether it became attractive (evoked a sign-tracking or goal-tracking conditioned response) or acted as a conditioned reinforcer. However, with a tone CS all rats learned a goal-tracking response, and the tone CS was an equally effective conditioned reinforcer in sign-trackers and goal-trackers. Even when presented in compound (a lever-tone CS), the two elements of the compound differentially acquired motivational properties. In contrast, amphetamine and stress potentiated the conditioned reinforcing properties of both visual and auditory CSs similarly in rats that primarily sign-tracked or goal-tracked. We conclude that variation in the to the ability of CSs to acquire incentive salience, and thus their ability to act as incentive stimuli capable of motivating behavior, is determined in part by properties of the CS itself.	[Meyer, Paul J.; Cogan, Elizabeth S.; Robinson, Terry E.] Univ Michigan, Dept Psychol, Ann Arbor, MI USA	University of Michigan System; University of Michigan	Meyer, PJ (corresponding author), SUNY Buffalo, Dept Psychol, Behav Neurosci Program, Buffalo, NY 14260 USA.	pmeyer@buffalo.edu	Meyer, Paul/GQJ-8502-2022	Cogan, Elizabeth/0000-0003-2075-4494	National Institute of Drug Abuse (National Institutes of Health) [P01 DA031656, T32 DA007268]; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA031656, T32DA007268] Funding Source: NIH RePORTER	National Institute of Drug Abuse (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Research was supported by grants from the National Institute of Drug Abuse (National Institutes of Health): P01 DA031656 (T. E. R.), and T32 DA007268 (P.J.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKINS CK, 1994, J EXP PSYCHOL ANIM B, V20, P199, DOI 10.1037/0097-7403.20.2.199; Anselme P, 2013, BEHAV BRAIN RES, V238, P53, DOI 10.1016/j.bbr.2012.10.006; Arroyo M, 1998, PSYCHOPHARMACOLOGY, V140, P331, DOI 10.1007/s002130050774; BENINGER RJ, 1981, BRIT J PHARMACOL, V74, P149, DOI 10.1111/j.1476-5381.1981.tb09967.x; Berridge KC, 2001, PSYCHOL LEARN MOTIV, V40, P223, DOI 10.1016/s0079-7421(00)80022-5; Bevins Rick A, 2004, Behav Cogn Neurosci Rev, V3, P143, DOI 10.1177/1534582304272005; BINDRA D, 1978, BEHAV BRAIN SCI, V1, P41, DOI 10.1017/S0140525X00059380; Blaiss CA, 2007, NEUROBIOL LEARN MEM, V87, P644, DOI 10.1016/j.nlm.2006.12.007; Boakes RA, 1977, OPERANT PAVLOVIAN IN, V1st, P35; Brown ZJ, 2012, PSYCHOPHARMACOLOGY, V224, P431, DOI 10.1007/s00213-012-2772-3; Cabrera F, 2009, BEHAV PROCESS, V82, P229, DOI 10.1016/j.beproc.2009.06.010; Caggiula AR, 2009, NEBR SYM MOTIV, V55, P91, DOI 10.1007/978-0-387-78748-0_6; Chang SE, 2013, BEHAV BRAIN RES, V256, P36, DOI 10.1016/j.bbr.2013.07.046; Chaudhri N, 2006, PSYCHOPHARMACOLOGY, V184, P353, DOI 10.1007/s00213-005-0178-1; Cheng JJ, 2003, EUR J NEUROSCI, V18, P1306, DOI 10.1046/j.1460-9568.2003.02849.x; Chow JJ, 2013, DISSOCIATING SIGN GO; CLELAND GG, 1983, J EXP ANAL BEHAV, V40, P47, DOI 10.1901/jeab.1983.40-47; Corbit LH, 2003, J EXP PSYCHOL ANIM B, V29, P99, DOI 10.1037/0097-7403.29.2.99; Costa DSJ, 2007, LEARN BEHAV, V35, P95, DOI 10.3758/BF03193044; Danna CL, 2010, PHARMACOL BIOCHEM BE, V96, P40, DOI 10.1016/j.pbb.2010.04.004; Danna CL, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00781; Demos KE, 2012, J NEUROSCI, V32, P5549, DOI 10.1523/JNEUROSCI.5958-11.2012; Difeliceantonio AG, 2012, BEHAV BRAIN RES; Eyny YS, 2003, J NEUROSCI, V23, P1584; Feltenstein MW, 2006, BEHAV BRAIN RES, V174, P1, DOI 10.1016/j.bbr.2006.06.039; Flagel SB, 2007, PSYCHOPHARMACOLOGY, V191, P599, DOI 10.1007/s00213-006-0535-8; Flagel SB, 2011, NATURE, V469, P53, DOI 10.1038/nature09588; Flagel SB, 2010, NEUROPSYCHOPHARMACOL, V35, P388, DOI 10.1038/npp.2009.142; Flagel SB, 2009, NEUROPHARMACOLOGY, V56, P139, DOI 10.1016/j.neuropharm.2008.06.027; Gancarz AM, 2012, EXP CLIN PSYCHOPHARM, V20, P16, DOI 10.1037/a0025701; Gerdjikov TV, 2011, PSYCHOPHARMACOLOGY, V214, P891, DOI 10.1007/s00213-010-2099-x; Grimm JW, 2001, NATURE, V412, P141, DOI 10.1038/35084134; Guy EG, 2013, PSYCHOPHARMACOLOGY B; Guy EG, 2013, PSYCHOPHARMACOLOGY, V225, P429, DOI 10.1007/s00213-012-2832-8; Hearst E, 1974, P PSYCHONOMIC SOC; Hill R, 1970, AMPHETAMINES RELATED; HOLLAND PC, 1980, J EXP PSYCHOL ANIM B, V6, P155, DOI 10.1037/0097-7403.6.2.155; HOLLAND PC, 1977, J EXP PSYCHOL ANIM B, V3, P77, DOI 10.1037/0097-7403.3.1.77; Holland PC, 2013, LEARN BEHAV; HOLLIS KL, 1982, ADV STUD BEHAV, V12, P1, DOI 10.1016/S0065-3454(08)60045-5; Horsley RR, 2008, PROG NEURO-PSYCHOPH, V32, P1057, DOI 10.1016/j.pnpbp.2008.02.005; JENKINS HM, 1973, J EXP ANAL BEHAV, V20, P197, DOI 10.1901/jeab.1973.20-197; Kamin L. J., 1969, PUNISHMENT AVERSIVE, P279, DOI DOI 10.2105/AJPH.2006.090910; LeBlanc KH, 2012, BEHAV NEUROSCI, V126, P681, DOI 10.1037/a0029534; Lloyd DR, 2012, BEHAV BRAIN RES, V234, P312, DOI 10.1016/j.bbr.2012.07.012; Lomanowska AM, 2011, BEHAV BRAIN RES, V220, P91, DOI 10.1016/j.bbr.2011.01.033; Mackintosh N. J., 1974, PSYCHOL ANIMAL LEARN; Mahler SV, 2012, PSYCHOPHARMACOLOGY, V221, P407, DOI 10.1007/s00213-011-2588-6; Mahler SV, 2009, J NEUROSCI, V29, P6500, DOI 10.1523/JNEUROSCI.3875-08.2009; MartinIverson MT, 1996, BEHAV PHARMACOL, V7, P24; MAZURSKI EJ, 1986, PSYCHOPHARMACOLOGY, V90, P239; Meyer PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038987; Meyer PJ, 2012, PSYCHOPHARMACOLOGY, V219, P999, DOI 10.1007/s00213-011-2429-7; Milton AL, 2010, EUR J NEUROSCI, V31, P2308, DOI 10.1111/j.1460-9568.2010.07249.x; Mingote S, 2004, J NEUROSCI, V24, P2475, DOI 10.1523/JNEUROSCI.4547-03.2004; Nair SG, 2011, NEUROPSYCHOPHARMACOL, V36, P497, DOI 10.1038/npp.2010.181; Palmatier MI, 2007, PSYCHOPHARMACOLOGY, V195, P235, DOI 10.1007/s00213-007-0897-6; Palmatier MI, 2007, DRUG ALCOHOL DEPEN, V89, P52, DOI 10.1016/j.drugalcdep.2006.11.020; Palmatier MI, 2013, PSYCHOPHARMACOLOGY, V226, P247, DOI 10.1007/s00213-012-2892-9; Palmatier MI, 2012, PSYCHOPHARMACOLOGY, V219, P1119, DOI 10.1007/s00213-011-2439-5; Pavlov I.P., 1927, CONDITIONED REFLEXES; Phillips A.G., 1990, Behav Pharmacol, V1, P269; Phillips GD, 2003, BEHAV NEUROSCI, V117, P675, DOI 10.1037/0735-7044.117.4.675; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; RESCORLA RA, 1988, AM PSYCHOL, V43, P151, DOI 10.1037/0003-066X.43.3.151; ROBBINS TW, 1978, PHARMACOL BIOCHEM BE, V8, P219, DOI 10.1016/0091-3057(78)90308-8; ROBBINS TW, 1978, PSYCHOPHARMACOLOGY, V58, P79, DOI 10.1007/BF00426794; Robinson MJF, 2014, BEHAV BRAIN RES, V266, P119, DOI 10.1016/j.bbr.2014.03.004; Robinson TE, 2014, NEUROPHARMACOLOGY, V76, P450, DOI 10.1016/j.neuropharm.2013.05.040; Robinson TE, 2009, BIOL PSYCHIAT, V65, P869, DOI 10.1016/j.biopsych.2008.09.006; Saunders BT, 2013, NEUROSCI BIOBEHAV R, V37, P1955, DOI 10.1016/j.neubiorev.2013.02.008; Saunders BT, 2013, J NEUROSCI, V33, P13989, DOI 10.1523/JNEUROSCI.0450-13.2013; Saunders BT, 2012, EUR J NEUROSCI, V36, P2521, DOI 10.1111/j.1460-9568.2012.08217.x; Saunders BT, 2011, NEUROPSYCHOPHARMACOL, V36, P1668, DOI 10.1038/npp.2011.48; Saunders BT, 2010, BIOL PSYCHIAT, V67, P730, DOI 10.1016/j.biopsych.2009.11.015; Schroeder JP, 2013, NEUROPSYCHOPHARMACOL, V38, P1032, DOI 10.1038/npp.2012.267; Shaham Y, 2000, BRAIN RES REV, V33, P13, DOI 10.1016/S0165-0173(00)00024-2; SILVA FJ, 1992, J EXP ANAL BEHAV, V57, P17, DOI 10.1901/jeab.1992.57-17; SOLOMON RL, 1974, PSYCHOL REV, V81, P119, DOI 10.1037/h0036128; Taylor JR, 2001, BIOL PSYCHIAT, V50, P137, DOI 10.1016/S0006-3223(01)01106-4; TAYLOR JR, 1984, PSYCHOPHARMACOLOGY, V84, P405, DOI 10.1007/BF00555222; TIMBERLAKE W, 1982, J EXP PSYCHOL ANIM B, V8, P62, DOI 10.1037/0097-7403.8.1.62; Tindell AJ, 2005, EUR J NEUROSCI, V22, P2617, DOI 10.1111/j.1460-9568.2005.04411.x; TOMIE A, 1976, SCIENCE, V192, P1244, DOI 10.1126/science.192.4245.1244; Uslaner JM, 2008, NEUROPSYCHOPHARMACOL, V33, P2352, DOI 10.1038/sj.npp.1301653; Uslaner JM, 2006, BEHAV BRAIN RES, V169, P320, DOI 10.1016/j.bbr.2006.02.001; Wassum KM, 2011, LEARN MEMORY, V18, P475, DOI 10.1101/lm.2229311; WEISS SJ, 1993, J EXP ANAL BEHAV, V59, P309, DOI 10.1901/jeab.1993.59-309; Winterbauer NE, 2007, FRONT INTEGR NEUROSC, V1, DOI [10.3389/neuro.07.009.2007, 10.3389/neuro.07/009.2007]; Yager LM, 2013, PSYCHOPHARMACOLOGY, V226, P217, DOI 10.1007/s00213-012-2890-y; Yager LM, 2010, BEHAV BRAIN RES, V214, P30, DOI 10.1016/j.bbr.2010.04.021; Yager LM, 2012, PSYCHOPHARMACOLOGY B; Zener K, 1937, AM J PSYCHOL, V50, P384, DOI 10.2307/1416644	93	59	59	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98163	10.1371/journal.pone.0098163	http://dx.doi.org/10.1371/journal.pone.0098163			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP1YS	24905195	gold, Green Published, Green Submitted			2022-12-27	WOS:000341869000019
J	Wu, CY; Lin, F; Qiu, SW; Jiang, ZL				Wu, Chuyan; Lin, Feng; Qiu, Shuwei; Jiang, Zhongli			The Characterization of Obese Polycystic Ovary Syndrome Rat Model Suitable for Exercise Intervention	PLOS ONE			English	Article							LIFE-STYLE MODIFICATION; NERVE GROWTH-FACTOR; INSULIN-RESISTANCE; METABOLIC SYNDROME; FEMALE RATS; SKELETAL-MUSCLE; GLUCOSE-TRANSPORT; DIET; WOMEN; RISK	Objective: To develop a new polycystic ovary syndrome (PCOS) rat model suitable for exercise intervention. Method: Thirty six rats were randomly divided into three experimental groups: PCOS rats with high-fat diet (PF, n = 24), PCOS rats with ordinary diet (PO, n = 6), and control rats with ordinary diet (CO, n = 6). Two kinds of PCOS rat model were made by adjustment diet structure and testosterone injection for 28 days. After a successful animal model, PF model rats were randomly assigned to three groups: exercise with a continuation of high-fat diet (PF-EF, n = 6), sedentary with a continuation of high-fat diet (PF-SF, n = 6), exercise with an ordinary diet (PF-EO, n = 6). Fasting blood glucose (FBG) and insulin (FINS), estrogen (E2), progesterone (P), and testosterone (T) in serum were determined by RIA, and ovarian morphology was evaluated by Image-Pro plus 6.0. Results: Body weight, Lee index, FINS increased significantly in PF rat model. Serum levels of E2 and T were significantly higher in PF and PO than in CO. Ovary organ index and ovarian areas were significant lower in PF than in CO. After intervention for 2 weeks, the levels of 1 h postprandial blood glucose (PBG(1)), 2 h postprandial blood glucose (PBG(2)), FINS and the serum levels of T decreased significantly in PF-EF rats and PF-EO rats. The ratio of FBG/FINS was significant higher in PF-EO rats than in PF-SF rats. Ovarian morphology showed that the numbers of preantral follicles and atretic follicles decreased significantly, and the numbers of antral follicles and corpora lutea increased significantly in the rats of PF-EF and PF-EO. Conclusion: By combination of high-fat diet and testosterone injection, the obese PCOS rat model is conformable with the lifestyle habits of fatty foods and insufficient exercise, and has metabolic and reproductive characteristics of human PCOS. This model can be applied to study exercise intervention.	[Wu, Chuyan; Lin, Feng; Qiu, Shuwei; Jiang, Zhongli] Nanjing Med Univ, Affiliated Hosp 1, Dept Rehabil Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Jiang, ZL (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Rehabil Med, Nanjing, Jiangsu, Peoples R China.	jiangzh3721@163.com	wu, chuyan/ABH-1698-2021					Al-Nozha Omar, 2013, Pathophysiology, V20, P131, DOI 10.1016/j.pathophys.2013.03.002; Azziz R, 2006, J CLIN ENDOCR METAB, V91, P4237, DOI 10.1210/jc.2006-0178; Beloosesky R, 2004, INT J MOL MED, V14, P207; Benrick A, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/964070; Cai WJ, 2002, MOL MED, V8, P337, DOI 10.1007/BF03402014; Cataldo NA, 2006, HUM REPROD, V21, P109, DOI 10.1093/humrep/dei289; Cavagni J, 2013, ARCH ORAL BIOL, V58, P1034, DOI 10.1016/j.archoralbio.2013.03.006; Coviello AD, 2006, J CLIN ENDOCR METAB, V91, P492, DOI 10.1210/jc.2005-1666; Diamanti-Kandarakis E, 2007, J MOL MED-JMM, V85, P1413, DOI 10.1007/s00109-007-0246-6; Diamanti-Kandarakis E, 2012, CURR PHARM DESIGN, V18, P270, DOI 10.2174/138161212799040457; Douglas CC, 2006, FERTIL STERIL, V85, P679, DOI 10.1016/j.fertnstert.2005.08.045; Dunaif A, 1997, ENDOCR REV, V18, P774, DOI 10.1210/er.18.6.774; Flanagan AM, 2008, J NUTR BIOCHEM, V19, P505, DOI 10.1016/j.jnutbio.2007.06.005; Franks S, 2008, HUM REPROD UPDATE, V14, P367, DOI 10.1093/humupd/dmn015; Goldberg T, 2004, J AM DIET ASSOC, V104, P1287, DOI 10.1016/j.jada.2004.05.214; Guzick DS, 2007, CLIN OBSTET GYNECOL, V50, P255, DOI 10.1097/GRF.0b013e31802f361e; HAMILTONFAIRLEY D, 1993, CLIN ENDOCRINOL, V39, P363, DOI 10.1111/j.1365-2265.1993.tb02378.x; Hawley JA, 2004, DIABETES-METAB RES, V20, P383, DOI 10.1002/dmrr.505; Hayashi T, 1997, AM J PHYSIOL-ENDOC M, V273, pE1039, DOI 10.1152/ajpendo.1997.273.6.E1039; Hickey M, 2011, HUM REPROD, V26, P1469, DOI 10.1093/humrep/der102; Hoeger KM, 2007, CLIN OBSTET GYNECOL, V50, P277, DOI 10.1097/GRF.0b013e31802f54c8; Khorram O, 2006, FERTIL STERIL, V85, P1448, DOI 10.1016/j.fertnstert.2005.10.042; LARA HE, 1993, ENDOCRINOLOGY, V133, P2690, DOI 10.1210/en.133.6.2690; Liu GT, 2005, REPROD NUTR DEV, V45, P185, DOI 10.1051/rnd:2005010; Lord JM, 2006, BRIT MED J, V332, P609, DOI 10.1136/bmj.332.7541.609-a; Lunger F, 2013, GYNECOL ENDOCRINOL, V29, P541, DOI 10.3109/09513590.2013.774362; Maliqueo M, 2013, ENDOCRINOLOGY, V154, P434, DOI 10.1210/en.2012-1693; Manneras L, 2007, ENDOCRINOLOGY, V148, P3781, DOI 10.1210/en.2007-0168; Manni L, 2005, J NEUROENDOCRINOL, V17, P846, DOI 10.1111/j.1365-2826.2005.01378.x; Moran LJ, 2013, HUM REPROD, V28, P2276, DOI 10.1093/humrep/det256; Morifuji M, 2006, BRIT J NUTR, V96, P469, DOI 10.1079/BJN20061855; National Institute of Clinical Excellence, 2004, FERT ASS TREATM PEOP; Norman RJ, 2004, MED J AUSTRALIA, V180, P132, DOI 10.5694/j.1326-5377.2004.tb05838.x; Norman RJ, 2002, TRENDS ENDOCRIN MET, V13, P251, DOI 10.1016/S1043-2760(02)00612-4; Norman RJ, 2007, LANCET, V370, P685, DOI 10.1016/S0140-6736(07)61345-2; Palomba S, 2008, HUM REPROD, V23, P642, DOI 10.1093/humrep/dem391; Qiu S, 2009, HORM METAB RES, V41, P880, DOI 10.1055/s-0029-1234119; Rajaie S, 2014, NUTRITION, V30, P61, DOI 10.1016/j.nut.2013.06.011; Schuering Andreas N., 2008, Gynaekologisch-Geburtshilfliche Rundschau, V48, P9, DOI 10.1159/000111465; Shi D, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.04.006; Stener-Victorin E, 2000, BIOL REPROD, V63, P1497, DOI 10.1095/biolreprod63.5.1497; Stener-Victorin E, 2004, BIOL REPROD, V70, P329, DOI 10.1095/biolreprod.103.022368; Tanaka S, 2007, METABOLISM, V56, P1719, DOI 10.1016/j.metabol.2007.07.017; Tierney AC, 2011, INT J OBESITY, V35, P800, DOI 10.1038/ijo.2010.209; Tyndall V, 2012, REPRODUCTION, V143, P21, DOI 10.1530/REP-11-0239; Vignesh JP, 2007, J POSTGRAD MED, V53, P128; Yildiz BO, 2008, J CLIN ENDOCR METAB, V93, P162, DOI 10.1210/jc.2007-1834; Zhang M, 2008, EXP DIABETES RES, DOI 10.1155/2008/704045; Zhao S, 2008, J ANIM PHYSIOL AN N, V92, P105, DOI 10.1111/j.1439-0396.2007.00723.x	49	17	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99155	10.1371/journal.pone.0099155	http://dx.doi.org/10.1371/journal.pone.0099155			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905232	Green Submitted, Green Published, gold			2022-12-27	WOS:000341869000107
J	Huang, FY; Wong, DKH; Seto, WK; Zhang, AY; Lee, CK; Lin, CK; Fung, J; Lai, CL; Yuen, MF				Huang, Fung-Yu; Wong, Danny Ka-Ho; Seto, Wai-Kay; Zhang, An-Ye; Lee, Cheuk-Kwong; Lin, Che-Kit; Fung, James; Lai, Ching-Lung; Yuen, Man-Fung			Sequence Variations of Full-Length Hepatitis B Virus Genomes in Chinese Patients with HBsAg-Negative Hepatitis B Infection	PLOS ONE			English	Article							SURFACE-ANTIGEN; FUNCTIONAL-ANALYSIS; MOLECULAR CHARACTERIZATION; DELAYED CLEARANCE; SERUM HBSAG; GENOTYPE-C; CARRIERS; GENE; PROTEIN; SEROCLEARANCE	Background: The underlying mechanism of HBsAg-negative hepatitis B virus (HBV) infection is notoriously difficult to elucidate because of the extremely low DNA levels which define the condition. We used a highly efficient amplification method to overcome this obstacle and achieved our aim which was to identify specific mutations or sequence variations associated with this entity. Methods: A total of 185 sera and 60 liver biopsies from HBsAg-negative, HBV DNA-positive subjects or known chronic hepatitis B (CHB) subjects with HBsAg seroclearance were amplified by rolling circle amplification followed by full-length HBV genome sequencing. Eleven HBsAg-positive CHB subjects were included as controls. The effects of pivotal mutations identified on regulatory regions on promoter activities were analyzed. Results: 22 and 11 full-length HBV genomes were amplified from HBsAg-negative and control subjects respectively. HBV genotype C was the dominant strain. A higher mutation frequency was observed in HBsAg-negative subjects than controls, irrespective of genotype. The nucleotide diversity over the entire HBV genome was significantly higher in HBsAg-negative subjects compared with controls (p = 0.008) and compared with 49 reference sequences from CHB patients (p = 0.025). In addition, HBsAg-negative subjects had significantly higher amino acid substitutions in the four viral genes than controls (all p<0.001). Many mutations were uniquely found in HBsAg-negative subjects, including deletions in promoter regions (13.6%), abolishment of pre-S2/S start codon (18.2%), disruption of pre-S2/S mRNA splicing site (4.5%), nucleotide duplications (9.1%), and missense mutations in ``alpha'' determinant region, contributing to defects in HBsAg production. Conclusions: These data suggest an accumulation of multiple mutations constraining viral transcriptional activities contribute to HBsAg-negativity in HBV infection.	[Huang, Fung-Yu; Wong, Danny Ka-Ho; Seto, Wai-Kay; Zhang, An-Ye; Fung, James; Lai, Ching-Lung; Yuen, Man-Fung] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Wong, Danny Ka-Ho; Fung, James; Lai, Ching-Lung; Yuen, Man-Fung] Univ Hong Kong, Queen Mary Hosp, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China; [Lee, Cheuk-Kwong; Lin, Che-Kit] Hosp Author, Hong Kong Red Cross Blood Transfus Serv, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Yuen, MF (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China.	mfyuen@hku.hk	Fung, James/AAG-4832-2020; SETO, Wai-Kay/H-4452-2012	SETO, Wai-Kay/0000-0002-9012-313X; Lai, Ching-Lung/0000-0002-5927-2436; /0000-0001-9078-5005; Fung, James/0000-0002-1286-8902	Research Grants Council General Research Fund [HKU 782809M]	Research Grants Council General Research Fund	The study was supported by Research Grants Council General Research Fund (HKU 782809M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain JP, 2009, HEPATOLOGY, V49, P1868, DOI 10.1002/hep.22879; Allain JP, 2004, VOX SANG, V86, P83, DOI 10.1111/j.0042-9007.2004.00406.x; ALWARD WLM, 1985, J INFECT DIS, V151, P604, DOI 10.1093/infdis/151.4.604; Bock CT, 1999, HEPATOLOGY, V30, P517, DOI 10.1002/hep.510300206; Candotti D, 2012, GUT, V61, P1744, DOI 10.1136/gutjnl-2011-301281; Carman WF, 1997, J VIRAL HEPATITIS, V4, P11, DOI 10.1111/j.1365-2893.1997.tb00155.x; Chan HLY, 2005, J INFECT DIS, V191, P2022, DOI 10.1086/430324; Chaudhuri V, 2004, GASTROENTEROLOGY, V127, P1356, DOI 10.1053/j.gastro.2004.08.003; Coleman PF, 1999, J MED VIROL, V59, P19, DOI 10.1002/(SICI)1096-9071(199909)59:1<19::AID-JMV4>3.0.CO;2-B; DaSilva LC, 1996, J GASTROENTEROL, V31, P696, DOI 10.1007/BF02347619; De Mitri MS, 2010, EUR J CANCER, V46, P2178, DOI 10.1016/j.ejca.2010.03.034; Fang Y, 2009, J MED VIROL, V81, P826, DOI 10.1002/jmv.21463; Fattovich G, 1998, AM J GASTROENTEROL, V93, P896, DOI 10.1111/j.1572-0241.1998.00272.x; Gunther S, 1998, J CLIN MICROBIOL, V36, P531; Hass M, 2005, HEPATOLOGY, V42, P93, DOI 10.1002/hep.20748; Hou JL, 2001, HEPATOLOGY, V34, P1027, DOI 10.1053/jhep.2001.28708; Hunt CM, 2000, HEPATOLOGY, V31, P1037, DOI 10.1053/he.2000.6709; Huo TI, 1998, HEPATOLOGY, V28, P231, DOI 10.1002/hep.510280130; Kramvis A, 1999, J VIRAL HEPATITIS, V6, P415, DOI 10.1046/j.1365-2893.1999.00189.x; Lai CL, 2006, NEW ENGL J MED, V354, P1011, DOI 10.1056/NEJMoa051287; Lee SA, 2012, J HEPATOL, V56, P63, DOI 10.1016/j.jhep.2011.06.028; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; LIAW YF, 1991, HEPATOLOGY, V13, P627, DOI 10.1002/hep.1840130403; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Margeridon S, 2008, ANTIMICROB AGENTS CH, V52, P3068, DOI 10.1128/AAC.01318-07; Martin CM, 2012, J VIRAL HEPATITIS, V19, P716, DOI 10.1111/j.1365-2893.2012.01595.x; Moolla N, 2002, J VIRAL HEPATITIS, V9, P323, DOI 10.1046/j.1365-2893.2002.00381.x; Pollicino T, 2007, HEPATOLOGY, V45, P277, DOI 10.1002/hep.21529; Pollicino T, 2012, HEPATOLOGY, V56, P434, DOI 10.1002/hep.25592; Raimondo G, 2008, J HEPATOL, V49, P652, DOI 10.1016/j.jhep.2008.07.014; Raimondo G, 2013, SEMIN IMMUNOPATHOL, V35, P39, DOI 10.1007/s00281-012-0327-7; Sommer G, 2008, FRONT BIOSCI-LANDMRK, V13, P5533; Sugauchi F, 2002, J VIROL, V76, P5985, DOI 10.1128/JVI.76.12.5985-5992.2002; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TIOLLAIS P, 1985, NATURE, V317, P489, DOI 10.1038/317489a0; Vivekanandan P, 2008, CLIN INFECT DIS, V46, P1227, DOI 10.1086/529437; Weinberger KM, 2000, J GEN VIROL, V81, P1165, DOI 10.1099/0022-1317-81-5-1165; Xu ZC, 1996, J VIROL, V70, P133, DOI 10.1128/JVI.70.1.133-140.1996; Xu ZC, 1997, J VIROL, V71, P7387, DOI 10.1128/JVI.71.10.7387-7392.1997; YAMAMOTO K, 1994, J VIROL, V68, P2671, DOI 10.1128/JVI.68.4.2671-2676.1994; Yuen MF, 2008, GASTROENTEROLOGY, V135, P1192, DOI 10.1053/j.gastro.2008.07.008; Yuen MF, 2004, J CLIN MICROBIOL, V42, P4882, DOI 10.1128/JCM.42.10.4882-4884.2004; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	43	14	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99028	10.1371/journal.pone.0099028	http://dx.doi.org/10.1371/journal.pone.0099028			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901840	Green Published, gold			2022-12-27	WOS:000336841400088
J	Liu, Z; Duan, ZJ; Chang, JY; Zhang, ZF; Chu, R; Li, YL; Dai, KH; Mo, GQ; Chang, QY				Liu, Zhen; Duan, Zhi-Jun; Chang, Jiu-Yang; Zhang, Zhi-feng; Chu, Rui; Li, Yu-Ling; Dai, Ke-Hang; Mo, Guang-quan; Chang, Qing-Yong			Sinomenine Sensitizes Multidrug-Resistant Colon Cancer Cells (Caco-2) to Doxorubicin by Downregulation of MDR-1 Expression	PLOS ONE			English	Article							NF-KAPPA-B; P-GLYCOPROTEIN; INDUCED APOPTOSIS; UP-REGULATION; CYCLOOXYGENASE-2; CARCINOMA; MECHANISM; CELECOXIB; COX-2; PATHWAY	Chemoresistance in multidrug-resistant (MDR) cells over expressing P-glycoprotein (P-gp) encoded by the MDR1 gene, is a major obstacle to successful chemotherapy for colorectal cancer. Previous studies have indicated that sinomenine can enhance the absorption of various P-gp substrates. In the present study, we investigated the effect of sinomenine on the chemoresistance in colon cancer cells and explored the underlying mechanism. We developed multidrug-resistant Caco-2 (MDR-Caco-2) cells by exposure of Caco-2 cells to increasing concentrations of doxorubicin. We identified overexpression of COX-2 and MDR-1 genes as well as activation of the NF-kappa B signal pathway in MDR-Caco-2 cells. Importantly, we found that sinomenine enhances the sensitivity of MDR-Caco-2 cells towards doxorubicin by downregulating MDR-1 and COX-2 expression through inhibition of the NF-kappa B signaling pathway. These findings provide a new potential strategy for the reversal of P-gp-mediated anticancer drug resistance.	[Liu, Zhen; Duan, Zhi-Jun; Chang, Jiu-Yang; Zhang, Zhi-feng; Chu, Rui; Li, Yu-Ling; Dai, Ke-Hang; Mo, Guang-quan] Dalian Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Dalian, Liaoning, Peoples R China; [Chang, Qing-Yong] Dalian Univ, Zhongshan Affiliated Hosp, Dept Neurosurg, Dalian 116012, Liaoning, Peoples R China	Dalian Medical University; Dalian University	Duan, ZJ (corresponding author), Dalian Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Dalian, Liaoning, Peoples R China.	cathydoctor@sina.com; qychang0409@163.com						Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Andorfer P, 2013, FEBS LETT, V587, P1504, DOI 10.1016/j.febslet.2013.03.026; Arunasree KM, 2008, LEUKEMIA RES, V32, P855, DOI 10.1016/j.leukres.2007.11.007; Baeuerle PA, 1998, CURR BIOL, V8, pR19, DOI 10.1016/S0960-9822(98)70010-7; Chan K, 2006, J ETHNOPHARMACOL, V103, P425, DOI 10.1016/j.jep.2005.08.020; Chen C, 2011, J CANCER RES CLIN, V137, P9, DOI 10.1007/s00432-010-0854-3; Choi YH, 2013, EXP EYE RES, V113, P1, DOI 10.1016/j.exer.2013.05.001; Dannenberg AJ, 2005, J CLIN ONCOL, V23, P254, DOI 10.1200/JCO.2005.09.112; Dannenberg AJ, 2003, CANCER CELL, V4, P431, DOI 10.1016/S1535-6108(03)00310-6; de Groot DJA, 2007, CRIT REV ONCOL HEMAT, V61, P52, DOI 10.1016/j.critrevonc.2006.07.001; Dorai T, 2004, CANCER LETT, V215, P129, DOI 10.1016/j.canlet.2004.07.013; Fantappie O, 2007, CANCER RES, V67, P4915, DOI 10.1158/0008-5472.CAN-06-3952; Gottesman MM, 2006, FEBS LETT, V580, P998, DOI 10.1016/j.febslet.2005.12.060; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; He XB, 2005, IMMUNOL LETT, V98, P91, DOI 10.1016/j.imlet.2004.10.027; Hong Y, 2013, CANCER IMMUNOL IMMUN, V62, P447, DOI 10.1007/s00262-012-1337-y; Januchowski R, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/241763; Lee JY, 2007, RES VET SCI, V83, P210, DOI 10.1016/j.rvsc.2006.12.012; Liu DJ, 2013, FUTURE ONCOL, V9, P595, DOI [10.2217/fon.13.15, 10.2217/FON.13.15]; Liu ZQ, 2006, PHARM RES-DORDR, V23, P2768, DOI 10.1007/s11095-006-9100-8; Loo TW, 2005, J MEMBRANE BIOL, V206, P173, DOI 10.1007/s00232-005-0792-1; Luo L, 2013, CHEM-BIOL INTERACT, V203, P430, DOI 10.1016/j.cbi.2013.03.009; Miller B, 2006, J AM SOC NEPHROL, V17, P977, DOI 10.1681/ASN.2005101076; Neuschafer-Rube F, 2013, BRIT J PHARMACOL, V168, P704, DOI 10.1111/j.1476-5381.2012.02182.x; Oh YC, 2012, EUR REV MED PHARMACO, V16, P1184; Raspollini MR, 2005, INT J GYNECOL CANCER, V15, P255, DOI 10.1111/j.1525-1438.2005.15212.x; Roy KR, 2010, CANCER CHEMOTH PHARM, V65, P903, DOI 10.1007/s00280-009-1097-3; Saika Kumiko, 2013, Gan To Kagaku Ryoho, V40, P2475; Shain KH, 2001, MOL CANCER THER, V1, P69; Sun JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040720; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; Tsai TH, 2003, LIFE SCI, V72, P2413, DOI 10.1016/S0024-3205(03)00118-8; van Wijngaarden J, 2007, EUR J CANCER, V43, P433, DOI 10.1016/j.ejca.2006.09.010; Wang LJ, 2013, J NAT PROD, V76, P909, DOI 10.1021/np400071c; Wang Y, 2005, J ETHNOPHARMACOL, V98, P37, DOI 10.1016/j.jep.2004.12.022; Xing AY, 2013, EXP MOL PATHOL, V94, P481, DOI 10.1016/j.yexmp.2013.03.004; Xu XB, 2013, ENDOCRINOLOGY, V154, P2900, DOI 10.1210/en.2012-1993; Zatelli MC, 2005, J CLIN ENDOCR METAB, V90, P5754, DOI 10.1210/jc.2005-1362; Zhao Y, 2007, INT IMMUNOPHARMACOL, V7, P637, DOI 10.1016/j.intimp.2007.01.007; Zrieki A, 2010, EUR J PHARMACOL, V636, P189, DOI 10.1016/j.ejphar.2010.03.039	40	6	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98560	10.1371/journal.pone.0098560	http://dx.doi.org/10.1371/journal.pone.0098560			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901713	Green Published, gold, Green Submitted			2022-12-27	WOS:000336841400038
J	Ramos, CG; Grilo, AM; Sousa, SA; Feliciano, JR; da Costa, PJP; Leitao, JH				Ramos, Christian G.; Grilo, Andre M.; Sousa, Silvia A.; Feliciano, Joana R.; da Costa, Paulo J. P.; Leitao, Jorge H.			Regulation of Hfq mRNA and Protein Levels in Escherichia coli and Pseudomonas aeruginosa by the Burkholderia cenocepacia MtvR sRNA	PLOS ONE			English	Article							NONCODING RNAS; GENE-EXPRESSION; CHAPERONE HFQ; CEPACIA; PREDICTION; BACTERIA; PATHOGENICITY; CONSTRUCTION; RESISTANCE; VIRULENCE	Small non-coding RNAs (sRNAs) are important players of gene expression regulation in bacterial pathogens. MtvR is a 136-nucleotide long sRNA previously identified in the human pathogen Burkholderia cenocepacia J2315 and with homologues restricted to bacteria of the Burkholderia cepacia complex. In this work we have investigated the effects of expressing MtvR in Escherichia coli and Pseudomonas aeruginosa. Results are presented showing that MtvR negatively regulates the hfq mRNA levels in both bacterial species. In the case of E. coli, this negative regulation is shown to involve binding of MtvR to the 5'-UTR region of the hfq(Ec) mRNA. Results presented also show that expression of MtvR in E. coli and P. aeruginosa originates multiple phenotypes, including reduced resistance to selected stresses, biofilm formation ability, and increased susceptibility to various antibiotics.	[Leitao, Jorge H.] Univ Lisbon, Inst Super Tecn, Dept Bioengn, P-1699 Lisbon, Portugal; Univ Lisbon, Inst Super Tecn, Inst Biotechnol & Bioengn, P-1699 Lisbon, Portugal	Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico	Leitao, JH (corresponding author), Univ Lisbon, Inst Super Tecn, Dept Bioengn, P-1699 Lisbon, Portugal.	jorgeleitao@tecnico.ulisboa.pt	Sousa, Sílvia A./G-8502-2011; Ramos, Christian G/A-8588-2010; Ramos, Christian Gomes/H-5855-2019; Leitão, Jorge H./A-5122-2012; Feliciano, Joana R/K-1473-2016	Sousa, Sílvia A./0000-0001-9291-9169; Ramos, Christian G/0000-0003-0970-7750; Ramos, Christian Gomes/0000-0003-0970-7750; Leitão, Jorge H./0000-0001-8850-274X; Feliciano, Joana R/0000-0002-4906-676X	Fundacao Ciencia e Tecnologia, Portugal [PTDC/BIA-MIC/119091/2010, PTDC/BBB-BIO/1958/2012]	Fundacao Ciencia e Tecnologia, Portugal	This work was partially supported by Fundacao Ciencia e Tecnologia, Portugal (contracts PTDC/BIA-MIC/119091/2010 and PTDC/BBB-BIO/1958/2012), a post-Doc grant to CGR, and doctoral grants to AMG and JRF, respectively. SAS and PJPDC acknowledge research grants from projects PTDC/BBB-BIO/1958/2012 and PTDC/BIA-MIC/119091/2010, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman YM, 2011, NUCLEIC ACIDS RES, V39, P1843, DOI 10.1093/nar/gkq1065; Bobrovskyy M, 2013, ANNU REV GENET, V47, P209, DOI 10.1146/annurev-genet-111212-133445; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Chao YJ, 2010, CURR OPIN MICROBIOL, V13, P24, DOI 10.1016/j.mib.2010.01.001; CLSI, 2013, PERFORMANCE STANDARD; Eggenhofer F, 2011, NUCLEIC ACIDS RES, V39, pW149, DOI 10.1093/nar/gkr467; Ferreira AS, 2007, APPL ENVIRON MICROB, V73, P524, DOI 10.1128/AEM.01450-06; Frohlich KS, 2009, CURR OPIN MICROBIOL, V12, P674, DOI 10.1016/j.mib.2009.09.009; Gottesman S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003798; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Han YP, 2013, FUTURE MICROBIOL, V8, P579, DOI [10.2217/FMB.13.20, 10.2217/fmb.13.20]; Harris JF, 2013, VIRULENCE, V4, P785, DOI 10.4161/viru.26119; HASSAN HM, 1979, J BIOL CHEM, V254, P846; KAJITANI M, 1994, J BACTERIOL, V176, P531, DOI 10.1128/JB.176.2.531-534.1994; Lefebre MD, 2002, APPL ENVIRON MICROB, V68, P5956, DOI 10.1128/AEM.68.12.5956-5964.2002; Leitao JH, 2008, EUR J CLIN MICROBIOL, V27, P1101, DOI 10.1007/s10096-008-0552-0; Leitao JH, 2010, APPL MICROBIOL BIOT, V87, P31, DOI 10.1007/s00253-010-2528-0; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; Moon K, 2009, MOL MICROBIOL, V74, P1314, DOI 10.1111/j.1365-2958.2009.06944.x; Pichon C, 2008, BIOINFORMATICS, V24, P2807, DOI 10.1093/bioinformatics/btn560; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Ramos CG, 2013, J BACTERIOL, V195, P3514, DOI 10.1128/JB.00242-13; Ramos CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047896; Ramos CG, 2011, J BACTERIOL, V193, P1515, DOI 10.1128/JB.01375-10; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Roscetto E, 2012, J BACTERIOL, V194, P5864, DOI 10.1128/JB.00746-12; Shimoni Y, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100181; Sousa SA, 2010, MICROBIOL-SGM, V156, P896, DOI 10.1099/mic.0.035139-0; Tjaden B, 2006, NUCLEIC ACIDS RES, V34, P2791, DOI 10.1093/nar/gkl356; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Vecerek B, 2005, RNA, V11, P976, DOI 10.1261/rna.2360205; Vecerek B, 2008, NUCLEIC ACIDS RES, V36, P133, DOI 10.1093/nar/gkm985; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Wesolowski D, 2013, P NATL ACAD SCI USA, V110, P8686, DOI 10.1073/pnas.1306911110; Wright JS, 2001, J BACTERIOL, V183, P3149, DOI 10.1128/JB.183.10.3149-3159.2001; Yamada J, 2010, J ANTIMICROB CHEMOTH, V65, P853, DOI 10.1093/jac/dkq067; Zhang AX, 2002, MOL CELL, V9, P11, DOI 10.1016/S1097-2765(01)00437-3; Zhao YL, 2008, BIOCHEM BIOPH RES CO, V372, P346, DOI 10.1016/j.bbrc.2008.05.046; Zhou YN, 1998, J BACTERIOL, V180, P1154, DOI 10.1128/JB.180.5.1154-1158.1998	40	9	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98813	10.1371/journal.pone.0098813	http://dx.doi.org/10.1371/journal.pone.0098813			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901988	gold, Green Published, Green Submitted			2022-12-27	WOS:000336841400054
J	Ahmed, W; Philip, PS; Tariq, S; Khan, G				Ahmed, Waqar; Philip, Pretty S.; Tariq, Saeed; Khan, Gulfaraz			Epstein-Barr Virus-Encoded Small RNAs (EBERs) Are Present in Fractions Related to Exosomes Released by EBV-Transformed Cells	PLOS ONE			English	Article							CONFERS RESISTANCE; INDUCED APOPTOSIS; CARCINOMA CELLS; NONCODING RNA; VIRAL MIRNAS; IN-VITRO; PROTEIN; LYMPHOMA; GROWTH; GENES	Epstein-Barr virus (EBV) is an oncogenic herpesvirus associated with a number of human malignancies of epithelial and lymphoid origin. However, the mechanism of oncogenesis is unclear. A number of viral products, including EBV latent proteins and non-protein coding RNAs have been implicated. Recently it was reported that EBV-encoded small RNAs (EBERs) are released from EBV infected cells and they can induce biological changes in cells via signaling from toll-like receptor 3. Here, we investigated if these abundantly expressed non-protein coding EBV RNAs (EBER-1 and EBER-2) are excreted from infected cells in exosomal fractions. Using differential ultracentrifugation we isolated exosomes from three EBV positive cell lines (B95-8, EBV-LCL, BL30-B95-8), one EBER-1 transfected cell line (293T-pHEBo-E1) and two EBV-negative cell lines (BL30, 293T-pHEBo). The identity of purified exosomes was determined by electron microscopy and western blotting for CD63. The presence of EBERs in cells, culture supernatants and purified exosomal fractions was determined using RT-PCR and confirmed by sequencing. Purified exosomal fractions were also tested for the presence of the EBER-1-binding protein La, using western blotting. Both EBER-1 and EBER-2 were found to be present not only in the culture supernatants, but also in the purified exosome fractions of all EBV-infected cell lines. EBER-1 could also be detected in exosomal fractions from EBER-1 transfected 293T cells whilst the fractions from vector only transfectants were clearly negative. Furthermore, purified exosomal fractions also contained the EBER-binding protein (La), supporting the notion that EBERs are most probably released from EBV infected cells in the form of EBER-La complex in exosomes.	[Ahmed, Waqar; Philip, Pretty S.; Khan, Gulfaraz] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Microbiol & Immunol, Al Alin, U Arab Emirates; [Tariq, Saeed] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Anat, Al Alin, U Arab Emirates	United Arab Emirates University; United Arab Emirates University	Khan, G (corresponding author), United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Microbiol & Immunol, Al Alin, U Arab Emirates.	g_khan@uaeu.ac.ae	Khan, Gulfaraz/AAC-2859-2022	Khan, Gulfaraz/0000-0001-6836-1783	College of Medicine & Health Sciences [NP-14-05]; UAE University [31R016]	College of Medicine & Health Sciences; UAE University	This work was funded by a Faculty Grant from the College of Medicine & Health Sciences (NP-14-05), UAE University and a Center-Based Interdisciplinary Grant (31R016) from UAE University awarded to GK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed W, 2014, REV MED VIROL, V24, P3, DOI 10.1002/rmv.1763; Amoroso R, 2011, J VIROL, V85, P996, DOI 10.1128/JVI.01528-10; ARRAND JR, 1982, J VIROL, V41, P376, DOI 10.1128/JVI.41.2.376-389.1982; Canitano A, 2013, CANCER LETT, V337, P193, DOI 10.1016/j.canlet.2013.05.012; CLARKE PA, 1991, NUCLEIC ACIDS RES, V19, P243, DOI 10.1093/nar/19.2.243; CLARKE PA, 1992, J GEN VIROL, V73, P3169, DOI 10.1099/0022-1317-73-12-3169; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Dellis O, 2011, J BIOL CHEM, V286, P18583, DOI 10.1074/jbc.M111.222257; Flanagan J, 2003, J GEN VIROL, V84, P1871, DOI 10.1099/vir.0.18944-0; Forte E, 2012, J VIROL, V86, P6889, DOI 10.1128/JVI.07056-11; GLICKMAN JN, 1988, J VIROL, V62, P902, DOI 10.1128/JVI.62.3.902-911.1988; Gregorovic G, 2011, J VIROL, V85, P3535, DOI 10.1128/JVI.02086-10; HENDERSON E, 1977, VIROLOGY, V76, P152, DOI 10.1016/0042-6822(77)90292-6; HENDERSON S, 1991, CELL, V65, P1107, DOI 10.1016/0092-8674(91)90007-L; HOWE JG, 1988, J VIROL, V62, P2790, DOI 10.1128/JVI.62.8.2790-2798.1988; Hui-Yuen J, 2011, JOVE-J VIS EXP, DOI 10.3791/3321; Iwakiri D, 2003, CANCER RES, V63, P7062; Iwakiri D, 2009, J EXP MED, V206, P2091, DOI 10.1084/jem.20081761; Kapsogeorgou EK, 2005, ARTHRITIS RHEUM-US, V52, P1517, DOI 10.1002/art.21005; Kelly GL, 2006, P NATL ACAD SCI USA, V103, P14935, DOI 10.1073/pnas.0509988103; Keryer-Bibens C, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-283; Khan G, 2012, BRIT J CANCER, V106, P1166, DOI 10.1038/bjc.2012.51; KHAN G, 1992, J CLIN PATHOL, V45, P616, DOI 10.1136/jcp.45.7.616; Kieff E, 2007, FIELDS VIROLOGY, P2603; Komano J, 1999, J VIROL, V73, P9827, DOI 10.1128/JVI.73.12.9827-9831.1999; Laing KG, 2002, VIROLOGY, V297, P253, DOI 10.1006/viro.2002.1354; Lee N, 2012, RNA, V18, P2073, DOI 10.1261/rna.034900.112; LERNER MR, 1981, P NATL ACAD SCI-BIOL, V78, P805, DOI 10.1073/pnas.78.2.805; Meckes DG, 2013, P NATL ACAD SCI USA, V110, pE2925, DOI 10.1073/pnas.1303906110; Meckes DG, 2010, P NATL ACAD SCI USA, V107, P20370, DOI 10.1073/pnas.1014194107; Meckes DG, 2010, P NATL ACAD SCI; MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190; Nanbo A, 2002, EMBO J, V21, P954, DOI 10.1093/emboj/21.5.954; Nanbo A, 2013, J VIROL, V87, P10334, DOI 10.1128/JVI.01310-13; Ochieng J, 2009, EXP CELL RES, V315, P1875, DOI 10.1016/j.yexcr.2009.03.010; Owen TJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-241; Pant S, 2012, BIOCHEM PHARMACOL, V83, P1484, DOI 10.1016/j.bcp.2011.12.037; Pegtel DM, 2011, BBA-GENE REGUL MECH, V1809, P715, DOI 10.1016/j.bbagrm.2011.08.002; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; POPE JH, 1968, INT J CANCER, V3, P857, DOI 10.1002/ijc.2910030619; Repellin CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009092; Riley KJ, 2012, EMBO J, V31, P2207, DOI 10.1038/emboj.2012.63; RIO DC, 1985, SCIENCE, V227, P23, DOI 10.1126/science.2981116; Ruf IK, 2005, J VIROL, V79, P14562, DOI 10.1128/JVI.79.23.14562-14569.2005; Samanta M, 2006, EMBO J, V25, P4207, DOI 10.1038/sj.emboj.7601314; SCHWEMMLE M, 1992, P NATL ACAD SCI USA, V89, P10292, DOI 10.1073/pnas.89.21.10292; SWAMINATHAN S, 1991, P NATL ACAD SCI USA, V88, P1546, DOI 10.1073/pnas.88.4.1546; Takada K, 2012, SEMIN CANCER BIOL, V22, P162, DOI 10.1016/j.semcancer.2011.12.007; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; TOCZYSKI DP, 1993, MOL CELL BIOL, V13, P703, DOI 10.1128/MCB.13.1.703; TOCZYSKI DPW, 1991, EMBO J, V10, P459, DOI 10.1002/j.1460-2075.1991.tb07968.x; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Verweij Frederik J, 2013, Methods Mol Biol, V1024, P53, DOI 10.1007/978-1-62703-453-1_5; Verweij FJ, 2011, EMBO J, V30, P2115, DOI 10.1038/emboj.2011.123; WANG D, 1985, CELL, V43, P831, DOI 10.1016/0092-8674(85)90256-9; WANG F, 1990, J VIROL, V64, P2309, DOI 10.1128/JVI.64.5.2309-2318.1990; WEISS LM, 1991, AM J PATHOL, V139, P1259; Wolin SL, 2002, ANNU REV BIOCHEM, V71, P375, DOI 10.1146/annurev.biochem.71.090501.150003; Wong HL, 2005, MOL CARCINOGEN, V44, P92, DOI 10.1002/mc.20133; Wu Y, 2007, J VIROL, V81, P11236, DOI 10.1128/JVI.00579-07; Yamamoto N, 2000, FEBS LETT, V484, P153, DOI 10.1016/S0014-5793(00)02145-1; Yang LX, 2004, CANCER RES, V64, P5332, DOI 10.1158/0008-5472.CAN-04-0733	63	63	69	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99163	10.1371/journal.pone.0099163	http://dx.doi.org/10.1371/journal.pone.0099163			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896633	gold, Green Published, Green Submitted			2022-12-27	WOS:000338430700121
J	Khezrian, M; Jahan, A; Kadir, WMNW; Ibrahim, S				Khezrian, Mojtaba; Jahan, Ali; Kadir, Wan Mohd Nasir Wan; Ibrahim, Suhaimi			An Approach for Web Service Selection Based on Confidence Level of Decision Maker	PLOS ONE			English	Article							QOS; MODEL	Web services today are among the most widely used groups for Service Oriented Architecture (SOA). Service selection is one of the most significant current discussions in SOA, which evaluates discovered services and chooses the best candidate from them. Although a majority of service selection techniques apply Quality of Service (QoS), the behaviour of QoS-based service selection leads to service selection problems in Multi-Criteria Decision Making (MCDM). In the existing works, the confidence level of decision makers is neglected and does not consider their expertise in assessing Web services. In this paper, we employ the VIKOR (VIsekriterijumskoKOmpromisnoRangiranje) method, which is absent in the literature for service selection, but is well-known in other research. We propose a QoS-based approach that deals with service selection by applying VIKOR with improvement of features. This research determines the weights of criteria based on user preference and accounts for the confidence level of decision makers. The proposed approach is illustrated by an example in order to demonstrate and validate the model. The results of this research may facilitate service consumers to attain a more efficient decision when selecting the appropriate service.	[Khezrian, Mojtaba; Kadir, Wan Mohd Nasir Wan] Univ Teknol Malaysia, Fac Comp, Johor Baharu, Malaysia; [Jahan, Ali] Islamic Azad Univ, Semnan Branch, Fac Engn, Semnan, Iran; [Ibrahim, Suhaimi] Univ Teknol Malaysia, Adv Informat Sch, Kuala Lumpur, Malaysia	Universiti Teknologi Malaysia; Islamic Azad University; Universiti Teknologi Malaysia	Khezrian, M (corresponding author), Univ Teknol Malaysia, Fac Comp, Johor Baharu, Malaysia.	m_khezryan@yahoo.com	Jahan, Ali/B-2460-2010; Wan-Kadir, Wan/K-5568-2012	Jahan, Ali/0000-0001-6347-1676; Wan-Kadir, Wan/0000-0003-4459-4050	Universiti Teknologi Malaysia (UTM); Malaysian Ministry of Education	Universiti Teknologi Malaysia (UTM); Malaysian Ministry of Education	This research is funded by the Universiti Teknologi Malaysia (UTM) in collaboration with the Malaysian Ministry of Education under the Vot no. H074. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Oliveira FGA, 2011, J UNIVERS COMPUT SCI, V17, P712; Chen D, 2011, WORLD WIDE WEB, P1; Chen S.J., 1992, FUZZY MULTIPLE ATTRI; Chi-Chun Lo, 2010, Proceedings of the 2010 IEEE 24th International Conference on Advanced Information Networking and Applications Workshops (WAINA 2010), P367, DOI 10.1109/WAINA.2010.117; da Silva EG, 2011, COMPUT COMMUN, V34, P159, DOI 10.1016/j.comcom.2010.04.003; Godse M, 2008, 2008 IEEE ASIA-PACIFIC SERVICES COMPUTING CONFERENCE, VOLS 1-3, PROCEEDINGS, P1103, DOI 10.1109/APSCC.2008.218; Grossman DA, 2004, INFORM RETRIEVAL ALG, V2nd; Haas H., 2004, WEB SERVICES GLOSSAR; Harman DK, 1998, 4 TEXT RETR C; Karim R., 2011, 2011 Proceedings of IEEE International Conference on Services Computing (SCC 2011), P536, DOI 10.1109/SCC.2011.81; Kerrigan M., 2006, Applied Computing 2006. 21st Annual ACM Symposium on Applied Computing, P1664, DOI 10.1145/1141277.1141671; Li L, 2010, J UNIVERS COMPUT SCI, V16, P1720; Menasce DA, 2002, IEEE INTERNET COMPUT, V6, P72, DOI 10.1109/MIC.2002.1067740; O'Sullivan J, 2002, DISTRIB PARALLEL DAT, V12, P117, DOI 10.1023/A:1016547000822; Opricovic S, 2004, EUR J OPER RES, V156, P445, DOI 10.1016/s0377-2217(03)00020-1; Opricovic S., 1998, THESIS FACULTY CIVIL, V2, P5; Pan Z, 2010, J WEB ENG, V9, P327; Qu LL, 2009, INT C MANAGE SCI ENG, P45, DOI 10.1109/ICMSE.2009.5317544; Schutze H., 2008, INTRO INFORM RETRIEV, V39; Tabatabaei Sayed, 2008, 2008 The Third International Conference on Software Engineering Advances (ICSEA), P488, DOI 10.1109/ICSEA.2008.68; Toma L, 2007, LECT NOTES COMPUT SC, V4749, P435; Wang P, 2006, INT CONF E BUS ENG, P585; Wang P, 2010, EXPERT SYST APPL, V37, P440, DOI 10.1016/j.eswa.2009.05.070; Yu T., 2005, ISEB, V3, P103, DOI DOI 10.1007/S10257-005-0052-Z; Zuo MY, 2008, IEEE/SOLI'2008: PROCEEDINGS OF 2008 IEEE INTERNATIONAL CONFERENCE ON SERVICE OPERATIONS AND LOGISTICS, AND INFORMATICS, VOLS 1 AND 2, P2763, DOI 10.1109/SOLI.2008.4683004	25	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e97831	10.1371/journal.pone.0097831	http://dx.doi.org/10.1371/journal.pone.0097831			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897426	Green Published, gold, Green Submitted			2022-12-27	WOS:000338430700014
J	Cole, HA; Ohba, T; Ichikawa, J; Nyman, JS; Cates, JMM; Haro, H; Schwartz, HS; Schoenecker, JG				Cole, Heather A.; Ohba, Tetsuro; Ichikawa, Jiro; Nyman, Jeffry S.; Cates, Justin M. M.; Haro, Hirotaka; Schwartz, Herbert S.; Schoenecker, Jonathan G.			Micro-Computed Tomography Derived Anisotropy Detects Tumor Provoked Deviations in Bone in an Orthotopic Osteosarcoma Murine Model	PLOS ONE			English	Article							TRABECULAR BONE; PERIOSTEAL OSTEOSARCOMA; IN-VIVO; CT; MICROSTRUCTURE; OSTEOPOROSIS; GROWTH; CANCER	Radiographic imaging plays a crucial role in the diagnosis of osteosarcoma. Currently, computed-tomography (CT) is used to measure tumor-induced osteolysis as a marker for tumor growth by monitoring the bone fractional volume. As most tumors primarily induce osteolysis, lower bone fractional volume has been found to correlate with tumor aggressiveness. However, osteosarcoma is an exception as it induces osteolysis and produces mineralized osteoid simultaneously. Given that competent bone is highly anisotropic (systematic variance in its architectural order renders its physical properties dependent on direction of load) and that tumor induced osteolysis and osteogenesis are structurally disorganized relative to competent bone, we hypothesized that mu CT-derived measures of anisotropy could be used to qualitatively and quantitatively detect osteosarcoma provoked deviations in bone, both osteolysis and osteogenesis, in vivo. We tested this hypothesis in a murine model of osteosarcoma cells orthotopically injected into the tibia. We demonstrate that, in addition to bone fractional volume, mu CT-derived measure of anisotropy is a complete and accurate method to monitor osteosarcoma-induced osteolysis. Additionally, we found that unlike bone fractional volume, anisotropy could also detect tumor-induced osteogenesis. These findings suggest that monitoring tumor-induced changes in the structural property isotropy of the invaded bone may represent a novel means of diagnosing primary and metastatic bone tumors.	[Cole, Heather A.; Ohba, Tetsuro; Ichikawa, Jiro; Nyman, Jeffry S.; Schwartz, Herbert S.; Schoenecker, Jonathan G.] Vanderbilt Univ, Med Ctr, Dept Orthopaed & Rehabil, Nashville, TN 37232 USA; [Cates, Justin M. M.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Haro, Hirotaka] Univ Yamanashi, Dept Orthopaed Surg, Fac Med, Yamanashi, Japan	Vanderbilt University; Vanderbilt University; University of Yamanashi	Schoenecker, JG (corresponding author), Vanderbilt Univ, Med Ctr, Dept Orthopaed & Rehabil, Nashville, TN 37232 USA.	jon.schoenecker@vanderbilt.edu	Cates, Justin M/D-5927-2014	Cates, Justin M/0000-0002-7336-5196; Schoenecker, Jonathan/0000-0002-3097-5496; Nyman, Jeffry/0000-0001-7403-7605	Caitlin Lovejoy Foundation	Caitlin Lovejoy Foundation	The authors thank the Caitlin Lovejoy Foundation for funding this project. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERLIN O, 1993, CANCER RES, V53, P4890; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Chiba K, 2013, BONE, V56, P139, DOI 10.1016/j.bone.2013.05.019; Cole HA, 2011, J ORTHOP RES, V29, P1957, DOI 10.1002/jor.21474; DESANTOS LA, 1978, RADIOLOGY, V127, P123, DOI 10.1148/127.1.123; Effendy NM, 2013, CURR DRUG TARGETS, V14, P1542, DOI 10.2174/13894501113149990196; Gautam Ajay, 2003, Methods Mol Med, V75, P607; Gordon N, 2007, CLIN CANCER RES, V13, P4503, DOI 10.1158/1078-0432.CCR-07-0313; HARRIGAN TP, 1984, J MATER SCI, V19, P761, DOI 10.1007/BF00540446; Ichikawa J, 2012, CANCER-AM CANCER SOC, V118, P2494, DOI 10.1002/cncr.26518; Johnson LC, 2010, BONE; Klein MJ, 2006, AM J CLIN PATHOL, V125, P555, DOI 10.1309/UC6KQHLD9LV2KENN; Laib A, 2000, MED BIOL ENG COMPUT, V38, P326, DOI 10.1007/BF02347054; Liao SH, 2008, COMPUT MED IMAG GRAP, V32, P53, DOI 10.1016/j.compmedimag.2007.09.001; Lindner NJ, 1998, J CANCER RES CLIN, V124, P575, DOI 10.1007/s004320050217; Matsuura M, 2008, BIOMECH MODEL MECHAN, V7, P27, DOI 10.1007/s10237-006-0073-7; Moio A, 1994, Minerva Med, V85, P615; MULLER R, 1994, PHYS MED BIOL, V39, P145, DOI 10.1088/0031-9155/39/1/009; Murphey MD, 2004, RADIOLOGY, V233, P129, DOI 10.1148/radiol.2331030326; Ohba T, 2014, BONE; Ohba T, 2014, J BONE MINER RES; Ravoori M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009854; Szabo ME, 2013, J BIOMECH, V46, P2, DOI 10.1016/j.jbiomech.2012.08.002; Tabor Z, 2012, MED ENG PHYS; WHITEHOUSE WJ, 1974, J MICROSC-OXFORD, V101, P153, DOI 10.1111/j.1365-2818.1974.tb03878.x; Yarmish G, 2010, RADIOGRAPHICS, V30, P1653, DOI 10.1148/rg.306105524	26	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e97381	10.1371/journal.pone.0097381	http://dx.doi.org/10.1371/journal.pone.0097381			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892952	Green Published, Green Submitted, gold			2022-12-27	WOS:000336911400012
J	Hauser, A; Santos-Hoevener, C; Meixenberger, K; Zimmermann, R; Somogyi, S; Fiedler, S; Hofmann, A; Bartmeyer, B; Jansen, K; Hamouda, O; Bannert, N; Kuecherer, C				Hauser, Andrea; Santos-Hoevener, Claudia; Meixenberger, Karolin; Zimmermann, Ruth; Somogyi, Sybille; Fiedler, Stefan; Hofmann, Alexandra; Bartmeyer, Barbara; Jansen, Klaus; Hamouda, Osamah; Bannert, Norbert; Kuecherer, Claudia			Improved Testing of Recent HIV-1 Infections with the BioRad Avidity Assay Compared to the Limiting Antigen Avidity Assay and BED Capture Enzyme Immunoassay: Evaluation Using Reference Sample Panels from the German Seroconverter Cohort	PLOS ONE			English	Article							SUBTYPE-E INFECTION; TYPE-1 INCIDENCE; UNITED-STATES; IDENTIFICATION; ANTIBODIES; INDEX; INDIVIDUALS; SPECIFICITY; ACCURACY; ADULTS	Background: The variety and limitations of current laboratory methods for estimating HIV-incidence has driven attempts to improve and standardize the performance of serological 'Tests for Recent HIV-Infections' (TRI). Primary and follow-up HIV-1 positive plasma samples from individuals with well-defined dates of infection collected as part of the German Seroconverter Cohort provided specimens highly suitable for use in comparing the performance of three TRIs: the AWARE (TM) BED (TM) EIA HIV-1 Incidence test (BED-CEIA), Genetic systems HIV-1/HIV-2 Plus O EIA antibody avidity-based assay (BioRad Avidity) and Sedia (TM) HIV-1 LAg Avidity EIA (LAg Avidity). Methods: The evaluation panel included 180 specimens: 44 from antiretroviral (ARV)-naive individuals with recently acquired HIV-infection (<= 130 days; 25 B and 19 non-B subtypes) and 136 from long-term (. 12 months) infected individuals [ 101 ARV-naive subtype B, 16 non-B subtypes, 14 ARV-treated individuals, 5 slow progressors (SLP)]. Results: For long-term infected, ARV-naive individuals the false recent rates (FRR) of both the BioRad and LAg Avidity assays were 2% (2/101 for subtype B) and 6% (1/16 for subtype 'non-B'), while the FRR of the BED-CEIA was 7% (7/101 for subtype B) and 25% (4/16 for subtype 'non-B') (all p>0.05). Misclassification of ARV-treated individuals and SLP was rare by LAg (1/ 14, 0/5) and BioRad Avidity assays (2/14, 1/5) but more frequent by BED-CEIA (5/14, 3/5). Among recently-infected individuals (subtype B), 60% (15/25) were correctly classified by BED-CEIA, 88% (22/25) by BioRad Avidity and significantly fewer by LAg (48%, 12/25) compared to BioRad Avidity (p = 0.005) with a higher true-recency rate among non-B infections for all assays. Conclusions: This study using well-characterized specimens demonstrated lower FRRs for both avidity methods than with the BED-CEIA. For recently infected individuals the BioRad Avidity assay was shown to give the most accurate results.	[Hauser, Andrea; Meixenberger, Karolin; Somogyi, Sybille; Fiedler, Stefan; Bannert, Norbert; Kuecherer, Claudia] Robert Koch Inst, Div HIV & Other Retroviruses, Berlin, Germany; [Santos-Hoevener, Claudia; Zimmermann, Ruth; Hofmann, Alexandra; Bartmeyer, Barbara; Jansen, Klaus; Hamouda, Osamah] Robert Koch Inst, Div HIV AIDS STI & Blood Borne Infect, Berlin, Germany	Robert Koch Institute; Robert Koch Institute	Hauser, A (corresponding author), Robert Koch Inst, Div HIV & Other Retroviruses, Berlin, Germany.	hausera@rki.de		Hofmann, Alexandra/0000-0002-9915-3482; Zimmermann, Ruth/0000-0003-3635-2692	German Federal Ministry of Health	German Federal Ministry of Health	The study is funded by the German Federal Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atun R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001045; Batzing-Feigenbaum J, 2009, HIV MED, V10, P209, DOI 10.1111/j.1468-1293.2008.00672.x; Barin F, 2005, J CLIN MICROBIOL, V43, P4441, DOI 10.1128/JCM.43.9.4441-4447.2005; Bartmeyer B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012718; Busch MP, 2010, AIDS, V24, P2763, DOI 10.1097/QAD.0b013e32833f1142; Chawla A, 2007, J CLIN MICROBIOL, V45, P415, DOI 10.1128/JCM.01879-06; Curtis KA, 2012, AIDS RES HUM RETROV, V28, P188, DOI [10.1089/aid.2011.0037, 10.1089/AID.2011.0037]; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Duong YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033328; Eshleman SH, 2013, J INFECT DIS, V207, P223, DOI 10.1093/infdis/jis658; Granade TC, 2013, AIDS RES HUM RETROV, V29, P61, DOI 10.1089/aid.2012.0121; Guy R, 2009, LANCET INFECT DIS, V9, P747, DOI 10.1016/S1473-3099(09)70300-7; Hallett TB, 2011, CURR OPIN HIV AIDS, V6, P102, DOI 10.1097/COH.0b013e328343bfdb; Hallett TB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005720; Hargrove JW, 2008, AIDS, V22, P511, DOI 10.1097/QAD.0b013e3282f2a960; Hauser A, 2013, 20 C RETR OPP INF 20; Hu DJ, 2003, AIDS RES HUM RETROV, V19, P727, DOI 10.1089/088922203769232511; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Kassanjee R, 2013, 20 C RETR OPP INF 20; Kassanjee R, 2014, AIDS RES HUM RETROV, V30, P45, DOI [10.1089/aid.2013.0113, 10.1089/AID.2013.0113]; Keating SM, 2012, J CLIN MICROBIOL, V50, P3968, DOI 10.1128/JCM.01454-12; Kim AA, 2010, AIDS RES HUM RETROV, V26, P1051, DOI 10.1089/aid.2009.0218; Kothe D, 2003, JAIDS-J ACQ IMM DEF, V33, P625, DOI 10.1097/00126334-200308150-00012; Laeyendecker O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078818; Laeyendecker O, 2012, AIDS RES HUM RETROV, V28, P816, DOI [10.1089/aid.2011.0258, 10.1089/AID.2011.0258]; Laeyendecker O, 2012, AIDS RES HUM RETROV, V28, P1177, DOI 10.1089/aid.2011.0341; Laeyendecker O, 2013, J INFECT DIS, V207, P232, DOI 10.1093/infdis/jis659; Longosz AF, 2014, AIDS; Longosz AF, 2014, AIDS RES HUM RETROV, V30, P339, DOI [10.1089/aid.2013.0169, 10.1089/AID.2013.0169]; Loschen S, 2008, J CLIN MICROBIOL, V46, P341, DOI 10.1128/JCM.01055-07; Marinda ET, 2010, JAIDS-J ACQ IMM DEF, V53, P496, DOI 10.1097/QAI.0b013e3181b61938; Masciotra S., 2010, 17 C RETR OPP INF 20; Mastro Timothy D, 2010, J HIV AIDS Surveill Epidemiol, V2, P1; McDougal JS, 2006, AIDS RES HUM RETROV, V22, P945, DOI 10.1089/aid.2006.22.945; Murphy G, 2008, EUROSURVEILLANCE, V1, P13; Parekh BS, 2011, AIDS RES HUM RETROV, V27, P265, DOI 10.1089/aid.2010.0159; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Parekh BS, 2001, AIDS RES HUM RETROV, V17, P137, DOI 10.1089/08892220150217229; Pilcher C, 2012, 19 INT AIDS C WASH U; Pilcher C, 2012, 19 INT AIDS C TUPE19; Rawal BD, 2003, JAIDS-J ACQ IMM DEF, V33, P349, DOI 10.1097/00126334-200307010-00009; Scheer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055002; Suligoi B, 2002, J CLIN MICROBIOL, V40, P4015, DOI 10.1128/JCM.40.11.4015-4020.2002; Suligoi B, 2011, J CLIN MICROBIOL, V49, P2610, DOI 10.1128/JCM.02115-10; Surveillance UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance, 2011, WHEN HOW USE ASS REC; Thomas HIJ, 1996, CLIN EXP IMMUNOL, V103, P185, DOI 10.1046/j.1365-2249.1996.951642.x; Wei XR, 2010, AIDS RES HUM RETROV, V26, P61, DOI 10.1089/aid.2009.0133; Welte A, 2010, EURO SURVEILL, V15, p[pii, 19589]; Wendel SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055525; Young CL, 2003, AIDS RES HUM RETROV, V19, P481, DOI 10.1089/088922203766774522	50	28	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98038	10.1371/journal.pone.0098038	http://dx.doi.org/10.1371/journal.pone.0098038			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892795	Green Published, gold, Green Submitted			2022-12-27	WOS:000336911400030
J	Niu, JF; Feng, ZZ; Zhang, WW; Zhao, P; Wang, XK				Niu, Junfeng; Feng, Zhaozhong; Zhang, Weiwei; Zhao, Ping; Wang, Xiaoke			Non-Stomatal Limitation to Photosynthesis in Cinnamomum camphora Seedings Exposed to Elevated O-3	PLOS ONE			English	Article							GAS-EXCHANGE MEASUREMENTS; OZONE AIR-POLLUTION; CHLOROPHYLL FLUORESCENCE; PINUS-SYLVESTRIS; QUERCUS-ILEX; FOREST TREES; SCOTS PINE; HOLM OAK; RESPONSES; SEEDLINGS	Ozone (O-3) is the most phytotoxic air pollutant for global forests, with decreased photosynthesis widely regarded as one of its most common effects. However, controversy exists concerning the mechanism that underlies the depressing effects of O-3 on CO2 assimilation. In the present study, seedlings of Cinnamomum camphora, a subtropical evergreen tree species that has rarely been studied, were exposed to ambient air (AA), ambient air plus 60 [ppb] O-3 (AA+60), or ambient air plus 120 [ppb] O-3 (AA+120) in open-top chambers (OTCs) for 2 years. Photosynthetic CO2 exchange and chlorophyll a fluorescence were investigated in the second growing season (2010). We aim to determine whether stomatal or non-stomatal limitation is responsible for the photosynthesis reduction and to explore the potential implications for forest ecosystem functions. Results indicate that elevated O-3 (E-O-3) reduced the net photosynthetic rates (PN) by 6.0-32.2%, with significant differences between AA+60 and AA+120 and across the four measurement campaigns (MCs). The actual photochemical efficiency of photosystem II (PSII) in saturated light (F-v(')/F-m(')) was also significantly decreased by E-O-3, as was the effective quantum yield of PSII photochemistry (Phi(PSII)). Moreover, E-O-3 significantly and negatively impacted the maximum rates of carboxylation (V-cmax) and electron transport (J(max)). Although neither the stomatal conductance (g(s)) nor the intercellular CO2 concentration (C-i) was decreased by E-O-3, P-N/g(s) was significantly reduced. Therefore, the observed reduction in P-N in the present study should not be attributed to the unavailability of CO2 due to stomatal limitation, but rather to the O-3-induced damage to Ribulose-1,5-bisphosphate carboxylase/oxygenase and the photochemical apparatus. This suggests that the down-regulation of stomatal conductance could fail to occur, and the biochemical processes in protoplasts would become more susceptible to injuries under long-term O-3 exposure, which may have important consequences for forest carbon and water budget.	[Niu, Junfeng; Zhao, Ping] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Feng, Zhaozhong; Wang, Xiaoke] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China; [Zhang, Weiwei] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Black Soil Ecol, Harbin, Heilongjiang, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS	Wang, XK (corresponding author), Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China.	wangxk@rcees.ac.cn			National Natural Science Foundation of China [31170424, 71003092, 41030638, 41275169]; Tiantong National Station of Forest Ecosystems [XT200707]; South Botanical Garden, Chinese Academy of Sciences [201229]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tiantong National Station of Forest Ecosystems; South Botanical Garden, Chinese Academy of Sciences	Funding for this project was provided by the National Natural Science Foundation of China (No. 31170424, No. 71003092, No. 41030638 and No. 41275169), Tiantong National Station of Forest Ecosystems (No. XT200707) and South Botanical Garden, Chinese Academy of Sciences (No. 201229). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bortier K, 2000, NEW PHYTOL, V146, P271, DOI 10.1046/j.1469-8137.2000.00633.x; Bussotti F, 2007, J MEDITERRANEAN ECOL, V3, P23; Bussotti F, 2008, GLOBAL CHANGE BIOL, V14, P2727, DOI 10.1111/j.1365-2486.2008.01677.x; Bussotti F, 2007, ENVIRON POLLUT, V147, P430, DOI 10.1016/j.envpol.2006.08.036; Bussotti F, 2007, PHYSIOL PLANTARUM, V130, P122, DOI 10.1111/j.1399-3054.2007.00894.x; Bussotti F, 2011, ENVIRON EXP BOT, V73, P19, DOI 10.1016/j.envexpbot.2010.10.022; Calatayud A, 2006, PHOTOSYNTHETICA, V44, P548, DOI 10.1007/s11099-006-0070-1; Calatayud V, 2011, ENVIRON POLLUT, V159, P55, DOI 10.1016/j.envpol.2010.09.024; DANN MS, 1989, PLANT PHYSIOL, V91, P427, DOI 10.1104/pp.91.1.427; Darbah JNT, 2010, ENVIRON POLLUT, V158, P983, DOI 10.1016/j.envpol.2009.10.022; Degl'Innocenti E, 2003, PLANT PHYSIOL BIOCH, V41, P485, DOI 10.1016/S0981-9428(03)00057-3; Eichelmann H, 2004, PLANT CELL ENVIRON, V27, P479, DOI 10.1111/j.1365-3040.2003.01166.x; Feng ZZ, 2011, TREES-STRUCT FUNCT, V25, P617, DOI 10.1007/s00468-011-0538-x; Feng ZZ, 2011, GLOBAL CHANGE BIOL, V17, P580, DOI 10.1111/j.1365-2486.2010.02184.x; Fontaine V, 1999, PHYSIOL PLANTARUM, V105, P187, DOI 10.1034/j.1399-3054.1999.105201.x; Gerosa G, 2009, ENVIRON POLLUT, V157, P1737, DOI 10.1016/j.envpol.2007.11.025; Grulke NE, 2005, PHYTON-ANN REI BOT A, V45, P21; He XY, 2007, PHOTOSYNTHETICA, V45, P555, DOI 10.1007/s11099-007-0095-0; Karnosky DF, 2007, ENVIRON POLLUT, V147, P489, DOI 10.1016/j.envpol.2006.08.043; Karnosky DF, 2005, PLANT CELL ENVIRON, V28, P965, DOI 10.1111/j.1365-3040.2005.01362.x; Kets K, 2010, ENVIRON POLLUT, V158, P1000, DOI 10.1016/j.envpol.2009.09.001; Lombardozzi D, 2012, BIOGEOSCIENCES, V9, P3113, DOI 10.5194/bg-9-3113-2012; Long SP, 2003, J EXP BOT, V54, P2393, DOI 10.1093/jxb/erg262; Manes F, 2007, ENVIRON EXP BOT, V59, P235, DOI 10.1016/j.envexpbot.2005.12.001; MATYSSEK R, 1991, TREES-STRUCT FUNCT, V5, P5, DOI 10.1007/BF00225329; Matyssek R, 2008, ENVIRON POLLUT, V156, P567, DOI 10.1016/j.envpol.2008.04.017; Nali C, 2004, ATMOS ENVIRON, V38, P2247, DOI 10.1016/j.atmosenv.2003.11.043; Niu JF, 2011, J ENVIRON MONITOR, V13, P2873, DOI 10.1039/c1em10305a; Noormets A, 2001, PLANT CELL ENVIRON, V24, P327, DOI 10.1046/j.1365-3040.2001.00678.x; Noormets A, 2010, ENVIRON POLLUT, V158, P992, DOI 10.1016/j.envpol.2009.10.009; Novak K, 2007, TREE PHYSIOL, V27, P941, DOI 10.1093/treephys/27.7.941; Oksanen E, 2003, PLANT CELL ENVIRON, V26, P875, DOI 10.1046/j.1365-3040.2003.01020.x; Paoletti E, 2006, ENVIRON POLLUT, V144, P463, DOI 10.1016/j.envpol.2005.12.051; Ribas A, 2005, ATMOS ENVIRON, V39, P685, DOI 10.1016/j.atmosenv.2004.10.022; Ribas A, 2005, ENVIRON POLLUT, V134, P291, DOI 10.1016/j.envpol.2004.07.026; RICHARDSON CJ, 1992, FOREST ECOL MANAG, V51, P163, DOI 10.1016/0378-1127(92)90482-O; Rogers A, 2000, GLOBAL CHANGE BIOL, V6, P1005, DOI 10.1046/j.1365-2486.2000.00375.x; Samuelson L, 2001, NEW PHYTOL, V149, P21, DOI 10.1046/j.1469-8137.2001.00007.x; Soja G, 1998, PHYSIOL PLANTARUM, V104, P639, DOI 10.1034/j.1399-3054.1998.1040417.x; STRAND M, 1985, PHYSIOL PLANTARUM, V65, P117, DOI 10.1111/j.1399-3054.1985.tb02369.x; Sun G, 2012, GLOBAL CHANGE BIOL, V18, P3395, DOI 10.1111/j.1365-2486.2012.02787.x; Torsethaugen G, 1999, P NATL ACAD SCI USA, V96, P13577, DOI 10.1073/pnas.96.23.13577; Vitale M, 2008, WATER AIR SOIL POLL, V189, P113, DOI 10.1007/s11270-007-9560-4; Wang KY, 1997, NEW PHYTOL, V136, P277, DOI 10.1046/j.1469-8137.1997.00744.x; Warren CR, 2003, TREES-STRUCT FUNCT, V17, P359, DOI 10.1007/s00468-003-0246-2; Watanabe M, 2007, TREES-STRUCT FUNCT, V21, P421, DOI 10.1007/s00468-007-0134-2; Wittig VE, 2007, PLANT CELL ENVIRON, V30, P1150, DOI 10.1111/j.1365-3040.2007.01717.x; Yan K, 2010, ENVIRON EXP BOT, V69, P198, DOI 10.1016/j.envexpbot.2010.03.008; Zhang WW, 2011, PHOTOSYNTHETICA, V49, P29, DOI 10.1007/s11099-011-0003-5	49	6	11	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98572	10.1371/journal.pone.0098572	http://dx.doi.org/10.1371/journal.pone.0098572			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892748	gold, Green Submitted, Green Published			2022-12-27	WOS:000336911400069
J	Ramos-Silva, P; Kaandorp, J; Herbst, F; Plasseraud, L; Alcaraz, G; Stern, C; Corneillat, M; Guichard, N; Durlet, C; Luquet, G; Marin, F				Ramos-Silva, Paula; Kaandorp, Jaap; Herbst, Frederic; Plasseraud, Laurent; Alcaraz, Gerard; Stern, Christine; Corneillat, Marion; Guichard, Nathalie; Durlet, Christophe; Luquet, Gilles; Marin, Frederic			The Skeleton of the Staghorn Coral Acropora millepora: Molecular and Structural Characterization	PLOS ONE			English	Article							SOLUBLE ORGANIC MATRICES; SHELL MATRIX; CRYSTAL-GROWTH; MINERAL PHASE; PROTEINS; BIOMINERALIZATION; CALCIFICATION; POLYSACCHARIDES; ACIDIFICATION; PURIFICATION	The scleractinian coral Acropora millepora is one of the most studied species from the Great Barrier Reef. This species has been used to understand evolutionary, immune and developmental processes in cnidarians. It has also been subject of several ecological studies in order to elucidate reef responses to environmental changes such as temperature rise and ocean acidification (OA). In these contexts, several nucleic acid resources were made available. When combined to a recent proteomic analysis of the coral skeletal organic matrix (SOM), they enabled the identification of several skeletal matrix proteins, making A. millepora into an emerging model for biomineralization studies. Here we describe the skeletal microstructure of A. millepora skeleton, together with a functional and biochemical characterization of its occluded SOM that focuses on the protein and saccharidic moieties. The skeletal matrix proteins show a large range of isoelectric points, compositional patterns and signatures. Besides secreted proteins, there are a significant number of proteins with membrane attachment sites such as transmembrane domains and GPI anchors as well as proteins with integrin binding sites. These features show that the skeletal proteins must have strong adhesion properties in order to function in the calcifying space. Moreover this data suggest a molecular connection between the calcifying epithelium and the skeletal tissue during biocalcification. In terms of sugar moieties, the enrichment of the SOM in arabinose is striking, and the monosaccharide composition exhibits the same signature as that of mucus of acroporid corals. Finally, we observe that the interaction of the acetic acid soluble SOM on the morphology of in vitro grown CaCO3 crystals is very pronounced when compared with the calcifying matrices of some mollusks. In light of these results, we wish to commend Acropora millepora as a model for biocalcification studies in scleractinians, from molecular and structural viewpoints.	[Ramos-Silva, Paula; Guichard, Nathalie; Durlet, Christophe; Luquet, Gilles; Marin, Frederic] Univ Bourgogne, UMR Biogeosci 6282, Dijon, France; [Ramos-Silva, Paula; Kaandorp, Jaap] Univ Amsterdam, Fac Sci, Sect Computat Sci, Amsterdam, Netherlands; [Herbst, Frederic] Univ Bourgogne, UMR 5209, Dijon, France; [Plasseraud, Laurent; Stern, Christine] Univ Bourgogne, Inst Chim Mol, UMR 6302, Dijon, France; [Alcaraz, Gerard; Corneillat, Marion] Univ Bourgogne, UMR 1347, Agroecol INRA, AgroSup Dijon,ERL 6300, Dijon, France; [Luquet, Gilles] Museum Natl Hist Nat, UMR 7245, F-75231 Paris, France	Universite de Bourgogne; University of Amsterdam; Universite de Bourgogne; Universite de Technologie de Belfort-Montbeliard (UTBM); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN)	Kaandorp, J (corresponding author), Univ Amsterdam, Fac Sci, Sect Computat Sci, Amsterdam, Netherlands.	J.A.Kaandorp@uva.nl; frederic.marin@u-bourgogne.fr	Ramos-Silva, Paula/N-1196-2016; Herbst, Frederic/AAM-9143-2021; Plasseraud, Laurent/ABD-5845-2020; Ramos-Silva, Paula/AAC-6126-2020; Christine, Stern/G-1280-2014	Ramos-Silva, Paula/0000-0002-0798-1724; Plasseraud, Laurent/0000-0002-7870-1881; Ramos-Silva, Paula/0000-0002-0798-1724; Christine, Stern/0000-0002-2929-6429	Marie Curie ITN (Initial Training Network); ANR project (ACCRO-EARTH) [BLAN06-2_159971]; COST project [TD0903]; CNRS-INSU institute	Marie Curie ITN (Initial Training Network); ANR project (ACCRO-EARTH)(French National Research Agency (ANR)); COST project; CNRS-INSU institute	The work of P.R.-S. was supported by the Marie Curie ITN (Initial Training Network), BIOMINTEC piloted by the Johannes Gutenberg University, Mainz, Germany (Pr. H. C. Schroder, see www.biomintec.de) and the BioPreDyn project, coordinated by the Centre for Genomic Regulation (CRG) in Barcelona (see www.biopredyn.eu). Additional support included an ANR project (ACCRO-EARTH, ref. BLAN06-2_159971, Gilles Ramstein, LSCE) during the 2007-2011 period, and the COST project TD0903 ('Biomineralix', www.biomineralix.eu) during the 2012-2013 period. The work of F. Marin was also supported by an INTERRVIE project from the CNRS-INSU institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDADI L, 1987, P NATL ACAD SCI USA, V84, P2732, DOI 10.1073/pnas.84.9.2732; Adkins JF, 2003, GEOCHIM COSMOCHIM AC, V67, P1129, DOI 10.1016/S0016-7037(02)01203-6; Albeck S, 1996, CHEM-EUR J, V2, P278, DOI 10.1002/chem.19960020308; Allemand D, 1998, J EXP BIOL, V201, P2001; Allemand D, 2004, CR PALEVOL, V3, P453, DOI 10.1016/j.crpv.2004.07.011; Allemand D, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P119, DOI 10.1007/978-94-007-0114-4_9; BARNES DJ, 1970, SCIENCE, V170, P1305, DOI 10.1126/science.170.3964.1305; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Bryan W. H., 1941, PROC ROY SOC QUEENSLAND, V52, P78; Clode PL, 2011, CORAL REEFS, V30, P1, DOI 10.1007/s00338-010-0673-7; Clode PL, 2003, BIOL BULL-US, V204, P146, DOI 10.2307/1543550; Cohen AL, 2003, REV MINERAL GEOCHEM, V54, P151, DOI 10.2113/0540151; Cohen AL, 2001, PALEOCEANOGRAPHY, V16, P20, DOI 10.1029/1999PA000478; Cohen AL, 2009, OCEANOGRAPHY, V22, P118, DOI 10.5670/oceanog.2009.102; CONSTANTZ B, 1988, J EXP ZOOL, V248, P253, DOI 10.1002/jez.1402480302; CONSTANTZ B R, 1986, Palaios, V1, P152, DOI 10.2307/3514508; Cuif J.P., 1996, Bulletin de l'Institut Oceanographique Numero Special (Monaco), V14, P359; Cuif J-P, 1998, PALFIONTOLOGISCHE Z, V72; Cuif JP, 2005, J STRUCT BIOL, V150, P319, DOI 10.1016/j.jsb.2005.03.004; Cuif JP, 2003, GEOCHIM COSMOCHIM AC, V67, P75, DOI 10.1016/S0016-7037(02)01041-4; Cuif JP, 1999, INT J EARTH SCI, V88, P582, DOI 10.1007/s005310050286; Cuif JP, 1999, COMP BIOCHEM PHYS A, V123, P269, DOI 10.1016/S1095-6433(99)00059-8; Dauphin Y, 2008, COMP BIOCHEM PHYS B, V150, P10, DOI 10.1016/j.cbpb.2008.01.002; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; Debreuil J, 2012, J BIOL CHEM, V287, P19367, DOI 10.1074/jbc.M112.352005; Drake JL, 2013, P NATL ACAD SCI USA, V110, P3788, DOI 10.1073/pnas.1301419110; DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E; Eisenhaber B, 1998, PROTEIN ENG, V11, P1155, DOI 10.1093/protein/11.12.1155; Falini G., 2013, J STRUCT BIOL; Farre B, 2010, ZOOLOGY, V113, P250, DOI 10.1016/j.zool.2009.11.004; Fricain JC, 2002, BIOMATERIALS, V23, P673, DOI 10.1016/S0142-9612(01)00155-7; Fukuda I, 2003, BIOCHEM BIOPH RES CO, V304, P11, DOI 10.1016/S0006-291X(03)00527-8; GAFFEY SJ, 1993, J SEDIMENT PETROL, V63, P752, DOI 10.1306/D4267BE0-2B26-11D7-8648000102C1865D; Gaspard D, 2008, EARTH ENV SCI T R SO, V98, P415, DOI 10.1017/S1755691007078401; Gattuso JP, 1999, AM ZOOL, V39, P160; Goffredo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022338; GOREAU T, 1956, NATURE, V177, P1029, DOI 10.1038/1771029a0; Hayward DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026411; Ingalls AE, 2003, GEOCHIM COSMOCHIM AC, V67, P2827, DOI 10.1016/S0016-7037(03)00079-6; ISA Y, 1987, COMP BIOCHEM PHYS B, V87, P507, DOI 10.1016/0305-0491(87)90045-9; Iwai H, 2001, PLANTA, V213, P907, DOI 10.1007/s004250100559; Johnston I.S., 1980, International Review of Cytology, V67, P171; Jones GC., 1993, INFRARED TRANSMISSIO; KOIVUNEN E, 1994, J CELL BIOL, V124, P373, DOI 10.1083/jcb.124.3.373; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Marie B, 2008, CHEMBIOCHEM, V9, P2515, DOI 10.1002/cbic.200800159; Marie B, 2007, FEBS J, V274, P2933, DOI 10.1111/j.1742-4658.2007.05825.x; Marie B, 2009, CHEMBIOCHEM, V10, P1495, DOI 10.1002/cbic.200900009; Marin F, 2005, J BIOL CHEM, V280, P33895, DOI 10.1074/jbc.M506526200; Marin F, 2004, CR PALEVOL, V3, P469, DOI 10.1016/j.crpv.2004.07.009; Marin F, 1996, P NATL ACAD SCI USA, V93, P1554, DOI 10.1073/pnas.93.4.1554; Marin F, 2001, PROTEIN EXPRES PURIF, V23, P175, DOI 10.1006/prep.2001.1487; MARIN F, 1994, B SOC GEOL FR, V165, P77; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; Marxen JC, 1998, BIOL BULL-US, V194, P231, DOI 10.2307/1543052; Meibom A, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025968; MITTERER RM, 1978, B MAR SCI, V28, P173; Moore JP, 2008, PLANT SIGNAL BEHAV, V3, P102, DOI 10.4161/psb.3.2.4959; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; Mosele MM, 2011, PHYTOCHEMISTRY, V72, P1466, DOI 10.1016/j.phytochem.2011.03.027; Moya A, 2012, MOL ECOL, V21, P2440, DOI 10.1111/j.1365-294X.2012.05554.x; Ogilvie MM, 1896, P R SOC LOND, V59, P9; Pavat C, 2012, COMP BIOCHEM PHYS B, V161, P303, DOI 10.1016/j.cbpb.2011.12.003; Pramod SN, 2006, GLYCOCONJUGATE J, V23, P481, DOI 10.1007/s10719-006-6217-2; Puverel S, 2005, COMP BIOCHEM PHYS B, V141, P480, DOI 10.1016/j.cbpc.2005.05.013; Puverel S, 2005, CORAL REEFS, V24, P149, DOI 10.1007/s00338-004-0456-0; Rahman MA, 2006, CALCIFIED TISSUE INT, V78, P178, DOI 10.1007/s00223-005-0253-y; Ramos-Silva P, 2013, P NATL ACAD SCI USA, P3; Ramos-Silva P, 2013, MOL BIOL EVOL; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Stolarski J, 2003, ACTA PALAEONTOL POL, V48, P497; Tambutte S, 2008, HDB BIOMINERALIZATIO, P243; Tambutte S, 2011, J EXP MAR BIOL ECOL, V408, P58, DOI 10.1016/j.jembe.2011.07.026; Technau U, 2011, DEVELOPMENT, V138, P1447, DOI 10.1242/dev.048959; Todd PA, 2008, BIOL REV, V83, P315, DOI 10.1111/j.1469-185X.2008.00045.x; VANDERMEULEN JH, 1975, MAR BIOL, V31, P69, DOI 10.1007/BF00390649; Veis A, 2005, SCIENCE, V307, P1419, DOI 10.1126/science.1109440; von Koch G., 1882, MITTHEILUNGEN ZOOLOG, V3, P282; WAINWRIGHT SA, 1963, Q J MICROSC SCI, V104, P169; WAINWRIGHT SA, 1964, EXP CELL RES, V34, P213, DOI 10.1016/0014-4827(64)90358-1; Watanabe T, 2003, COMP BIOCHEM PHYS B, V136, P767, DOI 10.1016/S1096-4959(03)00177-5; Wendt J., 1990, P45; WHEELER AP, 1984, AM ZOOL, V24, P933; WHEELER AP, 1981, SCIENCE, V212, P1397, DOI 10.1126/science.212.4501.1397; Wild C, 2005, MAR ECOL PROG SER, V287, P87, DOI 10.3354/meps287087; XYLA AG, 1989, J CHEM SOC FARAD T 1, V85, P3165, DOI 10.1039/f19898503165; YOUNG SD, 1971, COMP BIOCHEM PHYSIOL, V40, P113, DOI 10.1016/0305-0491(71)90067-8	88	28	29	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e97454	10.1371/journal.pone.0097454	http://dx.doi.org/10.1371/journal.pone.0097454			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893046	Green Published, gold, Green Submitted			2022-12-27	WOS:000336911400013
J	Viola, V; Tosoni, A; Kruglanski, AW; Galati, G; Mannetti, L				Viola, Vanda; Tosoni, Annalisa; Kruglanski, Arie W.; Galati, Gaspare; Mannetti, Lucia			Routes of Motivation: Stable Psychological Dispositions Are Associated with Dynamic Changes in Cortico-Cortical Functional Connectivity	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; COGNITIVE CONTROL; HUMAN BRAIN; PSYCHOPHYSIOLOGICAL INTERACTIONS; CONFLICT ADAPTATION; NEED; CLOSURE; ACTIVATION; INTERFERENCE	The present study provides a neurobiological framework to the theory of epistemic motivation that has been extensively studied for the last three decades in the domain of social cognition. Epistemic motivations affect the way people generate and validate hypotheses, and ultimately form and modify knowledge. Strong dispositional measures such as need for cognitive closure (NCC), the desire for a quick firm answer (any answer) to a question, show gross and stable inter-individual differences. The cognitive mechanisms and neural underpinnings of such differences, however, remain largely unexplored. Here we show that high (compared to low) levels of NCC, measured with need for cognitive closure scale, are associated with reduced online adjustment in cognitive control, as indexed by behavioral conflict adaptation. This behavioral effect is mediated by dynamic changes in cortico-cortical functional connectivity between prefrontal regions involved in conflict monitoring and implementation of cognitive control. In particular, these regions show increased functional connectivity after exposure to conflict in low but not high NCC individuals. These results demonstrate that the level of flexibility of functional cortico-cortical connections can mediate stable psychological dispositions.	[Viola, Vanda; Galati, Gaspare] Univ Roma La Sapienza, Dept Psychol, I-00185 Rome, Italy; [Viola, Vanda; Galati, Gaspare] Fdn Santa Lucia, Neuropsychol Lab, Rome, Italy; [Tosoni, Annalisa] Univ G DAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [Tosoni, Annalisa] Fdn G DAnnunzio, Inst Adv Biomed Technol, Chieti, Italy; [Kruglanski, Arie W.] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA; [Mannetti, Lucia] Univ Roma La Sapienza, Dept Dev & Social Psychol, I-00185 Rome, Italy	Sapienza University Rome; IRCCS Santa Lucia; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University System of Maryland; University of Maryland College Park; Sapienza University Rome	Mannetti, L (corresponding author), Univ Roma La Sapienza, Dept Dev & Social Psychol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	lucia.mannetti@uniroma1.it	Galati, Gaspare/F-3277-2011; Tosoni, Annalisa/J-7410-2016	Galati, Gaspare/0000-0002-0640-4247; Tosoni, Annalisa/0000-0001-9004-2623	Italian Ministry of Health; Sapienza University of Rome [C26A12Y33P]	Italian Ministry of Health(Ministry of Health, Italy); Sapienza University of Rome	This work was supported by: "RC block grants by the Italian Ministry of Health to Fondazione Santa Lucia" and by "C26A12Y33P grant by Sapienza University of Rome" to the last author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio DM, 2007, NAT NEUROSCI, V10, P1246, DOI 10.1038/nn1979; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Caparos S, 2012, EMOTION, V12, P8, DOI 10.1037/a0026310; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Chirumbolo A, 2004, EUR J PERSONALITY, V18, P265, DOI 10.1002/per.518; Clayson PE, 2011, NEUROPSYCHOLOGIA, V49, P1953, DOI 10.1016/j.neuropsychologia.2011.03.023; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dijksterhuis A, 1996, J EXP SOC PSYCHOL, V32, P254, DOI 10.1006/jesp.1996.0012; Durston S, 2003, BIOL PSYCHIAT, V53, P871, DOI 10.1016/S0006-3223(02)01904-2; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; Egner T, 2005, NEUROIMAGE, V24, P539, DOI 10.1016/j.neuroimage.2004.09.007; Egner T, 2007, COGN AFFECT BEHAV NE, V7, P380, DOI 10.3758/CABN.7.4.380; Egner T, 2011, J COGNITIVE NEUROSCI, V23, P3903, DOI 10.1162/jocn_a_00064; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Hanslmayr S, 2008, J COGNITIVE NEUROSCI, V20, P215, DOI 10.1162/jocn.2008.20020; Hester RL, 2004, J COGNITIVE NEUROSCI, V16, P776, DOI 10.1162/089892904970726; Hommel B, 2004, TRENDS COGN SCI, V8, P494, DOI 10.1016/j.tics.2004.08.007; Hommel B, 2004, PSYCHOL RES-PSYCH FO, V68, P1, DOI 10.1007/s00426-003-0132-y; Jost JT, 2007, PERS SOC PSYCHOL B, V33, P989, DOI 10.1177/0146167207301028; Jost JT, 2012, MOTIV EMOTION, V36, P55, DOI 10.1007/s11031-011-9260-7; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kerns JG, 2006, NEUROIMAGE, V33, P399, DOI 10.1016/j.neuroimage.2006.06.012; Kouneiher F, 2009, NAT NEUROSCI, V12, P939, DOI 10.1038/nn.2321; Krug MK, 2010, COGN AFFECT BEHAV NE, V10, P357, DOI 10.3758/CABN.10.3.357; Kruglanski A, 2006, SHORTENED NEED UNPUB; Kruglanski A. W, 1989, LAY EPISTEMICS HUMAN; Kruglanski Arie W., 2004, PSYCHOL CLOSED MINDE; Kruglanski AW, 2006, PSYCHOL REV, V113, P84, DOI 10.1037/0033-295X.113.1.84; KRUGLANSKI AW, 1983, J EXP SOC PSYCHOL, V19, P448, DOI 10.1016/0022-1031(83)90022-7; KRUGLANSKI AW, 1993, J PERS SOC PSYCHOL, V65, P861, DOI 10.1037/0022-3514.65.5.861; Kruglanski AW, 1996, PSYCHOL REV, V103, P263, DOI 10.1037/0033-295X.103.2.263; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Leone L, 2008, J RES PERS, V42, P755, DOI 10.1016/j.jrp.2007.08.001; Luo QA, 2006, NEUROIMAGE, V30, P1449, DOI 10.1016/j.neuroimage.2005.11.005; MacKinnon D.P., 2012, INTRO STAT MEDIATION; Mannetti L, 2007, J ECON PSYCHOL, V28, P186, DOI 10.1016/j.joep.2005.12.004; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; McLaren DG, 2012, NEUROIMAGE, V61, P1277, DOI 10.1016/j.neuroimage.2012.03.068; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Orehek E, 2010, BASIC APPL SOC PSYCH, V32, P279, DOI 10.1080/01973533.2010.519196; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Rocchi P., 1998, G ITAL PSICOL, V25, P153; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Talairach J., 1988, COPLANAR STEREOTAXIC; Thompson-Schill SL, 2002, COGN AFFECT BEHAV NE, V2, P109, DOI 10.3758/CABN.2.2.109	57	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98010	10.1371/journal.pone.0098010	http://dx.doi.org/10.1371/journal.pone.0098010			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5ML	24892718	Green Submitted, Green Published, gold			2022-12-27	WOS:000336911400029
J	Fausther, M; Lavoie, EG; Goree, JR; Baldini, G; Dranoff, JA				Fausther, Michel; Lavoie, Elise G.; Goree, Jessica R.; Baldini, Giulia; Dranoff, Jonathan A.			NT5E Mutations That Cause Human Disease Are Associated with Intracellular Mistrafficking of NT5E Protein	PLOS ONE			English	Article							HUMAN BREAST-CANCER; ALKALINE-PHOSPHATASE; ECTO-5'-NUCLEOTIDASE CD73; ADENOSINE PRODUCTION; B-CELLS; ADHESION; ECTO-5-NUCLEOTIDASE; IDENTIFICATION; SUBSTITUTION; GENERATION	Ecto-5'-nucleotidase/CD73/NT5E, the product of the NT5E gene, is the dominant enzyme in the generation of adenosine from degradation of AMP in the extracellular environment. Nonsense (c.662C -> A, p.S221X designated F1, c. 1609dupA, p.V537fsX7 designated F3) and missense (c.1073G -> A, p.C358Y designated F2) NT5E gene mutations in three distinct families have been shown recently to cause premature arterial calcification disease in human patients. However, the underlying mechanisms by which loss-of-function NT5E mutations cause human disease are unknown. We hypothesized that human NT5E gene mutations cause mistrafficking of the defective proteins within cells, ultimately blocking NT5E catalytic function. To test this hypothesis, plasmids encoding cDNAs of wild type and mutant human NT5E tagged with the fluorescent probe DsRed were generated and used for transfection and heterologous expression in immortalized monkey COS-7 kidney cells that lack native NT5E protein. Enzyme histochemistry and Malachite green assays were performed to assess the biochemical activities of wild type and mutant fusion NT5E proteins. Subcellular trafficking of fusion NT5E proteins was monitored by confocal microscopy and western blot analysis of fractionated cell constituents. All 3 F1, F2, and F3 mutations result in a protein with significantly reduced trafficking to the plasma membrane and reduced ER retention as compared to wild type protein. Confocal immunofluorescence demonstrates vesicles containing DsRed-tagged NT5E proteins (F1, F2 and F3) in the cell synthetic apparatus. All 3 mutations resulted in absent NT5E enzymatic activity at the cell surface. In conclusion, three familial NT5E mutations (F1, F2, F3) result in novel trafficking defects associated with human disease. These novel genetic causes of human disease suggest that the syndrome of premature arterial calcification due to NT5E mutations may also involve a novel "trafficking-opathy".	[Fausther, Michel; Lavoie, Elise G.; Goree, Jessica R.; Dranoff, Jonathan A.] Univ Arkansas Med Sci, Div Gastroenterol & Hepatol, Little Rock, AR 72205 USA; [Fausther, Michel; Lavoie, Elise G.; Goree, Jessica R.; Dranoff, Jonathan A.] Cent Arkansas VA Healthcare Syst, Res Serv, Little Rock, AR USA; [Baldini, Giulia] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Dranoff, JA (corresponding author), Univ Arkansas Med Sci, Div Gastroenterol & Hepatol, Little Rock, AR 72205 USA.	jadranoff@uams.edu		Fausther, Michel/0000-0002-5673-9360	NIH [UL1TR000039]; American Association for the Study of Liver Diseases; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070849] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Association for the Study of Liver Diseases; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors would like to acknowledge the UAMS Translational Research Institute's Digital Microscopy Core, supported by NIH grant UL1TR000039. Individual support to MF was provided by a Roger L. Jenkins MD, Postdoctoral Research Fellowship of the American Association for the Study of Liver Diseases. Individual support to JAD was provided by the National Institute of Diabetes and Digestive and Kidney Diseases in the form of NIH R01 DK070849. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airas L, 1998, LEUKEMIA LYMPHOMA, V29, P37, DOI 10.3109/10428199809058380; Airas L, 1996, BLOOD, V88, P1755, DOI 10.1182/blood.V88.5.1755.bloodjournal8851755; Airas L, 2000, J IMMUNOL, V165, P5411, DOI 10.4049/jimmunol.165.10.5411; Alam MS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04486; Antonioli L, 2013, NAT REV CANCER, V13, P842, DOI 10.1038/nrc3613; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Barry F, 2001, BIOCHEM BIOPH RES CO, V289, P519, DOI 10.1006/bbrc.2001.6013; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Bonner F, 2013, CIRC RES, V113, P301, DOI 10.1161/CIRCRESAHA.113.300180; Catoire H, 2008, HUM MOL GENET, V17, P2108, DOI 10.1093/hmg/ddn109; CHENG SH, 1995, AM J PHYSIOL-LUNG C, V268, pL615, DOI 10.1152/ajplung.1995.268.4.L615; Colgan Sean P, 2006, Purinergic Signal, V2, P351, DOI 10.1007/s11302-005-5302-5; Ernst PB, 2010, J IMMUNOL, V185, P1993, DOI 10.4049/jimmunol.1000108; Fankhauser N, 2005, BIOINFORMATICS, V21, P1846, DOI 10.1093/bioinformatics/bti299; Fausther Michel, 2013, Curr Pathobiol Rep, V1, P225; Fausther M, 2012, AM J PHYSIOL-GASTR L, V302, pG447, DOI [10.1152/ajpgi.00165.2011., 10.1152/ajpgi.00165.2011]; Fernandez P, 2013, AM J PATHOL, V183, P1740, DOI 10.1016/j.ajpath.2013.08.024; Fukushi-Irie M, 2000, BIOCHEM J, V348, P633, DOI 10.1042/0264-6021:3480633; Gahl WA, 2012, DIS MODEL MECH, V5, P3, DOI 10.1242/dmm.009258; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Hausler SFM, 2014, AM J TRANSL RES, V6, P129; Hasko G, 2011, J IMMUNOL, V187, P4256, DOI 10.4049/jimmunol.1003379; Ito M, 2002, BIOCHEM J, V361, P473, DOI 10.1042/0264-6021:3610473; KLEMENS MR, 1990, BIOCHEM BIOPH RES CO, V172, P1371, DOI 10.1016/0006-291X(90)91601-N; Koso H, 2009, INVEST OPHTH VIS SCI, V50, P5411, DOI 10.1167/iovs.08-3246; Kukulski F, 2005, Purinergic Signal, V1, P193, DOI 10.1007/s11302-005-6217-x; Martin-Satue M, 2010, HISTOCHEM CELL BIOL, V133, P659, DOI 10.1007/s00418-010-0704-z; MISUMI Y, 1990, EUR J BIOCHEM, V191, P563, DOI 10.1111/j.1432-1033.1990.tb19158.x; Murakami Y, 2012, J BIOL CHEM, V287, P6318, DOI 10.1074/jbc.M111.331090; Peng Z, 2008, FASEB J, V22, P2263, DOI 10.1096/fj.07-100685; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petrikovics I, 2012, AAPS PHARMSCITECH, V13, P112, DOI 10.1208/s12249-011-9728-5; Pfister S, 2012, CHEM SENSES, V37, P859, DOI 10.1093/chemse/bjs069; Resta R, 1998, IMMUNOL REV, V161, P95, DOI 10.1111/j.1600-065X.1998.tb01574.x; Rogan MP, 2011, CHEST, V139, P1480, DOI 10.1378/chest.10-2077; Rowe SM, 2009, BIODRUGS, V23, P165, DOI 10.2165/00063030-200923030-00003; Rubenstein RC, 1997, J CLIN INVEST, V100, P2457, DOI 10.1172/JCI119788; Sadej R, 2008, BBA-MOL BASIS DIS, V1782, P35, DOI 10.1016/j.bbadis.2007.11.001; Sadej R, 2012, ACTA BIOCHIM POL, V59, P647; Shibata H, 1998, J BIOCHEM-TOKYO, V123, P968; Snider NT, 2013, HEPATOLOGY, V58, P1790, DOI 10.1002/hep.26525; Sowa NA, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-20; St Hilaire C, 2011, NEW ENGL J MED, V364, P432, DOI [10.1056/NEJMoa0912923, 10.1056/NEJMc1102515]; Stagg J, 2012, CANCER RES, V72, P2190, DOI 10.1158/0008-5472.CAN-12-0420; Stagg J, 2011, CANCER RES, V71, P2892, DOI 10.1158/0008-5472.CAN-10-4246; Terp MG, 2013, J IMMUNOL, V191, P4165, DOI 10.4049/jimmunol.1301274; Tkacz K, 2000, ADV EXP MED BIOL, V486, P355; Volmer JB, 2006, J IMMUNOL, V176, P4449, DOI 10.4049/jimmunol.176.7.4449; Wang L, 2008, J CANCER RES CLIN, V134, P365, DOI 10.1007/s00432-007-0292-z; ZIMMERMANN H, 1992, BIOCHEM J, V285, P345, DOI 10.1042/bj2850345; Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4	51	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98568	10.1371/journal.pone.0098568	http://dx.doi.org/10.1371/journal.pone.0098568			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887587	Green Published, gold, Green Submitted			2022-12-27	WOS:000336956300087
J	Moran, P; Bromaghin, JF; Masuda, M				Moran, Paul; Bromaghin, Jeffrey F.; Masuda, Michele			Use of Genetic Data to Infer Population-Specific Ecological and Phenotypic Traits from Mixed Aggregations	PLOS ONE			English	Article							JUVENILE CHINOOK SALMON; COLUMBIA RIVER; STOCK; HABITATS; ESTUARY	Many applications in ecological genetics involve sampling individuals from a mixture of multiple biological populations and subsequently associating those individuals with the populations from which they arose. Analytical methods that assign individuals to their putative population of origin have utility in both basic and applied research, providing information about population-specific life history and habitat use, ecotoxins, pathogen and parasite loads, and many other non-genetic ecological, or phenotypic traits. Although the question is initially directed at the origin of individuals, in most cases the ultimate desire is to investigate the distribution of some trait among populations. Current practice is to assign individuals to a population of origin and study properties of the trait among individuals within population strata as if they constituted independent samples. It seemed that approach might bias population-specific trait inference. In this study we made trait inferences directly through modeling, bypassing individual assignment. We extended a Bayesian model for population mixture analysis to incorporate parameters for the phenotypic trait and compared its performance to that of individual assignment with a minimum probability threshold for assignment. The Bayesian mixture model outperformed individual assignment under some trait inference conditions. However, by discarding individuals whose origins are most uncertain, the individual assignment method provided a less complex analytical technique whose performance may be adequate for some common trait inference problems. Our results provide specific guidance for method selection under various genetic relationships among populations with different trait distributions.	[Moran, Paul] NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Conservat Biol Div, Seattle, WA 98112 USA; [Bromaghin, Jeffrey F.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK USA; [Masuda, Michele] Alaska Fisheries Sci Ctr, Ted Stevens Marine Res Inst, Auke Bay Labs, Juneau, AK USA	National Oceanic Atmospheric Admin (NOAA) - USA; United States Department of the Interior; United States Geological Survey; National Oceanic Atmospheric Admin (NOAA) - USA	Moran, P (corresponding author), NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Conservat Biol Div, Seattle, WA 98112 USA.	paul.moran@noaa.gov	Bromaghin, Jeffrey/B-5058-2009	Bromaghin, Jeffrey/0000-0002-7209-9500	HPC from the Arctic Region Supercomputing Center; University of Alaska, Fairbanks; National Marine Fisheries Service; United States Geological Survey	HPC from the Arctic Region Supercomputing Center; University of Alaska, Fairbanks; National Marine Fisheries Service; United States Geological Survey(United States Geological Survey)	This work was supported in part by a grant of HPC resources from the Arctic Region Supercomputing Center and the University of Alaska, Fairbanks. Support also came from National Marine Fisheries Service and United States Geological Survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EC, 2008, CAN J FISH AQUAT SCI, V65, P1475, DOI 10.1139/F08-049; Bottom D. L., 2008, SALMON LIFE HIST HAB; Bromaghin JF, 2011, T AM FISH SOC, V140, P235, DOI 10.1080/00028487.2011.558776; Claxton A, 2013, HYDROBIOLOGIA, V717, P27, DOI 10.1007/s10750-013-1564-z; Daly EA, 2012, ENVIRON BIOL FISH, V94, P117, DOI 10.1007/s10641-011-9857-4; FOURNIER DA, 1984, CAN J FISH AQUAT SCI, V41, P400, DOI 10.1139/f84-047; Gelman A., 2004, BAYESIAN DATA ANAL; Hanson M. Bradley, 2010, Endangered Species Research, V11, P69, DOI 10.3354/esr00263; *INS CORP, 2001, S PLUS 6 WIND GUID S, V1; Jacobson KC, 2008, MAR ECOL PROG SER, V354, P235, DOI 10.3354/meps07232; Johnson L, 2013, T AM FISH SOC, V142, P21, DOI 10.1080/00028487.2012.720627; Kalinowski S.T., 2007, ONCOR COMPUTER PROGR; Koljonen ML, 2005, CAN J FISH AQUAT SCI, V62, P2143, DOI 10.1139/F05-128; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; Mank JE, 2004, GENET RES, V84, P135, DOI 10.1017/S0016672304007190; MILLAR RB, 1987, CAN J FISH AQUAT SCI, V44, P583, DOI 10.1139/f87-071; Pella J, 2001, FISH B-NOAA, V99, P151; PELLA JJ, 1987, POPULATION GENETICS, P247; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rhodes LD, 2011, MAR ECOL PROG SER, V432, P161, DOI 10.3354/meps09160; Roegner GC, 2012, MAR COAST FISH, V4, P450, DOI 10.1080/19425120.2012.675982; Seeb LW, 2007, FISHERIES, V32, P540, DOI 10.1577/1548-8446(2007)32[540:DOASDD]2.0.CO;2	23	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98470	10.1371/journal.pone.0098470	http://dx.doi.org/10.1371/journal.pone.0098470			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905464	Green Published, Green Submitted, gold			2022-12-27	WOS:000341869000032
J	Ueda, S; Kuji, I; Shigekawa, T; Takeuchi, H; Sano, H; Hirokawa, E; Shimada, H; Suzuki, H; Oda, M; Osaki, A; Saeki, T				Ueda, Shigeto; Kuji, Ichiei; Shigekawa, Takashi; Takeuchi, Hideki; Sano, Hiroshi; Hirokawa, Eiko; Shimada, Hiroko; Suzuki, Hiroaki; Oda, Motoki; Osaki, Akihiko; Saeki, Toshiaki			Optical Imaging for Monitoring Tumor Oxygenation Response after Initiation of Single-Agent Bevacizumab followed by Cytotoxic Chemotherapy in Breast Cancer Patients	PLOS ONE			English	Article							NEOADJUVANT CHEMOTHERAPY; ANTIANGIOGENIC THERAPY; NORMALIZATION; VASCULATURE; TOMOGRAPHY; CRITERIA; VERSION	Purpose: Optical imaging techniques for measuring tissue hemoglobin concentration have been recently accepted as a way to assess tumor vascularity and oxygenation. We investigated the correlation between early optical response to single-agent bevacizumab and treatment outcome. Methods: Seven patients with advanced or metastatic breast cancer were treated with single-agent bevacizumab followed by addition of weekly paclitaxel. Optical imaging of patient's breasts was performed to measure tumor total hemoglobin concentration (tHb) and oxygen saturation (stO(2)) at baseline and on days 1, 3, 6, 8, and 13 after the first infusion of bevacizumab. To assess early metabolic response, 2-deoxy-2-(F-18)-fluoro-D-glucose (FDG) positron emission tomography/computed tomography (PET/CT), F-18-fluoromisonidazole (FMISO)-PET/CT, and magnetic resonance imaging were performed at baseline and after two cycles of the regimen. Results: Seven patients were grouped as responders (n = 4) and nonresponders (n = 3) on the basis of metabolic response measured by FDG-PET/CT. The responders showed remarkable tumor shrinkage and low accumulations of FMISO tracer relative to those of the nonresponders at the completion of two cycles of chemotherapy. Tumors of both groups showed remarkable attenuation of mean tHb as early as day 1 after therapy initiation. The nonresponders had lower baseline stO(2) levels compared with adjacent breast tissue stO(2) levels along with a pattern of steadily low stO(2) levels during the observation window. On the other hand, the responders appeared to sustain high stO(2) levels with temporal fluctuation. Conclusions: Low tumor stO(2) level after single-agent bevacizumab treatment was characteristic of the nonresponders. Tumor stO(2) level could be a predictor of an additional benefit of bevacizumab over that provided by paclitaxel.	[Ueda, Shigeto; Shigekawa, Takashi; Takeuchi, Hideki; Sano, Hiroshi; Hirokawa, Eiko; Shimada, Hiroko; Osaki, Akihiko; Saeki, Toshiaki] Saitama Med Univ, Int Med Ctr, Dept Breast Oncol, Hidaka, Saitama, Japan; [Kuji, Ichiei] Saitama Med Univ, Int Med Ctr, Dept Nucl Med, Hidaka, Saitama, Japan; [Suzuki, Hiroaki; Oda, Motoki] Hamamatsu Photon KK, Cent Res Lab, Hamakita Ku, Hamamatsu, Shizuoka, Japan	Saitama Medical University; Saitama Medical University; Hamamatsu Photonics	Ueda, S (corresponding author), Saitama Med Univ, Int Med Ctr, Dept Breast Oncol, Hidaka, Saitama, Japan.	syueda@saitama-med.ac.jp		Kuji, Ichiei/0000-0002-5797-3482	JSPS KAKENHI [25830105]; Hidaka Research Grant	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Hidaka Research Grant	This work was supported by JSPS KAKENHI Grant Number 25830105 and Hidaka Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aogi K, 2011, BREAST CANCER RES TR, V129, P829, DOI 10.1007/s10549-011-1685-x; Bear HD, 2012, NEW ENGL J MED, V366, P310, DOI 10.1056/NEJMoa1111097; Cerussi A, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2337546; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Imabayashi E, 2011, BRAIN BEHAV, V1, P63, DOI 10.1002/brb3.13; Jain RK, 2009, NAT REV CLIN ONCOL, V6, P327, DOI 10.1038/nrclinonc.2009.63; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kurosumi M, 2008, BREAST CANCER-TOKYO, V15, P5, DOI 10.1007/s12282-007-0016-x; Mghanga FP, 2013, CLIN BREAST CANCER, V13, P271, DOI 10.1016/j.clbc.2013.02.003; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Mizukoshi W, 2013, EUR RADIOL, V23, P75, DOI 10.1007/s00330-012-2555-6; PATTERSON MS, 1989, APPL OPTICS, V28, P2331, DOI 10.1364/AO.28.002331; Robinson ES, 2010, HYPERTENSION, V56, P1131, DOI 10.1161/HYPERTENSIONAHA.110.160481; Roblyer D, 2011, P NATL ACAD SCI USA, V108, P14626, DOI 10.1073/pnas.1013103108; Tromberg BJ, 2005, BREAST CANCER RES, V7, P279, DOI 10.1186/bcr1358; Ueda S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-514; Ueda S, 2012, CANCER RES, V72, P4318, DOI 10.1158/0008-5472.CAN-12-0056; Ueda S, 2012, INT J CLIN ONCOL, V17, P276, DOI 10.1007/s10147-011-0287-2; Ueda Y, 2011, TECHNOL CANCER RES T, V10, P393, DOI 10.7785/tcrt.2012.500217; Van der Veldt AAM, 2012, CANCER CELL, V21, P82, DOI 10.1016/j.ccr.2011.11.023; Wang YT, 2012, BREAST CANCER RES TR, V131, P357, DOI 10.1007/s10549-011-1780-z; Zhu Q, 2013, RADIOLOGY, V266, P433, DOI 10.1148/radiol.12112415	23	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98715	10.1371/journal.pone.0098715	http://dx.doi.org/10.1371/journal.pone.0098715			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905225	Green Published, gold, Green Submitted			2022-12-27	WOS:000341869000052
J	Van Bellinghen, LA; Meier, G; Van Vlaenderen, I				Van Bellinghen, Laure-Anne; Meier, Genevieve; Van Vlaenderen, Ilse			The Potential Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in Elderly People and Clinical Risk Groups in the UK: A Lifetime Multi-Cohort Model	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; POPULATION; OSELTAMIVIR; EFFICACY; ADULTS	Objective: To estimate the potential cost-effectiveness of quadrivalent influenza vaccine compared with trivalent influenza vaccine in the UK. Methods: A lifetime, multi-cohort, static Markov model was constructed, with nine age groups each divided into healthy and at-risk categories. Influenza A and B were accounted for separately. The model was run in one-year cycles for a lifetime (maximum age: 100 years). The analysis was from the perspective of the UK National Health Service. Costs and benefits were discounted at 3.5%. 2010 UK vaccination policy (vaccination of people at risk and those aged >= 65 years) was applied. Herd effect was not included. Inputs were derived from national databases and published sources where possible. The quadrivalent influenza vaccine price was not available when the study was conducted. It was estimated at 6.72,15 pound% above the trivalent vaccine price of 5.85 pound. Sensitivity analyses used an incremental price of up to 50%. Results: Compared with trivalent influenza vaccine, the quadrivalent influenza vaccine would be expected to reduce the numbers of influenza cases by 1,393,720, medical visits by 439,852 complications by 167,357, hospitalisations for complications by 26,424 and influenza deaths by 16,471. The estimated base case incremental cost-effectiveness ratio (ICER) was 5,299 pound/quality-adjusted life-year (QALY). Sensitivity analyses indicated that the ICER was sensitive to changes in circulation of influenza virus subtypes and vaccine mismatch; all other parameters had little effect. In 96% of simulations the ICER was <20,000 pound/QALY. Since this analysis was completed, quadrivalent influenza vaccine has become available in the UK at a list price of 9.94 pound. Using this price in the model, the estimated ICER for quadrivalent compared with trivalent vaccination was 27,378 pound/QALY, still within the NICE cost-effectiveness threshold (20,000- pound 30,000) pound. Conclusions: Quadrivalent influenza vaccine could reduce influenza disease burden and would be cost-effective compared with trivalent influenza vaccine in elderly people and clinical risk groups in the UK.	[Van Bellinghen, Laure-Anne; Van Vlaenderen, Ilse] CHESS, Ternat, Belgium; [Meier, Genevieve] GlaxoSmithKline Vaccines, Hlth Econ, Wavre, Belgium	GlaxoSmithKline	Meier, G (corresponding author), GlaxoSmithKline Vaccines, Hlth Econ, Wavre, Belgium.	genevieve.c.meier@gsk.com			GlaxoSmithKline group of companies; GlaxoSmithKline Biologicals SA	GlaxoSmithKline group of companies(GlaxoSmithKline); GlaxoSmithKline Biologicals SA(GlaxoSmithKline)	The authors disclose the following direct or indirect financial relationships with the sponsors: Genevieve Meier is an employee of the GlaxoSmithKline group of companies and holds restricted shares in the GlaxoSmithKline group of companies; Ilse Van Vlaenderen's and Laure-Anne Van Bellinghen's institution received consulting fees from the GlaxoSmithKline group of companies for conducting the present study and has also received consultancy fees from the GlaxoSmithKline group of companies for other projects and for writing manuscript outlines related to these other projects. This study, including preparation of the manuscript, was funded by GlaxoSmithKline Biologicals SA, which was involved in: design and operation of the model; data inputs, analysis and interpretation; manuscript preparation, review and decision to submit for publication.	[Anonymous], 2013, SUMMARY PRODUCT CHAR; [Anonymous], COCHRANE DATABASE SY; [Anonymous], 2011, ROYAL PHARM SOC BRIT; Belshe RB, 2010, VACCINE, V28, pD45, DOI 10.1016/j.vaccine.2010.08.028; Burch J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13580; Burls A, 2006, VACCINE, V24, P4212, DOI 10.1016/j.vaccine.2005.12.043; Burls A, 2002, Health Technol Assess, V6, P1; Daley AJ, 2000, J PAEDIATR CHILD H, V36, P332, DOI 10.1046/j.1440-1754.2000.00533.x; Department of Health, 2011, NHS TRUST REF COST S; Department of Health, 2013, GREEN BOOK; Department of Health, 2011, SEAS FLU IMM PROGR 2; Department of Health, 2012, GREEN BOOK; DiazGranados CA, 2012, VACCINE, V31, P49, DOI 10.1016/j.vaccine.2012.10.084; Domachowske J, 2012, INFL VACC WORLD IVW; Fleming DM, 2006, VACCINE, V24, P4378, DOI 10.1016/j.vaccine.2006.02.053; Griffin AD, 2001, PHARMACOECONOMICS, V19, P293, DOI 10.2165/00019053-200119030-00007; Health Protection Agency (HPA), 2012, SEAS INFL EP DAT; Hite LK, 2007, INT J INFECT DIS, V11, P40, DOI 10.1016/j.ijid.2005.10.008; HPA, 2011, INFL VACC UPT MON BE; Irving SA, 2012, INFLUENZA OTHER RESP, V6, P37, DOI 10.1111/j.1750-2659.2011.00263.x; Jain VK, 2013, NEW ENGL J MED, V369, P2481, DOI 10.1056/NEJMoa1215817; Jefferson T, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004879.pub3; Joint Committee on Vaccination and Immunisation (JCVI), 2012, M WEDN 13 JUN 2012; Joint Committee on Vaccination and Immunisation (JCVI) Scientific Secretariat, 2012, JCVI STAT ANN INFL V; Kieninger D, 2012, INFL VACC WORLD IVW; Knipe DM, 2007, FIELDS VIROLOGY; Meier CR, 2000, EUR J CLIN MICROBIOL, V19, P834, DOI 10.1007/s100960000376; National Institute for Health and Clinical Excellence, 2011, AM OS ZAN TREATM INF; National Institute for Health and Clinical Excellence, 2007, INC HLTH EC GUID ASS; National Institute for Health and Clinical Excellence, 2011, OS AM REV ZAN PROPH; Office for National Statistics, 2011, POP EST UK ENGL WAL; Office for National Statistics, 2011, INT LIF TABL UK 1980; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Personal Social Services Research Unit, 2011, UN COSTS HLTH SOC CA; Pitman RJ, 2007, J INFECTION, V54, P530, DOI 10.1016/j.jinf.2006.09.017; Prosser LA, 2006, EMERG INFECT DIS, V12, P1548, DOI 10.3201/eid1210.051015; Public Health England, 2013, PHE GUID US ANT AG T; Rawlins M, 2010, BRIT J CLIN PHARMACO, V70, P346, DOI 10.1111/j.1365-2125.2009.03589.x; Reed C, 2012, VACCINE, V30, P1993, DOI 10.1016/j.vaccine.2011.12.098; Reisinger K, 2004, CLIN DRUG INVEST, V24, P395, DOI 10.2165/00044011-200424070-00003; Rothberg MB, 2003, ANN INTERN MED, V139, P321, DOI 10.7326/0003-4819-139-5_Part_1-200309020-00007; Sander B, 2006, PHARMACOECONOMICS, V24, P373, DOI 10.2165/00019053-200624040-00007; Sander B, 2004, J MED EC, V7, P67; Sander Beate, 2005, Eur J Health Econ, V6, P244, DOI 10.1007/s10198-005-0297-y; Smyth A, 2002, BRIT MED BULL, V61, P247, DOI 10.1093/bmb/61.1.247; Tappenden P, 2009, HLTH TECHNOLOGY ASSE, V13, piii; Thompson WW, 2009, INFLUENZA OTHER RESP, V3, P37, DOI 10.1111/j.1750-2659.2009.00073.x; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Tinoco JC, 2012, ID WEEK SAN DIEG CA; Tricco AC, 2013, BMC MED IN PRESS; Turner D, 2003, HLTH TECHNOLOGY ASSE, V7; Weinstein MC, 2003, VALUE HEALTH, V6, P9, DOI 10.1046/j.1524-4733.2003.00234.x; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211	53	47	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98437	10.1371/journal.pone.0098437	http://dx.doi.org/10.1371/journal.pone.0098437			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905235	Green Published, gold, Green Submitted			2022-12-27	WOS:000341869000030
J	Zhang, ML; Meng, HH; Zhang, HX; Vyacheslav, BV; Sanderson, SC				Zhang, Ming-Li; Meng, Hong-Hu; Zhang, Hong-Xiang; Vyacheslav, Byalt V.; Sanderson, Stewart C.			Himalayan Origin and Evolution of Myricaria (Tamaricaeae) in the Neogene	PLOS ONE			English	Article							DISPERSAL-VICARIANCE ANALYSIS; QINGHAI-TIBETAN PLATEAU; MOLECULAR PHYLOGENY; GEOGRAPHIC RANGE; CENOZOIC UPLIFT; NUCLEAR RDNA; DIVERSIFICATION; HISTORY; MIOCENE; BIOGEOGRAPHY	Background: Myricaria consists of about twelve-thirteen species and occurs in Eurasian North Temperate zone, most species in the Qinghai-Tibet Plateau (QTP) and adjacent areas. Methodology/Principal Findings: Twelve species of Myricaria plus two other genera Tamarix and Reaumuria in Tamaricaceae, were sampled, and four markers, ITS, rps16, psbB-psbH, and trnL-trnF were sequenced. The relaxed Bayesian molecular clock BEAST method was used to perform phylogenetic analysis and molecular dating, and Diva, S-Diva, and maximum likelihood Lagrange were used to estimate the ancestral area. The results indicated that Myricaria could be divided into four phylogenetic clades, which correspond to four sections within the genus, of them two are newly described in this paper. The crown age of Myricaria was dated to early Miocene ca. 20 Ma, at the probable early uplifting time of the Himalayas. The Himalayas were also shown as the center of origin for Myricaria from the optimization of ancestral distribution. Migration and dispersal of Myricaria were indicated to have taken place along the Asian Mountains, including the Himalayas, Kunlun, Altun, Hendukosh, Tianshan, Altai, and Caucasus etc., westward to Europe, eastward to Central China, and northward to the Mongolian Plateau. Conclusions/Significance: Myricaria spatiotemporal evolution presented here, especially the Himalayan origin at early Miocene ca. 20 Ma, and then migrated westward and eastward along the Asian mountains, offers a significant evolutionary case for QTP and Central Asian biogeography.	[Zhang, Ming-Li; Meng, Hong-Hu; Zhang, Hong-Xiang] Chinese Acad Sci, Key Lab Biogeog & Bioresource Arid Land, Xinjiang Inst Ecol & Geog, Urumqi, Peoples R China; [Zhang, Ming-Li] Chinese Acad Sci, Inst Bot, Beijing, Peoples R China; [Vyacheslav, Byalt V.] Russian Acad Sci, VL Komarov Bot Inst, St Petersburg 196140, Russia	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Russian Academy of Sciences; Komarov Botanical Institute, Russian Academy of Sciences	Zhang, ML (corresponding author), Chinese Acad Sci, Key Lab Biogeog & Bioresource Arid Land, Xinjiang Inst Ecol & Geog, Urumqi, Peoples R China.	zhangml@ibcas.ac.cn	Meng, Hong-Hu/Y-9861-2019; Meng, Hong-Hu/B-6775-2016	Meng, Hong-Hu/0000-0002-4504-0001; Meng, Hong-Hu/0000-0002-4504-0001	China National Key Basic Research Program [2012FY111500, 2014CB954201]; CAS Important Direction for Knowledge Innovation Project [KZCX2-EW-305]; Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences	China National Key Basic Research Program(National Basic Research Program of China); CAS Important Direction for Knowledge Innovation Project; Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was funded by China National Key Basic Research Program (No. 2012FY111500, 2014CB954201), CAS Important Direction for Knowledge Innovation Project (No. KZCX2-EW-305), and the Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CL, 2005, AM J BOT, V92, P1737, DOI 10.3732/ajb.92.10.1737; [Anonymous], 1984, BULL BOT RES; Baum B., 1966, MONOGRAPHIC REVISION; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Carlquist S, 2010, BOT J LINN SOC, V164, P342, DOI 10.1111/j.1095-8339.2010.01095.x; Che J, 2010, P NATL ACAD SCI USA, V107, P13765, DOI 10.1073/pnas.1008415107; Clark MK, 2005, GEOLOGY, V33, P525, DOI 10.1130/G21265.1; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Eggens F, 2006, SYSTEMATICS SILENEAE; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Fior S, 2006, AM J BOT, V93, P399, DOI 10.3732/ajb.93.3.399; Gaskin JF, 2004, ANN MO BOT GARD, V91, P401; Gorschkova S G, 1949, FLORA USSR, V15, P290; Guo ZT, 2008, CLIM PAST, V4, P153, DOI 10.5194/cp-4-153-2008; Harris AJ, 2009, TAXON, V58, P108, DOI 10.1002/tax.581012; Hua Li, 2004, Acta Botanica Yunnanica, V26, P283; Institute of Botany NIoGaP Academia Sinica (IB-NIGP), 1978, CHIN PLANT FOSS; Jia DR, 2012, NEW PHYTOL, V194, P1123, DOI 10.1111/j.1469-8137.2012.04115.x; JOHNSON LA, 1995, ANN MO BOT GARD, V82, P149, DOI 10.2307/2399875; Kadereit JW, 2008, PLANT ECOL DIVERS, V1, P171, DOI 10.1080/17550870802328751; Kitamura S, 1955, FAUNA FLORA NEPAL HI, P73; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Liu DL, 2010, TECTONOPHYSICS, V486, P108, DOI 10.1016/j.tecto.2010.01.014; Liu J, 2007, NEWSLETT HIMALAYAN B, V40, P20; Liu JQ, 2006, MOL PHYLOGENET EVOL, V38, P31, DOI 10.1016/j.ympev.2005.09.010; Liu JQ, 2002, MOL PHYLOGENET EVOL, V23, P307, DOI 10.1016/S1055-7903(02)00039-8; Liu YF, 2006, AM J BOT, V93, P206, DOI 10.3732/ajb.93.2.206; Liu YF, 2009, MOL ECOL, V18, P2700, DOI 10.1111/j.1365-294X.2009.04214.x; Magallon S, 2009, AM J BOT, V96, P349, DOI 10.3732/ajb.0800060; Mao KS, 2010, NEW PHYTOL, V188, P254, DOI 10.1111/j.1469-8137.2010.03351.x; Miao YF, 2012, EARTH-SCI REV, V112, P155, DOI 10.1016/j.earscirev.2012.02.003; Molnar P, 2005, PALAEONTOL ELECTRON, V8; MULLER J, 1981, BOT REV, V47, P1, DOI 10.1007/BF02860537; Najman YMR, 1997, GEOLOGY, V25, P535, DOI 10.1130/0091-7613(1997)025<0535:LAADOS>2.3.CO;2; Niedenzu F, 1925, NATURL PFLANZ, P276; Nylander JAA, 2008, SYSTEMATIC BIOL, V57, P257, DOI 10.1080/10635150802044003; Ovezinrlikov PN, 1977, DOKL AKAD NAUK SSSR, V20, P54; Owen LA, 2005, QUATERN INT, V138, P55, DOI 10.1016/j.quaint.2005.02.006; Oxelman B, 1997, PLANT SYST EVOL, V206, P393, DOI 10.1007/BF00987959; QAISER M, 1978, Blumea, V24, P151; Qiang XK, 2011, SCI CHINA EARTH SCI, V54, P136, DOI 10.1007/s11430-010-4126-5; Rajbhandary S., 2011, Gardens' Bulletin (Singapore), V63, P277; Ree RH, 2005, EVOLUTION, V59, P2299; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Reveal James L., 2011, Kew Bulletin, V66, P5, DOI 10.1007/s12225-011-9259-y; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; RONQUIST F, 1996, DIVA VERSION 1 1 COM; Royle JF, 1839, ILLUSTRATION BOT OTH; Schuster TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061261; Sun Hang, 2002, Acta Botanica Yunnanica, V24, P273; Sun JM, 2010, GEOLOGY, V38, P515, DOI 10.1130/G30776.1; Sun JM, 2006, SCIENCE, V312, P1621, DOI 10.1126/science.1124616; TABATA H, 1988, Acta Phytotaxonomica et Geobotanica, V39, P13; Tabata H, 2004, HIMALAYAN J SCI, V2, P256; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P73, DOI 10.5962/bhl.part.13179; Tu TY, 2010, MOL PHYLOGENET EVOL, V57, P1226, DOI 10.1016/j.ympev.2010.09.007; Wang CS, 2008, P NATL ACAD SCI USA, V105, P4987, DOI 10.1073/pnas.0703595105; Wang LY, 2009, MOL ECOL, V18, P709, DOI 10.1111/j.1365-294X.2008.04055.x; Wang YD, 2012, GEOSCI FRONT, V3, P175, DOI 10.1016/j.gsf.2011.11.005; Wang Y, 2009, BOT STUD, V50, P343; Wang YJ, 2007, ANN BOT-LONDON, V99, P311, DOI 10.1093/aob/mcl259; Wang YJ, 2009, BIOL J LINN SOC, V97, P893, DOI 10.1111/j.1095-8312.2009.01225.x; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Willis K. J., 2002, EVOLUTION PLANTS; Wu ZY, 1987, FLORA XIZANGICA, P874; Wu ZY, 1988, J JPN BOT, V63, P1; WULFF E. V., 1943, An introduction to historical plant geography.; Xu DH, 2000, THEOR APPL GENET, V101, P724, DOI 10.1007/s001220051537; Xu L., 2010, FLORA CHINA, V10, P322; Xu TT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-194; Yang Q., 2007, FLORA CHINA, V13, P58; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Zhang Dao-Yuan, 2005, Acta Botanica Yunnanica, V27, P471; Zhang DY, 2000, ACTA BOT BOREALI-OCC, V20, P421; Zhang ML, 2010, PLANT SYST EVOL, V288, P191, DOI 10.1007/s00606-010-0324-z; Zhang Ming-Li, 2003, Acta Botanica Yunnanica, V25, P25; Zhang ML, 2009, MOL PHYLOGENET EVOL, V50, P547, DOI 10.1016/j.ympev.2008.12.001; Zhang ML, 1997, ACTA BOT YUNNAN, V19, P331; Zhang PY, 1990, FLORA REIPUBLICAE PO, P142; Zhou LL, 2012, J BIOGEOGR, V39, P322, DOI 10.1111/j.1365-2699.2011.02598.x	84	18	22	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e97582	10.1371/journal.pone.0097582	http://dx.doi.org/10.1371/journal.pone.0097582			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905234	Green Published, gold			2022-12-27	WOS:000341869000008
J	Huang, HL; Hsieh, MJ; Chien, MH; Chen, HY; Yang, SF; Hsiao, PC				Huang, Hsin-Lien; Hsieh, Ming-Ju; Chien, Ming-Hsien; Chen, Hui-Yu; Yang, Shun-Fa; Hsiao, Pei-Ching			Glabridin Mediate Caspases Activation and Induces Apoptosis through JNK1/2 and p38 MAPK Pathway in Human Promyelocytic Leukemia Cells	PLOS ONE			English	Article							CHINESE HERBAL MEDICINE; INHIBITS MIGRATION; CANCER; LICORICE; INVASION; ANGIOGENESIS; DYSFUNCTION; METASTASIS; GENERATION; DIOSCIN	Background: Glabridin, a prenylated isoflavonoid of G. glabra L. roots, has been associated with a wide range of biological properties such as regulation of energy metabolism, estrogenic, neuroprotective, anti-osteoporotic, and skin-whitening in previous studies. However, the effect of glabridin on tumor cells metastasis has not been clearly clarified. Here, the molecular mechanism by which glabridin anticancer effects in human promyelocytic leukemia cells was investigated. Methodology and Principal Findings: The results showed that glabridin significantly inhibited cell proliferation of four AML cell lines (HL-60, MV4-11, U937, and THP-1). Furthermore, glabridin induced apoptosis of HL-60 cells through caspases-3, -8, and -9 activations and PARP cleavage in dose-and time-dependent manner. Moreover, western blot analysis also showed that glabridin increase phosphorylation of ERK1/2, p38 MAPK and JNK1/2 in dose-and time-dependent manner. Inhibition of p38 MAPK and JNK1/2 by specific inhibitors significantly abolished the glabridin-induced activation of the caspase-3, -8 and -9. Conclusion: Taken together, our results suggest that glabridin induced HL-60 cell apoptosis through p38 MAPK and JNK1/2 pathways and could serve as a potential additional chemotherapeutic agent for treating AML.	[Huang, Hsin-Lien; Hsieh, Ming-Ju; Chen, Hui-Yu; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Hsieh, Ming-Ju] Changhua Christian Hosp, Canc Res Ctr, Changhua, Taiwan; [Hsieh, Ming-Ju] Chung Shan Med Univ, Sch Optometry, Taichung, Taiwan; [Chien, Ming-Hsien] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Chien, Ming-Hsien] Taipei Med Univ, Wan Fang Hosp, Taipei, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Hsiao, Pei-Ching] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Hsiao, Pei-Ching] Chung Shan Med Univ, Dept Internal Med, Taichung, Taiwan	Chung Shan Medical University; Changhua Christian Hospital; Chung Shan Medical University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University	Hsiao, PC (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.	cshy046@csh.org.tw	Yang, Shun-Fa/AAN-1519-2020; Hsieh, Ming-Ju/GQB-3025-2022	Yang, Shun-Fa/0000-0002-0365-7927; Hsieh, Ming-Ju/0000-0001-9726-3234	Chung Shan Medical University Hospital, Taiwan [CSH-2014-C-020]	Chung Shan Medical University Hospital, Taiwan	This study was supported by a grant (CSH-2014-C-020) from Chung Shan Medical University Hospital, Taiwan. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2013, FOOD CHEM TOXICOL, V51, P439, DOI 10.1016/j.fct.2012.08.048; Aoki F, 2007, J AM COLL NUTR, V26, P209, DOI 10.1080/07315724.2007.10719603; Belinky PA, 1998, FREE RADICAL BIO MED, V24, P1419, DOI 10.1016/S0891-5849(98)00006-9; Bishop JF, 1997, SEMIN ONCOL, V24, P57; Cai J, 2002, BIOL PHARM BULL, V25, P193, DOI 10.1248/bpb.25.193; Carmeli E, 2009, TOXICOL IND HEALTH, V25, P321, DOI 10.1177/0748233709103034; Carter BZ, 2012, LEUKEMIA, V26, P443, DOI 10.1038/leu.2011.246; CasciolaRosen L, 1996, J EXP MED, V183, P1957, DOI 10.1084/jem.183.5.1957; CasciolaRosen L, 1996, P NATL ACAD SCI USA, V93, P1624, DOI 10.1073/pnas.93.4.1624; Chen TF, 2008, J AGR FOOD CHEM, V56, P10574, DOI 10.1021/jf802125t; Chinkwo KA, 2005, J ETHNOPHARMACOL, V98, P163, DOI 10.1016/j.jep.2005.01.016; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Efferth T, 2007, TRENDS MOL MED, V13, P353, DOI 10.1016/j.molmed.2007.07.001; Hsu YL, 2011, MOL NUTR FOOD RES, V55, P318, DOI 10.1002/mnfr.201000148; Huang ST, 2010, PHYTOMEDICINE, V17, P47, DOI 10.1016/j.phymed.2009.06.005; Huang SM, 2011, J CELL BIOCHEM, V112, P643, DOI 10.1002/jcb.22966; Jemal A, 2002, CA-CANCER J CLIN, V52, P23, DOI 10.3322/canjclin.52.1.23; Jia W, 2003, PHYTOTHER RES, V17, P1127, DOI 10.1002/ptr.1398; Kang SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028706; Kim HS, 2013, INT J MOL MED, V31, P243, DOI 10.3892/ijmm.2012.1172; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016; Li QH, 2013, INT J HEMATOL, V97, P617, DOI 10.1007/s12185-013-1317-9; Li XM, 2005, ADV CHRONIC KIDNEY D, V12, P276, DOI 10.1016/j.ackd.2005.03.007; Lu DY, 2012, NEURO-ONCOLOGY, V14, P1367, DOI 10.1093/neuonc/nos262; Ravindranath MH, 2009, EVID-BASED COMPL ALT, V6, P523, DOI 10.1093/ecam/nem140; Repicky A, 2009, CANCER LETT, V277, P55, DOI 10.1016/j.canlet.2008.11.026; Sanchez Y, 2008, INT J CANCER, V123, P1205, DOI 10.1002/ijc.23639; Shankar S, 2008, FRONT BIOSCI-LANDMRK, V13, P440, DOI 10.2741/2691; Spencer SL, 2011, CELL, V144, P926, DOI 10.1016/j.cell.2011.03.002; Tallman MS, 2005, BLOOD, V106, P1154, DOI 10.1182/blood-2005-01-0178; Tsai CF, 2012, INT J MOL SCI, V13, P9877, DOI 10.3390/ijms13089877; Tsai YM, 2011, INTEGR CANCER THER, V10, P341, DOI 10.1177/1534735410384860; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wang J, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/732562; Wang Y, 2007, J PROTEOME RES, V6, P4703, DOI 10.1021/pr070399r; Wu CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039466; Wu FH, 2013, MOL MED REP, V7, P1278, DOI 10.3892/mmr.2013.1330; Yang SF, 2010, FOOD CHEM TOXICOL, V48, P1052, DOI 10.1016/j.fct.2010.01.019; Yu YL, 2012, J CELL PHYSIOL, V227, P213, DOI 10.1002/jcp.22719; Zhang SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046853; Zhou Fen, 2013, Chinese Medical Sciences Journal, V28, P72	42	36	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98943	10.1371/journal.pone.0098943	http://dx.doi.org/10.1371/journal.pone.0098943			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901249	Green Published, gold, Green Submitted			2022-12-27	WOS:000336841400076
J	Lei, HT; Chou, TH; Su, CC; Bolla, JR; Kumar, N; Radhakrishnan, A; Long, F; Delmar, JA; Do, SV; Rajashankar, KR; Shafer, WM; Yu, EW				Lei, Hsiang-Ting; Chou, Tsung-Han; Su, Chih-Chia; Bolla, Jani Reddy; Kumar, Nitin; Radhakrishnan, Abhijith; Long, Feng; Delmar, Jared A.; Do, Sylvia V.; Rajashankar, Kanagalaghatta R.; Shafer, William M.; Yu, Edward W.			Crystal Structure of the Open State of the Neisseria gonorrhoeae MtrE Outer Membrane Channel	PLOS ONE			English	Article							MULTIDRUG EFFLUX; FUSION PROTEIN; PUMP; RESISTANCE; SYSTEM; TRANSPORTER; MUTATIONS; SOFTWARE; AGENTS; MEMBER	Active efflux of antimicrobial agents is one of the most important strategies used by bacteria to defend against antimicrobial factors present in their environment. Mediating many cases of antibiotic resistance are transmembrane efflux pumps, composed of one or more proteins. The Neisseria gonorrhoeae MtrCDE tripartite multidrug efflux pump, belonging to the hydrophobic and amphiphilic efflux resistance-nodulation-cell division (HAE-RND) family, spans both the inner and outer membranes of N. gonorrhoeae and confers resistance to a variety of antibiotics and toxic compounds. We here describe the crystal structure of N. gonorrhoeae MtrE, the outer membrane component of the MtrCDE tripartite multidrug efflux system. This trimeric MtrE channel forms a vertical tunnel extending down contiguously from the outer membrane surface to the periplasmic end, indicating that our structure of MtrE depicts an open conformational state of this channel.	[Lei, Hsiang-Ting; Bolla, Jani Reddy; Kumar, Nitin; Radhakrishnan, Abhijith; Long, Feng; Yu, Edward W.] Iowa State Univ, Dept Chem, Ames, IA 50011 USA; [Chou, Tsung-Han; Su, Chih-Chia; Delmar, Jared A.; Yu, Edward W.] Iowa State Univ, Dept Phys & Astron, Ames, IA USA; [Do, Sylvia V.; Yu, Edward W.] Iowa State Univ, Bioinformat & Computat Biol Interdept Grad Progra, Ames, IA USA; [Rajashankar, Kanagalaghatta R.] NE CAT, Argonne, IL USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Argonne Natl Lab, Dept Chem & Chem Biol, Argonne, IL USA; [Shafer, William M.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Shafer, William M.] VA Med Ctr, Labs Microbial Pathogenesis, Decatur, GA USA	Iowa State University; Iowa State University; Iowa State University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Yu, EW (corresponding author), Iowa State Univ, Dept Chem, Ames, IA 50011 USA.	ewyu@iastate.edu	, Nitin/J-8078-2019; Bolla, Jani Reddy/AAT-1370-2020; Long, Feng/F-5475-2011; Radhakrishnan, Abhijith/V-6182-2019	Bolla, Jani Reddy/0000-0003-4346-182X; Long, Feng/0000-0001-6313-8558; Radhakrishnan, Abhijith/0000-0001-8107-3487	NIH [R37AI021150, R01GM086431]; VA Merit Award from the Medical Research Service of the Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI021150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, R01GM086431] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award from the Medical Research Service of the Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH Grants R37AI021150 (W. M. S.) and R01GM086431 (E.W.Y.) and a VA Merit Award (W. M. S.) from the Medical Research Service of the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akama H, 2004, J BIOL CHEM, V279, P52816, DOI 10.1074/jbc.C400445200; Akama H, 2004, J BIOL CHEM, V279, P25939, DOI 10.1074/jbc.C400164200; Andersen C, 2002, MOL MICROBIOL, V44, P1131, DOI 10.1046/j.1365-2958.2002.02898.x; Bavro VN, 2008, MOL CELL, V30, P114, DOI 10.1016/j.molcel.2008.02.015; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Delahay RM, 1997, MICROBIOL-SGM, V143, P2127, DOI 10.1099/00221287-143-7-2127; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Federici L, 2005, J BIOL CHEM, V280, P15307, DOI 10.1074/jbc.M500401200; Franke S, 2003, J BACTERIOL, V185, P3804, DOI 10.1128/JB.185.13.3804-3812.2003; Franke S, 2001, MICROBIOL-SGM, V147, P965, DOI 10.1099/00221287-147-4-965; Hagman KE, 1997, MICROBIOL-SGM, V143, P2117, DOI 10.1099/00221287-143-7-2117; HAGMAN KE, 1995, MICROBIOL-SGM, V141, P611, DOI 10.1099/13500872-141-3-611; Higgins MK, 2004, P NATL ACAD SCI USA, V101, P9994, DOI 10.1073/pnas.0400375101; Janganan TK, 2013, MOL MICROBIOL, V88, P590, DOI 10.1111/mmi.12211; Janganan TK, 2011, J BIOL CHEM, V286, P5484, DOI 10.1074/jbc.M110.187658; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Kulathila R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015610; Lee EH, 1999, MOL MICROBIOL, V33, P839, DOI 10.1046/j.1365-2958.1999.01530.x; Lei HT, 2014, J MOL BIOL, V426, P403, DOI 10.1016/j.jmb.2013.09.042; Long F, 2010, NATURE, V467, P484, DOI 10.1038/nature09395; LUCAS CE, 1995, MOL MICROBIOL, V16, P1001, DOI 10.1111/j.1365-2958.1995.tb02325.x; MANESS MJ, 1973, J INFECT DIS, V128, P321, DOI 10.1093/infdis/128.3.321; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pei XY, 2011, P NATL ACAD SCI USA, V108, P2112, DOI 10.1073/pnas.1012588108; Rouquette-Loughlin C, 2003, J BACTERIOL, V185, P1101, DOI 10.1128/JB.185.3.1101-1106.2003; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Sennhauser G, 2007, PLOS BIOL, V5, P106, DOI 10.1371/journal.pbio.0050007; Sennhauser G, 2009, J MOL BIOL, V389, P134, DOI 10.1016/j.jmb.2009.04.001; Shafer WM, 1998, P NATL ACAD SCI USA, V95, P1829, DOI 10.1073/pnas.95.4.1829; Shafer WM, 2001, J MOL MICROB BIOTECH, V3, P219; Su CC, 2012, J MOL BIOL, V422, P429, DOI 10.1016/j.jmb.2012.05.038; Su CC, 2011, NATURE, V470, P558, DOI 10.1038/nature09743; Su CC, 2009, J MOL BIOL, V393, P342, DOI 10.1016/j.jmb.2009.08.029; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Tapsall John, 2006, Expert Rev Anti Infect Ther, V4, P619, DOI 10.1586/14787210.4.4.619; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Veal WL, 1998, MICROBIOL-SGM, V144, P621, DOI 10.1099/00221287-144-3-621; Warner DM, 2008, MOL MICROBIOL, V70, P462, DOI 10.1111/j.1365-2958.2008.06424.x	44	37	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e97475	10.1371/journal.pone.0097475	http://dx.doi.org/10.1371/journal.pone.0097475			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901251	Green Published, Green Submitted, gold			2022-12-27	WOS:000336841400006
J	Sarria, FA; Morris, GK; Windmill, JFC; Jackson, J; Montealegre, F				Sarria-S, Fabio A.; Morris, Glenn K.; Windmill, James F. C.; Jackson, Joseph; Montealegre-Z, Fernando			Shrinking Wings for Ultrasonic Pitch Production: Hyperintense Ultra-Short-Wavelength Calls in a New Genus of Neotropical Katydids (Orthoptera: Tettigoniidae)	PLOS ONE			English	Article							SOUND PRODUCTION; GLEANING BAT; GENERATION; DESIGN; COMMUNICATION; CONSTRAINTS; PHYLOGENY	This article reports the discovery of a new genus and three species of predaceous katydid (Insecta: Orthoptera) from Colombia and Ecuador in which males produce the highest frequency ultrasonic calling songs so far recorded from an arthropod. Male katydids sing by rubbing their wings together to attract distant females. Their song frequencies usually range from audio (5 kHz) to low ultrasonic (30 kHz). However, males of Supersonus spp. call females at 115 kHz, 125 kHz, and 150 kHz. Exceeding the human hearing range (50 Hz-20 kHz) by an order of magnitude, these insects also emit their ultrasound at unusually elevated sound pressure levels (SPL). In all three species these calls exceed 110 dB SPL rms re 20 mu Pa (at 15 cm). Males of Supersonus spp. have unusually reduced forewings (<0.5 mm(2)). Only the right wing radiates appreciable sound, the left bears the file and does not show a particular resonance. In contrast to most katydids, males of Supersonus spp. position and move their wings during sound production so that the concave aspect of the right wing, underlain by the insect dorsum, forms a contained cavity with sharp resonance. The observed high SPL at extreme carrier frequencies can be explained by wing anatomy, a resonant cavity with a membrane, and cuticle deformation.	[Sarria-S, Fabio A.; Montealegre-Z, Fernando] Lincoln Univ, Sch Life Sci, Lincoln, England; [Morris, Glenn K.] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; [Windmill, James F. C.; Jackson, Joseph] Univ Strathclyde, Dept Elect & Elect Engn, Glasgow G1 1XW, Lanark, Scotland	University of Lincoln; University of Toronto; University Toronto Mississauga; University of Strathclyde	Montealegre, F (corresponding author), Lincoln Univ, Sch Life Sci, Riseholme Campus, Lincoln, England.	fmontealegrez@lincoln.ac.uk	Windmill, James F C/I-1117-2019; Jackson, Joseph/AAE-1204-2021	Windmill, James F C/0000-0003-4878-349X; Jackson, Joseph/0000-0001-9302-8157	National Geographic [GEFNE17-11]; Royal Society [RG120495]; Engineering and Physical Sciences Research Council (EPSRC) [EP/H02848X/1]; Biotechnology & Biological Sciences Research Council (BBSRC) [BB/H0046371]; BBSRC [BB/H004637/1] Funding Source: UKRI; EPSRC [EP/H02848X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H004637/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H02848X/1] Funding Source: researchfish	National Geographic(National Geographic Society); Royal Society(Royal Society of London); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology & Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was sponsored by National Geographic (http://www.nationalgeographic.co.uk/explorers/grants-programs/),grant #GEFNE17-11 to FM-Z). Royal Society (http://royalsociety.org/grants/) provided funds for equipment used in this research (grant no. RG120495) to FM-Z. JCJ was supported by the Engineering and Physical Sciences Research Council (EPSRC) (http://www.epsrc.ac.uk/Pages/default.aspx) grant no. EP/H02848X/1. JFCW was supported by the Biotechnology & Biological Sciences Research Council (BBSRC) (http://www.bbsrc.ac.uk/home/home.aspx) grant no. BB/H0046371. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennet-Clark HC, 1999, J EXP BIOL, V202, P1803; Bennet-Clark HC, 1998, PHILOS T ROY SOC B, V353, P407, DOI 10.1098/rstb.1998.0219; Bowen-Jones E., 1994, J ORTHOPTERA RES, V2, P46, DOI DOI 10.2307/3503609; Braun H, 2002, THESIS FRIEDRICH ALE; Chivers B, 2014, BIOACOUSTICS, V23, P67, DOI 10.1080/09524622.2013.816639; Cortes A, 2010, ANFIBIOS REPTILES AR, P37; Farris HE, 1998, PHYSIOL ENTOMOL, V23, P322, DOI 10.1046/j.1365-3032.1998.00093.x; FAURE PA, 1990, J COMP PHYSIOL A, V166, P843; Fletcher N. H., 1992, ACOUSTIC SYSTEMS BIO; FORREST TG, 1991, BEHAV ECOL, V2, P327, DOI 10.1093/beheco/2.4.327; FORREST TG, 1982, FLA ENTOMOL, V65, P33, DOI 10.2307/3494144; Gorochov A. V., 2012, ZOOSYSTEMATICA ROSSICA, V22, P59; Gorochov A. V., 2012, Trudy Zoologicheskogo Instituta, V316, P285; HEBARD MORGAN, 1927, TRANS AMER ENT SOC, V53, P79; Heller K.-G., 1988, BIOAKUSTIK EUROPAISC; Heller KG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092366; Karny H., 1911, Verhandlungen der Zoologisch-Botanischen Gesellschaft in Wien, V61; Montealegre Z. Fernando, 1999, Journal of Orthoptera Research, V8, P163; Montealegre-Z F, 2004, SYST ENTOMOL, V29, P21, DOI 10.1111/j.1365-3113.2004.00223.x; Montealegre-Z F, 2009, J EVOLUTION BIOL, V22, P355, DOI 10.1111/j.1420-9101.2008.01652.x; Montealegre-Z F, 2005, THESIS U TORONTO TOR; Montealegre-Z F, 2006, J EXP BIOL, V209, P4923, DOI 10.1242/jeb.02608; Montealegre F, 2014, REV BIOL TROP, V62, P289, DOI 10.15517/rbt.v62i0.16342; Montealegre F, 2013, ZOOTAXA, V3666, P591, DOI 10.11646/zootaxa.3666.4.11; Montealegre-Z F, 2011, SYST BIODIVERS, V9, P77, DOI 10.1080/14772000.2011.560209; MORRIS G K, 1982, Transactions of the American Entomological Society (Philadelphia), V108, P287; MORRIS GK, 1980, ANIM BEHAV, V28, P42, DOI 10.1016/S0003-3472(80)80006-6; MORRIS GK, 1988, T AM ENTOMOL SOC, V114, P215; MORRIS GK, 1994, J ZOOL, V233, P129, DOI 10.1111/j.1469-7998.1994.tb05266.x; MORRIS GK, 1995, NATURWISSENSCHAFTEN, V82, P96, DOI 10.1007/s001140050150; Morris Glenn K., 2001, Revista Colombiana de Entomologia, V27, P93; Mugleston JD, 2013, MOL PHYLOGENET EVOL, V69, P1120, DOI 10.1016/j.ympev.2013.07.014; Nickle David A., 2002, Journal of Orthoptera Research, V11, P125, DOI 10.1665/1082-6467(2002)011[0125:NSOKOT]2.0.CO;2; Pierce G. W., 1948, SONGS INSECTS RELATE; Prestwich KN, 2000, J EXP BIOL, V203, P585; RAFIQ M, 1991, MEAS SCI TECHNOL, V2, P168, DOI 10.1088/0957-0233/2/2/014; RANDELL RL, 1964, CAN ENTOMOL, V96, P1608, DOI 10.4039/Ent961608-12; Rausch M, 1999, ACUSTICA, V85, P412; Redtenbacher J., 1891, Verhandlungen der Zoologisch botanischen Wien, Vxli, P315; Russell DA, 1999, AM J PHYS, V67, P660, DOI 10.1119/1.19349; Sales GD, 1974, ULTRASONIC COMMUNICA; Sueur J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021089; SUGA N, 1966, J INSECT PHYSIOL, V12, P1039, DOI 10.1016/0022-1910(66)90119-3; ter Hofstede HM, 2008, J EXP BIOL, V211, P2431, DOI 10.1242/jeb.017285; ter Hofstede HM, 2010, J COMP PHYSIOL A, V196, P349, DOI 10.1007/s00359-010-0518-4; THEISS J, 1982, BEHAV ECOL SOCIOBIOL, V10, P225, DOI 10.1007/BF00299689; VanStaaden MJ, 1997, J EXP BIOL, V200, P2597; Vincent JFV, 2004, ARTHROPOD STRUCT DEV, V33, P187, DOI 10.1016/j.asd.2004.05.006; Windmill JFC, 2006, CURR BIOL, V16, P2418, DOI 10.1016/j.cub.2006.09.066	49	27	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98708	10.1371/journal.pone.0098708	http://dx.doi.org/10.1371/journal.pone.0098708			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901234	Green Published, Green Accepted, gold			2022-12-27	WOS:000336841400048
J	Chakraborty, D; Conley, SM; Al-Ubaidi, MR; Naash, MI				Chakraborty, Dibyendu; Conley, Shannon M.; Al-Ubaidi, Muayyad R.; Naash, Muna I.			Initiation of Rod Outer Segment Disc Formation Requires RDS	PLOS ONE			English	Article							MUTANT MICE; RETINAL DEGENERATION; PERIPHERIN/RDS; MORPHOGENESIS; CONE; KNOCKOUT; PHOTORECEPTORS; OLIGOMERIZATION; MEMBRANES; MOUSE	Rod outer segment (OS) morphogenesis involves assembly of flattened discs circumscribed by a hairpin-like rim, however, the role of the rim and rim proteins such as retinal degeneration slow (RDS) and its homologue rod OS membrane protein-1 (ROM-1) in this process remains unclear. Here we show that without RDS, no disc/OS formation occurs, while without rhodopsin, small OS structures form containing aligned nascent discs. In the absence of both rhodopsin and RDS, RDS-associated degeneration is slowed, and ROM-1 is stabilized and trafficked to the OS. These animals (rho(-/-)/rds(-/-)) exhibit OSs slightly better than those lacking only RDS, but still without signs of disc formation. These results clearly demonstrate that OS morphogenesis is initiated by RDS-mediated rim formation, a process ROM-1 cannot recapitulate, with subsequent disc growth mediated by rhodopsin. The critical role of RDS in this process helps explain why photoreceptors are so sensitive to varied RDS levels, and why mutations in RDS cause debilitating retinal disease.	[Chakraborty, Dibyendu; Conley, Shannon M.; Al-Ubaidi, Muayyad R.; Naash, Muna I.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73106 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Naash, MI (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73106 USA.	muna-naash@ouhsc.edu			National Institutes of Health [EY10609, 5P30EY021725]; Foundation Fighting Blindness; NATIONAL EYE INSTITUTE [R01EY010609, P30EY021725, R56EY010609, R55EY010609] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health (http://www.nei.nih.gov/) (EY10609, MIN, and core grant 5P30EY021725), and the Foundation Fighting Blindness (https://www.blindness.org/) (MIN, MRA). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIKAWA K, 1992, J CELL BIOL, V116, P659, DOI 10.1083/jcb.116.3.659; Boon CJF, 2008, PROG RETIN EYE RES, V27, P213, DOI 10.1016/j.preteyeres.2008.01.002; Chakraborty D, 2008, BIOCHEMISTRY-US, V47, P1144, DOI 10.1021/bi701807c; Chakraborty D, 2010, HUM MOL GENET, V19, P4799, DOI 10.1093/hmg/ddq410; Chakraborty D, 2009, HUM MOL GENET, V18, P797, DOI 10.1093/hmg/ddn406; Cheng T, 1997, J NEUROSCI, V17, P8118, DOI 10.1523/jneurosci.17-21-08118.1997; Chuang JZ, 2007, CELL, V130, P535, DOI 10.1016/j.cell.2007.06.030; Clarke G, 2000, NAT GENET, V25, P67, DOI 10.1038/75621; Conley SM, 2014, FASEB J; CONNELL G, 1991, P NATL ACAD SCI USA, V88, P723, DOI 10.1073/pnas.88.3.723; Ding XQ, 2004, HUM MOL GENET, V13, P2075, DOI 10.1093/hmg/ddh211; Fariss RN, 1997, J COMP NEUROL, V387, P148, DOI 10.1002/(SICI)1096-9861(19971013)387:1<148::AID-CNE12>3.0.CO;2-Q; Farjo R, 2006, J CELL BIOL, V173, P59, DOI 10.1083/jcb.200509036; Farjo R, 2007, J COMP NEUROL, V504, P619, DOI 10.1002/cne.21476; Gilliam JC, 2012, CELL, V151, P1029, DOI 10.1016/j.cell.2012.10.038; Goldberg AFX, 1996, BIOCHEMISTRY-US, V35, P6144, DOI 10.1021/bi960259n; HAROSI FI, 1975, J GEN PHYSIOL, V66, P357, DOI 10.1085/jgp.66.3.357; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Jaissle GB, 2001, INVEST OPHTH VIS SCI, V42, P506; JANSEN HG, 1984, J COMP NEUROL, V224, P71, DOI 10.1002/cne.902240107; Kisselev OG, 2005, EXP EYE RES, V81, P366, DOI 10.1016/j.exer.2005.06.018; Lee ES, 2006, INVEST OPHTH VIS SCI, V47, P2150, DOI 10.1167/iovs.05-0919; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Liang Y, 2004, J BIOL CHEM, V279, P48189, DOI 10.1074/jbc.M408362200; LIEBMAN PA, 1968, VISION RES, V8, P761, DOI 10.1016/0042-6989(68)90128-4; Loewen CJR, 2000, J BIOL CHEM, V275, P5370, DOI 10.1074/jbc.275.8.5370; Makino CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037832; MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50; Nour M, 2004, INVEST OPHTH VIS SCI, V45, P2514, DOI 10.1167/iovs.04-0065; PAPERMASTER DS, 1974, BIOCHEMISTRY-US, V13, P2438, DOI 10.1021/bi00708a031; Price BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049889; REUTER JH, 1984, NEUROSCI LETT, V48, P231, DOI 10.1016/0304-3940(84)90024-7; Salinas RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054292; SANYAL S, 1984, EXP EYE RES, V39, P231, DOI 10.1016/0014-4835(84)90011-3; SANYAL S, 1981, NEUROSCI LETT, V21, P23, DOI 10.1016/0304-3940(81)90051-3; SCHALKEN JJ, 1990, BIOCHIM BIOPHYS ACTA, V1033, P103, DOI 10.1016/0304-4165(90)90201-7; STEINBERG RH, 1980, J COMP NEUROL, V190, P501, DOI 10.1002/cne.901900307; Tam BM, 2004, MOL BIOL CELL, V15, P2027, DOI 10.1091/mbc.e03-09-0650; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; USUKURA J, 1987, EXP EYE RES, V45, P501, DOI 10.1016/S0014-4835(87)80061-1; Wen XH, 2009, BIOPHYS J, V96, P939, DOI 10.1016/j.bpj.2008.10.016; Zhang Y, 2009, J CELL SCI, V122, P1192, DOI 10.1242/jcs.042531	42	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98939	10.1371/journal.pone.0098939	http://dx.doi.org/10.1371/journal.pone.0098939			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897172	Green Submitted, Green Published, gold			2022-12-27	WOS:000338430700096
J	Dey, S; Chellappa, MM; Gaikwad, S; Kataria, JM; Vakharia, VN				Dey, Sohini; Chellappa, Madhan Mohan; Gaikwad, Satish; Kataria, Jag Mohan; Vakharia, Vikram N.			Genotype Characterization of Commonly Used Newcastle Disease Virus Vaccine Strains of India	PLOS ONE			English	Article							PROTEIN CLEAVAGE SITE; FUSION PROTEIN; HEMAGGLUTININ-NEURAMINIDASE; GENOME SEQUENCE; HN PROTEIN; VIRULENCE; GENE; PATHOGENICITY; IDENTIFICATION; GLYCOPROTEIN	Newcastle disease is an avian pathogen causing severe economic losses to the Indian poultry industry due to recurring outbreaks in vaccinated and unvaccinated flocks. India being an endemic country, advocates vaccination against the virus using lentogenic and mesogenic strains. Two virus strains which are commonly used for vaccination are strain F (a lentogenic virus) and strain R2B (a mesogenic virus). Strain F is given to 0-7 days old chicks and R2B is given to older birds which are around 6-8 weeks old. To understand the genetic makeup of these two strains, a complete genome study and phylogenetic analysis of the F, HN genes of these vaccine strains were carried out. Both the viral strains had a genome length of 15,186 nucleotides and consisted of six genes with conserved complimentary 3' leader and 5' trailer regions. The fusion protein cleavage site of strain F is GGRQGRL and strain R2B is RRQKRF. Although both the viral strains had different virulence attributes, the length of the HN protein was similar with 577 amino acids. Phylogenetic analysis of F, HN and complete genome sequences grouped these two strains in genotype II category which are considered as early genotypes and corroborated with their years of isolation.	[Dey, Sohini; Chellappa, Madhan Mohan] Indian Vet Res Inst, Div Vet Biotechnol, Bareilly, Uttar Pradesh, India; [Gaikwad, Satish] Anim & Plant Quarantine Agcy, Avian Dis Sect, OIE Reference Lab Newcastle Dis, Anyang, South Korea; [Kataria, Jag Mohan] Cent Avian Res Inst, Bareilly, Uttar Pradesh, India; [Vakharia, Vikram N.] Univ Maryland Baltimore Cty, Inst Marine & Environm Technol, Baltimore, MD 21228 USA	Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Animal & Plant Quarantine Agency; Indian Council of Agricultural Research (ICAR); ICAR - Central Avian Research Institute; University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology; University of Maryland Baltimore County	Dey, S (corresponding author), Indian Vet Res Inst, Div Vet Biotechnol, Bareilly, Uttar Pradesh, India.	sohinimadhan@yahoo.com	Gaikwad, Satish/AGZ-6274-2022; Dey, Sohini/GZM-9514-2022	Gaikwad, Satish/0000-0002-1031-5677; Vakharia, Vikram/0000-0002-0955-3010; Chellappa, Madhan Mohan/0000-0003-0477-6829	National Fund for Basic, Strategic and Frontier Application Research in Agriculture; Indian Council of Agricultural Research [NFBSFARA/BS-3010]; Department of Biotechnology, Ministry of Science and Technology [BT/PR15373/AAQ/57/116/2011]	National Fund for Basic, Strategic and Frontier Application Research in Agriculture; Indian Council of Agricultural Research(Indian Council of Agricultural Research (ICAR)); Department of Biotechnology, Ministry of Science and Technology	This work was supported by a research grant from the National Fund for Basic, Strategic and Frontier Application Research in Agriculture, Indian Council of Agricultural Research to S.D. (NFBSFARA/BS-3010), and a grant from Department of Biotechnology, Ministry of Science and Technology to M.M.C. (BT/PR15373/AAQ/57/116/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander D, 2001, BRIT POULTRY SCI, V42, P5, DOI 10.1080/713655022; Alexander D.J., 1989, LAB MANUAL ISOLATION; Alexander DJ, 2008, POULTRY DIS, P75; [Anonymous], 1954, ANN REP IND VET RES; ASPLIN F. D., 1952, VET REC, V64, P245; BallagiPordany A, 1996, ARCH VIROL, V141, P243, DOI 10.1007/BF01718397; Chellappa MM, 2012, J VIROL, V86, P13814, DOI 10.1128/JVI.02552-12; Chen L, 2001, STRUCTURE, V9, P255, DOI 10.1016/S0969-2126(01)00581-0; Chen L, 2001, VIROLOGY, V290, P290, DOI 10.1006/viro.2001.1172; COLEMAN NA, 1993, VIROLOGY, V195, P596, DOI 10.1006/viro.1993.1411; Connaris H, 2002, J VIROL, V76, P1816, DOI 10.1128/JVI.76.4.1816-1824.2002; Czegledi A, 2003, AVIAN PATHOL, V32, P271, DOI 10.1080/0307945031000097868; Czegledi A, 2006, VIRUS RES, V120, P36, DOI 10.1016/j.virusres.2005.11.009; de Leeuw O, 1999, J GEN VIROL, V80, P131, DOI 10.1099/0022-1317-80-1-131; Diel DG, 2012, INFECT GENET EVOL, V12, P1770, DOI 10.1016/j.meegid.2012.07.012; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Huang ZH, 2004, J VIROL, V78, P4176, DOI 10.1128/JVI.78.8.4176-4184.2004; IYER GS, 1945, INDIAN J VET SCI, V15, P155; Kapczynski DR, 2005, VACCINE, V23, P3424, DOI 10.1016/j.vaccine.2005.01.140; Kattenbelt JA, 2006, VIRUS RES, V116, P168, DOI 10.1016/j.virusres.2005.10.001; Khattar SK, 2009, J VIROL, V83, P7779, DOI 10.1128/JVI.00536-09; Krishnamurthy S, 1998, J GEN VIROL, V79, P2419, DOI 10.1099/0022-1317-79-10-2419; LANCASTER JE, 1962, CAN J COMP MED VET S, V26, P244; Li Z, 2005, J VIROL METHODS, V130, P154, DOI 10.1016/j.jviromet.2005.06.022; McGinnes LW, 2001, VIROLOGY, V289, P343, DOI 10.1006/viro.2001.1123; Miller PJ, 2007, VACCINE, V25, P7238, DOI 10.1016/j.vaccine.2007.07.017; Miller PJ, 2010, INFECT GENET EVOL, V10, P26, DOI 10.1016/j.meegid.2009.09.012; Mohamed MHA, 2009, VIRUS GENES, V39, P234, DOI 10.1007/s11262-009-0385-7; Morrison TG, 2003, BBA-BIOMEMBRANES, V1614, P73, DOI 10.1016/S0005-2736(03)00164-0; NAGAI Y, 1976, VIROLOGY, V72, P494, DOI 10.1016/0042-6822(76)90178-1; Nanthakumar T, 2000, AVIAN PATHOL, V29, P603, DOI 10.1080/713651205; Panda A, 2004, MICROB PATHOGENESIS, V36, P1, DOI 10.1016/j.micpath.2003.07.003; Ragavan VS, 1998, INDIAN VET J, V75, P1079; Romer-Oberdorfer A, 2006, AVIAN DIS, V50, P259, DOI 10.1637/7471-111505R.1; Romer-Oberdorfer A, 2003, J GEN VIROL, V84, P3121, DOI 10.1099/vir.0.19416-0; Rout SN, 2008, J VIROL, V82, P7828, DOI 10.1128/JVI.00578-08; SAKAGUCHI T, 1989, VIROLOGY, V169, P260, DOI 10.1016/0042-6822(89)90151-7; SCHUY W, 1984, VIRUS RES, V1, P415, DOI 10.1016/0168-1702(84)90027-3; SEETHARAMAN C., 1951, Indian Veterinary Journal, V28, P13; StoneHulslander J, 1997, J VIROL, V71, P6287, DOI 10.1128/JVI.71.9.6287-6295.1997; Tirumurugaan KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028414; Zanetti F, 2008, MICROB PATHOGENESIS, V44, P135, DOI 10.1016/j.micpath.2007.08.012	42	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98869	10.1371/journal.pone.0098869	http://dx.doi.org/10.1371/journal.pone.0098869			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897503	Green Published, Green Submitted, gold			2022-12-27	WOS:000338430700090
J	Guo, YL; Han, Y; Ma, J; Wang, HP; Sang, XC; Li, MY				Guo, Yulong; Han, Yao; Ma, Jing; Wang, Huiping; Sang, Xianchun; Li, Mingyang			Undesired Small RNAs Originate from an Artificial microRNA Precursor in Transgenic Petunia (Petunia hybrida)	PLOS ONE			English	Article							REAL-TIME PCR; ARABIDOPSIS-THALIANA; PLANT MICRORNAS; FLOWER DEVELOPMENT; BIOGENESIS; EXPRESSION; MIRNA; DISTINCT; TARGETS; GENES	Although artificial microRNA (amiRNA) technology has been used frequently in gene silencing in plants, little research has been devoted to investigating the accuracy of amiRNA precursor processing. In this work, amiRNAchs1 (amiRchs1), based on the Arabidopsis miR319a precursor, was expressed in order to suppress the expression of CHS genes in petunia. The transgenic plants showed the CHS gene-silencing phenotype. A modified 5' RACE technique was used to map small-RNA-directed cleavage sites and to detect processing intermediates of the amiRchs1 precursor. The results showed that the target CHS mRNAs were cut at the expected sites and that the amiRchs1 precursor was processed from loop to base. The accumulation of small RNAs in amiRchs1 transgenic petunia petals was analyzed using the deep-sequencing technique. The results showed that, alongside the accumulation of the desired artificial microRNAs, additional small RNAs that originated from other regions of the amiRNA precursor were also accumulated at high frequency. Some of these had previously been found to be accumulated at low frequency in the products of ath-miR319a precursor processing and some of them were accompanied by 3'-tailing variant. Potential targets of the undesired small RNAs were discovered in petunia and other Solanaceae plants. The findings draw attention to the potential occurrence of undesired target silencing induced by such additional small RNAs when amiRNA technology is used. No appreciable production of secondary small RNAs occurred, despite the fact that amiRchs1 was designed to have perfect complementarity to its CHS-J target. This confirmed that perfect pairing between an amiRNA and its targets is not the trigger for secondary small RNA production. In conjunction with the observation that amiRNAs with perfect complementarity to their target genes show high efficiency and specificity in gene silencing, this finding has an important bearing on future applications of amiRNAs in gene silencing in plants.	[Guo, Yulong; Han, Yao; Ma, Jing; Wang, Huiping; Li, Mingyang] Southwest Univ, Coll Hort & Landscape Architecture, Key Lab Hort Sci Southern Mountainous Reg, Chongqing Engn Res Ctr Floriculture,Minist Educ, Chongqing, Peoples R China; [Sang, Xianchun] Southwest Univ, Coll Agron & Biotechnol, Chongqing, Peoples R China	Southwest University - China; Southwest University - China	Li, MY (corresponding author), Southwest Univ, Coll Hort & Landscape Architecture, Key Lab Hort Sci Southern Mountainous Reg, Chongqing Engn Res Ctr Floriculture,Minist Educ, Chongqing, Peoples R China.	limy@swu.edu.cn	wang, hui/GRS-4730-2022	Guo, Yulong/0000-0003-0926-200X	National Natural Science Foundation of China [31272199]; Fundamental Research Funds for the Central Universities [2362014xk10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China (31272199, http://www.nsfc.gov.cn/) and Fundamental Research Funds for the Central Universities (2362014xk10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Alvarez JP, 2006, PLANT CELL, V18, P1134, DOI 10.1105/tpc.105.040725; Bologna NG, 2009, EMBO J, V28, P3646, DOI 10.1038/emboj.2009.292; De Paoli E, 2009, RNA, V15, P1965, DOI 10.1261/rna.1706109; Ehya F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066372; Eldem V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050298; Fang YD, 2007, CURR BIOL, V17, P818, DOI 10.1016/j.cub.2007.04.005; Fei QL, 2013, PLANT CELL, V25, P2400, DOI 10.1105/tpc.113.114652; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Haney CH, 2010, P NATL ACAD SCI USA, V107, P478, DOI 10.1073/pnas.0910081107; Hauser F, 2013, PLANT CELL, V25, P2848, DOI 10.1105/tpc.113.112805; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jorgensen RA, 1996, PLANT MOL BIOL, V31, P957, DOI 10.1007/BF00040715; Khraiwesh B, 2008, PLANT PHYSIOL, V148, P684, DOI 10.1104/pp.108.128025; KOES RE, 1990, PLANT CELL, V2, P379, DOI 10.1105/tpc.2.5.379; KOES RE, 1989, PLANT MOL BIOL, V12, P213, DOI 10.1007/BF00020506; Koseki M, 2005, PLANT CELL PHYSIOL, V46, P1879, DOI 10.1093/pcp/pci192; Liang G, 2010, PLANT J, V62, P1046, DOI 10.1111/j.1365-313X.2010.04216.x; Liu CG, 2012, PLANT PHYSIOL, V159, P748, DOI 10.1104/pp.112.193508; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Manavella PA, 2012, P NATL ACAD SCI USA, V109, P2461, DOI 10.1073/pnas.1200169109; Mateos JL, 2010, CURR BIOL, V20, P49, DOI 10.1016/j.cub.2009.10.072; Melito S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-104; Molnar A, 2009, PLANT J, V58, P165, DOI 10.1111/j.1365-313X.2008.03767.x; Niu QW, 2006, NAT BIOTECHNOL, V24, P1420, DOI 10.1038/nbt1255; Ossowski S, 2008, PLANT J, V53, P674, DOI 10.1111/j.1365-313X.2007.03328.x; Pant BD, 2008, PLANT J, V53, P731, DOI 10.1111/j.1365-313X.2007.03363.x; Parizotto EA, 2004, GENE DEV, V18, P2237, DOI 10.1101/gad.307804; Park W, 2009, PLANT CELL REP, V28, P469, DOI 10.1007/s00299-008-0651-5; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Rogers K, 2013, PLANT CELL, V25, P2383, DOI 10.1105/tpc.113.113159; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sobkowiak L, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00046; Song L, 2007, P NATL ACAD SCI USA, V104, P5437, DOI 10.1073/pnas.0701061104; Song L, 2010, CURR BIOL, V20, P37, DOI 10.1016/j.cub.2009.10.076; Sun GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032017; Sun PL, 2013, PLANT CELL, V25, P470, DOI 10.1105/tpc.112.106294; Szarzynska B, 2009, NUCLEIC ACIDS RES, V37, P3083, DOI 10.1093/nar/gkp189; Tedder P, 2009, RNA, V15, P1012, DOI 10.1261/rna.1517209; Toppino L, 2011, PLANT BIOTECHNOL J, V9, P684, DOI 10.1111/j.1467-7652.2010.00567.x; Tzfira T, 2005, PLANT MOL BIOL, V57, P503, DOI 10.1007/s11103-005-0340-5; Verdonk JC, 2013, BOTANY, V91, P117, DOI 10.1139/cjb-2012-0166; Warthmann N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001829; Werner S, 2010, CURR BIOL, V20, P42, DOI 10.1016/j.cub.2009.10.073; Xie ZX, 2005, PLANT PHYSIOL, V138, P2145, DOI 10.1104/pp.105.062943; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Zhai JX, 2013, PLANT CELL, V25, P2417, DOI 10.1105/tpc.113.114603; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhang WX, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r81; Zhao T, 2009, PLANT J, V58, P157, DOI 10.1111/j.1365-313X.2008.03758.x; Zhao YY, 2012, CURR BIOL, V22, P689, DOI 10.1016/j.cub.2012.02.051; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	56	10	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98783	10.1371/journal.pone.0098783	http://dx.doi.org/10.1371/journal.pone.0098783			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897430	Green Published, Green Submitted, gold			2022-12-27	WOS:000338430700076
J	Marth, K; Wollmann, E; Gallerano, D; Ndlovu, P; Makupe, I; Valenta, R; Sibanda, E				Marth, Katharina; Wollmann, Eva; Gallerano, Daniela; Ndlovu, Portia; Makupe, Ian; Valenta, Rudolf; Sibanda, Elopy			Persistence of IgE-Associated Allergy and Allergen-Specific IgE despite CD4+T Cell Loss in AIDS	PLOS ONE			English	Article							SERUM IGE; HIV; SENSITIZATION; INFECTION; INDIVIDUALS; REACTIVITY; ADULTS; T(H)2	The infection of CD4+ cells by HIV leads to the progressive destruction of CD4+ T lymphocytes and, after a severe reduction of CD4+ cells, to AIDS. The aim of the study was to investigate whether HIV-infected patients with CD4 cell counts <200 cells/mu l can suffer from symptoms of IgE-mediated allergy, produce allergen-specific IgE antibody responses and show boosts of allergen-specific IgE production. HIV-infected patients with CD4 counts <= 200 cells/mu l suffering from AIDS and from IgE-mediated allergy were studied. Allergy was diagnosed according to case history, physical examination, skin prick testing (SPT), and serological analyses including allergen microarrays. HIV infection was confirmed serologically and the disease was staged clinically. The predominant allergic symptoms in the studied patients were acute allergic rhinitis (73%) followed by asthma (27%) due to IgE-mediated mast cell activation whereas no late phase allergic symptoms such as atopic dermatitis, a mainly T cell-mediated skin manifestation, were found in patients suffering from AIDS. According to IgE serology allergies to house dust mites and grass pollen were most common besides IgE sensitizations to various food allergens. Interestingly, pollen allergen-specific IgE antibody levels in the patients with AIDS and in additional ten IgE-sensitized patients with HIV infections and low CD4 counts appeared to be boosted by seasonal allergen exposure and were not associated with CD4 counts. Our results indicate that secondary allergen-specific IgE production and IgE-mediated allergic inflammation do not require a fully functional CD4+ T lymphocyte repertoire.	[Marth, Katharina; Wollmann, Eva; Gallerano, Daniela; Valenta, Rudolf] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, Div Immunopathol, Vienna, Austria; [Marth, Katharina; Valenta, Rudolf] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, Christian Doppler Lab Allergy Res,Div Immunopatho, Vienna, Austria; [Ndlovu, Portia; Makupe, Ian; Sibanda, Elopy] Asthma Allergy & Immune Dysfunct Clin, Harare, Zimbabwe	Medical University of Vienna; Medical University of Vienna	Sibanda, E (corresponding author), Asthma Allergy & Immune Dysfunct Clin, Harare, Zimbabwe.	esibanda@africaonline.co.zw		Valenta, Rudolf/0000-0001-5944-3365; Rigler, Eva/0000-0002-3596-3937	Austrian Science Fund (FWF) [SFB F4605]; doctoral program IAI; Biomay AG, Vienna, Austria; Christian Doppler Research Association, Vienna, Austria	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); doctoral program IAI; Biomay AG, Vienna, Austria; Christian Doppler Research Association, Vienna, Austria	This study was supported by research grants from the Austrian Science Fund (FWF), SFB project F4605 and the doctoral program IAI, by research grants from Biomay AG, Vienna, Austria and the Christian Doppler Research Association, Vienna, Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castro KG, 1993, MMWR RECOMM REP, V4, P1; Durham SR, 2000, AM J RHINOL, V14, P305, DOI 10.2500/105065800781329492; Egger C, 2010, J ALLERGY CLIN IMMUN, V126, P1312, DOI 10.1016/j.jaci.2010.06.008; Goetz DW, 1997, ANN ALLERG ASTHMA IM, V78, P301, DOI 10.1016/S1081-1206(10)63186-9; GRAZIOSI C, 1994, SCIENCE, V265, P248, DOI 10.1126/science.8023143; Katelaris CH, 2012, CLIN EXP ALLERGY, V42, P186, DOI 10.1111/j.1365-2222.2011.03891.x; Kling S, 2013, SAMJ S AFR MED J, V103, P200, DOI [10.7196/SAMJ.6658, 10.7196/samj.6658]; LEVY JA, 1988, NATURE, V333, P519, DOI 10.1038/333519a0; Linhart B, 2007, J IMMUNOL, V178, P3924, DOI 10.4049/jimmunol.178.6.3924; Lupinek C, 2014, METHODS, V66, P106, DOI 10.1016/j.ymeth.2013.10.008; Lupinek C, 2012, J ALLERGY CLIN IMMUN, V130, P1418, DOI 10.1016/j.jaci.2012.06.028; MAGGI E, 1994, SCIENCE, V265, P244, DOI 10.1126/science.8023142; MAZZA DS, 1995, ANN ALLERG ASTHMA IM, V74, P411; Mpairwe H, 2008, T ROY SOC TROP MED H, V102, P367, DOI 10.1016/j.trstmh.2008.01.017; Niederberger V, 2007, INT ARCH ALLERGY IMM, V142, P133, DOI 10.1159/000096439; Obeng BB, 2011, INT ARCH ALLERGY IMM, V155, P63, DOI 10.1159/000318704; Romagnani S, 1997, IMMUNOL TODAY, V18, P263, DOI 10.1016/S0167-5699(97)80019-9; Rujeni N, 2012, INT ARCH ALLERGY IMM, V158, P288, DOI 10.1159/000332949; Schneider Eileen, 2008, Morbidity and Mortality Weekly Report, V57, P1; Sibanda E, 2012, EUR J IMMUNOL, V42, P1070, DOI 10.1002/eji.2012700025; Sibanda EN, 2003, INT ARCH ALLERGY IMM, V130, P2, DOI 10.1159/000068377; Suzuki K, 2009, J EXP MED, V206, P1485, DOI 10.1084/jem.20090209; Westritschnig K, 2003, CLIN EXP ALLERGY, V33, P22, DOI 10.1046/j.1365-2222.2003.01540.x; Zhang Y, 2013, J EXP MED, V210, P457, DOI 10.1084/jem.20120150	24	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e97893	10.1371/journal.pone.0097893	http://dx.doi.org/10.1371/journal.pone.0097893			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896832	Green Submitted, Green Published, gold			2022-12-27	WOS:000338430700018
J	Zhai, C; Zhang, Y; Yao, N; Lin, F; Liu, Z; Dong, ZQ; Wang, L; Pan, QH				Zhai, Chun; Zhang, Yu; Yao, Nan; Lin, Fei; Liu, Zhe; Dong, Zhongqiu; Wang, Ling; Pan, Qinghua			Function and Interaction of the Coupled Genes Responsible for Pik-h Encoded Rice Blast Resistance	PLOS ONE			English	Article							DISEASE-RESISTANCE; MAGNAPORTHE-ORYZAE; NUCLEAR ACCUMULATION; IMMUNE RECEPTORS; COILED-COIL; FLAX RUST; PROTEIN INTERACTIONS; DEFENSE RESPONSES; AVIRULENCE GENES; LRR PROTEIN	Pik-h, an allele of Pik, confers resistance against the rice blast pathogen Magnaporthe oryzae. Its positional cloning has shown that it comprises a pair of NBS-LRR genes, Pikh-1 and Pikh-2. While Pikh-1 appears to be constitutively transcribed, the transcript abundance of Pikh-2 responds to pathogen challenge. The Pikh-1 CC (coiled coil) domain interacts directly with both AvrPik-h and Pikh-2. Transient expression assays demonstrated that Pikh-2 mediates the initiation of the host defence response. Nucleocytoplasmic partitioning of both Pikh-1 and Pikh-2 is required for their functionalities. In a proposed mechanistic model of Pik-h resistance, it is suggested that Pikh-1 acts as an adaptor between AvrPik-h and Pikh-2, while Pikh-2 transduces the signal to trigger Pik-h-specific resistance.	[Zhai, Chun; Zhang, Yu; Lin, Fei; Dong, Zhongqiu; Wang, Ling; Pan, Qinghua] South China Agr Univ, Natl Key Lab Conservat & Utilizat Subtrop Agrobio, Guangzhou, Guangdong, Peoples R China; [Zhai, Chun; Zhang, Yu; Lin, Fei; Dong, Zhongqiu; Wang, Ling; Pan, Qinghua] South China Agr Univ, Guangdong Prov Key Lab Microbe Signals & Crop Dis, Guangzhou, Guangdong, Peoples R China; [Yao, Nan; Liu, Zhe] Sun Yat Sen Univ, Natl Key Lab Biocontrol, Coll Life Sci, Guangzhou 510275, Guangdong, Peoples R China	South China Agricultural University; South China Agricultural University; Sun Yat Sen University	Pan, QH (corresponding author), South China Agr Univ, Natl Key Lab Conservat & Utilizat Subtrop Agrobio, Guangzhou, Guangdong, Peoples R China.	panqh@scau.edu.cn	yao, nan/F-2095-2011	yao, nan/0000-0002-2045-5462	National Natural Science Foundation [U1131003, 30870102, 31170247]; National 973 Project [2011CB1007001]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National 973 Project(National Basic Research Program of China)	This research was carried out with financial support from the National Natural Science Foundation (U1131003; 30870102; 31170247) and the National 973 Project (2011CB1007001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ade J, 2007, P NATL ACAD SCI USA, V104, P2531, DOI 10.1073/pnas.0608779104; Ashikawa I, 2008, GENETICS, V180, P2267, DOI 10.1534/genetics.108.095034; Bernoux M, 2011, CELL HOST MICROBE, V9, P200, DOI 10.1016/j.chom.2011.02.009; Burch-Smith TM, 2007, PLOS BIOL, V5, P501, DOI 10.1371/journal.pbio.0050068; Caplan J, 2008, CELL HOST MICROBE, V3, P126, DOI 10.1016/j.chom.2008.02.010; Caplan JL, 2008, CELL, V132, P449, DOI 10.1016/j.cell.2007.12.031; Catanzariti AM, 2010, MOL PLANT MICROBE IN, V23, P49, DOI 10.1094/MPMI-23-1-0049; Cesari S, 2013, PLANT CELL, V25, P1463, DOI 10.1105/tpc.112.107201; Chen SB, 2006, MOL PLANT PATHOL, V7, P417, DOI 10.1111/j.1364-3703.2006.00346.x; Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; Chen Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002595; Cheng YT, 2009, PLANT CELL, V21, P2503, DOI 10.1105/tpc.108.064519; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; Dodds PN, 2006, P NATL ACAD SCI USA, V103, P8888, DOI 10.1073/pnas.0602577103; Eitas TK, 2010, CURR OPIN PLANT BIOL, V13, P472, DOI 10.1016/j.pbi.2010.04.007; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Frost D, 2004, MOL PLANT MICROBE IN, V17, P224, DOI 10.1094/MPMI.2004.17.2.224; Gao ZY, 2011, P NATL ACAD SCI USA, V108, P7619, DOI 10.1073/pnas.1104410108; Haasen D, 1999, PLANT J, V20, P695, DOI 10.1046/j.1365-313X.1999.00644.x; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Huitema E, 2005, MOL PLANT MICROBE IN, V18, P183, DOI 10.1094/MPMI-18-0183; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Kanzaki H, 2012, PLANT J, V72, P894, DOI 10.1111/j.1365-313X.2012.05110.x; KIYOSAWA S, 1982, ANNU REV PHYTOPATHOL, V20, P93, DOI 10.1146/annurev.py.20.090182.000521; Krasileva KV, 2010, PLANT CELL, V22, P2444, DOI 10.1105/tpc.110.075358; Lee SK, 2009, GENETICS, V181, P1627, DOI 10.1534/genetics.108.099226; Loutre C, 2009, PLANT J, V60, P1043, DOI 10.1111/j.1365-313X.2009.04024.x; Maekawa T, 2011, CELL HOST MICROBE, V9, P187, DOI 10.1016/j.chom.2011.02.008; Mang HG, 2012, PLANT CELL, V24, P1271, DOI 10.1105/tpc.112.096198; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Narusaka M, 2009, PLANT J, V60, P218, DOI 10.1111/j.1365-313X.2009.03949.x; Nombela G, 2003, MOL PLANT MICROBE IN, V16, P645, DOI 10.1094/MPMI.2003.16.7.645; Okuyama Y, 2011, PLANT J, V66, P467, DOI 10.1111/j.1365-313X.2011.04502.x; Peart JR, 2005, CURR BIOL, V15, P968, DOI 10.1016/j.cub.2005.04.053; Rairdan GJ, 2008, PLANT CELL, V20, P739, DOI 10.1105/tpc.107.056036; Ryu HS, 2006, PLANT CELL REP, V25, P836, DOI 10.1007/s00299-006-0138-1; Shen CJ, 2010, J EXP BOT, V61, P3971, DOI 10.1093/jxb/erq208; Shen CX, 2010, AM J BOT, V97, P1602, DOI 10.3732/ajb.1000073; Shen QH, 2007, SCIENCE, V315, P1098, DOI 10.1126/science.1136372; Sinapidou E, 2004, PLANT J, V38, P898, DOI 10.1111/j.1365-313X.2004.02099.x; Slootweg E, 2010, PLANT CELL, V22, P4195, DOI 10.1105/tpc.110.077537; Takken FLW, 2009, SCIENCE, V324, P744, DOI 10.1126/science.1171666; Takken FLW, 2006, CURR OPIN PLANT BIOL, V9, P383, DOI 10.1016/j.pbi.2006.05.009; Tameling WIL, 2002, PLANT CELL, V14, P2929, DOI 10.1105/tpc.005793; Tameling WIL, 2010, PLANT CELL, V22, P4176, DOI 10.1105/tpc.110.077461; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Wirthmueller L, 2007, CURR BIOL, V17, P2023, DOI 10.1016/j.cub.2007.10.042; Yahiaoui N, 2006, PLANT J, V47, P85, DOI 10.1111/j.1365-313X.2006.02772.x; Yoshida K, 2009, PLANT CELL, V21, P1573, DOI 10.1105/tpc.109.066324; Yuan B, 2011, THEOR APPL GENET, V122, P1017, DOI 10.1007/s00122-010-1506-3; Zhai C, 2011, NEW PHYTOL, V189, P321, DOI 10.1111/j.1469-8137.2010.03462.x	55	107	118	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98067	10.1371/journal.pone.0098067	http://dx.doi.org/10.1371/journal.pone.0098067			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896089	Green Published, gold			2022-12-27	WOS:000338430700022
J	Zheng, H; Wang, QF; Zhu, XJ; Li, YN; Yu, GR				Zheng, Han; Wang, Qiufeng; Zhu, Xianjin; Li, Yingnian; Yu, Guirui			Hysteresis Responses of Evapotranspiration to Meteorological Factors at a Diel Timescale: Patterns and Causes	PLOS ONE			English	Article							NET ECOSYSTEM EXCHANGE; TIBETAN PLATEAU; CARBON-DIOXIDE; WATER-VAPOR; TRANSPIRATION; AUSTRALIA; FLUX; CHINA; ASSIMILATION; CONDUCTANCE	Evapotranspiration (ET) is an important component of the water cycle in terrestrial ecosystems. Understanding the ways in which ET changes with meteorological factors is central to a better understanding of ecological and hydrological processes. In this study, we used eddy covariance measurements of ET from a typical alpine shrubland meadow ecosystem in China to investigate the hysteresis response of ET to environmental variables including air temperature (T-a), vapor pressure deficit (VPD) and net radiation (R-n) at a diel timescale. Meanwhile, the simulated ET by Priestly-Taylor equation was used to interpret the measured ET under well-watered conditions. Pronounced hysteresis was observed in both T-a and VPD response curves of ET. At a similar T-a and VPD, ET was always significantly depressed in the afternoon compared with the morning. But the hysteresis response of ET to R-n was not evident. Similar hysteresis patterns were also observed in the T-a/ VPD response curves of simulated ET. The magnitudes of the measured and simulated hysteresis loops showed similar seasonal variation, with relatively smaller values occurring from May to September, which agreed well with the lifetime of plants and the period of rainy season at this site. About 62% and 23% of changes in the strength of measured ET-T-a and ET-VPD loops could be explained by the changes in the strength of simulated loops, respectively. Thus, the time lag between R-n and T-a/VPD is the most important factor generating and modulating the ET-T-a/VPD hysteresis, but plants and water status also contribute to the hysteresis response of ET. Our research confirmed the different hysteresis in the responses of ET to meteorological factors and proved the vital role of Rn in driving the diel course of ET.	[Zheng, Han; Wang, Qiufeng; Zhu, Xianjin; Yu, Guirui] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Synth Res Ctr,Chinese Ecosyst Res Network, Beijing, Peoples R China; [Li, Yingnian] Chinese Acad Sci, Northwest Inst Plateau Biol, Xining, Peoples R China; [Zheng, Han; Zhu, Xianjin] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, QF (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Synth Res Ctr,Chinese Ecosyst Res Network, Beijing, Peoples R China.	qfwang@igsnrr.ac.cn; yugr@igsnrr.ac.cn	于, 贵瑞/C-1768-2014; wang, qiufeng/C-1654-2013; Zhu, XianJin/B-2779-2009	于, 贵瑞/0000-0002-1859-8966; Zhu, XianJin/0000-0002-5662-3472; Zheng, Han/0000-0002-0721-1594	Key program of National Natural Science Foundation of China [31290221]; National Basic Research Program [2010CB833504]; Remote Sensing Investigation and Assessment on National Ecological Environment Decade Changes program [STSN-02- 02]	Key program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); Remote Sensing Investigation and Assessment on National Ecological Environment Decade Changes program	This research was jointly supported by Key program of National Natural Science Foundation of China (Grant NO. 31290221), National Basic Research Program (Grant NO. 2010CB833504), and Remote Sensing Investigation and Assessment on National Ecological Environment Decade Changes (2000-2010) program (STSN-02-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldocchi D, 2001, B AM METEOROL SOC, V82, P2415, DOI 10.1175/1520-0477(2001)082<2415:FANTTS>2.3.CO;2; Chapin FS., 2011, PRINCIPLES TERRESTRI, V2nd ed.; Chen LX, 2011, J HYDROL, V402, P388, DOI 10.1016/j.jhydrol.2011.03.034; Eamus D, 1997, AUST J BOT, V45, P275, DOI 10.1071/BT96020; Falge E, 2001, AGR FOREST METEOROL, V107, P43, DOI 10.1016/S0168-1923(00)00225-2; Gu S, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009173; Gwenzi W, 2012, HYDROL PROCESS, V26, P3281, DOI 10.1002/hyp.8330; Hu ZM, 2009, AGR FOREST METEOROL, V149, P1410, DOI 10.1016/j.agrformet.2009.03.014; Jarvis PG, 1986, ADV ECOL RES, V15, P49; Jasechko S, 2013, NATURE, V496, P347, DOI 10.1038/nature11983; Klein JA, 2004, ECOL LETT, V7, P1170, DOI 10.1111/j.1461-0248.2004.00677.x; [李英年 Li Yingnian], 2003, [山地学报, Journal of Mountain Science], V21, P257; [李英年 Li Yingnian], 2004, [高原气象, Plateau Meteorology], V23, P558; Li ZQ, 2004, SCI CHINA SER D, V34, P46, DOI [10.1360/zd2004-34-S2-46, DOI 10.1360/ZD2004-34-S2-46]; Liu HZ, 2012, J APPL METEOROL CLIM, V51, P1875, DOI 10.1175/JAMC-D-11-0229.1; Lu N, 2011, J PLANT ECOL, V4, P49, DOI 10.1093/jpe/rtq035; Meinzer FC, 1997, PLANT CELL ENVIRON, V20, P1301, DOI 10.1046/j.1365-3040.1997.d01-18.x; O'Brien JJ, 2004, PLANT CELL ENVIRON, V27, P551, DOI 10.1111/j.1365-3040.2003.01160.x; O'Grady AP, 2008, AGR FOREST METEOROL, V148, P453, DOI 10.1016/j.agrformet.2007.10.006; O'Grady AP, 1999, TREE PHYSIOL, V19, P591; Pan RZ, 2008, PLANT PHYSL; PRIESTLEY CHB, 1972, MON WEATHER REV, V100, P81, DOI 10.1175/1520-0493(1972)100<0081:OTAOSH>2.3.CO;2; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Seneviratne SI, 2010, EARTH-SCI REV, V99, P125, DOI 10.1016/j.earscirev.2010.02.004; Unsworth MH, 2004, ECOSYSTEMS, V7, P468, DOI 10.1007/s10021-004-0138-3; Wang J, 2009, POWDER DIFFR, V24, P24, DOI 10.1154/1.3079687; Wang KC, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000373; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; Wever LA, 2002, AGR FOREST METEOROL, V112, P31, DOI 10.1016/S0168-1923(02)00041-2; Wilson KB, 2000, AGR FOREST METEOROL, V100, P1, DOI 10.1016/S0168-1923(99)00088-X; Yu Gui-Rui, 1996, Journal of Agricultural Meteorology, V52, P311; Yu GR, 2006, SCI CHINA SER D, V49, P1, DOI 10.1007/s11430-006-8001-3; Zeppel MJB, 2004, FUNCT PLANT BIOL, V31, P461, DOI 10.1071/FP03220; Zhang Q, 2014, J GEOPHYS RES-BIOGEO, V119, P125, DOI 10.1002/2013JG002484; Zhao L, 2005, J INTEGR PLANT BIOL, V47, P271, DOI 10.1111/j.1744-7909.2005.00066.x; Zheng CL, 2014, ECOHYDROLOGY, V7, P56, DOI 10.1002/eco.1321	36	36	41	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98857	10.1371/journal.pone.0098857	http://dx.doi.org/10.1371/journal.pone.0098857			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896829	Green Published, gold			2022-12-27	WOS:000338430700087
J	Belka, M; Hewelt-Belka, W; Slawinski, J; Baczek, T				Belka, Mariusz; Hewelt-Belka, Weronika; Slawinski, Jaroslaw; Baczek, Tomasz			Mass Spectrometry Based Identification of Geometric Isomers during Metabolic Stability Study of a New Cytotoxic Sulfonamide Derivatives Supported by Quantitative Structure-Retention Relationships	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; SPRAGUE-DAWLEY RATS; ANTITUMOR-ACTIVITY; DRUG DISCOVERY; 4-CHLORO-2-MERCAPTO-5-METHYLBENZENESULFONAMIDE DERIVATIVES; BENZENSULFONAMIDE DERIVATIVES; PHYSIOCHEMICAL PROPERTIES; MOLECULAR DESCRIPTORS; CYTOCHROME P4502C9; TISSUE DISPOSITION	A set of 15 new sulphonamide derivatives, presenting antitumor activity have been subjected to a metabolic stability study. The results showed that besides products of biotransformation, some additional peaks occurred in chromatograms. Tandem mass spectrometry revealed the same mass and fragmentation pathway, suggesting that geometric isomerization occurred. Thus, to support this hypothesis, quantitative structure-retention relationships were applied. Human liver microsomes were used as an in vitro model of metabolism. The biotransformation reactions were tracked by liquid chromatography assay and additionally, fragmentation mass spectra were recorded. In silico molecular modeling at a semi-empirical level was conducted as a starting point for molecular descriptor calculations. A quantitative structure-retention relationship model was built applying multiple linear regression based on selected three-dimensional descriptors. The studied compounds revealed high metabolic stability, with a tendency to form hydroxylated biotransformation products. However, significant chemical instability in conditions simulating human body fluids was noticed. According to literature and MS data geometrical isomerization was suggested. The developed in sillico model was able to describe the relationship between the geometry of isomer pairs and their chromatographic retention properties, thus it supported the hypothesis that the observed pairs of peaks are most likely geometric isomers. However, extensive structural investigations are needed to fully identify isomers' geometry. An effort to describe MS fragmentation pathways of novel chemical structures is often not enough to propose structures of potent metabolites and products of other chemical reactions that can be observed in compound solutions at early drug discovery studies. The results indicate that the relatively non-expensive and not time-and labor-consuming in sillico approach could be a good supportive tool assisting the identification of cis-trans isomers based on retention data. This methodology can be helpful during the structural identification of biotransformation and degradation products of new chemical entities - potential new drugs.	[Belka, Mariusz; Baczek, Tomasz] Med Univ Gdansk, Fac Pharm, Dept Pharmaceut Chem, Gdansk, Poland; [Hewelt-Belka, Weronika] Gdansk Univ Technol, Fac Chem, Dept Analyt Chem, Gdansk, Poland; [Hewelt-Belka, Weronika] Pomeranian Sci & Technol Pk, Mass Spectrometry & Chromatog Lab, Gdynia, Poland; [Slawinski, Jaroslaw] Med Univ Gdansk, Fac Pharm, Dept Organ Chem, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Gdansk University of Technology; Fahrenheit Universities; Medical University Gdansk	Baczek, T (corresponding author), Med Univ Gdansk, Fac Pharm, Dept Pharmaceut Chem, Gdansk, Poland.	tbaczek@gumed.edu.pl	Baczek, Tomasz/K-6467-2018; Hewelt-Belka, Weronika/ABF-1232-2021; Belka, Mariusz/AAQ-8911-2020; Belka, Mariusz/M-6288-2018; Hewelt-Belka, Weronika/X-9907-2019	Baczek, Tomasz/0000-0001-6468-1974; Hewelt-Belka, Weronika/0000-0002-1990-2130; Belka, Mariusz/0000-0003-4413-1080; 	Polish National Science Centre [UMO-2011/01/N/NZ1/00214, UMO-2011/03/B/NZ1/03113]; National Science Centre [UMO-2013/08/T/NZ1/00764]; system project "InnoDoktorant - Scholarships for PhD students, Vth edition"; European Union; quality-promoting subsidy under the KNOW programme	Polish National Science Centre; National Science Centre(National Science Centre, Poland); system project "InnoDoktorant - Scholarships for PhD students, Vth edition"; European Union(European Commission); quality-promoting subsidy under the KNOW programme	The project was funded by the Polish National Science Centre granted under decision no. UMO-2011/01/N/NZ1/00214 and UMO-2011/03/B/NZ1/03113. M. B has obtained funding for the preparation of a doctoral dissertation from the National Science Centre under decision no. UMO-2013/08/T/NZ1/00764. This research work was supported by the system project "InnoDoktorant - Scholarships for PhD students, Vth edition". The project was co-financed by the European Union in the frame of the European Social Fund supported by funds obtained from the quality-promoting subsidy under the KNOW programme 2012 - 2017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baczek T, 2005, J PROTEOME RES, V4, P555, DOI 10.1021/pr049780r; Baranczewski P, 2006, PHARMACOL REP, V58, P453; Baranczewski P, 2006, PHARMACOL REP, V58, P341; Belka M, 2013, MED CHEM, V9, P517, DOI 10.2174/1573406411309040005; Belka M, 2012, LETT DRUG DES DISCOV, V9, P288, DOI 10.2174/157018012799129945; Beumer JH, 2005, INVEST NEW DRUG, V23, P317, DOI 10.1007/s10637-005-1440-4; Bodzioch K, 2010, TALANTA, V81, P1711, DOI 10.1016/j.talanta.2010.03.028; Boobis A, 2002, EUR J PHARM SCI, V17, P183, DOI 10.1016/S0928-0987(02)00185-9; Boyer S, 2007, J CHEM INF MODEL, V47, P583, DOI 10.1021/ci600376q; Brozewicz K, 2012, MONATSH CHEM, V143, P975, DOI 10.1007/s00706-012-0732-6; Carta F, 2012, EXPERT OPIN THER PAT, V22, P747, DOI 10.1517/13543776.2012.698264; Casini A, 2002, CURR CANCER DRUG TAR, V2, P55, DOI 10.2174/1568009023334060; Cheng FX, 2012, J CHEM INF MODEL, V52, P3099, DOI 10.1021/ci300367a; Consonni V, 2002, J CHEM INF COMP SCI, V42, P682, DOI 10.1021/ci015504a; Creek DJ, 2011, ANAL CHEM, V83, P8703, DOI 10.1021/ac2021823; Dagliyan O, 2009, J CHEM INF MODEL, V49, P2403, DOI 10.1021/ci900247t; Dugave C, 2003, CHEM REV, V103, P2475, DOI 10.1021/cr0104375; Fox T, 2006, CURR TOP MED CHEM, V6, P1579, DOI 10.2174/156802606778108915; Greene N, 1999, SAR QSAR ENVIRON RES, V10, P299, DOI 10.1080/10629369908039182; Hakk H, 2006, XENOBIOTICA, V36, P79, DOI 10.1080/00498250500491675; Hakk H, 2004, CHEMOSPHERE, V54, P1367, DOI 10.1016/j.chemosphere.2003.10.032; Hennemann M, 2009, CHEMMEDCHEM, V4, P657, DOI 10.1002/cmdc.200800384; Kaliszan R, 2005, PROTEOMICS, V5, P409, DOI 10.1002/pmic.200400973; Keisner SV, 2011, DRUGS, V71, P443, DOI 10.2165/11588960-000000000-00000; Kirchmair J, 2012, J CHEM INF MODEL, V52, P617, DOI 10.1021/ci200542m; Kovarikova P, 2008, J PHARMACEUT BIOMED, V48, P295, DOI 10.1016/j.jpba.2007.12.017; Levsel K, 2007, J MASS SPECTROM, V42, P1024, DOI 10.1002/jms.1234; Liu RF, 2012, J CHEM INF MODEL, V52, P1698, DOI 10.1021/ci3001524; Mansuy D, 1998, COMP BIOCHEM PHYS C, V121, P5, DOI 10.1016/S0742-8413(98)10026-9; Naritomi Y, 2001, DRUG METAB DISPOS, V29, P1316; Nasal A, 2002, J SEP SCI, V25, P273, DOI 10.1002/1615-9314(20020401)25:5/6<273::AID-JSSC273>3.0.CO;2-5; Nassar AEF, 2004, DRUG DISCOV TODAY, V9, P317, DOI 10.1016/S1359-6446(03)03018-6; Prakash C, 2007, MASS SPECTROM REV, V26, P340, DOI 10.1002/mas.20128; Schuster Daniela, 2006, Curr Drug Discov Technol, V3, P1, DOI 10.2174/157016306776637609; Slawinski J, 2007, POL J CHEM, V81, P1433; Slawinski J, 2004, EUR J MED CHEM, V39, P179, DOI 10.1016/j.ejmech.2003.09.013; Slawinski J, 2013, J ENZYM INHIB MED CH, V28, P41, DOI 10.3109/14756366.2011.625024; Slawinski J, 2012, MONATSH CHEM, V143, P1705, DOI 10.1007/s00706-012-0849-7; Supuran CT, 2012, WORLD J CLIN ONCOL, V3, P98, DOI 10.5306/wjco.v3.i7.98; Sykes MJ, 2008, J MED CHEM, V51, P780, DOI 10.1021/jm7009793; Terhorst JP, 2010, J CHEM THEORY COMPUT, V6, P2762, DOI 10.1021/ct1004017; Todeschini R, 2009, MOL DESCRIPTORS CHEM; Tolonen A, 2009, DRUG DISCOV TODAY, V14, P120, DOI 10.1016/j.drudis.2008.11.002; Tyrkko E, 2012, ANAL CHIM ACTA, V720, P142, DOI 10.1016/j.aca.2012.01.024; Wang S, 2011, CHEMOSPHERE, V85, P379, DOI 10.1016/j.chemosphere.2011.07.002; Wiczling P, 2008, J CHROMATOGR A, V1214, P109, DOI 10.1016/j.chroma.2008.10.085; Zamora I, 2003, J MED CHEM, V46, P2313, DOI 10.1021/jm021104i; Zandvliet AS, 2007, CLIN CANCER RES, V13, P2970, DOI 10.1158/1078-0432.CCR-06-2978; Zhu MS, 2006, DRUG METAB DISPOS, V34, P1722, DOI 10.1124/dmd.106.009241	49	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98096	10.1371/journal.pone.0098096	http://dx.doi.org/10.1371/journal.pone.0098096			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893169	Green Submitted, Green Published, gold			2022-12-27	WOS:000336911400034
J	Montgomery, AL; Fadel, S; Kumar, R; Bondy, S; Moineddin, R; Jha, P				Montgomery, Ann L.; Fadel, Shaza; Kumar, Rajesh; Bondy, Sue; Moineddin, Rahim; Jha, Prabhat			The Effect of Health-Facility Admission and Skilled Birth Attendant Coverage on Maternal Survival in India: A Case-Control Analysis	PLOS ONE			English	Article							OBSTETRIC CARE; MORTALITY; DEATHS; MORBIDITY; PREGNANCY; INTERVENTIONS; SERVICES; SMOKING; NEWBORN; QUALITY	Background: Research in areas of low skilled attendant coverage found that maternal mortality is paradoxically higher in women who seek obstetric care. We estimated the effect of health-facility admission on maternal survival, and how this effect varies with skilled attendant coverage across India. Methods/Findings: Using unmatched population-based case-control analysis of national datasets, we compared the effect of health-facility admission at any time (antenatal, intrapartum, postpartum) on maternal deaths (cases) to women reporting pregnancies (controls). Probability of maternal death decreased with increasing skilled attendant coverage, among both women who were and were not admitted to a health-facility, however, the risk of death among women who were admitted was higher (at 50% coverage, OR = 2.32, 95% confidence interval 1.85-2.92) than among those women who were not; while at higher levels of coverage, the effect of health-facility admission was attenuated. In a secondary analysis, the probability of maternal death decreased with increasing coverage among both women admitted for delivery or delivered at home but there was no effect of admission for delivery on mortality risk (50% coverage, OR = 1.0, 0.80-1.25), suggesting that poor quality of obstetric care may have attenuated the benefits of facility-based care. Subpopulation analysis of obstetric hemorrhage cases and report of 'excessive bleeding' in controls showed that the probability of maternal death decreased with increasing skilled attendant coverage; but the effect of health-facility admission was attenuated (at 50% coverage, OR = 1.47, 0.95-1.79), suggesting that some of the effect in the main model can be explained by women arriving at facility with complications underway. Finally, highest risk associated with health-facility admission was clustered in women with education <= 8 years. Conclusions: The effect of health-facility admission did vary by skilled attendant coverage, and this effect appears to be driven partially by reverse causality; however, inequitable access to and possibly poor quality of healthcare for primary and emergency services appears to play a role in maternal survival as well.	[Montgomery, Ann L.; Fadel, Shaza; Jha, Prabhat] St Michael Hosp, Ctr Global Hlth Res, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Kumar, Rajesh] Post Grad Inst Med Educ, Sch Publ Hlth, Chandigarh, India; [Bondy, Sue; Jha, Prabhat] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 1A1, Canada; [Moineddin, Rahim] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Moineddin, Rahim] Inst Clin Evaluat Sci, Toronto, ON, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; University of Toronto; University of Toronto; University of Toronto	Montgomery, AL (corresponding author), St Michael Hosp, Ctr Global Hlth Res, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.	cghr@smh.on.ca	; Bondy, Susan/C-6737-2014	Fadel, Shaza/0000-0002-2336-6254; Bondy, Susan/0000-0002-6516-4159				Adisasmita Asri, 2008, BMC Pregnancy Childbirth, V8, P10, DOI 10.1186/1471-2393-8-10; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Balabanova D, 2013, LANCET, V381, P2118, DOI 10.1016/S0140-6736(12)62000-5; Bang RA, 2004, BJOG-INT J OBSTET GY, V111, P231, DOI 10.1111/j.1471-0528.2004.00063.x; Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Betran AP, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-131; Brentlinger PE, 2005, SOC SCI MED, V61, P1001, DOI 10.1016/j.socscimed.2004.12.022; Collin Simon M, 2007, Int J Equity Health, V6, P9, DOI 10.1186/1475-9276-6-9; CORNFIELD J, 1951, J NATL CANCER I, V11, P1269; Crowe S, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-4; Das J, 2007, HEALTH AFFAIR, V26, pW338, DOI 10.1377/hlthaff.26.3.w338; De Vries R, 2006, SOC SCI MED, V62, P2694, DOI 10.1016/j.socscimed.2005.11.026; Filippi V, 2005, ACTA OBSTET GYN SCAN, V84, P11, DOI 10.1111/j.0001-6349.2005.00636.x; Filippi V, 2000, STUD FAMILY PLANN, V31, P309, DOI 10.1111/j.1728-4465.2000.00309.x; Finlayson K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001373; Fournier P, 2009, B WORLD HEALTH ORGAN, V87, P30, DOI 10.2471/BLT.07.047076; Goli S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058573; Graham W.J., 2001, SAFE MOTHERHOOD STRA, P97; Graham WJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001368; Haththotuwa R, 2012, INT J GYNECOL OBSTET, V119, pS45, DOI 10.1016/j.ijgo.2012.03.016; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Hernan MA, 2013, CASUAL INFERENCE; Hernan MA, 2011, EPIDEMIOLOGY, V22, P368, DOI 10.1097/EDE.0b013e3182109296; Horton R, 2011, LANCET, V377, P181, DOI 10.1016/S0140-6736(10)62179-4; Hulton LA, 2007, SOC SCI MED, V64, P2083, DOI 10.1016/j.socscimed.2007.01.019; International Institute for Population Sciences (IIPS) Government of India., 2006, REPR CHILD HLTH DIST; Iyengar K, 2009, J HEALTH POPUL NUTR, V27, P293; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Loudon I, 1992, DEATH CHILDBIRTH ILL; McClure EM, 2007, INT J GYNECOL OBSTET, V96, P139, DOI 10.1016/j.ijgo.2006.10.010; Midhet F, 1998, SOC SCI MED, V46, P1587, DOI 10.1016/S0277-9536(97)10137-X; MIETTINEN O, 1976, AM J EPIDEMIOL, V103, P226, DOI 10.1093/oxfordjournals.aje.a112220; Montgomery AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033075; Montgomery AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014637; More NS, 2011, GLOB PUBLIC HEALTH, V6, P746, DOI 10.1080/17441692.2010.520725; Padmanaban P, 2009, J HEALTH POPUL NUTR, V27, P202; Pathak PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013593; Rabe-Hesketh S., 2012, MULTILEVEL LONGITUDI; Raj SS, 2013, GLOB HEALTH-SCI PRAC, V1, P84, DOI 10.9745/GHSP-D-12-00049; Rao M, 2011, LANCET, V377, P587, DOI 10.1016/S0140-6736(10)61888-0; RGI, 2010, SAMPL REG SYST; RGI, 2011, SPEC B MAT MORT IND; Ronsmans C, 2003, TROP MED INT HEALTH, V8, P940, DOI 10.1046/j.1365-3156.2003.01111.x; Ronsmans C, 2009, B WORLD HEALTH ORGAN, V87, P416, DOI 10.2471/BLT.08.051581; Ronsmans C, 2010, B WORLD HEALTH ORGAN, V88, P289, DOI 10.2471/BLT.09.069385; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Rubin DB, 2004, MULTIPLE IMPUTATION; Scott S, 2009, TROP MED INT HEALTH, V14, P1523, DOI 10.1111/j.1365-3156.2009.02402.x; Shiffman J, 2007, BJOG-INT J OBSTET GY, V114, P785, DOI 10.1111/j.1471-0528.2007.01374.x; Singh A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030947, 10.1371/journal.pone.0044728, 10.1371/journal.pone.0039812, 10.1371/journal.pone.0044931]; Sinha D, 2006, 7 CTR GLOB HLTH RES; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; Sri S, 2011, MATERNAL DEATHS DENI; Stapinski LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078323; Starfield B, 2007, SOC SCI MED, V64, P1355, DOI 10.1016/j.socscimed.2006.11.027; Victora CG, 2000, B WORLD HEALTH ORGAN, V78, P1246; WHO, 2012, WHO GLOB HLTH EXP AT; World Health Organization, 2006, QUAL CAR PROC MAK ST; World Health Organization, 1994, INT STAT CLASS DIS R; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990	62	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e95696	10.1371/journal.pone.0095696	http://dx.doi.org/10.1371/journal.pone.0095696			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI6CB	24887586	Green Submitted, Green Published, gold			2022-12-27	WOS:000336956300007
J	Lamarca, A; Gella, A; Martianez, T; Segura, M; Figueiro-Silva, J; Grijota-Martinez, C; Trullas, R; Casals, N				Lamarca, Aloa; Gella, Alejandro; Martianez, Tania; Segura, Monica; Figueiro-Silva, Joana; Grijota-Martinez, Carmen; Trullas, Ramon; Casals, Nuria			Uridine 5 '-Triphosphate Promotes In Vitro Schwannoma Cell Migration through Matrix Metalloproteinase-2 Activation	PLOS ONE			English	Article							RAT SCIATIC-NERVE; PERIPHERAL-NERVE; P2Y RECEPTORS; PROTEIN-KINASES; GROWTH-FACTOR; UP-REGULATION; SIGNALING MOLECULE; BASEMENT-MEMBRANE; MAP KINASES; INJURY	In response to peripheral nerve injury, Schwann cells adopt a migratory phenotype and modify the extracellular matrix to make it permissive for cell migration and axonal re-growth. Uridine 5'-triphosphate (UTP) and other nucleotides are released during nerve injury and activate purinergic receptors expressed on the Schwann cell surface, but little is known about the involvement of purine signalling in wound healing. We studied the effect of UTP on Schwannoma cell migration and wound closure and the intracellular signaling pathways involved. We found that UTP treatment induced Schwannoma cell migration through activation of P2Y(2) receptors and through the increase of extracellular matrix metalloproteinase-2 (MMP-2) activation and expression. Knockdown P2Y(2) receptor or MMP-2 expression greatly reduced wound closure and MMP-2 activation induced by UTP. MMP-2 activation evoked by injury or UTP was also mediated by phosphorylation of all 3 major mitogen-activated protein kinases (MAPKs): JNK, ERK1/2, and p38. Inhibition of these MAPK pathways decreased both MMP-2 activation and cell migration. Interestingly, MAPK phosphorylation evoked by UTP exhibited a biphasic pattern, with an early transient phosphorylation 5 min after treatment, and a late and sustained phosphorylation that appeared at 6 h and lasted up to 24 h. Inhibition of MMP-2 activity selectively blocked the late, but not the transient, phase of MAPK activation. These results suggest that MMP-2 activation and late MAPK phosphorylation are part of a positive feedback mechanism to maintain the migratory phenotype for wound healing. In conclusion, our findings show that treatment with UTP stimulates in vitro Schwannoma cell migration and wound repair through a MMP-2-dependent mechanism via P2Y(2) receptors and MAPK pathway activation.	[Lamarca, Aloa; Gella, Alejandro; Martianez, Tania; Segura, Monica; Grijota-Martinez, Carmen; Casals, Nuria] Univ Int Catalunya, Fac Med, Dept Basic Sci, Sant Cugat Del Valles, Spain; [Figueiro-Silva, Joana; Trullas, Ramon] CSIC, Inst Invest Biomed Pi & Sunyer, Neurobiol Unit, Inst Invest Biomed Barcelona, Barcelona, Spain; [Casals, Nuria] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain	Universitat Internacional de Catalunya (UIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Gella, A (corresponding author), Univ Int Catalunya, Fac Med, Dept Basic Sci, Sant Cugat Del Valles, Spain.	alexgella@gmail.com	Casals, Nuria/L-3378-2014; Trullas, Ramon/D-2197-2016; Gella, Alejandro/H-3845-2019; LAMARCA DAMS, ALOA/Q-4765-2017; Grijota-Martinez, Carmen/P-5093-2017	Casals, Nuria/0000-0002-6719-4300; Trullas, Ramon/0000-0001-7951-9881; Gella, Alejandro/0000-0002-3983-1392; LAMARCA DAMS, ALOA/0000-0001-8324-3195; Grijota-Martinez, Carmen/0000-0003-2656-9062	Ferrer S.A. (Barcelona, Spain); Ministerio de Economia y Competitividad of Spain [SAF2011-23550]	Ferrer S.A. (Barcelona, Spain); Ministerio de Economia y Competitividad of Spain(Spanish Government)	This research was supported by an unrestricted research grant from Ferrer S.A. (Barcelona, Spain) and by grant SAF2011-23550 from Ministerio de Economia y Competitividad of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 2009, TRENDS NEUROSCI, V32, P19, DOI 10.1016/j.tins.2008.10.001; Ando K, 2010, J PHARMACOL EXP THER, V334, P809, DOI 10.1124/jpet.110.167528; Arai K, 2003, GLIA, V43, P254, DOI 10.1002/glia.10255; Ben Yebdri F, 2009, EUR J IMMUNOL, V39, P2885, DOI 10.1002/eji.200939347; Birchmeier C, 2008, GLIA, V56, P1491, DOI 10.1002/glia.20753; Boucher I, 2007, EXP EYE RES, V85, P130, DOI 10.1016/j.exer.2007.03.009; Boucher I, 2010, AM J PHYSIOL-CELL PH, V299, pC411, DOI 10.1152/ajpcell.00100.2009; Braun OO, 2010, J MOL CELL CARDIOL, V49, P362, DOI 10.1016/j.yjmcc.2010.05.001; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Brunet A, 1996, SCIENCE, V272, P1652, DOI 10.1126/science.272.5268.1652; Carroll SL, 1997, J NEUROSCI, V17, P1642; Chang C, 2001, TRENDS CELL BIOL, V11, pS37, DOI 10.1016/S0962-8924(01)82222-4; Chattopadhyay S, 2009, GLIA, V57, P1316, DOI 10.1002/glia.20851; Cheng C, 2002, NEUROSCIENCE, V115, P321, DOI 10.1016/S0306-4522(02)00291-9; DAVIS RJ, 1995, MOL REPROD DEV, V42, P459, DOI 10.1002/mrd.1080420414; Demestre M, 2004, NEUROSCIENCE, V124, P767, DOI 10.1016/j.neuroscience.2003.12.037; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Ferguson TA, 2000, MOL CELL NEUROSCI, V16, P157, DOI 10.1006/mcne.2000.0859; Ferreira R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062345; Fields RD, 2000, TRENDS NEUROSCI, V23, P625, DOI 10.1016/S0166-2236(00)01674-X; Gerevich Zoltan, 2004, Purinergic Signal, V1, P3, DOI 10.1007/s11302-004-4740-9; Griffin JW, 2010, EXP NEUROL, V223, P60, DOI 10.1016/j.expneurol.2009.12.033; Gurjar MV, 2001, AM J PHYSIOL-HEART C, V281, pH2568, DOI 10.1152/ajpheart.2001.281.6.H2568; He Y, 2010, NAT NEUROSCI, V13, P1472, DOI 10.1038/nn.2686; HEUMANN R, 1987, P NATL ACAD SCI USA, V84, P8735, DOI 10.1073/pnas.84.23.8735; Hossain S, 2012, GLIA, V60, P1130, DOI 10.1002/glia.22340; Hsu JYC, 2006, J NEUROSCI, V26, P9841, DOI 10.1523/JNEUROSCI.1993-06.2006; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kaempchen K, 2003, HUM MOL GENET, V12, P1211, DOI 10.1093/hmg/ddg146; KENNEDY C, 1985, BLOOD VESSELS, V22, P145; Kherif S, 1998, NEUROPATH APPL NEURO, V24, P309; Kim MS, 2003, CANCER RES, V63, P5454; Klepeis VE, 2004, J CELL BIOCHEM, V93, P1115, DOI 10.1002/jcb.20258; KREIDER BQ, 1981, BRAIN RES, V207, P433, DOI 10.1016/0006-8993(81)90375-9; Krekoski CA, 2002, J NEUROSCI, V22, P10408; LaFleur M, 1996, J EXP MED, V184, P2311; Lakka SS, 2000, CLIN EXP METASTAS, V18, P245, DOI 10.1023/A:1006724826083; Lazarowski ER, 1999, BRIT J PHARMACOL, V127, P1272, DOI 10.1038/sj.bjp.0702654; Lehmann HC, 2009, GLIA, V57, P479, DOI 10.1002/glia.20774; Leppert D, 1999, NEUROLOGY, V53, P62, DOI 10.1212/WNL.53.1.62; Li SH, 2005, J CELL BIOL, V169, P179, DOI 10.1083/jcb.200501098; Li WH, 2013, BRIT J CANCER, V109, P1666, DOI 10.1038/bjc.2013.484; Lien SC, 2006, CELL SIGNAL, V18, P1270, DOI 10.1016/j.cellsig.2005.10.013; Mantuano E, 2008, J NEUROSCI, V28, P11571, DOI 10.1523/JNEUROSCI.3053-08.2008; Martianez T, 2013, PURINERG SIGNAL, V9, P259, DOI 10.1007/s11302-012-9348-x; Martianez T, 2012, PROTEOMICS, V12, P145, DOI 10.1002/pmic.201100187; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Newbern JM, 2011, NEURON, V69, P91, DOI 10.1016/j.neuron.2010.12.003; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pillois X, 2002, CIRC RES, V90, P678, DOI 10.1161/01.RES.0000013700.98464.8E; Pintor J, 2004, OPHTHAL PHYSL OPT, V24, P186, DOI 10.1111/j.1475-1313.2004.00182.x; Platt CI, 2003, J NEUROSCI RES, V74, P417, DOI 10.1002/jnr.10783; Ralevic V, 1998, PHARMACOL REV, V50, P413; Rodriguez-Zayas AE, 2010, INT J DEV NEUROSCI, V28, P413, DOI 10.1016/j.ijdevneu.2010.07.001; Santiago-Perez LI, 2001, J CELL PHYSIOL, V187, P196, DOI 10.1002/jcp.1063; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Sheu JY, 2000, EXP NEUROL, V166, P392, DOI 10.1006/exnr.2000.7508; Shubayev VI, 2000, BRAIN RES, V855, P83, DOI 10.1016/S0006-8993(99)02321-5; Van Kolen Kristof, 2006, Purinergic Signal, V2, P451, DOI 10.1007/s11302-006-9008-0; Vazquez-Cuevas FG, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-88; von Kugelgen I, 2006, PHARMACOL THERAPEUT, V110, P415, DOI 10.1016/j.pharmthera.2005.08.014; von Kugelgen I, 2000, N-S ARCH PHARMACOL, V362, P310, DOI 10.1007/s002100000310; Wanner IB, 2002, J NEUROSCI, V22, P4066, DOI 10.1523/JNEUROSCI.22-10-04066.2002; Weinger Ilene, 2005, Purinergic Signal, V1, P281, DOI 10.1007/s11302-005-8132-6; Weisman GA, 2012, PURINERG SIGNAL, V8, P559, DOI 10.1007/s11302-012-9307-6; Wildman SS, 2003, BRIT J PHARMACOL, V140, P1177, DOI 10.1038/sj.bjp.0705544; Woodhoo A, 2009, NAT NEUROSCI, V12, P839, DOI 10.1038/nn.2323; Yamauchi J, 2003, P NATL ACAD SCI USA, V100, P14421, DOI 10.1073/pnas.2336152100; Yang DP, 2012, J NEUROSCI, V32, P7158, DOI 10.1523/JNEUROSCI.5812-11.2012; Yang LL, 2004, J CELL BIOCHEM, V91, P938, DOI 10.1002/jcb.10774; Yuan BB, 2004, NUCLEIC ACIDS RES, V32, pW130, DOI 10.1093/nar/gkh366; Zhang HQ, 2011, NEUROTHERAPEUTICS, V8, P206, DOI 10.1007/s13311-011-0038-0; Zine A, 2004, CNS NEUROL DISORD-DR, V3, P325, DOI 10.2174/1568007043337166	76	16	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98998	10.1371/journal.pone.0098998	http://dx.doi.org/10.1371/journal.pone.0098998			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905332	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000341869000086
J	Qin, C; Han, ZJ; Qian, J; Bao, ML; Li, P; Ju, XB; Zhang, SB; Zhang, L; Li, S; Cao, Q; Lu, Q; Li, J; Shao, PF; Meng, XX; Zhang, W; Yin, CJ				Qin, Chao; Han, Zhijian; Qian, Jian; Bao, Meiling; Li, Pu; Ju, Xiaobing; Zhang, Shaobo; Zhang, Lei; Li, Shuang; Cao, Qiang; Lu, Qiang; Li, Jie; Shao, Pengfei; Meng, Xiaoxin; Zhang, Wei; Yin, Changjun			Expression Pattern of Long Non-Coding RNAs in Renal Cell Carcinoma Revealed by Microarray	PLOS ONE			English	Article							GENE-EXPRESSION; POLYCOMB GROUP; CANCER; TRANSCRIPTION; PROTEIN; BRAIN; MEG3; ACTIVATION; DOMAINS; COMPLEX	Background: Recent large-scale transcriptome analyses have found large numbers of transcripts, including that of long non-coding RNAs (IncRNAs), which are aberrant in various diseases, especially cancers. However, it is not clear whether IncRNAs are involved specifically in renal cell carcinoma (RCC). We investigated the expression patterns of IncRNAs in five RCC tumor samples M relative to those of matched adjacent non-tumor tissues (N) via microarray. Methods: A microarray with 33,045 IncRNA probes and 30,215 mRNA probes was used to identify deregulated IncRNAs in five RCC patients. Furthermore, we confirmed the relative expression levels of AK096725 and EN5T00000453068 in 70 paired samples by quantitative reverse transcription polymerase chain reaction (qRT-PCR). Results:The IncRNA microarray revealed 27,279 IncRNAs in RCC samples, of which 480 were significantly upregulated (P<0.05; T/N>1.5) and 417 were significantly downregulated (P<0.05; N/T>1.5) compared with the matched non-tumor samples. In addition, 19,995 mRNAs were detected, of which 458 were significantly upregulated (P<0.05; T/N>1.5) and 413 were significantly downregulated (P<0.05; N/T>1.5). The expression level changes of AK096725 (P=0.043) and ENST00000453068 (P<0.001) in 70 paired samples were in accord with the microarray data. Conclusions: The study uncovered expression patterns of IncRNAs in 5 RCC patients, as well as a number of aberrant IncRNAs and mRNAs in tumor samples compared with the non-tumor tissues. The revelation of an association between AK096725 expression and RCC is especially noteworthy. These findings may help to find new biomarkers in RCC.	[Qin, Chao; Han, Zhijian; Qian, Jian; Bao, Meiling; Li, Pu; Ju, Xiaobing; Zhang, Shaobo; Zhang, Lei; Li, Shuang; Cao, Qiang; Lu, Qiang; Li, Jie; Shao, Pengfei; Meng, Xiaoxin; Zhang, Wei; Yin, Changjun] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Zhang, W (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China.	drwzhang@163.com	Cao, Qiang/K-2349-2019		Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University, Provincial Initiative Program for Excellency Disciplines of Jiangsu Province; National Natural Science Foundation of China [81171963, 81201571]	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University, Provincial Initiative Program for Excellency Disciplines of Jiangsu Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), by the Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University, Provincial Initiative Program for Excellency Disciplines of Jiangsu Province, by the National Natural Science Foundation of China [grant number 81171963 and 81201571]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banfai B, 2012, GENOME RES, V22, P1646, DOI 10.1101/gr.134767.111; Beckedorff FC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003705; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Braconi C, 2011, ONCOGENE, V30, P4750, DOI 10.1038/onc.2011.193; Brito GC, 2008, MOL CARCINOGEN, V47, P757, DOI 10.1002/mc.20433; Chen F, 1999, MECH DEVELOP, V84, P181, DOI 10.1016/S0925-4773(99)00073-8; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Fachel AA, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-140; Garcia JA, 2009, CURR OPIN ONCOL, V21, P266, DOI 10.1097/CCO.0b013e32832a05c8; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; Gomez JA, 2013, CELL, V152, P743, DOI 10.1016/j.cell.2013.01.015; Gong YH, 2005, FEBS LETT, V579, P115, DOI 10.1016/j.febslet.2004.11.056; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Junco SE, 2013, STRUCTURE, V21, P665, DOI 10.1016/j.str.2013.02.013; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Li CH, 2013, INT J BIOCHEM CELL B, V45, P1895, DOI 10.1016/j.biocel.2013.05.030; Maruyama R, 2012, BMB REP, V45, P604, DOI 10.5483/BMBRep.2012.45.11.227; Mehler MF, 2007, PHYSIOL REV, V87, P799, DOI 10.1152/physrev.00036.2006; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Novikova Irina V, 2012, Bioarchitecture, V2, P189, DOI 10.4161/bioa.22592; Orom UA, 2013, CELL, V154, P1190, DOI 10.1016/j.cell.2013.08.028; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pang KC, 2007, NUCLEIC ACIDS RES, V35, pD178, DOI 10.1093/nar/gkl926; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Qiu MT, 2013, TUMOR BIOL, V34, P613, DOI 10.1007/s13277-013-0658-6; Ravasi T, 2006, GENOME RES, V16, P11, DOI 10.1101/gr.4200206; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Shi XF, 2013, CANCER LETT, V339, P159, DOI 10.1016/j.canlet.2013.06.013; Takahashi M, 2006, J MED INVESTIG, V53, P9, DOI 10.2152/jmi.53.9; Tano Keiko, 2012, Frontiers in Genetics, V3, P219, DOI 10.3389/fgene.2012.00219; van Spronsen DJ, 2005, ANTI-CANCER DRUG, V16, P709, DOI 10.1097/01.cad.0000167901.58877.a3; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Worner M, 2012, DRUG METAB DISPOS, V40, P414, DOI 10.1124/dmd.111.040402; Wu XD, 2008, NUCLEIC ACIDS RES, V36, P3590, DOI 10.1093/nar/gkn243; Yang L, 2005, CANCER EPIDEM BIOMAR, V14, P243; Yang Z, 2011, ANN SURG ONCOL, V18, P1243, DOI 10.1245/s10434-011-1581-y; Yu G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042377; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhou Y, 2007, J BIOL CHEM, V282, P24731, DOI 10.1074/jbc.M702029200; Zhou YL, 2012, J MOL ENDOCRINOL, V48, pR45, DOI 10.1530/JME-12-0008	47	25	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99372	10.1371/journal.pone.0099372	http://dx.doi.org/10.1371/journal.pone.0099372			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905231	Green Published, gold, Green Submitted			2022-12-27	WOS:000341869000118
J	Hernandez, C; Barrachina, MD; Cosin-Roger, J; Ortiz-Masia, D; Alvarez, A; Terradez, L; Nicolau, MJ; Alos, R; Esplugues, JV; Calatayud, S				Hernandez, Carlos; Dolores Barrachina, Maria; Cosin-Roger, Jesus; Ortiz-Masia, Dolores; Alvarez, Angeles; Terradez, Liria; Jesus Nicolau, Maria; Alos, Rafael; Vicente Esplugues, Juan; Calatayud, Sara			Progastrin Represses the Alternative Activation of Human Macrophages and Modulates Their Influence on Colon Cancer Epithelial Cells	PLOS ONE			English	Article							GASTRIN; INHIBITION; EXPRESSION; PEPTIDES; INVASION; GROWTH; M2	Macrophage infiltration is a negative prognostic factor for most cancers but gastrointestinal tumors seem to be an exception. The effect of macrophages on cancer progression depends on their phenotype, which may vary between M1 (pro-inflammatory, defensive) to M2 (tolerogenic, pro-tumoral). Gastrointestinal cancers often become an ectopic source of gastrins and macrophages present receptors for these peptides. The aim of the present study is to analyze whether gastrins can affect the pattern of macrophage infiltration in colorectal tumors. We have evaluated the relationship between gastrin expression and the pattern of macrophage infiltration in samples from colorectal cancer and the influence of these peptides on the phenotype of macrophages differentiated from human peripheral monocytes in vitro. The total number of macrophages (CD68+ cells) was similar in tumoral and normal surrounding tissue, but the number of M2 macrophages (CD206+ cells) was significantly higher in the tumor. However, the number of these tumor-associated M2 macrophages correlated negatively with the immunoreactivity for gastrin peptides in tumor epithelial cells. Macrophages differentiated from human peripheral monocytes in the presence of progastrin showed lower levels of M2-markers (CD206, IL10) with normal amounts of M1-markers (CD86, IL12). Progastrin induced similar effects in mature macrophages treated with IL4 to obtain a M2-phenotype or with LPS plus IFN gamma to generate M1-macrophages. Macrophages differentiated in the presence of progastrin presented a reduced expression of Wnt ligands and decreased the number and increased cell death of co-cultured colorectal cancer epithelial cells. Our results suggest that progastrin inhibits the acquisition of a M2-phenotype in human macrophages. This effect exerted on tumor associated macrophages may modulate cancer progression and should be taken into account when analyzing the therapeutic value of gastrin immunoneutralization.	[Dolores Barrachina, Maria; Cosin-Roger, Jesus; Ortiz-Masia, Dolores; Alvarez, Angeles; Vicente Esplugues, Juan; Calatayud, Sara] Univ Valencia, Dept Farmacol, Fac Med, Valencia, Spain; [Dolores Barrachina, Maria; Cosin-Roger, Jesus; Ortiz-Masia, Dolores; Alvarez, Angeles; Vicente Esplugues, Juan; Calatayud, Sara] Univ Valencia, CIBER, Fac Med, Valencia, Spain; [Hernandez, Carlos; Vicente Esplugues, Juan] Hosp Dr Peset, FISABIO, Valencia, Spain; [Hernandez, Carlos; Dolores Barrachina, Maria; Cosin-Roger, Jesus; Ortiz-Masia, Dolores; Alvarez, Angeles; Vicente Esplugues, Juan; Calatayud, Sara] UVEG, Hosp Dr Peset, FISABIO, Unidad Mixta Invest Biomed & Farmacol, Valencia, Spain; [Alvarez, Angeles] Fdn Gen Univ Valencia, Valencia, Spain; [Terradez, Liria; Jesus Nicolau, Maria; Alos, Rafael] Hosp Manises, Valencia, Spain	University of Valencia; University of Valencia	Calatayud, S (corresponding author), Univ Valencia, Dept Farmacol, Fac Med, Valencia, Spain.	sara.calatayud@uv.es	Calatayud, Sara/ABB-9665-2021; Alvarez, Angeles/ABF-4589-2020; ORTIZ-MASIA, MARIA DOLORES/M-1413-2017; Esplugues, Juan/ABC-1488-2021; Barrachina, Maria/ABB-9683-2021; SAEZ, CARLOS HERNANDEZ/M-3029-2014	Calatayud, Sara/0000-0001-9675-2423; ORTIZ-MASIA, MARIA DOLORES/0000-0002-7924-9962; SAEZ, CARLOS HERNANDEZ/0000-0001-8536-429X; Barrachina, Maria Dolores/0000-0002-4332-2929; Alvarez, Angeles/0000-0002-2301-9746; Cosin roger, Jesus/0000-0002-2468-4908; Esplugues Mota, Juan Vicente/0000-0001-8205-021X	Ministerio de Educacion y Ciencia/FEDER [SAF2007-064201]; Ministerio de Ciencia e Innovacion [SAF2010-20231, SAF2010-16030, RYC-2011-09571]; Ministerio de Sanidad y Consumo [PI11/00327]; CIBERehd [CB06/04/0071]; Generalitat Valenciana [PROMETEO/2010/060]; 'Ramon y Cajal' program from Ministerio de Ciencia e Innovacion of Spain [RYC-2011-09571]; Ministerio de Educacion, Cultura y Deporte	Ministerio de Educacion y Ciencia/FEDER(Spanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III); CIBERehd; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); 'Ramon y Cajal' program from Ministerio de Ciencia e Innovacion of Spain; Ministerio de Educacion, Cultura y Deporte(Spanish Government)	This work was supported by Ministerio de Educacion y Ciencia/FEDER [grant number SAF2007-064201], Ministerio de Ciencia e Innovacion [grant numbers SAF2010-20231, SAF2010-16030 and RYC-2011-09571], Ministerio de Sanidad y Consumo [grant number PI11/00327], CIBERehd [grant number CB06/04/0071] and Generalitat Valenciana [grant number PROMETEO/2010/060]. Carlos Hernandez acknowledges support from the 'Ramon y Cajal' program from Ministerio de Ciencia e Innovacion of Spain (RYC-2011-09571). Jesus Cosin-Roger is supported by FPU fellowships from Ministerio de Educacion, Cultura y Deporte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algars A, 2012, INT J CANCER, V131, P864, DOI 10.1002/ijc.26457; Alvarez A, 2007, J PHARMACOL EXP THER, V323, P406, DOI 10.1124/jpet.107.122754; Alvarez A, 2006, FASEB J, V20, P2396, DOI 10.1096/fj.05-5696fje; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cosin-Roger J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078128; Edin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074982; Edin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047045; Gilliam AD, 2007, EXPERT OPIN BIOL TH, V7, P397, DOI 10.1517/14712598.7.3.397; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Grabowska AM, 2007, CANCER LETT, V257, P1, DOI 10.1016/j.canlet.2007.06.017; Herrera M, 2013, CANCER SCI, V104, P437, DOI 10.1111/cas.12096; Ibiza S, 2009, AM J PHYSIOL-CELL PH, V297, pC1588, DOI 10.1152/ajpcell.00082.2009; Jin GC, 2009, J CLIN INVEST, V119, P2691, DOI 10.1172/JCI38918; Kaler P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011700; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nakanishi Y, 2011, CARCINOGENESIS, V32, P1333, DOI 10.1093/carcin/bgr128; Ojalvo LS, 2010, J IMMUNOL, V184, P702, DOI 10.4049/jimmunol.0902360; Ortiz-Masia D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048535; Pickert G, 2013, INT J CANCER, V132, P591, DOI 10.1002/ijc.27706; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; Rengifo-Cam W, 2004, CURR PHARM DESIGN, V10, P2345, DOI 10.2174/1381612043383999; Schaale K, 2011, EUR J CELL BIOL, V90, P553, DOI 10.1016/j.ejcb.2010.11.004; Singh P, 2007, ONCOGENE, V26, P425, DOI 10.1038/sj.onc.1209798; Singh P, 2012, CURR COLORECT CANC R, V8, P277, DOI 10.1007/s11888-012-0144-3; Swisher JFA, 2010, BLOOD, V115, P549, DOI 10.1182/blood-2009-06-226944; Tai SK, 2012, J IMMUNOL, V188, P2464, DOI 10.4049/jimmunol.1101101; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Watson SA, 2006, NAT REV CANCER, V6, P936, DOI 10.1038/nrc2014; White BD, 2012, GASTROENTEROLOGY, V142, P219, DOI 10.1053/j.gastro.2011.12.001	31	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98458	10.1371/journal.pone.0098458	http://dx.doi.org/10.1371/journal.pone.0098458			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901518	gold, Green Published, Green Submitted			2022-12-27	WOS:000336841400030
J	Liu, MF; He, ZH; Xi, LF; Li, JJ; Liu, FF; Liu, Y; Pan, YQ; Ning, T; Guo, CH; Xu, RP; Zhang, LX; Cai, H; Ke, Y				Liu, Mengfei; He, Zhonghu; Xi, Longfu; Li, Jingjing; Liu, Fangfang; Liu, Ying; Pan, Yaqi; Ning, Tao; Guo, Chuanhai; Xu, Ruiping; Zhang, Lixin; Cai, Hong; Ke, Yang			The Distribution and Common Amino Acid Polymorphisms of Human Papillomavirus (HPV)-31 Variants in 2700 Women from Northern China	PLOS ONE			English	Article							ABNORMAL CERVICAL CYTOLOGY; E7 ONCOPROTEINS; ADENOVIRUS E1A; TYPE-16 E6; HPV E6; CANCER; RISK; PROTEINS; P53; METAANALYSIS	To investigate the distribution of Human papillomavirus (HPV)-31 A, B and C variants as well as the common amino acid polymorphisms in Chinese women, all 14 HPV-31 positive cervical exfoliated cell specimens identified from a descriptive study including similar to 2700 women from Northern China were analyzed. HPV-31 positive specimens were identified by Mass Spectrometry and the fragments of partial Long Control Region, E6 and E7 were amplified and directly sequenced or cloned into vector and then sequenced to confirm the variant information. HPV-31 prevalence in Northern Chinese female population was 0.52%. Six different sequences represented all 14 isolates, and these isolates were subsequently classified into variant lineage A (9), B (0) and C (5) by phylogenetic analysis. Five common amino acid polymorphism sites (2 in E6 and 3 in E7) and a novel non-synonymous mutation were detected in the current study. Our investigation suggested that HPV-31 was much less detected in Chinese women population than that in western countries. A and C variants were commonly detected while B variants were rarely detected in this population.	[Liu, Mengfei; He, Zhonghu; Li, Jingjing; Liu, Fangfang; Liu, Ying; Pan, Yaqi; Ning, Tao; Guo, Chuanhai; Cai, Hong; Ke, Yang] Peking Univ, Key Lab Carcinogenesis & Translat Res, Genet Lab, Minist Educ,Canc Hosp & Inst, Beijing 100871, Peoples R China; [Xi, Longfu] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Xu, Ruiping; Zhang, Lixin] Anyang Canc Hosp, Anyang, Henan, Peoples R China	Peking University; University of Washington; University of Washington Seattle	Cai, H (corresponding author), Peking Univ, Key Lab Carcinogenesis & Translat Res, Genet Lab, Minist Educ,Canc Hosp & Inst, Beijing 100871, Peoples R China.	drhcai@gmail.com; keyang@bjmu.edu.cn	Zhang, Li/GWM-7501-2022	He, Zhonghu/0000-0002-4444-7950	National Natural Science Foundation of China [81161120411, 30930102]; "973" Project of National Ministry of Science and Technology [2011CB504300, 2012CB910800]; "863" Key Projects of National Ministry of Science and Technology [2012AA02A209, 2012AA022502]; Charity Project of National Ministry of Health [201202014, 200902002]; Specialized Research Fund for the Doctoral Program of Higher Education [20110001110037]; Natural Science Foundation of Beijing [7100001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "973" Project of National Ministry of Science and Technology; "863" Key Projects of National Ministry of Science and Technology(National High Technology Research and Development Program of China); Charity Project of National Ministry of Health; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation)	This work was supported by National Natural Science Foundation of China (grant number 81161120411, 30930102); "973" Project of National Ministry of Science and Technology Grant (grant number 2011CB504300, 2012CB910800); "863" Key Projects of National Ministry of Science and Technology Grant (grant number 2012AA02A209, 2012AA022502); Charity Project of National Ministry of Health (grant number 201202014, 200902002); the Specialized Research Fund for the Doctoral Program of Higher Education (20110001110037); and Natural Science Foundation of Beijing (grant number 7100001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YP, 2008, INT J GYNECOL CANCER, V18, P71, DOI 10.1111/j.1525-1438.2007.00959.x; BARBOSA MS, 1990, EMBO J, V9, P153, DOI 10.1002/j.1460-2075.1990.tb08091.x; Bernard HU, 2006, INT J CANCER, V118, P1071, DOI 10.1002/ijc.21655; Berumen J, 2001, JNCI-J NATL CANCER I, V93, P1325, DOI 10.1093/jnci/93.17.1325; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Calleja-Macias IE, 2004, VIROLOGY, V319, P315, DOI 10.1016/j.virol.2003.11.009; Cento V, 2011, J MED VIROL, V83, P1752, DOI 10.1002/jmv.22201; Chagas BS, 2011, GYNECOL ONCOL, V123, P284, DOI 10.1016/j.ygyno.2011.07.008; Chagas BS, 2013, INFECT GENET EVOL, V16, P13, DOI 10.1016/j.meegid.2013.02.001; Chen ZG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020183; CROOK T, 1994, BIOCHEM SOC T, V22, P52, DOI 10.1042/bst0220052; CROOK T, 1991, CELL, V67, P547, DOI 10.1016/0092-8674(91)90529-8; de Freitas AC, 2012, GYNECOL ONCOL, V126, P304, DOI 10.1016/j.ygyno.2012.03.047; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; DYSON N, 1992, J VIROL, V66, P6893, DOI 10.1128/JVI.66.12.6893-6902.1992; ELLIS JRM, 1995, NAT MED, V1, P464, DOI 10.1038/nm0595-464; Farthing Alan J., 1994, Trends in Microbiology, V2, P170, DOI 10.1016/0966-842X(94)90667-X; Ferenczi A, 2013, J MED VIROL, V85, P852, DOI 10.1002/jmv.23542; FOSTER SA, 1994, J VIROL, V68, P5698, DOI 10.1128/JVI.68.9.5698-5705.1994; Gagnon S, 2005, J MED VIROL, V75, P213, DOI 10.1002/jmv.20259; HO L, 1993, J VIROL, V67, P6413, DOI 10.1128/JVI.67.11.6413-6423.1993; KAST WM, 1994, J IMMUNOL, V152, P3904; Liu FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031602; MUNGER K, 1992, CANCER SURV, V12, P197; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Raiol T, 2009, J MED VIROL, V81, P685, DOI 10.1002/jmv.21432; Sichero L, 2007, INT J CANCER, V120, P1763, DOI 10.1002/ijc.22481; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Stoppler MC, 1996, J VIROL, V70, P6987; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Werness B A, 1991, Important Adv Oncol, P3; Xi LF, 2006, J NATL CANCER I, V98, P1045, DOI 10.1093/jnci/djj297; Xi LF, 2013, INT J CANCER, V132, P549, DOI 10.1002/ijc.27689; Xi LF, 2012, INT J CANCER, V131, P2300, DOI 10.1002/ijc.27520; YAMADA T, 1995, J VIROL, V69, P7743, DOI 10.1128/JVI.69.12.7743-7753.1995; Yi X, 2011, AM J CLIN PATHOL, V136, P913, DOI 10.1309/AJCPWTZDT0Q7DOVI; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	38	6	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99141	10.1371/journal.pone.0099141	http://dx.doi.org/10.1371/journal.pone.0099141			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901850	Green Published, gold, Green Submitted			2022-12-27	WOS:000336841400102
J	Schmidt, MA; Mennecke, A; Michelson, G; Doerfler, A; Engelhorn, T				Schmidt, Manuel A.; Mennecke, Angelika; Michelson, Georg; Doerfler, Arnd; Engelhorn, Tobias			DTI Analysis in Patients with Primary Open-Angle Glaucoma: Impact of Registration on Voxel-Wise Statistics	PLOS ONE			English	Article							WHITE-MATTER; NEURAL DEGENERATION; SPATIAL STATISTICS; VISUAL PATHWAY; BRAIN; MORPHOMETRY; PARAMETERS; INTEGRITY; CORTEX; FSL	Background and Purpose: Tract-based spatial statistics (TBSS) has been used to assess the integrity of the visual pathway in glaucoma patients. TBSS uses the subjects' FA data to create a mean FA skeleton of white matter tracts before running voxel-wise cross-subject statistics. We compared four different approaches of registration of FA maps to create the skeleton and evaluated alignment and subsequently the impact of the chosen registration on voxel-wise statistics. Material and Methods: Our study comprised 69 subjects, i.e. 46 patients with primary open angle glaucoma (POAG) and a healthy, age-matched control group of 23 subjects. Mean FA skeletons were created using the following registration approaches: registration to a standard template (T), registration to the group mean (GM), registration to a group-wise atlas (GW) and registration to the most typical subject (N). Subsequently, maps of standard deviation of the 4D images were created to assess the alignment. Voxel-wise statistics for each registration approach were performed. Results: We found distinct differences in voxel-wise statistics depending on the chosen registration approach. Best alignment results were achieved by registration to a study specific template, i.e. to the group mean (GM) or to a group-wise atlas (GW). Overall alignment did not differ between these two approaches. However, voxel-wise statistics showed clusters of significantly decreased FA values in the T and GM approach, which were not significant after GW registration. These voxels of significantly decreased FA values after T and GM registration did not represent white matter tracts and correlated with higher standard deviation in FA maps across subjects, thus implying registration errors, especially in the optic radiation. Conclusion: Registration to a study-specific template, i.e. to the group mean or a group-wise atlas seems to be the method of choice in TBSS-analysis of glaucoma patients as it shows better alignment of the optic radiation and helps to rule out registration errors due to misalignment.	[Schmidt, Manuel A.; Mennecke, Angelika; Doerfler, Arnd; Engelhorn, Tobias] Univ Erlangen Nurnberg, Dept Neuroradiol, D-91054 Erlangen, Germany; [Michelson, Georg] Univ Erlangen Nurnberg, Dept Ophthalmol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Schmidt, MA (corresponding author), Univ Erlangen Nurnberg, Dept Neuroradiol, D-91054 Erlangen, Germany.	manuel.schmidt@uk-erlangen.de	Schmidt, Manuel Alexander/HFZ-9950-2022; Schmidt, Manuel A./AAN-1586-2020	Schmidt, Manuel Alexander/0000-0002-8560-2582; Schmidt, Manuel A./0000-0002-8560-2582				Chen WW, 2013, INVEST OPHTH VIS SCI, V54, P545, DOI 10.1167/iovs.12-9893; Chen ZQ, 2013, CLIN EXP OPHTHALMOL, V41, P43, DOI 10.1111/j.1442-9071.2012.02832.x; Dai H, 2013, NEURORADIOLOGY, V55, P233, DOI 10.1007/s00234-012-1122-9; Douaud G, 2011, NEUROIMAGE, V55, P880, DOI 10.1016/j.neuroimage.2010.12.008; Engelhorn T, 2012, SCI WORLD J, P1, DOI 10.1100/2012/849632; Gupta N, 2006, BRIT J OPHTHALMOL, V90, P674, DOI 10.1136/bjo.2005.086769; Hernowo AT, 2011, INVEST OPHTH VIS SCI, V52, P2758, DOI 10.1167/iovs.10-5682; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Keihaninejad S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045996; Li CY, 2012, CURR EYE RES, V37, P794, DOI 10.3109/02713683.2012.683506; Lu PG, 2013, J NEURORADIOLOGY, V40, P89, DOI 10.1016/j.neurad.2012.04.001; Michelson G, 2013, GRAEF ARCH CLIN EXP, V251, P243, DOI 10.1007/s00417-011-1887-2; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Yucel Y, 2008, PROG BRAIN RES, V173, P465, DOI 10.1016/S0079-6123(08)01132-1; Zikou AK, 2012, AM J NEURORADIOL, V33, P128, DOI 10.3174/ajnr.A2714	20	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99344	10.1371/journal.pone.0099344	http://dx.doi.org/10.1371/journal.pone.0099344			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901535	Green Published, gold			2022-12-27	WOS:000336841400121
J	Steinbrunn, T; Chatterjee, M; Bargou, RC; Stuhmer, T				Steinbrunn, Torsten; Chatterjee, Manik; Bargou, Ralf C.; Stuehmer, Thorsten			Efficient Transient Transfection of Human Multiple Myeloma Cells by Electroporation - An Appraisal	PLOS ONE			English	Article							MOLECULAR PATHOGENESIS; SIRNAS; APOPTOSIS; STRATEGY; PATHWAY	Cell lines represent the everyday workhorses for in vitro research on multiple myeloma (MM) and are regularly employed in all aspects of molecular and pharmacological investigations. Although loss-of-function studies using RNA interference in MM cell lines depend on successful knockdown, no well-established and widely applied protocol for efficient transient transfection has so far emerged. Here, we provide an appraisal of electroporation as a means to introduce either short-hairpin RNA expression vectors or synthesised siRNAs into MM cells. We found that electroporation using siRNAs was much more efficient than previously anticipated on the basis of transfection efficiencies deduced from EGFP-expression off protein expression vectors. Such knowledge can even confidently be exploited in "hard-to-transfect'' MM cell lines to generate large numbers of transient knockdown phenotype MM cells. In addition, special attention was given to developing a protocol that provides easy implementation, good reproducibility and manageable experimental costs.	[Steinbrunn, Torsten; Chatterjee, Manik; Stuehmer, Thorsten] Univ Hosp Wurzburg, Div Hematol & Oncol, Dept Internal Med 2, Wurzburg, Germany; [Bargou, Ralf C.] Univ Hosp Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Stuhmer, T (corresponding author), Univ Hosp Wurzburg, Div Hematol & Oncol, Dept Internal Med 2, Wurzburg, Germany.	stuehmer_t@ukw.de			Deutsche Forschungsgemeinschaft [KFO 216]; Interdisziplinares Zentrum fur Klinische Forschung of the Universitatsklinikum Wurzburg [B-188]; Wilhelm Sander-Stiftung [2011.114.1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Interdisziplinares Zentrum fur Klinische Forschung of the Universitatsklinikum Wurzburg; Wilhelm Sander-Stiftung	This work was supported by the Deutsche Forschungsgemeinschaft (KFO 216), the Interdisziplinares Zentrum fur Klinische Forschung of the Universitatsklinikum Wurzburg (B-188), and the Wilhelm Sander-Stiftung (2011.114.1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brito JLR, 2008, J IMMUNOL METHODS, V333, P147, DOI 10.1016/j.jim.2008.01.009; Brito JLR, 2010, METHODS MOL BIOL, V623, P299, DOI 10.1007/978-1-60761-588-0_19; Burger R, 2001, Hematol J, V2, P42, DOI 10.1038/sj.thj.6200075; Chatterjee M, 2004, BLOOD, V104, P3712, DOI 10.1182/blood-2004-04-1670; Chesi M, 2013, INT J HEMATOL, V97, P313, DOI 10.1007/s12185-013-1291-2; de Queiroz FM, 2012, MOL BIOL REP, V39, P2187, DOI 10.1007/s11033-011-0967-z; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Fonseca R, 2013, SEMIN ONCOL, V40, P554, DOI 10.1053/j.seminoncol.2013.07.002; Gomez-Benito M, 2007, CELL SIGNAL, V19, P844, DOI 10.1016/j.cellsig.2006.10.009; Haan C, 2007, J IMMUNOL METHODS, V318, P11, DOI 10.1016/j.jim.2006.07.027; Kanduser M, 2009, BIOELECTROCHEMISTRY, V74, P265, DOI 10.1016/j.bioelechem.2008.09.002; Keats JJ, 2012, BLOOD, V120, P1067, DOI 10.1182/blood-2012-01-405985; Kuehl WM, 2012, J CLIN INVEST, V122, P3456, DOI 10.1172/JCI61188; Kumar SK, 2013, LEUKEMIA; Logue SE, 2009, NAT PROTOC, V4, P1383, DOI 10.1038/nprot.2009.143; Lohr JG, 2014, CANCER CELL, V25, P91, DOI 10.1016/j.ccr.2013.12.015; MacCallum DE, 2005, CANCER RES, V65, P5399, DOI 10.1158/0008-5472.CAN-05-0233; Mahindra A, 2012, NAT REV CLIN ONCOL, V9, P135, DOI 10.1038/nrclinonc.2012.15; Morgan GJ, 2012, NAT REV CANCER, V12, P335, DOI 10.1038/nrc3257; Muto A, 2007, MOL CANCER THER, V6, P987, DOI 10.1158/1535-7163.MCT-06-0605; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Steinbrunn T, 2012, LEUKEMIA RES, V36, P1165, DOI 10.1016/j.leukres.2012.05.005; Steinbrunn T, 2011, BLOOD, V117, P1998, DOI 10.1182/blood-2010-05-284422; Stroh T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009488; Stuhmer T, 2005, BLOOD, V106, P3609, DOI 10.1182/blood-2005-04-1489; Tiedemann RE, 2012, CANCER RES, V72, P757, DOI 10.1158/0008-5472.CAN-11-2781; Uphoff CC, 2004, METH MOLEC MED, V88, P319; Usmani SZ, 2013, LEUKEMIA, V27, P226, DOI 10.1038/leu.2012.160; Walters DK, 2002, ANTISENSE NUCLEIC A, V12, P411, DOI 10.1089/108729002321082483; Zhang HR, 2013, J INT MED RES, V41, P584, DOI 10.1177/0300060513480920; Zhang J, 2009, CANCER RES, V69, P5082, DOI 10.1158/0008-5472.CAN-08-4603; Zollinger A, 2008, BLOOD, V112, P3403, DOI 10.1182/blood-2007-11-119362	32	18	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e97443	10.1371/journal.pone.0097443	http://dx.doi.org/10.1371/journal.pone.0097443			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901949	Green Published, Green Submitted, gold			2022-12-27	WOS:000336841400005
J	Tang, HL; Mao, YR; Shi, CX; Han, J; Wang, LY; Xu, J; Qin, QQ; Detels, R; Wu, ZY				Tang, Houlin; Mao, Yurong; Shi, Cynthia X.; Han, Jing; Wang, Liyan; Xu, Juan; Qin, Qianqian; Detels, Roger; Wu, Zunyou			Baseline CD4 Cell Counts of Newly Diagnosed HIV Cases in China: 2006-2012	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; ACTIVE ANTIRETROVIRAL THERAPY; COMMERCIAL PLASMA DONORS; VIRAL LOAD; CARE; ENGAGEMENT; MORTALITY	Background: Late diagnosis of HIV infection is common. We aim to assess the proportion of newly diagnosed HIV cases receiving timely baseline CD4 count testing and the associated factors in China. Methods: Data were extracted from the Chinese HIV/AIDS Comprehensive Response Information Management System. Adult patients over 15 years old who had been newly diagnosed with HIV infection in China between 2006 and 2012 were identified. The study cohort comprised individuals who had a measured baseline CD4 count. Results: Among 388,496 newly identified HIV cases, the median baseline CD4 count was 294 cells/mu l (IQR: 130-454), and over half (N = 130,442, 58.8%) were less than 350 cells/mu l. The median baseline CD4 count increased from 221 (IQR: 63-410) in 2006 to 314 (IQR: 159-460) in 2012. A slight majority of patients (N = 221,980, 57.1%) received baseline CD4 count testing within 6 months of diagnosis. The proportion of individuals who received timely baseline CD4 count testing increased significantly from 20.0% in 2006 to 76.9% in 2012. Factors associated with failing to receiving timely CD4 count testing were: being male (OR: 1.17, 95% CI: 1.15-1.19), age 55 years or older (OR: 1.03, 95% CI: 1.00-1.06), educational attainment of primary school education or below (OR: 1.30, 95% CI: 1.28-1.32), infection with HIV through injection drug use (OR: 2.07, 95% CI: 2.02-2.12) or sexual contact and injection drug use (OR: 1.87, 95% CI: 1.76-1.99), diagnosis in a hospital (OR: 1.91, 95% CI: 1.88-1.95) or in a detention center (OR: 1.75, 95% CI: 1.70-1.80), and employment as a migrant worker (OR: 1.55, 95% CI: 1.53-1.58). Conclusion: The proportion of newly identified HIV patients receiving timely baseline CD4 testing has increased significantly in China from 2006-2012. Continued effort is needed for further promotion of early HIV diagnosis and timely baseline CD4 cell count testing.	[Tang, Houlin; Mao, Yurong; Shi, Cynthia X.; Han, Jing; Xu, Juan; Wu, Zunyou] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Div Integrat & Evaluat, Beijing, Peoples R China; [Shi, Cynthia X.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Wang, Liyan; Qin, Qianqian] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Div Epidemiol, Beijing, Peoples R China; [Detels, Roger] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Harvard University; Harvard T.H. Chan School of Public Health; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; University of California System; University of California Los Angeles	Wu, ZY (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Div Integrat & Evaluat, Beijing, Peoples R China.	wuzy@263.net	qin, qin x/GXG-6164-2022; tang, houlin/HGA-1502-2022; Qin, Qin/GVT-5910-2022		National Health and Family Planning Commission of the People's Republic of China [131-11-0001-0501]; US National Institutes of Health [U2RTW06918]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH058107] Funding Source: NIH RePORTER	National Health and Family Planning Commission of the People's Republic of China; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors report funding from the National Health and Family Planning Commission of the People's Republic of China (grant#131-11-0001-0501), and the US National Institutes of Health (grant# U2RTW06918). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLARDICE G, 1992, AIDS, V6, P213, DOI 10.1097/00002030-199202000-00013; Althoff KN, 2010, CLIN INFECT DIS, V50, P1512, DOI 10.1086/652650; [Anonymous], 2012, UNAIDS REP GLOB AIDS; Buchacz K, 2012, AIDS RES TREAT, V2012; Celentano DD, 2001, AIDS, V15, P1707, DOI 10.1097/00002030-200109070-00015; Chadborn TR, 2006, AIDS, V20, P2371, DOI 10.1097/QAD.0b013e32801138f7; Chaisson RE, 2000, JAMA-J AM MED ASSOC, V284, P3128, DOI 10.1001/jama.284.24.3128; Chen X, 2011, SEX TRANSM INFECT, V87, P538, DOI 10.1136/sextrans-2011-050228; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Tran DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051289; Dou ZH, 2010, INT J EPIDEMIOL, V39, pII56, DOI 10.1093/ije/dyq215; Dybul M, 2002, J INFECT DIS, V185, P1818, DOI 10.1086/340650; Easterbrook PJ, 2000, AIDS, V14, P561, DOI 10.1097/00002030-200003310-00012; Galvan FH, 2000, J ACQ IMMUN DEF SYND, V25, pS151, DOI 10.1097/00126334-200012152-00010; Garcia F, 2004, JAIDS-J ACQ IMM DEF, V36, P702, DOI 10.1097/00126334-200406010-00007; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gardner LI, 2005, AIDS, V19, P423, DOI 10.1097/01.aids.0000161772.51900.eb; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Hull MW, 2012, CURR OPIN HIV AIDS, V7, P579, DOI 10.1097/COH.0b013e3283590617; Jiang Y, 2010, INT J EPIDEMIOL, V39, pII72, DOI 10.1093/ije/dyq224; Kranzer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013801; Lawn SD, 2009, AIDS, V23, P335, DOI 10.1097/QAD.0b013e328321823f; Liu HJ, 2012, AIDS PATIENT CARE ST, V26, P565, DOI 10.1089/apc.2012.0227; Liu YF, 2010, INT J EPIDEMIOL, V39, pII90, DOI 10.1093/ije/dyq214; Mao YR, 2010, INT J EPIDEMIOL, V39, pII79, DOI 10.1093/ije/dyq213; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Mugavero MJ, 2007, AM J MED, V120, P370, DOI 10.1016/j.amjmed.2006.05.050; Ogbuanu IU, 2009, AM J PUBLIC HEALTH, V99, pS111, DOI 10.2105/AJPH.2006.104323; Smith K, 2012, INT J DRUG POLICY, V23, P327, DOI 10.1016/j.drugpo.2011.09.010; Thanawuth N, 2008, AIDS CARE, V20, P43, DOI 10.1080/09540120701439303; Wang N, 2010, INT J EPIDEMIOL, V39, pII21, DOI 10.1093/ije/dyq209; Wen Y, 2011, AIDS CARE, V23, P1226, DOI 10.1080/09540121.2011.555748; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Wu ZY, 2010, INT J EPIDEMIOL, V39, pII1, DOI 10.1093/ije/dyq220; WU ZY, 1995, LANCET, V346, P61, DOI 10.1016/S0140-6736(95)92698-4; Wu ZY, 2001, HEALTH POLICY PLANN, V16, P41, DOI 10.1093/heapol/16.1.41; Yin WY, 2010, INT J EPIDEMIOL, V39, pII29, DOI 10.1093/ije/dyq210; Zhang FJ, 2007, AIDS, V21, pS143, DOI 10.1097/01.aids.0000304710.10036.2b; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4; Zhang FJ, 2009, ANN INTERN MED, V151, P241, DOI 10.7326/0003-4819-151-4-200908180-00006; Zhang Y, 2011, CHINESE MED J-PEKING, V124, P1488, DOI 10.3760/cma.j.issn.0366-6999.2011.10.009; Zhao Y, 2013, ADDICTION IN PRESS; 吴尊友, 2011, [中国公共卫生, China Public Health], V27, P1505	45	20	28	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e96098	10.1371/journal.pone.0096098	http://dx.doi.org/10.1371/journal.pone.0096098			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901790	Green Published, gold, Green Submitted			2022-12-27	WOS:000336841400004
J	Zeng, SX; Zhang, ZS; Yu, XW; Song, RX; Wei, RC; Zhao, JJ; Wang, LH; Hou, JG; Sun, YH; Xu, CL				Zeng, Shuxiong; Zhang, Zhensheng; Yu, Xiaowen; Song, Ruixiang; Wei, Rongchao; Zhao, Junjie; Wang, Linhui; Hou, Jianguo; Sun, Yinghao; Xu, Chuanliang			Laparoscopic versus Open Radical Cystectomy for Elderly Patients over 75-Year-Old: A Single Center Comparative Analysis	PLOS ONE			English	Article							BLADDER-CANCER; ORTHOTOPIC NEOBLADDER; ONCOLOGICAL OUTCOMES; FOLLOW-UP; MORBIDITY; COMPLICATIONS; EXPERIENCE; CARCINOMA; MORTALITY; OLDER	Purpose: To explore the morbidity, mortality and oncological results of laparoscopic radical cystectomy (LRC) in the elderly patients over 75-year-old in contrast with open radical cystectomy (ORC). Materials and Methods: We analyzed 46 radical cystectomies from January 2009 to December 2013 in patients over 75year-old in our institute, 21 patients in the LRC group and 25 in the ORC group. Demographic parameters, operative variables and perioperative outcome were retrospectively collected and analyzed between the two groups. Perioperative morbidity and mortality were categorized as early (within 90 days after surgery) or late (more than 90 days) according to the time of occurrence. Results: Patients in both groups had comparable preoperative characteristics. A significant longer operative time (418 vs. 337 min, p = 0.018) and less estimated blood loss (400 vs. 500 ml p = 0.038) were observed in LRC group compared with ORC group. Infection and ileus were the most common early complications after surgery. Patients underwent ORC suffered from significantly more postoperative ileus (28.0% vs. 4.8%, P = 0.038) and infection (40% vs. 9.5%, P = 0.019) than LRC group within 90 days after surgery. The mortality rate was 4.7% (1/21) and 4% (1/25) for LRC group and ORC group respectively. At a median follow-up of 21 months (range 2-61 months), the Kaplan-Meier survival curves and log-rank analysis demonstrate that there were no significant differences between the LRC and ORC groups in the 3-year overall, cancer-specific, or recurrence-free survival rates. Conclusions: It is suggested that LRC should be recommended as the primary intervention to treat muscle invasive or high risk non-muscle invasive bladder cancer in elderly patients with a relative long life expectancy.	[Zeng, Shuxiong; Zhang, Zhensheng; Song, Ruixiang; Wei, Rongchao; Zhao, Junjie; Wang, Linhui; Hou, Jianguo; Sun, Yinghao; Xu, Chuanliang] Second Mil Med Univ, Changhai Hosp, Dept Urol, Shanghai, Peoples R China; [Yu, Xiaowen] Second Mil Med Univ, Changhai Hosp, Dept Geriatr, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Xu, CL (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Urol, Shanghai, Peoples R China.	xuchuanliang@medmail.com.cn	wang, lin/GSE-3040-2022	Zeng, Shuxiong/0000-0001-7656-9437				Bostrom PJ, 2009, BJU INT, V103, P191, DOI 10.1111/j.1464-410X.2008.07889.x; Chang SS, 2001, J UROLOGY, V166, P938, DOI 10.1016/S0022-5347(05)65868-5; Eble JN, 2004, WHO CLASSIFICATION T, P29; Farnham SB, 2004, UROL ONCOL-SEMIN ORI, V22, P178, DOI 10.1016/j.urolonc.2003.12.005; Froehner M, 2009, EUR UROL, V56, P443, DOI 10.1016/j.eururo.2009.05.008; Gakis G, 2013, EUR UROL, V63, P45, DOI 10.1016/j.eururo.2012.08.009; Game X, 2001, EUR UROL, V39, P525, DOI 10.1159/000052498; Guillotreau J, 2012, UROLOGY, V79, P585, DOI 10.1016/j.urology.2011.11.042; Guillotreau J, 2009, J UROLOGY, V181, P554, DOI 10.1016/j.juro.2008.10.011; Ha US, 2010, INT J UROL, V17, P55, DOI 10.1111/j.1442-2042.2009.02425.x; Haber GP, 2007, BJU INT, V100, P137, DOI 10.1111/j.1464-410X.2007.06865.x; Han S, 2013, ONCOLOGY PROCESS, V11, P89; Hemal AK, 2008, UROLOGY, V71, P41, DOI 10.1016/j.urology.2007.08.056; Hemal AK, 2007, J UROLOGY, V178, P2340, DOI 10.1016/j.juro.2007.08.020; Kader AK, 2013, BJU INT, V112, pE290, DOI 10.1111/bju.12167; May Matthias, 2007, Int. braz j urol., V33, P764; Mendiola Frederick P, 2007, Can J Urol, V14, P3628; Morgan TM, 2011, J UROLOGY, V186, P829, DOI 10.1016/j.juro.2011.04.089; PARRA RO, 1992, J UROLOGY, V148, P1140, DOI 10.1016/S0022-5347(17)36843-X; Prout GR, 2005, CANCER-AM CANCER SOC, V104, P1638, DOI 10.1002/cncr.21354; Richards KA, 2012, J ENDOUROL, V26, P1301, DOI 10.1089/end.2012.0035; Saika T, 2001, INT J UROL, V8, P533, DOI 10.1046/j.1442-2042.2001.00367.x; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Snow-Lisy DC, 2014, EUR UROL, V65, P193, DOI 10.1016/j.eururo.2013.08.021; Sobin LH, 2009, TNM CLASSIFICATION M, P262; Sogni F, 2008, UROLOGY, V71, P919, DOI 10.1016/j.urology.2007.11.125; Soulie M, 2002, J UROLOGY, V167, P1325, DOI 10.1016/S0022-5347(05)65292-5; Springer C, 2013, WORLD J URO IN PRESS; US Department of Health and Human Services, 2011, PROF OLD AM 2011; Wein A, 2012, CAMPBELL WALSH UROLO, P2379; Zebic N, 2005, BJU INT, V95, P1211, DOI 10.1111/j.1464-410X.2005.05507.x	31	16	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98950	10.1371/journal.pone.0098950	http://dx.doi.org/10.1371/journal.pone.0098950			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901359	Green Published, gold			2022-12-27	WOS:000336841400077
J	Zis, P; McHugh, P; McQuillin, A; Pratico, D; Dickinson, M; Shende, S; Walker, Z; Strydom, A				Zis, Panagiotis; McHugh, Patrick; McQuillin, Andrew; Pratico, Domenico; Dickinson, Mark; Shende, Sima; Walker, Zuzana; Strydom, Andre			Memory Decline in Down Syndrome and Its Relationship to iPF2alpha, a Urinary Marker of Oxidative Stress	PLOS ONE			English	Article							OXIDATIVE/NITROSATIVE STRESS; AMINO-ACIDS; ADULTS; CHILDREN; BIOMARKERS; DEMENTIA; F-2-ISOPROSTANES; ASSOCIATION; DYSFUNCTION; IMPAIRMENT	Background: Lipid peroxidation may be a marker of free-radical-mediated injury associated with Alzheimer's disease (AD). We aimed to investigate whether changes in lipid peroxidation is associated with cognitive decline in individuals with Down syndrome over a 4-year period. Methods: Thirty-two adults with DS participated in a longitudinal study with urinary isoprostane 8,12-iso-iPF2alpha (iPF2alpha) assays at baseline and four years follow-up. Informants rated their functional ability and memory function and the adults with DS attempted assessments of language skills and memory. Twenty-six individuals completed assessments of memory (Modified Memory Object Task, MOMT), adaptive behavior (ABAS), and receptive vocabulary (British Picture vocabulary, BPVS) at both time-points. Results: Overall change in iPF2alpha level was negatively correlated with change in the MOMT score (Spearman's Rho = -0.576, p = 0.006), i.e., increased lipid peroxidation was correlated with worse memory functioning over time. An increase of >= 0.02 ng/mg creatinine iPF2 alpha had good sensitivity (85.7%), positive predictive value (75%,), specificity (85.7%) and negative predictive value (92.3%) for memory decline. Conclusion: Change in iPF2alpha over time may have potential as a biomarker for memory decline in Down syndrome and potentially also help to track progression of MCI to AD in the general population.	[Zis, Panagiotis; Shende, Sima; Walker, Zuzana; Strydom, Andre] UCL, Div Psychiat, London, England; [McHugh, Patrick] Univ Huddersfield, Sch Appl Sci, Div Pharm & Pharmaceut Sci, Huddersfield HD1 3DH, W Yorkshire, England; [McQuillin, Andrew] UCL, Mol Psychiat Lab, London, England; [Pratico, Domenico] Temple Univ, Dept Pharmacol, Philadelphia, PA 19122 USA; [Pratico, Domenico] Temple Univ, Ctr Translat Med, Philadelphia, PA 19122 USA; [Dickinson, Mark] Enfield Integrated Learning Disabil Team, Enfield, Middx, England	University of London; University College London; University of Huddersfield; University of London; University College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Zis, P (corresponding author), UCL, Div Psychiat, London, England.	takiszis@gmail.com	Pratico, Domenico/ABA-9590-2020; McQuillin, Andrew/C-1623-2008; Zis, Panagiotis/L-1335-2019; Zis, Panagiotis/AAH-8027-2021; Walker, Zuzana/B-8339-2009	McQuillin, Andrew/0000-0003-1567-2240; Zis, Panagiotis/0000-0001-8567-3092; Walker, Zuzana/0000-0001-7346-8200; McHugh, Patrick/0000-0003-0661-919X; Strydom, Andre/0000-0002-2502-6704	north central London research consortium (NoCloR)	north central London research consortium (NoCloR)	Funding for the baseline work was provided by the north central London research consortium (NoCloR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akomolafe A, 2006, CLIN GENET, V70, P49, DOI 10.1111/j.1399-0004.2006.00638.x; Brugge K, 1999, BIOL PSYCHIAT, V46, P1682, DOI 10.1016/S0006-3223(99)00026-8; Burt DB, 2000, J INTELL DISABIL RES, V44, P175, DOI 10.1046/j.1365-2788.2000.00264.x; Callewaert DM, 2010, METHODS MOL BIOL, V610, P435, DOI 10.1007/978-1-60327-029-8_26; Campos C, 2011, LIFE SCI, V89, P655, DOI 10.1016/j.lfs.2011.08.006; Campos C, 2011, BBA-MOL BASIS DIS, V1812, P760, DOI 10.1016/j.bbadis.2011.03.013; Campos C, 2010, CLIN BIOCHEM, V43, P228, DOI 10.1016/j.clinbiochem.2009.09.017; Cardoso SM, 2004, J NEUROCHEM, V89, P1417, DOI 10.1111/j.1471-4159.2004.02438.x; Cenini G, 2012, BBA-MOL BASIS DIS, V1822, P130, DOI 10.1016/j.bbadis.2011.10.001; Coppus AMW, 2010, AMINO ACIDS, V38, P923, DOI 10.1007/s00726-009-0300-5; Coppus AW, 2007, J NEURAL TRANSM, V114, P1041, DOI 10.1007/s00702-007-0656-1; Di Domenico F, 2013, BBA-MOL BASIS DIS, V1832, P1249, DOI 10.1016/j.bbadis.2013.04.013; Dunn L. M., 1997, BRIT PICTURE VOCABUL; Evenhuis HM, 1996, J INTELL DISABIL RES, V40, P369, DOI 10.1046/j.1365-2788.1996.786786.x; Ferreiro E, 2012, Int J Cell Biol, V2012, P735206, DOI 10.1155/2012/735206; FULD PA, 1990, J CLIN EXP NEUROPSYC, V12, P520, DOI 10.1080/01688639008400998; Garlet TR, 2013, LIFE SCI, V93, P558, DOI 10.1016/j.lfs.2013.08.017; Guzman R, 2011, BIOMARKERS, V16, P679, DOI 10.3109/1354750X.2011.626527; Harrison P. L., 2000, ADAPTIVE BEHAV ASSES; Ji L, 2010, J ALZHEIMERS DIS, V22, P609, DOI 10.3233/JAD-2010-101029; Kester MI, 2012, FREE RADIC BIOL MED, V62, P157; Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006; Lott IT, 2012, BBA-MOL BASIS DIS, V1822, P657, DOI 10.1016/j.bbadis.2011.12.010; Nunomura A, 2000, J NEUROPATH EXP NEUR, V59, P1011, DOI 10.1093/jnen/59.11.1011; Pastor MC, 1998, CLIN CHEM, V44, P924; Patten DA, 2010, J ALZHEIMERS DIS, V20, pS357, DOI 10.3233/JAD-2010-100498; Pratico D, 1999, ATHEROSCLEROSIS, V147, P1, DOI 10.1016/S0021-9150(99)00257-9; Pratico D, 2000, ANN NEUROL, V48, P795, DOI 10.1002/1531-8249(200011)48:5<795::AID-ANA15>3.0.CO;2-#; Pratico D, 2001, J NEUROSCI, V21, P4183, DOI 10.1523/JNEUROSCI.21-12-04183.2001; Pratico D, 2010, BBA-MOL CELL BIOL L, V1801, P930, DOI 10.1016/j.bbalip.2010.01.009; Reddy PH, 2006, J NEUROCHEM, V96, P1, DOI 10.1111/j.1471-4159.2005.03530.x; Ripoll C, 2013, BIOMARKERS, V18, P373, DOI 10.3109/1354750X.2013.783117; Sanchez MM, 2012, BIOL PSYCHIAT, V71, P403, DOI 10.1016/j.biopsych.2011.08.016; SPSS Inc, 2001, SPSS WIND REL 11 0 0; Strydom A, 2009, PROG NEURO-PSYCHOPH, V33, P76, DOI 10.1016/j.pnpbp.2008.10.006; Sultana R, 2013, FREE RADICAL BIO MED, V62, P157, DOI 10.1016/j.freeradbiomed.2012.09.027; Tolun AA, 2012, ANN EPIDEMIOL, V22, P892, DOI 10.1016/j.annepidem.2012.09.005; Uberos J, 2010, J PEDIATR ENDOCR MET, V23, P277; Yang B, 2012, NEUROSCI BULL, V28, P233, DOI 10.1007/s12264-012-1239-1; Yang HX, 2010, BIOL PSYCHIAT, V68, P922, DOI 10.1016/j.biopsych.2010.04.010; Zis P, 2012, J ALZHEIMERS DIS, V31, P277, DOI 10.3233/JAD-2012-120073	41	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e97709	10.1371/journal.pone.0097709	http://dx.doi.org/10.1371/journal.pone.0097709			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901945	gold, Green Submitted, Green Published			2022-12-27	WOS:000336841400011
J	Fuqua, BK; Lu, Y; Darshan, D; Frazer, DM; Wilkins, SJ; Wolkow, N; Bell, AG; Hsu, J; Yu, CC; Chen, HJ; Dunaief, JL; Anderson, GJ; Vulpe, CD				Fuqua, Brie K.; Lu, Yan; Darshan, Deepak; Frazer, David M.; Wilkins, Sarah J.; Wolkow, Natalie; Bell, Austin G.; Hsu, JoAnn; Yu, Catherine C.; Chen, Huijun; Dunaief, Joshua L.; Anderson, Gregory J.; Vulpe, Chris D.			The Multicopper Ferroxidase Hephaestin Enhances Intestinal Iron Absorption in Mice	PLOS ONE			English	Article							LINKED ANEMIA; CERULOPLASMIN; CELLS; EXPRESSION; TRANSPORT; ANAEMIA; EFFLUX; MOUSE; GENE; FERROPORTIN	Hephaestin is a vertebrate multicopper ferroxidase important for the transfer of dietary iron from intestinal cells to the blood. Hephaestin is mutated in the sex-linked anemia mouse, resulting in iron deficiency. However, sex-linked anemia mice still retain some hephaestin ferroxidase activity. They survive, breed, and their anemia improves with age. To gain a better understanding of the role of hephaestin in iron homeostasis, we used the Cre-lox system to generate knockout mouse models with whole body or intestine-specific (Villin promoter) ablation of hephaestin. Both types of mice were viable, indicating that hephaestin is not essential and that other mechanisms, multicopper ferroxidase-dependent or not, must compensate for hephaestin deficiency. The knockout strains, however, both developed a microcytic, hypochromic anemia, suggesting severe iron deficiency and confirming that hephaestin plays an important role in body iron acquisition. Consistent with this, the knockout mice accumulated iron in duodenal enterocytes and had reduced intestinal iron absorption. In addition, the similarities of the phenotypes of the whole body and intestine-specific hephaestin knockout mice clarify the important role of hephaestin specifically in intestinal enterocytes in maintaining whole body iron homeostasis. These mouse models will serve as valuable tools to study the role of hephaestin and associated proteins in iron transport in the small intestine and other tissues.	[Fuqua, Brie K.; Bell, Austin G.; Hsu, JoAnn; Yu, Catherine C.; Vulpe, Chris D.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Fuqua, Brie K.; Lu, Yan; Darshan, Deepak; Frazer, David M.; Wilkins, Sarah J.; Anderson, Gregory J.] QIMR Berghofer Med Res Inst, Iron Metab Lab, Brisbane, Qld, Australia; [Wolkow, Natalie; Dunaief, Joshua L.] Univ Penn, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA; [Chen, Huijun] Nanjing Univ, Sch Med, Nanjing 210008, Jiangsu, Peoples R China; [Anderson, Gregory J.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia	University of California System; University of California Berkeley; QIMR Berghofer Medical Research Institute; University of Pennsylvania; Pennsylvania Medicine; Nanjing University; University of Queensland	Anderson, GJ (corresponding author), QIMR Berghofer Med Res Inst, Iron Metab Lab, Brisbane, Qld, Australia.	Greg.Anderson@qimrberghofer.edu.au	Frazer, David M/L-3570-2014; Anderson, Gregory J/G-4148-2013; Vulpe, Chris/AAF-9170-2020; Darshan, Deepak/B-8259-2013	Frazer, David M/0000-0003-4098-1379; Anderson, Gregory J/0000-0002-8814-5866; Vulpe, Chris/0000-0001-5134-8929; Darshan, Deepak/0000-0001-9719-5980; Bell, Austin/0000-0002-4647-1882; Wolkow, Natalie/0000-0003-1524-115X	National Institutes of Health (NIH)/NIGMS [1R01GM083198-01A1]; California Agricultural Experiment Station, University of California, Berkeley through NIFA Hatch Project [CA-B-NTS-0020H]; Australian Research Council [DP120103746]; NIH (NEI) [EY015240]; National Science Foundation; National Health and Medical Research Council of Australia; NATIONAL EYE INSTITUTE [R01EY015240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083198] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); California Agricultural Experiment Station, University of California, Berkeley through NIFA Hatch Project; Australian Research Council(Australian Research Council); NIH (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Science Foundation(National Science Foundation (NSF)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by research funding from the National Institutes of Health (NIH)/NIGMS, http://www.nih.gov, grant number 1R01GM083198-01A1, to CDV; the California Agricultural Experiment Station, University of California, Berkeley through NIFA Hatch Project CA-B-NTS-0020H, to CDV; the Australian Research Council, www.arc.gov.au, grant number DP120103746, to GJA and CDV; the NIH (NEI), grant number EY015240, to JLD; and the National Science Foundation graduate research fellowship to BKF. GJA is the recipient of a Senior Research Fellowship from the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANNERMAN RM, 1967, BRIT J HAEMATOL, V13, P1000, DOI 10.1111/j.1365-2141.1967.tb08869.x; Bouabe H, 2013, METHODS MOL BIOL, V1064, P315, DOI 10.1007/978-1-62703-601-6_23; Chen HJ, 2004, BLOOD, V103, P3933, DOI 10.1182/blood-2003-09-3139; Chen HJ, 2003, BLOOD, V102, P1893, DOI 10.1182/blood-2003-02-0347; Chen HJ, 2010, J NUTR, V140, P1728, DOI 10.3945/jn.109.117531; Chen HJ, 2009, BIOMETALS, V22, P827, DOI 10.1007/s10534-009-9229-0; Chen HJ, 2009, J CELL BIOCHEM, V107, P803, DOI 10.1002/jcb.22178; Cherukuri S, 2005, CELL METAB, V2, P309, DOI 10.1016/j.cmet.2005.10.003; Collins JF, 2012, PHYSL GASTROINTESTIN, P1921; CREAMER B, 1961, GUT, V2, P110, DOI 10.1136/gut.2.2.110; Darshan D, 2010, HAEMATOL-HEMATOL J, V95, P1660, DOI 10.3324/haematol.2010.022426; De Domenico I, 2007, EMBO J, V26, P2823, DOI 10.1038/sj.emboj.7601735; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Frazer DM, 2001, AM J PHYSIOL-GASTR L, V281, pG931, DOI 10.1152/ajpgi.2001.281.4.G931; GREWAL MS, 1962, GENET RES, V3, P238, DOI 10.1017/S0016672300035023; Hudson DM, 2009, AM J PHYSL GASTROINT; Jankowska Ewa A, 2010, Heart Fail Clin, V6, P295, DOI 10.1016/j.hfc.2010.03.003; Jeong SY, 2003, J BIOL CHEM, V278, P27144, DOI 10.1074/jbc.M301988200; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kono S, 2010, BBA-MOL BASIS DIS, V1802, P968, DOI 10.1016/j.bbadis.2010.07.011; Kuo YM, 2004, GUT, V53, P201, DOI 10.1136/gut.2003.019026; OSAKI S, 1966, J BIOL CHEM, V241, P2746; Perls M, 1867, VIRCHOW ARCH A, V39, P42, DOI DOI 10.1007/BF01878983; PINKERTO.PH, 1967, NATURE, V216, P482, DOI 10.1038/216482a0; PINKERTON PH, 1970, BRIT J HAEMATOL, V18, P211, DOI 10.1111/j.1365-2141.1970.tb01435.x; Qian ZM, 2007, BBA-MOL BASIS DIS, V1772, P527, DOI 10.1016/j.bbadis.2007.02.006; Qian ZM, 2007, J CELL BIOCHEM, V102, P1225, DOI 10.1002/jcb.21352; Ranganathan PN, 2012, P NATL ACAD SCI USA, V109, P3564, DOI 10.1073/pnas.1120833109; Schulz K, 2011, J NEUROSCI, V31, P13301, DOI 10.1523/JNEUROSCI.2838-11.2011; SORBIE J, 1974, BRIT J HAEMATOL, V27, P559, DOI 10.1111/j.1365-2141.1974.tb06621.x; Spasic MV, 2007, BLOOD, V109, P4511, DOI 10.1182/blood-2006-07-036186; Syed BA, 2002, PROTEIN ENG, V15, P205, DOI 10.1093/protein/15.3.205; TORRANCE J D, 1968, South African Journal of Medical Sciences, V33, P9; Vulpe CD, 1999, NAT GENET, V21, P195, DOI 10.1038/5979; WELCH S, 1992, TRANSFERRIN IRON CAR; Wolkow N, 2012, AM J PATHOL, V180, P1614, DOI 10.1016/j.ajpath.2011.12.041	36	57	60	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98792	10.1371/journal.pone.0098792	http://dx.doi.org/10.1371/journal.pone.0098792			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896847	gold, Green Published, Green Submitted			2022-12-27	WOS:000338430700080
J	Vaclavikova, E; Dvorakova, S; Skaba, R; Pos, L; Sykorova, V; Halkova, T; Vcelak, J; Bendlova, B				Vaclavikova, Eliska; Dvorakova, Sarka; Skaba, Richard; Pos, Lucie; Sykorova, Vlasta; Halkova, Tereza; Vcelak, Josef; Bendlova, Bela			RET Variants and Haplotype Analysis in a Cohort of Czech Patients with Hirschsprung Disease	PLOS ONE			English	Article							MEDULLARY-THYROID CARCINOMA; SOUTHEASTERN CHINESE; PROTOONCOGENE; COMMON; MUTATIONS; ALLELES; 3'UTR; RISK; RARE	Hirschsprung disease (HSCR) is a congenital aganglionosis of myenteric and submucosal plexuses in variable length of the intestine. This study investigated the influence and a possible modifying function of RET proto-oncogene's single nucleotide polymorphisms (SNPs) and haplotypes in the development and phenotype of the disease in Czech patients. Genotyping of 14 SNPs was performed using TaqMan Genotyping Assays and direct sequencing. The frequencies of SNPs and generated haplotypes were statistically evaluated using chi-square test and the association with the risk of HSCR was estimated by odds ratio. SNP analysis revealed significant differences in frequencies of 11 polymorphic RET variants between 162 HSCR patients and 205 unaffected controls. Particularly variant alleles of rs1864410, rs2435357, rs2506004 (intron 1), rs1800858 (exon 2), rs1800861 (exon 13), and rs2565200 (intron 19) were strongly associated with increased risk of HSCR (p<0.00000) and were over-represented in males vs. females. Conversely, variant alleles of rs1800860, rs1799939 and rs1800863 (exons 7, 11, 15) had a protective role. The haploblock comprising variants in intron 1 and exon 2 was constructed. It represented a high risk of HSCR, however, the influence of other variants was also found after pruning from effect of this haploblock. Clustering patients according to genotype status in haploblock revealed a strong co-segregation with several SNPs and pointed out the differences between long and short form of HSCR. This study involved a large number of SNPs along the entire RET proto-oncogene with demonstration of their risk/protective role also in haplotype and diplotype analysis in the Czech population. The influence of some variant alleles on the aggressiveness of the disease and their role in gender manifestation differences was found. These data contribute to worldwide knowledge of the genetics of HSCR.	[Vaclavikova, Eliska; Dvorakova, Sarka; Sykorova, Vlasta; Halkova, Tereza; Vcelak, Josef; Bendlova, Bela] Res Inst Endocrinol, Dept Mol Endocrinol, CR-11694 Prague, Czech Republic; [Skaba, Richard; Pos, Lucie] Charles Univ Prague, Fac Med 2, Dept Paediat Surg, Prague, Czech Republic; [Skaba, Richard; Pos, Lucie] Hosp Motol, Prague, Czech Republic	Institute of Endocrinology - Prague; Charles University Prague; Motol University Hospital	Vaclavikova, E (corresponding author), Res Inst Endocrinol, Dept Mol Endocrinol, CR-11694 Prague, Czech Republic.	evaclavikova@endo.cz	Hálková, Tereza/Q-9275-2017	Hálková, Tereza/0000-0001-9320-4210	IGA MH CR [NT13901-4]; GAUK [411611]; MH CZ	IGA MH CR; GAUK; MH CZ	This work was supported by grant projects IGA MH CR NT13901-4, GAUK 411611 and MH CZ for conceptual development of research organisation 00023761 (Institute of Endocrinology, Prague, Czech Republic). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Borrego S, 2000, J MED GENET, V37, P572, DOI 10.1136/jmg.37.8.572; Burzynski GM, 2005, AM J HUM GENET, V76, P850, DOI 10.1086/429589; Dvorakova S, 2005, J PEDIATR SURG, V40, DOI 10.1016/j.jpedsurg.2005.03.031; Emison ES, 2010, AM J HUM GENET, V87, P60, DOI 10.1016/j.ajhg.2010.06.007; Fernandez RM, 2005, J MED GENET, V42, P322, DOI 10.1136/jmg.2004.023960; Fitze G, 2002, LANCET, V359, P1200, DOI 10.1016/S0140-6736(02)08218-1; Garcia-Barcelo M, 2005, HUM MOL GENET, V14, P191, DOI 10.1093/hmg/ddi015; Garcia-Barcelo MM, 2003, J MED GENET, V40; Griseri P, 2000, EUR J HUM GENET, V8, P721, DOI 10.1038/sj.ejhg.5200521; Griseri P, 2007, HUM MUTAT, V28, P168, DOI 10.1002/humu.20397; Lantieri F, 2006, ANN HUM GENET, V70, P12, DOI 10.1111/j.1529-8817.2005.00196.x; Lesueur F, 2002, J MED GENET, V39, P260, DOI 10.1136/jmg.39.4.260; Miao XP, 2010, HUM MOL GENET, V19, P1461, DOI 10.1093/hmg/ddq020; Nunez-Torres R, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-138; Pan ZW, 2012, J PEDIATR SURG, V47, P1699, DOI 10.1016/j.jpedsurg.2012.03.057; Sribudiani Y, 2011, GASTROENTEROLOGY, V140, P572, DOI 10.1053/j.gastro.2010.10.044; Tou JF, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-32; Vaclavikova E, 2012, PEDIATR SURG INT, V28, P123, DOI 10.1007/s00383-011-2993-2	19	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98957	10.1371/journal.pone.0098957	http://dx.doi.org/10.1371/journal.pone.0098957			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897126	Green Published, Green Submitted, gold			2022-12-27	WOS:000338430700102
J	Xu, KD; Chang, YX; Liu, K; Wang, FG; Liu, ZY; Zhang, T; Li, T; Zhang, Y; Zhang, FL; Zhang, J; Wang, Y; Niu, W; Jia, SZ; Xie, HC; Tan, GX; Li, CW				Xu, Kedong; Chang, Yunxia; Liu, Kun; Wang, Feige; Liu, Zhongyuan; Zhang, Ting; Li, Tong; Zhang, Yi; Zhang, Fuli; Zhang, Ju; Wang, Yan; Niu, Wei; Jia, Shuzhao; Xie, Hengchang; Tan, Guangxuan; Li, Chengwei			Regeneration of Solanum nigrum by Somatic Embryogenesis, Involving Frog Egg-Like Body, a Novel Structure	PLOS ONE			English	Article							L.; PROTOPLASTS; MECHANISM; APOPTOSIS; GROWTH; CELLS; FRUIT	A new protocol was established for the regeneration of Solanum nigrum by frog egg-like bodies (FELBs), which are novel somatic embryogenesis (SE) structures induced from the root, stem, and leaf explants. The root, stem, and leaf explants (93.33%, 85.10%, and 100.00%, respectively) were induced to form special embryonic calli on Murashige and Skoog (MS) medium containing 1.0 mg/L 2,4-dichlorophenoxyacetic acid, under dark condition. Further, special embryonic calli from the root, stem, and leaf explants (86.97%, 83.30%, and 99.47%, respectively) were developed into FELBs. Plantlets of FELBs from the three explants were induced in vitro on MS medium supplemented with 5.0 mg/L 6-benzylaminopurine and 0.1 mg/L gibberellic acid, and 100.00% plantlet induction rates were noted. However, plantlet induction in vivo on MS medium supplemented with 20 mg/L thidiazuron showed rates of 38.63%, 15.63%, and 61.30% for the root, stem, and leaf explants, respectively, which were lower than those of the in vitro culture. Morphological and histological analyses of FELBs at different development stages revealed that they are a novel type of SE structure that developed from the mesophyll (leaf) or cortex (stem and root) cells of S. nigrum.	[Xu, Kedong; Liu, Kun; Zhang, Yi; Zhang, Fuli; Zhang, Ju; Wang, Yan; Tan, Guangxuan; Li, Chengwei] Zhoukou Normal Univ, Key Lab Plant Genet & Mol Breeding, Zhoukou, Peoples R China; [Chang, Yunxia; Wang, Feige; Liu, Zhongyuan; Zhang, Ting; Li, Tong; Niu, Wei; Jia, Shuzhao; Xie, Hengchang] Zhoukou Normal Univ, Coll Life Sci & Agron, Zhoukou, Peoples R China; [Wang, Yan] Henan Agr Univ, Coll Life Sci, Zhengzhou, Peoples R China	Zhoukou Normal University; Zhoukou Normal University; Henan Agricultural University	Li, CW (corresponding author), Zhoukou Normal Univ, Key Lab Plant Genet & Mol Breeding, Zhoukou, Peoples R China.	lichengweiwau@hotmail.com			National Natural Science Foundation of China [31272168]; Plan For Scientific Innovation Talent of Henan Province [124100510021]; Science and Technology Research Major Projects of Department of Education of Henan Province [13B210270, 14A180003]; Doctoral Scientific Research Starting Foundation of Zhoukou Normal University [zksybscx201108]; Scientific Research and Innovation Fund Projects of Zhoukou Normal University [zksykycx201306]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Plan For Scientific Innovation Talent of Henan Province; Science and Technology Research Major Projects of Department of Education of Henan Province; Doctoral Scientific Research Starting Foundation of Zhoukou Normal University; Scientific Research and Innovation Fund Projects of Zhoukou Normal University	The research was funded by National Natural Science Foundation of China (No. 31272168) (http://www.nsfc.gov.cn/), Plan For Scientific Innovation Talent of Henan Province (No. 124100510021) (http://www.hnkjt.gov.cn), Science and Technology Research Major Projects of Department of Education of Henan Province (No. 13B210270 and No. 14A180003) (http://www.haedu.gov.cn/), Doctoral Scientific Research Starting Foundation of Zhoukou Normal University (No. zksybscx201108) (http://www.zknu.edu.cn/) and Scientific Research and Innovation Fund Projects of Zhoukou Normal University (No. zksykycx201306) (http://www.zknu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arulmozhi V, 2012, J BIOTECHNOL TECHNOL, V3, P339; Bedford ID, 1998, EUR J PLANT PATHOL, V104, P221, DOI 10.1023/A:1008627419450; BINDING H, 1982, THEOR APPL GENET, V63, P273, DOI 10.1007/BF00304007; Chen XQ, 2005, J CENT SOUTH UNIV T, V12, P556, DOI 10.1007/s11771-005-0122-x; Correia S, 2012, PLANT CELL TISS ORG, V109, P143, DOI 10.1007/s11240-011-0082-9; Ding X, 2012, J ETHNOPHARMACOL, V139, P599, DOI 10.1016/j.jep.2011.11.058; Essien EE, 2012, PHARM BIOL, V50, P474, DOI 10.3109/13880209.2011.614623; GUPTA PK, 1987, BIO-TECHNOL, V5, P147, DOI 10.1038/nbt0287-147; Inta A, 2008, J ETHNOPHARMACOL, V116, P508, DOI 10.1016/j.jep.2007.12.015; Jainu M, 2006, J ETHNOPHARMACOL, V104, P156, DOI 10.1016/j.jep.2005.08.064; Jainu Mallika, 2004, Indian J Clin Biochem, V19, P57, DOI 10.1007/BF02872391; Javed T, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-26; Jeong JB, 2007, J AGR FOOD CHEM, V55, P10707, DOI 10.1021/jf072363p; Jimoh FO, 2010, FOOD CHEM TOXICOL, V48, P964, DOI 10.1016/j.fct.2010.01.007; Kumar GK, 2012, PLANT CELL TISS ORG, V110, P141, DOI 10.1007/s11240-012-0138-5; Kumar VP, 2001, FITOTERAPIA, V72, P481, DOI 10.1016/S0367-326X(01)00266-0; Lebecka R, 2008, EUR J PLANT PATHOL, V120, P233, DOI 10.1007/s10658-007-9211-z; Luo SL, 2011, APPL MICROBIOL BIOT, V89, P1637, DOI 10.1007/s00253-010-2927-2; MACEK T, 1994, BIOTECHNOL LETT, V16, P621, DOI 10.1007/BF00128611; Man SL, 2012, PHYTOTHER RES, V26, P1449, DOI 10.1002/ptr.4609; Muhammad Zubair, 2011, International Journal of Phytomedicine, V3, P63; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NEHLS R, 1978, PLANT SCI LETT, V12, P183, DOI 10.1016/0304-4211(78)90152-9; QUAKENBUSH LS, 1985, WEED SCI, V33, P386, DOI 10.1017/S0043174500082473; Raghavendra K, 2009, INDIAN J MED RES, V130, P74; RAO GR, 1978, ACTA BOT INDICA, V6, P41; RAO MK, 1971, GENETICA, V42, P157, DOI 10.1007/BF00154846; Rawani A, 2010, PARASITOL RES, V107, P1235, DOI 10.1007/s00436-010-1993-9; Rohani ER, 2012, PLANT CELL TISS ORG, V110, P251, DOI 10.1007/s11240-012-0147-4; Son YO, 2003, FOOD CHEM TOXICOL, V41, P1421, DOI 10.1016/S0278-6915(03)00161-3; Sun Y, 2012, DRUG DISCOV THER, V6, P242, DOI 10.5582/ddt.2012.v6.5.242; Venkatesan D, 2004, BIOORGAN MED CHEM, V15, P2528; WEI ZM, 1986, PLANT CELL REP, V5, P93, DOI 10.1007/BF00269242; Xu J, 2009, PLANT CELL REP, V28, P325, DOI 10.1007/s00299-008-0643-5; Xu KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083556; Yang L, 2012, PLANT CELL TISS ORG, V109, P547, DOI 10.1007/s11240-012-0121-1; Yogananth N, 2012, GLOB J BIOTECHNOL BI, V7, P86; Zhao WN, 2011, PLANT CELL TISS ORG, V106, P475, DOI 10.1007/s11240-011-9946-2; Zhou HC, 2010, PLANT CELL TISS ORG, V101, P79, DOI 10.1007/s11240-010-9666-z; Zhou XL, 2006, J NAT PROD, V69, P1158, DOI 10.1021/np060091z; Zimnoch-Guzowska E, 2003, THEOR APPL GENET, V107, P43, DOI 10.1007/s00122-003-1221-4	41	15	18	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98672	10.1371/journal.pone.0098672	http://dx.doi.org/10.1371/journal.pone.0098672			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896090	gold, Green Submitted, Green Published			2022-12-27	WOS:000338430700063
J	Adams, VM; Pressey, RL; Stoeckl, N				Adams, Vanessa M.; Pressey, Robert L.; Stoeckl, Natalie			Estimating Landholders' Probability of Participating in a Stewardship Program, and the Implications for Spatial Conservation Priorities	PLOS ONE			English	Article							WILLINGNESS-TO-SELL; BIODIVERSITY CONSERVATION; DESIGN; COSTS; OPPORTUNITY; MANAGEMENT; PAYMENTS; AUCTIONS; SCALE	The need to integrate social and economic factors into conservation planning has become a focus of academic discussions and has important practical implications for the implementation of conservation areas, both private and public. We conducted a survey in the Daly Catchment, Northern Territory, to inform the design and implementation of a stewardship payment program. We used a choice model to estimate the likely level of participation in two legal arrangements conservation covenants and management agreements - based on payment level and proportion of properties required to be managed. We then spatially predicted landholders' probability of participating at the resolution of individual properties and incorporated these predictions into conservation planning software to examine the potential for the stewardship program to meet conservation objectives. We found that the properties that were least costly, per unit area, to manage were also the least likely to participate. This highlights a tension between planning for a cost-effective program and planning for a program that targets properties with the highest probability of participation.	[Adams, Vanessa M.; Pressey, Robert L.] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Adams, Vanessa M.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia; [Adams, Vanessa M.] Charles Darwin Univ, Northern Australia Natl Environm Res Program Hub, Darwin, NT 0909, Australia; [Stoeckl, Natalie] James Cook Univ, Sch Business, Townsville, Qld 4811, Australia; [Stoeckl, Natalie] James Cook Univ, Cairns Inst, Townsville, Qld 4811, Australia	James Cook University; Charles Darwin University; Charles Darwin University; James Cook University; James Cook University	Adams, VM (corresponding author), James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	vanessa.adams@cdu.edu.au	Stoeckl, Natalie/AAU-8562-2020; Adams, Vanessa M./A-3834-2012; Stoeckl, Natalie E/B-2000-2012	Stoeckl, Natalie/0000-0001-5899-4771; Adams, Vanessa M./0000-0002-3509-7901; Stoeckl, Natalie E/0000-0001-5899-4771	Nature Conservancy; Thomas Foundation; Australian Research Council	Nature Conservancy; Thomas Foundation; Australian Research Council(Australian Research Council)	VMA acknowledges funding for field work through The Nature Conservancy and The Thomas Foundation. RLP acknowledges support from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams VM, 2013, LAND USE POLICY, V30, P114, DOI 10.1016/j.landusepol.2012.03.009; Adams VM, 2012, BIOL CONSERV, V148, P44, DOI 10.1016/j.biocon.2012.01.064; Adams VM, 2013, ENVIRON RES LETT, V8, DOI [10.1088/1748-9326/1088/1082/025018, DOI 10.1088/1748-9326/1088/1082/025018.]; [Anonymous], [No title captured]; Armsworth PR, 2011, BIOL CONSERV, V144, P423, DOI 10.1016/j.biocon.2010.09.026; Armsworth PR, 2008, CONSERV LETT, V1, P182, DOI 10.1111/j.1755-263X.2008.00028.x; Armsworth PR, 2006, P NATL ACAD SCI USA, V103, P5403, DOI 10.1073/pnas.0505278103; Ban NC, 2013, FRONT ECOL ENVIRON, V11, P194, DOI 10.1890/110205; Ban NC, 2011, CONSERV LETT, V4, P241, DOI 10.1111/j.1755-263X.2011.00171.x; Broch SW, 2012, ENVIRON RESOUR ECON, V51, P561, DOI 10.1007/s10640-011-9512-8; Bruner AG, 2004, BIOSCIENCE, V54, P1119, DOI 10.1641/0006-3568(2004)054[1119:FCASOM]2.0.CO;2; Bryan BA, 2008, J ENVIRON MANAGE, V88, P1175, DOI 10.1016/j.jenvman.2007.06.003; Claassen R, 2008, ECOL ECON, V65, P737, DOI 10.1016/j.ecolecon.2007.07.032; Commonwealth of Australia, 2008, CAR OUR COUNTR OUTC; DERM, 2007, DELB AGR STAT RUR LE; Dillman D. A., 2014, INTERNET PHONE MAIL; Ferraro PJ, 2008, ECOL ECON, V65, P810, DOI 10.1016/j.ecolecon.2007.07.029; Fitzsimons JA, 2004, ENVIRON SCI POLICY, V7, P477, DOI 10.1016/j.envsci.2004.08.005; FITZSIMONS JA, 2006, ENV PLANNING LAW J, V23, P365; Game ET, 2011, CONSERV LETT, V4, P38, DOI 10.1111/j.1755-263X.2010.00140.x; Guerrero AM, 2010, CONSERV LETT, V3, P332, DOI 10.1111/j.1755-263X.2010.00116.x; Hajkowicz S, 2007, AUST J AGR RESOUR EC, V51, P39, DOI 10.1111/j.1467-8489.2007.00345.x; Hensher D.A, 2006, APPL CHOICE ANAL PRI; Horne P, 2006, SILVA FENN, V40, P169, DOI 10.14214/sf.359; Horne P, 2005, FOREST ECOL MANAG, V207, P189, DOI 10.1016/j.foreco.2004.10.026; Jack BK, 2009, CONSERV BIOL, V23, P359, DOI 10.1111/j.1523-1739.2008.01086.x; Jacobsen JB, 2010, ECOL ECON, V69, P1532, DOI 10.1016/j.ecolecon.2010.02.013; James AN, 1999, NATURE, V401, P323, DOI 10.1038/43774; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Knight AT, 2011, BIOL CONSERV, V144, P2623, DOI 10.1016/j.biocon.2011.07.013; Lombard AT, 2010, ECOL SOC, V15; McCrea-Strub A, 2011, MAR POLICY, V35, P1, DOI 10.1016/j.marpol.2010.07.001; Moon K, 2011, J RURAL STUD, V27, P331, DOI 10.1016/j.jrurstud.2011.04.001; Moon K, 2011, CONSERV BIOL, V25, P493, DOI 10.1111/j.1523-1739.2010.01639.x; Nicholson E, 2006, ECOL LETT, V9, P1049, DOI 10.1111/j.1461-0248.2006.00956.x; NRETAS, 2009, REC SIT CONS SIGN BI; Orme B, 1998, SAMPLE SIZE ISSUES C; Polasky S, 2008, P NATL ACAD SCI USA, V105, P6505, DOI 10.1073/pnas.0802815105; Pressey RL, 2013, BIOL CONSERV, V166, P155, DOI 10.1016/j.biocon.2013.06.025; Rose JM, 2013, TRANSPORTATION, V40, P1021, DOI 10.1007/s11116-013-9451-z; Rouget M, 2006, CONSERV BIOL, V20, P549, DOI 10.1111/j.1523-1739.2006.00297.x; Seddon JA, 2010, CONSERV LETT, V3, P415, DOI 10.1111/j.1755-263X.2010.00135.x; Stewart RR, 2005, ENVIRON MODEL ASSESS, V10, P203, DOI 10.1007/s10666-005-9001-y; Stoneham G, 2003, AUST J AGR RESOUR EC, V47, P477, DOI 10.1111/j.1467-8489.2003.t01-1-00224.x; UNEP, 2010, 10 M C PAR CONV BIOL; Watts M. E, 2009, ENVIRON MODELL SOFTW, DOI [10.1016/j.envsoft.2009.06.005, DOI 10.1016/J.ENVS0FT.2009.06.005, DOI 10.1016/J.ENVSOFT.2009.06.005]; Woinarski JCZ, 2013, LAND, V2, P20, DOI 10.3390/land2010020; Zander KK, 2010, ECOL ECON, V69, P2417, DOI 10.1016/j.ecolecon.2010.07.010; Zander KK, 2010, J ENVIRON MANAGE, V91, P2519, DOI 10.1016/j.jenvman.2010.07.012	49	31	31	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e97941	10.1371/journal.pone.0097941	http://dx.doi.org/10.1371/journal.pone.0097941			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5ML	24892520	Green Accepted, Green Published, gold			2022-12-27	WOS:000336911400027
J	Inacio, V; Rocheta, M; Morais-Cecilio, L				Inacio, Vera; Rocheta, Margarida; Morais-Cecilio, Leonor			Molecular Organization of the 25S-18S rDNA IGS of Fagus sylvatica and Quercus suber: A Comparative Analysis	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; INTERGENIC SPACER REGION; STRUCTURAL-ANALYSIS; POLYMERASE-I; ARABIDOPSIS-THALIANA; NUCLEOTIDE-SEQUENCE; EXTERNAL SPACER; WESTERN EURASIA; LENGTH VARIANTS; DNA REPEAT	The 35S ribosomal DNA (rDNA) units, repeated in tandem at one or more chromosomal loci, are separated by an intergenic spacer (IGS) containing functional elements involved in the regulation of transcription of downstream rRNA genes. In the present work, we have compared the IGS molecular organizations in two divergent species of Fagaceae, Fagus sylvatica and Quercus suber, aiming to comprehend the evolution of the IGS sequences within the family. Self- and cross-hybridization FISH was done on representative species of the Fagaceae. The IGS length variability and the methylation level of 18 and 25S rRNA genes were assessed in representatives of three genera of this family: Fagus, Quercus and Castanea. The intergenic spacers in Beech and Cork Oak showed similar overall organizations comprising putative functional elements needed for rRNA gene activity and containing a non-transcribed spacer (NTS), a promoter region, and a 5'-external transcribed spacer. In the NTS: the sub-repeats structure in Beech is more organized than in Cork Oak, sharing some short motifs which results in the lowest sequence similarity of the entire IGS; the AT-rich region differed in both spacers by a GC-rich block inserted in Cork Oak. The 5'-ETS is the region with the higher similarity, having nonetheless different lengths. FISH with the NTS-5'-ETS revealed fainter signals in cross-hybridization in agreement with the divergence between genera. The diversity of IGS lengths revealed variants from similar to 2 kb in Fagus, and Quercus up to 5.3 kb in Castanea, and a lack of correlation between the number of variants and the number of rDNA loci in several species. Methylation of 25S Bam HI site was confirmed in all species and detected for the first time in the 18S of Q. suber and Q. faginea. These results provide important clues for the evolutionary trends of the rDNA 25S-18S IGS in the Fagaceae family.	[Inacio, Vera; Rocheta, Margarida; Morais-Cecilio, Leonor] Univ Lisbon, Inst Super Agron, CBAA, P-1699 Lisbon, Portugal	Universidade de Lisboa	Morais-Cecilio, L (corresponding author), Univ Lisbon, Inst Super Agron, CBAA, P-1699 Lisbon, Portugal.	lmorais@isa.ulisboa.pt	Rocheta, Margarida/E-9156-2015; Inacio, Vera/AAY-2356-2020; Morais-Cecilio, Leonor/AAH-5920-2019	Rocheta, Margarida/0000-0003-3939-4564; Inacio, Vera/0000-0002-5652-2540; Morais-Cecilio, Leonor/0000-0001-9313-2253	Fundacao para a Ciencia e Tecnologia - FCT [PTDC/AGR-GFL/104197/2008, SFRH/BPD/64905/2009]	Fundacao para a Ciencia e Tecnologia - FCT(Portuguese Foundation for Science and Technology)	This research was funded by Fundacao para a Ciencia e Tecnologia - FCT (www.fct.pt/) through project PTDC/AGR-GFL/104197/2008 and the post-doc grant SFRH/BPD/64905/2009 that supported MR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose CD, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-13; APPELS R, 1986, CAN J GENET CYTOL, V28, P673, DOI 10.1139/g86-097; APPELS R, 1980, CHROMOSOMA, V78, P293, DOI 10.1007/BF00327389; ARNHEIM N, 1980, P NATL ACAD SCI-BIOL, V77, P7323, DOI 10.1073/pnas.77.12.7323; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; BARKER RF, 1988, J MOL BIOL, V201, P1, DOI 10.1016/0022-2836(88)90434-2; Bauer N, 2009, MOL GENET GENOMICS, V281, P207, DOI 10.1007/s00438-008-0404-8; Bellarosa R, 2005, MOL PHYLOGENET EVOL, V34, P355, DOI 10.1016/j.ympev.2004.10.014; BELLAROSA R, 1990, PLANT SYST EVOL, V172, P127, DOI 10.1007/BF00937803; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bhatia S, 1996, J MOL EVOL, V43, P460, DOI 10.1007/BF02337518; Bierhoff H, 2013, EPIGENETICS, V9; BORISJUK N, 1993, PLANT MOL BIOL, V21, P381, DOI 10.1007/BF00019953; Borisjuk NV, 1997, PLANT MOL BIOL, V35, P655, DOI 10.1023/A:1005856618898; BROWN DD, 1972, J MOL BIOL, V63, P57, DOI 10.1016/0022-2836(72)90521-9; Bryant JA, 2011, ANN BOT-LONDON, V107, P1119, DOI 10.1093/aob/mcr075; Cannon CH, 2001, SYST BIOL, V50, P860, DOI 10.1080/106351501753462849; Chang KD, 2010, GENOMICS, V96, P181, DOI 10.1016/j.ygeno.2010.05.005; Chokchaichamnankit P, 2008, SILVAE GENET, V57, P5, DOI 10.1515/sg-2008-0002; Coffman FD, 2006, CELL CYCLE, V5, P1223, DOI 10.4161/cc.5.11.2814; CORDESSE F, 1993, J MOL EVOL, V36, P369, DOI 10.1007/BF00182184; CROTHERS DM, 1990, J BIOL CHEM, V265, P7093; DAROCHA PSCF, 1995, EUR J BIOCHEM, V229, P550, DOI 10.1111/j.1432-1033.1995.tb20497.x; DELCASSOTREMOUSAYGUE D, 1988, EUR J BIOCHEM, V172, P767, DOI 10.1111/j.1432-1033.1988.tb13956.x; Denk T, 2002, PLANT SYST EVOL, V232, P213, DOI 10.1007/s006060200044; Denk T, 2010, TAXON, V59, P351, DOI 10.1002/tax.592002; Denk T, 2009, INT J PLANT SCI, V170, P926, DOI 10.1086/600134; DOELLING JH, 1993, P NATL ACAD SCI USA, V90, P7528, DOI 10.1073/pnas.90.16.7528; DOVER GA, 1986, PHILOS T R SOC B, V312, P275, DOI 10.1098/rstb.1986.0007; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; ELLIS THN, 1984, CHROMOSOMA, V91, P74, DOI 10.1007/BF00286487; Gallois A, 1999, ANN FOREST SCI, V56, P615, DOI 10.1051/forest:19990709; Garcia S, 2013, HEREDITY, V111, P23, DOI 10.1038/hdy.2013.11; GERLACH WL, 1979, NUCLEIC ACIDS RES, V7, P1869, DOI 10.1093/nar/7.7.1869; GERSTNER J, 1988, GENOME, V30, P723, DOI 10.1139/g88-120; GONZALEZ IL, 1995, GENOMICS, V27, P320, DOI 10.1006/geno.1995.1049; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; GRUENDLER P, 1991, J MOL BIOL, V221, P1209, DOI 10.1016/0022-2836(91)90929-Z; Grummt I, 2003, NAT REV MOL CELL BIO, V4, P641, DOI 10.1038/nrm1171; Guerra M, 2000, GENET MOL BIOL, V23, P1029, DOI 10.1590/S1415-47572000000400049; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HUANG LH, 1982, NUCLEIC ACIDS RES, V10, P1579, DOI 10.1093/nar/10.5.1579; Huang Y, 2004, BIOINFORMATICS, V20, P460, DOI 10.1093/bioinformatics/btg429; KARVONEN P, 1993, HEREDITY, V71, P614, DOI 10.1038/hdy.1993.186; KATO A, 1990, PLANT MOL BIOL, V14, P983, DOI 10.1007/BF00019395; KELLY RJ, 1989, GENE, V80, P239, DOI 10.1016/0378-1119(89)90288-6; KIM J, 1995, J BIOL CHEM, V270, P1282, DOI 10.1074/jbc.270.3.1282; KING K, 1993, J MOL EVOL, V36, P144, DOI 10.1007/BF00166250; Komarova NY, 2008, PLANT SYST EVOL, V276, P59, DOI 10.1007/s00606-008-0091-2; Komarova NY, 2004, PLANT MOL BIOL, V56, P439, DOI 10.1007/s11103-004-4678-x; Kremer Antoine, 2007, V7, P161; KUHN A, 1990, P NATL ACAD SCI USA, V87, P7527, DOI 10.1073/pnas.87.19.7527; LABHART P, 1984, CELL, V37, P285, DOI 10.1016/0092-8674(84)90324-6; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lim KY, 2004, GENETICS, V166, P1935, DOI 10.1534/genetics.166.4.1935; MAGGINI F, 1981, PROTOPLASMA, V108, P163, DOI 10.1007/BF01276890; MAGGINI F, 1992, PLANT MOL BIOL, V18, P1073, DOI 10.1007/BF00047710; Maggini F, 2008, TREE GENET GENOMES, V4, P293, DOI 10.1007/s11295-007-0109-x; Manos PS, 1999, MOL PHYLOGENET EVOL, V12, P333, DOI 10.1006/mpev.1999.0614; Manos PS, 2001, INT J PLANT SCI, V162, P1361, DOI 10.1086/322949; Matyasek R, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-722; MCMULLEN MD, 1986, NUCLEIC ACIDS RES, V14, P4953, DOI 10.1093/nar/14.12.4953; MITCHELSON K, 1987, NUCLEIC ACIDS RES, V15, P9577, DOI 10.1093/nar/15.22.9577; Miyano M, 2001, MOL BIOL REP, V28, P53, DOI 10.1023/A:1011999730828; MOSS T, 1995, PROG NUCLEIC ACID RE, V50, P25, DOI 10.1016/S0079-6603(08)60810-7; Muir G, 2001, MOL BIOL EVOL, V18, P112, DOI 10.1093/oxfordjournals.molbev.a003785; Narayanan V, 2006, CELL, V125, P1283, DOI 10.1016/j.cell.2006.04.042; NEVES N, 1995, THEOR APPL GENET, V91, P529, DOI 10.1007/BF00222984; Oh SH, 2008, TAXON, V57, P434, DOI 10.2307/25066014; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Parvaresh M, 2013, PLANT SYST EVOL, P1, DOI DOI 10.1109/ICIEV.2013.6572592; Pedrosa-Harand A, 2006, THEOR APPL GENET, V112, P924, DOI 10.1007/s00122-005-0196-8; PERRY KL, 1990, MOL GEN GENET, V221, P102, DOI 10.1007/BF00280374; PIKAARD CS, 1994, P NATL ACAD SCI USA, V91, P464, DOI 10.1073/pnas.91.2.464; Poczai P, 2010, MOL BIOL REP, V37, P1897, DOI 10.1007/s11033-009-9630-3; Polanco C, 1998, GENETICS, V149, P243; POLANS NO, 1986, THEOR APPL GENET, V72, P289, DOI 10.1007/BF00288563; Pollard KS, 2006, PLOS GENET, V2, P1599, DOI 10.1371/journal.pgen.0020168; Pontvianne F, 2012, GENE DEV, V26, P945, DOI 10.1101/gad.182865.111; Preuss SB, 2008, MOL CELL, V32, P673, DOI 10.1016/j.molcel.2008.11.009; Ribeiro T, 2011, TREE GENET GENOMES, V7, P1113, DOI 10.1007/s11295-011-0399-x; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roa F, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-225; ROGERS SO, 1987, GENETICS, V117, P285; Santoro R, 2010, EMBO REP, V11, P52, DOI 10.1038/embor.2009.254; SCHIEBEL K, 1989, MOL GEN GENET, V218, P302, DOI 10.1007/BF00331282; Schwarzacher T, 2000, PRACTICAL SITU HYBRI, V2; Singh GB., 2000, ACM SIGKDD EXPLOR NE, V1, P39, DOI [10.1145/846183.846184, DOI 10.1145/846183.846184]; Smarda P, 2012, PLANT GENOME DIVERSI, V1, P209, DOI [10.1007/978-3-7091-1130-7_14, DOI 10.1007/978-3-7091-1130-7_14]; Suzuki A, 1996, PLANT CELL PHYSIOL, V37, P233, DOI 10.1093/oxfordjournals.pcp.a028937; Tanaka H, 2009, NAT REV CANCER, V9, P215, DOI 10.1038/nrc2591; TORRES RA, 1990, J MOL EVOL, V30, P170, DOI 10.1007/BF02099943; TORRESRUIZ RA, 1994, PLANT MOL BIOL, V26, P1167, DOI 10.1007/BF00040697; TREMOUSAYGUE D, 1992, PLANT MOL BIOL, V18, P1013, DOI 10.1007/BF00019222; TUCCI GF, 1986, PROTOPLASMA, V132, P76, DOI 10.1007/BF01275793; UEKI M, 1992, PLANT MOL BIOL, V18, P175, DOI 10.1007/BF00018476; VIEIRA R, 1990, GENOME, V33, P707, DOI 10.1139/g90-106; Volkov RA, 1999, PLANT SYST EVOL, V218, P89, DOI 10.1007/BF01087037; Votkov RA, 2007, SYST BIODIVERS, V5, P261, DOI 10.1017/S1477200007002447; Weider LJ, 2005, ANNU REV ECOL EVOL S, V36, P219, DOI 10.1146/annurev.ecolsys.36.102003.152620; Woo HR, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-92; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; ZENTGRAF U, 1990, PLANT MOL BIOL, V15, P465, DOI 10.1007/BF00019163; Zhang DM, 1999, AM J BOT, V86, P735, DOI 10.2307/2656583; ZIMMER EA, 1980, P NATL ACAD SCI-BIOL, V77, P2158, DOI 10.1073/pnas.77.4.2158; Zoldos V, 1998, GENOME, V41, P162, DOI 10.1139/gen-41-2-162; Zoldos V, 1999, THEOR APPL GENET, V99, P969, DOI 10.1007/s001220051404	107	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98678	10.1371/journal.pone.0098678	http://dx.doi.org/10.1371/journal.pone.0098678			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893289	Green Published, Green Submitted, gold			2022-12-27	WOS:000336911400084
J	Johnston-Cox, H; Eisenstein, AS; Koupenova, M; Carroll, S; Ravid, K				Johnston-Cox, Hillary; Eisenstein, Anna S.; Koupenova, Milka; Carroll, Shannon; Ravid, Katya			The Macrophage A2b Adenosine Receptor Regulates Tissue Insulin Sensitivity	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; MOUSE PERITONEAL-MACROPHAGES; CORONARY-HEART-DISEASE; ADIPOSE-TISSUE; TNF-ALPHA; HEPATIC STEATOSIS; GENE-EXPRESSION; A(2B) RECEPTORS; HUMAN OBESITY; RESISTANCE	High fat diet (HFD)-induced type 2 diabetes continues to be an epidemic with significant risk for various pathologies. Previously, we identified the A2b adenosine receptor (A2bAR), an established regulator of inflammation, as a regulator of HFD-induced insulin resistance. In particular, HFD was associated with vast upregulation of liver A2bAR in control mice, and while mice lacking this receptor showed augmented liver inflammation and tissue insulin resistance. As the A2bAR is expressed in different tissues, here, we provide the first lead to cellular mechanism by demonstrating that the receptor's influence on tissue insulin sensitivity is mediated via its expression in macrophages. This was shown using a newly generated transgenic mouse model expressing the A2bAR gene in the macrophage lineage on an otherwise A2bAR null background. Reinstatement of macrophage A2bAR expression in A2bAR null mice fed HFD restored insulin tolerance and tissue insulin signaling to the level of control mice. The molecular mechanism for this effect involves A2bAR-mediated changes in cyclic adenosine monophosphate in macrophages, reducing the expression and release of inflammatory cytokines, which downregulate insulin receptor-2. Thus, our results illustrate that macrophage A2bAR signaling is needed and sufficient for relaying the protective effect of the A2bAR against HFD-induced tissue inflammation and insulin resistance in mice.	[Johnston-Cox, Hillary; Eisenstein, Anna S.; Koupenova, Milka; Ravid, Katya] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Koupenova, Milka; Carroll, Shannon; Ravid, Katya] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Johnston-Cox, Hillary; Eisenstein, Anna S.; Koupenova, Milka; Ravid, Katya] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Ravid, Katya] Boston Univ, Sch Med, Evans Ctr Interdisciplinary Biomed Res, Boston, MA 02118 USA	Boston University; Boston University; Boston University; Boston University	Ravid, K (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.	kravid@bu.edu	Koupenova, Milka/L-3576-2019		National Heart, Lung and Blood Institute [HL93149]; Boston Nutrition Obesity Research Center [DK046200]; National Institutes of Health [HL007969, HL007224]; National Institutes of Diabetes and Digestive and Kidney Diseases NRSA F30 award [DK098834]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007224, R01HL093149, T32HL007969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK098834, P30DK046200] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Boston Nutrition Obesity Research Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Diabetes and Digestive and Kidney Diseases NRSA F30 award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Heart, Lung and Blood Institute Grant (HL93149) to KR, and by the Boston Nutrition Obesity Research Center (DK046200) to K. R., an established Investigator with the American Heart Association. H.J.C., A. E., were supported by Cardiovascular Training Grant from the National Institutes of Health (HL007969). A. E was supported by the National Institutes of Diabetes and Digestive and Kidney Diseases NRSA F30 award (DK098834). M. K. was supported by Cardiovascular Training Grant from the National Institutes of Health (HL007969 and HL007224). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Boura-Halfon S, 2009, AM J PHYSIOL-ENDOC M, V296, pE581, DOI 10.1152/ajpendo.90437.2008; Bouzakri K, 2009, J BIOL CHEM, V284, P27892, DOI 10.1074/jbc.M109.048058; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277; Cancello R, 2006, DIABETES, V55, P1554, DOI 10.2337/db06-0133; Chen HJ, 2009, EXP HEMATOL, V37, P533, DOI 10.1016/j.exphem.2009.02.001; Csoka B, 2014, DIABETES, V63, P850, DOI 10.2337/db13-0573; De Taeye BM, 2007, AM J PHYSIOL-ENDOC M, V293, pE713, DOI 10.1152/ajpendo.00194.2007; Donath MY, 2011, ENDOCRINOLOGY, V152, P4005, DOI 10.1210/en.2011-1691; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Eigler A, 1998, J LEUKOCYTE BIOL, V63, P101, DOI 10.1002/jlb.63.1.101; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Endo M, 2007, EXP BIOL MED, V232, P614; ENDRES S, 1991, IMMUNOLOGY, V72, P56; Enjyoji K, 2008, DIABETES, V57, P2311, DOI 10.2337/db07-1265; Figler RA, 2011, DIABETES, V60, P669, DOI 10.2337/db10-1070; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Fukuda D, 2012, P NATL ACAD SCI USA, V109, pE1868, DOI 10.1073/pnas.1116889109; Gough PJ, 2001, IMMUNOLOGY, V103, P351, DOI 10.1046/j.1365-2567.2001.01256.x; Greaves DR, 1998, GENOMICS, V54, P165, DOI 10.1006/geno.1998.5546; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Huang W, 2010, DIABETES, V59, P347, DOI 10.2337/db09-0016; Johnston-Cox H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040584; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; KATAKAMI Y, 1988, IMMUNOLOGY, V64, P719; Koupenova M, 2012, CIRCULATION, V125, P354, DOI 10.1161/CIRCULATIONAHA.111.057596; Kreckler LM, 2006, J PHARMACOL EXP THER, V317, P172, DOI 10.1124/jpet.105.096016; Lawler JF, 1998, J BIOL CHEM, V273, P5053, DOI 10.1074/jbc.273.9.5053; Liang CP, 2007, CIRC RES, V100, P1546, DOI 10.1161/CIRCRESAHA.107.152165; Liang CP, 2004, J CLIN INVEST, V113, P764, DOI [10.1172/JCI200419528, 10.1172/JCI19528]; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; O'Reilly D, 2003, J BIOL CHEM, V278, P21909, DOI 10.1074/jbc.M212150200; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Orpana HM, 2010, OBESITY, V18, P214, DOI 10.1038/oby.2009.191; Papackova Z, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-22; Paz K, 1997, J BIOL CHEM, V272, P29911, DOI 10.1074/jbc.272.47.29911; Poulain-Godefroy O, 2008, AM J PHYSIOL-REG I, V295, pR1, DOI 10.1152/ajpregu.00926.2007; PULFORD KAF, 1990, INT IMMUNOL, V2, P973, DOI 10.1093/intimm/2.10.973; Qatanani M, 2009, J CLIN INVEST, V119, P531, DOI 10.1172/JCI37273; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Shi C, 2008, BLOOD, V112, P4699, DOI 10.1182/blood-2008-01-137018; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sun SY, 2012, ANNU REV NUTR, V32, P261, DOI 10.1146/annurev-nutr-071811-150623; Tanaka M, 2008, INFLAMM RES, V57, P593, DOI 10.1007/s00011-008-7171-1; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; VERGHESE MW, 1995, J PHARMACOL EXP THER, V272, P1313; WARNKE RA, 1989, AM J PATHOL, V135, P1089; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang D, 2006, J CLIN INVEST, V116, P1913, DOI 10.1172/JCI27933	61	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98775	10.1371/journal.pone.0098775	http://dx.doi.org/10.1371/journal.pone.0098775			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892847	Green Published, Green Submitted, gold			2022-12-27	WOS:000336911400091
J	Raza, SEA; Smith, HK; Clarkson, GJJ; Taylor, G; Thompson, AJ; Clarkson, J; Rajpoot, NM				Raza, Shan-e-Ahmed; Smith, Hazel K.; Clarkson, Graham J. J.; Taylor, Gail; Thompson, Andrew J.; Clarkson, John; Rajpoot, Nasir M.			Automatic Detection of Regions in Spinach Canopies Responding to Soil Moisture Deficit Using Combined Visible and Thermal Imagery	PLOS ONE			English	Article							STOMATAL CONDUCTANCE; STRESS; TEMPERATURE; THERMOGRAPHY; CLOSURE	Thermal imaging has been used in the past for remote detection of regions of canopy showing symptoms of stress, including water deficit stress. Stress indices derived from thermal images have been used as an indicator of canopy water status, but these depend on the choice of reference surfaces and environmental conditions and can be confounded by variations in complex canopy structure. Therefore, in this work, instead of using stress indices, information from thermal and visible light imagery was combined along with machine learning techniques to identify regions of canopy showing a response to soil water deficit. Thermal and visible light images of a spinach canopy with different levels of soil moisture were captured. Statistical measurements from these images were extracted and used to classify between canopies growing in well-watered soil or under soil moisture deficit using Support Vector Machines (SVM) and Gaussian Processes Classifier (GPC) and a combination of both the classifiers. The classification results show a high correlation with soil moisture. We demonstrate that regions of a spinach crop responding to soil water deficit can be identified by using machine learning techniques with a high accuracy of 97%. This method could, in principle, be applied to any crop at a range of scales.	[Raza, Shan-e-Ahmed; Rajpoot, Nasir M.] Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England; [Smith, Hazel K.; Taylor, Gail] Univ Southampton, Ctr Biol Sci, Southampton, Hants, England; [Clarkson, Graham J. J.] Vitacress Salads Ltd, Lower Link Farm, St Mary Bourne, Andover, England; [Thompson, Andrew J.] Cranfield Univ, Soil & Agri Food Inst, Sch Appl Sci, Bedford, England; [Clarkson, John] Univ Warwick, Sch Life Sci, Wellsbourne, Warwick, England; [Rajpoot, Nasir M.] Qatar Univ, Dept Comp Sci & Engn, Doha, Qatar	University of Warwick; University of Southampton; Cranfield University; University of Warwick; Qatar University	Raza, SEA (corresponding author), Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England.	s.e.a.raza@warwick.ac.uk; n.m.rajpoot@warwick.ac.uk	Thompson, Andrew J./AAF-3017-2020	Thompson, Andrew J./0000-0002-7419-3402; Taylor, Gail/0000-0001-8470-6390; Rajpoot, Nasir/0000-0002-4706-1308; Clarkson, John/0000-0001-5931-933X; Raza, Shan E Ahmed/0000-0002-1097-1738	Horticultural Development Company (HDC); Department of Computer Science, University of Warwick; Vitacress Salads Ltd.; Biotechnology and Biological Sciences Research Council (BBSRC)	Horticultural Development Company (HDC); Department of Computer Science, University of Warwick; Vitacress Salads Ltd.; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	S.E.A.R was funded by the Horticultural Development Company (HDC) and by the Department of Computer Science, University of Warwick. Work on sustainable water use in salad crops in the laboratory of GT is funded by Vitacress Salads Ltd. with the award of a PhD to H. K. S. Research on baby leaf salads in the lab of Gail Taylor is funded by Biotechnology and Biological Sciences Research Council (BBSRC). Field experiments were designed with the help of Vitacress Salads Ltd UK. All the other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alchanatis V, 2010, PRECIS AGRIC, V11, P27, DOI 10.1007/s11119-009-9111-7; Bazi Y, 2010, IEEE T GEOSCI REMOTE, V48, P186, DOI 10.1109/TGRS.2009.2023983; Cohen Y, 2012, PRECIS AGRIC, V13, P123, DOI 10.1007/s11119-011-9232-7; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Ebden M., 2008, GAUSSIAN PROCESSES R; Eberius M, 2011, 2 INT PLANT PHEN S; Eikvil L., 1993, OPTICAL CHARACTER RE; FUCHS M, 1990, THEOR APPL CLIMATOL, V42, P253, DOI 10.1007/BF00865986; Gonzalez R. C., 2008, DIGITAL IMAGE PROCES; Grant OM, 2007, J EXP BOT, V58, P815, DOI 10.1093/jxb/erl153; Grant OM, 2006, PHYSIOL PLANTARUM, V127, P507, DOI 10.1111/j.1399-3054.2006.00686.x; Hackl H, 2012, J AGRON CROP SCI, V198, P415, DOI 10.1111/j.1439-037X.2012.00512.x; Haranadh G, 2008, IEEE IJCNN, P2195, DOI 10.1109/IJCNN.2008.4634101; IDSO SB, 1981, AGR METEOROL, V24, P45, DOI 10.1016/0002-1571(81)90032-7; Jackson R. D., 1982, Advances in Irrigation, V1, P43; JACKSON RD, 1981, WATER RESOUR RES, V17, P1133, DOI 10.1029/WR017i004p01133; Jones, 1992, PLANTS MICROCLIMATES; Jones HG, 1999, PLANT CELL ENVIRON, V22, P1043, DOI 10.1046/j.1365-3040.1999.00468.x; Jones HG, 1999, AGR FOREST METEOROL, V95, P139, DOI 10.1016/S0168-1923(99)00030-1; Jones HG, 2002, J EXP BOT, V53, P2249, DOI 10.1093/jxb/erf083; Leinonen I, 2006, PLANT CELL ENVIRON, V29, P1508, DOI 10.1111/j.1365-3040.2006.01528.x; Leinonen I, 2004, J EXP BOT, V55, P1423, DOI 10.1093/jxb/erh146; Lopez A, 2012, SCI HORTIC-AMSTERDAM, V137, P49, DOI 10.1016/j.scienta.2012.01.022; Moller M, 2007, J EXP BOT, V58, P827, DOI 10.1093/jxb/erl115; PERONA P, 1990, IEEE T PATTERN ANAL, V12, P629, DOI 10.1109/34.56205; PIERCE LL, 1990, PHOTOGRAMM ENG REM S, V56, P579; Rasmussen CE, 2004, LECT NOTES ARTIF INT, V3176, P63, DOI 10.1007/978-3-540-28650-9_4; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Reinert S, 2012, TREE PHYSIOL, V32, P294, DOI 10.1093/treephys/tps017; Stoll M, 2007, J INT SCI VIGNE VIN, V41, P77	30	24	25	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e97612	10.1371/journal.pone.0097612	http://dx.doi.org/10.1371/journal.pone.0097612			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892284	Green Published, Green Accepted, gold			2022-12-27	WOS:000336911400015
J	Zhou, C; Mao, FL; Yin, YB; Huang, JL; Gogarten, JP; Xu, Y				Zhou, Chan; Mao, Fenglou; Yin, Yanbin; Huang, Jinling; Gogarten, Johann Peter; Xu, Ying			AST: An Automated Sequence-Sampling Method for Improving the Taxonomic Diversity of Gene Phylogenetic Trees	PLOS ONE			English	Article							SPECIES TREES; EVOLUTION; ACCURACY; ALGORITHM; INFERENCE; ALIGNMENT; GENERATION; MODEL; DNA	A challenge in phylogenetic inference of gene trees is how to properly sample a large pool of homologous sequences to derive a good representative subset of sequences. Such a need arises in various applications, e. g. when (1) accuracy-oriented phylogenetic reconstruction methods may not be able to deal with a large pool of sequences due to their high demand in computing resources; (2) applications analyzing a collection of gene trees may prefer to use trees with fewer operational taxonomic units (OTUs), for instance for the detection of horizontal gene transfer events by identifying phylogenetic conflicts; and (3) the pool of available sequences is biased towards extensively studied species. In the past, the creation of subsamples often relied on manual selection. Here we present an Automated sequence-Sampling method for improving the Taxonomic diversity of gene phylogenetic trees, AST, to obtain representative sequences that maximize the taxonomic diversity of the sampled sequences. To demonstrate the effectiveness of AST, we have tested it to solve four problems, namely, inference of the evolutionary histories of the small ribosomal subunit protein S5 of E. coli, 16 S ribosomal RNAs and glycosyl-transferase gene family 8, and a study of ancient horizontal gene transfers from bacteria to plants. Our results show that the resolution of our computational results is almost as good as that of manual inference by domain experts, hence making the tool generally useful to phylogenetic studies by non-phylogeny specialists. The program is available at http://csbl.bmb.uga.edu/similar to zhouchan/AST.php.	[Zhou, Chan; Mao, Fenglou; Yin, Yanbin; Xu, Ying] Univ Georgia, Dept Biochem & Mol Biol, Computat Syst Biol Lab, Athens, GA 30602 USA; [Zhou, Chan; Mao, Fenglou; Yin, Yanbin; Xu, Ying] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Huang, Jinling] E Carolina Univ, Dept Biol, Greenville, NC USA; [Gogarten, Johann Peter] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT USA; [Xu, Ying] Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Peoples R China	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of North Carolina; East Carolina University; University of Connecticut; Jilin University	Xu, Y (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Computat Syst Biol Lab, Athens, GA 30602 USA.	xyn@bmb.uga.edu	Huang, Jinling/ABI-6699-2020; Yin, Yanbin/AAH-2665-2020; ZHOU, Chan/A-7110-2009; Yin, Yanbin/C-9788-2010	Yin, Yanbin/0000-0001-7667-881X; ZHOU, Chan/0000-0002-0351-6235; Yin, Yanbin/0000-0001-7667-881X; Huang, Jinling/0000-0003-4893-4171; Gogarten, Johann Peter/0000-0001-6459-6518	National Science Foundation Assembling the Tree of Life program [DEB 0830024]; DOE; Direct For Biological Sciences [0830024] Funding Source: National Science Foundation	National Science Foundation Assembling the Tree of Life program(National Science Foundation (NSF)); DOE(United States Department of Energy (DOE)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The work was supported from the National Science Foundation Assembling the Tree of Life program (DEB 0830024 to CZ, FLM, JLH and JPG) and was in part supported by the DOE grant for the BioEnergy Science Center (to YB and YX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola V, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-484; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063; Chauve C, 2007, LECT N BIOINFORMAT, V4751, P45; Cranston KA, 2009, SYST BIOL, V58, P489, DOI 10.1093/sysbio/syp054; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisen JA, 1998, GENOME RES, V8, P163, DOI 10.1101/gr.8.3.163; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Frickey T, 2004, NUCLEIC ACIDS RES, V32, P5231, DOI 10.1093/nar/gkh867; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall BG, 2008, MOL BIOL EVOL, V25, P688, DOI 10.1093/molbev/msn008; Hillis DM, 1998, SYST BIOL, V47, P3, DOI 10.1080/106351598260987; Jacobsen F, 2011, MOL PHYLOGENET EVOL, V61, P460, DOI 10.1016/j.ympev.2011.06.017; Jenuth J P, 2000, Methods Mol Biol, V132, P301; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kim JH, 1996, SYST BIOL, V45, P363, DOI 10.2307/2413570; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Li KB, 2003, BIOINFORMATICS, V19, P1585, DOI 10.1093/bioinformatics/btg192; Linder CR, 2010, PLOS CURR-TREE LIFE, DOI 10.1371/currents.RRN1195; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Liu K, 2012, SYST BIOL, V61, P90, DOI 10.1093/sysbio/syr095; Liu L, 2007, SYST BIOL, V56, P504, DOI 10.1080/10635150701429982; Liu L, 2011, SYST BIOL, V60, P661, DOI 10.1093/sysbio/syr027; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Nabhan AR, 2012, BRIEF BIOINFORM, V13, P122, DOI 10.1093/bib/bbr014; Nelesen S, 2012, BIOINFORMATICS, V28, pI274, DOI 10.1093/bioinformatics/bts218; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nuin PAS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-471; Page RDM, 1998, BIOINFORMATICS, V14, P819, DOI 10.1093/bioinformatics/14.9.819; Pecon-Slattery J, 2004, MOL BIOL EVOL, V21, P2299, DOI 10.1093/molbev/msh241; Pick KS, 2010, MOL BIOL EVOL, V27, P1983, DOI 10.1093/molbev/msq089; Plazzi F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-209; Poptsova Maria, 2009, V532, P227, DOI 10.1007/978-1-60327-853-9_13; Poptsova MS, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-45; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Rannala B, 1998, SYST BIOL, V47, P702, DOI 10.1080/106351598260680; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenberg MS, 2001, P NATL ACAD SCI USA, V98, P10751, DOI 10.1073/pnas.191248498; Syvanen M, 2006, SYSTEMS BIOL, VI, P248; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Townsend JP, 2011, SYST BIOL, V60, P358, DOI 10.1093/sysbio/syq097; Townsend JP, 2010, SYST BIOL, V59, P446, DOI 10.1093/sysbio/syq025; VANEWRIGHT RI, 1991, BIOL CONSERV, V55, P235, DOI 10.1016/0006-3207(91)90030-D; Wehe A, 2008, BIOINFORMATICS, V24, P1540, DOI 10.1093/bioinformatics/btn230; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Yin YB, 2011, ANNU PLANT REV, V41, P167, DOI 10.1002/9781444391015.ch6; Yin YB, 2010, PLANT PHYSIOL, V153, P1729, DOI 10.1104/pp.110.154229; Zhou C, 2010, J PROTEOME RES, V9, P5025, DOI 10.1021/pr100249c; Zwickl DJ, 2002, SYST BIOL, V51, P588, DOI 10.1080/10635150290102339	55	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98844	10.1371/journal.pone.0098844	http://dx.doi.org/10.1371/journal.pone.0098844			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892935	gold, Green Published, Green Submitted			2022-12-27	WOS:000336911400101
J	Equbal, A; Suman, SS; Anwar, S; Singh, KP; Zaidi, A; Sardar, AH; Das, P; Ali, V				Equbal, Asif; Suman, Shashi Shekhar; Anwar, Shadab; Singh, Krishn Pratap; Zaidi, Amir; Sardar, Abul Hasan; Das, Pradeep; Ali, Vahab			Stage-Dependent Expression and Up-Regulation of Trypanothione Synthetase in Amphotericin B Resistant Leishmania donovani	PLOS ONE			English	Article							GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; CRITHIDIA-FASCICULATA; TRYPANOSOMA-BRUCEI; OXIDATIVE STRESS; ENTAMOEBA-HISTOLYTICA; ESCHERICHIA-COLI; HYDROPEROXIDE METABOLISM; TRYPAREDOXIN PEROXIDASE; ORNITHINE-DECARBOXYLASE; VISCERAL LEISHMANIASIS	Kinetoplastids differ from other organisms in their ability to conjugate glutathione and spermidine to form trypanothione which is involved in maintaining redox homeostasis and removal of toxic metabolites. It is also involved in drug resistance, antioxidant mechanism, and defense against cellular oxidants. Trypanothione synthetase (TryS) of thiol metabolic pathway is the sole enzyme responsible for the biosynthesis of trypanothione in Leishmania donovani. In this study, TryS gene of L. donovani (LdTryS) was cloned, expressed, and fusion protein purified with affinity column chromatography. The purified protein showed optimum enzymatic activity at pH 8.0-8.5. The TryS amino acids sequences alignment showed that all amino acids involved in catalytic and ligands binding of L. major are conserved in L. donovani. Subcellular localization using digitonin fractionation and immunoblot analysis showed that LdTryS is localized in the cytoplasm. Furthermore, RT-PCR coupled with immunoblot analysis showed that LdTryS is overexpressed in Amp B resistant and stationary phase promastigotes (similar to 2.0-folds) than in sensitive strain and logarithmic phase, respectively, which suggests its involvement in Amp B resistance. Also, H2O2 treatment upto 150 mu M for 8 hrs leads to 2-fold increased expression of LdTryS probably to cope up with oxidative stress generated by H2O2. Therefore, this study demonstrates stage-and Amp B sensitivity-dependent expression of LdTryS in L. donovani and involvement of TryS during oxidative stress to help the parasites survival.	[Equbal, Asif; Suman, Shashi Shekhar; Anwar, Shadab; Singh, Krishn Pratap; Zaidi, Amir; Ali, Vahab] Rajendra Mem Res Inst Med Sci, Dept Biochem, Lab Mol Biochem & Cell Biol, Patna, Bihar, India; [Sardar, Abul Hasan; Das, Pradeep] Rajendra Mem Res Inst Med Sci, Dept Mol Biol, Patna, Bihar, India	Indian Council of Medical Research (ICMR); ICMR - Rajendra Memorial Research Institute of Medical Sciences (RMRI); Indian Council of Medical Research (ICMR); ICMR - Rajendra Memorial Research Institute of Medical Sciences (RMRI)	Ali, V (corresponding author), Rajendra Mem Res Inst Med Sci, Dept Biochem, Lab Mol Biochem & Cell Biol, Patna, Bihar, India.	vahab_ali@yahoo.com	Equbal, Asif/AAJ-7149-2021	Zaidi, Amir/0000-0001-5029-4180	Indian Council of Medical Research (ICMR); Ministry of Health and Family Welfare; Department of Science & Technology, New Delhi, India [DST/INT/JSPSP-117]; ICMR; CSIR; DBT; DST, New Delhi	Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Ministry of Health and Family Welfare; Department of Science & Technology, New Delhi, India(Department of Science & Technology (India)); ICMR(Indian Council of Medical Research (ICMR)); CSIR(Council of Scientific & Industrial Research (CSIR) - India); DBT(Department of Biotechnology (DBT) India); DST, New Delhi(Department of Science & Technology (India))	This work was supported by a grant from Indian Council of Medical Research (ICMR), Ministry of Health and Family Welfare, and Department of Science & Technology, (DST/INT/JSPSP-117) New Delhi, India. The funder had no role in study design, data collection and analysis decision to publish, or preparation of the manuscript. Asif Equbal (ICMR), Shashi & Amir (CSIR), Shadab (DBT), & K. P. Singh (DST-INSPIRE Fellow) are working as SRF and acknowledged for fellowship support from ICMR & CSIR, DBT, DST, New Delhi respectively.	Ali V, 2004, EUR J BIOCHEM, V271, P2670, DOI 10.1111/j.1432-1033.2004.04195.x; Ali V, 2004, J BIOL CHEM, V279, P16863, DOI 10.1074/jbc.M313314200; Ali V, 2003, BIOCHEM J, V375, P729, DOI 10.1042/BJ20030630; Ariyanayagam MR, 2005, BIOCHEM J, V391, P425, DOI 10.1042/BJ20050911; Ariyanayagam MR, 2001, MOL BIOCHEM PARASIT, V115, P189, DOI 10.1016/S0166-6851(01)00285-7; Barr SD, 2003, J BIOL CHEM, V278, P10816, DOI 10.1074/jbc.M212990200; Barrett MP, 1999, TRENDS MICROBIOL, V7, P82, DOI 10.1016/S0966-842X(98)01433-4; BOLLINGER JM, 1995, J BIOL CHEM, V270, P14031, DOI 10.1074/jbc.270.23.14031; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Budde H, 2003, BIOFACTORS, V17, P83, DOI 10.1002/biof.5520170109; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; Carter KC, 2006, ANTIMICROB AGENTS CH, V50, P88, DOI 10.1128/AAC.50.1.88-95.2006; Colotti G, 2011, AMINO ACIDS, V40, P269, DOI 10.1007/s00726-010-0630-3; Comini M, 2003, BIOL CHEM, V384, P653, DOI 10.1515/BC.2003.072; Comini M, 2005, J BIOL CHEM, V280, P6850, DOI 10.1074/jbc.M404486200; Comini MA, 2008, J BIOL CHEM, V283, P27785, DOI 10.1074/jbc.M802010200; Comini MA, 2007, BIOCHEM J, V402, P43, DOI 10.1042/BJ20061341; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; DAVIES JMS, 1995, ARCH BIOCHEM BIOPHYS, V317, P1, DOI 10.1006/abbi.1995.1128; Dolai S, 2008, FREE RADICAL BIO MED, V45, P1520, DOI 10.1016/j.freeradbiomed.2008.08.029; Dormeyer M, 2001, J BIOL CHEM, V276, P10602, DOI 10.1074/jbc.M010352200; FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695; FAIRLAMB AH, 1985, SCIENCE, V227, P1485, DOI 10.1126/science.3883489; Flohe L, 1999, FREE RADICAL BIO MED, V27, P966, DOI 10.1016/S0891-5849(99)00172-0; Flohe L, 2012, BIOTECHNOL ADV, V30, P294, DOI 10.1016/j.biotechadv.2011.05.012; Fyfe PK, 2008, J BIOL CHEM, V283, P17672, DOI 10.1074/jbc.M801850200; Ghosh S, 2003, BIOCHEM J, V369, P447, DOI 10.1042/BJ20021684; Haimeur A, 1999, MOL MICROBIOL, V34, P726, DOI 10.1046/j.1365-2958.1999.01634.x; Haimeur A, 2000, MOL BIOCHEM PARASIT, V108, P131, DOI 10.1016/S0166-6851(00)00187-0; Hausler T, 1996, J CELL BIOL, V132, P311, DOI 10.1083/jcb.132.3.311; Hsu JY, 2008, MOL BIOCHEM PARASIT, V157, P193, DOI 10.1016/j.molbiopara.2007.11.002; JHA TK, 1995, AM J TROP MED HYG, V52, P536, DOI 10.4269/ajtmh.1995.52.536; KELLY JM, 1993, EUR J BIOCHEM, V218, P29, DOI 10.1111/j.1432-1033.1993.tb18348.x; Kim BY, 2001, FREE RADICAL BIO MED, V30, P686, DOI 10.1016/S0891-5849(00)00514-1; Koch O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056788; Koenig K, 1997, J BIOL CHEM, V272, P11908, DOI 10.1074/jbc.272.18.11908; Krauth-Siegel RL, 2008, BBA-GEN SUBJECTS, V1780, P1236, DOI 10.1016/j.bbagen.2008.03.006; Legare D, 1997, EXP PARASITOL, V87, P275, DOI 10.1006/expr.1997.4222; Mandal G, 2007, PARASITOLOGY, V134, P1679, DOI 10.1017/S0031182007003150; Manta B, 2013, BBA-GEN SUBJECTS, V1830, P3199, DOI 10.1016/j.bbagen.2013.01.013; MARTON LJ, 1995, ANNU REV PHARMACOL, V35, P55, DOI 10.1146/annurev.pa.35.040195.000415; Mbongo N, 1998, ANTIMICROB AGENTS CH, V42, P352; MEISTER A, 1989, ADV ENZYMOL RAMB, V62, P315; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Mittal MK, 2007, AM J TROP MED HYG, V76, P681, DOI 10.4269/ajtmh.2007.76.681; Mukherjee A, 2007, J ANTIMICROB CHEMOTH, V59, P204, DOI 10.1093/jac/dkl494; Mukherjee A, 2009, MOL MICROBIOL, V74, P914, DOI 10.1111/j.1365-2958.2009.06907.x; Mukhopadhyay R, 1996, P NATL ACAD SCI USA, V93, P10383, DOI 10.1073/pnas.93.19.10383; Muller S, 2001, TRENDS PARASITOL, V17, P242, DOI 10.1016/S1471-4922(01)01908-0; Nogoceke E, 1997, BIOL CHEM, V378, P827, DOI 10.1515/bchm.1997.378.8.827; Oza SL, 2002, J BIOL CHEM, V277, P35853, DOI 10.1074/jbc.M204403200; Oza SL, 2005, MOL BIOCHEM PARASIT, V139, P107, DOI 10.1016/j.molbiopara.2004.10.004; Oza SL, 2003, MOL BIOCHEM PARASIT, V131, P25, DOI 10.1016/S0166-6851(03)00176-2; Purkait B, 2012, ANTIMICROB AGENTS CH, V56, P1031, DOI 10.1128/AAC.00030-11; Reguera RM, 2005, COMP BIOCHEM PHYS C, V140, P151, DOI 10.1016/j.cca.2005.02.006; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Romao S, 2009, INT J PARASITOL, V39, P703, DOI 10.1016/j.ijpara.2008.11.009; Saas J, 2000, J BIOL CHEM, V275, P2745, DOI 10.1074/jbc.275.4.2745; Sahasrabuddhe AA, 2004, MOL BIOCHEM PARASIT, V134, P105, DOI 10.1016/j.molbiopara.2003.11.008; Sambrook J., 2001, MOL CLONING LAB MANU; Sardar AH, 2013, J PROTEOMICS, V81, P185, DOI 10.1016/j.jprot.2013.01.011; Saudagar P, 2011, BIOL CHEM, V392, P1113, DOI [10.1515/BC-2011-222, 10.1515/BC.2011.222]; SCHULZ I, 1990, METHOD ENZYMOL, V192, P280; SHIM H, 1988, J GEN MICROBIOL, V134, P807; Sinha PK, 2006, J INFECTION, V53, P60, DOI 10.1016/j.jinf.2005.09.011; SMITH K, 1992, PROTEIN SCI, V1, P874, DOI 10.1002/pro.5560010705; TABOR CW, 1970, J BIOL CHEM, V245, P2086; Torrie LS, 2009, J BIOL CHEM, V284, P36137, DOI 10.1074/jbc.M109.045336; Van Assche T, 2011, FREE RADICAL BIO MED, V51, P337, DOI 10.1016/j.freeradbiomed.2011.05.011; VANHAMME L, 1995, MICROBIOL REV, V59, P223, DOI 10.1128/MMBR.59.2.223-240.1995; WIESE AG, 1995, ARCH BIOCHEM BIOPHYS, V318, P231, DOI 10.1006/abbi.1995.1225; Wyllie S, 2008, ANTIMICROB AGENTS CH, V52, P1359, DOI 10.1128/AAC.01563-07; Wyllie S, 2010, MOL BIOCHEM PARASIT, V173, P162, DOI 10.1016/j.molbiopara.2010.05.015	73	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e97600	10.1371/journal.pone.0097600	http://dx.doi.org/10.1371/journal.pone.0097600			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901644	gold, Green Published, Green Submitted			2022-12-27	WOS:000336841400009
J	Fine, DH; Markowitz, K; Fairlie, K; Tischio-Bereski, D; Ferrandiz, J; Godboley, D; Furgang, D; Gunsolley, J; Best, A				Fine, Daniel H.; Markowitz, Kenneth; Fairlie, Karen; Tischio-Bereski, Debbie; Ferrandiz, Javier; Godboley, Dipti; Furgang, David; Gunsolley, John; Best, Al			Macrophage Inflammatory Protein-1 alpha Shows Predictive Value as a Risk Marker for Subjects and Sites Vulnerable to Bone Loss in a Longitudinal Model of Aggressive Periodontitis	PLOS ONE			English	Article							ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; SALIVARY BIOMARKER; FILIFACTOR-ALOCIS; ATTACHMENT LOSS; UNITED-STATES; DISEASE; PROGRESSION; DIAGNOSIS; HEALTH; COHORT	Improved diagnostics remains a fundamental goal of biomedical research. This study was designed to assess cytokine biomarkers that could predict bone loss (BL) in localized aggressive periodontitis. 2,058 adolescents were screened. Two groups of 50 periodontally healthy adolescents were enrolled in the longitudinal study. One group had Aggregatibacter actinomycetemcomitans (Aa), the putative pathogen, while the matched cohort did not. Cytokine levels were assessed in saliva and gingival crevicular fluid (GCF). Participants were sampled, examined, and radiographed every 6 months for 2-3 years. Disease was defined as radiographic evidence of BL. Saliva and GCF was collected at each visit, frozen, and then tested retrospectively after detection of BL. Sixteen subjects with Aa developed BL. Saliva from Aa-positive and Aa-negative healthy subjects was compared to subjects who developed BL. GCF was collected from 16 subjects with BL and from another 38 subjects who remained healthy. GCF from BL sites in the 16 subjects was compared to healthy sites in these same subjects and to healthy sites in subjects who remained healthy. Results showed that cytokines in saliva associated with acute inflammation were elevated in subjects who developed BL (i.e., MIP-1 alpha MIP-1 beta IL-alpha, IL-1 beta and IL-8; p<0.01). MIP-1 alpha was elevated 13-fold, 6 months prior to BL. When MIP-1 alpha levels were set at 40 pg/ml, 98% of healthy sites were below that level (Specificity); whereas, 93% of sites with BL were higher (Sensitivity), with comparable Predictive Values of 98%; p<0.0001; 95% C.I. = 42.5-52.7). MIP-1 alpha consistently showed elevated levels as a biomarker for BL in both saliva and GCF, 6 months prior to BL. MIP-1 alpha continues to demonstrate its strong candidacy as a diagnostic biomarker for both subject and site vulnerability to BL.	[Fine, Daniel H.; Markowitz, Kenneth; Fairlie, Karen; Tischio-Bereski, Debbie; Ferrandiz, Javier; Godboley, Dipti; Furgang, David] Rutgers State Univ, Dept Oral Biol, Sch Dent Med, Newark, NJ 07102 USA; [Gunsolley, John; Best, Al] Virginia Commonwealth Virginia, Dept Periodont, Sch Dent, Richmond, VA USA	Rutgers State University Newark; Rutgers State University New Brunswick	Fine, DH (corresponding author), Rutgers State Univ, Dept Oral Biol, Sch Dent Med, Newark, NJ 07102 USA.	finedh@sdm.rutgers.edu		Best, Al/0000-0002-6300-3925	National Institutes of Health [DE 017968]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017968] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was funded in full by a grant from the National Institutes of Health DE 017968 to DHF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The corresponding author accepts full responsibility for all aspects of the study and its resulting manuscript.	Al-Sabbagh M, 2012, J PERIODONTAL RES, V47, P389, DOI 10.1111/j.1600-0765.2011.01445.x; Albandar JM, 1999, J PERIODONTOL, V70, P13, DOI 10.1902/jop.1999.70.1.13; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Aruni AW, 2011, INFECT IMMUN, V79, P3872, DOI 10.1128/IAI.05631-11; BEST AM, 1990, J CLIN PERIODONTOL, V17, P564, DOI 10.1111/j.1600-051X.1990.tb01106.x; Bettelli E, 2007, CURR OPIN IMMUNOL, V19, P652, DOI 10.1016/j.coi.2007.07.020; Brown LJ, 1996, J PERIODONTOL, V67, P968, DOI 10.1902/jop.1996.67.10.968; CLEREHUGH V, 1990, J CLIN PERIODONTOL, V17, P702, DOI 10.1111/j.1600-051X.1990.tb01057.x; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Feghali CA, 1997, FRONT BIOSCI, V2, P12; Fine DH, 2006, PERIODONTOL 2000, V42, P114, DOI 10.1111/j.1600-0757.2006.00189.x; Fine DH, 2013, J CLIN MICROBIOL, V51, P2850, DOI 10.1128/JCM.00729-13; Fine DH, 2009, J PERIODONTOL, V80, P106, DOI [10.1902/jop.2009.080296, 10.1902/jop.2009.080296 ]; Giannobile WV, 2009, PERIODONTOL 2000, V50, P52, DOI 10.1111/j.1600-0757.2008.00288.x; GLAVIND LEIF, 1967, J PERIODONTAL RES, V2, P180, DOI 10.1111/j.1600-0765.1967.tb01887.x; GOLUB L M, 1976, Oral Sciences Reviews, V8, P49; GOODSON JM, 1982, J CLIN PERIODONTOL, V9, P472, DOI 10.1111/j.1600-051X.1982.tb02108.x; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Haubek D, 2008, LANCET, V371, P237, DOI 10.1016/S0140-6736(08)60135-X; Kinney JS, 2007, ANN NY ACAD SCI, V1098, P230, DOI 10.1196/annals.1384.028; LISTGARTEN MA, 1980, J CLIN PERIODONTOL, V7, P165, DOI 10.1111/j.1600-051X.1980.tb01960.x; MANDEL ID, 1993, ANN NY ACAD SCI, V694, P1, DOI 10.1111/j.1749-6632.1993.tb18336.x; McCauley LK, 2002, J PERIODONTOL, V73, P1377, DOI 10.1902/jop.2002.73.11.1377; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Preshaw PM, 2011, J CLIN PERIODONTOL, V38, P60, DOI 10.1111/j.1600-051X.2010.01671.x; Ryu OH, 2007, J PERIODONTOL, V78, P1627, DOI 10.1902/jop.2007.070066; Schuetz P, 2007, CURR OPIN CRIT CARE, V13, P578, DOI 10.1097/MCC.0b013e3282c9ac2a; Shaddox L, 2010, J DENT RES, V89, P143, DOI 10.1177/0022034509353397; Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064	30	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98541	10.1371/journal.pone.0098541	http://dx.doi.org/10.1371/journal.pone.0098541			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901458	Green Submitted, Green Published, gold			2022-12-27	WOS:000336841400036
J	Huebert, KB; Peck, MA				Huebert, Klaus B.; Peck, Myron A.			A Day in the Life of Fish Larvae: Modeling Foraging and Growth Using Quirks	PLOS ONE			English	Article							HERRING CLUPEA-HARENGUS; COD GADUS-MORHUA; ANCHOVY ENGRAULIS-ENCRASICOLUS; HADDOCK MELANOGRAMMUS-AEGLEFINUS; SPRAT SPRATTUS-SPRATTUS; ATLANTIC COD; NORTH-SEA; SELECTIVE PREDATION; FEEDING-BEHAVIOR; ENCOUNTER RATES	This article introduces "Quirks,'' a generic, individual-based model synthesizing over 40 years of empirical and theoretical insights into the foraging behavior and growth physiology of marine fish larvae. In Quirks, different types of larvae are defined by a short list of their biological traits, and all foraging and growth processes (including the effects of key environmental factors) are modeled following one unified set of mechanistic rules. This approach facilitates ecologically meaningful comparisons between different species and environments. We applied Quirks to model young exogenously feeding larvae of four species: 5.5-mm European anchovy (Engraulis encrasicolus), 7-mm Atlantic cod (Gadus morhua), 13-mm Atlantic herring (Clupea harengus), and 7-mm European sprat (Sprattus sprattus). Modeled growth estimates explained the majority of variability among 53 published empirical growth estimates, and displayed very little bias: 0.65%+/- 1.2% d(-1) (mean 6 standard error). Prey organisms of similar to 67% the maximum ingestible prey length were optimal for all larval types, in terms of the expected ingestion per encounter. Nevertheless, the foraging rate integrated over all favorable prey sizes was highest when smaller organisms made up >95% of the prey biomass under the assumption of constant normalized size spectrum slopes. The overall effect of turbulence was consistently negative, because its detrimental influence on prey pursuit success exceeded its beneficial influence on prey encounter rate. Model sensitivity to endogenous traits and exogenous environmental factors was measured and is discussed in depth. Quirks is free software and open source code is provided.	[Huebert, Klaus B.; Peck, Myron A.] Univ Hamburg, Inst Hydrobiol & Fisheries Sci, Hamburg, Germany	University of Hamburg	Huebert, KB (corresponding author), Univ Hamburg, Inst Hydrobiol & Fisheries Sci, Hamburg, Germany.	klaus.huebert@uni-hamburg.de	Huebert, Klaus B./G-2362-2011; Peck, Myron A/H-6164-2011	Huebert, Klaus B./0000-0002-2432-7337; Peck, Myron A/0000-0001-7423-1854	EU [FP7 244966, FP7 266445]	EU(European Commission)	This research was funded through the EU 7th Framework Programs FACTS (Forage Fish Interactions, FP7 244966) and VECTORS (VECTORS of Change in Oceans and Seas Marine Life, Impact on Economic Sectors, FP7 266445). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSHUTH S, 1988, MEERESFORSCHUNG, V32, P23; [Anonymous], 2005, EGGS LARVAE N SEA FI; [Anonymous], 2013, MAPTOOLS TOOLS READI; Antonov J.I., 2010, NOAA ATLAS NESDIS, V2, P184, DOI DOI 10.13140/2.1.1115.4889; Arrhenius F, 1996, ICES J MAR SCI, V53, P792, DOI 10.1006/jmsc.1996.0100; Baumann H, 2009, J SEA RES, V61, P234, DOI 10.1016/j.seares.2009.01.004; BLAXTER J. H. S., 1965, CALIF COOP OCEANIC FBH INVEST REP, V10, P79; BOEHLERT GW, 1984, J EXP MAR BIOL ECOL, V79, P251, DOI 10.1016/0022-0981(84)90199-0; BRANDER KM, 1994, ICES J MAR SCI, V51, P71, DOI 10.1006/jmsc.1994.1007; Brett J., 1979, FISH PHYSIOL, V8, P279, DOI DOI 10.1016/S1546-5098(08)60029-1; Broughton EA, 2010, NMFSNE217 NOAA; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Buckley LJ, 2006, DEEP-SEA RES PT II, V53, P2758, DOI 10.1016/j.dsr2.2006.08.009; Burchard H, 2002, J SEA RES, V47, P223, DOI 10.1016/S1385-1101(02)00126-0; BUSKEY EJ, 1993, B MAR SCI, V53, P29; Caldarone EM, 2003, MAR ECOL PROG SER, V262, P229, DOI 10.3354/meps262229; Catalan IA, 2010, ESTUAR COAST SHELF S, V86, P299, DOI 10.1016/j.ecss.2009.11.033; CHECKLEY DM, 1984, MAR ECOL PROG SER, V18, P215, DOI 10.3354/meps018215; Chesney EJ, 2008, J EXP MAR BIOL ECOL, V362, P117, DOI 10.1016/j.jembe.2008.06.011; CHESSON J, 1978, ECOLOGY, V59, P211, DOI 10.2307/1936364; Daewel U, 2011, CAN J FISH AQUAT SCI, V68, P426, DOI 10.1139/F10-164; Dulcic J, 1998, FISH RES, V36, P117, DOI 10.1016/S0165-7836(98)00108-8; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; ELDRIDGE MB, 1977, T AM FISH SOC, V106, P452, DOI 10.1577/1548-8659(1977)106<452:EOPHCH>2.0.CO;2; Fiksen O, 2002, MAR ECOL PROG SER, V243, P151, DOI 10.3354/meps243151; Fiksen O, 1998, FISH OCEANOGR, V7, P355, DOI 10.1046/j.1365-2419.1998.00068.x; Finn RN, 1995, MAR BIOL, V124, P355, DOI 10.1007/BF00363909; Folkvord A, 2004, SARSIA, V89, P297, DOI 10.1080/00364820410002532; Follows MJ, 2011, ANNU REV MAR SCI, V3, P427, DOI 10.1146/annurev-marine-120709-142848; FRANSZ HG, 1991, NETH J SEA RES, V28, P1, DOI 10.1016/0077-7579(91)90003-J; Galbraith PS, 2004, MAR ECOL PROG SER, V281, P241, DOI 10.3354/meps281241; Garcia A, 1998, MAR ECOL PROG SER, V166, P237, DOI 10.3354/meps166237; Geffen AJ, 2002, J FISH BIOL, V60, P479, DOI [10.1111/j.1095-8649.2002.tb00295.x, 10.1006/jfbi.2001.1859]; GERRITSEN J, 1977, J FISH RES BOARD CAN, V34, P73, DOI 10.1139/f77-008; GOVONI JJ, 1986, ENVIRON BIOL FISH, V16, P59, DOI 10.1007/BF00005160; HAY SJ, 1988, J PLANKTON RES, V10, P431, DOI 10.1093/plankt/10.3.431; HILL PS, 1992, J MAR RES, V50, P643, DOI 10.1357/002224092784797539; HOUDE ED, 1980, ENVIRON BIOL FISH, V5, P315, DOI 10.1007/BF00005186; HOUDE ED, 1983, MAR BIOL, V72, P283, DOI 10.1007/BF00396834; HOUDE ED, 1993, B MAR SCI, V53, P290; Houde ED, 1987, AM FISH SOC S, V2, P17; Houde Edward D., 2009, Journal of Northwest Atlantic Fishery Science, V41, P53; Hufnagl M, 2011, ICES J MAR SCI, V68, P1170, DOI 10.1093/icesjms/fsr078; HUNTER JR, 1972, FISH BULL NATL OC AT, V70, P821; ICES, 2013, REP HERR ASS WORK GR; Irigoien X, 2009, J PLANKTON RES, V31, P1, DOI 10.1093/plankt/fbn096; Johannessen A, 2000, SARSIA, V85, P461, DOI 10.1080/00364827.2000.10414595; Kato Y, 2008, FISHERIES SCI, V74, P48, DOI 10.1111/j.1444-2906.2007.01495.x; Kerr S. R., 2001, COM ECO SYS; Kimura S, 2004, NIPPON SUISAN GAKK, V70, P175, DOI 10.2331/suisan.70.175; Kiorboe T, 1995, J PLANKTON RES, V17, P2319, DOI 10.1093/plankt/17.12.2319; KIORBOE T, 1986, ENVIRON BIOL FISH, V17, P133, DOI 10.1007/BF00001743; KIORBOE T, 1987, MAR ECOL PROG SER, V40, P1, DOI 10.3354/meps040001; Kolmogoroff A, 1941, CR ACAD SCI URSS, V30, P301, DOI 10.1098/rspa.1991.0075; Kooijman B., 2009, DYNAMIC ENERGY BUDGE, DOI [10.1017/CBO9780511805400, DOI 10.1017/CBO9780511805400]; Kuhn W, 2008, J MARINE SYST, V74, P329, DOI 10.1016/j.jmarsys.2008.02.002; Laurel BJ, 2008, J PLANKTON RES, V30, P1051, DOI 10.1093/plankt/fbn057; LAURENCE GC, 1978, MAR BIOL, V50, P1, DOI 10.1007/BF00390536; Laurence GC, 1985, NMFS NATIONAL OCEANI, P1; Letcher BH, 1996, CAN J FISH AQUAT SCI, V53, P787, DOI 10.1139/cjfas-53-4-787; Lough RG, 2005, FISH OCEANOGR, V14, P241, DOI 10.1111/j.1365-2419.2005.00330.x; MacKenzie BR, 1995, LIMNOL OCEANOGR, V40, P1278, DOI 10.4319/lo.1995.40.7.1278; MACKENZIE BR, 1994, LIMNOL OCEANOGR, V39, P1790, DOI 10.4319/lo.1994.39.8.1790; MacKenzie BR, 2000, LIMNOL OCEANOGR, V45, P1; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; Miller TJ, 2007, MAR ECOL PROG SER, V347, P127, DOI 10.3354/meps06973; MILLER TJ, 1988, CAN J FISH AQUAT SCI, V45, P1657, DOI 10.1139/f88-197; MUNK P, 1985, MAR ECOL PROG SER, V24, P15, DOI 10.3354/meps024015; MUNK P, 1993, MAR ECOL PROG SER, V99, P17, DOI 10.3354/meps099017; MUNK P, 1992, MAR ECOL PROG SER, V80, P149, DOI 10.3354/meps080149; MUNK P, 1995, MAR BIOL, V122, P205; Oshima M, 2009, J FISH BIOL, V75, P1639, DOI 10.1111/j.1095-8649.2009.02390.x; Otterlei E, 1999, CAN J FISH AQUAT SCI, V56, P2099, DOI 10.1139/cjfas-56-11-2099; PALOMERA I, 1988, MAR BIOL, V99, P283, DOI 10.1007/BF00391991; Paulsen M, 2014, ICES J MAR SCI, V71, P991, DOI 10.1093/icesjms/fst168; Peck MA, 2007, MAR ECOL PROG SER, V347, P171, DOI 10.3354/meps06976; Peck MA, 2012, ADV ECOL RES, V47, P177, DOI 10.1016/B978-0-12-398315-2.00003-X; Peck MA, 2012, PROG OCEANOGR, V103, P42, DOI 10.1016/j.pocean.2012.04.013; Peck MA, 2012, J MARINE SYST, V93, P77, DOI 10.1016/j.jmarsys.2011.08.005; Peck MA, 2009, SCI MAR, V73, P23, DOI 10.3989/scimar.2009.73s1023; Peck WA, 2005, J FISH BIOL, V66, P882, DOI 10.1111/j.1095-8649.2005.00651.x; Pecseli HL, 2012, PROG OCEANOGR, V101, P14, DOI 10.1016/j.pocean.2011.12.001; Pedersen B.H., 1984, Dana, V3, P21; Pepin P, 2000, MAR ECOL PROG SER, V204, P199, DOI 10.3354/meps204199; PLATT T, 1977, HELGOLAND WISS MEER, V30, P575, DOI 10.1007/BF02207862; Portner HO, 2010, J FISH BIOL, V77, P1745, DOI 10.1111/j.1095-8649.2010.02783.x; Pope S.B., 2001, TURBULENT FLOWS, DOI DOI 10.1017/CBO9780511840531; Puvanendran V, 2002, AQUACULTURE, V214, P131, DOI 10.1016/S0044-8486(02)00045-5; R Core Team, 2021, R LANGUAGE ENV STAT; Re P, 1987, INVEST PESQ, V51; Record NR, 2013, ECOL MODEL, V260, P11, DOI 10.1016/j.ecolmodel.2013.03.018; Regner S, 1996, SCI MAR, V60, P167; Regner S, 1985, ECOLOGY PLANKTONIC S; ROSENTHAL H, 1969, MAR BIOL, V3, P208, DOI 10.1007/BF00360953; Rosenthal H., 1970, MARINE FOOD CHAINS, P344; ROTHSCHILD BJ, 1988, J PLANKTON RES, V10, P465, DOI 10.1093/plankt/10.3.465; Ruzicka JJ, 2006, DEEP-SEA RES PT II, V53, P2708, DOI 10.1016/j.dsr2.2006.08.014; Ruzicka JJ, 2006, DEEP-SEA RES PT II, V53, P2735, DOI 10.1016/j.dsr2.2006.09.003; Sabates A, 2007, FISH OCEANOGR, V16, P130, DOI 10.1111/j.1365-2419.2006.00416.x; SHELDON RW, 1972, LIMNOL OCEANOGR, V17, P327, DOI 10.4319/lo.1972.17.3.0327; SREENIVASAN KR, 1995, PHYS FLUIDS, V7, P2778, DOI 10.1063/1.868656; Stephens D.W., 1986, pi; Takasuka A, 2003, MAR ECOL PROG SER, V252, P223, DOI 10.3354/meps252223; Takasuka A, 2007, MAR ECOL PROG SER, V350, P99, DOI 10.3354/meps07158; THEILACKER GH, 1987, FISH B-NOAA, V85, P213; Tilseth S., 1984, Flodevigen Rapportserie, V1, P167; Titelman J, 2003, MAR ECOL PROG SER, V247, P123, DOI 10.3354/meps247123; Tudela S, 2002, J MAR BIOL ASSOC UK, V82, P349, DOI 10.1017/S0025315402005568; UYE S, 1995, MAR ECOL PROG SER, V118, P121, DOI 10.3354/meps118121; van der Veer HW, 2003, J SEA RES, V50, P255, DOI 10.1016/j.seares.2003.05.001; von Herbing IH, 2000, MAR BIOL, V136, P591, DOI 10.1007/s002270050719; Voss R, 2003, FISH RES, V63, P97, DOI 10.1016/S0165-7836(02)00282-5; Werner FE, 1996, DEEP-SEA RES PT II, V43, P1793, DOI 10.1016/S0967-0645(96)00042-2; Yeung PK, 1997, PHYS REV E, V56, P1746, DOI 10.1103/PhysRevE.56.1746; YIN MC, 1987, J EXP MAR BIOL ECOL, V107, P279, DOI 10.1016/0022-0981(87)90044-X	115	17	17	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98205	10.1371/journal.pone.0098205	http://dx.doi.org/10.1371/journal.pone.0098205			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901937	Green Published, Green Submitted, gold			2022-12-27	WOS:000336841400018
J	Kading, RC; Biggerstaff, BJ; Young, G; Komar, N				Kading, Rebekah C.; Biggerstaff, Brad J.; Young, Ginger; Komar, Nicholas			Mosquitoes Used to Draw Blood for Arbovirus Viremia Determinations in Small Vertebrates	PLOS ONE			English	Article							WEST-NILE-VIRUS; EQUINE ENCEPHALITIS-VIRUS; HIGHLANDS J-VIRUS; EXPERIMENTAL-INFECTION; CHICKENS; STRAINS; BIRDS	Serial samples from the same individuals may be required for certain virological studies, however, some small animals cannot easily be blood-sampled. Therefore, we evaluated the use of Culex quinquefasciatus Say and Aedes albopictus Skuse mosquitoes as "biological syringes'' to draw blood for virus titer determinations in small vertebrates. Groups of chicks (Gallus gallus), hamsters (Mesocricetus auratus), and house sparrows (Passer domesticus) were experimentally infected with West Nile virus (WNV) or Highlands J virus (HJV). In general, good correlation was seen between mosquito-and syringe-derived blood samples at titers >= 5.0 log(10) pfu/mL serum as compared with titers < 5.0 log(10) pfu/mL serum for chicks, hamsters, and sparrows. Ninety-two percent (24/26) of sparrows with virus titers > 10(5) pfu/mL serum had mosquito-and syringe-derived titers within one log of each other. Sparrow viremia profiles generated from single mosquito blood meals and syringe were not significantly different (p > 0.05). This technique is valuable for assessing the roles of small vertebrates in the ecologies of arboviruses, and could be used in applications beyond virology and infectious diseases, when < 10 mu L of whole blood is required.	[Kading, Rebekah C.; Biggerstaff, Brad J.; Young, Ginger; Komar, Nicholas] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO 80521 USA	Centers for Disease Control & Prevention - USA	Kading, RC (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO 80521 USA.	fxk7@cdc.gov	Kading, Rebekah C/E-5633-2017	Kading, Rebekah C/0000-0002-4996-915X; Young, Ginger/0000-0003-2403-8188	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	We would like to thank the late Dr. Andrew Spielman for inspiring this work. Animal care was provided by Verna O'Brien, Andrea Peterson, and Dr. Paul Spurlock. Insectary support was provided by Andrea Peterson and Erin Borland. Permission for sparrow capture was provided by Cozy Cow Dairy, Windsor, CO. This project was financially supported by the Centers for Disease Control and Prevention. The findings and conclusions in this report are those of the authors only, and do not necessarily reflect the views of the United States Government.	Beasley DWC, 2002, VIROLOGY, V296, P17, DOI 10.1006/viro.2002.1372; Beaty BC., 1995, VIRAL RICKETTSIAL CH, P189; Bolker B., 2012, BBMLE TOOLS GEN MAXI; CALISHER CH, 1988, AM J TROP MED HYG, V38, P447, DOI 10.4269/ajtmh.1988.38.447; Centers for Disease Control, 2004, MMWR-MORBID MORTAL W, V53, P1071; Centers for Disease Control, 1985, INT CAT ARB; Centers for Disease Control, 2006, MMWR-MORBID MORTAL W, V55, P1204; Centers for Disease Control, 2005, MMWR-MORBID MORTAL W, V54, P964; Clinis MJ, 1996, VIROLOGY, V218, P343; GUY JS, 1993, AVIAN DIS, V37, P389, DOI 10.2307/1591663; GUY JS, 1994, AVIAN DIS, V38, P572, DOI 10.2307/1592081; Klenk K, 2003, AM J TROP MED HYG, V69, P260, DOI 10.4269/ajtmh.2003.69.260; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; KONISHI E, 1989, J MED ENTOMOL, V26, P535, DOI 10.1093/jmedent/26.6.535; Langevin SA, 2005, AM J TROP MED HYG, V72, P99, DOI 10.4269/ajtmh.2005.72.99; Langevin SA, 2001, EMERG INFECT DIS, V7, P726, DOI 10.3201/eid0704.010422; Mahmood F, 2004, J MED ENTOMOL, V41, P965, DOI 10.1603/0022-2585-41.5.965; Morrey JD, 2004, ANTIVIR RES, V63, P41, DOI 10.1016/j.antiviral.2004.02.005; MORTON DB, 1993, LAB ANIM, V27, P1, DOI 10.1258/002367793780745633; Nemeth NM, 2008, AM J TROP MED HYG, V79, P283, DOI 10.4269/ajtmh.2008.79.283; Ogunrinade A, 1980, Afr J Med Med Sci, V9, P69; Pinheiro J., 2019, NLME LINEAR NONLINEA; Pyle P, 1997, IDENTIFICATION GUIDE; *R COR DEV TEAM, 2012, R LANG ENV STAT COMP; Sbrana E, 2005, AM J TROP MED HYG, V72, P325, DOI 10.4269/ajtmh.2005.72.325; Schneider BS, 2006, VIRAL IMMUNOL, V19, P74, DOI 10.1089/vim.2006.19.74; Sinden RE, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P139; Turell MJ, 2000, AM J TROP MED HYG, V62, P413, DOI 10.4269/ajtmh.2000.62.413; YUILL TM, 1969, T ROY SOC TROP MED H, V63, P407, DOI 10.1016/0035-9203(69)90019-4	29	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99342	10.1371/journal.pone.0099342	http://dx.doi.org/10.1371/journal.pone.0099342			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901448	Green Published, gold			2022-12-27	WOS:000336841400120
J	Kleppa, MJ; Erlenwein, SV; Darashchonak, N; von Kaisenberg, CS; von Versen-Hoynck, F				Kleppa, Marc-Jens; Erlenwein, Sarah-Vanessa; Darashchonak, Natallia; von Kaisenberg, Constantin S.; von Versen-Hoeynck, Frauke			Hypoxia and the Anticoagulants Dalteparin and Acetylsalicylic Acid Affect Human Placental Amino Acid Transport	PLOS ONE			English	Article							LOW-DOSE ASPIRIN; SPIRAL ARTERIES; TROPHOBLAST; SYSTEM; HEPARIN; OXYGEN; PREECLAMPSIA; PREGNANCIES; EXPRESSION; PREVENTION	Background: Anticoagulants, e. g. low-molecular weight heparins (LMWHs) and acetylsalicylic acid (ASA) are prescribed to women at risk for pregnancy complications that are associated with impaired placentation and placental hypoxia. Beyond their role as anticoagulants these compounds exhibit direct effects on trophoblast but their impact on placental function is unknown. The amino acid transport systems A and L, which preferably transfer essential amino acids, are well-described models to study placental nutrient transport. We aimed to examine the effect of hypoxia, LMWHs and ASA on the activity of the placental amino acid transport systems A and L and associated signalling mechanisms. Methods: The uptake of C-14-MeAIB (system A) or H-3-leucin (system L) was investigated after incubation of primary villous fragments isolated from term placentas. Villous tissue was incubated at 2% O-2 (hypoxia), 8% O-2 and standard culture conditions (21% O-2) or at 2% O-2 and 21% O-2 with dalteparin or ASA. Activation of the JAK/STAT or mTOR signalling pathways was determined by Western analysis of total and phosphorylated STAT3 or Raptor. Results: Hypoxia decreased system A mediated MeAIB uptake and increased system L mediated leucine uptake compared to standard culture conditions (21% O-2). This was accompanied by an impairment of STAT3 and a stimulation of Raptor signalling. System L activity increased at 8% O-2. Dalteparin treatment reduced system A and system L activity under normoxic conditions and ASA (1 mM) decreased system A and L transporter activity under normoxic and hypoxic conditions. Conclusions: Our data underline the dependency of placental function on oxygen supply. LMWHs and ASA are not able to reverse the effects of hypoxia on placental amino acid transport. These findings and the uncovering of the signalling mechanisms in more detail will help to understand the impact of LMWHs and ASA on placental function and fetal growth.	[Kleppa, Marc-Jens; Erlenwein, Sarah-Vanessa; Darashchonak, Natallia; von Kaisenberg, Constantin S.; von Versen-Hoeynck, Frauke] Hannover Med Sch, Dept Obstet & Gynecol, Hannover, Germany	Hannover Medical School	von Versen-Hoynck, F (corresponding author), Hannover Med Sch, Dept Obstet & Gynecol, Hannover, Germany.	vonversen-hoeynck.frauke@mh-hannover.de	von Versen-Höynck, Frauke/H-3719-2019; von Kaisenberg, Constantin/AAR-2756-2021	von Versen-Höynck, Frauke/0000-0002-1924-5695; 				Acevedo CG, 1999, EXP PHYSIOL, V84, P1127, DOI 10.1111/j.1469-445X.1999.01875.x; Audette MC, 2010, PLACENTA, V31, P97, DOI 10.1016/j.placenta.2009.11.016; Barbour LA, 1995, AM J OBSTET GYNECOL, V173, P1869, DOI 10.1016/0002-9378(95)90443-3; Bellik L, 2005, BRIT J PHARMACOL, V146, P568, DOI 10.1038/sj.bjp.0706347; Benirschke K, 2006, PATHOLOGY HUMAN PLAC, V5th; Burton GJ, 2006, METH MOLEC MED, V122, P413; CETIN I, 1988, AM J OBSTET GYNECOL, V158, P120, DOI 10.1016/0002-9378(88)90792-2; CETIN I, 1990, AM J OBSTET GYNECOL, V162, P253, DOI 10.1016/0002-9378(90)90860-A; DEKKER GA, 1993, AM J OBSTET GYNECOL, V168, P214, DOI 10.1016/S0002-9378(12)90917-5; Di Nisio M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004734.pub2; Dodd JM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006780.pub2; Drewlo S, 2011, J THROMB HAEMOST, V9, P2486, DOI 10.1111/j.1538-7836.2011.04526.x; Evans RW, 2003, REPRODUCTION, V125, P785, DOI 10.1530/rep.0.1250785; Ganapathy R, 2007, HUM REPROD, V22, P2523, DOI 10.1093/humrep/dem201; Gris JC, 2010, THROMB HAEMOSTASIS, V104, P771, DOI 10.1160/TH10-03-0167; Hills FA, 2006, MOL HUM REPROD, V12, P237, DOI 10.1093/molehr/gal026; Hirsh J, 2001, CHEST, V119, p64S, DOI 10.1378/chest.119.1_suppl.64S; Jansson N, 2003, J CLIN ENDOCR METAB, V88, P1205, DOI 10.1210/jc.2002-021332; Jansson N, 2013, J CLIN ENDOCR METAB, V98, P105, DOI 10.1210/jc.2012-2667; Jansson T, 1998, PEDIATR RES, V44, P532, DOI 10.1203/00006450-199810000-00011; Jansson T, 2002, PLACENTA, V23, P392, DOI 10.1053/plac.2002.0826; JOHNSON LW, 1988, AM J PHYSIOL, V254, pC773, DOI 10.1152/ajpcell.1988.254.6.C773; KARL PI, 1992, AM J PHYSIOL, V262, pC834, DOI 10.1152/ajpcell.1992.262.4.C834; Kaushal N, 2006, TOXICOL MECH METHOD, V16, P379, DOI 10.1080/15376520600640040; Kingdom JCP, 1997, PLACENTA, V18, P613, DOI 10.1016/S0143-4004(97)90000-X; Kingdom JCP, 1999, ADV EXP MED BIOL, V474, P259; Miller RK, 2005, PLACENTA, V26, P439, DOI 10.1016/j.placenta.2004.10.002; Nelson DM, 2003, AM J PHYSIOL-CELL PH, V284, pC310, DOI 10.1152/ajpcell.00253.2002; PARDI G, 1993, NEW ENGL J MED, V328, P692, DOI 10.1056/NEJM199303113281004; PIJNENBORG R, 1991, BRIT J OBSTET GYNAEC, V98, P648, DOI 10.1111/j.1471-0528.1991.tb13450.x; Quenby S, 2004, OBSTET GYNECOL, V104, P354, DOI 10.1097/01.AOG.0000128902.84876.d4; Regnault TRH, 2002, ENDOCRINE, V19, P23, DOI 10.1385/ENDO:19:1:23; Roberge S, 2013, ULTRASOUND OBST GYN, V41, P491, DOI 10.1002/uog.12421; Roberge S, 2013, AM J PERINAT; Roos S, 2004, AM J PHYSIOL-REG I, V287, pR886, DOI 10.1152/ajpregu.00232.2004; Roos S, 2009, AM J PHYSIOL-CELL PH, V297, pC723, DOI 10.1152/ajpcell.00191.2009; Roos S, 2007, J PHYSIOL-LONDON, V582, P449, DOI 10.1113/jphysiol.2007.129676; Searle J, 2011, ARTERIOSCL THROM VAS, V31, P2972, DOI 10.1161/ATVBAHA.111.237784; SHEPPARD BL, 1981, BRIT J OBSTET GYNAEC, V88, P695, DOI 10.1111/j.1471-0528.1981.tb01268.x; Shibata E, 2008, PLACENTA, V29, P879, DOI 10.1016/j.placenta.2008.07.001; Soleymanlou N, 2005, J CLIN ENDOCR METAB, V90, P4299, DOI 10.1210/jc.2005-0078; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; von Versen-Hoynck F, 2009, PLACENTA, V30, P361, DOI 10.1016/j.placenta.2009.01.004	43	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99217	10.1371/journal.pone.0099217	http://dx.doi.org/10.1371/journal.pone.0099217			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901243	Green Published, Green Submitted, gold			2022-12-27	WOS:000336841400111
J	Li, JQ; Miao, YG; Xue, Z				Li, Jun-Qing; Miao, Yan-Gang; Xue, Zhao			A Possible Method for Non-Hermitian and Non-PT-Symmetric Hamiltonian Systems	PLOS ONE			English	Article							PSEUDO-HERMITICITY; QUANTUM-MECHANICS; FIELD; OPERATORS	A possible method to investigate non-Hermitian Hamiltonians is suggested through finding a Hermitian operator eta(+) and defining the annihilation and creation operators to be eta(+) -pseudo-Hermitian adjoint to each other. The operator eta(+) represents the eta(+) -pseudo-Hermiticity of Hamiltonians. As an example, a non-Hermitian and non-PT-symmetric Hamiltonian with imaginary linear coordinate and linear momentum terms is constructed and analyzed in detail. The operator eta(+) is found, based on which, a real spectrum and a positive-definite inner product, together with the probability explanation of wave functions, the orthogonality of eigenstates, and the unitarity of time evolution, are obtained for the non-Hermitian and non-PT-symmetric Hamiltonian. Moreover, this Hamiltonian turns out to be coupled when it is extended to the canonical noncommutative space with noncommutative spatial coordinate operators and noncommutative momentum operators as well. Our method is applicable to the coupled Hamiltonian. Then the first and second order noncommutative corrections of energy levels are calculated, and in particular the reality of energy spectra, the positive-definiteness of inner products, and the related properties (the probability explanation of wave functions, the orthogonality of eigenstates, and the unitarity of time evolution) are found not to be altered by the noncommutativity.	[Li, Jun-Qing; Miao, Yan-Gang; Xue, Zhao] Nankai Univ, Sch Phys, Tianjin 300071, Peoples R China; [Miao, Yan-Gang] Chinese Acad Sci, Kavli Inst Theoret Phys China, Beijing, Peoples R China; [Miao, Yan-Gang] Univ Bonn, Bethe Ctr Theoret Phys, Bonn, Germany; [Miao, Yan-Gang] Univ Bonn, Inst Phys, Bonn, Germany	Nankai University; Chinese Academy of Sciences; University of Bonn; University of Bonn	Miao, YG (corresponding author), Nankai Univ, Sch Phys, Tianjin 300071, Peoples R China.	miaoyg@nankai.edu.cn			Alexander von Humboldt Foundation; National Natural Science Foundation of China [11175090]; Ministry of Education of China [20120031110027]	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	This work was supported in part by the Alexander von Humboldt Foundation under a short term programme, by the National Natural Science Foundation of China under grants No. 11175090 and by the Ministry of Education of China under grant No. 20120031110027. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender CM, 2007, REP PROG PHYS, V70, P947, DOI 10.1088/0034-4885/70/6/R03; Bender CM, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.270401; Bender CM, 1998, PHYS REV LETT, V80, P5243, DOI 10.1103/PhysRevLett.80.5243; Chong YD, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.093902; Dieudonne J, 1961, P 1960 INT S LIN SPA; Douglas MR, 2001, REV MOD PHYS, V73, P977, DOI 10.1103/RevModPhys.73.977; FAISAL FHM, 1981, J PHYS B-AT MOL OPT, V14, P3603, DOI 10.1088/0022-3700/14/19/012; Giri PR, 2009, EUR PHYS J C, V60, P157, DOI 10.1140/epjc/s10052-009-0866-9; LEE TD, 1969, NUCL PHYS B, VB  9, P209, DOI 10.1016/0550-3213(69)90098-4; Li JQ, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.042110; Miao YG, 2003, J HIGH ENERGY PHYS; Mostafazadeh A, 2002, J MATH PHYS, V43, P205, DOI 10.1063/1.1418246; Mostafazadeh A, 2003, J MATH PHYS, V44, P974, DOI 10.1063/1.1539304; Mostafazadeh A, 2002, J MATH PHYS, V43, P2814, DOI 10.1063/1.1461427; Pauli W, 1943, REV MOD PHYS, V15, P0175, DOI 10.1103/RevModPhys.15.175; Pauli W, 1985, SCI CORRES, VII, P15; Ramezani H, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.043803; SCHOLTZ FG, 1992, ANN PHYS-NEW YORK, V213, P74, DOI 10.1016/0003-4916(92)90284-S; Seiberg N, 1999, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/1999/09/032; SHETH IH, 1966, P AM MATH SOC, V17, P998, DOI 10.2307/2036076; SNYDER HS, 1947, PHYS REV, V71, P38, DOI 10.1103/PhysRev.71.38; SNYDER HS, 1947, PHYS REV, V72, P68, DOI 10.1103/PhysRev.72.68; Szabo RJ, 2003, PHYS REP, V378, P207, DOI 10.1016/S0370-1573(03)00059-0; WILLIAMS JP, 1969, P AM MATH SOC, V20, P121, DOI 10.2307/2035972; WONG J, 1967, J MATH PHYS, V8, P2039, DOI 10.1063/1.1705118	25	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e97107	10.1371/journal.pone.0097107	http://dx.doi.org/10.1371/journal.pone.0097107			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896084	Green Published, Green Submitted, gold			2022-12-27	WOS:000338430700008
J	Lugo, MR; Sharom, FJ				Lugo, Miguel Ramon; Sharom, Frances Jane			Kinetic Validation of the Models for P-Glycoprotein ATP Hydrolysis and Vanadate-Induced Trapping. Proposal for Additional Steps	PLOS ONE			English	Article							HAMSTER OVARY CELLS; OCCLUDED NUCLEOTIDE CONFORMATION; MULTIDRUG TRANSPORTER; CATALYTIC CYCLE; DRUG TRANSPORT; BINDING DOMAINS; RESISTANCE; SITES; STATE; RECONSTITUTION	P-Glycoprotein, a member of the ATP-binding cassette (ABC) superfamily, is a multidrug transporter responsible for cellular efflux of hundreds of structurally unrelated compounds, including natural products, many clinically used drugs and anticancer agents. Expression of P-glycoprotein has been linked to multidrug resistance in human cancers. ABC transporters are driven by ATP hydrolysis at their two cytoplasmic nucleotide-binding domains, which interact to form a closed ATP-bound sandwich dimer. Intimate knowledge of the catalytic cycle of these proteins is clearly essential for understanding their mechanism of action. P-Glycoprotein has been proposed to hydrolyse ATP by an alternating mechanism, for which there is substantial experimental evidence, including inhibition of catalytic activity by trapping of ortho-vanadate at one nucleotide-binding domain, and the observation of an asymmetric occluded state. Despite many studies of P-glycoprotein ATPase activity over the past 20 years, no comprehensive kinetic analysis has yet been carried out, and some puzzling features of its behaviour remain unexplained. In this work, we have built several progressively more complex kinetic models, and then carried out simulations and detailed analysis, to test the validity of the proposed reaction pathway employed by P-glycoprotein for ATP hydrolysis. To establish kinetic parameters for the catalytic cycle, we made use of the large amount of published data on ATP hydrolysis by hamster P-glycoprotein, both purified and in membrane vesicles. The proposed kinetic scheme(s) include a high affinity priming reaction for binding of the first ATP molecule, and an independent pathway for ADP binding outside the main catalytic cycle. They can reproduce to varying degrees the observed behavior of the protein's ATPase activity and its inhibition by ortho-vanadate. The results provide new insights into the mode of action of P-glycoprotein, and some hypotheses about the nature of the occluded nucleotide-bound state.	[Lugo, Miguel Ramon; Sharom, Frances Jane] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Sharom, FJ (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	fsharom@uoguelph.ca	Sharom, Frances/A-1613-2010	Sharom, Frances/0000-0002-9521-5367	Canadian Cancer Society [700248]; Cystic Fibrosis Canada	Canadian Cancer Society(Canadian Cancer Society (CCS)); Cystic Fibrosis Canada	This research was funded by an operating grant from the Canadian Cancer Society to FJS (grant # 700248). MRL currently holds a Kin Canada Fellowship from Cystic Fibrosis Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shawi MK, 2003, J BIOL CHEM, V278, P52629, DOI 10.1074/jbc.M308175200; ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197; AMBUDKAR SV, 1992, P NATL ACAD SCI USA, V89, P8472, DOI 10.1073/pnas.89.18.8472; AZZARIA M, 1989, MOL CELL BIOL, V9, P5289, DOI 10.1128/MCB.9.12.5289; Booth CL, 2000, BIOCHEMISTRY-US, V39, P5518, DOI 10.1021/bi992931x; Buxbaum E, 1999, EUR J BIOCHEM, V265, P54, DOI 10.1046/j.1432-1327.1999.00643.x; Delannoy S, 2005, BIOCHEMISTRY-US, V44, P14010, DOI 10.1021/bi0512445; DOIGE CA, 1992, BIOCHIM BIOPHYS ACTA, V1109, P149, DOI 10.1016/0005-2736(92)90078-Z; Eckford PDW, 2009, CHEM REV, V109, P2989, DOI 10.1021/cr9000226; HAMADA H, 1988, CANCER RES, V48, P4926; Jones PM, 2013, CRIT REV BIOCHEM MOL, V48, P39, DOI 10.3109/10409238.2012.735644; Liu RH, 1996, BIOCHEMISTRY-US, V35, P11865, DOI 10.1021/bi960823u; Liu RH, 2000, BIOCHEMISTRY-US, V39, P14927, DOI 10.1021/bi0018786; LOO TW, 1994, J BIOL CHEM, V269, P7750; LOO TW, 1995, J BIOL CHEM, V270, P22957, DOI 10.1074/jbc.270.39.22957; Lugo MR, 2011, BIOPHYS J, V100, P549; Qu Q, 2003, BIOCHEMISTRY-US, V42, P1345, DOI 10.1021/bi0267745; Qu Q, 2003, BIOCHEMISTRY-US, V42, P1170, DOI 10.1021/bi026555j; Russell PL, 2006, BIOCHEM J, V399, P315, DOI 10.1042/BJ20060015; Sankaran B, 1997, BIOCHEMISTRY-US, V36, P6847, DOI 10.1021/bi970034s; Sankaran B, 1997, ARCH BIOCHEM BIOPHYS, V341, P160, DOI 10.1006/abbi.1997.9944; Sauna ZE, 2000, P NATL ACAD SCI USA, V97, P2515, DOI 10.1073/pnas.97.6.2515; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Scian M, 2014, BIOCHEMISTRY-US, V53, P991, DOI 10.1021/bi401280v; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Senior AE, 1998, BIOCHEMISTRY-US, V37, P831, DOI 10.1021/bi9719962; SHAPIRO AB, 1994, J BIOL CHEM, V269, P3745; Sharom FJ, 2005, J BIOENERG BIOMEMBR, V37, P481, DOI 10.1007/s10863-005-9496-6; SHAROM FJ, 1995, BIOCHEM J, V308, P381, DOI 10.1042/bj3080381; SHAROM FJ, 1993, J BIOL CHEM, V268, P24197; Sharom FJ, 2006, BIOCHEM CELL BIOL, V84, P979, DOI 10.1139/O06-199; Sharom FJ, 2011, ESSAYS BIOCHEM, V50, P161, DOI [10.1042/BSE0500161, 10.1042/bse0500161]; Siarheyeva A, 2010, J BIOL CHEM, V285, P7575, DOI 10.1074/jbc.M109.047290; Tamaki A, 2011, ESSAYS BIOCHEM, V50, P209, DOI [10.1042/BSE0500209, 10.1042/bse0500209]; Tombline G, 2005, J BIOENERG BIOMEMBR, V37, P497, DOI [10.1007/s10863-005-9498-4, 10.1007/s10863-005-9498/4]; Tombline G, 2005, BIOCHEMISTRY-US, V44, P12879, DOI 10.1021/bi0509797; Tombline G, 2004, J BIOL CHEM, V279, P31212, DOI 10.1074/jbc.M404689200; Urbatsch IL, 2003, J BIOL CHEM, V278, P23171, DOI 10.1074/jbc.M301957200; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; URBATSCH IL, 1994, BIOCHEMISTRY-US, V33, P7069, DOI 10.1021/bi00189a008; URBATSCH IL, 1995, J BIOL CHEM, V270, P26956, DOI 10.1074/jbc.270.45.26956	41	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98804	10.1371/journal.pone.0098804	http://dx.doi.org/10.1371/journal.pone.0098804			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897122	Green Published, gold, Green Submitted			2022-12-27	WOS:000338430700081
J	Sharma, S; Markham, PF; Browning, GF				Sharma, Shukriti; Markham, Philip F.; Browning, Glenn F.			Genes Found Essential in Other Mycoplasmas Are Dispensable in Mycoplasma bovis	PLOS ONE			English	Article							SUBSP MYCOIDES SC; TRANSPOSON MUTAGENESIS; VIRULENCE FACTOR; SURFACE LIPOPROTEIN; MOLECULAR-BIOLOGY; GALLISEPTICUM; AGALACTIAE; IDENTIFICATION; PATHOGENICITY; CONSTRUCTION	Mycoplasmas are regarded to be useful models for studying the minimum genetic complement required for independent survival of an organism. Mycoplasma bovis is a globally distributed pathogen causing pneumonia, mastitis, arthritis, otitis media and reproductive tract disease, and genome sequences of three strains, the type strain PG45 and two strains isolated in China, have been published. In this study, several Tn4001 based transposon constructs were generated and used to create a M. bovis PG45 insertional mutant library. Direct genome sequencing of 319 independent insertions detected disruptions in 129 genes in M. bovis, 48 of which had homologues in Mycoplasma mycoides subspecies mycoides SC and 99 of which had homologues in Mycoplasma agalactiae. Sixteen genes found to be essential in previous studies on other mycoplasma species were found to be dispensable. Five of these genes have previously been predicted to be part of the core set of 153 essential genes in mycoplasmas. Thus this study has extended the list of non-essential genes of mycoplasmas from that previously generated by studies in other species.	[Sharma, Shukriti; Markham, Philip F.; Browning, Glenn F.] Univ Melbourne, Sch Vet Sci, Asia Pacific Ctr Anim Hlth, Parkville, Vic 3052, Australia	University of Melbourne	Browning, GF (corresponding author), Univ Melbourne, Sch Vet Sci, Asia Pacific Ctr Anim Hlth, Parkville, Vic 3052, Australia.	glenfb@unimelb.edu.au	Browning, Glenn Francis/P-4459-2014	Browning, Glenn Francis/0000-0002-0903-2469	Australian Government	Australian Government(Australian GovernmentCGIAR)	These studies were partially supported by financial support from the Australian Government under the AusAID program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Acevedo-Rocha CG, 2013, TRENDS GENET, V29, P273, DOI 10.1016/j.tig.2012.11.001; Akanuma G, 2012, J BACTERIOL, V194, P6282, DOI 10.1128/JB.01544-12; Baranowski E, 2010, INFECT IMMUN, V78, P1542, DOI 10.1128/IAI.01195-09; Barre A, 2004, NUCLEIC ACIDS RES, V32, pD307, DOI 10.1093/nar/gkh114; BEHRENS A, 1994, INFECT IMMUN, V62, P5075, DOI 10.1128/IAI.62.11.5075-5084.1994; Browning GF, 2011, VET MICROBIOL, V153, P44, DOI 10.1016/j.vetmic.2011.05.031; Caswell Jeff L., 2007, Animal Health Research Reviews, V8, P161, DOI 10.1017/S1466252307001351; Chiu CJ, 2006, PROTECTIVE IMMUNE RE; Chopra-Dewasthaly R, 2005, INT J MED MICROBIOL, V294, P447, DOI 10.1016/j.ijmm.2004.09.010; Cordova CMM, 2002, J BACTERIOL, V184, P5426, DOI 10.1128/JB.184.19.5426-5435.2002; Danchin A, 2007, PROTEOMICS, V7, P875, DOI 10.1002/pmic.200600442; De Maio A, 1999, SHOCK, V11, P1, DOI 10.1097/00024382-199901000-00001; Dybvig K, 1996, ANNU REV MICROBIOL, V50, P25, DOI 10.1146/annurev.micro.50.1.25; Dybvig K, 2010, FEMS MICROBIOL LETT, V311, P51, DOI 10.1111/j.1574-6968.2010.02078.x; Fang G, 2005, MOL BIOL EVOL, V22, P2147, DOI 10.1093/molbev/msi211; French CT, 2008, MOL MICROBIOL, V69, P67, DOI 10.1111/j.1365-2958.2008.06262.x; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Halbedel S, 2007, INT J MED MICROBIOL, V297, P37, DOI 10.1016/j.ijmm.2006.11.001; Hallamaa KM, 2006, J BACTERIOL, V188, P5393, DOI 10.1128/JB.01819-05; Hasselbring BA, 2006, J BACTERIOL, V188, P6335, DOI 10.1128/JB.00698-06; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Janis C, 2008, MICROBIOL-SGM, V154, P2427, DOI 10.1099/mic.0.2008/017640-0; Khan LA, 2005, VET RES COMMUN, V29, P181, DOI 10.1023/B:VERC.0000047506.04096.06; KNUDTSON KL, 1993, GENE, V137, P217, DOI 10.1016/0378-1119(93)90009-R; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Lartigue C, 2002, PLASMID, V48, P149, DOI 10.1016/S0147-619X(02)00121-X; Lee SW, 2008, MICROBIOL-SGM, V154, P2571, DOI 10.1099/mic.0.2008/019208-0; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020999; Lin Y, 2011, SCI REP-UK, V1, DOI 10.1038/srep00053; Liu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035698; Lysnyansky I, 1999, J BACTERIOL, V181, P5734, DOI 10.1128/JB.181.18.5734-5741.1999; Markham PF, 2003, J BACTERIOL, V185, P2538, DOI 10.1128/JB.185.8.2538-2547.2003; Masukagami Y, 2013, INFECT IMMUN, V81, P3220, DOI 10.1128/IAI.00365-13; McNamara Peter J., 2008, P89; Minion FC, 2002, FRONT BIOSCI-LANDMRK, V7, pD1410, DOI 10.2741/minion; Muneta Y, 2008, VACCINE, V26, P5449, DOI 10.1016/j.vaccine.2008.07.076; Panicker IS, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-138; Pilo P, 2005, J BACTERIOL, V187, P6824, DOI 10.1128/JB.187.19.6824-6831.2005; Pour-El I, 2002, PLASMID, V47, P129, DOI 10.1006/plas.2001.1558; Qi JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038239; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Rottem S, 2003, PHYSIOL REV, V83, P417, DOI 10.1152/physrev.00030.2002; Schmidt JA, 2004, J BACTERIOL, V186, P5790, DOI 10.1128/JB.186.17.5790-5798.2004; Schmidt JA, 2007, J BACTERIOL, V189, P3414, DOI 10.1128/JB.01835-06; Shil PK, 2011, VACCINE, V29, P3197, DOI 10.1016/j.vaccine.2011.02.035; Sirand-Pugnet P, 2007, PLOS GENET, V3, P744, DOI 10.1371/journal.pgen.0030075; Skapski A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025291; Szczepanek SM, 2010, INFECT IMMUN, V78, P3475, DOI 10.1128/IAI.00154-10; Thomas A, 2005, FEMS MICROBIOL LETT, V245, P249, DOI 10.1016/j.femsle.2005.03.013; Tseng CW, 2007, IMPROVING MYCOPLASMA; Vilei EM, 2001, CLIN DIAGN LAB IMMUN, V8, P85, DOI 10.1128/CDLI.8.1.85-92.2001; Whetzel PL, 2003, PLASMID, V49, P34, DOI 10.1016/S0147-619X(02)00114-2; Wise KS, 2011, INFECT IMMUN, V79, P982, DOI 10.1128/IAI.00726-10; Zhang R, 2004, NUCLEIC ACIDS RES, V32, pD271, DOI 10.1093/nar/gkh024	54	38	38	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e97100	10.1371/journal.pone.0097100	http://dx.doi.org/10.1371/journal.pone.0097100			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897538	Green Published, Green Submitted, gold			2022-12-27	WOS:000338430700007
J	Covolan, L; de Almeida, ACG; Amorim, B; Cavarsan, C; Miranda, MF; Aarao, MC; Madureira, AP; Rodrigues, AM; Nobrega, JN; Mello, LE; Hamani, C				Covolan, Luciene; de Almeida, Antonio-Carlos G.; Amorim, Beatriz; Cavarsan, Clarissa; Miranda, Maisa Ferreira; Aarao, Mayra C.; Madureira, Ana Paula; Rodrigues, Antonio M.; Nobrega, Jose N.; Mello, Luiz E.; Hamani, Clement			Effects of Anterior Thalamic Nucleus Deep Brain Stimulation in Chronic Epileptic Rats	PLOS ONE			English	Article							FREQUENCY ELECTRICAL-STIMULATION; PILOCARPINE-INDUCED SEIZURES; KINDLED SEIZURES; ADENOSINE; PROJECTIONS; RELEASE	Deep brain stimulation (DBS) has been investigated for the treatment of epilepsy. In rodents, an increase in the latency for the development of seizures and status epilepticus (SE) has been reported in different animal models but the consequences of delivering stimulation to chronic epileptic animals have not been extensively addressed. We study the effects of anterior thalamic nucleus (AN) stimulation at different current intensities in rats rendered epileptic following pilocarpine (Pilo) administration. Four months after Pilo-induced SE, chronic epileptic rats were bilaterally implanted with AN electrodes or had sham-surgery. Stimulation was delivered for 6 h/day, 5 days/week at 130 Hz, 90 mu sec. and either 100 mu A or 500 mu A. The frequency of spontaneous recurrent seizures in animals receiving stimulation was compared to that recorded in the preoperative period and in rats given sham treatment. To investigate the effects of DBS on hippocampal excitability, brain slices from animals receiving AN DBS or sham surgery were studied with electrophysiology. We found that rats treated with AN DBS at 100 mu A had a 52% non-significant reduction in the frequency of seizures as compared to sham-treated controls and 61% less seizures than at baseline. Animals given DBS at 500 mu A had 5.1 times more seizures than controls and a 2.8 fold increase in seizure rate as compared to preoperative values. In non-stimulated controls, the average frequency of seizures before and after surgery remained unaltered. In vitro recordings have shown that slices from animals previously given DBS at 100 mu A had a longer latency for the development of epileptiform activity, shorter and smaller DC shifts, and a smaller spike amplitude compared to non-stimulated controls. In contrast, a higher spike amplitude was recorded in slices from animals given AN DBS at 500 mu A.	[Covolan, Luciene; Amorim, Beatriz; Cavarsan, Clarissa; Mello, Luiz E.; Hamani, Clement] Univ Fed Sao Paulo, Disciplina Neurofisiol, Sao Paulo, Brazil; [de Almeida, Antonio-Carlos G.; Miranda, Maisa Ferreira; Aarao, Mayra C.; Madureira, Ana Paula; Rodrigues, Antonio M.] Univ Fed Sao Joao del Rei, Lab Neurociencia Expt & Computac, Sao Joao Del Rei, Brazil; [Nobrega, Jose N.; Hamani, Clement] Ctr Addict & Mental Hlth, Behav Neurobiol Lab, Toronto, ON, Canada; [Hamani, Clement] Univ Toronto, Toronto Western Hosp, Div Neurosurg, Toronto, ON M5T 2S8, Canada	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Joao del-Rei; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Hamani, C (corresponding author), Univ Fed Sao Paulo, Disciplina Neurofisiol, Sao Paulo, Brazil.	Clement.Hamani@uhn.on.ca	Rodrigues, Antônio M/D-3953-2012; ALMEIDA, ANTÔNIO-CARLOS GUIMARÃES/B-8028-2008; Covolan, Luciene/C-5926-2012; Cavarsan, Clarissa F./J-9221-2013; Mello, Luiz/B-4177-2009	Rodrigues, Antônio M/0000-0002-2678-9180; ALMEIDA, ANTÔNIO-CARLOS GUIMARÃES/0000-0003-4893-338X; Covolan, Luciene/0000-0002-9751-6438; Cavarsan, Clarissa F./0000-0002-6687-2130; Mello, Luiz/0000-0002-6969-1108	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2011/50680-2, 2012/50950-2]; Fapemig (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fapemig (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Support to conduct this work was provided by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; grants #2011/50680-2 and 2012/50950-2tel:2012%2F50950-2), Fapemig (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais), CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Otaibi FA, 2011, NEUROSURGERY, V69, P957, DOI 10.1227/NEU.0b013e31822b30cd; Andrade DM, 2006, NEUROLOGY, V66, P1571, DOI 10.1212/01.wnl.0000206364.19772.39; Arida RM, 1999, EPILEPSY RES, V34, P99, DOI 10.1016/S0920-1211(98)00092-8; Bekar L, 2008, NAT MED, V14, P75, DOI 10.1038/nm1693; Cooper I S, 1984, Int J Neurol, V18, P179; Cunha RA, 1996, J NEUROCHEM, V67, P2180; de Almeida ACG, 2008, EPILEPSIA, V49, P1908, DOI 10.1111/j.1528-1167.2008.01686.x; Fisher R, 2010, EPILEPSIA, V51, P899, DOI 10.1111/j.1528-1167.2010.02536.x; Hamani C, 2004, NEUROSURGERY, V54, P191, DOI 10.1227/01.NEU.0000097552.31763.AE; Hamani C, 2010, CLIN PHARMACOL THER, V88, P559, DOI 10.1038/clpt.2010.133; Hamani C, 2012, SCI TRANSL MED, V4, DOI DOI 10.1126/SCITRANSLMED.3003722; Hamani C, 2008, EPILEPSY RES, V78, P117, DOI 10.1016/j.eplepsyres.2007.09.010; Hamani C, 2010, EXP NEUROL, V225, P154, DOI 10.1016/j.expneurol.2010.06.007; Hamani C, 2009, INT J NEURAL SYST, V19, P213, DOI 10.1142/S0129065709001975; Hodaie M, 2002, EPILEPSIA, V43, P603, DOI 10.1046/j.1528-1157.2002.26001.x; Kerrigan JF, 2004, EPILEPSIA, V45, P346, DOI 10.1111/j.0013-9580.2004.01304.x; Lado FA, 2006, EPILEPSIA, V47, P27, DOI 10.1111/j.1528-1167.2006.00366.x; Lee KJ, 2006, ACTA NEUROCHIR SUPPL, V99, P87, DOI 10.1007/978-3-211-35205-2_17; Lim SN, 2007, EPILEPSIA, V48, P342, DOI 10.1111/j.1528-1167.2006.00898.x; Mirski MA, 1997, EPILEPSY RES, V28, P89, DOI 10.1016/S0920-1211(97)00034-X; Mohammad-Zadeh M, 2009, NEUROSCIENCE, V158, P1632, DOI 10.1016/j.neuroscience.2008.11.008; Osorio I, 2005, ANN NEUROL, V57, P258, DOI 10.1002/ana.20377; Paxinos G, 1988, RAT BRAIN STEREOTAXI; SANDER JWAS, 1993, EPILEPSIA, V34, P1007, DOI 10.1111/j.1528-1157.1993.tb02126.x; SHIBATA H, 1993, J COMP NEUROL, V337, P431, DOI 10.1002/cne.903370307; SHIBATA H, 1992, J COMP NEUROL, V323, P117, DOI 10.1002/cne.903230110; Takebayashi S, 2007, EPILEPSY RES, V74, P163, DOI 10.1016/j.eplepsyres.2007.03.007; Takebayashi S, 2007, EPILEPSIA, V48, P348, DOI 10.1111/j.1528-1167.2006.00948.x; Tawfik VL, 2010, NEUROSURGERY, V67, P367, DOI 10.1227/01.NEU.0000371988.73620.4C; Theodore WH, 2004, LANCET NEUROL, V3, P111, DOI 10.1016/S1474-4422(03)00664-1; Upton A R, 1985, Int J Neurol, V19-20, P223; Zhang Q, 2012, BRAIN RES BULL, V87, P221, DOI 10.1016/j.brainresbull.2011.11.023; Zhong XL, 2011, BRAIN RES BULL, V86, P422, DOI 10.1016/j.brainresbull.2011.08.014	33	26	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e97618	10.1371/journal.pone.0097618	http://dx.doi.org/10.1371/journal.pone.0097618			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892420	gold, Green Published, Green Submitted			2022-12-27	WOS:000336911400016
J	Leung, JM; Tran, F; Pathak, RB; Poupart, S; Heaslip, AT; Ballif, BA; Westwood, NJ; Ward, GE				Leung, Jacqueline M.; Tran, Fanny; Pathak, Ravindra B.; Poupart, Severine; Heaslip, Aoife T.; Ballif, Bryan A.; Westwood, Nicholas J.; Ward, Gary E.			Identification of T. gondii Myosin Light Chain-1 as a Direct Target of TachypleginA-2, a Small-Molecule Inhibitor of Parasite Motility and Invasion	PLOS ONE			English	Article							TOXOPLASMA-GONDII; MEMBRANE; GENE; SECRETION; COMPLEX; THIOLS; CELLS; ACIDS	Motility of the protozoan parasite Toxoplasma gondii plays an important role in the parasite's life cycle and virulence within animal and human hosts. Motility is driven by a myosin motor complex that is highly conserved across the Phylum Apicomplexa. Two key components of this complex are the class XIV unconventional myosin, TgMyoA, and its associated light chain, TgMLC1. We previously showed that treatment of parasites with a small-molecule inhibitor of T. gondii invasion and motility, tachypleginA, induces an electrophoretic mobility shift of TgMLC1 that is associated with decreased myosin motor activity. However, the direct target(s) of tachypleginA and the molecular basis of the compound-induced TgMLC1 modification were unknown. We show here by "click" chemistry labelling that TgMLC1 is a direct and covalent target of an alkyne-derivatized analogue of tachypleginA. We also show that this analogue can covalently bind to model thiol substrates. The electrophoretic mobility shift induced by another structural analogue, tachypleginA-2, was associated with the formation of a 225.118 Da adduct on S57 and/or C58, and treatment with deuterated tachypleginA-2 confirmed that the adduct was derived from the compound itself. Recombinant TgMLC1 containing a C58S mutation (but not S57A) was refractory to click labelling and no longer exhibited a mobility shift in response to compound treatment, identifying C58 as the site of compound binding on TgMLC1. Finally, a knock-in parasite line expressing the C58S mutation showed decreased sensitivity to compound treatment in a quantitative 3D motility assay. These data strongly support a model in which tachypleginA and its analogues inhibit the motility of T. gondii by binding directly and covalently to C58 of TgMLC1, thereby causing a decrease in the activity of the parasite's myosin motor.	[Leung, Jacqueline M.; Heaslip, Aoife T.; Ward, Gary E.] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA; [Leung, Jacqueline M.] Univ Vermont, Program Cellular & Mol Biomed Sci, Burlington, VT USA; [Tran, Fanny; Pathak, Ravindra B.; Poupart, Severine; Westwood, Nicholas J.] Univ St Andrews, Sch Chem & Biomed Sci Res Complex, St Andrews, Fife, Scotland; [Tran, Fanny; Pathak, Ravindra B.; Poupart, Severine; Westwood, Nicholas J.] EaStCHEM, St Andrews, Fife, Scotland; [Ballif, Bryan A.] Univ Vermont, Dept Biol, Burlington, VT USA	University of Vermont; University of Vermont; University of St Andrews; University of St Andrews; University of Vermont	Westwood, NJ (corresponding author), Univ St Andrews, Sch Chem & Biomed Sci Res Complex, St Andrews, Fife, Scotland.	njw3@st-andrews.ac.uk; gary.ward@uvm.edu		Ward, Gary/0000-0003-4138-3055; Heaslip, Aoife/0000-0002-7838-3617; Westwood, Nicholas/0000-0003-0630-0138	US Public Health Service [AI054961]; University Research Fellowship from the Royal Society; Vermont Genetics Network/NIH from the INBRE program of the NIGMS [8P20GM103449]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI054961, R01AI054961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103496, P20GM103449] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); University Research Fellowship from the Royal Society(Royal Society of London); Vermont Genetics Network/NIH from the INBRE program of the NIGMS; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US Public Health Service grant AI054961 (GEW/NJW), a University Research Fellowship from the Royal Society (NJW) and funding for the mass spectrometry analysis was provided by the Vermont Genetics Network/NIH Grant 8P20GM103449 from the INBRE program of the NIGMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BK, 2005, ANTI-CANCER DRUG, V16, P263, DOI 10.1097/00001813-200503000-00005; Andenmatten N, 2013, NAT METHODS, V10, P125, DOI 10.1038/NMETH.2301; Anderson-White BR, 2011, CELL MICROBIOL, V13, P18, DOI 10.1111/j.1462-5822.2010.01514.x; Aurrecoechea C, 2013, NUCLEIC ACIDS RES, V41, pD684, DOI 10.1093/nar/gks1113; Ballif BA, 2013, EMBO MOL MED, V5, P751, DOI 10.1002/emmm.201302466; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Bosch J, 2007, J MOL BIOL, V372, P77, DOI 10.1016/j.jmb.2007.06.016; Carey KL, 2004, P NATL ACAD SCI USA, V101, P7433, DOI 10.1073/pnas.0307769101; Catti F, 2008, TETRAHEDRON, V64, P9561, DOI 10.1016/j.tet.2008.07.063; Claisen L., 1881, BER DTSCH CHEM GES, V14, P2460, DOI [10.1002/cber, DOI 10.1002/CBER.18810140182, 10.1002/cber.188101402192, DOI 10.1002/CBER.188101402192]; Dimmock JR, 2001, J MED CHEM, V44, P586, DOI 10.1021/jm0002580; Dobrowolski JM, 1997, CELL MOTIL CYTOSKEL, V37, P253, DOI 10.1002/(SICI)1097-0169(1997)37:3&lt;253::AID-CM7&gt;3.0.CO;2-7; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; Frenal K, 2010, CELL HOST MICROBE, V8, P343, DOI 10.1016/j.chom.2010.09.002; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Hall CI, 2011, P NATL ACAD SCI USA, V108, P10568, DOI 10.1073/pnas.1105622108; Heaslip AT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000720; Herm-Gotz A, 2002, EMBO J, V21, P2149, DOI 10.1093/emboj/21.9.2149; Hsu JL, 2003, ANAL CHEM, V75, P6843, DOI 10.1021/ac0348625; Hu K, 2002, MOL BIOL CELL, V13, P593, DOI 10.1091/mbc.01-06-0309; Huynh MH, 2006, PLOS PATHOG, V2, P753, DOI 10.1371/journal.ppat.0020084; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Kortagere S, 2011, J COMPUT AID MOL DES, V25, P403, DOI 10.1007/s10822-011-9420-6; Leung JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085763; LOWEY S, 1995, BIOPHYS J, V68, pS120; Mann T, 2001, MOL BIOCHEM PARASIT, V115, P257, DOI 10.1016/S0166-6851(01)00289-4; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; MESSINA M, 1995, GENE, V165, P213, DOI 10.1016/0378-1119(95)00548-K; MUTUS B, 1989, ANAL BIOCHEM, V177, P237, DOI 10.1016/0003-2697(89)90045-6; Nebl T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002222; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Pati HN, 2007, MINI-REV MED CHEM, V7, P131, DOI 10.2174/138955707779802642; Pati HN, 2009, EUR J MED CHEM, V44, P54, DOI 10.1016/j.ejmech.2008.03.015; PEARSON RG, 1990, COORDIN CHEM REV, V100, P403, DOI 10.1016/0010-8545(90)85016-L; Polonais V, 2011, TRAFFIC, V12, P287, DOI 10.1111/j.1600-0854.2010.01148.x; PORCHET E, 1977, Z PARASITENKD, V54, P101, DOI 10.1007/BF00380795; Ravindran S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008143; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Salina G, 1964, CHEM IND, V1964, P2053; Salvatore RN, 2005, TETRAHEDRON LETT, V46, P8931, DOI 10.1016/j.tetlet.2005.10.062; Schmidt J.G., 1881, BER DTSCH CHEM GES, V14, P1459, DOI DOI 10.1002/CBER.188101401306; Sensfuss U, 2003, TETRAHEDRON LETT, V44, P2371, DOI 10.1016/S0040-4039(03)00247-8; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Sun AM, 2009, BIOORG MED CHEM LETT, V19, P6627, DOI 10.1016/j.bmcl.2009.10.023; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; TRYBUS KM, 1994, J MUSCLE RES CELL M, V15, P587, DOI 10.1007/BF00121066; TRYBUS KM, 1994, J BIOL CHEM, V269, P20819; van Dooren GG, 2008, P NATL ACAD SCI USA, V105, P13574, DOI 10.1073/pnas.0803862105	51	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98056	10.1371/journal.pone.0098056	http://dx.doi.org/10.1371/journal.pone.0098056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892871	Green Published, Green Submitted, gold			2022-12-27	WOS:000336911400031
J	Szlachetko, DL; Gorniak, M; Kolanowska, M; Mytnik-Ejsmont, J; Kowalkowska, AK; Rutkowski, P; Kolinski, T				Szlachetko, Dariusz L.; Gorniak, Marcin; Kolanowska, Marta; Mytnik-Ejsmont, Joanna; Kowalkowska, Agnieszka K.; Rutkowski, Piotr; Kolinski, Tomasz			Taxonomic Position and Phylogeny of the Genus Vargasiella (Orchidaceae, Vandoideae) Based on Molecular and Morphological Evidence	PLOS ONE			English	Article							GENETIC CONSEQUENCES; EVOLUTION	Since the description of the Neotropical genus Vargasiella in 1952, its taxonomic position has remained unclear, mainly due to a lack of sufficient data. In this study, the taxonomic position of Vargasiella was revised based on the outcomes of macro- and micromorphological studies, analyses of selected molecular markers and ecological methods of niche distribution modeling. The phylogenetic relationships were inferred using three DNA markers: matK, trnL-F and ITS sequences. The morphological studies included the analysis of macromorphological features of herbarium specimens as well as micromorphological examination of preserved flowers. The ecological niche modeling was applied to identify the distribution of the suitable niches of the studied taxa. The relationships between Vargasiella and most similar taxa remain unresolved based on the molecular analysis. The outcomes from the morphological studies indicated significant differences between Vargasiella, Warrea and Warreopsis. Moreover, a niche shift in response to changing climate after the last glacial maximum is observed in Vargasiella, while no substantial changes in the occupied habitats were identified in the other related taxa. The clocktree of the Zygopetaleae estimated from the matK gene indicated that the most recent common ancestors of Vargasiella, Warrea and Warreopsis originated in the Miocene, while the divergence time for Vargasiella and Warrea was assessed at approximately 5.4 Ma ago. Vargasiella seems to be an outshoot of the main branch of evolution of the Zygopetaleae. It is noteworthy that the Vargasiella-Warrea dichotomy could have taken place later than the divergence of Warreopsis from the mutual lineage. The molecular analysis and morphological data suggest that Vargasiella and Warrea could have evolved from a common ancestor. Accumulation of morphological differences and acceleration of the evolution of Vargasiella were more intensive than in other Warreinae and this could probably be synchronized with adaptation to different climatic conditions.	[Szlachetko, Dariusz L.; Kolanowska, Marta; Mytnik-Ejsmont, Joanna; Rutkowski, Piotr] Univ Gdansk, Dept Plant Taxon & Nat Conservat, PL-80952 Gdansk, Poland; [Gorniak, Marcin] Univ Gdansk, Dept Mol Evolut, PL-80952 Gdansk, Poland; [Kowalkowska, Agnieszka K.] Univ Gdansk, Dept Plant Cytol & Embryol, PL-80952 Gdansk, Poland; [Kolinski, Tomasz] Med Univ Gdansk, Dept Immunol, Gdansk, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk	Kolanowska, M (corresponding author), Univ Gdansk, Dept Plant Taxon & Nat Conservat, PL-80952 Gdansk, Poland.	martakolanowska@wp.pl	Kolanowska, Marta/AAR-3107-2020; Górniak, Marcin/HGB-0473-2022; Kowalkowska, Agnieszka Kamila/AAB-2402-2019	Kolanowska, Marta/0000-0001-5347-5403; Górniak, Marcin/0000-0002-7568-7818; Kowalkowska, Agnieszka Kamila/0000-0001-9685-8156; Kolinski, Tomasz/0000-0001-7839-0609; Rutkowski, Piotr/0000-0002-7059-0902; Mytnik, Joanna/0000-0003-4921-4950	Polish Ministry of Science and Higher Education [N N303 343735]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by the Polish Ministry of Science and Higher Education grant (N N303 343735). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman RM, 1999, SYST ASSOC SPEC VOL, V57, P432; Braconnot P, 2007, CLIM PAST, V3, P279, DOI 10.5194/cp-3-279-2007; Ch Schweinfurth, 1952, HARV U BOT MUS LEAF, V15, P139; Ch Schweinfurth, 1958, HARV U BOT MUS LEAF, V18, P219; Chase M.W., 2009, GENERA ORCHIDACEARUM, V5, P362; CHASE MW, 1991, TAXON, V40, P215, DOI 10.2307/1222975; Cuenoud P, 2002, AM J BOT, V89, P132, DOI 10.3732/ajb.89.1.132; Davies KL, 2011, ANN BOT-LONDON, V108, P945, DOI 10.1093/aob/mcr202; Dressler R.L., 1981, ORCHIDS NATURAL HIST; Dressler RL, 1993, PHYLOGENY CLASSIFICA; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eldredge N., 1972, P82; ESRI, 2009, ARCGIS DESKT REL 10; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Garzione CN, 2006, EARTH PLANET SC LETT, V241, P543, DOI 10.1016/j.epsl.2005.11.026; Gustafsson ALS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-177; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Latrubesse EM, 2010, EARTH-SCI REV, V99, P99, DOI 10.1016/j.earscirev.2010.02.005; MOLVRAY M, 2000, MONOCOTS SYSTEMATICS, P441, DOI DOI 10.1002/ECE3.752; Urbina-Cardona JN, 2008, TROP CONSERV SCI, V1, P417, DOI 10.1177/194008290800100408; Olson JS, 1983, DOENBB0037 CARB DIOX; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pupulin F, 2009, GENERA ORCHIDACEAR 2, V5, P456; Rambaut A, 2007, TRACER V 1 5; Romero Gustavo A., 1993, Novon, V3, P79, DOI 10.2307/3391429; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Senghas K-H, 1996, ORCHIDEEN, P1862; Senghas K-H, 1983, ORCHIDEEN, P800; SUN Y, 1994, THEOR APPL GENET, V89, P26, DOI 10.1007/BF00226978; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Szlachetko D. L., 1995, FRAGMENTA FLORISTICA, V3, P1; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Whitten M.W., 2005, LANKESTERIANA, V5, P87; WRIGHT S, 1982, EVOLUTION, V36, P427, DOI 10.1111/j.1558-5646.1982.tb05065.x	45	3	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98472	10.1371/journal.pone.0098472	http://dx.doi.org/10.1371/journal.pone.0098472			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892289	Green Published, gold, Green Submitted			2022-12-27	WOS:000336911400055
J	Vegter, S; Tolley, K				Vegter, Stefan; Tolley, Keith			A Network Meta-Analysis of the Relative Efficacy of Treatments for Actinic Keratosis of the Face or Scalp in Europe	PLOS ONE			English	Article							IMIQUIMOD 5-PERCENT CREAM; AMINOLEVULINATE-PHOTODYNAMIC THERAPY; EMITTING DIODE LIGHT; DOUBLE-BLIND; METHYL-AMINOLEVULINATE; BF-200 ALA; PHASE-III; MALIGNANT-TRANSFORMATION; TOPICAL FLUOROURACIL; COST-EFFECTIVENESS	Background: Several treatments are available for actinic keratosis (AK) on the face and scalp. Most treatment modalities were compared to placebo and therefore little is known on their relative efficacy. Objectives: To compare the different treatments for mild to moderate AK on the face and scalp available in clinical practice in Europe. Methods: A network meta-analysis (NMA) was performed on the outcome "complete patient clearance''. Ten treatment modalities were included: two 5-aminolaevulinic acid photodynamic therapies (ALA-PDT), applied as gel (BF-200 ALA) or patch; methyl-aminolevulinate photodynamic therapy (MAL-PDT); three modalities with imiquimod (IMI), applied as a 4-week or 16-week course with 5% imiquimod, or a 2-3 week course with 3.75% imiquimod; cryotherapy; diclofenac 3% in 2.5% hyaluronic acid; 0.5% 5-fluorouracil (5-FU); and ingenol mebutate (IMB). The only data available for 5% 5-FU was from one small study and was determined to be too limited to be reliably included in the analysis. For BF-200 ALA and MAL-PDT, data from illumination with narrow-band lights were selected as these are typically used in clinical practice. The NMA was performed with a random-effects Bayesian model. Results: 25 trials on 5,562 patients were included in the NMA. All active treatments were significantly better than placebo. BF-200 ALA showed the highest efficacy compared to placebo to achieve total patient clearance. BF-200 ALA had the highest probability to be the best treatment and the highest SUCRA score (64.8% and 92.1%), followed by IMI 5% 4 weeks (10.1% and 74.2%) and 5-FU 0.5% (7.2% and 66.8%). Conclusions: This NMA showed that BF-200 ALA, using narrow-band lights, was the most efficacious treatment for mild to moderate AK on the face and scalp. This analysis is relevant for clinical decision making and health technology assessment, assisting the improved management of AK.	[Vegter, Stefan] Univ Groningen, Dept Pharm, Groningen, Netherlands; [Vegter, Stefan] Vegter Hlth Econ Res, Groningen, Netherlands; [Tolley, Keith] Tolley Hlth Econ Consultancy Ltd, Buxton, England	University of Groningen	Vegter, S (corresponding author), Univ Groningen, Dept Pharm, Groningen, Netherlands.	s.vegter@rug.nl			Biofrontera, Germany	Biofrontera, Germany	The research was funded by Biofrontera, Germany. Biofrontera personnel reviewed the draft manuscript but did not have control of the methodology, conduct, results, or conclusion of this study. Additionally, this paper was not dependent on Biofrontera approval for submission to the journal.	Ades AE, 2006, PHARMACOECONOMICS, V24, P1, DOI 10.2165/00019053-200624010-00001; ALAM CAS, 1995, J PHARM PHARMACOL, V47, P407, DOI 10.1111/j.2042-7158.1995.tb05820.x; Alomar A, 2007, BRIT J DERMATOL, V157, P133, DOI 10.1111/j.1365-2133.2007.07942.x; [Anonymous], NCT00828568; Armoskaite V, 2011, MEDICINA S2, V47, P49; Brown MB, 2005, J EUR ACAD DERMATOL, V19, P308, DOI 10.1111/j.1468-3083.2004.01180.x; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Criscione VD, 2009, CANCER-AM CANCER SOC, V115, P2523, DOI 10.1002/cncr.24284; de Berker D, 2007, BRIT J DERMATOL, V156, P222, DOI 10.1111/j.1365-2133.2006.07692.x; Dirschka T, 2013, BRIT J DERMATOL, V168, P825, DOI 10.1111/bjd.12158; Dirschka T, 2012, BRIT J DERMATOL, V166, P137, DOI 10.1111/j.1365-2133.2011.10613.x; Falagas ME, 2006, J AM ACAD DERMATOL, V55, P537, DOI 10.1016/j.jaad.2006.05.030; Flohil SC, 2013, J INVEST DERMATOL, V133, P1971, DOI 10.1038/jid.2013.134; Freemantle C, 1995, INT J TISSUE REACT, V17, P157; Gebauer Kurt, 2003, Australas J Dermatol, V44, P40, DOI 10.1046/j.1440-0960.2002.00635.x; Glenny AM, 2005, HEALTH TECHNOL ASSES, V9, P1; Glogau RG, 2000, J AM ACAD DERMATOL, V42, pS23, DOI 10.1067/mjd.2000.103339; Greiner RA, 2013, VALUE HEALTH, V16, pA608, DOI 10.1016/j.jval.2013.08.1743; Gupta A, 2012, BMJ CASE REP, V3, P2012, DOI DOI 10.1038/NN.3138; Gupta AK, 2013, BRIT J DERMATOL, V169, P250, DOI 10.1111/bjd.12343; Gupta AK, 2005, J CUTAN MED SURG, V9, P209, DOI 10.1007/s10227-005-0148-6; Gupta AK, 2002, CUTIS, V70, P30; Hadley G, 2006, J INVEST DERMATOL, V126, P1251, DOI 10.1038/sj.jid.5700264; Hanke CW, 2010, J AM ACAD DERMATOL, V62, P573, DOI 10.1016/j.jaad.2009.06.020; Hauschild A, 2009, BRIT J DERMATOL, V160, P1066, DOI 10.1111/j.1365-2133.2009.09040.x; Jansen JP, 2008, VALUE HEALTH, V11, P956, DOI 10.1111/j.1524-4733.2008.00347.x; Jorizzo J, 2004, ARCH DERMATOL, V140, P813, DOI 10.1001/archderm.140.7.813; Jorizzo J, 2002, CUTIS, V70, P335; Jorizzo J, 2007, J AM ACAD DERMATOL, V57, P265, DOI 10.1016/j.jaad.2007.01.047; Kaur RR, 2010, J DERMATOL TREAT, V21, P267, DOI 10.3109/09546630903341937; Korman N, 2005, ARCH DERMATOL, V141, P467, DOI 10.1001/archderm.141.4.467; Krawtchenko N, 2007, BRIT J DERMATOL, V157, P34, DOI 10.1111/j.1365-2133.2007.08271.x; Lebwohl M, 2004, J AM ACAD DERMATOL, V50, P714, DOI 10.1016/j.jaad.2003.12.010; Lebwohl M, 2012, NEW ENGL J MED, V366, P1010, DOI 10.1056/NEJMoa1111170; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; MARKS R, 1988, LANCET, V1, P795, DOI 10.1016/s0140-6736(88)91658-3; Morton C, 2006, BRIT J DERMATOL, V155, P1029, DOI 10.1111/j.1365-2133.2006.07470.x; Muston D, 2009, J DERMATOL TREAT, V20, P266, DOI 10.1080/09546630902887211; Ooi T, 2006, BRIT J DERMATOL, V154, P72, DOI 10.1111/j.1365-2133.2005.06932.x; Pariser D, 2008, J AM ACAD DERMATOL, V59, P569, DOI 10.1016/j.jaad.2008.05.031; Piacquadio DJ, 2004, ARCH DERMATOL, V140, P41, DOI 10.1001/archderm.140.1.41; Rivers JK, 2002, BRIT J DERMATOL, V146, P94, DOI 10.1046/j.1365-2133.2002.04561.x; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Salasche SJ, 2000, J AM ACAD DERMATOL, V42, pS4, DOI 10.1067/mjd.2000.103342; Seed MP, 1997, CANCER RES, V57, P1625; Stanley MA, 2002, CLIN EXP DERMATOL, V27, P571, DOI 10.1046/j.1365-2230.2002.01151.x; Stockfleth E, 2011, BRIT J DERMATOL, V165, P1101, DOI 10.1111/j.1365-2133.2011.10387.x; Stockfleth E, 2006, EUR J DERMATOL, V16, P599, DOI 10.1684/ejd.2006.0017; Swanson N, 2010, J AM ACAD DERMATOL, V62, P582, DOI 10.1016/j.jaad.2009.07.004; Szeimies RM, 2010, BRIT J DERMATOL, V163, P386, DOI 10.1111/j.1365-2133.2010.09873.x; Szeimies RM, 2002, J AM ACAD DERMATOL, V47, P258, DOI 10.1067/mjd.2002.119649; Szeimies RM, 2004, J AM ACAD DERMATOL, V51, P547, DOI 10.1016/j.jaad.2004.02.022; Szeimies RM, 2009, DERMATOL SURG, V35, P586, DOI 10.1111/j.1524-4725.2009.01096.x; University of Bristol School of Social and Community Medicine, 2013, MIX TREATM COMP; Warino L, 2006, DERMATOL SURG, V32, P1045, DOI 10.1111/j.1524-4725.2006.32228.x; Weiss J, 2002, CUTIS, V70, P22; Werner RN, 2013, BRIT J DERMATOL, V169, P502, DOI 10.1111/bjd.12420; WHITE SJ, 1995, AM J OTOLARYNG, V16, P312, DOI 10.1016/0196-0709(95)90059-4; Wilson ECF, 2010, PHARMACOECONOMICS, V28, P1055, DOI 10.2165/11538670-000000000-00000; Wolf JE, 2001, INT J DERMATOL, V40, P709, DOI 10.1046/j.1365-4362.2001.01324.x	61	72	72	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e96829	10.1371/journal.pone.0096829	http://dx.doi.org/10.1371/journal.pone.0096829			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892649	Green Submitted, gold, Green Published			2022-12-27	WOS:000336911400008
J	Chen, GC; Yue, AH; Ruan, ZB; Yin, YG; Wang, RZ; Ren, Y; Zhu, L				Chen, Gecai; Yue, Aihuan; Ruan, Zhongbao; Yin, Yigang; Wang, RuZhu; Ren, Yin; Zhu, Li			Human Umbilical Cord-Derived Mesenchymal Stem Cells Do Not Undergo Malignant Transformation during Long-Term Culturing in Serum-Free Medium	PLOS ONE			English	Article							IN-VITRO CULTURE; BONE-MARROW; CROSS-CONTAMINATION; STROMAL CELLS; ISSUE	Background: Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) are in the foreground as a preferable application for treating diseases. However, the safety of hUC-MSCs after long-term culturing in vitro in serum-free medium remains unclear. Methods: hUC-MSCs were separated by adherent tissue culture. hUC-MSCs were cultured in serum-free MesenCult-XF medium and FBS-bases DMEM complete medium. At the 1st, 3rd, 5th, 8th, 10th, and 15th passage, the differentiation of MSCs into osteogenic, chondrogenic, and adipogenic cells was detected, and MTT, surface antigens were measured. Tumorigenicity was analyzed at the 15th passage. Conventional karyotyping was performed at passage 0, 8, and 15. The telomerase activity of hUC-MSCs at passage 1-15 was analyzed. Results: Flow cytometry analysis showed that very high expression was detected for CD105, CD73, and CD90 and very low expression for CD45, CD34, CD14, CD79a, and HLA-DR. MSCs could differentiate into osteocytes, chondrocytes, and adipocytes in vitro. There was no obvious chromosome elimination, displacement, or chromosomal imbalance as determined from the guidelines of the International System for Human Cytogenetic Nomenclature. Telomerase activity was down-regulated significantly when the culture time was prolonged. Further, no tumors formed in rats injected with hUC-MSCs (P-15) cultured in serum-free and in serum-containing conditions. Conclusion: Our data showed that hUC-MSCs met the International Society for Cellular Therapy standards for conditions of long-term in vitro culturing at P-15. Since hUC-MSCs can be safely expanded in vitro and are not susceptible to malignant transformation in serum-free medium, these cells are suitable for cell therapy.	[Chen, Gecai; Ruan, Zhongbao; Yin, Yigang; Wang, RuZhu; Ren, Yin; Zhu, Li] Taizhou Peoples Hosp, Dept Cardiol, Taizhou, Jiangsu, Peoples R China; [Yue, Aihuan] Jiangsu Beike Biotechnol Co Ltd, Taizhou, Jiangsu, Peoples R China		Zhu, L (corresponding author), Taizhou Peoples Hosp, Dept Cardiol, Taizhou, Jiangsu, Peoples R China.	yueaihuan@163.com	Wang, Ruzhu/A-6727-2012	Wang, Ruzhu/0000-0003-3586-5728				Aguilar S, 2007, STEM CELLS, V25, P1586, DOI 10.1634/stemcells.2006-0762; Ahrari Iman, 2013, Iran Red Crescent Med J, V15, P324, DOI 10.5812/ircmj.4506; Akiyama K, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt131; Al-Nbaheen M, 2013, STEM CELL REV REP, V9, P32, DOI 10.1007/s12015-012-9365-8; Bernardo ME, 2007, CANCER RES, V67, P9142, DOI 10.1158/0008-5472.CAN-06-4690; Binato R, 2013, CELL PROLIFERAT, V46, P10, DOI 10.1111/cpr.12002; Arufe MC, 2011, WORLD J ORTHOP, V2, P43, DOI 10.5312/wjo.v2.i6.43; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Forostyak S, 2013, BIOCHIMIE, V95, P2257, DOI 10.1016/j.biochi.2013.08.004; Hartmann I, 2010, J IMMUNOL METHODS, V363, P80, DOI 10.1016/j.jim.2010.10.008; Herberts CA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-29; Lansdorp PM, 2008, BLOOD, V111, P1759, DOI 10.1182/blood-2007-09-084913; Li WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074478; Patel DM, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/496218; Patrikoski M, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt175; Purandare B, 2014, REGEN MED, V9, P67, DOI [10.2217/RME.13.82, 10.2217/rme.13.82]; Redaelli S, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt138; Ren ZH, 2011, EXP CELL RES, V317, P2950, DOI 10.1016/j.yexcr.2011.09.008; Rosland GV, 2009, CANCER RES, V69, P5331, DOI 10.1158/0008-5472.CAN-08-4630; Sarugaser R, 2005, STEM CELLS, V23, P220, DOI 10.1634/stemcells.2004-0166; Sekulovic S, 2011, BLOOD, V118, P1766, DOI 10.1182/blood-2010-11-319632; Sensebe L, 2008, BIO-MED MATER ENG, V18, pS3; Tang QL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081844; Tolar J, 2007, STEM CELLS, V25, P371, DOI 10.1634/stemcells.2005-0620; Torsvik A, 2012, INT J BIOL SCI, V8, P1051, DOI 10.7150/ijbs.3665; Torsvik A, 2010, CANCER RES, V70, P6393, DOI 10.1158/0008-5472.CAN-10-1305; Troyer DL, 2008, STEM CELLS, V26, P591, DOI 10.1634/stemcells.2007-0439; Wang LM, 2011, REGEN MED, V6, P95, DOI [10.2217/rme.10.98, 10.2217/RME.10.98]; Zhang Y, 2012, SCI WORLD J, DOI 10.1100/2012/793823; Zhou YF, 2006, CANCER RES, V66, P10849, DOI 10.1158/0008-5472.CAN-06-2146	30	40	45	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98565	10.1371/journal.pone.0098565	http://dx.doi.org/10.1371/journal.pone.0098565			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887492	Green Published, Green Submitted, gold			2022-12-27	WOS:000336956300085
J	Fujisawa, T; Hozumi, H; Kono, M; Enomoto, N; Hashimoto, D; Nakamura, Y; Inui, N; Yokomura, K; Koshimizu, N; Toyoshima, M; Shirai, T; Yasuda, K; Hayakawa, H; Suda, T				Fujisawa, Tomoyuki; Hozumi, Hironao; Kono, Masato; Enomoto, Noriyuki; Hashimoto, Dai; Nakamura, Yutaro; Inui, Naoki; Yokomura, Koshi; Koshimizu, Naoki; Toyoshima, Mikio; Shirai, Toshihiro; Yasuda, Kazumasa; Hayakawa, Hiroshi; Suda, Takafumi			Prognostic Factors for Myositis-Associated Interstitial Lung Disease	PLOS ONE			English	Article							CLINICALLY AMYOPATHIC DERMATOMYOSITIS; IDIOPATHIC INFLAMMATORY MYOPATHIES; JAPANESE PATIENTS; SINE MYOSITIS; GENE 5; POLYMYOSITIS; SPECTRUM; FEATURES; SOCIETY	Background: Interstitial lung disease (ILD) is a common manifestation of polymyositis (PM), dermatomyositis (DM), and clinically amyopathic dermatomyositis (CADM); however, little is known about the factors influencing the prognosis for PM/DM/CADM-associated ILD. (PM/DM/CADM-ILD). The aim of the present study is to assess prognostic factors for PM/DM/CADM-ILD. Methods: The clinical features and survival of 114 consecutive patients diagnosed with PM/DM/CADM-ILD (39 men and 75 women; median age, 56 years) were analyzed retrospectively. Results: The study group included 30 PM-associated ILD, 41 DM-associated ILD, and 43 CADM-associated ILD cases. The clinical presentation of ILD was acute/subacute form in 59 patients (51.8%) and chronic form in 55 patients (48.2%). The major pulmonary symptoms were dyspnea, cough, and fever. High-resolution computed tomography frequently revealed ground-glass opacities, traction bronchiectasis, and consolidation. Most of the patients were treated with corticosteroids or corticosteroids in combination with immunosuppressive agents. The all-cause mortality was 27.2%. Acute/subacute form, % forced vital capacity (FVC), age, % of neutrophils in bronchoalveolar lavage (BAL) fluid, and a diagnosis of CADM (vs. PM) were significantly associated with poor outcome in univariate Cox proportional hazards models. Multivariate Cox proportional hazards analysis validated acute/subacute ILD, %FVC, age, and diagnosis of CADM (vs. PM) as significant predictors of overall mortality. Patients with acute/subacute ILD had a much lower survival rate than those with the chronic form (p<0.001). Patients with CADM-ILD had a lower survival rate than those with PM-ILD (p = 0.034). Conclusions: Acute/subacute form, older age, lower level of FVC and diagnosis of CADM predict poor outcome in PM/DM/ CADM-ILD.	[Fujisawa, Tomoyuki; Hozumi, Hironao; Kono, Masato; Enomoto, Noriyuki; Hashimoto, Dai; Nakamura, Yutaro; Suda, Takafumi] Hamamatsu Univ, Sch Med, Dept Internal Med, Div 2, Hamamatsu, Shizuoka 4312102, Japan; [Inui, Naoki] Hamamatsu Univ, Sch Med, Dept Clin Pharmacol & Therapeut, Hamamatsu, Shizuoka 4312102, Japan; [Yokomura, Koshi] Seirei Mikatahara Gen Hosp, Dept Resp Med, Hamamatsu, Shizuoka, Japan; [Koshimizu, Naoki] Fujieda Municipal Gen Hosp, Dept Resp Med, Fujieda, Shizuoka, Japan; [Toyoshima, Mikio] Hamamatsu Rosai Hosp, Dept Resp Med, Hamamatsu, Shizuoka, Japan; [Shirai, Toshihiro] Shizuoka Prefectural Gen Hosp, Dept Resp Med, Shizuoka, Japan; [Yasuda, Kazumasa] Iwata City Hosp, Dept Resp Med, Iwata, Japan; [Hayakawa, Hiroshi] Natl Hosp Org, Tenryu Hosp, Dept Resp Med, Hamamatsu, Shizuoka, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Shizuoka General Hospital	Fujisawa, T (corresponding author), Hamamatsu Univ, Sch Med, Dept Internal Med, Div 2, Hamamatsu, Shizuoka 4312102, Japan.	fujisawa@hama-med.ac.jp	Enomoto, Noriyuki/GLS-0691-2022	Enomoto, Noriyuki/0000-0003-3187-4264				Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; American Thoracic Society, 2002, Am J Respir Crit Care Med, V165, P277; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Connors GR, 2010, CHEST, V138, P1464, DOI 10.1378/chest.10-0180; Cottin V, 2003, EUR RESPIR J, V22, P245, DOI 10.1183/09031936.03.00026703; Ernste FC, 2013, MAYO CLIN PROC, V88, P83, DOI 10.1016/j.mayocp.2012.10.017; Fujisawa T, 2005, J RHEUMATOL, V32, P58; Gerami P, 2006, J AM ACAD DERMATOL, V54, P597, DOI 10.1016/j.jaad.2005.10.041; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Huh JW, 2007, RESP MED, V101, P1761, DOI 10.1016/j.rmed.2007.02.017; Koga T, 2012, RHEUMATOLOGY, V51, P1278, DOI 10.1093/rheumatology/ker518; Lee CS, 2002, CLIN RHEUMATOL, V21, P391, DOI 10.1007/s100670200104; Marie I, 2011, ARTHRITIS RHEUM-US, V63, P3439, DOI 10.1002/art.30513; Miyazaki E, 2007, CLIN RHEUMATOL, V26, P436, DOI 10.1007/s10067-005-0147-4; Mukae H, 2009, CHEST, V136, P1341, DOI 10.1378/chest.08-2740; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Sato S, 2005, ARTHRITIS RHEUM-US, V52, P1571, DOI 10.1002/art.21023; Sato S, 2013, MOD RHEUMATOL, V23, P496, DOI 10.1007/s10165-012-0663-4; Sato S, 2009, ARTHRITIS RHEUM-US, V60, P2193, DOI 10.1002/art.24621; Sontheimer RD, 2003, J AM ACAD DERMATOL, V48, P797, DOI 10.1067/mjd.2003.199; Sontheimer RD, 2002, J AM ACAD DERMATOL, V46, P626, DOI 10.1067/mjd.2002.120621; Suda T, 2006, EUR RESPIR J, V28, P1005, DOI 10.1183/09031936.06.00038806; SUDA T, 1995, CHEST, V107, P711, DOI 10.1378/chest.107.3.711; Sun YC, 2013, RHEUMATOL INT, V33, P1295, DOI 10.1007/s00296-012-2545-7; Tanizawa K, 2013, RESP MED, V107, P745, DOI 10.1016/j.rmed.2013.01.014; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Ye S, 2007, CLIN RHEUMATOL, V26, P1647, DOI 10.1007/s10067-007-0562-9	27	104	113	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98824	10.1371/journal.pone.0098824	http://dx.doi.org/10.1371/journal.pone.0098824			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905449	Green Published, Green Submitted, gold			2022-12-27	WOS:000341869000065
J	Labrousse, D; Perret, M; Hayez, D; Da Silva, S; Badiou, C; Couzon, F; Bes, M; Chavanet, P; Lina, G; Vandenesch, F; Croisier-Bertin, D; Henry, T				Labrousse, Delphine; Perret, Magali; Hayez, Davy; Da Silva, Sonia; Badiou, Cedric; Couzon, Florence; Bes, Michele; Chavanet, Pascal; Lina, Gerard; Vandenesch, Francois; Croisier-Bertin, Delphine; Henry, Thomas			Kineret (R)/IL-1ra Blocks the IL-1/IL-8 Inflammatory Cascade during Recombinant Panton Valentine Leukocidin-Triggered Pneumonia but Not during S-aureus Infection	PLOS ONE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; COMMUNITY-ACQUIRED PNEUMONIA; NLRP3 INFLAMMASOME; NECROTIZING PNEUMONIA; RESISTANT; ACTIVATION; HEMOLYSIN; DISEASES; THERAPY; GENES	Objectives: Community-acquired Staphylococcus aureus necrotizing pneumonia is a life-threatening disease. Panton Valentine Leukocidin (PVL) has been associated with necrotizing pneumonia. PVL triggers inflammasome activation in human macrophages leading to IL-1 beta release. IL-1 beta activates lung epithelial cells to release IL-8. This study aimed to assess the relevance of this inflammatory cascade in vivo and to test the potential of an IL-1 receptor antagonist (IL-1Ra/Kineret) to decrease inflammation-mediated lung injury. Methods: We used the sequential instillation of Heat-killed S. aureus and PVL or S. aureus infection to trigger necrotizing pneumonia in rabbits. In these models, we investigated inflammation in the presence or absence of IL-1Ra/Kineret. Results: We demonstrated that the presence of PVL was associated with IL-1 beta and IL-8 release in the lung. During PVL-mediated sterile pneumonia, Kineret/IL-1Ra reduced IL-8 production indicating the relevance of the PVL/IL-1/IL-8 cascade in vivo and the potential of Kineret/IL-1Ra to reduce lung inflammation. However, Kineret/IL-1Ra was ineffective in blocking IL-8 production during infection with S. aureus. Furthermore, treatment with Kineret increased the bacterial burden in the lung. Conclusions: Our data demonstrate PVL-dependent inflammasome activation during S. aureus pneumonia, indicate that IL-1 signaling controls bacterial burden in the lung and suggest that therapy aimed at targeting this pathway might be deleterious during pneumonia.	[Labrousse, Delphine; Hayez, Davy; Da Silva, Sonia; Croisier-Bertin, Delphine] Vivexia, Dijon, France; [Perret, Magali; Badiou, Cedric; Couzon, Florence; Bes, Michele; Lina, Gerard; Vandenesch, Francois; Henry, Thomas] Univ Lyon, Lyon, France; [Perret, Magali; Badiou, Cedric; Couzon, Florence; Bes, Michele; Lina, Gerard; Vandenesch, Francois; Henry, Thomas] INSERM, U1111, F-69008 Lyon, France; [Perret, Magali; Badiou, Cedric; Couzon, Florence; Bes, Michele; Lina, Gerard; Vandenesch, Francois; Henry, Thomas] CNRS, UMR 5308, Lyon, France; [Perret, Magali; Badiou, Cedric; Couzon, Florence; Bes, Michele; Lina, Gerard; Vandenesch, Francois; Henry, Thomas] Ecole Normale Super Lyon, F-69364 Lyon, France; [Chavanet, Pascal; Croisier-Bertin, Delphine] Univ Hosp, Dept Infect Dis, Dijon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); CHU Dijon Bourgogne	Henry, T (corresponding author), Univ Lyon, Lyon, France.	Thomas.henry@inserm.fr	Lina, Gerard J/L-9352-2014; Vandenesch, Francois/C-7209-2014; Henry, Thomas/G-3160-2013	Vandenesch, Francois/0000-0001-9412-7106; Henry, Thomas/0000-0002-0687-8565; Lina, Gerard/0000-0002-9236-7998; Croisier, Delphine/0000-0002-8744-5832	FINOVI	FINOVI	This work was supported by a FINOVI young investigator grant to TH. SOBI had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Cremieux AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007204; Croisier-Bertin D, 2014, ANTIMICROBIAL AGENTS; Croisier-Bertin D, 2011, ANTIMICROB AGENTS CH, V55, P3557, DOI 10.1128/AAC.01773-09; Day NP, 2012, LANCET INFECT DIS; Diep BA, 2013, J INFECT DIS; Diep BA, 2013, LANCET INFE IN PRESS; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Dubin G, 2002, BIOL CHEM, V383, P1075, DOI 10.1515/BC.2002.116; Giampietro C, 2013, ARTHRIT CARE RES, V65, P822, DOI 10.1002/acr.21901; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Gillet Y, 2011, INT J ANTIMICROB AG, V38, P457, DOI 10.1016/j.ijantimicag.2011.05.003; Herold S, 2011, AM J RESP CRIT CARE, V183, P1380, DOI 10.1164/rccm.201009-1431OC; Hoffman HM, 2004, LANCET, V364, P1779, DOI 10.1016/S0140-6736(04)17401-1; Holzinger D, 2012, J LEUKOCYTE BIOL, V92, P1069, DOI 10.1189/jlb.0112014; Joseph L, 2011, LANCET, V378, P980, DOI 10.1016/S0140-6736(11)61441-4; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; KONIG B, 1994, INFECT IMMUN, V62, P4831; Langereis JD, 2011, EUR RESPIR J, V37, P406, DOI 10.1183/09031936.00170409; Li HT, 2011, RESPIRATION, V81, P448, DOI 10.1159/000319557; Loffler B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000715; Ma XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034970; Malachowa N, 2013, J IMMUNOL, V191, P6022, DOI 10.4049/jimmunol.1301821; MALYAK M, 1994, J CLIN IMMUNOL, V14, P20, DOI 10.1007/BF01541172; McDuffie R S Jr, 2001, Infect Dis Obstet Gynecol, V9, P233, DOI 10.1155/S1064744901000382; Meijvis SCA, 2011, LANCET, V377, P2023, DOI 10.1016/S0140-6736(11)60607-7; Morgan MS, 2007, INT J ANTIMICROB AG, V30, P289, DOI 10.1016/j.ijantimicag.2007.04.019; Niemann S, 2012, J INFECT DIS, V206, P1138, DOI 10.1093/infdis/jis468; Perret M, 2012, CELL MICROBIOL, V14, P1019, DOI 10.1111/j.1462-5822.2012.01772.x; Piroth L, 1999, ANTIMICROB AGENTS CH, V43, P2484, DOI 10.1128/AAC.43.10.2484; PREVOST G, 1995, INFECT IMMUN, V63, P4121; Rouzic N, 2010, J CLIN MICROBIOL, V48, P1952, DOI 10.1128/JCM.01892-09; Schroder AK, 2006, IMMUNOLOGY, V119, P317, DOI 10.1111/j.1365-2567.2006.02435.x; Shallcross LJ, 2012, LANCET INFECT DIS; Spaan AN, 2013, CELL HOST MICROBE, V13, P584, DOI 10.1016/j.chom.2013.04.006; Surewaard BGJ, 2013, CELL MICROBIOL, V15, P1427, DOI 10.1111/cmi.12130; van de Beek D, 2012, LANCET, V380, P1693, DOI 10.1016/S0140-6736(12)61186-6; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Vandenesch F, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00012; Voiriot G, 2011, CHEST, V139, P387, DOI 10.1378/chest.09-3102; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Wargo KA, 2005, CLIN INFECT DIS, V40, P1376, DOI 10.1086/429509; Williams MR, 2011, TRENDS IMMUNOL, V32, P461, DOI 10.1016/j.it.2011.06.009	44	18	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e97546	10.1371/journal.pone.0097546	http://dx.doi.org/10.1371/journal.pone.0097546			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905099	Green Published, Green Submitted, gold			2022-12-27	WOS:000341869000007
J	Mahajan, RV; Kumar, V; Rajendran, V; Saran, S; Ghosh, PC; Saxena, RK				Mahajan, Richi V.; Kumar, Vinod; Rajendran, Vinoth; Saran, Saurabh; Ghosh, Prahlad C.; Saxena, Rajendra Kumar			Purification and Characterization of a Novel and Robust L-Asparaginase Having Low-Glutaminase Activity from Bacillus licheniformis: In Vitro Evaluation of Anti-Cancerous Properties	PLOS ONE			English	Article							ESCHERICHIA-COLI-ASPARAGINASE; CHILDHOOD; RESISTANT; LEUKEMIA; BINDING	L-asparaginase having low glutaminase has been a key therapeutic agent in the treatment of acute lymphpoblastic leukemia (A.L.L). In the present study, an extracellular L-asparaginase with low glutaminase activity, produced by Bacillus licheniformis was purified to homogeneity. Protein was found to be a homotetramer of 134.8 KDa with monomeric size of 33.7 KDa and very specific for its natural substrate i.e. L-asparagine. The activity of purified L-asparaginase enhanced in presence of cations including Na+ and K+, whereas it was moderately inhibited in the presence of divalent cations and thiol group blocking reagents. The purified enzyme was maximally active over the range of pH 6.0 to 10.0 and temperature of 40 degrees C and enzyme was stable maximum at pH 9.0 and -20 degrees C. CD spectra of L-asparaginase predicted the enzyme to consist of 63.05% alpha-helix and 3.29% beta-sheets in its native form with T-222 of 58 degrees C. Fluorescent spectroscopy showed the protein to be stable even in the presence of more than 3 M GdHCl. Kinetic parameters K-m, V-max and k(cat) of purified enzyme were found as 1.4x10(-5) M, 4.03 IU and 2.68x10(3) s(-1), respectively. The purified L-asparaginase had cytotoxic activity against various cancerous cell lines viz. Jurkat clone E6-1, MCF-7 and K-562 with IC50 of 0.22 IU, 0.78 IU and 0.153 IU respectively. However the enzyme had no toxic effect on human erythrocytes and CHO cell lines hence should be considered potential candidate for further pharmaceutical use as an anticancer drug.	[Mahajan, Richi V.; Kumar, Vinod; Saxena, Rajendra Kumar] Univ Delhi South Campus, Dept Microbiol, Delhi, India; [Rajendran, Vinoth; Ghosh, Prahlad C.] Univ Delhi South Campus, Dept Biochem, Delhi, India; [Saran, Saurabh] Univ Delhi South Campus, Delhi, India	University of Delhi; University of Delhi; University of Delhi	Saxena, RK (corresponding author), Univ Delhi South Campus, Dept Microbiol, Delhi, India.	rksmicro@yahoo.co.in	Rajendran, Vinoth/B-1069-2016	Rajendran, Vinoth/0000-0003-1453-1139; Kumar, Vinod/0000-0002-5766-1040				Abakumova OY, 2012, BIOCHEM MOSC-SUPPL S, V6, P307, DOI 10.1134/S1990750812040026; Aghaiypour K, 2001, BBA-PROTEIN STRUCT M, V1550, P117, DOI 10.1016/S0167-4838(01)00270-9; Aung HP, 2000, BBA-PROTEIN STRUCT M, V1481, P349, DOI 10.1016/S0167-4838(00)00179-5; Bansal S, 2012, FASEB J, V26, P1161, DOI 10.1096/fj.11-191254; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROOME JD, 1967, BIOCHIM BIOPHYS ACTA, V138, P637, DOI 10.1016/0005-2787(67)90569-2; CAMMACK KA, 1972, BIOCHEM J, V126, P361, DOI 10.1042/bj1260361; Dhanam JG, 2013, ADV BIOTECHNOL, V13; Duval M, 2002, BLOOD, V99, P2734, DOI 10.1182/blood.V99.8.2734; Godfrin Y, 2006, BIOMEDES, V1, P10; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; KLUMPER E, 1995, BLOOD, V86, P3861, DOI 10.1182/blood.V86.10.3861.bloodjournal86103861; Kumar S, 2011, BIORESOURCE TECHNOL, V102, P2077, DOI 10.1016/j.biortech.2010.07.114; Leung-Toung R, 2002, CURR MED CHEM, V9, P979, DOI 10.2174/0929867024606704; Lubkowski J, 1996, EUR J BIOCHEM, V241, P201, DOI 10.1111/j.1432-1033.1996.0201t.x; LUBRAN MM, 1989, ANN CLIN LAB SCI, V19, P114; Mahajan RV, 2012, BIORESOURCE TECHNOL, V125, P11, DOI 10.1016/j.biortech.2012.08.086; MASHBURN LT, 1964, ARCH BIOCHEM BIOPHYS, V105, P450, DOI 10.1016/0003-9861(64)90032-3; Muller HJ, 1998, CRIT REV ONCOL HEMAT, V28, P97, DOI 10.1016/S1040-8428(98)00015-8; Nagarethinam S., 2012, ASIAN J MEDICAL RES, V1, P159; NEUMAN RE, 1956, SCIENCE, V124, P124, DOI 10.1126/science.124.3212.124; OHNUMA T, 1970, CANCER RES, V30, P2297; PETERSON RE, 1969, APPL MICROBIOL, V18, P64, DOI 10.1128/AEM.18.1.64-67.1969; PRAGER MD, 1968, BIOCHEM BIOPH RES CO, V31, P43, DOI 10.1016/0006-291X(68)90028-4; Prakasham RS, 2010, APPL BIOCHEM BIOTECH, V160, P72, DOI 10.1007/s12010-009-8679-8; SHIFRIN S, 1974, J BIOL CHEM, V249, P1335; Surolia R, 2012, J BIOMED NANOTECHNOL, V8, P172, DOI 10.1166/jbn.2012.1366; Warangkar Suchita C, 2010, Enzyme Res, V2010, P165878, DOI 10.4061/2010/165878; WHITAKER JR, 1963, ANAL CHEM, V35, P1950, DOI 10.1021/ac60205a048; WILLIS RC, 1974, J BACTERIOL, V118, P231, DOI 10.1128/JB.118.1.231-241.1974; WRISTON JC, 1973, ADV ENZYMOL RAMB, V39, P185	31	87	90	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99037	10.1371/journal.pone.0099037	http://dx.doi.org/10.1371/journal.pone.0099037			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905227	Green Published, Green Submitted, gold			2022-12-27	WOS:000341869000096
J	Barbieri, C; Vicente, M; Oliveira, S; Bostoen, K; Rocha, J; Stoneking, M; Pakendorf, B				Barbieri, Chiara; Vicente, Mario; Oliveira, Sandra; Bostoen, Koen; Rocha, Jorge; Stoneking, Mark; Pakendorf, Brigitte			Migration and Interaction in a Contact Zone: mtDNA Variation among Bantu-Speakers in Southern Africa	PLOS ONE			English	Article							GENETIC PERSPECTIVES; Y-CHROMOSOME; POPULATIONS; HISTORY; EXPANSION; LANGUAGES; FARMERS; ORIGIN; CLICKS; VIEW	Bantu speech communities expanded over large parts of sub-Saharan Africa within the last 4000-5000 years, reaching different parts of southern Africa 1200-2000 years ago. The Bantu languages subdivide in several major branches, with languages belonging to the Eastern and Western Bantu branches spreading over large parts of Central, Eastern, and Southern Africa. There is still debate whether this linguistic divide is correlated with a genetic distinction between Eastern and Western Bantu speakers. During their expansion, Bantu speakers would have come into contact with diverse local populations, such as the Khoisan hunter-gatherers and pastoralists of southern Africa, with whom they may have intermarried. In this study, we analyze complete mtDNA genome sequences from over 900 Bantu-speaking individuals from Angola, Zambia, Namibia, and Botswana to investigate the demographic processes at play during the last stages of the Bantu expansion. Our results show that most of these Bantu-speaking populations are genetically very homogenous, with no genetic division between speakers of Eastern and Western Bantu languages. Most of the mtDNA diversity in our dataset is due to different degrees of admixture with autochthonous populations. Only the pastoralist Himba and Herero stand out due to high frequencies of particular L3f and L3d lineages; the latter are also found in the neighboring Damara, who speak a Khoisan language and were foragers and small-stock herders. In contrast, the close cultural and linguistic relatives of the Herero and Himba, the Kuvale, are genetically similar to other Bantu-speakers. Nevertheless, as demonstrated by resampling tests, the genetic divergence of Herero, Himba, and Kuvale is compatible with a common shared ancestry with high levels of drift, while the similarity of the Herero, Himba, and Damara probably reflects admixture, as also suggested by linguistic analyses.	[Barbieri, Chiara; Stoneking, Mark] MPI Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany; [Barbieri, Chiara] Univ Bologna, Lab Mol Anthropol, Dept Biol Geol & Environm Sci, Bologna, Italy; [Vicente, Mario; Oliveira, Sandra; Rocha, Jorge] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO, Vairao, Portugal; [Vicente, Mario] STAB VIDA, Invest & Serv Ciencias Biol, Oeiras, Portugal; [Oliveira, Sandra; Rocha, Jorge] Univ Porto, Fac Ciencias, Dept Biol, P-4100 Oporto, Portugal; [Bostoen, Koen] Univ Ghent, KongoKing Res Grp, Dept African Languages & Cultures, B-9000 Ghent, Belgium; [Bostoen, Koen] Univ Libre Bruxelles, Fac Philosophie & Lettres, Brussels, Belgium; [Pakendorf, Brigitte] CNRS, UMR5596, Lab Dynam Langage, Lyon, France; [Pakendorf, Brigitte] Univ Lyon 2, Lyon, France	Max Planck Society; University of Bologna; Universidade do Porto; Universidade do Porto; Ghent University; Universite Libre de Bruxelles; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite Lyon 2	Barbieri, C (corresponding author), MPI Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany.	barbieri.chiara@gmail.com; brigitte.pakendorf@cnrs.fr		Vicente, Mario/0000-0002-9122-4530; rocha, jorge/0000-0001-5460-7615; Bostoen, Koen/0000-0003-2284-6165; Barbieri, Chiara/0000-0001-8827-5655	Max Planck Society; FCT Project [PTDC/BIA-EVF/2907/2012]; EU FP7 REGPOT grant [CIBIO-New-Gen-28643]; "Genomics and Evolutionary Biology" project; North Portugal Regional Operational Programme (ON.2- O Novo Norte) under the National Strategic Reference Framework (NSRF), through the European Regional Development Fund (ERDF); European Research Council [ERC-2011-AdG 295733]; STAB VIDA, Investigacao e Servicos em Ciencias Biologicas, Lda; Portuguese Ministry for Science, Technology and Higher Education [SFRH/BDE/51828/2012, SFRH/BD/85776/2012]	Max Planck Society(Max Planck SocietyFoundation CELLEX); FCT Project(Portuguese Foundation for Science and Technology); EU FP7 REGPOT grant; "Genomics and Evolutionary Biology" project; North Portugal Regional Operational Programme (ON.2- O Novo Norte) under the National Strategic Reference Framework (NSRF), through the European Regional Development Fund (ERDF); European Research Council(European Research Council (ERC)European Commission); STAB VIDA, Investigacao e Servicos em Ciencias Biologicas, Lda; Portuguese Ministry for Science, Technology and Higher Education	This work was funded by the Max Planck Society, by FCT Project Grant PTDC/BIA-EVF/2907/2012, by the EU FP7 REGPOT grant CIBIO-New-Gen-28643, and by the "Genomics and Evolutionary Biology" project co-financed by the North Portugal Regional Operational Programme 2007/2013 (ON.2- O Novo Norte), under the National Strategic Reference Framework (NSRF), through the European Regional Development Fund (ERDF); CB was supported by the European Research Council ERC-2011-AdG 295733 grant (Langelin); MV was supported by STAB VIDA, Investigacao e Servicos em Ciencias Biologicas, Lda; MV and SO were supported by the Portuguese Ministry for Science, Technology and Higher Education through PhD grants SFRH/BDE/51828/2012 and SFRH/BD/85776/2012, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves I, 2011, HUM BIOL, V83, P13, DOI 10.3378/027.083.0102; Ashley CZ, 2010, AFR ARCHAEOL REV, V27, P135, DOI 10.1007/s10437-010-9074-0; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barbieri C, 2014, AM J PHYS ANTHROPOL, V153, P435, DOI 10.1002/ajpa.22441; Barbieri C, 2013, EUR J HUM GENET, V21, P430, DOI 10.1038/ejhg.2012.192; Barbieri C, 2013, AM J HUM GENET, V92, P285, DOI 10.1016/j.ajhg.2012.12.010; Barnard A, 1992, HUNTER HERDERS SO AF; Batai K, 2013, AM J PHYS ANTHROPOL, V150, P482, DOI 10.1002/ajpa.22227; Batini C, 2011, MOL BIOL EVOL, V28, P1099, DOI 10.1093/molbev/msq294; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Blench R. M., 2006, ARCHAEOLOGY LANGUAGE; Bostoen K, 2007, J AFR HIST, V48, P173, DOI 10.1017/S002185370700254X; Bostoen K, 2013, CR GEOSCI, V345, P336, DOI 10.1016/j.crte.2013.03.005; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Castri L, 2009, AM J PHYS ANTHROPOL, V140, P302, DOI 10.1002/ajpa.21070; Cerezo M, 2011, PLOS ONE, V6; Cerny V, 2007, ANN HUM GENET, V71, P433, DOI 10.1111/j.1469-1809.2006.00339.x; Clist B., 1987, MUNTU, V6, P35; Coelho M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-80; Creissels Denis, 1999, BANTU HIST LINGUISTI, P297; de Filippo C, 2012, P ROY SOC B-BIOL SCI, V279, P3256, DOI 10.1098/rspb.2012.0318; de Filippo C, 2011, MOL BIOL EVOL, V28, P1255, DOI 10.1093/molbev/msq312; de Filippo C, 2010, AM J PHYS ANTHROPOL, V141, P382, DOI 10.1002/ajpa.21155; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Fisch M, 2005, MBUKUSHU ANGOLA 1730; Forster P, 1996, AM J HUM GENET, V59, P935; Furrer R., 2012, FIELDS TOOLS SPATIAL; Gonder MK, 2007, MOL BIOL EVOL, V24, P757, DOI 10.1093/molbev/msl209; Gowlett D., 2003, BANTU LANGUAGES, P609; Guldemann T, 2008, ANNU REV ANTHROPOL, V37, P93, DOI 10.1146/annurev.anthro.37.081407.085109; Guldemann T, 2008, SOUTH AFR HUMANIT, V20, P93; Hartmann A, 2009, HUM MUTAT, V30, P115, DOI 10.1002/humu.20816; Kinahan J, 2011, BEGINNING ARCHAEOLOG, P15; Kivisild T, 2004, AM J HUM GENET, V75, P752, DOI 10.1086/425161; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Maricic T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014004; Meyer M., 2010, COLD SPRING HARB PRO; Mitchell P, 2002, ARCHAEOLOGY SO AFRIC; Mohlig WJG, 2009, PEOPLE CATTLE LAND T, P119; Nenadic O., 2007, J STAT SOFTW, V20, P3, DOI [DOI 10.18637/JSS.V020.I03, DOI 10.3354/MEPS086063]; Neumann K, 2012, QUATERN INT, V249, P53, DOI 10.1016/j.quaint.2011.03.024; Nurse D., 2003, BANTU LANGUAGES; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Pakendorf B, 2011, LANG DYN CHANG, V1, P50, DOI 10.1163/221058211X570349; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; PHILLIPSON DW, 2005, AFRICAN ARCHAEOLOGY; Pickrell JK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2140; Pleurdeau D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040340; Pour NA, 2013, EUR J HUM GENET, V21, P423, DOI 10.1038/ejhg.2012.176; Quintana-Murci L, 2010, AM J HUM GENET, V86, P611, DOI 10.1016/j.ajhg.2010.02.014; Reid DAM., 1998, DITSWA MMUNG ARCHAEO, P81; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Schadeberg Thilo C., 2003, BANTU LANGUAGES, P143; Schlebusch CM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-56; Sikora M, 2011, EUR J HUM GENET, V19, P84, DOI 10.1038/ejhg.2010.141; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Solway JS, 1991, ENCY WORLD CULTURES, P360; SOODYALL H, 1992, ANN HUM GENET, V56, P315, DOI 10.1111/j.1469-1809.1992.tb01159.x; SPURDLE AB, 1994, AM J HUM GENET, V54, P319; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; VANSINA J, 1995, J AFR HIST, V36, P173, DOI 10.1017/S0021853700034101; Venables WN, 2002, MASS MODERN APPL STA; Wood ET, 2005, EUR J HUM GENET, V13, P867, DOI 10.1038/sj.ejhg.5201408	64	32	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99117	10.1371/journal.pone.0099117	http://dx.doi.org/10.1371/journal.pone.0099117			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901532	Green Published, Green Submitted, gold			2022-12-27	WOS:000336841400100
J	Beard, PM; Griffiths, SJ; Gonzalez, O; Haga, IR; Jowers, TP; Reynolds, DK; Wildenhain, J; Tekotte, H; Auer, M; Tyers, M; Ghazal, P; Zimmer, R; Haas, J				Beard, Philippa M.; Griffiths, Samantha J.; Gonzalez, Orland; Haga, Ismar R.; Jowers, Tali Pechenick; Reynolds, Danielle K.; Wildenhain, Jan; Tekotte, Hille; Auer, Manfred; Tyers, Mike; Ghazal, Peter; Zimmer, Ralf; Haas, Juergen			A Loss of Function Analysis of Host Factors Influencing Vaccinia virus Replication by RNA Interference	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; WEST-NILE-VIRUS; GENE-EXPRESSION; VIRAL REPLICATION; GENOMIC SCREEN; IFITM PROTEINS; DENGUE VIRUS; EARLY-STAGE; INFECTION; RECEPTOR	Vaccinia virus (VACV) is a large, cytoplasmic, double-stranded DNA virus that requires complex interactions with host proteins in order to replicate. To explore these interactions a functional high throughput small interfering RNA (siRNA) screen targeting 6719 druggable cellular genes was undertaken to identify host factors (HF) influencing the replication and spread of an eGFP-tagged VACV. The experimental design incorporated a low multiplicity of infection, thereby enhancing detection of cellular proteins involved in cell-to-cell spread of VACV. The screen revealed 153 pro-and 149 anti-viral HFs that strongly influenced VACV replication. These HFs were investigated further by comparisons with transcriptional profiling data sets and HFs identified in RNAi screens of other viruses. In addition, functional and pathway analysis of the entire screen was carried out to highlight cellular mechanisms involved in VACV replication. This revealed, as anticipated, that many pro-viral HFs are involved in translation of mRNA and, unexpectedly, suggested that a range of proteins involved in cellular transcriptional processes and several DNA repair pathways possess anti-viral activity. Multiple components of the AMPK complex were found to act as pro-viral HFs, while several septins, a group of highly conserved GTP binding proteins with a role in sequestering intracellular bacteria, were identified as strong anti-viral VACV HFs. This screen has identified novel and previously unexplored roles for cellular factors in poxvirus replication. This advancement in our understanding of the VACV life cycle provides a reliable knowledge base for the improvement of poxvirus-based vaccine vectors and development of anti-viral theraputics.	[Beard, Philippa M.; Haga, Ismar R.; Jowers, Tali Pechenick; Reynolds, Danielle K.] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Beard, Philippa M.; Haga, Ismar R.; Jowers, Tali Pechenick; Reynolds, Danielle K.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland; [Griffiths, Samantha J.; Ghazal, Peter; Haas, Juergen] Univ Edinburgh, Div Pathway Med, Edinburgh, Midlothian, Scotland; [Gonzalez, Orland; Zimmer, Ralf] Univ Munich, Inst Informat, D-80539 Munich, Germany; [Wildenhain, Jan; Tekotte, Hille; Auer, Manfred; Tyers, Mike] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland; [Tyers, Mike] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada; [Ghazal, Peter] Univ Edinburgh, SynthSys, Ctr Integrat Syst Edinburgh, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Munich; University of Edinburgh; Universite de Montreal; University of Edinburgh	Beard, PM (corresponding author), Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland.	pip.beard@roslin.ed.ac.uk; juergen.haas@ed.ac.uk	Zimmer, Ralf/L-9295-2019; Tyers, Michael/ABE-3194-2021; Wildenhain, Jan/E-5597-2011; Wildenhain, Jan/Q-6596-2019	Wildenhain, Jan/0000-0002-5461-3828; Wildenhain, Jan/0000-0002-5461-3828; Beard, Pip/0000-0002-2285-810X; Tekotte, Hille/0000-0003-2164-7412; Auer, Manfred/0000-0001-8920-3522; Ghazal, Peter/0000-0003-0035-2228	BBSRC; Wellcome Trust; European Research Council [233457-SCG]; BBSRC [BB/D019621/1]; Wellcome Trust [GR066784]; Scottish Enterprise; EPSRC [BB/D019621/1]; BBSRC [BBS/E/D/20241864, BBS/E/D/20241866] Funding Source: UKRI; MRC [MC_G0802522] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20241864, BB/D019621/1, BBS/E/D/20241866] Funding Source: researchfish; Medical Research Council [MC_G0802522] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Scottish Enterprise; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Roslin Institute receives Institute Strategic Grant funding from the BBSRC. This work was supported by grants from the Wellcome Trust and the European Research Council (233457-SCG) (MT, JW and HT), BBSRC (BB/D019621/1), Wellcome Trust (GR066784), and Scottish Enterprise (PG). SynthSys is a Centre for Integrative Systems Biology (CISB) funded by BBSRC and EPSRC, reference BB/D019621/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCAMI A, 1992, CELL, V71, P153, DOI 10.1016/0092-8674(92)90274-G; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; BOONE RF, 1978, J VIROL, V26, P554, DOI 10.1128/JVI.26.3.554-569.1978; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Brown, 2006, APPL MIXED MODELS ME; Broyles SS, 2003, J GEN VIROL, V84, P2293, DOI 10.1099/vir.0.18942-0; Brum LM, 2003, VIROLOGY, V315, P322, DOI 10.1016/S0042-6822(03)00532-4; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Cao LH, 2009, CELL MOL LIFE SCI, V66, P3309, DOI 10.1007/s00018-009-0087-2; Carter GC, 2003, J GEN VIROL, V84, P2443, DOI 10.1099/vir.0.19271-0; CHANG HW, 1992, P NATL ACAD SCI USA, V89, P4825, DOI 10.1073/pnas.89.11.4825; Chen RAJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040022; Clemente R, 2010, J VIROL, V84, P3562, DOI 10.1128/JVI.02274-09; Coyne CB, 2011, CELL HOST MICROBE, V9, P70, DOI 10.1016/j.chom.2011.01.001; CUDMORE S, 1995, NATURE, V378, P636, DOI 10.1038/378636a0; De Braekeleer E, 2011, FUTURE ONCOL, V7, P77, DOI [10.2217/fon.10.158, 10.2217/FON.10.158]; de Magalhaes JC, 2001, J BIOL CHEM, V276, P38353, DOI 10.1074/jbc.M100183200; de Miranda MP, 2003, J GEN VIROL, V84, P2459, DOI 10.1099/vir.0.19292-0; Doceul V, 2010, SCIENCE, V327, P873, DOI 10.1126/science.1183173; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Gomez CE, 2011, CURR GENE THER, V11, P189; Griffiths SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003514; Haga IR, 2014, J VIROL, V88, P3664, DOI 10.1128/JVI.03013-13; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; Hirsch AJ, 2010, FUTURE MICROBIOL, V5, P303, DOI 10.2217/FMB.09.121; Hu NJ, 2009, VACCINE, V27, P2994, DOI 10.1016/j.vaccine.2009.02.103; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Humphries AC, 2012, CELL HOST MICROBE, V12, P346, DOI 10.1016/j.chom.2012.08.002; Husain M, 2003, J VIROL, V77, P11754, DOI 10.1128/JVI.77.21.11754-11766.2003; Iwamoto M, 2010, GENES CELLS, V15, P661, DOI 10.1111/j.1365-2443.2010.01415.x; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; Kiss A, 2003, VIROLOGY, V314, P591, DOI 10.1016/S0042-6822(03)00531-2; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Li QS, 2009, P NATL ACAD SCI USA, V106, P16410, DOI 10.1073/pnas.0907439106; Lilley CE, 2007, TRENDS MICROBIOL, V15, P119, DOI 10.1016/j.tim.2007.01.003; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; Luc PV, 2004, BIOINFORMATICS, V20, P1413, DOI 10.1093/bioinformatics/bth114; Maloney G, 2005, J BIOL CHEM, V280, P30838, DOI 10.1074/jbc.M501917200; Mercer J, 2012, CELL REP, V2, P1036, DOI 10.1016/j.celrep.2012.09.003; Moser TS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000954; Mostowy S, 2010, CELL HOST MICROBE, V8, P433, DOI 10.1016/j.chom.2010.10.009; Nagata K, 2004, J BIOL CHEM, V279, P55895, DOI 10.1074/jbc.M406153200; Ovsyannikova IG, 2012, VACCINE, V30, P4182, DOI 10.1016/j.vaccine.2012.04.055; Panda D, 2011, P NATL ACAD SCI USA, V108, P19036, DOI 10.1073/pnas.1113643108; Parrish S, 2006, J VIROL, V80, P553, DOI 10.1128/JVI.80.2.553-561.2006; Rubins KH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015615; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Santos CR, 2006, J VIROL, V80, P7667, DOI 10.1128/JVI.00967-06; Satterly N, 2007, P NATL ACAD SCI USA, V104, P1853, DOI 10.1073/pnas.0610977104; Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967; Shors T, 1999, J VIROL, V73, P791, DOI 10.1128/JVI.73.1.791-796.1999; Silva PNG, 2006, BIOCHEM J, V398, P83, DOI 10.1042/BJ20060509; Sivan G, 2013, P NATL ACAD SCI USA, V110, P3519, DOI 10.1073/pnas.1300708110; SMITH GL, 1991, J GEN VIROL, V72, P511, DOI 10.1099/0022-1317-72-3-511; Smith SE, 2014, CURR OPIN VIROL, V4, P71, DOI 10.1016/j.coviro.2013.11.004; Soares JAP, 2009, J VIROL, V83, P6883, DOI 10.1128/JVI.00245-09; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Taylor JM, 2006, VIROLOGY, V344, P139, DOI 10.1016/j.virol.2005.09.032; Townsley AC, 2006, J VIROL, V80, P8899, DOI 10.1128/JVI.01053-06; UPTON C, 1992, SCIENCE, V258, P1369, DOI 10.1126/science.1455233; Wang Y, 2000, GENE DEV, V14, P927; Wenzel M, 2012, J IMMUNOL, V188, P394, DOI 10.4049/jimmunol.1100523; Yang ZL, 2010, P NATL ACAD SCI USA, V107, P11513, DOI 10.1073/pnas.1006594107; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	73	22	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98431	10.1371/journal.pone.0098431	http://dx.doi.org/10.1371/journal.pone.0098431			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901222	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000336841400027
J	Chen, JF; Ding, ZY; Peng, YH; Pan, F; Li, JJ; Zou, L; Zhang, YL; Liang, HJ				Chen, Jianfang; Ding, Zhenyu; Peng, Yonghai; Pan, Feng; Li, Jianjun; Zou, Lan; Zhang, Yanling; Liang, Houjie			HIF-1 alpha Inhibition Reverses Multidrug Resistance in Colon Cancer Cells via Downregulation of MDR1/P-Glycoprotein	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; IN-VITRO; DRUG-RESISTANCE; GASTRIC-CANCER; MDR1 GENE; P-GP; CHEMOTHERAPY; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; CHEMOSENSITIVITY; CHEMORESISTANCE	Background: Multidrug resistance (MDR) is one of the major reasons chemotherapy-based treatments fail. Hypoxia is generally associated with tumor chemoresistance. However, the correlation between the heterodimeric hypoxia-inducible factor-1 (HIF-1) and the multidrug resistance (MDR1) gene/transporter P-glycoprotein (P-gp) remains unclear. This study aims to explore the molecular mechanisms of reversing colon cancer MDR by focusing on the target gene HIF-1 alpha. Methods: A chemotherapeutic sensitivity assay was used to observe the efficiency of MDR reversal in LoVo multicellular spheroids (MCS). The apoptotic level induced by different drugs was examined by flow cytometry (FCM). Binding of HIF-1 alpha to the MDR1 gene promoter was evaluated by Chromatin immunoprecipitation (ChIP). The relationship between HIF-1 alpha/P-gp expression and sensitivity to chemotherapy was analyzed. Results: The sensitivity of LoVo MCS to all four chemotherapy drugs was decreased to varying degrees under hypoxic conditions. After silencing the HIF-1 alpha gene, the sensitivities of LoVo MCS to all four chemotherapy drugs were restored. The apoptotic levels that all the drugs induced were all decreased to various extents in the hypoxic group. After silencing HI-1 alpha, the apoptosis level induced by all four chemotherapy drugs increased. The expression of HIF-1 alpha and P-gp was significantly enhanced in LoVo MCS after treatment with hypoxia. Inhibiting HIF-1 alpha significantly decreased the expression of MDR1/P-gp mRNA or protein in both the LoVo monolayers and LoVo MCS. The ChIP assay showed that HIF-1 alpha was bound to the MDR1 gene promoter. Advanced colon carcinoma patients with expression of both HIF-1 alpha and P-gp were more resistant to chemotherapy than that with non expression. Conclusions: HIF-1 alpha inhibition reverses multidrug resistance in colon cancer cells via downregulation of MDR1/P-gp. The expression of HIF-1 alpha and MDR1/P-gp can be used as a predictive marker for chemotherapy resistance in colon cancer.	[Chen, Jianfang; Ding, Zhenyu; Peng, Yonghai; Pan, Feng; Li, Jianjun; Zou, Lan; Zhang, Yanling; Liang, Houjie] Third Mil Med Univ, Southwest Hosp, Dept Oncol, Chongqing, Peoples R China; [Chen, Jianfang; Ding, Zhenyu; Peng, Yonghai; Pan, Feng; Li, Jianjun; Zou, Lan; Zhang, Yanling; Liang, Houjie] Third Mil Med Univ, Southwest Hosp, Southwest Canc Ctr, Chongqing, Peoples R China; [Ding, Zhenyu] Gen Hosp Shenyang Mil Reg, Dept Oncol, Shenyang, Liaoning, Peoples R China	Army Medical University; Army Medical University	Liang, HJ (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Oncol, Chongqing, Peoples R China.	lianghoujie@sina.com			National Natural Science Foundation of China [30973430, 81101629]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 30973430 and No. 81101629).(http://isisn.nsfc.gov.cn/egrantweb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown JM, 2007, METHOD ENZYMOL, V435, P297, DOI 10.1016/S0076-6879(07)35015-5; Brown JM, 2000, MOL MED TODAY, V6, P157, DOI 10.1016/S1357-4310(00)01677-4; Brown JM, 1998, CANCER RES, V58, P1408; Brown LM, 2006, MOL PHARMACOL, V69, P411, DOI 10.1124/mol.105.015743; Chang Q, 2006, PANCREAS, V32, P297, DOI 10.1097/00006676-200604000-00010; Chen LM, 2004, J PHARM PHARMACOL, V56, P1061, DOI 10.1211/0022357043879; Chen M, 2012, J CELL BIOCHEM, V113, P2474, DOI 10.1002/jcb.24122; Comerford KM, 2002, CANCER RES, V62, P3387; Cuvillier O, 2013, ADV CANCER RES, V117, P117, DOI 10.1016/B978-0-12-394274-6.00005-4; Desoize B, 2000, CRIT REV ONCOL HEMAT, V36, P193, DOI 10.1016/S1040-8428(00)00086-X; Ding ZY, 2010, J CANCER RES CLIN, V136, P1697, DOI 10.1007/s00432-010-0828-5; Dong XL, 2012, BIOMED PHARMACOTHER, V66, P70, DOI 10.1016/j.biopha.2011.11.016; Hao J, 2008, CANCER GENE THER, V15, P449, DOI 10.1038/cgt.2008.4; He QC, 2011, ONCOL REP, V25, P237, DOI 10.3892/or_00001066; Hussein D, 2006, MOL CANCER THER, V5, P2241, DOI 10.1158/1535-7163.MCT-06-0145; Kamiyama H, 2005, J CANCER RES CLIN, V131, P205, DOI 10.1007/s00432-004-0642-z; Kanagasabai R, 2011, J BIOL CHEM, V286, P33289, DOI 10.1074/jbc.M111.249102; Li J, 2006, BIOCHEM BIOPH RES CO, V342, P1341, DOI 10.1016/j.bbrc.2006.02.094; Liang Shuang, 2012, Genes Cancer, V3, P141, DOI 10.1177/1947601912457025; Liu LL, 2008, CANCER SCI, V99, P121, DOI 10.1111/j.1349-7006.2007.00643.x; Morin PJ, 2003, DRUG RESIST UPDATE, V6, P169, DOI 10.1016/S1368-7646(03)00059-1; Nardinocchi L, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-1; Oktem G, 2006, ONCOL RES, V16, P195; Owen MR, 2011, CANCER RES, V71, P2826, DOI 10.1158/0008-5472.CAN-10-2834; Ramaekers CHMA, 2011, RADIOTHER ONCOL, V101, P190, DOI 10.1016/j.radonc.2011.05.059; Ravizza R, 2009, EUR J CANCER, V45, P890, DOI 10.1016/j.ejca.2008.12.021; Rohwer N, 2011, DRUG RESIST UPDATE, V14, P191, DOI 10.1016/j.drup.2011.03.001; Sapra P, 2011, ANGIOGENESIS, V14, P245, DOI 10.1007/s10456-011-9209-1; Sasabe E, 2007, INT J CANCER, V120, P268, DOI 10.1002/ijc.22294; Sullivan R, 2008, MOL CANCER THER, V7, P1961, DOI 10.1158/1535-7163.MCT-08-0198; Tiwari AK, 2011, CURR PHARM BIOTECHNO, V12, P570; Unruh A, 2003, ONCOGENE, V22, P3213, DOI 10.1038/sj.onc.1206385; Wartenberg M, 2001, FASEB J, V15, P995, DOI 10.1096/fj.00-0350com; Westhoff MA, 2009, DRUG RESIST UPDATE, V12, P127, DOI 10.1016/j.drup.2009.08.001; Wu Chung-Pu, 2008, Curr Mol Pharmacol, V1, P93; Yeo EJ, 2003, J NATL CANCER I, V95, P516, DOI 10.1093/jnci/95.7.516	36	34	38	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98882	10.1371/journal.pone.0098882	http://dx.doi.org/10.1371/journal.pone.0098882			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901645	gold, Green Published, Green Submitted			2022-12-27	WOS:000336841400065
J	Inaba, T; Hisatsune, C; Sasaki, Y; Ogawa, Y; Ebisui, E; Ogawa, N; Matsui, M; Takeuchi, T; Mikoshiba, K; Tsubota, K				Inaba, Takaaki; Hisatsune, Chihiro; Sasaki, Yasumasa; Ogawa, Yoko; Ebisui, Etsuko; Ogawa, Naoko; Matsui, Minoru; Takeuchi, Tsutomu; Mikoshiba, Katsuhiko; Tsubota, Kazuo			Mice Lacking Inositol 1,4,5-Trisphosphate Receptors Exhibit Dry Eye	PLOS ONE			English	Article							LACRIMAL GLAND; SIGNAL-TRANSDUCTION; PROTEIN SECRETION; SJOGRENS-SYNDROME; TYPE-3; ROLES; CA2+	Tear secretion is important as it supplies water to the ocular surface and keeps eyes moist. Both the parasympathetic and sympathetic pathways contribute to tear secretion. Although intracellular Ca2+ elevation in the acinar cells of lacrimal glands is a crucial event for tear secretion in both the pathways, the Ca2+ channel, which is responsible for the Ca2+ elevation in the sympathetic pathway, has not been sufficiently analyzed. In this study, we examined tear secretion in mice lacking the inositol 1,4,5-trisphosphate receptor (IP3R) types 2 and 3 (Itpr2(-/-); Itpr3(-/-) double-knockout mice). We found that tear secretion in both the parasympathetic and sympathetic pathways was abolished in Itpr2(-/-); Itpr3(-/-) mice. Intracellular Ca2+ elevation in lacrimal acinar cells after acetylcholine and epinephrine stimulation was abolished in Itpr2(-/-); Itpr3(-/-) mice. Consequently, Itpr2(-/-); Itpr3(-/-) mice exhibited keratoconjunctival alteration and corneal epithelial barrier disruption. Inflammatory cell infiltration into the lacrimal glands and elevation of serum autoantibodies, a representative marker for Sjogren's syndrome (SS) in humans, were also detected in older Itpr2(-/-); Itpr3(-/-) mice. These results suggested that IP(3)Rs are essential for tear secretion in both parasympathetic and sympathetic pathways and that Itpr2(-/-); Itpr3(-/-) mice could be a new dry eye mouse model with symptoms that mimic those of SS.	[Inaba, Takaaki; Sasaki, Yasumasa; Ogawa, Yoko; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, Tokyo, Japan; [Takeuchi, Tsutomu] Keio Univ, Sch Med, Dept Rheumatol, Shinjuku Ku, Tokyo, Japan; [Inaba, Takaaki; Hisatsune, Chihiro; Ebisui, Etsuko; Ogawa, Naoko; Mikoshiba, Katsuhiko] RIKEN Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama, Japan; [Matsui, Minoru] Chiba Inst Sci, Dept Pharm, Choshi, Chiba, Japan; [Mikoshiba, Katsuhiko] Japan Sci & Technol Agcy, Calcium Oscillat Project, Int Cooperat Res Project Solut Oriented Res Sci &, Kawaguchi, Saitama, Japan	Keio University; Keio University; RIKEN; Japan Science & Technology Agency (JST)	Mikoshiba, K (corresponding author), RIKEN Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama, Japan.	mikosiba@brain.riken.jp	Hisatsune, Chihiro/C-6661-2017; Takeuchi, Tsutomu/L-2327-2013; Ogawa, Yoko/AAV-1932-2021; Takeuchi, Tsutomu/AFM-8316-2022; Mikoshiba, Katsuhiko/N-7943-2015	Hisatsune, Chihiro/0000-0001-7811-7784; Takeuchi, Tsutomu/0000-0003-1111-8218; Ogawa, Yoko/0000-0002-2906-9621; 	Japanese Ministry of Education, Culture, Sports, Science and Technology [20659272]; Nagao Memorial Fund; Moritani Scholarship Foundation; JSPS KAKENHI [20220007]; Japan Science and Technology Agency	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nagao Memorial Fund; Moritani Scholarship Foundation; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by a Grant-in-Aid for Challenging Exploratory Research (No. 20659272) from The Japanese Ministry of Education, Culture, Sports, Science and Technology, the Nagao Memorial Fund, the Moritani Scholarship Foundation (C.H.), JSPS KAKENHI Grant Number 20220007 (K.M.), and the Japan Science and Technology Agency (K.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DARTT DA, 1989, CURR EYE RES, V8, P619, DOI 10.3109/02713688908995762; DARTT DA, 1994, ADV EXP MED BIOL, V350, P1; DARTT DA, 1994, EXP EYE RES, V58, P423, DOI 10.1006/exer.1994.1035; Dartt DA, 2009, PROG RETIN EYE RES, V28, P155, DOI 10.1016/j.preteyeres.2009.04.003; Fox Robert I., 1995, Current Opinion in Rheumatology, V7, P409, DOI 10.1097/00002281-199509000-00008; Fox Robert I., 1997, Current Opinion in Rheumatology, V9, P393, DOI 10.1097/00002281-199709000-00004; Fukuda N, 2008, EUR J NEUROSCI, V27, P2665, DOI 10.1111/j.1460-9568.2008.06240.x; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; GROMADA J, 1995, PFLUG ARCH EUR J PHY, V429, P751, DOI 10.1007/BF00374798; Hattori M, 2004, J BIOL CHEM, V279, P11967, DOI 10.1074/jbc.M311456200; HODGES RR, 1992, AM J PHYSIOL, V262, pG1087, DOI 10.1152/ajpgi.1992.262.6.G1087; Iwai M, 2005, J BIOL CHEM, V280, P10305, DOI 10.1074/jbc.M413824200; Kamoi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043688; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Niederkorn JY, 2006, J IMMUNOL, V176, P3950, DOI 10.4049/jimmunol.176.7.3950; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554	16	26	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99205	10.1371/journal.pone.0099205	http://dx.doi.org/10.1371/journal.pone.0099205			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901844	Green Published, Green Submitted, gold			2022-12-27	WOS:000336841400109
J	Sidze, LK; Tekwu, EM; Kuaban, C; Assam, JPA; Tedom, JC; Eyangoh, S; Fouda, FX; Nolna, D; Ntoumi, F; Frank, M; Beng, VNP				Sidze, Larissa Kamgue; Tekwu, Emmanuel Mouafo; Kuaban, Christopher; Assam, Jean-Paul Assam; Tedom, Jean-Claude; Eyangoh, Sara; Fouda, Francois-Xavier; Nolna, Desire; Ntoumi, Francine; Frank, Matthias; Beng, Veronique N. Penlap			Strong Decrease in Streptomycin-Resistance and Absence of XDR 12 Years after the Reorganization of the National Tuberculosis Control Program in the Central Region of Cameroon	PLOS ONE			English	Article							ANTITUBERCULOSIS DRUG-RESISTANCE; MYCOBACTERIUM-TUBERCULOSIS; HONG-KONG; SURVEILLANCE; SUSCEPTIBILITY; IMPLEMENTATION; INFECTION; YAOUNDE; WEST	Background: In the 1990s, resistance rates of 15% for streptomycin-resistance and 0.6% for multidrug-resistance (MDR) were reported from the Central Region of Cameroon. This work assesses drug resistant tuberculosis in this region 12 years after reorganization of the National Tuberculosis Control Program (NTCP). Methods: This cross-sectional study was conducted from April 2010 to March 2011 in Jamot Hospital in Yaounde, Cameroon. Only patients with smear positive pulmonary tuberculosis were included. Sputa were cultured and subsequently underwent drug susceptibility testing (DST). All consenting individuals were tested for their HIV status. Results: A total of 665 smear positive pulmonary tuberculosis patients were enrolled. The HIV prevalence was 28.5% (95%CI [25.2-32.1]). Of the 582 sputa that grew Mycobacterium tuberculosis complex species, DST results were obtained for 576. The overall resistance rate was 10.9% (63/576). The overall resistance rates for single drug resistance were: isoniazid-resistance 4.7% (27/576), streptomycin-resistance 3.3% (19/576), rifampicin-resistance 0.2% (1/576), kanamycin-resistance 0.2% (1/576) and ofloxacin-resistance 0.2% (1/576). The MDR rate was 1.1% (6/576) and no extensively drug resistant tuberculosis (XDR) was detected. Conclusions: The data show that reorganization of the NTCP resulted in a strong decrease in streptomycin-resistance and suggest that it prevented the emergence of XDR in the Central Region of Cameroon.	[Sidze, Larissa Kamgue; Tekwu, Emmanuel Mouafo; Assam, Jean-Paul Assam; Tedom, Jean-Claude; Beng, Veronique N. Penlap] Univ Yaounde I, Biotechnol Ctr BTC, LTR, Yaounde, Cameroon; [Kuaban, Christopher] Jamot Hosp, Pneumol Unit, Yaounde, Cameroon; [Eyangoh, Sara] Ctr Pasteur Cameroon, Mycobacteriol Serv, NTP, Pasteur Inst Int Network,Reference Lab, Yaounde, Cameroon; [Fouda, Francois-Xavier] Mbalmayo Dist Hosp, Mbalmayo, Cameroon; [Nolna, Desire] NTCP, Yaounde, Cameroon; [Ntoumi, Francine] Univ Marien Ngouabi, Fdn Congolaise Rech Med, Brazzaville, Rep Congo; [Sidze, Larissa Kamgue; Tekwu, Emmanuel Mouafo; Ntoumi, Francine; Frank, Matthias] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Frank, Matthias] DZIF, Tubingen, Germany; [Sidze, Larissa Kamgue; Tekwu, Emmanuel Mouafo; Assam, Jean-Paul Assam; Tedom, Jean-Claude; Ntoumi, Francine; Frank, Matthias; Beng, Veronique N. Penlap] Cent African Network TB AIDS HIV & Malaria CANTAM, Brazzaville, Rep Congo	University of Yaounde I; Eberhard Karls University of Tubingen; German Center for Infection Research	Frank, M (corresponding author), Univ Tubingen, Inst Trop Med, Tubingen, Germany.	Matthias.Frank@uni-tuebingen.de; v.penlap@yahoo.fr			Central Africa Network for Tuberculosis, AIDS/HIV and Malaria (CANTAM); European Developing Countries Clinical Trials Partnership (EDCTP) [CB.2007.41700.006]	Central Africa Network for Tuberculosis, AIDS/HIV and Malaria (CANTAM); European Developing Countries Clinical Trials Partnership (EDCTP)	This study was financially supported by Central Africa Network for Tuberculosis, AIDS/HIV and Malaria (CANTAM), a network sponsored by the European Developing Countries Clinical Trials Partnership (EDCTP) (Grant No CB.2007.41700.006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assam-Assam JP, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-94; Bercion R, 1997, INT J TUBERC LUNG D, V1, P110; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Cauthen GM, 1996, AM J EPIDEMIOL, V144, P69, DOI 10.1093/oxfordjournals.aje.a008856; Caws M, 2006, J CLIN MICROBIOL, V44, P3934, DOI 10.1128/JCM.01181-06; Chaulet P, 1995, TUBERCLE LUNG DIS, V76, P487, DOI 10.1016/0962-8479(95)90523-5; Chode TM, 1989, B INT UNION TUBERC L, V64, P37; DEGOMMIER J, 1957, ANN I PASTEUR PARIS, V92, P692; DeRiemer K, 2005, LANCET, V365, P1239, DOI 10.1016/S0140-6736(05)74812-1; Dolgin E, 2010, NAT MED, V16, P8, DOI 10.1038/nm0110-8a; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Grosset J, 1990, BACTERIOLOGIE MED, P965; Kam KM, 2004, INT J TUBERC LUNG D, V8, P760; Kam KM, 2001, INT J TUBERC LUNG D, V5, P815; Keugoung B, 2013, REV EPIDEMIOL SANTE, V61, P129, DOI 10.1016/j.respe.2012.10.005; Kuaban C, 2000, INT J TUBERC LUNG D, V4, P356; Kuaban C, 2000, INT J TUBERC LUNG D, V4, P427; Meriki HD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077410; Noeske Jurgen, 2012, BMC Res Notes, V5, P160, DOI 10.1186/1756-0500-5-160; Sangare L, 2010, ANN AFR MED, V9, P15, DOI 10.4103/1596-3519.62619; Sharma SK, 2004, INDIAN J MED RES, V120, P354; Sidze LK, 2013, ADV INFECT DIS, V3, P55; Takiff H, 2011, ANTIMICROB AGENTS CH, V55, P5421, DOI 10.1128/AAC.00695-11; Tantchou J, 2007, EPIDEMIE POLITIQUE A, P267; *WHO, 2008, WHOHTMTB2008394; World Health Organization, 2012, WHOHTMTB201262; Zhang ZJ, 2014, ANTIMICROB AGENTS CH, V58, P364, DOI 10.1128/AAC.01228-13	28	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98374	10.1371/journal.pone.0098374	http://dx.doi.org/10.1371/journal.pone.0098374			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901982	Green Submitted, Green Published, gold			2022-12-27	WOS:000336841400026
J	Strech, D; Metz, C; Knuppel, H				Strech, Daniel; Metz, Courtney; Knueppel, Hannes			Do Editorial Policies Support Ethical Research? A Thematic Text Analysis of Author Instructions in Psychiatry Journals	PLOS ONE			English	Article							INFORMED-CONSENT; BOARD APPROVAL; PUBLICATIONS; FAILURE; ISSUES	Introduction: According to the Declaration of Helsinki and other guidelines, clinical studies should be approved by a research ethics committee and seek valid informed consent from the participants. Editors of medical journals are encouraged by the ICMJE and COPE to include requirements for these principles in the journal's instructions for authors. This study assessed the editorial policies of psychiatry journals regarding ethics review and informed consent. Methods and Findings: The information given on ethics review and informed consent and the mentioning of the ICMJE and COPE recommendations were assessed within author's instructions and online submission procedures of all 123 eligible psychiatry journals. While 54% and 58% of editorial policies required ethics review and informed consent, only 14% and 19% demanded the reporting of these issues in the manuscript. The TOP-10 psychiatry journals (ranked by impact factor) performed similarly in this regard. Conclusions: Only every second psychiatry journal adheres to the ICMJE's recommendation to inform authors about requirements for informed consent and ethics review. Furthermore, we argue that even the ICMJE's recommendations in this regard are insufficient, at least for ethically challenging clinical trials. At the same time, ideal scientific design sometimes even needs to be compromised for ethical reasons. We suggest that features of clinical studies that make them morally controversial, but not necessarily unethical, are analogous to methodological limitations and should thus be reported explicitly. Editorial policies as well as reporting guidelines such as CONSORT should be extended to support a meaningful reporting of ethical research.	[Strech, Daniel; Metz, Courtney; Knueppel, Hannes] Hannover Med Sch, CELLS, Inst Hist Eth & Philosophy Med, Hannover, Germany; [Metz, Courtney] Leibniz Univ Hannover, CELLS, Dept Philosophy, D-30167 Hannover, Germany	Hannover Medical School; Leibniz University Hannover	Strech, D (corresponding author), Hannover Med Sch, CELLS, Inst Hist Eth & Philosophy Med, Hannover, Germany.	strech.daniel@mh-hannover.de		Kahrass, Hannes/0000-0003-0694-0354; Strech, Daniel/0000-0002-9153-079X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amdur RJ, 1997, JAMA-J AM MED ASSOC, V277, P909, DOI 10.1001/jama.277.11.909; Angelski C, 2012, BMC MED ETHICS, V13, DOI 10.1186/1472-6939-13-4; [Anonymous], 2013, J CITATION REPORTS; [Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; Asai T, 1999, ANAESTHESIA, V54, P192, DOI 10.1046/j.1365-2044.1999.00712.x; Bauchner H, 2001, BRIT MED J, V323, P318, DOI 10.1136/bmj.323.7308.318; Bavdekar Sandeep B, 2008, Indian J Med Sci, V62, P134; BRACKBILL Y, 1980, HASTINGS CENT REP, V10, P20, DOI 10.2307/3561274; COPE, 2011, INT STAND ED AUTH; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Fernández Esteve, 2005, Gac Sanit, V19, P354, DOI 10.1157/13080132; Finlay KA, 2008, J MED ETHICS, V34, P761, DOI 10.1136/jme.2007.023325; Hardin Russell, 2006, TRUST; ICMJE, 2013, ICMJE REC COND REP E; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Matot I, 1998, CRIT CARE MED, V26, P1596, DOI 10.1097/00003246-199809000-00035; MCDONALD A, 1985, CAN MED ASSOC J, V133, P803; Miller FG, 1999, ARCH GEN PSYCHIAT, V56, P763, DOI 10.1001/archpsyc.56.8.763; Miller FG, 2002, LANCET, V360, P1326, DOI 10.1016/S0140-6736(02)11346-8; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Navaneetha C, 2011, CONTEMP CLIN DENT, V2, P84, DOI 10.4103/0976-237X.83066; Olson CM, 1996, RESUSCITATION, V31, P255, DOI 10.1016/0300-9572(95)00928-0; Riedel M, 2012, EUR ARCH PSY CLIN N, V262, P151, DOI 10.1007/s00406-011-0225-3; Rikkert MGMO, 1996, BMJ-BRIT MED J, V313, P1117, DOI 10.1136/bmj.313.7065.1117; Rowan-Legg A, 2009, J MED ETHICS, V35, P74, DOI 10.1136/jme.2008.024299; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Stocking CB, 2004, J AM GERIATR SOC, V52, P305, DOI 10.1111/j.1532-5415.2004.52075.x; Tullberg J., 2007, J SOCIO-ECON, V37, P2059; Wager E., 2010, POS STAT DEV 2 WORLD; Weil E, 2002, PEDIATRICS, V110, P364, DOI 10.1542/peds.110.2.364; Weingarten MA, 2004, BMJ-BRIT MED J, V328, P1013, DOI 10.1136/bmj.328.7446.1013; Yank V, 2002, JAMA-J AM MED ASSOC, V287, P2835, DOI 10.1001/jama.287.21.2835	32	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e97492	10.1371/journal.pone.0097492	http://dx.doi.org/10.1371/journal.pone.0097492			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4NF	24901366	Green Published, gold			2022-12-27	WOS:000336841400007
J	Zhong, C; Li, F; Liu, M; Yang, XN; Zhu, HX; Jia, YY; Jia, SR; Piergiovanni, L				Zhong, Cheng; Li, Fei; Liu, Miao; Yang, Xiao-Ning; Zhu, Hui-Xia; Jia, Yuan-Yuan; Jia, Shi-Ru; Piergiovanni, Luciano			Revealing Differences in Metabolic Flux Distributions between a Mutant Strain and Its Parent Strain Gluconacetobacter xylinus CGMCC 2955	PLOS ONE			English	Article							BACTERIAL CELLULOSE PRODUCTION; CORYNEBACTERIUM-GLUTAMICUM; DEHYDROGENASE; BIOSYNTHESIS; IMPROVEMENT; PATHWAYS	A better understanding of metabolic fluxes is important for manipulating microbial metabolism toward desired end products, or away from undesirable by-products. A mutant strain, Gluconacetobacter xylinus AX2-16, was obtained by combined chemical mutation of the parent strain (G. xylinus CGMCC 2955) using DEC (diethyl sulfate) and LiCl. The highest bacterial cellulose production for this mutant was obtained at about 11.75 g/L, which was an increase of 62% compared with that by the parent strain. In contrast, gluconic acid (the main byproduct) concentration was only 5.71 g/L for mutant strain, which was 55.7% lower than that of parent strain. Metabolic flux analysis indicated that 40.1% of the carbon source was transformed to bacterial cellulose in mutant strain, compared with 24.2% for parent strain. Only 32.7% and 4.0% of the carbon source were converted into gluconic acid and acetic acid in mutant strain, compared with 58.5% and 9.5% of that in parent strain. In addition, a higher flux of tricarboxylic acid (TCA) cycle was obtained in mutant strain (57.0%) compared with parent strain (17.0%). It was also indicated from the flux analysis that more ATP was produced in mutant strain from pentose phosphate pathway (PPP) and TCA cycle. The enzymatic activity of succinate dehydrogenase (SDH), which is one of the key enzymes in TCA cycle, was 1.65-fold higher in mutant strain than that in parent strain at the end of culture. It was further validated by the measurement of ATPase that 3.53-6.41 fold higher enzymatic activity was obtained from mutant strain compared with parent strain.	[Zhong, Cheng; Li, Fei; Liu, Miao; Yang, Xiao-Ning; Zhu, Hui-Xia; Jia, Yuan-Yuan; Jia, Shi-Ru] Tianjin Univ Sci & Technol, Key Lab Ind Fermentat Microbiol, Minist Educ, Tianjin, Peoples R China; [Li, Fei; Piergiovanni, Luciano] Univ Milan, Dept Food Environm & Nutr Sci, DeFENS, Milan, Italy; [Jia, Yuan-Yuan] Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Tianjin 300072, Peoples R China	Tianjin University Science & Technology; University of Milan; Tianjin University	Jia, SR (corresponding author), Tianjin Univ Sci & Technol, Key Lab Ind Fermentat Microbiol, Minist Educ, Tianjin, Peoples R China.	jiashiru@tust.edu.cn	jia, shi/HHS-4172-2022		National Natural Science Foundation of China [21106105, 20976133]; Foundation of Tianjin Educational Committee [20100602]; National High Technology Research and Development Programme ("863'' Program) of China [2012AA022108]; Changjiang Scholars and Innovative Research Team in University [IRT1166]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Tianjin Educational Committee; National High Technology Research and Development Programme ("863'' Program) of China(National High Technology Research and Development Program of China); Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	The authors are grateful for the financial support from the National Natural Science Foundation of China (Project No. 21106105, Project No. 20976133), the Foundation of Tianjin Educational Committee (No. 20100602), the National High Technology Research and Development Programme ("863'' Program) of China (No. 2012AA022108), and Changjiang Scholars and Innovative Research Team in University (No. IRT1166). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackrell B. A.C, 1992, CHEM BIOCH FLAVOPROT, V3, P229; Bae SO, 2005, APPL MICROBIOL BIOT, V67, P45, DOI 10.1007/s00253-004-1723-2; BASS A, 1969, EUR J BIOCHEM, V10, P198, DOI 10.1111/j.1432-1033.1969.tb00674.x; BENZIMAN M, 1964, J BACTERIOL, V88, P1010, DOI 10.1128/JB.88.4.1010-1018.1964; BENZIMAN M, 1978, J BACTERIOL, V134, P1; CSONKA LN, 1977, J BIOL CHEM, V252, P3382; Ha JH, 2012, KOREAN J CHEM ENG, V29, P563, DOI 10.1007/s11814-011-0224-0; Hu SY, 2004, SCI CHINA SER B, V47, P206, DOI 10.1360/03yb0204; Ishida T, 2003, BIOTECHNOL BIOENG, V83, P474, DOI 10.1002/bit.10690; Jung HI, 2010, BIORESOURCE TECHNOL, V101, P3602, DOI 10.1016/j.biortech.2009.12.111; Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587; Krystynowicz A, 2002, J IND MICROBIOL BIOT, V29, P189, DOI 10.1038/sj.jim.7000303; Kwon YD, 2007, J APPL MICROBIOL, V103, P2340, DOI 10.1111/j.1365-2672.2007.03485.x; Li YJ, 2012, APPL MICROBIOL BIOT, V96, P1479, DOI 10.1007/s00253-012-4242-6; Marx A, 1996, BIOTECHNOL BIOENG, V49, P111, DOI 10.1002/(SICI)1097-0290(19960120)49:2<111::AID-BIT1>3.0.CO;2-T; Ng RTL, 2012, CHEM ENGINEER TRANS, V29, P1123, DOI 10.3303/CET1229188; Noh K, 2011, APPL MICROBIOL BIOT, V91, P1247, DOI 10.1007/s00253-011-3390-4; Petersen N, 2011, APPL MICROBIOL BIOT, V91, P1277, DOI 10.1007/s00253-011-3432-y; Rauch B, 2010, APPL MICROBIOL BIOT, V88, P711, DOI 10.1007/s00253-010-2779-9; ROSS P, 1991, MICROBIOL REV, V55, P35, DOI 10.1128/MMBR.55.1.35-58.1991; Sarkar D, 2010, APPL MICROBIOL BIOT, V87, P127, DOI 10.1007/s00253-010-2474-x; Sauer U, 2005, FEMS MICROBIOL REV, V29, P765, DOI 10.1016/j.femsre.2004.11.002; Shang YZ, 2005, PHARMACOL BIOCHEM BE, V82, P67, DOI 10.1016/j.pbb.2005.06.018; Shi HD, 1997, J FERMENT BIOENG, V84, P579, DOI 10.1016/S0922-338X(97)81915-0; Shigematsu T, 2005, J BIOSCI BIOENG, V99, P415, DOI 10.1263/jbb.99.415; SWISSA M, 1980, J BACTERIOL, V143, P1142, DOI 10.1128/JB.143.3.1142-1150.1980; Tang WH, 2010, WORLD J MICROB BIOT, V26, P125, DOI 10.1007/s11274-009-0151-y; Taymaz-Nikerel H, 2010, BIOTECHNOL BIOENG, V107, P369, DOI 10.1002/bit.22802; Tonouchi N, 2003, BIOSCI BIOTECH BIOCH, V67, P2648, DOI 10.1271/bbb.67.2648; Ul-Islam M, 2012, CARBOHYD POLYM, V88, P596, DOI 10.1016/j.carbpol.2012.01.006; VALLINO JJ, 1993, BIOTECHNOL BIOENG, V41, P633, DOI 10.1002/bit.260410606; Velasco-Bedran H, 2007, PROCESS BIOCHEM, V42, P1180, DOI 10.1016/j.procbio.2007.05.017; Venkatesalu V, 2008, PHOTOSYNTHETICA, V46, P622, DOI 10.1007/s11099-008-0105-x; Venkatesh KV, 1997, PROCESS BIOCHEM, V32, P651, DOI 10.1016/S0032-9592(97)00014-9; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Yao XL, 2012, FOOD CHEM, V132, P1883, DOI 10.1016/j.foodchem.2011.12.021; Yunzhuan H, 1999, ACTA ENTOMOL SIN, V1; Zeng XB, 2011, CARBOHYD POLYM, V85, P506, DOI 10.1016/j.carbpol.2011.02.034; Zhong C, 2013, APPL MICROBIOL BIOT, V97, P6189, DOI 10.1007/s00253-013-4908-8; Zhong C, 2010, BIOFUEL BIOPROD BIOR, V4, P326, DOI 10.1002/bbb.207; Zhong C, 2009, APPL MICROBIOL BIOT, V84, P667, DOI 10.1007/s00253-009-2001-0; Zhu HX, 2011, BIOTECHNOL BIOTECHNO, V25	42	29	30	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98772	10.1371/journal.pone.0098772	http://dx.doi.org/10.1371/journal.pone.0098772			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901455	Green Submitted, Green Published, gold			2022-12-27	WOS:000336841400050
J	Ahlstrand, E; Hellmark, B; Svensson, K; Soderquist, B				Ahlstrand, Erik; Hellmark, Bengt; Svensson, Karolina; Soderquist, Bo			Long-Term Molecular Epidemiology of Staphylococcus epidermidis Blood Culture Isolates from Patients with Hematological Malignancies	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; HOSPITAL-ACQUIRED INFECTION; SCCMEC TYPE-IV; GENETIC DIVERSITY; SWEDISH COUNTY; UNITED-STATES; SUSCEPTIBILITY; COLONIZATION; RESISTANCE; SYSTEM	Staphylococcus epidermidis is an important cause of bloodstream infections in patients with hematological malignancies. Knowledge of the long-term epidemiology of these infections is limited. We surveyed all S. epidermidis blood culture isolates from patients treated for hematological malignancies at the University Hospital of Orebro, Sweden from 1980 to 2009. A total of 373 S. epidermidis isolates were identified and multilocus sequence typing, staphylococcal chromosome cassette mec (SCCmec) typing and standard antibiotic susceptibility testing were employed to characterize these isolates. The majority of the isolates 361/373 (97%) belonged to clonal complex 2, and the 373 isolates were divided into 45 sequence types (STs); Simpson's Diversity Index was 0.56. The most prevalent STs were ST2 (243/373, 65%) and ST215 (28/373, 8%). Ninety three percent (226/243) of the ST2 isolates displayed either SCCmec type III or IV. ST2 and 215 were isolated during the entire study period, and together these STs caused temporal peaks in the number of positive blood cultures of S. epidermidis. Methicillin resistance was detected in 213/273 (78%) of all isolates. In the two predominating STs, ST2 and ST215, methicillin resistance was detected in 256/271 isolates (95%), compared with 34/100 (34%) in other STs (p<0.001). In conclusion, in this long-term study of patients with hematological malignancies, we demonstrate a predominance of methicillin-resistant ST2 among S. epidermidis blood culture isolates.	[Ahlstrand, Erik] Orebro Univ Hosp, Dept Med, Div Hematol, Orebro, Sweden; [Hellmark, Bengt; Svensson, Karolina; Soderquist, Bo] Orebro Univ Hosp, Dept Lab Med, Orebro, Sweden; [Ahlstrand, Erik; Soderquist, Bo] Univ Orebro, Fac Med & Hlth, SE-70182 Orebro, Sweden	Orebro University; Orebro University; Orebro University	Ahlstrand, E (corresponding author), Orebro Univ Hosp, Dept Med, Div Hematol, Orebro, Sweden.	erik.ahlstrand@orebroll.se		Soderquist, Bo/0000-0001-5939-2932	Orebro county council research committee at the Orebro University Hospital, Sweden	Orebro county council research committee at the Orebro University Hospital, Sweden	The study was supported by grants from the Orebro county council research committee at the Orebro University Hospital, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlstrand E, 2011, EUR J CLIN MICROBIOL, V30, P1349, DOI 10.1007/s10096-011-1228-8; Beekmann SE, 2005, INFECT CONT HOSP EP, V26, P559, DOI 10.1086/502584; Berglund C, 2005, CLIN MICROBIOL INFEC, V11, P447, DOI 10.1111/j.1469-0691.2005.01150.x; Burnie JP, 1997, J CLIN MICROBIOL, V35, P1746, DOI 10.1128/JCM.35.7.1746-1750.1997; Claesson C, 2007, SCAND J INFECT DIS, V39, P1002, DOI 10.1080/00365540701472064; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Du X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062742; Gordon RJ, 2012, J INFECT DIS, V205, P1391, DOI 10.1093/infdis/jis218; Hellmark B, 2013, INT J MED MICROBIOL, V303, P32, DOI 10.1016/j.ijmm.2012.11.001; Ibrahem S, 2008, CLIN MICROBIOL INFEC, V14, P1020, DOI 10.1111/j.1469-0691.2008.02080.x; Jamaluddin TZMT, 2008, J CLIN MICROBIOL, V46, P3778, DOI 10.1128/JCM.02262-07; Kelly S, 2008, J ANTIMICROB CHEMOTH, V61, P901, DOI 10.1093/jac/dkn043; Krediet TG, 2004, J CLIN MICROBIOL, V42, P992, DOI 10.1128/JCM.42.3.992-995.2004; Li M, 2009, J MED MICROBIOL, V58, P456, DOI 10.1099/jmm.0.007567-0; Mendes RE, 2012, ANTIMICROB AGENTS CH, V56, P4656, DOI 10.1128/AAC.00279-12; Miragaia M, 2008, J CLIN MICROBIOL, V46, P118, DOI 10.1128/JCM.01685-07; Miragaia M, 2007, J BACTERIOL, V189, P2540, DOI 10.1128/JB.01484-06; Miragaia M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007722; Muldrew KL, 2008, J CLIN MICROBIOL, V46, P3391, DOI 10.1128/JCM.00115-08; Nouwen JL, 1998, J CLIN MICROBIOL, V36, P2696, DOI 10.1128/JCM.36.9.2696-2702.1998; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Persson L, 2006, EUR J CLIN MICROBIOL, V25, P299, DOI 10.1007/s10096-006-0129-8; Rogers KL, 2009, INFECT DIS CLIN N AM, V23, P73, DOI 10.1016/j.idc.2008.10.001; Rolo J, 2012, J ANTIMICROB CHEMOTH, V67, P1333, DOI 10.1093/jac/dks068; Sanches IS, 2000, MICROB DRUG RESIST, V6, P199, DOI 10.1089/mdr.2000.6.199; Thomas JC, 2007, J CLIN MICROBIOL, V45, P616, DOI 10.1128/JCM.01934-06; Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1046/j.1462-5822.2004.00367.x; Wang XM, 2003, J MED MICROBIOL, V52, P989, DOI 10.1099/jmm.0.05360-0; Widerstrom M, 2006, J HOSP INFECT, V64, P177, DOI 10.1016/j.jhin.2006.06.013; Widerstrom M, 2011, EUROPEAN J CLIN MICR; Widerstrom M, 2012, J CLIN MICROBIOL, V50, P2147, DOI 10.1128/JCM.06456-11; Widerstrom M, 2011, APMIS, V119, P505, DOI 10.1111/j.1600-0463.2011.02757.x; Widerstrom Micael, 2009, Scand J Infect Dis, V41, P642, DOI 10.1080/00365540903146987; Wisplinghoff H, 2003, CLIN INFECT DIS, V36, P1103, DOI 10.1086/374339; Wisplinghoff H, 2003, ANTIMICROB AGENTS CH, V47, P3574, DOI 10.1128/AAC.47.11.3574-3579.2003; [No title captured]	36	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99045	10.1371/journal.pone.0099045	http://dx.doi.org/10.1371/journal.pone.0099045			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896826	gold, Green Published, Green Submitted			2022-12-27	WOS:000338430700108
J	Cocos, R; Sendroiu, A; Schipor, S; Bohiltea, LC; Sendroiu, I; Raicu, F				Cocos, Relu; Sendroiu, Alina; Schipor, Sorina; Bohiltea, Laurentiu Camil; Sendroiu, Ionut; Raicu, Florina			Genotype-Phenotype Correlations in a Mountain Population Community with High Prevalence of Wilson's Disease: Genetic and Clinical Homogeneity	PLOS ONE			English	Article							ATP7B GENE; MUTATION ANALYSIS; MOLECULAR CHARACTERIZATION; CONSECUTIVE GENERATIONS; HAPLOTYPE ANALYSIS; COPPER-METABOLISM; 2 FAMILIES; DIAGNOSIS; IDENTIFICATION; MANIFESTATION	Wilson's disease is an autosomal recessive disorder caused by more than 500 mutations in ATP7B gene presenting considerably clinical manifestations heterogeneity even in patients with a particular mutation. Previous findings suggested a potential role of additional genetic modifiers and environment factors on phenotypic expression among the affected patients. We conducted clinical and genetic investigations to perform genotype-phenotype correlation in two large families living in a socio-culturally isolated community with the highest prevalence of Wilson's disease ever reported of 1:1130. Sequencing of ATP7B gene in seven affected individuals and 43 family members identified a common compound heterozygous genotype, H1069Q/M769H-fs, in five symptomatic and two asymptomatic patients and detected the presence of two out of seven identified single nucleotide polymorphisms in all affected patients. Symptomatic patients had similar clinical phenotype and age at onset (1861 years) showing dysarthria and dysphagia as common clinical features at the time of diagnosis. Moreover, all symptomatic patients presented Kayser-Fleischer rings and lack of dystonia accompanied by unfavourable clinical outcomes. Our findings add value for understanding of genotype-phenotype correlations in Wilson's disease based on a multifamily study in an isolated population with high extent of genetic and environmental homogeneity as opposed to majority of reports. We observed an equal influence of presumed other genetic modifiers and environmental factors on clinical presentation and age at onset of Wilson's disease in patients with a particular genotype. These data provide valuable inferences that could be applied for predicting clinical management in asymptomatic patients in such communities.	[Cocos, Relu; Bohiltea, Laurentiu Camil; Raicu, Florina] Carol Davila Univ Med & Pharm, Chair Med Genet, Bucharest, Romania; [Raicu, Florina] Acad Romana, Francisc I Rainer Anthropol Res Inst, Bucharest, Romania; [Cocos, Relu] Genome Life Res Ctr, Bucharest, Romania; [Schipor, Sorina] Natl Inst Endocrinol CI Parhon, Bucharest, Romania; [Sendroiu, Alina; Sendroiu, Ionut] Family Med Ctr, Rucar, Romania; [Bohiltea, Laurentiu Camil] Sf Pantelimon Clin Emergency Hosp, Bucharest, Romania	Carol Davila University of Medicine & Pharmacy; Romanian Academy of Sciences; National Institute of Endocrinology C.I. Parhon	Raicu, F (corresponding author), Carol Davila Univ Med & Pharm, Chair Med Genet, Bucharest, Romania.	florina_raicu@yahoo.com	Schipor, Sorina/B-5062-2012; Cocoș, Relu/O-4134-2017; Raicu, Florina/A-4531-2011; Cocos, Relu/AAS-3810-2021	Schipor, Sorina/0000-0002-4886-2174; Cocoș, Relu/0000-0002-6209-2305; 	Romanian National Authority for Scientific Research, CNCS-UEFISCDI [2005-CNCSIS-27677, PN-II-ID-PCCE 2011-2-0013]	Romanian National Authority for Scientific Research, CNCS-UEFISCDI	This work was financially supported by two grants of the Romanian National Authority for Scientific Research, CNCS-UEFISCDI, project numbers 2005-CNCSIS-27677 and PN-II-ID-PCCE 2011-2-0013. www.cncs-nrc.ro and http://uefiscdi.gov.ro/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala A, 2007, LANCET, V369, P397, DOI 10.1016/S0140-6736(07)60196-2; Barada K, 2007, CLIN GENET, V72, P264, DOI 10.1111/j.1399-0004.2007.00853.x; Bittles AH, 2010, P NATL ACAD SCI USA, V107, P1779, DOI 10.1073/pnas.0906079106; Brage A, 2007, HEPATOL RES, V37, P18, DOI 10.1111/j.1872-034X.2007.00010.x; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; Chabik G, 2014, J INHERIT METAB DIS, V37, P131, DOI 10.1007/s10545-013-9625-z; Coffey AJ, 2013, BRAIN, V136, P1476, DOI 10.1093/brain/awt035; Compston A., 1912, BRAIN, V34, P295, DOI DOI 10.1093/BRAIN/34.4.295; Cox DW, 2005, HUM MUTAT, V26, DOI 10.1002/humu.9358; Czlonkowska A, 2009, MOVEMENT DISORD, V24, P1066, DOI 10.1002/mds.22474; Dedoussis GVZ, 2005, ANN HUM GENET, V69, P268, DOI 10.1046/j.1529-8817.2005.00171.x; Duc HH, 1998, EUR J HUM GENET, V6, P616; Dziezyc K, 2011, PARKINSONISM RELAT D, V17, P577, DOI 10.1016/j.parkreldis.2011.04.013; Ferenci P, 2003, LIVER INT, V23, P139, DOI 10.1034/j.1600-0676.2003.00824.x; FIGUS A, 1995, AM J HUM GENET, V57, P1318; Firneisz G, 2001, AM J GASTROENTEROL, V96, P2269, DOI 10.1016/S0002-9270(01)02546-1; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Frydman F, 1985, P NATL ACAD SCI USA, V82, P1819; Garcia-Villarreal L, 2000, HEPATOLOGY, V32, P1329, DOI 10.1053/jhep.2000.20152; GILMAN PA, 1982, JAMA-J AM MED ASSOC, V248, P467, DOI 10.1001/jama.248.4.467; Gitlin JD, 2003, GASTROENTEROLOGY, V125, P1868, DOI 10.1053/j.gastro.2003.05.010; Gromadzka G, 2006, MOVEMENT DISORD, V21, P245, DOI 10.1002/mds.20671; Gromadzka G, 2005, CLIN GENET, V68, P524, DOI 10.1111/j.1399-0004.2005.00528.x; Gupta A, 2005, HUM GENET, V118, P49, DOI 10.1007/s00439-005-0007-y; Gupta A, 2007, CLIN CHEM, V53, P1601, DOI 10.1373/clinchem.2007.086066; Iacob R, 2012, J GASTROINTEST LIVER, V21, P181; Lee BH, 2011, LIVER INT, V31, P833, DOI 10.1111/j.1478-3231.2011.02503.x; Lepori MB, 2012, MOL CELL PROBE, V26, P147, DOI 10.1016/j.mcp.2012.03.007; Loudianos G, 1999, HUM MUTAT, V14, P294, DOI 10.1002/(SICI)1098-1004(199910)14:4<294::AID-HUMU4>3.0.CO;2-9; Merle U., 2010, BMC GASTROENTEROL, V18, P10; Moller LB, 2011, EUR J HUM GENET, V19, P935, DOI 10.1038/ejhg.2011.80; Nicastro E, 2009, J HEPATOL, V50, P555, DOI 10.1016/j.jhep.2008.09.020; Olsson C, 2000, EUR J HUM GENET, V8, P933, DOI 10.1038/sj.ejhg.5200566; Panagiotakaki E, 2004, AM J MED GENET A, V131A, P168, DOI 10.1002/ajmg.a.30345; REILLY M, 1993, J NEUROL NEUROSUR PS, V56, P298, DOI 10.1136/jnnp.56.3.298; Roberts EA, 2008, HEPATOLOGY, V47, P2089, DOI 10.1002/hep.22261; Santhosh S, 2008, WORLD J GASTROENTERO, V14, P4672, DOI 10.3748/wjg.14.4672; SCHEINBERG IH, 1952, SCIENCE, V116, P484, DOI 10.1126/science.116.3018.484; Scheinberg IH, 1984, WILSONS DIS, P23; Simon I, 2008, WORLD J GASTROENTERO, V14, P2383, DOI 10.3748/wjg.14.2383; Stapelbroek JM, 2004, J HEPATOL, V41, P758, DOI 10.1016/j.jhep.2004.07.017; STERNLIEB I, 1990, HEPATOLOGY, V12, P1234, DOI 10.1002/hep.1840120526; Stuehler B, 2004, J MOL MED, V82, P629, DOI 10.1007/s00109-004-0557-9; Takeshita Y, 2002, J HUM GENET, V47, P543, DOI 10.1007/s100380200082; THOMAS GR, 1995, NAT GENET, V9, P210, DOI 10.1038/ng0295-210; Usta J, 2012, JIMD REP, V4, P129, DOI 10.1007/8904_2011_91; Vrabelova S, 2005, MOL GENET METAB, V86, P277, DOI 10.1016/j.ymgme.2005.05.004; Wang LH, 2011, J HUM GENET, V56, P660, DOI 10.1038/jhg.2011.76; YAMAGUCHI Y, 1993, BIOCHEM BIOPH RES CO, V197, P271, DOI 10.1006/bbrc.1993.2471; Ye S, 2007, WORLD J GASTROENTERO, V13, P5147, DOI 10.3748/wjg.v13.i38.5147	50	25	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98520	10.1371/journal.pone.0098520	http://dx.doi.org/10.1371/journal.pone.0098520			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897373	Green Published, gold, Green Submitted			2022-12-27	WOS:000338430700047
J	Fang, BS; Niu, J; Ren, H; Guo, YX; Wang, SZ				Fang, Baishan; Niu, Jin; Ren, Hong; Guo, Yingxia; Wang, Shizhen			Mechanistic Study of Manganese-Substituted Glycerol Dehydrogenase Using a Kinetic and Thermodynamic Analysis	PLOS ONE			English	Article							ACTIVE-SITE METAL; ESCHERICHIA-COLI; STABILITY; BINDING; DESIGN	Mechanistic insights regarding the activity enhancement of dehydrogenase by metal ion substitution were investigated by a simple method using a kinetic and thermodynamic analysis. By profiling the binding energy of both the substrate and product, the metal ion's role in catalysis enhancement was revealed. Glycerol dehydrogenase (GDH) from Klebsiella pneumoniae sp., which demonstrated an improvement in activity by the substitution of a zinc ion with a manganese ion, was used as a model for the mechanistic study of metal ion substitution. A kinetic model based on an ordered Bi-Bi mechanism was proposed considering the noncompetitive product inhibition of dihydroxyacetone (DHA) and the competitive product inhibition of NADH. By obtaining preliminary kinetic parameters of substrate and product inhibition, the number of estimated parameters was reduced from 10 to 4 for a nonlinear regression-based kinetic parameter estimation. The simulated values of time-concentration curves fit the experimental values well, with an average relative error of 11.5% and 12.7% for Mn-GDH and GDH, respectively. A comparison of the binding energy of enzyme ternary complex for Mn-GDH and GDH derived from kinetic parameters indicated that metal ion substitution accelerated the release of dioxyacetone. The metal ion's role in catalysis enhancement was explicated.	[Fang, Baishan; Niu, Jin; Ren, Hong; Guo, Yingxia; Wang, Shizhen] Xiamen Univ, Coll Chem & Chem Engn, Dept Chem & Biochem Engn, Xiamen, Peoples R China; [Fang, Baishan; Wang, Shizhen] Xiamen Univ, Key Lab Synthet Biotechnol Xiamen City, Xiamen, Peoples R China	Xiamen University; Xiamen University	Wang, SZ (corresponding author), Xiamen Univ, Coll Chem & Chem Engn, Dept Chem & Biochem Engn, Xiamen, Peoples R China.	szwang@xmu.edu.cn	Guo, Ying/AGH-9666-2022		National Natural Science Foundation of China [41176111, 41306124, 21336009]; Natural Science Foundation of Fujian Province of China [2012J01049]; Fundamental Research Funds for the Central Universities [2013121029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (No. 41176111, No. 41306124), the Key Program of National Natural Science Foundation of China (No. 21336009), the Natural Science Foundation of Fujian Province of China (No. 2012J01049), and the Fundamental Research Funds for the Central Universities (No. 2013121029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberty RA, 2010, J PHYS CHEM B, V114, P17003, DOI 10.1021/jp107337g; Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; Arima J, 2009, BIOCHIMIE, V91, P568, DOI 10.1016/j.biochi.2009.01.015; Bogin O, 1997, PROTEIN SCI, V6, P450; BOHACEK RS, 1994, J AM CHEM SOC, V116, P5560, DOI 10.1021/ja00092a006; Cappiello M, 2006, BIOCHEMISTRY-US, V45, P3226, DOI 10.1021/bi052069v; Chen BH, 2008, AICHE J, V54, P2155, DOI 10.1002/aic.11545; Chen HC, 2010, INTEGR SER INFORM SY, V21, P177, DOI 10.1007/978-1-4419-1278-7_13; D'Antonio EL, 2011, BIOCHEMISTRY-US, V50, P8018, DOI 10.1021/bi201101t; Dobson R, 2012, J IND MICROBIOL BIOT, V39, P217, DOI 10.1007/s10295-011-1038-0; Enders D, 2005, ANGEW CHEM INT EDIT, V44, P1304, DOI 10.1002/anie.200400659; Fisher HF, 2001, ENCY LIFE SCI, P1, DOI [10.1038/npg.els.0001341, DOI 10.1038/NPG.ELS.0001341]; Fisher HF, 2010, EMERGENCY RELIEF SYS, P1, DOI [10.1002/9780470015902.a0001341.pub, DOI 10.1002/9780470015902.A0001341.PUB]; Kleifeld O, 2003, NAT STRUCT BIOL, V10, P98, DOI 10.1038/nsb889; Lapenaite I, 2006, CRIT REV ANAL CHEM, V36, P13, DOI 10.1080/10408340500451973; Lemire JA, 2013, NAT REV MICROBIOL, V11, P371, DOI 10.1038/nrmicro3028; Leskovac V, 2004, COMPREHENSIVE ENZYME, P141; Martinez-Rodriguez S, 2009, BIOPHYS CHEM, V139, P42, DOI 10.1016/j.bpc.2008.10.003; NISHISE H, 1984, AGR BIOL CHEM TOKYO, V48, P1603, DOI 10.1080/00021369.1984.10866361; Rochu D, 2004, BIOCHEM J, V380, P627, DOI 10.1042/BJ20031861; Ruzheinikov SN, 2001, STRUCTURE, V9, P789, DOI 10.1016/S0969-2126(01)00645-1; Salgado EN, 2010, P NATL ACAD SCI USA, V107, P1827, DOI 10.1073/pnas.0906852107; Siddiqui KS, 2006, ANNU REV BIOCHEM, V75, P403, DOI 10.1146/annurev.biochem.75.103004.142723; Sokic-Lazic D, 2010, ELECTROANAL, V22, P757, DOI 10.1002/elan.200980010; Sparta M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047172; TANG JCT, 1982, J BACTERIOL, V152, P1169; Wang SZ, 2013, BIOTECHNOL BIOPROC E, V18, P796, DOI 10.1007/s12257-013-0125-7; Wang Y, 2014, J BIOL CHEM, V289, P6080, DOI 10.1074/jbc.M113.525535; Zhang K, 2009, MED MICROBIOL IMMUN, V198, P195, DOI 10.1007/s00430-009-0119-4; Zhang Y, 2011, BIORESOURCE TECHNOL, V102, P1837, DOI 10.1016/j.biortech.2010.09.069; Zheng MQ, 2011, BIOCATAL BIOTRANSFOR, V29, P278, DOI 10.3109/10242422.2011.631212	31	5	5	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99162	10.1371/journal.pone.0099162	http://dx.doi.org/10.1371/journal.pone.0099162			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896258	Green Published, gold, Green Submitted			2022-12-27	WOS:000338430700120
J	Marianelli, C; Petrucci, P; Comelli, MC; Calderini, G				Marianelli, Cinzia; Petrucci, Paola; Comelli, Maria Cristina; Calderini, Gabriella			Silver Sucrose Octasulfate (IASOS (TM)) as a Valid Active Ingredient into a Novel Vaginal Gel against Human Vaginal Pathogens: In Vitro Antimicrobial Activity Assessment	PLOS ONE			English	Article							CANDIDA-ALBICANS; BACTERIAL VAGINOSIS; AEROBIC VAGINITIS; NANOPARTICLES; BIOFILMS; ION; MICROSCOPY; ADHESION; THYMOL	This in vitro study assessed the antimicrobial properties of a novel octasilver salt of Sucrose Octasulfate (IASOS) as well as of an innovative vaginal gel containing IASOS (SilSOS Femme), against bacterial and yeast pathogens isolated from human clinical cases of symptomatic vaginal infections. In BHI and LAPT culture media, different ionic silver concentrations and different pHs were tested. IASOS exerted a strong antimicrobial activity towards all the pathogens tested in both culture media. The results demonstrated that salts and organic compounds present in the culture media influenced IASOS efficacy only to a moderate extent. Whereas comparable MBCs (Minimal Bactericidal Concentrations) were observed for G. vaginalis (10 mg/L Ag+), E. coli and E. aerogenes (25 mg/L Ag+) in both media, higher MBCs were found for S. aureus and S. agalactiae in LAPT cultures (50 mg/L Ag+ versus 25 mg/L Ag+). No minimal concentration totally inhibiting the growth of C. albicans was found. Nevertheless, in both media at the highest ionic silver concentrations (50-200 mg/L Ag+), a significant 34-52% drop in Candida growth was observed. pH differently affected the antimicrobial properties of IASOS against bacteria or yeasts; however, a stronger antimicrobial activity at pH higher than the physiological pH was generally observed. It can be therefore concluded that IASOS exerts a bactericidal action against all the tested bacteria and a clear fungistatic action against C. albicans. The antimicrobial activity of the whole vaginal gel SilSOS Femme further confirmed the antimicrobial activity of IASOS. Overall, our findings support IASOS as a valid active ingredient into a vaginal gel.	[Marianelli, Cinzia; Petrucci, Paola] Ist Super Sanita, Dept Food Safety & Vet Publ Hlth, I-00161 Rome, Italy; [Comelli, Maria Cristina; Calderini, Gabriella] CM&D Pharma Srl, Padua, Italy	Istituto Superiore di Sanita (ISS)	Marianelli, C (corresponding author), Ist Super Sanita, Dept Food Safety & Vet Publ Hlth, Viale Regina Elena 299, I-00161 Rome, Italy.	cinzia.marianelli@iss.it	MARIANELLI, CINZIA/C-7036-2015	MARIANELLI, CINZIA/0000-0002-5190-4574	CM&D Pharma Limited, UK; Istituto Superiore di Santia	CM&D Pharma Limited, UK; Istituto Superiore di Santia	The study was funded by CM&D Pharma Limited, UK pursuant to a technical and scientific service agreement with Istituto Superiore di Santia. The authors hold the following patents: US 61/715,226 Compositions comprising a silver salt of sucrose octasulfate and a potassium salt of sucrose octasulfate for protection of mucosal epithelia, authors Comelli Maria Cristina, Calderini Gabriella; US 7,183,315 Silver salts of sucrose octasulfate, authors Calderini Gabriella, Prosdocimi Marco, Antico Claudio, Miglierini Giuliana, Casadei Massari Danilo. InterAlia Pharma Srl, Italy (IP owner), kindly supported publication costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Arakawa H, 2001, BIOPHYS J, V81, P1580, DOI 10.1016/S0006-3495(01)75812-2; Austin MN, 2005, J CLIN MICROBIOL, V43, P4492, DOI 10.1128/JCM.43.9.4492-4497.2005; BERGER TJ, 1976, ANTIMICROB AGENTS CH, V10, P856, DOI 10.1128/AAC.10.5.856; Biggs WS, 2009, PRIMARY CARE, V36, P33, DOI 10.1016/j.pop.2008.10.002; Borges S, 2012, ANTON LEEUW INT J G, V101, P677, DOI 10.1007/s10482-011-9666-y; Braga PC, 2010, ARZNEIMITTELFORSCH, V60, P675, DOI 10.1055/s-0031-1296346; BRAGG PD, 1974, CAN J MICROBIOL, V20, P883, DOI 10.1139/m74-135; Chaw KC, 2005, ANTIMICROB AGENTS CH, V49, P4853, DOI 10.1128/AAC.49.12.4853-4859.2005; Chen MW, 2011, INT J NANOMED, V6, P2873, DOI 10.2147/IJN.S23945; Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x; Chernousova S, 2013, ANGEW CHEM INT EDIT, V52, P1636, DOI 10.1002/anie.201205923; Clement J L, 1994, Met Based Drugs, V1, P467, DOI 10.1155/MBD.1994.467; Donati L, 2010, ARCH GYNECOL OBSTET, V281, P589, DOI 10.1007/s00404-009-1318-3; Donders GGG, 2011, BJOG-INT J OBSTET GY, V118, P1163, DOI 10.1111/j.1471-0528.2011.03020.x; Donders GGG, 2002, BJOG-INT J OBSTET GY, V109, P34, DOI 10.1016/S1470-0328(02)00432-9; Donders GGG, 2007, BEST PRACT RES CL OB, V21, P355, DOI 10.1016/j.bpobgyn.2007.01.002; Elechiguerra Jose Luis, 2005, J Nanobiotechnology, V3, P6; ESCHENBACH DA, 1989, J CLIN MICROBIOL, V27, P251, DOI 10.1128/JCM.27.2.251-256.1989; Harriott MM, 2010, MICROBIOL-SGM, V156, P3635, DOI 10.1099/mic.0.039354-0; Hwang IS, 2012, FEBS J, V279, P1327, DOI 10.1111/j.1742-4658.2012.08527.x; Kim J, 2008, ANTIMICROB AGENTS CH, V52, P1446, DOI 10.1128/AAC.00054-07; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Kumar SA, 2007, BIOTECHNOL LETT, V29, P439, DOI 10.1007/s10529-006-9256-7; LaFleur MD, 2006, ANTIMICROB AGENTS CH, V50, P3839, DOI 10.1128/AAC.00684-06; Lee JH, 2006, J AGR FOOD CHEM, V54, P8717, DOI 10.1021/jf061603i; Lu L, 2008, ANTIVIR THER, V13, P253; Menard JP, 2011, INT J WOMENS HEALTH, V3, P295, DOI 10.2147/IJWH.S23814; Mendling W, 2002, ARZNEIMITTEL-FORSCH, V52, P8; Monteiro DR, 2013, J APPL MICROBIOL, V114, P1175, DOI 10.1111/jam.12102; Monteiro DR, 2011, BIOFOULING, V27, P711, DOI 10.1080/08927014.2011.599101; Mumtaz Shamim, 2008, J Ayub Med Coll Abbottabad, V20, P113; Paiva LCF, 2012, MICRON, V43, P497, DOI 10.1016/j.micron.2011.09.013; Rentz Eric J., 2003, Journal of Nutritional & Environmental Medicine (Abingdon), V13, P109, DOI 10.1080/13590840310001594061; Sintubin L, 2011, APPL MICROBIOL BIOT, V91, P153, DOI 10.1007/s00253-011-3225-3; Sobel J D, 1988, Ann N Y Acad Sci, V544, P547, DOI 10.1111/j.1749-6632.1988.tb40450.x; Sobel Jack D, 2006, Curr Infect Dis Rep, V8, P481, DOI 10.1007/s11908-006-0023-7; Sobel JD, 2007, LANCET, V369, P1961, DOI 10.1016/S0140-6736(07)60917-9; Sobel JD., 2005, MEDICINE, V33, P62; Sosto F, 2011, ARZNEIMITTELFORSCH, V61, P126, DOI 10.1055/s-0031-1296178; SPIEGEL CA, 1991, CLIN MICROBIOL REV, V4, P485, DOI 10.1128/CMR.4.4.485-502.1991; Srinivasan Sujatha, 2008, Interdiscip Perspect Infect Dis, V2008, P750479, DOI 10.1155/2008/750479; Strandberg KL, 2010, ANTIMICROB AGENTS CH, V54, P597, DOI 10.1128/AAC.01151-09; Swidsinski A, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.039; Tempera G, 2004, INT J ANTIMICROB AG, V24, P85, DOI 10.1016/j.ijantimicag.2003.12.013; Tempera G, 2010, GYNECOL OBSTET INVES, V70, P244, DOI 10.1159/000314013; Togni G, 2011, ANTIMICROB AGENTS CH, V55, P2490, DOI 10.1128/AAC.01623-10; Verstraelen H, 2013, CURR OPIN INFECT DIS, V26, P86, DOI 10.1097/QCO.0b013e32835c20cd; Weindl G, 2004, SKIN PHARMACOL PHYS, V17, P207, DOI 10.1159/000080213; Yamanaka M, 2005, APPL ENVIRON MICROB, V71, P7589, DOI 10.1128/AEM.71.11.7589-7593.2005; Yeh BK, 2002, MOL CELL BIOL, V22, P7184, DOI 10.1128/MCB.22.20.7184-7192.2002; Zhang ST, 2001, APPL ENVIRON MICROB, V67, P4030, DOI 10.1128/AEM.67.9.4030-4035.2001	52	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e97791	10.1371/journal.pone.0097791	http://dx.doi.org/10.1371/journal.pone.0097791			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897299	gold, Green Submitted, Green Published			2022-12-27	WOS:000338430700013
J	Wyshak, G				Wyshak, Grace			Height, Socioeconomic and Subjective Well-Being Factors among US Women, Ages 49-79	PLOS ONE			English	Article							SOCIAL-CLASS; BODY-HEIGHT; SUCCESS; HEALTH; ENVIRONMENT; DISEASE; RISK; LIFE; MEN	Background: A vast literature has associated height with numerous factors, including biological, psychological, socioeconomic, anthropologic, genetic, environmental, and ecologic, among others. The aim of this study is to examine, among U.S. women, height factors focusing on health, income, education, occupation, social activities, religiosity and subjective well-being. Methods/Findings: Data are from the Women's Health Initiative (WHI) Observational Study. Participants are 93,676 relatively healthy women ages 49-79; 83% of whom are White, 17% Non-White. Statistical analyses included descriptive statistics, chi-square and multivariable covariance analyses. The mean height of the total sample is 63.67 inches. White women are significantly taller than Non-White women, mean heights 63.68 vs. 63.63 inches (p = 0.0333). Among both Non-White and White women height is associated with social behavior, i.e. attendance at clubs/lodges/groups. Women who reported attendance 'once a week or more often' were taller than those who reported 'none' and 'once to 3 times a month'. Means in inches are respectively for: White women-63.73 vs. 63.67 and 63.73 vs. 63.67, p = 0.0027. p = 0.0298; Non-White women: 63.77 vs. 63.61 and 63.77 vs. 63.60, p = 0.0050, P = 0.0094. In both White and Non-White women, income, education and subjective well-being were not associated with height. However, other factors differed by race/ethnicity. Taller White women hold or have held managerial/professional jobs-yes vs. no-63.70 vs. 63.66 inches; P = 0.036; and given 'a little' strength and comfort from religion' compared to 'none' and 'a great deal', 63.73 vs. 63.66 P = 0.0418 and 63.73 vs. 63.67, P = 0.0130. Taller Non-White women had better health-excellent or very good vs. good, fair or poor-63.70 vs. 63.59, P = 0.0116. Conclusions: Further research in diverse populations is suggested by the new findings: being taller is associated with social activities -frequent attendance clubs/lodges/groups'', and with 'a little' vs. 'none' or 'great deal' of strength and comfort from religion.	[Wyshak, Grace] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Wyshak, Grace] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Wyshak, Grace] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Wyshak, G (corresponding author), Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA.	Wyshak@hsph.harvard.edu						Barro RJ, 2003, AM SOCIOL REV, P1; Batty GD, 2009, ECON HUM BIOL, V7, P137, DOI 10.1016/j.ehb.2009.06.004; Beard AS, 2002, PERSPECT BIOL MED, V45, P475, DOI 10.1353/pbm.2002.0064; Beeri MS, 2005, AM J GERIAT PSYCHIAT, V13, P116, DOI 10.1097/00019442-200502000-00005; Case A, 2008, J POLIT ECON, V116, P499, DOI 10.1086/589524; Case A, 2009, ECON LETT, V102, P174, DOI 10.1016/j.econlet.2008.12.011; Cavelaars AEJM, 2000, ANN HUM BIOL, V27, P407, DOI 10.1080/03014460050044883; Deaton A, 2009, ECON HUM BIOL, V7, P133, DOI 10.1016/j.ehb.2009.06.001; Fogel R W, 1982, Soc Sci Hist, V6, P401; HENSLEY WE, 1992, PSYCHOL REP, V70, P457, DOI 10.2466/PR0.70.2.457-458; HENSLEY WE, 1993, PSYCHOLOGY, V30, P40; HENSLEY WE, 1987, PSYCHOL REP, V60, P843, DOI 10.2466/pr0.1987.60.3.843; Huang TL, 2008, NEUROLOGY, V70, P1818, DOI 10.1212/01.wnl.0000311444.20490.98; Judge TA, 2004, J APPL PSYCHOL, V89, P428, DOI 10.1037/0021-9010.89.3.428; Koenig Harold G, 2012, ISRN Psychiatry, V2012, P278730, DOI 10.5402/2012/278730; Kortt M, 2010, ECON REC, V86, P71, DOI 10.1111/j.1475-4932.2009.00566.x; KUH DL, 1991, INT J EPIDEMIOL, V20, P1001, DOI 10.1093/ije/20.4.1001; Langenberg C, 2005, AM J PUBLIC HEALTH, V95, P628, DOI 10.2105/2004.046219; Mark QJ, 2012, J BIOSOC SCI, P1; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Novak M, 2012, PUBLIC HEALTH, V126, P349, DOI 10.1016/j.puhe.2012.01.012; Ozaltin E, 2012, INT J EPIDEMIOL, V41, P1434, DOI 10.1093/ije/dys144; Persico N, 2004, J POLIT ECON, V112, P1019, DOI 10.1086/422566; Pollet TV, 2008, AM J HUM BIOL, V20, P264, DOI 10.1002/ajhb.20708; Silventoinen K, 1999, INT J EPIDEMIOL, V28, P911, DOI 10.1093/ije/28.5.911; Smith GD, 2000, J EPIDEMIOL COMMUN H, V54, P97, DOI 10.1136/jech.54.2.97; Smits J, 2012, AM J HUM BIOL, V24, P473, DOI 10.1002/ajhb.22248; Steckel RH, 2008, J ECON PERSPECT, V22, P129, DOI 10.1257/jep.22.1.129; Steckel RH, 2009, EXPLOR ECON HIST, V46, P1, DOI 10.1016/j.eeh.2008.12.001; Subramanian SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018962; Tucker-Seeley RD, 2011, ECON HUM BIOL, V9, P194, DOI 10.1016/j.ehb.2010.11.002; WALKER M, 1988, J EPIDEMIOL COMMUN H, V42, P299, DOI 10.1136/jech.42.3.299	32	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e96061	10.1371/journal.pone.0096061	http://dx.doi.org/10.1371/journal.pone.0096061			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK4YO	24896649	Green Published, gold, Green Submitted			2022-12-27	WOS:000338430700003
J	Du, N; Peng, H; Chao, XQ; Zhang, Q; Tian, HG; Li, HM				Du, Nan; Peng, Hao; Chao, Xiangqin; Zhang, Qiu; Tian, Honggang; Li, Hongmei			Interaction of Obesity and Central Obesity on Elevated Urinary Albumin-to-Creatinine Ratio	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; BODY-MASS INDEX; WAIST CIRCUMFERENCE; CARDIOVASCULAR RISK; ADIPOSE-TISSUE; WEIGHT-LOSS; MORTALITY; MICROALBUMINURIA; DISEASE	Background: Microalbuminuria was much more common among obese individuals indicating a probable association with obesity. However, association of microalbuminuria with interaction between obesity and central obesity has not yet been studied. Design and Methods: A cross-sectional study was conducted in a 2889 general population aged >= 30 years. Obesity was defined as body mass index >= 28.0 kg/m(2) and central obesity was defined as waist-to-hip ratio >= 0.85 for females and >= 0.90 for males. Both additive and multipliable interactions between obesity and central obesity on elevated urinary albumin-to-creatinine ratio (UACR) were evaluated. Results: After controlling for potential covariates, participants with both obesity and central obesity have significantly increased risk for elevated UACR (OR = 1.82 P<0.001) compared to those with neither. Additive interaction analysis indicated that about 43.9% of the risk of elevated UACR in participants with both obesity and central obesity was attributed to the interaction between obesity and central obesity (the attributable proportion because of the interaction: 0.439; 95% CI: 0.110-0.768). The multipliable interactive effect between obesity and central obesity on elevated UACR was not found significant (OR = 1.82, P = 0.078). Conclusions: Microalbuminuria was significantly associated with the interaction between obesity and central obesity. Our results indicated that individuals with both obesity and central obesity should be intensively managed to prevent renal diseases.	[Du, Nan; Peng, Hao; Zhang, Qiu; Li, Hongmei] Soochow Univ, Coll Med, Sch Publ Hlth, Dept Epidemiol, Suzhou, Peoples R China; [Chao, Xiangqin; Zhang, Qiu; Tian, Honggang] Ctr Dis Prevent & Control GuSu Dist, Suzhou, Peoples R China	Soochow University - China	Li, HM (corresponding author), Soochow Univ, Coll Med, Sch Publ Hlth, Dept Epidemiol, Suzhou, Peoples R China.	lihongmei@suda.edu.cn	Peng, Hao/I-1134-2014; Peng, Hao/AAB-4759-2022	Peng, Hao/0000-0001-6277-662X; 	National Natural Science Foundation of China [81102189]; Suzhou Science and Technology Project [SS0910]; Priority Academic Program Development of Jiangsu Higher Education Institutions of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Suzhou Science and Technology Project; Priority Academic Program Development of Jiangsu Higher Education Institutions of China	The study is supported by Youth Found of the National Natural Science Foundation of China (Grant No. 81102189) and the Suzhou Science and Technology Project (grant NO. SS0910) and partially supported by a Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha A, 2009, SAUDI J KIDNEY DIS T, V20, P429; Baik I, 2000, AM J EPIDEMIOL, V152, P264, DOI 10.1093/aje/152.3.264; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Chen BD, 2010, CLIN CHIM ACTA, V411, P705, DOI 10.1016/j.cca.2010.01.038; Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; Eckel RH, 2004, CIRCULATION, V110, P2968, DOI 10.1161/01.CIR.0000140086.88453.9A; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fischer-Posovszky P, 2007, HORM METAB RES, V39, P314, DOI 10.1055/s-2007-976539; Futrakul N, 2009, RENAL FAILURE, V31, P140, DOI 10.1080/08860220802595948; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; GRAY DS, 1991, J CLIN EPIDEMIOL, V44, P545, DOI 10.1016/0895-4356(91)90218-X; Hallqvist T, 1996, J INTERN MED, V239, P377, DOI 10.1046/j.1365-2796.1996.431782000.x; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Kalmijn S, 1999, INT J OBESITY, V23, P395, DOI 10.1038/sj.ijo.0800832; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Lambers Heerspink HJ, 2008, AM J EPIDEMIOL, V168, P897, DOI 10.1093/aje/kwn209; Morales E, 2003, AM J KIDNEY DIS, V41, P319, DOI 10.1053/ajkd.2003.50039; Naidoo D P, 2002, Cardiovasc J S Afr, V13, P194; Nishida C, 2010, EUR J CLIN NUTR, V64, P2, DOI 10.1038/ejcn.2009.139; Palmer AJ, 2006, DEUT MED WOCHENSCHR, V131, P1721, DOI 10.1055/s-2006-947822; Pedrinelli R, 2002, J HUM HYPERTENS, V16, P79, DOI 10.1038/sj.jhh.1001316; Peng H, 2012, METAB SYNDR RELAT D, V10, P202, DOI 10.1089/met.2011.0119; Rutkowski P, 2006, J RENAL NUTR, V16, P216, DOI 10.1053/j.jrn.2006.04.017; Saiki A, 2005, INT J OBESITY, V29, P1115, DOI 10.1038/sj.ijo.0803009; Shaw PKC, 2007, DIABETES CARE, V30, P1840, DOI 10.2337/dc07-0028; Solbu MD, 2009, ATHEROSCLEROSIS, V204, P503, DOI 10.1016/j.atherosclerosis.2008.11.002; SWEETING HN, 2007, NUTR J, V6, DOI DOI 10.1186/1475-2891-6-32; Thoenes M, 2009, VASC HEALTH RISK MAN, V5, P577; Visscher TLS, 2001, INT J OBESITY, V25, P1730, DOI 10.1038/sj.ijo.0801787; ZANCHETTI A, 1993, HYPERTENSION, V22, P392	31	15	16	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98926	10.1371/journal.pone.0098926	http://dx.doi.org/10.1371/journal.pone.0098926			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892930	Green Submitted, Green Published, gold			2022-12-27	WOS:000336911400111
J	McQueen, CM; Doan, R; Dindot, SV; Bourquin, JR; Zlatev, ZZ; Chaffin, MK; Blodgett, GP; Ivanov, I; Cohen, ND				McQueen, Cole M.; Doan, Ryan; Dindot, Scott V.; Bourquin, Jessica R.; Zlatev, Zlatomir Z.; Chaffin, M. Keith; Blodgett, Glenn P.; Ivanov, Ivan; Cohen, Noah D.			Identification of Genomic Loci Associated with Rhodococcus equi Susceptibility in Foals	PLOS ONE			English	Article							COPY NUMBER VARIATION; SINGLE NUCLEOTIDE POLYMORPHISMS; WIDE ASSOCIATION; CYTOKINE EXPRESSION; VARIANT ANALYSIS; BREEDING FARMS; IN-VITRO; PNEUMONIA; NEUTROPHILS; INFECTION	Pneumonia caused by Rhodococcus equi is a common cause of disease and death in foals. Although agent and environmental factors contribute to the incidence of this disease, the genetic factors influencing the clinical outcomes of R. equi pneumonia are ill-defined. Here, we performed independent single nucleotide polymorphism (SNP)-and copy number variant (CNV)-based genome-wide association studies to identify genomic loci associated with R. equi pneumonia in foals. Foals at a large Quarter Horse breeding farm were categorized into 3 groups: 1) foals with R. equi pneumonia (clinical group [N = 43]); 2) foals with ultrasonographic evidence of pulmonary lesions that never developed clinical signs of pneumonia (subclinical group [N = 156]); and, 3) foals without clinical signs or ultrasonographic evidence of pneumonia (unaffected group [N = 49]). From each group, 24 foals were randomly selected and used for independent SNP-and CNV-based genome-wide association studies (GWAS). The SNP-based GWAS identified a region on chromosome 26 that had moderate evidence of association with R. equi pneumonia when comparing clinical and subclinical foals. A joint analysis including all study foals revealed a 3- to 4-fold increase in odds of disease for a homozygous SNP within the associated region when comparing the clinical group with either of the other 2 groups of foals or their combination. The region contains the transient receptor potential cation channel, subfamily M, member 2 (TRPM2) gene, which is involved in neutrophil function. No associations were identified in the CNV-based GWAS. Collectively, these data identify a region on chromosome 26 associated with R. equi pneumonia in foals, providing evidence that genetic factors may indeed contribute to this important disease of foals.	[McQueen, Cole M.; Bourquin, Jessica R.; Chaffin, M. Keith; Cohen, Noah D.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Large Anim Clin Sci, College Stn, TX 77843 USA; [Doan, Ryan; Dindot, Scott V.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX USA; [Dindot, Scott V.] Texas A&M Univ, Coll Med, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Zlatev, Zlatomir Z.] Texas A&M Univ, Dept Elect & Comp Engn, Dwight Look Coll Engn, College Stn, TX USA; [Blodgett, Glenn P.] 6666 Ranch, Guthrie, TX USA; [Ivanov, Ivan] Texas A&M Univ, Dept Vet Physiol & Pharmacol, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Cohen, ND (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Large Anim Clin Sci, College Stn, TX 77843 USA.	ncohen@cvm.tamu.edu		Mcqueen, Cole/0000-0002-9557-3068	Morris Animal Foundation; Link Equine Research Endowment; American Quarter Horse Foundation; USDA-NIFA [2011-68004-30367]	Morris Animal Foundation; Link Equine Research Endowment; American Quarter Horse Foundation; USDA-NIFA(United States Department of Agriculture (USDA))	Supported by a grant from the Morris Animal Foundation. Additional funding was provided by the Link Equine Research Endowment. Blood sample collection was made possible by a grant from the American Quarter Horse Foundation. Cole McQueen (CMM) was supported by a grant from the USDA-NIFA #2011-68004-30367. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2007, PATHOLOGIC BASIS VET, P120; Ainsworth DM, 1998, J AM VET MED ASSOC, V213, P510; ARDANS AA, 1986, P AM ASS EQUINE PRAC, V32, P129; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bordin AI, 2012, VET IMMUNOL IMMUNOP, V145, P290, DOI 10.1016/j.vetimm.2011.11.012; Brosnahan MM, 2010, EQUINE VET J, V42, P658, DOI 10.1111/j.2042-3306.2010.00166.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carter NP, 2007, NAT GENET, V39, pS16, DOI 10.1038/ng2028; Chaffin MK, 2004, VET IMMUNOL IMMUNOP, V100, P33, DOI 10.1016/j.vetimm.2004.02.010; Chaffin MK, 2003, J AM VET MED ASSOC, V222, P467, DOI 10.2460/javma.2003.222.467; Cohen ND, 2012, AM J VET RES, V73, P1603, DOI 10.2460/ajvr.73.10.1603; Corbin LJ, 2012, MAMM GENOME, V23, P294, DOI 10.1007/s00335-011-9363-1; Dawson TRMY, 2010, VET IMMUNOL IMMUNOP, V135, P1, DOI 10.1016/j.vetimm.2009.12.004; Doan R, 2012, GENOME RES, V22, P899, DOI 10.1101/gr.128991.111; Doan R, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-78; Dupuis MC, 2013, ANIM GENET, V44, P206, DOI 10.1111/j.1365-2052.2012.02373.x; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Giguere S, 2011, J VET INTERN MED, V25, P1221, DOI 10.1111/j.1939-1676.2011.00804.x; Giguere S, 2011, J VET INTERN MED, V25, P1209, DOI 10.1111/j.1939-1676.2011.00835.x; Gokcumen O, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r52; Graves KT, 2009, ANIM GENET, V40, P35, DOI 10.1111/j.1365-2052.2008.01795.x; Halbert ND, 2006, J VET INTERN MED, V20, P974, DOI 10.1892/0891-6640(2006)20[974:VIESNG]2.0.CO;2; Heller MC, 2010, VET IMMUNOL IMMUNOP, V136, P144, DOI 10.1016/j.vetimm.2010.02.016; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Horin P, 2010, INT J IMMUNOGENET, V37, P67, DOI 10.1111/j.1744-313X.2009.00890.x; Hou Y, 2012, FUNCT INTEGR GENOMIC, P1; Hou YL, 2012, FUNCT INTEGR GENOMIC, V12, P81, DOI 10.1007/s10142-011-0252-1; Kato M, 2010, HUM MOL GENET, V19, P761, DOI 10.1093/hmg/ddp541; Lee T, 2013, BMB REP, V46, P346, DOI 10.5483/BMBRep.2013.46.7.211; Liu GE, 2011, MAMM GENOME, V22, P111, DOI 10.1007/s00335-010-9308-0; Liu GE, 2010, GENOME RES, V20, P693, DOI 10.1101/gr.105403.110; Liu M, 2009, CYTOKINE, V48, P280, DOI 10.1016/j.cyto.2009.08.012; Luo J, 2013, G3-GENES GENOM GENET, V3, P217, DOI 10.1534/g3.112.005132; Lykkjen S, 2013, ANIM GENET, V44, P766, DOI 10.1111/age.12064; Lykkjen S, 2010, ANIM GENET, V41, P111, DOI 10.1111/j.1365-2052.2010.02117.x; Lyons MJ, 2004, TUBERCULOSIS, V84, P283, DOI 10.1016/j.tube.2003.09.003; MARTENS RJ, 1989, EQUINE VET J, V21, P249, DOI 10.1111/j.2042-3306.1989.tb02161.x; Martens RJ, 2005, INFECT IMMUN, V73, P7040, DOI 10.1128/IAI.73.10.7040-7042.2005; Metzger J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-487; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Mousel MR, 2003, J VET DIAGN INVEST, V15, P470, DOI 10.1177/104063870301500512; Nerren JR, 2009, VET IMMUNOL IMMUNOP, V127, P212, DOI 10.1016/j.vetimm.2008.10.004; Nicholas TJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-414; Nicholas TJ, 2009, GENOME RES, V19, P491, DOI 10.1101/gr.084715.108; Petersen JL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003211; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raudsepp T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003139; Signer-Hasler H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037282; Slovis N.M., 2005, P AM ASS EQUINE PRAC, V51; Tateda K, 2001, INFECT IMMUN, V69, P2017, DOI 10.1128/IAI.69.4.2017-2024.2001; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vazquez AI, 2010, J ANIM SCI, V88, P497, DOI 10.2527/jas.2009-1952; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88; Zhang W, 2003, J BIOL CHEM, V278, P16222, DOI 10.1074/jbc.M300298200	56	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98710	10.1371/journal.pone.0098710	http://dx.doi.org/10.1371/journal.pone.0098710			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892408	Green Published, Green Submitted, gold			2022-12-27	WOS:000336911400086
J	Wang, SY; Shiboski, S; Belair, CD; Cooperberg, MR; Simko, JP; Stoppler, H; Cowan, J; Carroll, PR; Blelloch, R				Wang, Siao-Yi; Shiboski, Stephen; Belair, Cassandra D.; Cooperberg, Matthew R.; Simko, Jeffrey P.; Stoppler, Hubert; Cowan, Janet; Carroll, Peter R.; Blelloch, Robert			miR-19, miR-345, miR-519c-5p Serum Levels Predict Adverse Pathology in Prostate Cancer Patients Eligible for Active Surveillance	PLOS ONE			English	Article							CIRCULATING MICRORNAS; RISK-ASSESSMENT; EXPRESSION; RECURRENCE; DIAGNOSIS; BIOPSY; TARGET; GENE; MEN	Serum microRNAs hold great promise as easily accessible and measurable biomarkers of disease. In prostate cancer, serum miRNA signatures have been associated with the presence of disease as well as correlated with previously validated risk models. However, it is unclear whether miRNAs can provide independent prognostic information beyond current risk models. Here, we focus on a group of low-risk prostate cancer patients who were eligible for active surveillance, but chose surgery. A major criteria for the low risk category is a Gleason score of 6 or lower based on pre-surgical biopsy. However, a third of these patients are upgraded to Gleason 7 on post surgical pathological analysis. Both in a discovery and a validation cohort, we find that pre-surgical serum levels of miR-19, miR-345 and miR-519c-5p can help identify these patients independent of their pre-surgical age, PSA, stage, and percent biopsy involvement. A combination of the three miRNAs increased the area under a receiver operator characteristics curve from 0.77 to 0.94 (p<0.01). Also, when combined with the CAPRA risk model the miRNA signature significantly enhanced prediction of patients with Gleason 7 disease. In-situ hybridizations of matching tumors showed miR-19 upregulation in transformed versus normal-appearing tumor epithelial, but independent of tumor grade suggesting an alternative source for the increase in serum miR-19a/b levels or the release of pre-existing intracellular miR-19a/b upon progression. Together, these data show that serum miRNAs can predict relatively small steps in tumor progression improving the capacity to predict disease risk and, therefore, potentially drive clinical decisions in prostate cancer patients. It will be important to validate these findings in a larger multi-institutional study as well as with independent methodologies.	[Wang, Siao-Yi; Shiboski, Stephen; Belair, Cassandra D.; Cooperberg, Matthew R.; Simko, Jeffrey P.; Stoppler, Hubert; Cowan, Janet; Carroll, Peter R.; Blelloch, Robert] Univ Calif San Francisco, Dept Urol, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Blelloch, R (corresponding author), Univ Calif San Francisco, Dept Urol, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.	blellochr@stemcell.ucsf.edu	Cooperberg, Matthew R/G-6249-2017	Cooperberg, Matthew R/0000-0003-4339-6685; Wang, Siao-Yi/0000-0001-6741-2024	National Institutes of Health [R21 CA161615]; NATIONAL CANCER INSTITUTE [R21CA161615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by the National Institutes of Health R21 CA161615 and a private donation by John and Donna Shoemaker. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaoglu FY, 2011, TUMOR BIOL, V32, P583, DOI 10.1007/s13277-011-0154-9; Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brase JC, 2011, INT J CANCER, V128, P608, DOI 10.1002/ijc.25376; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Conti SL, 2009, J UROLOGY, V181, P1628, DOI 10.1016/j.juro.2008.11.107; Cooperberg MR, 2007, J UROLOGY, V178, pS14, DOI 10.1016/j.juro.2007.03.135; Cooperberg MR, 2011, J CLIN ONCOL, V29, P3669, DOI 10.1200/JCO.2011.34.9738; Cooperberg MR, 2011, J CLIN ONCOL, V29, P228, DOI 10.1200/JCO.2010.31.4252; Cooperberg MR, 2005, J UROLOGY, V173, P1938, DOI 10.1097/01.ju.0000158155.33890.e7; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Dahia PLM, 2000, ENDOCR-RELAT CANCER, V7, P115, DOI 10.1677/erc.0.0070115; Dall'Era MA, 2011, BJU INT, V107, P1232, DOI 10.1111/j.1464-410X.2010.09589.x; Esserman L, 2009, JAMA-J AM MED ASSOC, V302, P1685, DOI 10.1001/jama.2009.1498; Gray IC, 1998, BRIT J CANCER, V78, P1296, DOI 10.1038/bjc.1998.674; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Klotz Laurence, 2010, Curr Urol Rep, V11, P165, DOI 10.1007/s11934-010-0110-z; Lodes MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006229; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Moltzahn F, 2011, CANCER RES, V71, P550, DOI 10.1158/0008-5472.CAN-10-1229; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Pepe MS, 2008, J NATL CANCER I, V100, P1432, DOI 10.1093/jnci/djn326; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Porten SP, 2011, J CLIN ONCOL, V29, P2795, DOI 10.1200/JCO.2010.33.0134; Scattoni V, 2007, EUR UROL, V52, P1309, DOI 10.1016/j.eururo.2007.08.006; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Selth LA, 2013, BRIT J CANCER, V109, P641, DOI 10.1038/bjc.2013.369; Shariat SF, 2008, CANCER-AM CANCER SOC, V113, P3075, DOI 10.1002/cncr.23908; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Suardi N, 2008, CANCER-AM CANCER SOC, V113, P2068, DOI 10.1002/cncr.23827; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Tong AW, 2009, CANCER GENE THER, V16, P206, DOI 10.1038/cgt.2008.77; Whang YE, 1998, P NATL ACAD SCI USA, V95, P5246, DOI 10.1073/pnas.95.9.5246; Wilt TJ, 2008, ANN INTERN MED, V148, P435, DOI 10.7326/0003-4819-148-6-200803180-00209; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	43	40	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98597	10.1371/journal.pone.0098597	http://dx.doi.org/10.1371/journal.pone.0098597			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893170	Green Published, gold			2022-12-27	WOS:000336911400073
J	Young, ME; Webb, TL; Rung, JM; McCoy, AW				Young, Michael E.; Webb, Tara L.; Rung, Jillian M.; McCoy, Anthony W.			Outcome Probability versus Magnitude: When Waiting Benefits One at the Cost of the Other	PLOS ONE			English	Article							RISK-TASK BART; ESCALATING INTEREST TASK; INNER-CITY ADOLESCENTS; BEHAVIORAL MEASURES; CONSTRUCT-VALIDITY; IMPULSIVITY; CHOICE; DELAY; UNCERTAINTY; REWARDS	Using a continuous impulsivity and risk platform (CIRP) that was constructed using a video game engine, choice was assessed under conditions in which waiting produced a continuously increasing probability of an outcome with a continuously decreasing magnitude (Experiment 1) or a continuously increasing magnitude of an outcome with a continuously decreasing probability (Experiment 2). Performance in both experiments reflected a greater desire for a higher probability even though the corresponding wait times produced substantive decreases in overall performance. These tendencies are considered to principally reflect hyperbolic discounting of probability, power discounting of magnitude, and the mathematical consequences of different response rates. Behavior in the CIRP is compared and contrasted with that in the Balloon Analogue Risk Task (BART).	[Young, Michael E.; McCoy, Anthony W.] Kansas State Univ, Manhattan, KS 66506 USA; [Webb, Tara L.] So Illinois Univ, Carbondale, IL 62901 USA; [Rung, Jillian M.] Utah State Univ, Logan, UT 84322 USA	Kansas State University; Southern Illinois University System; Southern Illinois University; Utah System of Higher Education; Utah State University	Young, ME (corresponding author), Kansas State Univ, Manhattan, KS 66506 USA.	michaelyoung@ksu.edu		Young, Michael/0000-0003-1493-9548	National Institute for Drug Abuse (NIDA) [1R15-D026290]	National Institute for Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	The study was funded by the National Institute for Drug Abuse (NIDA 1R15-D026290, www.drugabuse.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aklin WM, 2005, BEHAV RES THER, V43, P215, DOI 10.1016/j.brat.2003.12.007; CHAPMAN GB, 1995, MED DECIS MAKING, V15, P373, DOI 10.1177/0272989X9501500408; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Dougherty DM, 2005, BEHAV RES METHODS, V37, P82, DOI 10.3758/BF03206401; Green L, 2004, PSYCHOL BULL, V130, P769, DOI 10.1037/0033-2909.130.5.769; Hopko DR, 2006, J PSYCHOPATHOL BEHAV, V28, P95, DOI 10.1007/s10862-006-7487-5; Hunt MK, 2005, ASSESSMENT, V12, P416, DOI 10.1177/1073191105278740; Kahneman D., 1979, ECONOMETRICA, V47, P313, DOI DOI 10.2307/1914185; Lakshminarayanan VR, 2011, J EXP SOC PSYCHOL, V47, P689, DOI 10.1016/j.jesp.2010.12.011; Lejuez CW, 2007, J CLIN CHILD ADOLESC, V36, P106, DOI 10.1207/s15374424jccp3601_11; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; LOEWENSTEIN GF, 1988, MANAGE SCI, V34, P200, DOI 10.1287/mnsc.34.2.200; Lynam D. R., 2006, UNPUB; Miller J, 2003, PERS INDIV DIFFER, V34, P1403, DOI 10.1016/S0191-8869(02)00122-8; Okasha S, 2007, J PHILOS, V104, P217, DOI 10.5840/jphil2007104523; Paglieri F, 2013, J EXPT ANAL BEHAV; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pinheiro JC, 2004, MIXED EFFECTS MODELS; Pleskac TJ, 2008, EXP CLIN PSYCHOPHARM, V16, P555, DOI 10.1037/a0014245; RACHLIN H, 1991, J EXP ANAL BEHAV, V55, P233, DOI 10.1901/jeab.1991.55-233; Reynolds B, 2006, PHARMACOL BIOCHEM BE, V83, P194, DOI 10.1016/j.pbb.2006.01.007; Shead NW, 2009, J EXP ANAL BEHAV, V92, P1, DOI 10.1901/jeab.2009.92-1; STEVENS SS, 1957, PSYCHOL REV, V64, P153, DOI 10.1037/h0046162; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; Wallsten TS, 2005, PSYCHOL REV, V112, P862, DOI 10.1037/0033-295X.112.4.862; Weber BJ, 2005, ORGAN BEHAV HUM DEC, V96, P104, DOI 10.1016/j.obhdp.2005.01.001; Young ME, 2013, J EXP ANAL BEHAV, V99, P335, DOI 10.1002/jeab.24; Young ME, 2013, PSYCHON B REV, V20, P302, DOI 10.3758/s13423-012-0350-7; Young ME, 2012, BEHAV RES METHODS, V44, P176, DOI 10.3758/s13428-011-0133-5; Young ME, 2011, BEHAV PROCESS, V88, P101, DOI 10.1016/j.beproc.2011.08.003	30	7	7	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98996	10.1371/journal.pone.0098996	http://dx.doi.org/10.1371/journal.pone.0098996			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5ML	24892657	gold, Green Published, Green Submitted			2022-12-27	WOS:000336911400118
J	Zhang, W; Han, ZX; Guo, QL; Liu, Y; Zheng, YX; Wu, FL; Jin, WB				Zhang, Wei; Han, Zhaoxue; Guo, Qingli; Liu, Yu; Zheng, Yuxian; Wu, Fangli; Jin, Weibo			Identification of Maize Long Non-Coding RNAs Responsive to Drought Stress	PLOS ONE			English	Article							MESSENGER-RNA; PLANT DEVELOPMENT; GENOME-WIDE; MICRORNAS; ARABIDOPSIS; PROTEIN; ROLES; SEQ; TRANSCRIPTOMES; ENVIRONMENTS	Long non-coding RNAs (lncRNAs) represent a class of riboregulators that either directly act in long form or are processed to shorter miRNAs and siRNAs. Emerging evidence shows that lncRNAs participate in stress responsive regulation. In this study, to identify the putative maize lncRNAs responsive to drought stress, 8449 drought responsive transcripts were first uploaded to the Coding Potential Calculator website for classification as protein coding or non-coding RNAs, and 1724 RNAs were identified as potential non-coding RNAs. A Perl script was written to screen these 1724 ncRNAs and 664 transcripts were ultimately identified as drought-responsive lncRNAs. Of these 664 transcripts, 126 drought-responsive lncRNAs were highly similar to known maize lncRNAs; the remaining 538 transcripts were considered as novel lncRNAs. Among the 664 lncRNAs identified as drought responsive, 567 were upregulated and 97 were downregulated in drought-stressed leaves of maize. 8 lncRNAs were identified as miRNA precursor lncRNAs, 62 were classified as both shRNA and siRNA precursors, and 279 were classified as siRNA precursors. The remaining 315 lncRNAs were classified as other lncRNAs that are likely to function as longer molecules. Among these 315 lncRNAs, 10 are identified as antisense lncRNAs and 7 could pair with 17 CDS sequences with near-perfect matches. Finally, RT-qPCR results confirmed that all selected lncRNAs could respond to drought stress. These findings extend the current view on lncRNAs as ubiquitous regulators under stress conditions.	[Zhang, Wei; Han, Zhaoxue; Guo, Qingli; Liu, Yu; Zheng, Yuxian; Jin, Weibo] Northwest A&F Univ, Coll Life Sci, Yangling, Peoples R China; [Wu, Fangli; Jin, Weibo] Zhejiang Sci Tech Univ, Coll Life Sci, Inst Bioengn, Hangzhou, Zhejiang, Peoples R China	Northwest A&F University - China; Zhejiang Sci-Tech University	Jin, WB (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling, Peoples R China.	weibojin@gmail.com		Guo, Qingli/0000-0001-8467-8828; Han, Zhaoxue/0000-0002-6935-9535	Natural Science Foundation of China [31000913, 31372075, 31201268]; Fundamental Research Funds for the Central Universities [QN2011095]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Natural Science Foundation of China (grant No. 31000913, 31372075 and 31201268), and the website is http://isisn.nsfc.gov.cn/egrantweb/. This work was also supported by the Fundamental Research Funds for the Central Universities (grant No. QN2011095), the website is http://www.dost.moe.edu.cn/dostmoe/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 2001, ANN STAT, V29, P1165; Boerner S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043047; Campalans A, 2004, PLANT CELL, V16, P1047, DOI 10.1105/tpc.019406; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; de Lima JC, 2012, GENET MOL BIOL, V35, P1069, DOI 10.1590/S1415-47572012000600023; Deikman J, 2012, CURR OPIN BIOTECH, V23, P243, DOI 10.1016/j.copbio.2011.11.003; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fu FengLing, 2008, Agricultural Sciences in China, V7, P280, DOI 10.1016/S1671-2927(08)60067-X; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; He HS, 2006, NUCLEIC ACIDS RES, V34, P2976, DOI 10.1093/nar/gkl371; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Hirsch J, 2006, PLANT PHYSIOL, V140, P1192, DOI 10.1104/pp.105.073817; Jiang TB, 2012, PLANT MOL BIOL REP, V30, P360, DOI 10.1007/s11105-011-0347-9; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Kim ED, 2012, TRENDS PLANT SCI, V17, P16, DOI 10.1016/j.tplants.2011.10.008; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laporte P, 2007, BIOCHEM SOC T, V35, P1638, DOI 10.1042/BST0351638; Li JS, 2013, J INTEGR AGR, V12, P1414, DOI 10.1016/S2095-3119(13)60311-1; Liu J, 2012, PLANT CELL, V24, P4333, DOI 10.1105/tpc.112.102855; Lu YL, 2011, FIELD CROP RES, V124, P37, DOI 10.1016/j.fcr.2011.06.003; Matsui A, 2008, PLANT CELL PHYSIOL, V49, P1135, DOI 10.1093/pcp/pcn101; Mazzucotelli E, 2008, PLANT SCI, V174, P420, DOI 10.1016/j.plantsci.2008.02.005; MICHEL BE, 1973, PLANT PHYSIOL, V51, P914, DOI 10.1104/pp.51.5.914; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prasanth KV, 2007, GENE DEV, V21, P11, DOI 10.1101/gad.1484207; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rymarquis LA, 2008, TRENDS PLANT SCI, V13, P329, DOI 10.1016/j.tplants.2008.02.009; Sasidharan R, 2008, NATURE, V453, P729, DOI 10.1038/453729a; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Soares LMM, 2006, EMBO J, V25, P923, DOI 10.1038/sj.emboj.7601023; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Tambo JA, 2012, MITIG ADAPT STRAT GL, V17, P277, DOI 10.1007/s11027-011-9325-7; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang XF, 2009, PLANT CELL, V21, P1053, DOI 10.1105/tpc.109.065714; Xin MM, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-61; Zhang XY, 2008, SCIENCE, V320, P489, DOI 10.1126/science.1153996; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237	42	120	127	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98958	10.1371/journal.pone.0098958	http://dx.doi.org/10.1371/journal.pone.0098958			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892290	Green Submitted, gold, Green Published			2022-12-27	WOS:000336911400115
J	Callan, D; Mills, L; Nott, C; England, R; England, S				Callan, Daniel; Mills, Lloyd; Nott, Connie; England, Robert; England, Shaun			A Tool for Classifying Individuals with Chronic Back Pain: Using Multivariate Pattern Analysis with Functional Magnetic Resonance Imaging Data	PLOS ONE			English	Article							PRIMARY SOMATOSENSORY CORTEX; BRAIN ACTIVITY; THRESHOLD MEASURES; SIGNAL-DETECTION; RADIANT-HEAT; GRAY-MATTER; PERCEPTION; STIMULATION; ACTIVATION; INTENSITY	Chronic pain is one of the most prevalent health problems in the world today, yet neurological markers, critical to diagnosis of chronic pain, are still largely unknown. The ability to objectively identify individuals with chronic pain using functional magnetic resonance imaging (fMRI) data is important for the advancement of diagnosis, treatment, and theoretical knowledge of brain processes associated with chronic pain. The purpose of our research is to investigate specific neurological markers that could be used to diagnose individuals experiencing chronic pain by using multivariate pattern analysis with fMRI data. We hypothesize that individuals with chronic pain have different patterns of brain activity in response to induced pain. This pattern can be used to classify the presence or absence of chronic pain. The fMRI experiment consisted of alternating 14 seconds of painful electric stimulation (applied to the lower back) with 14 seconds of rest. We analyzed contrast fMRI images in stimulation versus rest in pain-related brain regions to distinguish between the groups of participants: 1) chronic pain and 2) normal controls. We employed supervised machine learning techniques, specifically sparse logistic regression, to train a classifier based on these contrast images using a leave-one-out cross-validation procedure. We correctly classified 92.3% of the chronic pain group (N = 13) and 92.3% of the normal control group (N = 13) by recognizing multivariate patterns of activity in the somatosensory and inferior parietal cortex. This technique demonstrates that differences in the pattern of brain activity to induced pain can be used as a neurological marker to distinguish between individuals with and without chronic pain. Medical, legal and business professionals have recognized the importance of this research topic and of developing objective measures of chronic pain. This method of data analysis was very successful in correctly classifying each of the two groups.	[Callan, Daniel] Osaka Univ, Ctr Informat & Neural Networks, Natl Inst Informat & Commun Technol, Osaka, Japan; [Callan, Daniel; Mills, Lloyd; Nott, Connie; England, Robert; England, Shaun] Chron Pain Diagnost, Roseville, CA USA	National Institute of Information & Communications Technology (NICT) - Japan; Osaka University	Callan, D (corresponding author), Osaka Univ, Ctr Informat & Neural Networks, Natl Inst Informat & Commun Technol, Osaka, Japan.	dcallan@nict.go.jp; shaun.england@chronicpd.com		Callan, Daniel/0000-0002-8851-6065	Chronic Pain Diagnostics	Chronic Pain Diagnostics	This research was funded entirely by Chronic Pain Diagnostics (www.chronicpd.com). The funder provided support in the form of company shares for all authors who were directed to conduct the studies presented in this manuscript. Otherwise, this organisation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adler LJ, 1997, ANESTH ANALG, V84, P120, DOI 10.1097/00000539-199701000-00023; Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; Andersson Gunnar B. J., 1997, P93; Apkarian AV, 2013, TRENDS COGN SCI, V17, P309, DOI 10.1016/j.tics.2013.05.001; Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Baliki MN, 2006, J NEUROSCI, V26, P12165, DOI 10.1523/JNEUROSCI.3576-06.2006; Baliki MN, 2012, NAT NEUROSCI, V15, P1117, DOI 10.1038/nn.3153; Baliki MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026010; Barati Z, 2013, ANN BIOMED ENG, V41, P223, DOI 10.1007/s10439-012-0642-0; Brodersen Kay H., 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P3121, DOI 10.1109/ICPR.2010.764; Brodersen KH, 2012, NEUROIMAGE, V63, P1162, DOI 10.1016/j.neuroimage.2012.08.035; Brown JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024124; Cecchi GA, 2012, PLOS COMPUTATIONAL B, V8, P1; Chiou RJ, 2012, BRAIN RES, V1463, P42, DOI 10.1016/j.brainres.2012.04.027; Clauw DJ, 1999, SPINE, V24, P2035, DOI 10.1097/00007632-199910010-00013; Coghill RC, 1999, J NEUROPHYSIOL, V82, P1934, DOI 10.1152/jn.1999.82.4.1934; COHEN MJ, 1983, PAIN, V16, P245, DOI 10.1016/0304-3959(83)90112-4; Corradi-Dell'Acqua C, 2011, J NEUROSCI, V31, P17996, DOI 10.1523/JNEUROSCI.2686-11.2011; Davis KD, 2012, PAIN, V153, P1555, DOI 10.1016/j.pain.2012.02.037; Deyo RA, 2001, NEW ENGL J MED, V344, P363, DOI 10.1056/NEJM200102013440508; Eickhoff SB, 2008, CEREB CORTEX, V18, P2820, DOI 10.1093/cercor/bhn039; Fabri M, 2005, HUM BRAIN MAPP, V25, P287, DOI 10.1002/hbm.20099; Farmer MA, 2012, NEUROSCI LETT, V520, P197, DOI 10.1016/j.neulet.2012.05.001; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; Flor H, 1997, NEUROSCI LETT, V224, P5, DOI 10.1016/S0304-3940(97)13441-3; Freund W, 2010, CLIN J PAIN, V26, P339, DOI 10.1097/AJP.0b013e3181cb4055; Freund W, 2010, SOMATOSENS MOT RES, V27, P15, DOI 10.3109/08990220903516593; Friston KJ, 2008, NEUROIMAGE, V39, P181, DOI 10.1016/j.neuroimage.2007.08.013; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Giesecke T, 2004, ARTHRITIS RHEUM-US, V50, P613, DOI 10.1002/art.20063; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Herr K, 2006, J PAIN SYMPTOM MANAG, V31, P170, DOI 10.1016/j.jpainsymman.2005.07.001; Institute of Medicine (IOM), 2011, REL PAIN AM BLUE PRI; JENSEN MP, 1995, PAIN, V60, P203, DOI 10.1016/0304-3959(94)00118-X; Li D, 2008, J PAIN, V9, P2, DOI 10.1016/j.jpain.2007.08.009; Linton SJ, 2000, SPINE, V25, P1148, DOI 10.1097/00007632-200005010-00017; MACKAY DJC, 1992, NEURAL COMPUT, V4, P415, DOI [10.1162/neco.1992.4.3.415, 10.1162/neco.1992.4.3.448]; Mackey SC, 2013, J PAIN, V14, P328, DOI 10.1016/j.jpain.2013.01.001; Marquand A, 2010, NEUROIMAGE, V49, P2178, DOI 10.1016/j.neuroimage.2009.10.072; Merskey H., 1994, CLASSIFICATION CHRON, V2nd ed; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; NALIBOFF BD, 1981, J ABNORM PSYCHOL, V90, P271, DOI 10.1037/0021-843X.90.3.271; Neal RM, 1996, LECT NOTES STAT, V118; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; O'Toole AJ, 2007, J COGNITIVE NEUROSCI, V19, P1735, DOI 10.1162/jocn.2007.19.11.1735; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Prato M, 2011, NEUROIMAGE, V56, P258, DOI 10.1016/j.neuroimage.2011.01.074; PRICE DD, 1983, PAIN, V17, P45, DOI 10.1016/0304-3959(83)90126-4; Riley JL, 1998, PAIN, V74, P181, DOI 10.1016/S0304-3959(97)00199-1; Robinson ME, 2013, J PAIN, V14, P323, DOI 10.1016/j.jpain.2012.05.007; Rosa MJ, 2014, PAIN, V155, P864, DOI 10.1016/j.pain.2014.02.013; Rosner B., 2006, FUNDAMENTALS BIOSTAT; Schmidt-Wilcke T, 2006, PAIN, V125, P89, DOI 10.1016/j.pain.2006.05.004; Schulz E, 2012, CEREB CORTEX, V22, P1118, DOI 10.1093/cercor/bhr186; Stephenson DT, 2008, J PAIN, V9, P567, DOI 10.1016/j.jpain.2008.02.008; Sullivan MD, 2013, J PAIN, V14, P317, DOI 10.1016/j.jpain.2012.02.012; Tracey I, 2008, BRIT J ANAESTH, V101, P32, DOI 10.1093/bja/aen102; Tracey I, 2000, NEUROSCI LETT, V288, P159, DOI 10.1016/S0304-3940(00)01224-6; Tracey I, 2011, NAT REV NEUROL, V7, P173, DOI 10.1038/nrneurol.2011.4; Tracey I, 2009, J PAIN, V10, P1113, DOI 10.1016/j.jpain.2009.09.001; Ung H, 2012, CEREBRAL CORTEX; WADDELL G, 1980, SPINE, V5, P117, DOI 10.1097/00007632-198003000-00005; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; Wager TD, 2013, NEW ENGL J MED, V368, P1388, DOI 10.1056/NEJMoa1204471; Yamashita O, 2008, NEUROIMAGE, V42, P1414, DOI 10.1016/j.neuroimage.2008.05.050	67	34	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98007	10.1371/journal.pone.0098007	http://dx.doi.org/10.1371/journal.pone.0098007			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905072	Green Submitted, Green Published, gold			2022-12-27	WOS:000341869000018
J	Ke, WX; Liu, L; Zhang, C; Ye, XH; Gao, YH; Zhou, SD; Yang, Y				Ke, Weixia; Liu, Li; Zhang, Chi; Ye, Xiaohua; Gao, Yanhui; Zhou, Shudong; Yang, Yi			Comparison of Efficacy and Safety of Tenofovir and Entecavir in Chronic Hepatitis B Virus Infection: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							NAIVE PATIENTS; LAMIVUDINE; THERAPY; RESISTANCE; DISEASE	Objective: Tenofovir (TDF) and entecavir (ETV) are both potent antiviral agents for the treatment of chronic hepatitis B virus (HBV) infection. Multiple studies have compared efficacy and safety of these two agents, but yielded inconsistent results. Hence, we conducted a meta-analysis to discern comparative efficacy and safety. Methods: Published data relevant to a comparison of TDF and ETV used in HBV were included. HBV DNA suppression rate, ALT normalization rate, and HBeAg seroconversion rate at 24 weeks and 48 weeks were reviewed. Drug safety profiles and resistance were also discussed. Results: Seven articles met entry criteria. Four and six articles included data for 24 and 48-week HBV DNA suppression rates, respectively, and no significant differences for the rates between the two drugs were found in chronic HBV patients (TDF vs. ETV: relative risk [RR] = 1.10, 95% CI = 0.91-1.33 and RR = 1.07, 95% CI = 0.99-1.17 for 24 weeks and 48 weeks, respectively). For the ALT normalization rate (three studies for 24 weeks, four articles for 48 weeks) and HBeAg seroconversion rate (two and four studies for 24 weeks and 48 weeks, respectively), no difference was observed between TDF and ETV. Additionally, no significant distinction in short term safety was found for CHB patients. Conclusions: TDF and ETV are similarly effective and safe in chronic HBV patients after 24 weeks and 48 weeks of anti-viral therapy. Nevertheless, the long-term efficacy and safety of TDF and ETV should be monitored in prolonged therapy.	[Yang, Yi] Guangdong Pharmaceut Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Guangzhou, Guangdong, Peoples R China; Guangdong Pharmaceut Univ, Sch Publ Hlth, Guangdong Key Lab Mol Epidemiol, Guangzhou, Guangdong, Peoples R China	Guangdong Pharmaceutical University; Guangdong Pharmaceutical University	Yang, Y (corresponding author), Guangdong Pharmaceut Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Guangzhou, Guangdong, Peoples R China.	yangyigz@163.com			Program for Guangdong Medical research Foundation [B2012176]; National Natural Science Foundation of China [NSFC-81302493]; Foundation for Distinguished Young Talents in Higher Education of Guangdong [2012LYM_0082]	Program for Guangdong Medical research Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Distinguished Young Talents in Higher Education of Guangdong	This work was supported by Program for Guangdong Medical research Foundation (Grant No. B2012176), National Natural Science Foundation of China (NSFC-81302493) and Foundation for Distinguished Young Talents in Higher Education of Guangdong (Grant No. 2012LYM_0082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2002, NATL MED J INDIA, V15, P320; Ayoub WS, 2008, ALIMENT PHARM THER, V28, P167, DOI 10.1111/j.1365-2036.2008.03731.x; Carey I, 2011, HEPATOLOGY, V54, pA1396; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dogan UB, 2012, TURK J GASTROENTEROL, V23, P247, DOI 10.4318/tjg.2012.0380; Duarte-Rojo Andres, 2010, Therap Adv Gastroenterol, V3, P107, DOI 10.1177/1756283X09354562; Fontana RJ, 2009, HEPATOLOGY, V49, pS185, DOI 10.1002/hep.22885; Fried MW, 2010, HEPATOLOGY, V52, p403A; Fung J, 2011, J ANTIMICROB CHEMOTH, V66, P2715, DOI 10.1093/jac/dkr388; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Gao LY, 2013, GASTROENTEROLOGY, V144, pS971; Heathcote EJ, 2011, GASTROENTEROLOGY, V140, P132, DOI 10.1053/j.gastro.2010.10.011; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jayakumar Rajeswari, 2012, J Lab Physicians, V4, P10, DOI 10.4103/0974-2727.98664; Karino Y, 2010, HEPATOL INT, V4, P414, DOI 10.1007/s12072-009-9162-x; Koklu S, 2013, CLIN GASTROENTEROL H, V11, P88, DOI 10.1016/j.cgh.2012.10.003; Lampertico P, 2011, HEPATOLOGY, V54, pA1433; Lampertico P, 2011, HEPATOLOGY, V54, p1043A; Langley DR, 2007, J VIROL, V81, P3992, DOI 10.1128/JVI.02395-06; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Leung N, 2009, HEPATOLOGY, V49, P72, DOI 10.1002/hep.22658; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Liaw YF, 2011, HEPATOLOGY, V53, P62, DOI 10.1002/hep.23952; Lin CL, 2011, J GASTROEN HEPATOL, V26, P123, DOI 10.1111/j.1440-1746.2010.06541.x; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marcellin P, 2010, HEPATOLOGY, V52, p145A; Marcellin P, 2009, J HEPATOL, V50, P227, DOI 10.1016/j.jhep.2008.10.001; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Ovunc AOK, 2011, GASTROENTEROLOGY, V140, pS930; Patterson SJ, 2011, GUT, V60, P247, DOI 10.1136/gut.2010.223206; Petersen J, 2012, EXPERT REV GASTROENT, V6, P683, DOI [10.1586/egh.12.52, 10.1586/EGH.12.52]; Reijnders JGP, 2010, J HEPATOL, V52, P493, DOI 10.1016/j.jhep.2010.01.012; Ridruejo E, 2011, INT J CLIN PRACT, V65, P866, DOI 10.1111/j.1742-1241.2011.02719.x; Safioleas M, 2007, HEPATO-GASTROENTEROL, V54, P545; Sheng YJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-393; Sriprayoon T, 2012, GASTROENTEROLOGY, V142, pS695; Suzuki Y, 2009, J GASTROEN HEPATOL, V24, P429, DOI 10.1111/j.1440-1746.2008.05760.x; Tenney DJ, 2009, J HEPATOL, V50, pS10, DOI 10.1016/S0168-8278(09)60022-2; Tenney DJ, 2009, HEPATOLOGY, V49, P1503, DOI 10.1002/hep.22841; Tenny DJ, 2008, HEPATOL INT, V2, pA88; van Bommel F, 2010, HEPATOLOGY, V51, P73, DOI 10.1002/hep.23246; Woo G, 2010, GASTROENTEROLOGY, V139, P1218, DOI 10.1053/j.gastro.2010.06.042; Zoulim F, 2009, GASTROENTEROLOGY, V137, P1593, DOI 10.1053/j.gastro.2009.08.063	44	55	61	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98865	10.1371/journal.pone.0098865	http://dx.doi.org/10.1371/journal.pone.0098865			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905092	Green Published, gold, Green Submitted			2022-12-27	WOS:000341869000073
J	Qin, LX; Zhou, Q				Qin, Li-Xuan; Zhou, Qin			MicroRNA Array Normalization: An Evaluation Using a Randomized Dataset as the Benchmark	PLOS ONE			English	Article							MICROARRAYS; SUMMARIES; VARIANCE	MicroRNA arrays possess a number of unique data features that challenge the assumption key to many normalization methods. We assessed the performance of existing normalization methods using two microRNA array datasets derived from the same set of tumor samples: one dataset was generated using a blocked randomization design when assigning arrays to samples and hence was free of confounding array effects; the second dataset was generated without blocking or randomization and exhibited array effects. The randomized dataset was assessed for differential expression between two tumor groups and treated as the benchmark. The non-randomized dataset was assessed for differential expression after normalization and compared against the benchmark. Normalization improved the true positive rate significantly in the non-randomized data but still possessed a false discovery rate as high as 50%. Adding a batch adjustment step before normalization further reduced the number of false positive markers while maintaining a similar number of true positive markers, which resulted in a false discovery rate of 32% to 48%, depending on the specific normalization method. We concluded the paper with some insights on possible causes of false discoveries to shed light on how to improve normalization for microRNA arrays.	[Qin, Li-Xuan; Zhou, Qin] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Qin, LX (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA.	qinl@mskcc.org			National Institutes of Health [CA151947, CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA151947] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health [CA151947 and CA008748 to LXQ and QZ]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Babak T, 2004, RNA, V10, P1813, DOI 10.1261/rna.7119904; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chen C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017238; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fan JQ, 2004, P NATL ACAD SCI USA, V101, P1135, DOI 10.1073/pnas.0307557100; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Huber W., 2003, STAT APPL GENET MOL, V2, pARTICL, DOI [10.2202/1544-6115.1008, DOI 10.2202/1544-6115.1008]; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Pepe M. S., 2003, STAT EVALUATION MED; Pradervand S, 2009, RNA, V15, P493, DOI 10.1261/rna.1295509; Qin LX, 2013, CANCER INFORM, V12, P83, DOI 10.4137/CIN.S11384; Qin LX, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1339; Qin LX, 2014, CLIN CANCER RES, V20, P1; Rao YL, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1287; Sharma S, 2009, CARCINOGENESIS; Simon R, 2002, GENET EPIDEMIOL, V23, P21, DOI 10.1002/gepi.202; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Speed T., 2003, STAT ANAL GENE EXPRE; Tseng GC, 2001, NUCLEIC ACIDS RES, V29, P2549, DOI 10.1093/nar/29.12.2549	26	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98879	10.1371/journal.pone.0098879	http://dx.doi.org/10.1371/journal.pone.0098879			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905456	gold, Green Published, Green Submitted			2022-12-27	WOS:000341869000076
J	Xing, EP; Curtis, RE; Schoenherr, G; Lee, S; Yin, JM; Puniyani, K; Wu, W; Kinnaird, P				Xing, Eric P.; Curtis, Ross E.; Schoenherr, Georg; Lee, Seunghak; Yin, Junming; Puniyani, Kriti; Wu, Wei; Kinnaird, Peter			GWAS in a Box: Statistical and Visual Analytics of Structured Associations via GenAMap	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; POPULATION-STRUCTURE; CANCER SUSCEPTIBILITY; MOLECULAR NETWORKS; INFERENCE; SOFTWARE; TRAITS; TOOL; IDENTIFICATION	With the continuous improvement in genotyping and molecular phenotyping technology and the decreasing typing cost, it is expected that in a few years, more and more clinical studies of complex diseases will recruit thousands of individuals for pan-omic genetic association analyses. Hence, there is a great need for algorithms and software tools that could scale up to the whole omic level, integrate different omic data, leverage rich structure information, and be easily accessible to nontechnical users. We present GenAMap, an interactive analytics software platform that 1) automates the execution of principled machine learning methods that detect genome- and phenome-wide associations among genotypes, gene expression data, and clinical or other macroscopic traits, and 2) provides new visualization tools specifically designed to aid in the exploration of association mapping results. Algorithmically, GenAMap is based on a new paradigm for GWAS and PheWAS analysis, termed structured association mapping, which leverages various structures in the omic data. We demonstrate the function of GenAMap via a case study of the Brem and Kruglyak yeast dataset, and then apply it on a comprehensive eQTL analysis of the NIH heterogeneous stock mice dataset and report some interesting findings. GenAMap is available from http://sailing.cs.cmu.edu/genamap.	[Xing, Eric P.] Carnegie Mellon Univ, Machine Learning Dept, Pittsburgh, PA 15213 USA; [Curtis, Ross E.] Joint Carnegie Mellon Univ Pittsburgh, PhD Program Computat Biol, Pittsburgh, PA USA; [Schoenherr, Georg; Lee, Seunghak] Carnegie Mellon Univ, Dept Comp Sci, Pittsburgh, PA 15213 USA; [Curtis, Ross E.; Yin, Junming; Wu, Wei] Carnegie Mellon Univ, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA; [Kinnaird, Peter] Carnegie Mellon Univ, Human Comp Interact Inst, Pittsburgh, PA 15213 USA; [Puniyani, Kriti] Carnegie Mellon Univ, Language Technol Inst, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University	Xing, EP (corresponding author), Carnegie Mellon Univ, Machine Learning Dept, Pittsburgh, PA 15213 USA.	epxing@cs.cmu.edu; gschoenh@cs.cmu.edu	Yin, Junming/C-7963-2016		National Science Foundation [DBI-0640543, IIS-0713379]; National Institutes of Health [1R01GM087694, 1R01GM093156, 0015699]; Alfred P. Sloan Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087694, R01GM093156] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Research Fellowship(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Science Foundation [DBI-0640543, IIS-0713379]; National Institutes of Health [1R01GM087694, 1R01GM093156, 0015699]; and an Alfred P. Sloan Research Fellowship to EPX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Blake JA, 2011, NUCLEIC ACIDS RES, V39, pD842, DOI 10.1093/nar/gkq1008; Boyd Stephen, 2010, Foundations and Trends in Machine Learning, V3, P1, DOI 10.1561/2200000016; Boyd S., 2004, CONVEX OPTIMIZATION; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Card S. K., 1999, READINGS INFORM VISU; Castle T, 2009, JHEATCHART; Chen X., 2011, UAI, P105; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Curtis RE, 2011, 61 ANN M AM SOC HUM; Curtis RE, 2012, BIOCOMPUT-PAC SYM, P327; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Fekete JD, 2008, LECT NOTES COMPUT SC, V4950, P1, DOI 10.1007/978-3-540-70956-5_1; Friedman J., 2010, ARXIV10010736V1MATHS; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Ge DL, 2008, GENOME RES, V18, P640, DOI 10.1101/gr.071571.107; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; Gilbert D, 2010, JFREECHART OPEN SOUR; Hindorff LA, 2011, CATALOG PUBLISHED GE; Hsu YH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000977; Huang GJ, 2009, GENOME RES, V19, P1133, DOI 10.1101/gr.088120.108; Johannesson M, 2009, GENOME RES, V19, P150, DOI 10.1101/gr.081497.108; Kamada T, 2005, STAT APPL GENET MOL, V31, P7; Kim S., 2010, P 27 INT C MACH LEAR, P543; Kim S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000587; KRUGLYAK L, 1995, GENETICS, V139, P1421; Kullo IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013011; Lee S., 2010, PROC INT C NEURAL IN, P1306; Lee S, 2012, BIOINFORMATICS, V28, pI137, DOI 10.1093/bioinformatics/bts227; Lee SI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000358; Lindgren B., 1993, STAT THEORY; Madadhain J, 2005, J STAT SOFTW, V10, P1; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCarthy MI, 2008, HUM MOL GENET, V17, pR156, DOI 10.1093/hmg/ddn289; Meinshausen N, 2009, J AM STAT ASSOC, V104, P1671, DOI 10.1198/jasa.2009.tm08647; Meyer M, 2010, IEEE T VIS COMPUT GR, V16, P908, DOI 10.1109/TVCG.2010.137; Nesterov Y, 2005, MATH PROGRAM, V103, P127, DOI 10.1007/s10107-004-0552-5; Nicolae DL, 2010, PLOS GENET, V6; Park MY, 2008, BIOSTATISTICS, V9, P30, DOI 10.1093/biostatistics/kxm010; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pritchard JK, 2000, GENETICS, V155, P945; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Puniyani K, 2010, BIOINFORMATICS, V26, pi208, DOI 10.1093/bioinformatics/btq191; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2020, R LANG ENV STAT COMP; Reynolds PR, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-175; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shneiderman B, 1996, IEEE SYMPOSIUM ON VISUAL LANGUAGES, PROCEEDINGS, P336, DOI 10.1109/VL.1996.545307; Shringarpure S, 2009, GENETICS, V182, P575, DOI 10.1534/genetics.108.100222; Silveira AC, 2010, VISION RES, V50, P698, DOI 10.1016/j.visres.2009.09.016; Singh S, 2012, FREE RADICAL BIO MED, V53, P1782, DOI 10.1016/j.freeradbiomed.2012.07.025; Sohn KA, 2007, BIOINFORMATICS, V23, pI479, DOI 10.1093/bioinformatics/btm171; Stuart PM, 2010, MAJOR HISTOCOMPATIBI; Thain D, 2005, CONCURR COMP-PRACT E, V17, P323, DOI 10.1002/cpe.938; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tomioka R, 2009, IEEE SIGNAL PROC LET, V16, P1067, DOI 10.1109/LSP.2009.2030111; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Tseng P, 2009, MATH PROGRAM, V117, P387, DOI 10.1007/s10107-007-0170-0; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Waring SC, 2008, ARCH NEUROL-CHICAGO, V65, P329, DOI 10.1001/archneur.65.3.329; Wasserman L, 2009, ANN STAT, V37, P2178, DOI 10.1214/08-AOS646; Wu TT, 2009, BIOINFORMATICS, V25, P714, DOI 10.1093/bioinformatics/btp041; Yaguchi H, 2005, GENOMICS, V85, P591, DOI 10.1016/j.ygeno.2005.01.006; Yeager M, 2009, NAT GENET, V41, P1055, DOI 10.1038/ng.444; Yin Junming, 2012, Proc Int Conf Mach Learn, V2012, P871; Yuan M, 2006, J R STAT SOC B, V68, P49, DOI 10.1111/j.1467-9868.2005.00532.x; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhu J, 2008, NAT GENET, V40, P854, DOI 10.1038/ng.167	83	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e97524	10.1371/journal.pone.0097524	http://dx.doi.org/10.1371/journal.pone.0097524			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905018	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000341869000006
J	Barley, EA; Walters, P; Haddad, M; Phillips, R; Achilla, E; McCrone, P; Van Marwijk, H; Mann, A; Tylee, A				Barley, Elizabeth A.; Walters, Paul; Haddad, Mark; Phillips, Rachel; Achilla, Evanthia; McCrone, Paul; Van Marwijk, Harm; Mann, Anthony; Tylee, Andre			The UPBEAT Nurse-Delivered Personalized Care Intervention for People with Coronary Heart Disease Who Report Current Chest Pain and Depression: A Randomised Controlled Pilot Study	PLOS ONE			English	Article							UK PRIMARY-CARE; MANAGING DEPRESSION; COLLABORATIVE CARE; VALIDITY; PROGRAM; LIFE; CONSTRUCTION; RELIABILITY; PREVALENCE; DISORDERS	Background: Depression is common in people with coronary heart disease (CHD) and associated with worse outcome. This study explored the acceptability and feasibility of procedures for a trial and for an intervention, including its potential costs, to inform a definitive randomized controlled trial (RCT) of a nurse-led personalised care intervention for primary care CHD patients with current chest pain and probable depression. Methods: Multi-centre, outcome assessor-blinded, randomized parallel group study. CHD patients reporting chest pain and scoring 8 or more on the HADS were randomized to personalized care (PC) or treatment as usual (TAU) for 6 months and followed for 1 year. Primary outcome was acceptability and feasibility of procedures; secondary outcomes included mood, chest pain, functional status, well being and psychological process variables. Result: 1001 people from 17 General Practice CHD registers in South London consented to be contacted; out of 126 who were potentially eligible, 81 (35% female, mean age = 65 SD11 years) were randomized. PC participants (n = 41) identified wide ranging problems to work on with nurse-case managers. Good acceptability and feasibility was indicated by low attrition (9%), high engagement and minimal nurse time used (mean/SD = 78/19 mins assessment, 125/91 mins telephone follow up). Both groups improved on all outcomes. The largest between group difference was in the proportion no longer reporting chest pain (PC 37% vs TAU 18%; mixed effects model OR 2.21 95% CI 0.69, 7.03). Some evidence was seen that self efficacy (mean scale increase of 2.5 vs 0.9) and illness perceptions (mean scale increase of 7.8 vs 2.5) had improved in PC vs TAU participants at 1 year. PC appeared to be more cost effective up to a QALY threshold of approximately 3,000 pound. Conclusions: Trial and intervention procedures appeared to be feasible and acceptable. PC allowed patients to work on unaddressed problems and appears cheaper than TAU.	[Barley, Elizabeth A.] Kings Coll London, Florence Nightingale Sch Nursing & Midwifery, London WC2R 2LS, England; [Walters, Paul] Dorset HealthCare Univ NHS Fdn Trust, Weymouth & Portland Community Mental Hlth Team, Mental Hlth Ctr, Weymouth, Dorset, England; [Haddad, Mark] City Univ London, Sch Hlth Sci, London EC1V 0HB, England; [Phillips, Rachel; Achilla, Evanthia; McCrone, Paul; Mann, Anthony; Tylee, Andre] Kings Coll London, Inst Psychiat, Hlth Serv & Populat Res Dept, London WC2R 2LS, England; [Van Marwijk, Harm] Vrije Univ Amsterdam, Med Ctr, Dept Gen Practice & Elderly Care Med, Amsterdam, Netherlands; [Van Marwijk, Harm] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands	University of London; King's College London; City University London; University of London; King's College London; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Barley, EA (corresponding author), Kings Coll London, Florence Nightingale Sch Nursing & Midwifery, James Clerk Maxwell Bldg, London WC2R 2LS, England.	elizabeth.barley@kcl.ac.uk	Van Marwijk, Harm/K-6306-2013; Barley, Elizabeth/M-6663-2019; Haddad, Mark/A-9866-2011	Van Marwijk, Harm/0000-0001-6206-485X; Haddad, Mark/0000-0002-4822-5482; McCrone, Paul/0000-0001-7001-4502; Barley, Elizabeth/0000-0001-9955-0384; Phillips, Rachel/0000-0002-3634-7845	NIHR Biomedical Research Centre for Mental Health at the South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London; NIHR Statistics Fellowship;  [RP-PG-0606-1048]; National Institute for Health Research [MET-08-08-101, RP-PG-0606-1048] Funding Source: researchfish	NIHR Biomedical Research Centre for Mental Health at the South London(National Institute for Health Research (NIHR)); Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London; NIHR Statistics Fellowship; ; National Institute for Health Research(National Institute for Health Research (NIHR))	This report/article presents independent research commissioned by the National Institute for Health Research (NIHR) (http://www.nihr.ac.uk/Pages/default.aspx) under its Programme Grants for Applied Research scheme (RP-PG-0606-1048). The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. Andre Tylee is partly funded by the NIHR Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust and The Institute of Psychiatry, King's College London (http://brc.slam.nhs.uk/). Rachel Phillips was funded by an NIHR Statistics Fellowship (http://www.nihr.ac.uk/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragones E, 2012, J AFFECT DISORDERS, V142, P297, DOI 10.1016/j.jad.2012.05.020; Barber JA, 2000, STAT MED, V19, P3219, DOI 10.1002/1097-0258(20001215)19:23<3219::AID-SIM623>3.0.CO;2-P; Barley EA, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-119; Barley EA, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-1; Barley EA, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-47; Baumeister H, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008012.pub3; Beecham J, 2001, MEASURING MENTAL HLT, V2nd, P200; Bennett M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075810; Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020; Buszewicz M, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-61; Butler CC, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1191; Centre HaSCI, 2013, HOSP EP STAT; Centre. NI, 2009, QUAL OUTC FRAM ACH D; CORNEY RH, 1985, PSYCHOL MED, V15, P637, DOI 10.1017/S0033291700031494; Curtis L., 2010, UNIT COSTS HLTH SOCI; Davidson KW, 2006, PSYCHOSOM MED, V68, P645, DOI 10.1097/01.psy.0000233233.48738.22; DOLAN P, 1995, APPL ECON, V27, P1103, DOI 10.1080/00036849500000093; Egede LE, 2007, GEN HOSP PSYCHIAT, V29, P409, DOI 10.1016/j.genhosppsych.2007.06.002; Fenwick E, 2005, BRIT J PSYCHIAT, V187, P106, DOI 10.1192/bjp.187.2.106; Gerrits MMJG, 2012, PAIN, V153, P429, DOI 10.1016/j.pain.2011.11.001; GOLDMAN L, 1981, CIRCULATION, V64, P1227, DOI 10.1161/01.CIR.64.6.1227; Government DfCaL, 2011, ENGL IND DEPR; Health Do, 2011, NHS REF COSTS 2009 2; Hurst NP, 1997, BRIT J RHEUMATOL, V36, P551; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; Kennedy A, 2013, BMJ, V346; Kisely SR, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004101.pub4; Kisely SR, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004101.pub3; Knowles SE, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-110; Koopmanschap MA, 2008, PHARMACOECONOMICS, V26, P269, DOI 10.2165/00019053-200826040-00001; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lenfant C, 2010, METABOLISM, V59, pS41, DOI 10.1016/j.metabol.2010.07.014; Licht-Strunk E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3079; Manca A, 2005, APPL HEALTH ECON HEA, V4, P65, DOI 10.2165/00148365-200504020-00001; Medical Research Council, 2008, DEV EV COMPL INT NEW; Morgan M, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-46; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Noordman J, 2013, SOC SCI MED, V87, P60, DOI 10.1016/j.socscimed.2013.03.019; Penninx BWJH, 2011, J AFFECT DISORDERS, V133, P76, DOI 10.1016/j.jad.2011.03.027; Richards DA, 2008, PSYCHOL MED, V38, P279, DOI 10.1017/S0033291707001365; Richards DA, 2009, PSYCHOL MED, V39, P701, DOI 10.1017/S0033291709005200; Richards DA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4913; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Rutledge T, 2013, PSYCHOSOM MED, V75, P335, DOI 10.1097/PSY.0b013e318291d798; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; Sharp DJ, HLTH TECHNOLOGY ASSE, V14, pix; Sharp DJ, HLTH TECHNOLOGY ASSE, V14, piii; Shepherd M, 2005, COUNS PSYCHOTHER RES, V5, P273, DOI 10.1080/14733140600571326; Simmonds RL, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-38; StataCorp, 2011, STAT STAT SOFTW REL, P173; Tennant R, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-63; Thombs BD, 2006, J GEN INTERN MED, V21, P30, DOI 10.1111/j.1525-1497.2005.00269.x; Tylee A, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-58; Tylee A, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-38; Walters P, 2013, DEPRESSION PRIMARY C; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	58	31	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98704	10.1371/journal.pone.0098704	http://dx.doi.org/10.1371/journal.pone.0098704			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4NF	24901956	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000336841400047
J	Clauzure, M; Valdivieso, AG; Copiz, MMM; Schulman, G; Teiber, ML; Santa-Coloma, TA				Clauzure, Mariangeles; Valdivieso, Angel G.; Massip Copiz, Maria M.; Schulman, Gustavo; Luz Teiber, Maria; Santa-Coloma, Tomas A.			Disruption of Interleukin-1 beta Autocrine Signaling Rescues Complex I Activity and Improves ROS Levels in Immortalized Epithelial Cells with Impaired Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Function	PLOS ONE			English	Article							NF-KAPPA-B; MITOCHONDRIAL NADH DEHYDROGENASE; PSEUDOMONAS-AERUGINOSA; GENE-EXPRESSION; TNF-ALPHA; TGF-BETA; OXIDATIVE STRESS; CHLORIDE CHANNEL; MESSENGER-RNA; CYTOCHROME-C	Patients with cystic fibrosis (CF) have elevated concentration of cytokines in sputum and a general inflammatory condition. In addition, CF cells in culture produce diverse cytokines in excess, including IL-1 beta. We have previously shown that IL-1 beta, at low doses (similar to 30 pM), can stimulate the expression of CFTR in T84 colon carcinoma cells, through NF-kappa B signaling. However, at higher doses (similar to 2.5 ng/ml, similar to 150 pM), IL-1 beta inhibit CFTR mRNA expression. On the other hand, by using differential display, we found two genes with reduced expression in CF cells, corresponding to the mitochondrial proteins CISD1 and MTND4. The last is a key subunit for the activity of mitochondrial Complex I (mCx-I); accordingly, we later found a reduced mCx-I activity in CF cells. Here we found that IB3-1 cells (CF cells), cultured in serum-free media, secrete 323 +/- 5 pg/ml of IL-1 beta in 24 h vs 127 +/- 3 pg/ml for S9 cells (CFTR-corrected IB3-1 cells). Externally added IL-1 beta (5 ng/ml) reduces the mCx-I activity and increases the mitochondrial (MitoSOX probe) and cellular (DCFH-DA probe) ROS levels of S9 (CFTR-corrected IB3-1 CF cells) or Caco-2/pRSctrl cells (shRNA control cells) to values comparable to those of IB3-1 or Caco-2/pRS26 cells (shRNA specific for CFTR). Treatments of IB3-1 or Caco-2/pRS26 cells with either IL-1b blocking antibody, IL-1 receptor antagonist, IKK inhibitor III (NF-kappa B pathway) or SB203580 (p38 MAPK pathway), restored the mCx-I activity. In addition, in IB3-1 or Caco-2/pRS26 cells, IL-1b blocking antibody, IKK inhibitor III or SB203580 reduced the mitochondrial ROS levels by,50% and the cellular ROS levels near to basal values. The AP-1 inhibitors U0126 (MEK1/2) or SP600125 (JNK1/2/3 inhibitor) had no effects. The results suggest that in these cells IL-1 beta, through an autocrine effect, acts as a bridge connecting the CFTR with the mCx-I activity and the ROS levels.	[Santa-Coloma, Tomas A.] Pontifical Catholic Univ Argentina UCA, Sch Med Sci, Inst Biomed Res BIOMED, Lab Cellular & Mol Biol, Buenos Aires, DF, Argentina; Natl Sci & Tech Res Council CONICET, Buenos Aires, DF, Argentina	Pontifical Catholic University of Argentina; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Santa-Coloma, TA (corresponding author), Pontifical Catholic Univ Argentina UCA, Sch Med Sci, Inst Biomed Res BIOMED, Lab Cellular & Mol Biol, Buenos Aires, DF, Argentina.	tsantacoloma@gmail.com	Santa-Coloma, Tomas/I-1254-2019; Valdivieso, Ángel/AAP-3888-2020	Santa-Coloma, Tomas/0000-0002-3266-1095; Clauzure, Mariangeles/0000-0002-8490-6197	National Agency for the Promotion of Science and Technology of Argentina (ANPCYT) [BID OC-AR 1728, PICT 2004-13970, PICT 2007-00628]; National Research Council of Argentina (CONICET) [PIP 11220080 102551]; Pontifical Catholic University of Argentina (UCA)	National Agency for the Promotion of Science and Technology of Argentina (ANPCYT)(ANPCyT); National Research Council of Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Pontifical Catholic University of Argentina (UCA)	This work was supported by the National Agency for the Promotion of Science and Technology of Argentina (ANPCYT;www.agencia.mincyt.gob.ar), grants BID OC-AR 1728, PICT 2004-13970 and PICT 2007-00628 to TASC and fellowship to MG; The National Research Council of Argentina (CONICET;www.conicet.gov.ar), grant PIP 11220080 102551, 2009-2011 to TASC and research fellowships to MC, AGV, MMMC and GS; and The Pontifical Catholic University of Argentina (UCA; www.uca.edu.ar), grant to TASC and fellowships to AGV and MLT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseeva L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-33; ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; AREND W P, 1990, Progress in Growth Factor Research, V2, P193, DOI 10.1016/0955-2235(90)90018-F; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Bartling TR, 2009, AM J RESP CELL MOL, V40, P58, DOI 10.1165/rcmb.2007-0464OC; Becker MN, 2004, AM J RESP CRIT CARE, V169, P645, DOI 10.1164/rccm.200207-765OC; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; BESANCON F, 1994, AM J PHYSIOL-CELL PH, V267, pC1398, DOI 10.1152/ajpcell.1994.267.5.C1398; Black JP, 2000, BIOMATERIALS, V21, P2287, DOI 10.1016/S0142-9612(00)00155-1; Borgatti M, 2007, BIOCHEM BIOPH RES CO, V357, P977, DOI 10.1016/j.bbrc.2007.04.081; Bourges I, 2004, BIOCHEM J, V383, P491, DOI 10.1042/BJ20040256; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Cafferata E.G., 1995, 31 ANN M ARG SOC BIO; Cafferata E.G.A., 2002, THESIS, P99; Cafferata EG, 2000, BBA-MOL BASIS DIS, V1500, P241, DOI 10.1016/S0925-4439(99)00105-2; Cafferata EGA, 2001, J BIOL CHEM, V276, P15441, DOI 10.1074/jbc.M010061200; Cafferata EGA, 1997, PEDIAT PULMONOLOGY, V14, P71; Carrabino S, 2006, J CYST FIBROS, V5, P113, DOI 10.1016/j.jcf.2005.12.003; Carrillo C, 1998, CELL MOL BIOL, V44, P543; CARTER DB, 1990, NATURE, V344, P633, DOI 10.1038/344633a0; Chen Y, 2003, J BIOL CHEM, V278, P17036, DOI 10.1074/jbc.M210429200; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Clauzure M, 2010, MEDICINA-BUENOS AIRE, V70, P107, DOI DOI 10.13140/RG.2.1.1240.8561; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; DiMango E, 1998, J CLIN INVEST, V101, P2598, DOI 10.1172/JCI2865; DUPONT H, 1990, J IMMUNOL METHODS, V128, P287, DOI 10.1016/0022-1759(90)90222-H; EGAN M, 1992, NATURE, V358, P581, DOI 10.1038/358581a0; Eidelman O, 2001, MOL MED, V7, P523, DOI 10.1007/BF03401858; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FEIGAL RJ, 1982, LIFE SCI, V30, P93, DOI 10.1016/0024-3205(82)90640-3; FEIGAL RJ, 1979, NATURE, V278, P276, DOI 10.1038/278276a0; Valdivieso AG, 2013, REDOX BIOL, V1, P190, DOI 10.1016/j.redox.2012.11.007; Galvin Paul, 2004, J Cyst Fibros, V3 Suppl 2, P29, DOI 10.1016/j.jcf.2004.05.006; Garcia-Vicuna R, 2004, ARTHRITIS RHEUM-US, V50, P3866, DOI 10.1002/art.20615; Gillette DD, 2013, J BIOL CHEM, V288, P3691, DOI 10.1074/jbc.C112.430298; Gonzalez-Guerrico AM, 2002, J BIOL CHEM, V277, P17239, DOI 10.1074/jbc.M112456200; GRASSO P, 1993, ENDOCRINOLOGY, V132, P1745, DOI 10.1210/en.132.4.1745; Hayashi Hidetoshi, 2005, Nihon Rinsho, V63 Suppl 8, P60; Howe K, 2002, AM J PHYSIOL-CELL PH, V283, pC1667, DOI 10.1152/ajpcell.00414.2001; Howe KL, 2004, EXP CELL RES, V298, P473, DOI 10.1016/j.yexcr.2004.04.026; Jacquot J, 2008, INT J BIOCHEM CELL B, V40, P1703, DOI 10.1016/j.biocel.2008.02.002; Jang BC, 2000, J BIOL CHEM, V275, P39507, DOI 10.1074/jbc.M003224200; Joshi AKR, 2011, ANAL BIOCHEM, V415, P209, DOI 10.1016/j.ab.2011.04.014; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; Knorre A, 2002, BIOL CHEM, V383, P271, DOI 10.1515/BC.2002.029; Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Li JD, 1998, P NATL ACAD SCI USA, V95, P5718, DOI 10.1073/pnas.95.10.5718; Loor G, 2011, BBA-MOL CELL RES, V1813, P1382, DOI 10.1016/j.bbamcr.2010.12.008; Lopez-Armada MJ, 2006, OSTEOARTHR CARTILAGE, V14, P660, DOI 10.1016/j.joca.2006.01.005; Lopez-Armada MJ, 2006, OSTEOARTHR CARTILAGE, V14, P1011, DOI 10.1016/j.joca.2006.03.008; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; MAJANDER A, 1991, FEBS LETT, V292, P289, DOI 10.1016/0014-5793(91)80886-8; Marcucci F, 2001, BIOCELL S2, V25, P49; Matthews RP, 1996, J BIOL CHEM, V271, P31869, DOI 10.1074/jbc.271.50.31869; Moss RB, 2000, CLIN EXP IMMUNOL, V120, P518, DOI 10.1046/j.1365-2249.2000.01232.x; Muselet-Charlier C, 2007, BIOCHEM BIOPH RES CO, V357, P402, DOI 10.1016/j.bbrc.2007.03.141; NAKAMURA H, 1992, FEBS LETT, V314, P366, DOI 10.1016/0014-5793(92)81507-I; Navarro A, 2010, J BIOENERG BIOMEMBR, V42, P405, DOI 10.1007/s10863-010-9309-4; Nogrady N, 1998, J BIOTECHNOL, V60, P15, DOI 10.1016/S0168-1656(97)00156-9; Okada SF, 2006, J BIOL CHEM, V281, P22992, DOI 10.1074/jbc.M603019200; Osika E, 1999, EUR RESPIR J, V14, P339, DOI 10.1034/j.1399-3003.1999.14b17.x; Paradies G, 2002, GENE, V286, P135, DOI 10.1016/S0378-1119(01)00814-9; PARK KC, 1994, P NATL ACAD SCI USA, V91, P8772, DOI 10.1073/pnas.91.19.8772; Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798; Pongnimitprasert N, 2008, ANN BIOL CLIN-PARIS, V66, P621, DOI 10.1684/abc.2008.0285; Reiniger N, 2007, INFECT IMMUN, V75, P1598, DOI 10.1128/IAI.01980-06; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; RIORDAN JR, 1989, SCIENCE, V245, P1066; Robinson BH, 1998, BBA-BIOENERGETICS, V1364, P271, DOI 10.1016/S0005-2728(98)00033-4; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Scholl FA, 2007, DEV CELL, V12, P615, DOI 10.1016/j.devcel.2007.03.009; SHAPIRO BL, 1982, AM J HUM GENET, V34, P846; SHAPIRO BL, 1989, LIFE SCI, V44, P1327, DOI 10.1016/0024-3205(89)90389-5; SHAPIRO BL, 1988, LANCET, V2, P290; SHAPIRO BL, 1973, P SOC EXP BIOL MED, V144, P181; SHAPIRO BL, 1979, P NATL ACAD SCI USA, V76, P2979, DOI 10.1073/pnas.76.6.2979; SPORN MB, 1985, CANCER SURV, V4, P627; SPORN MB, 1980, NEW ENGL J MED, V303, P878, DOI 10.1056/NEJM198010093031511; Srivastava M, 1999, MOL MED, V5, P753, DOI 10.1007/BF03402099; Stecenko AA, 2001, INFLAMMATION, V25, P145, DOI 10.1023/A:1011080229374; Sun HX, 2008, CANCER PREV RES, V1, P316, DOI 10.1158/1940-6207.CAPR-07-0002; Tabary O, 2000, J IMMUNOL, V164, P3377, DOI 10.4049/jimmunol.164.6.3377; Tabary O, 2001, PFLUG ARCH EUR J PHY, V443, pS40, DOI 10.1007/s004240100642; Taminelli GL, 2008, BIOCHEM BIOPH RES CO, V365, P856, DOI 10.1016/j.bbrc.2007.11.076; Tang A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037689; Teiber ML, 2010, MEDICINA BUENOS A S2, V70, P109; TURNER M, 1991, EUR J IMMUNOL, V21, P1635, DOI 10.1002/eji.1830210708; Valdivieso AG, 2007, BIOCHEM BIOPH RES CO, V356, P805, DOI 10.1016/j.bbrc.2007.03.057; Valdivieso AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048059; Van Seuningen I, 2001, FRONT BIOSCI-LANDMRK, V6, pD1216; Velsor LW, 2006, AM J RESP CELL MOL, V35, P579, DOI 10.1165/rcmb.2005-0473OC; Venkatakrishnan A, 2000, AM J RESP CELL MOL, V23, P396, DOI 10.1165/ajrcmb.23.3.3949; Verhaeghe C, 2007, BIOCHEM PHARMACOL, V73, P1982, DOI 10.1016/j.bcp.2007.03.019; Weber AJ, 2001, AM J PHYSIOL-LUNG C, V281, pL71, DOI 10.1152/ajplung.2001.281.1.L71; Wesley UV, 2007, J BIOL CHEM, V282, P3213, DOI 10.1074/jbc.M606533200; Wier EM, 2012, J BIOL CHEM, V287, P43019, DOI 10.1074/jbc.M112.388694; ZEITLIN PL, 1991, AM J RESP CELL MOL, V4, P313, DOI 10.1165/ajrcmb/4.4.313; Zell R, 1997, MOL CELL BIOCHEM, V177, P61, DOI 10.1023/A:1006896832582	104	30	31	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99257	10.1371/journal.pone.0099257	http://dx.doi.org/10.1371/journal.pone.0099257			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901709	gold, Green Published, Green Submitted			2022-12-27	WOS:000336841400115
J	Kim, EJ; Kim, BH; Seo, HS; Lee, YJ; Kim, HH; Son, HH; Choi, MH				Kim, Eung Ju; Kim, Baek-hui; Seo, Hong Seog; Lee, Yong Jik; Kim, Hyun Hee; Son, Hyun-Hwa; Choi, Man Ho			Cholesterol-Induced Non-Alcoholic Fatty Liver Disease and Atherosclerosis Aggravated by Systemic Inflammation	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; TOLL-LIKE RECEPTOR-4; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; DIETARY-CHOLESTEROL; LIPID-ACCUMULATION; METABOLIC SYNDROME; RISK; STEATOHEPATITIS; ASSOCIATION	Although triglyceride accumulation in the liver causes non-alcoholic fatty liver disease (NAFLD), hypercholesterolemia is also a main cause of NAFLD as well as atherosclerosis. However, NAFLD and atherosclerosis have not been investigated simultaneously in animal models fed a high-cholesterol diet. Moreover, it is unclear whether systemic inflammation can exacerbate both pathologies in the same model. Accordingly, this study investigated the effect of additional systemic inflammation on NAFLD and atherosclerosis induced by cholesterol overload in wild animals. New Zealand white rabbits were divided into 4 groups: groups I (control) and II received normal chow, and groups III and IV received a 1% cholesterol diet. To induce inflammation via toll-like receptor (TLR)-4 signaling, groups II and IV received subcutaneous injections of 0.5 mL of 1% carrageenan every 3 weeks. After 3 months, total cholesterol markedly increased in groups III and IV, and the serum expressions of systemic inflammatory markers were elevated in the groups II-IV. Early NAFLD lesions (e. g., mild fatty changes in the liver with sporadic fibrosis) and atherosclerosis (e. g., intimal hyperplasia composed of foam cells) were observed in both the liver and aorta specimens from group III, and advanced lesions were observed in group IV. The expressions of inflammatory cellular receptors, TLR-2 and TLR-4, in the aorta gradually increased from group I to IV but were similar in the liver in groups II-IV. Cholesteryl ester (CE) levels were higher in group IV than in group III, although the difference was not significant. CE levels in the aorta were similar between groups III and IV. Systemic inflammation can simultaneously exacerbate existing early lesions due to cholesterol overload in both the liver and aorta of rabbits. However, the cellular response of inflammatory receptors and expression of cholesterol metabolites differ between these organs.	[Kim, Eung Ju; Seo, Hong Seog; Lee, Yong Jik; Kim, Hyun Hee] Korea Univ, Coll Med, Guro Hosp, Cardiovasc Ctr,Div Cardiol,Dept Internal Med, Seoul 136705, South Korea; [Kim, Baek-hui] Korea Univ, Coll Med, Guro Hosp, Dept Pathol, Seoul 136705, South Korea; [Seo, Hong Seog] Korea Inst Sci & Technol, Korea Univ Korea Inst Sci & Technol KU KIST Grad, Seoul, South Korea; [Son, Hyun-Hwa; Choi, Man Ho] Korea Inst Sci & Technol, Future Convergence Res Div, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea Institute of Science & Technology (KIST); Korea Institute of Science & Technology (KIST)	Seo, HS (corresponding author), Korea Univ, Coll Med, Guro Hosp, Cardiovasc Ctr,Div Cardiol,Dept Internal Med, Seoul 136705, South Korea.	mdhsseo@korea.ac.kr; mh_choi@kist.re.kr		Lee, Yong-Jik/0000-0001-8814-0099; Seo, Hong Seog/0000-0002-3228-7988; Kim, Eung Ju/0000-0003-2322-6267	Korea Institute of Science and Technology Institutional Program [2E24080]; Korean Health Technology R&D Project of the Ministry for Health, Welfare & Family Affairs of the Republic of Korea [A070001]; Korea University-Korea Institute of Science and Technology Graduate School Converging Science and Technology [R1307921]	Korea Institute of Science and Technology Institutional Program; Korean Health Technology R&D Project of the Ministry for Health, Welfare & Family Affairs of the Republic of Korea; Korea University-Korea Institute of Science and Technology Graduate School Converging Science and Technology	This study was partly supported by the Korea Institute of Science and Technology Institutional Program (Project No. 2E24080); a grant from the Korean Health Technology R&D Project of the Ministry for Health, Welfare & Family Affairs of the Republic of Korea (A070001); and a grant from the Korea University-Korea Institute of Science and Technology Graduate School Converging Science and Technology(R1307921). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, J GASTROEN HEPATOL, V17, pS186, DOI 10.1046/j.1440-1746.17.s1.10.x; Bhattacharyya S, 2008, J BIOL CHEM, V283, P10550, DOI 10.1074/jbc.M708833200; Sarmiento-Monroy JC, 2012, ARTHRITIS, DOI 10.1155/2012/371909; Chowdhary VR, 2008, J RHEUMATOL, V35, P2159, DOI 10.3899/jrheum.080336; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Dick TJM, 2013, ATHEROSCLEROSIS, V226, P208, DOI 10.1016/j.atherosclerosis.2012.10.040; Diehl AM, 2002, AM J PHYSIOL-GASTR L, V282, pG1, DOI 10.1152/ajpgi.00384.2001; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158; El Fadl KA, 2011, ANGIOLOGY, V62, P62, DOI 10.1177/0003319710371617; Faure E, 2001, J IMMUNOL, V166, P2018, DOI 10.4049/jimmunol.166.3.2018; FREDRICK.DS, 1965, CIRCULATION, V31, P321, DOI 10.1161/01.CIR.31.3.321; Furuta M, 2010, ACTA ODONTOL SCAND, V68, P27, DOI 10.3109/00016350903291913; Gastaldelli A, 2009, HEPATOLOGY, V49, P1537, DOI 10.1002/hep.22845; Gisondi P, 2010, ACTA DERMATOVENER CR, V18, P297; Higashimori M, 2011, ARTERIOSCL THROM VAS, V31, P50, DOI 10.1161/ATVBAHA.110.210971; Ioannou GN, 2006, HEPATOLOGY, V43, P1145, DOI 10.1002/hep.21171; Jung HJ, 2010, CLIN CHIM ACTA, V411, P818, DOI 10.1016/j.cca.2010.02.068; Kleemann R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r200; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kolodgie FD, 1996, ARTERIOSCL THROM VAS, V16, P1454, DOI 10.1161/01.ATV.16.12.1454; Kotronen A, 2008, ARTERIOSCL THROM VAS, V28, P27, DOI 10.1161/ATVBAHA.107.147538; Kuipers F, 1996, HEPATOLOGY, V24, P241; KWITEROVICH PO, 1987, ARTERIOSCLEROSIS, V7, P211, DOI 10.1161/01.ATV.7.3.211; Lee L, 2009, HEPATOLOGY, V50, P56, DOI 10.1002/hep.22904; Lehr HA, 2001, CIRCULATION, V104, P914, DOI 10.1161/hc3401.093153; Ma KL, 2008, HEPATOLOGY, V48, P770, DOI 10.1002/hep.22423; Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5; Marchesini G, 2008, J CLIN ENDOCR METAB, V93, pS74, DOI 10.1210/jc.2008-1399; Mullick AE, 2008, J EXP MED, V205, P373, DOI 10.1084/jem.20071096; Ohnishi S, 2008, PROTEIN SCI, V17, P1531, DOI 10.1110/ps.035329.108; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Schoenfeld SR, 2013, SEMIN ARTHRITIS RHEU, V43, P77, DOI 10.1016/j.semarthrit.2012.12.002; Son HH, 2014, J LIPID RES, V55, P155, DOI 10.1194/jlr.D040790; Sung KC, 2009, ATHEROSCLEROSIS, V203, P581, DOI 10.1016/j.atherosclerosis.2008.07.024; Sung KC, 2012, DIABETES CARE, V35, P2359, DOI 10.2337/dc12-0515; Targher G, 2008, DIABETOLOGIA, V51, P444, DOI 10.1007/s00125-007-0897-4; Tous M, 2005, MOL CELL BIOCHEM, V268, P53, DOI 10.1007/s11010-005-2997-0; Tsuji RF, 2003, CLIN EXP ALLERGY, V33, P249, DOI 10.1046/j.1365-2222.2003.01575.x; Villanova N, 2005, HEPATOLOGY, V42, P473, DOI 10.1002/hep.20781; Visintin A, 2001, J IMMUNOL, V166, P249, DOI 10.4049/jimmunol.166.1.249; Wobser H, 2009, CELL RES, V19, P996, DOI 10.1038/cr.2009.73; Xu XH, 2001, CIRCULATION, V104, P3103, DOI 10.1161/hc5001.100631; Yang X, 2005, ARTERIOSCL THROM VAS, V25, P2308, DOI 10.1161/01.ATV.0000187468.00675.a3; Yanni AE, 2004, LAB ANIM-UK, V38, P246, DOI 10.1258/002367704323133628; Zhang YQ, 2010, VACCINE, V28, P5212, DOI 10.1016/j.vaccine.2010.05.068	46	41	41	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e97841	10.1371/journal.pone.0097841	http://dx.doi.org/10.1371/journal.pone.0097841			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901254	gold, Green Published, Green Submitted			2022-12-27	WOS:000336841400013
J	Ratnoglik, SL; Jiang, DP; Aoki, C; Sudarmono, P; Shoji, I; Deng, L; Hotta, H				Ratnoglik, Suratno Lulut; Jiang, Da-Peng; Aoki, Chie; Sudarmono, Pratiwi; Shoji, Ikuo; Deng, Lin; Hotta, Hak			Induction of Cell-Mediated Immune Responses in Mice by DNA Vaccines That Express Hepatitis C Virus NS3 Mutants Lacking Serine Protease and NTPase/RNA Helicase Activities	PLOS ONE			English	Article							VIRAL CLEARANCE; RNA HELICASES; T-CELLS; NONSTRUCTURAL PROTEIN-3; HCV INFECTION; CORE PROTEIN; CD4(+); REPLICATION; CANCER; EPITOPES	Effective therapeutic vaccines against virus infection must induce sufficient levels of cell-mediated immune responses against the target viral epitopes and also must avoid concomitant risk factors, such as potential carcinogenic properties. The nonstructural protein 3 (NS3) of hepatitis C virus (HCV) carries a variety of CD4(+) and CD8(+) T cell epitopes, and induces strong HCV-specific T cell responses, which are correlated with viral clearance and resolution of acute HCV infection. On the other hand, NS3 possesses serine protease and nucleoside triphosphatase (NTPase)/RNA helicase activities, which not only play important roles in viral life cycle but also concomitantly interfere with host defense mechanisms by deregulating normal cellular functions. In this study, we constructed a series of DNA vaccines that express NS3 of HCV. To avoid the potential harm of NS3, we introduced mutations to the catalytic triad of the serine protease (H57A, D81A and S139A) and the NTPase/RNA helicase domain (K210N, F444A, R461Q and W501A) to eliminate the enzymatic activities. Immunization of BALB/c mice with each of the DNA vaccine candidates (pNS3[S139A/K210N], pNS3[S139A/F444A], pNS3[S139A/R461Q] and pNS3[S139A/W501A]) that expresses an NS3 mutant lacking both serine protease and NTPase/helicase activities induced T cell immune responses to the degree comparable to that induced by the wild type NS3 and the NS3/4A complex, as demonstrated by interferon-gamma production and cytotoxic T lymphocytes activities against NS3. The present study has demonstrated that plasmids expressing NS3 mutants, NS3(S139A/K210N), NS3(S139A/F444A), NS3(S139A/R461Q) and NS3(S139A/W501A), which lack both serine protease and NTPase/RNA helicase activities, would be good candidates for safe and efficient therapeutic DNA vaccines against HCV infection.	[Ratnoglik, Suratno Lulut; Jiang, Da-Peng; Aoki, Chie; Shoji, Ikuo; Deng, Lin; Hotta, Hak] Kobe Univ Grad Sch Med, Div Microbiol, Kobe, Hyogo, Japan; [Aoki, Chie] Univ Indonesia, JST JICA SATREPS Lab, Fac Med, Kobe Univ, Jakarta, Indonesia; [Ratnoglik, Suratno Lulut; Sudarmono, Pratiwi] Univ Indonesia, Fac Med, Jakarta, Indonesia	Kobe University; University of Indonesia; University of Indonesia	Hotta, H (corresponding author), Kobe Univ Grad Sch Med, Div Microbiol, Kobe, Hyogo, Japan.	hotta@kobe-u.ac.jp	Shoji, Ikuo/Y-7079-2019	Shoji, Ikuo/0000-0002-0730-4379	SATREPS Grant from Japan Science and Technology Agency (JST); Japan International Cooperation Agency (JICA); Japan Initiative for Global Research Network on Infectious Diseases (J-GRID), Ministry of Education, Culture, Sports, Science and Technology, Japan; Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare, Japan; Grants-in-Aid for Scientific Research [26461003] Funding Source: KAKEN	SATREPS Grant from Japan Science and Technology Agency (JST); Japan International Cooperation Agency (JICA); Japan Initiative for Global Research Network on Infectious Diseases (J-GRID), Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a SATREPS Grant from Japan Science and Technology Agency (JST) and Japan International Cooperation Agency (JICA), a grant from the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID), Ministry of Education, Culture, Sports, Science and Technology, Japan, and the Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare, Japan. This study was also carried out as part of the Global Center of Excellence (G-COE) Program at Kobe University Graduate School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhaleem M, 2004, BBA-REV CANCER, V1704, P37, DOI 10.1016/j.bbcan.2004.05.001; Alaoui-Ismaili MH, 2000, ANTIVIR RES, V46, P181, DOI 10.1016/S0166-3542(00)00085-1; Banerjee A, 2010, VIRUSES-BASEL, V2, P2108, DOI 10.3390/v2092108; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Botlagunta M, 2008, ONCOGENE, V27, P3912, DOI 10.1038/onc.2008.33; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Brenndorfer ED, 2009, HEPATOLOGY, V49, P1810, DOI 10.1002/hep.22857; Castelli FA, 2007, EUR J IMMUNOL, V37, P1513, DOI 10.1002/eji.200636783; Day CL, 2002, J VIROL, V76, P12584, DOI 10.1128/JVI.76.24.12584-12595.2002; Deng L, 2006, J GEN VIROL, V87, P1703, DOI 10.1099/vir.0.81735-0; Deng L, 2011, J VIROL, V85, P8556, DOI 10.1128/JVI.00146-11; Diepolder HM, 1997, J VIROL, V71, P6011, DOI 10.1128/JVI.71.8.6011-6019.1997; DIEPOLDER HM, 1995, LANCET, V346, P1006, DOI 10.1016/S0140-6736(95)91691-1; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Frick DN, 2007, CURR ISSUES MOL BIOL, V9, P1; Gale M, 2005, NATURE, V436, P939, DOI 10.1038/nature04078; GRAKOUI A, 1993, J VIROL, V67, P2832, DOI 10.1128/JVI.67.5.2832-2843.1993; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hegde R, 2005, J VIROL, V79, P14688, DOI 10.1128/JVI.79.23.14688-14697.2005; Hidajat R, 2005, J GEN VIROL, V86, P2197, DOI 10.1099/vir.0.80862-0; JARVIS TC, 1991, TRENDS GENET, V7, P186, DOI 10.1016/0168-9525(91)90434-R; Kaukinen P, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-66; Kuang WF, 2004, BIOCHEM BIOPH RES CO, V317, P211, DOI 10.1016/j.bbrc.2004.03.032; Levrero M, 2006, ONCOGENE, V25, P3834, DOI 10.1038/sj.onc.1209562; LIN C, 1994, J VIROL, V68, P8147, DOI 10.1128/JVI.68.12.8147-8157.1994; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Love RA, 1996, CELL, V87, P331, DOI 10.1016/S0092-8674(00)81350-1; MacDonald AJ, 2002, J INFECT DIS, V185, P720, DOI 10.1086/339340; Martinez MA, 2003, ANTIMICROB AGENTS CH, V47, P1760, DOI 10.1128/AAC.47.5.1760-1765.2003; Mashiba T, 2007, IMMUNOGENETICS, V59, P197, DOI 10.1007/s00251-006-0185-3; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Missale G, 1996, J CLIN INVEST, V98, P706, DOI 10.1172/JCI118842; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Morikawa K, 2011, J VIRAL HEPATITIS, V18, P305, DOI 10.1111/j.1365-2893.2011.01451.x; Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053; Nascimbeni M, 2003, J VIROL, V77, P4781, DOI 10.1128/JVI.77.8.4781-4793.2003; Penna A, 2002, HEPATOLOGY, V35, P1225, DOI 10.1053/jhep.2002.33153; Rajkowitsch L, 2007, RNA BIOL, V4, P118, DOI 10.4161/rna.4.3.5445; Raviprakash Kanakatte, 2006, V127, P83; Robert F, 2013, WIRES RNA, V4, P333, DOI 10.1002/wrna.1163; Scheel TKH, 2013, NAT MED, V19, P837, DOI 10.1038/nm.3248; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Sun SY, 2010, CURR OPIN STRUC BIOL, V20, P114, DOI 10.1016/j.sbi.2009.12.006; Tai CL, 2001, J VIROL, V75, P8289, DOI 10.1128/JVI.75.17.8289-8297.2001; Takaki A, 2000, NAT MED, V6, P578, DOI 10.1038/75063; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; TOMEI L, 1993, J VIROL, V67, P4017, DOI 10.1128/JVI.67.7.4017-4026.1993; Vlachakis D, 2011, PROTOCOL EXCHANGE, DOI [10.1038/protex.2011.275., DOI 10.1038/PROTEX.2011.275]; Wedemeyer H, 2002, J IMMUNOL, V169, P3447, DOI 10.4049/jimmunol.169.6.3447; Wertheimer AM, 2003, HEPATOLOGY, V37, P577, DOI 10.1053/jhep.2003.50115; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; Zhou F, 2012, J VIROL, V86, P6970, DOI 10.1128/JVI.06930-11	54	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98877	10.1371/journal.pone.0098877	http://dx.doi.org/10.1371/journal.pone.0098877			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901478	Green Submitted, Green Published, gold			2022-12-27	WOS:000336841400064
J	Baudier, KM; Kaschock-Marenda, SD; Patel, N; Diangelus, KL; O'Donnell, S; Marenda, DR				Baudier, Kaitlin M.; Kaschock-Marenda, Simon D.; Patel, Nirali; Diangelus, Katherine L.; O'Donnell, Sean; Marenda, Daniel R.			Erythritol, a Non-Nutritive Sugar Alcohol Sweetener and the Main Component of Truvia (R), Is a Palatable Ingested Insecticide	PLOS ONE			English	Article							MANNOSE TOXICITY; DROSOPHILA; TOLERANCE	Insecticides have a variety of commercial applications including urban pest control, agricultural use to increase crop yields, and prevention of proliferation of insect-borne diseases. Many pesticides in current use are synthetic molecules such as organochlorine and organophosphate compounds. Some synthetic insecticides suffer drawbacks including high production costs, concern over environmental sustainability, harmful effects on human health, targeting non-intended insect species, and the evolution of resistance among insect populations. Thus, there is a large worldwide need and demand for environmentally safe and effective insecticides. Here we show that Erythritol, a non-nutritive sugar alcohol, was toxic to the fruit fly Drosophila melanogaster. Ingested erythritol decreased fruit fly longevity in a dose-dependent manner, and erythritol was ingested by flies that had free access to control (sucrose) foods in choice and CAFE studies. Erythritol was US FDA approved in 2001 and is used as a food additive in the United States. Our results demonstrate, for the first time, that erythritol may be used as a novel, environmentally sustainable and human safe approach for insect pest control.	[Baudier, Kaitlin M.; Kaschock-Marenda, Simon D.; Patel, Nirali; Diangelus, Katherine L.; O'Donnell, Sean; Marenda, Daniel R.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Baudier, Kaitlin M.; O'Donnell, Sean] Drexel Univ, Dept Biodivers Earth & Environm Sci, Philadelphia, PA 19104 USA; [Marenda, Daniel R.] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19104 USA	Drexel University; Drexel University; Drexel University	O'Donnell, S (corresponding author), Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA.	so356@drexel.edu; Daniel.Marenda@drexel.edu	Baudier, Kaitlin/I-4138-2019	Baudier, Kaitlin/0000-0001-8450-3788	NSF IOS [1256114, 1209072]; Direct For Biological Sciences [1209072] Funding Source: National Science Foundation	NSF IOS(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Support was provided by NSF IOS 1256114 (to DRM); NSF IOS 1209072 (to SO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUST JG, 1979, PHYSIOL ENTOMOL, V4, P1, DOI 10.1111/j.1365-3032.1979.tb00171.x; Bornet FRJ, 1996, REGUL TOXICOL PHARM, V24, pS296, DOI 10.1006/rtph.1996.0111; Chakraborty R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020799; Danks HV, 2004, INTEGR COMP BIOL, V44, P85, DOI 10.1093/icb/44.2.85; DELAFUENTE M, 1986, BIOCHEM BIOPH RES CO, V140, P51, DOI 10.1016/0006-291X(86)91056-9; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Kostal V, 2007, J INSECT PHYSIOL, V53, P580, DOI 10.1016/j.jinsphys.2007.02.009; LEBOURG E, 1992, GERONTOLOGY, V38, P71; McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968; Moon HJ, 2010, APPL MICROBIOL BIOT, V86, P1017, DOI 10.1007/s00253-010-2496-4; Oku T, 1996, NUTR RES, V16, P577, DOI 10.1016/0271-5317(96)00036-X; Pimentel David, 2005, Environment Development and Sustainability, V7, P229, DOI 10.1007/s10668-005-7314-2; SILVA CP, 1995, INSECT BIOCHEM MOLEC, V25, P487, DOI 10.1016/0965-1748(94)00088-G; SOLS A, 1960, SCIENCE, V131, P297, DOI 10.1126/science.131.3396.297; Storey D, 2007, EUR J CLIN NUTR, V61, P349, DOI 10.1038/sj.ejcn.1602532; Subramanian Meera, 2013, NY TIMES; Tetzloff W, 1996, REGUL TOXICOL PHARM, V24, pS286, DOI 10.1006/rtph.1996.0110; TOKUOKA K, 1992, J GEN APPL MICROBIOL, V38, P145, DOI 10.2323/jgam.38.145; Wong R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006063	19	42	44	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98949	10.1371/journal.pone.0098949	http://dx.doi.org/10.1371/journal.pone.0098949			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896294	Green Published, gold, Green Submitted			2022-12-27	WOS:000338430700099
J	Hall, JB; Dumitrescu, L; Dilks, HH; Crawford, DC; Bush, WS				Hall, Jacob B.; Dumitrescu, Logan; Dilks, Holli H.; Crawford, Dana C.; Bush, William S.			Accuracy of Administratively-Assigned Ancestry for Diverse Populations in an Electronic Medical Record-Linked Biobank	PLOS ONE			English	Article							PHENOME-WIDE; GENETIC ANCESTRY; RACE; ETHNICITY; STRATIFICATION; ASSOCIATION; CHALLENGES; PHEWAS	Recently, the development of biobanks linked to electronic medical records has presented new opportunities for genetic and epidemiological research. Studies based on these resources, however, present unique challenges, including the accurate assignment of individual-level population ancestry. In this work we examine the accuracy of administratively-assigned race in diverse populations by comparing assigned races to genetically-defined ancestry estimates. Using 220 ancestry informative markers, we generated principal components for patients in our dataset, which were used to cluster patients into groups based on genetic ancestry. Consistent with other studies, we find a strong overall agreement (Kappa = 0.872) between genetic ancestry and assigned race, with higher rates of agreement for African-descent and European-descent assignments, and reduced agreement for Hispanic, East Asian-descent, and South Asian-descent assignments. These results suggest caution when selecting study samples of non-African and non-European backgrounds when administratively-assigned race from biobanks is used.	[Hall, Jacob B.; Dumitrescu, Logan; Crawford, Dana C.; Bush, William S.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37235 USA; [Dilks, Holli H.] Vanderbilt Univ, Vanderbilt Technol Adv Genom VANTAGE, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University	Bush, WS (corresponding author), Vanderbilt Univ, Ctr Human Genet Res, 221 Kirkland Hall, Nashville, TN 37235 USA.	william.s.bush@vanderbilt.edu	Crawford, Dana/O-5578-2019; Bush, William/N-1369-2019	Crawford, Dana/0000-0002-6437-6248; Bush, William/0000-0002-9729-6519	NCATS/NIH [UL1 TR000445]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [T32EY021453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178] Funding Source: NIH RePORTER	NCATS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The dataset used for the analyses described was obtained from Vanderbilt University Medical Center's BioVU, which is supported by institutional funding and by the Vanderbilt CTSA grant UL1 TR000445 from NCATS/NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamshad M, 2004, NAT REV GENET, V5, P598, DOI 10.1038/nrg1401; Barnholtz-Sloan JS, 2005, CANCER EPIDEM BIOMAR, V14, P1545, DOI 10.1158/1055-9965.EPI-04-0832; Denny JC, 2011, AM J HUM GENET, V89, P529, DOI 10.1016/j.ajhg.2011.09.008; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Dumitrescu L, 2010, GENET MED, V12, P648, DOI 10.1097/GIM.0b013e3181efe2df; Fraley C., 2006, MCLUST VERSION 3 R P; Gomez SL, 2005, ANN EPIDEMIOL, V15, P71, DOI 10.1016/j.annepidem.2004.03.002; Gravlee CC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006821; Hasnain-Wynia R, 2006, HEALTH SERV RES, V41, P1501, DOI 10.1111/j.1475-6773.2006.00552.x; Kressin NR, 2003, AM J PUBLIC HEALTH, V93, P1734, DOI 10.2105/AJPH.93.10.1734; Moscou S, 2003, AM J PUBLIC HEALTH, V93, P1084, DOI 10.2105/AJPH.93.7.1084; Pendergrass SA, 2011, GENET EPIDEMIOL, V35, P410, DOI 10.1002/gepi.20589; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Reich D, 2008, NAT GENET, V40, P491, DOI 10.1038/ng0508-491; Ritchie MD, 2010, AM J HUM GENET, V86, P560, DOI 10.1016/j.ajhg.2010.03.003; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Roden DM, 2012, CLIN PHARMACOL THER, V91, P1083, DOI 10.1038/clpt.2012.42; Swallen KC, 1997, ANN EPIDEMIOL, V7, P200, DOI 10.1016/S1047-2797(96)00154-8; Terrell KM, 2009, J AM GERIATR SOC, V57, P1388, DOI 10.1111/j.1532-5415.2009.02352.x; U.S. Census Bureau, 2010, PROF GEN POP HOUS CH; Wickens T. D., 1989, MULTIWAY CONTINGENCY; Wilke RA, 2011, CLIN PHARMACOL THER, V89, P379, DOI 10.1038/clpt.2010.260; Wright A, J AM MED INFORM ASS, V16, P637; Yaeger R, 2008, CANCER EPIDEM BIOMAR, V17, P1329, DOI 10.1158/1055-9965.EPI-07-2505	25	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99161	10.1371/journal.pone.0099161	http://dx.doi.org/10.1371/journal.pone.0099161			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK4YO	24896101	Green Published, Green Submitted, gold			2022-12-27	WOS:000338430700119
J	Kougioumtzi, A; Tsaparas, P; Magklara, A				Kougioumtzi, Anastasia; Tsaparas, Panayiotis; Magklara, Angeliki			Deep Sequencing Reveals New Aspects of Progesterone Receptor Signaling in Breast Cancer Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INDUCED LEUCINE-ZIPPER; FOCAL ADHESION KINASE; MAMMARY-GLAND; GENE-REGULATION; RNA-SEQ; ESTROGEN-RECEPTOR; EMERGING ROLES; GENOMIC DATA; EXPRESSION	Despite the pleiotropic effects of the progesterone receptor in breast cancer, the molecular mechanisms in play remain largely unknown. To gain a global view of the PR-orchestrated networks, we used next-generation sequencing to determine the progestin-regulated transcriptome in T47D breast cancer cells. We identify a large number of PR target genes involved in critical cellular programs, such as regulation of transcription, apoptosis, cell motion and angiogenesis. Integration of the transcriptomic data with the PR-binding profiling of hormonally treated cells identifies numerous components of the small-GTPases signaling pathways as direct PR targets. Progestin-induced deregulation of the small GTPases may contribute to the PR's role in mammary tumorigenesis. Transcript expression analysis reveals significant expression changes of specific transcript variants in response to the extracellular hormonal stimulus. Using the NET1 gene as an example, we show that the PR can dictate alternative promoter usage leading to the upregulation of an isoform that may play a role in metastatic breast cancer. Future studies should aim to characterize these selectively regulated variants and evaluate their clinical utility in prognosis and targeted therapy of hormonally responsive breast tumors.	[Kougioumtzi, Anastasia] Univ Ioannina, Dept Biol Applicat & Technol, GR-45110 Ioannina, Greece; [Tsaparas, Panayiotis] Univ Ioannina, Dept Comp Sci & Engn, GR-45110 Ioannina, Greece; [Magklara, Angeliki] Univ Ioannina, Sch Med, Clin Chem Lab, GR-45110 Ioannina, Greece; [Magklara, Angeliki] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Dept Biomed Res, Ioannina, Greece	University of Ioannina; University of Ioannina; University of Ioannina; Foundation for Research & Technology - Hellas (FORTH)	Magklara, A (corresponding author), Univ Ioannina, Sch Med, Clin Chem Lab, GR-45110 Ioannina, Greece.	magklara@cc.uoi.gr	Magklara, Angeliki/AAK-8347-2020	Magklara, Angeliki/0000-0003-3408-6722; Tsaparas, Panayiotis/0000-0002-3490-1507	Marie Curie Career Integration Grant [PCIG10-GA-2011-303519]; internal IMBB grant	Marie Curie Career Integration Grant; internal IMBB grant	This work was supported by a Marie Curie Career Integration Grant (PCIG10-GA-2011-303519) and an internal IMBB grant to AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2007, NUCLEIC ACIDS RES, V35, pW91, DOI 10.1093/nar/gkm260; Ballare C, 2013, MOL CELL, V49, P67, DOI 10.1016/j.molcel.2012.10.019; Bhat-Nakshatri P, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-21; Brisken C, 2013, NAT REV CANCER, V13, P385, DOI 10.1038/nrc3518; Caputo E, 2000, J BIOL CHEM, V275, P7935, DOI 10.1074/jbc.275.11.7935; Carr HS, 2013, MOL CELL BIOL, V33, P2773, DOI 10.1128/MCB.00175-13; Chatterton RT, 2002, CANCER LETT, V188, P47, DOI 10.1016/S0304-3835(02)00461-5; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chu PG, 2002, HISTOPATHOLOGY, V40, P403, DOI 10.1046/j.1365-2559.2002.01387.x; Clarke CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035859; Conneely OM, 2003, J MAMMARY GLAND BIOL, V8, P205, DOI 10.1023/A:1025952924864; Croce MV, 2003, BREAST CANCER RES TR, V81, P195, DOI 10.1023/A:1026110417294; Csepanyi-Komi R, 2012, MOL CELL ENDOCRINOL, V353, P10, DOI 10.1016/j.mce.2011.11.005; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Dutertre M, 2010, RNA BIOL, V7, P403, DOI 10.4161/rna.7.4.12152; Dutertre M, 2010, CANCER RES, V70, P3760, DOI 10.1158/0008-5472.CAN-09-3988; Echeverria PC, 2010, BBA-MOL CELL RES, V1803, P641, DOI 10.1016/j.bbamcr.2009.11.012; Eswaran J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00264; Fritzsche FR, 2006, CLIN CANCER RES, V12, P1728, DOI 10.1158/1078-0432.CCR-05-2057; Fu XD, 2010, ENDOCR-RELAT CANCER, V17, P431, DOI 10.1677/ERC-09-0258; Fu XD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002790; Garcia-Murillas I, 2013, ONCOGENE; Ghatge RP, 2005, BREAST CANCER RES, V7, pR1036, DOI 10.1186/bcr1340; Graham JD, 2005, MOL ENDOCRINOL, V19, P2713, DOI 10.1210/me.2005-0126; Groshong SD, 1997, MOL ENDOCRINOL, V11, P1593, DOI 10.1210/me.11.11.1593; Hah N, 2014, MOL CELL ENDOCRINOL, V382, P652, DOI 10.1016/j.mce.2013.06.021; Heiss G, 2008, JAMA-J AM MED ASSOC, V299, P1036, DOI 10.1001/jama.299.9.1036; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hubler TR, 2004, CELL STRESS CHAPERON, V9, P243, DOI 10.1379/CSC-32R.1; Hyder SM, 2009, ENDOCR-RELAT CANCER, V16, P809, DOI 10.1677/ERC-08-0311; Hyder SM, 1998, CANCER RES, V58, P392; Hyder SM, 2001, INT J CANCER, V92, P469, DOI 10.1002/ijc.1236; Jacobsen BM, 2005, MOL ENDOCRINOL, V19, P574, DOI 10.1210/me.2004-0287; Kakinuma N, 2009, CELL MOL LIFE SCI, V66, P2651, DOI 10.1007/s00018-009-0038-y; Kato S, 2005, J CLIN ENDOCR METAB, V90, P1181, DOI 10.1210/jc.2004-0857; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim JJ, 2013, ENDOCR REV, V34, P130, DOI 10.1210/er.2012-1043; Knutson TP, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3211; Kornblihtt AR, 2013, NAT REV MOL CELL BIO, V14, P153, DOI 10.1038/nrm3525; Lain AR, 2013, MOL ENDOCRINOL, V27, P1743, DOI 10.1210/me.2013-1144; Lange CA, 1999, MOL ENDOCRINOL, V13, P829, DOI 10.1210/me.13.6.829; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang YY, 2006, ENDOCR-RELAT CANCER, V13, P905, DOI 10.1677/erc.1.01221; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Lydon JP, 1999, CANCER RES, V59, P4276; Magklara A, 2009, MOL ENDOCRINOL, V23, P61, DOI 10.1210/me.2008-0028; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Meyer CA, 2012, MOL ENDOCRINOL, V26, P1651, DOI 10.1210/me.2012-1150; Mulac-Jericevic B, 2004, REPRODUCTION, V128, P139, DOI 10.1530/rep.1.00189; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Obr AE, 2012, MOL CELL ENDOCRINOL, V357, P4, DOI 10.1016/j.mce.2011.10.030; Omenn GS, 2013, J PROTEOMICS, V90, P28, DOI 10.1016/j.jprot.2013.04.007; Pajares MJ, 2007, LANCET ONCOL, V8, P349, DOI 10.1016/S1470-2045(07)70104-3; Papadimitriou E, 2012, ONCOGENE, V31, P2862, DOI 10.1038/onc.2011.457; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Redjimi N, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-83; Richer JK, 2002, J BIOL CHEM, V277, P5209, DOI 10.1074/jbc.M110090200; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schnelzer A, 2000, ONCOGENE, V19, P3013, DOI 10.1038/sj.onc.1203621; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Simmen RCM, 2010, J ENDOCRINOL, V204, P223, DOI 10.1677/JOE-09-0329; Soundararajan R, 2007, J BIOL CHEM, V282, P36303, DOI 10.1074/jbc.M707287200; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wan YH, 2002, MOL ENDOCRINOL, V16, P1204, DOI 10.1210/me.16.6.1204; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Wang Y, 2005, BIOCHEM BIOPH RES CO, V330, P1247, DOI 10.1016/j.bbrc.2005.03.106; Wertheimer E, 2012, CELL SIGNAL, V24, P353, DOI 10.1016/j.cellsig.2011.08.011; Whitman S, 2000, MOL CELL BIOL, V20, P583, DOI 10.1128/MCB.20.2.583-593.2000; Wu JB, 2004, CANCER RES, V64, P2238, DOI 10.1158/0008-5472.CAN-03-3044; Xu X, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S9-S1; Yee KO, 2009, BREAST CANCER RES TR, V114, P85, DOI 10.1007/s10549-008-9992-6; Yin P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029021; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng Rena, 2010, Genes Cancer, V1, P1178, DOI 10.1177/1947601911404223	76	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98404	10.1371/journal.pone.0098404	http://dx.doi.org/10.1371/journal.pone.0098404			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897521	Green Published, Green Submitted, gold			2022-12-27	WOS:000338430700042
J	Seth, I; Schwartz, JL; Stewart, RD; Emery, R; Joiner, MC; Tucker, JD				Seth, Isheeta; Schwartz, Jeffrey L.; Stewart, Robert D.; Emery, Robert; Joiner, Michael C.; Tucker, James D.			Neutron Exposures in Human Cells: Bystander Effect and Relative Biological Effectiveness	PLOS ONE			English	Article							SERUM SEROTONIN LEVELS; INDUCED GENOMIC INSTABILITY; COSMIC-RADIATION; IONIZING-RADIATION; SIGNALING PATHWAYS; SECONDARY NEUTRONS; HUMAN-LYMPHOCYTES; HUMAN FIBROBLASTS; EPITHELIAL-CELLS; CAPTURE THERAPY	Bystander effects have been observed repeatedly in mammalian cells following photon and alpha particle irradiation. However, few studies have been performed to investigate bystander effects arising from neutron irradiation. Here we asked whether neutrons also induce a bystander effect in two normal human lymphoblastoid cell lines. These cells were exposed to fast neutrons produced by targeting a near-monoenergetic 50.5 MeV proton beam at a Be target (17 MeV average neutron energy), and irradiated-cell conditioned media (ICCM) was transferred to unirradiated cells. The cytokinesis-block micronucleus assay was used to quantify genetic damage in radiation-naive cells exposed to ICCM from cultures that received 0 (control), 0.5, 1, 1.5, 2, 3 or 4 Gy neutrons. Cells grown in ICCM from irradiated cells showed no significant increase in the frequencies of micronuclei or nucleoplasmic bridges compared to cells grown in ICCM from sham irradiated cells for either cell line. However, the neutron beam has a photon dose-contamination of 5%, which may modulate a neutron-induced bystander effect. To determine whether these low doses of contaminating photons can induce a bystander effect, cells were irradiated with cobalt-60 at doses equivalent to the percent contamination for each neutron dose. No significant increase in the frequencies of micronuclei or bridges was observed at these doses of photons for either cell line when cultured in ICCM. As expected, high doses of photons induced a clear bystander effect in both cell lines for micronuclei and bridges (p<0.0001). These data indicate that neutrons do not induce a bystander effect in these cells. Finally, neutrons had a relative biological effectiveness of 2.0 +/- 0.13 for micronuclei and 5.8 +/- 2.9 for bridges compared to cobalt-60. These results may be relevant to radiation therapy with fast neutrons and for regulatory agencies setting standards for neutron radiation protection and safety.	[Seth, Isheeta; Tucker, James D.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Schwartz, Jeffrey L.; Stewart, Robert D.; Emery, Robert] Univ Washington, Sch Med, Dept Radiat Oncol, Seattle, WA USA; [Joiner, Michael C.] Wayne State Univ, Dept Radiat Oncol, Detroit, MI 48202 USA	Wayne State University; University of Washington; University of Washington Seattle; Wayne State University	Tucker, JD (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	jtucker@biology.biosci.wayne.edu	Stewart, Robert/A-3609-2013; seth, isheeta/AIB-4204-2022	Stewart, Robert/0000-0001-5946-0595; 	Wayne State University	Wayne State University	This work was in part supported by Wayne State University Graduate Enhancement Research Funds to Isheeta Seth. The remaining funds came from Dr. Tucker's Wayne State University Indirect Cost Account. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dagrosa MA, 2011, INT J RADIAT ONCOL, V79, P262, DOI 10.1016/j.ijrobp.2010.07.020; Asur RS, 2009, MUTAT RES-GEN TOX EN, V676, P11, DOI 10.1016/j.mrgentox.2009.02.012; Azzam EI, 2004, HUM EXP TOXICOL, V23, P61, DOI 10.1191/0960327104ht418oa; Baskar Rajamanickam, 2010, Genome Integr, V1, P13, DOI 10.1186/2041-9414-1-13; Belloni P, 2011, MUTAT RES-FUND MOL M, V713, P32, DOI 10.1016/j.mrfmmm.2011.05.010; Belyakov OV, 2001, BRIT J CANCER, V84, P674, DOI 10.1054/bjoc.2000.1665; Brooks AL, 2004, HUM EXP TOXICOL, V23, P67, DOI 10.1191/0960327104ht419oa; Burdak-Rothkamm S, 2008, CANCER RES, V68, P7059, DOI 10.1158/0008-5472.CAN-08-0545; CARNES BA, 1989, RADIAT RES, V119, P39, DOI 10.2307/3577366; Chapman KL, 2012, INT J RADIAT BIOL, V88, P781, DOI 10.3109/09553002.2012.710926; Chen S, 2011, MUTAT RES-FUND MOL M, V706, P59, DOI 10.1016/j.mrfmmm.2010.10.011; Chen SP, 2009, MUTAT RES-FUND MOL M, V666, P68, DOI 10.1016/j.mrfmmm.2009.04.006; Cheong HSJ, 2013, MUTAGENESIS, V28, P433, DOI 10.1093/mutage/get020; Chiba S, 2002, BONE MARROW TRANSPL, V29, P935, DOI 10.1038/sj.bmt.1703568; Dale Walter M., 1942, BIOCHEM JOUR, V36, P80; Dale WM, 1940, BIOCHEM J, V34, P1367, DOI 10.1042/bj0341367; DUNCAN W, 1987, RADIOTHER ONCOL, V8, P97, DOI 10.1016/S0167-8140(87)80162-7; EASTMOND DA, 1989, ENVIRON MOL MUTAGEN, V13, P34, DOI 10.1002/em.2850130104; Edwards GO, 2004, BRIT J CANCER, V90, P1450, DOI 10.1038/sj.bjc.6601686; Fenech M, 2011, MUTAGENESIS, V26, P125, DOI 10.1093/mutage/geq052; Fowler J F, 1975, J Can Assoc Radiol, V26, P40; Geard CR, 2002, RADIAT PROT DOSIM, V99, P233, DOI 10.1093/oxfordjournals.rpd.a006771; Ghandhi SA, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-63; Hamada Nobuyuki, 2011, Curr Mol Pharmacol, V4, P79; Han W, 2007, BRIT J RADIOL, V80, pS7, DOI 10.1259/bjr/44550200; Hei TK, 2008, J PHARM PHARMACOL, V60, P943, DOI 10.1211/jpp.60.8.0001; Heilbronn L, 2005, RADIAT PROT DOSIM, V116, P140, DOI 10.1093/rpd/nci033; Hu BR, 2006, CARCINOGENESIS, V27, P245, DOI 10.1093/carcin/bgi224; Ivanov VN, 2010, CELL SIGNAL, V22, P1076, DOI 10.1016/j.cellsig.2010.02.010; Joiner Michael, 2009, BASIC CLIN RADIOBIOL, DOI DOI 10.1201/B15450; Kalanxhi E, 2012, INT J RADIAT BIOL, V88, P773, DOI 10.3109/09553002.2012.711919; Kinashi Y, 2007, INT J RADIAT ONCOL, V68, P508, DOI 10.1016/j.ijrobp.2007.02.002; Lennox AJ, INT C ADV NEUTR SOUR; Liu ZF, 2006, RADIAT RES, V166, P19, DOI 10.1667/RR3580.1; Liu ZF, 2007, RADIAT RES, V168, P627, DOI 10.1667/RR1014.1; Lukina Ye Yu, 2010, Voprosy Onkologii (St. Petersburg), V56, P413; Lyng FM, 2006, RADIAT RES, V165, P400, DOI 10.1667/RR3527.1; Maguire P, 2005, RADIAT RES, V163, P384, DOI 10.1667/RR3325; Morgan WF, 2013, CANC LETT, DOI 101016/jcanlet201309009; Morgan WF, 2007, MUTAT RES-FUND MOL M, V616, P159, DOI 10.1016/j.mrfmmm.2006.11.009; Mothersill C, 2003, ONCOGENE, V22, P7028, DOI 10.1038/sj.onc.1206882; Mothersill C, 1997, INT J RADIAT BIOL, V71, P421, DOI 10.1080/095530097144030; Mothersill C, 2013, RAD ENV BIOPHYS; Mothersill C, 2013, J ENV RADIOACT; Mothersill C, 2012, INT J RADIAT BIOL, V88, P763, DOI 10.3109/09553002.2012.715795; Mothersill C, 2012, INT J RADIAT BIOL, V88, P583, DOI 10.3109/09553002.2012.698366; Mothersill C, 2011, INT J RADIAT BIOL, V87, P1120, DOI 10.3109/09553002.2011.610866; Mothersill C, 2010, RADIAT RES, V174, P119, DOI 10.1667/RR2036.1; NAGASAWA H, 1992, CANCER RES, V52, P6394; *NAT TOX PROGR, 2004, REP CARC; Ohnishi T, 2002, J RADIAT RES, V43, pS7; Perez-Andujar A, 2013, MED PHYS, V40, DOI 10.1118/1.4829512; Pinho C, 2012, INT J RADIAT BIOL, V88, P791, DOI 10.3109/09553002.2012.715794; Poon RCC, 2007, ENVIRON RES, V105, P200, DOI 10.1016/j.envres.2006.12.003; Prise KM, 2009, NAT REV CANCER, V9, P351, DOI 10.1038/nrc2603; Priyadarshi A, 2011, P NATL ACAD SCI USA, V108, P14422, DOI 10.1073/pnas.1109449108; Rajendran S, 2011, RADIAT RES, V175, P159, DOI 10.1667/RR2296.1; Resat MBS, 2004, J CELL BIOCHEM, V92, P1013, DOI 10.1002/jcb.20149; Ruhm W, 2009, RADIAT PROT DOSIM, V136, P256, DOI 10.1093/rpd/ncp161; Ruhm W, 2009, RADIAT ENVIRON BIOPH, V48, P125, DOI 10.1007/s00411-009-0219-y; Ryan LA, 2006, HEALTH PHYS, V91, P68, DOI 10.1097/01.HP.0000200339.91550.6b; Schettino G, 2005, RADIAT RES, V163, P332, DOI 10.1667/RR3319; Schmid E, 2003, RADIAT ENVIRON BIOPH, V42, P87, DOI 10.1007/s00411-003-0200-0; Schwartz JL, 2007, MUTAT RES-FUND MOL M, V616, P196, DOI 10.1016/j.mrfmmm.2006.11.016; Scott AH, 2013, DMSO HDB DOCTORS; Shao CL, 2004, J RADIAT RES, V45, P97, DOI 10.1269/jrr.45.97; Sokolov MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014195; Stannard C, 2013, RADIOTHER ONCOL, V109, P262, DOI 10.1016/j.radonc.2013.08.013; Task Group on Radiation Protection in Space ICRP Committee 2, 2013, Ann ICRP, V42, P1, DOI 10.1016/j.icrp.2013.05.004; Vukovic B, 2007, J ENVIRON RADIOACTIV, V98, P264, DOI 10.1016/j.jenvrad.2007.05.002; Vukovic B, 2010, APPL RADIAT ISOTOPES, V68, P2398, DOI 10.1016/j.apradiso.2010.06.017; Wang C, 2011, INT J RADIAT BIOL, V87, P964, DOI 10.3109/09553002.2011.584939; Wang H, 2013, CANC LETT, DOI 101016/jcanlet201309031; Watson GE, 2000, CANCER RES, V60, P5608; Yang M, 2011, RADIAT RES, V176, P303, DOI 10.1667/RR2589.1; Zhou HN, 2005, P NATL ACAD SCI USA, V102, P14641, DOI 10.1073/pnas.0505473102	76	27	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98947	10.1371/journal.pone.0098947	http://dx.doi.org/10.1371/journal.pone.0098947			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896095	Green Submitted, gold, Green Published			2022-12-27	WOS:000338430700098
J	Abidi, SH; Kalish, ML; Abbas, F; Rowland-Jones, S; Ali, S				Abidi, Syed Hani; Kalish, Marcia L.; Abbas, Farhat; Rowland-Jones, Sarah; Ali, Syed			HIV-1 Subtype A Gag Variability and Epitope Evolution	PLOS ONE			English	Article							DRUG-USERS; PHYLODYNAMICS; PREDICTION; INFECTION; SEQUENCES; COMMUNITY; NAIROBI; SINGLE; HBV; HCV	Objective: The aim of this study was to examine the course of time-dependent evolution of HIV-1 subtype A on a global level, especially with respect to the dynamics of immunogenic HIV gag epitopes. Methods: We used a total of 1,893 HIV-1 subtype A gag sequences representing a timeline from 1985 through 2010, and 19 different countries in Africa, Europe and Asia. The phylogenetic relationship of subtype A gag and its epidemic dynamics was analysed through a Maximum Likelihood tree and Bayesian Skyline plot, genomic variability was measured in terms of G -> A substitutions and Shannon entropy, and the time-dependent evolution of HIV subtype A gag epitopes was examined. Finally, to confirm observations on globally reported HIV subtype A sequences, we analysed the gag epitope data from our Kenyan, Pakistani, and Afghan cohorts, where both cohort-specific gene epitope variability and HLA restriction profiles of gag epitopes were examined. Results: The most recent common ancestor of the HIV subtype A epidemic was estimated to be 1956 +/- 1. A period of exponential growth began about 1980 and lasted for approximately 7 years, stabilized for 15 years, declined for 2-3 years, then stabilized again from about 2004. During the course of evolution, a gradual increase in genomic variability was observed that peaked in 2005-2010. We observed that the number of point mutations and novel epitopes in gag also peaked concurrently during 2005-2010. Conclusion: It appears that as the HIV subtype A epidemic spread globally, changing population immunogenetic pressures may have played a role in steering immune-evolution of this subtype in new directions. This trend is apparent in the genomic variability and epitope diversity of HIV-1 subtype A gag sequences.	[Abidi, Syed Hani; Ali, Syed] Aga Khan Univ, Dept Biol & Biomed Sci, Karachi, Pakistan; [Kalish, Marcia L.] Vanderbilt Univ, Vanderbilt Inst Global Hlth, Nashville, TN 37235 USA; [Abbas, Farhat] Aga Khan Univ, Dept Surg, Karachi, Pakistan; [Rowland-Jones, Sarah] Univ Oxford, Nuffield Dept Med, Oxford, England	Aga Khan University; Vanderbilt University; Aga Khan University; University of Oxford	Ali, S (corresponding author), Aga Khan Univ, Dept Biol & Biomed Sci, Karachi, Pakistan.	syed.ali@aku.edu		Abidi, Syed Hani/0000-0001-9497-0902	HIV Research Trust [HIVRT 10-059]	HIV Research Trust	For this study, Syed Hani Abidi's training was funded by HIV Research Trust (scholarship no. HIVRT 10-059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidi SH, 2013, INFECT GENET EVOL, V16, P78, DOI 10.1016/j.meegid.2013.02.003; Abidi SH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002926; Abidi SH, 2014, MED MICROBIOL IMMUN, V203, P57, DOI 10.1007/s00430-013-0314-1; Ansari AS, 2011, AIDS, V25, P1427, DOI 10.1097/QAD.0b013e32834800e7; Bettinotti MP, 1997, J IMMUNOTHER, V20, P425, DOI 10.1097/00002371-199711000-00001; Bhasin M, 2004, VACCINE, V22, P3195, DOI 10.1016/j.vaccine.2004.02.005; Bhasin M, 2007, J BIOSCIENCES, V32, P31, DOI 10.1007/s12038-007-0004-5; Brumme ZL, 2009, J EXP MED, V206, P1215, DOI 10.1084/jem.20091094; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Frost SDW, 2010, PHILOS T R SOC B, V365, P1879, DOI 10.1098/rstb.2010.0060; Hewitt EW, 2003, IMMUNOLOGY, V110, P163, DOI 10.1046/j.1365-2567.2003.01738.x; Jern P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000367; Khan S, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-164; Khanani MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022449; Khanani MR, 2010, J INFECTION, V61, P507, DOI 10.1016/j.jinf.2010.09.035; Khanani MR, 2010, J INFECTION, V61, P434, DOI 10.1016/j.jinf.2010.08.009; Khoja S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003191; Matthews PC, 2008, J VIROL, V82, P8548, DOI 10.1128/JVI.00580-08; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Novitsky V, 2010, VIRUSES-BASEL, V2, P33, DOI 10.3390/v2010033; Rai MA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-7; Robinson J, NUCL ACIDS RES, V39, pD1171; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Singh H, 2003, BIOINFORMATICS, V19, P1009, DOI 10.1093/bioinformatics/btg108; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Yang OO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007388; Zhang YH, 2011, J IMMUNOL, V187, P684, DOI 10.4049/jimmunol.1100316	29	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e93415	10.1371/journal.pone.0093415	http://dx.doi.org/10.1371/journal.pone.0093415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892852	Green Submitted, gold, Green Published			2022-12-27	WOS:000336911400001
J	Moustgaard, H; Joutsenniemi, K; Myrskyla, M; Martikainen, P				Moustgaard, Heta; Joutsenniemi, Kaisla; Myrskyla, Mikko; Martikainen, Pekka			Antidepressant Sales and the Risk for Alcohol-Related and Non-Alcohol-Related Suicide in Finland-An Individual-Level Population Study	PLOS ONE			English	Article							SEROTONIN REUPTAKE INHIBITORS; RANDOMIZED CONTROLLED-TRIALS; NORDIC COUNTRIES; FOLLOW-UP; RATES; MORTALITY; REGISTER; NONALCOHOL; DISORDERS; TRENDS	Objectives: A marked decline in suicide rates has co-occurred with increased antidepressant sales in several countries but the causal connection between the trends remains debated. Most previous studies have focused on overall suicide rates and neglected differential effects in population subgroups. Our objective was to investigate whether increasing sales of non-tricyclic antidepressants have reduced alcohol-and non-alcohol-related suicide risk in different population subgroups. Methods: We followed a nationally representative sample of 950,158 Finnish adults in 1995-2007 for alcohol-related (n = 2,859) and non-alcohol-related (n = 8,632) suicides. We assessed suicide risk by gender and social group according to regional sales of non-tricyclic antidepressants, measured by sold doses per capita, prevalence of antidepressant users, and proportion of antidepressant users with doses reflecting minimally adequate treatment. Fixed-effects Poisson regression models controlled for regional differences and time trends that may influence suicide risk irrespective of antidepressant sales. Results: The number of sold antidepressant doses per capita and the prevalence of antidepressant users were unrelated to male suicide risk. However, one percentage point increase in the proportion of antidepressant users receiving minimally adequate treatment reduced non-alcohol-related male suicide risk by one percent (relative risk 0.987, 95% confidence interval 0.976-0.998). This beneficial effect only emerged among men with high education, high income, and employment, among men without a partner, and men not owning their home. Alcohol-related suicides and female suicides were unrelated to all measures of antidepressant sales. Conclusion: We found little evidence that increase in overall sales or in the prevalence of non-tricyclic antidepressant users would have caused the fall in suicide rates in Finland in 1995-2007. However, the rise in the proportion of antidepressant users receiving minimally adequate treatment, possibly due to enhanced treatment compliance, may have prevented non-alcohol-related suicides among men.	[Moustgaard, Heta; Martikainen, Pekka] Univ Helsinki, Populat Res Unit, Dept Social Res, FIN-00014 Helsinki, Finland; [Joutsenniemi, Kaisla] Natl Inst Hlth & Welf, Dept Mental Hlth & Subst Abuse Serv, Helsinki, Finland; [Myrskyla, Mikko] Univ London London Sch Econ & Polit Sci, Dept Social Policy, London WC2A 2AE, England	University of Helsinki; Finland National Institute for Health & Welfare; University of London; London School Economics & Political Science	Moustgaard, H (corresponding author), Univ Helsinki, Populat Res Unit, Dept Social Res, FIN-00014 Helsinki, Finland.	heta.moustgaard@helsinki.fi		Moustgaard, Heta/0000-0001-6632-4727; Martikainen, Pekka/0000-0001-9374-1438	Finnish Doctoral Programs in Public Health; Academy of Finland; Finnish National Institute for Health and Welfare; Max Planck Society	Finnish Doctoral Programs in Public Health; Academy of Finland(Academy of Finland); Finnish National Institute for Health and Welfare; Max Planck Society(Max Planck SocietyFoundation CELLEX)	The study was funded by the Finnish Doctoral Programs in Public Health (HM) and Academy of Finland (HM & PM). KJ was funded by the Finnish National Institute for Health and Welfare. MM was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison P., 2009, FIXED EFFECTS REGRES, DOI [10.4135/9781412993869, DOI 10.4135/9781412993869]; Baldessarini RJ, 2007, HARVARD REV PSYCHIAT, V15, P133, DOI 10.1080/10673220701551102; Barbui C, 2009, CAN MED ASSOC J, V180, P291, DOI 10.1503/cmaj.081514; Beskow J, 1999, PSYCHIAT FENNICA, V30, P31; Bramness JG, 2007, J AFFECT DISORDERS, V102, P1, DOI 10.1016/j.jad.2006.12.002; Brook OH, 2006, J CLIN PSYCHOPHARM, V26, P643, DOI 10.1097/01.jcp.0000246217.34024.53; Chachamovich E, 2012, ALCOHOL, V46, P529, DOI 10.1016/j.alcohol.2012.03.007; Dahlberg M, 2005, ADV HEALTH ECON HEAL, V16, P121; Fergusson D, 2005, BMJ-BRIT MED J, V330, P396, DOI 10.1136/bmj.330.7488.396; Gardarsdottir H, 2007, J AFFECT DISORDERS, V98, P109, DOI 10.1016/j.jad.2006.07.003; Gibbons RD, 2005, ARCH GEN PSYCHIAT, V62, P165, DOI 10.1001/archpsyc.62.2.165; Grunebaum MF, 2004, J CLIN PSYCHIAT, V65, P1456, DOI 10.4088/JCP.v65n1103; Gunnell D, 2003, SOC SCI MED, V57, P595, DOI 10.1016/S0277-9536(02)00408-2; Gunnell D, 2005, BMJ-BRIT MED J, V330, P385, DOI 10.1136/bmj.330.7488.385; Gusmao R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066455; Harris EC, 1998, BRIT J PSYCHIAT, V173, P11, DOI 10.1192/bjp.173.1.11; Hirschfeld RMA, 2001, BRIT J PSYCHIAT, V179, pS4, DOI 10.1192/bjp.179.42.s4; Isacsson G, 2010, BRIT J PSYCHIAT, V196, P429, DOI 10.1192/bjp.bp.109.076166; Karlsson H, 2000, ACTA PSYCHIAT SCAND, V102, P354, DOI 10.1034/j.1600-0447.2000.102005354.x; Kelly CB, 2003, EUR PSYCHIAT, V18, P325, DOI 10.1016/j.eurpsy.2003.03.005; Kivimaki M, 2007, PSYCHOL MED, V37, P373, DOI 10.1017/S0033291706009457; Korkeila J, 2007, J CLIN PSYCHIAT, V68, P505, DOI 10.4088/JCP.v68n0403; Loomis D, 2005, OCCUP ENVIRON MED, V62, P325, DOI 10.1136/oem.2004.017459; Ludwig J, 2009, J HEALTH ECON, V28, P659, DOI 10.1016/j.jhealeco.2009.02.002; Maki N, 2009, SOC SCI MED, V68, P2161, DOI 10.1016/j.socscimed.2009.04.006; Maki N, 2008, EUR J POPUL, V24, P385, DOI 10.1007/s10680-007-9147-1; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; Moustgaard H, 2013, J AFFECT DISORDERS, V148, P278, DOI 10.1016/j.jad.2012.12.008; National Agency for Medicines, 2008, FINN STAT MED 2007; National Agency for Medicines and Social Insurance Institution, 1996, FINN STAT MED 1995; Reseland S, 2006, BRIT J PSYCHIAT, V188, P354, DOI 10.1192/bjp.188.4.354; Safer DJ, 2007, PUBLIC HEALTH, V121, P274, DOI 10.1016/j.puhe.2006.09.024; Sihvo S, 2008, J AFFECT DISORDERS, V110, P94, DOI 10.1016/j.jad.2008.01.012; StataCorp, 2009, STAT STAT SOFTW REL; Statistics Finland, 2009, CAUS DEATH 2007; SUOKAS J, 1995, ACTA PSYCHIAT SCAND, V91, P36, DOI 10.1111/j.1600-0447.1995.tb09739.x; Suominen KH, 2002, SCHIZOPHRENIA BULL, V28, P637, DOI 10.1093/oxfordjournals.schbul.a006970; Zahl PH, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-62	38	6	6	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98405	10.1371/journal.pone.0098405	http://dx.doi.org/10.1371/journal.pone.0098405			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5ML	24892560	Green Published, Green Accepted, gold			2022-12-27	WOS:000336911400047
J	von Versen-Hoynck, F; Brodowski, L; Dechend, R; Myerski, AC; Hubel, CA				von Versen-Hoeynck, Frauke; Brodowski, Lars; Dechend, Ralf; Myerski, Ashley C.; Hubel, Carl A.			Vitamin D Antagonizes Negative Effects of Preeclampsia on Fetal Endothelial Colony Forming Cell Number and Function	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; INTRAUTERINE GROWTH RESTRICTION; PROGENITOR CELLS; IN-VITRO; RISK; PREGNANCY; WOMEN; DISEASE; 1,25-DIHYDROXYVITAMIN-D; METAANALYSIS	Context: Endothelial dysfunction is a primary feature of preeclampsia, a pregnancy complication associated with an increased future cardiovascular risk for mother and offspring. Endothelial colony forming cells (ECFC) are endothelial progenitor cells that participate in vasculogenesis and endothelial repair. Objective: We hypothesized that the number and functional properties of fetal cord blood-derived ECFCs are reduced in preeclampsia compared to uncomplicated pregnancy (controls), and asked if adverse effects of preeclampsia on ECFC function are reversed by 1,25 (OH)(2) vitamin D-3. Design, Setting, Patients: This was a nested, case-control study. Forty women with uncomplicated pregnancy and 33 women with PE were recruited at Magee-Womens Hospital (USA) or at Hannover Medical School (Germany). Main Outcome Measures: Time to ECFC colony appearance in culture, and number of colonies formed, were determined. Functional abilities of ECFCs were assessed in vitro by tubule formation in Matrigel assay, migration, and proliferation. ECFC function was tested in the presence or absence of 1,25 (OH)(2) vitamin D-3, and after vitamin D receptor (VDR) or VEGF signaling blockade. Results: The number of cord ECFC colonies was lower (P = 0.04) in preeclampsia compared to controls. ECFCs from preeclampsia showed reduced proliferation (P < 0.0001), formed fewer tubules (P = 0.02), and migrated less (P = 0.049) than control. Vitamin D-3 significantly improved preeclampsia ECFC functional properties. VDR- or VEGF blockade reduced tubule formation, partially restorable by vitamin D-3. Conclusion: Fetal ECFCs from preeclamptic pregnancies are reduced in number and dysfunctional. Vitamin D-3 had rescuing effects. This may have implications for the increased cardiovascular risk associated with preeclampsia.	[von Versen-Hoeynck, Frauke; Brodowski, Lars] Hannover Med Sch, Gynecol Res Unit, Dept Obstet & Gynecol, Hannover, Germany; [Dechend, Ralf] Helios Klinikum Berlin Buch, Expt & Clin Res Ctr, Max Delbruck Ctr Mol Med, Berlin, Germany; [Dechend, Ralf] Helios Klinikum Berlin Buch, Fac Med, Charite, Berlin, Germany; [Dechend, Ralf] Helios Klinikum Berlin Buch, Franz Volhard Clin, Berlin, Germany; [Myerski, Ashley C.; Hubel, Carl A.] Univ Pittsburgh, Sch Med, Magee Womens Res Inst, Pittsburgh, PA 15260 USA; [Myerski, Ashley C.; Hubel, Carl A.] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA	Hannover Medical School; Helios Kliniken; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helios Kliniken; Franz-Volhard Clinical Research Center; Helios Kliniken; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hubel, CA (corresponding author), Univ Pittsburgh, Sch Med, Magee Womens Res Inst, Pittsburgh, PA 15260 USA.	chubel@mwri.magee.edu	von Versen-Höynck, Frauke/H-3719-2019	von Versen-Höynck, Frauke/0000-0002-1924-5695	National Institutes of Health [P01HD030367, UL1RR024153, UL1TR000005]; Hannover Medical School; Boehringer Ingelheim; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD030367] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hannover Medical School; Boehringer Ingelheim(Boehringer Ingelheim); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The study was supported by National Institutes of Health Grants P01HD030367 (CAH), UL1RR024153, and UL1TR000005 (University of Pittsburgh Clinical and Translational Science Institute), and a HiLF grant by Hannover Medical School. LB was supported by the Boehringer Ingelheim Funds travel grant program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUGUST P, 1992, AM J OBSTET GYNECOL, V166, P1295, DOI 10.1016/S0002-9378(11)90625-5; Bainbridge SA, 2009, AM J PHYSIOL-CELL PH, V297, pC440, DOI 10.1152/ajpcell.00593.2008; Brown MC, 2013, EUR J EPIDEMIOL, V28, P1, DOI 10.1007/s10654-013-9762-6; Chung I, 2009, CANCER RES, V69, P967, DOI 10.1158/0008-5472.CAN-08-2307; Davis EF, 2012, PEDIATRICS, V129, pE1552, DOI 10.1542/peds.2011-3093; Diaz L, 2009, J REPROD IMMUNOL, V81, P17, DOI 10.1016/j.jri.2009.02.005; Dignat-George F, 2003, PATHOPHYSIOL HAEMO T, V33, P495, DOI 10.1159/000083851; Egorova AD, 2012, IN VITRO CELL DEV-AN, V48, P21, DOI 10.1007/s11626-011-9470-z; FINA L, 1990, BLOOD, V75, P2417; Fraser A, 2013, HYPERTENSION, V62, P614, DOI 10.1161/HYPERTENSIONAHA.113.01513; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Grundmann M, 2012, AM J PHYSIOL-CELL PH, V303, pC954, DOI 10.1152/ajpcell.00030.2012; Halhali A, 2004, J STEROID BIOCHEM, V89-90, P553, DOI 10.1016/j.jsbmb.2004.03.069; Halhali A, 2014, J STEROID BIOCHEM, V144, P44, DOI 10.1016/j.jsbmb.2013.12.014; Haugen M, 2009, EPIDEMIOLOGY, V20, P720, DOI 10.1097/EDE.0b013e3181a70f08; Holick MF, 2004, AM J CLIN NUTR, V79, P362; Hwang HS, 2012, J MATERN-FETAL NEO M, V25, P1769, DOI 10.3109/14767058.2012.663826; Hwang HS, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.060; Hypponen E, 2013, ANN NUTR METAB, V63, P331, DOI 10.1159/000358338; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Ingram DA, 2008, DIABETES, V57, P724, DOI 10.2337/db07-1507; Kajantie E, 2009, STROKE, V40, P1176, DOI 10.1161/STROKEAHA.108.538025; Kwon JY, 2007, GYNECOL OBSTET INVES, V64, P103, DOI 10.1159/000100081; Lee JH, 2008, J AM COLL CARDIOL, V52, P1949, DOI 10.1016/j.jacc.2008.08.050; Lin C, 2009, AM J HYPERTENS, V22, P1014, DOI 10.1038/ajh.2009.101; Luppi P, 2010, REPROD SCI, V17, P643, DOI 10.1177/1933719110366164; Mantell DJ, 2000, CIRC RES, V87, P214, DOI 10.1161/01.RES.87.3.214; Monga R, 2012, J MATERN-FETAL NEO M, V25, P2385, DOI 10.3109/14767058.2012.697228; Povsic Thomas J, 2008, Ther Adv Cardiovasc Dis, V2, P199, DOI 10.1177/1753944708093412; Reynolds J, 2014, LANCET, V383, P89; Roberts JM, 2013, J REPROD IMMUNOL, V99, P1, DOI 10.1016/j.jri.2013.05.003; Roberts JM, 2000, SEMIN PERINATOL, V24, P24, DOI 10.1016/S0146-0005(00)80050-6; Sipos PI, 2010, PLACENTA, V31, P1, DOI 10.1016/j.placenta.2009.10.006; Sipos PI, 2013, J CLIN ENDOCR METAB, V98, P4953, DOI 10.1210/jc.2013-2580; Sipos PI, 2013, STEM CELLS, V31, P1363, DOI 10.1002/stem.1385; Sugawara J, 2005, J CLIN ENDOCR METAB, V90, P5329, DOI 10.1210/jc.2005-0532; Tabesh M, 2013, J CLIN ENDOCR METAB, V98, P3165, DOI 10.1210/jc.2013-1257; Wang YP, 2004, AM J OBSTET GYNECOL, V190, P817, DOI 10.1016/j.ajog.2003.09.049; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471	40	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98990	10.1371/journal.pone.0098990	http://dx.doi.org/10.1371/journal.pone.0098990			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892558	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000336911400117
J	Wang, GD; Wang, JL; Luo, XM; Ansari, GAS; Khan, MF				Wang, Gangduo; Wang, Jianling; Luo, Xuemei; Ansari, G. A. Shakeel; Khan, M. Firoze			Nitrosative Stress and Nitrated Proteins in Trichloroethene-Mediated Autoimmunity	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; NITRIC-OXIDE SYNTHASE; FACTOR-KAPPA-B; N-ACETYLCYSTEINE; DISEASE-ACTIVITY; LIPID-PEROXIDATION; OXIDATIVE STRESS; CHRONIC EXPOSURE; REACTIVE OXYGEN; UNITED-STATES	Exposure to trichloroethene (TCE), a ubiquitous environmental contaminant, has been linked to a variety of autoimmune diseases (ADs) including SLE, scleroderma and hepatitis. Mechanisms involved in the pathogenesis of ADs are largely unknown. Earlier studies from our laboratory in MRL+/+ mice suggested the contribution of oxidative/nitrosative stress in TCE-induced autoimmunity, and N-acetylcysteine (NAC) supplementation provided protection by attenuating oxidative stress. This study was undertaken to further evaluate the contribution of nitrosative stress in TCE-mediated autoimmunity and to identify proteins susceptible to nitrosative stress. Groups of female MRL+/+ mice were given TCE, NAC or TCE + NAC for 6 weeks (TCE, 10 mmol/kg, i.p., every 4th day; NAC, similar to 250 mg/kg/day via drinking water). TCE exposure led to significant increases in serum anti-nuclear and anti-histone antibodies together with significant induction of iNOS and increased formation of nitrotyrosine (NT) in sera and livers. Proteomic analysis identified 14 additional nitrated proteins in the livers of TCE-treated mice. Furthermore, TCE exposure led to decreased GSH levels and increased activation of NF-kappa B. Remarkably, NAC supplementation not only ameliorated TCE-induced nitrosative stress as evident from decreased iNOS, NT, nitrated proteins, NF-kappa B p65 activation and increased GSH levels, but also the markers of autoimmunity, as evident from decreased levels of autoantibodies in the sera. These findings provide support to the role of nitrosative stress in TCE-mediated autoimmune response and identify specific nitrated proteins which could have autoimmune potential. Attenuation of TCE-induced autoimmunity in mice by NAC provides an approach for designing therapeutic strategies.	[Wang, Gangduo; Wang, Jianling; Ansari, G. A. Shakeel; Khan, M. Firoze] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Luo, Xuemei] Univ Texas Med Branch, Biomol Resource Facil, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Khan, MF (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.	mfkhan@utmb.edu			National Institute of Environmental Health Sciences (NIEHS), NIH [ES016302]; NIEHS center grant [P30ES06676]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676, R01ES016302] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS center grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Grant ES016302 from the National Institute of Environmental Health Sciences (NIEHS), NIH and P30ES06676 (NIEHS center grant). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIEHS, NIH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi-Ashtiani H, 2012, J NAT MED-TOKYO, V66, P85, DOI 10.1007/s11418-011-0554-6; Aktunc E, 2010, CLIN EXP DERMATOL, V35, P902, DOI 10.1111/j.1365-2230.2010.03823.x; Al-Shobaili HA, 2013, LUPUS, V22, P1024, DOI 10.1177/0961203313498803; Al-Shobaili HA, 2013, IMMUNOL INVEST, V42, P191, DOI 10.3109/08820139.2012.751396; Amrouche-Mekkioui I, 2012, EUR J PHARMACOL, V691, P209, DOI 10.1016/j.ejphar.2012.06.014; Andresen L, 2005, GUT, V54, P503, DOI 10.1136/gut.2003.034165; Cai P, 2008, TOXICOL APPL PHARM, V228, P68, DOI 10.1016/j.taap.2007.11.031; Channel SR, 1998, TOXICOL SCI, V43, P145; de Andres MC, 2013, ARTHRITIS RHEUM-US, V65, P732, DOI 10.1002/art.37806; Downs I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038051; Egner W, 2000, J CLIN PATHOL, V53, P424, DOI 10.1136/jcp.53.6.424; Fan XZ, 2011, TOXICOL APPL PHARM, V255, P103, DOI 10.1016/j.taap.2011.06.005; Frostegard J, 2005, ARTHRITIS RHEUM-US, V52, P192, DOI 10.1002/art.20780; Griffin JM, 2000, IMMUNOPHARMACOLOGY, V46, P123, DOI 10.1016/S0162-3109(99)00164-2; Griffiths HR, 2008, AUTOIMMUN REV, V7, P544, DOI 10.1016/j.autrev.2008.04.013; Hill BG, 2010, J BIOL CHEM, V285, P19699, DOI 10.1074/jbc.R110.101618; Ho E, 1999, FASEB J, V13, P1845, DOI 10.1096/fasebj.13.13.1845; Jacobson DL, 1997, CLIN IMMUNOL IMMUNOP, V84, P223, DOI 10.1006/clin.1997.4412; Karpuzoglu E, 2006, NITRIC OXIDE-BIOL CH, V15, P177, DOI 10.1016/j.niox.2006.03.009; KHAN MF, 1995, TOXICOL APPL PHARM, V134, P155, DOI 10.1006/taap.1995.1179; Khan MF, 2001, TOXICOL APPL PHARM, V170, P88, DOI 10.1006/taap.2000.9086; KILBURN KH, 1992, ENVIRON RES, V57, P1, DOI 10.1016/S0013-9351(05)80014-3; Kim DH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059316, 10.1371/journal.pone.0070684]; Kurien BT, 2008, AUTOIMMUN REV, V7, P567, DOI 10.1016/j.autrev.2008.04.019; Lai ZW, 2012, ARTHRITIS RHEUM-US, V64, P2937, DOI 10.1002/art.34502; Li Y, 2013, NEUROSCIENCE, V248, P681, DOI 10.1016/j.neuroscience.2013.06.030; Morgan PE, 2009, FREE RADICAL RES, V43, P117, DOI 10.1080/10715760802623896; Nagareddy PR, 2006, J CARDIOVASC PHARM, V47, P513, DOI 10.1097/01.fjc.0000211744.93701.25; Nagy G, 2007, IMMUNOL LETT, V111, P1, DOI 10.1016/j.imlet.2007.04.013; Niwano S, 2011, CIRC J, V75, P662, DOI 10.1253/circj.CJ-10-0673; Nur E, 2012, ANN HEMATOL, V91, P1097, DOI 10.1007/s00277-011-1404-z; Oates JC, 1999, P ASSOC AM PHYSICIAN, V111, P611, DOI 10.1046/j.1525-1381.1999.99110.x; Oates JC, 2010, AUTOIMMUNITY, V43, P56, DOI 10.3109/08916930903374683; Ohmori H, 2005, AUTOIMMUN REV, V4, P224, DOI 10.1016/j.autrev.2004.11.011; Owen JB, 2010, METHODS MOL BIOL, V648, P269, DOI 10.1007/978-1-60761-756-3_18; Perricone C, 2009, AUTOIMMUN REV, V8, P697, DOI 10.1016/j.autrev.2009.02.020; Phillips DC, 2010, ANTIOXID REDOX SIGN, V12, P743, DOI 10.1089/ars.2009.2607; Reveille J, 2004, LUPUS, V13, P290, DOI 10.1191/0961203303lu1015oa; Samuni Y, 2013, BBA-GEN SUBJECTS, V1830, P4117, DOI 10.1016/j.bbagen.2013.04.016; Shah D, 2010, IMMUNOL LETT, V129, P7, DOI 10.1016/j.imlet.2010.01.005; Suwannaroj S, 2001, LUPUS, V10, P258, DOI 10.1191/096120301680416940; Walsh SJ, 2000, AM J PUBLIC HEALTH, V90, P1463, DOI 10.2105/AJPH.90.9.1463; Wanchu A, 1998, RHEUMATOL INT, V18, P41, DOI 10.1007/s002960050055; Wang GD, 2008, FREE RADICAL BIO MED, V44, P1475, DOI 10.1016/j.freeradbiomed.2008.01.012; Wang GD, 2007, TOXICOLOGY, V229, P186, DOI 10.1016/j.tox.2006.10.014; Wang GD, 2013, TOXICOL APPL PHARM, V273, P189, DOI 10.1016/j.taap.2013.08.020; Wang GD, 2012, TOXICOLOGY, V292, P113, DOI 10.1016/j.tox.2011.12.001; Wang GD, 2010, ARTHRITIS RHEUM-US, V62, P2064, DOI 10.1002/art.27442; Wang GD, 2009, TOXICOL APPL PHARM, V237, P188, DOI 10.1016/j.taap.2009.03.010; Wang JL, 2008, TOXICOL APPL PHARM, V230, P227, DOI 10.1016/j.taap.2008.02.022; WEINBERG JB, 1994, J EXP MED, V179, P651, DOI 10.1084/jem.179.2.651; Wu SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040727; Xia Y, 1997, P NATL ACAD SCI USA, V94, P6954, DOI 10.1073/pnas.94.13.6954; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001; Zhu QX, 2005, TOXICOLOGY, V209, P55, DOI 10.1016/j.tox.2004.12.006	55	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98660	10.1371/journal.pone.0098660	http://dx.doi.org/10.1371/journal.pone.0098660			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892995	Green Submitted, gold, Green Published			2022-12-27	WOS:000336911400082
J	Wang, W; Yao, XF; Zhai, JP; Ji, MH				Wang, Wei; Yao, Xinfeng; Zhai, Junpeng; Ji, Minhe			A Tetrahedron-Based Endmember Selection Approach for Urban Impervious Surface Mapping	PLOS ONE			English	Article							SPECTRAL MIXTURE ANALYSIS; MULTIOBJECTIVE OPTIMIZATION; PIXEL CLASSIFICATION; LAND-USE; MODEL; EXTRACTION; ALGORITHM; INDIANAPOLIS; INDEX	The pixel purity index (PPI) and two-dimensional (2-D) scatter plots are two popular techniques for endmember extraction in remote sensing spectral mixture analysis, yet both suffer from one major drawback, that is, the selection of a final set of endmembers has to endure a cumbersome process of iterative visual inspection and human intervention, especially when a spectrally-complex urban scene is involved. Within the conceptual framework of a V-H-L-S (vegetation-high albedo-low albedo-soil) model, which is expanded from the classic V-I-S (vegetation-impervious surface-soil) model, a tetrahedron-based endmember selection approach combined with a multi-objective optimization genetic algorithm (MOGA) was designed to identify urban endmembers from multispectral imagery. The tetrahedron defining the enclosing volume of MNF-transformed pixels in a three-dimensional (3-D) space was algorithmically sought, so that the tetrahedral vertices can ideally match the four components of the adopted model. A case study with Landsat Enhanced Thematic Mapper Plus (ETM+) satellite imagery in Shanghai, China was conducted to verify the validity of the method. The method performance was compared with those of the traditional PPI and 2-D scatter plots approaches. The results indicated that the tetrahedron-based endmember selection approach performed better in both accuracy and ease of identification for urban surface endmembers owing to the 3-D visualization analysis and use of the MOGA.	[Wang, Wei; Zhai, Junpeng; Ji, Minhe] E China Normal Univ, Key Lab GISci, Educ Minist China, Shanghai 200062, Peoples R China; [Yao, Xinfeng] Shanghai Acad Agr Sci, Agr Informat Inst Sci & Technol, Shanghai, Peoples R China	East China Normal University; Shanghai Academy of Agricultural Sciences	Ji, MH (corresponding author), E China Normal Univ, Key Lab GISci, Educ Minist China, Shanghai 200062, Peoples R China.	mhji@geo.ecnu.edu.cn			National Basic Research Program of China [2010CB951603]; Shanghai Natural Science Foundation [13ZR1436900]	National Basic Research Program of China(National Basic Research Program of China); Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai)	This work was supported by National Basic Research Program of China (No. 2010CB951603) and the Shanghai Natural Science Foundation (No. 13ZR1436900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JB, 1995, REMOTE SENS ENVIRON, V52, P137, DOI 10.1016/0034-4257(94)00098-8; Alberti M, 2005, INT REGIONAL SCI REV, V28, P168, DOI 10.1177/0160017605275160; Asner GP, 2000, REMOTE SENS ENVIRON, V74, P99, DOI 10.1016/S0034-4257(00)00126-7; Awad MM, 2012, INT J REMOTE SENS, V33, P5819, DOI 10.1080/01431161.2012.674228; Boardman J.W., 1993, AVIRIS WORKSH, V1, P11; Boardman J. W., 1995, JPL PUBLICATION, V951, P23; Chang CI, 2006, IEEE GEOSCI REMOTE S, V3, P63, DOI 10.1109/LGRS.2005.856701; Dai XY, 2010, INT J REMOTE SENS, V31, P6095, DOI 10.1080/01431160903376407; Dare PM, 2005, PHOTOGRAMM ENG REM S, V71, P169, DOI 10.14358/PERS.71.2.169; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Deb K., 2001, MULTIOBJECTIVE OPTIM; Eschenauer H., 1990, MULTICRITERIA DESIGN; FOODY GM, 1994, INT J REMOTE SENS, V15, P619, DOI 10.1080/01431169408954100; Ghoggali N, 2009, IEEE T GEOSCI REMOTE, V47, P1707, DOI 10.1109/TGRS.2008.2007128; GREEN AA, 1988, IEEE T GEOSCI REMOTE, V26, P65, DOI 10.1109/36.3001; Hendrix EMT, 2010, INT GEOSCI REMOTE SE, P193, DOI 10.1109/IGARSS.2010.5649694; JI M, 1999, GEOCARTO INT, V14, P33, DOI DOI 10.1080/10106049908542126; Konak A, 2006, RELIAB ENG SYST SAFE, V91, P992, DOI 10.1016/j.ress.2005.11.018; Lu D, 2004, INT J REMOTE SENS, V25, P5345, DOI 10.1080/01431160412331269733; Lu DS, 2006, REMOTE SENS ENVIRON, V102, P146, DOI 10.1016/j.rse.2006.02.010; Lu DS, 2006, INT J REMOTE SENS, V27, P3553, DOI 10.1080/01431160600617202; Lu DS, 2011, INT J REMOTE SENS, V32, P2519, DOI 10.1080/01431161003698393; Lu DS, 2009, INT J REMOTE SENS, V30, P1297, DOI 10.1080/01431160802508985; Lu DS, 2004, PHOTOGRAMM ENG REM S, V70, P1053, DOI 10.14358/PERS.70.9.1053; M Kasprzak E., 2000, J ENG VALUAT COST AN, V3, P173; Phinn S, 2002, INT J REMOTE SENS, V23, P4131, DOI 10.1080/01431160110114998; Plaza A, 2002, IEEE T GEOSCI REMOTE, V40, P2025, DOI 10.1109/TGRS.2002.802494; Powell RL, 2007, REMOTE SENS ENVIRON, V106, P253, DOI 10.1016/j.rse.2006.09.005; Rashed T., 2001, GEOCARTO INT, V16, P5, DOI [10.1080/10106040108542210, DOI 10.1080/10106040108542210]; Rassafi AA, 2012, INT J TRANSPORTATION, V1, P47; RIDD MK, 1995, INT J REMOTE SENS, V16, P2165, DOI 10.1080/01431169508954549; Rogge DM, 2007, REMOTE SENS ENVIRON, V110, P287, DOI 10.1016/j.rse.2007.02.019; Saha S, 2010, INT J REMOTE SENS, V31, P5751, DOI 10.1080/01431161.2010.512302; Small C, 2001, INT J REMOTE SENS, V22, P1305, DOI 10.1080/01431160151144369; SMITH MO, 1985, J GEOPHYS RES, V90, pC797, DOI 10.1029/JB090iS02p0C797; Somers B, 2011, REMOTE SENS ENVIRON, V115, P1603, DOI 10.1016/j.rse.2011.03.003; Van de Voorde T, 2009, INT J REMOTE SENS, V30, P4785, DOI 10.1080/01431160802665918; Weng QH, 2008, INT J APPL EARTH OBS, V10, P68, DOI 10.1016/j.jag.2007.05.002; Weng QH, 2012, REMOTE SENS ENVIRON, V117, P34, DOI 10.1016/j.rse.2011.02.030; Weng QH, 2009, INT J REMOTE SENS, V30, P4807, DOI 10.1080/01431160802665926; Winter ME, 1999, P SOC PHOTO-OPT INS, V3753, P266, DOI 10.1117/12.366289; Wu CS, 2009, INT J REMOTE SENS, V30, P2915, DOI 10.1080/01431160802558634; Wu CS, 2003, REMOTE SENS ENVIRON, V84, P493, DOI 10.1016/S0034-4257(02)00136-0; Wu CS, 2004, REMOTE SENS ENVIRON, V93, P480, DOI 10.1016/j.rse.2004.08.003; Xu HQ, 2006, INT J REMOTE SENS, V27, P3025, DOI 10.1080/01431160600589179; Yuan F, 2007, REMOTE SENS ENVIRON, V106, P375, DOI 10.1016/j.rse.2006.09.003	46	6	7	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e93479	10.1371/journal.pone.0093479	http://dx.doi.org/10.1371/journal.pone.0093479			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892938	gold, Green Published, Green Submitted			2022-12-27	WOS:000336911400002
J	Mambelli, LI; Mattos, RC; Winter, GHZ; Madeiro, DS; Morais, BP; Malschitzky, E; Miglino, MA; Kerkis, A; Kerkis, I				Mambelli, Lisley I.; Mattos, Rodrigo C.; Winter, Gustavo H. Z.; Madeiro, Dener S.; Morais, Bruna P.; Malschitzky, Eduardo; Miglino, Maria Angelica; Kerkis, Alexandre; Kerkis, Irina			Changes in Expression Pattern of Selected Endometrial Proteins following Mesenchymal Stem Cells Infusion in Mares with Endometrosis	PLOS ONE			English	Article							INTERMEDIATE-FILAMENTS; IN-VITRO; COEXPRESSION; CYTOKERATIN; VIMENTIN; BIOPSY	Mesenchymal stem cells (MSCs) due to their self-renewal potential and differentiation capacity are useful for tissue regeneration. Immunomodulatory and trophic properties of MSCs were demonstrated suggesting their use as medicinal signaling cells able to positively change local environment in injured tissue. Equine endometrosis is a progressive degenerative disease responsible for glandular alterations and endometrial fibrosis which causes infertility in mares. More precisely, this disease is characterized by phenotypic changes in the expression pattern of selected endometrial proteins. Currently, no effective treatment is available for endometrosis. Herein, we aimed at the evaluation of expression pattern of these proteins after allogeneic equine adipose tissue-derived multipotent mesenchymal stem cells (eAT-MSCs) infusion as well as at testing the capacity of these cells to promote endometrial tissue remodeling in mares with endometrosis. eAT-MSC (2x10(7)/animal) were transplanted into mares' uterus and control animals received only placebo. Uterine biopsies were collected before (day 0) and after (days 7, 21 and 60) cells transplantation. Conventional histopathology as well as expression analysis of such proteins as laminin, vimentin, Ki-67-antigen, alpha-smooth muscle actin (alpha-SMA) and cytokeratin 18 (CK18) have been performed before and after eAT-MSCs transplantation. We demonstrated that eAT-MSCs induced early (at day 7) remodeling of endometrial tissue microenvironment through changes observed in intra cellular and intra glandular localization of aforementioned proteins. We demonstrated that eAT-MSCs were able to positively modulate the expression pattern of studied secretory proteins as well as, to promote the induction of glandular epithelial cells proliferation suggesting local benefits to committed endometrial tissue environment after eAT-MSCs transplantation.	[Mambelli, Lisley I.; Madeiro, Dener S.; Morais, Bruna P.; Kerkis, Alexandre; Kerkis, Irina] Inst Butantan, Genet Lab, Sao Paulo, Brazil; [Mambelli, Lisley I.; Miglino, Maria Angelica] Univ Sao Paulo, Programa Posgrad Anat Anim Domest & Silvestres, Fac Med Vet & Zootecnia, Sao Paulo, Brazil; [Mattos, Rodrigo C.; Winter, Gustavo H. Z.] Univ Fed Rio Grande do Sul, Fac Med Vet, Reprolab, Porto Alegre, RS, Brazil; [Malschitzky, Eduardo] Univ Luterana Brasil, Curso Med Vet, Canoas, RS, Brazil	Instituto Butantan; Universidade de Sao Paulo; Universidade Federal do Rio Grande do Sul; Universidade Luterana do Brasil	Kerkis, I (corresponding author), Inst Butantan, Genet Lab, Sao Paulo, Brazil.	irina.kerkis@butantan.gov.br	Miglino, Maria Angelica/B-9519-2012; Kerkis, Irina/AAD-1006-2019; Winter, Gustavo H Z/M-3617-2014	Miglino, Maria Angelica/0000-0003-4979-115X; 	Sao Paulo Research Foundations (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP) [2006/51839-7, 2007/50212-3, 2009/06764-7]; Coordination of Improvement of Higher Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES)	Sao Paulo Research Foundations (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination of Improvement of Higher Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES)	This work was supported by the Sao Paulo Research Foundations (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP. Grant numbers: 2006/51839-7(PIPE); 2007/50212-3 (BP.IC); 2009/06764-7 (BP.MS)) and Coordination of Improvement of Higher Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES) - fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Aupperle H, 2000, EQUINE VET J, V32, P228, DOI 10.2746/042516400776563554; Aupperle H, 2004, RES VET SCI, V76, P249, DOI 10.1016/j.rvsc.2003.11.003; Bader H, 1997, PFERDEHEILKUNDE, V5, P544; Brunckhorst D., 1991, FERTILITAT, V7, P44; Caplan AI, 2010, TISSUE ENG PT A, V16, P2415, DOI 10.1089/ten.TEA.2010.0216; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; CZERNOBILSKY B, 1993, VIRCHOWS ARCH A, V422, P313, DOI 10.1007/BF01608341; DABBS DJ, 1986, AM J SURG PATHOL, V10, P568, DOI 10.1097/00000478-198608000-00007; FRANKE WW, 1979, EUR J CELL BIOL, V19, P255; Gerstenberg C, 1999, MOL REPROD DEV, V53, P255, DOI 10.1002/(SICI)1098-2795(199907)53:3&lt;255::AID-MRD1&gt;3.0.CO;2-D; Hoffmann C, 2009, ANIM REPROD SCI, V111, P261, DOI 10.1016/j.anireprosci.2008.03.019; Kenney R.M., 1986, CURRENT THERAPY THER, P723; KENNEY RM, 1978, J AM VET MED ASSOC, V172, P241; Kenney RM, 1992, EQUINE VET J, V25, P186; Kozubenko N, 2010, CELL TRANSPLANT, V19, P471, DOI 10.3727/096368909X484707; Lehmann J, 2011, THERIOGENOLOGY, V76, P1326, DOI 10.1016/j.theriogenology.2011.06.001; Mambelli LI, 2013, THERIOGENOLOGY, V79, P744, DOI 10.1016/j.theriogenology.2012.11.030; Mambelli LI, 2009, TISSUE ENG PART C-ME, V15, P87, DOI 10.1089/ten.tec.2008.0186; MCNUTT MA, 1985, ULTRASTRUCT PATHOL, V9, P31, DOI 10.3109/01913128509055483; NISOLLE M, 1995, FERTIL STERIL, V64, P69, DOI 10.1016/S0015-0282(16)57657-2; NORWITZ ER, 1991, HUM REPROD, V6, P1470; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; SCHMITTGRAFF A, 1994, VIRCHOWS ARCH, V425, P3, DOI 10.1007/BF00193944; Schoon H A, 2000, J Reprod Fertil Suppl, P381; Schoon H. A., 1992, Pferdeheilkunde, V8, P355; Schoon HA, 1997, PFERDEHEILKUNDE, V13, P453, DOI 10.21836/PEM19970506; Semont A, 2010, CELL DEATH DIFFER, V17, P952, DOI 10.1038/cdd.2009.187; Sorrell JM, 2009, TISSUE ENG PT A, V15, P1751, DOI 10.1089/ten.tea.2008.0254; TABIBZADEH S, 1991, ENDOCR REV, V12, P272, DOI 10.1210/edrv-12-3-272; TIMPL R, 1979, J BIOL CHEM, V254, P9933; Uccelli A, 2010, CURR OPIN IMMUNOL, V22, P768, DOI 10.1016/j.coi.2010.10.012; Wagner J, 2009, CURR OPIN BIOTECH, V20, P531, DOI 10.1016/j.copbio.2009.08.009; Walter I, 2001, REPRODUCTION, V121, P581, DOI 10.1530/rep.0.1210581	34	28	28	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e97889	10.1371/journal.pone.0097889	http://dx.doi.org/10.1371/journal.pone.0097889			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901368	Green Published, gold, Green Submitted			2022-12-27	WOS:000336841400014
J	Finegersh, A; Homanics, GE				Finegersh, Andrey; Homanics, Gregg E.			Paternal Alcohol Exposure Reduces Alcohol Drinking and Increases Behavioral Sensitivity to Alcohol Selectively in Male Offspring	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DNA METHYLATION; MESSENGER-RNA; FEMALE RATS; BDNF; CONSUMPTION; ETHANOL; GENE; INHERITANCE; ANXIETY	Alcohol use disorder (AUD) is heritable, but the genetic basis for this disease remains poorly understood. Although numerous gene variants have been associated with AUD, these variants account for only a small fraction of the total risk. The idea of inheritance of acquired characteristics, i.e. "epigenetic inheritance,'' is re-emerging as a proven adjunct to traditional modes of genetic inheritance. We hypothesized that alcohol drinking and neurobiological sensitivity to alcohol are influenced by ancestral alcohol exposure. To test this hypothesis, we exposed male mice to chronic vapor ethanol or control conditions, mated them to ethanol-naive females, and tested adult offspring for ethanol drinking, ethanol-induced behaviors, gene expression, and DNA methylation. We found that ethanol-sired male offspring had reduced ethanol preference and consumption, enhanced sensitivity to the anxiolytic and motor-enhancing effects of ethanol, and increased Bdnf expression in the ventral tegmental area (VTA) compared to control-sired male offspring. There were no differences among ethanol-and control-sired female offspring on these assays. Ethanol exposure also decreased DNA methylation at the Bdnf promoter of sire's germ cells and hypomethylation was maintained in the VTA of both male and female ethanol-sired offspring. Our findings show that paternal alcohol exposure is a previously unrecognized regulator of alcohol drinking and behavioral sensitivity to alcohol in male, but not female, offspring. Paternal alcohol exposure also induces epigenetic alterations (DNA hypomethylation) and gene expression changes that persist in the VTA of offspring. These results provide new insight into the inheritance and development of alcohol drinking behaviors.	[Homanics, Gregg E.] Univ Pittsburgh, Dept Anesthesiol, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Homanics, GE (corresponding author), Univ Pittsburgh, Dept Anesthesiol, Pittsburgh, PA 15260 USA.	homanicsge@anes.upmc.edu	; Burne, Thomas/C-5656-2009	Finegersh, Andrey/0000-0002-2639-2132; Burne, Thomas/0000-0003-3502-9789	National Institute on Alcohol Abuse and Alcoholism [R37AA10422, F30AA021632]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA010422, F30AA021632] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by grants R37AA10422 (GEH) and F30AA021632 (AF) from the National Institute on Alcohol Abuse and Alcoholism. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL EL, 1990, PSYCHOPHARMACOLOGY, V100, P159, DOI 10.1007/BF02244399; ABEL EL, 1991, ALCOHOL, V8, P21, DOI 10.1016/0741-8329(91)91168-2; ABEL EL, 1989, ALCOHOL CLIN EXP RES, V13, P533, DOI 10.1111/j.1530-0277.1989.tb00373.x; ABEL EL, 1993, ALCOHOL, V10, P237, DOI 10.1016/0741-8329(93)90042-M; Adler ID, 1996, MUTAT RES-FUND MOL M, V352, P169, DOI 10.1016/0027-5107(95)00223-5; Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; BECKER HC, 1993, ALCOHOL CLIN EXP RES, V17, P94, DOI 10.1111/j.1530-0277.1993.tb00731.x; Bielawski DM, 2002, ALCOHOL CLIN EXP RES, V26, P347, DOI 10.1097/00000374-200203000-00007; Bienkowski P, 1999, ALCOHOL, V18, P131, DOI 10.1016/S0741-8329(98)00075-5; Bierut LJ, 2010, P NATL ACAD SCI USA, V107, P5082, DOI 10.1073/pnas.0911109107; Blakley G, 2006, PHARMACOL BIOCHEM BE, V84, P51, DOI 10.1016/j.pbb.2006.04.005; Bouchery EE, 2011, AM J PREV MED, V41, P516, DOI 10.1016/j.amepre.2011.06.045; Byrnes EM, 2005, PSYCHOPHARMACOLOGY, V182, P537, DOI 10.1007/s00213-005-0122-4; Byrnes JJ, 2011, BEHAV BRAIN RES, V218, P200, DOI 10.1016/j.bbr.2010.11.059; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Carr IM, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm330; Conner JM, 1997, J NEUROSCI, V17, P2295; Dias BG, 2014, NAT NEUROSCI, V17, P89, DOI 10.1038/nn.3594; Ferron SR, 2011, NATURE, V475, P381, DOI 10.1038/nature10229; Govorko D, 2012, BIOL PSYCHIAT, V72, P378, DOI 10.1016/j.biopsych.2012.04.006; Griffin WC, 2009, PSYCHOPHARMACOLOGY, V201, P569, DOI 10.1007/s00213-008-1324-3; Heath AC, 1999, PSYCHOL MED, V29, P1069, DOI 10.1017/S0033291799008909; Jamerson PA, 2004, DEV BRAIN RES, V149, P103, DOI 10.1016/j.devbrainres.2003.12.010; Jeanblanc J, 2013, EUR J NEUROSCI, V37, P607, DOI 10.1111/ejn.12067; Jeanblanc J, 2009, J NEUROSCI, V29, P13494, DOI 10.1523/JNEUROSCI.2243-09.2009; Jenkins TG, 2012, REPRODUCTION, V143, P727, DOI 10.1530/REP-11-0450; Jensen CH, 2001, NEUROREPORT, V12, P3959, DOI 10.1097/00001756-200112210-00021; Kaminen-Ahola N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000811; Knezovich Jaysen Gregory, 2012, Frontiers in Genetics, V3, P10, DOI 10.3389/fgene.2012.00010; Ledig M, 1998, NEUROPHARMACOLOGY, V37, P57, DOI 10.1016/S0028-3908(97)00185-8; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li JY, 2004, GENOMICS, V84, P952, DOI 10.1016/j.ygeno.2004.08.012; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Logrip ML, 2009, J NEUROCHEM, V109, P1459, DOI 10.1111/j.1471-4159.2009.06073.x; Lopez MF, 2003, ADDICT BIOL, V8, P419, DOI 10.1080/13556210310001648176; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Moonat S, 2013, BIOL PSYCHIAT, V73, P763, DOI 10.1016/j.biopsych.2013.01.012; NEWLIN DB, 1990, PSYCHOL BULL, V108, P383, DOI 10.1037/0033-2909.108.3.383; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Niculescu MD, 2002, J NUTR, V132, p2333S, DOI 10.1093/jn/132.8.2333S; Nueda M-L, J MOL BIO, V367, P1281; Ouko LA, 2009, ALCOHOL CLIN EXP RES, V33, P1615, DOI 10.1111/j.1530-0277.2009.00993.x; Pandey SC, 2008, J NEUROSCI, V28, P3729, DOI 10.1523/JNEUROSCI.5731-07.2008; Pietrzykowski AZ, 2008, NEURON, V59, P274, DOI 10.1016/j.neuron.2008.05.032; Prescott CA, 1999, AM J PSYCHIAT, V156, P34, DOI 10.1176/ajp.156.1.34; Purohit V, 2007, AM J CLIN NUTR, V86, P14, DOI 10.1093/ajcn/86.1.14; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Rodgers AB, 2013, J NEUROSCI, V33, P9003, DOI 10.1523/JNEUROSCI.0914-13.2013; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Schuckit MA, 1996, ARCH GEN PSYCHIAT, V53, P202; TANAKA H, 1982, BRAIN DEV-JPN, V4, P1; Treutlein J, 2011, CURR PSYCHIAT REP, V13, P147, DOI 10.1007/s11920-011-0176-4; Treutlein J, 2009, ARCH GEN PSYCHIAT, V66, P773, DOI 10.1001/archgenpsychiatry.2009.83; Vassoler FM, 2013, NAT NEUROSCI, V16, P42, DOI 10.1038/nn.3280; WOZNIAK DF, 1991, PSYCHOPHARMACOLOGY, V105, P289, DOI 10.1007/BF02244324	58	79	82	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99078	10.1371/journal.pone.0099078	http://dx.doi.org/10.1371/journal.pone.0099078			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896617	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000338430700114
J	Jacques, JF; Mercier, A; Brault, A; Mourer, T; Labbe, S				Jacques, Jean-Francois; Mercier, Alexandre; Brault, Ariane; Mourer, Thierry; Labbe, Simon			Fra2 Is a Co-Regulator of Fep1 Inhibition in Response to Iron Starvation	PLOS ONE			English	Article							YEAST SCHIZOSACCHAROMYCES-POMBE; TRANSCRIPTION FACTOR FEP1; BINDING FACTOR PHP4; MONOTHIOL GLUTAREDOXINS; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; SULFUR CLUSTER; MOLECULAR-GENETICS; DNA-BINDING	Iron is required for several metabolic functions involved in cellular growth. Although several players involved in iron transport have been identified, the mechanisms by which iron-responsive transcription factors are controlled are still poorly understood. In Schizosaccharomyces pombe, the Fep1 transcription factor represses genes involved in iron acquisition in response to high levels of iron. In contrast, when iron levels are low, Fep1 becomes inactive and loses its ability to associate with chromatin. Although the molecular basis by which Fep1 is inactivated under iron starvation remains unknown, this process requires the monothiol glutaredoxin Grx4. Here, we demonstrate that Fra2 plays a role in the negative regulation of Fep1 activity. Disruption of fra2(+) (fra2 Delta) led to a constitutive repression of the fio1(+) gene transcription. Fep1 was consistently active and constitutively bound to its target gene promoters in cells lacking fra2+. A constitutive activation of Fep1 was also observed in a php4 Delta fra2 Delta double mutant strain in which the behavior of Fep1 is freed of its transcriptional regulation by Php4. Microscopic analyses of cells expressing a functional Fra2-Myc(13) protein revealed that Fra2 localized throughout the cells with a significant proportion of Fra2 being observed within the nuclei. Further analysis by coimmunoprecipitation showed that Fra2, Fep1 and Grx4 are associated in a heteroprotein complex. Bimolecular fluorescence complementation experiments brought further evidence that an interaction between Fep1 and Fra2 occurs in the nucleus. Taken together, results reported here revealed that Fra2 plays a role in the Grx4-mediated pathway that inactivates Fep1 in response to iron deficiency.	[Jacques, Jean-Francois; Mercier, Alexandre; Brault, Ariane; Mourer, Thierry; Labbe, Simon] Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Labbe, S (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Sherbrooke, PQ J1K 2R1, Canada.	Simon.Labbe@USherbrooke.ca		Labbe, Simon/0000-0002-4947-523X; Mourer, Thierry/0000-0003-1651-6768	Faculty of Medicine and Health Sciences of the Universite de Sherbrooke; Natural Sciences and Engineering Research Council of Canada [MOP-238238-01]	Faculty of Medicine and Health Sciences of the Universite de Sherbrooke; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	A.B. is the recipient of a studentship from the Faculty of Medicine and Health Sciences of the Universite de Sherbrooke. This work was supported by the Natural Sciences and Engineering Research Council of Canada (Grant no. MOP-238238-01) to S.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam M, 2001, MOL CELL BIOL, V21, P6270, DOI 10.1128/MCB.21.18.6270-6279.2001; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bandyopadhyay S, 2008, EMBO J, V27, P1122, DOI 10.1038/emboj.2008.50; Beaudoin J, 2006, MICROBIOL-SGM, V152, P209, DOI 10.1099/mic.0.28392-0; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Chen OS, 2004, J BIOL CHEM, V279, P29513, DOI 10.1074/jbc.M403209200; Chung WH, 2005, BIOCHEM BIOPH RES CO, V330, P604, DOI 10.1016/j.bbrc.2005.02.183; Haas H, 2003, APPL MICROBIOL BIOT, V62, P316, DOI 10.1007/s00253-003-1335-2; Haas H, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00028; HALLIWELL B, 1992, FEBS LETT, V307, P108, DOI 10.1016/0014-5793(92)80911-Y; Herrero E, 2007, CELL MOL LIFE SCI, V64, P1518, DOI 10.1007/s00018-007-6554-8; Herrero E, 2010, CURR PROTEIN PEPT SC, V11, P659, DOI 10.2174/138920310794557637; Hoffmann B, 2011, ANTIOXID REDOX SIGN, V15, P19, DOI 10.1089/ars.2010.3811; Ioannoni R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011964; Iwema T, 2009, BIOCHEMISTRY-US, V48, P6041, DOI 10.1021/bi900440m; Jbel M, 2011, EUKARYOT CELL, V10, P629, DOI 10.1128/EC.00015-11; Jbel M, 2009, EUKARYOT CELL, V8, P649, DOI 10.1128/EC.00001-09; Kaplan J, 2013, CURR BIOL, V23, pR642, DOI 10.1016/j.cub.2013.05.033; Kim KD, 2011, BIOCHEM BIOPH RES CO, V408, P609, DOI 10.1016/j.bbrc.2011.04.069; Kronstad JW, 2013, CURR OPIN MICROBIOL, V16, P659, DOI 10.1016/j.mib.2013.08.009; Kumanovics A, 2008, J BIOL CHEM, V283, P10276, DOI 10.1074/jbc.M801160200; Labbe S, 2013, CURR OPIN MICROBIOL, V16, P669, DOI 10.1016/j.mib.2013.07.007; Larochelle M, 2012, NUCLEIC ACIDS RES, V40, P10240, DOI 10.1093/nar/gks838; Li HR, 2012, BIOCHEMISTRY-US, V51, P4377, DOI 10.1021/bi300393z; Li HR, 2011, J BIOL CHEM, V286, P867, DOI 10.1074/jbc.M110.184176; Li HR, 2009, BIOCHEMISTRY-US, V48, P9569, DOI 10.1021/bi901182w; Mercier A, 2008, EUKARYOT CELL, V7, P493, DOI 10.1128/EC.00446-07; Mercier A, 2006, EUKARYOT CELL, V5, P1866, DOI 10.1128/EC.00199-06; Mercier A, 2009, J BIOL CHEM, V284, P20249, DOI 10.1074/jbc.M109.009563; Muhlenhoff U, 2010, CELL METAB, V12, P373, DOI 10.1016/j.cmet.2010.08.001; Ojeda L, 2006, J BIOL CHEM, V281, P17661, DOI 10.1074/jbc.M602165200; Pelletier B, 2005, J BIOL CHEM, V280, P25146, DOI 10.1074/jbc.M502947200; Pelletier B, 2003, NUCLEIC ACIDS RES, V31, P4332, DOI 10.1093/nar/gkg647; Pelletier B, 2002, J BIOL CHEM, V277, P22950, DOI 10.1074/jbc.M202682200; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Philpott CC, 2012, BBA-MOL CELL RES, V1823, P1509, DOI 10.1016/j.bbamcr.2012.01.012; Picciocchi A, 2007, BIOCHEMISTRY-US, V46, P15018, DOI 10.1021/bi7013272; Poor CB, 2014, P NATL ACAD SCI US, V3; Pujol-Carrion N, 2006, J CELL SCI, V119, P4554, DOI 10.1242/jcs.03229; Rouhier N, 2010, TRENDS BIOCHEM SCI, V35, P43, DOI 10.1016/j.tibs.2009.08.005; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Rutherford JC, 2003, J BIOL CHEM, V278, P27636, DOI 10.1074/jbc.M300076200; Sabatinos SA, 2010, METHOD ENZYMOL, V470, P759, DOI 10.1016/S0076-6879(10)70032-X; Sung MK, 2007, YEAST, V24, P767, DOI 10.1002/yea.1504; Ueta R, 2012, MOL CELL BIOL, V32, P4998, DOI 10.1128/MCB.00726-12; Vachon P, 2012, EUKARYOT CELL, V11, P806, DOI 10.1128/EC.00060-12; YamaguchiIwai Y, 1996, EMBO J, V15, P3377, DOI 10.1002/j.1460-2075.1996.tb00703.x	47	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98959	10.1371/journal.pone.0098959	http://dx.doi.org/10.1371/journal.pone.0098959			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897379	Green Published, gold, Green Submitted			2022-12-27	WOS:000338430700103
J	Li, YH; Jiang, L; Jia, ZR; Xin, W; Yang, SW; Yang, Q; Wang, LY				Li, Yinhua; Jiang, Long; Jia, Zhangrong; Xin, Wei; Yang, Shiwei; Yang, Qiu; Wang, Luya			A Meta-Analysis of Red Yeast Rice: An Effective and Relatively Safe Alternative Approach for Dyslipidemia	PLOS ONE			English	Article							PURPUREUS WENT RICE; MONASCUS-PURPUREUS; CARDIOVASCULAR-DISEASE; LDL CHOLESTEROL; DOUBLE-BLIND; LOW-RISK; EFFICACY; COMBINATION; INTOLERANT; PREVENTION	Objective: To explore whether red yeast rice is a safe and effective alternative approach for dyslipidemia. Methods: Pubmed, the Cochrane Library, EBSCO host, Chinese VIP Information (VIP), China National Knowledge Infrastructure (CNKI), Wanfang Databases were searched for appropriate articles. Randomized trials of RYR (not including Xuezhikang and Zhibituo) and placebo as control in patients with dyslipidemia were considered. Two authors read all papers and independently extracted all relevant information. The primary outcomes were serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), triglyceride (TG), and high-density lipoprotein cholesterol (HDL-C). The secondary outcomes were increased levels of alanine transaminase, aspartate aminotransferase, creatine kinase, creatinine and fasting blood glucose. Results: A total of 13 randomized, placebo-controlled trials containing 804 participants were analyzed. Red yeast rice exhibited significant lowering effects on serum TC [WMD = -0.97 (95% CI: -1.13, -0.80) mmol/L, P<0.001], TG [WMD = -0.23 (95% CI: -0.31, -0.14) mmol/L, P<0.001], and LDL-C [WMD = -0.87 (95% CI: -1.03, -0.71) mmol/L, P<0.001] but no significant increasing effect on HDL-C [WMD = 0.08 (95% CI: -0.02, 0.19) mmol/L, P = 0.11] compared with placebo. No serious side effects were reported in all trials. Conclusions: The meta-analysis suggests that red yeast rice is an effective and relatively safe approach for dyslipidemia. However, further long-term, rigorously designed randomized controlled trials are still warranted before red yeast rice could be recommended to patients with dyslipidemia, especially as an alternative to statins.	[Li, Yinhua; Jiang, Long; Jia, Zhangrong; Xin, Wei; Yang, Shiwei; Yang, Qiu; Wang, Luya] Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing Anzhen Hosp, Dept Arteriosclerosis, Beijing, Peoples R China	Capital Medical University	Yang, Q (corresponding author), Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing Anzhen Hosp, Dept Arteriosclerosis, Beijing, Peoples R China.	yangqiu6666@163.com; wangluya@126.com		Jiang, Long/0000-0002-1506-7385	National Natural Science Foundation of China [81271923, 81170810]; Beijing Natural Science Foundation [7112022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This study was supported by grants from the National Natural Science Foundation of China (No. 81271923, 81170810) and Beijing Natural Science Foundation (No. 7112022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affuso F, 2010, NUTR METAB CARDIOVAS, V20, P656, DOI 10.1016/j.numecd.2009.05.017; Armitage J, 2007, LANCET, V370, P1781, DOI 10.1016/S0140-6736(07)60716-8; Arora R, 2006, J CARDIOVASC PHARM T, V11, P105, DOI 10.1177/1074248406288758; Barrat E, 2013, EUR J NUTR, V52, P1843, DOI 10.1007/s00394-012-0486-2; Barrat E, 2013, INT J FOOD SCI NUTR, V64, P882, DOI 10.3109/09637486.2013.809405; Becker DJ, 2008, MAYO CLIN PROC, V83, P758, DOI 10.4065/83.7.758; Becker DJ, 2009, ANN INTERN MED, V150, P830, DOI 10.7326/0003-4819-150-12-200906160-00006; Bogsrud MP, 2010, SCAND CARDIOVASC J, V44, P197, DOI 10.3109/14017431003624123; Chen CH, 2013, INT J PHARMACEUT, V444, P18, DOI 10.1016/j.ijpharm.2013.01.028; Childress L, 2013, J CLIN LIPIDOL, V7, P117, DOI 10.1016/j.jacl.2012.09.003; Cicero AFG, 2005, COMPLEMENT THER MED, V13, P273, DOI 10.1016/j.ctim.2005.07.008; Erdogrul O Azirak SJKJoS Engineering, 2005, J KING SAUD U ENG SC, V8, P10; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Gheith O, 2008, CLIN EXP NEPHROL, V12, P189, DOI 10.1007/s10157-008-0033-x; Gordon RY, 2010, ARCH INTERN MED, V170, P1722, DOI 10.1001/archinternmed.2010.382; Gotto AM, 2006, AM J CARDIOL, V97, p3C, DOI 10.1016/j.amjcard.2005.12.005; Guardamagna O, 2011, NUTR METAB CARDIOVAS, V21, P424, DOI 10.1016/j.numecd.2009.10.015; Halbert SC, 2010, AM J CARDIOL, V105, P198, DOI 10.1016/j.amjcard.2009.08.672; Heber D, 1999, AM J CLIN NUTR, V69, P231; Higashikawa F, 2012, CLIN NUTR, V31, P261, DOI 10.1016/j.clnu.2011.10.008; Huang CF, 2007, EUR J CARDIOV PREV R, V14, P438, DOI 10.1097/HJR.0b013e32801da137; Karl M, 2012, J CLIN LIPIDOL, V6, P150, DOI 10.1016/j.jacl.2011.09.004; Lee IT, 2012, NUTR RES, V32, P85, DOI 10.1016/j.nutres.2011.12.011; Liu Jianping, 2006, Chin Med, V1, P4, DOI 10.1186/1749-8546-1-4; Lu JH, 2013, SHANGHAI J PREVENTIV, V25, P501; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Mancini GBJ, 2011, CAN J CARDIOL, V27, P635, DOI 10.1016/j.cjca.2011.05.007; Marazzi G, 2011, ADV THER, V28, P1105, DOI 10.1007/s12325-011-0082-5; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Ogier N, 2013, EUR J NUTR, V52, P547, DOI 10.1007/s00394-012-0357-x; Ross SM, 2012, HOLIST NURS PRACT, V26, P173, DOI 10.1097/HNP.0b013e3182510596; Sathasivam S, 2012, EUR J INTERN MED, V23, P317, DOI 10.1016/j.ejim.2012.01.004; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Tayal U, 2013, BMJ CASE REP; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; Venero CV, 2010, AM J CARDIOL, V105, P664, DOI 10.1016/j.amjcard.2009.10.045; WHO, 2010, GLOB STAT REP NONC D; Yang CW, 2012, COMPLEMENT THER MED, V20, P466, DOI 10.1016/j.ctim.2012.07.004; Yang NC, 2009, ASIA PAC J CLIN NUTR, V18, P310	40	48	56	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98611	10.1371/journal.pone.0098611	http://dx.doi.org/10.1371/journal.pone.0098611			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897342	Green Submitted, Green Published, gold			2022-12-27	WOS:000338430700054
J	Swaminathan, S; Hu, ZH; Rupert, AW; Higgins, JM; Dewar, RL; Stevens, R; Chen, Q; Rehm, CA; Metcalf, JA; Baseler, MW; Lane, HC; Imamichi, T				Swaminathan, Sanjay; Hu, Zonghui; Rupert, Adam W.; Higgins, Jeanette M.; Dewar, Robin L.; Stevens, Randy; Chen, Qian; Rehm, Catherine A.; Metcalf, Julia A.; Baseler, Michael W.; Lane, H. Clifford; Imamichi, Tomozumi			Plasma Interleukin-27 (IL-27) Levels Are Not Modulated in Patients with Chronic HIV-1 Infection	PLOS ONE			English	Article							MACROPHAGES; INTERFERON; CYTOKINE; BIOLOGY; CD163; CELLS	Objective: IL-27 is an immunomodulatory cytokine with potent anti-HIV properties in PBMCs, CD4+ T cells, macrophages and immature dendritic cells. Previous smaller studies have suggested that HIV-1 infection may alter IL-27 and influence HIV-1 pathogenesis. The aim of this study was to examine the relationship between plasma IL-27 levels in a well-characterised cohort of HIV-1 infected patients. Methods: Patients were stratified into four groups based on HIV-1 viral load and matched according to age, gender and those receiving antiretroviral treatment. IL-27 levels and C-reactive protein (CRP) were measured using electrochemiluminescence assays. D-dimer and CD4+ T cell counts were measured using an Enzyme Linked Fluorescence Assay and FACS, respectively. sCD14 and sCD163 were measured using ELISA. HIV-1 viral load was measured by bDNA or qRT-PCR assays. Results: Plasma IL-27 levels were measured in 505 patients (462 HIV+, 43 controls). The mean level (+/- SEM) of IL-27 in controls was 2990.7 +/- 682.1 pg/ml, in the <50 copies/ml group it was 2008.0 +/- 274.8 pg/ml, in the 51-10,000 copies group it was 1468.7 +/- 172.3 pg/ml, in the 10,001-100,000 copies/ml group it was 1237.9 +/- 127.3 pg/ml and in the >100,000 copies/ml group it was 1590.1 +/- 223.7 pg/ml. No statistically significant difference in IL-27 levels between groups were seen. There were no correlations noted between IL-27 and HIV-1 viral load or CD4+ T cell counts. There was a small correlation noted between D-dimer and IL-27 (Spearman r = 0.09, p = 0.03) and sCD163 and IL-27 (Spearman r = 0.12, p = 0.005). No correlation was observed between IL-27 and CRP or sCD14 levels. Conclusions: This is the largest study examining the levels of plasma IL-27 in HIV-1 infection. While IL-27 levels are not significantly altered in HIV-1 infection compared to uninfected controls there may be a small association between IL-27 and D-dimer levels and IL-27 and sCD163 levels.	[Swaminathan, Sanjay; Rupert, Adam W.; Higgins, Jeanette M.; Dewar, Robin L.; Stevens, Randy; Chen, Qian; Baseler, Michael W.; Imamichi, Tomozumi] Frederick Natl Lab Canc Res, Leidos Biomed Res Inc, Appl & Dev Res Directorate, Frederick, MD 21702 USA; [Swaminathan, Sanjay] Western Sydney Local Hlth Dist, Dept Clin Immunol, Sydney, NSW, Australia; [Swaminathan, Sanjay] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Swaminathan, Sanjay] Univ Western Sydney, Sch Med, Sydney, NSW, Australia; [Hu, Zonghui] NIAID, Biostat Res Branch, NIH, Bethesda, MD 20892 USA; [Rehm, Catherine A.; Lane, H. Clifford] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Metcalf, Julia A.] NIAID, Div Clin Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Sydney; Western Sydney University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Imamichi, T (corresponding author), Frederick Natl Lab Canc Res, Leidos Biomed Res Inc, Appl & Dev Res Directorate, Frederick, MD 21702 USA.	timamichi@mail.nih.gov		Swaminathan, Sanjay/0000-0001-5315-6445; Imamichi, Tomozumi/0000-0002-1474-1796	National Cancer Institute, National Institutes of Health [HHSN261200800001E]; National Institute of Allergy and Infectious Disease; Leidos Biomedical Research, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000585] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Leidos Biomedical Research, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. This research was supported [in part] by the National Institute of Allergy and Infectious Disease. Leidos Biomedical Research, Inc., provided support in the form of salaries for authors SS, AWR, JMH, RLD, RS, QC, MWB and TI, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Batten M, 2007, J MOL MED-JMM, V85, P661, DOI 10.1007/s00109-007-0164-7; Braun P, 2007, CLIN CHEM LAB MED, V45, P93, DOI 10.1515/CCLM.2007.008; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Burdo TH, 2011, J INFECT DIS, V204, P154, DOI 10.1093/infdis/jir214; Chen Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059194; Dai L, 2013, J EXP MED, V210, P517, DOI 10.1084/jem.20120572; DEWAR RL, 1994, J INFECT DIS, V170, P1172, DOI 10.1093/infdis/170.5.1172; Fabriek BO, 2005, IMMUNOBIOLOGY, V210, P153, DOI 10.1016/j.imbio.2005.05.010; Fakruddin JM, 2007, BLOOD, V109, P1841, DOI 10.1182/blood-2006-02-001578; FREY EA, 1992, J EXP MED, V176, P1665, DOI 10.1084/jem.176.6.1665; Greenwell-Wild T, 2009, BLOOD, V114, P1864, DOI 10.1182/blood-2009-03-211540; Guzzo C, 2010, AIDS, V24, P1371, DOI 10.1097/QAD.0b013e3283391d2b; He L, 2011, J AIDS HIV RES, V3, P6; Hunt PW, 2012, CURR HIV-AIDS REP, V9, P139, DOI 10.1007/s11904-012-0118-8; Imamichi T, 2008, AIDS, V22, P39, DOI 10.1097/QAD.0b013e3282f3356c; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Shen H, 2011, ARTHRITIS RHEUM-US, V63, P860, DOI 10.1002/art.30180; Su GL, 1999, J HEPATOL, V31, P435, DOI 10.1016/S0168-8278(99)80034-8; Swaminathan S, 2013, CYTOKINE GROWTH FACT; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Wojno EDT, 2012, TRENDS IMMUNOL, V33, P91, DOI 10.1016/j.it.2011.11.003	23	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98989	10.1371/journal.pone.0098989	http://dx.doi.org/10.1371/journal.pone.0098989			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896094	Green Published, Green Submitted, gold			2022-12-27	WOS:000338430700105
J	Chujo, T; Miyamoto, K; Ogawa, S; Masuda, Y; Shimizu, T; Kishi-Kaboshi, M; Takahashi, A; Nishizawa, Y; Minami, E; Nojiri, H; Yamane, H; Okada, K				Chujo, Tetsuya; Miyamoto, Koji; Ogawa, Satoshi; Masuda, Yuka; Shimizu, Takafumi; Kishi-Kaboshi, Mitsuko; Takahashi, Akira; Nishizawa, Yoko; Minami, Eiichi; Nojiri, Hideaki; Yamane, Hisakazu; Okada, Kazunori			Overexpression of Phosphomimic Mutated OsWRKY53 Leads to Enhanced Blast Resistance in Rice	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; WRKY TRANSCRIPTION FACTORS; MAP KINASE; DEFENSE RESPONSES; PLANT DEFENSE; PHYTOALEXIN BIOSYNTHESIS; BINDING-PROTEINS; CELL-DEATH; GENE; ARABIDOPSIS	WRKY transcription factors and mitogen-activated protein kinase (MAPK) cascades have been shown to play pivotal roles in the regulation of plant defense responses. We previously reported that OsWRKY53-overexpressing rice plants showed enhanced resistance to the rice blast fungus. In this study, we identified OsWRKY53 as a substrate of OsMPK3/OsMPK6, components of a fungal PAMP-responsive MAPK cascade in rice, and analyzed the effect of OsWRKY53 phosphorylation on the regulation of basal defense responses to a virulence race of rice blast fungus Magnaporthe oryzae strain Ina86-137. An in vitro phosphorylation assay revealed that the OsMPK3/OsMPK6 activated by OsMKK4 phosphorylated OsWRKY53 recombinant protein at its multiple clustered serine-proline residues (SP cluster). When OsWRKY53 was coexpressed with a constitutively active mutant of OsMKK4 in a transient reporter gene assay, the enhanced transactivation activity of OsWRKY53 was found to be dependent on phosphorylation of the SP cluster. Transgenic rice plants overexpressing a phospho-mimic mutant of OsWRKY53 (OsWRKY53SD) showed further-enhanced disease resistance to the blast fungus compared to native OsWRKY53-overexpressing rice plants, and a substantial number of defense-related genes, including pathogenesis-related protein genes, were more upregulated in the OsWRKY53SD-overexpressing plants compared to the OsWRKY53-overexpressing plants. These results strongly suggest that the OsMKK4-OsMPK3/OsMPK6 cascade regulates transactivation activity of OsWRKY53, and overexpression of the phospho-mimic mutant of OsWRKY53 results in a major change to the rice transcriptome at steady state that leads to activation of a defense response against the blast fungus in rice plants.	[Chujo, Tetsuya; Miyamoto, Koji; Ogawa, Satoshi; Masuda, Yuka; Shimizu, Takafumi; Nojiri, Hideaki; Yamane, Hisakazu; Okada, Kazunori] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo, Japan; [Kishi-Kaboshi, Mitsuko; Takahashi, Akira; Nishizawa, Yoko; Minami, Eiichi] Natl Inst Agrobiol Sci, Genetically Modified Organism Res Ctr, Tsukuba, Ibaraki, Japan; [Miyamoto, Koji; Yamane, Hisakazu] Teikyo Univ, Dept Biosci, Utsunomiya, Tochigi, Japan	University of Tokyo; National Institute of Agrobiological Sciences - Japan; Teikyo University	Okada, K (corresponding author), Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo, Japan.	ukokada@mail.ecc.u-tokyo.ac.jp	Ogawa, Satoshi/F-2719-2017; Shimizu, Takafumi/C-4123-2017; Kishi-Kaboshi, Mitsuko/ABE-6455-2020; Miyamoto, Koji/N-1504-2014; Kishi-Kaboshi, Mitsuko/AAE-2828-2022	Ogawa, Satoshi/0000-0002-4790-546X; Shimizu, Takafumi/0000-0003-4372-1337; Kishi-Kaboshi, Mitsuko/0000-0002-1552-2608; Miyamoto, Koji/0000-0002-9862-7412; 	JSPS KAKENHI [22380066]; Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN)	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN)	This work was supported by JSPS KAKENHI (grant no. 22380066) and by the Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando S, 2011, MOL PLANT MICROBE IN, V24, P519, DOI 10.1094/MPMI-07-10-0172; Ando S, 2009, J PHYTOPATHOL, V157, P420, DOI 10.1111/j.1439-0434.2008.01515.x; Andreasson E, 2005, EMBO J, V24, P2579, DOI 10.1038/sj.emboj.7600737; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Cheng Y, 2012, PLANT PHYSIOL, V159, P810, DOI 10.1104/pp.112.196816; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Chuio T, 2007, BBA-GENE STRUCT EXPR, V1769, P497, DOI 10.1016/j.bbaexp.2007.04.006; Chujo T, 2013, PLANT MOL BIOL, V82, P23, DOI 10.1007/s11103-013-0032-5; Chujo T, 2009, BIOSCI BIOTECH BIOCH, V73, P1901, DOI 10.1271/bbb.90262; Cohen P, 1997, TRENDS CELL BIOL, V7, P353, DOI 10.1016/S0962-8924(97)01105-7; Eulgem T, 1999, EMBO J, V18, P4689, DOI 10.1093/emboj/18.17.4689; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Hiratsu K, 2004, BIOCHEM BIOPH RES CO, V321, P172, DOI 10.1016/j.bbrc.2004.06.115; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Ishihama N, 2012, CURR OPIN PLANT BIOL, V15, P431, DOI 10.1016/j.pbi.2012.02.003; Ishihama N, 2011, PLANT CELL, V23, P1153, DOI 10.1105/tpc.110.081794; Jin HL, 2003, PLANT J, V33, P719, DOI 10.1046/j.1365-313X.2003.01664.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kim CY, 2004, PLANT J, V38, P142, DOI 10.1111/j.1365-313X.2004.02033.x; Kishi-Kaboshi M, 2010, PLANT SIGNAL BEHAV, V5, P1653, DOI 10.4161/psb.5.12.13982; Kishi-Kaboshi M, 2010, PLANT J, V63, P599, DOI 10.1111/j.1365-313X.2010.04264.x; Kitagawa K, 2010, PLANT CELL PHYSIOL, V51, P1315, DOI 10.1093/pcp/pcq092; Koo SC, 2009, BIOCHEM BIOPH RES CO, V387, P365, DOI 10.1016/j.bbrc.2009.07.026; Lai ZB, 2011, PLANT CELL, V23, P3824, DOI 10.1105/tpc.111.090571; Liu YD, 2007, PLANT J, V51, P941, DOI 10.1111/j.1365-313X.2007.03191.x; Mao GH, 2011, PLANT CELL, V23, P1639, DOI 10.1105/tpc.111.084996; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Menke FLH, 2005, MOL PLANT MICROBE IN, V18, P1027, DOI 10.1094/MPMI-18-1027; Okada A, 2009, J BIOL CHEM, V284, P26510, DOI 10.1074/jbc.M109.036871; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Qiu JL, 2008, EMBO J, V27, P2214, DOI 10.1038/emboj.2008.147; Ren DT, 2008, P NATL ACAD SCI USA, V105, P5638, DOI 10.1073/pnas.0711301105; Ross CA, 2007, J INTEGR PLANT BIOL, V49, P827, DOI 10.1111/j.1744-7909.2007.00504.x; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Rushton PJ, 1996, EMBO J, V15, P5690, DOI 10.1002/j.1460-2075.1996.tb00953.x; SEO S, 1995, SCIENCE, V270, P1988, DOI 10.1126/science.270.5244.1988; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Shimizu T, 2008, PHYTOCHEMISTRY, V69, P973, DOI 10.1016/j.phytochem.2007.10.005; Shimono M, 2007, PLANT CELL, V19, P2064, DOI 10.1105/tpc.106.046250; Shimura K, 2007, J BIOL CHEM, V282, P34013, DOI 10.1074/jbc.M703344200; Tanaka S, 2009, PLANT CELL, V21, P2517, DOI 10.1105/tpc.109.068023; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Toyomasu T, 2014, PHYSIOL PLANTARUM, V150, P55, DOI 10.1111/ppl.12066; Wang QA, 2011, PLANT J, V65, P87, DOI 10.1111/j.1365-313X.2010.04408.x; Yang PZ, 1999, PLANT J, V18, P141, DOI 10.1046/j.1365-313X.1999.00437.x; Yang SH, 2003, GENE, V320, P3, DOI 10.1016/S0378-1119(03)00816-3; Yokotani N, 2013, J EXP BOT, V64, P5085, DOI 10.1093/jxb/ert298; Zhang SQ, 1998, P NATL ACAD SCI USA, V95, P7225, DOI 10.1073/pnas.95.12.7225; Zhang SQ, 1997, PLANT CELL, V9, P809, DOI 10.1105/tpc.9.5.809; Zipfel C, 2010, PLANT PHYSIOL, V154, P551, DOI 10.1104/pp.110.161547	52	72	76	7	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98737	10.1371/journal.pone.0098737	http://dx.doi.org/10.1371/journal.pone.0098737			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892523	Green Published, gold, Green Submitted			2022-12-27	WOS:000336911400087
J	Hoffmann, J; Ospelt, M; Troidl, C; Voss, S; Liebetrau, C; Kim, WK; Rolf, A; Wietelmann, A; Braun, T; Troidl, K; Sadayappan, S; Barefield, D; Hamm, C; Nef, H; Mollmann, H				Hoffmann, Jedrzej; Ospelt, Manuel; Troidl, Christian; Voss, Sandra; Liebetrau, Christoph; Kim, Won-Keun; Rolf, Andreas; Wietelmann, Astrid; Braun, Thomas; Troidl, Kerstin; Sadayappan, Sakthivel; Barefield, David; Hamm, Christian; Nef, Holger; Moellmann, Helge			Sham Surgery and Inter-Individual Heterogeneity Are Major Determinants of Monocyte Subset Kinetics in a Mouse Model of Myocardial Infarction	PLOS ONE			English	Article							SPLENIC RESERVOIR; BONE-MARROW; MICE; BLOOD; MACROPHAGE; IDENTIFICATION; INFLAMMATION; INHIBITION; CONTRIBUTE; CELLS	Aims: Mouse models of myocardial infarction (MI) are commonly used to explore the pathophysiological role of the monocytic response in myocardial injury and to develop translational strategies. However, no study thus far has examined the potential impact of inter-individual variability and sham surgical procedures on monocyte subset kinetics after experimental MI in mice. Our goal was to investigate determinants of systemic myeloid cell subset shifts in C57BL/6 mice following MI by developing a protocol for sequential extensive flow cytometry (FCM). Methods and Results: Following cross-sectional multiplex FCM analysis we provide for the first time a detailed description of absolute quantities, relative subset composition, and biological variability of circulating classical, intermediate, and non-classical monocyte subsets in C57BL/6 mice. By using intra-individual longitudinal measurements after MI induction, a time course of classical and non-classical monocytosis was recorded. This approach disclosed a significant reduction of monocyte subset dispersion across all investigated time points following MI. We found that in the current invasive model of chronic MI the global pattern of systemic monocyte kinetics is mainly determined by a nonspecific inflammatory response to sham surgery and not by the extent of myocardial injury. Conclusions: Application of sequential multiplexed FCM may help to reduce the impact of biological variability in C57BL/6 mice. Furthermore, the confounding influence of sham surgical procedures should always be considered when measuring monocyte subset kinetics in a murine model of MI.	[Hoffmann, Jedrzej; Ospelt, Manuel; Troidl, Christian; Voss, Sandra; Liebetrau, Christoph; Kim, Won-Keun; Rolf, Andreas; Hamm, Christian; Nef, Holger; Moellmann, Helge] Kerckhoff Heart & Thorax Ctr, Dept Cardiol, Bad Nauheim, Germany; [Liebetrau, Christoph; Rolf, Andreas; Hamm, Christian; Nef, Holger; Moellmann, Helge] Univ Giessen, Dept Cardiol, Med Clin 1, D-35390 Giessen, Germany; [Wietelmann, Astrid; Braun, Thomas; Troidl, Kerstin] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany; [Sadayappan, Sakthivel; Barefield, David] Loyola Univ Chicago, Dept Cell & Mol Physiol, Div Hlth Sci, Maywood, IL USA	Kerckhoff Clinic; Justus Liebig University Giessen; Max Planck Society; Loyola University Chicago	Hoffmann, J (corresponding author), Kerckhoff Heart & Thorax Ctr, Dept Cardiol, Bad Nauheim, Germany.	j.hoffmann@kerckhoff-fgi.de	Hamm, Christian W./I-3155-2017; Kim, Won-Keun/AAS-8945-2021; Rolf, Andreas/ABH-4255-2020	Hamm, Christian W./0000-0001-6763-4161; Kim, Won-Keun/0000-0002-0799-7478; Braun, Thomas/0000-0002-6165-4804; Rolf, Andreas/0000-0002-8771-297X; Barefield, David/0000-0002-6166-640X; Sadayappan, Sakthivel/0000-0003-2006-7678; Hoffmann, Jedrzej/0000-0003-0487-4373	William G. Kerckhoff-Stiftung, Bad Nauheim, Germany	William G. Kerckhoff-Stiftung, Bad Nauheim, Germany	Research funding was received from William G. Kerckhoff-Stiftung, Bad Nauheim, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Breslin WL, 2013, J IMMUNOL METHODS, V390, P1, DOI 10.1016/j.jim.2011.03.005; Combadiere C, 2008, CIRCULATION, V117, P1649, DOI 10.1161/CIRCULATIONAHA.107.745091; Francke A, 2011, J HISTOCHEM CYTOCHEM, V59, P813, DOI 10.1369/0022155411416007; Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.223925; Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hoff J, 2000, LAB ANIMAL, V29, P47; Hoffmann J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047155; Jakubzick C, 2013, IMMUNITY, V39, P599, DOI 10.1016/j.immuni.2013.08.007; Jensen CJ, 2009, CLIN RES CARDIOL, V98, P651, DOI 10.1007/s00392-009-0051-z; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Leuschner F, 2010, CIRC RES, V107, P1364, DOI 10.1161/CIRCRESAHA.110.227454; Mollmann H, 2006, CARDIOVASC RES, V71, P661, DOI 10.1016/j.cardiores.2006.06.013; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Nossuli TO, 2000, AM J PHYSIOL-HEART C, V278, pH1049, DOI 10.1152/ajpheart.2000.278.4.H1049; Panizzi P, 2010, J AM COLL CARDIOL, V55, P1629, DOI 10.1016/j.jacc.2009.08.089; Sanchez O, 2002, CELL STRESS CHAPERON, V7, P36, DOI 10.1379/1466-1268(2002)007<0036:ASITII>2.0.CO;2; Schneider JE, 2006, J CARDIOVASC MAGN R, V8, P693, DOI 10.1080/10976640600723664; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Troidl C, 2009, J CELL MOL MED, V13, P3485, DOI 10.1111/j.1582-4934.2009.00707.x; Tsujioka H, 2009, J AM COLL CARDIOL, V54, P130, DOI 10.1016/j.jacc.2009.04.021; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yona S, 2010, CURR OPIN HEMATOL, V17, P53, DOI 10.1097/MOH.0b013e3283324f80; Ziegler-Heitbrock L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00023; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	31	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98456	10.1371/journal.pone.0098456	http://dx.doi.org/10.1371/journal.pone.0098456			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893162	Green Published, gold, Green Submitted			2022-12-27	WOS:000336911400053
J	Wang, J; Jia, LH; Kuang, ZR; Wu, T; Hong, Y; Chen, XB; Leung, WK; Xia, J; Cheng, B				Wang, Juan; Jia, Lihua; Kuang, Zirong; Wu, Tong; Hong, Yun; Chen, Xiaobing; Leung, W. Keung; Xia, Juan; Cheng, Bin			The In Vitro and In Vivo Antitumor Effects of Clotrimazole on Oral Squamous Cell Carcinoma (Publication with Expression of Concern. See vol. 15, 2020)	PLOS ONE			English	Article; Publication with Expression of Concern							HUMAN BREAST-CANCER; GLIOBLASTOMA CELLS; VIABILITY; GROWTH; CARCINOGENESIS; ADENOCARCINOMA; CYTOSKELETON; INHIBITION; BLOCKAGE; THERAPY	Background: Clotrimazole is an antifungal imidazole derivative showing anti-neoplastic effect in some tumors, but its anticancer potential is still unclear in oral squamous cell carcinoma (OSCC). The aim of this study was to evaluate the antitumor effect of clotrimazole, and to investigate the possible mechanism of clotrimazole-mediated antitumor activity in OSCC. Methodology: In vitro experiments, the cell viability and clonogenic ability of three human OSCC cell lines CAL27, SCC25 and UM1 were detected after clotrimazole treatment by CCK8 assay and colony formation assay. Cell cycle progression and apoptosis were assessed by flow cytometry, and the involvement of several mediators of apoptosis was examined by western blot analysis. Then, the in vivo antitumor effect of clotrimazole was investigated in CAL27 xenograft model. Immunohistochemistry and western blot analysis were performed to determine the presence of apoptotic cells and the expression of Bcl-2 and Bax in tumors from mice treated with or without clotrimazole. Results: Clotrimazole inhibited proliferation in all three OSCC cell lines in a dose-and time-dependent manner, and significantly reduced the colony formation of OSCC cells in vitro. Clotrimazole caused cell cycle arrest at the G(0)/G(1) phase. In addition, clotrimazole induced apoptosis in OSCC cells, and significantly down-regulated the anti-apoptotic protein Bcl-2 and up-regulated the pro-apoptotic protein Bax. Notably, clotrimazole treatment inhibited OSCC tumor growth and cell proliferation in CAL27 xenograft model. Clotrimazole also markedly reduced Bcl-2 expression and increased the protein level of Bax in tumor tissues of xenograft model. Conclusion: Our findings demonstrated a potent anticancer effect of clotrimazole by inducing cell cycle arrest and cellular apoptosis in OSCC.	[Wang, Juan; Jia, Lihua; Kuang, Zirong; Wu, Tong; Hong, Yun; Chen, Xiaobing; Xia, Juan; Cheng, Bin] Sun Yat Sen Univ, Guangdong Prov Key Lab Stomatol, Guanghua Sch Stomatol, Dept Oral Med, Guangzhou 510275, Guangdong, Peoples R China; [Leung, W. Keung] Univ Hong Kong, Fac Dent, Prince Philip Dent Hosp, Hong Kong, Hong Kong, Peoples R China	Sun Yat Sen University; University of Hong Kong	Xia, J (corresponding author), Sun Yat Sen Univ, Guangdong Prov Key Lab Stomatol, Guanghua Sch Stomatol, Dept Oral Med, Guangzhou 510275, Guangdong, Peoples R China.	xiajuan@mail.sysu.edu.cn; chengbin@mail.sysu.edu.cn	LEUNG, Wai Keung/B-2159-2009; li, jia/GVT-7587-2022; Jia, li/GPW-8015-2022	LEUNG, Wai Keung/0000-0003-1979-910X; 	National Natural Science Foundation of China [91029712, 81272948, 81371148]; Guangdong Translation Medicine Public Platform	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Translation Medicine Public Platform	This work was supported by the National Natural Science Foundation of China (Nos. 91029712, 81272948, and 81371148), Guangdong Translation Medicine Public Platform. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas H, 1998, P NATL ACAD SCI USA, V95, P8280, DOI 10.1073/pnas.95.14.8280; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Burmeister BH, 2013, LANCET ONCOL, V14, P569, DOI 10.1016/S1470-2045(13)70157-8; Cao MY, 2004, J PHARMACOL EXP THER, V308, P538, DOI 10.1124/jpet.103.059618; Coelho RG, 2011, MOL GENET METAB, V103, P394, DOI 10.1016/j.ymgme.2011.04.003; Czerninski R, 2010, CLIN ORAL INVEST, V14, P71, DOI 10.1007/s00784-009-0275-3; DEFRANCESCHI L, 1994, J CLIN INVEST, V93, P1670, DOI 10.1172/JCI117149; Furtado CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030462; Goncalves P, 2012, ANTI-CANCER DRUG, V23, P220, DOI 10.1097/CAD.0b013e32834d9ad2; Horng CT, 2013, J RECEPT SIG TRANSD, V33, P89, DOI 10.3109/10799893.2013.764321; Ito C, 2002, LEUKEMIA, V16, P1344, DOI 10.1038/sj.leu.2402510; Jager H, 2004, MOL PHARMACOL, V65, P630, DOI 10.1124/mol.65.3.630; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Johnson NW, 2011, PERIODONTOL 2000, V57, P19, DOI 10.1111/j.1600-0757.2011.00401.x; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Katanyoo K, 2012, GYNECOL ONCOL, V125, P292, DOI 10.1016/j.ygyno.2012.01.034; Khalid MH, 2005, J NEUROSURG, V103, P79, DOI 10.3171/jns.2005.103.1.0079; Khalid MH, 1999, J NEUROSURG, V90, P918, DOI 10.3171/jns.1999.90.5.0918; Liu H, 2010, ANTI-CANCER DRUG, V21, P841, DOI 10.1097/CAD.0b013e32833e8022; Marcondes MC, 2010, ARCH BIOCHEM BIOPHYS, V497, P62, DOI 10.1016/j.abb.2010.03.013; Meira DD, 2005, MOL GENET METAB, V84, P354, DOI 10.1016/j.ymgme.2004.11.012; Mhawech-Fauceglia P, 2011, HISTOPATHOLOGY, V59, P1015, DOI 10.1111/j.1365-2559.2011.03944.x; Penso J, 2002, MOL GENET METAB, V76, P181, DOI 10.1016/S1096-7192(02)00046-X; Pienaar ED, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003940.pub3; Rufo PA, 1997, J CLIN INVEST, V100, P3111, DOI 10.1172/JCI119866; Tait SWG, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008706; Takei S, 2003, INT J UROL, V10, P78, DOI 10.1046/j.1442-2042.2003.00575.x; Vitale-Cross L, 2009, CANCER PREV RES, V2, P419, DOI 10.1158/1940-6207.CAPR-09-0058; Wang ZH, 2007, ONCOGENE, V26, P5107, DOI 10.1038/sj.onc.1210308	29	15	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98885	10.1371/journal.pone.0098885	http://dx.doi.org/10.1371/journal.pone.0098885			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892421	Green Published, Green Submitted, gold			2022-12-27	WOS:000336911400106
J	Lechenet, M; Bretagnolle, V; Bockstaller, C; Boissinot, F; Petit, MS; Petit, S; Munier-Jolain, NM				Lechenet, Martin; Bretagnolle, Vincent; Bockstaller, Christian; Boissinot, Francois; Petit, Marie-Sophie; Petit, Sandrine; Munier-Jolain, Nicolas M.			Reconciling Pesticide Reduction with Economic and Environmental Sustainability in Arable Farming	PLOS ONE			English	Article							BIODIVERSITY; MANAGEMENT; IMPACTS; RISK	Reducing pesticide use is one of the high-priority targets in the quest for a sustainable agriculture. Until now, most studies dealing with pesticide use reduction have compared a limited number of experimental prototypes. Here we assessed the sustainability of 48 arable cropping systems from two major agricultural regions of France, including conventional, integrated and organic systems, with a wide range of pesticide use intensities and management (crop rotation, soil tillage, cultivars, fertilization, etc.). We assessed cropping system sustainability using a set of economic, environmental and social indicators. We failed to detect any positive correlation between pesticide use intensity and both productivity (when organic farms were excluded) and profitability. In addition, there was no relationship between pesticide use and workload. We found that crop rotation diversity was higher in cropping systems with low pesticide use, which would support the important role of crop rotation diversity in integrated and organic strategies. In comparison to conventional systems, integrated strategies showed a decrease in the use of both pesticides and nitrogen fertilizers, they consumed less energy and were frequently more energy efficient. Integrated systems therefore appeared as the best compromise in sustainability trade-offs. Our results could be used to re-design current cropping systems, by promoting diversified crop rotations and the combination of a wide range of available techniques contributing to pest management.	[Lechenet, Martin; Petit, Sandrine; Munier-Jolain, Nicolas M.] INRA, Unite Mixte Rech Agroecol 1347, Dijon, Cote Dor, France; [Bretagnolle, Vincent] Ctr Natl Rech Sci, Ctr Etud Biol Chize, Beauvoir Sur Niort, Deux Sevres, France; [Bockstaller, Christian] INRA, Unite Rech Agron & Environm 1121, Colmar, Haut Rhin, France; [Bockstaller, Christian] Univ Lorraine, Vandoeuvre Les Nancy, Meurthe Et Mose, France; [Boissinot, Francois] Chambre Agr Pays Loire, Angers, Maine Et Loire, France; [Petit, Marie-Sophie] Chambre Reg Agr Bourgogne, Quetigny, Cote Dor, France	INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); INRAE; Universite de Lorraine	Munier-Jolain, NM (corresponding author), INRA, Unite Mixte Rech Agroecol 1347, Dijon, Cote Dor, France.	nicolas.munier-jolain@dijon.inra.fr	Petit, Sandrine/C-3310-2013	Petit, Sandrine/0000-0001-8781-8873; Shang, Rachel/0000-0002-2296-608X	French National Research Agency ANR (STRA-08-02 Advherb project); Region Bourgogne; European Network of Excellence ENDURE	French National Research Agency ANR (STRA-08-02 Advherb project)(French National Research Agency (ANR)); Region Bourgogne(Region Bourgogne-Franche-Comte); European Network of Excellence ENDURE	Funding for the study was provided by the French National Research Agency ANR (STRA-08-02 Advherb project) and from Region Bourgogne. The Burgundy farms network was developed in the framework of the Reseau Mixte Technologique "Systemes de Culture Innovants" and the project "Plus d'Agronomie, Moins d'intrants" initiated by Region Bourgogne. The long term experiment at Dijon-Epoisses was partly funded by the European Network of Excellence ENDURE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aavik T, 2010, AGR ECOSYST ENVIRON, V135, P178, DOI 10.1016/j.agee.2009.09.005; ADEME (Agence de l'Environment et de la Maitrise de l'Energie), 2011, GUID VAL DIAT VERS R; ALTIERI MA, 2009, CROP DIVERSIFICATION, P116; Andersson GKS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031599; [Anonymous], 2011, PEST IND SAL US 2006; Ascherio A, 2006, ANN NEUROL, V60, P197, DOI 10.1002/ana.20904; Aubertot JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073202; Bastiaans L, 2008, WEED RES, V48, P481, DOI 10.1111/j.1365-3180.2008.00662.x; BCMA, 2012, SIMC ONL DEC TOOL; Beckie HJ, 2009, PRAIRIE SOILS CROPS, V2, P3; Beketov MA, 2013, P NATL ACAD SCI USA, V110, P11039, DOI 10.1073/pnas.1305618110; Bockstaller C, 2000, 3 INT CROP SCI C 200, P195; Bukowski R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033047, 10.1371/journal.pone.0047149]; Centre d'Etudes Biologiques de Chize, 2009, ZON AT PLAIN VAL SER; Chikowo R, 2009, AGR ECOSYST ENVIRON, V132, P237, DOI 10.1016/j.agee.2009.04.009; Deike S, 2008, EUR J AGRON, V28, P461, DOI 10.1016/j.eja.2007.11.009; Di Falco S, 2008, LAND ECON, V84, P83, DOI 10.3368/le.84.1.83; European commission, 2010, EUR AGR ONL DAT; Ferron P, 2005, AGRON SUSTAIN DEV, V25, P17, DOI 10.1051/agro:2004050; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Food and Agriculture Organization of the United Nations (FAO), 2013, FAOSTAT RES PEST US; Halberg N, 2005, LIVEST PROD SCI, V96, P33, DOI 10.1016/j.livprodsci.2005.05.013; HOLLAND JM, 1994, ANN APPL BIOL, V125, P399, DOI 10.1111/j.1744-7348.1994.tb04980.x; Hulme MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054597; Hulsbergen KJ, 2001, AGR ECOSYST ENVIRON, V86, P303, DOI 10.1016/S0167-8809(00)00286-3; Krupinsky JM, 2002, AGRON J, V94, P198, DOI 10.2134/agronj2002.0198; Li R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051897; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; Meiss H, 2010, WEED RES, V50, P331, DOI 10.1111/j.1365-3180.2010.00784.x; Meynard J.M., 2013, FREINS LEVIERS DIVER, P1; Ministere de l'Agriculture de l'Agro-alimentaire et de la Foret, 2012, NOT SUIV PLAN EC 201; Munier-Jolain N, 2010, INNOVATIONS AGRONOMI, V8, P57; Nemecek T, 2008, EUR J AGRON, V28, P380, DOI 10.1016/j.eja.2007.11.004; OECD, 2001, ENV IND AGR METH RES, V3; Pardo G, 2010, EUR J AGRON, V33, P24, DOI 10.1016/j.eja.2010.02.003; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Pimentel D, 2005, BIOSCIENCE, V55, P573, DOI 10.1641/0006-3568(2005)055[0573:EEAECO]2.0.CO;2; Pimentel D, 2003, AM J CLIN NUTR, V78, p660S, DOI 10.1093/ajcn/78.3.660S; PIMENTEL D, 1995, J AGR ENVIRON ETHIC, V8, P17, DOI 10.1007/BF02286399; R Development Core Team, 2012, R LANG ENV STAT COMP; Reganold JP, 2001, NATURE, V410, P926, DOI 10.1038/35073574; Reidsma P, 2010, EUR J AGRON, V32, P91, DOI 10.1016/j.eja.2009.06.003; Seufert V, 2012, NATURE, V485, P229, DOI 10.1038/nature11069; Theobald DM, 2001, GEOGR REV, V91, P544, DOI 10.2307/3594740; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Trewavas A, 2001, NATURE, V410, P409, DOI 10.1038/35068639; USDA Economic Research Service, 2010, US CERT ORG FARML AC; van der Werf HMG, 1998, CHEMOSPHERE, V36, P2225, DOI 10.1016/S0045-6535(97)10194-1	49	94	97	1	138	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97922	10.1371/journal.pone.0097922	http://dx.doi.org/10.1371/journal.pone.0097922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887494	Green Published, Green Submitted, gold			2022-12-27	WOS:000336956300026
J	Streicher, W; Luedeke, M; Azoitei, A; Zengerling, F; Herweg, A; Genze, F; Schrader, MG; Schrader, AJ; Cronauer, MV				Streicher, Wolfgang; Luedeke, Manuel; Azoitei, Anca; Zengerling, Friedemann; Herweg, Alexander; Genze, Felicitas; Schrader, Mark G.; Schrader, Andres J.; Cronauer, Marcus V.			Stilbene Induced Inhibition of Androgen Receptor Dimerization: Implications for AR and ARDLBD-Signalling in Human Prostate Cancer Cells	PLOS ONE			English	Article							SPLICE VARIANTS; FULL-LENGTH; ABIRATERONE ACETATE; ANTITUMOR-ACTIVITY; RESVERATROL; GROWTH; ENZALUTAMIDE; EXPRESSION; DOCETAXEL; MECHANISM	Background: Advanced castration resistant prostate cancer (CRPC) is often characterized by an increase of C-terminally truncated, constitutively active androgen receptor (AR) variants. Due to the absence of a ligand binding domain located in the AR-C-terminus, these receptor variants (also termed AR Delta LBD) are unable to respond to all classical forms of endocrine treatments like surgical/chemical castration and/or application of anti-androgens. Methodology: In this study we tested the effects of the naturally occurring stilbene resveratrol (RSV) and (E)-4-(2, 6-Difluorostyryl)-N, N-dimethylaniline, a fluorinated dialkylaminostilbene (FIDAS) on AR-and AR Delta LBD in prostate cancer cells. The ability of the compounds to modulate transcriptional activity of AR and the AR Delta LBD-variant Q640X was shown by reporter gene assays. Expression of endogenous AR and AR Delta LBD mRNA and protein levels were determined by qRT-PCR and Western Blot. Nuclear translocation of AR-molecules was analyzed by fluorescence microscopy. AR and AR Delta LBD/Q640X homo-/heterodimer formation was assessed by mammalian two hybrid assays. Biological activity of both compounds in vivo was demonstrated using a chick chorioallantoic membrane xenograft assay. Results: The stilbenes RSV and FIDAS were able to significantly diminish AR and Q640X-signalling. Successful inhibition of the Q640X suggests that RSV and FIDAS are not interfering with the AR-ligand binding domain like all currently available anti-hormonal drugs. Repression of AR and Q640X-signalling by RSV and FIDAS in prostate cancer cells was caused by an inhibition of the AR and/or Q640X-dimerization. Although systemic bioavailability of both stilbenes is very low, both compounds were also able to downregulate tumor growth and AR-signalling in vivo. Conclusion: RSV and FIDAS are able to inhibit the dimerization of AR and AR Delta LBD molecules suggesting that stilbenes might serve as lead compounds for a novel generation of AR-inhibitors.	[Streicher, Wolfgang; Luedeke, Manuel; Azoitei, Anca; Zengerling, Friedemann; Herweg, Alexander; Genze, Felicitas; Schrader, Mark G.; Schrader, Andres J.; Cronauer, Marcus V.] Univ Ulm, Dept Urol, D-89069 Ulm, Germany	Ulm University	Cronauer, MV (corresponding author), Univ Ulm, Dept Urol, D-89069 Ulm, Germany.	marcus.cronauer@uni-ulm.de	Cronauer, Marcus/AAG-7457-2021		Anneliese Pohl Stiftung; Ferdinand Eisenberger Grant of the German Society of Urology [ZeF1/FE-11]	Anneliese Pohl Stiftung; Ferdinand Eisenberger Grant of the German Society of Urology	This work was supported by the Anneliese Pohl Stiftung (AJS, MVC), and a Ferdinand Eisenberger Grant of the German Society of Urology - grant ID ZeF1/FE-11 (FZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amri A, 2012, J CONTROL RELEASE, V158, P182, DOI 10.1016/j.jconrel.2011.09.083; Andersen RJ, 2010, CANCER CELL, V17, P535, DOI 10.1016/j.ccr.2010.04.027; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bianchini D, 2014, EUR J CANCER, V50, P78, DOI 10.1016/j.ejca.2013.08.020; Cai CM, 2011, ENDOCR-RELAT CANCER, V18, pR175, DOI 10.1530/ERC-10-0339; Ceraline J, 2004, INT J CANCER, V108, P152, DOI 10.1002/ijc.11404; Chan SC, 2012, J BIOL CHEM, V287, P19736, DOI 10.1074/jbc.M112.352930; Chen HL, 2010, ENDOCR-RELAT CANCER, V17, P857, DOI 10.1677/ERC-10-0081; Cronauer MV, 2007, ONCOGENE, V26, P1875, DOI 10.1038/sj.onc.1209984; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Dias SJ, 2013, PROSTATE, V73, P1135, DOI 10.1002/pros.22657; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Haile S, 2011, CELL MOL LIFE SCI, V68, P3971, DOI 10.1007/s00018-011-0766-7; Harada N, 2007, J NUTR SCI VITAMINOL, V53, P556, DOI 10.3177/jnsv.53.556; Harada N, 2011, J STEROID BIOCHEM, V123, P65, DOI 10.1016/j.jsbmb.2010.11.002; Hornberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019059; Hsieh TC, 2000, ANTICANCER RES, V20, P225; Hsieh TC, 1999, EXP CELL RES, V249, P109, DOI 10.1006/excr.1999.4471; Hu R, 2012, CANCER RES, V72, P3457, DOI 10.1158/0008-5472.CAN-11-3892; Iguchi K, 2012, J ANDROL, V33, P1208, DOI 10.2164/jandrol.112.016782; JENSTER G, 1991, MOL ENDOCRINOL, V5, P1396, DOI 10.1210/mend-5-10-1396; Jernberg E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077407; Jones SB, 2005, CANCER EPIDEM BIOMAR, V14, P596, DOI 10.1158/1055-9965.EPI-04-0398; Kemper JK, 2009, CELL METAB, V10, P392, DOI 10.1016/j.cmet.2009.09.009; Kuefer R, 2004, BRIT J CANCER, V90, P535, DOI 10.1038/sj.bjc.6601510; Laschak M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-130; Li XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031213; Li YM, 2013, CANCER RES, V73, P483, DOI 10.1158/0008-5472.CAN-12-3630; Libertini SJ, 2007, CANCER RES, V67, P9001, DOI 10.1158/0008-5472.CAN-07-1072; Loriot Y, 2013, ANN ONCOL, V24, P1807, DOI 10.1093/annonc/mdt136; Meimetis LG, 2012, J MED CHEM, V55, P503, DOI 10.1021/jm2014056; Mitchell SH, 1999, CANCER RES, V59, P5892; Mostaghel EA, 2011, CLIN CANCER RES, V17, P5913, DOI 10.1158/1078-0432.CCR-11-0728; Mudryj M, 2013, HORM CANCER-US, V4, P259, DOI 10.1007/s12672-013-0152-z; Noonan KL, 2013, ANN ONCOL, V24, P1802, DOI 10.1093/annonc/mdt138; Reid J, 2002, J BIOL CHEM, V277, P20079, DOI 10.1074/jbc.M201003200; Rinnab L, 2008, NEOPLASIA, V10, P624, DOI 10.1593/neo.08248; Sadar MD, 2008, ORG LETT, V10, P4947, DOI 10.1021/ol802021w; Sadar MD, 2012, WORLD J UROL, V30, P311, DOI 10.1007/s00345-011-0745-5; Schrader AJ, 2014, EUR UROL, V65, P30, DOI 10.1016/j.eururo.2013.06.042; Schutz SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025341; Schutz SV, 2010, J CELL BIOCHEM, V109, P1192, DOI 10.1002/jcb.22500; Shi WF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007398; Streicher W, 2012, WORLD J UROL, V30, P333, DOI 10.1007/s00345-012-0842-0; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Tepper CG, 2002, CANCER RES, V62, P6606; van Royen ME, 2012, J CELL SCI, V125, P1970, DOI 10.1242/jcs.096792; Vang O, 2013, ANN NY ACAD SCI, V1290, P1, DOI 10.1111/nyas.12173; Wang TTY, 2008, CARCINOGENESIS, V29, P2001, DOI 10.1093/carcin/bgn131; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; WU HC, 1994, INT J CANCER, V57, P406, DOI 10.1002/ijc.2910570319; Yamashita S, 2012, NEOPLASIA, V14, P74, DOI 10.1593/neo.111436; Zhang W, 2013, ACS CHEM BIOL, V8, P796, DOI 10.1021/cb3005353; Zhang W, 2011, J MED CHEM, V54, P1288, DOI 10.1021/jm101248v; Zhang XT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027970	56	23	25	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98566	10.1371/journal.pone.0098566	http://dx.doi.org/10.1371/journal.pone.0098566			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887556	gold, Green Published, Green Submitted			2022-12-27	WOS:000336956300086
J	Weitkamp, JH; Rosen, MJ; Zhao, ZG; Koyama, T; Geem, D; Denning, TL; Rock, MT; Moore, DJ; Halpern, MD; Matta, P; Denning, PW				Weitkamp, Joern-Hendrik; Rosen, Michael J.; Zhao, Zhiguo; Koyama, Tatsuki; Geem, Duke; Denning, Timothy L.; Rock, Michael T.; Moore, Daniel J.; Halpern, Melissa D.; Matta, Pranathi; Denning, Patricia W.			Small Intestinal Intraepithelial TCR gamma delta(+) T Lymphocytes Are Present in the Premature Intestine but Selectively Reduced in Surgical Necrotizing Enterocolitis	PLOS ONE			English	Article							GAMMA-DELTA; TIGHT JUNCTIONS; DEFICIENT MICE; IMMUNE-SYSTEM; EXPRESSION; EPIDEMIOLOGY; GROWTH; CELLS; MODEL; PROTECTION	Background: Gastrointestinal barrier immaturity predisposes preterm infants to necrotizing enterocolitis (NEC). Intraepithelial lymphocytes (IEL) bearing the unconventional T cell receptor (TCR) gamma delta (gamma delta IEL) maintain intestinal integrity and prevent bacterial translocation in part through production of interleukin (IL) 17. Objective: We sought to study the development of gamma delta IEL in the ileum of human infants and examine their role in NEC pathogenesis. We defined the ontogeny of gamma delta IEL proportions in murine and human intestine and subjected tc delta(-/-) mice to experimental gut injury. In addition, we used polychromatic flow cytometry to calculate percentages of viable IEL (defined as CD3(+) CD8(+) CD103(+) lymphocytes) and the fraction of gamma delta IEL in surgically resected tissue from infants with NEC and gestational age matched non-NEC surgical controls. Results: In human preterm infants, the proportion of IEL was reduced by 66% in 11 NEC ileum resections compared to 30 non-NEC controls (p<0.001). While gamma delta IEL dominated over conventional alpha beta IEL early in gestation in mice and in humans, gamma delta IEL were preferential decreased in the ileum of surgical NEC patients compared to non-NEC controls (50% reduction, p<0.05). Loss of IEL in human NEC was associated with downregulation of the Th17 transcription factor retinoic acid-related orphan nuclear hormone receptor C (RORC, p<0.001). TCRd-deficient mice showed increased severity of experimental gut injury (p<0.05) with higher TNF alpha expression but downregulation of IL17A. Conclusion: Complimentary mouse and human data suggest a role of gamma delta IEL in IL17 production and intestinal barrier production early in life. Specific loss of the gamma delta IEL fraction may contribute to NEC pathogenesis. Nutritional or pharmacological interventions to support gamma delta IEL maintenance in the developing small intestine could serve as novel strategies for NEC prevention.	[Weitkamp, Joern-Hendrik; Rock, Michael T.; Moore, Daniel J.; Matta, Pranathi] Vanderbilt Univ Sch Med, Dept Pediat, Nashville, TN 37232 USA; [Weitkamp, Joern-Hendrik; Rock, Michael T.; Moore, Daniel J.; Matta, Pranathi] Monroe Carell Jr Childrens Hosp Vanderbilt, Nashville, TN USA; [Rosen, Michael J.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA; [Zhao, Zhiguo; Koyama, Tatsuki] Vanderbilt Univ Sch Med, Dept Biostat, Nashville, TN USA; [Geem, Duke; Denning, Timothy L.] Georgia State Univ, Inst Biomed Sci, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA; [Halpern, Melissa D.] Univ Arizona, Dept Pediat, Tucson, AZ 85721 USA; [Halpern, Melissa D.] Univ Arizona, Steele Childrens Res Ctr, Tucson, AZ USA; [Denning, Patricia W.] Emory Univ Sch Med, Dept Pediat, Atlanta, GA USA	Vanderbilt University; Vanderbilt University; Cincinnati Children's Hospital Medical Center; Vanderbilt University; University System of Georgia; Georgia State University; University of Arizona; University of Arizona; Emory University	Weitkamp, JH (corresponding author), Vanderbilt Univ Sch Med, Dept Pediat, Nashville, TN 37232 USA.	weitkamp@Vanderbilt.Edu; pllin@emory.edu	Weitkamp, Joern-Hendrik/AAZ-8272-2020; Moore, Daniel J/A-4924-2008; Denning, Patricia W/G-4485-2011; Moore, Daniel/V-6145-2019	Weitkamp, Joern-Hendrik/0000-0002-6654-4823; Moore, Daniel J/0000-0002-6889-9345; Moore, Daniel/0000-0002-6889-9345; Denning, Timothy/0000-0002-1072-7444; Rosen, Michael/0000-0002-5149-718X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059122, K08HD061607] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK090146, P30DK058404, P30DK020593, R24DK064399, K23DK094832, R21DK102058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER; NCATS NIH HHS [2 UL1 TR000445-06, UL1 TR000445] Funding Source: Medline; NCRR NIH HHS [UL1 RR024975, UL1 RR024975-01] Funding Source: Medline; NICHD NIH HHS [R01 HD059122, R01HD05922, K08HD061607, K08 HD061607] Funding Source: Medline; NIDDK NIH HHS [P30DK058404, K08 DK090146, 5K08DK090146-03, P30DK20593, R24 DK064399, R21 DK102058, P30 DK058404, K23DK094832, K23 DK094832, DK 063399, P30 DK020593] Funding Source: Medline; NIGMS NIH HHS [T32 GM008169] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asigbetse KE, 2010, J INVEST ALLERG CLIN, V20, P391; Been JV, 2013, J PEDIATR-US, V162, P236, DOI 10.1016/j.jpeds.2012.07.012; Bergmann KR, 2013, AM J PATHOL, V182, P1595, DOI 10.1016/j.ajpath.2013.01.013; Bhagat G, 2008, J CLIN INVEST, V118, P281, DOI 10.1172/JCI30989; BOISMENU R, 1994, SCIENCE, V266, P1253, DOI 10.1126/science.7973709; CAMERINI V, 1993, J IMMUNOL, V151, P1765; CEPEK KL, 1993, J IMMUNOL, V150, P3459; Chen YP, 2002, P NATL ACAD SCI USA, V99, P14338, DOI 10.1073/pnas.212290499; Clark JA, 2006, AM J PHYSIOL-GASTR L, V291, pG938, DOI 10.1152/ajpgi.00090.2006; Claud EC, 2004, P NATL ACAD SCI USA, V101, P7404, DOI 10.1073/pnas.0401710101; Dalton JE, 2006, GASTROENTEROLOGY, V131, P818, DOI 10.1053/j.gastro.2006.06.003; Denning TL, 2007, J IMMUNOL, V178, P4230, DOI 10.4049/jimmunol.178.7.4230; Edelblum KL, 2012, P NATL ACAD SCI USA, V109, P7097, DOI 10.1073/pnas.1112519109; Fanaroff Avroy A, 2007, Am J Obstet Gynecol, V196, DOI 10.1016/j.ajog.2006.09.014; FU YX, 1994, J IMMUNOL, V153, P3101; Fuss IJ, 2002, J IMMUNOL, V168, P900, DOI 10.4049/jimmunol.168.2.900; Gibbons DL, 2009, EUR J IMMUNOL, V39, P1794, DOI 10.1002/eji.200939222; Gordon PV, 2012, EJ NEONATOL RES, V2, P145; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Holman RC, 1997, AM J PUBLIC HEALTH, V87, P2026, DOI 10.2105/AJPH.87.12.2026; HSUEH W, 1987, FASEB J, V1, P403, DOI 10.1096/fasebj.1.5.3678700; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Ismail AS, 2009, J IMMUNOL, V182, P3047, DOI 10.4049/jimmunol.0802705; Istvanic S, 2007, AM J CLIN PATHOL, V127, P816, DOI 10.1309/V1GCW4DHTHM9WVXJ; Khailova L, 2009, AM J PHYSIOL-GASTR L, V297, pG940, DOI 10.1152/ajpgi.00141.2009; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; KLIEGMAN RM, 1981, AM J DIS CHILD, V135, P603, DOI 10.1001/archpedi.1981.02130310009005; KOMANO H, 1995, P NATL ACAD SCI USA, V92, P6147, DOI 10.1073/pnas.92.13.6147; Kuo S, 2001, PEDIATR RES, V49, P543, DOI 10.1203/00006450-200104000-00017; Li ZY, 2012, INFECT IMMUN, V80, P565, DOI 10.1128/IAI.05078-11; Lin PW, 2006, LANCET, V368, P1271, DOI 10.1016/S0140-6736(06)69525-1; Llanos AR, 2002, PAEDIATR PERINAT EP, V16, P342, DOI 10.1046/j.1365-3016.2002.00445.x; Maheshwari A, 2011, GASTROENTEROLOGY, V140, P242, DOI 10.1053/j.gastro.2010.09.043; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; McElroy Steven J, 2011, Neoreviews, V12, pe517; Mirpuri J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051955; Monteleone I, 2011, GASTROENTEROLOGY, V141, P237, DOI 10.1053/j.gastro.2011.04.007; MUSEMECHE C, 1991, J PEDIATR SURG, V26, P1047, DOI 10.1016/0022-3468(91)90671-F; Namachivayam K, 2013, AM J PHYSIOL-GASTR L, V304, pG167, DOI 10.1152/ajpgi.00141.2012; Neu J, 2005, ACTA PAEDIATR, V94, P100, DOI 10.1080/08035320510043637; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Park SG, 2010, IMMUNITY, V33, P791, DOI 10.1016/j.immuni.2010.10.014; Patel RM, 2012, AM J PATHOL, V180, P626, DOI 10.1016/j.ajpath.2011.10.025; Piena-Spoel M, 2001, J PEDIATR SURG, V36, P587, DOI 10.1053/jpsu.2001.22288; Roberts SJ, 1996, P NATL ACAD SCI USA, V93, P11774, DOI 10.1073/pnas.93.21.11774; Romano-Keeler J, 2014, GUT MICROBES, V5, P192, DOI 10.4161/gmic.28442; Schaefer JS, 2010, J LEUKOCYTE BIOL, V87, P301, DOI 10.1189/jlb.0409238; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shah TA, 2012, J PERINATOL, V32, P552, DOI 10.1038/jp.2011.176; Sharma AA, 2012, CLIN IMMUNOL, V145, P61, DOI 10.1016/j.clim.2012.08.006; Shibahara T, 2000, GASTROENTEROLOGY, V118, P289, DOI 10.1016/S0016-5085(00)70211-3; Shiou SR, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.154625; Sun XM, 1997, AM J PHYSIOL-GASTR L, V273, pG56, DOI 10.1152/ajpgi.1997.273.1.G56; Suzuki R, 2002, INT IMMUNOL, V14, P339, DOI 10.1093/intimm/14.4.339; Tian RL, 2010, INT J CLIN EXP MED, V3, P293; Unutmaz D, 2009, EUR J IMMUNOL, V39, P1452, DOI 10.1002/eji.200939540; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Weitkamp JH, 2013, GUT, V62, P73, DOI 10.1136/gutjnl-2011-301551; Weitkamp JH, 2009, PEDIATR DEVEL PATHOL, V12, P443, DOI 10.2350/08-09-0533.1; Yang H, 2004, J IMMUNOL, V172, P4151, DOI 10.4049/jimmunol.172.7.4151; Zhang F, 2014, MUCOSAL IMMUNOL, V7, P521, DOI 10.1038/mi.2013.69	62	31	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99042	10.1371/journal.pone.0099042	http://dx.doi.org/10.1371/journal.pone.0099042			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905458	gold, Green Published, Green Submitted			2022-12-27	WOS:000341869000098
J	Giles, JT; Darrah, E; Danoff, S; Johnson, C; Andrade, F; Rosen, A; Bathon, JM				Giles, Jon T.; Darrah, Erika; Danoff, Sonye; Johnson, Cheilonda; Andrade, Felipe; Rosen, Antony; Bathon, Joan M.			Association of Cross-Reactive Antibodies Targeting Peptidyl-Arginine Deiminase 3 and 4 with Rheumatoid Arthritis-Associated Interstitial Lung Disease	PLOS ONE			English	Article							RESOLUTION COMPUTED-TOMOGRAPHY; ATHEROSCLEROSIS MESA; CARDIAC CT; CITRULLINATION; MORTALITY; FIBROSIS; GENES; PAD	Background: A subset of rheumatoid arthritis (RA) patients have detectable antibodies directed against the peptidylarginine deiminase (PAD) enzyme isoforms 3 and 4. Anti-PAD3/4 cross-reactive antibodies (anti-PAD3/4XR) have been shown to lower the calcium threshold required for PAD4 activation, an effect potentially relevant to the pathogenesis of RA-associated interstitial lung disease (ILD). Methods: RA patients underwent multi-detector computed tomography (MDCT) of the chest with interpretation by a pulmonary radiologist for ILD features. A semi-quantitative ILD Score (range 0-32) was calculated. Concurrent serum samples were assessed for antibodies against PAD by immunoprecipitation with radiolabeled PAD3 and PAD4. Results: Among the 176 RA patients studied, any ILD was observed in 58 (33%) and anti-PAD3/4XR was detected in 19 (11%). The frequency of any ILD among those with anti-PAD3/4XR was 68% vs. 29% among those with no anti-PAD (crude OR = 5.39; p = 0.002) and vs. 27% among those with anti-PAD4 that was not cross-reactive with PAD3 (crude OR = 5.74; p = 0.001). Both associations were stronger after adjustment for relevant confounders (adjusted ORs = 7.22 and 6.61, respectively; both p-values<0.01). Among ever smokers with anti-PAD3/4XR, the adjusted frequency of any ILD was 93% vs. 17% for never smokers without the antibody (adjusted OR = 61.4; p = 0.001, p-value for the interaction of smoking with anti-PAD3/4XR<0.05). Conclusions: The prevalence and extent of ILD was markedly higher among RA patients with anti-PAD3/4 cross-reactive antibodies, even after accounting for relevant confounders, particularly among ever smokers. These findings may suggest etiopathologic mechanisms of RA-ILD, and their clinical utility for predicting ILD warrants additional study.	[Giles, Jon T.; Bathon, Joan M.] Columbia Univ, Coll Phys & Surg, Div Rheumatol, New York, NY 10027 USA; [Darrah, Erika; Andrade, Felipe; Rosen, Antony] Johns Hopkins Univ, Div Rheumatol, Baltimore, MD USA; [Danoff, Sonye; Johnson, Cheilonda] Johns Hopkins Univ, Div Pulm & Crit Care Med, Baltimore, MD USA	Columbia University; Johns Hopkins University; Johns Hopkins University	Giles, JT (corresponding author), Columbia Univ, Coll Phys & Surg, Div Rheumatol, New York, NY 10027 USA.	jtg2122@columbia.edu	Johnson, Cheilonda/AAB-4555-2020	Johnson, Cheilonda/0000-0003-3040-4981; Danoff, Sonye K./0000-0001-9172-8977; Darrah, Erika/0000-0003-1119-0279	National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [AR050026-01]; Stabler Family Foundation; Mackley Fund from Sibley Memorial Hospital; NIH [P30 AR053503]; American College of Rheumatology Research and Education Foundation Within-Our-Reach Campaign; Johns Hopkins Bayview Medical Center General Clinical Research Center [M01RR02719]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R55AR050026, P30AR053503, R01AR050026] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Stabler Family Foundation; Mackley Fund from Sibley Memorial Hospital; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American College of Rheumatology Research and Education Foundation Within-Our-Reach Campaign; Johns Hopkins Bayview Medical Center General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) AR050026-01 (JMB), grant support from the Stabler Family Foundation, the Mackley Fund from Sibley Memorial Hospital, and NIH grant P30 AR053503 (AR, ED, FA), and awards from the American College of Rheumatology Research and Education Foundation Within-Our-Reach Campaign (SKD, JTG). Additional support was provided by the Johns Hopkins Bayview Medical Center General Clinical Research Center (Grant Number M01RR02719). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baumgartner KB, 2000, AM J EPIDEMIOL, V152, P307, DOI 10.1093/aje/152.4.307; Bongartz T, 2007, RHEUMATOLOGY, V46, P70, DOI 10.1093/rheumatology/kel202; Bongartz T, 2010, ARTHRITIS RHEUM-US, V62, P1583, DOI 10.1002/art.27405; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Darrah E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005370; Dawson JK, 2001, THORAX, V56, P622, DOI 10.1136/thorax.56.8.622; Felsenfeld DP, 1996, NATURE, V383, P438, DOI 10.1038/383438a0; Giles JT, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2641; Giles JT, 2013, ANN RHEUM DIS, DOI 10.1136; Goldin JG, 2008, CHEST, V134, P358, DOI 10.1378/chest.07-2444; Hoffman EA, 2009, ACAD RADIOL, V16, P689, DOI 10.1016/j.acra.2008.12.024; Kallberg H, 2011, ANN RHEUM DIS, V70, P508, DOI 10.1136/ard.2009.120899; Kobayashi H, 2010, J RHEUMATOL, V37, P730, DOI 10.3899/jrheum.090670; Koduri G, 2010, RHEUMATOLOGY, V49, P1483, DOI 10.1093/rheumatology/keq035; Luzina IG, 2009, ARTHRITIS RHEUM-US, V60, P1530, DOI 10.1002/art.24435; MCDONAGH J, 1994, BRIT J RHEUMATOL, V33, P118; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mortier A, 2010, J BIOL CHEM, V285, P29750, DOI 10.1074/jbc.M110.119388; Olson AL, 2011, AM J RESP CRIT CARE, V183, P372, DOI 10.1164/rccm.201004-0622OC; Ordonez A, 2009, FEBS J, V276, P6763, DOI 10.1111/j.1742-4658.2009.07391.x; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; ROBERTSON WG, 1981, CRC CR REV CL LAB SC, V15, P85, DOI 10.3109/10408368109105869; Sheetz MP, 1998, TRENDS CELL BIOL, V8, P51, DOI 10.1016/S0962-8924(98)80005-6; Shelef MA, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4083; Sokolove J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035296; Solomon JJ, 2013, RESP MED, V107, P1247, DOI 10.1016/j.rmed.2013.05.002; van der Heijde D, 2000, J RHEUMATOL, V27, P261; van Gaalen FA, 2004, ARTHRITIS RHEUM, V50, P2113, DOI 10.1002/art.20316; Vij R, 2013, CHEST, V143, P814, DOI 10.1378/chest.12-0741; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Willis VC, 2013, ARTHRITIS RHEUM-US, V65, P2545, DOI 10.1002/art.38066; WOLFE F, 1988, J RHEUMATOL, V15, P1480; Young A, 2007, RHEUMATOLOGY, V46, P350, DOI 10.1093/rheumatology/kel253	34	45	50	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98794	10.1371/journal.pone.0098794	http://dx.doi.org/10.1371/journal.pone.0098794			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901704	Green Published, gold, Green Submitted			2022-12-27	WOS:000336841400052
J	Tran, HB; Ahern, J; Hodge, G; Holt, P; Dean, MM; Reynolds, PN; Hodge, S				Tran, Hai B.; Ahern, Jessica; Hodge, Greg; Holt, Phillip; Dean, Melinda M.; Reynolds, Paul N.; Hodge, Sandra			Oxidative Stress Decreases Functional Airway Mannose Binding Lectin in COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; MACROPHAGE SCAVENGER RECEPTOR; SURFACTANT PROTEIN-A; ALVEOLAR MACROPHAGES; STAPHYLOCOCCUS-AUREUS; EPITHELIAL-CELLS; PHAGOCYTOSIS; MBL; RECOGNITION; EXPRESSION	We have previously established that a defect in the ability of alveolar macrophages (AM) to phagocytose apoptotic cells (efferocytosis) and pathogens is a potential therapeutic target in COPD. We further showed that levels of mannose binding lectin (MBL; required for effective macrophage phagocytic function) were reduced in the airways but not circulation of COPD patients. We hypothesized that increased oxidative stress in the airway could be a cause for such disturbances. We therefore studied the effects of oxidation on the structure of the MBL molecule and its functional interactions with macrophages. Oligomeric structure of plasma derived MBL (pdMBL) before and after oxidation (oxMBL) with 2,2'-azobis(2-methylpropionamidine) dihydrochroride (AAPH) was investigated by blue native PAGE. Macrophage function in the presence of pd/oxMBL was assessed by measuring efferocytosis, phagocytosis of non-typeable Haemophilus influenzae (NTHi) and expression of macrophage scavenger receptors. Oxidation disrupted higher order MBL oligomers. This was associated with changed macrophage function evident by a significantly reduced capacity to phagocytose apoptotic cells and NTHi in the presence of oxMBL vs pdMBL (eg, NTHi by 55.9 and 27.0% respectively). Interestingly, oxidation of MBL significantly reduced macrophage phagocytic ability to below control levels. Flow cytometry and immunofluorescence revealed a significant increase in expression of macrophage scavenger receptor (SRA1) in the presence of pdMBL that was abrogated in the presence of oxMBL. We show the pulmonary macrophage dysfunction in COPD may at least partially result from an oxidative stress-induced effect on MBL, and identify a further potential therapeutic strategy for this debilitating disease.	[Tran, Hai B.; Ahern, Jessica; Hodge, Greg; Holt, Phillip; Reynolds, Paul N.; Hodge, Sandra] Royal Adelaide Hosp, Hanson Inst, Adelaide, SA 5000, Australia; [Tran, Hai B.; Ahern, Jessica; Hodge, Greg; Holt, Phillip; Reynolds, Paul N.; Hodge, Sandra] Royal Adelaide Hosp, Dept Thorac Med, Adelaide, SA 5000, Australia; [Hodge, Greg; Reynolds, Paul N.; Hodge, Sandra] Univ Adelaide, Dept Med, Adelaide, SA 5001, Australia; [Dean, Melinda M.] Australian Red Cross Blood Serv, Brisbane, Qld, Australia	Hanson Institute; Royal Adelaide Hospital; Royal Adelaide Hospital; University of Adelaide; Australian Red Cross Blood Service	Tran, HB (corresponding author), Royal Adelaide Hosp, Hanson Inst, Adelaide, SA 5000, Australia.	hai.tran@health.sa.gov.au		Holt, Phillip/0000-0003-1999-1927	Hanson Institute Brine Bequest for Emphysema Research	Hanson Institute Brine Bequest for Emphysema Research	The work was supported by a Hanson Institute Brine Bequest for Emphysema Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang P, 2008, SCAND J INFECT DIS, V40, P44, DOI 10.1080/00365540701522959; Butler GS, 2002, J BIOL CHEM, V277, P17511, DOI 10.1074/jbc.M201461200; Dehle FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061573; Fidler KJ, 2009, THORAX, V64, P150, DOI 10.1136/thx.2008.100073; Fraser DA, 2006, J LEUKOCYTE BIOL, V80, P107, DOI 10.1189/jlb.1105683; Ghiran I, 2000, J EXP MED, V192, P1797, DOI 10.1084/jem.192.12.1797; Hodge S, 2006, EUR RESPIR J, V28, P486, DOI 10.1183/09031936.06.00001506; Hodge S, 2005, EUR RESPIR J, V25, P447, DOI 10.1183/09031936.05.00077604; Hodge S, 2003, IMMUNOL CELL BIOL, V81, P289, DOI 10.1046/j.1440-1711.2003.t01-1-01170.x; Hodge S, 2008, AM J RESP CRIT CARE, V178, P139, DOI 10.1164/rccm.200711-1666OC; Hodge S, 2007, AM J RESP CELL MOL, V37, P748, DOI 10.1165/rcmb.2007-0025OC; Hodge S, 2012, RESPIROLOGY, V17, P802, DOI 10.1111/j.1440-1843.2012.02135.x; Hodge S, 2011, AM J RESP CELL MOL, V44, P673, DOI 10.1165/rcmb.2009-0459OC; Hodge S, 2011, J HEART LUNG TRANSPL, V30, P589, DOI 10.1016/j.healun.2011.01.710; Hodge S, 2010, AM J RESP CELL MOL, V42, P235, DOI 10.1165/rcmb.2008-0486OC; Hoenderdos K, 2013, AM J RESP CELL MOL, V48, P531, DOI 10.1165/rcmb.2012-0492TR; Kirkham PA, 2013, CHEST, V144, P266, DOI 10.1378/chest.12-2664; Krarup A, 2005, INFECT IMMUN, V73, P1052, DOI 10.1128/IAI.73.2.1052-1060.2005; Kuronuma K, 2004, J BIOL CHEM, V279, P21421, DOI 10.1074/jbc.M312490200; Kuzmenko AI, 2005, J BIOL CHEM, V280, P25913, DOI 10.1074/jbc.M411344200; LIPSCOMBE RJ, 1995, IMMUNOLOGY, V85, P660; Moghaddam SJ, 2011, INT J CHRONIC OBSTR, V6, P113, DOI 10.2147/COPD.S15417; Mukaro VR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056147; Nakanishi Y, 2009, AM J RESP CRIT CARE, V179, P271, DOI 10.1164/rccm.200806-905OC; Nauta AJ, 2003, EUR J IMMUNOL, V33, P2853, DOI 10.1002/eji.200323888; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Ono K, 2006, J IMMUNOL, V177, P5517, DOI 10.4049/jimmunol.177.8.5517; Ozment TR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002967; Peiser L, 2002, INFECT IMMUN, V70, P5346, DOI 10.1128/IAI.70.10.5346-5354.2002; Platt N, 1996, P NATL ACAD SCI USA, V93, P12456, DOI 10.1073/pnas.93.22.12456; Shimizu T, 2009, BBA-GEN SUBJECTS, V1790, P1705, DOI 10.1016/j.bbagen.2009.10.006; Simpson JL, 2013, CLIN EXP ALLERGY, V43, P29, DOI 10.1111/j.1365-2222.2012.04075.x; Starosta V, 2006, FREE RADICAL RES, V40, P419, DOI 10.1080/10715760600571248; Starosta V, 2006, PEDIATR PULM, V41, P67, DOI 10.1002/ppul.20289; Teillet F, 2005, J IMMUNOL, V174, P2870, DOI 10.4049/jimmunol.174.5.2870; Terai I, 2003, EUR J IMMUNOL, V33, P2755, DOI 10.1002/eji.200323955; Theakston F, 2008, WORLD HLTH STAT; Todt JC, 2008, J LEUKOCYTE BIOL, V84, P510, DOI 10.1189/jlb.0307135; Valdimarsson H, 2003, BIOCHEM SOC T, V31, P768, DOI 10.1042/bst0310768; Wang MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083517; Wang MY, 2011, CELL MOL IMMUNOL, V8, P265, DOI 10.1038/cmi.2011.1; Wilkinson TMA, 2003, AM J RESP CRIT CARE, V167, P1090, DOI 10.1164/rccm.200210-1179OC; Wittig I, 2010, MOL CELL PROTEOMICS, V9, P2149, DOI 10.1074/mcp.M900526-MCP200; Yu XF, 2011, J BIOL CHEM, V286, P18795, DOI 10.1074/jbc.M111.224345	44	27	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98571	10.1371/journal.pone.0098571	http://dx.doi.org/10.1371/journal.pone.0098571			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901869	Green Published, gold, Green Submitted			2022-12-27	WOS:000336841400039
J	Wu, WX; Cheng, ZW; Liu, MJ; Yang, XF; Qiu, DW				Wu, Wenxian; Cheng, Zhiwei; Liu, Mengjie; Yang, Xiufen; Qiu, Dewen			C3HC4-Type RING Finger Protein NbZFP1 Is Involved in Growth and Fruit Development in Nicotiana benthamiana	PLOS ONE			English	Article							S-TYPE ANION; ARABIDOPSIS; GENE; EXPRESSION; LIGASE; RESISTANCE; CHANNELS; ELEMENTS; DROUGHT; BINDING	C3HC4-type RING finger proteins constitute a large family in the plant kingdom and play important roles in various physiological processes of plant life. In this study, a C3HC4-type zinc finger gene was isolated from Nicotiana benthamiana. Sequence analysis indicated that the gene encodes a 24-kDa protein with 191 amino acids containing one typical C3HC4-type zinc finger domain; this gene was named NbZFP1. Transient expression of pGDG-NbZFP1 demonstrated that NbZFP1 was localized to the chloroplast, especially in the chloroplasts of cells surrounding leaf stomata. Virus-induced gene silencing (VIGS) analysis indicated that silencing of NbZFP1 hampered fruit development, although the height of the plants was normal. An overexpression construct was then designed and transferred into Nicotiana benthamiana, and PCR and Southern blot showed that the NbZFP1 gene was successfully integrated into the Nicotiana benthamiana genome. The transgenic lines showed typical compactness, with a short internode length and sturdy stems. This is the first report describing the function of a C3HC4-type RING finger protein in tobacco.	[Wu, Wenxian; Cheng, Zhiwei; Liu, Mengjie; Yang, Xiufen; Qiu, Dewen] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Qiu, DW (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	qiudewen@caas.cn			National Science Foundation of China [31371984]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Science Foundation of China (31371984). The website is http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; An G, 1989, BINARY VECTORS, P29; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Chen JC, 2004, PLANT MOL BIOL, V55, P521, DOI 10.1007/s11103-004-0590-7; Chiba S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002146; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Crawford BCW, 2007, CURR BIOL, V17, P1101, DOI 10.1016/j.cub.2007.05.079; De Smet I, 2003, PLANT J, V33, P543, DOI 10.1046/j.1365-313X.2003.01652.x; Dong Y, 2007, PLANT PHYSIOL, V145, P1161, DOI 10.1104/pp.107.107391; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Goodin MM, 2002, PLANT J, V31, P375, DOI 10.1046/j.1365-313X.2002.01360.x; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Jin J, 2008, NAT GENET, V40, P1365, DOI 10.1038/ng.247; Kobayashi A, 1998, PLANT J, V13, P571, DOI 10.1046/j.1365-313X.1998.00043.x; Kulye M, 2012, PLANT CELL ENVIRON, V35, P2104, DOI 10.1111/j.1365-3040.2012.02539.x; KUMAGAI MH, 1995, P NATL ACAD SCI USA, V92, P1679, DOI 10.1073/pnas.92.5.1679; Leung J, 1998, ANNU REV PLANT PHYS, V49, P199, DOI 10.1146/annurev.arplant.49.1.199; Levchenko V, 2005, P NATL ACAD SCI USA, V102, P4203, DOI 10.1073/pnas.0500146102; Liu KM, 2007, PLANTA, V226, P1007, DOI 10.1007/s00425-007-0548-5; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Liu YL, 2002, PLANT J, V30, P415, DOI 10.1046/j.1365-313X.2002.01297.x; Ma K, 2009, GENE, V444, P33, DOI 10.1016/j.gene.2009.05.018; Matsuda N, 2001, J CELL SCI, V114, P1949; Narusaka Y, 2003, PLANT J, V34, P137, DOI 10.1046/j.1365-313X.2003.01708.x; Parent B, 2009, PLANT PHYSIOL, V149, P2000, DOI 10.1104/pp.108.130682; Pepper AE, 1997, GENETICS, V145, P1125; Potuschak T, 1998, P NATL ACAD SCI USA, V95, P7904, DOI 10.1073/pnas.95.14.7904; Sakai H, 1995, ROLE SUPERMAN MAINTA; Schumann U, 2003, P NATL ACAD SCI USA, V100, P9626, DOI 10.1073/pnas.1633697100; Siegel RS, 2009, PLANT J, V59, P207, DOI 10.1111/j.1365-313X.2009.03872.x; Simon AR, 2000, SCIENCE, V290, P144, DOI 10.1126/science.290.5489.144; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Stone SL, 2005, PLANT PHYSIOL, V137, P13, DOI 10.1104/pp.104.052423; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vahisalu T, 2008, NATURE, V452, P487, DOI 10.1038/nature06608; VONARNIM AG, 1993, J BIOL CHEM, V268, P19626; Wang YS, 2006, PLANT CELL, V18, P3635, DOI 10.1105/tpc.106.046730; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Zhang SS, 2009, P NATL ACAD SCI USA, V106, P4543, DOI 10.1073/pnas.0900349106; Zhang YY, 2007, PLANT CELL, V19, P1912, DOI 10.1105/tpc.106.048488	41	24	25	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99352	10.1371/journal.pone.0099352	http://dx.doi.org/10.1371/journal.pone.0099352			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901716	Green Published, gold, Green Submitted			2022-12-27	WOS:000336841400122
J	Kelly, SBA; Kelly, DJ; Cooper, N; Bahrun, A; Analuddin, K; Marples, NM				Kelly, Sean B. A.; Kelly, David J.; Cooper, Natalie; Bahrun, Andi; Analuddin, Kangkuso; Marples, Nicola M.			Molecular and Phenotypic Data Support the Recognition of the Wakatobi Flowerpecker (Dicaeum kuehni) from the Unique and Understudied Sulawesi Region	PLOS ONE			English	Article							BAYESIAN PHYLOGENETIC INFERENCE; BODY-SIZE; BIRDS; DNA	Accurate estimates of species richness are essential to macroecological and macroevolutionary research, as well as to the effective management and conservation of biodiversity. The resolution of taxonomic relationships is therefore of vital importance. While molecular methods have revolutionised taxonomy, contemporary species delimitation requires an integrative, multi-disciplinary approach. Despite boasting a remarkably high level of endemism, the avifauna of the Sulawesi region of Indonesia remains poorly studied. Previous studies of avian diversity in Sulawesi have focussed predominantly on phenotypic characteristics, thus potentially overlooking any genetically distinct lineages. Grey-sided Flowerpecker Dicaeum celebicum populations from the Wakatobi archipelago were originally described as a separate species from those on nearby mainland Sulawesi. However, for reasons that remain unknown, the Wakatobi populations were reclassified as a subspecies of the mainland form. Combining estimates of genetic divergence with phylogenetic and morphological analyses, we reassessed the status of Wakatobi populations. Our results describe the Wakatobi populations as a separate species to those on mainland Sulawesi; reproductively isolated, genetically and morphologically distinct. We therefore recommend the reclassification of these populations to their original status of Dicaeum kuehni and propose the vernacular name 'Wakatobi Flowerpecker'. In consideration of our findings and the lack of integrative ornithological research within the Sulawesi region, we believe species richness and avian endemism within the region are underestimated.	[Kelly, Sean B. A.; Kelly, David J.; Cooper, Natalie; Marples, Nicola M.] Trinity Coll Dublin, Dept Zool, Dublin, Ireland; [Kelly, Sean B. A.; Kelly, David J.; Cooper, Natalie; Marples, Nicola M.] Trinity Coll Dublin, Trinity Ctr Biodivers Res, Dublin, Ireland; [Bahrun, Andi] Univ Haluoleo, Dept Agrotechnol, Kendari, Southeast Sulaw, Indonesia; [Analuddin, Kangkuso] Univ Haluoleo, Dept Biol, Kendari, Southeast Sulaw, Indonesia	Trinity College Dublin; Trinity College Dublin; Universitas Halu Oleo; Universitas Halu Oleo	Kelly, SBA (corresponding author), Trinity Coll Dublin, Dept Zool, Dublin, Ireland.	kellys17@tcd.ie	Cooper, Natalie/I-7976-2012; Analuddin, Kangkuso/ABD-6036-2020; Kelly, David/AAE-8278-2019	Cooper, Natalie/0000-0003-4919-8655; Analuddin, Kangkuso/0000-0003-0258-9376; Marples, Nicola/0000-0003-4693-2607; Kelly, David/0000-0002-5880-4162; Kelly, Sean/0000-0002-3078-8404	Trinity College Dublin; Operation Wallacea	Trinity College Dublin; Operation Wallacea	This research was primarily funded by Trinity College Dublin and partially funded by Operation Wallacea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstrom P, 2008, ZOOL J LINN SOC, V154; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Beheregaray Luciano B, 2007, J Biol, V6, P9, DOI 10.1186/jbiol60; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; BirdLife International, 2013, END BIRD AR FACTSH K; BirdLife International, 2013, DAT ZON TAX; Blair CP, 2005, EVOLUTION, V59, P304; Cheke R.A., 2008, P350; Cheke R. A., 2008, HDB BIRDS WORLD, P196; Chesser RT, 1999, CONDOR, V101, P439, DOI 10.2307/1370012; Clegg SM, 2002, P ROY SOC B-BIOL SCI, V269, P1359, DOI 10.1098/rspb.2002.2024; Coates B.J., 1997, GUIDE BIRDS WALLACEA; Dennis AB, 2010, MOL ECOL, V19, P3206, DOI 10.1111/j.1365-294X.2010.04689.x; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fjeldsa J, 2010, IBIS, V152, P747, DOI 10.1111/j.1474-919X.2010.01053.x; Funk WC, 2012, P ROY SOC B-BIOL SCI, V279, P1806, DOI 10.1098/rspb.2011.1653; GRANT PR, 1968, SYST ZOOL, V17, P319, DOI 10.2307/2412010; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hartert E., 1903, NOVITATES ZOOLOGICAE, V10, P18; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; HOLM S, 1979, SCAND J STAT, V6, P65; Indrawan M., 2004, Bulletin of the British Ornithologists' Club, V124, P160; Indrawan M, 2008, WILSON J ORNITHOL, V120, P1, DOI 10.1676/06-051.1; Isaac NJB, 2004, TRENDS ECOL EVOL, V19, P464, DOI 10.1016/j.tree.2004.06.004; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Lambert FR, 1998, NEW SPECIES GYMNOCRE, V13, P1; Lambert Frank R., 1998, Bulletin of the British Ornithologists' Club, V118, P204; Lambert Frank R., 1998, Bulletin of the British Ornithologists' Club, V118, P67; Lohman DJ, 2010, BIOL CONSERV, V143, P1885, DOI 10.1016/j.biocon.2010.04.042; Lohman DJ, 2009, MOL ECOL RESOUR, V9, P37, DOI 10.1111/j.1755-0998.2008.02221.x; Luo A-Rong, 2010, Acta Entomologica Sinica, V53, P192; Maddison WP, 2009, MESQUITE MODULAR SYS; Mayr E., 1942, P1; Mayr E., 1947, Araer Mus Nov, P1; Mckay BD, 2010, AUK, V127, P932, DOI 10.1525/auk.2010.09093; Melo M, 2010, J ZOOL, V282, P120, DOI 10.1111/j.1469-7998.2010.00720.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nyari AS, 2009, MOL PHYLOGENET EVOL, V53, P613, DOI 10.1016/j.ympev.2009.06.014; R Core Team, 2021, R LANGUAGE ENV STAT; Rasmussen P.C., 2000, Forktail, V16, P69; Rasmussen PC, 1999, WILSON BULL, V111, P457; Redfern C. P. F, 2001, RINGERS MANUAL; Robinson-Wolrath SI, 2003, J EVOLUTION BIOL, V16, P1106, DOI 10.1046/j.1420-9101.2003.00615.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rubinoff D, 2005, SYST BIOL, V54, P952, DOI 10.1080/10635150500234674; Scott SN, 2003, EVOLUTION, V57, P2147; SMITH RB, 1991, GEOL SOC AM BULL, V103, P660, DOI 10.1130/0016-7606(1991)103<0660:GOAMCC>2.3.CO;2; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tavares ES, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-81; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354	53	12	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98694	10.1371/journal.pone.0098694	http://dx.doi.org/10.1371/journal.pone.0098694			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896822	Green Published, Green Submitted, gold			2022-12-27	WOS:000338430700066
J	Park, CY; Hong, JH; Lee, JH; Lee, KE; Cho, HS; Lim, SJ; Kwak, JW; Kim, KS; Kim, HJ				Park, Chong Yoon; Hong, Joon Hyeong; Lee, Jae Heon; Lee, Kyu Eun; Cho, Hyun Sang; Lim, Su Jin; Kwak, Jin Wook; Kim, Kyung Soo; Kim, Hyun Jik			Clinical Effect of Surgical Correction for Nasal Pathology on the Treatment of Obstructive Sleep Apnea Syndrome	PLOS ONE			English	Article							UPPER AIRWAY; SURGERY; RESISTANCE; PATHOGENESIS; PRESSURE	Objectives: This study aimed to evaluate the hypothesis that relief of nasal obstruction in subjects with obstructive sleep apnea (OSA) would lead to reduce OSA severity and to discuss the available evidence on the clinical efficacy of nasal surgery as a treatment modality for OSA. Study Design: Twenty-five subjects who had reduced patency of nasal cavity and narrowing of retroglossal or retropalatal airways were diagnosed with OSA and underwent nasal surgery, such as septoplasty or turbinoplasty to correct nasal pathologies. The effect of the surgery on nasal patency was quantified by measuring minimal cross-sectional area (MCA) using acoustic rhinometry. The watch-PAT-derived respiratory disturbance index (RDI), apnea and hypopnea index (AHI), lowest oxygen saturation, and valid sleep time were measured before and after nasal surgery. Results: The present study shows that the AHI and RDI decreased significantly and the lowest oxygen saturation and valid sleep time rose after nasal surgery in 25 OSA subjects. In addition, a reduction in subjective symptoms was observed in subjects and mean MCA increased after nasal surgery. Fourteen subjects were classified as responders and 11 subjects as non-responders. Responders showed considerable improvement of their subjective symptoms and the AHI and RDI were significantly lower after surgery. We found that the changes between pre- and post-operative AHI and RDI values were minimal in 11 non-responders. However, daytime somnolence and REM sleep time improved after nasal surgery in non-responders. Conclusions: Our study provides evidence that the surgical treatment of nasal pathology improves nasal airway patency and reduces OSA severity in 56% subjects. Furthermore, correction of nasal pathology appears to result in improved sleep quality in both responder and non-responders OSA subjects.	[Park, Chong Yoon; Hong, Joon Hyeong; Lee, Jae Heon; Lee, Kyu Eun; Cho, Hyun Sang; Lim, Su Jin; Kwak, Jin Wook; Kim, Kyung Soo; Kim, Hyun Jik] Chung Ang Univ, Coll Med, Dept Otorhinolaryngol & Head & Neck Surg, Seoul 156756, South Korea	Chung Ang University; Chung Ang University Hospital	Kim, HJ (corresponding author), Chung Ang Univ, Coll Med, Dept Otorhinolaryngol & Head & Neck Surg, Seoul 156756, South Korea.	hyunjk@cau.ac.kr	Kim, Hyun Jik/HCH-3332-2022	Kim, Hyun Jik/0000-0001-8631-928X				ATKINS M, 1994, CHEST, V105, P1133, DOI 10.1378/chest.105.4.1133; BRAVER HM, 1994, SLEEP, V17, P516, DOI 10.1093/sleep/17.6.516; Craig TJ, 2003, ALLERGY ASTHMA PROC, V24, P53; FERRIS BG, 1964, J APPL PHYSIOL, V19, P653, DOI 10.1152/jappl.1964.19.4.653; Friedman M, 2000, OTOLARYNG HEAD NECK, V122, P71, DOI 10.1016/S0194-5998(00)70147-1; Georgalas C, 2011, EUR ARCH OTO-RHINO-L, V268, P1365, DOI 10.1007/s00405-010-1469-7; HOFFSTEIN V, 1992, AM REV RESPIR DIS, V145, P841, DOI 10.1164/ajrccm/145.4_Pt_1.841; HOIJER U, 1992, ARCH OTOLARYNGOL, V118, P281; KERR P, 1992, J OTOLARYNGOL, V21, P189; Kim ST, 2004, ACTA OTO-LARYNGOL, V124, P297, DOI 10.1080/00016480410016252; Kohler M, 2007, EUR RESPIR J, V30, P1208, DOI 10.1183/09031936.00032007; Koutsourelakis I, 2008, EUR RESPIR J, V31, P110, DOI 10.1183/09031936.00087607; McLean HA, 2005, EUR RESPIR J, V25, P521, DOI 10.1183/09031936.05.00045004; Nakata S, 2005, RHINOLOGY, V43, P296; Nakata S, 2008, AM J RHINOL, V22, P59, DOI 10.2500/ajr.2008.22.3120; Park SS, 1993, LUNG, V64, P311; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; REMMERS JE, 1978, J APPL PHYSIOL, V44, P931, DOI 10.1152/jappl.1978.44.6.931; SERIES F, 1993, THORAX, V48, P360, DOI 10.1136/thx.48.4.360; Sher AE, 1996, SLEEP, V19, P156, DOI 10.1093/sleep/19.2.156; SMITH PL, 1988, J APPL PHYSIOL, V64, P789, DOI 10.1152/jappl.1988.64.2.789; Tasali E, 2008, CHEST, V133, P496, DOI 10.1378/chest.07-0828; Verse T, 2002, LARYNGOSCOPE, V112, P64, DOI 10.1097/00005537-200201000-00012; Virkkula P, 2006, CHEST, V129, P81, DOI 10.1378/chest.129.1.81	24	29	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98765	10.1371/journal.pone.0098765	http://dx.doi.org/10.1371/journal.pone.0098765			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896824	gold, Green Submitted, Green Published			2022-12-27	WOS:000338430700073
J	Takano, S; Fukasawa, M; Maekawa, S; Kadokura, M; Miura, M; Shindo, H; Takahashi, E; Sato, T; Enomoto, N				Takano, Shinichi; Fukasawa, Mitsuharu; Maekawa, Shinya; Kadokura, Makoto; Miura, Mika; Shindo, Hiroko; Takahashi, Ei; Sato, Tadashi; Enomoto, Nobuyuki			Deep Sequencing of Cancer-Related Genes Revealed GNAS Mutations to Be Associated with Intraductal Papillary Mucinous Neoplasms and Its Main Pancreatic Duct Dilation	PLOS ONE			English	Article							INTERNATIONAL CONSENSUS GUIDELINES; STIMULATORY G-PROTEIN; K-RAS; FREQUENT GNAS; SOMATIC MUTATIONS; JUICE; CARCINOMA; IPMN; P53; MANAGEMENT	Background: To clarify the genetic mutations associated with intraductal papillary mucinous neoplasms (IPMN) and IPMN-related pancreatic tumours, we conducted cancer-related gene profiling analyses using pure pancreatic juice and resected pancreatic tissues. Methods: Pure pancreatic juice was collected from 152 patients [nine with a normal pancreas, 22 with chronic pancreatitis (CP), 39 with pancreatic ductal adenocarcinoma (PDAC), and 82 with IPMN], and resected tissues from the pancreas were collected from 48 patients (six IPMNs and 42 PDACs). The extracted DNA was amplified by multiplexed polymerase chain reaction (PCR) targeting 46 cancer-related genes containing 739 mutational hotspots. The mutations were analysed using a semiconductor-based DNA sequencer. Results: Among the 46 cancer-related genes, KRAS and GNAS mutations were most frequently detected in both PDAC and IPMN cases. In pure pancreatic juice, GNAS mutations were detected in 7.7% of PDAC cases and 41.5% of IPMN cases (p<0.001 vs. others). All PDAC cases with GNAS mutations (n = 3) were accompanied by IPMN. Multivariate analysis revealed that GNAS mutations in IPMN cases were associated with dilated main pancreatic ducts (MPD, p = 0.016), while no statistically independent associations with clinical variables were observed for KRAS mutations. In the resected pancreatic tissues, GNAS mutations were detected in 50% of PDAC cases concomitant with IPMN, 33.3% of PDAC cases derived from IPMN, and 66.7% of IPMN cases, while no GNAS mutations were detected in cases of PDAC without IPMN. Conclusions: The GNAS mutation was specifically found in the cases with IPMN and it was speculated that some PDACs might be influenced by the concomitant but separately-located IPMN in their pathogenic mechanism. Furthermore, the GNAS mutation was significantly associated with MPD dilatation in IPMN cases, suggesting its role in mucus hypersecretion.	[Takano, Shinichi; Fukasawa, Mitsuharu; Maekawa, Shinya; Kadokura, Makoto; Miura, Mika; Shindo, Hiroko; Takahashi, Ei; Sato, Tadashi; Enomoto, Nobuyuki] Univ Yamanashi, Dept Internal Med 1, Fac Med, Chuo Ku, Yamanashi, Japan	University of Yamanashi	Takano, S (corresponding author), Univ Yamanashi, Dept Internal Med 1, Fac Med, Chuo Ku, Yamanashi, Japan.	stakano@yamanashi.ac.jp	Seco-Granados, Gonzalo/C-7058-2008; Morell, Antoni/AFP-3174-2022; Maekawa, Shinya/AAF-1349-2019	Seco-Granados, Gonzalo/0000-0003-2494-6872; Morell, Antoni/0000-0003-2249-8594; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [25860527]; Foundation for Advancement of International Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Foundation for Advancement of International Science(Foundation for Advancement of International Science (FAIS))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (25860527, http://www.jsps.go.jp/j-grantsinaid/) and by grants from the Foundation for Advancement of International Science (http://www.fais.or.jp/grant/fy25/01_file/2013_01members.pdf). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beadling C, 2013, J MOL DIAGN, V15, P171, DOI 10.1016/j.jmoldx.2012.09.003; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Dal Molin M, 2013, ANN SURG ONCOL, V20, P3802, DOI 10.1245/s10434-013-3096-1; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Furukawa T, 2005, VIRCHOWS ARCH, V447, P794, DOI 10.1007/s00428-005-0039-7; Furukawa T, 2011, SCI REP-UK, V1, DOI 10.1038/srep00161; Hayward BE, 2001, J CLIN INVEST, V107, pR31, DOI 10.1172/JCI11887; Hosoda W, 2010, PATHOL INT, V60, P358, DOI 10.1111/j.1440-1827.2010.02527.x; Ideno N, 2013, ANN SURG, V258, P141, DOI 10.1097/SLA.0b013e31828cd008; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kaino M, 1999, PANCREAS, V18, P294, DOI 10.1097/00006676-199904000-00011; Kanda M, 2013, GUT, V62, P1024, DOI 10.1136/gutjnl-2012-302823; Kanda M, 2012, GASTROENTEROLOGY, V142, P730, DOI 10.1053/j.gastro.2011.12.042; Kawakubo K, 2013, PANCREAS, V42, P687, DOI 10.1097/MPA.0b013e318270ea97; Komatsu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087875; KONDO H, 1994, CANCER, V73, P1589, DOI 10.1002/1097-0142(19940315)73:6<1589::AID-CNCR2820730609>3.0.CO;2-7; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; Matsubara A, 2013, J PATHOL, V229, P579, DOI 10.1002/path.4153; Moore PS, 2001, VIRCHOWS ARCH, V439, P798, DOI 10.1007/s004280100474; Nishikawa G, 2013, BRIT J CANCER, V108, P951, DOI 10.1038/bjc.2013.47; Sasaki M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081706; TADA M, 1993, CANCER RES, V53, P2472; Tada M, 2006, CLIN GASTROENTEROL H, V4, P1265, DOI 10.1016/j.cgh.2006.07.013; Tanaka M, 2006, PANCREATOLOGY, V6, P17, DOI 10.1159/000090023; Tanaka M, 2012, PANCREATOLOGY, V12, P183, DOI 10.1016/j.pan.2012.04.004; Tanno S, 2010, PANCREATOLOGY, V10, P173, DOI 10.1159/000231982; Tateishi K, 1999, GUT, V45, P737, DOI 10.1136/gut.45.5.737; Tsai JH, 2013, AM J SURG PATHOL, V37, P1862, DOI 10.1097/PAS.0b013e3182986bb5; Uehara H, 2008, GUT, V57, P1561, DOI 10.1136/gut.2007.145631; Wang LH, 2012, GENOME RES, V22, P208, DOI 10.1101/gr.123109.111; Wang Y, 2004, PANCREAS, V28, P13, DOI 10.1097/00006676-200401000-00002; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; Weinstein LS, 2001, ENDOCR REV, V22, P675, DOI 10.1210/er.22.5.675; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543; Yamaguchi K, 2011, PANCREAS, V40, P571, DOI 10.1097/MPA.0b013e318215010c	37	42	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98718	10.1371/journal.pone.0098718	http://dx.doi.org/10.1371/journal.pone.0098718			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897499	Green Published, gold, Green Submitted			2022-12-27	WOS:000338430700069
J	Wu, JR; Yu, MZ; Xu, JH; Du, J; Ji, F; Dong, F; Li, XH; Shi, JR				Wu, Jirong; Yu, Mingzheng; Xu, Jianhong; Du, Juan; Ji, Fang; Dong, Fei; Li, Xinhai; Shi, Jianrong			Impact of Transgenic Wheat with wheat yellow mosaic virus Resistance on Microbial Community Diversity and Enzyme Activity in Rhizosphere Soil	PLOS ONE			English	Article							GENETICALLY-MODIFIED CROPS; COAT PROTEIN; FUNCTIONAL DIVERSITY; RISK-ASSESSMENT; BT COTTON; PLANTS; MICROORGANISMS; PERSISTENCE; LOCATION; BACTERIA	The transgenic wheat line N12-1 containing the WYMV-Nib8 gene was obtained previously through particle bombardment, and it can effectively control the wheat yellow mosaic virus (WYMV) disease transmitted by Polymyxa graminis at turngreen stage. Due to insertion of an exogenous gene, the transcriptome of wheat may be altered and affect root exudates. Thus, it is important to investigate the potential environmental risk of transgenic wheat before commercial release because of potential undesirable ecological side effects. Our 2-year study at two different experimental locations was performed to analyze the impact of transgenic wheat N12-1 on bacterial and fungal community diversity in rhizosphere soil using polymerase chain reaction-denaturing gel gradient electrophoresis (PCR-DGGE) at four growth stages (seeding stage, turngreen stage, grain-filling stage, and maturing stage). We also explored the activities of urease, sucrase and dehydrogenase in rhizosphere soil. The results showed that there was little difference in bacterial and fungal community diversity in rhizosphere soil between N12-1 and its recipient Y158 by comparing Shannon's, Simpson's diversity index and evenness (except at one or two growth stages). Regarding enzyme activity, only one significant difference was found during the maturing stage at Xinxiang in 2011 for dehydrogenase. Significant growth stage variation was observed during 2 years at two experimental locations for both soil microbial community diversity and enzyme activity. Analysis of bands from the gel for fungal community diversity showed that the majority of fungi were uncultured. The results of this study suggested that virus-resistant transgenic wheat had no adverse impact on microbial community diversity and enzyme activity in rhizosphere soil during 2 continuous years at two different experimental locations. This study provides a theoretical basis for environmental impact monitoring of transgenic wheat when the introduced gene is derived from a virus.	[Wu, Jirong; Yu, Mingzheng; Xu, Jianhong; Du, Juan; Ji, Fang; Dong, Fei; Shi, Jianrong] Jiangsu Acad Agr Sci, Inst Food Safety & Detect, Nanjing, Jiangsu, Peoples R China; [Wu, Jirong; Yu, Mingzheng; Xu, Jianhong; Du, Juan; Ji, Fang; Dong, Fei; Shi, Jianrong] State Key Lab Breeding Base, Key Lab Food Qual & Safety Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Wu, Jirong; Yu, Mingzheng; Xu, Jianhong; Du, Juan; Ji, Fang; Dong, Fei; Shi, Jianrong] Jiangsu Ctr GMO Evaluat & Detect, Nanjing, Jiangsu, Peoples R China; [Li, Xinhai] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China	Jiangsu Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Li, XH (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China.	lixinhai@caas.cn; shiji@jaas.ac.cn	Shi, Jianrong/AAQ-1805-2020; xu, jianhong/AAQ-4773-2021; Shi, Jianrong/AAQ-3456-2020	Shi, Jianrong/0000-0003-3818-5074; shi, jianrong/0000-0001-8650-248X	National Special Transgenic Project [2014ZX08011-003]; Natural Science Foundation of Jiangsu Province, China [BK20130721]; Jiangsu Agriculture Science and Technology Innovation Fund [cx(11)4064]	National Special Transgenic Project; Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); Jiangsu Agriculture Science and Technology Innovation Fund	This work was supported by the National Special Transgenic Project (2014ZX08011-003), Natural Science Foundation of Jiangsu Province, China (BK20130721) and Jiangsu Agriculture Science and Technology Innovation Fund [cx(11)4064]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL PP, 1986, SCIENCE, V232, P738, DOI 10.1126/science.3457472; Alef K., 1995, METHODS APPL SOIL MI, P350; Andow DA, 2006, ECOL LETT, V9, P196, DOI 10.1111/j.1461-0248.2005.00846.x; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Bakke I, 2011, J MICROBIOL METH, V84, P349, DOI 10.1016/j.mimet.2010.12.015; BEACHY RN, 1990, ANNU REV PHYTOPATHOL, V28, P451, DOI 10.1146/annurev.py.28.090190.002315; Blackwood CB, 2004, J ENVIRON QUAL, V33, P832, DOI 10.2134/jeq2004.0832; BURNS RG, 1982, SOIL BIOL BIOCHEM, V14, P423, DOI 10.1016/0038-0717(82)90099-2; Cardenas E, 2008, CURR OPIN BIOTECH, V19, P544, DOI 10.1016/j.copbio.2008.10.010; CHEN JP, 1993, ANN APPL BIOL, V123, P55, DOI 10.1111/j.1744-7348.1993.tb04072.x; Chen ZH, 2011, PLANT SOIL ENVIRON, V57, P67, DOI 10.17221/237/2010-PSE; Chun YJ, 2011, APPL SOIL ECOL, V51, P130, DOI 10.1016/j.apsoil.2011.09.008; Conner AJ, 2003, PLANT J, V33, P19, DOI 10.1046/j.0960-7412.2002.001607.x; Coz I, 2008, J ENVIRON QUAL, V37, P647, DOI 10.2134/jeq2007.0352; Das M, 2007, APPL ENVIRON MICROB, V73, P756, DOI 10.1128/AEM.01170-06; Devare MH, 2004, J ENVIRON QUAL, V33, P837, DOI 10.2134/jeq2004.0837; Dick R.P., 1996, METHODS ASSESSING SO, P247, DOI DOI 10.2136/SSSASPECPUB49.C15; DONEGAN KK, 1995, APPL SOIL ECOL, V2, P111, DOI 10.1016/0929-1393(94)00043-7; Donegan KK, 1999, J APPL ECOL, V36, P920, DOI 10.1046/j.1365-2664.1999.00448.x; Duc C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025014; Fang M, 2005, APPL ENVIRON MICROB, V71, P4132, DOI 10.1128/AEM.71.7.4132-4136.2005; Faragova N, 2011, BIOLOGIA, V66, P768, DOI 10.2478/s11756-011-0082-6; Fierer N, 2007, APPL ENVIRON MICROB, V73, P7059, DOI 10.1128/AEM.00358-07; Fuchs M, 2007, ANNU REV PHYTOPATHOL, V45, P173, DOI 10.1146/annurev.phyto.45.062806.094434; Graef F, 2005, ENVIRON MONIT ASSESS, V111, P1, DOI 10.1007/s10661-005-8044-5; Guan SY, 1986, SOIL ENZYME ITS RES, P62; Gyaneshwar P, 2002, PLANT SOIL, V245, P83, DOI 10.1023/A:1020663916259; Hen CG, 2000, PLANT DIS, V84, P627, DOI 10.1094/PDIS.2000.84.6.627; Hirsch PR, 2010, SOIL BIOL BIOCHEM, V42, P878, DOI 10.1016/j.soilbio.2010.02.019; HORSCH RB, 1984, SCIENCE, V223, P496, DOI 10.1126/science.223.4635.496; Kent AD, 2002, ANNU REV MICROBIOL, V56, P211, DOI 10.1146/annurev.micro.56.012302.161120; Kowalchuk GA, 2003, TRENDS ECOL EVOL, V18, P403, DOI 10.1016/S0169-5347(03)00187-3; Li YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055555; Lin CH, 2010, APPL ENVIRON MICROB, V76, P3370, DOI 10.1128/AEM.00018-10; Lindfeld Andreas, 2012, Open Ecology Journal, V5, P45, DOI 10.2174/1874213001205010045; Liu B, 2005, PLANT SOIL, V271, P1, DOI 10.1007/s11104-004-1610-8; Liu W, 2008, SOIL BIOL BIOCHEM, V40, P475, DOI 10.1016/j.soilbio.2007.09.017; Lu HH, 2010, PLANT SOIL, V336, P279, DOI 10.1007/s11104-010-0476-1; Lu R.K, 1999, SOIL AGROCHEMISTRY A; Lupwayi NZ, 2007, SOIL BIOL BIOCHEM, V39, P1418, DOI 10.1016/j.soilbio.2006.12.038; MCGREGOR AN, 2000, NZ SOIL NEWS, V48, P166; Meyer JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053825; O'Callaghan M, 2001, N Z PLANT PROTECT-SE, V54, P105, DOI 10.30843/nzpp.2001.54.3725; Raybould A, 2012, TRANSGENIC RES, V21, P655, DOI 10.1007/s11248-011-9560-4; Robinson DJ, 1996, TRANSGENIC RES, V5, P359, DOI 10.1007/BF01968945; Romeis J, 2003, PEDOBIOLOGIA, V47, P141, DOI 10.1078/0031-4056-00177; Saxena D, 1999, NATURE, V402, P480, DOI 10.1038/44997; Sengelov G, 2001, CURR MICROBIOL, V42, P160, DOI 10.1007/s002840010197; SERRAWITTLING C, 1995, BIOL FERT SOILS, V20, P226, DOI 10.1007/BF00336082; Shen RF, 2006, PLANT SOIL, V285, P149, DOI 10.1007/s11104-006-9000-z; Sun CX, 2007, BIOL FERT SOILS, V43, P617, DOI 10.1007/s00374-006-0158-6; Tan FX, 2010, PLANT SOIL, V329, P349, DOI 10.1007/s11104-009-0163-2; Tepfer M, 2002, ANNU REV PHYTOPATHOL, V40, P467, DOI 10.1146/annurev.phyto.40.120301.093728; Uroz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055929; Vauramo S, 2006, APPL SOIL ECOL, V32, P338, DOI 10.1016/j.apsoil.2005.07.007; Weaver R.W., 1994, METHODS SOIL ANAL 2; Wei XD, 2006, PLANT SOIL, V285, P347, DOI 10.1007/s11104-006-9020-8; Weinert N, 2010, PLANT SOIL, V326, P437, DOI 10.1007/s11104-009-0024-z; Wu HongYa, 2006, Journal of Triticeae Crops, V26, P11; Xu H, 2001, ACTA AGRONOMICA SINI, V27, P688; Yi H, 2009, J PLANT BIOL, V52, P577, DOI 10.1007/s12374-009-9075-1; Zughart W, 2008, EUPHYTICA, V164, P845, DOI 10.1007/s10681-007-9475-6	62	23	28	3	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98394	10.1371/journal.pone.0098394	http://dx.doi.org/10.1371/journal.pone.0098394			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897124	Green Submitted, Green Published, gold			2022-12-27	WOS:000338430700040
J	Kim, DS; Song, HN; Nam, HJ; Kim, SG; Park, YS; Park, JC; Woo, EJ; Lim, HK				Kim, Dong-Sik; Song, Hyung-Nam; Nam, Hyo Jung; Kim, Sung-Geun; Park, Young-Seoub; Park, Jae-Chan; Woo, Eui-Jeon; Lim, Hyung-Kwon			Directed Evolution of Human Heavy Chain Variable Domain (V-H) Using In Vivo Protein Fitness Filter	PLOS ONE			English	Article							ARGININE TRANSLOCATION PATHWAY; FOLDING QUALITY-CONTROL; ESCHERICHIA-COLI; SINGLE-DOMAIN; GENETIC SELECTION; ANTIBODY; SOLUBILITY; IMMUNOGENICITY; RESISTANCE; STABILITY	Human immunoglobulin heavy chain variable domains (V-H) are promising scaffolds for antigen binding. However, V-H is an unstable and aggregation-prone protein, hindering its use for therapeutic purposes. To evolve the V-H domain, we performed in vivo protein solubility selection that linked antibiotic resistance to the protein folding quality control mechanism of the twin-arginine translocation pathway of E. coli. After screening a human germ-line V-H library, 95% of the V-H proteins obtained were identified as V(H)3 family members; one V-H protein, MG2x1, stood out among separate clones expressing individual V-H variants. With further screening of combinatorial framework mutation library of MG2x1, we found a consistent bias toward substitution with tryptophan at the position of 50 and 58 in V-H. Comparison of the crystal structures of the V-H variants revealed that those substitutions with bulky side chain amino acids filled the cavity in the V-H interface between heavy and light chains of the Fab arrangement along with the increased number of hydrogen bonds, decreased solvation energy, and increased negative charge. Accordingly, the engineered V-H acquires an increased level of thermodynamic stability, reversible folding, and soluble expression. The library built with the V-H variant as a scaffold was qualified as most of V-H clones selected randomly were expressed as soluble form in E. coli regardless length of the combinatorial CDR. Furthermore, a non-aggregation feature of the selected V-H conferred a free of humoral response in mice, even when administered together with adjuvant. As a result, this selection provides an alternative directed evolution pathway for unstable proteins, which are distinct from conventional methods based on the phage display.	[Kim, Dong-Sik; Nam, Hyo Jung; Kim, Sung-Geun; Park, Young-Seoub; Park, Jae-Chan; Lim, Hyung-Kwon] Mogam Biotechnol Res Inst, Yongin, South Korea; [Song, Hyung-Nam; Woo, Eui-Jeon] Korea Res Inst Biosci & Biotechnol, BioMed Prote Res Ctr, Taejon, South Korea; [Song, Hyung-Nam] Korea Univ, Dept Biotechnol & Bioinformat, Sejong, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea University	Lim, HK (corresponding author), Mogam Biotechnol Res Inst, Yongin, South Korea.	lhk@mogam.re.kr		Woo, Eui-Jeon/0000-0001-6983-0270	Green Cross Corporation	Green Cross Corporation	The authors are grateful to Green Cross Corporation (http://www.greencross.com) for funding this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargou R, 2008, SCIENCE, V321, P974, DOI 10.1126/science.1158545; Barthelemy PA, 2008, J BIOL CHEM, V283, P3639, DOI 10.1074/jbc.M708536200; Berks BC, 2005, CURR OPIN MICROBIOL, V8, P174, DOI 10.1016/j.mib.2005.02.010; Bleicher L, 2011, J PHYS CHEM B, V115, P7940, DOI 10.1021/jp200330z; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Christ D, 2007, PROTEIN ENG DES SEL, V20, P413, DOI 10.1093/protein/gzm037; Conrath KE, 2001, J BIOL CHEM, V276, P7346, DOI 10.1074/jbc.M007734200; da Silva FA, 2004, J MOL BIOL, V340, P525, DOI 10.1016/j.jmb.2004.04.062; DAVIES J, 1994, FEBS LETT, V339, P285, DOI 10.1016/0014-5793(94)80432-X; DeLisa MP, 2003, P NATL ACAD SCI USA, V100, P6115, DOI 10.1073/pnas.0937838100; Dolk E, 2005, PROTEINS, V59, P555, DOI 10.1002/prot.20378; Dudgeon K, 2012, P NATL ACAD SCI USA, V109, P10879, DOI 10.1073/pnas.1202866109; Enever C, 2009, CURR OPIN BIOTECH, V20, P405, DOI 10.1016/j.copbio.2009.07.002; Ewert S, 2002, BIOCHEMISTRY-US, V41, P3628, DOI 10.1021/bi011239a; Fisher AC, 2006, PROTEIN SCI, V15, P449, DOI 10.1110/ps.051902606; Fisher AC, 2009, J MOL BIOL, V385, P299, DOI 10.1016/j.jmb.2008.10.051; Foit L, 2009, MOL CELL, V36, P861, DOI 10.1016/j.molcel.2009.11.022; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Hermeling S, 2004, PHARM RES-DORDR, V21, P897, DOI 10.1023/B:PHAM.0000029275.41323.a6; Hudson PJ, 2003, NAT MED, V9, P129, DOI 10.1038/nm0103-129; Jespers L, 2004, NAT BIOTECHNOL, V22, P1161, DOI 10.1038/nbt1000; Jespers L, 2004, J MOL BIOL, V337, P893, DOI 10.1016/j.jmb.2004.02.013; Joubert MK, 2011, J BIOL CHEM, V286, P25118, DOI 10.1074/jbc.M110.160457; Jung TY, 2012, J BIOL CHEM, V287, P7979, DOI 10.1074/jbc.M111.304774; Karlsson AJ, 2012, J MOL BIOL, V416, P94, DOI 10.1016/j.jmb.2011.12.021; KORTT AA, 1995, J PROTEIN CHEM, V14, P167, DOI 10.1007/BF01980329; Lee PA, 2006, ANNU REV MICROBIOL, V60, P373, DOI 10.1146/annurev.micro.60.080805.142212; Lim HK, 2009, PROTEIN SCI, V18, P2537, DOI 10.1002/pro.262; Oates J, 2003, J MOL BIOL, V330, P277, DOI 10.1016/S0022-2836(03)00621-1; Ribnicky B, 2007, J MOL BIOL, V369, P631, DOI 10.1016/j.jmb.2007.03.068; Riechmann L, 1996, J MOL BIOL, V259, P957, DOI 10.1006/jmbi.1996.0373; Rothe C, 2008, J MOL BIOL, V376, P1182, DOI 10.1016/j.jmb.2007.12.018; Schellekens H, 2002, NAT REV DRUG DISCOV, V1, P457, DOI 10.1038/nrd818; Shaw BF, 2008, PROTEIN SCI, V17, P1446, DOI 10.1110/ps.035154.108; Silence K, 2011, Single domain antibodies directed against tumor necrosis factor-alpha and uses therefor, Patent No. [EP2390268A1, 2390268]; Tijink BM, 2008, MOL CANCER THER, V7, P2288, DOI 10.1158/1535-7163.MCT-07-2384; To R, 2005, J BIOL CHEM, V280, P41395, DOI 10.1074/jbc.M509900200; WARD ES, 1989, NATURE, V341, P544, DOI 10.1038/341544a0; Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7; Wigley WC, 2001, NAT BIOTECHNOL, V19, P131, DOI 10.1038/84389	40	11	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98178	10.1371/journal.pone.0098178	http://dx.doi.org/10.1371/journal.pone.0098178			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892548	Green Published, gold, Green Submitted			2022-12-27	WOS:000336911400037
J	Randrianambinintsoa, FJ; Leger, N; Robert, V; Depaquit, J				Randrianambinintsoa, Fano Jose; Leger, Nicole; Robert, Vincent; Depaquit, Jerome			Paraphyly of the Subgenus Sintonius (Diptera, Psychodidae, Sergentomyia): Status of the Malagasy Species. Creation of a New Subgenus and Description of a New Species	PLOS ONE			English	Article							WORLD PHLEBOTOMINAE DIPTERA; MADAGASCAR DIPTERA; NUMERICAL TAXONOMY; N. SP; SANDFLIES; FEMALE	During an inventory of Phlebotomine sand flies carried out in Madagascar, we have identified some specimens showing morphological characters related to the subgenus Sintonius of the genus Sergentomyia. We started a molecular study based on cytochrome b mtDNA and on D1-D2 and D8 domains of the rDNA. The sampling includes all the Sergentomyia species available and also S. (Sergentomyia) schwetzi, S. (Parrotomyia) magna, and the following species belonging to the subgenus Sintonius: S. clydei, S. christophersi, S. affinis vorax, S. adleri and S. meilloni. The Sintonius subgenus (sensu Theodor) is paraphyletic. The Malagasy specimens morphologically Sintonius-like are never clustered with the continental Sintonius. We propose a new subgenus to include them: Trouilletomyia subg. nov. Due to the lack of mesanepisternal setae, the species huberti is removed from the genus Phlebotomus and we propose here a new combination: Sergentomyia huberti comb. nov. The male of S. huberti is pinpointed and described for the first time. Lastly, a new species for Science is described on one female: Sergentomyia (Trouilletomyia) boironis n. sp.	[Randrianambinintsoa, Fano Jose] Univ Antananarivo, Fac Sci, Dept Biol Anim, Antananarivo, Madagascar; [Randrianambinintsoa, Fano Jose; Leger, Nicole; Depaquit, Jerome] Univ Reims, ANSES, SFR Cap Sante, USC Transmiss Vectorielle & Epidemiosurveillance, Reims, France; [Randrianambinintsoa, Fano Jose; Robert, Vincent] MIVEGEC, UMR IRD CNRS UM1 UM2 224 5290, Montpellier, France; [Randrianambinintsoa, Fano Jose] Inst Pasteur Madagascar, Antananarivo, Madagascar	University Antananarivo; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Universite de Reims Champagne-Ardenne; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar	Randrianambinintsoa, FJ (corresponding author), Univ Antananarivo, Fac Sci, Dept Biol Anim, Antananarivo, Madagascar.	fanoujo@yahoo.fr	Randrianambinintsoa, Fano José/G-1198-2014; Depaquit, Jérôme/AAT-7586-2021; Randrianambinintsoa, Fano José/M-3737-2019	Randrianambinintsoa, Fano José/0000-0002-9654-1850; Depaquit, Jérôme/0000-0001-6995-0088; Randrianambinintsoa, Fano José/0000-0002-9654-1850	Institute of Research for Development; Institut Pasteur de Madagascar; Volkswagen Stiftung; Program of Institut Francais de la biodiversite/CNRS/AIRD Biodiversite dans les iles de l'Ocean Indien; GDRI "Biodiversite et Developpement Durable a Madagascar"; Universite de Reims Champagne - Ardenne; Robert S. McNamara Fellowship Program of the World Bank	Institute of Research for Development; Institut Pasteur de Madagascar; Volkswagen Stiftung(Volkswagen); Program of Institut Francais de la biodiversite/CNRS/AIRD Biodiversite dans les iles de l'Ocean Indien; GDRI "Biodiversite et Developpement Durable a Madagascar"; Universite de Reims Champagne - Ardenne; Robert S. McNamara Fellowship Program of the World Bank	The fieldwork received funding from the Institute of Research for Development, Institut Pasteur de Madagascar, and Volkswagen Stiftung. Laboratory work received funding from: (i) the Program of "Institut Francais de la biodiversite/CNRS/AIRD Biodiversite dans les iles de l'Ocean Indien"' itself included in the Regional Project "Insectes vecteurs (phlebotomes et moustiques) dans les iles de l'Ocean Indien: Madagascar, Seychelles et Comores", the GDRI "Biodiversite et Developpement Durable a Madagascar"; (ii) "Universite de Reims Champagne - Ardenne"; and (iii) the Robert S. McNamara Fellowship Program of the World Bank. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABONNENC E, 1976, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V14, P69; Abonnenc E, 1972, SER ENT MED PARASITO, V55; Aransay AM, 2000, INSECT MOL BIOL, V9, P157, DOI 10.1046/j.1365-2583.2000.00168.x; Berdjane-Brouk Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028266; Bonfield JK, 1996, DNA SEQUENCE, V6, P109, DOI 10.3109/10425179609010197; Charrel RN, 2006, EMERG INFECT DIS, V12, P1299, DOI 10.3201/eid1708.060345; Depaquit J, 2008, PARASITE, V15, P15, DOI 10.1051/parasite/2008151015; Depaquit J, 2007, PARASITE, V14, P219, DOI 10.1051/parasite2007143219; Depaquit J, 2010, EUROSURVEILLANCE, V15, P40; Depaquit J, 2004, PARASITE, V11, P261, DOI 10.1051/parasite/2004113261; Depaquit J, 2004, PARASITE, V11, P201, DOI 10.1051/parasite/2004112201; Depaquit J, 1998, CR ACAD SCI III-VIE, V321, P849, DOI 10.1016/S0764-4469(99)80025-0; Depaquit J, 2002, PARASITE, V9, P325, DOI 10.1051/parasite/2002094325; Esseghir S, 1997, INSECT MOL BIOL, V6, P211, DOI 10.1046/j.1365-2583.1997.00175.x; FRANCA C., 1920, Bulletin de la Societe de Pathologie Exotique, V13, P695; Goodman SM, 2005, ORYX, V39, P73, DOI 10.1017/S0030605305000128; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Jung H. F., 1958, P1; Leger N, 2005, PARASITE, V12, P51, DOI 10.1051/parasite/2005121051; LEGER N, 1978, B SOC PATHOL EXOT, V71, P476; Lewis D.J., 1978, BULLETIN OF THE BRITISH MUSEUM (NATURAL HISTORY) ENTOMOLOGY SUPPLEMENT, V37, P217; NITZULESCU VIRGIL, 1931, ANN PARASITOL HUMAINE ET COMP, V9, P271; Perfiliev P., 1968, FAUNA USSR DIPTERA P; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Randrianambinintsoa F.J., 2013, Bulletin de la Societe de Pathologie Exotique, V106, P206, DOI 10.1007/s13149-013-0305-x; Randrianambinintsoa FJ, 2013, PARASITE, V20, DOI 10.1051/parasite/2013005; Rispail P, 1998, MEM I OSWALDO CRUZ, V93, P787, DOI 10.1590/S0074-02761998000600016; Rispail P, 1998, MEM I OSWALDO CRUZ, V93, P773, DOI 10.1590/S0074-02761998000600015; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Senghor MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014773; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; THEODOR O, 1948, B ENTOMOL RES, V39, P85, DOI 10.1017/S0007485300024305; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	36	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98065	10.1371/journal.pone.0098065	http://dx.doi.org/10.1371/journal.pone.0098065			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893009	gold, Green Published, Green Submitted			2022-12-27	WOS:000336911400033
J	Saiki, A; Kimura, R; Samura, T; Fujiwara-Tsukamoto, Y; Sakai, Y; Isomura, Y				Saiki, Akiko; Kimura, Rie; Samura, Toshikazu; Fujiwara-Tsukamoto, Yoko; Sakai, Yutaka; Isomura, Yoshikazu			Different Modulation of Common Motor Information in Rat Primary and Secondary Motor Cortices	PLOS ONE			English	Article							MEDIAL AGRANULAR CORTEX; CONTRASTING NEURONAL-ACTIVITY; SKILLED FORELIMB MOVEMENTS; LABELED PYRAMIDAL NEURONS; PREFRONTAL UNIT-ACTIVITY; GO/NO-GO DISCRIMINATION; VOLUNTARY MOVEMENT; INTRACORTICAL MICROSTIMULATION; CORTICOCORTICAL CONNECTIONS; SENSORIMOTOR CORTEX	Rodents have primary and secondary motor cortices that are involved in the execution of voluntary movements via their direct and parallel projections to the spinal cord. However, it is unclear whether the rodent secondary motor cortex has any motor function distinct from the primary motor cortex to properly control voluntary movements. In the present study, we quantitatively examined neuronal activity in the caudal forelimb area (CFA) of the primary motor cortex and rostral forelimb area (RFA) of the secondary motor cortex in head-fixed rats performing forelimb movements (pushing, holding, and pulling a lever). We found virtually no major differences between CFA and RFA neurons, regardless of neuron subtypes, not only in their basal spiking properties but also in the time-course, amplitude, and direction preference of their functional activation for simple forelimb movements. However, the RFA neurons, as compared with the CFA neurons, showed obviously a greater susceptibility of their functional activation to an alteration in a behavioral situation, a 'rewarding' response that leads to reward or a 'consummatory' response that follows reward water, which might be accompanied by some internal adaptations without affecting the motor outputs. Our results suggest that, although the CFA and RFA neurons commonly process fundamental motor information to properly control forelimb movements, the RFA neurons may be functionally differentiated to integrate motor information with internal state information for an adaptation to goal-directed behaviors.	[Saiki, Akiko; Kimura, Rie; Samura, Toshikazu; Fujiwara-Tsukamoto, Yoko; Sakai, Yutaka; Isomura, Yoshikazu] Tamagawa Univ, Brain Sci Inst, Machida, Tokyo, Japan; [Saiki, Akiko; Sakai, Yutaka; Isomura, Yoshikazu] Tamagawa Univ, Grad Sch Brain Sci, Machida, Tokyo, Japan; [Saiki, Akiko; Kimura, Rie; Fujiwara-Tsukamoto, Yoko; Sakai, Yutaka; Isomura, Yoshikazu] JST CREST, Chiyoda Ku, Tokyo, Japan; [Samura, Toshikazu] Yamaguchi Univ, Dept Appl Mol Biosci, Grad Sch Med, Ube, Yamaguchi 755, Japan; [Samura, Toshikazu] Doshisha Univ, Grad Sch Brain Sci, Lab Neural Circuitry, Kyoto 602, Japan	Yamaguchi University; Doshisha University	Isomura, Y (corresponding author), Tamagawa Univ, Brain Sci Inst, Machida, Tokyo, Japan.	isomura@lab.tamagawa.ac.jp		Kimura, Rie/0000-0003-1798-5400	JST CREST; MEXT [22120520, 24120715, 24300143]; Uehara Memorial Foundation; Brain Science Foundation; Grants-in-Aid for Scientific Research [26119526] Funding Source: KAKEN	JST CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Brain Science Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JST CREST (Y.I.), Grants-in-Aid for Scientific Research on Innovative Areas (Y.I., 22120520, 24120715) and for Scientific Research (B) (Y.I., 24300143) from MEXT, and research grants from the Uehara Memorial Foundation (Y.I.) and Brain Science Foundation (Y.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CT, 2010, NAT NEUROSCI, V13, P739, DOI 10.1038/nn.2538; Bonazzi L, 2013, J NEUROSCI, V33, P2097, DOI 10.1523/JNEUROSCI.3454-12.2013; Brasted PJ, 2000, BEHAV BRAIN RES, V111, P139, DOI 10.1016/S0166-4328(00)00147-9; Brecht M, 2004, J COMP NEUROL, V479, P360, DOI 10.1002/cne.20306; BROWN VJ, 1991, BEHAV NEUROSCI, V105, P567, DOI 10.1037/0735-7044.105.4.567; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; CHAPIN JK, 1986, EXP NEUROL, V91, P502, DOI 10.1016/0014-4886(86)90048-8; Cho RH, 2004, NEUROSCI RES, V50, P381, DOI 10.1016/j.neures.2004.08.006; Cho RH, 2004, NEUROSCI RES, V50, P395, DOI 10.1016/j.neures.2004.08.007; DONOGHUE JP, 1982, J COMP NEUROL, V212, P76, DOI 10.1002/cne.902120106; DONOGHUE JP, 1985, BRAIN RES, V333, P173, DOI 10.1016/0006-8993(85)90141-6; EBRAHIMI A, 1992, NEUROSCI RES, V14, P39, DOI 10.1016/S0168-0102(05)80005-7; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Gharbawie OA, 2007, EUR J NEUROSCI, V26, P3309, DOI 10.1111/j.1460-9568.2007.05874.x; Guggenmos DJ, 2013, P NATL ACAD SCI USA, V110, P21177, DOI 10.1073/pnas.1316885110; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Hermer-Vazquez L, 2004, BEHAV BRAIN RES, V150, P93, DOI 10.1016/S0166-4328(03)00226-2; Hira R, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00055; Hira R, 2013, J NEUROSCI, V33, P1377, DOI 10.1523/JNEUROSCI.2550-12.2013; Hyland B, 1998, BEHAV BRAIN RES, V94, P255, DOI 10.1016/S0166-4328(97)00157-5; Igarashi J, 2013, J NEUROSCI, V33, P18515, DOI 10.1523/JNEUROSCI.2126-13.2013; Isomura Y, 2003, J NEUROSCI, V23, P8002; Isomura Y, 2013, J NEUROSCI, V33, P10209, DOI 10.1523/JNEUROSCI.0381-13.2013; Isomura Y, 2009, NAT NEUROSCI, V12, P1586, DOI 10.1038/nn.2431; Iwaniuk AN, 2000, TRENDS NEUROSCI, V23, P372, DOI 10.1016/S0166-2236(00)01618-0; KALASKA JF, 1995, CEREB CORTEX, V5, P410, DOI 10.1093/cercor/5.5.410; Kimura R, 2012, J NEUROPHYSIOL, V108, P1781, DOI 10.1152/jn.00356.2012; Kleim JA, 1998, J NEUROPHYSIOL, V80, P3321, DOI 10.1152/jn.1998.80.6.3321; KURATA K, 1985, J NEUROPHYSIOL, V53, P142, DOI 10.1152/jn.1985.53.1.142; Laubach M, 2000, NATURE, V405, P567, DOI 10.1038/35014604; LIANG FY, 1993, SOMATOSENS MOT RES, V10, P51, DOI 10.3109/08990229309028823; Mansoori BK, 2014, EXP NEUROL, V254, P18, DOI 10.1016/j.expneurol.2014.01.010; MILLER MW, 1987, EXP BRAIN RES, V67, P339; Morishima M, 2011, J NEUROSCI, V31, P10380, DOI 10.1523/JNEUROSCI.0772-11.2011; MUSHIAKE H, 1991, J NEUROPHYSIOL, V66, P705, DOI 10.1152/jn.1991.66.3.705; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; NUDO RJ, 1990, SOMATOSENS MOT RES, V7, P463, DOI 10.3109/08990229009144720; OKANO K, 1987, EXP BRAIN RES, V66, P155; Ostlund SB, 2009, J NEUROSCI, V29, P8280, DOI 10.1523/JNEUROSCI.1176-09.2009; PASSINGHAM RE, 1988, BEHAV NEUROSCI, V102, P101, DOI 10.1037/0735-7044.102.1.101; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; REEP RL, 1990, J COMP NEUROL, V294, P262, DOI 10.1002/cne.902940210; ROUILLER EM, 1993, SOMATOSENS MOT RES, V10, P269, DOI 10.3109/08990229309028837; Schwarz C, 2010, SOMATOSENS MOT RES, V27, P131, DOI 10.3109/08990220.2010.513111; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; SHIMA K, 1991, J NEUROPHYSIOL, V65, P188, DOI 10.1152/jn.1991.65.2.188; SIEVERT CF, 1986, BRAIN RES, V381, P15, DOI 10.1016/0006-8993(86)90684-0; Smith NJ, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00124; Sul JH, 2011, NAT NEUROSCI, V14, P1202, DOI 10.1038/nn.2881; Takekawa T, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00005; Takekawa T, 2010, EUR J NEUROSCI, V31, P263, DOI 10.1111/j.1460-9568.2009.07068.x; TANJI J, 1985, J NEUROPHYSIOL, V53, P129, DOI 10.1152/jn.1985.53.1.129; Tennant KA, 2011, CEREB CORTEX, V21, P865, DOI 10.1093/cercor/bhq159; Umeda T, 2011, EUR J NEUROSCI, V34, P1453, DOI 10.1111/j.1460-9568.2011.07866.x; VandenBerg PM, 2002, BRAIN RES BULL, V59, P197, DOI 10.1016/S0361-9230(02)00865-1; VANKAN PLE, 1985, EXP BRAIN RES, V60, P559, DOI 10.1007/BF00236942; Wang Y, 1998, BRAIN RES, V781, P137, DOI 10.1016/S0006-8993(97)01223-7; WATANABE M, 1986, BRAIN RES, V382, P1, DOI 10.1016/0006-8993(86)90104-6; WATANABE M, 1986, BRAIN RES, V382, P15, DOI 10.1016/0006-8993(86)90105-8; Zeiler SR, 2013, STROKE, V44, P483, DOI 10.1161/STROKEAHA.112.676940; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	63	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98662	10.1371/journal.pone.0098662	http://dx.doi.org/10.1371/journal.pone.0098662			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893154	Green Published, Green Submitted, gold			2022-12-27	WOS:000336911400083
J	Chow, WY; Lago, S; Barrios, S; Parker, D; Morini, G; Lau, E				Chow, Wing-Yee; Lago, Sol; Barrios, Shannon; Parker, Dan; Morini, Giovanna; Lau, Ellen			Additive Effects of Repetition and Predictability during Comprehension: Evidence from Event-Related Potentials	PLOS ONE			English	Article							SENTENCE-LEVEL CONTEXT; WORD REPETITION; BRAIN POTENTIALS; SPREADING ACTIVATION; LEXICAL REPETITION; PREDICTION; MEMORY; DISCOURSE; TIME; ANTICIPATION	Previous research has shown that neural responses to words during sentence comprehension are sensitive to both lexical repetition and a word's predictability in context. While previous research has often contrasted the effects of these variables (e.g. by looking at cases in which word repetition violates sentence-level constraints), little is known about how they work in tandem. In the current study we examine how recent exposure to a word and its predictability in context combine to impact lexical semantic processing. We devise a novel paradigm that combines reading comprehension with a recognition memory task, allowing for an orthogonal manipulation of a word's predictability and its repetition status. Using event-related brain potentials (ERPs), we show that word repetition and predictability have qualitatively similar and additive effects on the N400 amplitude. We propose that prior exposure to a word and predictability impact lexical semantic processing in an additive and independent fashion	[Chow, Wing-Yee; Lago, Sol; Barrios, Shannon; Parker, Dan; Lau, Ellen] Univ Maryland, Dept Linguist, College Pk, MD 20742 USA; [Chow, Wing-Yee] Basque Ctr Cognit Brain & Language, Donostia San Sebastian, Gipuzkoa, Spain; [Barrios, Shannon] Univ Utah, Dept Linguist, Salt Lake City, UT USA; [Morini, Giovanna] Univ Maryland, Dept Hearing & Speech Sci, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; Utah System of Higher Education; University of Utah; University System of Maryland; University of Maryland College Park	Chow, WY (corresponding author), Univ Maryland, Dept Linguist, College Pk, MD 20742 USA.	wingyeechow.zoey@gmail.com	Lago, Sol/AAF-8054-2021	Lago, Sol/0000-0002-4966-1913; Chow, Wing Yee/0000-0002-1734-485X; Basque Center on Cognition, Brain and Language, BCBL./0000-0002-8345-6892	National Science Foundation [NSF IGERT DGE-0801465]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation (NSF IGERT DGE-0801465) to the University of Maryland. The views expressed here are those of the authors and not necessarily those of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J.R., 1976, LANGUAGE MEMORY THOU; Anderson J.R., 1983, ARCHITECTURE COGNITI; Anderson JE, 2005, BRAIN LANG, V94, P200, DOI 10.1016/j.bandl.2005.01.001; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bader R, 2010, NEUROIMAGE, V50, P772, DOI 10.1016/j.neuroimage.2009.12.100; BESSON M, 1992, J COGNITIVE NEUROSCI, V4, P132, DOI 10.1162/jocn.1992.4.2.132; BESSON M, 1993, J EXP PSYCHOL LEARN, V19, P1115, DOI 10.1037/0278-7393.19.5.1115; Brysbaert M, 2009, BEHAV RES METHODS, V41, P977, DOI 10.3758/BRM.41.4.977; Chafe Wallace, 1994, DISCOURSE CONSCIOUSN; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; COLLINS AM, 1969, J VERB LEARN VERB BE, V8, P240, DOI 10.1016/S0022-5371(69)80069-1; Coulson S, 2005, J EXP PSYCHOL LEARN, V31, P129, DOI 10.1037/0278-7393.31.1.129; DEGROOT AMB, 1985, Q J EXP PSYCHOL-A, V37, P281, DOI 10.1080/14640748508400934; DeLong KA, 2005, NAT NEUROSCI, V8, P1117, DOI 10.1038/nn1504; DeLong KA, 2012, BRAIN LANG, V121, P226, DOI 10.1016/j.bandl.2012.02.006; DUNCANJOHNSON CC, 1977, PSYCHOPHYSIOLOGY, V14, P456, DOI 10.1111/j.1469-8986.1977.tb01312.x; Federmeier KD, 2007, BRAIN RES, V1146, P75, DOI 10.1016/j.brainres.2006.06.101; Federmeier KD, 2007, PSYCHOPHYSIOLOGY, V44, P491, DOI 10.1111/j.1469-8986.2007.00531.x; Federmeier KD, 2009, PSYCHOL LEARN MOTIV, V51, P1, DOI 10.1016/S0079-7421(09)51001-8; Fennell CT, 2007, PROCEEDINGS OF THE 31ST ANNUAL BOSTON UNIVERSITY CONFERENCE ON LANGUAGE DEVELOPMENT VOLS 1 AND 2, P206; Fennell CT, 2010, CHILD DEV, V81, P1376, DOI 10.1111/j.1467-8624.2010.01479.x; Gibson E, 2006, J MEM LANG, V54, P363, DOI 10.1016/j.jml.2005.12.005; Gunter TC, 2000, J COGNITIVE NEUROSCI, V12, P556, DOI 10.1162/089892900562336; HAUTUS MJ, 1995, BEHAV RES METH INS C, V27, P46, DOI 10.3758/BF03203619; Holcomb PJ, 2005, COGNITIVE BRAIN RES, V24, P155, DOI 10.1016/j.cogbrainres.2005.01.003; HOLCOMB PJ, 1993, LANG COGNITIVE PROC, V8, P379, DOI 10.1080/01690969308407583; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Johnson Jr. R., 1988, ADV PSYCHOPHYSIOLOGY, V3, P69; JOHNSON R, 1993, PSYCHOPHYSIOLOGY, V30, P90; Joyce CA, 1999, PSYCHOPHYSIOLOGY, V36, P655, DOI 10.1017/S0048577299981015; Kennison SM, 1997, DISCOURSE PROCESS, V24, P229, DOI 10.1080/01638539709545014; KIRSNER K, 1984, J VERB LEARN VERB BE, V23, P519, DOI 10.1016/S0022-5371(84)90336-0; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; KUHN R, 1990, IEEE T PATTERN ANAL, V12, P570, DOI 10.1109/34.56193; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Kutas M, 1989, J Cogn Neurosci, V1, P38, DOI 10.1162/jocn.1989.1.1.38; KUTAS M, 1984, NATURE, V307, P161, DOI 10.1038/307161a0; Kutas M., 2011, PREDICTIONBRAIN US, P190, DOI DOI 10.1093/ACPROF:OSO/9780195395518.003.0065; Lau EF, 2013, J COGNITIVE NEUROSCI, V25, P484, DOI 10.1162/jocn_a_00328; Lau EF, 2008, NAT REV NEUROSCI, V9, P920, DOI 10.1038/nrn2532; Ledoux K, 2007, MEM COGNITION, V35, P801, DOI 10.3758/BF03193316; Ledoux Kerry, 2006, Behav Cogn Neurosci Rev, V5, P107, DOI 10.1177/1534582306289573; LIBERMAN A, 1961, LANG SPEECH, V4, P175, DOI 10.1177/002383096100400401; LIBERMAN AM, 1981, PERCEPT PSYCHOPHYS, V30, P133, DOI 10.3758/BF03204471; Macmillan NA, 2005, DETECTION THEORY USE; Meyer P, 2007, NEUROREPORT, V18, P1009, DOI 10.1097/WNR.0b013e32815277eb; NAGY ME, 1989, PSYCHOPHYSIOLOGY, V26, P431, DOI 10.1111/j.1469-8986.1989.tb01946.x; NEELY JH, 1977, J EXP PSYCHOL GEN, V106, P226, DOI 10.1037/0096-3445.106.3.226; Otten M, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-89; Otten M, 2008, DISCOURSE PROCESS, V45, P464, DOI 10.1080/01638530802356463; Pinheiro J, 2001, MIXED EFFECTS MODELS; Posner M. I., 1975, ATTENTION PERFORM, P669; R Core Team, 2021, R LANGUAGE ENV STAT; RUGG MD, 1990, MEM COGNITION, V18, P367, DOI 10.3758/BF03197126; RUGG MD, 1987, Q J EXP PSYCHOL-A, V39, P123, DOI 10.1080/02724988743000060; RUGG MD, 1985, PSYCHOPHYSIOLOGY, V22, P642, DOI 10.1111/j.1469-8986.1985.tb01661.x; RUGG MD, 1988, PSYCHOPHYSIOLOGY, V25, P55, DOI 10.1111/j.1469-8986.1988.tb00958.x; RUGG MD, 1987, MEM COGNITION, V15, P473, DOI 10.3758/BF03198381; Schegloff Emanuel, 1990, CONVERSATIONAL ORG I, P51; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; SCHUBERTH RE, 1981, MEM COGNITION, V9, P68, DOI 10.3758/BF03196952; SEIDENBERG MS, 1984, MEM COGNITION, V12, P315, DOI 10.3758/BF03198291; Smith M E, 1987, Electroencephalogr Clin Neurophysiol Suppl, V40, P417; STANOVICH KE, 1983, J EXP PSYCHOL GEN, V112, P1, DOI 10.1037/0096-3445.112.1.1; Summerfield C, 2008, NAT NEUROSCI, V11, P1004, DOI 10.1038/nn.2163; Swaab TY, 2004, J COGNITIVE NEUROSCI, V16, P715, DOI 10.1162/089892904970744; Van Berkum JJA, 2005, J EXP PSYCHOL LEARN, V31, P443, DOI 10.1037/0278-7393.31.3.443; van Dijk TA, 1977, PAPERS SLAVIC PHILOL; Van Petten C, 2006, BRAIN LANG, V97, P279, DOI 10.1016/j.bandl.2005.11.003; Van Petten C, 2012, INT J PSYCHOPHYSIOL, V83, P176, DOI 10.1016/j.ijpsycho.2011.09.015; VANPETTEN C, 1993, LANG COGNITIVE PROC, V8, P485, DOI 10.1080/01690969308407586; VANPETTEN C, 1991, J COGNITIVE NEUROSCI, V3, P131, DOI 10.1162/jocn.1991.3.2.131; Wlotko EW, 2012, NEUROIMAGE, V62, P356, DOI 10.1016/j.neuroimage.2012.04.054	75	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99199	10.1371/journal.pone.0099199	http://dx.doi.org/10.1371/journal.pone.0099199			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP1YS	24905459	Green Published, gold			2022-12-27	WOS:000341869000109
J	Bente, G; Dratsch, T; Kaspar, K; Hassler, T; Bungard, O; Al-Issa, A				Bente, Gary; Dratsch, Thomas; Kaspar, Kai; Haessler, Tabea; Bungard, Oliver; Al-Issa, Ahmad			Cultures of Trust: Effects of Avatar Faces and Reputation Scores on German and Arab Players in an Online Trust-Game	PLOS ONE			English	Article							E-COMMERCE; IMPACT; COOPERATION; ATTENTION; COGNITION; EMOTION; GENDER	Reputation systems as well as seller depictions (photos; avatars) have been shown to reduce buyer uncertainty and to foster trust in online trading. With the emergence of globalized e-markets, it remains an urgent question whether these mechanisms, found to be effective for Western cultures, also apply to other cultures. Hypothesizing that members of collectivistic cultures in contrast to those of individualistic cultures would rely more on visual social cues (seller faces) than on factual information (reputation scores), we compared buying decisions of Arab and German participants in an experimental trust game. Photo-realistic avatars were used instead of photos to control facial features and expressions. The results revealed significant main effects for both reputation scores and avatar faces. Moreover, both variables significantly affected the purchase behavior of Arab as well as German buyers, suggesting cross-cultural universals in the processing of trust cues. The results have implications for future cross-cultural studies in e-commerce as well as the design of online markets and shared virtual environments.	[Bente, Gary; Dratsch, Thomas; Kaspar, Kai; Haessler, Tabea; Bungard, Oliver] Univ Cologne, Dept Psychol, D-50931 Cologne, Germany; [Al-Issa, Ahmad] Amer Univ Sharjah, Dept English, Sharjah, U Arab Emirates	University of Cologne; American University of Sharjah	Dratsch, T (corresponding author), Univ Cologne, Dept Psychol, D-50931 Cologne, Germany.	t.dratsch@mac.com	Al-Issa, Ahmad/AAJ-6560-2021; Hässler, Tabea/C-5244-2017	Al-Issa, Ahmad/0000-0002-8969-3688; Hässler, Tabea/0000-0002-9371-2423	VW Foundation	VW Foundation(Volkswagen)	This study was supported by a project grant of the VW Foundation to Gary Bente. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	14Tullberg J., 2008, J SOCIO-ECON, V37, P2059, DOI DOI 10.1016/J.SOCEC.2007.10.004; ANDERSON NH, 1965, J EXP PSYCHOL, V70, P394, DOI 10.1037/h0022280; [Anonymous], 2012, IBM SPSS STAT 21; Bente G, 2014, LNCS, V8527, P461, DOI DOI 10.1007/978-3-319-07293-7_45; Bente G, 2012, INT J HUM-COMPUT ST, V70, P1, DOI 10.1016/j.ijhcs.2011.08.005; Berger CR, 1975, HUM COMMUN RES, V1, P99, DOI [10.1111/j.1468-2958.1975.tb00258.x, DOI 10.1111/J.1468-2958.1975.TB00258.X]; BIRNBAUM MH, 1972, J EXP PSYCHOL, V93, P35, DOI 10.1037/h0032589; Bolton G.E., 2004, ANAL KRITIK, V26, P185; Bolton GE, 2004, MANAGE SCI, V50, P1587, DOI 10.1287/mnsc.1030.0199; Brynjolfsson E, 2000, MANAGE SCI, V46, P563, DOI 10.1287/mnsc.46.4.563.12061; Chen CC, 1998, ACAD MANAGE REV, V23, P285, DOI 10.2307/259375; Cohen J.E., 1988, STAT POWER ANAL BEHA; Corritore C, 2001, USABILITY EVALUATION, V1, P1548; Corritore CL, 2003, INT J HUM-COMPUT ST, V58, P737, DOI 10.1016/S1071-5819(03)00041-7; Dakhli M, 2009, PSYCHOL J, V6, P90; DERRYBERRY D, 1994, J PERS SOC PSYCHOL, V66, P1128, DOI 10.1037/0022-3514.66.6.1128; Duarte J, 2012, REV FINANC STUD, V25, P2455, DOI 10.1093/rfs/hhs071; Egger F.N., 2001, P CAHD 2001 C AFFECT, P317; FISKE ST, 1980, J PERS SOC PSYCHOL, V38, P889, DOI 10.1037/0022-3514.38.6.889; Flanagin AJ, 2007, NEW MEDIA SOC, V9, P401, DOI 10.1177/1461444807076966; Fogg B. J., 2001, ACM SIGCHI, DOI [10.1145/365024.365037, DOI 10.1145/365024.365037]; Garbarino E, 2004, J BUS RES, V57, P768, DOI 10.1016/S0148-2963(02)00363-6; Gefen D, 2003, MIS QUART, V27, P51, DOI 10.2307/30036519; Gefen D, 2000, OMEGA-INT J MANAGE S, V28, P725, DOI 10.1016/S0305-0483(00)00021-9; Gheorghiu MA, 2009, SOC PSYCHOL QUART, V72, P365, DOI 10.1177/019027250907200408; Glaeser EL, 2000, Q J ECON, V115, P811, DOI 10.1162/003355300554926; Grabner-Krauter S, 2003, INT J HUM-COMPUT ST, V58, P783, DOI 10.1016/S1071-5819(03)00043-0; Haley KJ, 2005, EVOL HUM BEHAV, V26, P245, DOI 10.1016/j.evolhumbehav.2005.01.002; Hardin R., 2001, TRUST SOC, P3; Hofstede G., 2010, CULTURES ORG SOFTWAR, V3rd; Hofstede G., 2001, CULTURES CONSEQUENCE, V2nd, DOI DOI 10.1016/S0005-7967(02)00184-5; Huff L, 2003, ORGAN SCI, V14, P81, DOI 10.1287/orsc.14.1.81.12807; Jarvenpaa S. L., 2000, Information Technology & Management, V1, P45, DOI 10.1023/A:1019104520776; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kao DT, 2009, CYBERPSYCHOL BEHAV, V12, P225, DOI 10.1089/cpb.2008.0212; KELLERMANN K, 1989, HUM COMMUN RES, V16, P147, DOI 10.1111/j.1468-2958.1989.tb00208.x; Kim DJ, 2005, P ICIS 2005 LAS VEG, P11; Kramer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066335; LEWIS JD, 1985, SOC FORCES, V63, P967, DOI 10.2307/2578601; Liu WW, 2011, 1105 FLOR STAT U; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; MCALLISTER DJ, 1995, ACAD MANAGE J, V38, P24, DOI 10.2307/256727; Mcknight DH, 1998, ACAD MANAGE REV, V23, P473, DOI 10.5465/AMR.1998.926622; McKnight DH, 2001, INT J ELECTRON COMM, V6, P35, DOI 10.1080/10864415.2001.11044235; Metzger MJ, 2006, COMMUN RES, V33, P155, DOI 10.1177/0093650206287076; Meyerson D., 1996, TRUST ORG FRONTIERS, P166, DOI [10.4135/9781452243610.n9, DOI 10.4135/9781452243610.N9]; Misztal BA, 1996, TRUST MODERN SOC SEA; Payne C., 2002, MARK INTELL PLAN, V20, P206, DOI [10.1108/02634500210431595, DOI 10.1108/02634500210431595]; PUTNAM RD, 1995, J DEMOCRACY, V0006; Rezlescu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034293; Riegelsberger J, 2005, INT J HUM-COMPUT ST, V62, P381, DOI 10.1016/j.ijhcs.2005.01.001; Riegelsberger J, 2007, OXFORD HDB INTERNET, P53; Riegelsberger J, 2002, INT FEDERATION INFOR, V74, P17; Rodgers S, 2003, J ADVERTISING RES, V43, P322, DOI 10.1017/S0021849903030307; Rosser BA, 2010, BODY IMAGE, V7, P251, DOI 10.1016/j.bodyim.2010.02.007; ROTTER JB, 1971, AM PSYCHOL, V26, P443, DOI 10.1037/h0031464; Smith RA, 2002, HUM COMMUN RES, V28, P515, DOI 10.1093/hcr/28.4.515; Standifird SS, 2001, J MANAGE, V27, P279, DOI 10.1016/S0149-2063(01)00092-7; Tan T, 2009, INT SYMP EMP SOFTWAR, P1, DOI 10.1109/ESEM.2009.5316044; Tan YH, 2000, INT J ELECTRON COMM, V5, P61; Todorov A, 2008, ANN NY ACAD SCI, V1124, P208, DOI 10.1196/annals.1440.012; Triandis HC, 1995, INDIVIDUALISM COLLEC; Uslaner EM, 2000, COMMUN ACM, V43, P60, DOI 10.1145/355112.355125; van Reekum CM, 1997, ADV PSYCHOL, V124, P259; Wang YD, 2005, COMPUT HUM BEHAV, V21, P105, DOI 10.1016/j.chb.2003.11.008; Wilson RK, 2006, POLIT RES QUART, V59, P189, DOI 10.1177/106591290605900202; Yang SC, 2006, PSYCHOL MARKET, V23, P429, DOI 10.1002/mar.20120; Yee N, 2007, CYBERPSYCHOL BEHAV, V10, P115, DOI 10.1089/cpb.2006.9984	68	15	16	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98297	10.1371/journal.pone.0098297	http://dx.doi.org/10.1371/journal.pone.0098297			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4NF	24901696	Green Published, Green Accepted, gold			2022-12-27	WOS:000336841400024
J	Illarionava, NB; Brismar, H; Aperia, A; Gunnarson, E				Illarionava, Nina B.; Brismar, Hjalmar; Aperia, Anita; Gunnarson, Eli			Role of Na,K-ATPase alpha 1 and alpha 2 Isoforms in the Support of Astrocyte Glutamate Uptake	PLOS ONE			English	Article							NEURONAL-ACTIVITY; NA+; TRANSPORTERS; GLT-1; SUBUNIT; DYNAMICS; KINETICS; SIGNALS; GLAST; MICE	Glutamate released during neuronal activity is cleared from the synaptic space via the astrocytic glutamate/Na+ co-transporters. This transport is driven by the transmembrane Na+ gradient mediated by Na,K-ATPase. Astrocytes express two isoforms of the catalytic Na, K-ATPase alpha subunits; the ubiquitously expressed alpha 1 subunit and the alpha 2 subunit that has a more specific expression profile. In the brain alpha 2 is predominantly expressed in astrocytes. The isoforms differ with regard to Na+ affinity, which is lower for alpha 2. The relative roles of the alpha 1 and alpha 2 isoforms in astrocytes are not well understood. Here we present evidence that the presence of the alpha 2 isoform may contribute to a more efficient restoration of glutamate triggered increases in intracellular sodium concentration [Na+](i). Studies were performed on primary astrocytes derived from E17 rat striatum expressing Na, K-ATPase alpha 1 and alpha 2 and the glutamate/Na+ co-transporter GLAST. Selective inhibition of alpha 2 resulted in a modest increase of [Na+](i) accompanied by a disproportionately large decrease in uptake of aspartate, an indicator of glutamate uptake. To compare the capacity of alpha 1 and alpha 2 to handle increases in [Na+](i) triggered by glutamate, primary astrocytes overexpressing either alpha 1 or alpha 2 were used. Exposure to glutamate 200 mM caused a significantly larger increase in [Na+](i) in alpha 1 than in alpha 2 overexpressing cells, and as a consequence restoration of [Na+](i), after glutamate exposure was discontinued, took longer time in alpha 1 than in alpha 2 overexpressing cells. Both alpha 1 and alpha 2 interacted with astrocyte glutamate/Na+ co-transporters via the 1st intracellular loop.	[Illarionava, Nina B.; Brismar, Hjalmar; Aperia, Anita; Gunnarson, Eli] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Brismar, Hjalmar] Royal Inst Technol, Sci Life Lab, Dept Cell Phys, Stockholm, Sweden	Karolinska Institutet; Royal Institute of Technology	Gunnarson, E (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.	eli.gunnarson@ki.se	Brismar, Hjalmar/E-8524-2011	Brismar, Hjalmar/0000-0003-0578-4003	Swedish Research Council; Erling-Persson Family Foundation; Stockholm County Council; Karolinska Institutet; Sallskapet Barnavard	Swedish Research Council(Swedish Research CouncilEuropean Commission); Erling-Persson Family Foundation; Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Sallskapet Barnavard	This study has been supported by grants from the Swedish Research Council (AA), the Erling-Persson Family Foundation, the Regional Agreement on Medical Training and Clinical Research (ALF) between Stockholm County Council and Karolinska Institutet (EG) and Sallskapet Barnavard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aperia A, 2012, J AM SOC NEPHROL, V23, P1283, DOI 10.1681/ASN.2012010102; Azarias G, 2012, J BIOL CHEM; Bagrov AY, 2009, PHARMACOL REV, V61, P9, DOI 10.1124/pr.108.000711; Barcroft LC, 2004, MECH DEVELOP, V121, P417, DOI 10.1016/j.mod.2004.04.005; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Bernardinelli Y, 2004, P NATL ACAD SCI USA, V101, P14937, DOI 10.1073/pnas.0405315101; Bottger P, 2012, NEUROSCI BIOBEHAV R, V36, P855, DOI 10.1016/j.neubiorev.2011.10.005; Chatton JY, 2000, EUR J NEUROSCI, V12, P3843, DOI 10.1046/j.1460-9568.2000.00269.x; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; Cholet N, 2002, CEREB CORTEX, V12, P515, DOI 10.1093/cercor/12.5.515; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Diarra A, 2001, AM J PHYSIOL-CELL PH, V280, pC1623, DOI 10.1152/ajpcell.2001.280.6.C1623; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; Genda EN, 2011, J NEUROSCI, V31, P18275, DOI 10.1523/JNEUROSCI.3305-11.2011; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Herman MA, 2007, J NEUROSCI, V27, P9736, DOI 10.1523/JNEUROSCI.3009-07.2007; HOYER J, 1991, J GEN PHYSIOL, V97, P1073, DOI 10.1085/jgp.97.5.1073; Ikeda K, 2004, J NEUROSCI, V24, P10693, DOI 10.1523/JNEUROSCI.2909-04.2004; James PF, 1999, MOL CELL, V3, P555, DOI 10.1016/S1097-2765(00)80349-4; Kirischuk S, 2012, TRENDS NEUROSCI, V35, P497, DOI 10.1016/j.tins.2012.04.003; Langer J, 2009, J PHYSIOL-LONDON, V587, P5859, DOI 10.1113/jphysiol.2009.182279; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Liebmann T, 2012, J NEUROSCI, V32, P17998, DOI 10.1523/JNEUROSCI.1804-12.2012; Lingrel JB, 2010, ANNU REV PHYSIOL, V72, P395, DOI 10.1146/annurev-physiol-021909-135725; Longuemare MC, 1999, NEUROSCIENCE, V93, P285, DOI 10.1016/S0306-4522(99)00152-9; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; OBRIEN WJ, 1994, ARCH BIOCHEM BIOPHYS, V310, P32, DOI 10.1006/abbi.1994.1136; Pellerin L, 1997, J NEUROCHEM, V69, P2132; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Perego C, 2000, J NEUROCHEM, V75, P1076, DOI 10.1046/j.1471-4159.2000.0751076.x; Rose CR, 2001, J NEUROSCI, V21, P4207, DOI 10.1523/JNEUROSCI.21-12-04207.2001; Rose EM, 2009, J NEUROSCI, V29, P8143, DOI 10.1523/JNEUROSCI.1081-09.2009; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Sambrook J., 2001, MOL CLONING LAB MANU; Tanaka K, 2000, NEUROSCI RES, V37, P15, DOI 10.1016/S0168-0102(00)00104-8; TURNER RJ, 1982, J MEMBRANE BIOL, V70, P37, DOI 10.1007/BF01871587; Yang YJ, 2009, NEURON, V61, P880, DOI 10.1016/j.neuron.2009.02.010; Zahler R, 1997, J GEN PHYSIOL, V110, P201, DOI 10.1085/jgp.110.2.201	38	44	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98469	10.1371/journal.pone.0098469	http://dx.doi.org/10.1371/journal.pone.0098469			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901986	gold, Green Published, Green Submitted			2022-12-27	WOS:000336841400033
J	Nozawa, T; Sugiura, M; Yokoyama, R; Ihara, M; Kotozaki, Y; Miyauchi, CM; Kanno, A; Kawashima, R				Nozawa, Takayuki; Sugiura, Motoaki; Yokoyama, Ryoichi; Ihara, Mizuki; Kotozaki, Yuka; Miyauchi, Carlos Makoto; Kanno, Akitake; Kawashima, Ryuta			Ongoing Activity in Temporally Coherent Networks Predicts Intra-Subject Fluctuation of Response Time to Sporadic Executive Control Demands	PLOS ONE			English	Article							INTRINSIC CONNECTIVITY NETWORKS; EVENT-RELATED FMRI; TOP-DOWN CONTROL; HUMAN BRAIN; FUNCTIONAL CONNECTIVITY; ANTERIOR CINGULATE; DEFAULT-MODE; INDEPENDENT COMPONENTS; NEURAL PREDICTORS; VISUAL-CORTEX	Can ongoing fMRI BOLD signals predict fluctuations in swiftness of a person's response to sporadic cognitive demands? This is an important issue because it clarifies whether intrinsic brain dynamics, for which spatio-temporal patterns are expressed as temporally coherent networks (TCNs), have effects not only on sensory or motor processes, but also on cognitive processes. Predictivity has been affirmed, although to a limited extent. Expecting a predictive effect on executive performance for a wider range of TCNs constituting the cingulo-opercular, fronto-parietal, and default mode networks, we conducted an fMRI study using a version of the color-word Stroop task that was specifically designed to put a higher load on executive control, with the aim of making its fluctuations more detectable. We explored the relationships between the fluctuations in ongoing pre-trial activity in TCNs and the task response time (RT). The results revealed the existence of TCNs in which fluctuations in activity several seconds before the onset of the trial predicted RT fluctuations for the subsequent trial. These TCNs were distributed in the cingulo-opercular and fronto-parietal networks, as well as in perceptual and motor networks. Our results suggest that intrinsic brain dynamics in these networks constitute "cognitive readiness,'' which plays an active role especially in situations where information for anticipatory attention control is unavailable. Fluctuations in these networks lead to fluctuations in executive control performance.	[Nozawa, Takayuki; Ihara, Mizuki; Kotozaki, Yuka; Kawashima, Ryuta] Tohoku Univ, Smart Ageing Int Res Ctr, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Sugiura, Motoaki; Yokoyama, Ryoichi; Miyauchi, Carlos Makoto; Kanno, Akitake; Kawashima, Ryuta] Tohoku Univ, Dept Funct Brain Imaging, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Yokoyama, Ryoichi] Japan Soc Promot Sci, Tokyo, Japan	Tohoku University; Tohoku University; Japan Society for the Promotion of Science	Nozawa, T (corresponding author), Tohoku Univ, Smart Ageing Int Res Ctr, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan.	nozawa@idac.tohoku.ac.jp	Kotozaki, Yuka/ABA-2267-2020; Nozawa, Takayuki/Y-9610-2019; Kotozaki, Yuka/ABA-2922-2020	Nozawa, Takayuki/0000-0001-6300-4373; Kotozaki, Yuka/0000-0002-4659-1200	System Development Program for Advanced Measurement and Analysis, Japan Science and Technology Agency (JST); MEXT/JSPS [23700137, 26330171]	System Development Program for Advanced Measurement and Analysis, Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); MEXT/JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was partially supported by System Development Program for Advanced Measurement and Analysis, Japan Science and Technology Agency (JST; http://www.jst.go.jp/), and also by MEXT/JSPS (http://www.jsps.go.jp/) KAKENHI Grant Number 23700137 and 26330171. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Elseoud A, 2010, HUM BRAIN MAPP, V31, P1207, DOI 10.1002/hbm.20929; Albert NB, 2009, CURR BIOL, V19, P1023, DOI 10.1016/j.cub.2009.04.028; Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Barnes A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006626; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Boly M, 2007, P NATL ACAD SCI USA, V104, P12187, DOI 10.1073/pnas.0611404104; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Bressler SL, 2008, J NEUROSCI, V28, P10056, DOI 10.1523/JNEUROSCI.1776-08.2008; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Calhoun VD, 2008, HUM BRAIN MAPP, V29, P828, DOI 10.1002/hbm.20581; Calhoun VD, 2009, NEUROIMAGE, V45, pS163, DOI 10.1016/j.neuroimage.2008.10.057; Cheyne JA, 2011, COGNITION, V121, P437, DOI 10.1016/j.cognition.2011.07.010; Cocchi L, 2013, TRENDS COGN SCI, V17, P493, DOI 10.1016/j.tics.2013.08.006; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Coste CP, 2011, CEREB CORTEX, V21, P2612, DOI 10.1093/cercor/bhr050; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Egner T, 2005, NEUROIMAGE, V24, P539, DOI 10.1016/j.neuroimage.2004.09.007; Eichele T, 2008, P NATL ACAD SCI USA, V105, P6173, DOI 10.1073/pnas.0708965105; Erhardt EB, 2011, HUM BRAIN MAPP, V32, P2075, DOI 10.1002/hbm.21170; Fair DA, 2007, NEUROIMAGE, V35, P396, DOI 10.1016/j.neuroimage.2006.11.051; Fox MD, 2006, NAT NEUROSCI, V9, P23, DOI 10.1038/nn1616; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fransson P, 2006, NEUROPSYCHOLOGIA, V44, P2836, DOI 10.1016/j.neuropsychologia.2006.06.017; Gordon EM, 2012, HUM BRAIN MAPP, V33, P1536, DOI 10.1002/hbm.21306; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Hasenkamp W, 2012, NEUROIMAGE, V59, P750, DOI 10.1016/j.neuroimage.2011.07.008; Hasson U, 2009, P NATL ACAD SCI USA, V106, P10841, DOI 10.1073/pnas.0903253106; Hesselmann G, 2008, P NATL ACAD SCI USA, V105, P10984, DOI 10.1073/pnas.0712043105; Hesselmann G, 2008, J NEUROSCI, V28, P14481, DOI 10.1523/JNEUROSCI.4398-08.2008; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Kane MJ, 2003, J EXP PSYCHOL GEN, V132, P47, DOI 10.1037/0096-3445.132.1.47; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Laird AR, 2005, HUM BRAIN MAPP, V25, P6, DOI 10.1002/hbm.20129; Leber AB, 2008, P NATL ACAD SCI USA, V105, P13592, DOI 10.1073/pnas.0805423105; Leber AB, 2010, J NEUROSCI, V30, P11458, DOI 10.1523/JNEUROSCI.0809-10.2010; Leung HC, 2000, CEREB CORTEX, V10, P552, DOI 10.1093/cercor/10.6.552; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Li CSR, 2007, NEUROIMAGE, V38, P640, DOI 10.1016/j.neuroimage.2007.07.021; Logan GD, 2001, PSYCHOL REV, V108, P393, DOI 10.1037//0033-295X.108.2.393; Lotze M, 2000, NEUROIMAGE, V11, P473, DOI 10.1006/nimg.2000.0556; MacLeod CM, 2000, TRENDS COGN SCI, V4, P383, DOI 10.1016/S1364-6613(00)01530-8; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Milham MP, 2001, COGNITIVE BRAIN RES, V12, P467, DOI 10.1016/S0926-6410(01)00076-3; Milham MP, 2003, COGNITIVE BRAIN RES, V17, P212, DOI 10.1016/S0926-6410(03)00108-3; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; R Core Team, 2018, R LANG ENV STAT COMP; Raichle ME, 2009, J NEUROSCI, V29, P12729, DOI 10.1523/JNEUROSCI.4366-09.2009; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Robinson S, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-137; Sadaghiani S, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00020; Sadaghiani S, 2009, J NEUROSCI, V29, P13410, DOI 10.1523/JNEUROSCI.2592-09.2009; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Tambini A, 2010, NEURON, V65, P280, DOI 10.1016/j.neuron.2010.01.001; Tang YY, 2012, TRENDS COGN SCI, V16, P330, DOI 10.1016/j.tics.2012.05.001; van de Ven VG, 2004, HUM BRAIN MAPP, V22, P165, DOI 10.1002/hbm.20022; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	80	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99166	10.1371/journal.pone.0099166	http://dx.doi.org/10.1371/journal.pone.0099166			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901995	Green Submitted, Green Published, gold			2022-12-27	WOS:000336841400103
J	Tang, YL; Cao, Y; Qiu, JB; Gao, Z; Ou, ZH; Wang, YJ; Zheng, YZ				Tang, Yulin; Cao, Yan; Qiu, Jianbin; Gao, Zhan; Ou, Zhonghua; Wang, Yajing; Zheng, Yizhi			Expression of a Vacuole-Localized BURP-Domain Protein from Soybean (SALI3-2) Enhances Tolerance to Cadmium and Copper Stresses	PLOS ONE			English	Article							HEAVY-METAL DETOXIFICATION; ARABIDOPSIS-THALIANA; DIFFERENTIAL EXPRESSION; TRANSPORTING ATPASES; CONTAINING GENES; HIGHER-PLANTS; IDENTIFICATION; METALLOTHIONEINS; PHYTOCHELATINS; FRUIT	The plant-specific BURP family proteins play diverse roles in plant development and stress responses, but the function mechanism of these proteins is still poorly understood. Proteins in this family are characterized by a highly conserved BURP domain with four conserved Cys-His repeats and two other Cys, indicating that these proteins potentially interacts with metal ions. In this paper, an immobilized metal affinity chromatography (IMAC) assay showed that the soybean BURP protein SALI3-2 could bind soft transition metal ions (Cd2+, Co2+, Ni2+, Zn2+ and Cu2+) but not hard metal ions (Ca2+ and Mg2+) in vitro. A subcellular localization analysis by confocal laser scanning microscopy revealed that the SALI3-2-GFP fusion protein was localized to the vacuoles. Physiological indexes assay showed that Sali3-2-transgenic Arabidopsis thaliana seedlings were more tolerant to Cu2+ or Cd2+ stresses than the wild type. An inductively coupled plasma optical emission spectrometry (ICP-OES) analysis illustrated that, compared to the wild type seedlings the Sali3-2-transgenic seedlings accumulated more cadmium or copper in the roots but less in the upper ground tissues when the seedlings were exposed to excessive CuCl2 or CdCl2 stress. Therefore, our findings suggest that the SALI3-2 protein may confer cadmium (Cd2+) and copper (Cu2+) tolerance to plants by helping plants to sequester Cd2+ or Cu2+ in the root and reduce the amount of heavy metals transported to the shoots.	[Tang, Yulin; Gao, Zhan; Ou, Zhonghua; Wang, Yajing; Zheng, Yizhi] Shenzhen Univ, Coll Life Sci, Shenzhen Key Lab Microbial & Gene Engn, Shenzhen, Guangdong, Peoples R China; [Cao, Yan; Qiu, Jianbin] Shenzhen Univ, Coll Life Sci, Key Lab Marine Bioresource & Ecoenvironm Sci, Shenzhen, Guangdong, Peoples R China	Shenzhen University; Shenzhen University	Tang, YL (corresponding author), Shenzhen Univ, Coll Life Sci, Shenzhen Key Lab Microbial & Gene Engn, Shenzhen, Guangdong, Peoples R China.	yltang@szu.edu.cn; yzzheng@szu.edu.cn	Tang, Yulin/F-7201-2012		National Natural Science Foundation of China [30770184]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (30770184). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2005, PLANT CELL, V17, P1233, DOI 10.1105/tpc.104.030452; Batchelor AK, 2002, PLANTA, V215, P523, DOI 10.1007/s00425-002-0798-1; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Cobbett CS, 2000, PLANT PHYSIOL, V123, P825, DOI 10.1104/pp.123.3.825; Ding XP, 2009, PLANTA, V230, P149, DOI 10.1007/s00425-009-0929-z; Fernandez L, 2007, PLANT MOL BIOL, V63, P307, DOI 10.1007/s11103-006-9090-2; Gan DF, 2011, MOL BIOL REP, V38, P4553, DOI 10.1007/s11033-010-0587-z; Granger C, 2002, GENOME, V45, P693, DOI [10.1139/g02-032, 10.1139/G02-032]; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; GRILL E, 1985, SCIENCE, V230, P674, DOI 10.1126/science.230.4726.674; Hara M, 2005, J EXP BOT, V56, P2695, DOI 10.1093/jxb/eri262; Hattori J, 1998, MOL GEN GENET, V259, P424, DOI 10.1007/s004380050832; Huang J, 2012, PLANT PHYSIOL, V158, P1779, DOI 10.1104/pp.111.192872; Liu H., 2013, PLANT CELL ENV; Lutsenko S, 2003, J MEMBRANE BIOL, V191, P1, DOI 10.1007/s00232-002-1040-6; Malik MR, 2008, J EXP BOT, V59, P2857, DOI 10.1093/jxb/ern149; Memon AR, 2009, ENVIRON SCI POLLUT R, V16, P162, DOI 10.1007/s11356-008-0079-z; Mendoza-Cozatl DG, 2011, CURR OPIN PLANT BIOL, V14, P554, DOI 10.1016/j.pbi.2011.07.004; Murphy A, 1997, PLANT PHYSIOL, V113, P1293, DOI 10.1104/pp.113.4.1293; Narukawa T, 2014, ANAL SCI, V30, P245, DOI 10.2116/analsci.30.245; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rensing C, 1999, J BACTERIOL, V181, P5891, DOI 10.1128/JB.181.19.5891-5897.1999; Romero-Isart N, 2002, J INORG BIOCHEM, V88, P388, DOI 10.1016/S0162-0134(01)00347-6; Shao YH, 2011, J INTEGR PLANT BIOL, V53, P743, DOI 10.1111/j.1744-7909.2011.01068.x; Shikanai T, 2003, PLANT CELL, V15, P1333, DOI 10.1105/tpc.011817; Song WY, 2010, P NATL ACAD SCI USA, V107, P21187, DOI 10.1073/pnas.1013964107; Tang YL, 2013, CHEM J CHINESE U, V34, P128, DOI 10.7503/cjcu20120184; Teerawanichpan P, 2009, PLANT MOL BIOL, V71, P331, DOI 10.1007/s11103-009-9541-7; Van Son L, 2009, PLANT MOL BIOL, V71, P319, DOI 10.1007/s11103-009-9526-6; Verbruggen N, 2009, CURR OPIN PLANT BIOL, V12, P364, DOI 10.1016/j.pbi.2009.05.001; Wang AM, 2003, P NATL ACAD SCI USA, V100, P14487, DOI 10.1073/pnas.2231254100; Wang HM, 2012, PLANT CELL ENVIRON, V35, P1932, DOI 10.1111/j.1365-3040.2012.02526.x; Wang JA, 2010, PLANT CELL, V22, P4009, DOI 10.1105/tpc.110.080697; Xu B, 2013, MOL PLANT, V6, P945, DOI 10.1093/mp/sss112; Xu HL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-197; Yu W, 1996, MOL CELL BIOL, V16, P2464; Yue YS, 2012, J EXP BOT, V63, P3741, DOI 10.1093/jxb/ers069; Zenk MH, 1996, GENE, V179, P21, DOI 10.1016/S0378-1119(96)00422-2; ZHENG LS, 1994, PLANT PHYSIOL, V105, P1189, DOI 10.1104/pp.105.4.1189; ZHOU JM, 1994, PLANT CELL, V6, P875, DOI 10.1105/tpc.6.6.875; 唐玉林, 2009, [自然科学进展, Progress in Natural Science], V19, P241	42	15	18	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98830	10.1371/journal.pone.0098830	http://dx.doi.org/10.1371/journal.pone.0098830			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901737	Green Submitted, gold, Green Published			2022-12-27	WOS:000336841400059
J	Wang, H; Zhang, HD; Zou, Y; Mi, YL; Lin, SJ; Xie, ZX; Yan, YJ; Zhang, HJ				Wang, Hua; Zhang, Huaidong; Zou, Yi; Mi, Yanling; Lin, Shuangjun; Xie, Zhixiong; Yan, Yunjun; Zhang, Houjin			Structural Insight into the Tetramerization of an Iterative Ketoreductase SiaM through Aromatic Residues in the Interfaces	PLOS ONE			English	Article							CARRIER PROTEIN REDUCTASE; CRYSTAL-STRUCTURE; TRIOSEPHOSPHATE ISOMERASE; STACKING INTERACTIONS; POLYKETIDE; STEREOCHEMISTRY; CATALYSIS; DOMAINS; BIOSYNTHESIS; SCATTERING	In the biosynthesis of polyketides, ketoreductases (KRs) are an important group of enzymes that determine the chiralities of the carbon backbones. SiaM is a special member of this group that can recognize substrates with different lengths and can be used iteratively. Here we report the crystal structure of SiaM. Structural analysis indicates that the overall structure resembles those of other KRs. However, significant disparity can be found in the conserved LDD motif that is replaced with IRD motif in SiaM. The isoleucine and aspartic acid residues take similar orientations as leucine and aspartic acid in the conserved LDD motif, while the arginine residue points out towards the solvent. PISA analysis shows that SiaM forms a tetramer. Several aromatic residues are found in the interfaces, which have aromatic stacking interactions with the aromatic residues in the neighboring protomers. Mutagenesis studies performed on the aromatic residues show that these sites are important for maintaining the structural integrity of SiaM. However, the aromatic residues contribute differently to the enzymatic activity. In the N-terminal interface, the aromatic residues can be replaced with leucine without affecting the enzymatic activity while, in the other interface, such mutations abolish the enzymatic activity.	[Wang, Hua; Zhang, Huaidong; Mi, Yanling; Yan, Yunjun; Zhang, Houjin] Minist Educ, Key Lab Mol Biophys, Wuhan, Hubei, Peoples R China; [Wang, Hua; Zhang, Huaidong; Mi, Yanling; Yan, Yunjun; Zhang, Houjin] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Biotechnol, Wuhan 430074, Hubei, Peoples R China; [Zou, Yi; Lin, Shuangjun] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Xie, Zhixiong] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China	Huazhong University of Science & Technology; Shanghai Jiao Tong University; Wuhan University	Zhang, HJ (corresponding author), Minist Educ, Key Lab Mol Biophys, Wuhan, Hubei, Peoples R China.	hjzhang@hust.edu.cn		Zhang, Huaidong/0000-0001-6572-4737; Zou, Yi/0000-0002-1742-9650	National Key Basic Research Program of China [2013CB933900]; National Natural Science Foundation of China [31000326, 31070057]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was financially supported by National Key Basic Research Program of China (No. 2013CB933900) and National Natural Science Foundation of China (No. 31000326 & No. 31070057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anand S, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-10; Baerga-Ortiz A, 2006, CHEM BIOL, V13, P277, DOI 10.1016/j.chembiol.2006.01.004; Bobeck MJ, 2007, BIOCHEMISTRY-US, V46, P6753, DOI 10.1021/bi700212s; Brandl M, 2001, J MOL BIOL, V307, P357, DOI 10.1006/jmbi.2000.4473; Caffrey P, 2003, CHEMBIOCHEM, V4, P654, DOI 10.1002/cbic.200300581; Caffrey P, 2005, CHEM BIOL, V12, P1060, DOI 10.1016/j.chembiol.2005.10.002; Cane DE, 1998, SCIENCE, V282, P63, DOI 10.1126/science.282.5386.63; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dutta D, 2012, PROTEINS, V80, P1250, DOI 10.1002/prot.24024; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Espinoza-Fonseca LM, 2005, BIOCHEM BIOPH RES CO, V328, P922, DOI 10.1016/j.bbrc.2005.01.043; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Fisher M, 2000, STRUCTURE, V8, P339, DOI 10.1016/S0969-2126(00)00115-5; Gullo VP, 2006, J IND MICROBIOL BIOT, V33, P523, DOI 10.1007/s10295-006-0107-2; Hopwood DA, 1997, CHEM REV, V97, P2465, DOI 10.1021/cr960034i; Javidpour P, 2011, BIOCHEMISTRY-US, V50, P4638, DOI 10.1021/bi200335f; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keatinge-Clay A, 2008, J MOL BIOL, V384, P941, DOI 10.1016/j.jmb.2008.09.084; Keatinge-Clay AT, 2007, CHEM BIOL, V14, P898, DOI 10.1016/j.chembiol.2007.07.009; Keatinge-Clay AT, 2006, STRUCTURE, V14, P737, DOI 10.1016/j.str.2006.01.009; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Korman TP, 2004, BIOCHEMISTRY-US, V43, P14529, DOI 10.1021/bi048133a; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwan DH, 2011, MOLECULES, V16, P6092, DOI 10.3390/molecules16076092; Li RH, 2002, BIOCHEMISTRY-US, V41, P2246, DOI 10.1021/bi0116947; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; MOROKUMA K, 1977, ACCOUNTS CHEM RES, V10, P294, DOI 10.1021/ar50116a004; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Ostergaard LH, 2002, BIOCHEMISTRY-US, V41, P2719, DOI 10.1021/bi0117605; PERUTZ MF, 1993, PHILOS T R SOC A, V345, P105, DOI 10.1098/rsta.1993.0122; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Price AC, 2004, STRUCTURE, V12, P417, DOI 10.1016/j.str.2004.02.008; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Reid R, 2003, BIOCHEMISTRY-US, V42, P72, DOI 10.1021/bi0268706; REINEMER P, 1992, J MOL BIOL, V227, P214, DOI 10.1016/0022-2836(92)90692-D; Rutledge LR, 2007, CHEM PHYS LETT, V444, P167, DOI 10.1016/j.cplett.2007.06.090; Schrodinger L., 2020, PYMOL; Siskos AP, 2005, CHEM BIOL, V12, P1145, DOI 10.1016/j.chembiol.2005.08.017; Sutch BT, 2009, J CHEM INF MODEL, V49, P2139, DOI 10.1021/ci900154a; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tellez-Valencia A, 2004, J MOL BIOL, V341, P1355, DOI 10.1016/j.jmb.2004.06.056; WAKSMAN G, 1992, NATURE, V358, P646, DOI 10.1038/358646a0; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wongsantichon J, 2006, BIOCHEM J, V394, P135, DOI 10.1042/BJ20050915; Yamamoto K, 2001, J BIOCHEM, V129, P303, DOI 10.1093/oxfordjournals.jbchem.a002858; Yin YF, 2001, BIOORG MED CHEM LETT, V11, P1477, DOI 10.1016/S0960-894X(00)00529-1; You YO, 2013, J AM CHEM SOC, V135, P7406, DOI 10.1021/ja4014776; Zaccai NR, 2008, PROTEINS, V70, P562, DOI 10.1002/prot.21624; Zhang YQ, 2003, J BIOL CHEM, V278, P10417, DOI 10.1074/jbc.M211044200; Zheng JT, 2010, STRUCTURE, V18, P913, DOI 10.1016/j.str.2010.04.015; Zou Y, 2013, CHEMBIOCHEM, V14, P679, DOI 10.1002/cbic.201300068	54	19	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e97996	10.1371/journal.pone.0097996	http://dx.doi.org/10.1371/journal.pone.0097996			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901639	gold, Green Submitted, Green Published			2022-12-27	WOS:000336841400016
J	Babu, VMP; Sutton, MD				Babu, Vignesh M. P.; Sutton, Mark D.			A dnaN Plasmid Shuffle Strain for Rapid In Vivo Analysis of Mutant Escherichia coli beta Clamps Provides Insight Into the Role of Clamp in umuDC-Mediated Cold Sensitivity	PLOS ONE			English	Article							POLYMERASE-III HOLOENZYME; AMINO-ACID-RESIDUES; SLIDING-CLAMP; PROCESSIVITY CLAMP; SOS MUTAGENESIS; RECA PROTEIN; LEXA PROTEIN; POL IV; REPLICATION; REPAIR	The E. coli umuDC gene products participate in two temporally distinct roles: UmuD(2)C acts in a DNA damage checkpoint control, while UmuD'C-2, also known as DNA polymerase V (Pol V), catalyzes replication past DNA lesions via a process termed translesion DNA synthesis. These different roles of the umuDC gene products are managed in part by the dnaN-encoded beta sliding clamp protein. Co-overexpression of the beta clamp and Pol V severely blocked E. coli growth at 30 degrees C. We previously used a genetic assay that was independent of the ability of beta clamp to support E. coli viability to isolate 8 mutant clamp proteins (beta(Q61K), beta(S107L), beta(D150N), beta(G157S), beta(V170M), beta(E202K), beta(M204K) and beta(P363S)) that failed to block growth at 30 degrees C when co-overexpressed with Pol V. It was unknown whether these mutant clamps were capable of supporting E. coli viability and normal umuDC functions in vivo. The goals of this study were to answer these questions. To this end, we developed a novel dnaN plasmid shuffle assay. Using this assay, beta(D150N) and beta(P363S) were unable to support E. coli viability. The remaining 6 mutant clamps, each of which supported viability, were indistinguishable from beta(+) with respect to umuDC functions in vivo. In light of these findings, we analyzed phenotypes of strains overexpressing either beta clamp or Pol V alone. The strain overexpressing beta(+), but not those expressing mutant beta clamps, displayed slowed growth irrespective of the incubation temperature. Moreover, growth of the Pol V-expressing strain was modestly slowed at 30 degrees, but not 42 degrees C. Taken together, these results suggest the mutant clamps were identified due to their inability to slow growth rather than an inability to interact with Pol V. They further suggest that cold sensitivity is due, at least in part, to the combination of their individual effects on growth at 30 degrees C.	[Babu, Vignesh M. P.; Sutton, Mark D.] SUNY Buffalo, Dept Biochem, Sch Med & Biomed Sci, Buffalo, NY 14214 USA; [Babu, Vignesh M. P.; Sutton, Mark D.] SUNY Buffalo, Sch Med & Biomed Sci, Witebsky Ctr Microbial Pathogenesis & Immunol, Buffalo, NY 14260 USA; [Sutton, Mark D.] SUNY Buffalo, Sch Med & Biomed Sci, Genet Genom & Bioinformat Program, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Sutton, MD (corresponding author), SUNY Buffalo, Dept Biochem, Sch Med & Biomed Sci, Buffalo, NY 14214 USA.	mdsutton@buffalo.edu	Babu, Vignesh/X-1443-2019	Babu, Vignesh/0000-0003-2603-7605	United States National Institutes of Health, National Institute of General Medical Sciences [GM066094]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM066094, R01GM066094] Funding Source: NIH RePORTER	United States National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States National Institutes of Health, National Institute of General Medical Sciences grant GM066094 (http://www.nigms.nih.gov/) awarded to MDS. The sponsor had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beuning PJ, 2009, J BACTERIOL, V191, P5910, DOI 10.1128/JB.00292-09; Beuning PJ, 2006, MOL MICROBIOL, V59, P460, DOI 10.1111/j.1365-2958.2005.04959.x; Bunting KA, 2003, EMBO J, V22, P5883, DOI 10.1093/emboj/cdg568; BURCKHARDT SE, 1988, P NATL ACAD SCI USA, V85, P1811, DOI 10.1073/pnas.85.6.1811; BURGERS PMJ, 1981, P NATL ACAD SCI-BIOL, V78, P5391, DOI 10.1073/pnas.78.9.5391; CHURCHWARD G, 1984, GENE, V31, P165, DOI 10.1016/0378-1119(84)90207-5; Courcelle J, 2001, GENETICS, V158, P41; COYLE MB, 1970, CANCER RES, V30, P2314; Dalrymple BP, 2001, P NATL ACAD SCI USA, V98, P11627, DOI 10.1073/pnas.191384398; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Saro FJL, 2001, P NATL ACAD SCI USA, V98, P8376, DOI 10.1073/pnas.121009498; Duzen JIM, 2004, DNA REPAIR, V3, P301, DOI 10.1016/j.dnarep.2003.11.008; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Friedberg EC, 2001, ENVIRON MOL MUTAGEN, V38, P105, DOI 10.1002/em.1059; Furukohri A, 2008, J BIOL CHEM, V283, P11260, DOI 10.1074/jbc.M709689200; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Goodman MF, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010363; Grigorian AV, 2003, J BACTERIOL, V185, P630, DOI 10.1128/JB.185.2.630-644.2003; Heltzel JMH, 2012, J BACTERIOL, V194, P3589, DOI 10.1128/JB.00520-12; Heltzel JMH, 2009, P NATL ACAD SCI USA, V106, P12664, DOI 10.1073/pnas.0903460106; Heltzel JMH, 2009, J MOL BIOL, V387, P74, DOI 10.1016/j.jmb.2009.01.050; HO C, 1993, J BACTERIOL, V175, P5411, DOI 10.1128/JB.175.17.5411-5419.1993; Indiani C, 2009, P NATL ACAD SCI USA, V106, P6031, DOI 10.1073/pnas.0901403106; Jeruzalmi D, 2001, CELL, V106, P417, DOI 10.1016/S0092-8674(01)00462-7; KATO T, 1977, MOL GEN GENET, V156, P121, DOI 10.1007/BF00283484; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; LITTLE JW, 1980, P NATL ACAD SCI-BIOL, V77, P3225, DOI 10.1073/pnas.77.6.3225; LITTLE JW, 1981, P NATL ACAD SCI-BIOL, V78, P4199, DOI 10.1073/pnas.78.7.4199; LUSTIG B, 1995, NUCLEIC ACIDS RES, V23, P4707, DOI 10.1093/nar/23.22.4707; MARSH L, 1991, MUTAT RES, V250, P183, DOI 10.1016/0027-5107(91)90175-N; Maul RW, 2007, MOL MICROBIOL, V65, P811, DOI 10.1111/j.1365-2958.2007.05828.x; Miller JH, 1999, SHORT COURSE BACTERI; Neuwald AF, 2003, NUCLEIC ACIDS RES, V31, P4503, DOI 10.1093/nar/gkg486; NOHMI T, 1988, P NATL ACAD SCI USA, V85, P1816, DOI 10.1073/pnas.85.6.1816; OHMORI H, 1984, GENE, V28, P159, DOI 10.1016/0378-1119(84)90253-1; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Opperman T, 1999, P NATL ACAD SCI USA, V96, P9218, DOI 10.1073/pnas.96.16.9218; Opperman T, 1996, J BACTERIOL, V178, P4400, DOI 10.1128/jb.178.15.4400-4411.1996; PEREZROGER I, 1991, BIOCHIMIE, V73, P329, DOI 10.1016/0300-9084(91)90220-U; PHIZICKY EM, 1981, CELL, V25, P259, DOI 10.1016/0092-8674(81)90251-8; Pritchard AE, 2000, EMBO J, V19, P6536, DOI 10.1093/emboj/19.23.6536; Reuven NB, 1999, J BIOL CHEM, V274, P31763, DOI 10.1074/jbc.274.45.31763; Reuven NB, 1998, MOL CELL, V2, P191, DOI 10.1016/S1097-2765(00)80129-X; Sale JE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012708; SHINAGAWA H, 1988, P NATL ACAD SCI USA, V85, P1806, DOI 10.1073/pnas.85.6.1806; SOMMER S, 1993, MOL GEN GENET, V239, P137, DOI 10.1007/BF00281612; Sommer S, 1998, MOL MICROBIOL, V28, P281, DOI 10.1046/j.1365-2958.1998.00803.x; STEINBORN G, 1978, MOL GEN GENET, V165, P87, DOI 10.1007/BF00270380; Sutton MD, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-102; Sutton MD, 2010, BBA-PROTEINS PROTEOM, V1804, P1167, DOI 10.1016/j.bbapap.2009.06.010; Sutton MD, 1999, P NATL ACAD SCI USA, V96, P12373, DOI 10.1073/pnas.96.22.12373; Sutton MD, 2005, MOL MICROBIOL, V55, P1751, DOI 10.1111/j.1365-2958.2005.04500.x; Sutton MD, 2006, DNA REPAIR, V5, P312, DOI 10.1016/j.dnarep.2005.10.011; Sutton MD, 2004, J BACTERIOL, V186, P6738, DOI 10.1128/JB.186.20.6738-6748.2004; SUTTON MD, 1995, J BACTERIOL, V177, P6657, DOI 10.1128/jb.177.22.6657-6665.1995; Sutton MD, 2001, J BACTERIOL, V183, P2897, DOI 10.1128/JB.183.9.2897-2909.2001; Sutton MD, 2001, J BACTERIOL, V183, P1215, DOI 10.1128/JB.183.4.1215-1224.2001; Sutton MD, 2001, J BACTERIOL, V183, P1085, DOI 10.1128/JB.183.3.1085-1089.2001; Tang MJ, 1999, P NATL ACAD SCI USA, V96, P8919, DOI 10.1073/pnas.96.16.8919; Tang MJ, 1998, P NATL ACAD SCI USA, V95, P9755, DOI 10.1073/pnas.95.17.9755; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; Uchida K, 2008, MOL MICROBIOL, V70, P608, DOI 10.1111/j.1365-2958.2008.06423.x; Villarroya M, 1998, EMBO J, V17, P1829, DOI 10.1093/emboj/17.6.1829; Wagner J, 2009, MOL MICROBIOL, V74, P1143, DOI 10.1111/j.1365-2958.2009.06920.x; WALKER GC, 1979, MOL GEN GENET, V172, P17, DOI 10.1007/BF00276210; WARNER HR, 1969, J VIROL, V3, P331, DOI 10.1128/JVI.3.3.331-336.1969	66	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98791	10.1371/journal.pone.0098791	http://dx.doi.org/10.1371/journal.pone.0098791			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896652	gold, Green Submitted, Green Published			2022-12-27	WOS:000338430700079
J	Carl, C; de Nys, R; Paul, NA				Carl, Christina; de Nys, Rocky; Paul, Nicholas A.			The Seeding and Cultivation of a Tropical Species of Filamentous Ulva for Algal Biomass Production	PLOS ONE			English	Article							INTRASPECIFIC COMPETITION; MASS CULTIVATION; NITROGEN UPTAKE; WATER MOTION; FRESH-WATER; ENTEROMORPHA; CHLOROPHYTA; SALINITY; MARINE; RHODOPHYTA	Filamentous species of Ulva are ideal for cultivation because they are robust with high growth rates and maintained across a broad range of environments. Temperate species of filamentous Ulva are commercially cultivated on nets which can be artificially 'seeded' under controlled conditions allowing for a high level of control over seeding density and consequently biomass production. This study quantified for the first time the seeding and culture cycle of a tropical species of filamentous Ulva (Ulva sp. 3) and identified seeding density and nursery period as key factors affecting growth and biomass yield. A seeding density of 621,000 swarmers m(-1) rope in combination with a nursery period of five days resulted in the highest growth rate and correspondingly the highest biomass yield. A nursery period of five days was optimal with up to six times the biomass yield compared to ropes under either shorter or longer nursery periods. These combined parameters of seeding density and nursery period resulted in a specific growth rate of more than 65% day(-1) between 7 and 10 days of outdoor cultivation post-nursery. This was followed by a decrease in growth through to 25 days. This study also demonstrated that the timing of harvest is critical as the maximum biomass yield of 23.0 +/- 8.8 g dry weight m(-1) (228.7 +/- 115.4 g fresh weight m(-1)) was achieved after 13 days of outdoor cultivation whereas biomass degraded to 15.5 +/- 7.3 g dry weight m(-1) (120.2 +/- 71.8 g fresh weight m(-1)) over a longer outdoor cultivation period of 25 days. Artificially seeded ropes of Ulva with high biomass yields over short culture cycles may therefore be an alternative to unattached cultivation in integrated pond-based aquaculture systems.	[Carl, Christina; de Nys, Rocky; Paul, Nicholas A.] James Cook Univ, Sch Marine & Trop Biol, MACRO Ctr Macroalgal Resources & Biotechnol, Townsville, Qld 4811, Australia	James Cook University	Carl, C (corresponding author), James Cook Univ, Sch Marine & Trop Biol, MACRO Ctr Macroalgal Resources & Biotechnol, Townsville, Qld 4811, Australia.	tine.carl@jcu.edu.au	Praeger, Christina/A-7224-2013; de Nys, Rocky/D-6741-2012; Paul, Nicholas/B-6496-2009	Praeger, Christina/0000-0002-1947-122X; de Nys, Rocky/0000-0003-3869-4928; Paul, Nicholas/0000-0002-9275-1535	Australian Government through the Australian Renewable Energy Agency; Advanced Manufacturing Cooperative Research Centre (AMCRC) through Australian Government's Cooperative Research Centre	Australian Government through the Australian Renewable Energy Agency(Australian Renewable Energy Agency (ARENA)); Advanced Manufacturing Cooperative Research Centre (AMCRC) through Australian Government's Cooperative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This research is part of the MBD Energy Research and Development program for Biological Carbon Capture and Storage. The project is supported by the Australian Government through the Australian Renewable Energy Agency, and the Advanced Manufacturing Cooperative Research Centre (AMCRC), funded through the Australian Government's Cooperative Research Centre Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alveal K, 1997, AQUACULTURE, V148, P77, DOI 10.1016/S0044-8486(96)01415-9; Angell AR, 2014, J PHYCOL, V50, P216, DOI 10.1111/jpy.12154; Bolton JJ, 2009, J APPL PHYCOL, V21, P575, DOI 10.1007/s10811-008-9385-6; Bruhn A, 2011, BIORESOURCE TECHNOL, V102, P2595, DOI 10.1016/j.biortech.2010.10.010; Callow ME, 1997, J PHYCOL, V33, P938, DOI 10.1111/j.0022-3646.1997.00938.x; Carl C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097396; Conitz JM, 2013, BOT MAR, V56, P525, DOI 10.1515/bot-2013-0067; Dan A, 2002, FISHERIES SCI, V68, P1182, DOI 10.1046/j.1444-2906.2002.00553.x; Demetropoulos CL, 2004, AQUACULTURE, V235, P471, DOI 10.1016/j.aquaculture.2003.09.012; Cruz-Suarez LE, 2010, AQUACULTURE, V301, P64, DOI 10.1016/j.aquaculture.2010.01.021; Finlay JA, 2002, BIOFOULING, V18, P251, DOI 10.1080/08927010290029010; Food and Agriculture Organization (FAO), 2012, STAT WORLD FISH AQ 2; Gamboa-Delgado J, 2011, J SHELLFISH RES, V30, P969, DOI 10.2983/035.030.0340; Gorley C.K., 2006, GETTING STARTED PRIM; Handa A, 2013, AQUACULTURE, V414, P191, DOI 10.1016/j.aquaculture.2013.08.006; Hayden HS, 2003, EUR J PHYCOL, V38, P277, DOI 10.1080/1364253031000136321; Hiraoka M, 2004, PHYCOL RES, V52, P17, DOI 10.1111/j.1440-1835.2003.00321.x; Hiraoka M, 2008, J APPL PHYCOL, V20, P97, DOI 10.1007/s10811-007-9186-3; Hurd CL, 2000, J PHYCOL, V36, P453, DOI 10.1046/j.1529-8817.2000.99139.x; Hwang EK, 2006, J APPL PHYCOL, V18, P251, DOI 10.1007/s10811-006-9021-2; Ichihara K, 2013, PHYCOL RES, V61, P52, DOI 10.1111/j.1440-1835.2012.00668.x; Kawashima Y, 2013, FISHERIES SCI, V79, P521, DOI 10.1007/s12562-013-0610-0; Kim JK, 2007, J APPL PHYCOL, V19, P431, DOI 10.1007/s10811-006-9150-7; Kirkendale L, 2013, J PHYCOL, V49, P69, DOI 10.1111/jpy.12016; Kregting LT, 2008, J PHYCOL, V44, P320, DOI 10.1111/j.1529-8817.2008.00484.x; Lahaye M, 2007, BIOMACROMOLECULES, V8, P1765, DOI 10.1021/bm061185q; Lawton RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077344; Luning K, 2003, J APPL PHYCOL, V15, P115, DOI 10.1023/A:1023807503255; Luo MB, 2011, J EXP MAR BIOL ECOL, V409, P223, DOI 10.1016/j.jembe.2011.08.023; MAIRH OP, 1986, INDIAN J MAR SCI, V15, P212; Mata L, 2010, J APPL PHYCOL, V22, P639, DOI 10.1007/s10811-010-9504-z; MOLL B, 1995, BIORESOURCE TECHNOL, V52, P255, DOI 10.1016/0960-8524(95)00036-E; Msuya FE, 2006, AQUACULTURE, V254, P284, DOI 10.1016/j.aquaculture.2005.10.044; Neveux N, 2014, BIORESOURCE TECHNOL, V155, P334, DOI 10.1016/j.biortech.2013.12.083; Ohno M, 1981, REP USA MAR BIOL I, V3, P51; Ohno M, 2006, ADV SEAWEED CULTIVAT, P1; Pandey RS, 1985, REP US MAR BIOL I, V7, P21; Pang SJ, 2009, J APPL PHYCOL, V21, P413, DOI 10.1007/s10811-008-9386-5; Paul NA, 2008, AQUACULTURE, V281, P49, DOI 10.1016/j.aquaculture.2008.05.024; Paul NA, 2012, AQUACULTURE: FARMING AQUATIC ANIMALS AND PLANTS, 2ND EDITION, P268; Peteiro C, 2013, J APPL PHYCOL, V25, P205, DOI 10.1007/s10811-012-9854-9; Peteiro C, 2012, J APPL PHYCOL, V24, P1361, DOI 10.1007/s10811-012-9788-2; Sanderson JC, 2012, AQUACULTURE, V354, P128, DOI 10.1016/j.aquaculture.2012.03.019; Shimada S, 2008, J APPL PHYCOL, V20, P979, DOI 10.1007/s10811-007-9296-y; Silva PHD, 2008, AQUACULTURE, V284, P74, DOI 10.1016/j.aquaculture.2008.07.035; Steen H, 2004, MAR BIOL, V144, P61, DOI 10.1007/s00227-003-1175-8; Steen H, 2003, BOT MAR, V46, P36, DOI 10.1515/BOT.2003.006; van der Wal H, 2013, BIORESOURCE TECHNOL, V128, P431, DOI 10.1016/j.biortech.2012.10.094; Yokoyama H, 2010, AQUACULTURE, V310, P74, DOI 10.1016/j.aquaculture.2010.10.018; Zhang C, 2012, FOOD SCI BIOTECHNOL, V21, P625, DOI 10.1007/s10068-012-0081-6; Zhang QS, 2012, J APPL PHYCOL, V24, P707, DOI 10.1007/s10811-011-9689-9	51	30	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98700	10.1371/journal.pone.0098700	http://dx.doi.org/10.1371/journal.pone.0098700			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897115	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000338430700067
J	Suthar, N; Roy, S; Call, DR; Besser, TE; Davis, MA				Suthar, Neeraj; Roy, Sandip; Call, Douglas R.; Besser, Thomas E.; Davis, Margaret A.			An Individual-Based Model of Transmission of Resistant Bacteria in a Veterinary Teaching Hospital	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; NONINHERITED ANTIBIOTIC-RESISTANCE; ANTIMICROBIAL DRUG-USE; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; RISK-FACTORS; NOSOCOMIAL INFECTIONS; PET ANIMALS; DOGS; IMPACT	Veterinary nosocomial infections caused by antibiotic resistant bacteria cause increased morbidity, higher cost and length of treatment and increased zoonotic risk because of the difficulty in treating them. In this study, an individual-based model was developed to investigate the effects of movements of canine patients among ten areas (transmission points) within a veterinary teaching hospital, and the effects of these movements on transmission of antibiotic susceptible and resistant pathogens. The model simulates contamination of transmission points, healthcare workers, and patients as well as the effects of decontamination of transmission points, disinfection of healthcare workers, and antibiotic treatments of canine patients. The model was parameterized using data obtained from hospital records, information obtained by interviews with hospital staff, and the published literature. The model suggested that transmission resulting from contact with healthcare workers was common, and that certain transmission points (housing wards, diagnostics room, and the intensive care unit) presented higher risk for transmission than others (lobby and surgery). Sensitivity analyses using a range of parameter values demonstrated that the risk of acquisition of colonization by resistant pathogens decreased with shorter patient hospital stays (P<0.0001), more frequent decontamination of transmission points and disinfection of healthcare workers (P<0.0001) and better compliance of healthcare workers with hygiene practices (P<0.0001). More frequent decontamination of heavily trafficked transmission points was especially effective at reducing transmission of the model pathogen.	[Suthar, Neeraj; Roy, Sandip; Call, Douglas R.; Besser, Thomas E.; Davis, Margaret A.] Washington State Univ, Coll Vet Med, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Roy, Sandip] Washington State Univ, Coll Vet Med, Sch Elect Engn & Comp Sci, Pullman, WA 99164 USA; [Call, Douglas R.; Besser, Thomas E.] Washington State Univ, Coll Vet Med, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Davis, Margaret A.] Washington State Univ, Coll Vet Med, Dept Vet Clin Sci, Pullman, WA 99164 USA	Washington State University; Washington State University; Washington State University; Washington State University	Davis, MA (corresponding author), Washington State Univ, Coll Vet Med, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.	madavis@vetmed.wsu.edu			Paul G. Allen School for Global Animal Health, Washington State University, Pullman Washington	Paul G. Allen School for Global Animal Health, Washington State University, Pullman Washington	This work was entirely supported by the Paul G. Allen School for Global Animal Health, Washington State University, Pullman Washington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham S., 2014, J ANTIMICROB CHEMOTH; Ahmed MO, 2012, MICROB DRUG RESIST, V18, P161, DOI 10.1089/mdr.2011.0213; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Banu A, 2012, J CLIN DIAGN RES, V6, P1381, DOI 10.7860/JCDR/2012/4286.2364; Boerlin Patrick, 2004, Animal Health Research Reviews, V5, P95, DOI 10.1079/AHR200465; Bootsma MCJ, 2012, B MATH BIOL, V74, P1691, DOI 10.1007/s11538-012-9731-3; Burke JP, 2003, NEW ENGL J MED, V348, P651, DOI 10.1056/NEJMhpr020557; D'Agata EMC, 2009, CLIN INFECT DIS, V48, P274, DOI 10.1086/595844; D'Agata EMC, 2007, J THEOR BIOL, V249, P487, DOI 10.1016/j.jtbi.2007.08.011; D'Agata EMC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004036; D'Agata EMC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030170; Frieden DT, 2013, ANTIBIOTIC RESISTANC; Gastmeier P, 2006, J HOSP INFECT, V62, P181, DOI 10.1016/j.jhin.2005.08.010; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; Ghosh A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00062; Gibson JS, 2011, EPIDEMIOL INFECT, V139, P1511, DOI 10.1017/S0950268810002785; Grundmann H, 2002, J INFECT DIS, V185, P481, DOI 10.1086/338568; Guardabassi L, 2004, J ANTIMICROB CHEMOTH, V54, P321, DOI 10.1093/jac/dkh332; Hamilton E, 2013, JAVMA-J AM VET MED A, V243, P990, DOI 10.2460/javma.243.7.990; Heller J, 2010, RISK ANAL, V30, P458, DOI 10.1111/j.1539-6924.2009.01342.x; Heuer OE, 2005, EMERG INFECT DIS, V11, P344; Howard DH, 2003, CLIN INFECT DIS, V36, pS4, DOI 10.1086/344656; Johnson JA, 2002, VET CLIN N AM-SMALL, V32, P1101, DOI 10.1016/S0195-5616(02)00038-4; Kouyos R., 2011, PLOS PATHOGENS, V7; KuKanich KS, 2012, JAVMA-J AM VET MED A, V240, P437, DOI 10.2460/javma.240.4.437; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; Lipsitch M, 2000, P NATL ACAD SCI USA, V97, P1938, DOI 10.1073/pnas.97.4.1938; Lloyd DH, 2007, CLIN INFECT DIS, V45, pS148, DOI 10.1086/519254; McBryde ES, 2007, J THEOR BIOL, V245, P470, DOI 10.1016/j.jtbi.2006.11.008; Morley PS, 2005, J VET INTERN MED, V19, P617, DOI 10.1892/0891-6640(2005)19[617:ADUIVM]2.0.CO;2; Murphy C, 2009, CAN VET J, V50, P1047; Murray P.R., 2003, MANUAL CLIN MICROBIO, V8th; Ogeer-Gyles J, 2006, JAVMA-J AM VET MED A, V229, P694, DOI 10.2460/javma.229.5.694; Opatowski L, 2011, CURR OPIN INFECT DIS, V24, P279, DOI 10.1097/QCO.0b013e3283462362; Orsini JA, 2005, CAN J VET RES, V69, P278; Prescott JF, 2002, CAN VET J, V43, P107; Raboud J, 2005, INFECT CONT HOSP EP, V26, P607, DOI 10.1086/502589; Sebille V, 1997, INFECT CONT HOSP EP, V18, P84; Song SJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00458; Stolle I, 2013, J ANTIMICROB CHEMOTH, V68, P2802, DOI 10.1093/jac/dkt259; van den Bogaard AE, 1999, LANCET, V354, P163, DOI 10.1016/S0140-6736(05)75297-1; Vatopoulos AC, 1996, J HOSP INFECT, V34, P11, DOI 10.1016/S0195-6701(96)90121-8; Webb GF, 2005, P NATL ACAD SCI USA, V102, P13343, DOI 10.1073/pnas.0504053102; Webb GF, 2009, J BIOL DYNAM, V48, P271	44	14	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98589	10.1371/journal.pone.0098589	http://dx.doi.org/10.1371/journal.pone.0098589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893006	gold, Green Submitted, Green Published			2022-12-27	WOS:000336911400072
J	Sun, QR; Jia, N; Wang, WX; Jin, H; Xu, JH; Hu, HT				Sun, Qinru; Jia, Ning; Wang, Weixi; Jin, Hui; Xu, Jiehua; Hu, Haitao			Protective Effects of Astragaloside IV against Amyloid Beta1-42 Neurotoxicity by Inhibiting the Mitochondrial Permeability Transition Pore Opening	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; OXIDATIVE STRESS; CELL-DEATH; OVEREXPRESSION; DYSFUNCTION; PATHWAYS; CALCIUM; NEURONS; KINASE; INJURY	Mitochondrial dysfunction caused by amyloid beta-peptide (A beta) plays an important role in the pathogenesis of Alzheimer disease (AD). Substantial evidence has indicated that the mitochondrial permeability transition pore (mPTP) opening is involved in A beta-induced neuronal death and reactive oxygen species (ROS) generation. Astragaloside IV (AS-IV), one of the major active constituents of Astragalus membranaceus, has been reported as an effective anti-oxidant for treating neurodegenerative diseases. However, the molecular mechanisms still need to be clarified. In this study, we investigated whether AS-IV could prevent A beta 1-42-induced neurotoxicity in SK-N-SH cells via inhibiting the mPTP opening. The results showed that pretreatment of AS-IV significantly increased the viability of neuronal cells, reduced apoptosis, decreased the generation of intracellular reactive oxygen species (ROS) and decreased mitochondrial superoxide in the presence of A beta 1-42. In addition, pretreatment of AS-IV inhibited the mPTP opening, rescued mitochondrial membrane potential (Delta Psi m), enhanced ATP generation, improved the activity of cytochrome c oxidase and blocked cytochrome c release from mitochondria in A beta 1-42 rich milieu. Moreover, pretreatment of AS-IV reduced the expression of Bax and cleaved caspase-3 and increased the expression of Bcl-2 in an A beta 1-42 rich environment. These data indicate that AS-IV prevents A beta 1-42-induced SK-N-SH cell apoptosis via inhibiting the mPTP opening and ROS generation. These results provide novel insights of AS-IV for the prevention and treatment of neurodegenerative disorders such as AD.	[Sun, Qinru; Jia, Ning; Wang, Weixi; Jin, Hui; Xu, Jiehua; Hu, Haitao] Xi An Jiao Tong Univ, Hlth Sci Ctr, Dept Human Anat & Histoembryol, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University	Jia, N (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Dept Human Anat & Histoembryol, Xian, Shaanxi, Peoples R China.	jianing@mail.xjtu.edu.cn; huht1944@163.com	Sun, Qinru/H-7767-2014					Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bartley MG, 2012, J ALZHEIMERS DIS, V28, P855, DOI 10.3233/JAD-2011-111172; Brustovetsky T, 2010, BBA-BIOENERGETICS, V1797, P1795, DOI 10.1016/j.bbabio.2010.07.006; Chafekar SM, 2007, ANTIOXID REDOX SIGN, V9, P2245, DOI 10.1089/ars.2007.1797; Chan WS, 2009, NEUROCHEM INT, V55, P414, DOI 10.1016/j.neuint.2009.04.012; Chen Q, 2011, FEBS LETT, V585, P921, DOI 10.1016/j.febslet.2011.02.029; Cheng CY, 2006, J BIOMED MATER RES A, V76A, P463, DOI 10.1002/jbm.a.30249; Dartigues JF, 2009, LANCET NEUROL, V8, P1082, DOI 10.1016/S1474-4422(09)70298-4; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Du H, 2010, P NATL ACAD SCI USA, V107, P18670, DOI 10.1073/pnas.1006586107; Du H, 2011, NEUROBIOL AGING, V32, P398, DOI 10.1016/j.neurobiolaging.2009.03.003; Du H, 2010, BBA-MOL BASIS DIS, V1802, P198, DOI 10.1016/j.bbadis.2009.07.005; Ebenezer PJ, 2010, J ALZHEIMERS DIS, V22, P839, DOI 10.3233/JAD-2010-101161; Federico A, 2012, J NEUROL SCI, V322, P254, DOI 10.1016/j.jns.2012.05.030; Fernandez-Morales JC, 2012, ACS CHEM NEUROSCI, V3, P873, DOI 10.1021/cn3001069; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Guo L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054914; Halestrap AP, 2009, BBA-BIOENERGETICS, V1787, P1402, DOI 10.1016/j.bbabio.2008.12.017; Halestrap AP, 2006, BIOCHEM SOC T, V34, P232, DOI 10.1042/BST0340232; Horiuchi M, 2012, NEUROBIOL AGING, V33, P499, DOI 10.1016/j.neurobiolaging.2010.05.007; Kadowaki H, 2005, CELL DEATH DIFFER, V12, P19, DOI 10.1038/sj.cdd.4401528; Kawamata J, 2011, J ALZHEIMERS DIS, V24, P95, DOI 10.3233/JAD-2011-110173; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Krstic D, 2013, NAT REV NEUROL, V9, P25, DOI 10.1038/nrneurol.2012.236; Li DC, 2004, CANCER SCI, V95, P644, DOI 10.1111/j.1349-7006.2004.tb03323.x; Liu T, 2010, BRAIN RES, V1347, P149, DOI 10.1016/j.brainres.2010.05.079; Martin LJ, 2012, PROG MOL BIOL TRANSL, V107, P355, DOI 10.1016/B978-0-12-385883-2.00005-9; Nam JH, 2012, ANTIOXID REDOX SIGN, V16, P1369, DOI 10.1089/ars.2011.4175; Polat E, 2010, PHYTOCHEMISTRY, V71, P658, DOI 10.1016/j.phytochem.2009.11.013; Qu MY, 2012, NEUROSCI RES, V72, P94, DOI 10.1016/j.neures.2011.09.009; Ren R, 2011, J CELL BIOCHEM, V112, P1450, DOI 10.1002/jcb.23062; Ren S, 2013, J TRADIT CHIN MED, V33, P413, DOI 10.1016/S0254-6272(13)60189-2; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Takuma K, 2005, FASEB J, V19, P597, DOI 10.1096/fj.04-2582fje; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Wang-Dietrich L, 2013, J ALZHEIMERS DIS, V34, P985, DOI 10.3233/JAD-122047; Zamzami N, 1998, ONCOGENE, V16, P2265, DOI 10.1038/sj.onc.1201989; Zhang DW, 2012, PHARMACOLOGY, V90, P95, DOI 10.1159/000339476; Zhang N, 2011, MOLECULES, V16, P3896, DOI 10.3390/molecules16053896; Zhang ZG, 2012, MOL CELL BIOCHEM, V364, P209, DOI 10.1007/s11010-011-1219-1; Zhu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035823	44	96	108	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98866	10.1371/journal.pone.0098866	http://dx.doi.org/10.1371/journal.pone.0098866			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905226	Green Submitted, Green Published, gold			2022-12-27	WOS:000341869000074
J	Clement, G				Clement, Gilles			Effects of Varying Gravity Levels in Parabolic Flight on the Size-Mass Illusion	PLOS ONE			English	Article							WEIGHT; DISCRIMINATION; PERCEPTION; OBJECTS	When an observer lifts two objects with the same weight but different sizes, the smaller object is consistently reported to feel heavier than the larger object even after repeated trials. Here we explored the effect of reduced and increased gravity on this perceptual size-mass illusion. Experiments were performed on board the CNES Airbus A300 Zero-G during parabolic flights eliciting repeated exposures to short periods of zero g, 0.16 g, 0.38 g, one g, and 1.8 g. Subjects were asked to assess perceived heaviness by actively oscillating objects with various sizes and masses. The results showed that a perceptual size-mass illusion was clearly present at all gravity levels. During the oscillations, the peak arm acceleration varied as a function of the gravity level, irrespective of the mass and size of the objects. In other words we did not observe a sensorimotor size-mass illusion. These findings confirm dissociation between the sensorimotor and perceptual systems for determining object mass. In addition, they suggest that astronauts on the Moon or Mars with the eyes closed will be able to accurately determine the relative difference in mass between objects.	Int Space Univ, Illkirch Graffenstaden, France		Clement, G (corresponding author), Int Space Univ, Illkirch Graffenstaden, France.	gilles.clement@isunet.edu	Clement, Gilles/I-1973-2017		Centre National d'Etudes Spatiales (CNES); European Space Agency (ESA)	Centre National d'Etudes Spatiales (CNES)(Centre National D'etudes Spatiales); European Space Agency (ESA)(European Space Agency)	Sources of funding are the Centre National d'Etudes Spatiales (CNES) and the European Space Agency (ESA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERY W, 1992, ACTA ASTRONAUT, V26, P119, DOI 10.1016/0094-5765(92)90052-K; ALBERY WB, 1989, AVIAT SPACE ENVIR MD, V60, P943; Augurelle AS, 2003, EXP BRAIN RES, V148, P533, DOI 10.1007/s00221-002-1322-3; Buckingham G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054709; Buckingham G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009709; DARWOOD JJ, 1991, AVIAT SPACE ENVIR MD, V62, P319; Flanagan JR, 2008, CURR BIOL, V18, P1742, DOI 10.1016/j.cub.2008.09.042; Flanagan JR, 2000, NAT NEUROSCI, V3, P737, DOI 10.1038/76701; Gazenko O, 1980, P 6 INT S MAN SPAC B; Goodale MA, 1998, COGNITION, V67, P181, DOI 10.1016/S0010-0277(98)00017-1; Grandy MS, 2006, J NEUROPHYSIOL, V95, P3887, DOI 10.1152/jn.00851.2005; Kawai S, 2002, EXP BRAIN RES, V147, P23, DOI 10.1007/s00221-002-1210-x; Lackner JR, 1996, CURR OPIN NEUROBIOL, V6, P744, DOI 10.1016/S0959-4388(96)80023-7; Murray DJ, 1999, PERCEPT PSYCHOPHYS, V61, P1681, DOI 10.3758/BF03213127; Plaisier MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042518; Platkiewicz J, 2014, J NEUROPHYS IN PRESS; ROSS H, 1984, SCIENCE, V225, P219, DOI 10.1126/science.6729479; ROSS HE, 1987, AVIAT SPACE ENVIR MD, V58, pA148; ROSS HE, 1982, PERCEPT PSYCHOPHYS, V31, P429, DOI 10.3758/BF03204852; ROSS HE, 1987, Q J EXP PSYCHOL-A, V39, P77, DOI 10.1080/02724988743000042; ROSS HE, 1986, NATURWISSENSCHAFTEN, V73, P453, DOI 10.1007/BF00367296; ROSS HE, 1969, Q J EXP PSYCHOL, V21, P346, DOI 10.1080/14640746908400230; Ross HE, 1987, P 3 EUR S LIF SCI RE, P142; Tiest WMB, 2010, ATTEN PERCEPT PSYCHO, V72, P1144, DOI 10.3758/APP.72.4.1144; Zhu Q, 2011, EVOL HUM BEHAV, V32, P288, DOI 10.1016/j.evolhumbehav.2010.11.005	25	1	1	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99188	10.1371/journal.pone.0099188	http://dx.doi.org/10.1371/journal.pone.0099188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901519	Green Published, Green Submitted, gold			2022-12-27	WOS:000336841400107
J	Little, SJ; Pond, SLK; Anderson, CM; Young, JA; Wertheim, JO; Mehta, SR; May, S; Smith, DM				Little, Susan J.; Pond, Sergei L. Kosakovsky; Anderson, Christy M.; Young, Jason A.; Wertheim, Joel O.; Mehta, Sanjay R.; May, Susanne; Smith, Davey M.			Using HIV Networks to Inform Real Time Prevention Interventions	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; TRANSMISSION NETWORK; INFECTION; SEX; EPIDEMIOLOGY; AFRICA; RATES; RISK; MEN; ACT	Objective: To reconstruct the local HIV-1 transmission network from 1996 to 2011 and use network data to evaluate and guide efforts to interrupt transmission. Design: HIV-1 pol sequence data were analyzed to infer the local transmission network. Methods: We analyzed HIV-1 pol sequence data to infer a partial local transmission network among 478 recently HIV-1 infected persons and 170 of their sexual and social contacts in San Diego, California. A transmission network score (TNS) was developed to estimate the risk of HIV transmission from a newly diagnosed individual to a new partner and target prevention interventions. Results: HIV-1 pol sequences from 339 individuals (52.3%) were highly similar to sequences from at least one other participant (i.e., clustered). A high TNS (top 25%) was significantly correlated with baseline risk behaviors (number of unique sexual partners and insertive unprotected anal intercourse (p = 0.014 and p = 0.0455, respectively) and predicted risk of transmission (p<0.0001). Retrospective analysis of antiretroviral therapy (ART) use, and simulations of ART targeted to individuals with the highest TNS, showed significantly reduced network level HIV transmission (p<0.05). Conclusions: Sequence data from an HIV-1 screening program focused on recently infected persons and their social and sexual contacts enabled the characterization of a highly connected transmission network. The network-based risk score (TNS) was highly correlated with transmission risk behaviors and outcomes, and can be used identify and target effective prevention interventions, like ART, to those at a greater risk for HIV-1 transmission.	[Little, Susan J.; Pond, Sergei L. Kosakovsky; Anderson, Christy M.; Young, Jason A.; Wertheim, Joel O.; Mehta, Sanjay R.; Smith, Davey M.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [May, Susanne] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Smith, Davey M.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA	University of California System; University of California San Diego; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Little, SJ (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	slittle@ucsd.edu	Little, Susan/AAA-6116-2019; Pond, Sergei LK/G-9830-2012	Pond, Sergei LK/0000-0003-4817-4029; Smith, Davey/0000-0003-3603-1733	National Institutes of Health [AI43638, AI74621, AI106039, GM093939, AI093163, MH083552, AI090970, AI96189, DA034978, AI067039, AI097061, AI100665, AI080353, MH097520, AI36214, MH62512, TW008908, AI69432, AI096113, AI47745]; California HIV-1 Research Program (CHRP) [RN07-SD-702]; FOGARTY INTERNATIONAL CENTER [R24TW008908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069432, R24AI067039, P30AI036214, R56AI047745, U19AI090970, K24AI100665, K23AI093163, U01AI043638, R21AI080353, K01AI110181, P01AI074621, U01AI069432, R01AI047745, R24AI106039, R21AI097061, U19AI096113, R21AI047745, R01AI096189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097520, R01MH100974, R01MH083552, P30MH062512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA034978] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California HIV-1 Research Program (CHRP); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by funds from the following: National Institutes of Health grants AI43638, AI74621, AI106039, AI47745, GM093939, AI093163, MH083552, AI090970, AI96189, DA034978, AI067039, AI097061, AI100665, AI080353, MH097520, AI36214, MH62512, TW008908, AI69432, AI096113, AI47745 and California HIV-1 Research Program (CHRP) RN07-SD-702. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2013, AM J PUBLIC HEALTH, V103, P322, DOI 10.2105/AJPH.2012.300908; Althaus CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051438; Armstrong MP, 1999, STAT MED, V18, P497, DOI 10.1002/(SICI)1097-0258(19990315)18:5<497::AID-SIM45>3.3.CO;2-R; Bernard EJ, 2007, HIV MED, V8, P382, DOI 10.1111/j.1468-1293.2007.00486.x; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Brown AJL, 2011, J INFECT DIS, V204, P1463, DOI 10.1093/infdis/jir550; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Dennis AM, 2012, AIDS, V26, P1813, DOI 10.1097/QAD.0b013e3283573244; Frost SDW, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0208; Gandhi NR, 2013, J INFECT DIS, V207, P9, DOI 10.1093/infdis/jis631; Guan Y, 2004, LANCET, V363, P99, DOI 10.1016/S0140-6736(03)15259-2; Helleringer S, 2007, AIDS, V21, P2323, DOI 10.1097/QAD.0b013e328285df98; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Hughes GJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000590; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Kassanjee R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020027; Kothe D, 2003, JAIDS-J ACQ IMM DEF, V33, P625, DOI 10.1097/00126334-200308150-00012; Le T, 2013, NEW ENGL J MED, V368, P218, DOI 10.1056/NEJMoa1110187; Lee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036439; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Morris SR, 2010, ANN INTERN MED, V152, P778, DOI 10.7326/0003-4819-152-12-201006150-00005; Pilcher CD, 2007, AIDS, V21, P1723, DOI 10.1097/QAD.0b013e3281532c82; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rivas AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039778; Rodriguez K, 2013, AIDS CARE, V25, P828, DOI 10.1080/09540121.2012.748164; Schneeberger A, 2004, SEX TRANSM DIS, V31, P380, DOI 10.1097/00007435-200406000-00012; Smith D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001473; Smith DA, 2009, AIDS, V23, P225, DOI 10.1097/QAD.0b013e32831d2a81; Volz EM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002947; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wertheim JO, 2014, J INFECT DIS, V209, P304, DOI 10.1093/infdis/jit524; Wertheim JO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027775	36	120	135	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98443	10.1371/journal.pone.0098443	http://dx.doi.org/10.1371/journal.pone.0098443			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901437	Green Submitted, Green Published, gold			2022-12-27	WOS:000336841400029
J	Yin, R; Gu, L; Li, M; Jiang, CZ; Cao, TC; Zhang, XB				Yin, Rong; Gu, Liang; Li, Min; Jiang, Cizhong; Cao, Tongcheng; Zhang, Xiaobai			Gene Expression Profiling Analysis of Bisphenol A-Induced Perturbation in Biological Processes in ER-Negative HEK293 Cells	PLOS ONE			English	Article							BREAST-CANCER; DNA-DAMAGE; RNA-SEQ; EXPOSURE; RECEPTOR; POPULATION; APOPTOSIS; REVEALS; RISK	Bisphenol A (BPA) is an environmental endocrine disruptor which has been detected in human bodies. Many studies have implied that BPA exposure is harmful to human health. Previous studies mainly focused on BPA effects on estrogen receptor (ER)-positive cells. Genome-wide impacts of BPA on gene expression in ER-negative cells is unclear. In this study, we performed RNA-seq to characterize BPA-induced cellular and molecular impacts on ER-negative HEK293 cells. The microscopic observation showed that low-dose BPA exposure did not affect cell viability and morphology. Gene expression profiling analysis identified a list of differentially expressed genes in response to BPA exposure in HEK293 cells. These genes were involved in variable important biological processes including ion transport, cysteine metabolic process, apoptosis, DNA damage repair, etc. Notably, BPA up-regulated the expression of ERCC5 encoding a DNA endonuclease for nucleotide-excision repair. Further electrochemical experiment showed that BPA induced significant DNA damage in ER-positive MCF-7 cells but not in ER-negative HEK293 cells. Collectively, our study revealed that ER-negative HEK293 cells employed mechanisms in response to BPA exposure different from ER-positive cells.	[Yin, Rong; Cao, Tongcheng] Tongji Univ, Dept Chem, Shanghai 200092, Peoples R China; [Gu, Liang; Li, Min; Jiang, Cizhong; Zhang, Xiaobai] Tongji Univ, Shanghai Key Lab Signaling & Dis Res, Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Jiang, CZ (corresponding author), Tongji Univ, Dept Chem, Shanghai 200092, Peoples R China.	czjiang@tongji.edu.cn; ctc@tongji.edu.cn; zhangxb@tongji.edu.cn			Ministry of Science and Technology of China [2010CB944901, 2011CB965104, 2012AA020405]; National Natural Science Foundation of China [91019017, 31271373, 31200952]; China Postdoctoral Science Foundation [2013M531207]; Shanghai Postdoctoral Sustentation Fund [13R21416700]; Aurora Talent Project of Shanghai [10SG24]; program for Eastern Scholar of Shanghai; Fundamental Research Funds for the Central Universities [20113048, 20113109]; Ministry of Education, China [IRT1168]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shanghai Postdoctoral Sustentation Fund; Aurora Talent Project of Shanghai; program for Eastern Scholar of Shanghai; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Ministry of Education, China(Ministry of Education, China)	This study was supported in part by grants from the Ministry of Science and Technology of China (2010CB944901, 2011CB965104, 2012AA020405); and the National Natural Science Foundation of China (91019017, 31271373, 31200952); China Postdoctoral Science Foundation (2013M531207); the Shanghai Postdoctoral Sustentation Fund (13R21416700); Aurora Talent Project of Shanghai (10SG24); the program for Eastern Scholar of Shanghai; the Fundamental Research Funds for the Central Universities (20113048, 20113109); and IRT1168 from the Ministry of Education, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard P, 2010, P NATL ACAD SCI USA, V107, P20405, DOI 10.1073/pnas.1010386107; Bhandari R, 2013, AM J EPIDEMIOL, V177, P1263, DOI 10.1093/aje/kws391; Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Chepelev NL, 2013, CHEM RES TOXICOL, V26, P498, DOI 10.1021/tx400036v; Crain DA, 2008, FERTIL STERIL, V90, P911, DOI 10.1016/j.fertnstert.2008.08.067; Diel P, 2002, J STEROID BIOCHEM, V80, P61, DOI 10.1016/S0960-0760(01)00173-X; Erler C, 2010, J PEDIATR NURS, V25, P400, DOI 10.1016/j.pedn.2009.05.006; Flint S, 2012, J ENVIRON MANAGE, V104, P19, DOI 10.1016/j.jenvman.2012.03.021; Foster Warren G, 2008, Fertil Steril, V89, pe53, DOI 10.1016/j.fertnstert.2007.12.028; Geens T, 2012, FOOD CHEM TOXICOL, V50, P3725, DOI 10.1016/j.fct.2012.07.059; Gentilcore D, 2013, TOXICOLOGY, V304, P21, DOI 10.1016/j.tox.2012.12.001; Gertz J, 2012, GENOME RES, V22, P2153, DOI 10.1101/gr.135681.111; Huang YQ, 2012, ENVIRON INT, V42, P91, DOI 10.1016/j.envint.2011.04.010; Iso T, 2006, BIOL PHARM BULL, V29, P206, DOI 10.1248/bpb.29.206; Krieter DH, 2013, ARTIF ORGANS, V37, P283, DOI 10.1111/j.1525-1594.2012.01556.x; Li DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065399; Lozada KW, 2011, BIOL REPROD, V85, P490, DOI 10.1095/biolreprod.110.090431; Nadal A, 2013, NAT REV ENDOCRINOL, V9, P9, DOI 10.1038/nrendo.2012.205; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rajapandi T, 2000, J BIOL CHEM, V275, P22597, DOI 10.1074/jbc.M002035200; Rogers JA, 2013, MOL IMMUNOL, V53, P421, DOI 10.1016/j.molimm.2012.09.013; Singleton DW, 2006, ENVIRON RES, V100, P86, DOI 10.1016/j.envres.2005.05.004; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsai WT, 2006, J ENVIRON SCI HEAL C, V24, P225, DOI 10.1080/10590500600936482; Wang J, 2004, CLIN GENET, V65, P483, DOI 10.1111/j.1399-0004.2004.00250.x; Wang TG, 2013, EPIDEMIOLOGY, V24, P295, DOI 10.1097/EDE.0b013e318280e02f; Xu JP, 2002, BIOCHEM BIOPH RES CO, V292, P456, DOI 10.1006/bbrc.2002.6644; Zhou LP, 2003, J AM CHEM SOC, V125, P1431, DOI 10.1021/ja0290274	30	13	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98635	10.1371/journal.pone.0098635	http://dx.doi.org/10.1371/journal.pone.0098635			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901218	gold, Green Published, Green Submitted			2022-12-27	WOS:000336841400041
J	Alsmadi, O; John, SE; Thareja, G; Hebbar, P; Antony, D; Behbehani, K; Thanaraj, TA				Alsmadi, Osama; John, Sumi E.; Thareja, Gaurav; Hebbar, Prashantha; Antony, Dinu; Behbehani, Kazem; Thanaraj, Thangavel Alphonse			Genome at Juncture of Early Human Migration: A Systematic Analysis of Two Whole Genomes and Thirteen Exomes from Kuwaiti Population Subgroup of Inferred Saudi Arabian Tribe Ancestry	PLOS ONE			English	Article							METACHROMATIC LEUKODYSTROPHY; STRUCTURAL VARIATION; GENOTYPE IMPUTATION; GENETIC-STRUCTURE; SHORT-READ; SEQUENCE; VARIANTS; MUTATIONS; COMMON; DATABASE	Population of the State of Kuwait is composed of three genetic subgroups of inferred Persian, Saudi Arabian tribe and Bedouin ancestry. The Saudi Arabian tribe subgroup traces its origin to the Najd region of Saudi Arabia. By sequencing two whole genomes and thirteen exomes from this subgroup at high coverage (> 40X), we identify 4,950,724 Single Nucleotide Polymorphisms (SNPs), 515,802 indels and 39,762 structural variations. Of the identified variants, 10,098 (8.3%) exomic SNPs, 139,923 (2.9%) non-exomic SNPs, 5,256 (54.3%) exomic indels, and 374,959 (74.08%) non-exomic indels are 'novel'. Up to 8,070 (79.9%) of the reported novel biallelic exomic SNPs are seen in low frequency (minor allele frequency < 5%). We observe 5,462 known and 1,004 novel potentially deleterious nonsynonymous SNPs. Allele frequencies of common SNPs from the 15 exomes is significantly correlated with those from genotype data of a larger cohort of 48 individuals (Pearson correlation coefficient, 0.91; p < 2.2x10(-16)). A set of 2,485 SNPs show significantly different allele frequencies when compared to populations from other continents. Two notable variants having risk alleles in high frequencies in this subgroup are: a nonsynonymous deleterious SNP (rs2108622 [19: g. 15990431C > T] from CYP4F2 gene [MIM:* 604426]) associated with warfarin dosage levels [MIM:# 122700] required to elicit normal anticoagulant response; and a 39 UTR SNP (rs6151429 [22: g. 51063477 > C]) from ARSA gene [MIM:* 607574]) associated with Metachromatic Leukodystrophy [MIM:# 250100]. Hemoglobin Riyadh variant (identified for the first time in a Saudi Arabian woman) is observed in the exome data. The mitochondrial haplogroup profiles of the 15 individuals are consistent with the haplogroup diversity seen in Saudi Arabian natives, who are believed to have received substantial gene flow from Africa and eastern provenance. We present the first genome resource imperative for designing future genetic studies in Saudi Arabian tribe subgroup. The fulllength genome sequences and the identified variants are available at ftp://dgr. dasmaninstitute. org and http://dgr. dasmaninstitute. org/DGR/gb. html.	[Alsmadi, Osama; John, Sumi E.; Thareja, Gaurav; Hebbar, Prashantha; Antony, Dinu; Behbehani, Kazem; Thanaraj, Thangavel Alphonse] Dasman Diabet Inst, Dasman, Kuwait		Alsmadi, O (corresponding author), Dasman Diabet Inst, Dasman, Kuwait.	osama.alsmadi@dasmaninstitute.org; alphonse.thangavel@dasmaninsitute.org	Hebbar, Prashantha/S-8748-2019; Thareja, Gaurav/GRE-8285-2022		Kuwait Foundation for the Advancement of Sciences (KFAS)	Kuwait Foundation for the Advancement of Sciences (KFAS)(Kuwait Foundation for the Advancement of Sciences (KFAS))	The Kuwait Foundation for the Advancement of Sciences (KFAS) is acknowledged for funding the activities at our institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-45; Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahmed F, 2011, INT J FOOD SCI NUTR, V62, P585, DOI 10.3109/09637486.2011.566848; Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Alsmadi O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074913; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; [Anonymous], 2006, NAT GENET, V38, P851; [Anonymous], SNP VAR SUIT VERS 7; Armitage SJ, 2011, SCIENCE, V331, P453, DOI 10.1126/science.1199113; Bedard K, 2009, HUM MUTAT, V30, P1123, DOI 10.1002/humu.21029; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Cabrera VM, 2009, VERTEBR PALEOBIOL PA, P79, DOI 10.1007/978-90-481-2719-1_6; Caldwell MD, 2008, BLOOD, V111, P4106, DOI 10.1182/blood-2007-11-122010; Carter R, 2006, ANTIQUITY, V80, P52, DOI 10.1017/S0003598X0009325X; Cha PC, 2010, HUM MOL GENET, V19, P4735, DOI 10.1093/hmg/ddq389; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Chiaroni J, 2010, EUR J HUM GENET, V18, P348, DOI 10.1038/ejhg.2009.166; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; De La Vega F, 2009, FUNCTIONAL ANAL GENE; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; ELHAZMI MAF, 1977, HEMOGLOBIN, V1, P59, DOI 10.3109/03630267609031022; ELKHATEEB I, 1988, BRAIN DEV-JPN, V10, P243; Falush D, 2003, GENETICS, V164, P1567; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gao Xiaoyi, 2012, Frontiers in Genetics, V3, P117, DOI 10.3389/fgene.2012.00117; Ghelli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007922; Gianfrancesco F, 2003, AM J HUM GENET, V72, P1479, DOI 10.1086/375628; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Grove ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068095; HAGER J, 1995, NAT GENET, V9, P299, DOI 10.1038/ng0395-299; Hardison R, 1998, GENOMICS, V47, P429, DOI 10.1006/geno.1997.5147; Hardison RC, 2002, HUM MUTAT, V19, P225, DOI 10.1002/humu.10044; HEINISCH U, 1995, AM J HUM GENET, V56, P51; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jones AC, 1999, AM J HUM GENET, V64, P1305, DOI 10.1086/302381; Kenna KP, 2013, J MED GENET, V50, P776, DOI 10.1136/jmedgenet-2013-101795; Kennet D., 2011, P SEMINAR ARABIAN ST, V41, P161; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Kofler B, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-35; Koul R L, 1994, Indian Pediatr, V31, P694; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lam HYK, 2012, NAT BIOTECHNOL, V30, P226, DOI 10.1038/nbt.2134; Lam HYK, 2010, NAT BIOTECHNOL, V28, P47, DOI 10.1038/nbt.1600; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Lohmueller KE, 2013, AM J HUM GENET, V93, P1072, DOI 10.1016/j.ajhg.2013.11.005; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Marouf R, 2002, MED PRIN PRACT, V11, P38, DOI 10.1159/000048659; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; McKusick V.A., 1998, MENDELIAN INHERITANC; Mehdi Syed Riaz, 2011, Indian J Hum Genet, V17, P207, DOI 10.4103/0971-6866.92106; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Moore B, 2011, GENET MED, V13, P210, DOI 10.1097/GIM.0b013e31820ed321; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Niida Y, 1999, HUM MUTAT, V14, P412, DOI 10.1002/(SICI)1098-1004(199911)14:5<412::AID-HUMU7>3.0.CO;2-K; Pushkarev D, 2009, NAT BIOTECHNOL, V27, P847, DOI 10.1038/nbt.1561; Rajab A, 2005, COMMUNITY GENET, V8, P27, DOI 10.1159/000083334; Regis S, 2002, HUM GENET, V110, P351, DOI 10.1007/s00439-002-0701-y; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; Rodriguez-Flores JL, 2014, HUM MUTAT, V35, P105, DOI 10.1002/humu.22460; Rodriguez-Flores JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047614; Rose JI, 2009, VERTEBR PALEOBIOL PA, P1, DOI 10.1007/978-90-481-2719-1_1; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; Shen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059494; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Stranger BE, 2011, GENETICS, V187, P367, DOI 10.1534/genetics.110.120907; Sung YJ, 2012, GENET EPIDEMIOL, V36, P508, DOI 10.1002/gepi.21647; Tadmouri GO, 2006, NUCLEIC ACIDS RES, V34, pD602, DOI 10.1093/nar/gkj015; Takeuchi F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000433; Teebi AS, 2010, GENETIC DISORDERS AMONG ARAB POPULATIONS, SECOND EDITION, P3, DOI 10.1007/978-3-642-05080-0_1; Theyab JB, 2012, HUM BIOL, V84, P379, DOI 10.3378/027.084.0403; Triki-Fendri S, 2010, ANN HUM BIOL, V37, P827, DOI 10.3109/03014461003720296; Van Geystelen A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-101; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Westesson O, 2013, BRIEF BIOINFORM, V14, P172, DOI 10.1093/bib/bbr078; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Wong LP, 2013, AM J HUM GENET, V92, P52, DOI 10.1016/j.ajhg.2012.12.005; Wu JT, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-305; Wu Y, 2001, NAT GENET, V29, P137, DOI 10.1038/ng1001-137; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zhang H, 2008, MOL PSYCHIATR, V13, P531, DOI 10.1038/sj.mp.4002035; ZLOTOGORA J, 1994, J MED GENET, V31, P672, DOI 10.1136/jmg.31.9.672; Zubaid M, 2013, HELL J CARDIOL, V54, P102	114	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99069	10.1371/journal.pone.0099069	http://dx.doi.org/10.1371/journal.pone.0099069			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896259	Green Published, gold			2022-12-27	WOS:000338430700113
J	Amiri, FB; Gouya, MM; Saifi, M; Rohani, M; Tabarsi, P; Sedaghat, A; Fahimfar, N; Memarnejadian, A; Aghasadeghi, MR; Haghdoost, AA; Jahanbakhsh, F; Nasehi, M; Mostafavi, E				Amiri, Fahimeh Bagheri; Gouya, Mohammad Mehdi; Saifi, Mahnaz; Rohani, Mehdi; Tabarsi, Payam; Sedaghat, Abbas; Fahimfar, Noushin; Memarnejadian, Arash; Aghasadeghi, Mohammad Reza; Haghdoost, Ali Akbar; Jahanbakhsh, Fatemeh; Nasehi, Mahshid; Mostafavi, Ehsan			Vulnerability of Homeless People in Tehran, Iran, to HIV, Tuberculosis and Viral Hepatitis	PLOS ONE			English	Article							INJECTION-DRUG USERS; RISK-FACTORS; C VIRUS; PREVALENCE; INFECTION; SYPHILIS; HBV; HCV	Background: Homeless people are at risk of contracting communicable infectious diseases, as they indulge in risky behaviours and lifestyle. This study was conducted to determine the prevalence of the aforementioned infections and related risk behaviours among homeless people in Tehran. Methods: In this study a convenience sample of 593 homeless individuals was studied. The ELISA method was used for the detection of HIV, HCV and HBV. Clinical symptoms, sputum cultures, acid fast bacilli smears, and chest X-rays were used to identify active pulmonary tuberculosis, and the Interferon Gamma Release Assay (IGRA) test was used to identify latent tuberculosis. Results: The prevalence of HIV, HBV, HCV and latent tuberculosis was 3.4%, 2.6%, 23.3% and 46.7%, respectively. Active pulmonary tuberculosis was found in 7 persons (1.2%). Injection drug use was an independent risk factor for HIV, HCV and HBV infections. Older people had a higher proportion of Mycobacterium tuberculosis infection (OR: 2.6, 95%CI: 1.9, 3.7) and HCV positivity (OR: 1.7, 95% CI: 1.1, 2.5). Conclusion: Our findings highlighted that much more attention needs to be paid to the health of homeless people.	[Amiri, Fahimeh Bagheri; Jahanbakhsh, Fatemeh; Mostafavi, Ehsan] Pasteur Inst Iran, Dept Epidemiol, Tehran, Iran; [Amiri, Fahimeh Bagheri] Univ Tehran, Dept Epidemiol, Tehran, Iran; [Gouya, Mohammad Mehdi; Sedaghat, Abbas; Fahimfar, Noushin; Nasehi, Mahshid] Minist Hlth & Med Educ, Ctr Dis Control, Tehran, Iran; [Saifi, Mahnaz] Pasteur Inst Iran, Dept TB & Lung Res, Tehran, Iran; [Rohani, Mehdi] Pasteur Inst Iran, Dept Bacteriol, Tehran, Iran; [Tabarsi, Payam] Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis, Mycobacteriol Res Ctr, Tehran, Iran; [Memarnejadian, Arash; Aghasadeghi, Mohammad Reza] Pasteur Inst Iran, Dept Hepatitis & AIDS, Tehran, Iran; [Haghdoost, Ali Akbar] Kerman Univ Med Sci, Inst Futures Studies Hlth, Reg Knowledge Hub, Kerman, Iran; [Haghdoost, Ali Akbar] Kerman Univ Med Sci, Inst Futures Studies Hlth, WHO Collaborating Ctr HIV Surveillance, Kerman, Iran; [Haghdoost, Ali Akbar] Kerman Univ Med Sci, Inst Futures Studies Hlth, Res Ctr Modeling Hlth, Kerman, Iran; [Nasehi, Mahshid] Univ Tehran Med Sci, Dept Epidemiol & Biostat, Sch Publ Hlth, Tehran, Iran; [Mostafavi, Ehsan] Pasteur Inst Iran, Res Ctr Emerging & Reemerging Infect Dis Akanlu, Kabudar Ahang, Hamadan, Iran	Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; University of Tehran; Ministry of Health & Medical Education (MOHME); Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Shahid Beheshti University Medical Sciences; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Kerman University of Medical Sciences; Kerman University of Medical Sciences; World Health Organization; Kerman University of Medical Sciences; Tehran University of Medical Sciences; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran	Mostafavi, E (corresponding author), Pasteur Inst Iran, Dept Epidemiol, Tehran, Iran.	mostafavi@pasteur.ac.ir	Mostafavi, Ehsan/A-7627-2011; Fahimfar, Noushin/M-2310-2018; Gouya, Mohammad Mehdi/ABI-4325-2020; Memarnejadian, Arash/I-3979-2019; Rohani, Mahdi/K-9489-2017; Amiri, Fahimeh Bagheri/M-7724-2019; aghasadeghi, mohammad reza/K-9497-2017; Rohani, Mahdi/ABG-3890-2021; Haghdoost, Ali Akbar/C-2823-2009; tabarsi, payam/G-8735-2017	Mostafavi, Ehsan/0000-0002-1997-517X; Memarnejadian, Arash/0000-0003-4005-8787; Rohani, Mahdi/0000-0001-8956-5072; Amiri, Fahimeh Bagheri/0000-0003-2943-2846; aghasadeghi, mohammad reza/0000-0003-2186-0774; Rohani, Mahdi/0000-0001-8956-5072; Haghdoost, Ali Akbar/0000-0003-4628-4849; Fahimfar, Noushin/0000-0001-6205-9794; tabarsi, payam/0000-0002-8932-5420	Ministry of health and Medical education of Iran	Ministry of health and Medical education of Iran	Centre for communicable disease control in the Ministry of health and Medical education of Iran, financially supported this project. The funders had cooperation in study design and data collection process.	Adjei AA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-33; Aliverdinia A, 2012, SOCIOL SPECTRUM, V32, P209, DOI 10.1080/02732173.2012.663710; Andersson M. I., 2011, South African Gastroenterology Review, V9, P16; Asl S. K. H., 2004, Archives of Iranian Medicine, V7, P20; Beijer U, 2012, LANCET INFECT DIS, V12, P859, DOI 10.1016/S1473-3099(12)70177-9; Celentano D, 2009, CAN MED ASSOC J, V181, P571, DOI 10.1503/cmaj.091574; DeBeck K, 2009, CAN MED ASSOC J, V181, P585, DOI 10.1503/cmaj.082054; Dinenno Elizabeth A, 2012, Open AIDS J, V6, P169, DOI 10.2174/1874613601206010169; EDLIN BR, 1994, NEW ENGL J MED, V331, P1422, DOI 10.1056/NEJM199411243312106; Garfein RS, 2010, EMERG INFECT DIS, V16, P757, DOI 10.3201/eid1605.091446; Grimley DM, 2006, SEX TRANSM DIS, V33, P666, DOI 10.1097/01.olq.0000223285.18331.4d; Haddad MB, 2005, JAMA-J AM MED ASSOC, V293, P2762, DOI 10.1001/jama.293.22.2762; Haghdoost AA, 2011, J AIDS HIV RES, V3, P231, DOI [https://doi.org/10.5897/JAHR11.030, DOI 10.5897/JAHR11.030]; Hussain H, 2003, INT J EPIDEMIOL, V32, P794, DOI 10.1093/ije/dyg247; Mahmoodian-Shooshtari Mahmood, 2006, Arch Iran Med, V9, P200; Mardani M, 2010, ANN THORAC MED, V5, P43, DOI 10.4103/1817-1737.58959; Martini A, 2007, G Ital Med Lav Ergon, V29, P767; Mazurek GH, 2010, UPDATED GUIDELINES U; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Noell J, 2001, SEX TRANSM DIS, V28, P4, DOI 10.1097/00007435-200101000-00003; Organization WH, 2012, WHOHTMTB20123; Poorolajal J, 2009, J RES MED SCI, V14, P249; Razani N, 2007, ADDICTION, V102, P1472, DOI 10.1111/j.1360-0443.2007.01914.x; Shannon K, 2010, ARCH PEDIAT ADOL MED, V164, P61, DOI 10.1001/archpediatrics.2009.241; Shirinbayan P, 2010, SCI RES ESSAYS, V5, P3231; Springer S, 2000, HABITAT INT, V24, P475, DOI 10.1016/S0197-3975(00)00010-2; Story A, 2007, THORAX, V62, P667, DOI 10.1136/thx.2006.065409; Strathdee SA, 2001, ARCH INTERN MED, V161, P1281, DOI 10.1001/archinte.161.10.1281; Tabuchi T, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-22; Vahdani P, 2009, ARCH IRAN MED, V12, P483; Volf V, 2008, EUR J PUBLIC HEALTH, V18, P44, DOI 10.1093/eurpub/ckm072; ZOLOPA AR, 1994, JAMA-J AM MED ASSOC, V272, P455, DOI 10.1001/jama.272.6.455	32	21	22	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98742	10.1371/journal.pone.0098742	http://dx.doi.org/10.1371/journal.pone.0098742			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK4YO	24896247	Green Published, gold, Green Submitted			2022-12-27	WOS:000338430700071
J	Csordas, G; Varga, GIB; Honti, V; Jankovics, F; Kurucz, E; Ando, I				Csordas, Gabor; Varga, Gergely I. B.; Honti, Viktor; Jankovics, Ferenc; Kurucz, Eva; Ando, Istvan			In Vivo Immunostaining of Hemocyte Compartments in Drosophila for Live Imaging	PLOS ONE			English	Article							CELLULAR IMMUNE-RESPONSE; NERVOUS-SYSTEM; LYMPH GLAND; EXPRESSION; LARVAL; BLOOD; PHAGOCYTOSIS; TRANSPORT; LINEAGES; RECEPTOR	In recent years, Drosophila melanogaster has become an attractive model organism in which to study the structure and development of the cellular immune components. The emergence of immunological markers greatly accelerated the identification of the immune cells (hemocytes), while the creation of genetic reporter constructs allowed unique insight into the structural organization of hematopoietic tissues. However, investigation of the hemocyte compartments by the means of immunological markers requires dissection and fixation, which regularly disrupt the delicate structure and hamper the microanatomical characterization. Moreover, the investigation of transgenic reporters alone can be misleading as their expression often differs from the native expression pattern of their respective genes. We describe here a method that combines the reporter constructs and the immunological tools in live imaging, thereby allowing use of the array of available immunological markers while retaining the structural integrity of the hematopoietic compartments. The procedure allows the reversible immobilization of Drosophila larvae for high-resolution confocal imaging and the time-lapse video analysis of in vivo reporters. When combined with our antibody injection-based in situ immunostaining assay, the resulting double labeling of the hemocyte compartments can provide new information on the microanatomy and functional properties of the hematopoietic tissues in an intact state. Although this method was developed to study the immune system of Drosophila melanogaster, we anticipate that such a combination of genetic and immunological markers could become a versatile technique for in vivo studies in other biological systems too.	[Csordas, Gabor; Varga, Gergely I. B.; Honti, Viktor; Kurucz, Eva; Ando, Istvan] Hungarian Acad Sci, Biol Res Ctr, Immunol Unit, Inst Genet, H-6701 Szeged, Hungary; [Jankovics, Ferenc] Hungarian Acad Sci, Biol Res Ctr, Dev Genet Unit, Inst Genet, H-6701 Szeged, Hungary	Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Academy of Sciences; Hungarian Biological Research Center	Ando, I (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Immunol Unit, Inst Genet, H-6701 Szeged, Hungary.	ando.istvan@brc.mta.hu		Csordas, Gabor/0000-0001-6871-6839; Jankovics, Ferenc/0000-0001-9697-4472	Hungarian Science Foundation, OTKA [NK 101730, TAMOP 4.2.2.A-11/1KONV-2012-0035]; European Union; State of Hungary; European Social Fund [TAMOP 4.2.4.A/2-11-1-2012-0001]	Hungarian Science Foundation, OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Union(European Commission); State of Hungary; European Social Fund(European Social Fund (ESF))	This research was financed by grants from the Hungarian Science Foundation, OTKA grant NK 101730 to (IA) (www.otka.hu), and TAMOP 4.2.2.A-11/1KONV-2012-0035 to (IA) (www.ujszechenyiterv.gov.hu). This research was supported by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP 4.2.4.A/2-11-1-2012-0001 'National Excellence Program' (for VH and GIBV) (www.nemzetikivalosag.hu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badre NH, 2005, COMP BIOCHEM PHYS A, V140, P363, DOI 10.1016/j.cbpb.2005.01.019; Beetz S, 2004, J INSECT PHYSIOL, V50, P805, DOI 10.1016/j.jinsphys.2004.06.003; Dreschers S., 1994, European Journal of Cell Biology, V63, P82; Dushay MS, 1998, AM J HUM GENET, V62, P10, DOI 10.1086/301694; Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6; Fuger P, 2007, NAT PROTOC, V2, P3285, DOI 10.1038/nprot.2007.472; Ghannad-Rezaie M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029869; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Honti V, 2010, MOL IMMUNOL, V47, P1997, DOI 10.1016/j.molimm.2010.04.017; Honti V, 2009, IMMUNOL LETT, V126, P83, DOI 10.1016/j.imlet.2009.08.004; HULTMARK D, 1994, NATURE, V367, P116, DOI 10.1038/367116a0; Jankovics F, 2006, DEV CELL, V11, P375, DOI 10.1016/j.devcel.2006.07.014; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; King JG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-55; Krzemien J, 2010, DEV BIOL, V346, P310, DOI 10.1016/j.ydbio.2010.08.003; Kurucz E, 2003, P NATL ACAD SCI USA, V100, P2622, DOI 10.1073/pnas.0436940100; Kurucz E, 2007, ACTA BIOL HUNG, V58, P95, DOI 10.1556/ABiol.58.2007.Suppl.8; Kurucz E, 2007, CURR BIOL, V17, P649, DOI 10.1016/j.cub.2007.02.041; Makhijani K, 2011, DEVELOPMENT, V138, P5379, DOI 10.1242/dev.067322; Markus R, 2009, P NATL ACAD SCI USA, V106, P4805, DOI 10.1073/pnas.0801766106; Martinek N, 2008, J CELL SCI, V121, P1671, DOI 10.1242/jcs.021931; Miller KE, 2005, CURR BIOL, V15, P684, DOI 10.1016/j.cub.2005.02.061; Minakhina S, 2006, GENETICS, V174, P253, DOI 10.1534/genetics.106.061978; Nakahara Y, 2009, DEV COMP IMMUNOL, V33, P439, DOI 10.1016/j.dci.2008.09.005; Olofsson B, 2005, DEV BIOL, V279, P233, DOI 10.1016/j.ydbio.2004.12.020; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; RIZKI MOHAMMED TAHIR MIRZA, 1957, J MORPH, V100, P437, DOI 10.1002/jmor.1051000303; RIZKI MTM, 1959, J BIOPHYS BIOCHEM CY, V5, P235, DOI 10.1083/jcb.5.2.235; RIZKI TM, 1980, EXPERIENTIA, V36, P1223, DOI 10.1007/BF01976142; ROEHRBORN G, 1961, EXPERIENTIA, V17, P507; SAMAKOVLIS C, 1990, EMBO J, V9, P2969, DOI 10.1002/j.1460-2075.1990.tb07489.x; Schmid A, 2008, NAT NEUROSCI, V11, P659, DOI 10.1038/nn.2122; SHRESTHA R, 1982, DEV GROWTH DIFFER, V24, P83; Sinenko SA, 2004, ONCOGENE, V23, P9120, DOI 10.1038/sj.onc.1208156; Sorrentino RP, 2002, DEV BIOL, V243, P65, DOI 10.1006/dbio.2001.0542; Stofanko M, 2008, GENETICS, V180, P253, DOI 10.1534/genetics.108.089094; Stramer B, 2005, J CELL BIOL, V168, P567, DOI 10.1083/jcb.200405120; Tokusumi T, 2009, GENESIS, V47, P771, DOI 10.1002/dvg.20561; Ulvila J, 2011, APMIS, V119, P651, DOI 10.1111/j.1600-0463.2011.02792.x; Vilmos P, 2009, EUR J CELL BIOL, V88, P609, DOI 10.1016/j.ejcb.2009.05.006; Zettervall CJ, 2004, P NATL ACAD SCI USA, V101, P14192, DOI 10.1073/pnas.0403789101; Zsamboki J, 2013, CENT EUR J BIOL, V8, P633, DOI 10.2478/s11535-013-0183-4	42	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98191	10.1371/journal.pone.0098191	http://dx.doi.org/10.1371/journal.pone.0098191			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892745	Green Submitted, Green Published, gold			2022-12-27	WOS:000336911400039
J	Gredzens, C; Marsh, H; Fuentes, MMPB; Limpus, CJ; Shimada, T; Hamann, M				Gredzens, Christian; Marsh, Helene; Fuentes, Mariana M. P. B.; Limpus, Colin J.; Shimada, Takahiro; Hamann, Mark			Satellite Tracking of Sympatric Marine Megafauna Can Inform the Biological Basis for Species Co-Management	PLOS ONE			English	Article							GREAT-BARRIER-REEF; PROTECTED AREA DESIGN; HOME-RANGE; CHELONIA-MYDAS; GREEN TURTLES; RESERVE DESIGN; TORRES STRAIT; FORAGING AREA; DUGONG-DUGON; SAMPLE-SIZE	Context: Systematic conservation planning is increasingly used to identify priority areas for protection in marine systems. However, ecosystem-based approaches typically use density estimates as surrogates for animal presence and spatial modeling to identify areas for protection and may not take into account daily or seasonal movements of animals. Additionally, sympatric and inter-related species are often managed separately, which may not be cost-effective. This study aims to demonstrate an evidence-based method to inform the biological basis for co-management of two sympatric species, dugongs and green sea turtles. This approach can then be used in conservation planning to delineate areas to maximize species protection. Methodology/Results: Fast-acquisition satellite telemetry was used to track eleven dugongs and ten green turtles at two geographically distinct foraging locations in Queensland, Australia to evaluate the inter-and intra-species spatial relationships and assess the efficacy of existing protection zones. Home-range analysis and bathymetric modeling were used to determine spatial use and compared with existing protection areas using GIS. Dugong and green turtle home-ranges significantly overlapped in both locations. However, both species used different core areas and differences existed between regions in depth zone use and home-range size, especially for dugongs. Both species used existing protection areas in Shoalwater Bay, but only a single tracked dugong used the existing protection area in Torres Strait. Conclusions/Significance:: Fast-acquisition satellite telemetry can provide evidence-based information on individual animal movements to delineate relationships between dugongs and green turtles in regions where they co-occur. This information can be used to increase the efficacy of conservation planning and complement more broadly based survey information. These species also use similar habitats, making complimentary co-management possible, but important differences exist between locations making it essential to customize management. This methodology could be applied on a broader scale to include other sympatric and inter-related species.	[Gredzens, Christian; Marsh, Helene; Shimada, Takahiro; Hamann, Mark] James Cook Univ, Sch Earth & Environm Sci, Townsville, Qld 4811, Australia; [Gredzens, Christian] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Marsh, Helene; Hamann, Mark] James Cook Univ, Ctr Trop Water & Aquat Ecosyst Res, Townsville, Qld 4811, Australia; [Fuentes, Mariana M. P. B.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Limpus, Colin J.] Queensland Dept Environm & Heritage Protect, Aquat Threatened Species Unit, Brisbane, Qld, Australia	James Cook University; James Cook University; James Cook University; James Cook University	Gredzens, C (corresponding author), James Cook Univ, Sch Earth & Environm Sci, Townsville, Qld 4811, Australia.	Christian.Gredzens@my.jcu.edu.au	Shimada, Takahiro/F-9876-2017	Shimada, Takahiro/0000-0002-3364-5169; Hamann, Mark/0000-0003-4588-7955; Gredzens, Christian/0000-0002-9366-6623; Marsh, Helene/0000-0003-3492-4992	Australian National Environment Research Program scholarship; Australian Government's Australian Marine Mammal Centre; Marine and Tropical Science Research Facility and National Environment Research Program; Torres Strait Regional Authority; Great Barrier Reef Marine Park Authority; Queensland Department of Environment and Heritage Protection	Australian National Environment Research Program scholarship; Australian Government's Australian Marine Mammal Centre(Australian Government); Marine and Tropical Science Research Facility and National Environment Research Program; Torres Strait Regional Authority; Great Barrier Reef Marine Park Authority; Queensland Department of Environment and Heritage Protection	The Torres Strait field work was funded by an Australian National Environment Research Program scholarship. The project was funded by the Australian Government's Australian Marine Mammal Centre, Marine and Tropical Science Research Facility and National Environment Research Program, the Torres Strait Regional Authority, the Great Barrier Reef Marine Park Authority, the Queensland Department of Environment and Heritage Protection, and an anonymous donor with a passion for dugongs. The identity of the donor is not considered relevant to the editors or reviewers' assessment of the validity of the work. None of the research was funded, in whole or in part, by a tobacco company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre J, 2005, WILDLIFE RES, V32, P53, DOI 10.1071/WR04015; Bailey H, 2012, ECOL APPL, V22, P735, DOI 10.1890/11-0633; Beaman R., 2010, 25I1A MTSRF REEF RAI, P13; Beyer H. L, 2012, GEOSPATIAL MODELLING; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Boersma PD, 1999, ECOL ECON, V31, P287, DOI 10.1016/S0921-8009(99)00085-3; Bolten Alan B., 1999, P110; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Boyle SA, 2009, FOLIA PRIMATOL, V80, P33, DOI 10.1159/000201092; Chilvers BL, 2004, J EXP MAR BIOL ECOL, V304, P203, DOI 10.1016/j.jembe.2003.12.010; Christie P, 2003, FISHERIES, V28, P22; Coles R., 2003, WORLD ATLAS SEAGRASS, P119; Cuevas E, 2007, AMPHIBIA-REPTILIA, V28, P337, DOI 10.1163/156853807781374683; Daniell JJ, 2008, J GEOPHYS RES EARTH, V113; De Iongh HH, 1998, MAR ECOL-P S Z N I, V19, P179; Dobbs K., 2007, MARINE TURTLE DUGONG; Dobbs K, 2008, OCEAN COAST MANAGE, V51, P368, DOI 10.1016/j.ocecoaman.2007.08.001; Dobbs Kirstin, 2007, Pacific Conservation Biology, V13, P293; Dryden J, 2008, WILDLIFE RES, V35, P477, DOI 10.1071/WR07087; ESRI, 2011, ARCGIS DESKT V 10 0; Fernandes L, 2005, CONSERV BIOL, V19, P1733, DOI 10.1111/j.1523-1739.2005.00302.x; Fuentes MMPB, 2013, MAR MAMMAL SCI, V29, P159, DOI 10.1111/j.1748-7692.2011.00531.x; Gerber LR, 2003, ECOL APPL, V13, pS47; Gitzen RA, 2006, J WILDLIFE MANAGE, V70, P1334, DOI 10.2193/0022-541X(2006)70[1334:BSFFAO]2.0.CO;2; Grech A, 2008, AQUAT CONSERV, V18, P1127, DOI 10.1002/aqc.943; Grech A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017993; Hagihara R, 2014, MAR MAMMAL SCI, V30, P348, DOI 10.1111/mms.12041; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hays GC, 2002, MAR BIOL, V141, P985, DOI 10.1007/s00227-002-0885-7; Hazel J, 2013, MAR BIOL, V160, P617, DOI 10.1007/s00227-012-2117-0; Hazen EL, 2012, MAR ECOL PROG SER, V457, P221, DOI 10.3354/meps09857; Heithaus MR, 2002, MAR BIOL, V140, P229, DOI 10.1007/s00227-001-0712-6; Hemson G, 2005, J ANIM ECOL, V74, P455, DOI 10.1111/j.1365-2656.2005.00944.x; Hoelzel AR., 2009, MARINE MAMMAL BIOL E; Hooker SK, 2004, BIOSCIENCE, V54, P27, DOI 10.1641/0006-3568(2004)054[0027:MRAATF]2.0.CO;2; Horne JS, 2006, J WILDLIFE MANAGE, V70, P641, DOI 10.2193/0022-541X(2006)70[641:LCVLSC]2.0.CO;2; IUCN, 2012, IUCN RED LIST THREAT; Lanyon Janet M., 2006, Aquatic Mammals, V32, P196, DOI 10.1578/AM.32.2.2006.196; Lee KA, 2014, AQUAT CONSERV; Limpus C.J., 1978, EXPLORATION N AUSTR, P187; LIMPUS CJ, 1992, WILDLIFE RES, V19, P347, DOI 10.1071/WR9920347; Limpus Colin J., 2003, Memoirs of the Queensland Museum, V49, P349; Long BG, 1997, TORRES STRAIT REEF R; Lutz P.L., 1997, BIOL SEA TURTLES; Lynch TP, 2013, ENVIRON MANAGE, V52, P1341, DOI 10.1007/s00267-013-0174-x; Maiorano L, 2009, ICES J MAR SCI, V66, P137, DOI 10.1093/icesjms/fsn148; MARSH H, 1990, AUST WILDLIFE RES, V17, P83; Marsh H, 2000, MAR MAMMAL SCI, V16, P684, DOI 10.1111/j.1748-7692.2000.tb00965.x; MARSH H, 1981, BIOL CONSERV, V19, P255, DOI 10.1016/0006-3207(81)90002-1; Marsh H., 2011, ECOLOGY CONSERVATION, DOI DOI 10.1017/CBO9781139013277; Marsh H., 2011, AERIAL SURVEY TORRES; McKenzie L, 2010, QUEENSLAND SEAGRASSE; NIETSCHMANN B, 1981, NAT HIST, V90, P54; O'Neill P, 2009, STATE ENV REPORT SHO, P180; Parnell PE, 2006, ECOL APPL, V16, P945, DOI 10.1890/1051-0761(2006)016[0945:MRDOSH]2.0.CO;2; Pendoley KL, 2014, MAR BIOL, V161, P1455, DOI 10.1007/s00227-014-2433-7; Poiner IR, 1996, SEAGRASSES; Preen A., 1992, THESIS J COOK U TOWN; Pressey RL, 2004, CONSERV BIOL, V18, P1677, DOI 10.1111/j.1523-1739.2004.00434.x; R Core Team, 2012, R LANG ENV STAT COMP; Rasheed MA, 2008, CONT SHELF RES, V28, P2292, DOI 10.1016/j.csr.2008.03.026; Roberts C.M., 2001, CONSERV PRACT, V2, P10, DOI [DOI 10.1111/J.1526-4629.2001.TB00012.X, 10.1111/j.1526-4629.2001.tb00012.x]; ROBERTS CM, 2006, ROADMAP RECOVERY GLO; Rondinini C, 2006, ECOL LETT, V9, P1136, DOI 10.1111/j.1461-0248.2006.00970.x; Schofield G, 2013, DIVERS DISTRIB, V19, P834, DOI 10.1111/ddi.12077; Scott R, 2012, GLOBAL ECOL BIOGEOGR, V21, P1053, DOI 10.1111/j.1466-8238.2011.00757.x; Seaman DE, 1999, J WILDLIFE MANAGE, V63, P739, DOI 10.2307/3802664; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Seminoff JA, 2002, MAR ECOL PROG SER, V242, P253, DOI 10.3354/meps242253; Sheppard JK, 2006, J EXP MAR BIOL ECOL, V334, P64, DOI 10.1016/j.jembe.2006.01.011; Sheppard JK, 2010, MAR MAMMAL SCI, V26, P855, DOI 10.1111/j.1748-7692.2010.00374.x; Sheppard JK, 2009, J WILDLIFE MANAGE, V73, P45, DOI 10.2193/2007-468; Shimada T, 2012, MAR ECOL PROG SER, V457, P171, DOI 10.3354/meps09747; Silverman B. W., 1986, MONOGRAPHS STAT APPL, P176; Taylor H. A, 2010, TORRES STRAITS DUGON; Telonics, 2012, GEN4 GPS SYST MAN; Thompson PM, 2000, CONSERV BIOL, V14, P1253, DOI 10.1046/j.1523-1739.2000.00099-410.x; Zbinden JA, 2008, MAR BIOL, V153, P899, DOI 10.1007/s00227-007-0862-2; [No title captured]	79	40	40	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98944	10.1371/journal.pone.0098944	http://dx.doi.org/10.1371/journal.pone.0098944			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893163	gold, Green Accepted, Green Published			2022-12-27	WOS:000336911400113
J	Rich, ME; deCardenas, EJ; Lee, HJ; Caldwell, HK				Rich, Megan E.; deCardenas, Emily J.; Lee, Heon-Jin; Caldwell, Heather K.			Impairments in the Initiation of Maternal Behavior in Oxytocin Receptor Knockout Mice	PLOS ONE			English	Article							EDINBURGH-POSTNATAL-DEPRESSION; BRAIN OXYTOCIN; SOMATOSENSORY DETERMINANTS; PERIAQUEDUCTAL GRAY; POSTPARTUM PERIOD; NURSING BEHAVIOR; GENE-EXPRESSION; VASOPRESSIN 1A; OESTROUS CYCLE; LACTATING RATS	Oxytocin (Oxt) acting through its single receptor subtype, the Oxtr, is important for the coordination of physiology and behavior associated with parturition and maternal care. Knockout mouse models have been helpful in exploring the contributions of Oxt to maternal behavior, including total body Oxt knockout (Oxt -/-) mice, forebrain conditional Oxtr knockout (Oxtr FB/FB) mice, and total body Oxtr knockout (Oxtr -/-) mice. Since Oxtr -/- mice are unable to lactate, maternal behavior has only been examined in virgin females, or in dams within a few hours of parturition, and there have been no studies that have examined their anxiety-like and depression-like behavior following parturition. To improve our understanding of how the absence of Oxt signaling affects maternal behavior, mood and anxiety, we designed a study using Oxtr -/- mice that separated nursing behavior from other aspects of maternal care, such as licking and grooming by thelectomizing (i.e. removing the nipples) of Oxtr +/+ mice and sham-thelectomizing Oxtr -/- mice, and pairing both genotypes with a wet nurse. We then measured pup abandonment, maternal behavior, and postpartum anxiety-like and depression-like behaviors. We hypothesized that genetic disruption of the Oxtr would impact maternal care, mood and anxiety. Specifically, we predicted that Oxtr -/- dams would have impaired maternal care and increased anxiety-like and depression-like behaviors in the postpartum period. We found that Oxtr -/- dams had significantly higher levels of pup abandonment compared to controls, which is consistent with previous work in Oxtr FB/FB mice. Interestingly, Oxtr -/- dams that initiated maternal care did not differ from wildtype controls in measures of maternal behavior. We also did not find any evidence of altered anxiety-like or depressive-like behavior in the postpartum period of Oxtr -/- dams. Thus, our data suggest that Oxt lowers the threshold for the initiation of maternal behavior.	[Rich, Megan E.; deCardenas, Emily J.; Caldwell, Heather K.] Kent State Univ, Dept Biol Sci, Neuroendocrinol & Behav Lab, Kent, OH 44242 USA; [Rich, Megan E.; Caldwell, Heather K.] Kent State Univ, Sch Biomed Sci, Kent, OH 44242 USA; [Lee, Heon-Jin] Kyungpook Natl Univ, Sch Dent, Dept Oral Microbiol, Taegu, South Korea; [Lee, Heon-Jin] Kyungpook Natl Univ, Brain Sci & Engn Inst, Taegu, South Korea	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Kyungpook National University; Kyungpook National University	Caldwell, HK (corresponding author), Kent State Univ, Dept Biol Sci, Neuroendocrinol & Behav Lab, Kent, OH 44242 USA.	hcaldwel@kent.edu		Lee, Heon-Jin/0000-0002-1911-5014; Caldwell, Heather/0000-0002-2172-3860	Kent State Department of Biological Sciences	Kent State Department of Biological Sciences	The research was funded by the Kent State Department of Biological Sciences. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bale TL, 1995, ADV EXP MED BIOL, V395, P269; Bale TL, 2001, J NEUROSCI, V21, P2546, DOI 10.1523/JNEUROSCI.21-07-02546.2001; Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; Bealer SL, 2006, AM J PHYSIOL-REG I, V291, pR53, DOI 10.1152/ajpregu.00766.2005; Bergant AM, 1999, J PSYCHOSOM RES, V46, P391, DOI 10.1016/S0022-3999(98)00116-0; Bifulco A, 2004, BRIT J PSYCHIAT, V184, pS31, DOI 10.1192/bjp.184.46.s31; Blanks AM, 2003, BJOG-INT J OBSTET GY, V110, P46, DOI 10.1016/S1470-0328(03)00024-7; Blume A, 2008, EUR J NEUROSCI, V27, P1947, DOI 10.1111/j.1460-9568.2008.06184.x; Bosch OJ, 2005, J NEUROSCI, V25, P6807, DOI 10.1523/JNEUROSCI.1342-05.2005; Bosch OJ, 2008, P NATL ACAD SCI USA, V105, P17139, DOI 10.1073/pnas.0807412105; Bosch OJ, 2012, HORM BEHAV, V61, P293, DOI 10.1016/j.yhbeh.2011.11.002; BROIDA J, 1982, BEHAV NEURAL BIOL, V35, P76, DOI 10.1016/S0163-1047(82)91318-8; Caldwell HK, 2006, NEUROPEPTIDES, V40, P325, DOI 10.1016/j.npep.2006.08.001; Caldwell HK, 2012, ADV EXP MED BIOL, V739, P187, DOI 10.1007/978-1-4614-1704-0_12; Caldwell HK, 2010, HORM BEHAV, V58, P257, DOI 10.1016/j.yhbeh.2010.03.008; CALDWELL JD, 1987, NEUROENDOCRINOLOGY, V46, P39, DOI 10.1159/000124794; Champagne F, 2001, P NATL ACAD SCI USA, V98, P12736, DOI 10.1073/pnas.221224598; Dhakar MB, 2012, HORM BEHAV; FAHRBACH SE, 1985, NEUROENDOCRINOLOGY, V40, P526, DOI 10.1159/000124125; Feijo L, 2006, INFANT BEHAV DEV, V29, P476, DOI 10.1016/j.infbeh.2006.02.003; Feldman R, 2007, PSYCHOL SCI, V18, P965, DOI 10.1111/j.1467-9280.2007.02010.x; Francis DD, 2000, J NEUROENDOCRINOL, V12, P1145, DOI 10.1046/j.1365-2826.2000.00599.x; Heinrichs M, 2008, PROG BRAIN RES, V170, P337, DOI 10.1016/S0079-6123(08)00428-7; Heron J, 2004, J AFFECT DISORDERS, V80, P65, DOI 10.1016/j.jad.2003.08.004; INSEL TR, 1986, NEUROENDOCRINOLOGY, V44, P515, DOI 10.1159/000124694; INSEL TR, 1992, PSYCHONEUROENDOCRINO, V17, P3, DOI 10.1016/0306-4530(92)90073-G; INSEL TR, 1989, PHYSIOL BEHAV, V45, P1033, DOI 10.1016/0031-9384(89)90234-5; JONES SE, 1987, BEHAV GENET, V17, P87, DOI 10.1007/BF01066013; KENDRICK KM, 1992, ANN NY ACAD SCI, V652, P102, DOI 10.1111/j.1749-6632.1992.tb34349.x; KENDRICK KM, 1992, BRAIN RES, V569, P199, DOI 10.1016/0006-8993(92)90631-I; KENDRICK KM, 1987, NEUROENDOCRINOLOGY, V46, P56, DOI 10.1159/000124796; Kimura T, 2006, TXB PERINATAL MED, P619; LANDGRAF R, 1992, ANN NY ACAD SCI, V652, P326, DOI 10.1111/j.1749-6632.1992.tb34364.x; Lee HJ, 2008, ENDOCRINOLOGY, V149, P3256, DOI 10.1210/en.2007-1710; LINCOLN DW, 1982, J REPROD FERTIL, V65, P571, DOI 10.1530/jrf.0.0650571; Lonstein JS, 2007, FRONT NEUROENDOCRIN, V28, P115, DOI 10.1016/j.yfrne.2007.05.002; Lonstein JS, 2005, HORM BEHAV, V47, P241, DOI 10.1016/j.yhbeh.2004.11.001; Lonstein JS, 1997, J NEUROSCI, V17, P3364; Lonstein JS, 1997, HORM BEHAV, V32, P155, DOI 10.1006/hbeh.1997.1416; Lonstein JS, 1999, HORM BEHAV, V36, P242, DOI 10.1006/hbeh.1999.1544; Lyons-Ruth K, 1986, New Dir Child Dev, P61; Macbeth AH, 2010, BEHAV NEUROSCI, V124, P677, DOI 10.1037/a0020799; MAESTRIPIERI D, 1991, J COMP PSYCHOL, V105, P295, DOI 10.1037/0735-7036.105.3.295; MANNING M, 1989, J MED CHEM, V32, P382, DOI 10.1021/jm00122a016; MCCARTHY MM, 1990, HORM BEHAV, V24, P365, DOI 10.1016/0018-506X(90)90015-P; Meddle SL, 2007, ENDOCRINOLOGY, V148, P5095, DOI 10.1210/en.2007-0615; MEZEY E, 1991, ENDOCRINOLOGY, V129, P1814, DOI 10.1210/endo-129-4-1814; MOOS F, 1989, EXP BRAIN RES, V76, P593, DOI 10.1007/BF00248916; Nephew BC, 2009, BEHAV NEUROSCI, V123, P949, DOI 10.1037/a0016734; NEUMANN I, 1993, NEUROSCIENCE, V53, P65, DOI 10.1016/0306-4522(93)90285-N; NEUMANN I, 1989, J NEUROENDOCRINOL, V1, P305, DOI 10.1111/j.1365-2826.1989.tb00120.x; Neumann ID, 2000, NEUROSCIENCE, V95, P567; Nishimori K, 1996, P NATL ACAD SCI USA, V93, P11699, DOI 10.1073/pnas.93.21.11699; NUMAN M, 1994, ACTA PAEDIATR, V83, P19, DOI 10.1111/j.1651-2227.1994.tb13261.x; NUMAN M, 1985, PHYSIOL BEHAV, V35, P417, DOI 10.1016/0031-9384(85)90318-X; PEDERSEN CA, 1979, P NATL ACAD SCI USA, V76, P6661, DOI 10.1073/pnas.76.12.6661; PEDERSEN CA, 1985, NEUROPEPTIDES, V6, P175, DOI 10.1016/0143-4179(85)90108-8; Pedersen CA, 2006, GENES BRAIN BEHAV, V5, P274, DOI 10.1111/j.1601-183X.2005.00162.x; Pedersen CA, 1997, ANN NY ACAD SCI, V807, P126, DOI 10.1111/j.1749-6632.1997.tb51916.x; PEDERSEN CA, 1982, SCIENCE, V216, P648, DOI 10.1126/science.7071605; Pedersen CA, 2003, PHYSIOL BEHAV, V80, P233, DOI 10.1016/j.physbeh.2003.07.011; Ragnauth AK, 2004, NEUROENDOCRINOLOGY, V80, P92, DOI 10.1159/000081844; Ring RH, 2006, PSYCHOPHARMACOLOGY, V185, P218, DOI 10.1007/s00213-005-0293-z; Ross LE, 2004, ACTA PSYCHIAT SCAND, V109, P457, DOI 10.1111/j.1600-0047.2004.00296.x; Skrundz M, 2011, NEUROPSYCHOPHARMACOL, V36, P1886, DOI 10.1038/npp.2011.74; STERN JM, 1990, PHYSIOL BEHAV, V47, P993, DOI 10.1016/0031-9384(90)90026-Z; STERN JM, 1992, PSYCHOBIOLOGY, V20, P71; Stuart S, 1998, J NERV MENT DIS, V186, P420, DOI 10.1097/00005053-199807000-00006; Takayanagi Y, 2005, P NATL ACAD SCI USA, V102, P16096, DOI 10.1073/pnas.0505312102; Teissedre F, 2004, ENCEPHALE, V30, P376; Teissedre F, 2004, CAN J PSYCHIAT, V49, P51, DOI 10.1177/070674370404900108; VANLEENGOED E, 1987, J ENDOCRINOL, V112, P275, DOI 10.1677/joe.0.1120275; VANTOL HHM, 1988, ENDOCRINOLOGY, V122, P945, DOI 10.1210/endo-122-3-945; Wersinger SR, 2007, GENES BRAIN BEHAV, V6, P540, DOI 10.1111/j.1601-183X.2006.00281.x; WHITTEN WK, 1956, J ENDOCRINOL, V13, P399, DOI 10.1677/joe.0.0130399; WHITTEN WK, 1958, J ENDOCRINOL, V17, P307, DOI 10.1677/joe.0.0170307; Windle RJ, 1997, ENDOCRINOLOGY, V138, P2829, DOI 10.1210/en.138.7.2829; Young LJ, 1997, J NEUROENDOCRINOL, V9, P859, DOI 10.1046/j.1365-2826.1997.00654.x; Young WS, 1996, J NEUROENDOCRINOL, V8, P847, DOI 10.1046/j.1365-2826.1996.05266.x; ZINGG HH, 1988, MOL BRAIN RES, V4, P1, DOI 10.1016/0169-328X(88)90011-3	81	60	60	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98839	10.1371/journal.pone.0098839	http://dx.doi.org/10.1371/journal.pone.0098839			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892749	Green Submitted, Green Published, gold			2022-12-27	WOS:000336911400099
J	Wang, YY; Hu, CS; Ming, H; Oenema, O; Schaefer, DA; Dong, WX; Zhang, YM; Li, XX				Wang, Yuying; Hu, Chunsheng; Ming, Hua; Oenema, Oene; Schaefer, Douglas A.; Dong, Wenxu; Zhang, Yuming; Li, Xiaoxin			Methane, Carbon Dioxide and Nitrous Oxide Fluxes in Soil Profile under a Winter Wheat-Summer Maize Rotation in the North China Plain	PLOS ONE			English	Article							CO2 EFFLUX; GAS EMISSIONS; N2O FLUXES; CH4; RESPIRATION; MITIGATION; DIFFUSION; WATER; TEMPERATURE; TRANSPORT	The production and consumption of the greenhouse gases (GHGs) methane (CH4), carbon dioxide (CO2) and nitrous oxide (N2O) in soil profile are poorly understood. This work sought to quantify the GHG production and consumption at seven depths (0-30, 30-60, 60-90, 90-150, 150-200, 200-250 and 250-300 cm) in a long-term field experiment with a winter wheat-summer maize rotation system, and four N application rates (0; 200; 400 and 600 kg N ha(-1) year(-1)) in the North China Plain. The gas samples were taken twice a week and analyzed by gas chromatography. GHG production and consumption in soil layers were inferred using Fick's law. Results showed nitrogen application significantly increased N2O fluxes in soil down to 90 cm but did not affect CH4 and CO2 fluxes. Soil moisture played an important role in soil profile GHG fluxes; both CH4 consumption and CO2 fluxes in and from soil tended to decrease with increasing soil water filled pore space (WFPS). The top 0-60 cm of soil was a sink of atmospheric CH4, and a source of both CO2 and N2O, more than 90% of the annual cumulative GHG fluxes originated at depths shallower than 90 cm; the subsoil (>90 cm) was not a major source or sink of GHG, rather it acted as a 'reservoir'. This study provides quantitative evidence for the production and consumption of CH4, CO2 and N2O in the soil profile.	[Wang, Yuying; Hu, Chunsheng; Ming, Hua; Dong, Wenxu; Zhang, Yuming; Li, Xiaoxin] Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Agr Resources Res, Key Lab Agr Water Resources, Shijiazhuang, Hebei, Peoples R China; [Oenema, Oene] Wageningen Univ, Dept Soil Qual, Alterra, Wageningen, Netherlands; [Schaefer, Douglas A.] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Menglun, Yunnan, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Wageningen University & Research; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS	Hu, CS (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Agr Resources Res, Key Lab Agr Water Resources, Shijiazhuang, Hebei, Peoples R China.	cshu@sjziam.ac.cn			Strategic Priority Research Program of Chinese Academy of Sciences [XDA0505050202, XDA05050601]; National Science & Technology Pillar Program [2012BAD14B07-5]; National Basic Research Program of China [2010CB833501]; National Natural Science Foundation of China [30970534]; Main Direction Program of Knowledge Innovation of Chinese Academy of Sciences [KSCX2-EW-J-5]	Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences); National Science & Technology Pillar Program; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Main Direction Program of Knowledge Innovation of Chinese Academy of Sciences(Chinese Academy of Sciences)	This research is supported by the "Strategic Priority Research Program of Chinese Academy of Sciences" (Grant No. XDA0505050202 and XDA05050601) and the "National Science & Technology Pillar Program" (Grant No. 2012BAD14B07-5). It is also supported by the "National Basic Research Program of China" (Grant No. 2010CB833501); the "National Natural Science Foundation of China" (Grant No. 30970534) and the "Main Direction Program of Knowledge Innovation of Chinese Academy of Sciences" (Grant No. KSCX2-EW-J-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajracharya RM, 2000, SOIL SCI SOC AM J, V64, P694, DOI 10.2136/sssaj2000.642694x; Banger K, 2012, GLOBAL CHANGE BIOL, V18, P3259, DOI 10.1111/j.1365-2486.2012.02762.x; Borken W, 2009, GLOBAL CHANGE BIOL, V15, P808, DOI 10.1111/j.1365-2486.2008.01681.x; BOWDEN WB, 1986, SCIENCE, V233, P867, DOI 10.1126/science.233.4766.867; Campbell GS, 1985, SOIL SCIENCE SOCIETY; Chu H, 2004, SOIL SCI PLANT NUTR, V50, P287, DOI 10.1080/00380768.2004.10408480; Clough TJ, 2004, SOIL SCI SOC AM J, V68, P1600, DOI 10.2136/sssaj2004.1600; Clough TJ, 2003, AUST J SOIL RES, V41, P439, DOI 10.1071/SR02079; DAVIDSON EA, 1992, SOIL SCI SOC AM J, V56, P95, DOI 10.2136/sssaj1992.03615995005600010015x; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Denef K, 2001, SOIL BIOL BIOCHEM, V33, P1599, DOI 10.1016/S0038-0717(01)00076-1; Ding WX, 2013, SCI TOTAL ENVIRON, V465, P115, DOI 10.1016/j.scitotenv.2012.11.020; Dobbie KE, 2003, GLOBAL CHANGE BIOL, V9, P204, DOI 10.1046/j.1365-2486.2003.00563.x; Fang C, 2001, SOIL BIOL BIOCHEM, V33, P155, DOI 10.1016/S0038-0717(00)00125-5; Fang YT, 2009, PLANT SOIL, V319, P37, DOI 10.1007/s11104-008-9847-2; Fierer N, 2005, ECOSYSTEMS, V8, P412, DOI 10.1007/s10021-003-0151-y; Flessa H, 2000, J ENVIRON QUAL, V29, P262, DOI 10.2134/jeq2000.00472425002900010033x; Gebert J, 2011, WASTE MANAGE, V31, P987, DOI 10.1016/j.wasman.2010.10.008; Gee G.W., 1986, METHODS SOIL ANAL PA, P383; GILLILAND ER, 1974, IND ENG CHEM FUND, V13, P95, DOI 10.1021/i160050a001; Grandy AS, 2006, GLOBAL CHANGE BIOL, V12, P1507, DOI 10.1111/j.1365-2486.2006.01166.x; Guo JP, 2007, AGR FOREST METEOROL, V142, P270, DOI 10.1016/j.agrformet.2006.03.029; Jassal RS, 2010, GEODERMA, V157, P118, DOI 10.1016/j.geoderma.2010.04.002; Jassal RS, 2004, AGR FOREST METEOROL, V124, P219, DOI 10.1016/j.agrformet.2004.01.013; Jury WA, 1991, SOIL PHYSICS; Kelting DL, 1998, SOIL BIOL BIOCHEM, V30, P961, DOI 10.1016/S0038-0717(97)00186-7; Kim Y, 2007, TELLUS B, V59, P223, DOI 10.1111/j.1600-0889.2006.00233.x; KOSCHORRECK M, 1993, GLOBAL BIOGEOCHEM CY, V7, P109, DOI 10.1029/92GB02814; Kravchenko I, 2002, SOIL BIOL BIOCHEM, V34, P669, DOI 10.1016/S0038-0717(01)00232-2; Li XX, 2007, AGR WATER MANAGE, V89, P137, DOI 10.1016/j.agwat.2006.12.012; MARSHALL TJ, 1959, J SOIL SCI, V10, P79, DOI 10.1111/j.1365-2389.1959.tb00667.x; MILLINGTON R, 1961, T FARADAY SOC, V57, P1200, DOI 10.1039/tf9615701200; Reth S., 2008, FOCUS, V8, P129, DOI DOI 10.1007/S11267-007-9165-3; Rodhe L, 2006, SOIL USE MANAGE, V22, P229, DOI 10.1111/j.1475-2743.2006.00043.x; Rolston D.E., 1986, METHODS SOIL ANAL 1, P1103, DOI DOI 10.2136/SSSABOOKSER5.1.2ED.C47; SALLAM A, 1984, SOIL SCI SOC AM J, V48, P3, DOI 10.2136/sssaj1984.03615995004800010001x; Sanz-Cobena A, 2014, SCI TOTAL ENVIRON, V466, P164, DOI 10.1016/j.scitotenv.2013.07.023; Sanz-Cobena A, 2012, AGR ECOSYST ENVIRON, V149, P64, DOI 10.1016/j.agee.2011.12.016; Sherlock RR, 2002, J ENVIRON QUAL, V31, P1491, DOI 10.2134/jeq2002.1491; Shrestha BM, 2004, NUTR CYCL AGROECOSYS, V68, P155, DOI 10.1023/B:FRES.0000019044.52811.11; Smith P, 2008, PHILOS T R SOC B, V363, P789, DOI 10.1098/rstb.2007.2184; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; STEUDLER PA, 1989, NATURE, V341, P314, DOI 10.1038/341314a0; Stiehl-Braun PA, 2011, SOIL BIOL BIOCHEM, V43, P1034, DOI 10.1016/j.soilbio.2011.01.020; Tang JW, 2003, AGR FOREST METEOROL, V118, P207, DOI 10.1016/S0168-1923(03)00112-6; Thomas G. W., 1996, Methods of soil analysis. Part 3 - chemical methods., P475; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084; Wang Y, 2010, PLANT SOIL ENVIRON, V56, P16, DOI 10.17221/144/2009-PSE; Wang YY, 2013, AGR ECOSYST ENVIRON, V164, P260, DOI 10.1016/j.agee.2012.10.004; Wu X, 2010, SOIL BIOL BIOCHEM, V42, P773, DOI 10.1016/j.soilbio.2010.01.013; Zhu B, 2009, SOIL SCI SOC AM J, V73, P1419, DOI 10.2136/sssaj2008.0259; Zhu H.J., 1992, SOIL GEOGRAPHY; Zou GY, 2001, SOIL ENV SCI, V10, P273	53	24	30	5	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98445	10.1371/journal.pone.0098445	http://dx.doi.org/10.1371/journal.pone.0098445			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892931	gold, Green Published, Green Submitted			2022-12-27	WOS:000336911400051
J	Cho, H; Noh, KH; Chung, JY; Takikita, M; Chung, EJ; Kim, BW; Hewitt, SM; Kim, TW; Kim, JH				Cho, Hanbyoul; Noh, Kyung Hee; Chung, Joon-Yong; Takikita, Mikiko; Chung, Eun Joo; Kim, Bo Wook; Hewitt, Stephen M.; Kim, Tae Woo; Kim, Jae-Hoon			Synaptonemal Complex Protein 3 Is a Prognostic Marker in Cervical Cancer	PLOS ONE			English	Article							CELL LUNG-CANCER; ACTIVATION; GENE; EXPRESSION; RESISTANCE; CHEMOTHERAPY; SURVIVAL; PATHWAY; FAMILY; DEATH	Synaptonemal complex protein 3 (SCP3), a member of Cor1 family, is up-regulated in various cancer cells; however, its oncogenic potential and clinical significance has not yet been characterized. In the present study, we investigated the oncogenic role of SCP3 and its relationship with phosphorylated AKT (pAKT) in cervical neoplasias. The functional role of SCP3 expression was investigated by overexpression or knockdown of SCP3 in murine cell line NIH3T3 and human cervical cancer cell lines CUMC6, SiHa, CaSki, and HeLa both in vitro and in vivo. Furthermore, we examined SCP3 expression in tumor specimens from 181 cervical cancer and 400 cervical intraepithelial neoplasia (CIN) patients by immunohistochemistry and analyzed the correlation between SCP3 expression and clinicopathologic factors or survival. Overexpression of SCP3 promoted AKT-mediated tumorigenesis both in vitro and in vivo. Functional studies using NIH3T3 cells demonstrated that the C-terminal region of human SCP3 is important for AKT activation and its oncogenic potential. High expression of SCP3 was significantly associated with tumor stage (P = 0.002) and tumor grade (P<0.001), while SCP3 expression was positively associated with pAKT protein level in cervical neoplasias. Survival times for patients with cervical cancer overexpressing both SCP3 and pAKT (median, 134.0 months, n = 68) were significantly shorter than for patients with low expression of either SCP3 or pAKT (161.5 months, n = 108) as determined by multivariate analysis (P = 0.020). Our findings suggest that SCP3 plays an important role in the progression of cervical cancer through the AKT signaling pathway, supporting the possibility that SCP3 may be a promising novel cancer target for cervical cancer therapy.	[Cho, Hanbyoul; Kim, Jae-Hoon] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Obstet & Gynecol, Seoul, South Korea; [Cho, Hanbyoul; Kim, Jae-Hoon] Yonsei Univ, Coll Med, Inst Womens Life Med Sci, Seoul, South Korea; [Noh, Kyung Hee; Kim, Tae Woo] Korea Univ, Grad Sch Med, Lab Infect & Immunol, Ansan, Gyeonggi Do, South Korea; [Noh, Kyung Hee; Kim, Tae Woo] Korea Univ, Coll Med, Dept Biochem, Seoul 136705, South Korea; [Chung, Joon-Yong; Takikita, Mikiko; Kim, Bo Wook; Hewitt, Stephen M.] NCI, Tissue Array Res Program, Pathol Lab, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Chung, Eun Joo] NCI, Radiat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kim, TW (corresponding author), Korea Univ, Grad Sch Med, Lab Infect & Immunol, Ansan, Gyeonggi Do, South Korea.	twkim0421@korea.com; jaehoonkim@yuhs.ac	Chung, Joon-Yong/J-9177-2017	Chung, Joon-Yong/0000-0001-5041-5982; Hewitt, Stephen/0000-0001-8283-1788; Cho, Hanbyoul/0000-0002-6177-1648; Jae-Hoon, Kim/0000-0001-6599-7065	National Research Foundation of Korea [2012R1A2A2A01007527, 2012R1A6A3A01010537, 2011-0005230, 2011-0010286, 2011-0007146]; Korea Healthcare Technology RD Project [A121387, A110057, A062260]; Yonsei University College of Medicine [3-2010-0072, 6-2011-0073, 6-2013-0106]; NIH, National Cancer Institute, Center for Cancer research; NATIONAL CANCER INSTITUTE [ZICBC010923] Funding Source: NIH RePORTER	National Research Foundation of Korea(National Research Foundation of Korea); Korea Healthcare Technology RD Project; Yonsei University College of Medicine(General Electric); NIH, National Cancer Institute, Center for Cancer research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the National Research Foundation of Korea (2012R1A2A2A01007527, 2012R1A6A3A01010537, 2011-0005230, 2011-0010286, and 2011-0007146), the Korea Healthcare Technology R&D Project (A121387, A110057 and A062260), and faculty research grants from Yonsei University College of Medicine (3-2010-0072, 6-2011-0073, and 6-2013-0106). This research was supported, in part, by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai SX, 2005, MOL CELL BIOL, V25, P1238, DOI 10.1128/MCB.25.4.1238-1257.2005; Bansal N, 2012, J GYNECOL ONCOL, V23, P35, DOI 10.3802/jgo.2012.23.1.35; Botelho RJ, 2001, BBA-GENE STRUCT EXPR, V1518, P294, DOI 10.1016/S0167-4781(01)00171-3; Brognard J, 2001, CANCER RES, V61, P3986; Chung JY, 2013, HUM PATHOL, V44, P472, DOI 10.1016/j.humpath.2012.06.018; Gliki G, 2002, CELL BIOL INT, V26, P751, DOI 10.1016/S1065-6995(02)90926-1; Goodwin Scott C, 2003, J Vasc Interv Radiol, V14, pS467; Huang WC, 2009, J FORMOS MED ASSOC, V108, P180, DOI 10.1016/S0929-6646(09)60051-6; Imai K, 2011, BRIT J CANCER, V104, P300, DOI 10.1038/sj.bjc.6606052; Kang TH, 2010, CANCER RES, V70, P3062, DOI 10.1158/0008-5472.CAN-09-3856; Kim D, 2005, FRONT BIOSCI-LANDMRK, V10, P975, DOI 10.2741/1592; Lim SH, 1999, BRIT J CANCER, V81, P1162, DOI 10.1038/sj.bjc.6690824; Miemeyer P, 2003, LEUKEMIA RES, V27, P655, DOI 10.1016/S0145-2126(02)00230-8; Noh KH, 2009, MOL THER, V17, P439, DOI 10.1038/mt.2008.255; Parmigiani RB, 2006, P NATL ACAD SCI USA, V103, P18066, DOI 10.1073/pnas.0608853103; Shulkla S, 2007, INT J CANCER, V121, P1424, DOI 10.1002/ijc.22862; Smith HA, 2011, CANCER RES, V71, P6785, DOI 10.1158/0008-5472.CAN-11-2127; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; West KA, 2002, DRUG RESIST UPDATE, V5, P234, DOI 10.1016/S1368-7646(02)00120-6; Yuan L, 2002, SCIENCE, V296, P1115, DOI 10.1126/science.1070594; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9	22	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98712	10.1371/journal.pone.0098712	http://dx.doi.org/10.1371/journal.pone.0098712			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905095	gold, Green Published, Green Submitted			2022-12-27	WOS:000341869000051
J	Coelho, L; Cardoso, SW; Amancio, RT; Moreira, RI; Campos, DP; Veloso, VG; Grinsztejn, B; Luz, PM				Coelho, Lara; Cardoso, Sandra Wagner; Amancio, Rodrigo Teixeira; Moreira, Ronaldo Ismerio; Campos, Dayse Pereira; Veloso, Valdilea Goncalves; Grinsztejn, Beatriz; Luz, Paula Mendes			Trends in AIDS-Defining Opportunistic Illnesses Incidence over 25 Years in Rio de Janeiro, Brazil	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; ISONIAZID PREVENTIVE THERAPY; HIV-INFECTED ADULTS; UNITED-STATES; EARLY MORTALITY; CLINICAL CARE; SOUTH-AFRICA; COHORT; TUBERCULOSIS	Objectives: To assess the temporal trends in incidence of AIDS-defining opportunistic illnesses in an urban cohort of a middle-income country. Methods: HIV infected patients aged >= 18 years at cohort entry were included in this analysis. We calculated incidence rates per 1000 persons-years of observation for the first opportunistic illness presented after cohort enrollment, from 1987 to 2012. Trends for overall and specific opportunistic illnesses were tested and incidence rate ratios for the most recent calendar period were calculated as the ratio between the incidence rate observed in the most recent period of the study (2009-2012) and the incidence rate observed in first period of the study (1987-1990). Results: Overall, 3378 patients were included in this analysis; of which 1119 (33%) patients presented an opportunistic illness during follow up. Incidence rates of all opportunistic illnesses decreased over time, and the overall opportunistic illness incidence rates fell from 295.4/1000 persons-years in 1987-1990 to 34.6/1000 persons-years in 2009-2012. Tuberculosis, esophageal candidiasis, cerebral toxoplasmosis and Pneumocystis jirovecii pneumonia were the most incident opportunistic illnesses in the cohort. Tuberculosis had the highest incidence rate in the study period. The peak in tuberculosis incidence occurred in 1991-1993 (80.8/1000 persons-years). Cerebral toxoplasmosis was the third most incident opportunistic illness in the study, with a peak of incidence of 43.6/1000 persons-year in 1987-1990. Conclusions: All opportunistic illnesses incidence rates decreased over the years but they still occur in an unacceptable frequency. Tuberculosis co-infection among HIV-infected persists as an important challenge for health care professionals and policy makers in our setting. Impressively high rates of cerebral toxoplasmosis were found suggesting that its incidence among HIV-infected is linked to the high prevalence of Toxoplasma gondii infection in the general population.	[Coelho, Lara; Cardoso, Sandra Wagner; Amancio, Rodrigo Teixeira; Moreira, Ronaldo Ismerio; Campos, Dayse Pereira; Veloso, Valdilea Goncalves; Grinsztejn, Beatriz; Luz, Paula Mendes] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz	Coelho, L (corresponding author), Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil.	lara.coelho@ipec.fiocruz.br	Cardoso, Sandra W/D-7965-2015	Cardoso, Sandra W/0000-0001-5230-0003; Luz, Paula/0000-0001-9746-719X	National Council of Technological and Scientific Development (CNPq); Research Funding Agency of the State of Rio de Janeiro (FAPERJ)	National Council of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Research Funding Agency of the State of Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	BG and PML acknowledge funding from the National Council of Technological and Scientific Development (CNPq) and the Research Funding Agency of the State of Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; [Anonymous], 2011, GUID INT TUB CAS FIN; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Brodt HR, 1997, AIDS, V11, P1731, DOI 10.1097/00002030-199714000-00010; Buchacz K, 2008, AIDS, V22, P1345, DOI 10.1097/QAD.0b013e328304b38b; Buchacz K, 2010, AIDS, V24, P1549, DOI 10.1097/QAD.0b013e32833a3967; CDC, 1992, MMWR RECOMM REP, V41; *CDC, 1991, MMWR-MORBID MORTAL W, V40, P27; CHAISSON RE, 1992, AM REV RESPIR DIS, V146, P285, DOI 10.1164/ajrccm/146.2.285; Charurat M, 2004, J WOMENS HEALTH, V13, P719, DOI 10.1089/jwh.2004.13.719; Coelho L, 2013, BRAZILIAN J INFECT D; Conde MB, 2009, J BRAS PNEUMOL, V35, P1018, DOI 10.1590/S1806-37132009001000011; Dubey JP, 2012, PARASITOLOGY, V139, P1375, DOI 10.1017/S0031182012000765; Durovni B, 2013, LANCET INFECT DIS, V13, P852, DOI 10.1016/S1473-3099(13)70187-7; Golub JE, 2009, AIDS, V23, P631, DOI 10.1097/QAD.0b013e328327964f; Grinsztejn B, 2014, LANCET INFE IN PRESS; Grinsztejn B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059768; Grinsztejn B, 2009, AIDS, V23, P2107, DOI 10.1097/QAD.0b013e32832ec494; Grinszten B, 2007, JAIDS-J ACQ IMM DEF, V45, P515, DOI 10.1097/QAI.0b013e3180decb6a; ISRAELSKI DM, 1993, J ACQ IMMUN DEF SYND, V6, P414; Kaplan JE, 2000, CLIN INFECT DIS, V30, pS5, DOI 10.1086/313843; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Ledergerber B, 1999, JAMA-J AM MED ASSOC, V282, P2220, DOI 10.1001/jama.282.23.2220; MATHEWS WC, 1994, ARCH PATHOL LAB MED, V118, P807; Mocroft A, 1999, J ACQ IMMUN DEF SYND, V21, P401; Mocroft A, 1998, ARCH INTERN MED, V158, P491, DOI 10.1001/archinte.158.5.491; Moreira RI, 2011, JAIDS-J ACQ IMM DEF, V57, pS171, DOI 10.1097/QAI.0b013e31821e9d59; Pacheco AG, 2009, JAIDS-J ACQ IMM DEF, V51, P624, DOI 10.1097/QAI.0b013e3181a4ecf5; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; PAPE JW, 1993, LANCET, V342, P268, DOI 10.1016/0140-6736(93)91817-6; Podlasin RB, 2006, INFECTION, V34, P196, DOI 10.1007/s15010-006-5030-y; Ribeiro S, 2013, ANTIVIRAL THERAPY; Rojanawiwat A, 2011, INT HEALTH, V3, P101, DOI 10.1016/j.inhe.2010.12.004; Sackoff JE, 2006, ANN INTERN MED, V145, P397, DOI 10.7326/0003-4819-145-6-200609190-00003; Sacktor N, 2001, NEUROLOGY, V56, P257, DOI 10.1212/WNL.56.2.257; San-Andres FJ, 2003, CLIN INFECT DIS, V36, P1177, DOI 10.1086/374358; Santoro-Lopes G, 2002, CLIN INFECT DIS, V34, P543, DOI 10.1086/338641; Schwarcz L, 2013, AIDS, V27, P597, DOI 10.1097/QAD.0b013e32835b0fa2; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wood R, 2005, S AFR J HIV MED, V2005, P11; World Health Organisation, 2007, WHO CAS DEF HIV SURV; Xavier GA, 2013, REV INST MED TROP SP, V55, P25, DOI 10.1590/S0036-46652013000100005; Yazdanpanah Y, 2001, INT J EPIDEMIOL, V30, P864, DOI 10.1093/ije/30.4.864	45	31	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98666	10.1371/journal.pone.0098666	http://dx.doi.org/10.1371/journal.pone.0098666			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901419	Green Published, gold, Green Submitted			2022-12-27	WOS:000336841400043
J	Evens, E; Lanham, M; Hart, C; Loolpapit, M; Oguma, I; Obiero, W				Evens, Emily; Lanham, Michele; Hart, Catherine; Loolpapit, Mores; Oguma, Isaac; Obiero, Walter			Identifying and Addressing Barriers to Uptake of Voluntary Medical Male Circumcision in Nyanza, Kenya among Men 18-35: A Qualitative Study	PLOS ONE			English	Article							HIV PREVENTION; RANDOMIZED-TRIAL; ACCEPTABILITY; PROVINCE; UGANDA; RAKAI	Background: Uptake of VMMC among adult men has been lower than desired in Nyanza, Kenya. Previous research has identified several barriers to uptake but qualitative exploration of barriers is limited and evidence-informed interventions have not been fully developed. This study was conducted in 2012 to 1) increase understanding of barriers to VMMC and 2) to inform VMMC rollout through the identification of evidence-informed interventions among adult men at high risk of HIV in Nyanza Province, Kenya. Methods: Focus groups (n = 8) and interviews were conducted with circumcised (n = 8) and uncircumcised men (n = 14) from the two districts in Nyanza, Kenya. Additional interviews were conducted with female partners (n = 20), health providers (n = 12), community leaders (n = 12) and employers (n = 12). Interview and focus group guides included questions about individual, interpersonal and societal barriers to VMMC uptake and ways to overcome them. Inductive thematic coding and analysis were conducted through a standard iterative process. Results: Two primary concerns with VMMC emerged 1) financial issues including missing work, losing income during the procedure and healing and family survival during the recovery period and 2) fear of pain during and after the procedure. Key interventions to address financial concerns included: a food or cash transfer, education on saving and employer-based benefits. Interventions to address concerns about pain included refining the content of demand creation and counseling messages about pain and improving the ways these messages are delivered. Conclusions: Men need accurate and detailed information on what to expect during and after VMMC regarding both pain and time away from work. This information should be incorporated into demand creation activities for men considering circumcision. Media content should frankly and correctly address these concerns. Study findings support scale up and/or further improvement of these ongoing educational programs and specifically targeting the demand creation period.	[Evens, Emily] FHI 360, Hlth Serv Res, Durham, NC 27713 USA; [Lanham, Michele; Hart, Catherine] FHI 360, Social & Behav Hlth Sci, Durham, NC USA; [Loolpapit, Mores] APHIAplus IMARISHA, Amref Hlth Africa, Nairobi, Kenya; [Oguma, Isaac] FHI 360, Kisumu, Kenya; [Obiero, Walter] Univ Illinois, Sch Publ Hlth, Chicago, IL USA; [Obiero, Walter] Nyanza Reprod Hlth Soc, Kisumu, Kenya	FHI 360; FHI 360; African Medical & Research Foundation (AMREF); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Evens, E (corresponding author), FHI 360, Hlth Serv Res, Durham, NC 27713 USA.	eevens@fhi360.org		Lanham, Michele/0000-0003-3012-5683	Bill & Melinda Gates Foundation under the Male Circumcision Consortium	Bill & Melinda Gates Foundation under the Male Circumcision Consortium	This work was funded by the Bill & Melinda Gates Foundation under the Male Circumcision Consortium. http://www.gatesfoundation.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, PLUSNEWS; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2002, AIDS CARE, V14, P27, DOI 10.1080/09540120220097919; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Barone MA, 2012, JAIDS-J ACQ IMM DEF, V60, pE82, DOI 10.1097/QAI.0b013e31824ea1f2; Barone MA, 2011, JAIDS-J ACQ IMM DEF, V57, pE7, DOI 10.1097/QAI.0b013e3182158967; Gray R, 2013, SEX TRANSM INFECT; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Guest G., 2008, HDB TEAM BASED QUALI; Guest G., 2011, APPL THEMAT ANAL; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hankins C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001127; Herman-Roloff A, 2010, ACCEPTABILITY MED MA; Herman-Roloff A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018299; Holsti O. R., 1969, CONTENT ANAL SOCIAL; IMPACT Research and Development Organization Nyanza Reproductive Health Society (NRHS) Male Circumcision Consoritum (MCC), 2010, VOL MED MAL IN PRESS; Infotrak Research and Consulting, 2010, REP BAS SURV SUPP DE; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; Kwena ZA, 2012, AJAR-AFR J AIDS RES, V11, P9, DOI 10.2989/16085906.2012.671267; Lanham M, 2014, INT C AIDS STIS AFR; Mattson CL, 2005, AIDS CARE, V17, P182, DOI 10.1080/09540120512331325671; MCLELLAN E, 2003, FIELD METHOD, V15, P63, DOI DOI 10.1177/1525822X02239573; Mutabazi V, 2012, JAIDS-J ACQ IMM DEF, V61, P49, DOI 10.1097/QAI.0b013e3182631d69; Mwandi Z, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001130; National AIDS and STI Control Programme Ministry of Helath K, 2013, KEN AIDS IND SURV 20; Odeny TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043832; Ssekubugu R, 2013, QUAL HEALTH RES, V23, P795, DOI 10.1177/1049732313482189; USAID/Kenya, 2010, CHANG CYCL; Westercamp M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015552; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; Westercamp N, 2010, MAL CIRC CONS DISS W	31	40	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98221	10.1371/journal.pone.0098221	http://dx.doi.org/10.1371/journal.pone.0098221			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4NF	24901226	Green Published, gold, Green Submitted			2022-12-27	WOS:000336841400020
J	Jing, LJ; Su, L; Ring, BZ				Jing, Lijun; Su, Li; Ring, Brian Z.			Ethnic Background and Genetic Variation in the Evaluation of Cancer Risk: A Systematic Review	PLOS ONE			English	Review							GENOME-WIDE ASSOCIATION; BREAST-CANCER; PROSTATE-CANCER; LUNG-CANCER; COLORECTAL-CANCER; POPULATION STRATIFICATION; HEPATOCELLULAR-CARCINOMA; RACIAL-DIFFERENCES; GASTRIC-CANCER; POLYMORPHISM	The clinical use of genetic variation in the evaluation of cancer risk is expanding, and thus understanding how determinants of cancer susceptibility identified in one population can be applied to another is of growing importance. However there is considerable debate on the relevance of ethnic background in clinical genetics, reflecting both the significance and complexity of genetic heritage. We address this via a systematic review of reported associations with cancer risk for 82 markers in 68 studies across six different cancer types, comparing association results between ethnic groups and examining linkage disequilibrium between risk alleles and nearby genetic loci. We find that the relevance of ethnic background depends on the question. If asked whether the association of variants with disease risk is conserved across ethnic boundaries, we find that the answer is yes, the majority of markers show insignificant variability in association with cancer risk across ethnic groups. However if the question is whether a significant association between a variant and cancer risk is likely to reproduce, the answer is no, most markers do not validate in an ethnic group other than the discovery cohort's ancestry. This lack of reproducibility is not attributable to studies being inadequately populated due to low allele frequency in other ethnic groups. Instead, differences in local genomic structure between ethnic groups are associated with the strength of association with cancer risk and therefore confound interpretation of the implied physiologic association tracked by the disease allele. This suggest that a biological association for cancer risk alleles may be broadly consistent across ethnic boundaries, but reproduction of a clinical study in another ethnic group is uncommon, in part due to confounding genomic architecture. As clinical studies are increasingly performed globally this has important implications for how cancer risk stratifiers should be studied and employed.	[Jing, Lijun; Ring, Brian Z.] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Inst Genom & Personalized Med, Wuhan 430074, Hubei, Peoples R China; [Su, Li] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Ring, BZ (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Inst Genom & Personalized Med, Wuhan 430074, Hubei, Peoples R China.	bzring@hust.edu.cn			Huazhong University of Science and Technology [0124170068]	Huazhong University of Science and Technology	This work was supported by research grants from Huazhong University of Science and Technology (0124170068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berndt SI, 2008, HUM MOL GENET, V17, P2665, DOI 10.1093/hmg/ddn166; Brawley OW, 2003, CANCER METAST REV, V22, P11, DOI 10.1023/A:1022244618834; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Chen B, 2012, MOL BIOL REP, V39, P1305, DOI 10.1007/s11033-011-0863-6; Chen B, 2011, CYTOKINE, V55, P266, DOI 10.1016/j.cyto.2011.04.008; Chen MB, 2011, MOL BIOL REP, V38, P4687, DOI 10.1007/s11033-010-0603-3; Chinegwundoh F, 2006, BJU INT, V98, P1216, DOI 10.1111/j.1464-410X.2006.06503.x; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; Cui R, 2011, GUT, V60, P799, DOI 10.1136/gut.2010.215947; Ding DP, 2011, BREAST CANCER RES TR, V129, P203, DOI 10.1007/s10549-011-1447-9; Dong J, 2010, J GASTROEN HEPATOL, V25, P1042, DOI 10.1111/j.1440-1746.2010.06293.x; Economopoulos KP, 2010, BREAST CANCER RES TR, V124, P293, DOI 10.1007/s10549-010-1097-3; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fang F, 2011, MED ONCOL, V28, P999, DOI 10.1007/s12032-010-9591-3; Fang F, 2010, MED ONCOL, V27, P1324, DOI 10.1007/s12032-009-9383-9; Fejerman L, 2008, PHARMACOGENOMICS, V9, P323, DOI 10.2217/14622416.9.3.323; Ferlay J, 2010, IARC CANCERBASE, V2; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Garte S, 1998, CARCINOGENESIS, V19, P1329, DOI 10.1093/carcin/19.8.1329; Geng J, 2009, UROLOGY, V74, P648, DOI 10.1016/j.urology.2009.02.046; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Glickman SW, 2009, NEW ENGL J MED, V360, P816, DOI 10.1056/NEJMsb0803929; Green VL, 2013, OBSTET GYN CLIN N AM, V40, P525, DOI 10.1016/j.ogc.2013.05.003; Gu DY, 2011, BREAST CANCER RES TR, V125, P489, DOI 10.1007/s10549-010-0991-z; Gu DY, 2010, BREAST CANCER RES TR, V122, P527, DOI 10.1007/s10549-009-0723-4; Gui XH, 2009, EUR J CANCER, V45, P2023, DOI 10.1016/j.ejca.2009.02.002; Haerian MS, 2011, J GASTROEN HEPATOL, V26, P1475, DOI 10.1111/j.1440-1746.2011.06831.x; Haiman CA, 2006, NEW ENGL J MED, V354, P333, DOI 10.1056/NEJMoa033250; He BS, 2012, MOL BIOL REP, V39, P3117, DOI 10.1007/s11033-011-1076-8; Hothorn T, 2008, J STAT SOFTW, V28, P1; Hu J, 2010, BREAST CANCER RES TR, V124, P779, DOI 10.1007/s10549-010-0892-1; Hu J, 2010, BREAST CANCER RES TR, V124, P425, DOI 10.1007/s10549-010-0841-z; Huang Q, 2011, J CANCER RES CLIN, V137, P1147, DOI 10.1007/s00432-011-0981-5; Huang YS, 2010, BREAST CANCER RES TR, V123, P863, DOI 10.1007/s10549-010-0796-0; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ioannidis JPA, 2004, NAT GENET, V36, P1312, DOI 10.1038/ng1474; Jiang Z, 2010, INT J COLORECTAL DIS, V25, P169, DOI 10.1007/s00384-009-0817-9; Jorde LB, 2004, NAT GENET, V36, pS28, DOI 10.1038/ng1435; Kaufman JS, 2001, AM J EPIDEMIOL, V154, P291, DOI 10.1093/aje/154.4.291; Keku T, 2002, CANCER EPIDEM BIOMAR, V11, P1611; Kheirandish P, 2011, BRIT J CANCER, V105, P481, DOI 10.1038/bjc.2011.273; Kolonel LN, 2004, NAT REV CANCER, V4, P519, DOI 10.1038/nrc1389; Kupfer SS, 2010, GASTROENTEROLOGY, V139, P1677, DOI 10.1053/j.gastro.2010.07.038; Lang TD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001228; Li Y, 2009, LUNG CANCER, V66, P15, DOI 10.1016/j.lungcan.2008.12.009; Lin ZH, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-145; Liu D, 2011, INT J COLORECTAL DIS, V26, P1099, DOI 10.1007/s00384-011-1198-4; Liu F, 2011, LIVER INT, V31, P804, DOI 10.1111/j.1478-3231.2011.02508.x; Liu F, 2010, ASIAN PAC J CANCER P, V11, P1257; Liu L, 2011, J CANCER RES CLIN, V137, P1027, DOI 10.1007/s00432-010-0966-9; Lu PH, 2011, BREAST CANCER RES TR, V125, P537, DOI 10.1007/s10549-010-1033-6; Lu S, 2011, BREAST CANCER RES TR, V125, P253, DOI 10.1007/s10549-010-0969-x; Ma XY, 2010, BREAST CANCER RES TR, V124, P453, DOI 10.1007/s10549-010-0843-x; Ma XY, 2010, BREAST CANCER RES TR, V122, P509, DOI 10.1007/s10549-009-0725-2; Ma YL, 2011, BREAST CANCER RES TR, V125, P237, DOI 10.1007/s10549-010-0965-1; Manica A, 2005, HUM GENET, V118, P366, DOI 10.1007/s00439-005-0039-3; Mao C, 2012, MOL BIOL REP, V39, P1113, DOI 10.1007/s11033-011-0839-6; Mao C, 2010, J CANCER RES CLIN, V136, P975, DOI 10.1007/s00432-009-0742-x; Mao C, 2010, BREAST CANCER RES TR, V121, P719, DOI 10.1007/s10549-009-0650-4; Mitchell G, 2006, CANCER RES, V66, P1866, DOI 10.1158/0008-5472.CAN-05-3368; Nock NL, 2011, CARCINOGENESIS, V32, P748, DOI 10.1093/carcin/bgr026; Ntais C, 2003, CANCER EPIDEM BIOMAR, V12, P120; Ntzani EE, 2012, HUM GENET, V131, P1057, DOI 10.1007/s00439-011-1124-4; O'Donovan PJ, 2010, CARCINOGENESIS, V31, P961, DOI 10.1093/carcin/bgq069; Ollberding NJ, 2011, INT J CANCER, V129, P1899, DOI 10.1002/ijc.25822; Pabalan N, 2010, BREAST CANCER RES TR, V124, P531, DOI 10.1007/s10549-010-0863-6; Parkin DM, 2004, ONCOGENE, V23, P6329, DOI 10.1038/sj.onc.1207726; Plon SE, 2011, GENET MED, V13, P148, DOI 10.1097/GIM.0b013e318207f564; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Qi XW, 2010, BREAST CANCER RES TR, V123, P499, DOI 10.1007/s10549-010-0773-7; Qian Qian, 2011, Zhongguo Fei Ai Za Zhi, V14, P205, DOI 10.3779/j.issn.1009-3419.2011.03.05; Qiu LX, 2010, BREAST CANCER RES TR, V124, P475, DOI 10.1007/s10549-010-0858-3; Qiu LX, 2010, BREAST CANCER RES TR, V123, P543, DOI 10.1007/s10549-010-0777-3; Qiu LX, 2010, BREAST CANCER RES TR, V123, P487, DOI 10.1007/s10549-010-0767-5; Qiu LX, 2010, BREAST CANCER RES TR, V122, P521, DOI 10.1007/s10549-009-0731-4; Qiu LX, 2010, BREAST CANCER RES TR, V122, P867, DOI 10.1007/s10549-010-0739-9; Rebbeck TR, 2005, CANCER EPIDEM BIOMAR, V14, P2467, DOI 10.1158/1055-9965.EPI-05-0649; Rennert G, 2007, NEW ENGL J MED, V357, P115, DOI 10.1056/NEJMoa070608; Robson M, 2010, HEMATOL ONCOL CLIN N, V24, P793, DOI 10.1016/j.hoc.2010.06.005; Rosenberg NA, 2010, NAT REV GENET, V11, P356, DOI 10.1038/nrg2760; Sergentanis TN, 2011, MOL BIOL REP, V38, P4955, DOI 10.1007/s11033-010-0639-4; Sergentanis TN, 2010, BREAST CANCER RES TR, V122, P459, DOI 10.1007/s10549-009-0694-5; Shavers VL, 2002, JNCI-J NATL CANCER I, V94, P334; Shen C, 2011, BREAST CANCER RES TR, V126, P763, DOI 10.1007/s10549-010-1184-5; Shifman S, 2003, HUM MOL GENET, V12, P771, DOI 10.1093/hmg/ddg088; Sun HM, 2011, BREAST CANCER RES TR, V125, P175, DOI 10.1007/s10549-010-0936-6; Taioli E, 2009, AM J EPIDEMIOL, V170, P1207, DOI 10.1093/aje/kwp275; TARONE RE, 1985, BIOMETRIKA, V72, P91, DOI 10.1093/biomet/72.1.91; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; Udler MS, 2009, HUM MOL GENET, V18, P1692, DOI 10.1093/hmg/ddp078; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Vincenzi B, 2008, ONCOL REP, V20, P1213, DOI 10.3892/or_00000132; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P513; Wang B, 2010, J HEPATOL, V53, P508, DOI 10.1016/j.jhep.2010.03.026; Wang CY, 2010, PROSTATE, V70, P170, DOI 10.1002/pros.21050; Wang JJ, 2011, MOL BIOL REP, V38, P4847, DOI 10.1007/s11033-010-0619-8; Wang J, 2011, BREAST CANCER RES TR, V128, P203, DOI 10.1007/s10549-010-1314-0; Wang ZW, 2010, BREAST CANCER RES TR, V123, P557, DOI 10.1007/s10549-010-0772-8; Wang ZW, 2010, BREAST CANCER RES TR, V122, P193, DOI 10.1007/s10549-009-0648-y; Wei YG, 2011, DIGEST DIS SCI, V56, P2227, DOI 10.1007/s10620-011-1617-y; Wilson PM, 2010, CANCER J, V16, P262, DOI 10.1097/PPO.0b013e3181e07738; Xi B, 2011, BREAST CANCER RES TR, V130, P561, DOI [10.1007/s10549-011-1583-2, 10.1007/s10549-011-1602-3, 10.1007/s10549-011-1615-y]; Xu B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-84; Xu WH, 2012, MOL BIOL REP, V39, P2821, DOI 10.1007/s11033-011-1041-6; Yamada H, 2009, JNCI-J NATL CANCER I, V101, P1330, DOI 10.1093/jnci/djp287; Yao L, 2010, BREAST CANCER RES TR, V124, P223, DOI 10.1007/s10549-010-0800-8; Yao L, 2010, BREAST CANCER RES TR, V123, P577, DOI 10.1007/s10549-010-0784-4; Yao L, 2010, BREAST CANCER RES TR, V122, P879, DOI 10.1007/s10549-010-0742-1; Yao L, 2010, BREAST CANCER RES TR, V122, P503, DOI 10.1007/s10549-009-0717-2; Yao L, 2010, BREAST CANCER RES TR, V122, P237, DOI 10.1007/s10549-009-0689-2; Yu K, 2010, EUR J HUM GENET, V18, P370, DOI 10.1038/ejhg.2009.131; Zhang J, 2010, BREAST CANCER RES TR, V124, P419, DOI 10.1007/s10549-010-0846-7; Zhang J, 2010, EUR J CANCER, V46, P2479, DOI 10.1016/j.ejca.2010.05.008; Zhang LQ, 2011, INT J COLORECTAL DIS, V26, P1249, DOI 10.1007/s00384-011-1220-x; Zhao EJ, 2012, MOL BIOL REP, V39, P3471, DOI 10.1007/s11033-011-1119-1; Zheng Y, 2012, MOL BIOL REP, V39, P3533, DOI 10.1007/s11033-011-1126-2; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Zhou GW, 2011, BREAST CANCER RES TR, V125, P529, DOI 10.1007/s10549-010-1031-8	120	48	48	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e97522	10.1371/journal.pone.0097522	http://dx.doi.org/10.1371/journal.pone.0097522			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901479	gold, Green Published, Green Submitted			2022-12-27	WOS:000336841400008
J	Kim, MJ; Lim, NK; Choi, YM; Kim, JJ; Hwang, KR; Chae, SJ; Park, CW; Choi, DS; Kang, BM; Lee, BS; Kim, T; Park, HY				Kim, Min-Ju; Lim, Nam-Kyoo; Choi, Young-Min; Kim, Jin-Ju; Hwang, Kyu-Ri; Chae, Soo-Jin; Park, Chan-Woo; Choi, Doo-Seok; Kang, Byung-Moon; Lee, Byung-Seok; Kim, Tak; Park, Hyun-Young			Prevalence of Metabolic Syndrome Is Higher among Non-Obese PCOS Women with Hyperandrogenism and Menstrual Irregularity in Korea	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; INSULIN-RESISTANCE; CRITERIA; HEALTH; SAMPLE; RISK	Background: Hyperandrogenism (HA) has been linked with several components of metabolic syndrome (MetS). Few studies in Asian women have evaluated the important risk factors for and prevalence of MetS according to PCOS subtype. In this study, we investigated differences in metabolic parameters and the prevalence of MetS in two major phenotypic subgroups of PCOS in Korea. Furthermore, we investigated the relationship between HA-associated parameters and MetS. Materials and Methods: This cross-sectional observational study was conducted from May 2010 to December 2011 in Korea. A total of 837 females with PCOS, aged 15-40, were recruited from Departments of Obstetrics and Gynecology at 13 hospitals. Of those, 700 subjects with either polycystic ovaries (PCO)+HA+oligomenorrhea/amenorrhea (O) or PCO+O were eligible for this study. MetS was diagnosed according to the modified National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) III guidelines and the International Diabetes Federation (IDF) criteria. Results: MetS was more prevalent in the PCO+HA+O group (19.7%) than in the PCO+O (11.9%) group. There were statistically significant trends for an increased risk of MetS in the PCO+HA+O group compared to the PCO+O group. After adjustment for age, the odds ratio of MetS was 2.192 in non-obese subjects with PCO+HA+O compared to those with PCO+O, whereas the risk of MetS was not different in obese patients. Multivariate logistic regression analysis showed that high free androgen index and low sex hormone-binding globulin were significantly associated with MetS in non-obese women with PCOS, with odds ratios of 4.234 (95% CI, 1.893-9.474) and 4.612 (95% CI, 1.978-10.750), respectively. However, no associations were detected between MetS and SHBG and FAI in obese PCOS subjects. Conclusions: Our results indicate that HA and its associated parameters (FAI and SHBG) are significantly associated with MetS in non-obese PCOS subjects, whereas this association was not observed in obese subjects.	[Kim, Min-Ju; Lim, Nam-Kyoo; Park, Hyun-Young] Korea Natl Inst Hlth, Ctr Biomed Sci, Div Cardiovasc & Rare Dis, Chungbuk, South Korea; [Choi, Young-Min; Kim, Jin-Ju; Hwang, Kyu-Ri] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Choi, Young-Min] Seoul Natl Univ, Coll Med, Med Res Ctr, Inst Reprod Med & Populat, Seoul, South Korea; [Kim, Jin-Ju] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Seoul 110744, South Korea; [Hwang, Kyu-Ri] Seoul Natl Univ, Boramae Med Ctr, Seoul, South Korea; [Chae, Soo-Jin] Maria Fertil Hosp, Dept Obstet & Gynecol, Seoul, South Korea; [Park, Chan-Woo] Cheil Gen Hosp, Dept Obstet & Gynecol, Seoul, South Korea; [Park, Chan-Woo] Womens Healthcare Ctr, Seoul, South Korea; [Choi, Doo-Seok] Sungkyunkwan Univ, Sch Med, Dept Obstet & Gynecol, Seoul Samsung Hosp, Seoul, South Korea; [Kang, Byung-Moon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea; [Lee, Byung-Seok] Yonsei Univ, Coll Med, Dept Obstet & Gynecol, Gangnam Severance Hosp, Seoul, South Korea; [Kim, Tak] Korea Univ, Coll Med, Dept Obstet & Gynecol, Seoul 136705, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; University of Ulsan; Asan Medical Center; Yonsei University; Yonsei University Health System; Korea University; Korea University Medicine (KU Medicine)	Park, HY (corresponding author), Korea Natl Inst Hlth, Ctr Biomed Sci, Div Cardiovasc & Rare Dis, Chungbuk, South Korea.	mdhypark@gmail.com		Park, Hyun-Young/0000-0002-6698-7368; Chae, Soojin/0000-0002-3376-0167; Kim, Tak/0000-0003-1514-3576	Korea National Institute of Health [4800-4861-303 (2012-N63001-00), 4800-4845-302 (2010-N63001-00)]	Korea National Institute of Health	This work was supported by the Korea National Institute of Health intramural research grant, 4800-4861-303 (2012-N63001-00) and 4800-4845-302 (2010-N63001-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apridonidze T, 2005, J CLIN ENDOCR METAB, V90, P1929, DOI 10.1210/jc.2004-1045; Asuncion M, 2000, J CLIN ENDOCR METAB, V85, P2434, DOI 10.1210/jc.85.7.2434; Azziz R, 2009, FERTIL STERIL, V91, P456, DOI 10.1016/j.fertnstert.2008.06.035; Chae SJ, 2008, HUM REPROD, V23, P1924, DOI 10.1093/humrep/den239; Christakou CD, 2008, WOMENS HEALTH, V4, P583, DOI 10.2217/17455057.4.6.583; Coviello AD, 2006, J CLIN ENDOCR METAB, V91, P492, DOI 10.1210/jc.2005-1666; Cussons AJ, 2008, HUM REPROD, V23, P2352, DOI 10.1093/humrep/den263; Dieudonne MN, 1998, AM J PHYSIOL-CELL PH, V274, pC1645, DOI 10.1152/ajpcell.1998.274.6.C1645; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Escobar-Morreale HF, 2007, TRENDS ENDOCRIN MET, V18, P266, DOI 10.1016/j.tem.2007.07.003; Essah PA, 2006, J ENDOCRINOL INVEST, V29, P270, DOI 10.1007/BF03345554; Fauser BCJM, 2012, FERTIL STERIL, V97, P28, DOI 10.1016/j.fertnstert.2011.09.024; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Fruzzetti F, 2009, GYNECOL ENDOCRINOL, V25, P335, DOI 10.1080/09513590802630146; Glueck CJ, 2003, METABOLISM, V52, P908, DOI 10.1016/S0026-0495(03)00104-5; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Holte J, 1996, BAILLIERE CLIN ENDOC, V10, P221, DOI 10.1016/S0950-351X(96)80085-1; Kandaraki E, 2009, ARQ BRAS ENDOCRINOL, V53, P227, DOI 10.1590/S0004-27302009000200014; Kim JJ, 2011, HUM REPROD, V26, P214, DOI 10.1093/humrep/deq303; Knochenhauer ES, 1998, J CLIN ENDOCR METAB, V83, P3078, DOI 10.1210/jc.83.9.3078; Korhonen S, 2003, FERTIL STERIL, V79, P1327, DOI 10.1016/S0015-0282(03)00347-9; Mehrabian F, 2011, J RES MED SCI, V16, P763; On JY, 2004, DIABETES CARE, V27, P2027, DOI 10.2337/diacare.27.8.2027; Park HR, 2007, DIABETES RES CLIN PR, V77, pS243, DOI 10.1016/j.diabres.2007.01.065; Teede H, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-41; Weerakiet S, 2007, GYNECOL ENDOCRINOL, V23, P153, DOI 10.1080/09513590701214158; Yilmaz M, 2011, J OBSTET GYNAECOL RE, V37, P1020, DOI 10.1111/j.1447-0756.2010.01478.x	27	16	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99252	10.1371/journal.pone.0099252	http://dx.doi.org/10.1371/journal.pone.0099252			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901345	gold, Green Published, Green Submitted			2022-12-27	WOS:000336841400112
J	Yan, TL; Li, L; Sun, BY; Liu, F; Yang, P; Chen, T; Li, T; Liu, XS				Yan, Tinglin; Li, Lu; Sun, Baiyu; Liu, Fei; Yang, Peng; Chen, Teng; Li, Tao; Liu, Xinshe			Luteolin Inhibits Behavioral Sensitization by Blocking Methamphetamine-Induced MAPK Pathway Activation in the Caudate Putamen in Mice	PLOS ONE			English	Article							SIGNAL-REGULATED KINASE; GENE-EXPRESSION; DELTA-FOSB; PROTEIN-KINASES; COCAINE; RAT; AMPHETAMINE; MECHANISMS; PLASTICITY; APOPTOSIS	Goal: To investigate the effect of luteolin on methamphetamine (MA)-induced behavioral sensitization and mitogen-activated protein kinase (MAPK) signal transduction pathway activation in mice. Methods: Mice received a single dose of MA to induce hyperactivity or repeated intermittent intraperitoneal injections of MA to establish an MA-induced behavioral sensitization mouse model. The effect of luteolin on the development and expression of MA-induced hyperactivity and behavioral sensitization was examined. The expression and activity of Delta FosB and the levels of phosphorylated extracellular signal-regulated kinase 1/2 (pERK1/2), phosphorylated c-Jun N-terminal kinase (pJNK), and phosphorylated p38 mitogen-activated protein kinase (pp38) in the caudate putamen (CPu) were measured by western blot. Results: Luteolin significantly decreased hyperactivity as well as the development and expression of MA-induced behavioral sensitization in mice. Delta FosB, pERK1/2, and pJNK levels in the CPu were higher in MA-treated mice than in control mice, whereas the pp38 level did not change. Injection of luteolin inhibited the MA-induced increase in Delta FosB, pERK1/2, and pJNK levels, but did not affect the pp38 level. Conclusions: Luteolin inhibits MA-induced hyperactivity and behavioral sensitization in mice through the ERK1/2/Delta FosB pathway. Furthermore, the JNK signaling pathway might be involved in MA-induced neurodegeneration in the CPu, and luteolin inhibits this process.	[Yan, Tinglin; Li, Lu; Sun, Baiyu; Liu, Fei; Yang, Peng; Chen, Teng; Li, Tao; Liu, Xinshe] Xi An Jiao Tong Univ, Sch Med, Dept Forens Med, Xian 710049, Shaanxi, Peoples R China; [Chen, Teng; Li, Tao; Liu, Xinshe] Xi An Jiao Tong Univ, Hlth Minist Forens Sci, Key Lab, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Li, T (corresponding author), Xi An Jiao Tong Univ, Sch Med, Dept Forens Med, Xian 710049, Shaanxi, Peoples R China.	litao@mail.xjtu.edu.cn; lxins@mail.xjtu.edu.cn			National Natural Science Foundation of China [81273351, 81373253]; Key Program for International S&T Cooperation Projects of Shaanxi Province [2012kw-36-02]; Fundamental Research Funds for the Central Universities; Shaanxi Key Project on Science and Technology [2013K12-01-09]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program for International S&T Cooperation Projects of Shaanxi Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Shaanxi Key Project on Science and Technology	National Natural Science Foundation of China (No. 81273351), National Natural Science Foundation of China (No. 81373253; http://www.nsfc.gov.cn). 2012 Key Program for International S&T Cooperation Projects of Shaanxi Province (2012kw-36-02; http://www.sninfo.gov.cn). The Fundamental Research Funds for the Central Universities, Shaanxi Key Project on Science and Technology (2013K12-01-09; http://www.xjtu.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibhai IN, 2007, BRAIN RES, V1143, P22, DOI 10.1016/j.brainres.2007.01.069; Besnard A, 2011, J NEUROSCI, V31, P14296, DOI 10.1523/JNEUROSCI.2890-11.2011; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Buchanan JB, 2010, BRAIN BEHAV IMMUN, V24, P502, DOI 10.1016/j.bbi.2009.12.008; Cadet JL, 2005, NEUROTOX RES, V8, P199, DOI 10.1007/BF03033973; Cadet JL, 1998, NEUROCHEM INT, V32, P117, DOI 10.1016/S0197-0186(97)00031-4; CHAN P, 1994, J NEUROCHEM, V62, P2484, DOI 10.1046/j.1471-4159.1994.62062484.x; Chapman DE, 2001, J PHARMACOL EXP THER, V296, P520; CHEN JS, 1995, MOL PHARMACOL, V48, P880; Chinen CC, 2006, NEUROPSYCHOPHARMACOL, V31, P151, DOI 10.1038/sj.npp.1300789; Cohen-Matsliah SI, 2007, J NEUROSCI, V27, P12584, DOI 10.1523/JNEUROSCI.3728-07.2007; Crozier SJ, 2010, AM J PHYSIOL-GASTR L, V299, pG1154, DOI 10.1152/ajpgi.00445.2009; Do H, 2013, CELL BIOL TOXICOL, V29, P365, DOI 10.1007/s10565-013-9260-3; Fan XL, 2003, NEUROSCIENCE, V122, P997, DOI 10.1016/j.neuroscience.2003.08.062; Fasano S, 2009, BIOL PSYCHIAT, V66, P758, DOI 10.1016/j.biopsych.2009.03.014; Han SH, 2010, J CELL BIOCHEM, V111, P1493, DOI 10.1002/jcb.22879; Hiroi N, 1998, J NEUROSCI, V18, P6952; HOTCHKISS AJ, 1980, J PHARMACOL EXP THER, V214, P257; Huang GH, 2014, ONCOL REP, V31, P2377, DOI 10.3892/or.2014.3099; Jayanthi S, 2002, MOL PHARMACOL, V61, P1124, DOI 10.1124/mol.61.5.1124; Jung DH, 2010, INT IMMUNOPHARMACOL, V10, P1047, DOI 10.1016/j.intimp.2010.06.004; Kaplan GB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023574; Kohlstedt K, 2004, CIRC RES, V94, P60, DOI 10.1161/01.RES.0000107195.13573.E4; Li JX, 2008, J CHINESE PHARM SCI, V17, P1; Licata SC, 2003, J NEUROCHEM, V85, P14, DOI 10.1046/j.1471-4159.2003.01662.x; McClung CA, 2004, MOL BRAIN RES, V132, P146, DOI 10.1016/j.molbrainres.2004.05.014; Mendez IA, 2009, BEHAV BRAIN RES, V201, P74, DOI 10.1016/j.bbr.2009.01.034; Mierzejewska K, 2013, INT J MOL MED, V32, P281, DOI 10.3892/ijmm.2013.1389; Mitew S, 2013, NEUROSCIENCE; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nestler EJ, 2008, PHILOS T R SOC B, V363, P3245, DOI 10.1098/rstb.2008.0067; Nikaido T, 2001, MOL PHARMACOL, V59, P894, DOI 10.1124/mol.59.4.894; Pavon N, 2006, BIOL PSYCHIAT, V59, P64, DOI 10.1016/j.biopsych.2005.05.044; Perez-Otano I, 1998, MOL BRAIN RES, V53, P41, DOI 10.1016/S0169-328X(97)00269-6; Pierce RC, 1997, BRAIN RES REV, V25, P192, DOI 10.1016/S0165-0173(97)00021-0; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Rangaswami H, 2009, J BIOL CHEM, V284, P14796, DOI 10.1074/jbc.M806486200; Robinson TE, 2000, ADDICTION, V95, pS91; Ryu SY, 2013, EUR J PHARMACOL, V720, P391, DOI 10.1016/j.ejphar.2013.09.064; Scibelli AC, 2011, PSYCHOPHARMACOLOGY, V214, P791, DOI 10.1007/s00213-010-2086-2; Shrimali D, 2013, CANCER LETT, V341, P139, DOI 10.1016/j.canlet.2013.08.023; Skalnikova HK, 2013, J PROTEOMICS, V91, P41, DOI 10.1016/j.jprot.2013.06.028; SONSALLA PK, 1986, J PHARMACOL EXP THER, V238, P932; Stark F, 2011, CELL SIGNAL, V23, P876, DOI 10.1016/j.cellsig.2011.01.013; Sueyoshi N, 2009, ARCH BIOCHEM BIOPHYS, V488, P48, DOI 10.1016/j.abb.2009.06.003; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Ujike Hiroshi, 2002, Curr Psychiatry Rep, V4, P177, DOI 10.1007/s11920-002-0024-7; Ulery PG, 2006, J NEUROSCI, V26, P5131, DOI 10.1523/JNEUROSCI.4970-05.2006; Valjent E, 2000, J NEUROSCI, V20, P8701; van der Schaaf ME, 2013, NEUROPSYCHOPHARMACOL, V38, P2011, DOI 10.1038/npp.2013.100; Wang JQ, 2004, MOL NEUROBIOL, V29, P1, DOI 10.1385/MN:29:1:01; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469; Yim DG, 2014, ONCOGENE; Zhao N, 2014, NEUROSCIENCE, V258, P101, DOI 10.1016/j.neuroscience.2013.11.025	55	20	22	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98981	10.1371/journal.pone.0098981	http://dx.doi.org/10.1371/journal.pone.0098981			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901319	Green Published, Green Submitted, gold			2022-12-27	WOS:000336841400084
J	Coggins, NL; Trakimas, D; Chang, SL; Ehrlich, A; Ray, P; Luker, KE; Linderman, JJ; Luker, GD				Coggins, Nathaniel L.; Trakimas, Danielle; Chang, S. Laura; Ehrlich, Anna; Ray, Paramita; Luker, Kathryn E.; Linderman, Jennifer J.; Luker, Gary D.			CXCR7 Controls Competition for Recruitment of beta-Arrestin 2 in Cells Expressing Both CXCR4 and CXCR7	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; G-PROTEIN; LIGAND; CXCL12; MIGRATION; BINDING; ACTIVATION; BREAST; SDF-1; INTERNALIZATION	Chemokine CXCL12 promotes growth and metastasis of more than 20 different human cancers, as well as pathogenesis of other common diseases. CXCL12 binds two different receptors, CXCR4 and CXCR7, both of which recruit and signal through the cytosolic adapter protein beta-arrestin 2. Differences in CXCL12-dependent recruitment of beta-arrestin 2 in cells expressing one or both receptors remain poorly defined. To quantitatively investigate parameters controlling association of beta-arrestin 2 with CXCR4 or CXCR7 in cells co-expressing both receptors, we used a systems biology approach combining real-time, multi-spectral luciferase complementation imaging with computational modeling. Cells expressing only CXCR4 maintain low basal association with beta-arrestin 2, and CXCL12 induces a rapid, transient increase in this interaction. In contrast, cells expressing only CXCR7 have higher basal association with beta-arrestin 2 and exhibit more gradual, prolonged recruitment of beta-arrestin 2 in response to CXCL12. We developed and fit a data-driven computational model for association of either CXCR4 or CXCR7 with beta-arrestin 2 in cells expressing only one type of receptor. We then experimentally validated model predictions that co-expression of CXCR4 and CXCR7 on the same cell substantially decreases both the magnitude and duration of CXCL12-regulated recruitment of beta-arrestin 2 to CXCR4. Co-expression of both receptors on the same cell only minimally alters recruitment of beta-arrestin 2 to CXCR7. In silico experiments also identified beta-arrestin 2 as a limiting factor in cells expressing both receptors, establishing that CXCR7 wins the "competition'' with CXCR4 for CXCL12 and recruitment of beta-arrestin 2. These results reveal how competition for beta-arrestin 2 controls integrated responses to CXCL12 in cells expressing both CXCR4 and CXCR7. These results advance understanding of normal and pathologic functions of CXCL12, which is critical for developing effective strategies to target these pathways therapeutically.	[Coggins, Nathaniel L.; Ehrlich, Anna; Ray, Paramita; Luker, Kathryn E.; Luker, Gary D.] Univ Michigan, Dept Microbiol & Immunol, Dept Radiol, Ctr Mol Imaging, Ann Arbor, MI 48109 USA; [Trakimas, Danielle; Chang, S. Laura; Linderman, Jennifer J.] Univ Michigan, Dept Microbiol & Immunol, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Linderman, Jennifer J.; Luker, Gary D.] Univ Michigan, Dept Microbiol & Immunol, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Luker, Gary D.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Linderman, JJ (corresponding author), Univ Michigan, Dept Microbiol & Immunol, Dept Chem Engn, Ann Arbor, MI 48109 USA.	linderma@umich.edu; gluker@umich.edu		luker, gary/0000-0001-6832-2581	United States National Institutes of Health National Cancer Institute [R01CA136553, R01CA136829, R01CA142750, P50CA093990, R01GM096040, R01EB012579]; NATIONAL CANCER INSTITUTE [P50CA093990, R01CA142750, R01CA136829, R01CA136553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096040] Funding Source: NIH RePORTER	United States National Institutes of Health National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States National Institutes of Health National Cancer Institute Grants for G. D. L.: R01CA136553, R01CA136829, R01CA142750 and P50CA093990, and for J. J. L.: R01GM096040 and R01EB012579. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Sanchez-Alcaniz JA, 2011, NEURON, V69, P77, DOI 10.1016/j.neuron.2010.12.006; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Boudot A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020898; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Chen G, 2012, J BIOL CHEM, V287, P12132, DOI 10.1074/jbc.M111.302299; Cruz-Orengo L, 2011, J EXP MED, V208, P327, DOI 10.1084/jem.20102010; Decaillot FM, 2011, J BIOL CHEM, V286, P32188, DOI 10.1074/jbc.M111.277038; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Drury LJ, 2011, P NATL ACAD SCI USA, V108, P17655, DOI 10.1073/pnas.1101133108; Falkenburger BH, 2010, J GEN PHYSIOL, V135, P81, DOI 10.1085/jgp.200910344; Fallahi-Sichani M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000778; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; Hattermann K, 2010, CANCER RES, V70, P3299, DOI 10.1158/0008-5472.CAN-09-3642; Heinrich EL, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-68; Heitzler D, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.22; Hesselgesser J, 1998, J IMMUNOL, V160, P877; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Kinzer-Ursem TL, 2007, PLOS COMPUT BIOL, V3, P84, DOI 10.1371/journal.pcbi.0030006; Kinzer-Ursem TL, 2006, CELL SIGNAL, V18, P1732, DOI 10.1016/j.cellsig.2006.01.014; Kumar R, 2012, CELL IMMUNOL, V272, P230, DOI 10.1016/j.cellimm.2011.09.015; Lagane B, 2008, BLOOD, V112, P34, DOI 10.1182/blood-2007-07-102103; Lazarini F, 2003, GLIA, V42, P139, DOI 10.1002/glia.10139; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Linderman JJ, 2009, J BIOL CHEM, V284, P5427, DOI 10.1074/jbc.R800028200; Luker KE, 2010, ONCOGENE, V29, P4599, DOI 10.1038/onc.2010.212; Luker KE, 2008, ANAL CHEM, V80, P5565, DOI 10.1021/ac8005457; Luker KE, 2012, NAT MED, V18, P172, DOI 10.1038/nm.2590; Luker KE, 2009, NEOPLASIA, V11, P1022, DOI 10.1593/neo.09724; Ma WS, 2013, J BIOL CHEM, V288, P15481, DOI 10.1074/jbc.M112.445510; Majka M, 2006, FOLIA HISTOCHEM CYTO, V44, P155; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Molinari P, 2008, BIOCHEM J, V409, P251, DOI 10.1042/BJ20070803; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Navratilova I, 2006, ANAL BIOCHEM, V355, P132, DOI 10.1016/j.ab.2006.04.021; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Rath D, 2013, EUR HEART J; Santiago B, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1900; Shcherbo D, 2010, NAT METHODS, V7, P827, DOI [10.1038/NMETH.1501, 10.1038/nmeth.1501]; Shea L, 1997, BIOCHEM PHARMACOL, V53, P519, DOI 10.1016/S0006-2952(96)00768-X; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Villalobos V, 2010, CHEM BIOL, V17, P1018, DOI 10.1016/j.chembiol.2010.06.018; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; Vrecl M, 2000, PFLUG ARCH EUR J PHY, V439, pR19, DOI 10.1007/s004240000075; Wang YL, 2011, NEURON, V69, P61, DOI 10.1016/j.neuron.2010.12.005; WYMAN J, 1975, P NATL ACAD SCI USA, V72, P3983, DOI 10.1073/pnas.72.10.3983; Zabel BA, 2009, J IMMUNOL, V183, P3204, DOI 10.4049/jimmunol.0900269; ZIGMOND SH, 1982, J CELL BIOL, V92, P34, DOI 10.1083/jcb.92.1.34; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	53	44	46	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98328	10.1371/journal.pone.0098328	http://dx.doi.org/10.1371/journal.pone.0098328			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896823	Green Submitted, gold, Green Published			2022-12-27	WOS:000338430700032
J	Eby, LA; Helmy, O; Holsinger, LM; Young, MK				Eby, Lisa A.; Helmy, Olga; Holsinger, Lisa M.; Young, Michael K.			Evidence of Climate-Induced Range Contractions in Bull Trout Salvelinus confluentus in a Rocky Mountain Watershed, USA	PLOS ONE			English	Article							BROOK TROUT; POPULATION-STRUCTURE; STREAM TEMPERATURES; LIFE-HISTORY; RIVER-BASIN; WILDFIRE; TRENDS; DISTRIBUTIONS; CONSERVATION; ABUNDANCE	Many freshwater fish species are considered vulnerable to stream temperature warming associated with climate change because they are ectothermic, yet there are surprisingly few studies documenting changes in distributions. Streams and rivers in the U.S. Rocky Mountains have been warming for several decades. At the same time these systems have been experiencing an increase in the severity and frequency of wildfires, which often results in habitat changes including increased water temperatures. We resampled 74 sites across a Rocky Mountain watershed 17 to 20 years after initial samples to determine whether there were trends in bull trout occurrence associated with temperature, wildfire, or other habitat variables. We found that site abandonment probabilities (0.36) were significantly higher than colonization probabilities (0.13), which indicated a reduction in the number of occupied sites. Site abandonment probabilities were greater at low elevations with warm temperatures. Other covariates, such as the presence of wildfire, nonnative brook trout, proximity to areas with many adults, and various stream habitat descriptors, were not associated with changes in probability of occupancy. Higher abandonment probabilities at low elevation for bull trout provide initial evidence validating the predictions made by bioclimatic models that bull trout populations will retreat to higher, cooler thermal refuges as water temperatures increase. The geographic breadth of these declines across the region is unknown but the approach of revisiting historical sites using an occupancy framework provides a useful template for additional assessments.	[Eby, Lisa A.; Helmy, Olga] Univ Montana, Wildlife Biol Program, Missoula, MT 59812 USA; [Eby, Lisa A.; Helmy, Olga] Coll Forestry & Conservat, Dept Ecosyst & Conservat Sci, Missoula, MT USA; [Holsinger, Lisa M.] US Forest Serv, USDA, Rocky Mt Res Stn, Fire Sci Lab, Missoula, MT USA; [Young, Michael K.] US Forest Serv, USDA, Rocky Mt Res Stn, Forestry Sci Lab, Missoula, MT USA	University of Montana System; University of Montana; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service	Young, MK (corresponding author), US Forest Serv, USDA, Rocky Mt Res Stn, Forestry Sci Lab, Missoula, MT USA.	mkyoung@fs.fed.us			Joint Fire Sciences Project [JFSP-09-1002-9]; MT NSF EPSCoR [EPS-0701906]; Longwell Foundation	Joint Fire Sciences Project; MT NSF EPSCoR; Longwell Foundation	This project was primarily funded by the Joint Fire Sciences Project (JFSP-09-1002-9). MT NSF EPSCoR (EPS-0701906) and the Longwell Foundation also provided fellowship support to O.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Chokhachy R, 2008, T AM FISH SOC, V137, P1709, DOI 10.1577/T07-247.1; Al-Chokhachy R, 2009, CAN J FISH AQUAT SCI, V66, P649, DOI 10.1139/F09-026; Almodovar A, 2012, GLOBAL CHANGE BIOL, V18, P1549, DOI 10.1111/j.1365-2486.2011.02608.x; Altwegg R, 2008, BIOL LETTERS, V4, P581, DOI 10.1098/rsbl.2008.0051; Arismendi I, 2013, FRESHWATER BIOL, V58, P880, DOI 10.1111/fwb.12094; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Beer WN, 2013, GLOBAL CHANGE BIOL, V19, P2547, DOI 10.1111/gcb.12242; BJORNN TED C, 1964, TRANS AMER FISH SOC, V93, P70, DOI 10.1577/1548-8659(1964)93[70:MOPAWT]2.0.CO;2; Burkhead NM, 2012, BIOSCIENCE, V62, P798, DOI 10.1525/bio.2012.62.9.5; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Comte L, 2013, ECOGRAPHY, V36, P1236, DOI 10.1111/j.1600-0587.2013.00282.x; Comte L, 2013, FRESHWATER BIOL, V58, P625, DOI 10.1111/fwb.12081; Copeland T, 2011, T AM FISH SOC, V140, P928, DOI 10.1080/00028487.2011.599261; Crozier LG, 2011, AM NAT, V178, P755, DOI 10.1086/662669; Donovan T.M., 2007, EXERCISES OCCUPANCY; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Dunham J, 2003, N AM J FISH MANAGE, V23, P894, DOI 10.1577/M02-028; Dunham JB, 2007, ECOSYSTEMS, V10, P335, DOI 10.1007/s10021-007-9029-8; Dunham JB, 1999, ECOL APPL, V9, P642, DOI 10.2307/2641151; Elliott JM, 2010, J FISH BIOL, V77, P1793, DOI 10.1111/j.1095-8649.2010.02762.x; Ficke AD, 2007, REV FISH BIOL FISHER, V17, P581, DOI 10.1007/s11160-007-9059-5; Gresswell RE, 1999, T AM FISH SOC, V128, P193, DOI 10.1577/1548-8659(1999)128&lt;0193:FAAEIF&gt;2.0.CO;2; Hari RE, 2006, GLOBAL CHANGE BIOL, V12, P10, DOI 10.1111/j.1365-2486.2005.001051.x; High B, 2008, N AM J FISH MANAGE, V28, P1687, DOI 10.1577/M06-164.1; Hines JE, 2006, PRESENCE2 V4 1 SOFTW; Howell PJ, 2010, ECOL FRESHW FISH, V19, P96, DOI 10.1111/j.1600-0633.2009.00393.x; Isaak DJ, 2012, CLIMATIC CHANGE, V113, P499, DOI 10.1007/s10584-011-0326-z; Isaak DJ, 2013, GLOBAL CHANGE BIOL, V19, P742, DOI 10.1111/gcb.12073; Isaak DJ, 2012, FISHERIES, V37, P542, DOI 10.1080/03632415.2012.742808; Isaak DJ, 2010, ECOL APPL, V20, P1350, DOI 10.1890/09-0822.1; Keane RE, 2008, INT J WILDLAND FIRE, V17, P696, DOI 10.1071/WF07148; Keeley JE, 2009, INT J WILDLAND FIRE, V18, P116, DOI 10.1071/WF07049; Knowles N, 2006, J CLIMATE, V19, P4545, DOI 10.1175/JCLI3850.1; Leppi JC, 2012, CLIMATIC CHANGE, V112, P997, DOI 10.1007/s10584-011-0235-1; Luce CH, 2013, SCIENCE, V342, P1360, DOI 10.1126/science.1242335; Mahlum SK, 2011, INT J WILDLAND FIRE, V20, P240, DOI 10.1071/WF09132; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Maxwell D, 2005, J APPL ECOL, V42, P25, DOI 10.1111/j.1365-2664.2005.01000.x; McKenzie D, 2004, CONSERV BIOL, V18, P890, DOI 10.1111/j.1523-1739.2004.00492.x; McMahon TE, 2007, T AM FISH SOC, V136, P1313, DOI 10.1577/T06-217.1; Meyer KA, 2014, N AM J FISH MANAGE, V34, P202, DOI 10.1080/02755947.2013.869280; Montana Bull Trout Restoration Team, 2000, REST PLAN B TROUT CL; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; Nelson ML, 2002, ENVIRON BIOL FISH, V64, P321, DOI 10.1023/A:1016062708588; Nyce LG, 2013, N AM J FISH MANAGE, V33, P432, DOI 10.1080/02755947.2013.768565; Parmesan C, 2013, ECOL LETT, V16, P58, DOI 10.1111/ele.12098; Pederson GT, 2010, CLIMATIC CHANGE, V98, P133, DOI 10.1007/s10584-009-9642-y; Peterson EE, 2013, ECOL LETT, V16, P707, DOI 10.1111/ele.12084; Rich CF, 2003, T AM FISH SOC, V132, P1053, DOI 10.1577/T02-109; Rieman BE, 2006, CAN J FISH AQUAT SCI, V63, P63, DOI 10.1139/F05-206; Rieman BE, 2000, ECOL FRESHW FISH, V9, P51, DOI 10.1034/j.1600-0633.2000.90106.x; Rieman BE, 2007, T AM FISH SOC, V136, P1552, DOI 10.1577/T07-028.1; Ruesch AS, 2012, CONSERV BIOL, V26, P873, DOI 10.1111/j.1523-1739.2012.01897.x; Selong JH, 2001, T AM FISH SOC, V130, P1026, DOI 10.1577/1548-8659(2001)130<1026:EOTOGA>2.0.CO;2; Sestrich CM, 2011, T AM FISH SOC, V140, P136, DOI 10.1080/00028487.2011.557019; Starcevich SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037257; Tarboton D. G., 2008, TERRAIN ANAL USING D; Tingley MW, 2009, TRENDS ECOL EVOL, V24, P625, DOI 10.1016/j.tree.2009.05.009; *US GEOL SURV, 2006, NAT EL DAT; Warren DR, 2012, GLOBAL CHANGE BIOL, V18, P1804, DOI 10.1111/j.1365-2486.2012.02670.x; Wenger SJ, 2013, GLOBAL CHANGE BIOL, V19, P3343, DOI 10.1111/gcb.12294; Wenger SJ, 2011, P NATL ACAD SCI USA, V108, P14175, DOI 10.1073/pnas.1103097108; Wenger SJ, 2011, CAN J FISH AQUAT SCI, V68, P988, DOI [10.1139/F2011-034, 10.1139/f2011-034]; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Williams JE, 2011, FISHERIES, V36, P267, DOI 10.1080/03632415.2011.582398; Winfield IJ, 2010, HYDROBIOLOGIA, V650, P55, DOI 10.1007/s10750-009-0078-1	66	59	63	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98812	10.1371/journal.pone.0098812	http://dx.doi.org/10.1371/journal.pone.0098812			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897341	gold, Green Published, Green Submitted			2022-12-27	WOS:000338430700082
J	Yednock, BK; Neigel, JE				Yednock, Bree K.; Neigel, Joseph E.			Detecting Selection in the Blue Crab, Callinectes sapidus, Using DNA Sequence Data from Multiple Nuclear Protein-Coding Genes	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; NATURAL-POPULATIONS; STATISTICAL TESTS; HAPLOTYPE RECONSTRUCTION; PARASITIC DINOFLAGELLATE; POSITIVE SELECTION; ESCAPE MUTATIONS; NEUTRAL MODEL; NULL ALLELES; C-SIMILIS	The identification of genes involved in the adaptive evolution of non-model organisms with uncharacterized genomes constitutes a major challenge. This study employed a rigorous and targeted candidate gene approach to test for positive selection on protein-coding genes of the blue crab, Callinectes sapidus. Four genes with putative roles in physiological adaptation to environmental stress were chosen as candidates. A fifth gene not expected to play a role in environmental adaptation was used as a control. Large samples (n > 800) of DNA sequences from C. sapidus were used in tests of selective neutrality based on sequence polymorphisms. In combination with these, sequences from the congener C. similis were used in neutrality tests based on interspecific divergence. In multiple tests, significant departures from neutral expectations and indicative of positive selection were found for the candidate gene trehalose 6-phosphate synthase (tps). These departures could not be explained by any of the historical population expansion or bottleneck scenarios that were evaluated in coalescent simulations. Evidence was also found for balancing selection at ATP-synthase subunit 9 (atps) using a maximum likelihood version of the Hudson, Kreitmen, and Aguade test, and positive selection favoring amino acid replacements within ATP/ADP translocase (ant) was detected using the McDonald-Kreitman test. In contrast, test statistics for the control gene, ribosomal protein L12 (rpl), which presumably has experienced the same demographic effects as the candidate loci, were not significantly different from neutral expectations and could readily be explained by demographic effects. Together, these findings demonstrate the utility of the candidate gene approach for investigating adaptation at the molecular level in a marine invertebrate for which extensive genomic resources are not available.	[Yednock, Bree K.; Neigel, Joseph E.] Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA	University of Louisiana Lafayette	Yednock, BK (corresponding author), Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA.	breeyednock@gmail.com			Gulf of Mexico Research Initiative; National Science Foundation [OCE-0315995]; NSF [PFUND-214]; Louisiana Board of Regents [ENH_2008-09]	Gulf of Mexico Research Initiative; National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Louisiana Board of Regents	This research was made possible by grants from The Gulf of Mexico Research Initiative, the National Science Foundation (OCE-0315995 and NSF (2010)-PFUND-214), and the Louisiana Board of Regents (ENH_2008-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKASHI H, 1994, GENETICS, V136, P927; AKASHI H, 1995, GENETICS, V139, P1067; Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; ALLENDORF FW, 1982, GENETICS, V100, P497; Andolfatto P, 2000, GENETICS, V156, P257; Andolfatto P, 2008, GENETICS, V180, P1767, DOI 10.1534/genetics.108.091850; [Anonymous], 1981, ECOLOGIC ATLAS BENTH; BARNWELL FH, 1984, ZOOL J LINN SOC-LOND, V81, P23, DOI 10.1111/j.1096-3642.1984.tb02558.x; Beaumont MA, 2005, TRENDS ECOL EVOL, V20, P435, DOI 10.1016/j.tree.2005.05.017; Bishop JG, 2000, P NATL ACAD SCI USA, V97, P5322, DOI 10.1073/pnas.97.10.5322; Biswas S, 2006, GENOMIC INSIGHTS POS; BRUNNER CA, 1982, QUATERNARY RES, V17, P105, DOI 10.1016/0033-5894(82)90048-5; Calderon I, 2010, MAR ECOL PROG SER, V408, P149, DOI 10.3354/meps08576; Calderon I, 2009, J MOL EVOL, V68, P366, DOI 10.1007/s00239-009-9219-4; Chen QF, 2004, J EXP BIOL, V207, P3125, DOI 10.1242/jeb.01133; Chung J Sook, 2008, Saline Syst, V4, P18, DOI 10.1186/1746-1448-4-18; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; DAS T, 1993, MAR ECOL PROG SER, V98, P263, DOI 10.3354/meps098263; EANES WF, 1993, P NATL ACAD SCI USA, V90, P7475, DOI 10.1073/pnas.90.16.7475; Eckert AJ, 2010, MOL ECOL RESOUR, V10, P542, DOI 10.1111/j.1755-0998.2009.02768.x; Eckert AJ, 2009, GENETICS, V183, P289, DOI 10.1534/genetics.109.103895; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; ENGEL DW, 1977, MAR BIOL, V41, P275, DOI 10.1007/BF00394915; Erickson AL, 2001, IMMUNITY, V15, P883, DOI 10.1016/S1074-7613(01)00245-X; Eyre-Walker A, 2002, GENETICS, V162, P2017; Eyre-Walker A, 2006, TRENDS ECOL EVOL, V21, P569, DOI 10.1016/j.tree.2006.06.015; Fay JC, 2000, GENETICS, V155, P1405; Foxe JP, 2009, GENETICS, V183, P663, DOI 10.1534/genetics.109.104778; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; GUERIN JL, 1992, MAR BIOL, V114, P391, DOI 10.1007/BF00350029; Harrigan RJ, 2008, MOL ECOL RESOUR, V8, P1239, DOI 10.1111/j.1755-0998.2008.02241.x; Hey J, 1997, GENETICS, V145, P833; HSUEH PW, 1993, PSZNI MAR ECOL, V14, P239, DOI 10.1111/j.1439-0485.1993.tb00482.x; HSUEH PW, 1992, J CRUSTACEAN BIOL, V12, P615, DOI 10.2307/1548842; HUDSON RR, 1987, GENETICS, V116, P153; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; HUDSON RR, 1985, GENETICS, V111, P147; HUGHES AL, 1990, MOL BIOL EVOL, V7, P515; Hundley H, 2002, P NATL ACAD SCI USA, V99, P4203, DOI 10.1073/pnas.062048399; Issartel J, 2005, J EXP BIOL, V208, P2923, DOI 10.1242/jeb.01737; Jones FC, 2012, CURR BIOL, V22, P83, DOI 10.1016/j.cub.2011.11.045; Joost S, 2007, MOL ECOL, V16, P3955, DOI 10.1111/j.1365-294X.2007.03442.x; KAPLAN NL, 1989, GENETICS, V123, P887; Kaushik JK, 2003, J BIOL CHEM, V278, P26458, DOI 10.1074/jbc.M300815200; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Kimura M., 1983, NEUTRAL THEORY MOL E; Kohn MH, 2004, MOL BIOL EVOL, V21, P374, DOI 10.1093/molbev/msh026; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Limborg MT, 2012, MOL ECOL, V21, P3686, DOI 10.1111/j.1365-294X.2012.05639.x; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Messick GA, 2000, DIS AQUAT ORGAN, V43, P139, DOI 10.3354/dao043139; Metcalf KS, 1995, B MAR SCI, V57, P781; Mosca E, 2012, EVOL APPL, V5, P762, DOI 10.1111/j.1752-4571.2012.00256.x; Nei M., 1987, MOL EVOLUTIONARY GEN; NEWMAN MW, 1975, J PARASITOL, V61, P554, DOI 10.2307/3279346; Nielsen EE, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-276; Nielsen R, 2001, HEREDITY, V86, P641, DOI 10.1046/j.1365-2540.2001.00895.x; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; OTTERSON GA, 1994, EMBO J, V13, P1216, DOI 10.1002/j.1460-2075.1994.tb06371.x; Otterson GA, 1997, GENE, V199, P287, DOI 10.1016/S0378-1119(97)00383-1; Palumbi S, 1991, SIMPLE FOOLS GUIDE P; PILLER SC, 1995, J EXP BIOL, V198, P349; Platt AR, 2007, BIOTECHNIQUES, V43, P58, DOI 10.2144/000112499; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Robles R, 2007, MAR BIOL, V150, P1265, DOI 10.1007/s00227-006-0437-7; ROSAS C, 1994, J CRUSTACEAN BIOL, V14, P371, DOI 10.2307/1548915; Rozas J, 2001, GENETICS, V158, P1147; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Schlotterer C, 2004, NAT REV GENET, V5, P63, DOI 10.1038/nrg1249; SIEBERS D, 1972, MAR BIOL, V17, P291, DOI 10.1007/BF00366739; SIMONSEN KL, 1995, GENETICS, V141, P413; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Smith NGC, 2002, NATURE, V415, P1022, DOI 10.1038/4151022a; Stajich JE, 2005, MOL BIOL EVOL, V22, P63, DOI 10.1093/molbev/msh252; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sung DY, 2001, PLANT PHYSIOL, V126, P789, DOI 10.1104/pp.126.2.789; TAJIMA F, 1989, GENETICS, V123, P585; Vallender EJ, 2004, HUM MOL GENET, V13, pR245, DOI 10.1093/hmg/ddh253; VOELKER RA, 1980, P NATL ACAD SCI-BIOL, V77, P1091, DOI 10.1073/pnas.77.2.1091; Wall JD, 2002, GENETICS, V162, P203; Wang B, 2006, MAR BIOTECHNOL, V8, P491, DOI 10.1007/s10126-005-6136-4; Watanabe M, 2006, APPL ENTOMOL ZOOL, V41, P15, DOI 10.1303/aez.2006.15; WATTERSON GA, 1978, GENETICS, V88, P405; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wheat CW, 2010, MOL BIOL EVOL, V27, P267, DOI 10.1093/molbev/msp227; WILLIAMS AB, 1974, FISH B-NOAA, V72, P685; Wright SI, 2004, GENETICS, V168, P1071, DOI 10.1534/genetics.104.026500; Yang ZH, 2000, MOL BIOL EVOL, V17, P1446, DOI 10.1093/oxfordjournals.molbev.a026245; Yednock BK, 2014, MAR BIOL, V161, P871, DOI 10.1007/s00227-013-2387-1; Zeng K, 2007, MOL BIOL EVOL, V24, P1562, DOI 10.1093/molbev/msm078; Zeng K, 2007, MOL BIOL EVOL, V24, P1898, DOI 10.1093/molbev/msm119; Zeng K, 2006, GENETICS, V174, P1431, DOI 10.1534/genetics.106.061432; Zhai WW, 2009, MOL BIOL EVOL, V26, P273, DOI 10.1093/molbev/msn231	94	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99081	10.1371/journal.pone.0099081	http://dx.doi.org/10.1371/journal.pone.0099081			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896825	Green Published, gold, Green Submitted			2022-12-27	WOS:000338430700115
J	Arana, A; Cilla, G; Montes, M; Gomariz, MA; Perez-Trallero, E				Arana, Ainara; Cilla, Gustavo; Montes, Milagrosa; Gomariz, Maria; Perez-Trallero, Emilio			Genotypes, Recombinant Forms, and Variants of Norovirus GII.4 in Gipuzkoa (Basque Country, Spain), 2009-2012	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; ACUTE GASTROENTERITIS; CHILDREN; OUTBREAKS; STRAINS; SURVEILLANCE; PREVALENCE; EVOLUTION; INFECTION	Background: Noroviruses (NoVs) are genetically diverse, with genogroup II-and within it-genotype 4 (GII.4) being the most prevalent cause of acute gastroenteritis worldwide. The aim of this study was to characterize genogroup II NoV causing acute gastroenteritis in the Basque Country (northern Spain) from 2009-2012. Methods: The presence of NoV RNA was investigated by reverse transcriptase-polymerase chain reaction (RT-PCR) in stool specimens from children younger than 15 years old with community-acquired acute gastroenteritis, and from hospitalized adults or elderly residents of nursing homes with acute gastroenteritis. For genotyping, the open reading frames ORF1 (encoding the polymerase) and ORF2 (encoding the major capsid protein) were partially amplified and sequenced. Recombinant strains were confirmed by PCR of the ORF1/ORF2 junction region. Results: NoV was detected in 16.0% (453/2826) of acute gastroenteritis episodes in children younger than 2 years, 9.9% (139/1407) in children from 2 to 14 years, and 35.8% (122/341) in adults. Of 317 NoVs characterized, 313 were genogroup II and four were genogroup I. The GII.4 variants Den Haag-2006b and New Orleans-2009 predominated in 2009 and 2010-2011, respectively. In 2012, the New Orleans-2009 variant was partially replaced by the Sydney-2012 variant (GII.Pe/GII.4) and New Orleans-2009/Sydney-2012 recombinant strains. The predominant capsid genotype in all age groups was GII.4, which was the only genotype detected in outbreaks. The second most frequent genotype was GII.3 (including the recently described recombination GII.P16/GII.3), which was detected almost exclusively in children. Conclusion: Nine different genotypes of NoV genogroup II were detected; among these, intergenotype recombinant strains represented an important part, highlighting the role of recombination in the evolution of NoVs. Detection of new NoV strains, not only GII.4 strains, shortly after their first detection in other parts of the world shows that many NoV strains can spread rapidly.	[Arana, Ainara; Cilla, Gustavo; Montes, Milagrosa; Gomariz, Maria; Perez-Trallero, Emilio] Hosp Univ Donostia, Inst Invest Biodonostia, Serv Microbiol, San Sebastian, Spain; [Cilla, Gustavo; Montes, Milagrosa; Perez-Trallero, Emilio] Ctr Invest Biomed Red Enfermedades Resp CIBERES, San Sebastian, Spain; [Perez-Trallero, Emilio] Univ Pais Vasco UPV EHU, Fac Med, Dept Med Prevent & Salud Publ, San Sebastian, Spain	Instituto de Investigacion Sanitaria Biodonostia; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Basque Country	Cilla, G (corresponding author), Hosp Univ Donostia, Inst Invest Biodonostia, Serv Microbiol, San Sebastian, Spain.	gustavo.cillaeguiluz@osakidetza.net			Basque Country Government [IT656-13]; Basque Government, San Sebastian, Spain [PRE-2013-2-319]	Basque Country Government(Basque Government); Basque Government, San Sebastian, Spain	This work was partly funded by a grant from the Basque Country Government to the University Research Groups (grant IT656-13). Ainara Arana is supported by a grant for the training of predoctoral researchers, Basque Government, San Sebastian, Spain; grant PRE-2013-2-319. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075922; Boga JA, 2004, J CLIN MICROBIOL, V42, P2668, DOI 10.1128/JCM.42.6.2668-2674.2004; Boon D, 2011, J VIROL, V85, P8656, DOI 10.1128/JVI.00472-11; Buesa J, 2002, J CLIN MICROBIOL, V40, P2854, DOI 10.1128/JCM.40.8.2854-2859.2002; Buesa J, 2008, J MED VIROL, V80, P1288, DOI 10.1002/jmv.21182; Bull RA, 2007, J GEN VIROL, V88, P3347, DOI 10.1099/vir.0.83321-0; Eden JS, 2013, J VIROL, V87, P6270, DOI 10.1128/JVI.03464-12; Fonager J, 2013, EUROSURVEILLANCE, V2012, P18; Giammanco GM, 2012, INFECT GENET EVOL, V12, P169, DOI 10.1016/j.meegid.2011.10.021; GREEN J, 1995, J MED VIROL, V47, P392, DOI 10.1002/jmv.1890470416; Grohskopf L, 2011, AM J TRANSPLANT, V11, P2250, DOI 10.1111/j.1600-6143.2011.03793.x; Hassine-Zaafrane M, 2013, J MED VIROL, V85, P1100, DOI 10.1002/jmv.23552; Iturriza-Gomara M, 2009, EPIDEMIOL INFECT, V137, P922, DOI 10.1017/S0950268808001556; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Kroneman A, 2008, J CLIN MICROBIOL, V46, P2959, DOI 10.1128/JCM.00499-08; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Kroneman A, 2013, ARCH VIROL, V158, P2059, DOI 10.1007/s00705-013-1708-5; Mahar JE, 2014, J VIROL, V88, P1942, DOI 10.1128/JVI.02992-13; Mahar JE, 2013, J VIROL, V87, P3687, DOI 10.1128/JVI.03056-12; Mahar JE, 2011, J MED VIROL, V83, P2213, DOI 10.1002/jmv.22215; Martella V, 2013, J CLIN MICROBIOL, V51, P3855, DOI 10.1128/JCM.01847-13; Mathijs E, 2012, FOOD ENVIRON VIROL, V4, P131, DOI 10.1007/s12560-012-9091-z; McAllister G, 2012, EPIDEMIOL INFECT, V140, P2273, DOI 10.1017/S0950268812000052; Nahar S, 2013, INFECT GENET EVOL, V20, P325, DOI 10.1016/j.meegid.2013.09.021; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589; Puustinen L, 2012, EPIDEMIOL INFECT, V140, P268, DOI 10.1017/S0950268811000549; Sai LT, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-302; Sanchez-Fauquier A, 2005, EMERG INFECT DIS, V11, P1327; Siebenga JJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000884; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Tran TNH, 2013, J CLIN VIROL, V56, P185, DOI 10.1016/j.jcv.2012.11.011; van Beek J, 2013, EUROSURVEILLANCE, V18, P8; Vega E, 2014, J CLIN MICROBIOL, V52, P147, DOI 10.1128/JCM.02680-13; Wang YH, 2012, ARCH VIROL, V157, P2417, DOI 10.1007/s00705-012-1437-1; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	37	24	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98875	10.1371/journal.pone.0098875	http://dx.doi.org/10.1371/journal.pone.0098875			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893307	Green Published, gold, Green Submitted			2022-12-27	WOS:000336911400104
J	Mariano, VS; Zorzetto-Fernandes, AL; da Silva, TA; Ruas, LP; Nohara, LL; de Almeida, IC; Roque-Barreira, MC				Mariano, Vania Sammartino; Zorzetto-Fernandes, Andre Luiz; da Silva, Thiago Aparecido; Ruas, Luciana Pereira; Nohara, Lilian L.; de Almeida, Igor Correia; Roque-Barreira, Maria Cristina			Recognition of TLR2 N-Glycans: Critical Role in ArtinM Immunomodulatory Activity	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-2; PARACOCCIDIOIDES-BRASILIENSIS INFECTION; MURINE PERITONEAL-MACROPHAGES; ARTOCARPUS-INTEGRIFOLIA; PATTERN-RECOGNITION; INDUCED EXPRESSION; CUTTING EDGE; IMMUNE-RESPONSE; DENDRITIC CELLS; UP-REGULATION	TLR2 plays a critical role in the protection against Paracoccidioides brasiliensis conferred by ArtinM administration. ArtinM, a D-mannose-binding lectin from Artocarpus heterophyllus, induces IL-12 production in macrophages and dendritic cells, which accounts for the T helper1 immunity that results from ArtinM administration. We examined the direct interaction of ArtinM with TLR2using HEK293A cells transfected with TLR2, alone or in combination with TLR1 or TLR6, together with accessory proteins. Stimulation with ArtinM induced NF-kappa B activation and interleukin (IL)-8 production in cells transfected with TLR2, TLR2/1, or TLR2/6. Murine macrophages that were stimulated with ArtinM had augmented TLR2 mRNA expression. Furthermore, pre-incubation of unstimulated macrophages with an anti-TLR2 antibody reduced the cell labeling with ArtinM. In addition, a microplate assay revealed that ArtinM bound to TLR2 molecules that had been captured by specific antibodies from a macrophages lysate. Notably, ArtinM binding to TLR2 was selectively inhibited when the lectin was pre-incubated with mannotriose. The biological relevance of the direct interaction of ArtinM with TLR2 glycans was assessed using macrophages from TLR2-KOmice, which produced significantly lower levels of IL-12 and IL-10 in response to ArtinM than macrophages from wild-type mice. Pre-treatment of murine macrophages with pharmacological inhibitors of signaling molecules demonstrated the involvement of p38 MAPK and JNK in the IL-12 production induced by ArtinM and the involvement ofPI3K in IL-10 production. Thus, ArtinM interacts directly with TLR2 or TLR2 heterodimers in a carbohydrate recognition-dependent manner and functions as a TLR2 agonist with immunomodulatory properties.	[Mariano, Vania Sammartino; Zorzetto-Fernandes, Andre Luiz; da Silva, Thiago Aparecido; Ruas, Luciana Pereira; Roque-Barreira, Maria Cristina] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, BR-09500900 Sao Paulo, Brazil; [Nohara, Lilian L.; de Almeida, Igor Correia] Univ Texas El Paso, Dept Biol Sci, Border Biomed Res Ctr, El Paso, TX 79968 USA	Universidade de Sao Paulo; University of Texas System; University of Texas El Paso	Roque-Barreira, MC (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, BR-09500900 Sao Paulo, Brazil.	mcrbarre@fmrp.usp.br	Roque-Barreira, Maria-Cristina/A-4552-2008; da Silva, Thiago Aparecido/I-2315-2015; Ruas, Luciana/A-4259-2013; Mariano, Vânia Sammartino/AAV-1851-2020; Mariano, Vania/L-1953-2014	Roque-Barreira, Maria-Cristina/0000-0001-7425-0908; da Silva, Thiago Aparecido/0000-0001-5017-6539; Ruas, Luciana/0000-0002-1028-7872; Mariano, Vânia Sammartino/0000-0002-5399-5676; Almeida, Igor/0000-0002-2443-8213	National Institutes of Health (NIH) [5G12MD007592]; FAPESP [2006/60642-2]; Biomolecule Analysis, Cytometry, Screening and Imaging, and Genomic Analysis Core Facilities at BBRC/UTEP (NIH/NIMHD) [5G12MD007592]; National Institute on Minority Health and Health Disparities [G12MD007592] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Biomolecule Analysis, Cytometry, Screening and Imaging, and Genomic Analysis Core Facilities at BBRC/UTEP (NIH/NIMHD); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was partly supported by the National Institutes of Health (NIH) grant 5G12MD007592 (to BBRC/UTEP), and by grants from FAPESP (2006/60642-2). We are thankful to the Biomolecule Analysis, Cytometry, Screening and Imaging, and Genomic Analysis Core Facilities at BBRC/UTEP (NIH/NIMHD grant 5G12MD007592). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi S, 2000, J IMMUNOL, V164, P3471, DOI 10.4049/jimmunol.164.7.3471; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Beckett EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039460; Cardoso MRD, 2011, VACCINE, V29, P9183, DOI 10.1016/j.vaccine.2011.09.136; Carneiro AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076233; Chau TA, 2009, NAT MED, V15, P641, DOI 10.1038/nm.1965; Coltri KC, 2008, AM J PATHOL, V173, P423, DOI 10.2353/ajpath.2008.080126; Coltri KC, 2010, MED MYCOL, V48, P792, DOI 10.3109/13693780903501671; Custodio LA, 2011, INT IMMUNOPHARMACOL, V11, P1510, DOI 10.1016/j.intimp.2011.05.005; DePaolo RW, 2008, CELL HOST MICROBE, V4, P350, DOI 10.1016/j.chom.2008.09.004; Dessing MC, 2008, J INFECT DIS, V197, P245, DOI 10.1086/524873; Dziarski R, 2001, J IMMUNOL, V166, P1938, DOI 10.4049/jimmunol.166.3.1938; Flo TH, 2001, J LEUKOCYTE BIOL, V69, P474; Ganiko L, 1998, GLYCOCONJUGATE J, V15, P527; Hadley JS, 2005, INFECT IMMUN, V73, P7613, DOI 10.1128/IAI.73.11.7613-7619.2005; Hajishengallis G, 2005, J BIOL CHEM, V280, P38902, DOI 10.1074/jbc.M507326200; Hajjar AM, 2001, J IMMUNOL, V166, P15, DOI 10.4049/jimmunol.166.1.15; Henneke P, 2001, J IMMUNOL, V167, P7069, DOI 10.4049/jimmunol.167.12.7069; Hernandez JC, 2011, AIDS RES HUM RETROV, V27, P1099, DOI [10.1089/aid.2010.0302, 10.1089/AID.2010.0302]; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Kataoka H, 2006, CELL MICROBIOL, V8, P1199, DOI 10.1111/j.1462-5822.2006.00702.x; Kim SY, 2013, EUR J PHARMACOL, V721, P294, DOI 10.1016/j.ejphar.2013.09.022; Landmann R, 1996, INFECT IMMUN, V64, P1762, DOI 10.1128/IAI.64.5.1762-1769.1996; Liang S, 2007, J BIOL CHEM, V282, P7532, DOI 10.1074/jbc.M611722200; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Moreno AN, 2003, INT ARCH ALLERGY IMM, V132, P221, DOI 10.1159/000074303; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Panunto-Castelo A, 2001, GLYCOBIOLOGY, V11, P1035, DOI 10.1093/glycob/11.12.1035; Pereira-Da-Silva G, 2006, BBA-GEN SUBJECTS, V1760, P86, DOI 10.1016/j.bbagen.2005.09.011; Qian C, 2013, ANN NY ACAD SCI, V1283, P67, DOI 10.1111/j.1749-6632.2012.06786.x; Rogers J, 2007, INFECT IMMUN, V75, P3205, DOI 10.1128/IAI.01950-06; SANTOSDEOLIVEIRA R, 1994, J IMMUNOL, V153, P1798; SCHINDLER U, 1994, MOL CELL BIOL, V14, P5820, DOI 10.1128/MCB.14.9.5820; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schroder NWJ, 2004, J IMMUNOL, V173, P2683, DOI 10.4049/jimmunol.173.4.2683; Shams H, 2003, FEMS IMMUNOL MED MIC, V36, P63, DOI 10.1016/S0928-8244(03)00039-7; Shin HS, 2013, PATHOG DIS, V69, P149, DOI 10.1111/2049-632X.12074; Sladek Z, 2009, RES VET SCI, V86, P235, DOI 10.1016/j.rvsc.2008.07.016; Sodhi A, 2007, GLYCOCONJUGATE J, V24, P573, DOI 10.1007/s10719-007-9054-z; Sodhi A, 2007, INT IMMUNOPHARMACOL, V7, P454, DOI 10.1016/j.intimp.2006.11.014; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Sweetser MT, 1998, J BIOL CHEM, V273, P34775, DOI 10.1074/jbc.273.52.34775; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Teixeira CR, 2006, VACCINE, V24, P3001, DOI 10.1016/j.vaccine.2005.11.067; Traore K., 2012, ISRN ONCOL, V2012; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Unitt J, 2011, BIOCHEM PHARMACOL, V81, P1324, DOI 10.1016/j.bcp.2011.03.010; Uphoff CC, 1999, METHOD MOL BIOL, V731, P93; van de Veerdonk FL, 2008, CURR OPIN MICROBIOL, V11, P305, DOI 10.1016/j.mib.2008.06.002; Wagner C, 2003, SHOCK, V19, P5, DOI 10.1097/00024382-200301000-00002; Weber ANR, 2004, J BIOL CHEM, V279, P34589, DOI 10.1074/jbc.M403830200	55	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98512	10.1371/journal.pone.0098512	http://dx.doi.org/10.1371/journal.pone.0098512			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892697	Green Submitted, Green Published, gold			2022-12-27	WOS:000336911400059
J	Vayssade, C; de Fazio, C; Quaglietti, B; Auguste, A; Ris, N; Fauvergue, X				Vayssade, Chloe; de Fazio, Celine; Quaglietti, Bastien; Auguste, Alexandra; Ris, Nicolas; Fauvergue, Xavier			Inbreeding Depression in a Parasitoid Wasp with Single-Locus Complementary Sex Determination	PLOS ONE			English	Article							DIFFERENT HABITATS; ENERGY ALLOCATION; POPULATION-SIZE; GENETIC LOAD; FITNESS; RATIO; CONSEQUENCES; PERSPECTIVE; EXTINCTION; BIOLOGY	Inbreeding and inbreeding depression are key processes in small or isolated populations and are therefore central concerns for the management of threatened or (re) introduced organisms. Haplodiploid species of the order Hymenoptera have a particular status with regard to inbreeding depression. Although recessive deleterious alleles that are expressed in males should be purged, an alternative form of inbreeding depression exists in species with single-locus complementary sex determination (sl-CSD). Under sl-CSD, genetically-related parents have a high probability of producing sterile sons instead of fertile daughters. In this article, we study inbreeding depression in Venturia canescens (Hymenoptera: Ichneumonidae), a parasitoid wasp with sl-CSD. We used a crossing design to manipulate relatedness according to three levels: within-family, between-family and between-population. For each level, several fitness components were measured on parents and female offspring. We found a 20% reduction in egg load at emergence for inbred crosses. Inbred crosses also yielded a higher proportion of males, as expected in a species with sl-CSD. Mating probability, presence of daughters among offspring, body size, symmetry and longevity were unaffected by inbreeding.	[Vayssade, Chloe; de Fazio, Celine; Quaglietti, Bastien; Auguste, Alexandra; Ris, Nicolas; Fauvergue, Xavier] INRA, UMR 1355, Inst Sophia Agrobiotech, Sophia Antipolis, France; [Vayssade, Chloe; de Fazio, Celine; Quaglietti, Bastien; Auguste, Alexandra; Ris, Nicolas; Fauvergue, Xavier] Univ Nice Sophia Antipolis, UMR, Inst Sophia Agrobiotech, Sophia Antipolis, France; [Vayssade, Chloe; de Fazio, Celine; Quaglietti, Bastien; Auguste, Alexandra; Ris, Nicolas; Fauvergue, Xavier] CNRS, UMR 7254, Inst Sophia Agrobiotech, Sophia Antipolis, France	INRAE; UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur	Fauvergue, X (corresponding author), INRA, UMR 1355, Inst Sophia Agrobiotech, Sophia Antipolis, France.	xavier.fauvergue@sophia.inra.fr	fauvergue, xavier/B-9108-2012	fauvergue, xavier/0000-0002-3579-7721; Ris, Nicolas/0000-0003-1183-234X	Agence Nationale de la Recherche [ANR-2010-BLAN-1717]; Fondation pour la Recherche sur la Biodiversite [AAP-IN-2009-052]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche sur la Biodiversite	This work was supported by the Agence Nationale de la Recherche (www.agence-nationale-recherche.fr), grant ANR-2010-BLAN-1717 'Sextinction' attributed to XF, and the Fondation pour la Recherche sur la Biodiversite (www.fondationbiodiversite.fr), grant AAP-IN-2009-052 'Vortex' attributed to XF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos W, 2001, HEREDITY, V87, P257, DOI 10.1046/j.1365-2540.2001.00940.x; Antolin MF, 1999, RES POPUL ECOL, V41, P29, DOI 10.1007/PL00011979; Asplen MK, 2009, J EVOLUTION BIOL, V22, P1762, DOI 10.1111/j.1420-9101.2009.01774.x; Bateson P., 1983, MATE CHOICE; Benvenuto C, 2012, EVOL APPL, V5, P498, DOI 10.1111/j.1752-4571.2012.00279.x; Beukeboom L. W., 1999, P 8 M EXP APPL ENT N, V10, P23; Beukeboom LW, 2001, NETH J ZOOL, V51, P1, DOI 10.1163/156854201750210805; BRUCKNER D, 1978, EVOLUTION, V32, P456, DOI [10.2307/2407613, 10.1111/j.1558-5646.1978.tb00661.x]; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; COOK JM, 1995, TRENDS ECOL EVOL, V10, P281, DOI 10.1016/0169-5347(95)90011-X; Crnokrak P, 2002, EVOLUTION, V56, P2347, DOI 10.1111/j.0014-3820.2002.tb00160.x; Crnokrak P, 1999, HEREDITY, V83, P260, DOI 10.1038/sj.hdy.6885530; DeRose MA, 1999, EVOLUTION, V53, P1288, DOI 10.2307/2640831; Desouhant E, 2003, ECOL ENTOMOL, V28, P257, DOI 10.1046/j.1365-2311.2003.00511.x; Driessen G, 1999, J ANIM ECOL, V68, P445, DOI 10.1046/j.1365-2656.1999.00296.x; Dudash MR, 1998, NATURE, V393, P682, DOI 10.1038/31468; Eliopoulos PA, 2003, PHYSIOL ENTOMOL, V28, P268, DOI 10.1111/j.1365-3032.2003.00341.x; Ellmer M, 2004, INT J PLANT SCI, V165, P1055, DOI 10.1086/423868; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; Falconer D. S., 1989, Introduction to quantitative genetics.; Fauvergue X, 2012, EVOL APPL, V5, P424, DOI 10.1111/j.1752-4571.2012.00272.x; Fischer M, 2003, CONSERV GENET, V4, P325, DOI 10.1023/A:1024051129024; Foray V, 2011, NATURWISSENSCHAFTEN, V98, P683, DOI 10.1007/s00114-011-0818-8; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Gilpin M.E., 1986, P19; Glemin S, 2003, EVOLUTION, V57, P2678; Grillenberger BK, 2008, MOL ECOL, V17, P2854, DOI 10.1111/j.1365-294X.2008.03800.x; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; HARVEY JA, 1994, ECOLOGY, V75, P1420, DOI 10.2307/1937465; Harvey JA, 1997, ENTOMOL EXP APPL, V84, P93, DOI 10.1023/A:1003007730958; Harvey JA, 2001, J INSECT BEHAV, V14, P573, DOI 10.1023/A:1012219116341; Hassell MP, 2000, J ANIM ECOL, V69, P543, DOI 10.1046/j.1365-2656.2000.00445.x; Heber S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2228; Hedrick PW, 2000, ANNU REV ECOL SYST, V31, P139, DOI 10.1146/annurev.ecolsys.31.1.139; Heimpel GE, 2008, ANNU REV ENTOMOL, V53, P209, DOI 10.1146/annurev.ento.53.103106.093441; Henter HJ, 2003, EVOLUTION, V57, P1793, DOI 10.1111/j.0014-3820.2003.tb00587.x; HERRE EA, 1985, SCIENCE, V228, P896, DOI 10.1126/science.228.4701.896; Karkkainen K, 1999, EVOLUTION, V53, P1354, DOI [10.2307/2640882, 10.1111/j.1558-5646.1999.tb05400.x]; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kristensen TN, 2010, TRENDS ECOL EVOL, V25, P44, DOI 10.1016/j.tree.2009.06.014; Leberg PL, 2008, MOL ECOL, V17, P334, DOI 10.1111/j.1365-294X.2007.03433.x; Luna MG, 2004, ENVIRON ENTOMOL, V33, P765, DOI 10.1603/0046-225X-33.3.765; Lynch M., 1998, GENETICS ANAL QUANTI; Mattila ALK, 2012, P NATL ACAD SCI USA, V109, pE2496, DOI 10.1073/pnas.1205789109; Metzger M, 2010, J ANIMAL ECOLOGY; Metzger M, 2008, ECOL ENTOMOL, V33, P167, DOI 10.1111/j.1365-2311.2007.00953.x; Metzger M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013505; Moller AP, 1997, AM NAT, V149, P916, DOI 10.1086/286030; NUNNEY L, 1993, TRENDS ECOL EVOL, V8, P234, DOI 10.1016/0169-5347(93)90197-W; ODE PJ, 1995, ANIM BEHAV, V49, P1239, DOI 10.1006/anbe.1995.0156; Peer K, 2005, EVOLUTION, V59, P317; Pelosse P, 2007, EVOL ECOL, V21, P669, DOI 10.1007/s10682-006-9145-5; Pelosse P, 2010, ENTOMOL EXP APPL, V135, P68, DOI 10.1111/j.1570-7458.2009.00965.x; R Core Team, 2012, R LANG ENV STAT COMP; Roberts HLS, 2004, J INSECT PHYSIOL, V50, P195, DOI 10.1016/j.jinsphys.2003.11.007; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; Saito Y, 2000, J EVOLUTION BIOL, V13, P668, DOI 10.1046/j.1420-9101.2000.00198.x; Schrempf A, 2006, HEREDITY, V97, P75, DOI 10.1038/sj.hdy.6800846; Tortajada AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008195; Werren John H., 1993, P42; Whitehorn PR, 2011, P ROY SOC B-BIOL SCI, V278, P1195, DOI 10.1098/rspb.2010.1550; Whitehorn PR, 2009, BMC EVOLUTIONARY BIO; Wright SI, 2008, INT J PLANT SCI, V169, P105, DOI 10.1086/523366; Zayed A, 2005, P NATL ACAD SCI USA, V102, P10742, DOI 10.1073/pnas.0502271102	64	11	11	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e97733	10.1371/journal.pone.0097733	http://dx.doi.org/10.1371/journal.pone.0097733			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892828	Green Published, Green Submitted, gold			2022-12-27	WOS:000336911400020
J	Yokogawa, N; Murakami, H; Demura, S; Kato, S; Yoshioka, K; Hayashi, H; Ishii, T; Igarashi, T; Fang, X; Tsuchiya, H				Yokogawa, Noriaki; Murakami, Hideki; Demura, Satoru; Kato, Satoshi; Yoshioka, Katsuhito; Hayashi, Hiroyuki; Ishii, Takayoshi; Igarashi, Takashi; Fang, Xiang; Tsuchiya, Hiroyuki			Perioperative Complications of Total En Bloc Spondylectomy: Adverse Effects of Preoperative Irradiation	PLOS ONE			English	Article							SPINAL TUMORS; SURGERY; HEAD	Background: Total en bloc spondylectomy (TES) is associated with a high complication rate because it is technically demanding and involves patients compromised by cancer. Specifically, perioperative complications are more likely to occur in patients receiving preoperative irradiation. We examined the perioperative complications associated with TES in patients receiving preoperative irradiation. Methods: Seventy-seven patients underwent TES between May 2010 and April 2013. We performed a retrospective review of prospectively collected data for 50 patients with metastatic tumors of the thoracic spine, excluding patients with primary spinal tumors, lumbar spinal metastasis, and combined anterior and posterior approach TES. Patients were divided into 2 groups: those with preoperative irradiation (RT-TES group, 18 patients) and those without preoperative irradiation (TES group, 32 patients). The following perioperative complications, occurring within 2 months of surgery, were compared between the groups: intraoperative dural injuries, epidural hematomas, deep surgical-site infections, postoperative cerebrospinal fluid leakage, wound dehiscence, pleural effusions, and neurological deficits. Results: Significant differences in patient characteristics were not observed between the RT-TES and TES groups. Perioperative TES complications occurred in 20/50 patients (40.0%). The complication rate in the RT-TES group was 77.8% (14 out of 18), threefold higher than the 18.8% (6 out of 32) in the TES group (P<0.01). The incidence of complications, including intraoperative dural injuries, postoperative cerebrospinal fluid leakage, wound dehiscence, and pleural effusions, was significantly higher in the RT-TES group (P<0.01). Conclusion: The perioperative complication rate associated with TES for spinal metastasis was significantly higher among patients receiving preoperative irradiation than among those not receiving preoperative irradiation.	[Yokogawa, Noriaki; Murakami, Hideki; Demura, Satoru; Kato, Satoshi; Yoshioka, Katsuhito; Hayashi, Hiroyuki; Ishii, Takayoshi; Igarashi, Takashi; Fang, Xiang; Tsuchiya, Hiroyuki] Kanazawa Univ, Dept Orthoped Surg, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan	Kanazawa University	Yokogawa, N (corresponding author), Kanazawa Univ, Dept Orthoped Surg, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan.	chakkun1981chakkun@yahoo.co.jp	DEMURA, Satoru/X-8589-2019	Kato, Satoshi/0000-0003-4762-5932	Grants-in-Aid for Scientific Research [26293333] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Boriani S, 2010, EUR SPINE J, V19, P231, DOI 10.1007/s00586-009-1137-z; Demura S, 2009, SPINE, V34, P635, DOI 10.1097/BRS.0b013e31819712ca; Devalia HL, 2008, INT WOUND J, V5, P40, DOI 10.1111/j.1742-481X.2007.00351.x; Dormand Emma-Louise, 2005, Int Wound J, V2, P112, DOI 10.1111/j.1742-4801.2005.00079.x; Ghogawala Z, 2001, SPINE, V26, P818, DOI 10.1097/00007632-200104010-00025; JOSEPH DL, 1973, ARCH OTOLARYNGOL, V97, P381; Kawahara N, 2009, ORTHOP CLIN N AM, V40, P47, DOI 10.1016/j.ocl.2008.09.004; Murakami Hideki, 2010, Orthopedics, V33, DOI 10.3928/01477447-20100129-10; Murakami H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064818; Shirai T, 2011, ACTA BIOMATER, V7, P1928, DOI 10.1016/j.actbio.2010.11.036; TAYLOR JMG, 1992, INT J RADIAT ONCOL, V23, P41, DOI 10.1016/0360-3016(92)90541-O; TERZ JJ, 1981, SURGERY, V89, P449; TOMITA K, 1994, INT ORTHOP, V18, P291; Tomita K, 1997, SPINE, V22, P324, DOI 10.1097/00007632-199702010-00018; Tomita K, 2006, J ORTHOP SCI, V11, P3, DOI 10.1007/s00776-005-0964-y; Tsuchiya H, 2012, J ORTHOP SCI, V17, P595, DOI 10.1007/s00776-012-0247-3; Wang Junru, 2006, Hernia, V10, P502, DOI 10.1007/s10029-006-0150-y	17	34	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98797	10.1371/journal.pone.0098797	http://dx.doi.org/10.1371/journal.pone.0098797			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893004	Green Submitted, gold, Green Published			2022-12-27	WOS:000336911400093
J	Bruns, H; Lozanovski, VJ; Schultze, D; Hillebrand, N; Hinz, U; Buchler, MW; Schemmer, P				Bruns, Helge; Lozanovski, Vladimir J.; Schultze, Daniel; Hillebrand, Norbert; Hinz, Ulf; Buechler, Markus W.; Schemmer, Peter			Prediction of Postoperative Mortality in Liver Transplantation in the Era of MELD-Based Liver Allocation: A Multivariate Analysis	PLOS ONE			English	Article							DONOR-RISK-INDEX; SINGLE-CENTER EXPERIENCE; CORONARY-ARTERY-DISEASE; COLD ISCHEMIA TIME; BILIARY COMPLICATIONS; GRAFT-SURVIVAL; SERUM SODIUM; CANDIDATES; MODEL; IMPACT	Background and Aims: Liver transplantation is the only curative treatment for end-stage liver disease. While waiting list mortality can be predicted by the MELD-score, reliable scoring systems for the postoperative period do not exist. This study's objective was to identify risk factors that contribute to postoperative mortality. Methods: Between December 2006 and March 2011, 429 patients underwent liver transplantation in our department. Risk factors for postoperative mortality in 266 consecutive liver transplantations were identified using univariate and multivariate analyses. Patients who were <18 years, HU-listings, and split-, living related, combined or re-transplantations were excluded from the analysis. The correlation between number of risk factors and mortality was analyzed. Results: A labMELD >= 20, female sex, coronary heart disease, donor risk index >1.5 and donor Na+>145 mmol/L were identified to be independent predictive factors for postoperative mortality. With increasing number of these risk-factors, postoperative 90-day and 1-year mortality increased (0-1: 0 and 0%; 2: 2.9 and 17.4%; 3: 5.6 and 16.8%; 4: 22.2 and 33.3%; 5-6: 60.9 and 66.2%). Conclusions: In this analysis, a simple score was derived that adequately identified patients at risk after liver transplantation. Opening a discussion on the inclusion of these parameters in the process of organ allocation may be a worthwhile venture.	[Bruns, Helge; Lozanovski, Vladimir J.; Schultze, Daniel; Hillebrand, Norbert; Hinz, Ulf; Buechler, Markus W.; Schemmer, Peter] Heidelberg Univ, Dept Gen & Transplant Surg, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Bruns, H (corresponding author), Heidelberg Univ, Dept Gen & Transplant Surg, Heidelberg, Germany.	helge.bruns@med.uni-heidelberg.de	Bruns, Helge/N-6013-2014; Lozanovski, Vladimir J/AAP-9781-2020	Bruns, Helge/0000-0003-1010-1043; Lozanovski, Vladimir J/0000-0002-7332-3973				Afonso RC, 2008, TRANSPL P, V40, P800, DOI 10.1016/j.transproceed.2008.03.017; Annicchiarico BE, 2008, TRANSPL P, V40, P1918, DOI 10.1016/j.transproceed.2008.05.070; AVOLIO AW, 1991, TRANSPLANT P, V23, P2451; Benckert C, 2011, SCAND J GASTROENTERO, V46, P941, DOI 10.3109/00365521.2011.568521; Boin IFSF, 2008, TRANSPL P, V40, P789, DOI 10.1016/j.transproceed.2008.02.058; Bonney GK, 2009, TRANSPLANTATION, V87, P1858, DOI 10.1097/TP.0b013e3181a75b37; Brooks BK, 1996, TRANSPLANTATION, V62, P1784, DOI 10.1097/00007890-199612270-00017; Bruns H, 2011, CLIN TRANSPLANT, V25, pE558, DOI 10.1111/j.1399-0012.2011.01483.x; Bruns H, 2011, MICROCIRCULATION, V18, P205, DOI 10.1111/j.1549-8719.2010.00078.x; Buenadicha AL, 2005, TRANSPL P, V37, P3881, DOI 10.1016/j.transproceed.2005.09.165; Carbo J, 1998, REV ESP ENFERM DIG, V90, P109; CAREY WD, 1995, TRANSPLANTATION, V59, P859, DOI 10.1097/00007890-199503270-00010; Cywinski JB, 2008, LIVER TRANSPLANT, V14, P59, DOI 10.1002/lt.21305; David AI, 2012, EINSTEIN-SAO PAULO, V10, P57, DOI 10.1590/S1679-45082012000100012; Desschans B, 2008, ACTA CHIR BELG, V108, P31, DOI 10.1080/00015458.2008.11680171; Donovan CL, 1996, TRANSPLANTATION, V61, P1180, DOI 10.1097/00007890-199604270-00011; Edwards E, 2004, LIVER TRANSPLANT, V10, pS10, DOI 10.1002/lt.20271; Feng S, 2006, AM J TRANSPLANT, V6, P783, DOI 10.1111/j.1600-6143.2006.01242.x; Filippone EJ, 2012, CARDIOL REV, V20, P253, DOI 10.1097/CRD.0b013e3182564a34; Fuller JH, 2001, DIABETOLOGIA, V44, pS54, DOI 10.1007/PL00002940; Garg A, 2013, JACC-CARDIOVASC IMAG, V6, P105, DOI 10.1016/j.jcmg.2012.11.002; Gastaca M, 2012, TRANSPL P, V44, P1554, DOI [10.1016/j.transproceed.2012.05.025, 10.1016/j.transproceed.2012.05.008]; Halldorson JB, 2009, AM J TRANSPLANT, V9, P318, DOI 10.1111/j.1600-6143.2008.02491.x; JENKINS RL, 1989, SURG CLIN N AM, V69, P371; Jin B, 2008, HEPATO-GASTROENTEROL, V55, P207; KAHN D, 1989, HEPATOLOGY, V10, P861, DOI 10.1002/hep.1840100519; KAHN D, 1993, DIGEST DIS SCI, V38, P1485, DOI 10.1007/BF01308608; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kaseje N, 2013, EUR J PEDIATR SURG, V23, P8, DOI 10.1055/s-0032-1329703; Kim HJ, 2010, AM J TRANSPLANT, V10, P2652, DOI 10.1111/j.1600-6143.2010.03315.x; Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209; Marino IR, 1995, HEPATOLOGY, V22, P1754, DOI 10.1016/0270-9139(95)90202-3; Mateo R, 2006, AM J TRANSPLANT, V6, P791, DOI 10.1111/j.1600-6143.2006.01243.x; Merion RM, 2010, SEMIN LIVER DIS, V30, P411, DOI 10.1055/s-0030-1267541; Mieth M., 2006, HEIDELBERGER MANUAL; Piratvisuth T, 1995, Liver Transpl Surg, V1, P296, DOI 10.1002/lt.500010505; Plotkin J S, 1996, Liver Transpl Surg, V2, P426, DOI 10.1002/lt.500020604; Porte R J, 1998, Transpl Int, V11 Suppl 1, pS164, DOI 10.1007/s001470050452; PORTE RJ, 1993, SEMIN THROMB HEMOST, V19, P191, DOI 10.1055/s-2007-994025; Quante M, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/264015; Rahimi RS, 2013, CURR OPIN GASTROENTE; Rossi Elsabetta, 1997, Rays (Rome), V22, P595; Schmidt J, 2008, CHIRURG, V79, P112, DOI 10.1007/s00104-007-1452-z; Schmied BM, 2005, TRANSPLANTATION, V80, pS147, DOI 10.1097/01.tp.0000186907.58294.d1; Schrem H, 2012, ANN TRANSPL, V17, P5; SCOTTE M, 1994, J HEPATOL, V21, P340, DOI 10.1016/S0168-8278(05)80311-3; STAHL RL, 1990, HEPATOLOGY, V12, P553, DOI 10.1002/hep.1840120317; STARZL TE, 1981, NEW ENGL J MED, V305, P266, DOI 10.1056/NEJM198107303050507; Susantitaphong P, 2012, AM J KIDNEY DIS, V59, P829, DOI 10.1053/j.ajkd.2012.01.015; Tiukinhoy-Laing SD, 2006, AM J CARDIOL, V98, P178, DOI 10.1016/j.amjcard.2006.01.089; Togashi J, 2013, HEPATOL RES; Totsuka E, 2002, SURG TODAY, V32, P792, DOI 10.1007/s005950200152; Tsui TY, 2009, LANGENBECK ARCH SURG, V394, P235, DOI 10.1007/s00423-008-0348-9; TURNER TB, 1981, JOHNS HOPKINS MED J, V148, P53; Venettoni S, 2004, TRANSPL INT, V17, P402, DOI 10.1007/s00147-004-0718-3; Weismuller TJ, 2011, TRANSPL INT, V24, P91, DOI 10.1111/j.1432-2277.2010.01161.x; Weiss KH, 2007, NEPHROL DIAL TRANSPL, V22, P9, DOI 10.1093/ndt/gfm658; Wheeler MD, 1999, CELL MOL LIFE SCI, V56, P843, DOI 10.1007/s000180050030; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; YERSIZ H, 1995, TRANSPLANTATION, V60, P790, DOI 10.1097/00007890-199510270-00005; Yong CM, 2010, LIVER TRANSPLANT, V16, P1242, DOI 10.1002/lt.22152; Zhai Y, 2011, AM J TRANSPLANT, V11, P1563, DOI 10.1111/j.1600-6143.2011.03579.x	62	48	49	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98782	10.1371/journal.pone.0098782	http://dx.doi.org/10.1371/journal.pone.0098782			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905210	Green Published, gold, Green Submitted			2022-12-27	WOS:000341869000063
J	Hassan, AKM; Dimitry, SR; Agban, GW				Hassan, Ayman K. M.; Dimitry, Salwa R.; Agban, George W.			Can Exercise Capacity Assessed by the 6 Minute Walk Test Predict the Development of Major Adverse Cardiac Events in Patients with STEMI after Fibrinolysis?	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; 6-MINUTE WALK; HEART-FAILURE; RISK SCORE; ELDERLY-PATIENTS; MORTALITY; ELEVATION; DISEASE; TRIAL	Background: To assess the added value of the 6 minute walk test distance (6MWTD) in the risk-stratification methods for patients with ST -segment elevation myocardial infarction (STEMI) treated with fibrinolysis. Methodology/Principal Findings: This is a prospective cohort study of one hundred consecutive patients with STEMI, who had received fibrinolysis, at Assuit University Hospital. All patients underwent 6MWT pre-discharge and were followed up for 3 months to monitor the incidence of major adverse cardiac events (MACE). Patients were divided into 3 groups according to the level of 6MWTD (level I>450 m, level II = 300-450 m and level III<300 m). Among the study population, the median 6MWT distance was 370 meters (interquartile range 162-462). The mean age was 60.9 +/- 10.7 years, 71.9% of them were males, 2/3 had anterior MI. only 10.5% had successful thrombolysis. Compared to patients in level I (>450 m), patients in level III (<300 m) were more likely to have clinical risk factors as hypertension, diabetes and impaired renal function. The patient's mean TIMI score was 3.4 +/- 2.2, the mean GRACE score was 150.5 +/- 27.7. There was a significant negative correlation between the 6 MWTD and GRACE risk score (r = -0.80, p<0.001). At 3 months of follow-up, 51% had MACE including 16% were dead. Multivariate logistic regression analysis identified that the GRACE risk score and 6MWT distance levels were the best predictors of the MACE at 3 month of follow up. The incidence of MACE was 4 times higher in patients with high GRACE risk score who couldn't walk more than 300 meters (OR = 4.66, 95% CI = 1.1-14.5, p = 0.006). Conclusions/Significance: In patients with STEMI treated with fibrinolysis, the addition of 6MWTD assessment pre-discharge to the traditional GRACE risk score improved the risk prediction of cardiovascular events at 3 month follow up.	[Hassan, Ayman K. M.; Dimitry, Salwa R.; Agban, George W.] Assiut Univ, Fac Med, Dept Cardiovasc Med, Assiut, Egypt	Egyptian Knowledge Bank (EKB); Assiut University	Hassan, AKM (corresponding author), Assiut Univ, Fac Med, Dept Cardiovasc Med, Assiut, Egypt.	aymankhairy11@gmail.com	HASSAN, AYMAN K.M./ABC-5219-2021	HASSAN, AYMAN K.M./0000-0002-7719-0805				Addala S, 2004, AM J CARDIOL, V93, P629, DOI 10.1016/j.amjcard.2003.11.036; [Anonymous], 2002, AM J RESP CRIT CARE, V166, P111; Beatty AL, 2012, ARCH INTERN MED, V172, P1096, DOI 10.1001/archinternmed.2012.2198; BITTNER V, 1993, JAMA-J AM MED ASSOC, V270, P1702, DOI 10.1001/jama.270.14.1702; Boden WE, 2013, JAMA-J AM MED ASSOC, V309, P143, DOI 10.1001/jama.2012.128367; Bonnefoy E, 2011, ANN CARDIOL ANGEIOL, V60, P311, DOI 10.1016/j.ancard.2011.10.001; BRUSCHKE AVG, 1990, CLEV CLIN J MED, V57, P547, DOI 10.3949/ccjm.57.6.547; bu-Assi E, 2010, REV ESP CARDIOL, V63, P640; Cacciatore F, 2012, EUR J PREV CARDIOL, V19, P1401, DOI 10.1177/1741826711422991; Cahalin LP, 1996, CHEST, V110, P325, DOI 10.1378/chest.110.2.325; Capodanno D, 2010, AM HEART J, V159, P103, DOI 10.1016/j.ahj.2009.10.021; Casanova C, 2011, EUR RESPIR J, V37, P150, DOI 10.1183/09031936.00194909; Chetta A, 2006, RESP MED, V100, P1573, DOI 10.1016/j.rmed.2006.01.001; De Luca G, 2004, CIRCULATION, V109, P2737, DOI 10.1161/01.CIR.0000131765.73959.87; Granger CB, 2003, ARCH INTERN MED, V163, P2345, DOI 10.1001/archinte.163.19.2345; Guazzi M, 2009, CIRC-HEART FAIL, V2, P549, DOI 10.1161/CIRCHEARTFAILURE.109.881326; Halkin A, 2005, J AM COLL CARDIOL, V45, P1397, DOI 10.1016/j.jacc.2005.01.041; Hassan AKM, 2009, CATHETER CARDIO INTE, V74, P335, DOI 10.1002/ccd.21980; Ingle L, 2005, EUR HEART J, V26, P1742, DOI 10.1093/eurheartj/ehi259; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; Morrow DA, 2000, CIRCULATION, V102, P2031, DOI 10.1161/01.CIR.102.17.2031; Pollentier Brittany, 2010, Cardiopulm Phys Ther J, V21, P13; Raber L, 2012, JAMA-J AM MED ASSOC, V308, P777, DOI 10.1001/jama.2012.10065; Rasekaba T, 2009, INTERN MED J, V39, P495, DOI 10.1111/j.1445-5994.2008.01880.x; Rostagno C, 2003, EUR J HEART FAIL, V5, P247, DOI 10.1016/S1388-9842(02)00244-1; Selvarajah S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040249; Shah MR, 2001, AM J CARDIOL, V88, P987, DOI 10.1016/S0002-9149(01)01975-0; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Stevens D, 1999, AM J RESP CRIT CARE, V160, P1540, DOI 10.1164/ajrccm.160.5.9808139; Swiston JR, 2010, RESP MED, V104, P1588, DOI 10.1016/j.rmed.2010.08.003; Taher T, 2004, J AM COLL CARDIOL, V44, P38, DOI 10.1016/j.jacc.2004.03.041	31	8	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99035	10.1371/journal.pone.0099035	http://dx.doi.org/10.1371/journal.pone.0099035			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905094	Green Published, gold, Green Submitted			2022-12-27	WOS:000341869000095
J	Lai, CK; Saxena, V; Tseng, CH; Jeng, KS; Kohara, M; Lai, MMC				Lai, Chao-Kuen; Saxena, Vikas; Tseng, Chung-Hsin; Jeng, King-Song; Kohara, Michinori; Lai, Michael M. C.			Nonstructural Protein 5A Is Incorporated into Hepatitis C Virus Low-Density Particle through Interaction with Core Protein and Microtubules during Intracellular Transport	PLOS ONE			English	Article							IN-VITRO MODEL; RNA REPLICATION; HCV RNA; GRADIENT CENTRIFUGATION; BUOYANT DENSITY; LIPID DROPLET; IDENTIFICATION; CULTURE; MEMBRANE; RELEASE	Nonstructural protein 5A (NS5A) of hepatitis C virus (HCV) serves dual functions in viral RNA replication and virus assembly. Here, we demonstrate that HCV replication complex along with NS5A and Core protein was transported to the lipid droplet (LD) through microtubules, and NS5A-Core complexes were then transported from LD through early-to-late endosomes to the plasma membrane via microtubules. Further studies by cofractionation analysis and immunoelectron microscopy of the released particles showed that NS5A-Core complexes, but not NS4B, were present in the low-density fractions, but not in the high-density fractions, of the HCV RNA-containing virions and associated with the internal virion core. Furthermore, exosomal markers CD63 and CD81 were also detected in the low-density fractions, but not in the high-density fractions. Overall, our results suggest that HCV NS5A is associated with the core of the low-density virus particles which exit the cell through a preexisting endosome/exosome pathway and may contribute to HCV natural infection.	[Lai, Chao-Kuen; Saxena, Vikas; Jeng, King-Song; Lai, Michael M. C.] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Lai, Michael M. C.] Univ So Calif, Dept Mol Microbiol & Immunol, Los Angeles, CA USA; [Tseng, Chung-Hsin; Lai, Michael M. C.] Natl Cheng Kung Univ, Dept Microbiol & Immunol, Tainan 70101, Taiwan; [Tseng, Chung-Hsin; Lai, Michael M. C.] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan; [Lai, Chao-Kuen] Natl Taiwan Univ, Grad Inst Toxicol, Taipei 10764, Taiwan; [Kohara, Michinori] Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Tokyo 113, Japan	Academia Sinica - Taiwan; University of Southern California; National Cheng Kung University; National Cheng Kung University; National Taiwan University; Tokyo Metropolitan Institute of Medical Science	Lai, MMC (corresponding author), Acad Sinica, Inst Mol Biol, Taipei, Taiwan.	michlai@gate.sinica.edu.tw	Saxena, Vikas/A-9472-2016	Saxena, Vikas/0000-0003-4816-4875				Abid K, 2005, J HEPATOL, V42, P744, DOI 10.1016/j.jhep.2004.12.034; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Ariumi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014517; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Bost AG, 2003, J VIROL, V77, P4401, DOI 10.1128/JVI.77.7.4401-4408.2003; Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x; BRADLEY D, 1991, J MED VIROL, V34, P206, DOI 10.1002/jmv.1890340315; Cai ZH, 2005, J VIROL, V79, P13963, DOI 10.1128/JVI.79.22.13963-13973.2005; Cho NJ, 2009, ACS CHEM BIOL, V4, P1061, DOI 10.1021/cb900149b; Cho NJ, 2009, ANAL CHEM, V81, P4752, DOI 10.1021/ac900242s; Coller KE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002466; Corless L, 2010, J GEN VIROL, V91, P362, DOI 10.1099/vir.0.017285-0; Dreux M, 2012, CELL HOST MICROBE, V12, P558, DOI 10.1016/j.chom.2012.08.010; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Falanga A, 2009, PROTEIN PEPTIDE LETT, V16, P751, DOI 10.2174/092986609788681760; Feng ZD, 2013, NATURE, V496, P367, DOI 10.1038/nature12029; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Gastaminza P, 2010, J VIROL, V84, P10999, DOI 10.1128/JVI.00526-10; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; Grove J, 2008, J VIROL, V82, P12020, DOI 10.1128/JVI.01569-08; Heller T, 2005, P NATL ACAD SCI USA, V102, P2579, DOI 10.1073/pnas.0409666102; Ishida S, 2001, HEPATOL RES, V20, P335, DOI 10.1016/S1386-6346(01)00080-8; Izquierdo-Useros N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000740; Jones DM, 2010, J BIOL CHEM, V285, P22732, DOI 10.1074/jbc.R110.133017; KAITO M, 1994, J GEN VIROL, V75, P1755, DOI 10.1099/0022-1317-75-7-1755; KANTO T, 1994, HEPATOLOGY, V19, P296; Lai CK, 2008, J VIROL, V82, P8838, DOI 10.1128/JVI.00398-08; Lai CK, 2008, VIROLOGY, V370, P295, DOI 10.1016/j.virol.2007.08.037; Lai CK, 2010, J VIROL, V84, P11590, DOI 10.1128/JVI.00587-10; Li X, 1995, J VIRAL HEPATITIS, V2, P227, DOI 10.1111/j.1365-2893.1995.tb00034.x; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Listenberger LL, 2007, CURR PROTOC CELL BIO, DOI [DOI 10.1002/0471143030.CB2402S35, 10.1002/0471143030.cb2402s35]; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lohmann V, 1996, J HEPATOL, V24, P11; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; Masciopinto F, 2004, EUR J IMMUNOL, V34, P2834, DOI 10.1002/eji.200424887; Matsumoto M, 1996, VIROLOGY, V218, P43, DOI 10.1006/viro.1996.0164; Meckes DG, 2011, J VIROL, V85, P12844, DOI 10.1128/JVI.05853-11; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; MIYAMOTO H, 1992, J GEN VIROL, V73, P715, DOI 10.1099/0022-1317-73-3-715; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Nelson HB, 2006, J VIROL, V80, P1181, DOI 10.1128/JVI.80.3.1181-1190.2006; Neuman BW, 2008, J VIROL, V82, P5279, DOI 10.1128/JVI.02631-07; Parent R, 2009, HEPATOLOGY, V49, P1798, DOI 10.1002/hep.22852; PATERSON RG, 1995, VIROLOGY, V208, P121, DOI 10.1006/viro.1995.1135; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Prince AM, 1996, J VIRAL HEPATITIS, V3, P11, DOI 10.1111/j.1365-2893.1996.tb00075.x; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; RICHARDSON JC, 1991, ARCH VIROL, V116, P69, DOI 10.1007/BF01319232; Roohvand F, 2009, J BIOL CHEM, V284, P13778, DOI 10.1074/jbc.M807873200; Rouille Y, 2006, J VIROL, V80, P2832, DOI 10.1128/JVI.80.6.2832-2841.2006; Saxena V, 2012, J VIROL, V86, P4139, DOI 10.1128/JVI.06327-11; Sette P, 2011, STRUCTURE, V19, P1485, DOI 10.1016/j.str.2011.07.016; Shi ST, 2003, J VIROL, V77, P4160, DOI 10.1128/JVI.77.7.4160-4168.2003; Shimoike T, 1999, J VIROL, V73, P9718, DOI 10.1128/JVI.73.12.9718-9725.1999; Tamai K, 2012, VIROLOGY, V422, P377, DOI 10.1016/j.virol.2011.11.009; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; WU XY, 1994, J VIROL, V68, P6161, DOI 10.1128/JVI.68.10.6161-6169.1994	63	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99022	10.1371/journal.pone.0099022	http://dx.doi.org/10.1371/journal.pone.0099022			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905011	gold, Green Submitted, Green Published			2022-12-27	WOS:000341869000094
J	Mannelqvist, M; Wik, E; Stefansson, IM; Akslen, LA				Mannelqvist, Monica; Wik, Elisabeth; Stefansson, Ingunn M.; Akslen, Lars A.			An 18-Gene Signature for Vascular Invasion Is Associated with Aggressive Features and Reduced Survival in Breast Cancer	PLOS ONE			English	Article							GENE-EXPRESSION PATTERNS; PROGNOSTIC IMPORTANCE; MOLECULAR SUBTYPES; CHEMOTHERAPY; THERAPY; TRANSCRIPTOME; RECURRENCE; PREDICTOR; TRIAL	Aims: Vascular invasion by tumor cells is known to be important for cancer progression. By microarray and qPCR analyses, we earlier identified an 18-gene signature associated with vascular involvement in endometrial cancer. Here, we explored the significance of this vascular invasion signature in multiple series of breast cancer patients. Methods and Results: The study includes 11 open access gene expression data sets which collectively provide information on 2423 breast cancer patients. The 18-gene signature showed consistent associations with aggressive features of breast cancer, like high tumor grade, hormone receptor negativity, HER2 positivity, a basal-like phenotype, reduced patient survival, and response to neoadjuvant chemotherapy. Also, the vascular invasion signature was associated with several other gene expression profiles related to vascular biology and tumor progression, including the Oncotype DX breast cancer recurrence signature. Conclusions: The 18-gene vascular invasion signature showed strong and consistent associations with aggressive features of breast cancer and reduced survival.	[Mannelqvist, Monica; Wik, Elisabeth; Stefansson, Ingunn M.; Akslen, Lars A.] Univ Bergen, Dept Clin Med, Ctr Canc Biomarkers CCBIO, N-5020 Bergen, Norway; [Wik, Elisabeth; Stefansson, Ingunn M.; Akslen, Lars A.] Haukeland Hosp, Gade Inst, Dept Pathol, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital	Akslen, LA (corresponding author), Univ Bergen, Dept Clin Med, Ctr Canc Biomarkers CCBIO, N-5020 Bergen, Norway.	lars.akslen@gades.uib.no	Akslen, Lars A./AAG-6097-2021; Wik, E./AAA-9105-2020; Akslen, Lars A/C-1202-2017	Akslen, Lars A./0000-0003-2710-9543; Akslen, Lars A/0000-0003-2710-9543	Norwegian Cancer Society; Research Council of Norway; University of Bergen; Helse Vest	Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); University of Bergen; Helse Vest	The study is funded by the Norwegian Cancer Society, the Research Council of Norway, Helse Vest research and the University of Bergen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albain KS, 2010, LANCET ONCOL, V11, P55, DOI 10.1016/S1470-2045(09)70314-6; Anders CK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001373; Borgan E, 2013, MOL ONCOL, V7, P130, DOI 10.1016/j.molonc.2012.10.005; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; de Cremoux P, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-215; Gardner RE, 2000, ARCH OTOLARYNGOL, V126, P309, DOI 10.1001/archotol.126.3.309; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Gluck S, 2011, BREAST CANC RES TREA; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatzis C, 2011, JAMA-J AM MED ASSOC, V305, P1873, DOI 10.1001/jama.2011.593; Hu ZY, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-9; Kadivar M, 2012, ASIAN PAC J CANCER P, V13, P1881, DOI 10.7314/APJCP.2012.13.5.1881; Kao KJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-143; Lerebours F, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-41; Lu XS, 2008, BREAST CANCER RES TR, V108, P191, DOI 10.1007/s10549-007-9596-6; Mannelqvist M, 2011, AM J PATHOL, V178, P861, DOI 10.1016/j.ajpath.2010.10.040; Mannelqvist M, 2009, HISTOPATHOLOGY, V54, P174, DOI 10.1111/j.1365-2559.2008.03201.x; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; PINDER SE, 1994, HISTOPATHOLOGY, V24, P41, DOI 10.1111/j.1365-2559.1994.tb01269.x; Popovici V, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2468; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Straume O, 1996, CANCER, V78, P1211, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1211::AID-CNCR7>3.3.CO;2-O; Symmans WF, 2010, J CLIN ONCOL, V28, P4111, DOI 10.1200/JCO.2010.28.4273; Tabchy A, 2010, CLIN CANCER RES, V16, P5351, DOI 10.1158/1078-0432.CCR-10-1265; Zhang Y, 2009, BREAST CANCER RES TR, V116, P303, DOI 10.1007/s10549-008-0183-2	27	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98787	10.1371/journal.pone.0098787	http://dx.doi.org/10.1371/journal.pone.0098787			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905342	Green Published, gold, Green Submitted			2022-12-27	WOS:000341869000064
J	Vanroy, C; Vanlandewijck, Y; Cras, P; Feys, H; Truijen, S; Michielsen, M; Vissers, D				Vanroy, Christel; Vanlandewijck, Yves; Cras, Patrick; Feys, Hilde; Truijen, Steven; Michielsen, Marc; Vissers, Dirk			Is a Coded Physical Activity Diary Valid for Assessing Physical Activity Level and Energy Expenditure in Stroke Patients?	PLOS ONE			English	Article							DOUBLY LABELED WATER; AMBULATORY ACTIVITY; AMERICAN-COLLEGE; ACCELEROMETRY; PREVENTION; REHABILITATION; DISABILITIES; INDIVIDUALS; PEDOMETERS; SURVIVORS	Objectives: to determine the concurrent validity of a physical activity diary for measuring physical activity level and total energy expenditure in hospitalized stroke patients. Method: Sixteen stroke patients kept coded activity diaries and wore SenseWear Pro2 multi-sensor activity monitors during daytime hours for one day. A researcher observed the patients and completed a diary. Data from the patients' diaries were compared with observed and measured data to determine total activity (METs*minutes), activity level and total energy expenditure. Results: Spearman correlations between the patients' and researchers' diaries revealed a high correlation for total METs*minutes (r(s) = 0.75, p<0.01) for sedentary (r(s) = 0.74, p<0.01) and moderate activities (r(s) = 0.71, p<0.01) and a very high correlation (r(s) = 0.92, p<0.01) for the total energy expenditure. Comparisons between the patients' diaries and activity monitor data revealed a low correlation (r(s) 0.29) for total METs*minutes and energy expenditure. Conclusion: Coded self-monitoring activity diaries appear feasible as a low-tech alternative to labor-intensive observational diaries for determining sedentary, moderate, and total physical activity and for quantifying energy expenditure in hospitalized stroke patients. Given the poor correlation with objective measurements of physical activity, however, further research is needed to validate its use against a gold-standard measure of physical activity intensity and energy expenditure.	[Vanroy, Christel; Truijen, Steven; Vissers, Dirk] Univ Antwerp, Fac Med & Hlth Sci, Dept Rehabil Sci & Physiotherapy, B-2020 Antwerp, Belgium; [Vanroy, Christel; Cras, Patrick] Univ Antwerp, Fac Med & Hlth Sci, B-2020 Antwerp, Belgium; [Vanroy, Christel; Vanlandewijck, Yves; Feys, Hilde] Katholieke Univ Leuven, Dept Rehabil Sci, Leuven, Belgium; [Cras, Patrick] Univ Antwerp Hosp, Dept Neurol, Antwerp, Belgium; [Cras, Patrick] Born Bunge Inst, Dept Neurol, Antwerp, Belgium; [Michielsen, Marc] Jessa Hosp, Herk De Stad, Belgium	University of Antwerp; University of Antwerp; KU Leuven; University of Antwerp	Vanroy, C (corresponding author), Univ Antwerp, Fac Med & Hlth Sci, Dept Rehabil Sci & Physiotherapy, B-2020 Antwerp, Belgium.	christel.vanroy@uantwerpen.be	truijen, steven/G-4179-2016	truijen, steven/0000-0002-0604-1431; Vanlandewijck, Yves/0000-0003-2982-0849; Vanroy, Christel/0000-0002-3228-8913; Vissers, Dirk/0000-0001-5901-6515	Artesis University College Antwerp, Belgium [G841]	Artesis University College Antwerp, Belgium	This research is funded by a research grant (G841) from the Artesis University College Antwerp, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Alzahrani MA, 2011, J PHYSIOTHER, V57, P47, DOI 10.1016/S1836-9553(11)70007-8; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Baert I, 2012, DISABIL REHABIL, V34, P1835, DOI 10.3109/09638288.2012.665130; Bernhardt J, 2004, STROKE, V35, P1005, DOI 10.1161/01.STR.0000120727.40792.40; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Borms J, 1999, BLOSO BRUSSEL, P239; BOUCHARD C, 1983, AM J CLIN NUTR, V37, P461, DOI 10.1093/ajcn/37.3.461; Bratteby LE, 1997, EUR J CLIN NUTR, V51, P585, DOI 10.1038/sj.ejcn.1600449; Carroll SL, 2012, ARCH PHYS MED REHAB, V93, P466, DOI 10.1016/j.apmr.2011.08.047; Chen KY, 2005, MED SCI SPORT EXER, V37, pS490, DOI 10.1249/01.mss.0000185571.49104.82; Conway JM, 2002, AM J CLIN NUTR, V75, P519, DOI 10.1093/ajcn/75.3.519; De Wit L, 2005, STROKE, V36, P1977, DOI 10.1161/01.STR.0000177871.59003.e3; Gebruers N, 2010, ARCH PHYS MED REHAB, V91, P288, DOI 10.1016/j.apmr.2009.10.025; Gibbons RJ, 2002, CIRCULATION, V106, P1883, DOI 10.1161/01.CIR.0000034670.06526.15; Green LB, 2007, TOP STROKE REHABIL, V14, P9, DOI 10.1310/tsr1406-9; Haeuber E, 2004, ARCH PHYS MED REHAB, V85, P1997, DOI 10.1016/j.apmr.2003.11.035; Hale LA, 2008, ARCH PHYS MED REHAB, V89, P1765, DOI 10.1016/j.apmr.2008.02.027; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Hinkle DE, 1988, APPL STAT BEHAV SCI, P117; Koebnick C, 2005, INT J OBESITY, V29, P302, DOI 10.1038/sj.ijo.0802882; Kramer SF, 2013, BIOMED RES INT, V2013, P1; Lincoln N, 1979, Physiotherapy, V65, P48; Machado-Rodrigues AM, 2012, SCAND J MED SCI SPOR, V22, P259, DOI 10.1111/j.1600-0838.2010.01155.x; Macko RF, 2002, MED SCI SPORT EXER, V34, P394, DOI 10.1097/00005768-200203000-00002; Meeus M, 2011, DISABIL REHABIL, V33, P9, DOI 10.3109/09638288.2010.483307; Melanson EL, 2004, PREV MED, V39, P361, DOI 10.1016/j.ypmed.2004.01.032; Michael KM, 2005, ARCH PHYS MED REHAB, V86, P1552, DOI 10.1016/j.apmr.2004.12.026; Pang MYC, 2006, CLIN REHABIL, V20, P97, DOI 10.1191/0269215506cr926oa; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Rimmer JH, 1999, PHYS THER, V79, P495, DOI 10.1093/ptj/79.5.495; Rush EC, 2008, ANN HUM BIOL, V35, P416, DOI 10.1080/03014460802089825; Speck BJ, 2006, PUBLIC HEALTH NURS, V23, P88, DOI 10.1111/j.0737-1209.2006.230112.x; St-Onge M, 2007, AM J CLIN NUTR, V85, P742, DOI 10.1093/ajcn/85.3.742; Stoller O, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-45; Uswatte G, 2005, ARCH PHYS MED REHAB, V86, P1498, DOI 10.1016/j.apmr.2005.01.010; Vanroy C, 2013, DISABIL REHABIL, P1; Wannamethee SG, 1999, J CARDIOVASC RISK, V6, P213; Washburn RA, 2002, ARCH PHYS MED REHAB, V83, P193, DOI 10.1053/apmr.2002.27467; Wendel-Vos GCW, 2004, INT J EPIDEMIOL, V33, P787, DOI 10.1093/ije/dyh168; Wetten AA, 2013, J PHYS ACT HLTH; Wickel EE, 2006, MED SCI SPORT EXER, V38, P373, DOI 10.1249/01.mss.0000183344.46077.bb	42	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98735	10.1371/journal.pone.0098735	http://dx.doi.org/10.1371/journal.pone.0098735			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP1YS	24905345	gold, Green Published, Green Submitted			2022-12-27	WOS:000341869000053
J	Smith, D; Wilkie, R; Uthman, O; Jordan, JL; McBeth, J				Smith, Diane; Wilkie, Ross; Uthman, Olalekan; Jordan, Joanne L.; McBeth, John			Chronic Pain and Mortality: A Systematic Review	PLOS ONE			English	Review							CHRONIC WIDESPREAD PAIN; MUSCULOSKELETAL PAIN; PHYSICAL-ACTIVITY; FOLLOW-UP; SUBSEQUENT MORTALITY; INCREASED RISK; LIFE-STYLE; BACK-PAIN; BODY PAIN; CANCER	Background: Chronic pain is common, often widespread and has a substantial impact on health and quality of life. The relationship between chronic pain and mortality is unclear. This systematic review aimed to identify and evaluate evidence for a relationship between chronic pain and mortality. Methods: A search of ten electronic databases including EMBASE and MEDLINE was conducted in March 2012, and updated until March 2014. Observational studies investigating the association between chronic or widespread pain (including fibromyalgia) and mortality were included. Risk of bias was assessed and a meta-analysis was undertaken to quantify heterogeneity and pool results. A narrative review was undertaken to explore similarities and differences between the included studies. Results: Ten studies were included in the review. Three reported significant associations between chronic or widespread pain and mortality in unadjusted results. In adjusted analyses, four studies reported a significant association. The remaining studies reported no statistically significant association. A meta-analysis showed statistically significant heterogeneity of results from studies using comparable outcome measures (n = 7)(I-2 = 78.8%) and a modest but non-significant pooled estimate (MRR1.14,95% CI 0.95-1.37) for the relationship between chronic pain and all-cause mortality. This association was stronger when analysis was restricted to studies of widespread pain (n = 5, I-2 = 82.3%) MRR1.22(95% CI 0.93-1.60). The same pattern was observed with deaths from cancer and cardiovascular diseases. Heterogeneity is likely to be due to differences in study populations, follow-up time, pain phenotype, methods of analysis and use of confounding factors. Conclusion: This review showed a mildly increased risk of death in people with chronic pain, particularly from cancer. However, the small number of studies and methodological differences prevented clear conclusions from being drawn. Consistently applied definitions of chronic pain and further investigation of the role of health, lifestyle, social and psychological factors in future studies will improve understanding of the relationship between chronic pain and mortality.	[Smith, Diane; Wilkie, Ross; Jordan, Joanne L.; McBeth, John] Keele Univ, Res Inst Primary Care & Hlth Sci, Arthrit Res UK Primary Care Ctr, Keele, Staffs, England; [Uthman, Olalekan] Univ Warwick, Warwick Med Sch, Div Hlth Sci, WCAHRD, Coventry CV4 7AL, W Midlands, England	Keele University; University of Warwick	Smith, D (corresponding author), Keele Univ, Res Inst Primary Care & Hlth Sci, Arthrit Res UK Primary Care Ctr, Keele, Staffs, England.	d.smith4@keele.ac.uk	McBeth, John/AAG-1954-2019; Uthman, Olalekan/N-5584-2019; Jordan, Joanne/E-8186-2014	Uthman, Olalekan/0000-0002-8567-3081; McBeth, John/0000-0001-7047-2183; Jordan, Joanne/0000-0002-7191-2977	Arthritis Research UK Primary Care Centre, Primary Care Sciences, Keele University; MRC [G0501798] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E500579/1] Funding Source: researchfish; Medical Research Council [G0501798] Funding Source: researchfish	Arthritis Research UK Primary Care Centre, Primary Care Sciences, Keele University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors' work was supported by Arthritis Research UK Primary Care Centre, Primary Care Sciences, Keele University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2005, J GERONTOL A-BIOL, V60, P1052, DOI 10.1093/gerona/60.8.1052; Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; Andersson HI, 2009, DISABIL REHABIL, V31, P1980, DOI 10.3109/09638280902874154; Andersson HI, 2004, EUR J PAIN, V8, P47, DOI 10.1016/S1090-3801(03)00064-8; [Anonymous], 2009, SYSTEMATIC REV CRDS; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Bergman S, 2005, DISABIL REHABIL, V27, P675, DOI 10.1080/09638280400009030; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Carnes D, 2007, RHEUMATOLOGY, V46, P1168, DOI 10.1093/rheumatology/kem118; CROFT P, 1993, J RHEUMATOL, V20, P710; Crombie IK, 2001, BMJ-BRIT MED J, V323, P662; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dickersin K, 2002, INT J EPIDEMIOL, V31, P6, DOI 10.1093/ije/31.1.6; Ditre JW, 2008, J ABNORM PSYCHOL, V117, P467, DOI 10.1037/0021-843X.117.2.467; Dreyer L, 2007, J RHEUMATOL, V34, P201; Dreyer L, 2010, ARTHRITIS RHEUM-US, V62, P3101, DOI 10.1002/art.27623; EGGER M, 2001, SYSTEMATIC REV HEALT; Elliott AM, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-158; Fagerstrom K, 2002, DRUGS, V62, P1, DOI 10.2165/00003495-200262002-00001; Fishbain DA, 2003, PAIN MED, V4, P51, DOI 10.1046/j.1526-4637.2003.03008.x; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Hardy SE, 2008, J AM GERIATR SOC, V56, P1910, DOI 10.1111/j.1532-5415.2008.01957.x; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; HELIOVAARA M, 1995, SPINE, V20, P2109, DOI 10.1097/00007632-199510000-00008; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hochber MC, 2008, CLIN EXP RHEUMATOL, V26, pS120; House JS, 2001, PSYCHOSOM MED, V63, P273, DOI 10.1097/00006842-200103000-00011; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Hunt IM, 1999, RHEUMATOLOGY, V38, P275, DOI 10.1093/rheumatology/38.3.275; Jordan K. P., 2010, BR J GEN PRACT, V60, P105; Jordan KP, 2013, INT J CANCER, V133, P713, DOI 10.1002/ijc.28055; Kamaleri Y, 2008, PAIN, V138, P41, DOI 10.1016/j.pain.2007.11.002; Kareholt I, 1998, PAIN, V77, P271, DOI 10.1016/S0304-3959(98)00103-1; Khang YH, 2010, J WOMENS HEALTH, V19, P109, DOI 10.1089/jwh.2009.1413; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Liu YP, 2011, EUR UROL, V60, P1029, DOI 10.1016/j.eururo.2011.07.007; Macfarlane GJ, 2007, RHEUMATOLOGY, V46, P805, DOI 10.1093/rheumatology/kel403; Macfarlane GJ, 2001, BMJ-BRIT MED J, V323, P1; MAKELA M, 1991, BRIT MED J, V303, P216, DOI 10.1136/bmj.303.6796.216; Maruta T, 1998, PAIN, V74, P199, DOI 10.1016/S0304-3959(97)00182-6; McBeth J, 2003, ARTHRITIS RHEUM, V48, P1686, DOI 10.1002/art.10973; McBeth J, 2009, RHEUMATOLOGY, V48, P74, DOI 10.1093/rheumatology/ken424; McBeth J, 2007, BEST PRACT RES CL RH, V21, P403, DOI 10.1016/j.berh.2007.03.003; Merskey H., 1994, CLASSIFICATION CHRON, V2nd ed; Monninkhof EM, 2007, EPIDEMIOLOGY, V18, P137, DOI 10.1097/01.ede.0000251167.75581.98; Moulin Dwight E, 2002, Pain Res Manag, V7, P179; Mykletun A, 2009, BRIT J PSYCHIAT, V195, P118, DOI 10.1192/bjp.bp.108.054866; Nitter AK, 2013, SCAND J PAIN, V4, P86, DOI 10.1016/j.sjpain.2012.12.002; PENTTINEN J, 1994, BRIT MED J, V309, P1267, DOI 10.1136/bmj.309.6964.1267; Ray L, 2011, PAIN, V152, P53, DOI 10.1016/j.pain.2010.08.043; Ryan R., 2014, COCHRANE CONSUM COMM; Sha MC, 2005, AM J MED, V118, P301, DOI 10.1016/j.amjmed.2004.12.015; Sjogren P, 2010, CLIN J PAIN, V26, P763, DOI 10.1097/AJP.0b013e3181f15daf; Smith BH, 2003, BRIT J GEN PRACT, V53, P45; Tang NKY, 2006, PSYCHOL MED, V36, P575, DOI 10.1017/S0033291705006859; Torrance N, 2010, EUR J PAIN, V14, P380, DOI 10.1016/j.ejpain.2009.07.006; VanDenKerkhof EG, 2011, PAIN RES MANAG, V16, P87, DOI 10.1155/2011/727094; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2011, J RHEUMATOL, V38, P1113, DOI 10.3899/jrheum.100594; Wolfe F, 2011, ARTHRIT CARE RES, V63, P94, DOI 10.1002/acr.20301; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Woolf AD, 2012, BEST PRACT RES CL RH, V26, P183, DOI 10.1016/j.berh.2012.03.005	63	75	75	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99048	10.1371/journal.pone.0099048	http://dx.doi.org/10.1371/journal.pone.0099048			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901358	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000336841400091
J	Dimitrieva, S; Anisimova, M				Dimitrieva, Slavica; Anisimova, Maria			Unraveling Patterns of Site-to-Site Synonymous Rates Variation and Associated Gene Properties of Protein Domains and Families	PLOS ONE			English	Article							MESSENGER-RNA STABILITY; CODON USAGE; PURIFYING SELECTION; ADAPTIVE EVOLUTION; SILENT SITES; TRANSLATIONAL SELECTION; STATISTICAL-METHODS; SPLICING ENHANCERS; BASE COMPOSITION; MUTATIONS	In protein-coding genes, synonymous mutations are often thought not to affect fitness and therefore are not subject to natural selection. Yet increasingly, cases of non-neutral evolution at certain synonymous sites were reported over the last decade. To evaluate the extent and the nature of site-specific selection on synonymous codons, we computed the site-to-site synonymous rate variation (SRV) and identified gene properties that make SRV more likely in a large database of protein-coding gene families and protein domains. To our knowledge, this is the first study that explores the determinants and patterns of the SRV in real data. We show that the SRV is widespread in the evolution of protein-coding sequences, putting in doubt the validity of the synonymous rate as a standard neutral proxy. While protein domains rarely undergo adaptive evolution, the SRV appears to play important role in optimizing the domain function at the level of DNA. In contrast, protein families are more likely to evolve by positive selection, but are less likely to exhibit SRV. Stronger SRV was detected in genes with stronger codon bias and tRNA reusage, those coding for proteins with larger number of interactions or forming larger number of structures, located in intracellular components and those involved in typically conserved complex processes and functions. Genes with extreme SRV show higher expression levels in nearly all tissues. This indicates that codon bias in a gene, which often correlates with gene expression, may often be a site-specific phenomenon regulating the speed of translation along the sequence, consistent with the co-translational folding hypothesis. Strikingly, genes with SRV were strongly overrepresented for metabolic pathways and those associated with several genetic diseases, particularly cancers and diabetes.	[Dimitrieva, Slavica] Swiss Inst Expt Canc Res ISREC, Lausanne, Switzerland; [Dimitrieva, Slavica] Swiss Fed Inst Technol Lausanne EPFL, Lausanne, Switzerland; [Dimitrieva, Slavica; Anisimova, Maria] Swiss Fed Inst Technol, Dept Comp Sci, Zurich, Switzerland; [Dimitrieva, Slavica; Anisimova, Maria] SIB, Lausanne, Switzerland	Swiss Institute Experimental Cancer Research; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics	Anisimova, M (corresponding author), Zurich Univ Appl Sci ZHAW, Inst Appl Simulat, Wadenswil, Switzerland.	maria.anisimova@zhaw.ch		Anisimova, Maria/0000-0001-8145-7966	Swiss State Secretariat for Education and Research; Swiss National Science Foundation [31003A_127325/1]; ETH Zurich	Swiss State Secretariat for Education and Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich)	SD was supported by the Swiss State Secretariat for Education and Research and has received an ETH medal for her Master thesis (including some work presented in this article). MA is supported by the ETH Zurich and is receiving funding from Swiss National Science Foundation (31003A_127325/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi H, 1998, CURR OPIN GENET DEV, V8, P688, DOI 10.1016/S0959-437X(98)80038-5; Amit M, 2012, CELL REP, V1, P543, DOI 10.1016/j.celrep.2012.03.013; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152; Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Anisimova M, 2012, CODON EVOLUTION MECH; Aris-Brosou S, 2005, MOL BIOL EVOL, V22, P200, DOI 10.1093/molbev/msi006; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balakirev ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022613; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENNETZEN JL, 1982, J BIOL CHEM, V257, P3026; Cannarrozzi G, 2010, CELL, V141, P355, DOI 10.1016/j.cell.2010.02.036; Capon F, 2004, HUM MOL GENET, V13, P2361, DOI 10.1093/hmg/ddh273; Chamary JV, 2009, SCI AM, V300, P46, DOI 10.1038/scientificamerican0609-46; Chamary JV, 2005, TRENDS GENET, V21, P256, DOI 10.1016/j.tig.2005.03.001; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Charneski CA, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001508; Chen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013574; CLARKE B, 1970, SCIENCE, V168, P1009, DOI 10.1126/science.168.3934.1009; Dimitrieva S, 2010, TRENDS EVOL BIOL, V2; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Duret L, 2002, CURR OPIN GENET DEV, V12, P640, DOI 10.1016/S0959-437X(02)00353-2; Eskesen ST, 2004, GENETICS, V167, P543, DOI 10.1534/genetics.167.1.543; Eyre-Walker A, 1999, GENETICS, V152, P675; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Frenkel-Morgenstern M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.3; Friberg MT, 2006, LECT NOTES COMPUT SC, V4175, P1; Gingold H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.14; Gonnet GH, 2000, BIOINFORMATICS, V16, P101, DOI 10.1093/bioinformatics/16.2.101; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hughes AL, 1997, J MOL EVOL, V45, P125, DOI 10.1007/PL00006211; Hurst LD, 2001, TRENDS GENET, V17, P62, DOI 10.1016/S0168-9525(00)02173-9; Iida K, 2000, GENE, V261, P93, DOI 10.1016/S0378-1119(00)00482-0; IKEMURA T, 1981, J MOL BIOL, V146, P1, DOI 10.1016/0022-2836(81)90363-6; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Kandasamy K, 2009, NUCLEIC ACIDS RES, V37, pD773, DOI 10.1093/nar/gkn701; Kelly AC, 2008, PRION, V2, P28, DOI 10.4161/pri.2.1.6321; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Komar AA, 2007, PHARMACOGENOMICS, V8, P1075, DOI 10.2217/14622416.8.8.1075; Komar AA, 2007, SCIENCE, V315, P466, DOI 10.1126/science.1138239; Komar AA, 2009, TRENDS BIOCHEM SCI, V34, P16, DOI 10.1016/j.tibs.2008.10.002; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Lu HC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000608; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Najafabadi HS, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r87; Necsulea A, 2009, TRENDS GENET, V25, P519, DOI 10.1016/j.tig.2009.10.001; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Orban TI, 2001, TRENDS GENET, V17, P252; Oresic M, 1998, J MOL BIOL, V281, P31, DOI 10.1006/jmbi.1998.1921; Park SG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-241; PEDEN JF, 1999, THESIS U NOTTINGHAM; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Presgraves DC, 2007, MOL BIOL EVOL, V24, P306, DOI 10.1093/molbev/msl157; Qian WF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002603; Resch AM, 2007, MOL BIOL EVOL, V24, P1821, DOI 10.1093/molbev/msm100; Roth A, 2012, CODON EVOLUTION: MECHANISMS AND MODELS, P189; Sauna ZE, 2007, CANCER RES, V67, P9609, DOI 10.1158/0008-5472.CAN-07-2377; Sauna ZE, 2007, PHARMACOGENOMICS, V8, P527, DOI 10.2217/14622416.8.6.527; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Shah JH, 2008, ADV EXP MED BIOL, V614, P145, DOI 10.1007/978-0-387-74911-2_17; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Thanaraj TA, 1996, PROTEIN SCI, V5, P1594, DOI 10.1002/pro.5560050814; Tsai CJ, 2008, J MOL BIOL, V383, P281, DOI 10.1016/j.jmb.2008.08.012; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Whelan S, 2006, NUCLEIC ACIDS RES, V34, pD327, DOI 10.1093/nar/gkj087; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Wright SI, 2004, MOL BIOL EVOL, V21, P1719, DOI 10.1093/molbev/msh191; Xing Y, 2006, NAT REV GENET, V7, P499, DOI 10.1038/nrg1896; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636; Zhang LQ, 2004, MOL BIOL EVOL, V21, P236, DOI 10.1093/molbev/msh010; Zhou T, 2010, MOL BIOL EVOL, V27, P1912, DOI 10.1093/molbev/msq077	79	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e95034	10.1371/journal.pone.0095034	http://dx.doi.org/10.1371/journal.pone.0095034			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896293	Green Submitted, Green Published, gold			2022-12-27	WOS:000338430700002
J	Gomes-Giacoia, E; Miyake, M; Goodison, S; Sriharan, A; Zhang, G; You, LJ; Egan, JO; Rhode, PR; Parker, AS; Chai, KX; Wong, HC; Rosser, CJ				Gomes-Giacoia, Evan; Miyake, Makito; Goodison, Steve; Sriharan, Aravindhan; Zhang, Ge; You, Lijing; Egan, Jack O.; Rhode, Peter R.; Parker, Alexander S.; Chai, Karl X.; Wong, Hing C.; Rosser, Charles J.			Intravesical ALT-803 and BCG Treatment Reduces Tumor Burden in a Carcinogen Induced Bladder Cancer Rat Model; a Role for Cytokine Production and NK Cell Expansion	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; UROTHELIAL CARCINOMA; GENE-THERAPY; N-BUTYL-N-(4-HYDROXYBUTYL) NITROSAMINE; MITOMYCIN-C; STAGE-TA; IMMUNOTHERAPY; INTERLEUKIN-15; IL-15; EXPRESSION	Intravesical Bacillus Calmette-Guerin (BCG) has been shown to induce a specific immunologic response (i.e., activation of IL-2 and effector T-cells), while preclinical studies using ALT-803 (mutated IL-15 analogue combined with IL-15R alpha-Fc fusion) have shown promising results by prolonging the agent's half-life and stimulating CD8+ T-cells. Based on these results, we hypothesized that the intravesical administration of ALT-803 along with BCG will generate an immunologic response leading to significant bladder tumor burden reduction. Using a well-established carcinogen induced rat non-muscle invasive bladder cancer (NMIBC) model, we studied the effects of intravesical ALT-803 with and without BCG. Rat tissues were evaluated to document treatment response. Intravesical ALT-803 was safe and well tolerated alone and in combination with BCG. As a single treatment agent, ALT-803 reduced tumor burden by 35% compared to control whereas BCG alone only reduced tumor burden by 15%. However, the combination of ALT-803 plus BCG reduced tumor burden by 46% compared to control. Immune monitoring suggested that the antitumor response was linked to the production and secretion of IL-1 alpha, IL-1 beta and RANTES, which in turn, induced the proliferation and activation of NK cells. Lastly, tumoral responses of the combinational treatment were associated with 76% reduction in angiogenesis, which is significantly higher than when assessed with either agent alone. The enhanced therapeutic index seen with this duplet provides justification for the development of this regimen for future clinical trials.	[Gomes-Giacoia, Evan; Miyake, Makito; Goodison, Steve; Zhang, Ge; Rosser, Charles J.] MD Anderson Canc Ctr Orlando, Canc Res Inst, Orlando, FL 32806 USA; [Goodison, Steve; Parker, Alexander S.] Mayo Clin, Dept Hlth Sci Res, Jacksonville, FL 32224 USA; [Sriharan, Aravindhan] MD Anderson Canc Ctr Orlando, Dept Pathol, Orlando, FL USA; [You, Lijing; Egan, Jack O.; Rhode, Peter R.; Wong, Hing C.] Altor Biosci Corp, Miramar, FL USA; [Chai, Karl X.] Univ Cent Florida, Burnett Coll Biomed Sci, Orlando, FL 32816 USA; [Rosser, Charles J.] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA	University of Texas System; UTMD Anderson Cancer Center; Mayo Clinic; University of Texas System; UTMD Anderson Cancer Center; State University System of Florida; University of Central Florida; Cancer Research Center of Hawaii; University of Hawaii System	Rosser, CJ (corresponding author), MD Anderson Canc Ctr Orlando, Canc Res Inst, Orlando, FL 32806 USA.	cjrosser@hawaii.edu		Wong, Hing C./0000-0002-6865-4313	James and Esther King Biomedical Team Science Project [1KT-01]; NATIONAL CANCER INSTITUTE [R01CA116161, R43CA156740] Funding Source: NIH RePORTER	James and Esther King Biomedical Team Science Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the James and Esther King Biomedical Team Science Project 1KT-01 (C.J. Rosser). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askeland EJ, 2012, ADV UROL, V2012, DOI 10.1155/2012/181987; Babjuk M, 2013, EUR UROL, V64, P639, DOI 10.1016/j.eururo.2013.06.003; BECICH MJ, 1991, J UROLOGY, V145, P1316, DOI 10.1016/S0022-5347(17)38622-6; Bevers RFM, 2004, BRIT J CANCER, V91, P607, DOI 10.1038/sj.bjc.6602026; BOHLE A, 1990, J UROLOGY, V144, P53, DOI 10.1016/S0022-5347(17)39365-5; Cheever MAM, 2008, IMMUNOL REV, V222, P357, DOI 10.1111/j.1600-065X.2008.00604.x; Chenoweth MJ, 2012, J IMMUNOL, V188, P4149, DOI 10.4049/jimmunol.1101883; Clark PE, 2013, J NATL COMPR CANC NE, V11, P446, DOI 10.6004/jnccn.2013.0059; Cobb D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/924023; de Reijke TM, 1999, J UROLOGY, V161, P67, DOI 10.1016/S0022-5347(01)62065-2; Dubsky P, 2007, EUR J IMMUNOL, V37, P1678, DOI 10.1002/eji.200636329; Fehniger TA, 2002, CYTOKINE GROWTH F R, V13, P169, DOI 10.1016/S1359-6101(01)00021-1; Greco O, 2002, FRONT BIOSCI-LANDMRK, V7, pD1516, DOI 10.2741/greco; Grubbs CJ, 2000, CANCER RES, V60, P5599; Hall MC, 2007, J UROLOGY, V178, P2314, DOI 10.1016/j.juro.2007.09.003; Han KP, 2011, CYTOKINE, V56, P804, DOI 10.1016/j.cyto.2011.09.028; Herr HW, 2012, J UROLOGY, V187, P435, DOI 10.1016/j.juro.2011.10.032; Herr HW, 2000, J UROLOGY, V163, P60, DOI 10.1016/S0022-5347(05)67972-4; Iida K, 2004, CANCER RES, V64, P6424, DOI 10.1158/0008-5472.CAN-04-1906; Kaempfer R, 1996, J CLIN ONCOL, V14, P1778, DOI 10.1200/JCO.1996.14.6.1778; Kandasamy M, 2011, CELL IMMUNOL, V271, P89, DOI 10.1016/j.cellimm.2011.06.004; Kitamura H, 2006, CLIN CANCER RES, V12, P4641, DOI 10.1158/1078-0432.CCR-06-0595; Krege S, 1996, J UROLOGY, V156, P962, DOI 10.1016/S0022-5347(01)65673-8; Krensky AM, 2009, TISSUE ANTIGENS, V73, P193, DOI 10.1111/j.1399-0039.2008.01218.x; Kresowik TP, 2009, IMMUNOTHERAPY-UK, V1, P281, DOI 10.2217/1750743X.1.2.281; Lamm DL, 2000, J UROLOGY, V163, P1124, DOI 10.1016/S0022-5347(05)67707-5; LeBlanc F, 2012, FUTURE ONCOL, V8, P787, DOI [10.2217/fon.12.75, 10.2217/FON.12.75]; Liu DF, 2012, J CLIN INVEST, V122, P2221, DOI 10.1172/JCI59535; Matsumoto K, 2011, HUM GENE THER, V22, P1423, DOI 10.1089/hum.2011.013; Miyamoto H, 2007, J NATL CANCER I, V99, P558, DOI 10.1093/jnci/djk113; Mortier E, 2006, J BIOL CHEM, V281, P1612, DOI 10.1074/jbc.M508624200; Nepple KG, 2010, J UROLOGY, V184, P1915, DOI 10.1016/j.juro.2010.06.147; Okamura T, 1999, CANCER LETT, V140, P129, DOI 10.1016/S0304-3835(99)00060-9; Oliveira PA, 2006, ANTICANCER RES, V26, P2995; PRESCOTT S, 1990, J UROLOGY, V144, P1248, DOI 10.1016/S0022-5347(17)39713-6; Saint F, 2003, INT J CANCER, V107, P434, DOI 10.1002/ijc.11352; Saint F, 2002, J UROLOGY, V167, P364, DOI 10.1016/S0022-5347(05)65469-9; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stoklasek TA, 2006, J IMMUNOL, V177, P6072, DOI 10.4049/jimmunol.177.9.6072; Suttmann H, 2003, INFECT IMMUN, V71, P4647, DOI 10.1128/IAI.71.8.4647-4656.2003; Sylvester RJ, 2010, EUR UROL, V57, P766, DOI 10.1016/j.eururo.2009.12.024; Tang FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076292; Thalmann GN, 2000, J UROLOGY, V164, P2129, DOI 10.1016/S0022-5347(05)66983-2; Tyagi A, 2007, MOL CANCER THER, V6, P3248, DOI 10.1158/1535-7163.MCT-07-2006; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Weidner N, 1998, J PATHOL, V184, P119, DOI 10.1002/(SICI)1096-9896(199802)184:2<119::AID-PATH17>3.0.CO;2-D; Williams PD, 2008, NEOPLASIA, V10, P838, DOI 10.1593/neo.08432; Wong HC, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26442; Xu WZ, 2012, SCI TECHNOL ENERG MA, V73, P15; YAGISAWA M, 1995, EXP HEMATOL, V23, P603; Yamashita M, 2002, CANCER GENE THER, V9, P687, DOI 10.1038/sj.cgt.7700488; Zhu XY, 2009, J IMMUNOL, V183, P3598, DOI 10.4049/jimmunol.0901244	52	67	71	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e96705	10.1371/journal.pone.0096705	http://dx.doi.org/10.1371/journal.pone.0096705			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896845	gold, Green Published, Green Submitted			2022-12-27	WOS:000338430700004
J	Andrade, AL; Ternes, YM; Vieira, MA; Moreira, WG; Lamaro-Cardoso, J; Kipnis, A; Cardoso, MR; Brandileone, MC; Moura, I; Pimenta, FC; Carvalho, MD; Saraiva, FO; Toscano, CM; Minamisava, R				Andrade, Ana Lucia; Ternes, Yves Mauro; Vieira, Maria Aparecida; Moreira, Weslley Garcia; Lamaro-Cardoso, Juliana; Kipnis, Andre; Cardoso, Maria Regina; Brandileone, Maria Cristina; Moura, Iaci; Pimenta, Fabiana C.; Carvalho, Maria da Gloria; Saraiva, Fabricia Oliveira; Toscano, Cristiana Maria; Minamisava, Ruth			Direct Effect of 10-Valent Conjugate Pneumococcal Vaccination on Pneumococcal Carriage in Children Brazil	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; DOSING SCHEDULES; IMPACT; COLONIZATION; DISEASE; EFFICACY; VACCINES; PROGRAM	Background: 10-valent conjugate pneumococcal vaccine/PCV10 was introduced in the Brazilian National Immunization Program along the year of 2010. We assessed the direct effectiveness of PCV10 vaccination in preventing nasopharyngeal/NP pneumococcal carriage in infants. Methods: A cross-sectional population-based household survey was conducted in Goiania Brazil, from December/2010-February/2011 targeting children aged 7-11 m and 15-18 m. Participants were selected using a systematic sampling. NP swabs, demographic data, and vaccination status were collected from 1,287 children during home visits. Main outcome and exposure of interest were PCV10 vaccine-type carriage and dosing schedules (3p+0, 2p+0, and one catch-up dose), respectively. Pneumococcal carriage was defined by a positive culture and serotyping was performed by Quellung reaction. Rate ratio/RR was calculated as the ratio between the prevalence of vaccine-types carriage in children exposed to different schedules and unvaccinated for PCV10. Adjusted RR was estimated using Poisson regression. PCV10 effectiveness/VE on vaccine-type carriage was calculated as 1-RR*100. Results: The prevalence of pneumococcal carriage was 41.0% (95% CI: 38.4-43.7). Serotypes covered by PCV10 and PCV13 were 35.2% and 53.0%, respectively. Vaccine serotypes 6B (11.6%), 23F (7.8%), 14 (6.8%), and 19F (6.6%) were the most frequently observed. After adjusted for confounders, children who had received 2p+0 or 3p+0 dosing schedule presented a significant reduction in pneumococcal vaccine-type carriage, with PCV10 VE equal to 35.9% (95% CI: 4.2-57.1; p = 0.030) and 44.0% (95% CI: 14.-63.5; p = 0.008), respectively, when compared with unvaccinated children. For children who received one catch-up dose, no significant VE was detected (p = 0.905). Conclusion: PCV10 was associated with high protection against vaccine-type carriage with 2p+0 and 3p+0 doses for children vaccinated before the second semester of life. The continuous evaluation of carriage serotypes distribution is likely to be useful for evaluating the long-term effectiveness and impact of pneumococcal vaccination on serotypes reduction.	[Andrade, Ana Lucia; Ternes, Yves Mauro; Moreira, Weslley Garcia; Saraiva, Fabricia Oliveira; Toscano, Cristiana Maria] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil; [Ternes, Yves Mauro] Secretariat Hlth Municipal Goiania, Epidemiol Branch, Goiania, Go, Brazil; [Vieira, Maria Aparecida] Pontifical Catholic Univ Goias, Goiania, Go, Brazil; [Moreira, Weslley Garcia; Lamaro-Cardoso, Juliana; Kipnis, Andre] Univ Fed Goias, Bacteriol Lab, Goiania, Go, Brazil; [Cardoso, Maria Regina] Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Sao Paulo, Brazil; [Brandileone, Maria Cristina] Adolfo Lutz Inst, Sao Paulo, Brazil; [Moura, Iaci; Pimenta, Fabiana C.; Carvalho, Maria da Gloria] Ctr Dis Control & Prevent, Resp Dis Branch, Atlanta, GA USA; [Minamisava, Ruth] Univ Fed Goias, Fac Nursing, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias; Universidade de Sao Paulo; Instituto Adolfo Lutz; Centers for Disease Control & Prevention - USA; Universidade Federal de Goias	Andrade, AL (corresponding author), Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil.	alssandrade@gmail.com	Kipnis, Andre/M-7485-2017; Kipnis, Andre/ABG-5707-2020; Andrade, Ana Lucia/L-5751-2013	Kipnis, Andre/0000-0001-5950-106X; Kipnis, Andre/0000-0001-5950-106X; Cardoso, Maria Regina/0000-0001-6092-9215; Oliveira, Fabricia da Silva/0000-0001-9419-5280; TOSCANO, CRISTIANA/0000-0002-9453-2643; Minamisava, Ruth/0000-0001-9352-5567	National Council for Scientific and Technological Development (CNPq); National Institute of Science and Technology for Health (IATS) [573826/2008-0, 306096/2010-2]; Research Foundation of the Goias State/ FAPEG-GO, Brazil [PRONEX/07-2009]; Foundation for Research Support/ FUNAPE-GO, Federal University of Goias [34131]; Fogarty International Center Global Infectious Diseases Research Training Program; National Institutes of Health [D43TW006592]	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institute of Science and Technology for Health (IATS); Research Foundation of the Goias State/ FAPEG-GO, Brazil; Foundation for Research Support/ FUNAPE-GO, Federal University of Goias; Fogarty International Center Global Infectious Diseases Research Training Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding provided by National Council for Scientific and Technological Development (CNPq) and National Institute of Science and Technology for Health (IATS) (#573826/2008-0; 306096/2010-2); Research Foundation of the Goias State/ FAPEG-GO, Brazil (Grant: PRONEX/07-2009); Foundation for Research Support/ FUNAPE-GO, Federal University of Goias (#34131). This work was supported in part by a Fogarty International Center Global Infectious Diseases Research Training Program grant, National Institutes of Health, to the University of Pittsburgh (D43TW006592). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso ET, 2013, EMERG INFECT DIS, V19, P589, DOI 10.3201/eid1904.121198; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P129; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P258; Auranen K, 2013, BIOMETRICS, V69, P235, DOI 10.1111/j.1541-0420.2012.01826.x; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Brazil Ministry of Health, 2010, PROP INTR VAC PNEUM, P14; Brazil Ministry of Health, 2014, SIST INF PROGR NAC I; BROOME CV, 1980, NEW ENGL J MED, V303, P549, DOI 10.1056/NEJM198009043031003; Carvalho MD, 2010, J CLIN MICROBIOL, V48, P1611, DOI 10.1128/JCM.02243-09; Cohen R, 2012, PEDIATR INFECT DIS J, V31, P297, DOI 10.1097/INF.0b013e318247ef84; Cooper D, 2011, VACCINE, V29, P7207, DOI 10.1016/j.vaccine.2011.06.056; Fernandez J, 2000, J INFECT DIS, V182, P1553, DOI 10.1086/315870; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; Fleming-Dutra KE, 2014, PEDIATR INFECT DIS J, V33, pS152, DOI 10.1097/INF.0000000000000083; Franco CM, 2010, PEDIATR INFECT DIS J, V29, P77, DOI 10.1097/INF.0b013e3181af7e90; Grijalva CG, 2007, LANCET, V369, P1179, DOI 10.1016/S0140-6736(07)60564-9; Grivea IN, 2008, PEDIATR INFECT DIS J, V27, P519, DOI 10.1097/INF.0b013e318168d28a; Halloran ME., 2010, DESIGN ANAL VACCINE; Hanquet G, 2013, VACCINE, V31, P5634, DOI 10.1016/j.vaccine.2013.07.006; Huang SS, 2009, PEDIATRICS, V124, pE1, DOI 10.1542/peds.2008-3099; Jansen AGSC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001480.pub3; Kellner JD, 2008, PEDIATR INFECT DIS J, V27, P526, DOI 10.1097/INF.0b013e3181658c5c; Kuo CY, 2011, VACCINE, V29, P5171, DOI 10.1016/j.vaccine.2011.05.034; Mbelle N, 1999, J INFECT DIS, V180, P1171, DOI 10.1086/315009; Miernyk K, 2011, J CLIN MICROBIOL, V49, P3209, DOI 10.1128/JCM.00610-11; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Park IH, 2012, MBIO, V3, DOI 10.1128/mBio.00035-12; Parra EL, 2013, VACCINE, V31, P4033, DOI 10.1016/j.vaccine.2013.04.074; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Prymula R, 2011, VACCINE, V29, P1959, DOI 10.1016/j.vaccine.2010.12.086; Roca A, 2012, CLIN INFECT DIS, V55, P816, DOI 10.1093/cid/cis554; Roca A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001107; Scott JR, 2012, J INFECT DIS, V205, P280, DOI 10.1093/infdis/jir730; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Spijkerman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039730; Spijkerman J, 2011, EMERG INFECT DIS, V17, P584, DOI 10.3201/eid1704.101115; Tocheva AS, 2011, VACCINE, V29, P4400, DOI 10.1016/j.vaccine.2011.04.004; van den Bergh MR, 2013, CLIN INFECT DIS, V56, pE30, DOI 10.1093/cid/cis922; Vestrheim DF, 2010, CLIN VACCINE IMMUNOL, V17, P325, DOI 10.1128/CVI.00435-09; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2; Whitney CG, 2014, PEDIATR INFECT DIS J, V33, pS172, DOI 10.1097/INF.0000000000000076; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	46	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98128	10.1371/journal.pone.0098128	http://dx.doi.org/10.1371/journal.pone.0098128			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892409	Green Published, gold, Green Submitted			2022-12-27	WOS:000336911400036
J	Jansson, KH; Castillo, DG; Morris, JW; Boggs, ME; Czymmek, KJ; Adams, EL; Schramm, LP; Sikes, RA				Jansson, Keith H.; Castillo, Deborah G.; Morris, Joseph W.; Boggs, Mary E.; Czymmek, Kirk J.; Adams, Elizabeth L.; Schramm, Lawrence P.; Sikes, Robert A.			Identification of Beta-2 as a Key Cell Adhesion Molecule in PCa Cell Neurotropic Behavior: A Novel Ex Vivo and Biophysical Approach	PLOS ONE			English	Article							GATED SODIUM-CHANNELS; RADICAL PROSTATECTOMY SPECIMENS; DORSAL-ROOT GANGLIA; PERINEURAL INVASION; CANCER CELLS; EXTRACELLULAR-MATRIX; RHOC GTPASE; LNCAP MODEL; IN-VITRO; SUBUNITS	Prostate cancer (PCa) is believed to metastasize through the blood/lymphatics systems; however, PCa may utilize the extensive innervation of the prostate for glandular egress. The interaction of PCa and its nerve fibers is observed in 80% of PCa and is termed perineural invasion (PNI). PCa cells have been observed traveling through the endoneurium of nerves, although the underlying mechanisms have not been elucidated. Voltage sensitive sodium channels (VSSC) are multimeric transmembrane protein complexes comprised of a pore-forming a subunit and one or two auxiliary beta (beta) subunits with inherent cell adhesion molecule (CAM) functions. The beta-2 isoform (gene SCN2B) interacts with several neural CAMs, while interacting putatively with other prominent neural CAMs. Furthermore, beta-2 exhibits elevated mRNA and protein levels in highly metastatic and castrate-resistant PCa. When overexpressed in weakly aggressive LNCaP cells (2BECFP), beta-2 alters LNCaP cell morphology and enhances LNCaP cell metastasis associated behavior in vitro. We hypothesize that PCa cells use beta-2 as a CAM during PNI and subsequent PCa metastasis. The objective of this study was to determine the effect of beta-2 expression on PCa cell neurotropic metastasis associated behavior. We overexpressed beta-2 as a fusion protein with enhanced cyan fluorescence protein (ECFP) in weakly aggressive LNCaP cells and observed neurotropic effects utilizing our novel ex vivo organotypic spinal cord co-culture model, and performed functional assays with neural matrices and atomic force microscopy. With increased beta-2 expression, PCa cells display a trend of enhanced association with nerve axons. On laminin, a neural CAM, overexpression of beta-2 enhances PCa cell migration, invasion, and growth. 2BECFP cells exhibit marked binding affinity to laminin relative to LNECFP controls, and recombinant beta-2 ectodomain elicits more binding events to laminin than BSA control. Functional overexpression of VSSC beta subunits in PCa may mediate PCa metastatic behavior through association with neural matrices.	[Jansson, Keith H.; Morris, Joseph W.; Sikes, Robert A.] Univ Delaware, Dept Biol Sci, Lab Canc Ontogeny & Therapeut, Newark, DE 19716 USA; [Jansson, Keith H.; Morris, Joseph W.; Boggs, Mary E.; Czymmek, Kirk J.; Sikes, Robert A.] Univ Delaware, Ctr Translat Canc Res, Newark, DE USA; [Castillo, Deborah G.; Schramm, Lawrence P.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Czymmek, Kirk J.; Adams, Elizabeth L.] Univ Delaware, Delaware Biotechnol Inst, Newark, DE USA	University of Delaware; University of Delaware; Johns Hopkins University; University of Delaware	Sikes, RA (corresponding author), Univ Delaware, Dept Biol Sci, Lab Canc Ontogeny & Therapeut, Newark, DE 19716 USA.	rasikes@udel.edu		Czymmek, Kirk/0000-0002-5471-7395	University of Delaware Center for Translational Cancer Research; University of Delaware Graduate Fellows Award; INBRE core waiver; COBRE NIH [P20 RR015588]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103446] Funding Source: NIH RePORTER	University of Delaware Center for Translational Cancer Research; University of Delaware Graduate Fellows Award; INBRE core waiver; COBRE NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding of this research was made possible through support by the University of Delaware Center for Translational Cancer Research, The University of Delaware Graduate Fellows Award, INBRE core waiver, and COBRE NIH P20 RR015588. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aman TK, 2009, J NEUROSCI, V29, P2027, DOI 10.1523/JNEUROSCI.4531-08.2009; Ayala GE, 2006, CANCER RES, V66, P5159, DOI 10.1158/0008-5472.CAN-05-1847; Ayala GE, 2006, PROSTATE, V66, P266, DOI 10.1002/pros.20323; Ayala GE, 2004, CANCER RES, V64, P6082, DOI 10.1158/0008-5472.CAN-04-0838; Ayala GE, 2001, PROSTATE, V49, P213, DOI 10.1002/pros.1137; Ayala GE, 2008, CLIN CANCER RES, V14, P7593, DOI 10.1158/1078-0432.CCR-08-1164; Bastatas L, 2012, BBA-GEN SUBJECTS, V1820, P1111, DOI 10.1016/j.bbagen.2012.02.006; Batson O V, 1995, Clin Orthop Relat Res, P4; Batson O V, 1967, Prog Clin Cancer, V3, P1; Brackenbury WJ, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00053; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Carlin Bruce I., 2000, Cancer, V88, P2989, DOI 10.1002/1097-0142(20000615)88:12+<2989::AID-CNCR14>3.3.CO;2-H; Castillo DG, 2011, CHARACTERIZATION AXO; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; CATTERALL WA, 1992, PHYSIOL REV, V72, pS15, DOI 10.1152/physrev.1992.72.suppl_4.S15; Chen CL, 2012, J BIOL CHEM, V287, P39061, DOI 10.1074/jbc.M112.397646; Diss JKJ, 2008, PROSTATE CANCER P D, V11, P325, DOI 10.1038/sj.pcan.4501012; Djamgoz MBA, 2013, RECENT PAT ANTI-CANC, V8, P66; Edlund M, 2001, CELL GROWTH DIFFER, V12, P99; ELDRIDGE CF, 1987, J CELL BIOL, V105, P1023, DOI 10.1083/jcb.105.2.1023; ELDRIDGE CF, 1989, J NEUROSCI, V9, P625; Epstein J I, 1998, Semin Urol Oncol, V16, P124; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fiske JL, 2006, CANCER METAST REV, V25, P493, DOI 10.1007/s10555-006-9017-z; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Grieco TM, 2005, NEURON, V45, P233, DOI 10.1016/j.neuron.2004.12.035; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hebert-Blouin MN, 2011, CLIN ANAT, V24, P101, DOI 10.1002/ca.21079; Hebert-Blouin MN, 2010, ACTA NEUROCHIR, V152, P1567, DOI 10.1007/s00701-010-0682-x; Hellerstedt BA, 2002, CA-CANCER J CLIN, V52, P154, DOI 10.3322/canjclin.52.3.154; Horoszewicz J S, 1980, Prog Clin Biol Res, V37, P115; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Isom LL, 1996, NATURE, V383, P307, DOI 10.1038/383307b0; Isom LL, 2001, NEUROSCIENTIST, V7, P42, DOI 10.1177/107385840100700108; ISOM LL, 1995, CELL, V83, P433, DOI 10.1016/0092-8674(95)90121-3; Jansson KH, 2012, PROSTATE, V72, P1080, DOI 10.1002/pros.21512; Jeon HG, 2009, INT J UROL, V16, P682, DOI 10.1111/j.1442-2042.2009.02331.x; Jin H, 2012, APPL MICROBIOL BIOT, V93, P1715, DOI 10.1007/s00253-011-3865-3; Kamiya N, 2012, INT J UROL, V19, P968, DOI 10.1111/j.1442-2042.2012.03098.x; Kazarinova-Noyes K, 2001, J NEUROSCI, V21, P7517, DOI 10.1523/JNEUROSCI.21-19-07517.2001; Koeneman KS, 1999, PROSTATE, V39, P246; Kuhn TB, 2000, J NEUROBIOL, V44, P126, DOI 10.1002/1097-4695(200008)44:2<126::AID-NEU4>3.0.CO;2-Z; Ladha SS, 2006, MUSCLE NERVE, V34, P659, DOI 10.1002/mus.20597; Lee IH, 2007, INT J RADIAT ONCOL, V68, P1059, DOI 10.1016/j.ijrobp.2007.01.039; Lee JT, 2010, KOREAN J UROL, V51, P745, DOI 10.4111/kju.2010.51.11.745; Lekka M, 2012, MICRON, V43, P1259, DOI 10.1016/j.micron.2012.01.019; Lekka M, 2012, ARCH BIOCHEM BIOPHYS, V518, P151, DOI 10.1016/j.abb.2011.12.013; Li QS, 2008, BIOCHEM BIOPH RES CO, V374, P609, DOI 10.1016/j.bbrc.2008.07.078; Liebig C, 2009, J CLIN ONCOL, V27, P5131, DOI 10.1200/JCO.2009.22.4949; Liebig C, 2009, CANCER-AM CANCER SOC, V115, P3379, DOI 10.1002/cncr.24396; Lin M, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-21; Loberg RD, 2005, J CELL BIOCHEM, V96, P439, DOI 10.1002/jcb.20522; Ma J, 2008, J GASTROEN HEPATOL, V23, P1852, DOI 10.1111/j.1440-1746.2008.05579.x; Magnon C, 2013, SCIENCE, V341, P143, DOI 10.1126/science.1236361; Malhotra JD, 2000, J BIOL CHEM, V275, P11383, DOI 10.1074/jbc.275.15.11383; Malhotra JD, 2002, J BIOL CHEM, V277, P26681, DOI 10.1074/jbc.M202354200; Marchesi F, 2010, CYTOKINE GROWTH F R, V21, P77, DOI 10.1016/j.cytogfr.2009.11.001; Masieri L, 2010, UROL INT, V85, P396, DOI 10.1159/000315491; McEwen DP, 2004, J BIOL CHEM, V279, P16044, DOI 10.1074/jbc.M400856200; McVary KT, 1998, PROSTATE, P2; MCVARY KT, 1994, BIOL REPROD, V51, P99, DOI 10.1095/biolreprod51.1.99; Meadows L, 2001, J NEUROCHEM, V76, P1871, DOI 10.1046/j.1471-4159.2001.00192.x; Mundy GR, 2000, CANC SKELETON; NAGLE RB, 1994, J CELL BIOCHEM, P232; Ng JC, 2004, J UROLOGY, V172, P2249, DOI 10.1097/01.ju.0000143973.22897.f8; OBREMSKI VJ, 1995, DEV BIOL, V168, P124, DOI 10.1006/dbio.1995.1066; Ozcan F, 2001, EUR UROL, V40, P308, DOI 10.1159/000049791; Panizza B, 2013, CURR ONCOL REP, V15, P128, DOI 10.1007/s11912-012-0288-y; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; PLATIKA D, 1985, P NATL ACAD SCI USA, V82, P3499, DOI 10.1073/pnas.82.10.3499; Powell MS, 2005, PROSTATE, V65, P52, DOI 10.1002/pros.20245; Sequeira L, 2008, CLIN EXP METASTAS, V25, P569, DOI 10.1007/s10585-008-9173-3; Shariat SF, 2004, J UROLOGY, V171, P1122, DOI 10.1097/01.ju.0000113249.82533.28; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Srinivasan J, 1998, P NATL ACAD SCI USA, V95, P15753, DOI 10.1073/pnas.95.26.15753; Sroka IC, 2010, J CELL PHYSIOL, V224, P283, DOI 10.1002/jcp.22149; THALMANN GN, 1994, CANCER RES, V54, P2577; Thalmann GN, 2000, PROSTATE, V44, P91; van Golen KL, 2000, CANCER RES, V60, P5832; Velazquez EF, 2008, AM J SURG PATHOL, V32, P974, DOI 10.1097/PAS.0b013e3181641365; VILLERS A, 1989, J UROLOGY, V142, P763, DOI 10.1016/S0022-5347(17)38881-X; Walsh PC, 2002, P WALSHS GUIDE SURVI, Vxvi; Xiao ZC, 1999, J BIOL CHEM, V274, P26511, DOI 10.1074/jbc.274.37.26511; Yu FH, 2003, J NEUROSCI, V23, P7577; Yu HHM, 2007, UROLOGY, V70, P111, DOI 10.1016/j.urology.2007.03.020	85	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98408	10.1371/journal.pone.0098408	http://dx.doi.org/10.1371/journal.pone.0098408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892658	gold, Green Published, Green Submitted			2022-12-27	WOS:000336911400048
J	Saucedo-Garcia, A; Anaya, AL; Espinosa-Garcia, FJ; Gonzalez, MC				Saucedo-Garcia, Aurora; Luisa Anaya, Ana; Espinosa-Garcia, Francisco J.; Gonzalez, Maria C.			Diversity and Communities of Foliar Endophytic Fungi from Different Agroecosystems of Coffea arabica L. in Two Regions of Veracruz, Mexico	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; BIODIVERSITY CONSERVATION; VEGETATION STRUCTURE; SPECIES-DIVERSITY; LEAVES; FOREST; PATHOGEN; PATTERNS; RICHNESS; SYSTEMS	Over the past 20 years, the biodiversity associated with shaded coffee plantations and the role of diverse agroforestry types in biodiversity conservation and environmental services have been topics of debate. Endophytic fungi, which are microorganisms that inhabit plant tissues in an asymptomatic manner, form a part of the biodiversity associated with coffee plants. Studies on the endophytic fungi communities of cultivable host plants have shown variability among farming regions; however, the variability in fungal endophytic communities of coffee plants among different coffee agroforestry systems is still poorly understood. As such, we analyzed the diversity and communities of foliar endophytic fungi inhabiting Coffea arabica plants growing in the rustic plantations and simple polycultures of two regions in the center of Veracruz, Mexico. The endophytic fungi isolates were identified by their morphological traits, and the majority of identified species correspond to species of fungi previously reported as endophytes of coffee leaves. We analyzed and compared the colonization rates, diversity, and communities of endophytes found in the different agroforestry systems and in the different regions. Although the endophytic diversity was not fully recovered, we found differences in the abundance and diversity of endophytes among the coffee regions and differences in richness between the two different agroforestry systems of each region. No consistent pattern of community similarity was found between the coffee agroforestry systems, but we found that rustic plantations shared the highest number of morphospecies. The results suggest that endophyte abundance, richness, diversity, and communities may be influenced predominantly by coffee region, and to a lesser extent, by the agroforestry system. Our results contribute to the knowledge of the relationships between agroforestry systems and biodiversity conservation and provide information regarding some endophytic fungi and their communities as potential management tools against coffee plant pests and pathogens.	[Saucedo-Garcia, Aurora] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico; [Saucedo-Garcia, Aurora; Luisa Anaya, Ana] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Func, Mexico City 04510, DF, Mexico; [Espinosa-Garcia, Francisco J.] Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Lab Ecol Quim, Morelia, Michoacan, Mexico; [Gonzalez, Maria C.] Univ Nacl Autonoma Mexico, Dept Bot, Inst Biol, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Anaya, AL (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Func, Mexico City 04510, DF, Mexico.	analanaya@ecologia.unam.mx	Espinosa-García, F. J./B-4040-2016	Espinosa-García, F. J./0000-0001-9173-1957	PAPIIT-DGAPA (UNAM) Project [IN209611]	PAPIIT-DGAPA (UNAM) Project	The present research received the financial support from PAPIIT-DGAPA (UNAM) Project IN209611 given to ALA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Angelini P, 2012, FUNGAL ECOL, V5, P683, DOI 10.1016/j.funeco.2012.03.001; Arita HT, 2008, AM NAT, V172, P519, DOI 10.1086/590954; Arita HT, 2012, GLOBAL ECOL BIOGEOGR, V21, P282, DOI 10.1111/j.1466-8238.2011.00662.x; Arnold AE, 2007, ECOLOGY, V88, P541, DOI 10.1890/05-1459; Arnold A. Elizabeth, 2007, Fungal Biology Reviews, V21, P51, DOI 10.1016/j.fbr.2007.05.003; Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; Arnold AE, 2003, MYCOLOGIA, V95, P388, DOI 10.2307/3761880; Avalos-Sartorio B, 2010, AGROFOREST SYST, V78, P169, DOI 10.1007/s10457-009-9248-4; Carrion G, 2006, NATURALEZA INTERACCI; Colwell R.K., 2016, ESTIMATES STAT ESTIM; Davis EC, 2003, AM J BOT, V90, P1661, DOI 10.3732/ajb.90.11.1661; Douanla-Meli C, 2013, FUNGAL ECOL, V6, P212, DOI 10.1016/j.funeco.2013.01.004; Ek-Ramos MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066049; ESPINOSAGARCIA FJ, 1990, NEW PHYTOL, V116, P89, DOI 10.1111/j.1469-8137.1990.tb00513.x; FISHER PJ, 1994, NEW PHYTOL, V127, P133, DOI 10.1111/j.1469-8137.1994.tb04267.x; Frohlich J, 2000, MYCOL RES, V104, P1202, DOI 10.1017/S095375620000263X; Gallina S., 2008, AGROECOSISTEMAS CAFE, P161; Gamboa MA, 2001, BIOTROPICA, V33, P352, DOI 10.1111/j.1744-7429.2001.tb00187.x; Gamboa Miguel A., 2002, Mycopathologia, V156, P41, DOI 10.1023/A:1021362217723; Gange AC, 2007, J ECOL, V95, P614, DOI 10.1111/j.1365-2745.2007.01245.x; Gazis R, 2010, FUNGAL ECOL, V3, P240, DOI 10.1016/j.funeco.2009.12.001; Gordon C, 2007, AGR ECOSYST ENVIRON, V118, P256, DOI 10.1016/j.agee.2006.05.023; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hata K, 2008, MYCOSCIENCE, V49, P229, DOI 10.1007/s10267-008-0411-y; Heredia Abarca G, 2008, AGROECOSISTEMAS CAFE, V14, P193; Hernandez-Martinez G., 2008, AGROECOSISTEMAS CAFE, P15; Hernandez-Martinez G, 2009, AGR ECOSYST ENVIRON, V134, P89, DOI 10.1016/j.agee.2009.05.020; Herre EA, 2007, ECOLOGY, V88, P550, DOI 10.1890/05-1606; Higgins KL, 2011, MYCOLOGIA, V103, P247, DOI 10.3852/09-158; Hoffman MT, 2008, MYCOL RES, V112, P331, DOI 10.1016/j.mycres.2007.10.014; Jiang H, 2011, ANN MICROBIOL, V61, P655, DOI 10.1007/s13213-010-0186-1; Johnston PR, 2012, FUNGAL BIOL-UK, V116, P401, DOI 10.1016/j.funbio.2011.12.010; Joshee S, 2009, MYCOL RES, V113, P1003, DOI 10.1016/j.mycres.2009.06.004; Junker C, 2012, FUNGAL ECOL, V5, P657, DOI 10.1016/j.funeco.2012.05.002; Lacap DC, 2003, FUNGAL DIVERS, V12, P53; Lashermes P, 1999, MOL GEN GENET, V261, P259, DOI 10.1007/s004380050965; Lodge DJ, 1996, MYCOLOGIA, V88, P733, DOI 10.2307/3760967; Lopez-Gomez AA, 2008, AGR ECOSYST ENVIRON, V124, P160, DOI 10.1016/j.agee.2007.09.008; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Manson R., 2008, AGROECOSISTEMAS CAFE; Arias RM, 2012, AGROFOREST SYST, V85, P179, DOI 10.1007/s10457-011-9414-3; Matsumura E, 2013, FUNGAL BIOL-UK, V117, P191, DOI 10.1016/j.funbio.2013.01.007; Moguel P, 1999, CONSERV BIOL, V13, P11, DOI 10.1046/j.1523-1739.1999.97153.x; Muller MM, 1998, MYCOL RES, V102, P1183, DOI 10.1017/S0953756298006285; Osono T, 2002, MYCOLOGIA, V94, P421, DOI 10.2307/3761776; Osono T, 2013, MYCOSCIENCE, V54, P54, DOI 10.1016/j.myc.2012.08.003; Pan JJ, 2009, MICROB ECOL, V58, P668, DOI 10.1007/s00248-009-9543-7; Pancher M, 2012, APPL ENVIRON MICROB, V78, P4308, DOI 10.1128/AEM.07655-11; Perfecto I, 2005, ECOL ECON, V54, P435, DOI 10.1016/j.ecolecon.2004.10.009; Perfecto I, 2003, BIODIVERS CONSERV, V12, P1239, DOI 10.1023/A:1023039921916; Perfecto I, 2008, ANN NY ACAD SCI, V1134, P173, DOI 10.1196/annals.1439.011; PETRINI L, 1985, Sydowia, V38, P216; PETRINI O, 1982, CAN J BOT, V60, P789, DOI 10.1139/b82-102; Petrini O, 1991, MICROBIAL ECOLOGY LE, P179, DOI DOI 10.1007/978-1-4612-3168-4_9; Phoulivong S, 2010, FUNGAL DIVERS, V44, P33, DOI 10.1007/s13225-010-0046-0; Posada Francisco, 2006, Mycoscience, V47, P284, DOI 10.1007/s10267-006-0308-6; Prihastuti H, 2009, FUNGAL DIVERS, V39, P89; Qi Fenghui, 2012, PLoS One, V7, pe46785, DOI 10.1371/journal.pone.0046785; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Core Team, 2021, R LANGUAGE ENV STAT; Rice RA, 1999, GEOGR REV, V89, P554, DOI 10.2307/216102; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Saikkonen K, 1998, ANNU REV ECOL SYST, V29, P319, DOI 10.1146/annurev.ecolsys.29.1.319; Sanchez-Azofeifa A, 2012, TREES-STRUCT FUNCT, V26, P291, DOI 10.1007/s00468-011-0591-5; Santamaria J, 2005, MICROB ECOL, V50, P1, DOI 10.1007/s00248-004-0002-1; Scholtysik A, 2013, MYCOL PROG, V12, P291, DOI 10.1007/s11557-012-0835-9; Schulte RPO, 2005, J THEOR BIOL, V232, P305, DOI 10.1016/j.jtbi.2004.08.014; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Seghers D, 2004, APPL ENVIRON MICROB, V70, P1475, DOI 10.1128/AEM.70.3.1475-1482.2004; Sette LD, 2006, WORLD J MICROB BIOT, V22, P1185, DOI 10.1007/s11274-006-9160-2; Stone JK, 2000, BOOK SOIL P, P3; Teodoro A, 2008, AGR ECOSYST ENVIRON, V125, P120, DOI 10.1016/j.agee.2007.12.004; Toledo VM, 2012, J SUSTAIN AGR, V36, P353, DOI 10.1080/10440046.2011.583719; Unterseher M, 2007, MYCOL PROG, V6, P201, DOI 10.1007/s11557-007-0541-1; Unterseher M, 2013, FUNGAL DIVERS, V60, P43, DOI 10.1007/s13225-013-0222-0; Unterseher M, 2010, FUNGAL ECOL, V3, P366, DOI 10.1016/j.funeco.2010.03.001; Unterseher M, 2009, MYCOL RES, V113, P645, DOI 10.1016/j.mycres.2009.02.002; Van Hilten HJ, 2011, COFFEE EXPORTERS GUI; Vandermeer J, 2010, BIOSCIENCE, V60, P527, DOI 10.1525/bio.2010.60.7.8; Vega FE, 2008, BIOL CONTROL, V46, P72, DOI 10.1016/j.biocontrol.2008.01.008; Vega FE, 2010, FUNGAL ECOL, V3, P122, DOI [10.1016/j.funeco.2009.05.001, 10.1016/j.funeco.2009.07.002]; Fernandes MDV, 2009, BRAZ J PHARM SCI, V45, P677; WALLER J.M, 2007, COFFEE PESTS DIS THE; WALLER JM, 1993, MYCOL RES, V97, P989, DOI 10.1016/S0953-7562(09)80867-8; Wang Y, 2007, CAN J BOT, V85, P911, DOI 10.1139/B07-084; Wu LS, 2013, CURR MICROBIOL, V66, P40, DOI 10.1007/s00284-012-0235-z; Zimmerman NB, 2012, P NATL ACAD SCI USA, V109, P13022, DOI 10.1073/pnas.1209872109	88	40	42	2	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98454	10.1371/journal.pone.0098454	http://dx.doi.org/10.1371/journal.pone.0098454			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887512	gold, Green Published, Green Submitted			2022-12-27	WOS:000336956300067
J	Nascimento, FX; Rossi, MJ; Soares, CRFS; McConkey, BJ; Glick, BR				Nascimento, Francisco X.; Rossi, Marcio J.; Soares, Claudio R. F. S.; McConkey, Brendan J.; Glick, Bernard R.			New Insights into 1-Aminocyclopropane-1-Carboxylate (ACC) Deaminase Phylogeny, Evolution and Ecological Significance	PLOS ONE			English	Article							GROWTH-PROMOTING BACTERIA; BURKHOLDERIA-CEPACIA COMPLEX; D-CYSTEINE DESULFHYDRASE; PSEUDOMONAS-PUTIDA UW4; PLANT-GROWTH; ESCHERICHIA-COLI; TRANSCRIPTIONAL REGULATION; AGROBACTERIUM-TUMEFACIENS; SEQUENCE ALIGNMENT; CONFER RESISTANCE	The main objective of this work is the study of the phylogeny, evolution and ecological importance of the enzyme 1-aminocyclopropane-1-carboxylate (ACC) deaminase, the activity of which represents one of the most important and studied mechanisms used by plant growth promoting microorganisms. The ACC deaminase gene and its regulatory elements presence in completely sequenced organisms was verified by multiple searches in diverse databases, and based on the data obtained a comprehensive analysis was conducted. Strain habitat, origin and ACC deaminase activity were taken into account when analyzing the results. In order to unveil ACC deaminase origin, evolution and relationships with other closely related pyridoxal phosphate (PLP) dependent enzymes a phylogenetic analysis was also performed. The data obtained show that ACC deaminase is mostly prevalent in some Bacteria, Fungi and members of Stramenopiles. Contrary to previous reports, we show that ACC deaminase genes are predominantly vertically inherited in various bacterial and fungal classes. Still, results suggest a considerable degree of horizontal gene transfer events, including interkingdom transfer events. A model for ACC deaminase origin and evolution is also proposed. This study also confirms the previous reports suggesting that the Lrp-like regulatory protein AcdR is a common mechanism regulating ACC deaminase expression in Proteobacteria, however, we also show that other regulatory mechanisms may be present in some Proteobacteria and other bacterial phyla. In this study we provide a more complete view of the role for ACC deaminase than was previously available. The results show that ACC deaminase may not only be related to plant growth promotion abilities, but may also play multiple roles in microorganism's developmental processes. Hence, exploring the origin and functioning of this enzyme may be the key in a variety of important agricultural and biotechnological applications.	[Nascimento, Francisco X.; Rossi, Marcio J.; Soares, Claudio R. F. S.] Univ Fed Santa Catarina, Dept Microbiol, Lab Microbiol Solo, Florianopolis, SC, Brazil; [McConkey, Brendan J.; Glick, Bernard R.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	Universidade Federal de Santa Catarina (UFSC); University of Waterloo	Nascimento, FX (corresponding author), Univ Fed Santa Catarina, Dept Microbiol, Lab Microbiol Solo, Florianopolis, SC, Brazil.	fxnascimento@gmail.com	Nascimento, Francisco X./F-6537-2016; Jose Rossi, Marcio/M-3979-2014	Nascimento, Francisco X./0000-0003-1184-3794; Jose Rossi, Marcio/0000-0003-1062-5269; Sousa Soares, Claudio Roberto Fonseca/0000-0002-5443-6614	Fundacao de Ciencia e Tecnologia (FCT), Portugal [SFRH/BD/86954/2012]	Fundacao de Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology)	Francisco X. Nascimento acknowledges a PhD fellowship (SFRH/BD/86954/2012) from Fundacao de Ciencia e Tecnologia (FCT), Portugal. We thank Michael D.J. Lynch (University of Waterloo) for all the help in the phylogenetic analysis, and Clarisse Brigido (Universidade de Evora) for the suggestions provided for the elaboration of this manuscript.	Ali S, 2012, J APPL MICROBIOL, V113, P1139, DOI 10.1111/j.1365-2672.2012.05409.x; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Baldwin A, 2007, EMERG INFECT DIS, V13, P458, DOI 10.3201/eid1303.060403; Belimov AA, 2005, SOIL BIOL BIOCHEM, V37, P241, DOI 10.1016/j.soilbio.2004.07.033; Bharath SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036267; Blaha D, 2006, FEMS MICROBIOL ECOL, V56, P455, DOI 10.1111/j.1574-6941.2006.00082.x; Boussau B, 2004, P NATL ACAD SCI USA, V101, P9722, DOI 10.1073/pnas.0400975101; Brotman Y, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003221; Burd GI, 1998, APPL ENVIRON MICROB, V64, P3663; Chain PSG, 2006, P NATL ACAD SCI USA, V103, P15280, DOI 10.1073/pnas.0606924103; Chen SC, 2013, FUNGAL ECOL, V6, P110, DOI 10.1016/j.funeco.2012.08.003; Cheng ZY, 2008, CAN J MICROBIOL, V54, P128, DOI 10.1139/w07-128; Conforte VP, 2010, J GEN APPL MICROBIOL, V56, P331; Contesto C, 2008, PLANT SCI, V175, P178, DOI 10.1016/j.plantsci.2008.01.020; Cooper VS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000732; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Dastager SG, 2010, PLANT PHYSIOL BIOCH, V48, P987, DOI 10.1016/j.plaphy.2010.09.006; Dell'Amico E, 2008, SOIL BIOL BIOCHEM, V40, P74, DOI 10.1016/j.soilbio.2007.06.024; Destino Lauren, 2006, Ann Clin Microbiol Antimicrob, V5, P21, DOI 10.1186/1476-0711-5-21; Dobrindt U, 2010, MED MICROBIOL IMMUN, V199, P145, DOI 10.1007/s00430-010-0161-2; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; El-Tarabily KA, 2008, PLANT SOIL, V308, P161, DOI 10.1007/s11104-008-9616-2; Fedorov DN, 2013, FEMS MICROBIOL LETT, V343, P70, DOI 10.1111/1574-6968.12133; Fiore A, 2001, ENVIRON MICROBIOL, V3, P137, DOI 10.1046/j.1462-2920.2001.00175.x; Fujino A, 2004, J MOL BIOL, V341, P999, DOI 10.1016/j.jmb.2004.06.062; Gandhi PM, 2009, J MICROBIOL BIOTECHN, V19, P99, DOI 10.4014/jmb.0803.173; Ghosh S, 2003, PLANT PHYSIOL BIOCH, V41, P277, DOI 10.1016/S0981-9428(03)00019-6; Glick BR, 2007, EUR J PLANT PATHOL, V119, P329, DOI 10.1007/s10658-007-9162-4; Glick BR, 2007, CRIT REV PLANT SCI, V26, P227, DOI 10.1080/07352680701572966; Glick BR, 2014, MICROBIOL RES, V169, P30, DOI 10.1016/j.micres.2013.09.009; Glick BR, 2005, FEMS MICROBIOL LETT, V251, P1, DOI 10.1016/j.femsle.2005.07.030; Glick BR, 1998, J THEOR BIOL, V190, P63, DOI 10.1006/jtbi.1997.0532; GLICK BR, 1994, CAN J MICROBIOL, V40, P911, DOI 10.1139/m94-146; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grichko VP, 2001, PLANT PHYSIOL BIOCH, V39, P11, DOI 10.1016/S0981-9428(00)01212-2; Grichko VP, 2000, J BIOTECHNOL, V81, P45, DOI 10.1016/S0168-1656(00)00270-4; Grichko VP, 2000, CAN J MICROBIOL, V46, P1159, DOI 10.1139/cjm-46-12-1159; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gupta RS, 2007, J MOL EVOL, V64, P90, DOI 10.1007/s00239-006-0082-2; Gupta RS, 2005, CRIT REV MICROBIOL, V31, P101, DOI 10.1080/10408410590922393; Gupta RS, 2000, CRIT REV MICROBIOL, V26, P111, DOI 10.1080/10408410091154219; Hao YU, 2007, CAN J MICROBIOL, V53, P1291, DOI 10.1139/W07-099; Hao YA, 2011, CAN J MICROBIOL, V57, P278, DOI [10.1139/W11-006, 10.1139/w11-006]; HONMA M, 1978, AGR BIOL CHEM TOKYO, V42, P1825, DOI 10.1080/00021369.1978.10863261; Hontzeas N, 2005, APPL ENVIRON MICROB, V71, P7556, DOI 10.1128/AEM.71.11.7556-7558.2005; Hontzeas N, 2004, BBA-PROTEINS PROTEOM, V1703, P11, DOI 10.1016/j.bbapap.2004.09.015; Hyodo H, 1991, PLANT HORMONE ETHYLE, P65; Jia YJ, 1999, BIOSCI BIOTECH BIOCH, V63, P542, DOI 10.1271/bbb.63.542; Jia YJ, 2000, BIOSCI BIOTECH BIOCH, V64, P299, DOI 10.1271/bbb.64.299; KENDE H, 1993, ANNU REV PLANT PHYS, V44, P283, DOI 10.1146/annurev.pp.44.060193.001435; KLEE HJ, 1991, PLANT CELL, V3, P1187, DOI 10.1105/tpc.3.11.1187; Klich MA, 2002, MYCOLOGIA, V94, P21, DOI 10.2307/3761842; Li JP, 2001, CAN J MICROBIOL, V47, P359, DOI 10.1139/cjm-47-4-359; Li JP, 2000, CURR MICROBIOL, V41, P101, DOI 10.1007/s002840010101; Ludwig W., 2005, BERGEYS MANUAL SYSTE, P49, DOI DOI 10.1007/0-387-28021-9_; Ma WB, 2004, APPL ENVIRON MICROB, V70, P5891, DOI 10.1128/AEM.70.10.5891-5897.2004; Ma WB, 2003, APPL ENVIRON MICROB, V69, P4396, DOI 10.1128/AEM.69.8.4396-4402.2003; Maimaiti J, 2007, ENVIRON MICROBIOL, V9, P435, DOI 10.1111/j.1462-2920.2006.01155.x; Marques APGC, 2010, SOIL BIOL BIOCHEM, V42, P1229, DOI 10.1016/j.soilbio.2010.04.014; Massey RC, 2002, TRENDS MICROBIOL, V10, P580, DOI 10.1016/S0966-842X(02)02475-7; Mayak S, 2004, PLANT PHYSIOL BIOCH, V42, P565, DOI 10.1016/j.plaphy.2004.05.009; Mayak S, 2004, PLANT SCI, V166, P525, DOI 10.1016/j.plantsci.2003.10.025; McDonnell L, 2009, PHYSIOL PLANTARUM, V136, P94, DOI 10.1111/j.1399-3054.2009.01208.x; Minami R, 1998, J BIOCHEM, V123, P1112; Murset V, 2012, SYMBIOSIS, V57, P43, DOI 10.1007/s13199-012-0177-z; Nadeem SM, 2009, CAN J MICROBIOL, V55, P1302, DOI [10.1139/W09-092, 10.1139/w09-092]; NAGASAWA T, 1985, EUR J BIOCHEM, V153, P541, DOI 10.1111/j.1432-1033.1985.tb09335.x; Nandasena KG, 2007, ENVIRON MICROBIOL, V9, P2496, DOI 10.1111/j.1462-2920.2007.01368.x; Nascimento F, 2012, PLANT SOIL, V353, P221, DOI 10.1007/s11104-011-1025-2; Nascimento FX, 2012, LETT APPL MICROBIOL, V55, P15, DOI 10.1111/j.1472-765X.2012.03251.x; Nascimento FX, 2013, BIOCONTROL, V58, P427, DOI 10.1007/s10526-012-9500-0; Nascimento FX, 2012, FEMS MICROBIOL LETT, V336, P26, DOI 10.1111/j.1574-6968.2012.02648.x; Nie L, 2002, PLANT PHYSIOL BIOCH, V40, P355, DOI 10.1016/S0981-9428(02)01375-X; Nikolic B, 2011, ARCH MICROBIOL, V193, P665, DOI 10.1007/s00203-011-0703-z; Nukui N, 2006, APPL ENVIRON MICROB, V72, P4964, DOI 10.1128/AEM.02745-05; Onofre-Lemus J, 2009, APPL ENVIRON MICROB, V75, P6581, DOI 10.1128/AEM.01240-09; Prigent-Combaret C, 2008, FEMS MICROBIOL ECOL, V65, P202, DOI 10.1111/j.1574-6941.2008.00474.x; Reed MLE, 2005, CURR MICROBIOL, V51, P425, DOI 10.1007/s00284-005-4584-8; Riemenschneider A, 2005, FEBS J, V272, P1291, DOI 10.1111/j.1742-4658.2005.04567.x; Robison MM, 2001, MOL PLANT PATHOL, V2, P135, DOI 10.1046/j.1364-3703.2001.00060.x; Rothballer M, 2008, FEMS MICROBIOL ECOL, V66, P85, DOI 10.1111/j.1574-6941.2008.00582.x; Sergeeva E, 2006, WORLD J MICROB BIOT, V22, P277, DOI 10.1007/s11274-005-9032-1; Sharma M, 2011, PLANT SOIL, V341, P447, DOI 10.1007/s11104-010-0657-y; Siddikee MA, 2010, J MICROBIOL BIOTECHN, V20, P1577, DOI 10.4014/jmb.1007.07011; Singh N, 2012, J MOL MODEL, V18, P4101, DOI 10.1007/s00894-012-1389-0; Slater SC, 2009, J BACTERIOL, V191, P2501, DOI 10.1128/JB.01779-08; Soutourina J, 2001, J BIOL CHEM, V276, P40864, DOI 10.1074/jbc.M102375200; Stearns JC, 2012, MOL PLANT MICROBE IN, V25, P668, DOI 10.1094/MPMI-08-11-0213; Stiens M, 2006, APPL ENVIRON MICROB, V72, P3662, DOI 10.1128/AEM.72.5.3662-3672.2006; Suarez-Moreno ZR, 2012, MICROB ECOL, V63, P249, DOI 10.1007/s00248-011-9929-1; Sun YL, 2009, FEMS MICROBIOL LETT, V296, P131, DOI 10.1111/j.1574-6968.2009.01625.x; Sziderics AH, 2007, CAN J MICROBIOL, V53, P1195, DOI 10.1139/W07-082; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Timmusk S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017968; Todorovic B, 2008, PLANTA, V229, P193, DOI 10.1007/s00425-008-0820-3; Toklikishvili N, 2010, PLANT PATHOL, V59, P1023, DOI 10.1111/j.1365-3059.2010.02326.x; Uchiumi T, 2004, J BACTERIOL, V186, P2439, DOI 10.1128/JB.186.8.2439-2448.2004; URAKAMI T, 1994, INT J SYST BACTERIOL, V44, P235, DOI 10.1099/00207713-44-2-235; Viallard V, 1998, INT J SYST BACTERIOL, V48, P549, DOI 10.1099/00207713-48-2-549; Viterbo A, 2010, FEMS MICROBIOL LETT, V305, P42, DOI 10.1111/j.1574-6968.2010.01910.x; WALSH C, 1981, BIOCHEMISTRY-US, V20, P7509, DOI 10.1021/bi00529a028; Wang CX, 2000, CAN J MICROBIOL, V46, P898, DOI 10.1139/cjm-46-10-898; Woese C, 1998, P NATL ACAD SCI USA, V95, P6854, DOI 10.1073/pnas.95.12.6854; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656	105	142	149	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99168	10.1371/journal.pone.0099168	http://dx.doi.org/10.1371/journal.pone.0099168			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905353	Green Submitted, Green Published, gold			2022-12-27	WOS:000341869000108
J	Yamamoto, T; Byun, J; Zhai, PY; Ikeda, Y; Oka, S; Sadoshima, J				Yamamoto, Takanobu; Byun, Jaemin; Zhai, Peiyong; Ikeda, Yoshiyuki; Oka, Shinichi; Sadoshima, Junichi			Nicotinamide Mononucleotide, an Intermediate of NAD(+) Synthesis, Protects the Heart from Ischemia and Reperfusion	PLOS ONE			English	Article							POSSIBLE INVOLVEMENT; CALORIC RESTRICTION; CELL-SURVIVAL; SIRT1; ISCHEMIA/REPERFUSION; DEACETYLATION; METABOLISM; AUTOPHAGY; DISEASE; AMPK	Nicotinamide phosphoribosyltransferase (Nampt), the rate-limiting enzyme for nicotinamide adenine dinucleotide (NAD(+)) synthesis, and Sirt1, an NAD(+)-dependent histone deacetylase, protect the heart against ischemia/reperfusion (I/R). It remains unknown whether Nampt mediates the protective effect of ischemic preconditioning (IPC), whether nicotinamide mononucleotide (NMN, 500 mg/kg), a product of Nampt in the NAD(+) salvage pathway, mimics the effect of IPC, or whether caloric restriction (CR) upregulates Nampt and protects the heart through a Sirt1-dependent mechanism. IPC upregulated Nampt protein, and the protective effect of IPC against ischemia (30 minutes) and reperfusion (24 hours) was attenuated at both early and late phases in Nampt +/- mice, suggesting that Nampt plays an essential role in mediating the protective effect of IPC. In order to mimic the effect of Nampt, NMN was administered by intraperitoneal injection. NMN significantly increased the level of NAD(+) in the heart at baseline and prevented a decrease in NAD(+) during ischemia. NMN protected the heart from I/R injury when it was applied once 30 minutes before ischemia or 4 times just before and during reperfusion, suggesting that exogenous NMN protects the heart from I/R injury in both ischemic and reperfusion phases. The protective effect of NMN was accompanied by decreases in acetylation of FoxO1, but it was not obvious in Sirt1 KO mice, suggesting that the effect of NMN is mediated through activation of Sirt1. Compared to control diet (90% calories), CR (60% calories for 6 weeks) in mice led to a significant reduction in I/R injury, accompanied by upregulation of Nampt. The protective effect of CR against I/R injury was not significant in cardiac-specific Sirt1 KO mice, suggesting that the protective effect of CR is in part mediated through the Nampt-Sirt1 pathway. In conclusion, exogenous application of NMN and CR protects the heart by both mimicking IPC and activating Sirt1.	[Yamamoto, Takanobu; Byun, Jaemin; Zhai, Peiyong; Ikeda, Yoshiyuki; Oka, Shinichi; Sadoshima, Junichi] Rutgers New Jersey Med Sch, Cardiovasc Res Inst, Dept Cell Biol & Mol Med, Newark, NJ 07101 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Sadoshima, J (corresponding author), Rutgers New Jersey Med Sch, Cardiovasc Res Inst, Dept Cell Biol & Mol Med, Newark, NJ 07101 USA.	sadoshju@njms.rutgers.edu		Sadoshima, Junichi/0000-0003-3724-4132	United States Public Health Service [HL59139, HL67724, HL69020, HL91469, HL102738, AG27211]; Fondation Leducq Transatlantic Networks of Excellence; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091469, P01HL069020, R01HL067724, R01HL112330, R01HL102738, P01HL059139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023039, P01AG027211] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Fondation Leducq Transatlantic Networks of Excellence; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by United States Public Health Service Grants HL59139, HL67724, HL69020, HL91469, HL102738, and AG27211, and by the Fondation Leducq Transatlantic Networks of Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Bolli R, 2007, AM J PHYSIOL-HEART C, V292, pH19, DOI 10.1152/ajpheart.00712.2006; Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Hariharan N, 2011, ANTIOXID REDOX SIGN, V14, P2179, DOI 10.1089/ars.2010.3488; Hariharan N, 2010, CIRC RES, V107, P1470, DOI 10.1161/CIRCRESAHA.110.227371; Hsu CP, 2010, CIRCULATION, V122, P2170, DOI 10.1161/CIRCULATIONAHA.110.958033; Hsu CP, 2009, CIRC RES, V105, P481, DOI 10.1161/CIRCRESAHA.109.203703; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Imai S, 2011, FEBS LETT, V585, P1657, DOI 10.1016/j.febslet.2011.04.060; Koltai E, 2010, MECH AGEING DEV, V131, P21, DOI 10.1016/j.mad.2009.11.002; MAJNO G, 1995, AM J PATHOL, V146, P3; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Mayi TH, 2011, BIOCHEM BIOPH RES CO, V404, P458, DOI 10.1016/j.bbrc.2010.12.002; Montecucco F, 2013, ANTIOXID REDOX SIGN, V18, P630, DOI 10.1089/ars.2011.4487; Morrison A, 2011, BIOCHEM PHARMACOL, V82, P195, DOI 10.1016/j.bcp.2011.04.004; Nadtochiy SM, 2011, CARDIOVASC RES, V89, P643, DOI 10.1093/cvr/cvq287; Oka S, 2012, CIRC RES, V111, P611, DOI 10.1161/CIRCRESAHA.111.247932; Pillai VB, AM J PHYSL HEART CIR, V304, pH415; Pittelli M, 2011, MOL PHARMACOL, V80, P1136, DOI 10.1124/mol.111.073916; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Sanada S, 2011, AM J PHYSIOL-HEART C, V301, pH1723, DOI 10.1152/ajpheart.00553.2011; Shinmura K, 2013, TRENDS CARDIOVAS MED, V23, P18, DOI 10.1016/j.tcm.2012.08.006; Shinmura K, 2008, AM J PHYSIOL-HEART C, V295, pH2348, DOI 10.1152/ajpheart.00602.2008; Stein LR, 2012, TRENDS ENDOCRIN MET, V23, P420, DOI 10.1016/j.tem.2012.06.005; Tao RY, 2011, J BIOL CHEM, V286, P14681, DOI 10.1074/jbc.M110.201061; Yamamoto T, 2011, TRENDS CARDIOVAS MED, V21, P27, DOI 10.1016/j.tcm.2012.01.005; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667	29	169	174	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98972	10.1371/journal.pone.0098972	http://dx.doi.org/10.1371/journal.pone.0098972			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905194	Green Published, Green Submitted, gold			2022-12-27	WOS:000341869000085
J	Dimopoulou, M; Vuillemin, M; Campbell-Sills, H; Lucas, PM; Ballestra, P; Miot-Sertier, C; Favier, M; Coulon, J; Moine, V; Doco, T; Roques, M; Williams, P; Petrel, M; Gontier, E; Moulis, C; Remaud-Simeon, M; Dols-Lafargue, M				Dimopoulou, Maria; Vuillemin, Marlene; Campbell-Sills, Hugo; Lucas, Patrick M.; Ballestra, Patricia; Miot-Sertier, Cecile; Favier, Marion; Coulon, Joana; Moine, Virginie; Doco, Thierry; Roques, Maryline; Williams, Pascale; Petrel, Melina; Gontier, Etienne; Moulis, Claire; Remaud-Simeon, Magali; Dols-Lafargue, Marguerite			Exopolysaccharide (EPS) Synthesis by Oenococcus oeni: From Genes to Phenotypes	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; STREPTOCOCCUS-THERMOPHILUS; LEUCONOSTOC-MESENTEROIDES; MALOLACTIC FERMENTATION; PEDIOCOCCUS-PARVULUS; LACTOCOCCUS-LACTIS; FUNCTIONAL-CHARACTERIZATION; BIOSYNTHESIS; POLYSACCHARIDE; DIVERSITY	Oenococcus oeni is the bacterial species which drives malolactic fermentation in wine. The analysis of 50 genomic sequences of O. oeni (14 already available and 36 newly sequenced ones) provided an inventory of the genes potentially involved in exopolysaccharide (EPS) biosynthesis. The loci identified are: two gene clusters named eps1 and eps2, three isolated glycoside-hydrolase genes named dsrO, dsrV and levO, and three isolated glycosyltransferase genes named gtf, it3, it4. The isolated genes were present or absent depending on the strain and the eps gene clusters composition diverged from one strain to another. The soluble and capsular EPS production capacity of several strains was examined after growth in different culture media and the EPS structure was determined. Genotype to phenotype correlations showed that several EPS biosynthetic pathways were active and complementary in O. oeni. Can be distinguished: (i) a Wzy -dependent synthetic pathway, allowing the production of heteropolysaccharides made of glucose, galactose and rhamnose, mainly in a capsular form, (ii) a glucan synthase pathway (Gtf), involved in beta-glucan synthesis in a free and a cell-associated form, giving a ropy phenotype to growth media and (iii) homopolysaccharide synthesis from sucrose (alpha-glucan or beta-fructan) by glycoside-hydrolases of the GH70 and GH68 families. The eps gene distribution on the phylogenetic tree was examined. Fifty out of 50 studied genomes possessed several genes dedicated to EPS metabolism. This suggests that these polymers are important for the adaptation of O. oeni to its specific ecological niche, wine and possibly contribute to the technological performance of malolactic starters.	[Dimopoulou, Maria; Campbell-Sills, Hugo; Lucas, Patrick M.; Ballestra, Patricia; Miot-Sertier, Cecile; Dols-Lafargue, Marguerite] Univ Bordeaux, Inst Polytech Bordeaux, Unite Rech Oenol, ISVV,EA 4577,INRA USC 1366, Villenave Dornon, France; [Vuillemin, Marlene; Moulis, Claire; Remaud-Simeon, Magali] Univ Toulouse, INSA, UPS, INP,INRA,CNRS,LISBP, Toulouse, France; [Favier, Marion; Coulon, Joana; Moine, Virginie] BioLaffort, Res Subsidiary Laffort Grp, Bordeaux, France; [Doco, Thierry; Roques, Maryline; Williams, Pascale] INRA, UMR1083, F-34060 Montpellier, France; [Petrel, Melina; Gontier, Etienne] Univ Bordeaux, Bordeaux Imaging Ctr, UMS CNRS INSERM 34220 US4, Bordeaux, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; INRAE; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Dols-Lafargue, M (corresponding author), Univ Bordeaux, Inst Polytech Bordeaux, Unite Rech Oenol, ISVV,EA 4577,INRA USC 1366, Villenave Dornon, France.	dols@enscbp.fr	Vuillemin, Marlène/Q-6203-2016	Vuillemin, Marlène/0000-0002-1776-7844; Doco, Thierry/0000-0002-1453-8683; Lucas, Patrick/0000-0002-9054-5439; MIOT-SERTIER, Cecile/0000-0002-5158-3803; Dimopoulou, Maria/0000-0003-4883-7697; MOULIS, Claire/0000-0002-1937-9052	 [ANR-10-ALIA-003]		ANR-10-ALIA-003 (www.agence-nationale-recherche.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyrathne PD, 2005, J BACTERIOL, V187, P3002, DOI 10.1128/JB.187.9.3002-3012.2005; ALBERSHEIM PETER, 1967, CARBOHYD RES, V5, P340, DOI 10.1016/S0008-6215(00)80510-8; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Bilhere E, 2009, APPL ENVIRON MICROB, V75, P1291, DOI 10.1128/AEM.02563-08; Boels IC, 2001, INT DAIRY J, V11, P723, DOI 10.1016/S0958-6946(01)00116-9; Borneman AR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-373; Borneman AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029626; Borneman AR, 2010, APPL MICROBIOL BIOT, V86, P681, DOI 10.1007/s00253-009-2425-6; Bourdineaud JP, 2003, APPL ENVIRON MICROB, V69, P2512, DOI 10.1128/AEM.69.5.2512-2520.2003; Bridier J, 2010, APPL ENVIRON MICROB, V76, P7754, DOI 10.1128/AEM.01544-10; Chapot-Chartier MP, 2010, J BIOL CHEM, V285, P10464, DOI 10.1074/jbc.M109.082958; Ciezack G, 2010, J APPL MICROBIOL, V108, P499, DOI 10.1111/j.1365-2672.2009.04449.x; Coulon J, 2012, INT J FOOD MICROBIOL, V159, P25, DOI 10.1016/j.ijfoodmicro.2012.07.024; DAVIS CR, 1986, APPL ENVIRON MICROB, V51, P539, DOI 10.1128/AEM.51.3.539-545.1986; DAVIS CR, 1985, AM J ENOL VITICULT, V36, P290; De Vuyst L, 1999, FEMS MICROBIOL REV, V23, P153, DOI 10.1016/S0168-6445(98)00042-4; Degeest B, 2001, J APPL MICROBIOL, V91, P470, DOI 10.1046/j.1365-2672.2001.01404.x; Degeest B, 2000, APPL ENVIRON MICROB, V66, P3519, DOI 10.1128/AEM.66.8.3519-3527.2000; Dertli E, 2013, J BIOL CHEM, V288, P31938, DOI 10.1074/jbc.M113.507418; Dimopoulou M, 2012, INT J FOOD MICROBIOL, V153, P114, DOI 10.1016/j.ijfoodmicro.2011.10.024; Dols-Lafargue M, 2008, APPL ENVIRON MICROB, V74, P4079, DOI 10.1128/AEM.00673-08; Dols-Lafargue M, 2007, J AGR FOOD CHEM, V55, P9592, DOI 10.1021/jf071677+; Doria F, 2013, APPL ENVIRON MICROB, V79, P4799, DOI 10.1128/AEM.01307-13; Favier M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049082; Forde A, 2003, PLASMID, V49, P130, DOI 10.1016/S0147-619X(02)00156-7; FUNANE K, 1993, BIOCHEMISTRY-US, V32, P13696, DOI 10.1021/bi00212a039; Gammacurta M, 2011, P 9 INT S OEN 15 17; Ganzle MG, 2009, BACTERIAL POLYSACCHA; Golubchik T, 2012, NAT GENET, V44, P352, DOI 10.1038/ng.1072; Gorska S, 2010, CARBOHYD RES, V345, P108, DOI 10.1016/j.carres.2009.09.015; Grandvalet C, 2005, J BACTERIOL, V187, P5614, DOI 10.1128/JB.187.16.5614-5623.2005; HAKOMORI SI, 1964, J BIOCHEM-TOKYO, V55, P205; HARRIS PJ, 1984, CARBOHYD RES, V127, P59, DOI 10.1016/0008-6215(84)85106-X; HENICKKLING T, 1989, APPL ENVIRON MICROB, V55, P2010, DOI 10.1128/AEM.55.8.2010-2016.1989; Hidalgo-Cantabrana C, 2014, APPL ENVIRON MICROB, V80, P9, DOI 10.1128/AEM.02977-13; Hocine B, 2010, J INT SCI VIGNE VIN, V44, P31; Hong SH, 2001, J DAIRY SCI, V84, P1367, DOI 10.3168/jds.S0022-0302(01)70167-1; Jaomanjaka F, 2013, INT J FOOD MICROBIOL, V166, P331, DOI 10.1016/j.ijfoodmicro.2013.06.032; Kleerebezem M, 1999, ANTON LEEUW INT J G, V76, P357, DOI 10.1023/A:1002084822851; Lbarburu I, 2007, J APPL MICROBIOL, V103, P477, DOI 10.1111/j.1365-2672.2006.03266.x; Llull D, 1999, J EXP MED, V190, P241, DOI 10.1084/jem.190.2.241; Lonvaud-Funel A, 1999, ANTON LEEUW INT J G, V76, P317, DOI 10.1023/A:1002088931106; Looijesteijn PJ, 2001, INT J FOOD MICROBIOL, V64, P71, DOI 10.1016/S0168-1605(00)00437-2; LUDWIG THOMAS G., 1956, JOUR DENTAL RES, V35, P90, DOI 10.1177/00220345560350012301; Martins G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073013; Mills DA, 2005, FEMS MICROBIOL REV, V29, P465, DOI 10.1016/j.femsre.2005.04.011; Morales-Arrieta S, 2006, GENE, V376, P59, DOI 10.1016/j.gene.2006.02.007; Moulis C, 2006, J BIOL CHEM, V281, P31254, DOI 10.1074/jbc.M604850200; MUKASA H, 1973, INFECT IMMUN, V8, P555, DOI 10.1128/IAI.8.4.555-562.1973; MURCHISON H, 1981, INFECT IMMUN, V34, P1044, DOI 10.1128/IAI.34.3.1044-1055.1981; Olvera C, 2007, MICROBIOL-SGM, V153, P3994, DOI 10.1099/mic.0.2007/008854-0; Peant B, 2005, MICROBIOL-SGM, V151, P1839, DOI 10.1099/mic.0.27852-0; Peynaud E, 1959, CR ACAD AGR FR, V45, P355; Pluvinet A, 2004, INT DAIRY J, V14, P627, DOI 10.1016/j.idairyj.2003.12.009; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; Rodriguez C, 2008, LETT APPL MICROBIOL, V46, P462, DOI 10.1111/j.1472-765X.2008.02341.x; Ruas-Madiedo P, 2002, INT DAIRY J, V12, P689, DOI 10.1016/S0958-6946(01)00161-3; Stingele F, 1999, MOL MICROBIOL, V32, P1287, DOI 10.1046/j.1365-2958.1999.01441.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Torriani S, 2011, ANN MICROBIOL, V61, P33, DOI 10.1007/s13213-010-0072-x; Tripathi P, 2012, MICRON, V43, P1323, DOI 10.1016/j.micron.2012.01.001; Versari A, 1999, J IND MICROBIOL BIOT, V23, P447, DOI 10.1038/sj.jim.2900733; Walling E, 2005, INT J FOOD MICROBIOL, V98, P53, DOI 10.1016/j.ijfoodmicro.2004.05.016; Walling E, 2005, FOOD MICROBIOL, V22, P71, DOI 10.1016/j.fm.2004.04.003; Werning ML, 2006, J FOOD PROTECT, V69, P161, DOI 10.4315/0362-028X-69.1.161; Whitfield C, 1997, MOL MICROBIOL, V23, P629, DOI 10.1046/j.1365-2958.1997.2571614.x; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Wilson BA, 2002, CURR OPIN BIOTECH, V13, P267, DOI 10.1016/S0958-1669(02)00312-9; Wyres KL, 2013, J INFECT DIS, V207, P439, DOI 10.1093/infdis/jis703	70	46	48	3	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98898	10.1371/journal.pone.0098898	http://dx.doi.org/10.1371/journal.pone.0098898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901216	Green Published, Green Submitted, gold			2022-12-27	WOS:000336841400069
J	Johnson, DA; Barclay, RL; Mergener, K; Weiss, G; Konig, T; Beck, J; Potter, NT				Johnson, David A.; Barclay, Robert L.; Mergener, Klaus; Weiss, Gunter; Koenig, Thomas; Beck, Juergen; Potter, Nicholas T.			Plasma Septin9 versus Fecal Immunochemical Testing for Colorectal Cancer Screening: A Prospective Multicenter Study	PLOS ONE			English	Article							OCCULT BLOOD-TESTS; DNA METHYLATION; AMERICAN-COLLEGE; GENE; BIOMARKERS; MORTALITY	Background: Screening improves outcomes related to colorectal cancer (CRC); however, suboptimal participation for available screening tests limits the full benefits of screening. Non-invasive screening using a blood based assay may potentially help reach the unscreened population. Objective: To compare the performance of a new Septin9 DNA methylation based blood test with a fecal immunochemical test (FIT) for CRC screening. Design: In this trial, fecal and blood samples were obtained from enrolled patients. To compare test sensitivity for CRC, patients with screening identified colorectal cancer (n = 102) were enrolled and provided samples prior to surgery. To compare test specificity patients were enrolled prospectively (n = 199) and provided samples prior to bowel preparation for screening colonoscopy. Measurements: Plasma and fecal samples were analyzed using the Epi proColon and OC Fit-Check tests respectively. Results: For all samples, sensitivity for CRC detection was 73.3% (95% CI 63.9-80.9%) and 68.0% (95% CI 58.2-76.5%) for Septin9 and FIT, respectively. Specificity of the Epi proColon test was 81.5% (95% CI 75.5-86.3%) compared with 97.4% (95% CI 94.1-98.9%) for FIT. For paired samples, the sensitivity of the Epi proColon test (72.2%-95% CI 62.5-80.1%) was shown to be statistically non-inferior to FIT (68.0%-95% CI 58.2-76.5%). When test results for Epi proColon and FIT were combined, CRC detection was 88.7% at a specificity of 78.8%. Conclusions: At a sensitivity of 72%, the Epi proColon test is non-inferior to FIT for CRC detection, although at a lower specificity. With negative predictive values of 99.8%, both methods are identical in confirming the absence of CRC.	[Johnson, David A.] Eastern VA Med Sch, Div Gastroenterol, Norfolk, VA 23507 USA; [Barclay, Robert L.] Rockford Gastroenterol Associates Ltd, Rockford, IL USA; [Mergener, Klaus] Digest Hlth Specialists, Tacoma, WA USA; [Weiss, Gunter; Koenig, Thomas; Beck, Juergen] Epigen AG, Berlin, Germany; [Potter, Nicholas T.] Mol Pathol Lab Network Inc, Maryville, TN USA	Eastern Virginia Medical School	Johnson, DA (corresponding author), Eastern VA Med Sch, Div Gastroenterol, Norfolk, VA 23507 USA.	dajevms@aol.com			Epigenomics AG (Berlin, Germany)	Epigenomics AG (Berlin, Germany)	The study was sponsored by Epigenomics AG (Berlin, Germany) http://www.epigenomics.com. Epigenomics provided support in the form of salaries for authors GW, TK, JB, and designed this study which was conducted at US clinical sites through an independent clinical research organization (CRO). Results were collated and analyzed consecutively by the sponsor following completion of testing. As per study protocol, manuscript preparation and the decision to publish were overseen by a publication steering committee comprising of DAJ, JB, KM, NTP and RLB. Laboratory testing was performed at an independent US clinical laboratory on all submitted specimens. Eastern VA Medical School, Rockford Gastroenterology Associates, Ltd., Digestive Health Specialists and Molecular Pathology Laboratory Network, Inc., provided support in the form of salaries for authors DAJ, RLB, KM, NTP, respectively, but did not have any additional role in the study design, data collection	Adler A, 2012, GUT, V61, pA324; Ahmed D, 2012, CLIN TRANSL GASTROEN, V3, DOI 10.1038/ctg.2012.21; American Cancer Society, 2011, COL CANC FACTS FIG 2; Amri R, 2013, JAMA SURG, V148, P747, DOI 10.1001/jamasurg.2013.8; Boone JD, 2012, J GYNECOL ONCOL, V23, P282, DOI 10.3802/jgo.2012.23.4.282; Burch JA, 2007, J MED SCREEN, V14, P132, DOI 10.1258/096914107782066220; Chubak J, 2013, PREV MED, V57, P671, DOI 10.1016/j.ypmed.2013.08.032; Church TR, 2014, GUT, V63, P317, DOI 10.1136/gutjnl-2012-304149; Connolly D, 2011, BIOL CHEM, V392, P725, DOI 10.1515/BC.2011.073; deVos T, 2009, CLIN CHEM, V55, P1337, DOI 10.1373/clinchem.2008.115808; Garcia AZG, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/483417; Grutzmann R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003759; Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; Hoffman RM, 2011, PREV CHRONIC DIS, V8; Holden DJ, 2010, AHRQ PUBLICATION; Inadomi JM, 2012, ARCH INTERN MED, V172, P575, DOI 10.1001/archinternmed.2012.332; Joseph Djenaba A, 2012, MMWR Suppl, V61, P51; Klabunde CN, 2013, MMWR-MORBID MORTAL W, V62, P881; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Lofton-Day C, 2008, CLIN CHEM, V54, P414, DOI 10.1373/clinchem.2007.095992; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; McDade SS, 2007, HUM MOL GENET, V16, P742, DOI 10.1093/hmg/ddm003; Montagna C, 2003, CANCER RES, V63, P2179; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; Osaka M, 1999, P NATL ACAD SCI USA, V96, P6428, DOI 10.1073/pnas.96.11.6428; Payne SR, 2010, EPIGENOMICS-UK, V2, P575, DOI [10.2217/epi.10.35, 10.2217/EPI.10.35]; Pepe MS, 2003, STAT EVALUATION MED; Pignone M, 2002, ANN INTERN MED, V137, P96, DOI 10.7326/0003-4819-137-2-200207160-00007; Rex DK, 2009, AM J GASTROENTEROL, V104, P739, DOI 10.1038/ajg.2009.104; Russell SEH, 2000, CANCER RES, V60, P4729; Rutter CM, 2012, CANCER CAUSE CONTROL, V23, P289, DOI 10.1007/s10552-011-9878-5; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Taber JM, 2014, AM J HEALTH BEHAV, V38, P351, DOI 10.5993/AJHB.38.3.4; Toth K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046000; Warren JD, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-133; Wasserkort R, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-398; Weiss G, 2012, J CLIN ONCOL, V30, DOI 10.1200/jco.2012.30.4_suppl.419; Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244	38	113	116	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98238	10.1371/journal.pone.0098238	http://dx.doi.org/10.1371/journal.pone.0098238			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901436	gold, Green Published, Green Submitted			2022-12-27	WOS:000336841400022
J	Talarico, JA; Carter, RL; Grisanti, LA; Yu, JE; Repas, AA; Tilley, DG				Talarico, Jennifer A.; Carter, Rhonda L.; Grisanti, Laurel A.; Yu, Justine E.; Repas, Ashley A.; Tilley, Douglas G.			beta-Adrenergic Receptor-Dependent Alterations in Murine Cardiac Transcript Expression Are Differentially Regulated by Gefitinib In Vivo	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; GENE-EXPRESSION; BETA(2)-ADRENERGIC RECEPTOR; INDUCED APOPTOSIS; SEMAPHORIN 3A; HYPERTROPHY; THROMBOSPONDIN-1; TRANSACTIVATION; PATHWAY; HEART	beta-adrenergic receptor (bAR)-mediated transactivation of epidermal growth factor receptor (EGFR) has been shown to promote cardioprotection in a mouse model of heart failure and we recently showed that this mechanism leads to enhanced cell survival in part via regulation of apoptotic transcript expression in isolated primary rat neonatal cardiomyocytes. Thus, we hypothesized that this process could regulate cardiac transcript expression in vivo. To comprehensively assess cardiac transcript alterations in response to acute bAR-dependent EGFR transactivation, we performed whole transcriptome analysis of hearts from C57BL/6 mice given i.p. injections of the bAR agonist isoproterenol in the presence or absence of the EGFR antagonist gefitinib for 1 hour. Total cardiac RNA from each treatment group underwent transcriptome analysis, revealing a substantial number of transcripts regulated by each treatment. Gefitinib alone significantly altered the expression of 405 transcripts, while isoproterenol either alone or in conjunction with gefitinib significantly altered 493 and 698 distinct transcripts, respectively. Further statistical analysis was performed, confirming 473 transcripts whose regulation by isoproterenol were significantly altered by gefitinib (isoproterenol-induced up/downregulation antagonized/promoted by gefinitib), including several known to be involved in the regulation of numerous processes including cell death and survival. Thus, bAR-dependent regulation of cardiac transcript expression in vivo can be modulated by the EGFR antagonist gefitinib.	[Talarico, Jennifer A.] Thomas Jefferson Univ, Ctr Translat Med, Philadelphia, PA 19107 USA; [Carter, Rhonda L.; Grisanti, Laurel A.; Yu, Justine E.; Repas, Ashley A.; Tilley, Douglas G.] Temple Univ, Ctr Translat Med, Sch Med, Philadelphia, PA 19122 USA; [Tilley, Douglas G.] Temple Univ, Dept Pharmacol, Sch Med, Philadelphia, PA 19122 USA	Jefferson University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Tilley, DG (corresponding author), Temple Univ, Ctr Translat Med, Sch Med, Philadelphia, PA 19122 USA.	douglas.tilley@temple.edu		Tilley, Douglas/0000-0002-9681-3377	National Institutes of Health [HL105414]; WW Smith Charitable Trust [H1206]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105414] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WW Smith Charitable Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding provided by the National Institutes of Health (HL105414) and the WW Smith Charitable Trust (H1206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba MC, 2009, CANCER PREV RES, V2, P175, DOI 10.1158/1940-6207.CAPR-08-0104; Buehler A, 2013, FEBS LETT, V587, P1650, DOI 10.1016/j.febslet.2013.04.008; Carter BD, 2010, AM J PHYSIOL-HEART C, V298, pH1633, DOI 10.1152/ajpheart.00253.2010; Carter RL, 2014, PHARMACOL RES PERSPE, V2, DOI 10.1002/prp2.24; Chen H, 2012, CELL BIOL INT, V36, P237, DOI 10.1042/CBI20110162; Chen Y, 2013, LUNG CANCER, V82, P313, DOI 10.1016/j.lungcan.2013.08.013; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Errami M, 2008, J PHARMACOL EXP THER, V324, P1196, DOI 10.1124/jpet.107.133975; Galindo Cristi L., 2009, BMC Physiology, V9, P23, DOI 10.1186/1472-6793-9-23; Gonzalez-Quesada C, 2013, CIRC RES, V113, P1331, DOI 10.1161/CIRCRESAHA.113.302593; Grisanti LA, 2014, J MOL CELLU IN PRESS; Guo HF, 2013, BIOCHEMISTRY-US, V52, P7551, DOI 10.1021/bi401034q; Ieda M, 2004, J CLIN INVEST, V113, P876, DOI 10.1172/JCI200419480; Inoue R, 2006, ANTICANCER RES, V26, P4195; Irwin DM, 2014, MOL PHYLOGENET EVOL, V70, P195, DOI 10.1016/j.ympev.2013.09.016; Jin Z, 2006, DEV DYNAM, V235, P163, DOI 10.1002/dvdy.20614; Kawasaki Y, 2007, J MEMBRANE BIOL, V217, P53, DOI 10.1007/s00232-007-9051-y; Kim J, 2002, J BIOL CHEM, V277, P32116, DOI 10.1074/jbc.M204895200; Lee KS, 2011, CELL SIGNAL, V23, P1100, DOI 10.1016/j.cellsig.2011.01.006; Leggas M, 2006, CANCER RES, V66, P4802, DOI 10.1158/0008-5472.CAN-05-2915; Lewin G, 2009, CIRCULATION, V119, P79, DOI 10.1161/CIRCULATIONAHA.108.786533; Li JW, 2012, J VIROL, V86, P3200, DOI 10.1128/JVI.06699-11; Lu QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064265; Lynch JM, 2012, CELL, V149, P1257, DOI 10.1016/j.cell.2012.03.050; Ma YG, 2013, CIRC RES, V113, P1272, DOI 10.1161/CIRCRESAHA.113.302749; Makki N, 2013, INT J MOL SCI, V14, P20597, DOI 10.3390/ijms141020597; Malhotra R, 1999, J BIOL CHEM, V274, P12567, DOI 10.1074/jbc.274.18.12567; Mani SK, 2010, J MOL CELL CARDIOL, V48, P342, DOI 10.1016/j.yjmcc.2009.11.007; Matkovich SJ, 2010, CIRC RES, V106, P1459, DOI 10.1161/CIRCRESAHA.110.217513; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; Molojavyi A, 2010, PHYSIOL GENOMICS, V41, P137, DOI 10.1152/physiolgenomics.90297.2008; Mustonen E, 2013, BASIC CLIN PHARMACOL, V112, P4, DOI 10.1111/bcpt.12026; Myers SA, 2009, MOL CELL ENDOCRINOL, V309, P101, DOI 10.1016/j.mce.2009.05.006; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Orphanos GS, 2009, ACTA ONCOL, V48, P964, DOI 10.1080/02841860903229124; Parnes D, 2007, BBA-GENE STRUCT EXPR, V1769, P586, DOI 10.1016/j.bbaexp.2007.06.001; Recchia AG, 2009, J MOL CELL CARDIOL, V46, P352, DOI 10.1016/j.yjmcc.2008.11.017; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Ritchie A, 2009, CELL DEATH DIFFER, V16, P838, DOI 10.1038/cdd.2009.13; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Soker T, 2013, GENE, V512, P517, DOI 10.1016/j.gene.2012.10.002; Solmi R, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-227; Sun SQ, 2011, CHINESE MED J-PEKING, V124, P2173, DOI 10.3760/cmaj.issn.0366-6999.2011.14.017; Tilley DG, 2009, J BIOL CHEM, V284, P20375, DOI 10.1074/jbc.M109.005793; Wang Q, 2010, AM J PHYSIOL-REG I, V299, pR1013, DOI 10.1152/ajpregu.00241.2010; Wang W, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000249; Wen HZ, 2011, TOHOKU J EXP MED, V225, P51, DOI 10.1620/tjem.225.51; Xia Y, 2011, HYPERTENSION, V58, P902, DOI 10.1161/HYPERTENSIONAHA.111.175323; Xiong GF, 2012, CANCER RES, V72, P1728, DOI 10.1158/0008-5472.CAN-11-2762; Yan C, 2007, CIRC RES, V100, P489, DOI 10.1161/01.RES.0000258451.44949.d7; Zhang BH, 2013, HEART VESSELS; Zhang XY, 2013, CIRC RES, V112, P498, DOI 10.1161/CIRCRESAHA.112.273896	53	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99195	10.1371/journal.pone.0099195	http://dx.doi.org/10.1371/journal.pone.0099195			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901703	Green Published, gold, Green Submitted			2022-12-27	WOS:000336841400108
J	Vinn, O; Wilson, MA; Motus, MA				Vinn, Olev; Wilson, Mark A.; Motus, Mari-Ann			The Earliest Giant Osprioneides Borings from the Sandbian (Late Ordovician) of Estonia	PLOS ONE			English	Article							PREDATION; POLAND; RECORD	The earliest Osprioneides kampto borings were found in bryozoan colonies of Sandbian age from northern Estonia (Baltica). The Ordovician was a time of great increase in the quantities of hard substrate removed by single trace makers. Increased predation pressure was most likely the driving force behind the infaunalization of larger invertebrates such as the Osprioneides trace makers in the Ordovician. It is possible that the Osprioneides borer originated in Baltica or in other paleocontinents outside of North America.	[Vinn, Olev] Univ Tartu, Dept Geol, EE-50090 Tartu, Estonia; [Wilson, Mark A.] Coll Wooster, Dept Geol, Wooster, OH 44691 USA; [Motus, Mari-Ann] Tallinn Univ Technol, Inst Geol, EE-19086 Tallinn, Estonia	University of Tartu; College of Wooster; Tallinn University of Technology	Vinn, O (corresponding author), Univ Tartu, Dept Geol, Ulikooli 18, EE-50090 Tartu, Estonia.	olev.vinn@ut.ee	Vinn, Olev/AAG-6806-2020	Vinn, Olev/0000-0002-2889-2544	Sepkoski Grant program (Paleontological Society); Estonian Science Foundation [ETF9064]; Estonian Research Council [IUT20-34]; Estonian Ministry of Education and Science [SF0180051s08, SF0140020s08]	Sepkoski Grant program (Paleontological Society); Estonian Science Foundation; Estonian Research Council; Estonian Ministry of Education and Science(Ministry of Education and Research, Estonia)	O.V. is indebted to the Sepkoski Grant program (Paleontological Society), Estonian Science Foundation grant ETF9064, Estonian Research Council grant IUT20-34 and a target-financed project from the Estonian Ministry of Education and Science (SF0180051s08; Ordovician and Silurian climate changes, as documented from the biotic changes and depositional environments in the Baltoscandian Palaeobasin) for financial support. M-A.M was also supported by a target-financed project from the Estonian Ministry of Education and Science (SF0140020s08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beuck L, 2008, ACTA PALAEONTOL POL, V53, P147; Borszcz T, 2013, LETHAIA, V46, P141, DOI 10.1111/let.12007; Bromley RG, 2004, GEOL SOC SPEC PUBL, V228, P455, DOI 10.1144/GSL.SP.2004.228.01.20; Dronov Andrei V., 2002, Journal of the Czech Geological Society, V47, P133; Ekdale AA, 2001, LETHAIA, V34, P1; Erickson JM, 2003, J PALEONTOL, V77, P1002, DOI 10.1666/0022-3360(2003)077<1002:DAIOSL>2.0.CO;2; Huntley JW, 2007, P NATL ACAD SCI USA, V104, P15006, DOI 10.1073/pnas.0704960104; Jackson PNW, 2007, LETHAIA, V40, P237, DOI 10.1111/j.1502-3931.2007.00021.x; JAMES NP, 1977, SCIENCE, V197, P980, DOI 10.1126/science.197.4307.980-a; KOBLUK DR, 1978, PALEOBIOLOGY, V4, P163, DOI 10.1017/S0094837300005832; Motus M. -A., 2007, 10 INT S FOSS CNID P; NESTOR H, 1997, GEOLOGY MINERAL RESO, P192; Newall G., 1970, Geol. J. spec. Issue, VNo. 3, P335; NIELD EW, 1984, PALAEOGEOGR PALAEOCL, V48, P229, DOI 10.1016/0031-0182(84)90046-4; Palmer Tim, 1993, Geology Today, V9, P138, DOI 10.1111/j.1365-2451.1993.tb00469.x; Pojeta J, 1976, ALCHERINGA, V1, P167, DOI 10.1080/03115517608619068; Roomusoks A., 1970, STRATIGRAPHY VIRUAN; Tapanila L., 2002, Acta Geologica Hispanica, V37, P15; Taylor PD, 2003, EARTH-SCI REV, V62, P1, DOI 10.1016/S0012-8252(02)00131-9; TORSVIK TH, 1992, EARTH-SCI REV, V33, P133, DOI 10.1016/0012-8252(92)90023-M; Vinn O, 2005, CARNETS GEOL; Vinn Olev, 2004, Proceedings of the Estonian Academy of Sciences Geology, V53, P257; Vinn O, 2010, CARNETS GEOL; Vinn O, 2010, ICHNOS, V17, P166, DOI 10.1080/10420940.2010.502478; WILSON MA, 1988, J PALEONTOL, V62, P306, DOI 10.1017/S0022336000029978; Wilson Mark A., 2007, P356, DOI 10.1016/B978-044452949-7/50146-7; Wilson Mark A., 2006, Ichnos, V13, P109, DOI 10.1080/10420940600850505; Zaton M, 2014, PALAEOGEOGR PALAEOCL, V401, P142, DOI 10.1016/j.palaeo.2014.02.029; Zaton M, 2011, PALAEOGEOGR PALAEOCL, V307, P232, DOI 10.1016/j.palaeo.2011.05.022; Zaton M, 2011, FACIES, V57, P275, DOI 10.1007/s10347-010-0244-y	30	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99455	10.1371/journal.pone.0099455	http://dx.doi.org/10.1371/journal.pone.0099455			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901511	Green Published, gold, Green Submitted			2022-12-27	WOS:000336841400128
J	Darnell, AM; Graf, JA; Somers, MJ; Slotow, R; Gunther, MS				Darnell, Angela M.; Graf, Jan A.; Somers, Michael J.; Slotow, Rob; Gunther, Micaela Szykman			Space Use of African Wild Dogs in Relation to Other Large Carnivores	PLOS ONE			English	Article							HLUHLUWE-UMFOLOZI PARK; LYCAON-PICTUS; INTERSPECIFIC COMPETITION; HUNTING BEHAVIOR; SPOTTED HYAENAS; IMFOLOZI-PARK; NATIONAL-PARK; PANTHERA-LEO; PACK SIZE; POPULATION	Interaction among species through competition is a principle process structuring ecological communities, affecting behavior, distribution, and ultimately the population dynamics of species. High competition among large African carnivores, associated with extensive diet overlap, manifests in interactions between subordinate African wild dogs (Lycaon pictus) and dominant lions (Panthera leo) and spotted hyenas (Crocuta crocuta). Using locations of large carnivores in Hluhluwe-iMfolozi Park, South Africa, we found different responses from wild dogs to their two main competitors. Wild dogs avoided lions, particularly during denning, through a combination of spatial and temporal avoidance. However, wild dogs did not exhibit spatial or temporal avoidance of spotted hyenas, likely because wild dog pack sizes were large enough to adequately defend their kills. Understanding that larger carnivores affect the movements and space use of other carnivores is important for managing current small and fragmented carnivore populations, especially as reintroductions and translocations are essential tools used for the survival of endangered species, as with African wild dogs.	[Darnell, Angela M.; Gunther, Micaela Szykman] Humboldt State Univ, Dept Wildlife, Arcata, CA 95521 USA; [Graf, Jan A.; Slotow, Rob] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa; [Somers, Michael J.] Univ Pretoria, Ctr Wildlife Management, Ctr Invas Biol, ZA-0002 Pretoria, South Africa; [Gunther, Micaela Szykman] Smithsonian Conservat Biol Inst, Front Royal, VA USA	California State University System; California State Polytechnic University, Humboldt; University of Kwazulu Natal; University of Pretoria; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Darnell, AM (corresponding author), Humboldt State Univ, Dept Wildlife, Arcata, CA 95521 USA.	ange.darnell@gmail.com	Slotow, Rob/AAM-9053-2020; /A-1523-2008	Slotow, Rob/0000-0001-9469-1508; /0000-0002-5836-8823; Darnell Baker, Ange/0000-0003-1419-3248	Smithsonian Institution Undersecretary for Science Endowment Funds; American Zoo and Aquarium Association Conservation Endowment Fund; Humboldt State University Sponsored Program Foundation; University of Pretoria, Green Trust; Bateleurs and Wildlife Conservation Trust; NRF, NSF; University of KwaZulu-Natal; Walt Disney Foundation and MGM; Wild about Cats; Hluhluwe Tourism Association; THRIP; Grand Hotel grants	Smithsonian Institution Undersecretary for Science Endowment Funds; American Zoo and Aquarium Association Conservation Endowment Fund; Humboldt State University Sponsored Program Foundation; University of Pretoria, Green Trust; Bateleurs and Wildlife Conservation Trust; NRF, NSF; University of KwaZulu-Natal; Walt Disney Foundation and MGM; Wild about Cats; Hluhluwe Tourism Association; THRIP; Grand Hotel grants	Funding for this project was provided by the Smithsonian Institution Undersecretary for Science Endowment Funds, the American Zoo and Aquarium Association Conservation Endowment Fund, and Humboldt State University Sponsored Program Foundation (MSG); University of Pretoria, The Green Trust (WWF-SA), and Bateleurs and Wildlife Conservation Trust (KZN) (MS); NRF, NSF, University of KwaZulu-Natal, Walt Disney Foundation and MGM, Wild about Cats, and Hluhluwe Tourism Association (RS); and THRIP (N. Ferguson) and Grand Hotel grants (C. Packer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acocks JPH., 1988, MEMOIRS BOT SURVEY S, P1, DOI DOI 10.2307/212246; Andreka G, 1999, S AFR J WILDL RES, V29, P1; Ballard Warren B., 2003, P259; Berger KM, 2007, J ANIM ECOL, V76, P1075, DOI 10.1111/j.1365-2656.2007.01287.x; Carbone C, 2005, J ZOOL, V266, P153, DOI 10.1017/s0952836905006710; Caro TM, 2003, BIOL CONSERV, V110, P67, DOI 10.1016/S0006-3207(02)00177-5; Celesia GG, 2010, AFR J ECOL, V48, P58, DOI 10.1111/j.1365-2028.2009.01082.x; COOPER SM, 1990, AFR J ECOL, V28, P131, DOI 10.1111/j.1365-2028.1990.tb01145.x; Courchamp F, 2000, OIKOS, V91, P311, DOI 10.1034/j.1600-0706.2000.910212.x; Courchamp F, 2001, ANIM CONSERV, V4, P169, DOI 10.1017/S1367943001001196; Creel S, 2004, BIOLOGY AND CONSERVATION OF WILD CANIDS, P337; CREEL S, 1995, ANIM BEHAV, V50, P1325, DOI 10.1016/0003-3472(95)80048-4; Creel S, 1996, CONSERV BIOL, V10, P526, DOI 10.1046/j.1523-1739.1996.10020526.x; Creel S, 2001, CONSERV BIOL SER, V5, P35; Creel S, 2001, CONSERV BIOL, V15, P271, DOI 10.1046/j.1523-1739.2001.99534.x; Creel S., 2002, AFRICAN WILD DOG BEH; Davies-Mostert Harriet T., 2009, P10, DOI 10.1002/9781444312034.ch2; Durant SM, 1998, J ANIM ECOL, V67, P370, DOI 10.1046/j.1365-2656.1998.00202.x; ESTES RD, 1967, J WILDLIFE MANAGE, V31, P52, DOI 10.2307/3798360; ESTES RD, 1991, BEHAV GUIDE AFRICAN; FANSHAWE JH, 1993, ANIM BEHAV, V45, P479, DOI 10.1006/anbe.1993.1059; Fieberg J, 2005, J WILDLIFE MANAGE, V69, P1346, DOI 10.2193/0022-541X(2005)69[1346:QHOTIO]2.0.CO;2; Fuller TK, 2001, CONSERV BIOL SER, V5, P163; FULLER TK, 1990, AFR J ECOL, V28, P330, DOI 10.1111/j.1365-2028.1990.tb01168.x; Garton Edward O., 2001, P15, DOI 10.1016/B978-012497781-5/50003-7; Gorman ML, 1998, NATURE, V391, P479, DOI 10.1038/35131; Gorman TA, 2006, J MAMMAL, V87, P740, DOI 10.1644/05-MAMM-A-337R1.1; Graf JA, 2009, ACTA THERIOL, V54, P333, DOI 10.4098/j.at.0001-7051.095.2008; Greyling T, 1984, DIRECTOR SO AFRICAN; Gusset M, 2008, J APPL ECOL, V45, P100, DOI 10.1111/j.1365-2664.2007.01357.x; Gusset M, 2010, ANIM BEHAV, V79, P425, DOI 10.1016/j.anbehav.2009.11.021; Hampton SE, 2004, OECOLOGIA, V138, P475, DOI 10.1007/s00442-003-1446-6; HARRIS S, 1990, MAMMAL REV, V20, P97, DOI 10.1111/j.1365-2907.1990.tb00106.x; Hayward MW, 2009, S AFR J WILDL RES, V39, P109, DOI 10.3957/056.039.0207; Hopcraft JGC, 2005, J ANIM ECOL, V74, P559, DOI 10.1111/j.1365-2656.2005.00955.x; Hopcraft JGC, 2002, THESIS U BRIT COLUMB; Johnson WE, 1996, CARNIVORE BEHAV ECOL, P125; Kernohan Brian J., 2001, P125, DOI 10.1016/B978-012497781-5/50006-2; Kruger SC, 1999, J ZOOL, V248, P543, DOI 10.1111/j.1469-7998.1999.tb01054.x; Kruuk H., 1972, SPOTTED HYENA STUDY; LAURENSON MK, 1994, J ZOOL, V234, P387, DOI 10.1111/j.1469-7998.1994.tb04855.x; Linnell John D. C., 2000, Diversity and Distributions, V6, P169, DOI 10.1046/j.1472-4642.2000.00069.x; Maddock A., 1996, Lammergeyer, V44, P6; Maddock A, 1999, CONSERV BIOL, V13, P412, DOI 10.1046/j.1523-1739.1999.013002412.x; MCDOUGAL C, 1988, Journal of the Bombay Natural History Society, V85, P609; MILLS MGL, 1982, S AFR J WILDL RES, V12, P111; Mills MGL, 1997, CONSERV BIOL, V11, P1397, DOI 10.1046/j.1523-1739.1997.96252.x; MILLS MGL, 1993, SYM ZOOL S, P253; MILLS MGL, 1998, POPULATION HABITAT V; Mills Michael G.L., 2003, P370; MINTA SC, 1992, ECOL APPL, V2, P178, DOI 10.2307/1941774; Nelson JL, 2007, J WILDLIFE MANAGE, V71, P1467, DOI 10.2193/2006-234; Owen-Smith N, 2008, J ANIM ECOL, V77, P173, DOI 10.1111/j.1365-2656.2007.01314.x; Palomares F, 1996, J APPL ECOL, V33, P5, DOI 10.2307/2405010; Rasmussen GSA, 2012, J ZOOL, V286, P232, DOI 10.1111/j.1469-7998.2011.00874.x; Saleni P, 2007, CANID NEWS, V10, P2; Seaman DE, 1999, J WILDLIFE MANAGE, V63, P739, DOI 10.2307/3802664; Sillero-Zubiri C, 2004, CANIDS FOXES WOLVES; Smith JE, 2008, ANIM BEHAV, V76, P619, DOI 10.1016/j.anbehav.2008.05.001; Snyder RE, 2003, ECOL LETT, V6, P301, DOI 10.1046/j.1461-0248.2003.00434.x; Somers MJ, 2008, OECOLOGIA, V158, P239, DOI 10.1007/s00442-008-1134-7; Spiering PA, 2011, CONSERV GENET, V12, P401, DOI 10.1007/s10592-010-0147-z; Spiering PA, 2010, BEHAV ECOL SOCIOBIOL, V64, P583, DOI 10.1007/s00265-009-0875-6; Spong G, 2002, BEHAV ECOL SOCIOBIOL, V52, P303, DOI 10.1007/s00265-002-0515-x; Terborgh J., 1999, WILD EARTH, P42; Trinkel M, 2008, ANIM CONSERV, V11, P138, DOI 10.1111/j.1469-1795.2008.00163.x; Trinkel M, 2005, AFR J ECOL, V43, P220, DOI 10.1111/j.1365-2028.2005.00574.x; van der Meer E, 2011, BEHAV ECOL, V22, P985, DOI 10.1093/beheco/arr079; van Dyk G, 2003, AFR ZOOL, V38, P79; Vanak AT, 2013, ECOLOGY IN PRESS; Vucetich JA, 1999, CONSERV BIOL, V13, P1172, DOI 10.1046/j.1523-1739.1999.98366.x; Webster H, 2012, ETHOLOGY, V118, P147, DOI 10.1111/j.1439-0310.2011.01992.x; WHATELEY A, 1983, Bothalia, V14, P745; Whateley A, 1978, LAMMERGEYER, V35, P1; WOODROFFE R, 2004, CANIDS FOXES WOLVES; Woodroffe R, 2007, ORYX, V41, P215, DOI 10.1017/S0030605307001809; Woodroffe Rosie, 1997, P58; Zar JH, 1999, BIOSTATISTICAL ANAL	78	33	34	1	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98846	10.1371/journal.pone.0098846	http://dx.doi.org/10.1371/journal.pone.0098846			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896638	Green Published, gold, Green Submitted			2022-12-27	WOS:000338430700086
J	Mindur, JE; Ito, N; Dhib-Jalbut, S; Ito, K				Mindur, John E.; Ito, Naoko; Dhib-Jalbut, Suhayl; Ito, Kouichi			Early Treatment with Anti-VLA-4 mAb Can Prevent the Infiltration and/or Development of Pathogenic CD11b(+)CD4(+) T Cells in the CNS during Progressive EAE	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; ALPHA-4 INTEGRIN; CONTROLLED TRIAL; CD11B MAC-1; P-SELECTIN; RECEPTOR 2; GM-CSF; NATALIZUMAB	Natalizumab is a humanized monoclonal antibody against the leukocyte adhesion molecule very late antigen (VLA)-4, and is currently an approved therapy for patients with relapsing-remitting multiple sclerosis (RRMS). However, it is unknown whether natalizumab is beneficial for progressive forms of MS. Therefore, we assessed the effects of anti-VLA-4 monoclonal antibody (mAb) therapy in a progressive experimental autoimmune encephalomyelitis (EAE) mouse model. Notably, we found that early therapy could significantly reduce the severity of progressive EAE, while treatment initiated at an advanced stage was less efficient. Furthermore, we observed the accumulation of a novel subset of GM-CSF-producing CD11b(+)CD4(+) T cells in the CNS throughout disease progression. Importantly, early therapeutic anti-VLA-4 mAb treatment suppressed the accumulation of these GM-CSF-producing CD11b(+)CD4(+) T cells in the CNS along with activated microglia/macrophages populations, and also conferred a protective effect against inflammation-mediated neurodegeneration, including demyelination and axonal loss. Collectively, our data suggest that early treatment with anti-VLA-4 mAb can provide neuroprotection against progressive CNS autoimmune disease by preventing the accumulation of pathogenic GM-CSF-producing CD11b(+)CD4(+) T cells in the CNS.	[Mindur, John E.; Ito, Naoko; Dhib-Jalbut, Suhayl; Ito, Kouichi] Rutgers Robert Wood Johnson Med Sch, Dept Neurol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Ito, K (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Neurol, Piscataway, NJ 08854 USA.	itoko@rwjms.rutgers.edu	Mindur, John E./L-3299-2019	Mindur, John E./0000-0002-2212-3904	Biogen Idec; Elan [TYS-09-10003]	Biogen Idec(Biogen); Elan	This study was supported by an investigator initiated grant to Drs. Ito and Dhib-Jalbut from Biogen Idec and Elan (Grant# TYS-09-10003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; BARON JL, 1993, J EXP MED, V177, P57, DOI 10.1084/jem.177.1.57; Bauer J, 1998, AM J PATHOL, V153, P715, DOI 10.1016/S0002-9440(10)65615-5; Benveniste EN, 1997, J MOL MED-JMM, V75, P165, DOI 10.1007/s001090050101; Berard JL, 2010, GLIA, V58, P434, DOI 10.1002/glia.20935; Brocke S, 1999, P NATL ACAD SCI USA, V96, P6896, DOI 10.1073/pnas.96.12.6896; Bullard DC, 2005, J IMMUNOL, V175, P6327, DOI 10.4049/jimmunol.175.10.6327; Cannella B, 2003, J NEUROSCI RES, V71, P407, DOI 10.1002/jnr.10487; Chen XC, 2009, J INFECT DIS, V200, P399, DOI 10.1086/600075; Christensen JE, 2001, INT IMMUNOL, V13, P593, DOI 10.1093/intimm/13.4.593; CHULUYAN HE, 1993, J CLIN INVEST, V92, P2768, DOI 10.1172/JCI116895; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Engelhardt B, 1998, J CLIN INVEST, V102, P2096, DOI 10.1172/JCI4271; Fitzner D, 2010, CURR NEUROPHARMACOL, V8, P305, DOI 10.2174/157015910792246218; Getts DR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-246; Gunnarsson M, 2011, ANN NEUROL, V69, P83, DOI 10.1002/ana.22247; Hiraki K, 2009, J NEUROSCI RES, V87, P1175, DOI 10.1002/jnr.21924; HOSHINO T, 1993, J IMMUNOL, V151, P2237; Imanishi T, 2007, J IMMUNOL, V178, P6715, DOI 10.4049/jimmunol.178.11.6715; Issazadeh S, 2000, J CLIN INVEST, V105, P1109, DOI 10.1172/JCI8607; Ji NN, 2011, J IMMUNOL, V186, P2750, DOI 10.4049/jimmunol.1000907; Kanwar JR, 2000, IMMUNOL CELL BIOL, V78, P641, DOI 10.1046/j.1440-1711.2000.00947.x; Kerfoot SM, 2002, J IMMUNOL, V169, P1000, DOI 10.4049/jimmunol.169.2.1000; Kerfoot SM, 2006, J IMMUNOL, V176, P6225, DOI 10.4049/jimmunol.176.10.6225; Komai-Koma M, 2004, P NATL ACAD SCI USA, V101, P3029, DOI 10.1073/pnas.0400171101; Kotsougiani D, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/526740; Lin YL, 2003, EUR J IMMUNOL, V33, P2736, DOI 10.1002/eji.200324087; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; MCFARLAND HI, 1992, J IMMUNOL, V149, P1326; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; Miranda-Hernandez S, 2011, J IMMUNOL, V187, P791, DOI 10.4049/jimmunol.1001992; Peferoen L, 2013, IMMUNOLOGY; Peguillet I, 2014, CANC RES; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Ponomarev EA, 2006, J IMMUNOL, V176, P1402, DOI 10.4049/jimmunol.176.3.1402; Ponomarev ED, 2005, J NEUROSCI RES, V81, P374, DOI 10.1002/jnr.20488; Ponomarev ED, 2007, J IMMUNOL, V178, P39, DOI 10.4049/jimmunol.178.1.39; Quandt JA, 2012, J IMMUNOL, V189, P2897, DOI 10.4049/jimmunol.1103087; Rawji KS, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/948976; Reynolds JM, 2010, IMMUNITY, V32, P692, DOI 10.1016/j.immuni.2010.04.010; Rinaldi F, 2012, MULT SCLER J, V18, P1760, DOI 10.1177/1352458512447704; Rinaldi F, 2011, NEUROL SCI, V31, pS317, DOI 10.1007/s10072-010-0346-x; Rothhammer V, 2011, J EXP MED, V208, P2465, DOI 10.1084/jem.20110434; Steinman L, 2012, J CELL BIOL, V199, P413, DOI 10.1083/jcb.201207175; Theien BE, 2003, BLOOD, V102, P4464, DOI 10.1182/blood-2003-03-0974; Theien BE, 2001, J CLIN INVEST, V107, P995, DOI 10.1172/JCI11717; Tuohy VK, 1998, IMMUNOL REV, V164, P93, DOI 10.1111/j.1600-065X.1998.tb01211.x; Wagner C, 2001, EUR J IMMUNOL, V31, P1173, DOI 10.1002/1521-4141(200104)31:4<1173::AID-IMMU1173>3.0.CO;2-9; Weng NP, 2009, TRENDS IMMUNOL, V30, P306, DOI 10.1016/j.it.2009.03.013; Wright E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070954; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0	52	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99068	10.1371/journal.pone.0099068	http://dx.doi.org/10.1371/journal.pone.0099068			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896098	Green Submitted, Green Published, gold			2022-12-27	WOS:000338430700112
J	Poongavanam, V; Steinmann, C; Kongsted, J				Poongavanam, Vasanthanathan; Steinmann, Casper; Kongsted, Jacob			Inhibitor Ranking through QM Based Chelation Calculations for Virtual Screening of HIV-1 RNase H Inhibition	PLOS ONE			English	Article							MOLECULAR-ORBITAL METHOD; POLARIZABLE CONTINUUM MODEL; PROTEIN-LIGAND INTERACTIONS; SCORING FUNCTIONS; REVERSE-TRANSCRIPTASE; BINDING-AFFINITY; 2ND-ROW ELEMENTS; RIBONUCLEASE-H; BASIS-SET; DOCKING	Quantum mechanical (QM) calculations have been used to predict the binding affinity of a set of ligands towards HIV-1 RT associated RNase H (RNH). The QM based chelation calculations show improved binding affinity prediction for the inhibitors compared to using an empirical scoring function. Furthermore, full protein fragment molecular orbital (FMO) calculations were conducted and subsequently analysed for individual residue stabilization/destabilization energy contributions to the overall binding affinity in order to better understand the true and false predictions. After a successful assessment of the methods based on the use of a training set of molecules, QM based chelation calculations were used as filter in virtual screening of compounds in the ZINC database. By this, we find, compared to regular docking, QM based chelation calculations to significantly reduce the large number of false positives. Thus, the computational models tested in this study could be useful as high throughput filters for searching HIV-1 RNase H active-site molecules in the virtual screening process.	[Poongavanam, Vasanthanathan; Steinmann, Casper; Kongsted, Jacob] Univ Southern Denmark, Dept Phys Chem & Pharm, Odense M, Denmark	University of Southern Denmark	Poongavanam, V (corresponding author), Univ Southern Denmark, Dept Phys Chem & Pharm, Odense M, Denmark.	nathan@sdu.dk	Kongsted, Jacob/AAD-3458-2022; Poongavanam, Vasanthanathan/O-3945-2017; Svendsen, Casper/T-6775-2018	Poongavanam, Vasanthanathan/0000-0002-8880-9247; Svendsen, Casper/0000-0002-5638-1346; Kongsted, Jacob/0000-0002-7725-2164	Danish Councils for Independent Research; Villum Foundation	Danish Councils for Independent Research; Villum Foundation(Villum Fonden)	Support was provided by the Danish Councils for Independent Research and the Villum Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HC, 2001, MOL CELLS, V12, P127; [Anonymous], 2013, SMALL MOL DRUG DISC; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barone V, 1998, J COMPUT CHEM, V19, P404, DOI 10.1002/(SICI)1096-987X(199803)19:4<404::AID-JCC3>3.0.CO;2-W; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Budihas SR, 2005, NUCLEIC ACIDS RES, V33, P1249, DOI 10.1093/nar/gki268; Butina D, 2002, DRUG DISCOV TODAY, V7, pS83, DOI 10.1016/S1359-6446(02)02288-2; Cossi M, 2003, J COMPUT CHEM, V24, P669, DOI 10.1002/jcc.10189; de Ruiter A, 2011, CURR OPIN CHEM BIOL, V15, P547, DOI 10.1016/j.cbpa.2011.05.021; Didierjean J, 2005, ANTIMICROB AGENTS CH, V49, P4884, DOI 10.1128/AAC.49.12.4884-4894.2005; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; Fedorov DG, 2004, J CHEM PHYS, V121, P2483, DOI 10.1063/1.1769362; Fedorov DG, 2006, J COMPUT CHEM, V27, P976, DOI 10.1002/jcc.20406; Fedorov DG, 2008, J PHYS CHEM A, V112, P11808, DOI 10.1021/jp805435n; Fedorov DG, 2007, J PHYS CHEM A, V111, P6904, DOI 10.1021/jp0716740; Felts AK, 2011, J CHEM INF MODEL, V51, P1986, DOI 10.1021/ci200194w; Ferrara P, 2004, J MED CHEM, V47, P3032, DOI 10.1021/jm030489h; FRANCL MM, 1982, J CHEM PHYS, V77, P3654, DOI 10.1063/1.444267; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Frisch G. W., 2013, GAUSSIAN 09; GORDON MS, 1982, J AM CHEM SOC, V104, P2797, DOI 10.1021/ja00374a017; HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Himmel DM, 2009, STRUCTURE, V17, P1625, DOI 10.1016/j.str.2009.09.016; Huang SY, 2010, PHYS CHEM CHEM PHYS, V12, P12899, DOI 10.1039/c0cp00151a; Ilina Tatiana, 2012, Biology (Basel), V1, P521, DOI 10.3390/biology1030521; Jain AN, 2006, CURR PROTEIN PEPT SC, V7, P407, DOI 10.2174/138920306778559395; Klamt A., 1993, J CHEM SOC P2, V2, P799, DOI DOI 10.1039/P29930000799; Klumpp K, 2003, NUCLEIC ACIDS RES, V31, P6852, DOI 10.1093/nar/gkg881; Koes DR, 2012, NUCLEIC ACIDS RES, V40, pW409, DOI 10.1093/nar/gks378; Langdon SR, 2013, J CHEM INF MODEL, V53, P1100, DOI 10.1021/ci400100c; Lansdon EB, 2011, ANTIMICROB AGENTS CH, V55, P2905, DOI 10.1128/AAC.01594-10; Li BQ, 2000, BIOCHEM BIOPH RES CO, V276, P534, DOI 10.1006/bbrc.2000.3485; Li HL, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-58; McInnes C, 2007, CURR OPIN CHEM BIOL, V11, P494, DOI 10.1016/j.cbpa.2007.08.033; Nienhaus G.U., 2005, PROTEIN LIGAND INTER; Nowotny M, 2007, MOL CELL, V28, P264, DOI 10.1016/j.molcel.2007.08.015; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Schrodinger scientist(s), 2013, SMALL MOL DRUG DISC; Stahl M, 2001, J MED CHEM, V44, P1035, DOI 10.1021/jm0003992; Steinmann C., 2012, PLOS ONE, V7; STEPHENS PJ, 1994, CHEM PHYS LETT, V225, P247, DOI 10.1016/0009-2614(94)00605-9; Stjernschantz E, 2010, BIOPHYS J, V98, P2682, DOI 10.1016/j.bpj.2010.02.034; Tanaka R, 2009, BIOORGAN MED CHEM, V17, P5238, DOI 10.1016/j.bmc.2009.05.049; Tramontano E, 2010, CURR MED CHEM, V17, P2837, DOI 10.2174/092986710792065045; Vasanthanathan P, 2009, J CHEM INF MODEL, V49, P43, DOI 10.1021/ci800371f; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n	50	16	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98659	10.1371/journal.pone.0098659	http://dx.doi.org/10.1371/journal.pone.0098659			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897431	gold, Green Published, Green Submitted			2022-12-27	WOS:000338430700062
J	Tang, QC; Wang, YH; Huang, R; You, Q; Wang, GY; Chen, YG; Jiang, Z; Liu, Z; Yu, L; Muhammad, S; Wang, XS				Tang, Qingchao; Wang, Yihui; Huang, Rui; You, Qi; Wang, Guiyu; Chen, Yinggang; Jiang, Zheng; Liu, Zheng; Yu, Lei; Muhammad, Shan; Wang, Xishan			Preparation of Anti-Tumor Nanoparticle and Its Inhibition to Peritoneal Dissemination of Colon Cancer	PLOS ONE			English	Article							COLORECTAL-CANCER; TARGETED DELIVERY; GASTRIC-CANCER; CARCINOMATOSIS; 5-FU; SENSITIVITY; THERAPY; GROWTH; CELLS	Background: 5-Fluorouracil (5-FU) is one of the most classic chemotherapy drugs. Nanoparticle drug delivery vehicles offer superiority over target effect enhancement and abatement of side effects. Little is known however as to the specific effect of nanoparticle on peritoneal dissemination of colon cancer. The aim of this study is to prepare one NPs (nanoparticles) loaded with 5-FU and investigate the characteristic of NPs and the role of it in peritoneal metastasis nodules formation of human colon cancer. Methodology/Principal Findings: Prepared the NPs (nanoparticles) loaded with 5-FU (5-Fluorouracil) by PEG-PLGA with the method of double emulsion. Then evaluate the characteristics of the NPs by scanning electron microscopy, analyzing the particle diameter distribution and determining the loading efficiency. Detect the release features of NPs in vitro and in vivo. Nude mice with peritoneal metastases were treated with 5-FU solution or 5-FU-NPs through peritoneal cavity. Count the nodules on peritoneum and mesenterium and survey the size of them. We got NPs with average-diameter of 310 nm. In vitro release test shows NPs can release equably for 5 days with release rate of 99.2%. In vivo, NPs group can keep higher plasma concentration of 5-FU longer than it in solution group. The number of peritoneal dissemination nodule below 1 mm in 5-FU-sol group(17.3 +/- 3.5) and 5-FU-NP group(15.2 +/- 3.2) is less than control group(27.2 +/- 4.7)(P<0.05). The total number of nodules in 5-FU-NP group(28.7 +/- 4.2) is significantly smaller than in 5-FU-sol group(37.7 +/- 6.3) (P<0.05). Conclusions/Significance: The novel anti-tumor nanoparticles loaded with 5-FU by PEG-PLGA can release maintain 5 days and have inhibitory action to peritoneal dissemination of colon cancer in mice.	[Tang, Qingchao; Huang, Rui; Wang, Guiyu; Chen, Yinggang; Jiang, Zheng; Liu, Zheng; Yu, Lei; Muhammad, Shan; Wang, Xishan] Harbin Med Univ, Affiliated Hosp 2, Dept Colorectal Canc Surg, Ctr Canc, Harbin, Peoples R China; [Wang, Yihui; You, Qi] Harbin Med Univ, Affiliated Hosp 3, Dept Colorectal Surg, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Wang, XS (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Colorectal Canc Surg, Ctr Canc, Harbin, Peoples R China.	wxshan1208@126.com			"Wu Jie-ping'' Medicine Foundation of China [04102303]; Special Foundation of Harbin Technical Innovation [2006RFQXS075]; Heilongjiang Province of China [JC04-02]	"Wu Jie-ping'' Medicine Foundation of China; Special Foundation of Harbin Technical Innovation; Heilongjiang Province of China	This work was supported by the "Wu Jie-ping'' Medicine Foundation of China, (No. 04102303) and the Special Foundation of Harbin Technical Innovation for Talented Person (No. 2006RFQXS075) and the Science Fund for Distinguished Young Scholars of Heilongjiang Province of China under Grant No. JC04-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Botella P, 2011, J CONTROL RELEASE, V156, P246, DOI 10.1016/j.jconrel.2011.06.039; Brigger I, 2002, ADV DRUG DELIVER REV, V54, P631, DOI 10.1016/S0169-409X(02)00044-3; Burke AR, 2012, BIOMATERIALS, V33, P2961, DOI 10.1016/j.biomaterials.2011.12.052; Cai JC, 2013, J CLIN INVEST, V123, P566, DOI 10.1172/JCI65871; Chaturvedi K, 2013, J CONTROL RELEASE, V165, P129, DOI 10.1016/j.jconrel.2012.11.005; Chester JD, 2000, ANN ONCOL, V11, P235, DOI 10.1023/A:1008356017611; Couvreur P, 2013, ADV DRUG DELIVER REV, V65, P21, DOI 10.1016/j.addr.2012.04.010; de Cuba EMV, 2012, VIRCHOWS ARCH, V461, P231, DOI 10.1007/s00428-012-1287-y; Drecoll E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005715; Emoto S, 2012, CANCER SCI, V103, P1304, DOI 10.1111/j.1349-7006.2012.02274.x; Gomez-Portilla Alberto, 2005, Cir Esp, V77, P6; Hasegawa S, 2006, ONCOL REP, V15, P1185; Jayne DG, 2002, BRIT J SURG, V89, P1545, DOI 10.1046/j.1365-2168.2002.02274.x; Koppe MJ, 2006, ANN SURG, V243, P212, DOI 10.1097/01.sla.0000197702.46394.16; Lamppa JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017042; Li Q, 2013, CANCER LETT, V335, P168, DOI 10.1016/j.canlet.2013.02.029; Li S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-103; Lin H, 2008, CHEM RES CHINESE U, V24, P805; Lu HX, 2007, CANCER CHEMOTH PHARM, V59, P175, DOI 10.1007/s00280-006-0256-z; Pera M, 2012, ANN ONCOL, V23, P664, DOI 10.1093/annonc/mdr291; Smith MH, 2012, ACCOUNTS CHEM RES, V45, P985, DOI 10.1021/ar200216f; Soma D, 2009, CANCER SCI, V100, P1979, DOI 10.1111/j.1349-7006.2009.01265.x; Wang AZ, 2012, ANNU REV MED, V63, P185, DOI 10.1146/annurev-med-040210-162544; Wang YS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-402; Wohlfart S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019121; Yang SH, 2004, J SURG ONCOL, V87, P167, DOI 10.1002/jso.20109	26	19	20	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98455	10.1371/journal.pone.0098455	http://dx.doi.org/10.1371/journal.pone.0098455			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896096	Green Published, Green Submitted, gold			2022-12-27	WOS:000338430700043
J	van den Borne, P; Rygiel, TP; Hoogendoorn, A; Westerlaken, GHA; Boon, L; Quax, PHA; Pasterkamp, G; Hoefer, IE; Meyaard, L				van den Borne, Pleunie; Rygiel, Tomasz P.; Hoogendoorn, Ayla; Westerlaken, Geertje H. A.; Boon, Louis; Quax, Paul H. A.; Pasterkamp, Gerard; Hoefer, Imo E.; Meyaard, Linde			The CD200-CD200 Receptor Inhibitory Axis Controls Arteriogenesis and Local T Lymphocyte Influx	PLOS ONE			English	Article							VESSEL DEVELOPMENT; CD200; EXPRESSION; CELLS; MECHANISMS; MONOCYTES; ANGIOGENESIS; ACTIVATION; ISCHEMIA; GROWTH	The role of the CD200 ligand-CD200 receptor (CD200-CD200R) inhibitory axis is highly important in controlling myeloid cell function. Since the activation of myeloid cells is crucial in arteriogenesis, we hypothesized that disruption of the CD200-CD200R axis promotes arteriogenesis in a murine hindlimb ischemia model. Female Cd200(-/-) and wildtype (C57Bl/6J) mice underwent unilateral femoral artery ligation. Perfusion recovery was monitored over 7 days using Laser-Doppler analysis and was increased in Cd200(-/-) mice at day 3 and 7 after femoral artery ligation, compared to wildtype. Histology was performed on hindlimb muscles at baseline, day 3 and 7 to assess vessel geometry and number and inflammatory cell influx. Vessel geometry in non-ischemic muscles was larger, and vessel numbers in ischemic muscles were increased in Cd200(-/-) mice compared to wildtype. Furthermore, T lymphocyte influx was increased in Cd200(-/-) compared to wildtype. CD200R agonist treatment was performed in male C57Bl/6J mice to validate the role of the CD200-CD200R axis in arteriogenesis. CD200R agonist treatment after unilateral femoral artery ligation resulted in a significant decrease in vessel geometry, perfusion recovery and T lymphocyte influx at day 7 compared to isotype treatment. In this study, we show a causal role for the CD200-CD200R inhibitory axis in arteriogenesis in a murine hindlimb ischemia model. Lack of CD200R signaling is accompanied by increased T lymphocyte recruitment to the collateral vasculature and results in enlargement of preexisting collateral arteries.	[van den Borne, Pleunie; Hoogendoorn, Ayla; Pasterkamp, Gerard; Hoefer, Imo E.] Univ Med Ctr, Lab Expt Cardiol, Utrecht, Netherlands; [Rygiel, Tomasz P.; Westerlaken, Geertje H. A.; Meyaard, Linde] Univ Med Ctr Utrecht, Dept Immunol, Lab Translat Immunol, Utrecht, Netherlands; [Rygiel, Tomasz P.] Med Univ Warsaw, Dept Immunol, Ctr Biostruct Res, Warsaw, Poland; [Boon, Louis] Bioceros BV, Utrecht, Netherlands; [Quax, Paul H. A.] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands; [Quax, Paul H. A.] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [Pasterkamp, Gerard; Hoefer, Imo E.] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Medical University of Warsaw; Bioceros B.V.; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Interuniversity Cardiology Institute of the Netherlands; Utrecht University	Hoefer, IE (corresponding author), Univ Med Ctr, Lab Expt Cardiol, Utrecht, Netherlands.	I.Hoefer@umcutrecht.nl	Quax, Paul/ABD-5294-2020; Quax, Paul/W-8520-2019; Boon, Laurence/HCI-3629-2022	Quax, Paul/0000-0002-6853-5760; Rygiel, Tomasz/0000-0003-4746-6505; Boon, Louis/0000-0002-0937-9171; Meyaard, Linde/0000-0003-0707-4793	Dutch Ministry of Economic Affairs, Agriculture and Innovation; Dutch Heart Foundation; Association for International Cancer Research [AICR 07-0086]; Foundation for Polish Science [HOMING PLUS/2011-4/10]	Dutch Ministry of Economic Affairs, Agriculture and Innovation; Dutch Heart Foundation(Netherlands Heart Foundation); Association for International Cancer Research; Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission)	This research forms part of the Project P1.03 PENT of the research program of the Biomedical Materials institute, co-funded by the Dutch Ministry of Economic Affairs, Agriculture and Innovation. The financial contribution of the Dutch Heart Foundation is gratefully acknowledged. This work was supported by grants from Association for International Cancer Research (AICR 07-0086) and the Foundation for Polish Science (HOMING PLUS/2011-4/10) to L.M. and T.P.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arras M, 1998, J CLIN INVEST, V101, P40, DOI 10.1172/JCI119877; Bergmann CE, 2006, J LEUKOCYTE BIOL, V80, P59, DOI 10.1189/jlb.0206087; Buschmann IR, 2001, ATHEROSCLEROSIS, V159, P343, DOI 10.1016/S0021-9150(01)00637-2; Cai WJ, 2008, ACTA BIOCH BIOPH SIN, V40, P681, DOI 10.1111/j.1745-7270.2008.00436.x; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Costello DA, 2011, J BIOL CHEM, V286, P34722, DOI 10.1074/jbc.M111.280826; de Groot D, 2011, J MOL CELL CARDIOL, V50, P25, DOI 10.1016/j.yjmcc.2010.08.006; Dick AD, 2001, INVEST OPHTH VIS SCI, V42, P170; Gorczynski RM, 2011, TRANSPL IMMUNOL, V25, P187, DOI 10.1016/j.trim.2011.07.006; Grundmann S, 2007, EUR J CLIN INVEST, V37, P755, DOI 10.1111/j.1365-2362.2007.01861.x; Heil M, 2002, AM J PHYSIOL-HEART C, V283, pH2411, DOI 10.1152/ajpheart.01098.2001; Herold J, 2004, HUM GENE THER, V15, P1, DOI 10.1089/10430340460732517; Hoefer IE, 2002, CIRCULATION, V105, P1639, DOI 10.1161/01.CIR.0000014987.32865.8E; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Holmannova Drahomira, 2012, Acta Medica (Hradec Kralove), V55, P12; Horie S, 2013, SCI REP-UK, V3, DOI 10.1038/srep03072; Jenmalm MC, 2006, J IMMUNOL, V176, P191, DOI 10.4049/jimmunol.176.1.191; Karnam G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002710; Ko YC, 2009, J ANAT, V214, P183, DOI 10.1111/j.1469-7580.2008.00986.x; Koning N, 2010, J INNATE IMMUN, V2, P195, DOI 10.1159/000252803; Krejsek J, 2010, PERFUSION-UK, V25, P389, DOI 10.1177/0267659110381451; la Sala A, 2012, TRENDS MOL MED, V18, P494, DOI 10.1016/j.molmed.2012.06.007; Mukhopadhyay S, 2010, CELL HOST MICROBE, V8, P236, DOI 10.1016/j.chom.2010.08.005; Peng XZ, 2011, AM J PHYSIOL-HEART C, V300, pH2027, DOI 10.1152/ajpheart.00004.2011; Rijkers ESK, 2007, EUR J HAEMATOL, V79, P410, DOI 10.1111/j.1600-0609.2007.00920.x; Rosenblum MD, 2004, J INVEST DERMATOL, V123, P880, DOI 10.1111/j.0022-202X.2004.23461.x; Rygiel TP, 2012, ONCOGENE, V31, P2979, DOI 10.1038/onc.2011.477; Rygiel TP, 2009, J IMMUNOL, V183, P1990, DOI 10.4049/jimmunol.0900252; Schirmer SH, 2009, HEART, V95, P191, DOI 10.1136/hrt.2007.136119; Stabile E, 2006, CIRCULATION, V113, P118, DOI 10.1161/CIRCULATIONAHA.105.576702; Stabile E, 2003, CIRCULATION, V108, P205, DOI 10.1161/01.CIR.0000079225.50817.71; van Weel V, 2007, ARTERIOSCL THROM VAS, V27, P2310, DOI 10.1161/ATVBAHA.107.151407; Wang LX, 2010, EUR J IMMUNOL, V40, P2569, DOI 10.1002/eji.201040472; Wright GJ, 2003, J IMMUNOL, V171, P3034, DOI 10.4049/jimmunol.171.6.3034	34	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98820	10.1371/journal.pone.0098820	http://dx.doi.org/10.1371/journal.pone.0098820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897500	Green Published, gold, Green Submitted			2022-12-27	WOS:000338430700083
J	Yan, DF; Yan, SX; Lu, ZJ; Xie, C; Chen, W; Xu, X; Li, XK; Yu, HG; Zhu, XL; Zheng, LY				Yan, DanFang; Yan, SenXiang; Lu, ZhongJie; Xie, Cong; Chen, Wei; Xu, Xing; Li, Xinke; Yu, Haogang; Zhu, Xinli; Zheng, LingYan			Postoperative Radiotherapy for Glioma: Improved Delineation of the Clinical Target Volume Using the Geodesic Distance Calculation	PLOS ONE			English	Article							INTEROBSERVER VARIABILITY; COMPUTATION; IMAGES; TRIAL	Objects: To introduce a new method for generating the clinical target volume (CTV) from gross tumor volume (GTV) using the geodesic distance calculation for glioma. Methods: One glioblastoma patient was enrolled. The GTV and natural barriers were contoured on each slice of the computer tomography (CT) simulation images. Then, a graphic processing unit based on a parallel Euclidean distance transform was used to generate the CTV considering natural barriers. Three-dimensional (3D) visualization technique was applied to show the delineation results. Speed of operation and precision were compared between this new delineation method and the traditional method. Results: In considering spatial barriers, the shortest distance from the point sheltered from these barriers equals the sum of the distance along the shortest path between the two points; this consists of several segments and evades the spatial barriers, rather than being the direct Euclidean distance between two points. The CTV was generated irregularly rather than as a spherical shape. The time required to generate the CTV was greatly reduced. Moreover, this new method improved inter- and intra-observer variability in defining the CTV. Conclusions: Compared with the traditional CTV delineation, this new method using geodesic distance calculation not only greatly shortens the time to modify the CTV, but also has better reproducibility.	[Yan, DanFang; Yan, SenXiang; Lu, ZhongJie; Li, Xinke; Yu, Haogang; Zhu, Xinli; Zheng, LingYan] Zhejiang Univ, Dept Radiat Oncol, Affiliated Hosp 1, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Xie, Cong; Chen, Wei; Xu, Xing] Zhejiang Univ, State Key Lab CAD & CG, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Yan, SX (corresponding author), Zhejiang Univ, Dept Radiat Oncol, Affiliated Hosp 1, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China.	yansenxiang@zju.edu.cn		Xie, Cong/0000-0001-5760-7522	National Science Foundation of China [81172124]; Welfare and Social Development Projects of Zhejiang Province Technology [2013C33121]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Welfare and Social Development Projects of Zhejiang Province Technology	This work was supported by the National Science Foundation of China Fund: 2011 Project 81172124 and Welfare and Social Development Projects of Zhejiang Province Technology Research: 2013C33121. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataman F, 2004, EUR J CANCER, V40, P1724, DOI 10.1016/j.ejca.2004.03.026; Breen SL, 2007, INT J RADIAT ONCOL, V68, P763, DOI 10.1016/j.ijrobp.2006.12.039; Cattaneo GM, 2005, RADIOTHER ONCOL, V75, P217, DOI 10.1016/j.radonc.2005.03.012; Hayashi T, 1998, IEEE T PARALL DISTR, V9, P1153, DOI 10.1109/71.737693; Iuchi T, 2006, INT J RADIAT ONCOL, V64, P1317, DOI 10.1016/j.ijrobp.2005.12.005; Jena R, 2005, CLIN ONCOL-UK, V17, P581, DOI 10.1016/j.clon.2005.04.012; Karim ABMF, 2002, INT J RADIAT ONCOL, V52, P316, DOI 10.1016/S0360-3016(01)02692-X; KOLOUNTZAKIS MN, 1992, INFORM PROCESS LETT, V43, P181, DOI 10.1016/0020-0190(92)90197-4; Lee YH, 2003, IEEE T PARALL DISTR, V14, P203, DOI 10.1109/TPDS.2003.1189579; LEUNENS G, 1993, RADIOTHER ONCOL, V29, P169, DOI 10.1016/0167-8140(93)90243-2; Nakamatsu K, 2008, INT J CLIN ONCOL, V13, P48, DOI 10.1007/s10147-007-0722-6; Price SJ, 2006, AM J NEURORADIOL, V27, P1969; Rees JH, 1996, RADIOGRAPHICS, V16, P1413, DOI 10.1148/radiographics.16.6.8946545; Rong G, 2006, P 2006 S INTERACTIVE, P109, DOI DOI 10.1145/1111411.1111431; Rong GD, 2007, ISVD 2007: THE 4TH INTERNATIONAL SYMPOSIUM ON VORONOI DIAGRAMS IN SCIENCE AND ENGINEERING 2007, PROCEEDINGS, P176; Shaw E. G., 2002, International Journal of Radiation Oncology Biology Physics, V54, P206, DOI 10.1016/S0360-3016(02)03413-2; Struikmans H, 2005, RADIOTHER ONCOL, V76, P293, DOI 10.1016/j.radonc.2005.03.029; Sud A, 2004, COMPUT GRAPH FORUM, V23, P557, DOI 10.1111/j.1467-8659.2004.00787.x; Wang Y. C., 2001, P 8 AIAA AM I AER AS, P1	19	1	1	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98616	10.1371/journal.pone.0098616	http://dx.doi.org/10.1371/journal.pone.0098616			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896082	Green Submitted, Green Published, gold			2022-12-27	WOS:000338430700056
J	Srivathsa, A; Karanth, KK; Jathanna, D; Kumar, NS; Karanth, KU				Srivathsa, Arjun; Karanth, Krithi K.; Jathanna, Devcharan; Kumar, N. Samba; Karanth, K. Ullas			On a Dhole Trail: Examining Ecological and Anthropogenic Correlates of Dhole Habitat Occupancy in the Western Ghats of India	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; CUON-ALPINUS CANIDAE; PROTECTED AREAS; DETECTION PROBABILITIES; FRAGMENTED LANDSCAPE; MAMMAL CONSERVATION; TROPICAL FORESTS; POPULATION-SIZE; EXTINCTION RISK; PREY SELECTION	Although they play a critical role in shaping ecological communities, many threatened predator species are data-deficient. The Dhole Cuon alpinus is one such rare canid with a global population thought to be <2500 wild individuals. We assessed habitat occupancy patterns of dholes in the Western Ghats of Karnataka, India, to understand ecological and anthropogenic determinants of their distribution and habitat-use. We conducted spatially replicated detection/non-detection surveys of dhole signs along forest trails at two appropriate scales: the entire landscape and a single wildlife reserve. Landscape-scale habitat occupancy was assessed across 38,728 km(2) surveying 206 grid cells of 188-km(2) each. Finer scale habitat-use within 935 km(2) Bandipur Reserve was studied surveying 92 grid cells of 13-km(2) km each. We analyzed the resulting data of dhole signs using likelihood-based habitat occupancy models. The models explicitly addressed the problematic issue of imperfect detection of dhole signs during field surveys as well as potential spatial auto-correlation between sign detections made on adjacent trail segments. We show that traditional 'presence versus absence' analyses underestimated dhole habitat occupancy by 60% or 8682 km(2) [naive = 0.27; psi(L)(SE) = 0.68 (0.08)] in the landscape. Addressing imperfect sign detections by estimating detection probabilities [<(p)over cap>(t(L))(SE) = 0.12 (0.11)] was critical for reliable estimation. Similar underestimation occurred while estimating habitat-use probability at reserve-scale [naive = 0.39; (Psi) over cap (s)(SE) = 0.71 (0.06)]. At landscape scale, relative abundance of principal ungulate prey primarily influenced dhole habitat occupancy. Habitat-use within a reserve, however, was predominantly and negatively influenced by anthropogenic disturbance. Our results are the first rigorous assessment of dhole occupancy at multiple spatial scales with potential conservation value. The approach used in this study has potential utility for cost-effectively assessing spatial distribution and habitat-use in other species, landscapes and reserves.	[Srivathsa, Arjun] Tata Inst Fundamental Res, Natl Ctr Biol Sci, India Program, Postgrad Programme Wildlife Biol & Conservat,Wild, Bangalore, Karnataka, India; [Srivathsa, Arjun; Karanth, Krithi K.; Jathanna, Devcharan; Kumar, N. Samba; Karanth, K. Ullas] Ctr Wildlife Studies, Bangalore, Karnataka, India; [Karanth, Krithi K.; Karanth, K. Ullas] Wildlife Conservat Soc, Bronx, NY USA; [Kumar, N. Samba] India Program, Wildlife Conservat Soc, Bangalore, Karnataka, India; [Karanth, K. Ullas] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Wildlife Conservation Society; Duke University	Srivathsa, A (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, India Program, Postgrad Programme Wildlife Biol & Conservat,Wild, Bangalore, Karnataka, India.	arjuns.cws@gmail.com	Kumar, Samba/ADR-7829-2022; Jathanna, Devcharan/AAL-9107-2020	Kumar, Samba/0000-0002-1226-8552; Jathanna, Devcharan/0000-0002-7962-4582; Srivathsa, Arjun/0000-0003-2935-3857	Department of Science and Technology, Government of India; Save the Tiger Fund of National Fish and Wildlife Foundation; Rhino & Tiger Conservation Fund of US Fish and Wildlife Service, Washington, DC	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Save the Tiger Fund of National Fish and Wildlife Foundation; Rhino & Tiger Conservation Fund of US Fish and Wildlife Service, Washington, DC	Department of Science and Technology, Government of India. (URL: http://www.dst.gov.in). Save the Tiger Fund of National Fish and Wildlife Foundation (URL: http://www.nfwf.org/Pages/default.aspx). Rhino & Tiger Conservation Fund of US Fish and Wildlife Service, Washington, DC. (URL: http://www.fws.gov/international/wildlife-without-borders/rhino-and-tiger-conservation-fund.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andheria AP, 2007, J ZOOL, V273, P169, DOI 10.1111/j.1469-7998.2007.00310.x; Athreya V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057872; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Ceballos G, 2005, SCIENCE, V309, P603, DOI 10.1126/science.1114015; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Ceballos G, 2006, P NATL ACAD SCI USA, V103, P19374, DOI 10.1073/pnas.0609334103; COHEN J A, 1978, Mammalian Species, P1, DOI 10.2307/3503800; Das A, 2006, BIOL CONSERV, V133, P16, DOI 10.1016/j.biocon.2006.05.023; DeFries R, 2010, BIOL CONSERV, V143, P2870, DOI 10.1016/j.biocon.2010.02.010; Durbin LS, 2008, IUCN RED LIST THREAT; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Freckleton RP, 2005, J ANIM ECOL, V74, P353, DOI 10.1111/j.1365-2656.2005.00931.x; Gaston KJ, 2000, J APPL ECOL, V37, P39, DOI 10.1046/j.1365-2664.2000.00485.x; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Grassman LI, 2005, MAMMALIA, V69, P11, DOI 10.1515/mamm.2005.002; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Hartley S, 2003, CONSERV BIOL, V17, P1559, DOI 10.1111/j.1523-1739.2003.00015.x; He F., 2007, SCALING BIODIVERSITY; Hines JE, 2010, ECOL APPL, V20, P1456, DOI 10.1890/09-0321.1; Hines JE., 2006, PRESENCESOFTWARE EST; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Jenks KE, 2012, MAMMALIA, V76, P175, DOI 10.1515/mammalia-2011-0063; JOHNSINGH AJT, 1982, J ZOOL, V198, P443, DOI 10.1111/jzo.1982.198.4.443; Jones JPG, 2011, J APPL ECOL, V48, P9, DOI 10.1111/j.1365-2664.2010.01917.x; Kamler JF, 2012, J MAMMAL, V93, P627, DOI 10.1644/11-MAMM-A-241.1; KARANTH K U, 1986, Journal of the Bombay Natural History Society, V83, P166; Karanth KU, 2011, J APPL ECOL, V48, P1048, DOI 10.1111/j.1365-2664.2011.02002.x; Karanth KK, 2013, BIOL CONSERV, V166, P175, DOI 10.1016/j.biocon.2013.06.027; Karanth KK, 2010, P ROY SOC B-BIOL SCI, V277, P1971, DOI 10.1098/rspb.2010.0171; Karanth KK, 2009, J APPL ECOL, V46, P1189, DOI 10.1111/j.1365-2664.2009.01710.x; KARANTH KU, 1995, J ANIM ECOL, V64, P439, DOI 10.2307/5647; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; Karanth KU, 1998, ECOLOGY, V79, P2852; KARANTH KU, 1992, J TROP ECOL, V8, P21, DOI 10.1017/S0266467400006040; Karanth KU, 2000, J ZOOL, V250, P255; Karwanishi Kae, 2008, Mammal Study, V33, P173; Kendall WL, 2009, J APPL ECOL, V46, P1182, DOI 10.1111/j.1365-2664.2009.01732.x; Kodandapani N, 2008, FOREST ECOL MANAG, V256, P607, DOI 10.1016/j.foreco.2008.05.006; Kumar NS, 2010, THESIS MANIPAL U IND; Linkie M, 2006, J APPL ECOL, V43, P576, DOI 10.1111/j.1365-2664.2006.01153.x; Long RA, 2011, LANDSCAPE ECOL, V26, P327, DOI 10.1007/s10980-010-9547-1; Lyra-Jorge MC, 2008, BIODIVERS CONSERV, V17, P1573, DOI 10.1007/s10531-008-9366-8; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2006, J WILDLIFE MANAGE, V70, P367, DOI 10.2193/0022-541X(2006)70[367:MTPORU]2.0.CO;2; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Magoun AJ, 2007, J WILDLIFE MANAGE, V71, P2221, DOI 10.2193/2006-372; Miller DA, 2011, ECOLOGY, V92, P1422, DOI 10.1890/10-1396.1; Mondol S, 2009, BIOL CONSERV, V142, P2350, DOI 10.1016/j.biocon.2009.05.014; Mordecai RS, 2011, J APPL ECOL, V48, P56, DOI 10.1111/j.1365-2664.2010.01921.x; Morrison JC, 2007, J MAMMAL, V88, P1363, DOI 10.1644/06-MAMM-A-124R2.1; Narain S.P., 2005, JOINING DOTS REPORT; Nichols JD, 2008, J APPL ECOL, V45, P1321, DOI 10.1111/j.1365-2664.2008.01509.x; O'Connell AF, 2006, J WILDLIFE MANAGE, V70, P1625, DOI 10.2193/0022-541X(2006)70[1625:ESOADP]2.0.CO;2; OConnell AF, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P1, DOI 10.1007/978-4-431-99495-4; Rangarajan M., 2006, CONSERV SOC, V4, P359; Rhodes J, 2011, ECOGRAPHY, V34, P141, DOI 10.1111/j.1600-0587.2010.05908.x; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Robert A, 2009, OIKOS, V118, P1590, DOI 10.1111/j.1600-0706.2009.17818.x; Royle J. A., 2008, HIERARCHICAL MODELIN; Royle JA, 2012, METHODS ECOL EVOL, V3, P545, DOI 10.1111/j.2041-210X.2011.00182.x; Royle JA, 2006, BIOMETRICS, V62, P97, DOI 10.1111/j.1541-0420.2005.00439.x; Sankar K, 2010, TELEM WILDL SCI, V13, P69; Sargeant GA, 2005, J WILDLIFE MANAGE, V69, P483, DOI 10.2193/0022-541X(2005)069[0483:MCMCEO]2.0.CO;2; Sillero-Zubiri C, 2004, CANIDS FOXES WOLVES; Stanley TR, 2005, J WILDLIFE MANAGE, V69, P874, DOI 10.2193/0022-541X(2005)069[0874:ESOAAU]2.0.CO;2; Sunarto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030859; Thinley P, 2011, MAMM BIOL, V76, P518, DOI 10.1016/j.mambio.2011.02.003; Thorn M, 2011, BIOL CONSERV, V144, P1799, DOI 10.1016/j.biocon.2011.03.009; Trainor AM, 2014, ECOL APPL, V24, P204, DOI 10.1890/13-0336.1; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Velho N, 2012, BIOL CONSERV, V148, P210, DOI 10.1016/j.biocon.2012.01.022; Venkataraman AB, 1995, J ZOOL, V237, P543, DOI 10.1111/j.1469-7998.1995.tb05014.x; Wang SW, 2009, J ZOOL, V277, P275, DOI 10.1111/j.1469-7998.2008.00537.x; Wibisono HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025931; Wikramanayake ED, 1998, CONSERV BIOL, V12, P865, DOI 10.1046/j.1523-1739.1998.96428.x; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Williams TM, 2004, ECOLOGY, V85, P3373, DOI 10.1890/03-0696; Witmer GW, 2005, WILDLIFE RES, V32, P259, DOI 10.1071/WR04003; Woodroffe R, 2004, BIOLOGY AND CONSERVATION OF WILD CANIDS, P123; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; Yackulic CB, 2013, METHODS ECOL EVOL, V4, P236, DOI 10.1111/2041-210x.12004	85	41	43	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98803	10.1371/journal.pone.0098803	http://dx.doi.org/10.1371/journal.pone.0098803			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893166	Green Submitted, gold, Green Published			2022-12-27	WOS:000336911400094
J	Bai, XJ; Brenes-Arguedas, T; Ye, J; Wang, XG; Lin, F; Yuan, ZQ; Shi, S; Xing, DL; Hao, ZQ				Bai, Xuejiao; Brenes-Arguedas, Tania; Ye, Ji; Wang, Xugao; Lin, Fei; Yuan, Zuoqiang; Shi, Shuai; Xing, Dingliang; Hao, Zhanqing			Dynamics of Two Multi-Stemmed Understory Shrubs in Two Temperate Forests	PLOS ONE			English	Article							OLD-GROWTH; VEGETATIVE REPRODUCTION; BIOSPHERE RESERVE; LONG-TERM; TREES; OVERSTORY; COMMUNITIES; COMPETITION; DEMOGRAPHY; DIVERSITY	A multi-stemmed growth form may be an important trait enabling the persistence of individual shrubs in the forest understory. With the aim of evaluating the role of multiple stems, neighbor competition and soil nutrients in shrub performance, we study the dynamics of two temperate multi-stemmed shrub species. We modeled stem growth and survival of Corylus mandshurica and Acer barbinerve in two temperate forests with differing structure in northeastern China. One forest was an old growth broad-leaved Korean pine (Pinus koraiensis) mixed forest; the other was a secondary poplar-birch forest. Growth of the two species and survival of C. mandshurica increased with stem number in the old growth forest, but not the secondary forest, suggesting the benefits of a multi-stemmed growth form are facultative. C. mandshurica also suffered more from overstory neighbor competition in the old growth forest, which may suggest that this species is less shade-tolerant than A. barbinerve. Moreover, the performance of the two species were clearly influenced by understory neighbors and soil variables in the old growth forest relative to the secondary forest, which may be due to different forest structure. We conclude that multiple stems are not always important for the persistence of shrub species. Even within the same species, the multi-stemmed benefits might be facultative, differing among forests and neighborhood compositions.	[Bai, Xuejiao] Shenyang Agr Univ, Coll Forestry, Shenyang 110161, Liaoning Provin, Peoples R China; [Bai, Xuejiao; Ye, Ji; Wang, Xugao; Lin, Fei; Yuan, Zuoqiang; Shi, Shuai; Xing, Dingliang; Hao, Zhanqing] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Liaoning Provin, Peoples R China; [Brenes-Arguedas, Tania] Ctr Cient Trop, San Jose, Costa Rica; [Lin, Fei; Shi, Shuai; Xing, Dingliang] Univ Chinese Acad Sci, Beijing, Peoples R China	Shenyang Agricultural University; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Hao, ZQ (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Liaoning Provin, Peoples R China.	hzq@iae.ac.cn	Wang, Xugao/B-1111-2015; Xing, Dingliang/T-3134-2019	Wang, Xugao/0000-0003-1207-8852; Xing, Dingliang/0000-0001-9133-6674	National Natural Science Foundation of China [31300378, 31300517]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (No. 31300378 and No. 31300517). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anning AK, 2013, FOREST ECOL MANAG, V307, P74, DOI 10.1016/j.foreco.2013.07.008; Armesto JJ, 2007, OLD GROWTH FORESTS F, P367; Baayen RH, 2011, LANGUAGER DATA SETS; Bai Xue-jiao, 2010, Yingyong Shengtai Xuebao, V21, P1899; Bates D. M., 2010, LME4 MIXED EFFECTS M; Beckage B, 2000, CAN J FOREST RES, V30, P1617, DOI 10.1139/cjfr-30-10-1617; Bellingham PJ, 2009, J ECOL, V97, P472, DOI 10.1111/j.1365-2745.2009.01479.x; Chen YongLiang, 1998, Journal of Northeast Forestry University, V26, P7; Clarke PJ, 2005, J ECOL, V93, P544, DOI 10.1111/j.1365-2745.2005.00971.x; Condit R, 1999, PHILOS T R SOC B, V354, P1739, DOI 10.1098/rstb.1999.0517; DEKROON H, 1995, J ECOL, V83, P143, DOI 10.2307/2261158; Del Tredici P, 2001, BOT REV, V67, P121, DOI 10.1007/BF02858075; FINEGAN B, 1984, NATURE, V312, P109, DOI 10.1038/312109a0; Fujiki D, 2006, ECOL RES, V21, P380, DOI 10.1007/s11284-006-0169-7; Gracia M, 2007, FOREST ECOL MANAG, V242, P391, DOI 10.1016/j.foreco.2007.01.056; Grothendieck G, 2010, SQLDF PERFORM SQL SE; Guan JY, 1999, B BOT RES, V19, P100; Hao ZhanQing, 1994, Chinese Journal of Applied Ecology, V5, P16; HARCOMBE PA, 1983, OECOLOGIA, V57, P49, DOI 10.1007/BF00379561; Kanno H, 2004, PLANT ECOL, V170, P43, DOI 10.1023/B:VEGE.0000019027.88318.54; Kanno H, 2001, J VEG SCI, V12, P391, DOI 10.2307/3236853; Kobe RK, 1997, OIKOS, V80, P226, DOI 10.2307/3546590; KOOP H, 1987, VEGETATIO, V72, P103; Matsushita M, 2010, BOTANY, V88, P174, DOI 10.1139/B09-108; McKenzie D, 2000, CAN J FOREST RES, V30, P1655, DOI 10.1139/cjfr-30-10-1655; Nilsson MC, 2005, FRONT ECOL ENVIRON, V3, P421, DOI 10.2307/3868658; Nock CA, 2011, GLOBAL CHANGE BIOL, V17, P1049, DOI 10.1111/j.1365-2486.2010.02222.x; O'Brien MJ, 2007, FOREST ECOL MANAG, V240, P178, DOI 10.1016/j.foreco.2006.12.025; Ribeiro PJ, 2011, GEOR ANAL GEOSTATIST; SHAO GF, 1994, FOREST ECOL MANAG, V70, P169, DOI 10.1016/0378-1127(94)90084-1; Stone R, 2006, SCIENCE, V313, P1379, DOI 10.1126/science.313.5792.1379; Tanentzap AJ, 2012, J ECOL, V100, P171, DOI 10.1111/j.1365-2745.2011.01879.x; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U; WHITNEY GG, 1984, ECOLOGY, V65, P403, DOI 10.2307/1941403; Wilson Brayton T., 1995, P91, DOI 10.1016/B978-012276460-8/50006-0; Wirth C, 2009, ECOL STUD-ANAL SYNTH, V207, P1, DOI 10.1007/978-3-540-92706-8; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Xu H.C., 2001, NATURAL FORESTS PINU; Yang H., 1985, RES FOR ECOSYST, V5, P1; Yang X, 2003, BIODIVERS CONSERV, V12, P883, DOI 10.1023/A:1022841107685; Yoshida T, 1997, FOREST ECOL MANAG, V95, P35, DOI 10.1016/S0378-1127(97)00007-8; YOUNG SS, 1992, MT RES DEV, V12, P269, DOI 10.2307/3673670; Ziegler SS, 2000, GLOBAL ECOL BIOGEOGR, V9, P373, DOI 10.1046/j.1365-2699.2000.00191.x	43	4	4	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98200	10.1371/journal.pone.0098200	http://dx.doi.org/10.1371/journal.pone.0098200			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887513	Green Submitted, gold, Green Published			2022-12-27	WOS:000336956300046
J	Pretsch, A; Nagl, M; Schwendinger, K; Kreiseder, B; Wiederstein, M; Pretsch, D; Genov, M; Hollaus, R; Zinssmeister, D; Debbab, A; Hundsberger, H; Eger, A; Proksch, P; Wiesner, C				Pretsch, Alexander; Nagl, Michael; Schwendinger, Katja; Kreiseder, Birgit; Wiederstein, Martina; Pretsch, Dagmar; Genov, Miroslav; Hollaus, Ralph; Zinssmeister, Daniela; Debbab, Abdesamad; Hundsberger, Harald; Eger, Andreas; Proksch, Peter; Wiesner, Christoph			Antimicrobial and Anti-Inflammatory Activities of Endophytic Fungi Talaromyces wortmannii Extracts against Acne-Inducing Bacteria	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; FACTOR-KAPPA-B; PROPIONIBACTERIUM-ACNES; ACTIVATOR PROTEIN-1; INTERLEUKIN-8; PATHOGENESIS; INDUCTION	Acne vulgaris is the most common skin disease, causing significant psychosocial problems such as anxiety and depression similar to a chronic illness for those afflicted. Currently, obtainable agents for acne treatment have limited use. Thus, development of novel agents to treat this disease is a high medical need. The anaerobic bacterium Propionibacterium acnes has been implicated in the inflammatory phase of acne vulgaris by activating pro-inflammatory mediators such as the interleukin-8 (IL-8) via the NF-kappa B and MAPK pathways. Talaromyces wortmannii is an endophytic fungus, which is known to produce high bioactive natural compounds. We hypothesize that compound C but also the crude extract from T. wortmannii may possess both antibacterial activity especially against P. acnes and also anti-inflammatory properties by inhibiting TNF-alpha-induced ICAM-1 expression and P. acnes-induced IL-8 release. Treatment of keratinocytes (HaCaT) with P. acnes significantly increased NF-kappa B and activator protein-1 (AP-1) activation, as well as IL-8 release. Compound C inhibited P. acnes-mediated activation of NF-kappa B and AP-1 by inhibiting I kappa B degradation and the phosphorylation of ERK and JNK MAP kinases, and IL-8 release in a dose-dependent manner. Based on these results, compound C has effective antimicrobial activity against P. acnes and anti-inflammatory activity, and we suggest that this substance or the crude extract are alternative treatments for antibiotic/anti-inflammatory therapy for acne vulgaris.	[Pretsch, Alexander; Nagl, Michael; Schwendinger, Katja; Kreiseder, Birgit; Wiederstein, Martina; Pretsch, Dagmar; Genov, Miroslav; Hollaus, Ralph; Zinssmeister, Daniela; Wiesner, Christoph] SeaLife Pharma GmbH, Tulln, Austria; [Hundsberger, Harald; Eger, Andreas] Univ Appl Sci, Krems, Austria; [Debbab, Abdesamad; Proksch, Peter] Univ Dusseldorf, Inst Pharmaceut Biol & Biotechnol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Wiesner, C (corresponding author), SeaLife Pharma GmbH, Tulln, Austria.	wiesner@sealifepharma.com	Proksch, Peter/AAR-4593-2020; Genov, Miroslav/Y-9726-2019	Wiesner, Christoph/0000-0002-3281-0695; Genov, Miroslav/0000-0001-6854-4387; hundsberger, harald/0000-0002-8479-1633	Deutsche Bundes Stiftung fur Umwelt (DPU); Forschungsforderungsgesellschaft (FFG) [2427070]	Deutsche Bundes Stiftung fur Umwelt (DPU); Forschungsforderungsgesellschaft (FFG)	The studies were funded by the "Deutsche Bundes Stiftung fur Umwelt (DPU)" and the "Forschungsforderungsgesellschaft (FFG; eCall Nr. 2427070)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azimi H, 2012, FITOTERAPIA, V83, P1306, DOI 10.1016/j.fitote.2012.03.026; Bara R, 2013, J MED CHEM, V56, P3257, DOI 10.1021/jm301816a; Chen QJ, 2002, J DERMATOL SCI, V29, P97, DOI 10.1016/S0923-1811(02)00013-0; Debbab A, 2010, MICROB BIOTECHNOL, V3, P544, DOI 10.1111/j.1751-7915.2010.00179.x; Dong YS, 2006, J NAT PROD, V69, P128, DOI 10.1021/np0502894; Ebada SS, 2008, NAT PROTOC, V3, P1820, DOI 10.1038/nprot.2008.182; FRISVAD JC, 1990, ANTON LEEUW INT J G, V57, P179, DOI 10.1007/BF00403953; Grange PA, 2009, J DERMATOL SCI, V56, P106, DOI 10.1016/j.jdermsci.2009.08.001; GUIN JD, 1979, ACTA DERM-VENEREOL, V59, P552; HOEFFLER U, 1977, J CLIN MICROBIOL, V6, P555; Humphrey S, 2012, Skin Therapy Lett, V17, P1; Jappe U, 2003, ACTA DERM-VENEREOL, V83, P241, DOI 10.1080/00015550310016463; Jugeau S, 2005, BRIT J DERMATOL, V153, P1105, DOI 10.1111/j.1365-2133.2005.06933.x; Kang S, 2005, AM J PATHOL, V166, P1691, DOI 10.1016/S0002-9440(10)62479-0; Khanjani S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/504952; Kim J, 2002, J IMMUNOL, V169, P1535, DOI 10.4049/jimmunol.169.3.1535; Koreck A, 2003, DERMATOLOGY, V206, P96, DOI 10.1159/000068476; Kurokawa I, 2009, EXP DERMATOL, V18, P821, DOI 10.1111/j.1600-0625.2009.00890.x; Lakshminarayanan V, 1997, J BIOL CHEM, V272, P32910, DOI 10.1074/jbc.272.52.32910; Mouser PE, 2003, J INVEST DERMATOL, V121, P1226, DOI 10.1046/j.1523-1747.2003.12550_6.x; Nagy I, 2005, J INVEST DERMATOL, V124, P931, DOI 10.1111/j.0022-202X.2005.23705.x; PUHVEL SM, 1972, J INVEST DERMATOL, V58, P66, DOI 10.1111/1523-1747.ep12551495; Radic N, 2012, PHYTOMEDICINE, V19, P1270, DOI 10.1016/j.phymed.2012.09.007; Rahman I, 2000, BIOCHEM PHARMACOL, V60, P1041, DOI 10.1016/S0006-2952(00)00392-0; Rasool M, 2006, BIOL PHARM BULL, V29, P2483, DOI 10.1248/bpb.29.2483; Rice LB, 1996, ANTIBIOTICS LAB MED, P282; Romay C, 2003, CURR PROTEIN PEPT SC, V4, P207, DOI 10.2174/1389203033487216; Thiboutot D, 2004, J INVEST DERMATOL, V123, P1, DOI 10.1111/j.1523-1747.2004.t01-2-.x; Thiboutot D, 2009, J AM ACAD DERMATOL, V60, pS1, DOI 10.1016/j.jaad.2009.01.019; VOWELS BR, 1995, INFECT IMMUN, V63, P3158, DOI 10.1128/IAI.63.8.3158-3165.1995; Wawruch M, 2002, Bratisl Lek Listy, V103, P270; White GM, 1998, J AM ACAD DERMATOL, V39, pS34, DOI 10.1016/S0190-9622(98)70442-6; Wiesner Christoph, 2007, Drug Metab Lett, V1, P254, DOI 10.2174/187231207783221385; Yu YY, 2010, CHINESE MED J-PEKING, V123, P1017, DOI 10.3760/cma.j.issn.0366-6999.2010.08.008; ZACHARIAE COC, 1993, ACTA DERM-VENEREOL, P1; Zouboulis CC, 2005, EXP DERMATOL, V14, P144, DOI 10.1111/j.0906-6705.2005.0285c.x	36	30	31	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97929	10.1371/journal.pone.0097929	http://dx.doi.org/10.1371/journal.pone.0097929			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887557	gold, Green Published, Green Submitted			2022-12-27	WOS:000336956300027
J	Ciampaglia, GL; Lozano, S; Helbing, D				Ciampaglia, Giovanni Luca; Lozano, Sergi; Helbing, Dirk			Power and Fairness in a Generalized Ultimatum Game	PLOS ONE			English	Article							COOPERATION; INHIBITION; BEHAVIOR; PEOPLE	Power is the ability to influence others towards the attainment of specific goals, and it is a fundamental force that shapes behavior at all levels of human existence. Several theories on the nature of power in social life exist, especially in the context of social influence. Yet, in bargaining situations, surprisingly little is known about its role in shaping social preferences. Such preferences are considered to be the main explanation for observed behavior in a wide range of experimental settings. In this work, we set out to understand the role of bargaining power in the stylized environment of a Generalized Ultimatum Game (GUG). We modify the payoff structure of the standard Ultimatum Game (UG) to investigate three situations: two in which the power balance is either against the proposer or against the responder, and a balanced situation. We find that other-regarding preferences, as measured by the amount of money donated by participants, do not change with the amount of power, but power changes the offers and acceptance rates systematically. Notably, unusually high acceptance rates for lower offers were observed. This finding suggests that social preferences may be invariant to the balance of power and confirms that the role of power on human behavior deserves more attention.	[Ciampaglia, Giovanni Luca] Indiana Univ, Sch Informat & Comp, Giovanni Luca Ciampaglia Ctr Complex Networks & S, Bloomington, IN USA; [Lozano, Sergi] Inst Catala Paleoecol Humana & Evolucio Social, Sergi Lozano IPHES, Tarragona, Spain; [Lozano, Sergi] URV, Area Prehist, Tarragona, Spain; [Helbing, Dirk] ETH, Dirk Helbing Chair Sociol Particular Modeling & S, Zurich, Switzerland	Indiana University System; Indiana University Bloomington; ICREA; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Universitat Rovira i Virgili; Swiss Federal Institutes of Technology Domain; ETH Zurich	Helbing, D (corresponding author), ETH, Dirk Helbing Chair Sociol Particular Modeling & S, Zurich, Switzerland.	dhelbing@ethz.ch	Lozano, Sergi/B-5974-2015	Lozano, Sergi/0000-0003-1895-9327; Ciampaglia, Giovanni Luca/0000-0001-5354-9257				Bateson M, 2006, BIOL LETTERS, V2, P412, DOI 10.1098/rsbl.2006.0509; Berger R, 2012, SOC SCI RES, V41, P372, DOI 10.1016/j.ssresearch.2011.09.009; BINMORE K, 1991, GAME ECON BEHAV, V3, P295, DOI 10.1016/0899-8256(91)90030-I; Bowles S., 2009, MICROECONOMICS BEHAV; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Chen S, 2001, J PERS SOC PSYCHOL, V80, P173, DOI 10.1037//0022-3514.80.2.173; CLARK MS, 1979, J PERS SOC PSYCHOL, V37, P12, DOI 10.1037/0022-3514.37.1.12; Dillman DA, 2009, SOC SCI RES, V38, P3, DOI 10.1016/j.ssresearch.2008.03.007; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; FISKE ST, 1993, AM PSYCHOL, V48, P621, DOI 10.1037/0003-066X.48.6.621; FREY BS, 1995, J INST THEOR ECON, V151, P286; Galinsky AD, 2003, J PERS SOC PSYCHOL, V85, P453, DOI 10.1037/0022-3514.85.3.453; Gilbert N, 2014, QUALITY COLLECTIVES; Gintis H, 2013, HOMO SOCIALIS ANAL C; Grund T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01480; Guinote A, 2007, J EXP SOC PSYCHOL, V43, P685, DOI 10.1016/j.jesp.2006.06.008; Guinote A, 2007, PERS SOC PSYCHOL B, V33, P1076, DOI 10.1177/0146167207301011; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; GUTH W, 1990, J ECON PSYCHOL, V11, P417, DOI 10.1016/0167-4870(90)90021-Z; Handgraaf MJJ, 2008, J PERS SOC PSYCHOL, V95, P1136, DOI 10.1037/0022-3514.95.5.1136; Haney C, 1973, INT J CRIMINOLOGY PE; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Hogeveen J, 2013, J EXPT PSYCHOL GEN; Keltner D, 2003, PSYCHOL REV, V110, P265, DOI 10.1037/0033-295X.110.2.265; Kocher M. G., 2013, JENA EC RES PAPERS, V2013-035; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; Murphy RO, 2011, JUDGMENT DECISION MA, V6; Nowak MA, 2000, SCIENCE, V289, P1773, DOI 10.1126/science.289.5485.1773; Piff PK, 2012, P NATL ACAD SCI USA, V109, P4086, DOI 10.1073/pnas.1118373109; Rand DG, 2013, P NATL ACAD SCI USA, V110, P2581, DOI 10.1073/pnas.1214167110; ROTH AE, 1995, GAME ECON BEHAV, V8, P164, DOI 10.1016/S0899-8256(05)80020-X; Szolnoki A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.078701; Turner JC, 2005, EUR J SOC PSYCHOL, V35, P1, DOI 10.1002/ejsp.244; Winter F, 2012, SOC FORCES, V90, P919, DOI 10.1093/sf/sor028	35	10	10	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99039	10.1371/journal.pone.0099039	http://dx.doi.org/10.1371/journal.pone.0099039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP1YS	24905349	Green Published, gold			2022-12-27	WOS:000341869000097
J	D'Arcy, S; MacHale, E; Seheult, J; Holmes, MS; Hughes, C; Sulaiman, I; Hyland, D; O'Reilly, C; Glynn, S; Al-Zaabi, T; McCourt, J; Taylor, T; Keane, F; Killane, I; Reilly, RB; Costello, RW				D'Arcy, Shona; MacHale, Elaine; Seheult, Jansen; Holmes, Martin S.; Hughes, Cian; Sulaiman, Imran; Hyland, Deirdre; O'Reilly, Conor; Glynn, Senan; Al-Zaabi, Thekra; McCourt, John; Taylor, Terence; Keane, Frank; Killane, Isabelle; Reilly, Richard B.; Costello, Richard W.			A Method to Assess Adherence in Inhaler Use through Analysis of Acoustic Recordings of Inhaler Events	PLOS ONE			English	Article							MEDICATION ADHERENCE; NONADHERENCE; THERAPY; ADULTS; RISK	Rationale: Poor adherence to inhaler use can be due to poor temporal and/or technique adherence. Up until now there has been no way of reliably tracking both these factors in everyday inhaler use. Objectives: This paper introduces a device developed to create time stamped acoustic recordings of an individual/s inhaler use, in which empirical evidence of temporal and technique adherence in inhaler use can be monitored over time. The correlation between clinical outcomes and adherence, as determined by this device, was compared for temporal adherence alone and combined temporal and technique adherence. Findings: The technology was validated by showing that the doses taken matched the number of audio recordings (r(2) = 0.94, p < 0.01). To demonstrate that audio analysis of inhaler use gives objective information, in vitro studies were performed. These showed that acoustic profiles of inhalations correlated with the peak inspiratory flow rate (r(2) = 0.97, p<0.01), and that the acoustic energy of exhalations into the inhaler was related to the amount of drug removed. Despite training, 16% of participants exhaled into the mouthpiece after priming, in >20% of their inhaler events. Repeated training reduced this to 7% of participants (p = 0.03). When time of use was considered, there was no evidence of a relationship between adherence and changes in AQLQ (r(2) = 0.2) or PEFR (r(2) = 0.2). Combining time and technique the rate of adherence was related to changes in AQLQ (r(2) = 0.53, p = 0.01) and PEFR (r(2) = 0.29, p = 0.01). Conclusions: This study presents a novel method to objectively assess how errors in both time and technique of inhaler use impact on clinical outcomes.	[D'Arcy, Shona; Holmes, Martin S.; Hughes, Cian; Killane, Isabelle; Reilly, Richard B.] Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin, Ireland; [MacHale, Elaine; Seheult, Jansen; Sulaiman, Imran; O'Reilly, Conor; Glynn, Senan; Al-Zaabi, Thekra; Costello, Richard W.] Royal Coll Surgeons Ireland, Dept Med, Dublin 2, Ireland; [Hyland, Deirdre; Costello, Richard W.] Royal Coll Surgeons Ireland, Clin Res Ctr, Dublin 2, Ireland; [McCourt, John] Dublin Ctr Clin Res, Dublin, Ireland; [Taylor, Terence; Keane, Frank] Vitalograph, Ennis, Clare, Ireland	Trinity College Dublin; Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland	D'Arcy, S (corresponding author), Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin, Ireland.	shonadarcy@rcsi.ie	Taylor, Terence/M-2158-2019; Reilly, Richard/N-1080-2019; Seheult, Jansen/AAB-6713-2020; Reilly, Richard B/F-7034-2011	Reilly, Richard/0000-0001-8578-1245; Seheult, Jansen/0000-0002-6850-7495; Reilly, Richard B/0000-0001-8578-1245; Killane, Isabelle/0000-0002-4770-5273; Costello, Richard/0000-0003-1179-6692	Health Research Board in Ireland	Health Research Board in Ireland	The work was funded by the Health Research Board in Ireland, www.HRB.ie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshaer H, 2011, J CLIN MONIT COMPUT, V25, P285, DOI 10.1007/s10877-011-9307-z; ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; Costello RW, 2012, AM J RESP CRIT CARE, V185, P1; Costello RW, 2013, AM J RESP CRIT CARE, V187; Crompton GK, 2006, RESP MED, V100, P1479, DOI 10.1016/j.rmed.2006.01.008; Donahue JG, 1997, JAMA-J AM MED ASSOC, V277, P887, DOI 10.1001/jama.277.11.887; Foster JM, 2012, J ASTHMA, V49, P657, DOI 10.3109/02770903.2012.684253; Gamble J, 2011, AM J RESP CRIT CARE, V180, P814; Heaney LG, 2012, THORAX, V67, P268, DOI 10.1136/thoraxjnl-2011-200257; Holmes MS, 2013, TRANSLATIONAL ENG HL, V2, P1; Holmes MS, 2012, 34 ANN INT IEEE EMBS; Horne R, 2006, CONCORDANCE ADHERENC; JUNIPER EF, 1994, J CLIN EPIDEMIOL, V47, P81, DOI 10.1016/0895-4356(94)90036-1; Krishnan JA, 2004, AM J RESP CRIT CARE, V170, P1281, DOI 10.1164/rccm.200403-409OC; McNicholl DM, 2012, AM J RESP CRIT CARE, V186, P1102, DOI 10.1164/rccm.201204-0587OC; Melani AS, 2011, RESP MED, V105, P930, DOI 10.1016/j.rmed.2011.01.005; Milgrom H, 1996, J ALLERGY CLIN IMMUN, V98, P1051, DOI 10.1016/S0091-6749(96)80190-4; Murphy AC, 2012, THORAX, V67, P751, DOI 10.1136/thoraxjnl-2011-201096; Nikander K, 2011, ARCH DIS CHILD, V96, P168, DOI 10.1136/adc.2010.187724; Peters SP, 2010, NEW ENGL J MED, V363, P1715, DOI 10.1056/NEJMoa1008770; Press VG, 2011, J GEN INTERN MED, V26, P635, DOI 10.1007/s11606-010-1624-2; Price D, 2013, RESP MED, V107, P37, DOI 10.1016/j.rmed.2012.09.017; Selroos Olof, 2009, Ther Adv Respir Dis, V3, P81, DOI 10.1177/1753465809103737; Suissa S, 2000, NEW ENGL J MED, V343, P332, DOI 10.1056/NEJM200008033430504; Takemura M, 2011, INT J CHRONIC OBSTR, V6, P97, DOI 10.2147/COPD.S16173; Williams LK, 2004, J ALLERGY CLIN IMMUN, V114, P1288, DOI 10.1016/j.jaci.2004.09.028	26	52	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98701	10.1371/journal.pone.0098701	http://dx.doi.org/10.1371/journal.pone.0098701			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905012	Green Published, Green Submitted, gold			2022-12-27	WOS:000341869000050
J	Naspi, A; Panasiti, V; Abbate, F; Roberti, V; Devirgiliis, V; Curzio, M; Borghi, M; Lozupone, F; Carotti, S; Morini, S; Gaudio, E; Calvieri, S; Londei, P				Naspi, Antimo; Panasiti, Vincenzo; Abbate, Franco; Roberti, Vincenzo; Devirgiliis, Valeria; Curzio, Michela; Borghi, Martina; Lozupone, Francesco; Carotti, Simone; Morini, Sergio; Gaudio, Eugenio; Calvieri, Stefano; Londei, Paola			Insulin-Like-Growth-Factor-Binding-Protein-3 (IGFBP-3) Contrasts Melanoma Progression In Vitro and In Vivo	PLOS ONE			English	Article							IGF-BINDING PROTEIN-3; GROWTH-FACTOR (IGF)-I; CANCER-RISK; COLORECTAL-CANCER; PROSTATE-CANCER; PLASMA-LEVELS; TUMOR-GROWTH; CELLS	Insulin-like-factor-binding-protein 3 (IGFBP-3) is known to modulate the activity of insulin-like growth factors (IGFs) besides having a number of IGF-independent effects on cell growth and survival. IGFBP-3 has been reported to decrease significantly in the blood serum of patients affected by certain cancers. In the present work, we have evaluated the levels of IGFBP-3 in the blood serum and tissues of patients affected by cutaneous melanoma, showing that loss of IGFBP-3 from both is strongly correlated with disease progression and reduced survival. In vitro treatment with IGFBP-3 of human and murine metastatic melanoma cell lines specifically inhibited the cells' migratory and invasive behaviour, inducing up-regulation of melanocytic differentiation markers such as tyrosinase activity and melanin content. A molecular analysis of the cellular pathways transducing the effect of IGFBP-3 implicated the Akt-GSK3 beta axis. Moreover, administration of IGFBP-3 in vivo to SCID mice inoculated with human metastatic melanoma cells strongly reduced or completely inhibited tumor growth. In summary, IGFBP-3 appears to exert a specific inhibitory effect on melanoma growth and dissemination, suggesting that it may qualify as a useful therapeutic agent in melanomas and perhaps other cancers, at the least as a valid adjuvant therapy during treatment with conventional anti-tumoral drugs.	[Naspi, Antimo; Abbate, Franco; Londei, Paola] Univ Roma La Sapienza, Dept Biotecnol Cellulari & Ematol, Ist Pasteur Fdn Cenci Bolognetti, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Panasiti, Vincenzo; Devirgiliis, Valeria] Campus Biomed Univ Rome, Plast Surg Unit, Rome, Italy; [Roberti, Vincenzo; Curzio, Michela; Calvieri, Stefano] Univ Roma La Sapienza, Dept Internal Med & Med Specialties, I-00185 Rome, Italy; [Borghi, Martina; Lozupone, Francesco] Ist Super Sanita, Unit Antitumor Drugs, Dept Therapeut Res & Med Evaluat, I-00161 Rome, Italy; [Carotti, Simone; Morini, Sergio] Univ Campus Biomed Rome, Dept Human Anat CIR, Rome, Italy; [Gaudio, Eugenio] Univ Roma La Sapienza, Dept Human Anat, I-00185 Rome, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; University Campus Bio-Medico - Rome Italy; Sapienza University Rome; Istituto Superiore di Sanita (ISS); University Campus Bio-Medico - Rome Italy; Sapienza University Rome	Naspi, A (corresponding author), Univ Roma La Sapienza, Dept Biotecnol Cellulari & Ematol, Ist Pasteur Fdn Cenci Bolognetti, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	naspi@bce.uniroma1.it	Carotti, Simone/G-7822-2012; Lozupone, Francesco/H-2998-2016; Panasiti, Vincenzo/GPF-5731-2022; BORGHI, MARTINA/M-4355-2015; Morini, Sergio/AAB-8540-2022	Carotti, Simone/0000-0002-3164-1500; Lozupone, Francesco/0000-0002-4959-9400; BORGHI, MARTINA/0000-0001-6313-0273; Morini, Sergio/0000-0001-6137-2404; Panasiti, Vincenzo/0000-0003-1589-867X; calvieri, stefano/0000-0003-3735-4585	University of Rome	University of Rome	The study was financed by the following grants (2010-2011) from the University of Rome (www.uniroma1.it): "Role of IGF-binding proteins and other molecular markers in melanoma progression" and "Molecular markers in melanoma progression". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali O, 2003, HORM METAB RES, V35, P726; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Baldini PM, 2006, MELANOMA RES, V16, P501, DOI 10.1097/01.cmr.0000232296.99160.d7; Bellei B, 2008, CELL SIGNAL, V20, P1750, DOI 10.1016/j.cellsig.2008.06.001; Burrows C, 2006, ENDOCRINOLOGY, V147, P3484, DOI 10.1210/en.2006-0005; Dar AA, 2010, J INVEST DERMATOL, V130, P2071, DOI 10.1038/jid.2010.70; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Friedrich N, 2008, GROWTH HORM IGF RES, V18, P228, DOI 10.1016/j.ghir.2007.09.005; GERAN RI, 1972, CANC CHEMOTHER REP, V3, P1; Gribben L, 2012, CANCER LETT, V317, P41, DOI 10.1016/j.canlet.2011.11.011; Hankinson SE, 1998, LANCET, V351, P1393, DOI 10.1016/S0140-6736(97)10384-1; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Lal G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073953; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; Lomas J, 2008, FRONT BIOSCI-LANDMRK, V13, P5071, DOI 10.2741/3065; Lozupone F, 2000, INT J CANCER, V87, P569, DOI 10.1002/1097-0215(20000815)87:4<569::AID-IJC17>3.0.CO;2-U; Ma J, 1999, J NATL CANCER I, V91, P620, DOI 10.1093/jnci/91.7.620; Manola J, 2000, J CLIN ONCOL, V18, P3782, DOI 10.1200/JCO.2000.18.22.3782; Mattei F, 2014, J IMMUNOTOXICOL, V11, P337, DOI 10.3109/1547691X.2014.891677; Mehta HH, 2011, CANCER RES, V71, P5154, DOI 10.1158/0008-5472.CAN-10-4513; Panasiti V, 2011, J AM ACAD DERMATOL, V64, P865, DOI 10.1016/j.jaad.2010.03.035; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Ries LAG, 2000, CANCER-AM CANCER SOC, V88, P2398, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2398::AID-CNCR26>3.0.CO;2-I; Roddam AW, 2008, ANN INTERN MED, V149, P461, DOI 10.7326/0003-4819-149-7-200810070-00006; Yu H, 1999, JNCI-J NATL CANCER I, V91, P151, DOI 10.1093/jnci/91.2.151; Zumkeller W, 2001, J CLIN PATHOL-MOL PA, V54, P285, DOI 10.1136/mp.54.5.285	27	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98641	10.1371/journal.pone.0098641	http://dx.doi.org/10.1371/journal.pone.0098641			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905466	Green Published, Green Submitted, gold			2022-12-27	WOS:000341869000043
J	Belo, L; Nascimento, H; Kohlova, M; Bronze-da-Rocha, E; Fernandes, J; Costa, E; Catarino, C; Aires, L; Mansilha, HF; Rocha-Pereira, P; Quintanilha, A; Rego, C; Santos-Silva, A				Belo, Luis; Nascimento, Henrique; Kohlova, Michaela; Bronze-da-Rocha, Elsa; Fernandes, Joao; Costa, Elisio; Catarino, Cristina; Aires, Luisa; Mansilha, Helena Ferreira; Rocha-Pereira, Petronila; Quintanilha, Alexandre; Rego, Carla; Santos-Silva, Alice			Body Fat Percentage Is a Major Determinant of Total Bilirubin Independently of UGT1A1*28 Polymorphism in Young Obese	PLOS ONE			English	Article							SERUM BILIRUBIN; INSULIN-RESISTANCE; METABOLIC SYNDROME; OXIDATIVE STRESS; ENDOTHELIAL FUNCTION; INVERSE RELATIONSHIP; RACIAL VARIABILITY; CLINICAL-PRACTICE; MASS INDEX; GENE	Objectives: Bilirubin has potential antioxidant and anti-inflammatory properties. The UGT1A1*28 polymorphism (TA repeats in the promoter region) is a major determinant of bilirubin levels and recent evidence suggests that raised adiposity may also be a contributing factor. We aimed to study the interaction between UGT1A1 polymorphism, hematological and anthropometric variables with total bilirubin levels in young individuals. Methods: 350 obese (mean age of 11.6 years; 52% females) and 79 controls (mean age of 10.5 years; 59% females) were included. Total bilirubin and C-reactive protein (CRP) plasma levels, hemogram, anthropometric data and UGT1A1 polymorphism were determined. In a subgroup of 74 obese and 40 controls body composition was analyzed by dual-energy X-ray absorptiometry. Results: The UGT1A1 genotype frequencies were 49.9%, 42.7% and 7.5% for 6/6, 6/7 and 7/7 genotypes, respectively. Patients with 7/7 genotype presented the highest total bilirubin levels, followed by 6/7 and 6/6 genotypes. Compared to controls, obese patients presented higher erythrocyte count, hematocrit, hemoglobin and CRP levels, but no differences in bilirubin or in UGT1A1 genotype distribution. Body fat percentage was inversely correlated with bilirubin in obese patients but not in controls. This inverse association was observed either in 6/7 or 6/6 genotype obese patients. UGT1A1 polymorphism and body fat percentage were the main factors affecting bilirubin levels within obese patients (linear regression analysis). Conclusion: In obese children and adolescents, body fat composition and UGT1A1 polymorphism are independent determinants of total bilirubin levels. Obese individuals with 6/6 UGT1A1 genotype and higher body fat mass may benefit from a closer clinical follow-up.	[Belo, Luis; Nascimento, Henrique; Bronze-da-Rocha, Elsa; Fernandes, Joao; Costa, Elisio; Catarino, Cristina; Santos-Silva, Alice] Univ Porto, Fac Farm, Dept Ciencias Biol, P-4100 Oporto, Portugal; [Belo, Luis; Nascimento, Henrique; Bronze-da-Rocha, Elsa; Costa, Elisio; Catarino, Cristina; Quintanilha, Alexandre; Santos-Silva, Alice] Univ Porto, IBMC, P-4100 Oporto, Portugal; [Kohlova, Michaela; Fernandes, Joao] Univ Coimbra, Fac Med, Inst Biomed Imaging & Life Sci IBILI, Coimbra, Portugal; [Aires, Luisa] Univ Porto, Ctr Invest Actividade Fis Saude & Lazer CIAFEL, Fac Desporto, P-4100 Oporto, Portugal; [Aires, Luisa] Inst Univ Maia ISMAI, Maia, Portugal; [Mansilha, Helena Ferreira] Ctr Hosp Porto, Dept Infancia & Adolescencia, Serv Pediat, Oporto, Portugal; [Rocha-Pereira, Petronila] Univ Beira Interior, Ctr Invest Ciencias Saude, Covilha, Portugal; [Quintanilha, Alexandre] Univ Porto, ICBAS, P-4100 Oporto, Portugal; [Rego, Carla] Univ Porto, Fac Med, Ctr Hlth Technol & Serv Res CINTESIS, Hosp CUF Porto,Ctr Crianca & Adolescente, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade de Coimbra; Universidade do Porto; Instituto Universitario da Maia (ISMAI); Universidade da Beira Interior; Universidade do Porto; Universidade do Porto	Belo, L (corresponding author), Univ Porto, Fac Farm, Dept Ciencias Biol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	luisbelo@ff.up.pt	Fernandes, Joao C/AAF-2091-2019; Santos-Silva, Alice/AAC-7082-2020; Costa, Elisio MS/K-1990-2013; Belo, Luís FBA/K-5878-2013; Santos-Silva, Alice/K-2326-2013; Aires, Luisa/L-7528-2013; Bronze-da-Rocha, Elsa M R/K-2723-2013; Fernandes, João/K-3126-2013; Catarino, Cristina/K-5492-2013; Kohlova, Michaela/T-3587-2017; Rocha-Pereira, Petronila/K-3102-2013; Quintanilha, Alexandre/L-5371-2013	Fernandes, Joao C/0000-0003-1556-1698; Santos-Silva, Alice/0000-0002-2565-3169; Costa, Elisio MS/0000-0003-1158-1480; Belo, Luís FBA/0000-0002-3941-6850; Santos-Silva, Alice/0000-0002-2565-3169; Bronze-da-Rocha, Elsa M R/0000-0002-3571-2513; Fernandes, João/0000-0003-1556-1698; Catarino, Cristina/0000-0002-3229-1434; Kohlova, Michaela/0000-0002-9411-3449; Rocha-Pereira, Petronila/0000-0002-7985-1494; Aires, Luisa/0000-0001-9717-4186; Rego, Carla/0000-0003-1229-8775; Nascimento, Henrique/0000-0002-9105-018X; Quintanilha, Alexandre/0000-0001-8544-0061	FEDER funds through the Operational Competitiveness Programme - COMPETE; National Funds through FCT - Fundacao para a Ciencia e a Tecnologia [FCOMP-01-0124-FEDER-028613 (PTDC/DTP-DES/0393/2012)]; FCT [SFRH/BD/48060/2008]; Fundação para a Ciência e a Tecnologia [PTDC/DTP-DES/0393/2012] Funding Source: FCT	FEDER funds through the Operational Competitiveness Programme - COMPETE; National Funds through FCT - Fundacao para a Ciencia e a Tecnologia; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	This work was funded by FEDER funds through the Operational Competitiveness Programme - COMPETE and by National Funds through FCT - Fundacao para a Ciencia e a Tecnologia under the project FCOMP-01-0124-FEDER-028613 (PTDC/DTP-DES/0393/2012). A PhD grant was attributed to H. Nascimento by FCT (SFRH/BD/48060/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2008, CURR PHARM DESIGN, V14, P412, DOI 10.2174/138161208783597371; Alexander CM, 2008, DIABETES OBES METAB, V10, P246, DOI 10.1111/j.1463-1326.2006.00695.x; Andersson C, 2009, METABOLISM, V58, P1109, DOI 10.1016/j.metabol.2009.04.003; Beutler E, 1998, P NATL ACAD SCI USA, V95, P8170, DOI 10.1073/pnas.95.14.8170; Bondia-Pons I, 2012, J PHYSIOL BIOCHEM, V68, P701, DOI 10.1007/s13105-012-0154-2; BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; Bruce CR, 2003, DIABETES, V52, P2338, DOI 10.2337/diabetes.52.9.2338; Chang CL, 2011, ENDOCRINOLOGY, V152, P384, DOI 10.1210/en.2010-0493; Chauhan Alia, 2013, FP Essent, V410, P25; Clementi M, 2007, DIGEST LIVER DIS, V39, P351, DOI 10.1016/j.dld.2006.12.019; Coimbra S, 2013, OBES REV, V14, P771, DOI 10.1111/obr.12057; D'Archivio M, 2012, EUR J CLIN INVEST, V42, P70, DOI 10.1111/j.1365-2362.2011.02558.x; Devries MC, 2008, OBESITY, V16, P2281, DOI 10.1038/oby.2008.358; Fevery J, 2008, LIVER INT, V28, P592, DOI 10.1111/j.1478-3231.2008.01716.x; GAFFNEY D, 1994, J MED GENET, V31, P248, DOI 10.1136/jmg.31.3.248; Gong QH, 2001, PHARMACOGENETICS, V11, P357, DOI 10.1097/00008571-200106000-00011; Gourley G R, 1997, Adv Pediatr, V44, P173; Greco EA, 2013, WORLD J DIABETES, V4, P31, DOI 10.4239/wjd.v4.i2.31; Horsfall LJ, 2012, CIRCULATION, V126, P2556, DOI 10.1161/CIRCULATIONAHA.112.114066; Hwang HJ, 2011, CLIN CHEM LAB MED, V49, P1823, DOI 10.1515/CCLM.2011.662; Hwang HJ, 2010, CLIN CHIM ACTA, V411, P1496, DOI 10.1016/j.cca.2010.06.003; Jenko-Praznikar Z, 2013, METABOLISM, V62, P976, DOI 10.1016/j.metabol.2013.01.011; Jo J, 2011, ENDOCRINE, V39, P182, DOI 10.1007/s12020-010-9417-2; Kaniwa N, 2005, DRUG METAB DISPOS, V33, P458, DOI 10.1124/dmd.104.001800; Karatzas A, 2010, CANCER EPIDEMIOL, V34, P345, DOI 10.1016/j.canep.2010.02.009; Lin JP, 2006, CIRCULATION, V114, P1476, DOI 10.1161/CIRCULATIONAHA.106.633206; Lin LY, 2009, ATHEROSCLEROSIS, V203, P563, DOI 10.1016/j.atherosclerosis.2008.07.021; Maruhashi T, 2012, CIRCULATION, V126, P598, DOI 10.1161/CIRCULATIONAHA.112.105775; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nascimento Henrique, 2012, Open Biochem J, V6, P43, DOI 10.2174/1874091X01206010043; Nascimento H, 2009, ARCH PEDIAT ADOL MED, V163, P1030, DOI 10.1001/archpediatrics.2009.190; Novotny L, 2003, EXP BIOL MED, V228, P568, DOI 10.1177/15353702-0322805-29; Ohnaka K, 2010, DIABETES RES CLIN PR, V88, P103, DOI 10.1016/j.diabres.2009.12.022; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; Ostanek B, 2007, BLOOD CELL MOL DIS, V38, P78, DOI 10.1016/j.bcmd.2006.10.160; Padez C, 2004, AM J HUM BIOL, V16, P670, DOI 10.1002/ajhb.20080; Rocha S, 2010, BLOOD CELL MOL DIS, V44, P117, DOI 10.1016/j.bcmd.2009.10.012; Rodrigues C, 2012, BLOOD CELL MOL DIS, V48, P166, DOI 10.1016/j.bcmd.2012.01.004; Swift DL, 2012, MED SCI SPORT EXER, V44, P569, DOI 10.1249/MSS.0b013e3182357dd4; Taube A, 2012, AM J PHYSIOL-HEART C, V302, pH2148, DOI 10.1152/ajpheart.00907.2011; Temme EHM, 2001, CANCER CAUSE CONTROL, V12, P887, DOI 10.1023/A:1013794407325; Tiribelli C, 2005, J HEPATOL, V42, P170, DOI 10.1016/j.jhep.2004.12.002; Weinberger B, 2013, NEONATOLOGY, V103, P105, DOI 10.1159/000343097; Wonisch W, 2012, AGING MALE, V15, P159, DOI 10.3109/13685538.2012.669436; Wu TW, 1996, BIOCHEM PHARMACOL, V51, P859, DOI 10.1016/0006-2952(95)02395-X; Wu YH, 2011, J DIABETES, V3, P217, DOI 10.1111/j.1753-0407.2011.00138.x; YIP R, 1984, AM J CLIN NUTR, V39, P427, DOI 10.1093/ajcn/39.3.427; Yoshino S, 2011, J ATHEROSCLER THROMB, V18, P403, DOI 10.5551/jat.6346; Yu K, 2011, KOREAN J FAM MED, V32, P327, DOI 10.4082/kjfm.2011.32.6.327	49	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98467	10.1371/journal.pone.0098467	http://dx.doi.org/10.1371/journal.pone.0098467			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901842	Green Published, Green Submitted, gold			2022-12-27	WOS:000336841400032
J	Lexmond, AJ; Kruizinga, TJ; Hagedoorn, P; Rottier, BL; Frijlink, HW; de Boer, AH				Lexmond, Anne J.; Kruizinga, Tonnis J.; Hagedoorn, Paul; Rottier, Bart L.; Frijlink, Henderik W.; de Boer, Anne H.			Effect of Inhaler Design Variables on Paediatric Use of Dry Powder Inhalers	PLOS ONE			English	Article							INSPIRATORY FLOW-RATES; INHALATION TECHNIQUE; CYSTIC-FIBROSIS; YOUNG-CHILDREN; ASTHMA; RESISTANCE; TURBUHALER(R); DEPOSITION; ABILITY; DEVICE	Age appropriateness is a major concern of pulmonary delivery devices, in particular of dry powder inhalers (DPIs), since their performance strongly depends on the inspiratory flow manoeuvre of the patient. Previous research on the use of DPIs by children focused mostly on specific DPIs or single inspiratory parameters. In this study, we investigated the requirements for a paediatric DPI more broadly using an instrumented test inhaler. Our primary aim was to assess the impact of airflow resistance on children's inspiratory flow profiles. Additionally, we investigated children's preferences for airflow resistance and mouthpiece design and how these relate to what may be most suitable for them. We tested 98 children (aged 4.7-12.6 years), of whom 91 were able to perform one or more correct inhalations through the test inhaler. We recorded flow profiles at five airflow resistances ranging from 0.025 to 0.055 kPa(0.5).min.L-1 and computed various inspiratory flow parameters from these recordings. A sinuscope was used to observe any obstructions in the oral cavity during inhalation. 256 flow profiles were included for analysis. We found that both airflow resistance and the children's characteristics affect the inspiratory parameters. Our data suggest that a medium-high resistance is both suitable for and well appreciated by children aged 5-12 years. High incidences (up to 90%) of obstructions were found, which may restrict the use of DPIs by children. However, an oblong mouthpiece that was preferred the most appeared to positively affect the passageway through the oral cavity. To accommodate children from the age of 5 years onwards, a DPI should deliver a sufficiently high fine particle dose within an inhaled volume of 0.5 L and at a peak inspiratory flow rate of 25-40 L.min(-1). We recommend taking these requirements into account for future paediatric inhaler development.	[Lexmond, Anne J.; Kruizinga, Tonnis J.; Hagedoorn, Paul; Frijlink, Henderik W.; de Boer, Anne H.] Univ Groningen, Dept Pharmaceut Technol & Biopharm, Groningen, Netherlands; [Rottier, Bart L.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Div Paediat Pulmonol & Paediat Allergol, NL-9713 AV Groningen, Netherlands	University of Groningen; University of Groningen	Lexmond, AJ (corresponding author), Univ Groningen, Dept Pharmaceut Technol & Biopharm, Groningen, Netherlands.	a.j.lexmond@rug.nl	Frijlink, Henderik Willem/AAD-7382-2020	Frijlink, Henderik Willem/0000-0001-7901-8198				Adachi YS, 2006, PEDIATR INT, V48, P62, DOI 10.1111/j.1442-200X.2006.02173.x; Amirav I, 2005, PEDIATR PULM, V39, P447, DOI 10.1002/ppul.20180; BISGAARD H, 1994, EUR RESPIR J, V7, P740, DOI 10.1183/09031936.94.07040740; Bisgaard H, 1998, EUR RESPIR J, V11, P1111, DOI 10.1183/09031936.98.11051111; BROCKLEBANK D, 2001, HLTH TECHNOL ASSESS, V5; De Boeck K, 1999, J ALLERGY CLIN IMMUN, V103, P763, DOI 10.1016/S0091-6749(99)70417-3; de Koning JP, 2002, INT J PHARM, V234, P257, DOI 10.1016/S0378-5173(01)00969-3; Desager K. N., 2006, Pediatric Asthma Allergy & Immunology, V19, P6, DOI 10.1089/pai.2006.19.6; Devadason SG, 1997, EUR RESPIR J, V10, P2023, DOI 10.1183/09031936.97.10092023; Frijlink H W, 2004, Expert Opin Drug Deliv, V1, P67, DOI 10.1517/17425247.1.1.67; GOREN A, 1994, PEDIATR PULM, V18, P77, DOI 10.1002/ppul.1950180204; Kamps AWA, 2004, PEDIATR PULM, V37, P65, DOI 10.1002/ppul.10410; Kamps AWA, 2002, ACTA PAEDIATR, V91, P159, DOI 10.1080/080352502317285144; Kamps AWA, 2000, PEDIATR PULM, V29, P39, DOI 10.1002/(SICI)1099-0496(200001)29:1<39::AID-PPUL7>3.0.CO;2-G; Koopman M, 2011, RESP MED, V105, P15, DOI 10.1016/j.rmed.2010.07.020; Laube BL, 2011, EUR RESPIR J, V37, P1308, DOI 10.1183/09031936.00166410; Lavorini F, 2008, RESP MED, V102, P593, DOI 10.1016/j.rmed.2007.11.003; Nielsen KG, 1998, EUR RESPIR J, V11, P350, DOI 10.1183/09031936.98.11020350; PEDERSEN S, 1986, EUR J RESPIR DIS, V68, P207; PEDERSEN S, 1986, ARCH DIS CHILD, V61, P11, DOI 10.1136/adc.61.1.11; Pedersen S, 2010, PRIM CARE RESP J, V19, P209, DOI 10.4104/pcrj.2010.00043; Price D, 2013, RESP MED, V107, P37, DOI 10.1016/j.rmed.2012.09.017; Tiddens HA, 2006, J AEROSOL MED, V19, P456, DOI 10.1089/jam.2006.19.456; VIDGREN M, 1988, INT J PHARM, V42, P211, DOI 10.1016/0378-5173(88)90177-9	24	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99304	10.1371/journal.pone.0099304	http://dx.doi.org/10.1371/journal.pone.0099304			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901338	Green Published, Green Submitted, gold			2022-12-27	WOS:000336841400119
J	Tang, HJ; Liu, WL; Lin, HL; Lai, CC				Tang, Hung-Jen; Liu, Wei-Lun; Lin, Hsin-Lan; Lai, Chih-Cheng			Epidemiology and Prognostic Factors of Candidemia in Cancer Patients	PLOS ONE			English	Article							INVASIVE FUNGAL-INFECTIONS; BLOOD-STREAM INFECTIONS; HEMATOLOGICAL MALIGNANCIES; CHANGING EPIDEMIOLOGY; RISK-FACTORS; SUSCEPTIBILITY; SURVEILLANCE; FLUCONAZOLE; CANDIDAEMIA; CANDIDIASIS	Aim: The study of candidemia in cancer patients has been limited. This retrospective study aims to investigate the epidemiologic characteristics and prognostic factors of candidemia among cancer patients. Materials and Methods: From 2009 to 2012, cancer patients with candidemia were identified at a hospital in Taiwan. The medical records of all patients with bloodstream infections due to Candida species were retrospectively reviewed. Results: During the four-year period, a total of 242 episodes of candidemia were identified among cancer patients. Half of these patients were classified as elderly (>= 65 years old), and more than 95% of the candidemia episodes were classified as healthcare-associated infections. Among the 242 cancer patients with candidemia, head and neck cancer was the most common, followed by gastrointestinal tract and lung cancer. Additionally, most of the patients had variable underlying conditions, such as the presence of CVC (99%) or prior exposure to broad-spectrum antibiotics (93%) and were receiving an immunosuppressant (86%). Overall, C. albicans (n = 132, 54.5%) was the most common pathogen, followed by C. tropicalis (n = 52, 21.5%), C. parapsilosis (n = 38, 15.7%), and C. glabrata (n = 29, 12.0%). Seventeen patients had polycandidal candidemia, and 77 patients had concomitant bacteremia. Approximately one-third of the patients required admission to the intensive care unit (ICU) or mechanical ventilation, and the overall in-hospital mortality was 50.8%. Multivariable analysis showed that the in-hospital mortality was significantly associated with only the non-use of antifungal agents and acute respiratory failure (P<.001). Conclusions: Candidemia can develop in patients with both solid cancer and hematological malignancy, especially for patients with underlying conditions. Overall, the associated morbidity and mortality due to Candidemia remain high. It was also determined that the non-use of antifungal agents and acute respiratory failure conditions were associated with in-hospital mortality.	[Tang, Hung-Jen] Chi Mei Med Ctr, Dept Med, Tainan, Taiwan; [Tang, Hung-Jen] Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr, Tainan, Taiwan; [Liu, Wei-Lun; Lai, Chih-Cheng] Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan; [Lin, Hsin-Lan] Chi Mei Med Ctr, Dept Nursing, Tainan, Taiwan	Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Chi Mei Hospital; Chi Mei Hospital	Lai, CC (corresponding author), Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan.	dtmed141@gmail.com						Bergamasco MD, 2013, MYCOSES, V56, P256, DOI 10.1111/myc.12013; Chen YC, 2003, J ANTIMICROB CHEMOTH, V52, P71, DOI 10.1093/jac/dkg275; Cheng MF, 2004, DIAGN MICR INFEC DIS, V48, P33, DOI 10.1016/j.diagmicrobio.2003.08.002; Diekema D, 2012, DIAGN MICR INFEC DIS, V73, P45, DOI 10.1016/j.diagmicrobio.2012.02.001; Hachem R, 2008, CANCER, V112, P2493, DOI 10.1002/cncr.23466; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Hsueh PR, 2002, MICROB DRUG RESIST, V8, P311, DOI 10.1089/10766290260469570; Lai CC, 2012, INT J ANTIMICROB AG, V40, P349, DOI 10.1016/j.ijantimicag.2012.05.024; Lai Chih-Cheng, 2008, Journal of Infection and Chemotherapy, V14, P77, DOI 10.1007/s10156-007-0595-7; Lewis RE, 2013, MYCOSES, V56, P638, DOI 10.1111/myc.12081; Li D, 2013, MED MYCOL, V51, P378, DOI 10.3109/13693786.2012.727481; Lu Jang-Jih, 2004, Journal of Microbiology Immunology and Infection, V37, P335; Megalakaki C, 2006, J BUON, V11, P191; Montagna MT, 2013, INFECTION, V41, P645, DOI 10.1007/s15010-013-0432-0; Mor M, 2011, PEDIATR BLOOD CANCER, V56, P1092, DOI 10.1002/pbc.23005; Munoz P, 2011, CLIN MICROBIOL INFEC, V17, P1538, DOI 10.1111/j.1469-0691.2010.03338.x; Ortega M, 2011, J HOSP INFECT, V77, P157, DOI 10.1016/j.jhin.2010.09.026; Ruan SY, 2009, J FORMOS MED ASSOC, V108, P443, DOI 10.1016/S0929-6646(09)60091-7; Sabino R, 2010, MED MYCOL, V48, P346, DOI [10.3109/13693780903161216, 10.1080/13693780903161216]; Schuster MG, 2013, J INFECTION, V66, P278, DOI 10.1016/j.jinf.2012.11.002; Sipsas NV, 2009, CANCER-AM CANCER SOC, V115, P4745, DOI 10.1002/cncr.24507; Slavin MA, 2010, J ANTIMICROB CHEMOTH, V65, P1042, DOI 10.1093/jac/dkq053; Tragiannidis A, 2012, CLIN MICROBIOL INFEC, V18, pE27, DOI 10.1111/j.1469-0691.2011.03720.x; Velasco E, 2008, EUR J CLIN MICROBIOL, V27, P1071, DOI 10.1007/s10096-008-0546-y; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Yang YL, 2008, DIAGN MICR INFEC DIS, V61, P175, DOI 10.1016/j.diagmicrobio.2008.01.011; Zirkel J, 2012, MED MYCOL, V50, P50, DOI 10.3109/13693786.2011.587211	27	37	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99103	10.1371/journal.pone.0099103	http://dx.doi.org/10.1371/journal.pone.0099103			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901336	gold, Green Submitted, Green Published			2022-12-27	WOS:000336841400098
J	Wang, L; Zhou, L; Zhang, H; Li, Y; Ge, XN; Guo, X; Yu, KZ; Yang, HC				Wang, Li; Zhou, Lei; Zhang, Han; Li, Yan; Ge, Xinna; Guo, Xin; Yu, Kangzhen; Yang, Hanchun			Interactome Profile of the Host Cellular Proteins and the Nonstructural Protein 2 of Porcine Reproductive and Respiratory Syndrome Virus	PLOS ONE			English	Article							CYSTEINE PROTEASE DOMAIN; MOLECULAR-BIOLOGY; ECONOMIC-IMPACT; PAPAIN-LIKE; NSP2; APOPTOSIS; REPLICATION; ANTIGEN; INNATE; STRAIN	The nonstructural protein 2 (NSP2) is considered to be one of crucial viral proteins in the replication and pathogenesis of porcine reproductive and respiratory syndrome virus (PRRSV). In the present study, the host cellular proteins that interact with the NSP2 of PRRSV were immunoprecipitated with anti-Myc antibody from the MARC-145 cells infected by a recombinant PRRSV with 3xMyc tag insertion in its NSP2-coding region, and then 285 cellular proteins interacting with NSP2 were identified by LC-MS/ MS. The Gene Ontology and enriched KEGG Pathway bioinformatics analyses indicated that the identified proteins could be assigned to different subcellular locations and functional classes. Functional analysis of the interactome profile highlighted cellular pathways associated with infectious disease, translation, immune system, nervous system and signal transduction. Two interested cellular proteins-BCL2-associated athanogene 6 (BAG6) and apoptosis-inducing factor 1 (AIF1) which may involve in transporting of NSP2 to Endoplasmic reticulum (ER) or PRRSV-driven apoptosis were validated by Western blot. The interactome data between PRRSV NSP2 and cellular proteins contribute to the understanding of the roles of NSP2 in the replication and pathogenesis of PRRSV, and also provide novel cellular target proteins for elucidating the associated molecular mechanisms of the interaction of host cellular proteins with viral proteins in regulating the viral replication.	[Wang, Li; Zhou, Lei; Zhang, Han; Li, Yan; Ge, Xinna; Guo, Xin; Yu, Kangzhen; Yang, Hanchun] China Agr Univ, Key Lab Anim Epidemiol & Zoonosis, Minist Agr, Coll Vet Med, Beijing 100094, Peoples R China; [Wang, Li; Zhou, Lei; Zhang, Han; Li, Yan; Ge, Xinna; Guo, Xin; Yu, Kangzhen; Yang, Hanchun] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Yu, Kangzhen] Minist Agr Peoples Republ China, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University; Ministry of Agriculture & Rural Affairs	Yang, HC (corresponding author), China Agr Univ, Key Lab Anim Epidemiol & Zoonosis, Minist Agr, Coll Vet Med, Beijing 100094, Peoples R China.	yanghanchun1@cau.edu.cn		Zhou, Lei/0000-0002-8837-3965	Chinese Ministry of Science and Technology [2014CB542700]; National Natural Science Foundation of China [31330077]; Ministry of Agriculture of People's Republic of China [CARS-36]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of People's Republic of China	This work was supported by National Key Basic Research Plan Grant (2014CB542700) from the Chinese Ministry of Science and Technology (http://www.most.gov.cn/) and Key project of National Natural Science Funds from National Natural Science Foundation of China (31330077) (http://www.nsfc.gov.cn/), and the earmarked fund for Modern Agro-industry Technology Research System of China (CARS-36) from the Ministry of Agriculture of People's Republic of China (http://119.253.58.231/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albina E, 1997, VET RES, V28, P305; BANERJI J, 1990, P NATL ACAD SCI USA, V87, P2374, DOI 10.1073/pnas.87.6.2374; BENFIELD DA, 1992, J VET DIAGN INVEST, V4, P127, DOI 10.1177/104063879200400202; Beura LK, 2011, J VIROL, V85, P12939, DOI 10.1128/JVI.05177-11; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Cande C, 2002, BIOCHIMIE, V84, P215, DOI 10.1016/S0300-9084(02)01374-3; Cao JB, 2012, J VET DIAGN INVEST, V24, P767, DOI 10.1177/1040638712445764; Cavanagh D, 1997, ARCH VIROL, V142, P629; Chang AC, 2012, J VIROL, V80, P8705; Clementz MA, 2010, J VIROL, V84, P4619, DOI 10.1128/JVI.02406-09; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Costers S, 2008, ARCH VIROL, V153, P1453, DOI 10.1007/s00705-008-0135-5; Desmots F, 2008, J BIOL CHEM, V283, P3264, DOI 10.1074/jbc.M706419200; Fang Y, 2006, J VIROL, V80, P11447, DOI 10.1128/JVI.01032-06; Fang Y, 2012, P NATL ACAD SCI USA, V109, pE2920, DOI 10.1073/pnas.1211145109; Firth AE, 2011, J GEN VIROL, V92, P1097, DOI 10.1099/vir.0.029264-0; Frias-Staheli N, 2007, CELL HOST MICROBE, V2, P404, DOI 10.1016/j.chom.2007.09.014; Garner MG, 2001, REV SCI TECH OIE, V20, P671, DOI 10.20506/rst.20.3.1303; Gomez-Laguna J, 2013, TRANSBOUND EMERG DIS, V60, P273, DOI 10.1111/j.1865-1682.2012.01338.x; Gorbalenya AE, 2006, VIRUS RES, V117, P17, DOI 10.1016/j.virusres.2006.01.017; Halbur PG, 1996, VET PATHOL, V33, P159, DOI 10.1177/030098589603300205; Han J, 2007, J VIROL, V81, P9878, DOI 10.1128/JVI.00562-07; Han J, 2006, VIRUS RES, V122, P175, DOI 10.1016/j.virusres.2006.06.003; Han J, 2010, J VIROL, V84, P10102, DOI 10.1128/JVI.01208-10; Han J, 2009, J VIROL, V83, P9449, DOI 10.1128/JVI.00834-09; Johnson CR, 2011, J GEN VIROL, V92, P1107, DOI 10.1099/vir.0.030213-0; Jourdan SS, 2012, PROTEOMICS, V12, P1015, DOI 10.1002/pmic.201100469; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Keffaber K., 1989, AM ASS SWINE PRACT N, V1, P1; Kim DY, 2007, VIRUS RES, V128, P106, DOI 10.1016/j.virusres.2007.04.019; Kirchhoff F, 2010, CELL HOST MICROBE, V8, P55, DOI 10.1016/j.chom.2010.06.004; Knoops K, 2012, J VIROL, V86, P2474, DOI 10.1128/JVI.06677-11; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; Lamkanfi M, 2010, CELL HOST MICROBE, V8, P44, DOI 10.1016/j.chom.2010.06.007; Lee JG, 2013, BIOESSAYS, V35, P377, DOI 10.1002/bies.201200159; Lee SM, 2007, VIROLOGY, V365, P419, DOI 10.1016/j.virol.2007.04.001; Leznicki P, 2012, P NATL ACAD SCI USA, V109, P19214, DOI 10.1073/pnas.1209997109; Leznicki P, 2010, J CELL SCI, V123, P2170, DOI 10.1242/jcs.066738; Li LM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-203; Liu YC, 2005, NAT REV IMMUNOL, V5, P941, DOI 10.1038/nri1731; Ma ZT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069387; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Miller LC, 2004, VET IMMUNOL IMMUNOP, V102, P131, DOI 10.1016/j.vetimm.2004.09.004; Minami R, 2010, J CELL BIOL, V190, P637, DOI 10.1083/jcb.200908092; Molitor TW, 1997, VET MICROBIOL, V55, P265, DOI 10.1016/S0378-1135(96)01327-2; Music Nedzad, 2010, Animal Health Research Reviews, V11, P135, DOI 10.1017/S1466252310000034; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Pedersen KW, 1999, J VIROL, V73, P2016, DOI 10.1128/JVI.73.3.2016-2026.1999; Posthuma CC, 2008, J VIROL, V82, P4480, DOI 10.1128/JVI.02756-07; Preta G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047328; ROSSOW KD, 1995, VET PATHOL, V32, P361, DOI 10.1177/030098589503200404; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SNIJDER EJ, 1995, J BIOL CHEM, V270, P16671, DOI 10.1074/jbc.270.28.16671; Snijder EJ, 1998, J GEN VIROL, V79, P961, DOI 10.1099/0022-1317-79-5-961; Snijder EJ, 2001, J GEN VIROL, V82, P985, DOI 10.1099/0022-1317-82-5-985; Snijder EJ, 2013, J GEN VIROL, V94, P2141, DOI 10.1099/vir.0.056341-0; Sun Z, 2012, J VIROL, V86, P3839, DOI 10.1128/JVI.06466-11; Sun Z, 2010, J VIROL, V84, P7832, DOI 10.1128/JVI.00217-10; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tanaka S, 2005, J NEUROCHEM, V95, P179, DOI 10.1111/j.1471-4159.2005.03353.x; Thanawongnuwech R, 1997, J VET DIAGN INVEST, V9, P334, DOI 10.1177/104063879700900323; Thress K, 1999, EMBO J, V18, P5486, DOI 10.1093/emboj/18.20.5486; Thress K, 1998, EMBO J, V17, P6135, DOI 10.1093/emboj/17.21.6135; van Kasteren PB, 2013, P NATL ACAD SCI USA, V110, pE838, DOI 10.1073/pnas.1218464110; van Kasteren PB, 2012, J VIROL, V86, P773, DOI 10.1128/JVI.06277-11; Wang X, 2007, ARCH VIROL, V152, P289, DOI 10.1007/s00705-006-0857-1; Wassenaar ALM, 1997, J VIROL, V71, P9313, DOI 10.1128/JVI.71.12.9313-9322.1997; Watanabe T, 2010, CELL HOST MICROBE, V7, P427, DOI 10.1016/j.chom.2010.05.008; Yan YL, 2007, VIRUS RES, V126, P207, DOI 10.1016/j.virusres.2007.03.002; Yoo D, 2010, VIRUS RES, V154, P48, DOI 10.1016/j.virusres.2010.07.019; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zhang HM, 2009, J PROTEOME RES, V8, P3091, DOI 10.1021/pr900002f; Zhou L, 2010, VIRUS RES, V154, P31, DOI 10.1016/j.virusres.2010.07.016; Zhou L, 2009, VIRUS RES, V145, P97, DOI 10.1016/j.virusres.2009.06.014; Zhou L, 2009, J VIROL, V83, P5156, DOI 10.1128/JVI.02678-08	75	13	16	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99176	10.1371/journal.pone.0099176	http://dx.doi.org/10.1371/journal.pone.0099176			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901321	Green Published, Green Submitted, gold			2022-12-27	WOS:000336841400105
J	Zelnikar, M; Bencina, M; Jerala, R; Mancek-Keber, M				Zelnikar, Mojca; Bencina, Mojca; Jerala, Roman; Mancek-Keber, Mateja			Vanadate from Air Pollutant Inhibits Hrs-Dependent Endosome Fusion and Augments Responsiveness to Toll-Like Receptors	PLOS ONE			English	Article							OIL FLY-ASH; EPITHELIAL-CELLS; TYROSINE PHOSPHORYLATION; INFLAMMATORY RESPONSES; CYTOKINE PRODUCTION; EXPOSURE; TOLL-LIKE-RECEPTOR-4; SUSCEPTIBILITY; INCREASES; MORTALITY	There is a well-established association between exposure to air pollutants and pulmonary injuries. For example, metals found in ROFA (residual oil fly ash) increase susceptibility of mice as well as humans to microbial infections. In our research, we have found that vanadate substantially increased the response of several Toll-like receptors (TLRs) to stimulation with their ligands. Although vanadate caused generation of reactive oxygen species (ROS), the addition of ROS scavenger N-acetyl cysteine (NAC) had no effect on augmented lipopolysaccharide (LPS) stimulation. We further showed that vanadate inhibits endosome fusion. This effect was determined by measuring the size of endosomes, NF-kappa B activity and TLR4 degradation in Hrs (hepatocyte growth factor-regulated tyrosine kinase substrate) overexpressed cells. Moreover, we identified the role of Hrs phosphorylation in these processes. Based on our findings, we can conclude that vanadate potentiates TLR4 activity by increasing Hrs phosphorylation status, reducing the size of Hrs/TLR4-positive endosomes and impacting TLR4 degradation, thus contributing to the detrimental effects of air pollutants on human health.	[Zelnikar, Mojca; Bencina, Mojca; Jerala, Roman; Mancek-Keber, Mateja] Natl Inst Chem, Biotechnol Lab, Ljubljana, Slovenia; [Bencina, Mojca; Jerala, Roman; Mancek-Keber, Mateja] EN FIST Ctr Excellence, Ljubljana, Slovenia	National Institute of Chemistry - Slovenia	Mancek-Keber, M (corresponding author), Natl Inst Chem, Biotechnol Lab, Ljubljana, Slovenia.	mateja.mancek@ki.si	Jerala, Roman/H-9850-2015	Jerala, Roman/0000-0002-6337-5251	Slovenian Research Agency; Ministry of Science and Technology at the Centre of Excellence EN-FIST	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Ministry of Science and Technology at the Centre of Excellence EN-FIST	This work was supported by programs and projects from the Slovenian Research Agency and by the Ministry of Science and Technology at the Centre of Excellence EN-FIST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, CURR OPIN IMMUNOL, V15, P5, DOI 10.1016/S0952-7915(02)00013-4; Antonini JM, 2002, TOXICOL SCI, V70, P110, DOI 10.1093/toxsci/70.1.110; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Behndig AF, 2006, EUR RESPIR J, V27, P359, DOI 10.1183/09031936.06.00136904; BIDANI A, 1995, J LEUKOCYTE BIOL, V57, P275, DOI 10.1002/jlb.57.2.275; Carter JD, 1997, TOXICOL APPL PHARM, V146, P180, DOI 10.1006/taap.1997.8254; Cho HY, 2005, PHYSIOL GENOMICS, V22, P108, DOI 10.1152/physiolgenomics.00037.2005; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Dye JA, 1997, AM J RESP CELL MOL, V17, P625, DOI 10.1165/ajrcmb.17.5.2749; Gamero AM, 2001, J BIOL CHEM, V276, P13547, DOI 10.1074/jbc.M007948200; Gasparrini F, 2012, EUR J IMMUNOL, V42, P2744, DOI 10.1002/eji.201142278; Ghio AJ, 2002, ENVIRON HEALTH PERSP, V110, P89, DOI 10.1289/ehp.02110s1189; Gurgueira SA, 2002, ENVIRON HEALTH PERSP, V110, P749, DOI 10.1289/ehp.02110749; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; Hanyaloglu AC, 2005, EMBO J, V24, P2265, DOI 10.1038/sj.emboj.7600688; HAUSER R, 1995, OCCUP ENVIRON MED, V52, P353, DOI 10.1136/oem.52.5.353; Huffman GP, 2000, J AIR WASTE MANAGE, V50, P1106, DOI 10.1080/10473289.2000.10464157; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Inoue K, 2006, ARCH TOXICOL, V80, P275, DOI 10.1007/s00204-005-0040-6; Kim JY, 2004, ENVIRON HEALTH PERSP, V112, P666, DOI 10.1289/ehp.6827; Klein-Patel ME, 2006, TOXICOL SCI, V92, P115, DOI 10.1093/toxsci/kfj214; Komada M, 1999, GENE DEV, V13, P1475, DOI 10.1101/gad.13.11.1475; Longphre M, 2000, TOXICOL APPL PHARM, V162, P86, DOI 10.1006/taap.1999.8838; Nikula KJ, 2000, INHAL TOXICOL, V12, P123, DOI 10.1080/089583700750019549; NIOSH, 1994, PUBL NIOSH, P1; Pereira CEL, 2007, BRAZ J MED BIOL RES, V40, P1353, DOI 10.1590/S0100-879X2006005000164; Prahalad AK, 2001, CHEM RES TOXICOL, V14, P879, DOI 10.1021/tx010022e; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Reiland J, 1996, BIOCHEM J, V319, P39, DOI 10.1042/bj3190039; Rhoden CR, 2004, TOXICOL SCI, V79, P296, DOI 10.1093/toxsci/kfh122; Salnikow Konstantin, 2000, Journal of Environmental Pathology Toxicology and Oncology, V19, P307; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Stern KA, 2007, MOL CELL BIOL, V27, P888, DOI 10.1128/MCB.02356-05; Stringer B, 1998, J TOXICOL ENV HEAL A, V55, P31; Urbe S, 2000, MOL CELL BIOL, V20, P7685, DOI 10.1128/MCB.20.20.7685-7692.2000; Urbe S, 2003, J CELL SCI, V116, P4169, DOI 10.1242/jcs.00723; Uysal N, 2003, CURR OPIN PULM MED, V9, P144, DOI 10.1097/00063198-200303000-00009; van Eeden SF, 2001, AM J RESP CRIT CARE, V164, P826, DOI 10.1164/ajrccm.164.5.2010160; Woo CH, 2000, BIOCHEM J, V348, P525, DOI 10.1042/0264-6021:3480525; Zhang Z, 2001, ARCH BIOCHEM BIOPHYS, V392, P311, DOI 10.1006/abbi.2001.2464	40	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99287	10.1371/journal.pone.0099287	http://dx.doi.org/10.1371/journal.pone.0099287			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901993	Green Published, gold, Green Submitted			2022-12-27	WOS:000336841400117
J	Chen, ST; Siddarth, P; Ercoli, LM; Merrill, DA; Torres-Gil, F; Small, GW				Chen, Stephen T.; Siddarth, Prabha; Ercoli, Linda M.; Merrill, David A.; Torres-Gil, Fernando; Small, Gary W.			Modifiable Risk Factors for Alzheimer Disease and Subjective Memory Impairment across Age Groups	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; BODY-MASS INDEX; OLDER-ADULTS; PHYSICAL-ACTIVITY; BLOOD-PRESSURE; LATE-LIFE; DEPRESSIVE SYMPTOMS; DEVELOPING DEMENTIA; CONTROLLED TRIAL; SELF-APPRAISAL	Introduction: Previous research has identified modifiable risk factors for Alzheimer's disease (AD) in older adults. Research is limited on the potential link between these risk factors and subjective memory impairment (SMI), which may precede AD and other dementias. Examination of these potential relationships may help identify those at risk for AD at a stage when interventions may delay or prevent further memory problems. The objective of this study was to determine whether risk factors for AD are associated with SMI among different age groups. Method: Trained interviewers conducted daily telephone surveys (Gallup-Healthways) of a representative community sample of 18,614 U.S. respondents, including 4,425 younger (age 18 to 39 years), 6,365 middle-aged (40 to 59 years), and 7,824 older (60 to 99 years) adults. The surveyors collected data on demographics, lifestyles, and medical information. Less education, smoking, hypertension, diabetes, less exercise, obesity and depression, and interactions among them, were examined for associations with SMI. Weighted logistic regressions and chi-square tests were used to calculate odds ratios and confidence intervals for SMI with each risk factor and pairwise interactions across age groups. Results: Depression, less education, less exercise, and hypertension were significantly associated with SMI in all three age groups. Several interactions between risk factors were significant in younger and middle-aged adults and influenced their associations with SMI. Frequency of SMI increased with age and number of risk factors. Odds of having SMI increased significantly with just having one risk factor. Conclusions: These results indicate that modifiable risk factors for AD are also associated with SMI, suggesting that these relationships occur in a broad range of ages and may be targeted to mitigate further memory problems. Whether modifying these risk factors reduces SMI and the eventual incidence of AD and other dementias later in life remains to be determined.	[Chen, Stephen T.; Siddarth, Prabha; Ercoli, Linda M.; Merrill, David A.; Small, Gary W.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Chen, Stephen T.; Siddarth, Prabha; Ercoli, Linda M.; Merrill, David A.; Small, Gary W.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; [Ercoli, Linda M.; Small, Gary W.] Univ Calif Los Angeles, UCLA Longev Ctr Aging, Los Angeles, CA USA; [Torres-Gil, Fernando] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Torres-Gil, Fernando] Univ Calif Los Angeles, Dept Publ Policy, UCLA Sch Publ Affairs, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Small, GW (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA.	gsmall@ucla.edu		Merrill, David/0000-0003-2181-3839	Fran and Ray Stark Foundation Fund for Alzheimer's Disease Research; Semel Institute; Parlow-Solomon Professorship on Aging	Fran and Ray Stark Foundation Fund for Alzheimer's Disease Research; Semel Institute; Parlow-Solomon Professorship on Aging	Supported by the Fran and Ray Stark Foundation Fund for Alzheimer's Disease Research; the Parlow-Solomon Professorship on Aging; and the Semel Institute. No company provided support of any kind for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida OP, 2002, ADDICTION, V97, P15, DOI 10.1046/j.1360-0443.2002.00016.x; Angevaren M, 2008, COCHRANE DATABASE SY; [Anonymous], ALZHEIMERS DEMENT, V8, P131; Anstey KJ, 2011, OBES REV, V12, pe426, DOI 10.1111/j.1467-789X.2010.00825.x; Anstey KJ, 2007, AM J EPIDEMIOL, V166, P367, DOI 10.1093/aje/kwm116; Areosa S. A., 2002, COCHRANE DB SYST REV, V1, DOI [10.1002/ 14651858. CD003804, DOI 10.1002/14651858.CD003804, 10.1002/14651858.CD003804]; Atti AR, 2008, J AM GERIATR SOC, V56, P111, DOI 10.1111/j.1532-5415.2007.01458.x; Balash Y, 2013, ACTA NEUROL SCAND, V127, P344, DOI 10.1111/ane.12038; Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; BASSETT SS, 1993, J GERIATR PSYCH NEUR, V6, P105, DOI 10.1177/089198879300600207; Blazer DG, 1997, J AGING HEALTH, V9, P171, DOI 10.1177/089826439700900202; Cataldo JK, 2010, J ALZHEIMERS DIS, V19, P465, DOI 10.3233/JAD-2010-1240; Minett TSC, 2008, INT J GERIATR PSYCH, V23, P49, DOI 10.1002/gps.1836; Cohen AK, 2013, SOC SCI MED, V78, P34, DOI 10.1016/j.socscimed.2012.11.025; CUTLER SJ, 1988, J GERONTOL, V43, pS82, DOI 10.1093/geronj/43.3.S82; Dahl AK, 2008, J AM GERIATR SOC, V56, P2261, DOI 10.1111/j.1532-5415.2008.01958.x; Daviglus ML, 2010, NIH CONSENS STATE SC, V27, P1, DOI DOI 10.7326/0003-4819-153-3-201008030-00260; Devanand DP, 1996, ARCH GEN PSYCHIAT, V53, P175; Dik MG, 2001, NEUROLOGY, V57, P2217, DOI 10.1212/WNL.57.12.2217; DYER AR, 1976, CIRCULATION, V54, P987, DOI 10.1161/01.CIR.54.6.987; Ercoli L, 2006, ARCH GEN PSYCHIAT, V63, P442, DOI 10.1001/archpsyc.63.4.442; Gino S, 2010, GERONTOLOGY, V56, P272, DOI 10.1159/000240048; Hamer M, 2009, PSYCHOL MED, V39, P3, DOI 10.1017/S0033291708003681; Jessen F, 2013, ALZHEIMERS DEMENT; Jessen F, 2010, ARCH GEN PSYCHIAT, V67, P414, DOI 10.1001/archgenpsychiatry.2010.30; Jonker C, 2000, INT J GERIATR PSYCH, V15, P983, DOI 10.1002/1099-1166(200011)15:11<983::AID-GPS238>3.0.CO;2-5; Jorm AF, 1997, PSYCHOL MED, V27, P91, DOI 10.1017/S0033291796003923; Kessing LV, 2012, CURR OPIN PSYCHIATR, V25, P457, DOI 10.1097/YCO.0b013e328356c368; Kessing LV, 2011, INT CLIN PSYCHOPHARM, V26, P316, DOI 10.1097/YIC.0b013e32834ace0f; Kessing LV, 2004, J NEUROL NEUROSUR PS, V75, P1662, DOI 10.1136/jnnp.2003.031773; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Leroux C, 2014, CAN J DIABETES, V38, P62, DOI 10.1016/j.jcjd.2013.08.268; Ligthart SA, 2010, VASC HEALTH RISK MAN, V6, P775, DOI 10.2147/VHRM.S7343; McGuinness B, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004034.pub3; Merrill DA, 2012, INT PSYCHOGERIATR, V24, P1076, DOI 10.1017/S1041610212000051; Miller KJ, 2012, AM J GERIAT PSYCHIAT, V20, P514, DOI 10.1097/JGP.0b013e318227f821; Minett TSC, 2005, AM J GERIAT PSYCHIAT, V13, P665, DOI 10.1176/appi.ajgp.13.8.665; Modrego PJ, 2004, ARCH NEUROL-CHICAGO, V61, P1290, DOI 10.1001/archneur.61.8.1290; Panza F, 2010, AM J GERIAT PSYCHIAT, V18, P98, DOI 10.1097/JGP.0b013e3181b0fa13; Papp KV, 2009, ALZHEIMERS DEMENT, V5, P50, DOI 10.1016/j.jalz.2008.10.008; Peters R, 2008, LANCET NEUROL, V7, P683, DOI 10.1016/S1474-4422(08)70143-1; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Petersen RC, 2009, ARCH NEUROL-CHICAGO, V66, P1447, DOI 10.1001/archneurol.2009.266; Ponds RWHM, 1997, INT J AGING HUM DEV, V45, P207, DOI 10.2190/MVQ1-WB58-875H-Y4X0; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Qiu CX, 2005, LANCET NEUROL, V4, P487, DOI 10.1016/S1474-4422(05)70141-1; Rendell PG, 1999, J GERONTOL B-PSYCHOL, V54, pP256, DOI 10.1093/geronb/54B.4.P256; Rolland Y, 2008, J AM MED DIR ASSOC, V9, P390, DOI 10.1016/j.jamda.2008.02.007; Schneider Lon S, 2013, Continuum (Minneap Minn), V19, P339, DOI 10.1212/01.CON.0000429180.60095.d0; Schofield PW, 1997, ARCH NEUROL-CHICAGO, V54, P756, DOI 10.1001/archneur.1997.00550180064014; Schofield PW, 1997, AM J PSYCHIAT, V154, P609; Shah K, 2009, AM J GERIATR PHARMAC, V7, P250, DOI 10.1016/j.amjopharm.2009.11.001; Small GW, 2013, INT PSYCHOGERIATR, V25, P981, DOI 10.1017/S1041610213000082; Small GW, 1999, AM J PSYCHIAT, V156, P1035; Small GW, 2001, INT J GERIATR PSYCH, V16, P1071, DOI 10.1002/gps.481; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Strawbridge WJ, 2002, AM J EPIDEMIOL, V156, P328, DOI 10.1093/aje/kwf047; Troyer AK, 2002, J GERONTOL B-PSYCHOL, V57, pP19, DOI 10.1093/geronb/57.1.P19; Willis SL, 2006, JAMA-J AM MED ASSOC, V296, P2805, DOI 10.1001/jama.296.23.2805; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x	62	42	49	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98630	10.1371/journal.pone.0098630	http://dx.doi.org/10.1371/journal.pone.0098630			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK4YO	24896243	Green Published, gold			2022-12-27	WOS:000338430700057
J	Giguere, T; Adkar-Purushothama, CR; Perreault, JP				Giguere, Tamara; Adkar-Purushothama, Charith Raj; Perreault, Jean-Pierre			Comprehensive Secondary Structure Elucidation of Four Genera of the Family Pospiviroidae	PLOS ONE			English	Article							CADANG-CADANG DISEASE; COLEUS-BLUMEI; STRUCTURE PREDICTION; NUCLEOTIDE-SEQUENCE; VIROIDS; INFORMATION; SOFTWARE; HOMOLOGY; ACCURATE; TOMATO	Viroids are small, circular, single stranded RNA molecules that infect plants. Since they are non-coding, their structures play a critical role in their life cycles. To date, little effort has been spend on elucidating viroid structures in solution due to both the experimental difficulties and the time-consuming nature of the methodologies implicated. Recently, the technique of high-throughput selective 2'-hydroxyl acylation analyzed by primer extension (SHAPE) was adapted for the probing of the members of family Avsunviroidae, all of whom replicate in the chloroplast and demonstrate ribozyme activity. In the present work, twelve viroid species belonging to four different genera of the family Pospiviroidae, whose members are characterized by the presence of a central conserved region (CCR) and who replicate in nucleus of the host, were probed. Given that the structures of five distinct viroid species from the family Pospiviroidae have been previously reported, an overview of the different structural characteristics for all genera and the beginning of a manual classification of the different viroids based on their structural features are presented here.	[Giguere, Tamara; Adkar-Purushothama, Charith Raj; Perreault, Jean-Pierre] Univ Sherbrooke, Dept Biochim, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Perreault, JP (corresponding author), Univ Sherbrooke, Dept Biochim, Fac Med & Sci Sante, Pavillon Rech Appl Canc, Sherbrooke, PQ J1K 2R1, Canada.	jean-pierre.perreault@usherbrooke.ca	Adkar-Purushothama, Charith Raj/AAR-2159-2020	Adkar-Purushothama, Charith Raj/0000-0001-8868-6008	Natural Sciences and Engineering Research Council of Canada (NSERC) [155219-12]; Universite de Sherbrooke; Centre medicale de l'Universite de Sherbrooke	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Universite de Sherbrooke; Centre medicale de l'Universite de Sherbrooke	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada (NSERC, grant number 155219-12) to JPP. The RNA group is supported by grants from the Universite de Sherbrooke. JPP holds the Research Chair of Universite de Sherbrooke in RNA Structure and Genomics and is a member of the Centre de Recherche Clinique Etienne-Lebel. TG has a scholarship from the Centre medicale de l'Universite de Sherbrooke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bussiere F, 1996, NUCLEIC ACIDS RES, V24, P1793, DOI 10.1093/nar/24.10.1793; Bussiere F, 2000, J VIROL, V74, P2647, DOI 10.1128/JVI.74.6.2647-2654.2000; Desvignes JC, 1999, PLANT DIS, V83, P768, DOI 10.1094/PDIS.1999.83.8.768; Diener TO, 2003, NAT REV MICROBIOL, V1, P75, DOI 10.1038/nrmicro736; Ding BA, 2010, WIRES RNA, V1, P362, DOI 10.1002/wrna.22; Dube A, 2011, MOL PLANT PATHOL, V12, P688, DOI 10.1111/J.1364-3703.2010.00703.X; Flores R, 2005, ANNU REV PHYTOPATHOL, V43, P117, DOI 10.1146/annurev.phyto.43.040204.140243; Gast FU, 1996, J MOL BIOL, V262, P652, DOI 10.1006/jmbi.1996.0543; Giguere T, 2014, MOL PLANT PATHOL, V15, P767, DOI 10.1111/mpp.12130; Hajdin CE, 2013, P NATL ACAD SCI USA, V110, P5498, DOI 10.1073/pnas.1219988110; HAMMOND R, 1989, NUCLEIC ACIDS RES, V17, P10083, DOI 10.1093/nar/17.23.10083; HANOLD D, 1991, PLANT DIS, V75, P330, DOI 10.1094/PD-75-0330; HASELOFF J, 1981, NUCLEIC ACIDS RES, V9, P2741, DOI 10.1093/nar/9.12.2741; HASELOFF J, 1982, NATURE, V299, P316, DOI 10.1038/299316a0; HASHIMOTO J, 1987, NUCLEIC ACIDS RES, V15, P7045, DOI 10.1093/nar/15.17.7045; HERNANDEZ C, 1992, J GEN VIROL, V73, P2503, DOI 10.1099/0022-1317-73-10-2503; Hou WY, 2009, ARCH VIROL, V154, P993, DOI 10.1007/s00705-009-0388-7; Hou WY, 2009, ARCH VIROL, V154, P315, DOI 10.1007/s00705-008-0276-6; Ito T, 2001, ARCH VIROL, V146, P975, DOI 10.1007/s007050170129; Jiang DM, 2014, VIRUS RES, V180, P97, DOI 10.1016/j.virusres.2013.11.014; Jiang DM, 2011, J VIROL METHODS, V174, P123, DOI 10.1016/j.jviromet.2011.03.018; Karabiber F, 2013, RNA, V19, P63, DOI 10.1261/rna.036327.112; KEESE P, 1988, VIROLOGY, V162, P508, DOI 10.1016/0042-6822(88)90497-7; KIEFER MC, 1983, P NATL ACAD SCI-BIOL, V80, P6234, DOI 10.1073/pnas.80.20.6234; Leonard CW, 2013, BIOCHEMISTRY-US, V52, P588, DOI 10.1021/bi300755u; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Mortimer SA, 2008, J AM CHEM SOC, V130, P16178, DOI 10.1021/ja8061216; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Singh RP, 1999, J GEN VIROL, V80, P2823, DOI 10.1099/0022-1317-80-11-2823; SPIEKER RL, 1990, NUCLEIC ACIDS RES, V18, P3998, DOI 10.1093/nar/18.13.3998; Spieker RL, 1996, J GEN VIROL, V77, P2839, DOI 10.1099/0022-1317-77-11-2839; Tsushima T, 2011, J GEN PLANT PATHOL, V77, P253, DOI 10.1007/s10327-011-0316-z; Vasa SM, 2008, RNA, V14, P1979, DOI 10.1261/rna.1166808; Verhoeven JTJ, 2010, PLANT DIS, V94, P920, DOI 10.1094/PDIS-94-7-0920C; Verhoeven JTJ, 2004, EUR J PLANT PATHOL, V110, P823, DOI 10.1007/s10658-004-2493-5; Xu WX, 2012, MOL PLANT PATHOL, V13, P666, DOI 10.1111/j.1364-3703.2011.00776.x	36	42	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98655	10.1371/journal.pone.0098655	http://dx.doi.org/10.1371/journal.pone.0098655			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897295	gold, Green Published			2022-12-27	WOS:000338430700061
J	Iani, C; Anelli, F; Nicoletti, R; Rubichi, S				Iani, Cristina; Anelli, Filomena; Nicoletti, Roberto; Rubichi, Sandro			The Carry-Over Effect of Competition in Task-Sharing: Evidence from the Joint Simon Task	PLOS ONE			English	Article							ACTION CO-REPRESENTATION; COMPATIBILITY; INFORMATION; COOPERATION; BIAS	The Simon effect, that is the advantage of the spatial correspondence between stimulus and response locations when stimulus location is a task-irrelevant dimension, occurs even when the task is performed together by two participants, each performing a go/no-go task. Previous studies showed that this joint Simon effect, considered by some authors as a measure of self-other integration, does not emerge when during task performance co-actors are required to compete. The present study investigated whether and for how long competition experienced during joint performance of one task can affect performance in a following joint Simon task. In two experiments, we required pairs of participants to perform together a joint Simon task, before and after jointly performing together an unrelated non-spatial task (the Eriksen flanker task). In Experiment 1, participants always performed the joint Simon task under neutral instructions, before and after performing the joint flanker task in which they were explicitly required either to cooperate with (i.e., cooperative condition) or to compete against a co-actor (i.e., competitive condition). In Experiment 2, they were required to compete during the joint flanker task and to cooperate during the subsequent joint Simon task. Competition experienced in one task affected the way the subsequent joint task was performed, as revealed by the lack of the joint Simon effect, even though, during the Simon task participants were not required to compete (Experiment 1). However, prior competition no longer affected subsequent performance if a new goal that created positive interdependence between the two agents was introduced (Experiment 2). These results suggest that the emergence of the joint Simon effect is significantly influenced by how the goals of the co-acting individuals are related, with the effect of competition extending beyond the specific competitive setting and affecting subsequent interactions.	[Iani, Cristina; Rubichi, Sandro] Univ Modena & Reggio Emilia, Dept Commun & Econ, Reggio Emilia, Italy; [Anelli, Filomena; Nicoletti, Roberto] Univ Bologna, Dept Philosophy & Commun, Bologna, Italy; [Anelli, Filomena] Univ Bologna, Dept Psychol, Bologna, Italy	Universita di Modena e Reggio Emilia; University of Bologna; University of Bologna	Iani, C (corresponding author), Univ Modena & Reggio Emilia, Dept Commun & Econ, Reggio Emilia, Italy.	cristina.iani@unimore.it; sandro.rubichi@unimore.it	Iani, Cristina/D-1652-2009; Anelli, Filomena/K-1468-2016; Rubichi, Sandro/A-3265-2011	Iani, Cristina/0000-0002-7220-6337; Anelli, Filomena/0000-0002-3971-0101; RUBICHI, Sandro/0000-0002-0279-3353	Italian Ministry of Education [2008ZN5J5S]	Italian Ministry of Education	This work was supported by the Italian Ministry of Education (grant number 2008ZN5J5S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atmaca S, 2011, EXP BRAIN RES, V211, P371, DOI 10.1007/s00221-011-2709-9; Atmaca S, 2008, SOC NEUROSCI-UK, V3, P410, DOI 10.1080/17470910801900908; Bargh J. A., 2000, HDB RES METHODS SOCI, P253; Colzato LS, 2013, PSYCHON B REV, V20, P1011, DOI 10.3758/s13423-013-0413-4; Costantini M, 2013, EXP BRAIN RES, V227, P85, DOI 10.1007/s00221-013-3487-3; Decety J, 2004, NEUROIMAGE, V23, P744, DOI 10.1016/j.neuroimage.2004.05.025; Dittrich K, 2013, ATTEN PERCEPT PSYCHO, V75, P1725, DOI 10.3758/s13414-013-0524-z; Dolk T, PSYCHON B R IN PRESS; Dolk T, 2013, J EXP PSYCHOL HUMAN, V39, P1248, DOI 10.1037/a0031031; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Ferraro L, 2011, EXP BRAIN RES, V211, P337, DOI 10.1007/s00221-011-2711-2; Figliozzi F, 2010, NEUROPSYCHOLOGIA, V48, P1011, DOI 10.1016/j.neuropsychologia.2009.11.025; Georgiou I, 2007, COGNITION, V102, P415, DOI 10.1016/j.cognition.2006.01.008; Gollwitzer P. M., 1990, HDB MOTIVATION COGNI, V2, P53; Hommel B, 2009, PSYCHOL SCI, V20, P794, DOI 10.1111/j.1467-9280.2009.02367.x; Iani C, 2011, EXP BRAIN RES, V211, P439, DOI 10.1007/s00221-011-2651-x; Iani C, 2009, MEM COGNITION, V37, P358, DOI 10.3758/MC.37.3.358; Knoblich G, 2011, PSYCHOL LEARN MOTIV, V54, P59, DOI 10.1016/B978-0-12-385527-5.00003-6; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; Kuhbandner C, 2010, COGNITION EMOTION, V24, P1182, DOI 10.1080/02699930903119196; Lugli L, 2013, ACTA PSYCHOL, V144, P19, DOI 10.1016/j.actpsy.2013.04.021; Milanese N, 2011, EXP BRAIN RES, V211, P415, DOI 10.1007/s00221-011-2679-y; Milanese N, 2010, COGNITION, V116, P15, DOI 10.1016/j.cognition.2010.03.010; Proctor R.W., 2006, STIMULUS RESPONSE CO; Proctor RW, 1999, MEM COGNITION, V27, P63, DOI 10.3758/BF03201214; RABBIE JM, 1969, J PERS SOC PSYCHOL, V13, P269, DOI 10.1037/h0028284; Rubichi S, 2004, PERCEPT PSYCHOPHYS, V66, P255, DOI 10.3758/BF03194877; Rubichi S, 2006, PERCEPT PSYCHOPHYS, V68, P1059, DOI 10.3758/BF03193709; Rubichi S, 2006, PSYCHON B REV, V13, P201, DOI 10.3758/BF03193832; Ruys KI, 2010, J EXP SOC PSYCHOL, V46, P1130, DOI 10.1016/j.jesp.2010.05.016; Sassenberg K, 2007, J EXP SOC PSYCHOL, V43, P529, DOI 10.1016/j.jesp.2006.05.009; Sebanz N, 2003, COGNITION, V88, pB11, DOI 10.1016/S0010-0277(03)00043-X; Sebanz N, 2009, TOP COGN SCI, V1, P353, DOI 10.1111/j.1756-8765.2009.01024.x; Sherif M., 1961, INTERGROUP CONFLICT; SIMON JR, 1967, J APPL PSYCHOL, V51, P300, DOI 10.1037/h0020586; Stouten J., 2002, SOC JUSTICE RES, V16, P41, DOI [10.1023/A:1022974027023, DOI 10.1023/A:1022974027023]; Streuber S, 2011, EXP BRAIN RES, V214, P273, DOI 10.1007/s00221-011-2830-9; Toma C, 2010, J EXP SOC PSYCHOL, V46, P375, DOI 10.1016/j.jesp.2009.11.005; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Tomasello M, 2009, WHY WE COOPERATE, P1; Tsai CC, 2006, EXP BRAIN RES, V175, P353, DOI 10.1007/s00221-006-0557-9; Umilta C, 1999, ARCH ITAL BIOL, V137, P139; Wenke D, 2011, REV PHILOS PSYCHOL, V2, P147, DOI 10.1007/s13164-011-0057-0	43	17	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e97991	10.1371/journal.pone.0097991	http://dx.doi.org/10.1371/journal.pone.0097991			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK4YO	24897120	Green Published, Green Submitted, gold			2022-12-27	WOS:000338430700019
J	Li, Z; Yang, ZH; Wu, T; Wang, L				Li, Zhi; Yang, Zhihu; Wu, Te; Wang, Long			Aspiration-Based Partner Switching Boosts Cooperation in Social Dilemmas	PLOS ONE			English	Article							EVOLUTIONARY PRISONERS-DILEMMA; PROMOTES COOPERATION; GAMES; REPUTATION; DYNAMICS; STRATEGY	Most previous studies concerning linking dynamics often assumed that links pairing individuals should be identified and treated differently during topology adjusting procedure, in order to promote cooperation. A common assumption was that cooperators were expected to avoid being exploited by quickly breaking up relationships with defectors. Then the so-called prosocial links linking two cooperators (abbreviated as CC links hereafter) would be much favored by evolution, whereby cooperation was promoted. However, we suggest that this is not always necessary. Here, we developed a minimal model in which an aspiration-based partner switching mechanism was embedded to regulate the evolution of cooperation in social dilemmas. Individuals adjusted social ties in a self-questioning manner in line with the learning theory. Less game information was involved during dynamic linking and all links were tackled anonymously irrespective of their types (i.e., CD links, DD links, or CC links). The main results indicate that cooperation flourishes for a broad range of parameters. The denser the underlying network, the more difficult the evolution of cooperation. More importantly, moderate aspirations do much better in promoting the evolution of altruistic behavior and for most cases there exists the optimal aspiration level that most benefits cooperation. Too strong or too weak selection intensity turns out to be pretty conducive to the evolution of cooperation in such a dynamical system.	[Li, Zhi; Yang, Zhihu; Wu, Te; Wang, Long] Xidian Univ, Ctr Complex Syst, Dept Automat Control Engn, Xian, Peoples R China; [Wang, Long] Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Ctr Syst & Control, Beijing 100871, Peoples R China	Xidian University; Peking University	Li, Z (corresponding author), Xidian Univ, Ctr Complex Syst, Dept Automat Control Engn, Xian, Peoples R China.	zhilih@hotmail.com	Yang, Zhihu/Y-7699-2019; Gao, Y./GWZ-3665-2022; Wang, Long/A-7798-2010	Yang, Zhihu/0000-0002-0259-8080; Wang, Long/0000-0001-5600-8157	National Natural Science Foundation of China (NSFC) [61074120]; Ph.D. Programs Foundation of Ministry of Education of China [20110203110004]; Graduate School of Peking University; NSFC [61020106005, 61375120]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Graduate School of Peking University; NSFC(National Natural Science Foundation of China (NSFC))	This work was funded by National Natural Science Foundation of China (NSFC) under Grant No. 61074120 and by Ph.D. Programs Foundation of Ministry of Education of China under Grant 20110203110004. The authors also acknowledge the support from Graduate School of Peking University. LW and TW acknowledge the support from NSFC (Grant Nos. 61020106005 and 61375120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assenza S, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.017101; BOGLER O, 1990, P NATL ACAD SCI USA, V87, P6368, DOI 10.1073/pnas.87.16.6368; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Chen XJ, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.017103; Chen XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0043724, 10.1371/journal.pone.0036895]; Chen XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036260; Chen X, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051120; Cimini G, 2014, ARXIV14017287; Coleman J., 1990, FDN SOCIAL THEORY; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Du JM, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0077; ERDOS P, 1960, B INT STATIST INST, V38, P343; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fu F, 2007, EUR PHYS J B, V56, P367, DOI 10.1140/epjb/e2007-00124-5; Fu F, 2011, P ROY SOC B-BIOL SCI, V278, P42, DOI 10.1098/rspb.2010.1107; Fu F, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016104; Fu F, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036101; Gomez-Gardenes J, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/68003; Gomez-Gardenes J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00620; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Kianercy A, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.012815; Laird RA, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.012105; Li AM, 2013, EPL-EUROPHYS LETT, V103, DOI 10.1209/0295-5075/103/30007; Liu YK, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/60002; Macy MW, 2002, P NATL ACAD SCI USA, V99, P7229, DOI 10.1073/pnas.092080099; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Pacheco JM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.258103; Pacheco JM, 2006, J THEOR BIOL, V243, P437, DOI 10.1016/j.jtbi.2006.06.027; Perc M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/2/022; Perc M, 2006, EUROPHYS LETT, V75, P841, DOI 10.1209/epl/i2006-10217-3; Perc M, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.022101; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Poncela J, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/184; Santos FC, 2006, P ROY SOC B-BIOL SCI, V273, P51, DOI 10.1098/rspb.2005.3272; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Santos FC, 2006, PLOS COMPUT BIOL, V2, P1284, DOI 10.1371/journal.pcbi.0020140; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/30004; Szolnoki A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00576; Szolnoki A, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.026104; Szolnoki A, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046106; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056104; Traulsen A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.238701; Traulsen A, 2010, P NATL ACAD SCI USA, V107, P2962, DOI 10.1073/pnas.0912515107; Van Segbroeck S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.058105; Wang WX, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056113; Wang Z, 2012, PHYS REV E, V82; Wu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011187; Wu T, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066104; Yang HX, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.065101; Yang ZH, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042128; Zeng R, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40748-0; Zhang HF, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/18006; Zhong LX, 2006, EUROPHYS LETT, V76, P724, DOI 10.1209/epl/i2006-10323-2; Zimmermann MG, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.065102	61	19	19	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e97866	10.1371/journal.pone.0097866	http://dx.doi.org/10.1371/journal.pone.0097866			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896269	gold, Green Published, Green Submitted			2022-12-27	WOS:000338430700016
J	Mas, M; Dijkstra, J				Mas, Michael; Dijkstra, Jacob			Do Intergroup Conflicts Necessarily Result from Outgroup Hate?	PLOS ONE			English	Article							PUBLIC-GOODS EXPERIMENTS; SOCIAL DILEMMAS; CHEAP-TALK; GROUP IDENTITY; COMMUNICATION; COOPERATION; PROMISES; GAMES; PREFERENCES; TEAM	We developed a new experimental design to test whether or not individuals engage in conflict between social groups because they seek to harm outgroup members. Challenging prominent social psychological theories, we did not find support for such negative social preferences. Nevertheless, subjects heavily engaged in group conflict. Results support the argument that processes that act within social groups motivate engagement in conflict between groups even in the absence of negative social preferences. In particular, we found that "cheap talk'' communication between group members fuels conflict. Analyses did not support the notion that the effect of communication results from guilt-aversion processes.	[Mas, Michael] Swiss Fed Inst Technol, Chair Sociol Particular Modeling & Simulat, Zurich, Switzerland; [Dijkstra, Jacob] Univ Groningen, Dept Sociol ICS, Groningen, Netherlands	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Groningen	Mas, M (corresponding author), Swiss Fed Inst Technol, Chair Sociol Particular Modeling & Simulat, Zurich, Switzerland.	mmaes@ethz.ch	Maes, Michael/K-9603-2013	Maes, Michael/0000-0001-9416-3211	Department of Sociology of the University of Groningen	Department of Sociology of the University of Groningen	Financial support from the Department of Sociology of the University of Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink K, 2010, AM ECON REV, V100, P420, DOI 10.1257/aer.100.1.420; Akerlof GA, 2000, Q J ECON, V115, P715, DOI 10.1162/003355300554881; Allport G. W., 1954, NATURE PREJUDICE; Balliet D, 2010, J CONFLICT RESOLUT, V54, P39, DOI 10.1177/0022002709352443; Bicchieri C, 2002, RATION SOC, V14, P192, DOI 10.1177/1043463102014002003; Blanco M, 2010, EXP ECON, V13, P412, DOI 10.1007/s10683-010-9249-1; Bornstein G, 2003, PERS SOC PSYCHOL REV, V7, P129, DOI 10.1207/S15327957PSPR0702_129-145; Brewer MB, 1999, J SOC ISSUES, V55, P429, DOI 10.1111/0022-4537.00126; Camerer C, 2003, BEHAV GAME THEORY; Cason TN, 2012, GAME ECON BEHAV, V76, P26, DOI 10.1016/j.geb.2012.05.001; Charness G, 2006, ECONOMETRICA, V74, P1579, DOI 10.1111/j.1468-0262.2006.00719.x; Charness G, 2010, ECON LETT, V107, P281, DOI 10.1016/j.econlet.2010.02.009; Chen Y, 2009, AM ECON REV, V99, P431, DOI 10.1257/aer.99.1.431; Chen Y, 2008, ECONOMETRICA, V76, P117, DOI 10.1111/j.0012-9682.2008.00819.x; Coleman J., 1990, FDN SOCIAL THEORY; Cooper DJ, 2005, AM ECON REV, V95, P477, DOI 10.1257/0002828054201431; Dawes Robyn M., 1990, SELF INTEREST, P99; De Dreu CKW, 2011, P NATL ACAD SCI USA, V108, P1262, DOI 10.1073/pnas.1015316108; Duffy J, 2002, GAME ECON BEHAV, V39, P1, DOI 10.1006/game.2001.0892; Ellickson RC, 1991, ORDER LAW; Ellingsen T, 2004, ECON J, V114, P397, DOI 10.1111/j.1468-0297.2004.00214.x; Ellingsen T, 2010, GAME ECON BEHAV, V68, P95, DOI 10.1016/j.geb.2009.04.021; Farrell J, 1996, J ECON PERSPECT, V10, P103, DOI 10.1257/jep.10.3.103; Finkel S. E., 1995, CAUSAL ANAL PANEL DA; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Fischbacher U, 2010, AM ECON REV, V100, P541, DOI 10.1257/aer.100.1.541; Gachter S, 2010, EXP ECON, V13, P364, DOI 10.1007/s10683-010-9246-4; Gaertner S.L., 1993, EUROPEAN REV SOCIAL, V4, P1, DOI [https://doi.org/10.1080/14792779343000004, DOI 10.1080/14792779343000004, 10.1080/14792779343000004, 10.4135/9781446249222.n48, DOI 10.4135/9781446249222.N48]; Goren H, 2000, J CONFLICT RESOLUT, V44, P700, DOI 10.1177/0022002700044005007; Greiner B., 2004, GWDG BERICHT, V63, P79; Guth W, 2009, J ECON PSYCHOL, V30, P814, DOI 10.1016/j.joep.2009.07.001; Halevy N, 2008, PSYCHOL SCI, V19, P405, DOI 10.1111/j.1467-9280.2008.02100.x; Kagel JH, 1995, HDB EXPT EC; Kerr NL, 1997, PERS SOC PSYCHOL B, V23, P1300, DOI 10.1177/01461672972312007; Mason CF, 2002, J ECON MANAGE STRAT, V11, P685, DOI 10.1162/105864002320757307; OPP KD, 1993, AM SOCIOL REV, V58, P659, DOI 10.2307/2096280; Ostrom E., 1990, GOVERNING COMMONS EV; SALLY D, 1995, RATION SOC, V7, P58, DOI 10.1177/1043463195007001004; Sherif M., 1966, GROUP CONFLICT COOPE; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Sutter M, 2009, GAME ECON BEHAV, V66, P506, DOI 10.1016/j.geb.2008.02.014; Tajfel H, 1981, STUDIES SOCIAL PSYCO; Tak?cs K., 2005, REV SOCIOL, V11, P5, DOI 10.1556/RevSoc.11.2005.1.1; Turner J., 1986, PSYCHOL INTERGROUP R, P7, DOI DOI 10.1038/NATURE02121; Vanberg C, 2008, ECONOMETRICA, V76, P1467, DOI 10.3982/ECTA7673	45	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e97848	10.1371/journal.pone.0097848	http://dx.doi.org/10.1371/journal.pone.0097848			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK4YO	24896100	Green Submitted, Green Published, gold			2022-12-27	WOS:000338430700015
J	Slavik, O; Horky, P; Zavorka, L				Slavik, Ondrej; Horky, Pavel; Zavorka, Libor			Energy Costs of Catfish Space Use as Determined by Biotelemetry	PLOS ONE			English	Article							HOME-RANGE; EUROPEAN CATFISH; SILURUS-GLANIS; CORE AREAS; DENSITY; SIZE; ENERGETICS; RADIOTELEMETRY; MOVEMENTS; PATTERNS	Animals use dispersed resources within their home range (HR) during regular day-to-day activities. The high-quality area intensively used by an individual, where critical resources are concentrated, has been designated as the core area (CA). This study aimed to describe how animals utilize energy in the HR and CA assuming that changes would occur according to the size of the used areas. We observed energetic costs of space use in the largest European freshwater predator catfish, Silurus glanis, using physiological sensors. Catfish consumed significantly more energy within the CA compared to the rest of the HR area. In addition, energetic costs of space use within a large area were lower. These results generally indicate that utilization of larger areas is related to less demanding activities, such as patrolling and searching for new resources and mates. In contrast, fish occurrence in small areas appears to be related to energetically demanding use of spatially limited resources.	[Slavik, Ondrej; Horky, Pavel; Zavorka, Libor] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Zool & Fisheries, Prague, Czech Republic; [Zavorka, Libor] Univ Gothenburg, Dept Zool, Gothenburg, Sweden	Czech University of Life Sciences Prague; University of Gothenburg	Slavik, O (corresponding author), Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Zool & Fisheries, Prague, Czech Republic.	oslavik@af.czu.cz	Slavík, Ondrej/A-4732-2013; Horký, Pavel/A-3857-2013; Slavík, Ondřej/P-4253-2019	Horký, Pavel/0000-0002-1738-7753; Slavík, Ondřej/0000-0003-3443-4125	Czech Science Foundation [13-05872S]	Czech Science Foundation(Grant Agency of the Czech Republic)	The work was supported by the Czech Science Foundation (no. 13-05872S), www.gacr.cz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asensio N, 2012, J ZOOL, V287, P250, DOI 10.1111/j.1469-7998.2012.00911.x; Benson JF, 2006, ANIM BEHAV, V71, P685, DOI 10.1016/j.anbehav.2005.08.005; Bouletreau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025732; BRADBURY C, 1995, CAN J ZOOL, V73, P1268, DOI 10.1139/z95-151; Buskirk S, 2004, SCIENCE, V306, P238, DOI 10.1126/science.1104480; Carfagno GLF, 2008, J ANIM ECOL, V77, P416, DOI 10.1111/j.1365-2656.2008.01342.x; Carol J, 2007, ECOL FRESHW FISH, V16, P450, DOI 10.1111/j.1600-0633.2007.00225.x; Chilton EW, 1997, T AM FISH SOC, V126, P467, DOI 10.1577/1548-8659(1997)126<0467:DAMBOR>2.3.CO;2; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; Cooke SJ, 2004, FISH FISH, V5, P21, DOI 10.1111/j.1467-2960.2004.00136.x; Cooke SJ, 2002, CAN J ZOOL, V80, P756, DOI 10.1139/Z02-048; Cooke SJ, 2000, AQUAC RES, V31, P495, DOI 10.1046/j.1365-2109.2000.00470.x; Copp GH, 2009, FISH FISH, V10, P252, DOI 10.1111/j.1467-2979.2008.00321.x; Cucherousset J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050840; DAMUTH J, 1981, BIOL J LINN SOC, V15, P185, DOI 10.1111/j.1095-8312.1981.tb00758.x; GRANT JWA, 1992, BEHAV ECOL SOCIOBIOL, V31, P149; HARESTAD AS, 1979, ECOLOGY, V60, P389, DOI 10.2307/1937667; Hawkins LA, 2005, FUNCT ECOL, V19, P794, DOI 10.1111/j.1365-2435.2005.01039.x; HAYNE DW, 1949, J MAMMAL, V30, P1, DOI 10.2307/1375189; Holbrook SJ, 2002, ECOLOGY, V83, P2855, DOI 10.2307/3072021; Jetz W, 2004, SCIENCE, V306, P266, DOI 10.1126/science.1102138; Kaseloo PA, 1996, J FISH BIOL, V48, P664, DOI 10.1111/j.1095-8649.1996.tb01462.x; KAUFMANN JOHN H., 1962, UNIV CALIF PUBL ZOOL, V60, P95; Kelt DA, 2001, AM NAT, V157, P637, DOI 10.1086/320621; Kelt DA, 1999, ECOLOGY, V80, P337; Krause J, 2002, LIVING GROUPS; Mace G.M., 1983, P32; Marable MK, 2012, BEHAV PROCESS, V91, P119, DOI 10.1016/j.beproc.2012.06.006; Plowman BW, 2006, AM MIDL NAT, V156, P386, DOI 10.1674/0003-0031(2006)156[386:ADOBLR]2.0.CO;2; SAMUEL MD, 1985, J ANIM ECOL, V54, P711, DOI 10.2307/4373; SCHOENER TW, 1981, THEOR POPUL BIOL, V20, P281, DOI 10.1016/0040-5809(81)90049-6; SCHOENER TW, 1968, ECOLOGY, V49, P123, DOI 10.2307/1933567; SCHOENER TW, 1983, AM NAT, V121, P608, DOI 10.1086/284090; SEAMAN DE, 1990, INT C BEAR, V8, P243; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Slavik O, 2007, J FISH BIOL, V71, P101, DOI 10.1111/j.1095-8649.2007.01471.x; Slavik O, 2012, J FISH BIOL, V81, P2223, DOI 10.1111/j.1095-8649.2012.03436.x; Slavik O, 2011, AQUACULTURE, V313, P73, DOI 10.1016/j.aquaculture.2011.01.002; Slavik O, 2009, ECOL FRESHW FISH, V18, P501, DOI 10.1111/j.1600-0633.2009.00370.x; Stone PA, 2002, J HERPETOL, V36, P427, DOI 10.2307/1566187; SWIHART RK, 1985, ECOLOGY, V66, P1176, DOI 10.2307/1939170; SWIHART RK, 1985, J WILDLIFE MANAGE, V49, P1019, DOI 10.2307/3801388; Thompson ME, 2007, ANIM BEHAV, V73, P501, DOI 10.1016/j.anbehav.2006.09.007; Vander Wal E, 2012, ECOL MODEL, V224, P48, DOI 10.1016/j.ecolmodel.2011.10.006; White G.C., 1990, ANAL WILDLIFE RADIO; [No title captured]; [No title captured]; [No title captured]; [No title captured]	50	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98997	10.1371/journal.pone.0098997	http://dx.doi.org/10.1371/journal.pone.0098997			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896256	Green Published, gold, Green Submitted			2022-12-27	WOS:000338430700106
J	Tual-Chalot, S; Mahmoud, M; Allinson, KR; Redgrave, RE; Zhai, ZH; Oh, SP; Fruttiger, M; Arthur, HM				Tual-Chalot, Simon; Mahmoud, Marwa; Allinson, Kathleen R.; Redgrave, Rachael E.; Zhai, Zhenhua; Oh, S. Paul; Fruttiger, Marcus; Arthur, Helen M.			Endothelial Depletion of Acvrl1 in Mice Leads to Arteriovenous Malformations Associated with Reduced Endoglin Expression	PLOS ONE			English	Article							HEREDITARY HEMORRHAGIC TELANGIECTASIA; RECEPTOR-LIKE KINASE-1; CELL PROLIFERATION; VESSEL MATURATION; ALK1; BMP9; NOTCH; ANGIOGENESIS; PROTEIN; GENE	Rare inherited cardiovascular diseases are frequently caused by mutations in genes that are essential for the formation and/ or function of the cardiovasculature. Hereditary Haemorrhagic Telangiectasia is a familial disease of this type. The majority of patients carry mutations in either Endoglin (ENG) or ACVRL1 (also known as ALK1) genes, and the disease is characterized by arteriovenous malformations and persistent haemorrhage. ENG and ACVRL1 encode receptors for the TGF beta superfamily of ligands, that are essential for angiogenesis in early development but their roles are not fully understood. Our goal was to examine the role of Acvrl1 in vascular endothelial cells during vascular development and to determine whether loss of endothelial Acvrl1 leads to arteriovenous malformations. Acvrl1 was depleted in endothelial cells either in early postnatal life or in adult mice. Using the neonatal retinal plexus to examine angiogenesis, we observed that loss of endothelial Acvrl1 led to venous enlargement, vascular hyperbranching and arteriovenous malformations. These phenotypes were associated with loss of arterial Jag1 expression, decreased pSmad1/5/8 activity and increased endothelial cell proliferation. We found that Endoglin was markedly down-regulated in Acvrl1-depleted ECs showing endoglin expression to be downstream of Acvrl1 signalling in vivo. Endothelial-specific depletion of Acvrl1 in pups also led to pulmonary haemorrhage, but in adult mice resulted in caecal haemorrhage and fatal anaemia. We conclude that during development, endothelial Acvrl1 plays an essential role to regulate endothelial cell proliferation and arterial identity during angiogenesis, whilst in adult life endothelial Acvrl1 is required to maintain vascular integrity.	[Tual-Chalot, Simon; Mahmoud, Marwa; Allinson, Kathleen R.; Redgrave, Rachael E.; Zhai, Zhenhua; Arthur, Helen M.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Oh, S. Paul] Univ Florida, Dept Physiol, Gainesville, FL USA; [Fruttiger, Marcus] Inst Opthalmol, UCL, London, England	Newcastle University - UK; State University System of Florida; University of Florida; University of London; University College London	Arthur, HM (corresponding author), Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	helen.arthur@ncl.ac.uk	Zhai, Zhen/GYA-1598-2022; Arthur, Helen/C-7808-2009	Arthur, Helen/0000-0001-6522-1363; Tual-Chalot, Simon/0000-0002-9307-7175; Mahmoud, Marwa/0000-0003-4382-1725; Fruttiger, Marcus/0000-0002-6962-5485	Wellcome Trust; British Heart Foundation; National Institutes of Health [HL64024]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064024] Funding Source: NIH RePORTER; British Heart Foundation [RG/12/2/29416] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); British Heart Foundation(British Heart Foundation)	This study was supported by funding from the Wellcome Trust, the British Heart Foundation and National Institutes of Health grant HL64024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla SA, 2000, HUM MOL GENET, V9, P1227, DOI 10.1093/hmg/9.8.1227; Allinson KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039336; Alt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029948; Bautch VL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006452; BRANT AM, 1989, AM J OPHTHALMOL, V107, P642, DOI 10.1016/0002-9394(89)90261-4; Castonguay R, 2011, J BIOL CHEM, V286, P30034, DOI 10.1074/jbc.M111.260133; Chen WQ, 2014, STROKE, V45, P900, DOI 10.1161/STROKEAHA.113.003655; Chen WQ, 2013, ARTERIOSCL THROM VAS, V33, P305, DOI 10.1161/ATVBAHA.112.300485; Corti P, 2011, DEVELOPMENT, V138, P1573, DOI 10.1242/dev.060467; Cunha SI, 2010, J EXP MED, V207, P85, DOI 10.1084/jem.20091309; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Fernandez-L A, 2005, CARDIOVASC RES, V68, P235, DOI 10.1016/j.cardiores.2005.06.009; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Gonzalez-Nunez M, 2013, BBA-MOL BASIS DIS, V1832, P1492, DOI 10.1016/j.bbadis.2013.05.016; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Itoh F, 2004, EMBO J, V23, P541, DOI 10.1038/sj.emboj.7600065; Jerkic M, 2004, FASEB J, V18, P609, DOI 10.1096/fj.03-0197fje; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Krebs LT, 2010, GENESIS, V48, P146, DOI 10.1002/dvg.20599; Krueger J, 2011, DEVELOPMENT, V138, P2111, DOI 10.1242/dev.063933; Larrivee B, 2012, DEV CELL, V22, P489, DOI 10.1016/j.devcel.2012.02.005; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lebrin F, 2010, NAT MED, V16, P420, DOI 10.1038/nm.2131; Levet S, 2013, BLOOD, V122, P598, DOI 10.1182/blood-2012-12-472142; Mahmoud M, 2010, CIRC RES, V106, P1425, DOI 10.1161/CIRCRESAHA.109.211037; Mahmoud M, 2009, LAB INVEST, V89, P15, DOI 10.1038/labinvest.2008.112; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; McDonald J, 2005, HAEMATOLOGICA, V90, P728; Morikawa M, 2011, NUCLEIC ACIDS RES, V39, P8712, DOI 10.1093/nar/gkr572; Moya IM, 2012, DEV CELL, V22, P501, DOI 10.1016/j.devcel.2012.01.007; Murphy PA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002670; Niessen K, 2010, BLOOD, V115, P1654, DOI 10.1182/blood-2009-07-235655; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Park SO, 2008, BLOOD, V111, P633, DOI 10.1182/blood-2007-08-107359; Park SO, 2009, J CLIN INVEST, V119, P3487, DOI 10.1172/JCI39482; Pitulescu ME, 2010, NAT PROTOC, V5, P1518, DOI 10.1038/nprot.2010.113; Ricard N, 2012, BLOOD, V119, P6162, DOI 10.1182/blood-2012-01-407593; Roman BL, 2002, DEVELOPMENT, V129, P3009; Sanz-Rodriguez F, 2004, CLIN CHEM, V50, P2003, DOI 10.1373/clinchem.2004.035287; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Seo S, 2006, DEV BIOL, V294, P458, DOI 10.1016/j.ydbio.2006.03.035; Shovlin CL, 2010, BLOOD REV, V24, P203, DOI 10.1016/j.blre.2010.07.001; Siddiki H, 2008, RADIOGRAPHICS, V28, P171, DOI 10.1148/rg.281075037; Sobczak Magdalena, 2010, J Vis Exp, DOI 10.3791/2316; Tual-Chalot S, 2013, JOVE-J VIS EXP, DOI 10.3791/50546; Upton PD, 2009, J BIOL CHEM, V284, P15794, DOI 10.1074/jbc.M109.002881; Urness LD, 2000, NAT GENET, V26, P328, DOI 10.1038/81634; VASE I, 1979, ACTA OPHTHALMOL, V57, P1084; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047; Young K, 2012, BLOOD, V120, P4263, DOI 10.1182/blood-2012-07-440784	54	76	77	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98646	10.1371/journal.pone.0098646	http://dx.doi.org/10.1371/journal.pone.0098646			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896812	Green Published, gold, Green Submitted			2022-12-27	WOS:000338430700059
J	Iyer, V; Sampson, KJ; Kass, RS				Iyer, Vivek; Sampson, Kevin J.; Kass, Robert S.			Modeling Tissue- and Mutation- Specific Electrophysiological Effects in the Long QT Syndrome: Role of the Purkinje Fiber	PLOS ONE			English	Article							IDIOPATHIC VENTRICULAR-FIBRILLATION; ANDERSEN-TAWIL-SYNDROME; RECTIFIER K+ CURRENT; COMPUTATIONAL MODEL; LQT-3 MUTATION; MYOCYTES; ABLATION; BRUGADA; TACHYCARDIA; SIMULATION	Congenital long QT syndrome is a heritable family of arrhythmias caused by mutations in 13 genes encoding ion channel complex proteins. Mounting evidence has implicated the Purkinje fiber network in the genesis of ventricular arrhythmias. In this study, we explore the hypothesis that long QT mutations can demonstrate different phenotypes depending on the tissue type of expression. Using computational models of the human ventricular myocyte and the Purkinje fiber cell, the biophysical alteration in channel function in LQT1, LQT2, LQT3, and LQT7 are modeled. We identified that the plateau potential was important in LQT1 and LQT2, in which mutation led to minimal action potential prolongation in Purkinje fiber cells. The phenotype of LQT3 mutation was dependent on the biophysical alteration induced as well as tissue type. The canonical Delta KPQ mutation causes severe action potential prolongation in both tissue types. For LQT3 mutation F1473C, characterized by shifted channel availability, a more severe phenotype was seen in Purkinje fiber cells with action potential prolongation and early afterdepolarizations. The LQT3 mutation S1904L demonstrated striking effects on action potential duration restitution and more severe action potential prolongation in Purkinje fiber cells at higher heart rates. Voltage clamp simulations highlight the mechanism of effect of these mutations in different tissue types, and impact of drug therapy is explored. We conclude that arrhythmia formation in long QT syndrome may depend not only on the basis of mutation and biophysical alteration, but also upon tissue of expression. The Purkinje fiber network may represent an important therapeutic target in the management of patients with heritable channelopathies.	[Iyer, Vivek; Sampson, Kevin J.; Kass, Robert S.] Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY 10027 USA	Columbia University	Iyer, V (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY 10027 USA.	vi2108@columbia.edu			National Heart Lung and Blood Institute at the National Institutes of Health [K08HL116790]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL116790] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart Lung and Blood Institute at the National Institutes of Health http://www.nhlbi.nih.gov/[grant number K08HL116790 to VI]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baher AA, 2011, HEART RHYTHM, V8, P599, DOI 10.1016/j.hrthm.2010.11.038; Bankston JR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001258; Bankston JR, 2007, CHANNELS, V1, P273, DOI 10.4161/chan.4956; Ben Caref E, 2008, EUROPACE, V10, P1218, DOI 10.1093/europace/eun248; Bendahhou S, 2003, J BIOL CHEM, V278, P51779, DOI 10.1074/jbc.M310278200; BEUCKELMANN DJ, 1992, CIRCULATION, V85, P1046, DOI 10.1161/01.CIR.85.3.1046; BEUCKELMANN DJ, 1992, BASIC RES CARDIOL, V87, P235; Bosch RF, 1998, CARDIOVASC RES, V38, P441, DOI 10.1016/S0008-6363(98)00021-2; Boyden PA, 2010, HEART RHYTHM, V7, P127, DOI 10.1016/j.hrthm.2009.09.017; Clancy CE, 2002, CIRCULATION, V105, P1208, DOI 10.1161/hc1002.105183; Clancy CE, 1999, NATURE, V400, P566, DOI 10.1038/23034; CRIJNS HJGM, 1995, J CARDIOVASC ELECTR, V6, P486, DOI 10.1111/j.1540-8167.1995.tb00421.x; Dumaine R, 2007, J MOL CELL CARDIOL, V42, P378, DOI 10.1016/j.yjmcc.2006.10.019; Dun W, 2008, J MOL CELL CARDIOL, V45, P617, DOI 10.1016/j.yjmcc.2008.08.001; Fredj S, 2006, CIRC RES, V99, P1225, DOI 10.1161/01.RES.0000251305.25604.b0; Gintant GA, 2001, J CARDIOVASC PHARM, V37, P607, DOI 10.1097/00005344-200105000-00012; Haissaguerre M, 2002, CIRCULATION, V106, P962, DOI 10.1161/01.CIR.0000027564.55739.B1; Haissaguerre M, 2003, CIRCULATION, V108, P925, DOI 10.1161/01.CIR.0000088781.99943.95; Haissaguerre M, 2002, LANCET, V359, P677, DOI 10.1016/S0140-6736(02)07807-8; Iyer V, 2004, BIOPHYS J, V87, P1507, DOI 10.1529/biophysj.104.043299; Li GR, 1999, AM J PHYSIOL-HEART C, V276, pH98, DOI 10.1152/ajpheart.1999.276.1.H98; Li GR, 1996, CIRC RES, V78, P689, DOI 10.1161/01.RES.78.4.689; Magyar J, 2000, PFLUG ARCH EUR J PHY, V441, P144, DOI 10.1007/s004240000400; Napolitano C, 2012, CIRCULATION, V125, P2027, DOI 10.1161/CIRCULATIONAHA.111.055947; Pourrier M, 2003, CIRC RES, V93, P189, DOI 10.1161/01.RES.0000084851.60947.B5; Sampson KJ, 2010, J PHYSIOL-LONDON, V588, P2643, DOI 10.1113/jphysiol.2010.187328; Seemann G, 2007, AM J PHYSIOL-HEART C, V292, pH549, DOI 10.1152/ajpheart.00701.2006; Silver ES, 2009, J INTERV CARD ELECTR, V26, P41, DOI 10.1007/s10840-009-9428-1; Smith Andrew H, 2006, Indian Pacing Electrophysiol J, V6, P32; Sung RJ, 2006, AM J PHYSIOL-HEART C, V291, pH2597, DOI 10.1152/ajpheart.00393.2006; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Terrenoire C, 2013, J GEN PHYSIOL, V141, P61, DOI 10.1085/jgp.201210899; Tristani-Firouzi M, 2002, J CLIN INVEST, V110, P381, DOI 10.1172/JCI200215183; Weerasooriya R, 2003, HERZ, V28, P598, DOI 10.1007/s00059-003-2491-y; Xiao L, 2013, CIRC RES, V112, P1310, DOI 10.1161/CIRCRESAHA.112.300227	35	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e97720	10.1371/journal.pone.0097720	http://dx.doi.org/10.1371/journal.pone.0097720			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892747	Green Published, gold, Green Submitted			2022-12-27	WOS:000336911400019
J	Okabe, H; Delgado, E; Lee, JM; Yang, J; Kinoshita, H; Hayashi, H; Tsung, A; Behari, J; Beppu, T; Baba, H; Monga, SP				Okabe, Hirohisa; Delgado, Evan; Lee, Jung Min; Yang, Jing; Kinoshita, Hiroki; Hayashi, Hiromitsu; Tsung, Allan; Behari, Jaideep; Beppu, Toru; Baba, Hideo; Monga, Satdarshan P.			Role of Leukocyte Cell-Derived Chemotaxin 2 as a Biomarker in Hepatocellular Carcinoma	PLOS ONE			English	Article							MOUSE-LIVER TUMORS; BETA-CATENIN; CANCER; LECT2; PROMOTION; PATHWAY; MICE; HEPATOCARCINOGENESIS; IDENTIFICATION; REGENERATION	We sought to identify a secreted biomarker for beta-catenin activation commonly seen in hepatocellular carcinoma (HCC). By examination of our previously published genearray of hepatocyte-specific beta-catenin knockout (KO) livers, we identified secreted factors whose expression may be beta-catenin-dependent. We verified expression and secretion of the leading factor in HCC cells transfected with mutated (Hep3B(S33Y))-beta-catenin. Serum levels of biomarker were next investigated in a mouse model of HCC with beta-catenin gene (Ctnnb1) mutations and eventually in HCC patients. Leukocyte cell-derived chemotaxin-2 (LECT2) expression was decreased in KO livers. Hep3B(S33Y) expressed and secreted more LECT2 in media as compared to Hep3B(WT). Mice developing HCC with Ctnnb1 mutations showed significantly higher serum LECT2 levels. However patients with CTNNB1 mutations showed LECT2 levels of 54.28 +/- 22.32 ng/mL (Mean +/- SD; n = 8) that were insignificantly different from patients with non-neoplastic chronic liver disease (32.8 +/- 21.1 ng/mL; n = 15) or healthy volunteers (33.2 +/- 7.2 ng/mL; n = 11). Intriguingly, patients without beta-catenin mutations showed significantly higher serum LECT2 levels (54.26 +/- 22.25 ng/mL; n = 46). While beta-catenin activation was evident in a subset of non-mutant beta-catenin HCC group with high LECT2 expression, serum LECT2 was unequivocally similar between beta-catenin-active and -normal group. Further analysis showed that LECT2 levels greater than 50 ng/ml diagnosed HCC in patients irrespective of beta-catenin mutations with specificity of 96.1% and positive predictive value of 97.0%. Thus, LECT2 is regulated by beta-catenin in HCC in both mice and men, but serum LECT2 reflects beta-catenin activity only in mice. Serum LECT2 could be a potential biomarker of HCC in patients.	[Okabe, Hirohisa; Delgado, Evan; Lee, Jung Min; Yang, Jing; Monga, Satdarshan P.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA; [Okabe, Hirohisa; Kinoshita, Hiroki; Hayashi, Hiromitsu; Beppu, Toru; Baba, Hideo] Kumamoto Univ, Grad Sch Life Sci, Dept Surg Gastroenterol, Kumamoto, Japan; [Tsung, Allan] Univ Pittsburgh, Med Ctr, Dept Surg, Pittsburgh, PA USA; [Behari, Jaideep; Monga, Satdarshan P.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Beppu, Toru] Kumamoto Univ Hosp, Dept Multidisciplinary Treatment Gastroenterol Ca, Kumamoto, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kumamoto University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kumamoto University	Monga, SP (corresponding author), Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA.	smonga@pitt.edu		Delgado, Evan/0000-0003-2706-0946; Monga, Satdarshan/0000-0002-8437-3378	NIH [1R01DK62277, R01DK100287]; Endowed Chair for Experimental Pathology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL094295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100287, R01DK062277] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Endowed Chair for Experimental Pathology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by NIH grants 1R01DK62277, R01DK100287 and Endowed Chair for Experimental Pathology to SPM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anson M, 2012, J CLIN INVEST, V122, P586, DOI 10.1172/JCI43937; Awuah PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039771; Aydinlik H, 2001, ONCOGENE, V20, P7812, DOI 10.1038/sj.onc.1204982; Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Cadoret A, 2002, ONCOGENE, V21, P8293, DOI 10.1038/sj.onc.1206118; Dahmani R, 2011, CLIN RES HEPATOL GAS, V35, P709, DOI 10.1016/j.clinre.2011.05.010; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Han ZG, 2012, ANNU REV GENOM HUM G, V13, P171, DOI 10.1146/annurev-genom-090711-163752; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Lachenmayer A, 2012, CLIN CANCER RES, V18, P4997, DOI 10.1158/1078-0432.CCR-11-2322; Lee JM, 2013, CANC LETT; Loeppen S, 2002, CANCER RES, V62, P5685; Monga SPS, 2011, INT J BIOCHEM CELL B, V43, P1021, DOI 10.1016/j.biocel.2009.09.001; Nejak-Bowen KN, 2009, J BIOL CHEM, V284, P28115, DOI 10.1074/jbc.M109.047258; Nejak-Bowen KN, 2011, SEMIN CANCER BIOL, V21, P44, DOI 10.1016/j.semcancer.2010.12.010; Okabe H, 2012, INT J CANCER, V131, P2234, DOI 10.1002/ijc.27496; Okumura A, 2013, BIOSCI TRENDS, V7, P276, DOI 10.5582/bst.2013.v7.6.276; Ovejero C, 2004, HEPATOLOGY, V40, P167, DOI 10.1002/hep.20286; Rignall B, 2011, CARCINOGENESIS, V32, P52, DOI 10.1093/carcin/bgq226; Sato Y, 2004, TRANSPL P, V36, P2357, DOI 10.1016/j.transproceed.2004.07.006; Sato Y, 2004, TRANSPL P, V36, P2359, DOI 10.1016/j.transproceed.2004.07.007; Tan XP, 2006, GASTROENTEROLOGY, V131, P1561, DOI 10.1053/j.gastro.2006.08.042; Taniguchi K, 2002, ONCOGENE, V21, P4863, DOI 10.1038/sj.onc.1205591; Wickline ED, 2013, NEOPLASIA, V15, P421, DOI 10.1593/neo.122098; Yamagoe S, 1997, BIOCHEM BIOPH RES CO, V237, P116, DOI 10.1006/bbrc.1997.7095; Yamagoe S, 1996, IMMUNOL LETT, V52, P9, DOI 10.1016/0165-2478(96)02572-2; Zeng G, 2006, NEOPLASIA, V8, P279, DOI 10.1593/neo.05607; Zhang XF, 2010, HEPATOLOGY, V52, P954, DOI 10.1002/hep.23747	29	26	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98817	10.1371/journal.pone.0098817	http://dx.doi.org/10.1371/journal.pone.0098817			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892551	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000336911400097
J	Vannini, A; Roncarati, D; Spinsanti, M; Scarlato, V; Danielli, A				Vannini, Andrea; Roncarati, Davide; Spinsanti, Marco; Scarlato, Vincenzo; Danielli, Alberto			In Depth Analysis of the Helicobacter pylori cag Pathogenicity Island Transcriptional Responses	PLOS ONE			English	Article							GASTRIC EPITHELIAL-CELLS; VIRULENCE GENE-EXPRESSION; III SECRETION SYSTEM; IV SECRETION; GROWTH-PHASE; IRON; VIVO; INTERLEUKIN-8; ARCHITECTURE; INDUCTION	The severity of symptoms elicited by the widespread human pathogen Helicobacter pylori is strongly influenced by the genetic diversity of the infecting strain. Among the most important pathogen factors that carry an increased risk for gastric cancer are specific genotypes of the cag pathogenicity island (cag-PAI), encoding a type IV secretion system (T4SS) responsible for the translocation of the CagA effector oncoprotein. To date, little is known about the regulatory events important for the expression of a functional cag-T4SS. Here we demonstrate that the cag-PAI cistrons are subjected to a complex network of direct and indirect transcriptional regulations. We show that promoters of cag operons encoding structural T4SS components display homogeneous transcript levels, while promoters of cag operons encoding accessory factors vary considerably in their basal transcription levels and responses. Most cag promoters are transcriptionally responsive to growth-phase, pH and other stress-factors, although in many cases in a pleiotropic fashion. Interestingly, transcription from the Pcag zeta promoter controlling the expression of transglycolase and T4SS stabilizing factors, is triggered by co-culture with a gastric cell line, providing an explanation for the increased formation of the secretion system observed upon bacterial contact with host cells. Finally, we demonstrate that the highly transcribed cagA oncogene is repressed by iron limitation through a direct apo-Fur regulation mechanism. Together the results shed light on regulatory aspects of the cag-PAI, which may be involved in relevant molecular and etiological aspects of H. pylori pathogenesis.	[Vannini, Andrea; Roncarati, Davide; Spinsanti, Marco; Scarlato, Vincenzo; Danielli, Alberto] Univ Bologna, Dept Pharm & Biotechnol FaBiT, Bologna, Italy	University of Bologna	Scarlato, V (corresponding author), Univ Bologna, Dept Pharm & Biotechnol FaBiT, Bologna, Italy.	vincenzo.scarlato@unibo.it; alberto.danielli@unibo.it	DANIELLI, ALBERTO/AFQ-1474-2022; Scarlato, Vincenzo/B-8558-2019	DANIELLI, ALBERTO/0000-0002-9414-9898; Scarlato, Vincenzo/0000-0003-4227-677X; RONCARATI, DAVIDE/0000-0001-6923-6087; VANNINI, ANDREA/0000-0002-3767-3132	Italian Ministry of Instruction University and Research [2007LHN9JL, 2010P3S8BR]; Fondazione del Monte di Bologna [FDM756]; University of Bologna; PhD program in Functional Biology of Molecular and Cellular Systems of the University of Bologna	Italian Ministry of Instruction University and Research(Ministry of Education, Universities and Research (MIUR)); Fondazione del Monte di Bologna; University of Bologna; PhD program in Functional Biology of Molecular and Cellular Systems of the University of Bologna	This research was supported by grants from the Italian Ministry of Instruction University and Research (grant 2007LHN9JL to AD and grant 2010P3S8BR to VS), by Fondazione del Monte di Bologna (FDM756) to AD, and by the University of Bologna to VS. AV was the recipient of a fellowship from the PhD program in Functional Biology of Molecular and Cellular Systems of the University of Bologna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agriesti F, 2014, NUCLEIC ACIDS RES, V42, P3138, DOI 10.1093/nar/gkt1258; Backert S, 2005, TRENDS MICROBIOL, V13, P476, DOI 10.1016/j.tim.2005.08.002; Booniakuakul JK, 2004, J INFECT DIS, V190, P946, DOI 10.1086/423142; Boonjakuakul JK, 2005, INFECT IMMUN, V73, P4895, DOI 10.1128/IAI.73.8.4895-4904.2005; Bourzac KM, 2005, CELL MICROBIOL, V7, P911, DOI 10.1111/j.1462-5822.2005.00541.x; Busler VJ, 2006, J BACTERIOL, V188, P4787, DOI 10.1128/JB.00066-06; Carpenter BM, 2013, J BACTERIOLOGY; Christie PJ, 2004, BBA-MOL CELL RES, V1694, P219, DOI 10.1016/j.bbamcr.2004.02.013; Danielli A, 2006, J BACTERIOL, V188, P4654, DOI 10.1128/JB.00120-06; Danielli A, 2010, FEMS MICROBIOL REV, V34, P738, DOI 10.1111/j.1574-6976.2010.00233.x; Danielli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000938; Danielli A, 2009, J BACTERIOL, V191, P3717, DOI 10.1128/JB.01741-08; de Reuse H, 2007, FEMS IMMUNOL MED MIC, V50, P165, DOI 10.1111/j.1574-695X.2007.00244.x; Delany I, 2001, MOL MICROBIOL, V42, P1297, DOI 10.1046/j.1365-2958.2001.02696.x; Ellermeier CD, 2005, MOL MICROBIOL, V57, P691, DOI 10.1111/j.1365-2958.2005.04737.x; Ellermeier JR, 2008, J BACTERIOL, V190, P476, DOI 10.1128/JB.00926-07; Ernst FD, 2005, MICROBIOL-SGM, V151, P533, DOI 10.1099/mic.0.27404-0; Fischer W, 2001, MOL MICROBIOL, V42, P1337, DOI 10.1046/j.1365-2958.2001.02714.x; Fischer W, 2011, FEBS J, V278, P1203, DOI 10.1111/j.1742-4658.2011.08036.x; Gancz H, 2006, INFECT IMMUN, V74, P602, DOI 10.1128/IAI.74.1.602-614.2006; Gieseler S, 2005, MICROBES INFECT, V7, P437, DOI 10.1016/j.micinf.2004.11.018; Johnson EM, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00017; Joyce EA, 2001, INFECT IMMUN, V69, P4202, DOI 10.1128/IAI.69.7.4202-4209.2001; Karita M, 1996, INFECT IMMUN, V64, P4501, DOI 10.1128/IAI.64.11.4501-4507.1996; Kikuchi K, 2012, MICROBES INFECT, V14, P470, DOI 10.1016/j.micinf.2011.12.003; Kim N, 2004, INFECT IMMUN, V72, P2358, DOI 10.1128/IAI.72.4.2358-2368.2004; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Merrell DS, 2003, INFECT IMMUN, V71, P3529, DOI 10.1128/IAI.71.6.3529-3539.2003; Muller A, 2012, J CLIN INVEST, V122, P1192, DOI 10.1172/JCI61578; Noto JM, 2013, J CLIN INVEST, V123, P479, DOI 10.1172/JCI64373; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Pflock M, 2006, J BACTERIOL, V188, P3449, DOI 10.1128/JB.188.10.3449-3462.2006; Pich OQ, 2012, MOL MICROBIOL, V84, P921, DOI 10.1111/j.1365-2958.2012.08066.x; Rieder G, 1997, INFECT IMMUN, V65, P3622, DOI 10.1128/IAI.65.9.3622-3630.1997; Roncarati D, 2007, J BACTERIOL, V189, P7234, DOI 10.1128/JB.00626-07; Roncarati D, 2011, J BACTERIOL, V193, P5629, DOI 10.1128/JB.05295-11; Salama NR, 2013, NAT REV MICROBIOL, V11, P385, DOI 10.1038/nrmicro3016; Scott DR, 2007, P NATL ACAD SCI USA, V104, P7235, DOI 10.1073/pnas.0702300104; Sexton JA, 2004, INFECT IMMUN, V72, P5983, DOI 10.1128/IAI.72.10.5983-5992.2004; Shaffer CL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002237; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sieira R, 2013, FUTURE MICROBIOL, V8, P1193, DOI 10.2217/fmb.13.83; Spohn G, 1997, MOL MICROBIOL, V26, P361, DOI 10.1046/j.1365-2958.1997.5831949.x; Szczebara F, 1999, FEMS MICROBIOL LETT, V175, P165, DOI 10.1016/S0378-1097(99)00188-3; Ta LH, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00046; Tegtmeyer N, 2011, FEBS J, V278, P1190, DOI 10.1111/j.1742-4658.2011.08035.x; Terradot L, 2011, FEBS J, V278, P1213, DOI 10.1111/j.1742-4658.2011.08037.x; Thompson LJ, 2003, INFECT IMMUN, V71, P2643, DOI 10.1128/IAI.71.5.2643-2655.2003; Vannini A, 2012, APPL ENVIRON MICROB, V78, P6524, DOI 10.1128/AEM.01252-12; Wen Y, 2003, INFECT IMMUN, V71, P5921, DOI 10.1128/IAI.71.10.5921-5939.2003; Yahr TL, 2006, MOL MICROBIOL, V62, P631, DOI 10.1111/j.1365-2958.2006.05412.x; Zhang ZW, 2002, J MED MICROBIOL, V51, P495, DOI 10.1099/0022-1317-51-6-495	52	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98416	10.1371/journal.pone.0098416	http://dx.doi.org/10.1371/journal.pone.0098416			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892739	gold, Green Published, Green Submitted			2022-12-27	WOS:000336911400049
J	Bocksteins, E; Mayeur, E; Van Tilborg, A; Regnier, G; Timmermans, JP; Snyders, DJ				Bocksteins, Elke; Mayeur, Evy; Van Tilborg, Abbi; Regnier, Glenn; Timmermans, Jean-Pierre; Snyders, Dirk J.			The Subfamily-Specific Interaction between Kv2.1 and Kv6.4 Subunits Is Determined by Interactions between the N- and C-termini	PLOS ONE			English	Article							CHANNEL ALPHA-SUBUNITS; POTASSIUM CHANNEL; TETRAMERIZATION DOMAIN; CRYSTAL-STRUCTURE; T1 DOMAIN; ACTIVATION	The ``silent'' voltage-gated potassium (KvS) channel subunit Kv6.4 does not form electrically functional homotetramers at the plasma membrane but assembles with Kv2.1 subunits, generating functional Kv2.1/Kv6.4 heterotetramers. The N-terminal T1 domain determines the subfamily-specific assembly of Kv1-4 subunits by preventing interactions between subunits that belong to different subfamilies. For Kv6.4, yeast-two-hybrid experiments showed an interaction of the Kv6.4 N-terminus with the Kv2.1 N-terminus, but unexpectedly also with the Kv3.1 N-terminus. We confirmed this interaction by Fluorescence Resonance Energy Transfer (FRET) and co-immunoprecipitation (co-IP) using N-terminal Kv3.1 and Kv6.4 fragments. However, full-length Kv3.1 and Kv6.4 subunits do not form heterotetramers at the plasma membrane. Therefore, additional interactions between the Kv6.4 and Kv2.1 subunits should be important in the Kv2.1/Kv6.4 subfamily-specificity. Using FRET and co-IP approaches with N-and C-terminal fragments we observed that the Kv6.4 C-terminus physically interacts with the Kv2.1 N-terminus but not with the Kv3.1 N-terminus. The N-terminal amino acid sequence CDD which is conserved between Kv2 and KvS subunits appeared to be a key determinant since charge reversals with arginine substitutions abolished the interaction between the N-terminus of Kv2.1 and the C-terminus of both Kv2.1 and Kv6.4. In addition, the Kv6.4(CKv3.1) chimera in which the C-terminus of Kv6.4 was replaced by the corresponding domain of Kv3.1, disrupted the assembly with Kv2.1. These results indicate that the subfamily-specific Kv2.1/Kv6.4 heterotetramerization is determined by interactions between Kv2.1 and Kv6.4 that involve both the N-and C-termini in which the conserved N-terminal CDD sequence plays a key role.	[Bocksteins, Elke; Mayeur, Evy; Van Tilborg, Abbi; Regnier, Glenn; Snyders, Dirk J.] Univ Antwerp, Dept Biomed Sci, Lab Mol Biophys Physiol & Pharmacol, B-2020 Antwerp, Belgium; [Timmermans, Jean-Pierre] Univ Antwerp, Dept Vet Sci, Lab Cell Biol & Histol, B-2020 Antwerp, Belgium	University of Antwerp; University of Antwerp	Snyders, DJ (corresponding author), Univ Antwerp, Dept Biomed Sci, Lab Mol Biophys Physiol & Pharmacol, B-2020 Antwerp, Belgium.	dirk.snyders@uantwerpen.be	Snyders, Dirk/A-2713-2013	Snyders, Dirk/0000-0001-7142-6672; Timmermans, Jean-Pierre/0000-0003-2506-6252	Research Foundation - Flanders (FWO); FWO [G.0449.11N]	Research Foundation - Flanders (FWO)(FWO); FWO(FWO)	This work was supported by a postdoctoral fellowship of the Research Foundation - Flanders (FWO) to EB and the FWO research grant G.0449.11N to DJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley GN, 1999, BBA-BIOMEMBRANES, V1418, P176, DOI 10.1016/S0005-2736(99)00021-8; Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; Bocksteins E, 2012, PHYSIOLOGY, V27, P73, DOI 10.1152/physiol.00023.2011; Bocksteins E, 2009, J BIOL CHEM, V284, P31625, DOI 10.1074/jbc.M109.039479; DEAL KK, 1994, J NEUROSCI, V14, P1666, DOI 10.1523/JNEUROSCI.14-03-01666.1994; Gustina AS, 2011, J GEN PHYSIOL, V137, P315, DOI 10.1085/jgp.201010582; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Hugnot JP, 1996, EMBO J, V15, P3322, DOI 10.1002/j.1460-2075.1996.tb00697.x; Ju M, 2003, J BIOL CHEM, V278, P12769, DOI 10.1074/jbc.M212973200; Kerschensteiner D, 2005, P NATL ACAD SCI USA, V102, P6160, DOI 10.1073/pnas.0500468102; Kobertz WR, 1999, NAT STRUCT BIOL, V6, P1122; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; LEE TE, 1994, BIOPHYS J, V66, P667, DOI 10.1016/S0006-3495(94)80840-9; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lu JL, 2001, BIOCHEMISTRY-US, V40, P10934, DOI 10.1021/bi010763e; Schnitzler MMY, 2009, J BIOL CHEM, V284, P4695, DOI 10.1074/jbc.M808786200; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; Mohapatra DP, 2008, J NEUROSCI, V28, P4982, DOI 10.1523/JNEUROSCI.0186-08.2008; Nanao MH, 2003, P NATL ACAD SCI USA, V100, P8670, DOI 10.1073/pnas.1432840100; Ottschytsch N, 2002, P NATL ACAD SCI USA, V99, P7986, DOI 10.1073/pnas.122617999; Schulteis CT, 1996, BIOCHEMISTRY-US, V35, P12133, DOI 10.1021/bi961083s; SHEN NV, 1995, NEURON, V14, P625, DOI 10.1016/0896-6273(95)90319-4; SHEN NV, 1993, NEURON, V11, P67; Stocker M, 1999, J NEUROCHEM, V72, P1725, DOI 10.1046/j.1471-4159.1999.721725.x; Tu LW, 1996, J BIOL CHEM, V271, P18904, DOI 10.1074/jbc.271.31.18904; VANDONGEN AMJ, 1990, NEURON, V5, P433, DOI 10.1016/0896-6273(90)90082-Q; Varnum MD, 1997, SCIENCE, V278, P110, DOI 10.1126/science.278.5335.110; XU J, 1995, J BIOL CHEM, V270, P24761, DOI 10.1074/jbc.270.42.24761; Xu MX, 2007, J NEUROSCI, V27, P14158, DOI 10.1523/JNEUROSCI.3675-07.2007; Zerangue N, 2000, P NATL ACAD SCI USA, V97, P3591, DOI 10.1073/pnas.060016797	31	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98960	10.1371/journal.pone.0098960	http://dx.doi.org/10.1371/journal.pone.0098960			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901643	Green Published, gold, Green Submitted			2022-12-27	WOS:000336841400079
J	Borisow, N; Paul, F; Ohlraun, S; Pach, D; Fischer, F; Dorr, J				Borisow, Nadja; Paul, Friedemann; Ohlraun, Stephanie; Pach, Daniel; Fischer, Felix; Doerr, Jan			Pregnancy in Multiple Sclerosis: A Questionnaire Study	PLOS ONE			English	Article							DISEASE-MODIFYING DRUGS; SEXUAL DYSFUNCTION; WOMEN; OUTCOMES; DELIVERY; EXPOSURE; CORTICOSTEROIDS; EPIDEMIOLOGY; METAANALYSIS; ISSUES	Background: Multiple sclerosis (MS) preferentially affects females at childbearing age. For this reason patients and treating physicians were frequently confronted with questions concerning family planning, pregnancy and birth. Objective: The aim of this study was to evaluate the expertise about pregnancy related topics in multiple sclerosis of neurologists in private practice. Methods: We developed a survey with 16 multiple choice questions about pregnancy related topics and sent it to neurologists in private practice in Berlin, Germany. Results: 56 completed questionnaires were sent back. 54% of all questions were answered correctly, 21% of the questions were answered with ``I don't know''. Correct answers were more often given by physicians who treat more than 400 MS patients per year (p = 0.001). Further positive associations were found for assumed relevance of the topic (p = 0.002) and the degree of counseling (p<0.001). Conclusion: To provide a comprehensive counseling, MS patients with desire for children should be counseled by physicians with a lot of experience in MS treatment.	[Borisow, Nadja; Paul, Friedemann; Ohlraun, Stephanie; Doerr, Jan] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [Borisow, Nadja; Paul, Friedemann; Doerr, Jan] Charite, Dept Neurol, Clin & Expt Multiple Sclerosis Res Ctr, D-13353 Berlin, Germany; [Pach, Daniel; Fischer, Felix] Charite, Inst Social Med Epidemiol & Hlth Econ Charite, D-13353 Berlin, Germany; [Fischer, Felix] Charite, Clin Internal Med, Dept Psychosomat Med, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Borisow, N (corresponding author), Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany.	nadja.borisow@charite.de	Paul, Friedemann/ABF-9415-2020; fischer, felix/AAW-6634-2021	fischer, felix/0000-0002-9693-6676; paul, friedemann/0000-0002-6378-0070; Pach, Daniel/0000-0002-2459-6596	Deutsche Forschungsgemeinschaft [DFG Exc. 257]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported in part by Deutsche Forschungsgemeinschaft (DFG Exc. 257). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Amato MP, 2010, NEUROLOGY, V75, P1794, DOI 10.1212/WNL.0b013e3181fd62bb; Borisow N, 2012, EPMA J, V3, DOI 10.1186/1878-5085-3-9; Calabro RS, 2014, INT J NEUROSCI, V124, P547, DOI 10.3109/00207454.2013.865183; Celik DB, 2013, J NEUROL SCI, V324, P17, DOI 10.1016/j.jns.2012.08.019; Charles JA, 2013, NEUROLOGY, V80, P1068, DOI 10.1212/01.wnl.0000428359.07207.f6; Chen YH, 2009, MULT SCLER J, V15, P606, DOI 10.1177/1352458508101937; Confavreux C, 1998, NEW ENGL J MED, V339, P285, DOI 10.1056/NEJM199807303390501; Coyle PK, 2004, MULT SCLER J, V10, P582, DOI 10.1191/1352458504ms1083oa; Dahl J, 2005, NEUROLOGY, V65, P1961, DOI 10.1212/01.wnl.0000188898.02018.95; Dung Aldrin Anthony Dung, 2014, BMJ Case Rep, V2014, DOI 10.1136/bcr-2013-201273; Ferrero S, 2004, EUR J OBSTET GYN R B, V115, P3, DOI 10.1016/j.ejogrb.2003.10.020; Finkelsztejn A, 2011, BJOG-INT J OBSTET GY, V118, P790, DOI 10.1111/j.1471-0528.2011.02931.x; Gur C, 2004, REPROD TOXICOL, V18, P93, DOI 10.1016/j.reprotox.2003.10.007; Hellwig K, 2011, MULT SCLER J, V17, P958, DOI 10.1177/1352458511401944; Hellwig K, 2011, J NEUROL, V258, P502, DOI 10.1007/s00415-010-5758-2; Hellwig K, 2009, ARCH NEUROL-CHICAGO, V66, P1580, DOI 10.1001/archneurol.2009.281; Hoevenaren IA, 2011, ACTA NEUROL SCAND, V123, P430, DOI 10.1111/j.1600-0404.2010.01426.x; Hovland E J, 1980, J Dent Educ, V44, P270; Jalkanen A, 2010, MULT SCLER J, V16, P950, DOI 10.1177/1352458510372629; Kellerman SE, 2001, AM J PREV MED, V20, P61, DOI 10.1016/S0749-3797(00)00258-0; Kotzamani D, 2012, NEUROLOGY, V78, P1728, DOI 10.1212/WNL.0b013e31825830a9; Koutsouraki E, 2010, INT REV PSYCHIATR, V22, P2, DOI 10.3109/09540261003589216; Lu E, 2012, NEUROLOGY, V79, P1130, DOI 10.1212/WNL.0b013e3182698c64; McFarlane E, 2007, EVAL HEALTH PROF, V30, P170, DOI 10.1177/0163278707300632; Mueller BA, 2002, AM J OBSTET GYNECOL, V186, P446, DOI 10.1067/mob.2002.120502; Orton SM, 2006, LANCET NEUROL, V5, P932, DOI 10.1016/S1474-4422(06)70581-6; Park-Wyllie L, 2000, TERATOLOGY, V62, P385, DOI 10.1002/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z; Portaccio E, 2011, NEUROLOGY, V77, P145, DOI 10.1212/WNL.0b013e318224afc9; Pugliatti M, 2006, EUR J NEUROL, V13, P700, DOI 10.1111/j.1468-1331.2006.01342.x; Sandberg-Wollheim M, 2011, MULT SCLER J, V17, P423, DOI 10.1177/1352458510394610; SCHAPIRA K, 1966, BRAIN, V89, P419, DOI 10.1093/brain/89.3.419; Trojano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048078; van der Kop ML, 2011, ANN NEUROL, V70, P41, DOI 10.1002/ana.22483; Weber-Schoendorfer C, 2009, MULT SCLER J, V15, P1037, DOI 10.1177/1352458509106543; Zorzon M, 1999, MULT SCLER J, V5, P418, DOI 10.1191/135245899678846456	35	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99106	10.1371/journal.pone.0099106	http://dx.doi.org/10.1371/journal.pone.0099106			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901447	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000336841400099
J	Dorneles, EMS; Santana, JA; Ribeiro, D; Dorella, FA; Guimaraes, AS; Moawad, MS; Selim, SA; Garaldi, ALM; Miyoshi, A; Ribeiro, M'RG; Gouveia, AMG; Azevedo, V; Heinemann, MB; Lage, AP				Dorneles, Elaine M. S.; Santana, Jordana A.; Ribeiro, Dayana; Dorella, Fernanda Alves; Guimaraes, Alessandro S.; Moawad, Mohamed S.; Selim, Salah A.; Garaldi, Ana Luiza M.; Miyoshi, Anderson; Ribeiro, Marcio G.; Gouveia, Aurora M. G.; Azevedo, Vasco; Heinemann, Marcos B.; Lage, Andrey P.			Evaluation of ERIC-PCR as Genotyping Method for Corynebacterium pseudotuberculosis Isolates	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; CASEOUS-LYMPHADENITIS; MOLECULAR CHARACTERIZATION; NECROTIZING LYMPHADENITIS; TYPING SYSTEMS; SHEEP; INFECTION; PREVALENCE; SAMPLES; CATTLE	The aim of this study was to evaluate the Enterobacterial Repetitive Intergenic Consensus (ERIC-PCR) as a tool for molecular typing of C. pseudotuberculosis isolates from eight different hosts in twelve countries. Ninety-nine C. pseudotuberculosis field strains, one type strain (ATCC 19410(T)) and one vaccine strain (1002) were fingerprinted using the ERIC-1R and ERIC-2 primers, and the ERIC-1R+ERIC-2 primer pair. Twenty-nine different genotypes were generated by ERIC 1-PCR, 28 by ERIC 2-PCR and 35 by ERIC 1+2-PCR. The discriminatory index calculated for ERIC 1, ERIC 2, and ERIC 1+2-PCR was 0.89, 0.86, and 0.92, respectively. Epidemiological concordance was established for all ERIC-PCR assays. ERIC 1+2-PCR was defined as the best method based on suitability of the amplification patterns and discriminatory index. Minimal spanning tree for ERIC 1+2-PCR revealed three major clonal complexes and clustering around nitrate-positive (biovar Equi) and nitrate-negative (biovar Ovis) strains. Therefore, ERIC 1+2-PCR proved to be the best technique evaluated in this study for genotyping C. pseudotuberculosis strains, due to its usefulness for molecular epidemiology investigations.	[Dorneles, Elaine M. S.; Santana, Jordana A.; Gouveia, Aurora M. G.; Heinemann, Marcos B.; Lage, Andrey P.] Univ Fed Minas Gerais, Dept Med Vet Prevent, Escola Vet, Belo Horizonte, MG, Brazil; [Ribeiro, Dayana; Dorella, Fernanda Alves; Miyoshi, Anderson; Azevedo, Vasco] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Guimaraes, Alessandro S.] Empresa Brasileira Pesquisa Agr, Embrapa Gado Leite, Juiz De Fora, Brazil; [Guimaraes, Alessandro S.] Univ Fed Lavras, Dept Vet Med, Lavras, MG, Brazil; [Moawad, Mohamed S.; Selim, Salah A.] Cairo Univ, Dept Toxicol & Forens Med, Cairo, Egypt; [Garaldi, Ana Luiza M.] Univ Estado Rio de Janeiro, Ctr Biomed, Fac Ciencias Med, BR-20550011 Rio De Janeiro, Brazil; [Ribeiro, Marcio G.] Univ Estadual Paulista, Dept Higiene Vet & Saude Publ, Fac Med Vet & Zootecnia, Botucatu, SP, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Lavras; Egyptian Knowledge Bank (EKB); Cairo University; Universidade do Estado do Rio de Janeiro; Universidade Estadual Paulista	Lage, AP (corresponding author), Univ Fed Minas Gerais, Dept Med Vet Prevent, Escola Vet, Belo Horizonte, MG, Brazil.	alage@vet.ufmg.br	Santana, Jordana Almeida/AAV-3972-2020; Azevedo, Vasco A.C/F-4315-2011; Dorneles, Elaine/V-2816-2019; Heinemann, Marcos Bryan/AAI-9390-2020; Dorneles, Elaine/J-1115-2016; Azevedo, Vasco/B-1556-2019; Heinemann, Marcos B/G-2780-2015; Guimaraes, Alessandro/H-3454-2013; Garcia Ribeiro, Márcio/GLV-6457-2022	Santana, Jordana Almeida/0000-0002-0577-887X; Azevedo, Vasco A.C/0000-0002-4775-2280; Dorneles, Elaine/0000-0002-2753-1296; Heinemann, Marcos Bryan/0000-0001-6444-9788; Azevedo, Vasco/0000-0002-4775-2280; Heinemann, Marcos B/0000-0001-6444-9788; Garcia Ribeiro, Márcio/0000-0003-2682-9389	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - Fapemig; Fundacao de Estudo e Pesquisa em Medicina Veterinaria e Zootecnia - FEP-MVZ; CNPq	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - Fapemig(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fundacao de Estudo e Pesquisa em Medicina Veterinaria e Zootecnia - FEP-MVZ; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq, Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - Fapemig and Fundacao de Estudo e Pesquisa em Medicina Veterinaria e Zootecnia - FEP-MVZ. E. M. S. Dorneles, V. Azevedo, A. P. Lage and M. B. Heinemann had fellowships from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu SRD, 2008, PESQUI VET BRASIL, V28, P481, DOI 10.1590/S0100-736X2008001000007; Bregenzer Thomas, 1997, Clin Microbiol Infect, V3, P696, DOI 10.1111/j.1469-0691.1997.tb00482.x; Cerdeira LT, 2011, J BACTERIOL, V193, P7025, DOI 10.1128/JB.06293-11; Cerdeira LT, 2011, J BACTERIOL, V193, P6420, DOI 10.1128/JB.06044-11; Connor KM, 2007, VET RES, V38, P613, DOI 10.1051/vetres:2007013; Costa LRR, 1998, VET MICROBIOL, V62, P135, DOI 10.1016/S0378-1135(98)00202-8; Dorneles EMS, 2012, GENET MOL RES, V11, P2051, DOI 10.4238/2012.August.6.9; Estevao Belchior S, 2006, REV VET ARG, V224, P258; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Foley JE, 2004, AM J VET RES, V65, P1734, DOI 10.2460/ajvr.2004.65.1734; Foxman Betsy, 2005, Epidemiol Perspect Innov, V2, P10, DOI 10.1186/1742-5573-2-10; Guimaraes AS, 2009, SMALL RUMINANT RES, V87, P86, DOI 10.1016/j.smallrumres.2009.09.027; Guimaraes AD, 2011, IIOAB J, V2, P33; Guimaraes AS, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-68; Guimares AD, 2011, VET MICROBIOL, V153, P299, DOI 10.1016/j.vetmic.2011.06.002; Hassan SS, 2012, J BACTERIOL, V194, P5718, DOI 10.1128/JB.01373-12; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Instituto Brasileiro de Geografia e Estatistica, 2008, DIR PESQ COORD AGR P; Join-Lambert OF, 2006, PEDIATR INFECT DIS J, V25, P848, DOI 10.1097/01.inf.0000234071.93044.77; Li WJ, 2009, FEMS MICROBIOL REV, V33, P892, DOI 10.1111/j.1574-6976.2009.00182.x; Lopes T, 2012, J BACTERIOL, V194, P3567, DOI 10.1128/JB.00461-12; Matthias Gamer, 2012, **DATA OBJECT**; Pacheco LGC, 2007, J MED MICROBIOL, V56, P480, DOI 10.1099/jmm.0.46997-0; Paton MW, 2003, AUST VET J, V81, P91, DOI 10.1111/j.1751-0813.2003.tb11443.x; Peel MM, 1997, CLIN INFECT DIS, V24, P185, DOI 10.1093/clinids/24.2.185; Pratt SM, 2005, JAVMA-J AM VET MED A, V227, P441, DOI 10.2460/javma.2005.227.441; Ruiz JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018551; Salipante SJ, 2011, J CLIN MICROBIOL, V49, P3568, DOI 10.1128/JCM.00919-11; Selim SA, 2001, J VET MED B, V48, P241, DOI 10.1046/j.1439-0450.2001.00451.x; Seyffert N, 2010, RES VET SCI, V88, P50, DOI 10.1016/j.rvsc.2009.07.002; SHPIGEL NY, 1993, VET REC, V133, P89, DOI 10.1136/vr.133.4.89; Siegel, 1975, ESTATISTICA NAOPARAM; Silva A, 2012, J BACTERIOL, V194, P6663, DOI 10.1128/JB.01782-12; Silva A, 2011, J BACTERIOL, V193, P323, DOI 10.1128/JB.01211-10; Soares SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053818; SONGER JG, 1988, AM J VET RES, V49, P223; Struelens M, 2002, CURR OPIN INFECT DIS, V15, P383, DOI 10.1097/00001432-200208000-00005; Struelens MJ, 1998, MEM I OSWALDO CRUZ, V93, P581, DOI 10.1590/S0074-02761998000500004; Sutherland SS, 1996, VET MICROBIOL, V49, P1, DOI 10.1016/0378-1135(95)00146-8; SUTHERLAND SS, 1993, AUST VET J, V70, P454, DOI 10.1111/j.1751-0813.1993.tb00851.x; Tejedor-Junco MT, 2008, TROP ANIM HEALTH PRO, V40, P165, DOI 10.1007/s11250-007-9077-2; Trost E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-728; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Yeruham I, 1997, VET REC, V140, P423, DOI 10.1136/vr.140.16.423; Yeruham I, 1996, VET QUART, V18, P87, DOI 10.1080/01652176.1996.9694623	45	23	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98758	10.1371/journal.pone.0098758	http://dx.doi.org/10.1371/journal.pone.0098758			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901343	Green Published, gold, Green Submitted			2022-12-27	WOS:000336841400049
J	Haasdijk, E; Bredeche, N; Eiben, AE				Haasdijk, Evert; Bredeche, Nicolas; Eiben, A. E.			Combining Environment-Driven Adaptation and Task-Driven Optimisation in Evolutionary Robotics	PLOS ONE			English	Article							EMBODIED EVOLUTION; EMERGENCE	Embodied evolutionary robotics is a sub-field of evolutionary robotics that employs evolutionary algorithms on the robotic hardware itself, during the operational period, i.e., in an on-line fashion. This enables robotic systems that continuously adapt, and are therefore capable of (re-)adjusting themselves to previously unknown or dynamically changing conditions autonomously, without human oversight. This paper addresses one of the major challenges that such systems face, viz. that the robots must satisfy two sets of requirements. Firstly, they must continue to operate reliably in their environment (viability), and secondly they must competently perform user-specified tasks (usefulness). The solution we propose exploits the fact that evolutionary methods have two basic selection mechanisms-survivor selection and parent selection. This allows evolution to tackle the two sets of requirements separately: survivor selection is driven by the environment and parent selection is based on task-performance. This idea is elaborated in the Multi-Objective aNd open-Ended Evolution (MONEE) framework, which we experimentally validate. Experiments with robotic swarms of 100 simulated e-pucks show that MONEE does indeed promote task-driven behaviour without compromising environmental adaptation. We also investigate an extension of the parent selection process with a 'market mechanism' that can ensure equitable distribution of effort over multiple tasks, a particularly pressing issue if the environment promotes specialisation in single tasks.	[Haasdijk, Evert; Eiben, A. E.] Vrije Univ Amsterdam, Dept Comp Sci, Amsterdam, Netherlands; [Bredeche, Nicolas] Univ Paris 06, ISIR, Univ Sorbonne, UMR 7222, F-75005 Paris, France; [Bredeche, Nicolas] ISIR, CNRS, UMR 7222, F-75005 Paris, France	Vrije Universiteit Amsterdam; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Haasdijk, E (corresponding author), Vrije Univ Amsterdam, Dept Comp Sci, Amsterdam, Netherlands.	e.haasdijk@vu.nl	Bredeche, Nicolas/AAV-4422-2021	Bredeche, Nicolas/0000-0002-8241-7461	Agence Nationale de la Recherche [ANR-12-JS03-0009]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was funded by the Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr/), project Creadapt under grant agreement ANR-12-JS03-0009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami C., 1994, Artificial Life IV. Proceedings of the Fourth International Workshop on the Synthesis and Simulation of Living Systems, P377; [Anonymous], 1877, DIFFERENT FORMS FLOW; Arnold DV, 2002, IEEE T EVOLUT COMPUT, V6, P30, DOI [10.1109/4235.985690, 10.1023/A:1015059928466]; Bedau MA, 2000, ARTIF LIFE, V6, P363, DOI 10.1162/106454600300103683; Bianco R, 2004, CONNECT SCI, V16, P227, DOI 10.1080/09540090412331314759; Bredeche N, 2013, ABS13042888 CORR; Bredeche N, 2012, MATH COMPUTER MODELL, V18; Bredeche N, 2012, MATH COMP MODEL DYN, V18, P101, DOI 10.1080/13873954.2011.601425; Burtsev MS, 2001, LECT NOTES ARTIF INT, V2159, P413; Eiben AE, 2007, INTRO EVOLUTIONARY C; Eiben AE, 2003, INTRO EVOLUTIONARY C, DOI 10.1007/978-3-662-44874-8; Elfwing S, 2011, ADAPT BEHAV, V19, P101, DOI 10.1177/1059712310397633; Fisher RA, 1925, P CAMB PHILOS SOC, V22, P700, DOI 10.1017/S0305004100009580; Jones C, 2003, IROS 2003: PROCEEDINGS OF THE 2003 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-4, P1969; Lenski RE, 1999, NATURE, V400, P661, DOI 10.1038/23245; Mascaro S., 2005, ADV NATURAL COMPUTAT, V3, P171; Menczer F, 1994, CIKM WORKSH INT INF; Menczer Filippo, 1996, Santa Fe Institute Studies in the Sciences of Complexity Proceedings, V26, P191; Nolfi S., 2000, EVOLUTIONARY ROBOTIC; Prieto A, 2010, ROBOT AUTON SYST, V58, P1282, DOI 10.1016/j.robot.2010.08.004; Quang Uy Nguyen, 2012, Genetic Programming. Proceedings of the 15th European Conference, EuroGP 2012, P109, DOI 10.1007/978-3-642-29139-5_10; RASMUSSEN S, 1990, PHYSICA D, V42, P111, DOI 10.1016/0167-2789(90)90070-6; Ray TS, 1992, SCI EXCELLENCE SUPER, P489; Scheutz M, 2005, GECCO 2005: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOLS 1 AND 2, P35; Schwarzer C, 2011, INT J ADV INTELLIGEN, V4, P288; Schwarzer C, 2010, SYMBIOTIC MULTIROBOT, P384; Spector L, 2007, GECCO 2007: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOL 1 AND 2, P316; Tang F, 2007, IEEE INT CONF ROBOT, P3351, DOI 10.1109/ROBOT.2007.363990; Usui Y, 2003, P 8 INT S ART LIF RO, P1; Ventrella J, 2005, ARTIFICIAL LIFE MODELS IN SOFTWARE, P81, DOI 10.1007/1-84628-214-4_4; Walsh WE, 1998, INTERNATIONAL CONFERENCE ON MULTI-AGENT SYSTEMS, PROCEEDINGS, P325, DOI 10.1109/ICMAS.1998.699077; Watson RA, 2002, ROBOT AUTON SYST, V39, P1, DOI 10.1016/S0921-8890(02)00170-7; Weel Berend, 2012, Parallel Problem Solving from Nature - PPSN XII. Proceedings of the 12th International Conference, P245, DOI 10.1007/978-3-642-32964-7_25; Wischmann S, 2007, LECT NOTES ARTIF INT, V4648, P284; Yaeger L, 1994, ARTIF LIFE, V1, P1; Yaeger LS, 2008, ARTIF LIFE, P725	36	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98466	10.1371/journal.pone.0098466	http://dx.doi.org/10.1371/journal.pone.0098466			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901702	Green Published, gold			2022-12-27	WOS:000336841400031
J	Mizushima, R; Kim, JY; Suetake, I; Tanaka, H; Takai, T; Kamiya, N; Takano, Y; Mishima, Y; Tajima, S; Goto, Y; Fukui, K; Lee, YH				Mizushima, Ryota; Kim, Ju Yaen; Suetake, Isao; Tanaka, Hiroaki; Takai, Tomoyo; Kamiya, Narutoshi; Takano, Yu; Mishima, Yuichi; Tajima, Shoji; Goto, Yuji; Fukui, Kenji; Lee, Young-Ho			NMR Characterization of the Interaction of the Endonuclease Domain of MutL with Divalent Metal Ions and ATP	PLOS ONE			English	Article							C-TERMINAL DOMAIN; DNA MISMATCH REPAIR; BINDING; PROTEIN; SITES; ALPHA; MODEL; HYDROLYSIS; REVEALS	MutL is a multi-domain protein comprising an N-terminal ATPase domain (NTD) and C-terminal dimerization domain (CTD), connected with flexible linker regions, that plays a key role in DNA mismatch repair. To expand understanding of the regulation mechanism underlying MutL endonuclease activity, our NMR-based study investigated interactions between the CTD of MutL, derived from the hyperthermophilic bacterium Aquifex aeolicus (aqMutL-CTD), and putative binding molecules. Chemical shift perturbation analysis with the model structure of aqMutL-CTD and circular dichroism results revealed that tight Zn2+ binding increased thermal stability without changing secondary structures to function at high temperatures. Peak intensity analysis exploiting the paramagnetic relaxation enhancement effect indicated the binding site for Mn2+, which shared binding sites for Zn2+. The coexistence of these two metal ions appears to be important for the function of MutL. Chemical shift perturbation analysis revealed a novel ATP binding site in aqMutL-CTD. A docking simulation incorporating the chemical shift perturbation data provided a putative scheme for the intermolecular interactions between aqMutL-CTD and ATP. We proposed a simple and understandable mechanical model for the regulation of MutL endonuclease activity in MMR based on the relative concentrations of ATP and CTD through ATP binding-regulated interdomain interactions between CTD and NTD.	[Mizushima, Ryota; Kim, Ju Yaen; Suetake, Isao; Tanaka, Hiroaki; Takai, Tomoyo; Kamiya, Narutoshi; Takano, Yu; Mishima, Yuichi; Tajima, Shoji; Goto, Yuji; Lee, Young-Ho] Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan; [Fukui, Kenji] RIKEN SPring 8 Ctr, Harima Inst, Sayo, Hyogo, Japan	Osaka University; RIKEN	Lee, YH (corresponding author), Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan.	mr0505@protein.osaka-u.ac.jp	Takano, Yu/H-1785-2014; Mizushima, Ryota/AAL-2503-2020; Kamiya, Narutoshi/C-4548-2016; Suetake, Isao/D-4326-2009; Suetake, Isao/G-3144-2013	Takano, Yu/0000-0002-4165-8672; Mizushima, Ryota/0000-0001-6375-9944; Kamiya, Narutoshi/0000-0002-0527-6968; Suetake, Isao/0000-0002-1246-8474; Fukui, Kenji/0000-0003-2463-7578	Japanese Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [25440070, 25870407] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban C, 1998, CELL, V95, P541, DOI 10.1016/S0092-8674(00)81621-9; Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Dudev M, 2006, J PHYS CHEM B, V110, P1889, DOI 10.1021/jp054975n; Dudev T, 2003, CHEM REV, V103, P773, DOI 10.1021/cr020467n; Dudev T, 2003, J AM CHEM SOC, V125, P3168, DOI 10.1021/ja0209722; FISHEL R, 1995, CURR OPIN GENET DEV, V5, P382, DOI 10.1016/0959-437X(95)80055-7; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Fukui K, 2008, J BIOL CHEM, V283, P12136, DOI 10.1074/jbc.M800110200; Fukunishi Y, 2005, J MOL GRAPH MODEL, V24, P34, DOI 10.1016/j.jmgm.2005.04.004; Fukushima K, 2011, J DRUG TARGET, V19, P212, DOI [10.3109/1061186X.2010.492521, 10.4061/2010/260512]; Guarne A, 2004, EMBO J, V23, P4134, DOI 10.1038/sj.emboj.7600412; Guarne A, 2001, EMBO J, V20, P5521, DOI 10.1093/emboj/20.19.5521; Guarne A, 2012, PROG MOL BIOL TRANSL, V110, P41, DOI 10.1016/B978-0-12-387665-2.00003-1; Gueneau E, 2013, NAT STRUCT MOL BIOL, V20, P461, DOI 10.1038/nsmb.2511; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Harding MM, 2004, ACTA CRYSTALLOGR D, V60, P849, DOI 10.1107/S0907444904004081; Iino H, 2011, BIOSCIENCE REP, V31, P309, DOI 10.1042/BSR20100116; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Karlin S, 1997, P NATL ACAD SCI USA, V94, P14231, DOI 10.1073/pnas.94.26.14231; KURAMITSU S, 1990, BIOCHEMISTRY-US, V29, P5469, DOI 10.1021/bi00475a010; Larrea AA, 2010, CELL, V141, DOI 10.1016/j.cell.2010.05.002; Lee YH, 2009, J BIOL CHEM, V284, P2169, DOI 10.1074/jbc.M806939200; Levitt M, 2009, P NATL ACAD SCI USA, V106, P11079, DOI 10.1073/pnas.0905029106; Mauris J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007175; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; Namadurai S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013726; Pillon MC, 2010, MOL CELL, V39, P145, DOI 10.1016/j.molcel.2010.06.027; Ryde U, 1999, BIOPHYS J, V77, P2777, DOI 10.1016/S0006-3495(99)77110-9; Sacho EJ, 2008, MOL CELL, V29, P112, DOI 10.1016/j.molcel.2007.10.030; Shekhtman A, 2011, PROTEIN NMR TECHNIQU; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shimada A, 2013, FEBS J, V280, P3467, DOI 10.1111/febs.12344; Shumilin IA, 2003, BIOCHEMISTRY-US, V42, P3766, DOI 10.1021/bi027257p; Vega-Rocha S, 2007, J MOL BIOL, V367, P473, DOI 10.1016/j.jmb.2007.01.002; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Yamamoto T, 2011, J BIOL CHEM, V286, P42337, DOI 10.1074/jbc.M111.277335	43	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98554	10.1371/journal.pone.0098554	http://dx.doi.org/10.1371/journal.pone.0098554			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901533	Green Published, Green Submitted, gold			2022-12-27	WOS:000336841400037
J	Moskal, A; Pisa, PT; Ferrari, P; Byrnes, G; Freisling, H; Boutron-Ruault, MC; Cadeau, C; Nailler, L; Wendt, A; Kuhn, T; Boeing, H; Buijsse, B; Tjonneland, A; Halkjaer, J; Dahm, CC; Chiuve, SE; Quiros, JR; Buckland, G; Molina-Montes, E; Amiano, P; Castano, JMH; Gurrea, AB; Khaw, KT; Lentjes, MA; Key, TJ; Romaguera, D; Vergnaud, AC; Trichopoulou, A; Bamia, C; Orfanos, P; Palli, D; Pala, V; Tumino, R; Sacerdote, C; de Magistris, MS; Bueno-de-Mesquita, HB; Ocke, MC; Beulens, JWJ; Ericson, U; Drake, I; Nilsson, LM; Winkvist, A; Weiderpass, E; Hjartaker, A; Riboli, E; Slimani, N				Moskal, Aurelie; Pisa, Pedro T.; Ferrari, Pietro; Byrnes, Graham; Freisling, Heinz; Boutron-Ruault, Marie-Christine; Cadeau, Claire; Nailler, Laura; Wendt, Andrea; Kuehn, Tilman; Boeing, Heiner; Buijsse, Brian; Tjonneland, Anne; Halkjaer, Jytte; Dahm, Christina C.; Chiuve, Stephanie E.; Quiros, Jose R.; Buckland, Genevieve; Molina-Montes, Esther; Amiano, Pilar; Huerta Castano, Jose M.; Barricarte Gurrea, Aurelio; Khaw, Kay-Tee; Lentjes, Marleen A.; Key, Timothy J.; Romaguera, Dora; Vergnaud, Anne-Claire; Trichopoulou, Antonia; Bamia, Christina; Orfanos, Philippos; Palli, Domenico; Pala, Valeria; Tumino, Rosario; Sacerdote, Carlotta; de Magistris, Maria Santucci; Bueno-de-Mesquita, H. Bas; Ocke, Marga C.; Beulens, Joline W. J.; Ericson, Ulrika; Drake, Isabel; Nilsson, Lena M.; Winkvist, Anna; Weiderpass, Elisabete; Hjartaker, Anette; Riboli, Elio; Slimani, Nadia			Nutrient Patterns and Their Food Sources in an International Study Setting: Report from the EPIC Study	PLOS ONE			English	Article							DIETARY PATTERNS; COLORECTAL-CANCER; LARYNGEAL-CANCER; OLDER EUROPEANS; GASTRIC-CANCER; BREAST-CANCER; RISK; NUTRITION; CALIBRATION; HEAD	Background: Compared to food patterns, nutrient patterns have been rarely used particularly at international level. We studied, in the context of a multi-center study with heterogeneous data, the methodological challenges regarding pattern analyses. Methodology/Principal Findings: We identified nutrient patterns from food frequency questionnaires (FFQ) in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study and used 24-hour dietary recall (24-HDR) data to validate and describe the nutrient patterns and their related food sources. Associations between lifestyle factors and the nutrient patterns were also examined. Principal component analysis (PCA) was applied on 23 nutrients derived from country-specific FFQ combining data from all EPIC centers (N = 477,312). Harmonized 24-HDRs available for a representative sample of the EPIC populations (N = 34,436) provided accurate mean group estimates of nutrients and foods by quintiles of pattern scores, presented graphically. An overall PCA combining all data captured a good proportion of the variance explained in each EPIC center. Four nutrient patterns were identified explaining 67% of the total variance: Principle component (PC) 1 was characterized by a high contribution of nutrients from plant food sources and a low contribution of nutrients from animal food sources; PC2 by a high contribution of micro-nutrients and proteins; PC3 was characterized by polyunsaturated fatty acids and vitamin D; PC4 was characterized by calcium, proteins, riboflavin, and phosphorus. The nutrients with high loadings on a particular pattern as derived from country-specific FFQ also showed high deviations in their mean EPIC intakes by quintiles of pattern scores when estimated from 24-HDR. Center and energy intake explained most of the variability in pattern scores. Conclusion/Significance: The use of 24-HDR enabled internal validation and facilitated the interpretation of the nutrient patterns derived from FFQs in term of food sources. These outcomes open research opportunities and perspectives of using nutrient patterns in future studies particularly at international level.	[Moskal, Aurelie; Pisa, Pedro T.; Freisling, Heinz; Slimani, Nadia] Int Agcy Res Canc, Dietary Exposure Assessment Grp, F-69372 Lyon, France; [Ferrari, Pietro] Int Agcy Res Canc, Nutr Epidemiol Grp, F-69372 Lyon, France; [Byrnes, Graham] Int Agcy Res Canc, Biostat Grp, F-69372 Lyon, France; [Boutron-Ruault, Marie-Christine; Cadeau, Claire; Nailler, Laura] INSERM, Ctr Res Epidemiol & Populat Hlth, U1018, Villejuif, France; [Boutron-Ruault, Marie-Christine; Cadeau, Claire; Nailler, Laura] Univ Paris 11, UMRS 1018, Villejuif, France; [Boutron-Ruault, Marie-Christine; Cadeau, Claire; Nailler, Laura] Inst Gustave Roussy, Villejuif, France; [Wendt, Andrea; Kuehn, Tilman] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Boeing, Heiner; Buijsse, Brian] German Inst Human Nutr, Dept Epidemiol, Potsdam, Germany; [Tjonneland, Anne; Halkjaer, Jytte] Danish Canc Soc Res Ctr, Copenhagen, Denmark; [Dahm, Christina C.] Aarhus Univ, Inst Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Chiuve, Stephanie E.] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA; [Chiuve, Stephanie E.] Harvard Univ, Sch Med, Boston, MA USA; [Chiuve, Stephanie E.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Quiros, Jose R.] Publ Hlth & Hlth Planning Directorate, Asturias, Spain; [Buckland, Genevieve] Catalan Inst Oncol, Canc Epidemiol Res Programme, Unit Nutr Environm & Canc, Barcelona, Spain; [Molina-Montes, Esther] Andalusian Sch Publ Hlth, Granada, Spain; [Amiano, Pilar; Huerta Castano, Jose M.; Barricarte Gurrea, Aurelio] CIBERESP, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain; [Amiano, Pilar] BIODonostia Res Inst, Publ Hlth Div Gipuzkoa, San Sebastian, Spain; [Barricarte Gurrea, Aurelio] Navarre Publ Hlth Inst, Pamplona, Spain; [Huerta Castano, Jose M.] Murcia Reg Hlth Council, Dept Epidemiol, Murcia, Spain; [Khaw, Kay-Tee; Lentjes, Marleen A.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Key, Timothy J.] Univ Oxford, Canc Epidemiol Unit, Oxford, England; [Romaguera, Dora; Vergnaud, Anne-Claire; Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Romaguera, Dora] CIBER Fisiopatol Obesidad & Nutr, Madrid, Spain; [Trichopoulou, Antonia; Bamia, Christina; Orfanos, Philippos] Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, WHO Collaborating Ctr Food & Nutr Policies, GR-11527 Athens, Greece; [Trichopoulou, Antonia; Bamia, Christina; Orfanos, Philippos] Hellen Hlth Fdn, Athens, Greece; [Palli, Domenico] Canc Res & Prevent Inst ISPO, Mol & Nutr Epidemiol Unit, Florence, Italy; [Pala, Valeria] Fdn IRCCS Ist Nazl Tumori, Nutr Epidemiol Unit, Milan, Italy; [Tumino, Rosario] Civile MP Arezzo Hosp, Canc Registry, Ragusa, Italy; [Tumino, Rosario] Civile MP Arezzo Hosp, Histopathol Unit, Ragusa, Italy; [Sacerdote, Carlotta] HuGeF Fdn, Turin, Italy; [Sacerdote, Carlotta] Ctr Canc Prevent CPO Piemonte, Turin, Italy; [de Magistris, Maria Santucci] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy; [Bueno-de-Mesquita, H. Bas; Ocke, Marga C.] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Bueno-de-Mesquita, H. Bas] Univ Med Ctr, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [Beulens, Joline W. J.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Ericson, Ulrika] Lund Univ, Dept Clin Sci Malmo, Malmo, Sweden; [Drake, Isabel] Lund Univ, Res Grp Nutr Epidemiol, Dept Clin Sci Malmo, Malmo, Sweden; [Nilsson, Lena M.] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Winkvist, Anna] Univ Gothenburg, Dept Internal Med & Clin Nutr, Gothenburg, Sweden; [Weiderpass, Elisabete] Univ Tromso, Fac Hlth Sci, Dept Community Med, Tromso, Norway; [Weiderpass, Elisabete] Canc Registry Norway, Dept Res, Oslo, Norway; [Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Weiderpass, Elisabete] Samfundet Folkhalsan, Helsinki, Finland; [Hjartaker, Anette] Univ Oslo, Dept Nutr, Inst Basic Med Sci, Oslo, Norway	World Health Organization; International Agency for Research on Cancer (IARC); World Health Organization; International Agency for Research on Cancer (IARC); World Health Organization; International Agency for Research on Cancer (IARC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Helmholtz Association; German Cancer Research Center (DKFZ); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Danish Cancer Society; Aarhus University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Catalan Institute of Oncology; Escuela Andaluza de Salud Publica; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Public Health Institute of Navarra; Murcia Regional Health Council; University of Cambridge; University of Oxford; Imperial College London; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Athens Medical School; National & Kapodistrian University of Athens; World Health Organization; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Fondazione IRCCS Istituto Nazionale Tumori Milan; Civile M.P. Arezzo Hospital; Civile M.P. Arezzo Hospital; University of Naples Federico II; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Lund University; Lund University; Umea University; University of Gothenburg; UiT The Arctic University of Tromso; University of Oslo; Karolinska Institutet; Samfundet Folkhalsan; University of Oslo	Moskal, A (corresponding author), Int Agcy Res Canc, Dietary Exposure Assessment Grp, 150 Cours Albert Thomas, F-69372 Lyon, France.	moskala@iarc.fr	Orfanos, Philippos/AAL-2606-2021; Weiderpass, Elisabete/AAP-2747-2021; Weiderpass, Elisabete/M-4029-2016; Boutron-Ruault, Marie-Christine/H-3936-2014; TRICHOPOULOU, ANTONIA/ABF-8727-2021; Pala, Valeria/K-4738-2016; Winkvist, Anna/AAC-6178-2021; Dahm, Christina C/G-9787-2014; Huerta, José María/N-8654-2015; Khaw, Kay-Tee/AAZ-3209-2021; Romaguera, Dora/AAB-2852-2020; Romaguera, Dora/ABE-7004-2020	Weiderpass, Elisabete/0000-0003-2237-0128; Weiderpass, Elisabete/0000-0003-2237-0128; Boutron-Ruault, Marie-Christine/0000-0002-5956-5693; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; Pala, Valeria/0000-0001-5438-970X; Winkvist, Anna/0000-0001-9122-7240; Dahm, Christina C/0000-0003-0481-2893; Huerta, José María/0000-0002-9637-3869; Romaguera, Dora/0000-0002-5762-8558; PALLI, Domenico/0000-0002-5558-2437; Riboli, Elio/0000-0001-6795-6080; Drake, Isabel/0000-0002-6500-6310; Lentjes, Marleen/0000-0003-4713-907X; Nilsson, Lena Maria/0000-0002-2354-7258; Tjonneland, Anne/0000-0003-4385-2097; Freisling, Heinz/0000-0001-8648-4998; Buckland, Genevieve/0000-0003-2060-6598; moskal, aurelie/0000-0003-4127-4334; Orfanos, Philippos/0000-0002-9949-3137; Sacerdote, Carlotta/0000-0002-8008-5096; Beulens, Joline/0000-0002-4181-0937; tumino, rosario/0000-0003-2666-414X; Ericson, Ulrika/0000-0003-4629-4318; Gueranger, Anne-Claire/0000-0003-0728-9313; Byrnes, Graham/0000-0003-3893-7539; Molina-Montes, Esther/0000-0002-0428-2426	European Commission (DG-SANCO); International Agency for Research on Cancer; Danish Cancer Society (Denmark); Ligue Contre le Cancer; Institut Gustave Roussy; Mutuelle Generale de l'Education Nationale; Institut National de la Sante et de la Recherche Medicale (INSERM) (France); Deutsche Krebshilfe; Deutsches Krebsforschungszentrum; Federal Ministry of Education and Research (Germany); Hellenic Health Foundation (Greece); Italian Association for Research on Cancer (AIRC); National Research Council (Italy); Dutch Ministry of Public Health, Welfare and Sports (VWS); Netherlands Cancer Registry (NKR); LK Research Funds; Dutch Prevention Funds; Dutch ZON (Zorg Onderzoek Nederland); World Cancer Research Fund (WCRF); Statistics Netherlands (The Netherlands); Nordforsk; Nordic Centre of Excellence programme on Food, Nutrition and Health. (Norway); Health Research Fund (FIS) of the Spanish Ministry of Health; Spanish Regional Governments of Andalucia; Asturias; Basque Country; Murcia [6236]; Navarra; Catalan Institute of Oncology; ISCIII RETIC (Spain) [RD06/0020]; Swedish Cancer Society; Swedish Scientific Council; Regional Government of Skane; Vasterbotten (Sweden); Cancer Research UK; Medical Research Council; Stroke Association; British Heart Foundation; Department of Health; Food Standards Agency; Wellcome Trust (United Kingdom);  [ERC-2009-AdG 232997]; Cancer Research UK [14136, 16491] Funding Source: researchfish; Medical Research Council [G0401527, G1000143] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10114] Funding Source: researchfish	European Commission (DG-SANCO)(European CommissionEuropean Commission Joint Research Centre); International Agency for Research on Cancer; Danish Cancer Society (Denmark)(Danish Cancer Society); Ligue Contre le Cancer(Ligue nationale contre le cancer); Institut Gustave Roussy; Mutuelle Generale de l'Education Nationale; Institut National de la Sante et de la Recherche Medicale (INSERM) (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsches Krebsforschungszentrum; Federal Ministry of Education and Research (Germany)(Federal Ministry of Education & Research (BMBF)); Hellenic Health Foundation (Greece); Italian Association for Research on Cancer (AIRC)(Fondazione AIRC per la ricerca sul cancro); National Research Council (Italy)(Consiglio Nazionale delle Ricerche (CNR)); Dutch Ministry of Public Health, Welfare and Sports (VWS); Netherlands Cancer Registry (NKR); LK Research Funds; Dutch Prevention Funds; Dutch ZON (Zorg Onderzoek Nederland)(Netherlands Organization for Scientific Research (NWO)); World Cancer Research Fund (WCRF)(World Cancer Research Fund International (WCRF)); Statistics Netherlands (The Netherlands)(Netherlands Government); Nordforsk; Nordic Centre of Excellence programme on Food, Nutrition and Health. (Norway); Health Research Fund (FIS) of the Spanish Ministry of Health(Instituto de Salud Carlos III); Spanish Regional Governments of Andalucia; Asturias(Principality of Asturias); Basque Country(Basque Government); Murcia; Navarra; Catalan Institute of Oncology; ISCIII RETIC (Spain)(Instituto de Salud Carlos III); Swedish Cancer Society(Swedish Cancer Society); Swedish Scientific Council; Regional Government of Skane; Vasterbotten (Sweden); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stroke Association; British Heart Foundation(British Heart Foundation); Department of Health; Food Standards Agency; Wellcome Trust (United Kingdom)(Wellcome Trust); ; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The coordination of EPIC is supported by the European Commission (DG-SANCO) and the International Agency for Research on Cancer. The national cohorts are supported by Danish Cancer Society (Denmark); Ligue Contre le Cancer, Institut Gustave Roussy, Mutuelle Generale de l'Education Nationale, Institut National de la Sante et de la Recherche Medicale (INSERM) (France); Deutsche Krebshilfe, Deutsches Krebsforschungszentrum and Federal Ministry of Education and Research (Germany); Hellenic Health Foundation (Greece); Italian Association for Research on Cancer (AIRC) and National Research Council (Italy); Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF), Statistics Netherlands (The Netherlands); [ERC-2009-AdG 232997] and Nordforsk, Nordic Centre of Excellence programme on Food, Nutrition and Health. (Norway); Health Research Fund (FIS) of the Spanish Ministry of Health, Spanish Regional Governments of Andalucia, Asturias, Basque Country, Murcia [no. 6236] and Navarra and the Catalan Institute of Oncology, ISCIII RETIC [RD06/0020] (Spain); Swedish Cancer Society, Swedish Scientific Council and Regional Government of Skane and Vasterbotten (Sweden); Cancer Research UK, Medical Research Council, Stroke Association, British Heart Foundation, Department of Health, Food Standards Agency, and Wellcome Trust (United Kingdom). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamia C, 2005, BRIT J NUTR, V94, P100, DOI 10.1079/BJN20051456; Bamia C, 2007, PUBLIC HEALTH NUTR, V10, P590, DOI 10.1017/S1368980007382487; Bertuccio P, 2009, CANCER EPIDEM BIOMAR, V18, P2882, DOI 10.1158/1055-9965.EPI-09-0782; Bingham S, 2004, NAT REV CANCER, V4, P206, DOI 10.1038/nrc1298; Bosetti C, 2013, ANN EPIDEMIOL, V23, P124, DOI 10.1016/j.annepidem.2012.12.005; Bouckaert KP, 2011, MOL NUTR FOOD RES, V55, P166, DOI 10.1002/mnfr.201000391; Bravi F, 2012, ANN ONCOL, V23, P765, DOI 10.1093/annonc/mdr295; Bravi F, 2010, CANCER CAUSE CONTROL, V21, P1911, DOI 10.1007/s10552-010-9619-1; Brennan SF, 2010, AM J CLIN NUTR, V91, P1294, DOI 10.3945/ajcn.2009.28796; De Stefani E, 2008, LUNG CANCER, V61, P283, DOI 10.1016/j.lungcan.2008.01.004; De Stefani E, 2008, ANTICANCER RES, V28, P2499; De Stefani E, 2007, INT J CANCER, V121, P1086, DOI 10.1002/ijc.22765; De Stefani E, 2012, ASIAN PAC J CANCER P, V13, P231, DOI 10.7314/APJCP.2012.13.1.231; De Stefani E, 2011, ASIAN PAC J CANCER P, V12, P753; Deneo-Pellegrini H, 2013, CANCER CAUSE CONTROL, V24, P1167, DOI 10.1007/s10552-013-0196-y; Edefonti V, 2012, ANN ONCOL, V23, P1869, DOI 10.1093/annonc/mdr548; Edefonti V, 2008, INT J CANCER, V122, P609, DOI 10.1002/ijc.23064; Edefonti V, 2010, ORAL ONCOL, V46, P343, DOI 10.1016/j.oraloncology.2009.11.017; Edefonti V, 2010, CANCER EPIDEM BIOMAR, V19, P18, DOI 10.1158/1055-9965.EPI-09-0900; Ferrari P, 2008, INT J EPIDEMIOL, V37, P368, DOI 10.1093/ije/dym242; Freedman Laurence S, 2010, Epidemiol Perspect Innov, V7, P2, DOI 10.1186/1742-5573-7-2; Freisling H, 2010, J NUTR, V140, P1280, DOI 10.3945/jn.110.121152; Gibney MJ, 2005, AM J CLIN NUTR, V82, P497, DOI 10.1093/ajcn/82.3.497; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Imamura F, 2009, AM J EPIDEMIOL, V170, P37, DOI 10.1093/aje/kwp096; Jacobs DR, 2007, NUTR REV, V65, P439, DOI [10.1111/j.1753-4887.2007.tb00269.x, 10.1301/nr.2007.oct.439-450]; Jenab M, 2009, HUM GENET, V125, P507, DOI 10.1007/s00439-009-0662-5; Johnson RA., 2007, APPL MULTIVARIATE ST; Kaaks R, 1997, IARC Sci Publ, P103; Kaaks R, 1997, INT J EPIDEMIOL, V26, pS15, DOI 10.1093/ije/26.suppl_1.S15; KRZANOWSKI WJ, 1979, J AM STAT ASSOC, V74, P703, DOI 10.2307/2286995; McCann SE, 2001, PUBLIC HEALTH NUTR, V4, P903, DOI 10.1079/PHN2001122; Millen BE, 2001, J AM DIET ASSOC, V101, P187, DOI 10.1016/S0002-8223(01)00051-7; Newby PK, 2004, NUTR REV, V62, P177, DOI [10.1111/j.1753-4887.2004.tb00040.x, 10.1301/rn.2004.may.177-203]; O'Sullivan A, 2011, AM J CLIN NUTR, V93, P314, DOI 10.3945/ajcn.110.000950; Palli D, 2001, CANCER CAUSE CONTROL, V12, P163, DOI 10.1023/A:1008970310963; Randi G, 2010, NUTR REV, V68, P389, DOI 10.1111/j.1753-4887.2010.00299.x; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Ronco AL, 2010, ASIAN PAC J CANCER P, V11, P519; Schulze Matthias B, 2002, Curr Atheroscler Rep, V4, P462, DOI 10.1007/s11883-002-0051-1; Skeie G, 2009, EUR J CLIN NUTR, V63, pS226, DOI 10.1038/ejcn.2009.83; Slimani N, 2007, EUR J CLIN NUTR, V61, P1037, DOI 10.1038/sj.ejcn.1602679; Slimani N, 2002, PUBLIC HEALTH NUTR, V5, P1125, DOI 10.1079/PHN2002395; Slimani N, 2011, EUR J CLIN NUTR, V65, pS5, DOI 10.1038/ejcn.2011.83; Slimani N, 2002, PUBLIC HEALTH NUTR, V5, P1311, DOI 10.1079/PHN2002407; Slimani N, 2000, EUR J CLIN NUTR, V54, P900, DOI 10.1038/sj.ejcn.1601107; Slimani N, 2009, EUR J CLIN NUTR, pS1; Slimani N, 2014, METHODS DETERMINE DI; Tucker KL, 2010, APPL PHYSIOL NUTR ME, V35, P211, DOI 10.1139/H10-010; Turati F, 2011, EUR J CANCER PREV, V20, P456, DOI 10.1097/CEJ.0b013e328348fc0f; van Dam RM, 2005, BRIT J NUTR, V93, P573, DOI 10.1079/BJN20051453; Willett W., 2012, NUTR EPIDEMIOLOGY; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	56	37	38	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98647	10.1371/journal.pone.0098647	http://dx.doi.org/10.1371/journal.pone.0098647			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901309	Green Submitted, Green Published, gold			2022-12-27	WOS:000336841400042
J	Xing, H; Wang, DY; Han, FL; Sullivan, C; Ma, QY; He, YM; Hone, DWE; Yan, RH; Du, FM; Xu, X				Xing, Hai; Wang, Deyou; Han, Fenglu; Sullivan, Corwin; Ma, Qingyu; He, Yiming; Hone, David W. E.; Yan, Ronghao; Du, Fuming; Xu, Xing			A New Basal Hadrosauroid Dinosaur (Dinosauria: Ornithopoda) with Transitional Features from the Late Cretaceous of Henan Province, China	PLOS ONE			English	Article							CRANIAL ANATOMY; GANSU PROVINCE; ORNITHISCHIA; BIOGEOGRAPHY; PHYLOGENY; AGE	Background: Southwestern Henan Province in central China contains many down-faulted basins, including the Xixia Basin where the Upper Cretaceous continental sediments are well exposed. The Majiacun Formation is a major dinosaur-bearing stratigraphic unit that occurs in this basin. Methodology/Principal Findings: A new basal hadrosauroid dinosaur, Zhanghenglong yangchengensis gen. et sp. nov., is named based on newly collected specimens from the middle Santonian Majiacun Formation of Zhoujiagou Village, Xixia Basin. Two transitional features between basal hadrosauroids and hadrosaurids are attached to the diagnosis of the new taxon, namely five maxillary foramina consisting of four small scattered ones anteroposteriorly arranged in a row and a large one adjacent to the articular facet for the jugal, and dentary tooth crowns bearing both median and distally offset primary ridges. Zhanghenglong also displays a unique combination of plesiomorphic and derived features of hadrosauroids, and is clearly morphologically transitional between basal hadrosauroids and hadrosaurids. Furthermore, some measurement attributes in osteology are applied to the quantitative analysis of Zhanghenglong. For these attributes, the partition of the dataset on most hadrosauroid species resulting from model-based cluster analysis almost matches taxonomic separation between basal hadrosauroids and hadrosaurids. Data of Zhanghenglong on selected measurement attributes straddle the two combinations of intervals of partitioned datasets respectively related to basal hadrosauroids and hadrosaurids. This condition is similar to mosaic evolution of morphological characters present in the specimens of the taxon. The phylogenetic analysis of Hadrosauroidea recovers a clade composed of Zhanghenglong, Nanyangosaurus, and Hadrosauridae with an unresolved polytomy. Conclusions/Significance: Zhanghenglong is probably a relatively derived non-hadrosaurid hadrosauroid, based on the inferences made from the morphological comparisons, quantitative evaluation of measurements, and cladistic analysis. In combination with information on the stratigraphy, phylogeny and biogeography, the material of Zhanghenglong provides direct evidence for the hypothesis that hadrosaurids might have originated in Asia.	[Xing, Hai] China Univ Geosci, Coll Earth Sci & Resources, Beijing, Peoples R China; [Xing, Hai; Han, Fenglu; Sullivan, Corwin; He, Yiming; Xu, Xing] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China; [Xing, Hai] Canadian Museum Nat, Ottawa, ON K1P 6P4, Canada; [Wang, Deyou] Henan Acad Land & Resources Sci, Zhengzhou, Henan, Peoples R China; [Han, Fenglu; He, Yiming] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Ma, Qingyu] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Hone, David W. E.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Yan, Ronghao; Du, Fuming] Xixia Museum Dinosaur Fossil Eggs China, Xixia, Henan, Peoples R China	China University of Geosciences; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Bristol; University of London; Queen Mary University London	Xing, H (corresponding author), China Univ Geosci, Coll Earth Sci & Resources, Beijing, Peoples R China.	xinghaiivpp@gmail.com	Benton, Michael J/A-5639-2008	Benton, Michael J/0000-0002-4323-1824; Sullivan, Corwin/0000-0002-5488-6797	National Natural Science Foundation of China [41120124002, 41172037]; Graduate School of China University of Geosciences at Beijing [201225-B3001120058]; China Scholarship Council [20133009-201306400032]; Department of Land and Resources of Henan Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Graduate School of China University of Geosciences at Beijing; China Scholarship Council(China Scholarship Council); Department of Land and Resources of Henan Province	This work was funded by grants from the National Natural Science Foundation of China (41120124002 and 41172037), the Graduate School of China University of Geosciences at Beijing (201225-B3001120058), the China Scholarship Council (20133009-201306400032), and the Department of Land and Resources of Henan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averianov A., 2012, Journal of Stratigraphy, V36, P462; Averianov A. O., 2012, Trudy Zoologicheskogo Instituta, V316, P139; Barrett PM, 2009, ACTA PALAEONTOL POL, V54, P35, DOI 10.4202/app.2009.0105; Bolotsky YL, 2004, J VERTEBR PALEONTOL, V24, P351, DOI 10.1671/1110; BRETTSURMAN MK, 1979, NATURE, V277, P560, DOI 10.1038/277560a0; Cope E.D., 1869, T AM PHIL SOC, V14, P1; CURRIE PJ, 1991, CAN J EARTH SCI, V28, P102, DOI 10.1139/e91-009; Cuthbertson RS, 2010, ZOOL J LINN SOC-LOND, V159, P373, DOI 10.1111/j.1096-3642.2009.00612.x; Dalla Vecchia FM, 2009, J VERTEBR PALEONTOL, V29, P1100, DOI 10.1671/039.029.0428; [David W.E.HONE 洪大卫], 2010, [古脊椎动物学报, Vertebrata Palasiatica], V48, P19; DOLLO L, 1888, CR HEBD ACAD SCI, V106, P775; Evans DC, 2007, J VERTEBR PALEONTOL, V27, P373, DOI 10.1671/0272-4634(2007)27[373:AAROLM]2.0.CO;2; Evans DC, 2010, ZOOL J LINN SOC-LOND, V159, P398, DOI 10.1111/j.1096-3642.2009.00611.x; Fraley C., 2006, 504 U WASH DEP STAT, P1; Fraley C, 1998, 329 U WASH DEP STAT, P1; Gates TA, 2011, J VERTEBR PALEONTOL, V31, P798, DOI 10.1080/02724634.2011.577854; Gilmore CW, 1933, B AM MUS NAT HIST, V67, P23; Godefroit P, 2004, ACTA PALAEONTOL POL, V49, P585; Godefroit Pascal, 1998, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V68, P3; Godefroit P, 2008, ACTA PALAEONTOL POL, V53, P47, DOI 10.4202/app.2008.0103; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Head JJ, 1998, J VERTEBR PALEONTOL, V18, P718, DOI 10.1080/02724634.1998.10011101; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Horner John R., 1994, P312; Horner JR, 1992, MUSEUM ROCKIES OCCAS, V2, P1; Hu C.Z., 1973, ACTA GEOL SINICA, V2, P179; Kirkland James I., 1998, Bulletin of the New Mexico Museum of Natural History and Science, V14, P283; Langston WJ., 1960, FTELDIANA GEOL MEM, V3, P319; Lauters P, 2008, PALAIOS, V23, P153, DOI 10.2110/palo.2006.p06-031r; Lull R. S., 1942, Geological Society of America Special Paper, V40, P1; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; MARYANSKA T, 1984, Palaeontologia Polonica, P119; McDonald AT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045712; Mo JY, 2007, ACTA GEOL SIN-ENGL, V81, P550; Norman D.B., 1986, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V56, P281; Norman DB, 2002, ZOOL J LINN SOC-LOND, V136, P113, DOI 10.1046/j.1096-3642.2002.00027.x; Norman DB, 1998, ZOOL J LINN SOC-LOND, V122, P291; OSTROM JOHN H., 1961, BULL AMER MUS NAT HIST, V122, P33; Owen R., 1842, REPORTS BRIT ASS ADV, V11, P60; Prieto-Marquez A, 2006, ACTA PALAEONTOL POL, V51, P77; Prieto-Marquez A., 2010, ZOOLOGICAL J LINNEAN, V159, P135; Prieto-Marquez A, 2011, ZOOTAXA, P61; Prieto-Marquez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038207; Prieto-Marquez A, 2010, AM MUS NOVIT, P1, DOI 10.1206/3694.2; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P503, DOI 10.1111/j.1096-3642.2010.00642.x; Prieto-Marquez A, 2009, CRETACEOUS RES, V30, P1238, DOI 10.1016/j.cretres.2009.06.005; Riabinin AN, 1939, T TSENTRALNOGO NAUCH, V118, P3; Rozhdestvensky AK, 1966, PALEONTOL ZH, V1966, P103; Rozhdestvensky AK, 1968, UPPER PALEOZOIC MESO, P97; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno P.C., 1998, NEUES JB GEOLOGIE PA, V210, P41, DOI DOI 10.1127/NJGPA/210/1998/41; SERENO PC, 1986, NATL GEOGR RES, V2, P234; Sereno PC, 1997, ANNU REV EARTH PL SC, V25, P435, DOI 10.1146/annurev.earth.25.1.435; Sues HD, 2009, P R SOC B, V276, P2549, DOI 10.1098/rspb.2009.0229; Tang F, 2001, CRETACEOUS RES, V22, P115, DOI 10.1006/cres.2000.0242; Taquet R, 1976, CHAPITRE, P57; Wagner JR, 2009, J VERTEBR PALEONTOL, V29, P605, DOI 10.1671/039.029.0208; Wang D.Y., 2008, DINOSAUR EGGS SKELET, P1; Wang Deyou, 2013, Dizhi Xuebao, V87, P1049; WEISHAMPEL DB, 1993, PALAEONTOLOGY, V36, P361; Wiman C., 1929, Palaeontologia Sinica C vi, V1, P1; Wing Scott L., 1992, P327; Xi W-X, 1997, LITHOSTRATIGRAPHY HE, P1; Xing H., 2012, P 13 ANN M CHIN SOC, P1; Xing Hai, 2012, Vertebrata Palasiatica, V50, P160; Xu X, 2010, ZOOTAXA, P1; Xu Xing, 2000, Vertebrata Palasiatica, V38, P176; You HL, 2009, CAN J EARTH SCI, V46, P949, DOI 10.1139/E09-067; You H, 2011, ACTA GEOL SIN-ENGL, V85, P51, DOI 10.1111/j.1755-6724.2011.00377.x; You HL, 2003, CRETACEOUS RES, V24, P347, DOI 10.1016/S0195-6671(03)00048-X; You HL, 2003, ACTA GEOL SIN-ENGL, V77, P148; YOUNG CC, 1958, PALAEONTOLOGIA SIN C, V16, P53	72	25	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98821	10.1371/journal.pone.0098821	http://dx.doi.org/10.1371/journal.pone.0098821			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901454	Green Published, Green Submitted, gold			2022-12-27	WOS:000336841400057
J	Yu, C; Zhang, YG; Yao, SH; Wei, YQ				Yu, Chuan; Zhang, Yaguang; Yao, Shaohua; Wei, Yuquan			A PCR Based Protocol for Detecting Indel Mutations Induced by TALENs and CRISPR/Cas9 in Zebrafish	PLOS ONE			English	Article							TARGETED MUTAGENESIS; HUMAN-CELLS; GENOME; RECOMBINATION; NUCLEASE; GENE	Genome editing techniques such as the zinc-finger nucleases (ZFNs), transcription activator-like effecter nucleases (TALENs) and clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) system Cas9 can induce efficient DNA double strand breaks (DSBs) at the target genomic sequence and result in indel mutations by the error-prone non-homologous end joining (NHEJ) DNA repair system. Several methods including sequence specific endonuclease assay, T7E1 assay and high resolution melting curve assay (HRM) etc have been developed to detect the efficiency of the induced mutations. However, these assays have some limitations in that they either require specific sequences in the target sites or are unable to generate sequencing-ready mutant DNA fragments or unable to distinguish induced mutations from natural nucleotide polymorphism. Here, we developed a simple PCR-based protocol for detecting indel mutations induced by TALEN and Cas9 in zebrafish. We designed 2 pairs of primers for each target locus, with one putative amplicon extending beyond the putative indel site and the other overlapping it. With these primers, we performed a qPCR assay to efficiently detect the frequencies of newly induced mutations, which was accompanied with a T-vector-based colony analysis to generate single-copy mutant fragment clones for subsequent DNA sequencing. Thus, our work has provided a very simple, efficient and fast assay for detecting induced mutations, which we anticipate will be widely used in the area of genome editing.	[Yao, Shaohua] West China Hosp, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China; West China Hosp, Ctr Canc, Chengdu, Sichuan, Peoples R China; Sichuan Univ, Coll Life Sci, Chengdu 610064, Sichuan, Peoples R China	Sichuan University	Yao, SH (corresponding author), West China Hosp, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China.	Shaohuayao@scu.edu.cn	Zhang, Yaguang/GZM-9859-2022; Yu, Chuan/AAC-1440-2019	Zhang, Yaguang/0000-0002-9216-1834; Yao, Shaohua/0000-0002-0191-4889	National Natural Science Foundation of China [81372143, 31000646]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (No. 81372143 and No. 31000646). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Haber JE, 2000, CURR OPIN CELL BIOL, V12, P286, DOI 10.1016/S0955-0674(00)00090-9; Hisano Y, 2013, BIOL OPEN, V2, P363, DOI 10.1242/bio.20133871; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Kim HJ, 2009, GENOME RES, V19, P1279, DOI 10.1101/gr.089417.108; Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/NMETH.1733, 10.1038/nmeth.1733]; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Liang Z, 2014, J GENET GENOMICS, V41, P63, DOI 10.1016/j.jgg.2013.12.001; Liu X, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3565; Lo TW, 2013, GENETICS, V195, P331, DOI 10.1534/genetics.113.155382; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; ORUM H, 1993, NUCLEIC ACIDS RES, V21, P5332, DOI 10.1093/nar/21.23.5332; Ota S, 2013, GENES CELLS, V18, P450, DOI 10.1111/gtc.12050; RIGAT B, 1992, NUCLEIC ACIDS RES, V20, P1433, DOI 10.1093/nar/20.6.1433-a; van der Oost J, 2013, SCIENCE, V339, P768, DOI 10.1126/science.1234726; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Xing LY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043968; Zu Y, 2013, NAT METHODS, V10, P329, DOI 10.1038/NMETH.2374	23	58	63	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98282	10.1371/journal.pone.0098282	http://dx.doi.org/10.1371/journal.pone.0098282			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901507	gold, Green Submitted, Green Published			2022-12-27	WOS:000336841400023
J	Berhane, Y; Worku, A; Demissie, M; Tesfaye, N; Asefa, N; Aniemaw, W; Weldearegawi, B; Kebede, Y; Shiferaw, T; Worku, A; Olijira, L; Merdekios, B; Ashebir, Y; Tadesse, T; Dessie, Y; Meseret, S; Ayele, G				Berhane, Yemane; Worku, Alemayehu; Demissie, Meaza; Tesfaye, Neghist; Asefa, Nega; Aniemaw, Worku; Weldearegawi, Berhe; Kebede, Yigzaw; Shiferaw, Tigist; Worku, Amare; Olijira, Lemessa; Merdekios, Behailu; Ashebir, Yemane; Tadesse, Takele; Dessie, Yadeta; Meseret, Solomon; Ayele, Gestane			Children Who Received PCV-10 Vaccine from a Two-Dose Vial without Preservative Are Not More Likely to Develop Injection Site Abscess Compared with Those Who Received Pentavalent (DPT-HepB-Hib) Vaccine: A Longitudinal Multi-Site Study	PLOS ONE			English	Article							SAFETY	Background: The single dose pneumonia ten-valent vaccine has been widely used and is highly efficacious against selected Streptococcus pneumonia. A two-dose vial without preservative is being introduced in developing countries to reduce the cost of the vaccine. In routine settings improper immunization practice could result in microbial contamination leading to adverse events following immunization. Objective: To monitor adverse events following immunization recommended for routine administration during infancy by comparing the rate of injection-site abscess between children who received PCV-10 vaccine and children who received the Pentavalent (DPT-HepB-Hib) vaccine. Methods: A longitudinal population-based multi-site observational study was conducted between September 2011 and October 2012. The study was conducted in four existing Health and Demographic Surveillance sites run by public universities of Abraminch, Haramaya, Gondar and Mekelle. Adverse events following Immunization were monitored by trained data collectors. Children were identified at the time of vaccination and followed at home at 48 hour and 7 day following immunization. Incidence of abscess and relative risk with the corresponding 95% Confidence Intervals were calculated to examine the risk difference in the comparison groups. Results: A total of 55, 268 PCV and 37, 480 Pentavalent (DPT-HepB-Hib) vaccinations were observed. A total of 19 adverse events following immunization, 10 abscesses and 9 deaths, were observed during the one year study period. The risk of developing abscess was not statistically different between children who received PCV-10 vaccine and those received Pentavalent (RR = 2.7, 95% CI 0.576-12.770), and between children who received the first aliquot of PCV and those received the second aliquot of PCV (RR = 1.72, 95% CI 0.485-6.091). Conclusion: No significant increase in the risk of injection site abscess was observed between the injection sites of PCV-10 vaccine from a two-dose vial without preservative and pentavalent (DPT-HepB-Hib) vaccine in the first 7 days following vaccination.	[Berhane, Yemane; Worku, Alemayehu; Demissie, Meaza; Shiferaw, Tigist; Worku, Amare] Addis Continental Inst Publ Hlth, Addis Ababa, Ethiopia; [Tesfaye, Neghist] Fed Minist Hlth, Addis Ababa, Ethiopia; [Asefa, Nega; Olijira, Lemessa; Dessie, Yadeta] Haramaya Univ, Coll Hlth Sci, Harar, Ethiopia; [Aniemaw, Worku; Merdekios, Behailu; Ayele, Gestane] Arbaminch Univ, Coll Med & Hlth Sci, Arbaminch, Ethiopia; [Weldearegawi, Berhe; Ashebir, Yemane] Mekelle Univ, Dept Publ Hlth, Mekelle, Ethiopia; [Kebede, Yigzaw; Tadesse, Takele; Meseret, Solomon] Univ Gondar Gondar, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia	Addis Continental Institute of Public Health; Federal Ministry of Health - Ethiopia (FMOH); Haramaya University; Arba Minch University; Mekelle University	Worku, A (corresponding author), Addis Continental Inst Publ Hlth, Addis Ababa, Ethiopia.	alemayehuwy@yahoo.com	Woldeyohannes, Solomon Meseret/E-5783-2012; Bacha, Yadeta/AAF-8849-2021; Berhane, Yemane/ABB-8154-2020	Assefa, Nega/0000-0003-0341-2329; Berhane, Yemane/0000-0002-2527-1339; Sahle, Berhe W/0000-0003-3243-9176; Oljira, Lemessa/0000-0003-4542-2509	GlaxoSmithKline Biologicals (GSK)	GlaxoSmithKline Biologicals (GSK)(GlaxoSmithKline)	The source of funding for the study was GlaxoSmithKline Biologicals (GSK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chevallier B, 2009, PEDIATR INFECT DIS J, V28, pS109, DOI 10.1097/INF.0b013e318199f62d; Clements CJ, 2005, EXPERT REV VACCINES, V4, P281, DOI 10.1586/14760584.4.3.281; Drain PK, 2003, B WORLD HEALTH ORGAN, V81, P726; Fitzner J, 2004, VACCINE, V23, P156, DOI 10.1016/j.vaccine.2004.05.018; Knuf A, 2006, VACCINE, V24, P4727, DOI 10.1016/j.vaccine.2006.03.032; National Center for Immunization Research and Surveillance, 2021, HIST IMM AUSTR; Olivier C, 2008, VACCINE, V26, P3142, DOI 10.1016/j.vaccine.2007.11.096; Steven Black, 2009, PEDIAT HLTH, V3, P329; Tichmann-Schumann I, 2005, PEDIATR INFECT DIS J, V24, P70, DOI 10.1097/01.inf.0000148923.46453.48; Zhou Weigong, 2003, MMWR Surveill Summ, V52, P1	10	4	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e97376	10.1371/journal.pone.0097376	http://dx.doi.org/10.1371/journal.pone.0097376			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896582	gold, Green Published			2022-12-27	WOS:000338430700010
J	Kang, ZH; Wang, CY; Zhang, WL; Zhang, JT; Yuan, CH; Zhao, PW; Lin, YY; Hong, S; Li, CY; Wang, L				Kang, Zhen-Hua; Wang, Chun-Yan; Zhang, Wen-Liang; Zhang, Jian-Tao; Yuan, Chun-Hua; Zhao, Ping-Wei; Lin, Yu-Yang; Hong, Sen; Li, Chen-Yao; Wang, Lei			Histone Deacetylase HDAC4 Promotes Gastric Cancer SGC-7901 Cells Progression via p21 Repression	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; EXPRESSION; ACTIVATION; INHIBITORS	Gastric cancer (GC) is one of the leading causes of cancer death in the world. The role of histone deacetylase 4 (HDAC4) in specific cell and tissue types has been identified. However, its biological roles in the development of gastric cancer remain largely unexplored. Quantitative real time PCR (qRT-PCR) and western blot were used to analyze the expression of HDAC4 in the clinical samples. siRNA and overexpression of HDAC4 and siRNA p21 were used to study functional effects in a proliferation, a colony formation, a adenosine 5'-triphosphate (ATP) assay and reactive oxygen species(ROS) generation, cell cycle, cell apoptosis rates, and autophagy assays. HDAC4 was up-regulated in gastric cancer tissues and several gastric cancer cell lines. The proliferation, colony formation ability and ATP level were enhanced in HDAC4 overexpression SGC-7901 cells, but inhibited in HDAC4 knockdown SGC-7901 cells. HDAC4 knockdown led to G0/G1 phase cell arrest and caused apoptosis and ROS increase. Moreover, HDAC4 was found to inhibit p21 expression in gastric cancer SGC-7901 cells. p21 knockdown dramatically attenuated cell proliferation inhibition, cell cycle arrest, cell apoptosis promotion and autophagy up-regulation in HDAC4-siRNA SGC-7901 cells. We demonstrated that HDAC4 promotes gastric cancer cell progression mediated through the repression of p21. Our results provide an experimental basis for understanding the pro-tumor mechanism of HDAC4 as treatment for gastric cancer.	[Kang, Zhen-Hua; Zhang, Wen-Liang; Zhang, Jian-Tao; Yuan, Chun-Hua; Zhao, Ping-Wei; Lin, Yu-Yang; Hong, Sen; Li, Chen-Yao; Wang, Lei] Jilin Univ, Hosp 1, Dept Colorectal & Anus Surg, Changchun 130023, Peoples R China; [Wang, Chun-Yan] Tumor Res Inst JiLin Prov, Changchun, Peoples R China	Jilin University	Wang, L (corresponding author), Jilin Univ, Hosp 1, Dept Colorectal & Anus Surg, Changchun 130023, Peoples R China.	kzh5566@163.com			Health Department of JiLin Province [2012z119]	Health Department of JiLin Province	This work was supported by a grant from the Health Department of JiLin Province (No. 2012z119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Aoyagi Keishiro, 2003, Kurume Medical Journal, V50, P1; Bolger TA, 2005, J NEUROSCI, V25, P9544, DOI 10.1523/JNEUROSCI.1826-05.2005; Crew KD, 2004, SEMIN ONCOL, V31, P450, DOI 10.1053/j.seminoncol.2004.04.021; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gurvich N, 2004, CANCER RES, V64, P1079, DOI 10.1158/0008-5472.CAN-03-0799; Kao GD, 2003, J CELL BIOL, V160, P1017, DOI 10.1083/jcb.200209065; Khan HA, 2003, J BIOSCIENCES, V28, P379, DOI 10.1007/BF02705114; Kim JS, 2001, BIOCHEM BIOPH RES CO, V281, P866, DOI 10.1006/bbrc.2001.4434; Lee J, 2011, ONCOL REP, V25, P1517, DOI 10.3892/or.2011.1219; Liu F, 2006, MOL BIOL CELL, V17, P585, DOI 10.1091/mbc.E05-08-0775; Luo DH, 2014, ONCOL LETT, V7, P471, DOI 10.3892/ol.2013.1751; Mottet D, 2009, ONCOGENE, V28, P243, DOI 10.1038/onc.2008.371; Mutze K, 2010, ANN SURG ONCOL, V17, P3336, DOI 10.1245/s10434-010-1182-1; Ogawa M, 2001, INT J MOL MED, V7, P479; Park SY, 2011, ONCOL REP, V25, P1677, DOI 10.3892/or.2011.1236; Qu WL, 2013, INT J BIOL SCI, V9, P766, DOI 10.7150/ijbs.5711; Selimovic D, 2013, CELL SIGNAL, V25, P308, DOI 10.1016/j.cellsig.2012.10.004; Shabason JE, 2010, ONCOLOGY-NY, V24, P180; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Wilson AJ, 2008, MOL BIOL CELL, V19, P4062, DOI 10.1091/mbc.E08-02-0139; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Yuan RR, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-45	23	61	64	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98894	10.1371/journal.pone.0098894	http://dx.doi.org/10.1371/journal.pone.0098894			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896240	gold, Green Published, Green Submitted			2022-12-27	WOS:000338430700092
J	Mooij, SH; Boot, HJ; Speksnijder, AGCL; Meijer, CJLM; King, AJ; Verhagen, DWM; de Vries, HJC; Quint, WGV; Molijn, A; de Koning, MNC; van der Sande, MAB; van der Loeff, MFS				Mooij, Sofie H.; Boot, Hein J.; Speksnijder, Arjen G. C. L.; Meijer, Chris J. L. M.; King, Audrey J.; Verhagen, Dominique W. M.; de Vries, Henry J. C.; Quint, Wim G. V.; Molijn, Anco; de Koning, Maurits N. C.; van der Sande, Marianne A. B.; van der Loeff, Maarten F. Schim			Six-Month Incidence and Persistence of Oral HPV Infection in HIV-Negative and HIV-Infected Men Who Have Sex with Men	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; NECK-CANCER; NATURAL-HISTORY; GAMMAPAPILLOMAVIRUS GENERA; UNITED-STATES; RISK-FACTORS; YOUNG MEN; HEAD; PREVALENCE; METAANALYSIS	Objectives: Our aim was to assess incidence and persistence of oral HPV infection in HIV-negative and HIV-infected men who have sex with men (MSM). Methods: MSM aged >= 18 years were included in Amsterdam (the Netherlands) in 2010-2011, and followed up 6 months later. Participants completed risk factor questionnaires. HPV DNA was analyzed in oral-rinse and gargle specimens using the SPF10-PCR DEIA/LiPA(25) system (version 1). A subset of oral samples was subjected to SPF10 sequencing to identify additional HPV types. Multivariable logistic regression analyses using generalized estimating equations (GEE) were performed to assess determinants for oral high-risk HPV incidence and persistence. Results: 689/795 participant MSM provided both baseline and 6-month data. Baseline prevalence of high-risk HPV was 9.4% in HIV-negative and 23.9% in HIV-infected MSM (P<0.001). 56/689 MSM acquired >= 1 high-risk HPV infection (6-month incidence 8.1%; 95%CI 6.2-10.4%); incidence was 4.1% in HIV-negative and 14.1% in HIV-infected MSM (P<0.001). HIV infection and recent use of cannabis were both independently associated with high-risk HPV incidence. Persistent high-risk HPV was observed in 48/130 (36.9%) infections. Conclusion: Incidence of oral high-risk HPV infection in MSM is substantial, and is associated with HIV infection. Over a third of HPV infections persisted over a 6-month period.	[Mooij, Sofie H.; Speksnijder, Arjen G. C. L.; de Vries, Henry J. C.; van der Loeff, Maarten F. Schim] Publ Hlth Serv Amsterdam, Cluster Infect Dis, Amsterdam, Netherlands; [Boot, Hein J.; King, Audrey J.; de Vries, Henry J. C.; van der Sande, Marianne A. B.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [Meijer, Chris J. L. M.] Vrije Univ Amsterdam, Univ Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Verhagen, Dominique W. M.] Jan van Goyen Med Ctr, Dept Internal Med, Amsterdam, Netherlands; [Mooij, Sofie H.; van der Loeff, Maarten F. Schim] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [de Vries, Henry J. C.] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands; [Quint, Wim G. V.; Molijn, Anco; de Koning, Maurits N. C.] DDL Diagnost Lab, Rijswijk, Netherlands; [van der Sande, Marianne A. B.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Public Health Service Amsterdam; Netherlands National Institute for Public Health & the Environment; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; DDL Diagnostic Laboratory; Utrecht University; Utrecht University Medical Center	Mooij, SH (corresponding author), Publ Hlth Serv Amsterdam, Cluster Infect Dis, Amsterdam, Netherlands.	somooij@ggd.amsterdam.nl	Speksnijder, Arjen/M-3406-2017; de Vries, Henry/K-5963-2012	Speksnijder, Arjen/0000-0002-1966-7265; de Vries, Henry/0000-0001-9784-547X; van der Sande, Marianne AB/0000-0002-4778-6739	Aids Fonds [2009029]; Public Health Service of Amsterdam; RIVM; Sanofi Pasteur MSD; Stichting Pathologie Onderzoek en Ontwikkeling (SPOO); Netherlands National Institute for Public Health and the Environment	Aids Fonds; Public Health Service of Amsterdam; RIVM; Sanofi Pasteur MSD; Stichting Pathologie Onderzoek en Ontwikkeling (SPOO); Netherlands National Institute for Public Health and the Environment	This work was supported by Aids Fonds [grant number 2009029], and additional funding from the Public Health Service of Amsterdam and RIVM. Laboratory analysis of the 6-month oral samples was funded by Sanofi Pasteur MSD through an unrestricted grant. SPF10 sequencing of oral samples was funded by Stichting Pathologie Onderzoek en Ontwikkeling (SPOO). The Amsterdam Cohort Studies on HIV infection and AIDS, a collaboration between the Public Health Service of Amsterdam, the Academic Medical Center of the University of Amsterdam, Sanquin Blood Supply Foundation, and the University Medical Center Utrecht, are part of the Netherlands HIV Monitoring Foundation and financially supported by the Netherlands National Institute for Public Health and the Environment. DDL Diagnostic Laboratory provided support in the form of salaries for authors W. Quint, A. Molijn, and M. de Koning, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beachler DC, 2013, J INFECT DIS, V208, P330, DOI 10.1093/infdis/jit170; Beachler DC, 2012, CANCER EPIDEM BIOMAR, V21, P122, DOI 10.1158/1055-9965.EPI-11-0734; Bottalico D, 2011, J INFECT DIS, V204, P787, DOI 10.1093/infdis/jir383; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; D'Souza G, 2009, J INFECT DIS, V199, P1263, DOI 10.1086/597755; Dayyani F, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-15; Edelstein ZR, 2012, SEX TRANSM DIS, V39, P860, DOI 10.1097/OLQ.0b013e318269d098; Fakhry C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011918; Feller L, 2010, HEAD FACE MED, V6, DOI 10.1186/1746-160X-6-15; Forslund O, 2013, J INFECT DIS, V208, P1335, DOI 10.1093/infdis/jit326; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Gillison ML, 2012, JAMA-J AM MED ASSOC, V307, P693, DOI 10.1001/jama.2012.101; Goon PKC, 2009, HEAD NECK ONCOL, V1, DOI 10.1186/1758-3284-1-36; Gravitt PE, 2011, J CLIN INVEST, V121, P4593, DOI 10.1172/JCI57149; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Heijman RLJ, 2009, SEX TRANSM INFECT, V85, P249, DOI 10.1136/sti.2008.033258; Hobbs CGL, 2006, CLIN OTOLARYNGOL, V31, P259, DOI 10.1111/j.1749-4486.2006.01246.x; Hocking JS, 2011, BRIT J CANCER, V104, P886, DOI 10.1038/sj.bjc.6606091; Isayeva T, 2012, HEAD NECK PATHOL, V6, pS104, DOI 10.1007/s12105-012-0368-1; Jansen IAV, 2011, AIDS, V25, P493, DOI 10.1097/QAD.0b013e328342fbe9; Kreimer AR, 2013, LANCET, V382, P877, DOI 10.1016/S0140-6736(13)60809-0; Kreimer AR, 2010, SEX TRANSM DIS, V37, P386, DOI 10.1097/OLQ.0b013e3181c94a3b; Kreimer AR, 2004, J INFECT DIS, V189, P686, DOI 10.1086/381504; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Kuhs KAL, 2013, J INFECT DIS, V208, P1643, DOI 10.1093/infdis/jit369; Louvanto K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053413; Mehanna H, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4684; Molijn A, 2005, J CLIN VIROL, V32, pS43, DOI 10.1016/j.jcv.2004.12.004; Mooij SH, 2013, AIDS, V27, P2117, DOI 10.1097/QAD.0b013e328362395c; Munday JS, 2007, VET DERMATOL, V18, P241, DOI 10.1111/j.1365-3164.2007.00600.x; Pickard RKL, 2012, SEX TRANSM DIS, V39, P559, DOI 10.1097/OLQ.0b013e31824f1c65; Rietbergen MM, 2013, INT J CANCER, V132, P1565, DOI 10.1002/ijc.27821; Said AK, 2013, J ORAL PATHOL MED, V42, P435, DOI 10.1111/jop.12009; Silverberg MJ, 2009, AIDS, V23, P2337, DOI 10.1097/QAD.0b013e3283319184; Steinau M, 2012, J ORAL PATHOL MED, V41, P288, DOI 10.1111/j.1600-0714.2011.01093.x; Veldhuijzen NJ, 2010, LANCET INFECT DIS, V10, P862, DOI 10.1016/S1473-3099(10)70190-0; Xue XN, 2010, CANCER EPIDEM BIOMAR, V19, P159, DOI 10.1158/1055-9965.EPI-09-0546	38	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98955	10.1371/journal.pone.0098955	http://dx.doi.org/10.1371/journal.pone.0098955			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896848	gold, Green Published, Green Submitted			2022-12-27	WOS:000338430700101
J	Raj, A; Pandya, S; Shen, XB; LoCastro, E; Nguyen, TD; Gauthier, SA				Raj, Ashish; Pandya, Sneha; Shen, Xiaobo; LoCastro, Eve; Nguyen, Thanh D.; Gauthier, Susan A.			Multi-Compartment T2 Relaxometry Using a Spatially Constrained Multi-Gaussian Model	PLOS ONE			English	Article							MYELIN WATER QUANTIFICATION; NMR RELAXATION DATA; HUMAN BRAIN; T-2 RELAXATION; WHITE-MATTER; MAGNETIZATION-TRANSFER; REGULARIZATION; SCLEROSIS; TISSUE; IRON	The brain's myelin content can be mapped by T2-relaxometry, which resolves multiple differentially relaxing T2 pools from multi-echo MRI. Unfortunately, the conventional fitting procedure is a hard and numerically ill-posed problem. Consequently, the T2 distributions and myelin maps become very sensitive to noise and are frequently difficult to interpret diagnostically. Although regularization can improve stability, it is generally not adequate, particularly at relatively low signal to noise ratio (SNR) of around 100-200. The purpose of this study was to obtain a fitting algorithm which is able to overcome these difficulties and generate usable myelin maps from noisy acquisitions in a realistic scan time. To this end, we restrict the T2 distribution to only 3 distinct resolvable tissue compartments, modeled as Gaussians: myelin water, intra/extra-cellular water and a slow relaxing cerebrospinal fluid compartment. We also impose spatial smoothness expectation that volume fractions and T2 relaxation times of tissue compartments change smoothly within coherent brain regions. The method greatly improves robustness to noise, reduces spatial variations, improves definition of white matter fibers, and enhances detection of demyelinating lesions. Due to efficient design, the additional spatial aspect does not cause an increase in processing time. The proposed method was applied to fast spiral acquisitions on which conventional fitting gives uninterpretable results. While these fast acquisitions suffer from noise and inhomogeneity artifacts, our preliminary results indicate the potential of spatially constrained 3-pool T2 relaxometry.	[Raj, Ashish; Pandya, Sneha; Shen, Xiaobo; LoCastro, Eve; Nguyen, Thanh D.] Weill Cornell Med Coll, Dept Radiol, New York, NY 10065 USA; [Gauthier, Susan A.] Weill Cornell Med Coll, Dept Neurol & Neurosci, New York, NY USA	Cornell University; Cornell University	Raj, A (corresponding author), Weill Cornell Med Coll, Dept Radiol, New York, NY 10065 USA.	asr2004@med.cornell.edu	Pandya, Sneha/AAA-6879-2020; Gauthier, susan/AAW-7082-2021	Pandya, Sneha/0000-0002-3284-2603; LoCastro, Eve/0000-0003-3975-8153	National MS Society [0711009544]; NIH [5P41RR02953, 1R01NS075425]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR002953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075425] Funding Source: NIH RePORTER	National MS Society(National Multiple Sclerosis Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National MS Society grant #0711009544 partially supported AR, TN and SG. AR was additionally supported by NIH grants 5P41RR02953 and 1R01NS075425. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews T, 2005, MAGN RESON MED, V54, P449, DOI 10.1002/mrm.20599; BERTERO M, 1982, P ROY SOC LOND A MAT, V383, P15, DOI 10.1098/rspa.1982.0117; Bjarnason TA, 2010, MAGN RESON MED, V63, P212, DOI 10.1002/mrm.22173; CHENG KH, 1994, MAGN RESON IMAGING, V12, P1099, DOI 10.1016/0730-725X(94)91242-O; Coleman TF, 1996, SIAM J OPTIMIZ, V6, P418, DOI 10.1137/0806023; Deoni SCL, 2008, MAGN RESON MED, V60, P1372, DOI 10.1002/mrm.21704; Does MD, 1996, MAGNET RESON MED, V35, P207, DOI 10.1002/mrm.1910350212; Du YP, 2007, MAGN RESON MED, V58, P865, DOI 10.1002/mrm.21409; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Friston KJ, 2006, STAT PARAMETRIC MAPP; Gareau PJ, 2000, J MAGN RESON IMAGING, V11, P586, DOI 10.1002/1522-2586(200006)11:6<586::AID-JMRI3>3.0.CO;2-V; Gelman N, 1999, RADIOLOGY, V210, P759, DOI 10.1148/radiology.210.3.r99fe41759; Graham SJ, 1996, MAGNET RESON MED, V35, P370, DOI 10.1002/mrm.1910350315; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; Hwang D, 2009, J MAGN RESON IMAGING, V30, P203, DOI 10.1002/jmri.21783; JACKSON GD, 1993, NEUROLOGY, V43, P1793, DOI 10.1212/WNL.43.9.1793; Jones CK, 2003, MAGNET RESON MED, V50, P206, DOI 10.1002/mrm.10492; Kolind SH, 2011, MAGN RESON MED, V65, P551, DOI 10.1002/mrm.22634; Kolind SH, 2009, MAGN RESON MED, V62, P106, DOI 10.1002/mrm.21966; Kumar D, 2012, MAGN RESON MED, V68, P1536, DOI 10.1002/mrm.24170; Lancaster JL, 2003, J MAGN RESON IMAGING, V17, P1, DOI 10.1002/jmri.10230; Laule C, 2004, J NEUROL, V251, P284, DOI 10.1007/s00415-004-0306-6; Laule C, 2008, NEUROIMAGE, V40, P1575, DOI 10.1016/j.neuroimage.2007.12.008; Laule C, 2007, NEUROTHERAPEUTICS, V4, P460, DOI 10.1016/j.nurt.2007.05.004; Levesque IR, 2010, MAGN RESON MED, V63, P633, DOI 10.1002/mrm.22244; Li X, 2011, IEEE T IMAGE PROCESS, V20, P971, DOI 10.1109/TIP.2010.2081681; LoCastro E, 2013, P INT SOC MAG RESON, V21, P3620; MacKay A, 2006, MAGN RESON IMAGING, V24, P515, DOI 10.1016/j.mri.2005.12.037; Meyers SM, 2009, MAGN RESON IMAGING, V27, P1096, DOI 10.1016/j.mri.2009.02.001; Morassi A, 2008, CISM COURSES LECT, P137; Neema M, 2009, NEUROIMAGE, V46, P633, DOI 10.1016/j.neuroimage.2009.03.001; Nguyen TD, 2012, MAGN RESON MED, V67, P614, DOI 10.1002/mrm.24128; Oh J, 2006, MAGN RESON IMAGING, V24, P33, DOI 10.1016/j.mri.2005.10.016; Olafsson V, 2006, I S BIOMED IMAGING, P5; ORDIDGE RJ, 1994, MAGNET RESON MED, V32, P335, DOI 10.1002/mrm.1910320309; Pell GS, 2006, J MAGN RESON IMAGING, V23, P248, DOI 10.1002/jmri.20490; Raj A, 2007, MAGN RESON MED, V57, P8, DOI 10.1002/mrm.21012; Raj A, 2011, NEUROIMAGE, V54, P396, DOI 10.1016/j.neuroimage.2010.07.040; St Pierre TG, 2005, BLOOD, V105, P855, DOI 10.1182/blood-2004-01-0177; Stanisz GJ, 2005, MAGNET RESON MED, V54, P507, DOI 10.1002/mrm.20605; Tychonoff A. N., 1977, SOLUTION ILL POSED P; Vavasour IM, 2009, J NEUROL SCI, V276, P49, DOI 10.1016/j.jns.2008.08.022; WHITTALL KP, 1991, J MAGN RESON, V95, P221, DOI 10.1016/0022-2364(91)90213-D; WHITTALL KP, 1989, J MAGN RESON, V84, P134, DOI 10.1016/0022-2364(89)90011-5; Whittall KP, 1997, MAGNET RESON MED, V37, P34, DOI 10.1002/mrm.1910370107; Wood SJ, 2010, PSYCHIAT RES-NEUROIM, V182, P180, DOI 10.1016/j.pscychresns.2009.12.003; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Ziliani F, 2001, REAL-TIME IMAGING, V7, P389, DOI 10.1006/rtim.2000.0208	48	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98391	10.1371/journal.pone.0098391	http://dx.doi.org/10.1371/journal.pone.0098391			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896833	Green Published, Green Submitted, gold			2022-12-27	WOS:000338430700039
J	Schittko, C; Hawa, M; Wurst, S				Schittko, Conrad; Hawa, Mahmoud; Wurst, Susanne			Using a Multi-Trait Approach to Manipulate Plant Functional Diversity in a Biodiversity-Ecosystem Function Experiment	PLOS ONE			English	Article							SPECIES RICHNESS; PRODUCTIVITY; INVASION; COMPLEMENTARITY; COMMUNITIES; RESISTANCE; REGRESSION; SELECTION; IDENTITY; ECOLOGY	A frequent pattern emerging from biodiversity-ecosystem function studies is that functional group richness enhances ecosystem functions such as primary productivity. However, the manipulation of functional group richness goes along with major disadvantages like the transformation of functional trait data into categories or the exclusion of functional differences between organisms in the same group. In a mesocosm study we manipulated plant functional diversity based on the multi-trait Functional Diversity (FD)-approach of Petchey and Gaston by using database data of seven functional traits and information on the origin of the species in terms of being native or exotic. Along a gradient ranging from low to high FD we planted 40 randomly selected eight-species mixtures under controlled conditions. We found a significant positive linear correlation of FD with aboveground productivity and a negative correlation with invasibility of the plant communities. Based on community-weighted mean calculations for each functional trait, we figured out that the traits N-fixation and species origin, i.e. being native or exotic, played the most important role for community productivity. Our results suggest that the identification of the impact of functional trait diversity and the relative contributions of relevant traits is essential for a mechanistic understanding of the role of biodiversity for ecosystem functions such as aboveground biomass production and resistance against invasion.	[Schittko, Conrad; Hawa, Mahmoud; Wurst, Susanne] Free Univ Berlin, Dahlem Ctr Plant Sci, Berlin, Germany	Free University of Berlin	Schittko, C (corresponding author), Free Univ Berlin, Dahlem Ctr Plant Sci, Berlin, Germany.	conrad.schittko@fu-berlin.de		Schittko, Conrad/0000-0002-2200-8762	Freie Universitat Berlin	Freie Universitat Berlin	Funded by Freie Universitat Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDULRAHMAN AA, 1989, J CHEM ECOL, V15, P2289, DOI 10.1007/BF01012082; Byun C, 2013, J ECOL, V101, P128, DOI 10.1111/1365-2745.12016; Casanoves F, 2011, METHODS ECOL EVOL, V2, P233, DOI 10.1111/j.2041-210X.2010.00082.x; Celesti-Grapow L, 2006, DIVERS DISTRIB, V12, P490, DOI 10.1111/j.1366-9516.2006.00282.x; Crawley M. J., 2009, R BOOK; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Elton C., 1958; Fargione JE, 2005, ECOL LETT, V8, P604, DOI 10.1111/j.1461-0248.2005.00753.x; Flombaum P, 2014, OECOLOGIA, V174, P559, DOI 10.1007/s00442-013-2775-8; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Kieschnick R, 2003, STAT MODEL, V3, P193, DOI 10.1191/1471082X03st053oa; Kleyer M, 2008, J ECOL, V96, P1266, DOI 10.1111/j.1365-2745.2008.01430.x; Klotz S, 2002, SCHRIFTENREIHE VEGET, V38; Kowarik I., 2003, BIOLOGISCHE INVASION; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Lavorel S, 2008, FUNCT ECOL, V22, P134, DOI 10.1111/j.1365-2435.2007.01339.x; LEPS J, 1982, VEGETATIO, V50, P53, DOI 10.1007/BF00120678; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Marquard E, 2009, ECOLOGY, V90, P3290, DOI 10.1890/09-0069.1; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; McIntyre S, 1999, J VEG SCI, V10, P621, DOI 10.2307/3237077; Mokany K, 2008, J ECOL, V96, P884, DOI 10.1111/j.1365-2745.2008.01395.x; MORGAN SP, 1988, J MARRIAGE FAM, V50, P929, DOI 10.2307/352104; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Myers N, 1996, P NATL ACAD SCI USA, V93, P2764, DOI 10.1073/pnas.93.7.2764; Naeem S, 2003, ECOL LETT, V6, P567, DOI 10.1046/j.1461-0248.2003.00471.x; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Petchey OL, 2004, ECOLOGY, V85, P847, DOI 10.1890/03-0226; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Pokorny ML, 2005, RESTOR ECOL, V13, P448, DOI 10.1111/j.1526-100X.2005.00056.x; Prasse R, 2001, LISTE WILDWACHSENDEN; Prieur-Richard AH, 2002, OIKOS, V99, P338, DOI 10.1034/j.1600-0706.2002.990215.x; R Core Team, 2021, R LANGUAGE ENV STAT; Roscher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036760; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; SCHROEDER F-G, 1969, Vegetatio, V16, P225; Schumacher J, 2009, OIKOS, V118, P1659, DOI 10.1111/j.1600-0706.2009.17711.x; Spaekova I, 2001, ECOL LETT, V4, P585, DOI 10.1046/j.1461-0248.2001.00277.x; Tilman D, 1999, SCIENCE, V286, P1099, DOI 10.1126/science.286.5442.1099; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Zao LH, 2001, APPL ENVIRON MICROB, V67, P2129, DOI 10.1128/AEM.67.5.2129-2135.2001	50	14	15	7	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99065	10.1371/journal.pone.0099065	http://dx.doi.org/10.1371/journal.pone.0099065			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897501	Green Published, gold, Green Submitted			2022-12-27	WOS:000338430700111
J	van Riet-Nales, DA; Romkens, EGAW; Saint-Raymond, A; Kozarewicz, P; Schobben, AFAM; Egberts, TCG; Rademaker, CMA				van Riet-Nales, Diana A.; Romkens, Erwin G. A. W.; Saint-Raymond, Agnes; Kozarewicz, Piotr; Schobben, Alfred F. A. M.; Egberts, Toine C. G.; Rademaker, Carin M. A.			Oral Medicines for Children in the European Paediatric Investigation Plans	PLOS ONE			English	Article							MINI-TABLETS; FORMULATIONS; ACCEPTANCE; INFANTS	Introduction: Pharmaceutical industry is no longer allowed to develop new medicines for use in adults only, as the 2007 Paediatric Regulation requires children to be considered also. The plans for such paediatric development called Paediatric Investigation Plans (PIPs) are subject to agreement by the European Medicines Agency (EMA) and its Paediatric Committee (PDCO). The aim of this study was to evaluate the key characteristics of oral paediatric medicines in the PIPs and the changes implemented as a result of the EMA/PDCO review. Methods: All PIPs agreed by 31 December 2011 were identified through a proprietary EMA-database. PIPs were included if they contained an agreed proposal to develop an oral medicine for children 0 to 11 years. Information on the therapeutic area (EMA classification system); target age range (as defined by industry) and pharmaceutical characteristics (active substance, dosage form(s) as listed in the PIP, strength of each dosage form, excipients in each strength of each dosage form) was extracted from the EMA website or the EMA/PDCO assessment reports. Results: A hundred and fifty PIPs were included corresponding to 16 therapeutic areas and 220 oral dosage forms in 431 strengths/compositions. Eighty-two PIPs (37%) included tablets, 44 (20%) liquids and 35 (16%) dosage forms with a specific composition/strength that were stored as a solid but swallowed as a liquid e. g. dispersible tablets. The EMA/PDCO review resulted in an increase of 13 (207 to 220) oral paediatric dosage forms and 44 (387 to 431) dosage forms with a specific composition/strength. For many PIPs, the target age range was widened and the excipient composition and usability aspects modified. Conclusion: The EMA/PDCO review realized an increase in the number of requirements for the development of oral dosage forms and a larger increase in the number of dosage forms with a specific composition/strength, both targeting younger children. Changes to their pharmaceutical design were less profound.	[van Riet-Nales, Diana A.; Schobben, Alfred F. A. M.] Med Evaluat Board Netherlands MEB, Dept Chem Pharmaceut Assessment, Utrecht, Netherlands; [van Riet-Nales, Diana A.; Romkens, Erwin G. A. W.; Schobben, Alfred F. A. M.; Egberts, Toine C. G.] Univ Utrecht, Fac Sci, UIPS, Dept Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [Saint-Raymond, Agnes] European Med Agcy, Human Med Special Areas, London, England; [Kozarewicz, Piotr] European Med Agcy, Qual Med, London, England; [Egberts, Toine C. G.; Rademaker, Carin M. A.] Univ Med Ctr Utrecht, Dept Clin Pharm, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center	van Riet-Nales, DA (corresponding author), Med Evaluat Board Netherlands MEB, Dept Chem Pharmaceut Assessment, Utrecht, Netherlands.	da.v.riet@cbg-meb.nl	Egberts, Toine/A-6625-2012; Egberts, Toine/K-4579-2019	Egberts, Toine/0000-0003-1758-7779; Egberts, Toine/0000-0003-1758-7779	Medicines Evaluation Board in the Netherlands (MEB); National Institute for Public Health and the Environment (RIVM)	Medicines Evaluation Board in the Netherlands (MEB); National Institute for Public Health and the Environment (RIVM)	This study was supported by a grant from the Medicines Evaluation Board in the Netherlands (MEB) and the National Institute for Public Health and the Environment (RIVM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegaert K, 2010, ARCH DIS CHILD, V95, P1054, DOI 10.1136/adc.2010.190330; [Anonymous], 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.660; Breitkreutz J, 2008, CLIN THER, V30, P2146, DOI 10.1016/j.clinthera.2008.11.016; European Medicines Agency Committee for Medicinal Products for Human use, 2011, GUID PHARM IN PRESS; European Medicines Agency Committee for Medicinal Products for Human Use, 2013, GUID PHARM DEV MED P; Fabiano V, 2011, PHARMACOL RES, V63, P362, DOI 10.1016/j.phrs.2011.01.006; Fowles JR, 2013, CRIT REV TOXICOL, V43, P363, DOI 10.3109/10408444.2013.792328; Klingmann V, 2013, J PEDIATR-US, V163, P1728, DOI 10.1016/j.jpeds.2013.07.014; McCann D, 2007, LANCET, V370, P1542; Mentzer D, 2014, INT J PHARMACEUT, V469, P240, DOI 10.1016/j.ijpharm.2014.03.019; Michele TM, 2002, J ASTHMA, V39, P391, DOI 10.1081/JAS-120004032; Ruiz BQ, 2014, EXPERT REV CLIN PHAR, V7, P25, DOI 10.1586/17512433.2014.857600; Saint Raymond Agnes, 2005, Paediatr Respir Rev, V6, P45; Sam T, 2012, INT J PHARMACEUT, V435, P115, DOI 10.1016/j.ijpharm.2012.05.024; Spomer N, 2012, ARCH DIS CHILD, V97, P283, DOI 10.1136/archdischild-2011-300958; Sundh UB, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3155; Thomson SA, 2009, PEDIATRICS, V123, pE235, DOI 10.1542/peds.2008-2059; van Riet-Nales DA, 2014, INT J PHARMACEUT, V466, P44, DOI 10.1016/j.ijpharm.2014.02.031; van Riet-Nales DA, 2013, ARCH DIS CHILD, V98, P725, DOI 10.1136/archdischild-2012-303303; van Riet-Nales DA, 2012, INT J PHARMACEUT, V435, P132, DOI 10.1016/j.ijpharm.2012.05.053; van Riet-Nales DA, 2011, BRIT J CLIN PHARMACO, V72, P465, DOI 10.1111/j.1365-2125.2011.03982.x; Van Vooren L, 2002, J PHARM PHARM SCI, V5, P190; Walsh J, 2011, INT J PHARMACEUT, V415, P221, DOI 10.1016/j.ijpharm.2011.05.048	23	16	16	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98348	10.1371/journal.pone.0098348	http://dx.doi.org/10.1371/journal.pone.0098348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897509	Green Published, gold			2022-12-27	WOS:000338430700035
J	Brieber, D; Nadal, M; Leder, H; Rosenberg, R				Brieber, David; Nadal, Marcos; Leder, Helmut; Rosenberg, Raphael			Art in Time and Space: Context Modulates the Relation between Art Experience and Viewing Time	PLOS ONE			English	Article							LOOKING TIME; AESTHETIC APPRECIATION; INFORMATION; COMPLEXITY; JUDGMENTS; DETERMINANTS; PERCEPTION; ARTWORKS; PLEASURE; STIMULI	The experience of art emerges from the interaction of various cognitive and affective processes. The unfolding of these processes in time and their relation with viewing behavior, however, is still poorly understood. Here we examined the effect of context on the relation between the experience of art and viewing time, the most basic indicator of viewing behavior. Two groups of participants viewed an art exhibition in one of two contexts: one in the museum, the other in the laboratory. In both cases viewing time was recorded with a mobile eye tracking system. After freely viewing the exhibition, participants rated each artwork on liking, interest, understanding, and ambiguity scales. Our results show that participants in the museum context liked artworks more, found them more interesting, and viewed them longer than those in the laboratory. Analyses with mixed effects models revealed that aesthetic appreciation (compounding liking and interest), understanding, and ambiguity predicted viewing time for artworks and for their corresponding labels. The effect of aesthetic appreciation and ambiguity on viewing time was modulated by context: Whereas art appreciation tended to predict viewing time better in the laboratory than in museum context, the relation between ambiguity and viewing time was positive in the museum and negative in the laboratory context. Our results suggest that art museums foster an enduring and focused aesthetic experience and demonstrate that context modulates the relation between art experience and viewing behavior.	[Brieber, David; Nadal, Marcos; Leder, Helmut] Univ Vienna, Dept Basic Psychol Res & Res Methods, Fac Psychol, Vienna, Austria; [Rosenberg, Raphael] Univ Vienna, Fac Hist & Cultural Studies, Dept Art Hist, Vienna, Austria	University of Vienna; University of Vienna	Brieber, D (corresponding author), Univ Vienna, Dept Basic Psychol Res & Res Methods, Fac Psychol, Vienna, Austria.	david.brieber@univie.ac.at	Nadal, Marcos/A-5817-2009	Nadal, Marcos/0000-0002-9341-4688	WWTF [CS11-023]	WWTF	This research was supported by a grant from WWTF (CS11-023) to Helmut Leder (www.wwtf.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arielli E, 2012, EMPIR STUD ARTS, V30, P59, DOI 10.2190/EM.30.1.f; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Belke B., 2006, PSYCHOL SCI, V48, P115; BERLYNE DE, 1958, J EXP PSYCHOL, V55, P289, DOI 10.1037/h0043555; Bitgood S, 2009, VISIT STUD, V12, P93, DOI 10.1080/10645570903203406; BROWN LT, 1966, PERCEPT MOTOR SKILL, V23, P343, DOI 10.2466/pms.1966.23.2.343; BROWN LT, 1966, PERCEPT PSYCHOPHYS, V1, P2, DOI 10.3758/BF03207812; Chen X, 2006, VISION RES, V46, P4118, DOI 10.1016/j.visres.2006.08.008; Cupchik GC, 2009, BRAIN COGNITION, V70, P84, DOI 10.1016/j.bandc.2009.01.003; DAY HI, 1968, PERCEPT PSYCHOPHYS, V4, P279, DOI 10.3758/BF03210514; FECHNER GT, 1871, EXPT AESTHETIK; Gamboni D., 2002, POTENTIAL IMAGES AMB; Gehlen A, 1986, ZEIT BILDER SOZIOLOG; Halekoh U., 2013, PBKRTEST PARAMETRIC; Heidenreich SM, 2011, EMPIR STUD ARTS, V29, P51, DOI 10.2190/EM.29.1.d; Henderson JM, 1999, ANNU REV PSYCHOL, V50, P243, DOI 10.1146/annurev.psych.50.1.243; Huang Mengfei, 2011, Front Hum Neurosci, V5, P134, DOI 10.3389/fnhum.2011.00134; Jakesch M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074084; Jakesch M, 2009, Q J EXP PSYCHOL, V62, P2105, DOI 10.1080/17470210903038974; Judd CM, 2012, J PERS SOC PSYCHOL, V103, P54, DOI 10.1037/a0028347; Kaspar K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052737; Kemp S.W.P., 2007, VISUAL ARTS RES, V33, P72; Kirk U, 2009, BRAIN COGNITION, V69, P306, DOI 10.1016/j.bandc.2008.08.004; Kirk U, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003754; Kirk U, 2009, NEUROIMAGE, V44, P1125, DOI 10.1016/j.neuroimage.2008.10.009; Krieger Verena, 2010, KUNST GESCH GEGENWAR, V1; Kuznetsova A., 2013, LMERTEST TESTS RANDO; Kwart DG, 2012, PERCEPTION, V41, P925, DOI 10.1068/p7136; Lacey S, 2011, NEUROIMAGE, V55, P420, DOI 10.1016/j.neuroimage.2010.11.027; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Leckart B T, 1968, Percept Mot Skills, V27, P91; LECKART BT, 1965, PERCEPT MOTOR SKILL, V21, P16, DOI 10.2466/pms.1965.21.1.16; LECKART BT, 1966, PERCEPT PSYCHOPHYS, V1, P142, DOI 10.3758/BF03210045; Leder H, 2006, ACTA PSYCHOL, V121, P176, DOI 10.1016/j.actpsy.2005.08.005; Leder H, 2004, BRIT J PSYCHOL, V95, P489, DOI 10.1348/0007126042369811; Leder H, 2010, Q J EXP PSYCHOL, V63, P1858, DOI 10.1080/17470211003605142; Leder Helmut., 2001, EMPIR STUD ARTS, V19, P201, DOI [10.2190/5TAE-E5CV-XJAL-3885, DOI 10.2190/5TAE-E5CV-XJAL-3885]; Locher PJ, 2001, PERCEPTION, V30, P449, DOI 10.1068/p3008; Mastandrea S, 2009, PSYCHOL AESTHET CREA, V3, P164, DOI 10.1037/a0013142; Melton A. W., 1935, PROBLEMS INSTALLATIO; Millis K, 2001, EMOTION, V1, P320, DOI 10.1037//1528-3542.1.3.320; Nadal M, 2014, WHITE CUBE MUS UNPUB; Newman GE, 2012, J EXP PSYCHOL GEN, V141, P558, DOI 10.1037/a0026035; Noguchi Y, 2013, NEUROPSYCHOLOGIA, V51, P1077, DOI 10.1016/j.neuropsychologia.2013.03.003; Oliva A, 2007, TRENDS COGN SCI, V11, P520, DOI 10.1016/j.tics.2007.09.009; R Core Team, 2021, R LANGUAGE ENV STAT; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Shusterman Richard, 2000, PRAGMATIST AESTHETIC; Silvia PJ, 2009, PSYCHOL AESTHET CREA, V3, P48, DOI 10.1037/a0014632; SMETS G, 1975, PERCEPT MOTOR SKILL, V40, P3, DOI 10.2466/pms.1975.40.1.3; Smith J., 2001, EMPIRICAL STUDIES AR, V19, P229, DOI [10.2190/5MQM-59JH-X21R-JN5J, DOI 10.2190/5MQM-59JH-X21R-JN5J]; Swami V, 2013, PSYCHOL AESTHET CREA, V7, P285, DOI 10.1037/a0030965; Tschacher W, 2012, PSYCHOL AESTHET CREA, V6, P96, DOI 10.1037/a0023845; Zeki S, 2004, CONSCIOUS COGN, V13, P173, DOI 10.1016/j.concog.2003.10.003	55	136	137	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e99019	10.1371/journal.pone.0099019	http://dx.doi.org/10.1371/journal.pone.0099019			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5ML	24892829	Green Published, Green Submitted, gold			2022-12-27	WOS:000336911400120
J	Hansmann, J; Michaely, HJ; Morelli, JN; Luckscheiter, A; Schoenberg, SO; Attenberger, UI				Hansmann, Jan; Michaely, Henrik J.; Morelli, John N.; Luckscheiter, Andre; Schoenberg, Stefan O.; Attenberger, Ulrike I.			Enhancement Characteristics and Impact on Image Quality of Two Gadolinium Chelates at Equimolar Doses for Time-Resolved 3-Tesla MR-Angiography of the Calf Station	PLOS ONE			English	Article							MAGNETIC-RESONANCE-ANGIOGRAPHY; CONTINUOUS TABLE MOVEMENT; GADOBENATE DIMEGLUMINE; DIAGNOSTIC-ACCURACY; LOWER-EXTREMITIES; 3.0 T; GADOBUTROL; DISEASE; GADOTERATE; COIL	Purpose: To compare enhancement characteristics and image quality of two macrocyclic gadolinium chelates, gadoterate meglumine and gadobutrol, in low-dose, time-resolved MRA of the calf station. Materials and Methods: 100 consecutive patients with peripheral arterial disease (stages II-IV) were retrospectively analysed. Fifty patients were included in each group - 32 men and 18 women for gadobutrol (mean age 67 years) and 34 men, 16 women for gadoterate meglumine (mean age 64 years). 0.03 mmol/kg bw of either gadobutrol or gadoterate meglumine was injected. Gadobutrol was diluted 1: 1 with normal saline (0.9% NaCl) to provide similar injection volume and bolus geometry compared to the undiluted 0.5 M dose of gadoterate meglumine. Signal-to-noise-ratio (SNR), contrast-to-noise-ratio (CNR) and image quality were analysed and compared between the two groups. Results: Mean SNR ranged from 83.0 +/- 46.7 (peroneal artery) to 96.4 +/- 64.5 (anterior tibial artery) for gadobutrol, and from 37.6 +/- 13.8 (peroneal artery) to 45.3 +/- 16.4 (anterior tibial artery) for the gadoterate meglumine group (p<0.0001). CNR values ranged from 30.1 +/- 20.1 (peroneal artery) to 37.6 +/- 26.0 (anterior tibial artery) for gadobutrol and from 14.9 +/- 8.0 (peroneal artery) to 18.6 +/- 16.4 (anterior tibial artery) for gadoterate meglumine (p<0.0001). No significant difference in image quality was found except for the peroneal arteries (p = 0.006 and p = 0.04). Interreader agreement was excellent (kappa 0.87-0.93) Conclusion: The significantly better enhancement as assessed by SNR and CNR provided by gadobutrol compared to gadoterate meglumine does not translate into substantial differences in image quality in an equimolar, low-dose, time-resolved MRA protocol of the calves.	[Hansmann, Jan; Michaely, Henrik J.; Luckscheiter, Andre; Schoenberg, Stefan O.; Attenberger, Ulrike I.] Heidelberg Univ, Med Fac Mannheim, Univ Med Ctr Mannheim, Inst Clin Radiol & Nucl Med, Mannheim, Germany; [Morelli, John N.] Johns Hopkins Univ Hosp, Russel H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21287 USA	Ruprecht Karls University Heidelberg; Johns Hopkins University; Johns Hopkins Medicine	Attenberger, UI (corresponding author), Heidelberg Univ, Med Fac Mannheim, Univ Med Ctr Mannheim, Inst Clin Radiol & Nucl Med, Mannheim, Germany.	ulrike.attenberger@umm.de	Attenberger, Ulrike/ABD-8541-2020; Attenberger, Ulrike/HDN-2286-2022	Attenberger, Ulrike/0000-0002-8123-5447; Attenberger, Ulrike/0000-0002-8123-5447	Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitaet Heidelberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitaet Heidelberg	We acknowledge financial support by the Deutsche Forschungsgemeinschaft and the Ruprecht-Karls-Universitaet Heidelberg within the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abujudeh HH, 2009, J MAGN RESON IMAGING, V30, P1335, DOI 10.1002/jmri.21976; Achenbach M, 2010, J MAGN RESON IMAGING, V32, P1166, DOI 10.1002/jmri.22355; Andreisek G, 2007, RADIOLOGY, V242, P610, DOI 10.1148/radiol.2422051111; Anzalone N, 2011, EUR J RADIOL; Attenberger UI, 2010, RADIOLOGY, V257, P879, DOI 10.1148/radiol.10100781; Blackham KA, 2011, AM J ROENTGENOL, V196, pW613, DOI 10.2214/AJR.10.4227; Fink C, 2004, J MAGN RESON IMAGING, V19, P202, DOI 10.1002/jmri.10452; Giesel FL, 2006, INVEST RADIOL, V41, P222, DOI 10.1097/01.rli.0000192421.81037.d5; Haneder S, 2012, J MAGN RESON IMAGING, V36, P1213, DOI 10.1002/jmri.23760; Hansmann J, 2013, AM J ROENTGENOL, V201, P1368, DOI 10.2214/AJR.13.10584; Korosec FR, 1996, MAGNET RESON MED, V36, P345, DOI 10.1002/mrm.1910360304; Kramer H, 2008, INVEST RADIOL, V43, P627, DOI 10.1097/RLI.0b013e31817e90e9; Kramer H, 2007, INVEST RADIOL, V42, P477, DOI 10.1097/01.rli.0000263183.66407.69; Lanzman RS, 2011, ROFO-FORTSCHR RONTG, V183, P913, DOI 10.1055/s-0029-1246111; Menke J, 2010, ANN INTERN MED, V153, P325, DOI 10.7326/0003-4819-153-5-201009070-00007; Miyazaki M, 2008, RADIOLOGY, V248, P20, DOI 10.1148/radiol.2481071497; Reeder SB, 2005, MAGNET RESON MED, V54, P748, DOI 10.1002/mrm.20636; Rohrer M, 2005, INVEST RADIOL, V40, P715, DOI 10.1097/01.rli.0000184756.66360.d3; Szucs-Farkas Z, 2008, J MAGN RESON IMAGING, V27, P1399, DOI 10.1002/jmri.21351; Voth M, 2011, EUR RADIOL, V21, P1034, DOI 10.1007/s00330-010-1993-2; Voth M, 2009, INVEST RADIOL, V44, P627, DOI 10.1097/RLI.0b013e3181b4c26c; Wang Y, 2011, RADIOLOGY	22	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e99079	10.1371/journal.pone.0099079	http://dx.doi.org/10.1371/journal.pone.0099079			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893292	gold, Green Published, Green Submitted			2022-12-27	WOS:000336911400124
J	Winkler, T; Mahoney, EJ; Sinner, D; Wylie, CC; Dahia, CL				Winkler, Tamara; Mahoney, Eric J.; Sinner, Debora; Wylie, Christopher C.; Dahia, Chitra Lekha			Wnt Signaling Activates Shh Signaling in Early Postnatal Intervertebral Discs, and Re-Activates Shh Signaling in Old Discs in the Mouse	PLOS ONE			English	Article							NUCLEUS PULPOSUS CELLS; WNT/BETA-CATENIN; STEM-CELLS; IN-VITRO; C-MYC; GROWTH; DIFFERENTIATION; EXPRESSION; IDENTIFICATION; INHIBITORS	Intervertebral discs (IVDs) are strong fibrocartilaginous joints that connect adjacent vertebrae of the spine. As discs age they become prone to failure, with neurological consequences that are often severe. Surgical repair of discs treats the result of the disease, which affects as many as one in seven people, rather than its cause. An ideal solution would be to repair degenerating discs using the mechanisms of their normal differentiation. However, these mechanisms are poorly understood. Using the mouse as a model, we previously showed that Shh signaling produced by nucleus pulposus cells activates the expression of differentiation markers, and cell proliferation, in the postnatal IVD. In the present study, we show that canonical Wnt signaling is required for the expression of Shh signaling targets in the IVD. We also show that Shh and canonical Wnt signaling pathways are down-regulated in adult IVDs. Furthermore, this down-regulation is reversible, since re-activation of the Wnt or Shh pathways in older discs can re-activate molecular markers of the IVD that are lost with age. These data suggest that biological treatments targeting Wnt and Shh signaling pathways may be feasible as a therapeutic for degenerative disc disease.	[Dahia, Chitra Lekha] Hosp Special Surg, Tissue Engn Regenerat & Repair Program, New York, NY 10021 USA; [Wylie, Christopher C.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Winkler, Tamara; Mahoney, Eric J.] Cincinnati Childrens Hosp Med Ctr, Div Orthopaed Surg, Cincinnati, OH 45229 USA; [Sinner, Debora] Cincinnati Childrens Hosp Med Ctr, Perinatal Inst Div Neonatol Perinatal & Pulm Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Dahia, CL (corresponding author), Hosp Special Surg, Tissue Engn Regenerat & Repair Program, 535 E 70th St, New York, NY 10021 USA.	dahiac@hss.edu	Sinner, Debora/AAL-1761-2021	Sinner, Debora/0000-0002-0704-5223	Orthopaedic Research Education Foundation [11-228]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065530] Funding Source: NIH RePORTER	Orthopaedic Research Education Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The funding was kindly provided to Dr. Chitra Dahia by Orthopaedic Research Education Foundation to support this research. The grant number is 11-228. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Y, 2010, DEVELOPMENT, V137, P3221, DOI 10.1242/dev.054668; Alvarez-Medina R, 2009, DEVELOPMENT, V136, P3301, DOI 10.1242/dev.041772; Baek SH, 2003, P NATL ACAD SCI USA, V100, P3245, DOI 10.1073/pnas.0330217100; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bluske KK, 2012, DEVELOPMENT, V139, P2692, DOI 10.1242/dev.072314; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carpenter AC, 2010, GENESIS, V48, P554, DOI 10.1002/dvg.20651; Cho SW, 2011, DEVELOPMENT, V138, P1807, DOI 10.1242/dev.056051; Choi KS, 2011, P NATL ACAD SCI USA, V108, P9484, DOI 10.1073/pnas.1007566108; Choi KS, 2008, DEV DYNAM, V237, P3953, DOI 10.1002/dvdy.21805; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Cornett B, 2013, DEV BIOL, V379, P38, DOI 10.1016/j.ydbio.2013.03.010; Dahia CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035944; Dahia CL, 2009, SPINE, V34, P447, DOI 10.1097/BRS.0b013e3181990c64; Dahia CL, 2009, SPINE, V34, P456, DOI 10.1097/BRS.0b013e3181913e98; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DiPaola CP, 2005, J ORTHOP RES, V23, P1112, DOI 10.1016/j.orthres.2005.03.008; EPSTEIN JA, 1962, J NEUROL NEUROSUR PS, V25, P165, DOI 10.1136/jnnp.25.2.165; Fujita N, 2008, BIOCHEM BIOPH RES CO, V372, P367, DOI 10.1016/j.bbrc.2008.05.044; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hiyama A, 2011, J CELL PHYSIOL, V226, P1139, DOI 10.1002/jcp.22438; Hiyama A, 2010, ARTHRITIS RHEUM-US, V62, P3036, DOI 10.1002/art.27599; Hiyama A, 2010, J BONE MINER RES, V25, P1179, DOI 10.1359/jbmr.091202; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Iwatsuki K, 2007, P NATL ACAD SCI USA, V104, P2253, DOI 10.1073/pnas.0607399104; Jandial Rahul, 2008, Neurosurg Focus, V24, pE21, DOI 10.3171/FOC/2008/24/3-4/E20; Mak KK, 2006, DEVELOPMENT, V133, P3695, DOI 10.1242/dev.02546; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Kondo N, 2011, SPINE, V36, pE513, DOI 10.1097/BRS.0b013e3181f52cb5; Kronenberg H M, 2001, Novartis Found Symp, V232, P144; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Le Maitre CL, 2005, J PATHOL, V207, P445, DOI 10.1002/path.1862; Le Maitre CL, 2005, ARTHRITIS RES THER, V7, pR732, DOI 10.1186/ar1732; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Martinez-Ferre A, 2013, J NEUROSCI, V33, P3967, DOI 10.1523/JNEUROSCI.0726-12.2013; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Phiel CJ, 2001, ANNU REV PHARMACOL, V41, P789, DOI 10.1146/annurev.pharmtox.41.1.789; Polychronopoulos P, 2004, J MED CHEM, V47, P935, DOI 10.1021/jm031016d; POSTACCHINI F, 1984, SPINE, V9, P596, DOI 10.1097/00007632-198409000-00010; Pratsinis H, 2007, EUR SPINE J, V16, P1858, DOI 10.1007/s00586-007-0408-9; Radtke F, 2006, CURR MOL MED, V6, P275, DOI 10.2174/156652406776894527; Riffell JL, 2012, NAT REV DRUG DISCOV, V11, P923, DOI 10.1038/nrd3868; Risbud MV, 2006, SPINE, V31, P884, DOI 10.1097/01.brs.0000209335.57767.b5; Rodrigues-Pinto R, 2013, BONE JOINT RES, V2, P169, DOI 10.1302/2046-3758.28.2000184; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Sizer Phillip S Jr, 2002, Pain Pract, V2, P98, DOI 10.1046/j.1533-2500.2002.02012.x; Smolders LA, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4157; Smolders LA, 2012, J ORTHOP RES, V30, P950, DOI 10.1002/jor.22000; Sohn P, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-29; Tsai TT, 2007, SPINE, V32, P495, DOI 10.1097/01.brs.0000257341.88880.f1; Tseng AS, 2006, CHEM BIOL, V13, P957, DOI 10.1016/j.chembiol.2006.08.004; Urban JPG, 2000, AM ZOOL, V40, P53, DOI 10.1668/0003-1569(2000)040[0053:TNOTID]2.0.CO;2; Vadlakondalf L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00085; Wang Zhibo, 2013, INT J DISTRIB SENS N, V2013, P1; Yang SH, 2013, SPINE J; Ye SA, 2011, J HUAZHONG U SCI-MED, V31, P657, DOI 10.1007/s11596-011-0577-y; Yochum GS, 2008, MOL CELL BIOL, V28, P7368, DOI 10.1128/MCB.00744-08; Zhang HN, 2008, SPINE, V33, pE525, DOI 10.1097/BRS.0b013e31817c561b; Zhu Y, 2013, J ORTHOP RES, V31, P1144, DOI 10.1002/jor.22337	62	38	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98444	10.1371/journal.pone.0098444	http://dx.doi.org/10.1371/journal.pone.0098444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892825	Green Published, Green Submitted, gold			2022-12-27	WOS:000336911400050
J	Jiang, L; Xiao, X; Ren, J; Tang, YY; Weng, HQ; Yang, Q; Wu, MJ; Tang, W				Jiang, Li; Xiao, Xiao; Ren, Jin; Tang, YongYong; Weng, HongQing; Yang, Qi; Wu, MingJun; Tang, Wei			Proteomic Analysis of Bladder Cancer Indicates Prx-I as a Key Molecule in BI-TK/GCV Treatment System	PLOS ONE			English	Article							PEROXIREDOXIN-I; GENE-THERAPY; SELECTIVE LOCALIZATION; HYDROGEN-PEROXIDE; SULFINIC ACID; RAT MODEL; EXPRESSION; APOPTOSIS; CELLS; OVEREXPRESSION	In order to understand the molecular mechanisms of Bifidobacterium infantis thymidine kinase/nucleoside analogue ganciclovir (BI-TK/GCV) treatment system which was proven to exhibit sustainable anti-tumor growth activity and induce apoptosis in bladder cancer, a proteomic approach of isobaric tags for relative and absolute quantification (iTRAQ), followed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) was used. 192 down-regulated and 210 up-regulated proteins were identified after treatment with BI-TK/GCV system in Sprague-Dawley (SD) rats. Western blot analysis and immunohistochemistry analysis confirmed that Peroxiredoxin-I (Prx-I) was significantly down-regulated in bladder cancer after treatment. Prx-I silencing by transfection of Prx-I shRNA significantly suppressed growth, promoted apoptosis and regulated the cell cycle in T24 cells and reduced the phospho-NF-kappa B p50 and p65 protein expression which revealed the links between Prx-I and NF-kappa B pathway implied by Ingenuity pathway analysis (IPA). These findings yield new insights into the therapy of bladder cancer, revealing Prx-I as a new therapeutic target and indicating BI-TK/GCV system as a prospective therapy by down-regulation of Prx-I through NF-kappa B signaling pathway.	[Jiang, Li; Xiao, Xiao; Ren, Jin; Tang, YongYong; Weng, HongQing; Yang, Qi; Tang, Wei] Chongqing Med Univ, Affiliated Hosp 1, Dept Urol, Chongqing, Peoples R China; [Wu, MingJun] Chongqing Med Univ, Inst Life Sci, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Tang, W (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Urol, Chongqing, Peoples R China.	tangwei2060@163.com			Natural Scientific Foundation of China [81072087/H1619]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the research grant from the Natural Scientific Foundation of China (No. 81072087/H1619). The URL for National Natural Science Foundation of China: http://www.nsfc.gov.cn/publish/portal0/default.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ACS, 2014, CANC FACTS FIG 2014; Aguilar-Melero P, 2013, J PROTEOMICS, V79, P161, DOI 10.1016/j.jprot.2012.12.005; Chae HZ, 2012, ANTIOXID REDOX SIGN, V16, P506, DOI 10.1089/ars.2011.4260; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Du ZX, 2010, ENDOCR-RELAT CANCER, V17, P553, DOI 10.1677/ERC-09-0269; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Fujii J, 2002, REDOX REP, V7, P123, DOI 10.1179/135100002125000352; Gao MC, 2011, ACTA PHARMACOL SIN, V32, P528, DOI 10.1038/aps.2010.235; Goebell PJ, 2010, UROL ONCOL-SEMIN ORI, V28, P409, DOI 10.1016/j.urolonc.2010.04.003; Hanschmann EM, 2013, ANTIOXID REDOX SIGN, V19, P1539, DOI 10.1089/ars.2012.4599; Hansen JM, 2007, FREE RADICAL BIO MED, V43, P282, DOI 10.1016/j.freeradbiomed.2007.04.029; Haynes AC, 2013, J BIOL CHEM, V288, P29714, DOI 10.1074/jbc.M113.473470; Immenschuh S, 2005, ANTIOXID REDOX SIGN, V7, P768, DOI 10.1089/ars.2005.7.768; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kim H, 2000, J BIOL CHEM, V275, P18266, DOI 10.1074/jbc.275.24.18266; Kim HJ, 2003, CELL BIOL TOXICOL, V19, P285, DOI 10.1023/B:CBTO.0000004952.07979.3d; KIMURA NT, 1980, CANCER RES, V40, P2061; Kinnula VL, 2002, J PATHOL, V196, P316, DOI 10.1002/path.1042; Knoops Bernard, 2007, V44, P27; Lehtonen ST, 2004, INT J CANCER, V111, P514, DOI 10.1002/ijc.20294; Lowther WT, 2011, ANTIOXID REDOX SIGN, V15, P99, DOI 10.1089/ars.2010.3564; Neumann CA, 2009, CELL CYCLE, V8, P4072, DOI 10.4161/cc.8.24.10242; Noh DY, 2001, ANTICANCER RES, V21, P2085; Pasin Erik, 2008, Rev Urol, V10, P31; Poole Leslie B, 2011, Curr Protoc Toxicol, VChapter 7, DOI 10.1002/0471140856.tx0709s49; Quan CY, 2006, J UROLOGY, V175, P1512, DOI 10.1016/S0022-5347(05)00659-2; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Riddell JR, 2011, CANCER RES, V71, P1637, DOI 10.1158/0008-5472.CAN-10-3674; Sharma A, 2009, CURR DRUG THER, V4, P117, DOI 10.2174/157488509788185123; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Soini Y, 2011, INT J CLIN EXP PATHO, V4, P267; Tang W, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-155; Wang XM, 2010, MOL BIOL CELL, V21, P2987, DOI 10.1091/mbc.E10-02-0160; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Yanagawa T, 2005, INT J ORAL MAX SURG, V34, P915, DOI 10.1016/j.ijom.2005.04.015; Yanagawa T, 1999, CANCER LETT, V145, P127, DOI 10.1016/S0304-3835(99)00243-8; Yazawa K, 2000, CANCER GENE THER, V7, P269, DOI 10.1038/sj.cgt.7700122; Yin X, 2013, CANCER GENE THER, V20, P77, DOI 10.1038/cgt.2012.86; Zhang B, 2009, CANCER LETT, V286, P154, DOI 10.1016/j.canlet.2009.04.043	39	14	15	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98764	10.1371/journal.pone.0098764	http://dx.doi.org/10.1371/journal.pone.0098764			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24904997	gold, Green Published, Green Submitted			2022-12-27	WOS:000341869000061
J	Jin, CJ; Yu, SH; Wang, XM; Woo, SJ; Park, HJ; Lee, HC; Choi, SH; Kim, KM; Kim, JH; Park, KS; Jang, HC; Lim, S				Jin, Cheng Ji; Yu, Sung Hoon; Wang, Xiao-Mei; Woo, Se Joon; Park, Hyo Jin; Lee, Hyun Chul; Choi, Sung Hee; Kim, Kyoung Min; Kim, Jung Hee; Park, Kyong Soo; Jang, Hak Chul; Lim, Soo			The Effect of Lithospermic Acid, an Antioxidant, on Development of Diabetic Retinopathy in Spontaneously Obese Diabetic Rats	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PROTEIN-KINASE-C; TOKUSHIMA FATTY RATS; OXIDATIVE STRESS; VASCULAR LEAKAGE; DOWN-REGULATION; MACULAR EDEMA; VEGF; COMPLICATIONS; FIBRONECTIN	Background: Lithospermic acid B (LAB), an active component isolated from Salvia miltiorrhiza radix, has been reported to have antioxidant effects. We examined the effects of LAB on the prevention of diabetic retinopathy in Otsuka Long-Evans Tokushima Fatty (OLETF) rats, an animal model of type 2 diabetes. Methods and Findings: LAB (10 or 20 mg/kg) or normal saline were given orally once daily to 24-week-old male OLETF rats for 52 weeks. At the end of treatment, fundoscopic findings, vascular endothelial growth factor (VEGF) expression in the eyeball, VEGF levels in the ocular fluid, and any structural abnormalities in the retina were assessed. Glucose metabolism, serum levels of high-sensitivity C-reactive protein (hsCRP), monocyte chemotactic protein-1 (MCP1), and tumor necrosis factor-alpha (TNF alpha) and urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG) levels were also measured. Treatment with LAB prevented vascular leakage and basement membrane thickening in retinal capillaries in a dose-dependent manner. Insulin resistance and glucose intolerance were significantly improved by LAB treatment. The levels of serum hsCRP, MCP1, TNF alpha, and urinary 8-OHdG were lower in the LAB-treated OLETF rats than in the controls. Conclusions: Treatment with LAB had a preventive effect on the development of diabetic retinopathy in this animal model, probably because of its antioxidative effects and anti-inflammatory effects.	[Jin, Cheng Ji; Yu, Sung Hoon; Choi, Sung Hee; Kim, Kyoung Min; Jang, Hak Chul; Lim, Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Songnam, South Korea; [Jin, Cheng Ji; Yu, Sung Hoon; Woo, Se Joon; Park, Hyo Jin; Choi, Sung Hee; Kim, Kyoung Min; Jang, Hak Chul; Lim, Soo] Seoul Natl Univ, Bundang Hosp, Songnam, South Korea; [Woo, Se Joon] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Songnam, South Korea; [Park, Hyo Jin] Seoul Natl Univ, Coll Med, Dept Pathol, Songnam, South Korea; [Jin, Cheng Ji; Wang, Xiao-Mei] Dalian Univ, ZhongShan Hosp, Dept Endocrinol, Dalian 116012, Peoples R China; [Yu, Sung Hoon] Hallym Univ, Hangang Sacred Hosp, Dept Internal Med, Seoul, South Korea; [Lee, Hyun Chul] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Jung Hee; Park, Kyong Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Dalian University; Hallym University; Yonsei University; Yonsei University Health System; Seoul National University (SNU)	Lim, S (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Songnam, South Korea.	limsoo@snu.ac.kr	Lim, Soo/AAU-8107-2020; Park, Kyong Soo/C-2265-2008	Lim, Soo/0000-0002-4137-1671; Park, Kyong Soo/0000-0003-3597-342X; CHOI, SUNG HEE/0000-0003-0740-8116; Park, Hyo Jin/0000-0002-2198-5211; Kim, Kyoung Min/0000-0001-8150-0266	Korean Diabetes Association	Korean Diabetes Association	This work was supported by the Korean Diabetes Association (2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LP, 1995, P NATL ACAD SCI USA, V92, P10457, DOI 10.1073/pnas.92.23.10457; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Bandello F, 2013, ACTA DIABETOL, V50, P1, DOI 10.1007/s00592-012-0449-3; Barouch FC, 2000, INVEST OPHTH VIS SCI, V41, P1153; CLARK CM, 1995, NEW ENGL J MED, V332, P1210, DOI 10.1056/NEJM199505043321807; Cunningham ET, 2005, OPHTHALMOLOGY, V112, P1747, DOI 10.1016/j.ophtha.2005.06.007; Das Evcimen N, 2007, PHARMACOL RES, V55, P498, DOI 10.1016/j.phrs.2007.04.016; Dong QY, 2008, EUR J OPHTHALMOL, V18, P94, DOI 10.1177/112067210801800116; Feit-Leichman RA, 2005, INVEST OPHTH VIS SCI, V46, P4281, DOI 10.1167/iovs.04-1361; Geraldes P, 2009, NAT MED, V15, P1298, DOI 10.1038/nm.2052; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Harhaj NS, 2006, INVEST OPHTH VIS SCI, V47, P5106, DOI 10.1167/iovs.06-0322; Hur KY, 2008, EUR J PHARMACOL, V586, P226, DOI 10.1016/j.ejphar.2008.02.072; Hur KY, 2010, ATHEROSCLEROSIS, V211, P69, DOI 10.1016/j.atherosclerosis.2010.01.035; Imesch PD, 1997, RETINA-J RET VIT DIS, V17, P321, DOI 10.1097/00006982-199707000-00008; ISHIBASHI T, 1993, BRIT J OPHTHALMOL, V77, P574, DOI 10.1136/bjo.77.9.574; Jung KI, 2013, J PHARMACOL EXP THER, V345, P457, DOI 10.1124/jpet.113.203067; Jung M, 2002, CHEM PHARM BULL, V50, P1135, DOI 10.1248/cpb.50.1135; Kaliora AC, 2006, ATHEROSCLEROSIS, V187, P1, DOI 10.1016/j.atherosclerosis.2005.11.001; KAMATA K, 1994, GEN PHARMACOL, V25, P69, DOI 10.1016/0306-3623(94)90011-6; Kim YH, 2008, DIABETES, V57, P2181, DOI 10.2337/db07-1431; KLEIN R, 1989, DIABETES METAB REV, V5, P559, DOI 10.1002/dmr.5610050703; Lee BW, 2011, TOXICOL APPL PHARM, V252, P47, DOI 10.1016/j.taap.2011.01.018; Lee GT, 2003, J AM SOC NEPHROL, V14, P709, DOI 10.1097/01.ASN.0000051660.82593.19; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Limb GA, 2001, INVEST OPHTH VIS SCI, V42, P1586; Lu Y, 2014, INT J OPHTHALMOL-CHI, V7, P1, DOI 10.3980/j.issn.2222-3959.2014.01.01; Lu ZY, 2003, JPN J OPHTHALMOL, V47, P28, DOI 10.1016/S0021-5155(02)00631-7; Makino N, 2005, J DIABETES COMPLICAT, V19, P347, DOI 10.1016/j.jdiacomp.2005.04.002; Massin P, 2010, DIABETES CARE, V33, P2399, DOI 10.2337/dc10-0493; Michaelides M, 2010, OPHTHALMOLOGY, V117, P1078, DOI 10.1016/j.ophtha.2010.03.045; Mitamura Y, 2001, OPHTHALMOLOGICA, V215, P415, DOI 10.1159/000050900; Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836; Miyamoto K, 2000, AM J PATHOL, V156, P1733, DOI 10.1016/S0002-9440(10)65044-4; Nebbioso M, 2012, DIABETES TECHNOL THE, V14, P257, DOI 10.1089/dia.2011.0172; Park KS, 2001, DIABETES, V50, P2837, DOI 10.2337/diabetes.50.12.2837; Pescosolido N, 2008, DRUGS R&D, V9, P15, DOI 10.2165/0126839-200809001-00003; Porta M, 2011, DIABETES OBES METAB, V13, P784, DOI 10.1111/j.1463-1326.2011.01415.x; Praidou A, 2010, CURR DIABETES REV, V6, P304, DOI 10.2174/157339910793360815; Rask-Madsen C, 2013, CELL METAB, V17, P20, DOI 10.1016/j.cmet.2012.11.012; Roy S, 2003, DIABETES, V52, P1229, DOI 10.2337/diabetes.52.5.1229; Roy S, 2010, CURR EYE RES, V35, P1045, DOI 10.3109/02713683.2010.514659; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Soung DY, 2003, J PHARM PHARMACOL, V55, P1427, DOI 10.1211/0022357021891; Svoboda P, 2008, ANAL BIOCHEM, V383, P236, DOI 10.1016/j.ab.2008.09.014; Tanaka Y, 1997, LANCET, V349, P1520, DOI 10.1016/S0140-6736(05)62099-5; van Hecke MV, 2005, DIABETOLOGIA, V48, P1300, DOI 10.1007/s00125-005-1799-y; Waisbourd M, 2011, ACTA OPHTHALMOL, V89, P203, DOI 10.1111/j.1755-3768.2010.02010.x; Wang JJ, 2010, DIABETES, V59, P2297, DOI 10.2337/db09-1420; Wong TY, 2012, AM J OPHTHALMOL, V154, P6, DOI 10.1016/j.ajo.2012.03.013; Woo SJ, 2011, INVEST OPHTH VIS SCI, V52, P7697, DOI 10.1167/iovs.11-7784; Wu LL, 2004, CLIN CHIM ACTA, V339, P1, DOI 10.1016/j.cccn.2003.09.010; Wu YX, 2012, INVEST OPHTH VIS SCI, V53, P8405, DOI 10.1167/iovs.12-10553; Xu X, 2004, CURR EYE RES, V28, P251, DOI 10.1076/ceyr.28.4.251.27834; Yang JH, 2013, INVEST OPHTH VIS SCI, V54, P3844, DOI 10.1167/iovs.12-11309	56	28	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98232	10.1371/journal.pone.0098232	http://dx.doi.org/10.1371/journal.pone.0098232			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905410	Green Published, Green Submitted, gold			2022-12-27	WOS:000341869000021
J	Maheswaran, D; Zeng, YY; Chan-Yeung, M; Scott, J; Osornio-Vargas, A; Becker, AB; Kozyrskyj, AL				Maheswaran, Dharini; Zeng, Yiye; Chan-Yeung, Moira; Scott, James; Osornio-Vargas, Alvaro; Becker, Allan B.; Kozyrskyj, Anita L.			Exposure to Beta-(1,3)-D-Glucan in House Dust at Age 7-10 Is Associated with Airway Hyperresponsiveness and Atopic Asthma by Age 11-14	PLOS ONE			English	Article							BETA-GLUCANS; BRONCHIAL HYPERRESPONSIVENESS; RESPIRATORY HEALTH; FLOW VARIABILITY; MOISTURE DAMAGE; MOLD COMPONENTS; INNATE IMMUNITY; HOME DAMPNESS; CHILDREN; ENDOTOXIN	Background: Mould exposure has been linked to childhood asthma and bronchial hyper-responsiveness. Few studies have assessed beta-(1,3)-d-glucan (beta-glucan), a significant fungal cell wall constituent, in relation to asthma in adolescence. Objective: To determine whether house dust-derived beta-glucan exposure at age 7-10 is associated with the development and persistence of atopic and non-atopic asthma, and bronchial hyper-responsiveness (BHR) by age 11-14. Methods: Dust samples were collected from the 1995 Study of Asthma, Genes, and Environment (SAGE) birth cohort. This cohort was derived from Manitoba provincial healthcare administrative records of children high and low risk for asthma. Samples were collected from the homes of 422 children at age 7-10 and analyzed using beta-glucan and endotoxin-specific Limulus Amoebocyte Lysate assays. Asthma, atopy, and BHR status of each child were also assessed at ages 7-10 and 11-14. Results: At age 7-10, beta-glucan dust levels in the home were associated with persistent atopic asthma at age 11-14 (OR 1.79 for each unit increase in levels, 95% CI 1.14-2.81), independent of endotoxin exposure, and Alternaria or Cladosporium sensitization. The likelihood of BHR almost doubled with unit increases in dust beta-glucan in asthmatic children. In children without asthma, exposure to high beta-glucan levels at age 7-10 also elevated risk for BHR in adolescence (OR 1.74, 95% CI 1.05-2.89). New-onset atopic asthma was twice more likely following high beta-glucan exposure in children without asthma but the association did not reach statistical significance. No associations were evident with concurrent asthma phenotype at age 7-10 or non-atopic asthma at age 11-14. Conclusion: These findings implicate home beta-glucan exposure at school-age as a risk factor for persistent atopic asthma and new-onset BHR. The higher prevalence of BHR in urban adolescents may be propagated by this home exposure.	[Maheswaran, Dharini] Monash Univ, Fac Med Nursing & Hlth Sci, Melbourne, Vic 3004, Australia; [Zeng, Yiye; Osornio-Vargas, Alvaro; Kozyrskyj, Anita L.] Univ Alberta, Dept Pediat, Fac Med & Dent, Edmonton, AB, Canada; [Chan-Yeung, Moira] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Scott, James] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Becker, Allan B.] Univ Manitoba, Fac Med, Dept Pediat & Child Hlth, Winnipeg, MB, Canada; [Kozyrskyj, Anita L.] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada	Monash University; University of Alberta; University of British Columbia; University of Toronto; University of Manitoba; University of Alberta	Kozyrskyj, AL (corresponding author), Univ Alberta, Dept Pediat, Fac Med & Dent, Edmonton, AB, Canada.	kozyrsky@ualberta.ca	Scott, James A/A-8598-2011; Scott, James A/AAN-4011-2021; Osornio Vargas, Alvaro Roman/B-4645-2010	Scott, James A/0000-0002-5073-0832; Scott, James A/0000-0002-5073-0832; Osornio Vargas, Alvaro Roman/0000-0001-8287-7102	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	The funding for this project was provided by the Canadian Institutes of Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari A, 2010, SCI TOTAL ENVIRON, V408, P5489, DOI 10.1016/j.scitotenv.2010.07.087; Akramiene D, 2007, MEDICINA-LITHUANIA, V43, P597, DOI 10.3390/medicina43080076; Becker A, 2005, CAN MED ASSOC J, V173, pS3; Becklake MR, 1999, THORAX, V54, P1119, DOI 10.1136/thx.54.12.1119; Behbod B, 2013, ALLERGY, V68, P1410, DOI 10.1111/all.12254; Bendelac A, 1997, CURR OPIN IMMUNOL, V9, P1, DOI 10.1016/S0952-7915(97)80151-3; Bundy KW, 2009, ANN ALLERG ASTHMA IM, V103, P26, DOI 10.1016/S1081-1206(10)60139-1; CDC (Centre for Disease Control and Prevention), 2013, FASTSTATS ASTHM; Chan-Yeung M, 2010, ALLERGY, V65, P1404, DOI 10.1111/j.1398-9995.2010.02399.x; Cherid H, 2011, J OCCUP ENVIRON HYG, V8, P540, DOI 10.1080/15459624.2011.601994; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P235, DOI 10.1111/j.1365-2222.1977.tb01448.x; Collins RA, 2011, J ALLERGY CLIN IMMUN, V128, P301, DOI 10.1016/j.jaci.2011.03.016; Dales RE, 1997, INT J EPIDEMIOL, V26, P120, DOI 10.1093/ije/26.1.120; Douwes J, 2000, AM J RESP CRIT CARE, V162, P1348, DOI 10.1164/ajrccm.162.4.9909118; Fisk WJ, 2007, INDOOR AIR, V17, P284, DOI 10.1111/j.1600-0668.2007.00475.x; Foto M, 2004, ANAL BIOANAL CHEM, V379, P156, DOI 10.1007/s00216-004-2583-4; Fraser Institute, 2012, CAN ENV IND AIR QUAL; Garner Rochelle, 2008, Health Rep, V19, P45; Gehring U, 2001, ENVIRON HEALTH PERSP, V109, P139, DOI 10.2307/3434766; Giovannangelo MECA, 2007, ENVIRON INT, V33, P9, DOI 10.1016/j.envint.2006.06.018; Gowers AM, 2012, RESPIROLOGY, V17, P887, DOI 10.1111/j.1440-1843.2012.02195.x; Guerra S, 2004, AM J RESP CRIT CARE, V170, P78, DOI 10.1164/rccm.200309-1224OC; Han YY, 2009, PEDIAT ALLERG IMM-UK, V20, P748, DOI 10.1111/j.1399-3038.2009.00871.x; Haverinen-Shaughnessy U, 2005, INDOOR BUILT ENVIRON, V14, P133, DOI 10.1177/1420326X05051260; Hedman L, 2011, THORAX, V66, P20, DOI 10.1136/thx.2010.143800; Heinrich J, 2003, J EXPO ANAL ENV EPID, V13, P152, DOI 10.1038/sj.jea.7500267; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; Iossifova Y, 2008, INDOOR AIR, V18, P225, DOI 10.1111/j.1600-0668.2008.00526.x; Iossifova YY, 2007, ALLERGY, V62, P504, DOI 10.1111/j.1398-9995.2007.01340.x; Jogi R, 2004, INT J TUBERC LUNG D, V8, P1180; Kilpelainen M, 2001, THORAX, V56, P462, DOI 10.1136/thorax.56.6.462; Kim BS, 2010, PEDIATR PULM, V45, P1220, DOI 10.1002/ppul.21312; Kozyrskyj AL, 2009, ALLERGY, V64, P1185, DOI 10.1111/j.1398-9995.2009.02033.x; Krieger M, 1997, CURR OPIN LIPIDOL, V8, P275, DOI 10.1097/00041433-199710000-00006; Kuczmarski R J, 2000, Adv Data, P1; Lawson JA, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-56; Ly NP, 2008, CHEST, V133, P107, DOI 10.1378/chest.07-2130; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Masoli M, 2004, GLOBAL BURDEN ASTHMA, P1; Mendell MJ, 2011, ENVIRON HEALTH PERSP, V119, P748, DOI 10.1289/ehp.1002410; Mendy A, 2011, J ASTHMA, V48, P685, DOI 10.3109/02770903.2011.594140; Miller JD, 2007, J AIR WASTE MANAGE, V57, P297, DOI 10.1080/10473289.2007.10465337; Modlin RL, 1999, NEW ENGL J MED, V340, P1834, DOI 10.1056/NEJM199906103402312; Muller A, 1996, J IMMUNOL, V156, P3418; Nathan AT, 2009, J ALLERGY CLIN IMMUN, V123, P612, DOI 10.1016/j.jaci.2008.12.006; Noal RB, 2011, OBES REV, V12, P93, DOI 10.1111/j.1467-789X.2010.00741.x; Novak M, 2008, J IMMUNOTOXICOL, V5, P47, DOI 10.1080/15476910802019045; Papadopoulos NG, 2008, PEDIAT ALLERG IMM-UK, V19, P51, DOI 10.1111/j.1399-3038.2008.00767.x; Pekkanen J, 2007, EUR RESPIR J, V29, P509, DOI 10.1183/09031936.00040806; Reponen T, 2010, SCI TOTAL ENVIRON, V408, P5565, DOI 10.1016/j.scitotenv.2010.07.090; Rylander R, 1997, ARCH ENVIRON HEALTH, V52, P281, DOI 10.1080/00039899709602199; Rylander R, 1998, AM J RESP CRIT CARE, V158, P1685, DOI 10.1164/ajrccm.158.5.9712139; Ryu JH, 2013, J ALLERGY CLIN IMMUN, V131, P549, DOI 10.1016/j.jaci.2012.07.050; Sarinho E, 2009, ALLERGOL IMMUNOPATH, V37, P188, DOI 10.1016/j.aller.2009.02.005; Sjostrand M, 1997, INFLAMM RES, V46, P93, DOI 10.1007/s000110050108; Soltanian S, 2009, CRIT REV MICROBIOL, V35, P109, DOI 10.1080/10408410902753746; Sordillo JE, 2010, CLIN EXP ALLERGY, V40, P902, DOI 10.1111/j.1365-2222.2010.03509.x; Statistics Canada, 2012, TABL 105 0501 ASTHM; Stopinsek S, 2011, INT IMMUNOPHARMACOL, V11, P939, DOI 10.1016/j.intimp.2011.02.006; ten Have WHO, 2007, CLIN EXP ALLERGY, V37, P1827, DOI 10.1111/j.1365-2222.2007.02841.x; Tischer C, 2011, EUR RESPIR J, V38, P812, DOI 10.1183/09031936.00184010; Tischer C, 2011, EUR RESPIR J, V37, P1050, DOI 10.1183/09031936.00091210; World Health Organization, 2011, ASTHM FACT SHEET; Wu FF, 2012, ANN AGR ENV MED, V17, P327; Yiin LM, 2008, J OCCUP ENVIRON HYG, V5, P94, DOI 10.1080/15459620701805169	65	27	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98878	10.1371/journal.pone.0098878	http://dx.doi.org/10.1371/journal.pone.0098878			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905346	Green Published, Green Submitted, gold			2022-12-27	WOS:000341869000075
J	Bolla, JR; Su, CC; Do, SV; Radhakrishnan, A; Kumar, N; Long, F; Chou, TH; Delmar, JA; Lei, HT; Rajashankar, KR; Shafer, WM; Yu, EW				Bolla, Jani Reddy; Su, Chih-Chia; Do, Sylvia V.; Radhakrishnan, Abhijith; Kumar, Nitin; Long, Feng; Chou, Tsung-Han; Delmar, Jared A.; Lei, Hsiang-Ting; Rajashankar, Kanagalaghatta R.; Shafer, William M.; Yu, Edward W.			Crystal Structure of the Neisseria gonorrhoeae MtrD Inner Membrane Multidrug Efflux Pump	PLOS ONE			English	Article							ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; TRANSPORTER ACRB; FUSION PROTEIN; BINDING POCKET; SYSTEM; RESISTANCE; MECHANISM; SOFTWARE; CHANNEL	Neisseria gonorrhoeae is an obligate human pathogen and the causative agent of the sexually-transmitted disease gonorrhea. The control of this disease has been compromised by the increasing proportion of infections due to antibiotic-resistant strains, which are growing at an alarming rate. The MtrCDE tripartite multidrug efflux pump, belonging to the hydrophobic and amphiphilic efflux resistance-nodulation-cell division (HAE-RND) family, spans both the inner and outer membranes of N. gonorrhoeae and confers resistance to a variety of antibiotics and toxic compounds. We here report the crystal structure of the inner membrane MtrD multidrug efflux pump, which reveals a novel structural feature that is not found in other RND efflux pumps.	[Bolla, Jani Reddy; Radhakrishnan, Abhijith; Kumar, Nitin; Lei, Hsiang-Ting; Yu, Edward W.] Iowa State Univ, Dept Chem, Ames, IA 50011 USA; [Su, Chih-Chia; Long, Feng; Chou, Tsung-Han; Delmar, Jared A.; Yu, Edward W.] Iowa State Univ, Dept Phys & Astron, Ames, IA USA; [Do, Sylvia V.; Yu, Edward W.] Iowa State Univ, Bioinformat & Computat Biol Interdept Grad Progra, Ames, IA USA; [Rajashankar, Kanagalaghatta R.] NE CAT, Argonne, IL USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Argonne Natl Lab, Dept Chem & Chem Biol, Argonne, IL USA; [Shafer, William M.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Shafer, William M.] VA Med Ctr, Labs Microbial Pathogenesis, Decatur, GA USA	Iowa State University; Iowa State University; Iowa State University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Yu, EW (corresponding author), Iowa State Univ, Dept Chem, Ames, IA 50011 USA.	ewyu@iastate.edu	Bolla, Jani Reddy/AAT-1370-2020; Long, Feng/F-5475-2011; Radhakrishnan, Abhijith/V-6182-2019; , Nitin/J-8078-2019	Bolla, Jani Reddy/0000-0003-4346-182X; Long, Feng/0000-0001-6313-8558; Radhakrishnan, Abhijith/0000-0001-8107-3487; 	National Institutes of Health [R37AI021150, R01GM086431]; Medical Research Service of the Department of Veterans Affairs; National Institutes of General Medical Sciences [GM103403]; U.S. Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI021150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, R01GM086431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Service of the Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R37AI021150 (W. M. S.) and R01GM086431 (E.W.Y.) and a Veterans Affairs Merit Award (W. M. S.) from the Medical Research Service of the Department of Veterans Affairs. The Northeastern Collaborative Access Team beamlines of the Advanced Photon Source is supported by the National Institutes of General Medical Sciences under an award GM103403. Use of the Advanced Photon Source is supported by the U.S. Department of Energy, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akama H, 2004, J BIOL CHEM, V279, P52816, DOI 10.1074/jbc.C400445200; Akama H, 2004, J BIOL CHEM, V279, P25939, DOI 10.1074/jbc.C400164200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Eicher T, 2012, P NATL ACAD SCI USA, V109, P5687, DOI 10.1073/pnas.1114944109; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franke S, 2003, J BACTERIOL, V185, P3804, DOI 10.1128/JB.185.13.3804-3812.2003; Franke S, 2001, MICROBIOL-SGM, V147, P965, DOI 10.1099/00221287-147-4-965; Hagman KE, 1997, MICROBIOL-SGM, V143, P2117, DOI 10.1099/00221287-143-7-2117; Higgins MK, 2004, P NATL ACAD SCI USA, V101, P9994, DOI 10.1073/pnas.0400375101; Janganan TK, 2013, MOL MICROBIOL, V88, P590, DOI 10.1111/mmi.12211; Jerse AE, 2003, INFECT IMMUN, V71, P5576, DOI 10.1128/IAI.71.10.5576-5582.2003; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Kulathila R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015610; Lei HT, 2014, J MOL BIOL, V426, P403, DOI 10.1016/j.jmb.2013.09.042; Long F, 2010, NATURE, V467, P484, DOI 10.1038/nature09395; LUCAS CE, 1995, MOL MICROBIOL, V16, P1001, DOI 10.1111/j.1365-2958.1995.tb02325.x; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Nakashima R, 2013, NATURE, V500, P102, DOI 10.1038/nature12300; Nakashima R, 2011, NATURE, V480, P565, DOI 10.1038/nature10641; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Sennhauser G, 2007, PLOS BIOL, V5, P106, DOI 10.1371/journal.pbio.0050007; Sennhauser G, 2009, J MOL BIOL, V389, P134, DOI 10.1016/j.jmb.2009.04.001; Shafer WM, 1998, P NATL ACAD SCI USA, V95, P1829, DOI 10.1073/pnas.95.4.1829; STERN A, 1986, CELL, V47, P61, DOI 10.1016/0092-8674(86)90366-1; Su CC, 2012, J MOL BIOL, V422, P429, DOI 10.1016/j.jmb.2012.05.038; Su CC, 2011, NATURE, V470, P558, DOI 10.1038/nature09743; Su CC, 2009, J MOL BIOL, V393, P342, DOI 10.1016/j.jmb.2009.08.029; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Tapsall John, 2006, Expert Rev Anti Infect Ther, V4, P619, DOI 10.1586/14787210.4.4.619; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Warner DM, 2008, MOL MICROBIOL, V70, P462, DOI 10.1111/j.1365-2958.2008.06424.x	38	45	45	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e97903	10.1371/journal.pone.0097903	http://dx.doi.org/10.1371/journal.pone.0097903			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901477	Green Published, Green Submitted, gold			2022-12-27	WOS:000336841400015
J	O'Hara, B; de la Rosa, DA; Rajendran, VM				O'Hara, Bryan; de la Rosa, Diego Alvarez; Rajendran, Vazhaikkurichi M.			Multiple Mineralocorticoid Response Elements Localized in Different Introns Regulate Intermediate Conductance K+ (Kcnn4) Channel Expression in the Rat Distal Colon	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; GLUCOCORTICOID-RECEPTOR; CHIP-SEQ; DNA; ALDOSTERONE; SPECIFICITY; SECRETION; TRANSPORT; SEQUENCE; GENE	An elevated plasma aldosterone and an increased expression of the intermediate conductance K+ (IK/Kcnn4) channels are linked in colon. This observation suggests that the expression of Kcnn4 gene is controlled through the action of aldosterone on its cognate receptor (i.e., mineralocorticoid receptor; MR). In order to establish this, we performed chromatin immunoprecipitation (ChIP) assay to identify the MR response elements (MREs) in a region that spanned 20 kb upstream and 10 kb downstream of the presumed transcription start site (TSS) using chromatin from the colonic epithelial cells of normal and aldosterone-treated rats. MREs were immunoprecipitated in an approximately 5 kb region that spanned the first and second introns in the aldosterone rats. These regions were individually cloned in luciferase-expression vector lacking enhancer activity. These clones were tested for enhancer activity in vitro by transfecting in HEK293T and CaCo2 cells with MR and aldosterone treatment. At least four regions were found to be responsive to the MR and aldosterone. Two regions were identified to contain MREs using bioinformatics tools. These clones lost their enhancer activity after mutation of the presumptive MREs, and thus, established the functionality of the MREs. The third and fourth clones did not contain any bioinformatically obvious MREs. Further, they lost their activity upon additional sub-cloning, which suggest cooperativity between the regions that were separated upon sub-cloning. These results demonstrate the presence of intronic MREs in Kcnn4 and suggest a highly cooperative interaction between multiple intronic response elements.	[O'Hara, Bryan; Rajendran, Vazhaikkurichi M.] W Virginia Univ, Dept Biochem, Sch Med, Morgantown, WV 26506 USA; [de la Rosa, Diego Alvarez] Univ La Laguna, Dept Physiol, Tenerife, Spain	West Virginia University; Universidad de la Laguna	Rajendran, VM (corresponding author), W Virginia Univ, Dept Biochem, Sch Med, Morgantown, WV 26506 USA.	vrajendran@hsc.wvu.edu	Alvarez de la Rosa, Diego/H-8500-2015	Alvarez de la Rosa, Diego/0000-0002-4324-2793	National Institute of Diabetes and Digestive and Kidney Diseases [DK-018777]; Spanish Ministry of Science and Innovation [BFU2010-16265]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018777] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institute of Diabetes and Digestive and Kidney Diseases Grant DK-018777. BFU2010-16265 from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves C, 2012, ELECTROPHORESIS; ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; Arteaga MF, 2007, MOL BIOL CELL, V18, P2072, DOI 10.1091/mbc.E06-10-0968; Barmeyer C, 2010, AM J PHYSIOL-CELL PH, V299, pC251, DOI 10.1152/ajpcell.00091.2009; Binder HJ, 1999, SEMIN NEPHROL, V19, P405; Bujalska O, 1997, STEROIDS, V62, P77, DOI 10.1016/S0039-128X(96)00163-8; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Datson NA, 2011, ENDOCRINOLOGY, V152, P3749, DOI 10.1210/en.2011-0287; EDWARDS CRW, 1988, LANCET, V2, P986, DOI 10.1016/S0140-6736(88)90742-8; Fuller PJ, 2012, J ENDOCRINOL, V213, P15, DOI 10.1530/JOE-11-0372; FUNDER JW, 1988, SCIENCE, V242, P583, DOI 10.1126/science.2845584; Gaeggeler HP, 2005, J AM SOC NEPHROL, V16, P878, DOI 10.1681/ASN.2004121110; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gruber CJ, 2004, TRENDS ENDOCRIN MET, V15, P73, DOI 10.1016/j.tem.2004.01.008; Havlak P, 2004, GENOME RES, V14, P721, DOI 10.1101/gr.2264004; Hubler TR, 2004, CELL STRESS CHAPERON, V9, P243, DOI 10.1379/CSC-32R.1; Johnson AB, 2012, MOL CELL ENDOCRINOL, V348, P430, DOI 10.1016/j.mce.2011.04.021; Joiner WJ, 2003, AM J PHYSIOL-GASTR L, V285, pG185, DOI 10.1152/ajpgi.00337.2002; Kato S, 2011, TRENDS BIOCHEM SCI, V36, P272, DOI 10.1016/j.tibs.2011.01.001; Kumar NSN, 2010, AM J PHYSIOL-GASTR L, V299, pG707, DOI 10.1152/ajpgi.00101.2010; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; MARTIN RS, 1983, KIDNEY INT, V24, P386, DOI 10.1038/ki.1983.171; Martinerie L, 2013, BIOCHIMIE, V95, P148, DOI 10.1016/j.biochi.2012.09.030; McFarlan SC, 1997, MOL CELL ENDOCRINOL, V129, P219, DOI 10.1016/S0303-7207(97)00069-5; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Musch MW, 2008, AM J PHYSIOL-GASTR L, V295, pG909, DOI 10.1152/ajpgi.90312.2008; Nelson CC, 1999, MOL ENDOCRINOL, V13, P2090, DOI 10.1210/me.13.12.2090; Peng HZ, 2009, J BIOL CHEM, V284, P35670, DOI 10.1074/jbc.M109.032086; Rabinowitz L, 1996, KIDNEY INT, V49, P1738, DOI 10.1038/ki.1996.258; Rajendran VM, 1998, AM J PHYSIOL-GASTR L, V274, pG424, DOI 10.1152/ajpgi.1998.274.2.G424; Sandle GI, 2010, QJM-INT J MED, V103, P85, DOI 10.1093/qjmed/hcp159; SANDLE GI, 1987, GASTROENTEROLOGY, V93, P188, DOI 10.1016/0016-5085(87)90333-7; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Singh SK, 2012, AM J PHYSIOL-CELL PH, V302, pC1353, DOI 10.1152/ajpcell.00216.2011; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Stepanova M, 2006, COMPUT BIOL CHEM, V30, P339, DOI 10.1016/j.compbiolchem.2006.07.002; TURNAMIAN SG, 1989, J CLIN INVEST, V84, P1924, DOI 10.1172/JCI114380; Tyulmenkov VV, 2001, MOL CELL ENDOCRINOL, V182, P109, DOI 10.1016/S0303-7207(01)00508-1; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Ziera T, 2009, FASEB J, V23, P3936, DOI 10.1096/fj.09-134759	42	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98695	10.1371/journal.pone.0098695	http://dx.doi.org/10.1371/journal.pone.0098695			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901797	gold, Green Published, Green Submitted			2022-12-27	WOS:000336841400046
J	Pillai, AG; Henckens, MJAG; Fernandez, G; Joels, M				Pillai, Anup G.; Henckens, Marloes J. A. G.; Fernandez, Guillen; Joels, Marian			Delayed Effects of Corticosterone on Slow After-Hyperpolarization Potentials in Mouse Hippocampal versus Prefrontal Cortical Pyramidal Neurons	PLOS ONE			English	Article							SPIKE-FREQUENCY ADAPTATION; CALCIUM CURRENT AMPLITUDE; LONG-TERM POTENTIATION; GLUCOCORTICOID-RECEPTOR; ACUTE STRESS; BASOLATERAL AMYGDALA; DENDRITIC MORPHOLOGY; DNA-BINDING; CORTEX; AFTERHYPERPOLARIZATION	The rodent stress hormone corticosterone changes neuronal activity in a slow and persistent manner through transcriptional regulation. In the rat dorsal hippocampus, corticosterone enhances the amplitude of calcium-dependent potassium currents that cause a lingering slow after-hyperpolarization (sAHP) at the end of depolarizing events. In this study we compared the putative region-dependency of the delayed effects of corticosterone (approximately 5 hrs after treatment) on sAHP as well as other active and passive properties of layer 2/3 pyramidal neurons from three prefrontal areas, i.e. the lateral orbitofrontal, prelimbic and infralimbic cortex, with the hippocampus of adult mice. In agreement with previous studies, corticosterone increased sAHP amplitude in the dorsal hippocampus with depolarizing steps of increasing amplitude. However, in the lateral orbitofrontal, prelimbic and infralimbic cortices we did not observe any modifications of sAHP amplitude after corticosterone treatment. Properties of single action potentials or % ratio of the last spike interval with respect to the first spike interval, an indicator of accommodation in an action potential train, were not significantly affected by corticosterone in all brain regions examined. Lastly, corticosterone treatment did not induce any lasting changes in passive membrane properties of hippocampal or cortical neurons. Overall, the data indicate that corticosterone slowly and very persistently increases the sAHP amplitude in hippocampal pyramidal neurons, while this is not the case in the cortical regions examined. This implies that changes in excitability across brain regions reached by corticosterone may vary over a prolonged period of time after stress.	[Pillai, Anup G.; Henckens, Marloes J. A. G.; Joels, Marian] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Translat Neurosci, Utrecht, Netherlands; [Henckens, Marloes J. A. G.; Fernandez, Guillen] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Fernandez, Guillen] Radboud Univ Nijmegen, Med Ctr, Dep Cognit Neurosci, NL-6525 ED Nijmegen, Netherlands	Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Radboud University Nijmegen	Pillai, AG (corresponding author), Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Translat Neurosci, Utrecht, Netherlands.	a.g.pillai@umcutrecht.nl	Joëls, Marian/P-6415-2016; Henckens, Marloes J.A.G./J-7132-2015; Fernandez, Guillen/B-3771-2009	Henckens, Marloes J.A.G./0000-0002-2375-1611; Fernandez, Guillen/0000-0002-5522-0604; Pillai, Anup/0000-0001-9788-1286; Joels, Marian/0000-0002-4826-6209	Max Planck Society; Netherlands Organization for Scientific Research (NWO) [021.002.053]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	AGP wishes to thank the Max Planck Society for the post-doctoral research fellowship. MH was paid by a grant (021.002.053) from the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azouz R, 1996, J PHYSIOL-LONDON, V492, P211, DOI 10.1113/jphysiol.1996.sp021302; Badanich KA, 2013, NEUROPSYCHOPHARMACOL, V38, P1176, DOI 10.1038/npp.2013.12; Barzi F, 2004, AM J EPIDEMIOL, V160, P34, DOI 10.1093/aje/kwh175; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Blackwell M, 2012, MULTIPLE OVERIMPUTAT; Bodner TE, 2008, STRUCT EQU MODELING, V15, P651, DOI 10.1080/10705510802339072; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; Cerqueira JJ, 2005, J NEUROSCI, V25, P7792, DOI 10.1523/JNEUROSCI.1598-05.2005; Chameau P, 2007, J NEUROPHYSIOL, V97, P5, DOI 10.1152/jn.00821.2006; CINTRA A, 1994, NEUROSCIENCE, V62, P843, DOI 10.1016/0306-4522(94)90481-2; COOK RD, 1977, TECHNOMETRICS, V19, P15, DOI 10.2307/1268249; Cook SC, 2004, J NEUROBIOL, V60, P236, DOI 10.1002/neu.20025; Czeh B, 2008, BEHAV BRAIN RES, V190, P1, DOI 10.1016/j.bbr.2008.02.031; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Dias-Ferreira E, 2009, SCIENCE, V325, P621, DOI 10.1126/science.1171203; Dorey R, 2012, NEUROPSYCHOPHARMACOL, V37, P2870, DOI 10.1038/npp.2012.170; Duvarci S, 2007, J NEUROSCI, V27, P4482, DOI 10.1523/JNEUROSCI.0680-07.2007; Eagle DM, 2010, NEUROSCI BIOBEHAV R, V34, P50, DOI 10.1016/j.neubiorev.2009.07.003; Faber ESL, 2005, EUR J NEUROSCI, V22, P1627, DOI 10.1111/j.1460-9568.2005.04357.x; Fukushima F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0003993; Furay AR, 2008, ENDOCRINOLOGY, V149, P5482, DOI 10.1210/en.2008-0642; Gerlach AC, 2004, PFLUG ARCH EUR J PHY, V448, P187, DOI 10.1007/s00424-003-1237-2; Goodfellow NM, 2009, J NEUROSCI, V29, P10094, DOI 10.1523/JNEUROSCI.1960-09.2009; Groc L, 2008, NAT NEUROSCI, V11, P868, DOI 10.1038/nn.2150; HALBERG F, 1959, AM J PHYSIOL, V197, P1083, DOI 10.1152/ajplegacy.1959.197.5.1083; Hawley DF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053126; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Jacobsen KR, 2012, GEN COMP ENDOCR, V179, P406, DOI 10.1016/j.ygcen.2012.09.012; JOELS M, 1989, SCIENCE, V245, P1502, DOI 10.1126/science.2781292; Joels M, 2003, EUR J NEUROSCI, V18, P1315, DOI 10.1046/j.1460-9568.2003.02845.x; Joels M, 2012, PHARMACOL REV, V64, P901, DOI 10.1124/pr.112.005892; Johnson LR, 2005, NEUROSCIENCE, V136, P289, DOI 10.1016/j.neuroscience.2005.06.050; JONES RSG, 1988, BRAIN RES, V462, P367, DOI 10.1016/0006-8993(88)90567-7; Karst H, 2005, P NATL ACAD SCI USA, V102, P19204, DOI 10.1073/pnas.0507572102; Karst H, 2000, NAT NEUROSCI, V3, P977, DOI 10.1038/79910; KERR DS, 1989, SCIENCE, V245, P1505, DOI 10.1126/science.2781293; KERR DS, 1992, P NATL ACAD SCI USA, V89, P8527, DOI 10.1073/pnas.89.18.8527; Khawaja FA, 2007, HIPPOCAMPUS, V17, P1143, DOI 10.1002/hipo.20365; King G, 2001, AM POLIT SCI REV, V95, P49, DOI 10.1017/S0003055401000235; Kitchener P, 2004, EUR J NEUROSCI, V19, P1837, DOI 10.1111/j.1460-9568.2004.03267.x; Koot S, 2013, NEUROPHARMACOLOGY, V70, P306, DOI 10.1016/j.neuropharm.2013.02.008; KRITZER MF, 1995, J COMP NEUROL, V359, P131, DOI 10.1002/cne.903590109; Ksiazek A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00185; LANCASTER B, 1991, J NEUROSCI, V11, P23; Lancaster B, 2000, J PHYSIOL-LONDON, V522, P231, DOI 10.1111/j.1469-7793.2000.t01-1-00231.x; LANCASTER B, 1987, J PHYSIOL-LONDON, V389, P187, DOI 10.1113/jphysiol.1987.sp016653; Lehmann ML, 2011, J NEUROSCI, V31, P6159, DOI 10.1523/JNEUROSCI.0577-11.2011; Liebmann L, 2008, J NEUROPHYSIOL, V99, P958, DOI 10.1152/jn.01137.2007; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; Liu RJ, 2008, P NATL ACAD SCI USA, V105, P359, DOI 10.1073/pnas.0706679105; Liu WH, 2010, J BIOL CHEM, V285, P6101, DOI 10.1074/jbc.M109.050229; MADISON DV, 1982, NATURE, V299, P636, DOI 10.1038/299636a0; MADISON DV, 1984, J PHYSIOL-LONDON, V354, P319, DOI 10.1113/jphysiol.1984.sp015378; Maggio N, 2007, J NEUROSCI, V27, P5757, DOI 10.1523/JNEUROSCI.0155-07.2007; Maggio N, 2009, J NEUROSCI, V29, P8633, DOI 10.1523/JNEUROSCI.1901-09.2009; Maggio N, 2009, J NEUROSCI, V29, P2857, DOI 10.1523/JNEUROSCI.4399-08.2009; Magistretti J, 1996, TRENDS NEUROSCI, V19, P530, DOI 10.1016/S0166-2236(96)40004-2; Martin S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004714; McEwen BS, 1997, ANN NY ACAD SCI, V821, P271, DOI 10.1111/j.1749-6632.1997.tb48286.x; McKlveen JM, 2013, BIOL PSYCHIAT, V74, P672, DOI 10.1016/j.biopsych.2013.03.024; Nieuwenhuis R., 2012, INFLUENCE ME TOOLS D; Perez-Cruz C, 2009, BEHAV BRAIN RES, V205, P406, DOI 10.1016/j.bbr.2009.07.021; Pettorossi VE, 2011, NEUROSCIENCE, V187, P1, DOI 10.1016/j.neuroscience.2011.04.040; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Radley JJ, 2006, CEREB CORTEX, V16, P313, DOI 10.1093/cercor/bhi104; REUL JMHM, 1986, J STEROID BIOCHEM, V24, P269, DOI 10.1016/0022-4731(86)90063-4; Revollo JR, 2009, ANN NY ACAD SCI, V1179, P167, DOI 10.1111/j.1749-6632.2009.04986.x; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Rubin DB, 2004, MULTIPLE IMPUTATION; Sah R, 2005, NEUROSCIENCE, V133, P281, DOI 10.1016/j.neuroscience.2005.01.066; Schwabe L, 2012, J NEUROSCI, V32, P10146, DOI 10.1523/JNEUROSCI.1304-12.2012; Shah M, 2000, J NEUROPHYSIOL, V83, P2554, DOI 10.1152/jn.2000.83.5.2554; Shansky RM, 2009, BRAIN RES, V1293, P108, DOI 10.1016/j.brainres.2009.03.062; Stocker M, 1999, P NATL ACAD SCI USA, V96, P4662, DOI 10.1073/pnas.96.8.4662; STORM JF, 1990, PROG BRAIN RES, V83, P161; STORM JF, 1987, BRAIN RES, V435, P387, DOI 10.1016/0006-8993(87)91631-3; Thomas EA, 2003, NEUROSCIENCE, V120, P333, DOI 10.1016/S0306-4522(03)00039-3; van Gemert NG, 2009, ENDOCRINOLOGY, V150, P4615, DOI 10.1210/en.2009-0525; Velumian AA, 1999, J PHYSIOL-LONDON, V517, P201, DOI 10.1111/j.1469-7793.1999.0201z.x; Vyas A, 2002, J NEUROSCI, V22, P6810; Wellman CL, 2001, J NEUROBIOL, V49, P245, DOI 10.1002/neu.1079; Wilber AA, 2011, NEUROSCIENCE, V174, P115, DOI 10.1016/j.neuroscience.2010.10.070; Winter B., 2013, LINEAR MODELS LINEAR; WOMBLE MD, 1993, BRAIN RES, V621, P87, DOI 10.1016/0006-8993(93)90301-3; Yuen EY, 2011, MOL PSYCHIATR, V16, P156, DOI 10.1038/mp.2010.50; Zardooz H, 2010, PHYSIOL RES, V59, P973, DOI 10.33549/physiolres.931896; ZHANG L, 1995, J PHYSIOL-LONDON, V488, P661, DOI 10.1113/jphysiol.1995.sp020998; Zhang ZG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054129, 10.1371/journal.pone.0056344, 10.1371/journal.pone.0054577, 10.1371/journal.pone.0065268]	88	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99208	10.1371/journal.pone.0099208	http://dx.doi.org/10.1371/journal.pone.0099208			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901987	Green Published, Green Submitted, gold			2022-12-27	WOS:000336841400110
J	Troyer, EM; Devitt, SEC; Sunquist, ME; Goswami, VR; Oli, MK				Troyer, Elizabeth M.; Devitt, Susan E. Cameron; Sunquist, Melvin E.; Goswami, Varun R.; Oli, Madan K.			Survival, Recruitment, and Population Growth Rate of an Important Mesopredator: The Northern Raccoon	PLOS ONE			English	Article							CAUSE-SPECIFIC MORTALITY; LIFE-HISTORY; PROCYON-LOTOR; BAYLISASCARIS-PROCYONIS; RECAPTURE; PATTERNS; ILLINOIS; ISLANDS; ECOLOGY; TRENDS	Populations of mesopredators (mid-sized mammalian carnivores) are expanding in size and range amid declining apex predator populations and ever-growing human presence, leading to significant ecological impacts. Despite their obvious importance, population dynamics have scarcely been studied for most mesopredator species. Information on basic population parameters and processes under a range of conditions is necessary for managing these species. Here we investigate survival, recruitment, and population growth rate of a widely distributed and abundant mesopredator, the northern raccoon (Procyon lotor), using Pradel's temporal symmetry models and >6 years of monthly capture-mark-recapture data collected in a protected area. Monthly apparent survival probability was higher for females (0.949, 95% CI = 0.936-0.960) than for males (0.908, 95% CI = 0.893-0.920), while monthly recruitment rate was higher for males (0.091, 95% CI = 0.078-0.106) than for females (0.054, 95% CI = 0.042-0.067). Finally, monthly realized population growth rate was 1.000 (95% CI = 0.996-1.004), indicating that our study population has reached a stable equilibrium in this relatively undisturbed habitat. There was little evidence for substantial temporal variation in population growth rate or its components. Our study is one of the first to quantify survival, recruitment, and realized population growth rate of raccoons using long-term data and rigorous statistical models.	[Troyer, Elizabeth M.; Goswami, Varun R.] Univ Florida, Sch Nat Resources & Environm, Gainesville, FL 32611 USA; [Troyer, Elizabeth M.; Devitt, Susan E. Cameron; Sunquist, Melvin E.; Goswami, Varun R.; Oli, Madan K.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Troyer, EM (corresponding author), Univ Florida, Sch Nat Resources & Environm, Gainesville, FL 32611 USA.	e.m.troyer@ufl.edu	Goswami, Varun R/AAE-8780-2019	Goswami, Varun R/0000-0003-2575-7301	Ordway-Swisher Biological Station; School of Natural Resources and Environment; Department of Wildlife Ecology and Conservation, University of Florida	Ordway-Swisher Biological Station; School of Natural Resources and Environment; Department of Wildlife Ecology and Conservation, University of Florida(University of Florida)	This study was supported by the Ordway-Swisher Biological Station, the School of Natural Resources and Environment, and the Department of Wildlife Ecology and Conservation, University of Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIEV FF, 1966, J WILDLIFE MANAGE, V30, P497, DOI 10.2307/3798740; Asano M, 2003, J VET MED SCI, V65, P369, DOI 10.1292/jvms.65.369; Atwood TC, 2009, J WILDLIFE MANAGE, V73, P647, DOI 10.2193/2008-215; Beasley JC, 2012, J WILDLIFE MANAGE, V76, P1290, DOI 10.1002/jwmg.379; Beasley JC, 2011, LANDSCAPE ECOL, V26, P937, DOI 10.1007/s10980-011-9619-x; Beltran-Beck B, 2012, EUR J WILDLIFE RES, V58, P5, DOI 10.1007/s10344-011-0600-4; Bernstein L, 2008, CLIMATE CHANGE 2007; BIGLER W J, 1981, Florida Scientist, V44, P151; Brashares Justin S., 2010, P221; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Campbell RD, 2012, GLOBAL CHANGE BIOL, V18, P2730, DOI 10.1111/j.1365-2486.2012.02739.x; Chamberlain MJ, 1999, J WILDLIFE MANAGE, V63, P880, DOI 10.2307/3802801; CLARK WR, 1989, J WILDLIFE MANAGE, V53, P982, DOI 10.2307/3809599; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; DeStefano S, 2003, FRONT ECOL ENVIRON, V1, P95, DOI 10.1890/1540-9295(2003)001[0095:ETEOSW]2.0.CO;2; DeVault TL, 2011, BASIC APPL ECOL, V12, P268, DOI 10.1016/j.baae.2011.02.008; Eagan TS, 2011, CAN J ZOOL, V89, P724, DOI 10.1139/Z11-045; Ellis EC, 2010, GLOBAL ECOL BIOGEOGR, V19, P589, DOI 10.1111/j.1466-8238.2010.00540.x; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Fordham DA, 2012, AUSTRAL ECOL, V37, P945, DOI 10.1111/j.1442-9993.2011.02354.x; Frey SN, 2006, J WILDLIFE MANAGE, V70, P1111, DOI 10.2193/0022-541X(2006)70[1111:HUBMIA]2.0.CO;2; FRITZELL EK, 1985, J WILDLIFE MANAGE, V49, P901, DOI 10.2307/3801366; Galiano D, 2013, MAMMALIA, V77, P173, DOI 10.1515/mammalia-2011-0128; Garmestani AS, 2005, SOUTHEAST NAT, V4, P469, DOI 10.1656/1528-7092(2005)004[0469:RRRSTN]2.0.CO;2; Gehrt SD, 1999, J WILDLIFE MANAGE, V63, P889, DOI 10.2307/3802802; Gehrt SD, 2002, WILDLIFE SOC B, V30, P457; Hartman LH, 1999, BIOL CONSERV, V88, P1, DOI 10.1016/S0006-3207(98)00094-9; HASBROUCK JJ, 1992, J WILDLIFE MANAGE, V56, P693, DOI 10.2307/3809462; Hernandez SM, 2013, PARASITOL RES, V112, P693, DOI 10.1007/s00436-012-3186-1; Hines JE, 2002, J APPL STAT, V29, P573, DOI 10.1080/02664760120108872; Kamler JF, 2004, AM MIDL NAT, V151, P27, DOI 10.1674/0003-0031(2004)151[0027:SACMAF]2.0.CO;2; Laake J., 2010, PROGRAM MARK GENTLE; Lotze J.-H., 1979, Mammalian Species, P1, DOI 10.2307/3503959; MCLEAN RG, 1971, J INFECT DIS, V123, P680, DOI 10.1093/infdis/123.6.680; Nixon Charles M., 2009, Transactions of the Illinois State Academy of Science, V102, P117; Oli MK, 2005, AM NAT, V166, P124, DOI 10.1086/430332; Oli MK, 2004, BASIC APPL ECOL, V5, P449, DOI 10.1016/j.baae.2004.06.002; Oli MK, 2003, AM NAT, V161, P422, DOI 10.1086/367591; Page LK, 1998, AM MIDL NAT, V140, P180, DOI 10.1674/0003-0031(1998)140[0180:RLSAIP]2.0.CO;2; PAYNE N F, 1986, Transactions of the Wisconsin Academy of Sciences Arts and Letters, V74, P75; Pradel R, 1996, BIOMETRICS, V52, P703, DOI 10.2307/2532908; PROMISLOW DEL, 1990, J ZOOL, V220, P417, DOI 10.1111/j.1469-7998.1990.tb04316.x; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; RITKE ME, 1990, AM MIDL NAT, V123, P390, DOI 10.2307/2426567; Roemer GW, 2009, BIOSCIENCE, V59, P165, DOI 10.1525/bio.2009.59.2.9; Schmidt KA, 2003, CONSERV BIOL, V17, P1141, DOI 10.1046/j.1523-1739.2003.02316.x; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Sunquist Melvin E., 1993, Bulletin of the Florida Museum of Natural History Biological Sciences, V36, P109; Timm SF, 2009, J WILDLIFE DIS, V45, P333, DOI 10.7589/0090-3558-45.2.333; Troyer EM, 2014, J MAMMAL, V95, P421, DOI 10.1644/13-MAMM-A-164.1; Urbanek Rachael E., 2009, Transactions of the Illinois State Academy of Science, V102, P217; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Winchester C, 2009, J WILDLIFE MANAGE, V73, P374, DOI 10.2193/2008-154; Zeveloff S. I., 2002, RACCOONS NATURAL HIS	55	6	6	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98535	10.1371/journal.pone.0098535	http://dx.doi.org/10.1371/journal.pone.0098535			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901349	Green Published, Green Submitted, gold			2022-12-27	WOS:000336841400035
J	Zhong, S; Navaratnam, D; Santos-Sacchi, J				Zhong, Sheng; Navaratnam, Dhasakumar; Santos-Sacchi, Joseph			A Genetically-Encoded YFP Sensor with Enhanced Chloride Sensitivity, Photostability and Reduced pH Interference Demonstrates Augmented Transmembrane Chloride Movement by Gerbil Prestin (SLC26a5)	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; OUTER HAIR CELL; STATE PROTON-TRANSFER; MOTOR PROTEIN; ENVIRONMENTAL SENSITIVITY; CRYSTAL-STRUCTURE; ANION TRANSPORT; VARIANT; INDICATORS; MECHANISM	Background: Chloride is the major anion in cells, with many diseases arising from disordered Cl- regulation. For the non-invasive investigation of Cl- flux, YFP-H148Q and its derivatives chameleon and Cl-Sensor previously were introduced as genetically encoded chloride indicators. Neither the Cl- sensitivity nor the pH-susceptibility of these modifications to YFP is optimal for precise measurements of Cl- under physiological conditions. Furthermore, the relatively poor photostability of YFP derivatives hinders their application for dynamic and quantitative Cl- measurements. Dynamic and accurate measurement of physiological concentrations of chloride would significantly affect our ability to study effects of chloride on cellular events. Methodology/Principal Findings: In this study, we developed a series of YFP derivatives to remove pH interference, increase photostability and enhance chloride sensitivity. The final product, EYFP-F46L/Q69K/H148Q/I152L/V163S/S175G/ S205V/A206K (monomeric Cl-YFP), has a chloride K-d of 14 mM and pK(a) of 5.9. The bleach time constant of 175 seconds is over 15-fold greater than wild-type EYFP. We have used the sensor fused to the transmembrane protein prestin (gerbil prestin, SLC26a5), and shown for the first time physiological (mM) chloride flux in HEK cells expressing this protein. This modified fluorescent protein will facilitate investigations of dynamics of chloride ions and their mediation of cell function. Conclusions: Modifications to YFP (EYFP-F46L/Q69K/H148Q/I152L/V163S/S175G/S205V/A206K (monomeric Cl-YFP) results in a photostable fluorescent protein that allows measurement of physiological changes in chloride concentration while remaining minimally affected by changes in pH.	[Zhong, Sheng; Navaratnam, Dhasakumar; Santos-Sacchi, Joseph] Yale Univ, Sch Med, Dept Surg Otolaryngol, New Haven, CT 06520 USA; [Navaratnam, Dhasakumar] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Navaratnam, Dhasakumar; Santos-Sacchi, Joseph] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Santos-Sacchi, Joseph] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University	Santos-Sacchi, J (corresponding author), Yale Univ, Sch Med, Dept Surg Otolaryngol, New Haven, CT 06520 USA.	joseph.santos-sacchi@yale.edu		Zhong, Sheng/0000-0002-1620-2059	National Institutes of Health National Institute on Deafness and Other Communication Disorders [DC 000273]	National Institutes of Health National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Support was provided by National Institutes of Health National Institute on Deafness and Other Communication Disorders grants DC 000273 (to J.S.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai JP, 2009, BIOPHYS J, V96, P3179, DOI 10.1016/j.bpj.2008.12.3948; Battistutta R, 2000, PROTEINS, V41, P429, DOI 10.1002/1097-0134(20001201)41:4<429::AID-PROT10>3.0.CO;2-D; Baumgarten CM, 2003, PROG BIOPHYS MOL BIO, V82, P25, DOI 10.1016/S0079-6107(03)00003-8; Bell AF, 2003, J AM CHEM SOC, V125, P6919, DOI 10.1021/ja034588w; Cianchetta S, 2010, TOXICOL APPL PHARM, V243, P372, DOI 10.1016/j.taap.2009.12.004; Erez Y, 2011, J PHYS CHEM B, V115, P11776, DOI 10.1021/jp2052689; Galietta LJV, 2001, FEBS LETT, V499, P220, DOI 10.1016/S0014-5793(01)02561-3; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Jayaraman S, 2000, J BIOL CHEM, V275, P6047, DOI 10.1074/jbc.275.9.6047; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Jin L, 2012, NEURON, V75, P779, DOI 10.1016/j.neuron.2012.06.040; Kuner T, 2000, NEURON, V27, P447, DOI 10.1016/S0896-6273(00)00056-8; Lau L., 2011, P SOC PHOTO-OPT INST, P7910; Li YL, 2012, NAT NEUROSCI, V15, P1047, DOI 10.1038/nn.3126; Little RC, 2006, SAS MIXED MODELS; Mahon Matthew J, 2011, Adv Biosci Biotechnol, V2, P132; Mank M, 2008, CHEM REV, V108, P1550, DOI 10.1021/cr078213v; Markova O, 2008, J NEUROSCI METH, V170, P67, DOI 10.1016/j.jneumeth.2007.12.016; McAnaney TB, 2005, BIOCHEMISTRY-US, V44, P5510, DOI 10.1021/bi047581f; Mistrik P, 2012, J PHYSIOL-LONDON, V590, P5597, DOI 10.1113/jphysiol.2012.241448; Morimoto YV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019598; Murek M, 2010, EXP PHYSIOL, V95, P471, DOI 10.1113/expphysiol.2009.049445; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Okada Y, 2006, J MEMBRANE BIOL, V209, P21, DOI 10.1007/s00232-005-0836-6; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Perron A, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.005.2009; Planells-Cases R, 2009, BBA-MOL BASIS DIS, V1792, P173, DOI 10.1016/j.bbadis.2009.02.002; Rekas A, 2002, J BIOL CHEM, V277, P50573, DOI 10.1074/jbc.M209524200; Rhoden KJ, 2008, ANAL BIOCHEM, V373, P239, DOI 10.1016/j.ab.2007.10.020; Rybalchenko V, 2003, J PHYSIOL-LONDON, V547, P873, DOI 10.1113/jphysiol.2002.036434; Rybalchenko V, 2008, BIOPHYS J, V95, P4439, DOI 10.1529/biophysj.108.134197; Santos-Sacchi J, 2006, J NEUROSCI, V26, P3992, DOI 10.1523/JNEUROSCI.4548-05.2006; Schanzler M, 2012, J PHYSIOL-LONDON, V590, P259, DOI 10.1113/jphysiol.2011.209577; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shu X, 2007, PROTEIN SCI, V16, P2703, DOI 10.1110/ps.073112007; Siegel M. S., 2010, COLD SPRING HARB PRO, V2010; Song L, 2005, BIOPHYS J, V88, P2350, DOI 10.1529/biophysj.104.053579; Song L, 2010, BIOPHYS J, V98, P371, DOI 10.1016/j.bpj.2009.10.027; Sullivan LM, 2008, CIRCULATION, V117, P1238, DOI 10.1161/CIRCULATIONAHA.107.654350; Truong K, 2001, NAT STRUCT BIOL, V8, P1069, DOI 10.1038/nsb728; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; van Thor JJ, 2002, NAT STRUCT BIOL, V9, P37, DOI 10.1038/nsb739; Wachter RM, 2000, J MOL BIOL, V301, P157, DOI 10.1006/jmbi.2000.3905; Wachter RM, 1999, CURR BIOL, V9, pR628, DOI 10.1016/S0960-9822(99)80408-4; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	47	24	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99095	10.1371/journal.pone.0099095	http://dx.doi.org/10.1371/journal.pone.0099095			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901231	Green Published, gold, Green Submitted			2022-12-27	WOS:000336841400097
J	Bharaswadkar, S; Kanchar, A; Thakur, N; Shah, S; Patnaik, B; Click, ES; Kumar, AMV; Dewan, PK				Bharaswadkar, Sandeep; Kanchar, Avinash; Thakur, Narendra; Shah, Shubhangi; Patnaik, Brinda; Click, Eleanor S.; Kumar, Ajay M. V.; Dewan, Puneet Kumar			Tuberculosis Management Practices of Private Practitioners in Pune Municipal Corporation, India	PLOS ONE			English	Article							DELHI	Background: Private Practitioners (PP) are the primary source of health care for patients in India. Limited representative information is available on TB management practices of Indian PP or on the efficacy of India's Revised National Tuberculosis Control Programme (RNTCP) to improve the quality of TB management through training of PP. Methods: We conducted a cross-sectional survey of a systematic random sample of PP in one urban area in Western India (Pune, Maharashtra). We presented sample clinical vignettes and determined the proportions of PPs who reported practices consistent with International Standards of TB Care (ISTC). We examined the association between RNTCP training and adherence to ISTC by calculating odds ratios and 95% confidence intervals. Results: Of 3,391 PP practicing allopathic medicine, 249 were interviewed. Of these, 55% had been exposed to RNTCP. For new pulmonary TB patients, 63% (158/249) of provider responses were consistent with ISTC diagnostic practices, and 34% (84/249) of responses were consistent with ISTC treatment practices. However, 48% (120/249) PP also reported use of serological tests for TB diagnosis. In the new TB case vignette, 38% (94/249) PP reported use of at least one second line anti-TB drug in the treatment regimen. RNTCP training was not associated with diagnostic or treatment practices. Conclusion: In Pune, India, despite a decade of training activities by the RNTCP, high proportions of providers resorted to TB serology for diagnosis and second-line anti-TB drug use in new TB patients. Efforts to achieve universal access to quality TB management must account for the low quality of care by PP and the lack of demonstrated effect of current training efforts.	[Bharaswadkar, Sandeep; Kanchar, Avinash; Dewan, Puneet Kumar] Off World Hlth Org WHO Representat India, New Delhi, India; [Thakur, Narendra; Shah, Shubhangi] Pune Municipal Corp, Directorate Hlth Serv, Pune, Maharashtra, India; [Patnaik, Brinda] MIMER Med Coll, Dept Community Med, Pune, Maharashtra, India; [Click, Eleanor S.] Ctr Dis Control & Prevent CDC, Div TB Eliminat, Atlanta, GA USA; [Kumar, Ajay M. V.] Int Union TB & Lung Dis, Reg Off Southeast, New Delhi, India	World Health Organization; Centers for Disease Control & Prevention - USA	Bharaswadkar, S (corresponding author), Off World Hlth Org WHO Representat India, New Delhi, India.	bharaswadkars@rntcp.org	Thakur, N S/ABF-4119-2021	Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531	UNION-WHO-CTD-NTI Operational research Project	UNION-WHO-CTD-NTI Operational research Project	This operational research was funded under UNION-WHO-CTD-NTI Operational research Project 2010-2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Central TB Division Directorate General of Health Services Ministry of Health and Family Welfare, 2012, GUID PROGR MAN DRUG; Centre for health research and development, 2003, HLTH ADM, VXV, P61; Das J, 2007, HEALTH AFFAIR, V26, pW338, DOI 10.1377/hlthaff.26.3.w338; Datta Kisalay, 2010, Indian J Tuberc, V57, P199; Government of India, 2006, NATL FAM HLTH SURV I; Government of India Central TB Division, 2008, REV SCH NONG ORG PRI; Greaves F, 2007, INT J TUBERC LUNG D, V11, P110; Krishnan N, 2009, INT J TUBERC LUNG D, V13, P112; Singla N, 1998, INT J TUBERC LUNG D, V2, P384; Srinath S, 2011, PLOS ONE, V6; Tuberculosis coalition for technical assistance, 2009, INT STAND TB CAR; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; Uplekar M, 2001, LANCET, V358, P912, DOI 10.1016/S0140-6736(01)06076-7; UPLEKAR M, 1996, TUBERCULOSIS PATIENT; Uplekar MW, 1996, INDIAN J TUBERC, V43, P19	15	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e97993	10.1371/journal.pone.0097993	http://dx.doi.org/10.1371/journal.pone.0097993			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897374	Green Published, Green Submitted, gold			2022-12-27	WOS:000338430700020
J	Kumar, R; Jain, S; Kumari, B; Kumar, M				Kumar, Ravindra; Jain, Sohni; Kumari, Bandana; Kumar, Manish			Protein Sub-Nuclear Localization Prediction Using SVM and Pfam Domain Information	PLOS ONE			English	Article							SUPPORT VECTOR MACHINE; AMINO-ACID-COMPOSITION; SUBCELLULAR-LOCALIZATION; STRUCTURAL CLASS; WEB-SERVER; SUBNUCLEAR LOCALIZATION; BINDING SITES; CLASSIFICATION; LOCATION; IDENTIFICATION	The nucleus is the largest and the highly organized organelle of eukaryotic cells. Within nucleus exist a number of pseudo-compartments, which are not separated by any membrane, yet each of them contains only a specific set of proteins. Understanding protein sub-nuclear localization can hence be an important step towards understanding biological functions of the nucleus. Here we have described a method, SubNucPred developed by us for predicting the sub-nuclear localization of proteins. This method predicts protein localization for 10 different sub-nuclear locations sequentially by combining presence or absence of unique Pfam domain and amino acid composition based SVM model. The prediction accuracy during leave-one-out cross-validation for centromeric proteins was 85.05%, for chromosomal proteins 76.85%, for nuclear speckle proteins 81.27%, for nucleolar proteins 81.79%, for nuclear envelope proteins 79.37%, for nuclear matrix proteins 77.78%, for nucleoplasm proteins 76.98%, for nuclear pore complex proteins 88.89%, for PML body proteins 75.40% and for telomeric proteins it was 83.33%. Comparison with other reported methods showed that SubNucPred performs better than existing methods. A web-server for predicting protein sub-nuclear localization named SubNucPred has been established at http://14.139.227.92/mkumar/subnucpred/. Standalone version of SubNucPred can also be downloaded from the webserver.	[Kumar, Ravindra; Jain, Sohni; Kumari, Bandana; Kumar, Manish] Univ Delhi, Dept Biophys, South Campus, New Delhi, India	University of Delhi	Kumar, M (corresponding author), Univ Delhi, Dept Biophys, South Campus, New Delhi, India.	manish@south.du.ac.in	Kumar, Manish/AGP-1250-2022; Kumar, Ravindra/F-2211-2017	Kumar, Manish/0000-0002-7936-9892; Kumar, Ravindra/0000-0002-0121-8402	Science and Engineering Research Board [SR/FT/LS-84/2010]; University Grant Commission; M. Phil and Non-Net PhD Scholarships of Delhi University; Science and Engineering Research Board [SR/FT/LS-84/2010]; University Grant Commission; M. Phil and Non-Net PhD Scholarships of Delhi University	Science and Engineering Research Board; University Grant Commission(University Grants Commission, India); M. Phil and Non-Net PhD Scholarships of Delhi University; Science and Engineering Research Board; University Grant Commission(University Grants Commission, India); M. Phil and Non-Net PhD Scholarships of Delhi University	This work was supported by Science and Engineering Research Board [grant number SR/FT/LS-84/2010]. Ravindra Kumar is supported as SRF by University Grant Commission (http://www. ugc. ac. in) scholarship [20-12/2009(ii) EU-IV]. Sohni Jain and Bandana Kumari were supported by M. Phil and Non-Net PhD Scholarships of Delhi University respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Belkacem R, 2012, TRENDS BIOTECHNOL, V30, P466, DOI 10.1016/j.tibtech.2012.05.006; Bhasin M, 2004, NUCLEIC ACIDS RES, V32, pW414, DOI 10.1093/nar/gkh350; Bhasin M, 2004, NUCLEIC ACIDS RES, V32, pW383, DOI 10.1093/nar/gkh416; Bhasin M, 2004, J BIOL CHEM, V279, P23262, DOI 10.1074/jbc.M401932200; Carmo-Fonseca M, 2002, CELL, V108, P513, DOI 10.1016/S0092-8674(02)00650-5; Chen C, 2006, ANAL BIOCHEM, V357, P116, DOI 10.1016/j.ab.2006.07.022; Chen W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1450; Chou KC, 2004, BIOCHEM BIOPH RES CO, V321, P1007, DOI 10.1016/j.bbrc.2004.07.059; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Eddy Sean R, 2009, Genome Inform, V23, P205; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Feng PM, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/530696; Fletez-Brant C, 2013, NUCLEIC ACIDS RES, V41, pW544, DOI 10.1093/nar/gkt519; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Gao QB, 2009, ANAL BIOCHEM, V387, P54, DOI 10.1016/j.ab.2009.01.018; Gao Y, 2005, AMINO ACIDS, V28, P373, DOI 10.1007/s00726-005-0206-9; Garg A, 2005, J BIOL CHEM, V280, P14427, DOI 10.1074/jbc.M411789200; Gronemeyer T, 2013, FEBS LETT, V587, P328, DOI 10.1016/j.febslet.2012.12.025; Guda C, 2004, BIOINFORMATICS, V20, P1785, DOI 10.1093/bioinformatics/bth171; Han GS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057225; Hua SJ, 2001, BIOINFORMATICS, V17, P721, DOI 10.1093/bioinformatics/17.8.721; Huang WL, 2007, BIOSYSTEMS, V90, P573, DOI 10.1016/j.biosystems.2007.01.001; Jiang XY, 2008, AMINO ACIDS, V34, P669, DOI 10.1007/s00726-008-0034-9; Johnson Tanya L, 2013, Methods Mol Biol, V966, P157, DOI 10.1007/978-1-62703-245-2_10; Kawashima S, 1999, NUCLEIC ACIDS RES, V27, P368, DOI 10.1093/nar/27.1.368; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Kumar M, 2008, PROTEINS, V71, P189, DOI 10.1002/prot.21677; Kumar M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-22; Lei ZD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-291; Li FM, 2008, AMINO ACIDS, V34, P119, DOI 10.1007/s00726-007-0545-9; Li J, 2009, PROTEOMICS, V9, P4539, DOI 10.1002/pmic.200900101; Li T, 2013, BIOINFORMATICS, V29, P678, DOI 10.1093/bioinformatics/btt029; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu YC, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S5-S12; Marsh KL, 1998, HUM MOL GENET, V7, P1795, DOI 10.1093/hmg/7.11.1795; Mei SY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S17; Mundra P, 2007, PATTERN RECOGN, V28, P6; Murphy R F, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P251; Naveed M, 2012, AMINO ACIDS, V42, P1809, DOI 10.1007/s00726-011-0902-6; O'Fallon BD, 2013, BIOINFORMATICS, V29, P1361, DOI 10.1093/bioinformatics/btt172; Ramana J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-445; Shen HB, 2005, BIOCHEM BIOPH RES CO, V337, P752, DOI 10.1016/j.bbrc.2005.09.117; Shen HB, 2007, PROTEIN ENG DES SEL, V20, P561, DOI 10.1093/protein/gzm057; Stadler C, 2013, NAT METHODS, V10, P315, DOI [10.1038/NMETH.2377, 10.1038/nmeth.2377]; Sutherland HGE, 2001, HUM MOL GENET, V10, P1995, DOI 10.1093/hmg/10.18.1995; Tang SN, 2013, NUCLEIC ACIDS RES, V41, pW441, DOI 10.1093/nar/gkt428; Vapnik V., 2013, NATURE STAT LAERNING; Verma R, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S15-S9; Wan SB, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-290; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023505; Watanabe S, 2012, JOVE-J VIS EXP, DOI 10.3791/3995; Wilson KL, 2001, CELL, V104, P647, DOI 10.1016/S0092-8674(02)01452-6; Xiao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030869; Xie H., 2013, P IEEE INT C SIGN PR, P1, DOI DOI 10.1109/ICNP.2013.6733632; Xu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055844; Yabuki Y, 2005, NUCLEIC ACIDS RES, V33, pW148, DOI 10.1093/nar/gki495; Yabuki Y, 2009, OPEN STRUCT BIOL J, V3, P149; Zhou GP, 2003, PROTEINS, V50, P44, DOI 10.1002/prot.10251; Zhou GP, 2001, PROTEINS, V44, P57, DOI 10.1002/prot.1071; Zhu YN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S21	61	23	23	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98345	10.1371/journal.pone.0098345	http://dx.doi.org/10.1371/journal.pone.0098345			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897370	gold, Green Published, Green Submitted			2022-12-27	WOS:000338430700034
J	Liang, HB; Chen, JD; Xie, JX; Sun, L; Ji, FX; He, SY; Zheng, Y; Liang, CM; Zhang, GH; Su, S; Li, SJ				Liang, Huanbin; Chen, Jidang; Xie, Jiexiong; Sun, Long; Ji, Fangxiao; He, Shuyi; Zheng, Yun; Liang, Chumin; Zhang, Guihong; Su, Shuo; Li, Shoujun			Hepatitis E Virus Serosurvey among Pet Dogs and Cats in Several Developed Cities in China	PLOS ONE			English	Article							SPORADIC ACUTE; WILD RATS; INFECTION; SEROPREVALENCE; JAPAN; TRANSMISSION; PREVALENCE; ANTIBODIES; ANIMALS; DISEASE	Infection by Hepatitis E virus (HEV), as a zoonotic disease virus, is well studied in pigs in China, but few studies in pets have been performed. This study was designed to characterize the prevalence of HEV infection among pet dogs and cats in major metropolitan areas of China. We conducted a seroepidemiological survey from 2012 to 2013 in 5 developed cities, Beijing, Shanghai, Canton, Shenzhen and Macao, by enzyme-linked immunosorbent assay (ELISA). The overall HEV seroprevalence in 658 dog and 191 cat serum samples was 21.12% and 6.28%, respectively. The analysis in dogs suggested that there were significant differences among cities, and the positive rate of HEV-specific antibody in all cities ranged from 6.06% (Shenzhen) to 29.34% (Beijing). Older pet cats have a high risk (OR, 10.25) for HEV seropositivity, but no strong relationship was observed between different genders and age groups. Additionally, it was revealed that stray dogs, omnivorous pet dogs and pet cats who share food, such as kitchen residue, with the general population would have a higher risk for HEV seropositivity. The odds ratios for these groups are 2.40, 2.83 and 5.39, respectively, compared with pet dogs and cats fed on commercial food. In this study, we first report that HEV is prevalent in pet dogs and cats in several large cities in China. Swill and kitchen residue may be a potential risk for HEV transmission from human to pets. As the sample size was relatively small in this study and may not be fully representative of China, further investigation is required to confirm the conclusions.	[Liang, Huanbin; Chen, Jidang; Xie, Jiexiong; Sun, Long; Ji, Fangxiao; He, Shuyi; Zheng, Yun; Liang, Chumin; Zhang, Guihong; Su, Shuo; Li, Shoujun] South China Agr Univ, MOA Key Lab Anim Vaccine Dev, Coll Vet Med, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Li, SJ (corresponding author), South China Agr Univ, MOA Key Lab Anim Vaccine Dev, Coll Vet Med, Guangzhou, Guangdong, Peoples R China.	shoujunli@scau.edu.cn	Xie, Jiexiong/I-5454-2019; CHEN, JIDANG/AAF-7628-2020; Chen, Jidang/L-1247-2019	Xie, Jiexiong/0000-0002-3374-6605; CHEN, JIDANG/0000-0002-5719-0429; 	Industry technology system of modern agriculture construction fund [CARS-36]; Ph.D. Programs Foundation of Ministry of Education of China [20104404110009, 20114404120010]	Industry technology system of modern agriculture construction fund; Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China)	This work was supported by the Industry technology system of modern agriculture construction fund (No. CARS-36) and the Ph.D. Programs Foundation of Ministry of Education of China (No. 20104404110009 and No. 20114404120010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARANKALLE VA, 1994, P NATL ACAD SCI USA, V91, P3428, DOI 10.1073/pnas.91.8.3428; Bendall R, 2010, J MED VIROL, V82, P799, DOI 10.1002/jmv.21656; Chiu DMY, 2013, J MED VIROL, V85, P459, DOI 10.1002/jmv.23429; Dong C, 2012, HEPAT MON, V12, P386, DOI 10.5812/hepatmon.6194; Goens S. Denise, 2004, Animal Health Research Reviews, V5, P145, DOI 10.1079/AHR200495; Hirano M, 2003, HEPATOL RES, V27, P1, DOI 10.1016/S1386-6346(03)00192-X; Hu WP, 2008, CLIN VACCINE IMMUNOL, V15, P1151, DOI 10.1128/CVI.00186-07; Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7; Kuno A, 2003, HEPATOL RES, V26, P237, DOI 10.1016/S1386-6346(03)00197-9; Lee JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067180; Li TC, 2005, EMERG INFECT DIS, V11, P1958, DOI 10.3201/eid1112.051041; Li W, 2013, VET MICROBIOL, V165, P275, DOI 10.1016/j.vetmic.2013.03.017; Liu JF, 2009, SCAND J INFECT DIS, V41, P291, DOI 10.1080/00365540902767031; Mochizuki M, 2006, VET REC, V159, P853; Okamoto H, 2007, VIRUS RES, V127, P216, DOI 10.1016/j.virusres.2007.02.002; Purcell RH, 2008, J HEPATOL, V48, P494, DOI 10.1016/j.jhep.2007.12.008; Rutjes SA, 2010, J VIROL METHODS, V168, P197, DOI 10.1016/j.jviromet.2010.05.014; Saad MD, 2007, INFECT GENET EVOL, V7, P368, DOI 10.1016/j.meegid.2006.07.007; Shukla P, 2007, J VIRAL HEPATITIS, V14, P310, DOI 10.1111/j.1365-2893.2006.00815.x; Song YJ, 2010, J MED VIROL, V82, P583, DOI 10.1002/jmv.21730; Tang XH, 2011, P NATL ACAD SCI USA, V108, P10266, DOI 10.1073/pnas.1101309108; Tei S, 2004, J MED VIROL, V74, P67, DOI 10.1002/jmv.20147; Usui R, 2004, INFECTION, V32, P57, DOI 10.1007/s15010-004-3078-0; Vitral CL, 2005, MEM I OSWALDO CRUZ, V100, P117, DOI 10.1590/S0074-02762005000200003; Xiao P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033480; Yazaki Y, 2003, J GEN VIROL, V84, P2351, DOI 10.1099/vir.0.19242-0; Zhang JZ, 2001, J MED VIROL, V64, P125, DOI 10.1002/jmv.1027; Zhang W, 2008, EPIDEMIOL INFECT, V136, P1020, DOI 10.1017/S095026880700965X; Zhang W, 2008, ZOONOSES PUBLIC HLTH, V55, P291, DOI 10.1111/j.1863-2378.2008.01136.x	29	28	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98068	10.1371/journal.pone.0098068	http://dx.doi.org/10.1371/journal.pone.0098068			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896257	Green Published, Green Submitted, gold			2022-12-27	WOS:000338430700023
J	OlaOlorun, FM; Hindin, MJ				OlaOlorun, Funmilola M.; Hindin, Michelle J.			Having a Say Matters: Influence of Decision-Making Power on Contraceptive Use among Nigerian Women Ages 35-49 Years	PLOS ONE			English	Article							AUTONOMY; EMPOWERMENT; BEHAVIOR; YORUBA; INDIA	Background: Research suggests that women of reproductive age who are involved in household decision-making are more likely than those who are not involved to be able to control their fertility. Little is known, however, about this relationship among women at the upper end of the reproductive spectrum. The aim of this study was to determine the association between household decision-making power and modern contraceptive use among Nigerian women ages 35-49 years. Methods: A descriptive, cross-sectional study involving a secondary analysis of data from the Nigerian 2008 Demographic and Health Survey was conducted among women ages 35-49 years who were considered to be in need of contraception. The outcome was modern contraceptive use while the main independent variable was a woman's household decision-making power score, constructed using principal component analysis. Multivariate logistic regression was performed to determine whether the women's household decision-making power score, categorized into tertiles, was independently associated with modern contraceptive use. Data were weighted and adjusted for the complex survey design. Results: Prevalence of modern contraceptive use among Nigerian women deemed to be in need of contraception in this study was 18.7%. Multivariate logistic regression showed that women's decision-making power remained statistically significantly associated with modern contraceptive use, even after adjusting for age, education, religion, polygyny, parity, wealth and domicile. Women who were in the highest decision-making power tertile had more than one and a half times the odds of using modern contraception compared with women in the lowest tertile [Adjusted Odds Ratio = 1.70; 95% Confidence Interval = 1.31-2.21, p<0.001]. Significance: Older Nigerian women who are involved in making household decisions are also able to make decisions related to their fertility. Programs in Nigeria focused on increasing modern contraceptive use should include strategies to increase women's status through encouraging more visible involvement in decision-making across different spheres of their lives.	[OlaOlorun, Funmilola M.] Univ Ibadan, Dept Prevent Med & Primary Care, Coll Med, Ibadan, Nigeria; [Hindin, Michelle J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD USA	University of Ibadan; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	OlaOlorun, FM (corresponding author), Univ Ibadan, Dept Prevent Med & Primary Care, Coll Med, Ibadan, Nigeria.	fmolaolorun@gmail.com	OlaOlorun, Funmilola/ABN-6506-2022	OlaOlorun, Funmilola/0000-0001-5544-2875; Hindin, Michelle/0000-0001-9941-7639				Acharya DR, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-15; [Anonymous], 2002, WORLD BANK WORKSH PO; [Anonymous], 2011, WORLD POP PROSP 2010; Barak B., 1981, COGNITIVE AGE NONCHR; Beasley A, 2010, SEMIN REPROD MED, V28, P147, DOI 10.1055/s-0030-1248140; Clark-Kazak CR, 2009, J DEV STUD, V45, P1307, DOI 10.1080/00220380902862952; Dimka Ritgak A, 2013, Afr J Reprod Health, V17, P102; Do M, 2012, INT PERSPECT SEX R H, V38, P23, DOI 10.1363/3802312; Federal Ministry of Women Affairs & Social Development, 2006, NIG NAT GEND POL; Feyisetan BJ, 2000, POPUL RES POLICY REV, V19, P29, DOI 10.1023/A:1006388011947; GAGE AJ, 1995, STUD FAMILY PLANN, V26, P264, DOI 10.2307/2138012; Hindin MJ, 2000, SOC SCI MED, V51, P1517, DOI 10.1016/S0277-9536(00)00051-4; Hogan DP, 1999, STUD FAMILY PLANN, V30, P302, DOI 10.1111/j.1728-4465.1999.t01-2-.x; Jacobsson B, 2004, OBSTET GYNECOL, V104, P727, DOI 10.1097/01.AOG.0000140682.63746.be; Jarrett M E, 1990, Nurse Pract, V15, P34; Jejeebhoy SJ, 2002, STUD FAMILY PLANN, V33, P299, DOI 10.1111/j.1728-4465.2002.00299.x; Jejeebhoy SJ, 2001, POPUL DEV REV, V27, P687, DOI 10.1111/j.1728-4457.2001.00687.x; Joliffe I T, 1992, Stat Methods Med Res, V1, P69, DOI 10.1177/096228029200100105; Koster W, 2010, SOC SCI MED, V71, P1788, DOI 10.1016/j.socscimed.2010.06.033; Lawrence PG, 2003, EVOLUTION HOUSEHOLD; Musalia JM, 2005, SEX ROLES, V53, P835, DOI 10.1007/s11199-005-8296-0; NPC and ICF Macro, 2009, NIG DEM HLTH SURV 20; ODDENS BJ, 1994, CONTRACEPTION, V49, P73, DOI 10.1016/0010-7824(94)90110-4; SCHULER SR, 1994, STUD FAMILY PLANN, V25, P65, DOI 10.2307/2138085; Senarath U, 2009, ASIA-PAC J PUBLIC HE, V21, P137, DOI 10.1177/1010539509331590; Sherman CA, 2005, J SOC ISSUES, V61, P139, DOI 10.1111/j.0022-4537.2005.00398.x; Stephenson R, 2008, HEALTH PLACE, V14, P841, DOI 10.1016/j.healthplace.2008.01.005; Woldemicael G, 2009, J BIOSOC SCI, V41, P161, DOI 10.1017/S0021932008003040	28	50	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98702	10.1371/journal.pone.0098702	http://dx.doi.org/10.1371/journal.pone.0098702			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK4YO	24897300	Green Published, gold, Green Submitted			2022-12-27	WOS:000338430700068
J	Pruvost, O; Magne, M; Boyer, K; Leduc, A; Tourterel, C; Drevet, C; Ravigne, V; Gagnevin, L; Guerin, F; Chiroleu, F; Koebnik, R; Verdier, V; Verniere, C				Pruvost, Olivier; Magne, Maxime; Boyer, Karine; Leduc, Alice; Tourterel, Christophe; Drevet, Christine; Ravigne, Virginie; Gagnevin, Lionel; Guerin, Fabien; Chiroleu, Frederic; Koebnik, Ralf; Verdier, Valerie; Verniere, Christian			A MLVA Genotyping Scheme for Global Surveillance of the Citrus Pathogen Xanthomonas citri pv. citri Suggests a Worldwide Geographical Expansion of a Single Genetic Lineage	PLOS ONE			English	Article							VARIABLE-NUMBER; 1ST REPORT; RALSTONIA-SOLANACEARUM; BACTERIAL WILT; TYPING SYSTEMS; CANKER; REPEATS; STRAINS; IDENTIFICATION; 1ST-REPORT	MultiLocus Variable number of tandem repeat Analysis (MLVA) has been extensively used to examine epidemiological and evolutionary issues on monomorphic human pathogenic bacteria, but not on bacterial plant pathogens of agricultural importance albeit such tools would improve our understanding of their epidemiology, as well as of the history of epidemics on a global scale. Xanthomonas citri pv. citri is a quarantine organism in several countries and a major threat for the citrus industry worldwide. We screened the genomes of Xanthomonas citri pv. citri strain IAPAR 306 and of phylogenetically related xanthomonads for tandem repeats. From these in silico data, an optimized MLVA scheme was developed to assess the global diversity of this monomorphic bacterium. Thirty-one minisatellite loci (MLVA-31) were selected to assess the genetic structure of 129 strains representative of the worldwide pathological and genetic diversity of X. citri pv. citri. Based on Discriminant Analysis of Principal Components (DAPC), four pathotype-specific clusters were defined. DAPC cluster 1 comprised strains that were implicated in the major geographical expansion of X. citri pv. citri during the 20th century. A subset of 12 loci (MLVA-12) resolved 89% of the total diversity and matched the genetic structure revealed by MLVA-31. MLVA-12 is proposed for routine epidemiological identification of X. citri pv. citri, whereas MLVA-31 is proposed for phylogenetic and population genetics studies. MLVA-31 represents an opportunity for international X. citri pv. citri genotyping and data sharing. The MLVA-31 data generated in this study was deposited in the Xanthomonas citri genotyping database (http://www.biopred.net/MLVA/).	[Pruvost, Olivier; Magne, Maxime; Boyer, Karine; Leduc, Alice; Gagnevin, Lionel; Chiroleu, Frederic; Verniere, Christian] CIRAD, UMR Peuplements Vegetaux & Bioagresseurs Milieu T, St Pierre, Reunion, France; [Tourterel, Christophe; Koebnik, Ralf; Verdier, Valerie] IRD CIRAD UM2, UMR Resistance Plantes Bioagresseurs RPB, Inst Rech Dev, Montpellier, France; [Tourterel, Christophe; Drevet, Christine] Univ Paris 11, Inst Genet & Microbiol, UMR 8621, F-91405 Orsay, France; [Tourterel, Christophe; Drevet, Christine] CNRS, Inst Genet & Microbiol, UMR 8621, F-91405 Orsay, France; [Ravigne, Virginie] CIRAD, UMR Biol & Genet Interact Plante Paras BGPI, Montpellier, France; [Guerin, Fabien] Univ Reunion, UMR Peuplements Vegetaux & Bioagresseurs Milieu T, St Pierre, Reunion, France	CIRAD; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CIRAD; University of La Reunion	Pruvost, O (corresponding author), CIRAD, UMR Peuplements Vegetaux & Bioagresseurs Milieu T, St Pierre, Reunion, France.	olivier.pruvost@cirad.fr	VerniÃre, Christian/AAX-6165-2021; Ravigné, Virginie/AAC-5427-2020; RAVIGNE, Virginie/B-5876-2011; Koebnik, Ralf/J-5627-2014; Verdier, Valerie/K-1004-2016; Gagnevin, Lionel/C-3397-2014	Ravigné, Virginie/0000-0002-4252-2574; RAVIGNE, Virginie/0000-0002-4252-2574; Koebnik, Ralf/0000-0002-4419-0542; Verdier, Valerie/0000-0001-5425-9454; Gagnevin, Lionel/0000-0002-2943-0827; Verniere, Christian/0000-0002-2312-2073; CHIROLEU, Frederic/0000-0002-4874-5357; Pruvost, Olivier/0000-0002-3175-9795	European Union (ERDF); Conseil Regional de La Reunion; French Agence Nationale de la Recherche [ANR-2010-BLAN-1723]; French Direction Generale de l'Armement [2010 34 006, 2011 60 080]; CIRAD	European Union (ERDF)(European Commission); Conseil Regional de La Reunion; French Agence Nationale de la Recherche(French National Research Agency (ANR)); French Direction Generale de l'Armement(French National Research Agency (ANR)); CIRAD	We thank C. Boyer, P. Grygiel, J. Hoareau, C. Juhasz, I.Robene and A.Dereeper for their contributions.The European Union (ERDF; http://europa.eu/legislation_summaries/agriculture/general_framework/g24234_en.htm), Conseil Regional de La Reunion (http://www.regionreunion.com/fr/spip/), the French Agence Nationale de la Recherche (ANR-2010-BLAN-1723; http://www.agence-nationale-recherche.fr/suivi-bilan/recherches-exploratoires-et-emergentes/blancgeneralite-et-contacts/blanc-presentation-synthetique-du-projet/?tx_lwmsuivibilan_pi2% 5BCODE%5D=ANR-10-BLAN-1723), the French Direction Generale de l'Armement (contract no 2010 34 006; http://www.defense.gouv.fr/dga), and CIRAD (http://www.cirad.fr) provided financial support. AL acknowledges support from the French Direction Generale de l'Armement (contract no 2011 60 080) and CIRAD.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; Achtman M, 2012, PHILOS T R SOC B, V367, P860, DOI 10.1098/rstb.2011.0303; Almeida NF, 2010, PHYTOPATHOLOGY, V100, P208, DOI 10.1094/PHYTO-100-3-0208; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Balestra GM, 2008, PLANT DIS, V92, P981, DOI 10.1094/PDIS-92-6-0981C; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; BROADBENT P, 1995, AUSTRALAS PLANT PATH, V24, P90, DOI 10.1071/APP9950090; Buhlmann A, 2014, ENVIRON MICROBIOL, V16, P2112, DOI 10.1111/1462-2920.12289; Ciammaruconi A, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-21; CIVEROLO E L, 1984, Journal of the Rio Grande Valley Horticultural Society, V37, P127; Croucher NJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0202; Cubero J, 2002, APPL ENVIRON MICROB, V68, P1257, DOI 10.1128/AEM.68.3.1257-1264.2002; Das A. K., 2003, Journal of Applied Horticulture (Lucknow), V5, P52; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Della Coletta H, 2001, APPL ENVIRON MICROB, V67, P4091, DOI 10.1128/AEM.67.9.4091-4095.2001; Denoeud F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-4; Derso E, 2009, PLANT DIS, V93, P203, DOI 10.1094/PDIS-93-2-0203B; Doidge EM, 1929, UNION S AFRICA DEP A, V51, P1; DYE DW, 1969, NEW ZEAL J AGR, V118, P20; Escalon A, 2013, MOL PLANT PATHOL, V14, P483, DOI 10.1111/mpp.12019; Estoup A, 2002, MOL ECOL, V11, P1591, DOI 10.1046/j.1365-294X.2002.01576.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87; Gironde S, 2012, APPL ENVIRON MICROB, V78, P3266, DOI 10.1128/AEM.06655-11; Gough C. L., 1988, Molecular Plant-Microbe Interactions, V1, P275, DOI 10.1094/MPMI-1-275; Graham JH, 2004, MOL PLANT PATHOL, V5, P1, DOI 10.1046/j.1364-3703.2004.00197.x; Grissa I, 2008, BIOCHIMIE, V90, P660, DOI 10.1016/j.biochi.2007.07.014; Hasse CH, 1915, J AGRIC RES, V4, P97; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Juhasz CC, 2013, PLANT DIS, V97, P1653, DOI 10.1094/PDIS-06-13-0600-PDN; Kado CI., 2010, PLANT BACTERIOLOGY; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Keim P, 2004, INFECT GENET EVOL, V4, P205, DOI 10.1016/j.meegid.2004.02.005; Kremer K, 2005, J CLIN MICROBIOL, V43, P5628, DOI 10.1128/JCM.43.11.5628-5638.2005; Leduc A, 2011, PLANT DIS, V95, P1311, DOI 10.1094/PDIS-03-11-0217; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Li WB, 2007, P NATL ACAD SCI USA, V104, P18427, DOI 10.1073/pnas.0705590104; Li XJ, 2013, DIAGN MICR INFEC DIS, V75, P203, DOI 10.1016/j.diagmicrobio.2012.11.007; Macdonald TE, 2011, APPL ENVIRON MICROB, V77, P8625, DOI 10.1128/AEM.05155-11; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Moreno P, 2008, MOL PLANT PATHOL, V9, P251, DOI 10.1111/J.1364-3703.2007.00455.X; N'Guessan CA, 2013, J MICROBIOL METH, V92, P366, DOI 10.1016/j.mimet.2013.01.012; Ngoc LBT, 2007, PLANT DIS, V91, P771, DOI 10.1094/PDIS-91-6-0771A; Ngoc LBT, 2009, MOL ECOL RESOUR, V9, P125, DOI 10.1111/j.1755-0998.2008.02242.x; Ngoc LBT, 2010, INT J SYST EVOL MICR, V60, P515, DOI 10.1099/ijs.0.009514-0; Ngoc LBT, 2009, APPL ENVIRON MICROB, V75, P1173, DOI 10.1128/AEM.02245-08; Ollitrault P, 2012, HANDB PLANT BREED, V8, P623, DOI 10.1007/978-1-4419-0763-9_16; Parkinson N, 2013, APPL ENVIRON MICROB, V79, P6016, DOI 10.1128/AEM.01219-13; Pereyre S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038585; Pourcel C, 2011, MOLECULAR MICROBIOLOGY: DIAGNOSTIC PRINCIPLES AND PRACTICE, SECOND EDITION, P179; Rossetti V., 1977, CITRUS CANKER LATIN, P918; Rybak M, 2009, MOL PLANT PATHOL, V10, P249, DOI 10.1111/j.1364-3703.2008.00528.x; Schubert TS, 2001, PLANT DIS, V85, P340, DOI 10.1094/PDIS.2001.85.4.340; Skaria M., 2012, SUBTROP PLANT SCI, V64, P29; Struelens M. J., 1996, Clin Microbiol Infect, V2, P2, DOI 10.1111/j.1469-0691.1996.tb00193.x; Struelens MJ, 1998, MEM I OSWALDO CRUZ, V93, P581, DOI 10.1590/S0074-02761998000500004; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Traore YN, 2008, PLANT DIS, V92, P977, DOI 10.1094/PDIS-92-6-0977B; Urwin R, 2003, TRENDS MICROBIOL, V11, P479, DOI 10.1016/j.tim.2003.08.006; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; van Belkum A, 2001, CLIN MICROBIOL REV, V14, P547, DOI 10.1128/CMR.14.3.547-560.2001; van Belkum A, 1998, MICROBIOL MOL BIOL R, V62, P275, DOI 10.1128/MMBR.62.2.275-293.1998; Verniere C, 1998, EUR J PLANT PATHOL, V104, P477, DOI 10.1023/A:1008676508688; Verniere C, 2014, ENVIRON MICROBIOL, V16, P2226, DOI 10.1111/1462-2920.12369; Vogler AJ, 2006, J BACTERIOL, V188, P4253, DOI 10.1128/JB.00001-06; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; Young JM, 2008, PHYTOPATHOLOGY, V98, P1060, DOI 10.1094/PHYTO-98-10-1060; Zaluga J, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-126; Zhao S, 2012, PHYTOPATHOLOGY, V102, P948, DOI 10.1094/PHYTO-04-12-0078-R	71	48	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98129	10.1371/journal.pone.0098129	http://dx.doi.org/10.1371/journal.pone.0098129			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897119	gold, Green Published, Green Submitted			2022-12-27	WOS:000338430700026
J	Zumbrennen-Bullough, KB; Becker, L; Garrett, L; Holter, SM; Calzada-Wack, J; Mossbrugger, I; Quintanilla-Fend, L; Racz, I; Rathkolb, B; Klopstock, T; Wurst, W; Zimmer, A; Wolf, E; Fuchs, H; Gailus-Durner, V; de Angelis, MH; Romney, SJ; Leibold, EA				Zumbrennen-Bullough, Kimberly B.; Becker, Lore; Garrett, Lillian; Hoelter, Sabine M.; Calzada-Wack, Julia; Mossbrugger, Ilona; Quintanilla-Fend, Leticia; Racz, Ildiko; Rathkolb, Birgit; Klopstock, Thomas; Wurst, Wolfgang; Zimmer, Andreas; Wolf, Eckhard; Fuchs, Helmut; Gailus-Durner, Valerie; de Angelis, Martin Hrabe; Romney, Steven J.; Leibold, Elizabeth A.			Abnormal Brain Iron Metabolism in Irp2 Deficient Mice Is Associated with Mild Neurological and Behavioral Impairments	PLOS ONE			English	Article							ELEMENT-BINDING-PROTEIN; REGULATORY PROTEIN-2; NEURODEGENERATIVE DISEASE; TARGETED DELETION; MESSENGER-RNAS; KNOCKOUT MICE; HOMEOSTASIS; MOUSE; GENE; TRANSFERRIN	Iron Regulatory Protein 2 (Irp2, Ireb2) is a central regulator of cellular iron homeostasis in vertebrates. Two global knockout mouse models have been generated to explore the role of Irp2 in regulating iron metabolism. While both mouse models show that loss of Irp2 results in microcytic anemia and altered body iron distribution, discrepant results have drawn into question the role of Irp2 in regulating brain iron metabolism. One model shows that aged Irp2 deficient mice develop adult-onset progressive neurodegeneration that is associated with axonal degeneration and loss of Purkinje cells in the central nervous system. These mice show iron deposition in white matter tracts and oligodendrocyte soma throughout the brain. A contrasting model of global Irp2 deficiency shows no overt or pathological signs of neurodegeneration or brain iron accumulation, and display only mild motor coordination and balance deficits when challenged by specific tests. Explanations for conflicting findings in the severity of the clinical phenotype, brain iron accumulation and neuronal degeneration remain unclear. Here, we describe an additional mouse model of global Irp2 deficiency. Our aged Irp2(-/-) mice show marked iron deposition in white matter and in oligodendrocytes while iron content is significantly reduced in neurons. Ferritin and transferrin receptor 1 (TfR1, Tfrc), expression are increased and decreased, respectively, in the brain from Irp2(-/-) mice. These mice show impairments in locomotion, exploration, motor coordination/balance and nociception when assessed by neurological and behavioral tests, but lack overt signs of neurodegenerative disease. Ultrastructural studies of specific brain regions show no evidence of neurodegeneration. Our data suggest that Irp2 deficiency dysregulates brain iron metabolism causing cellular dysfunction that ultimately leads to mild neurological, behavioral and nociceptive impairments.	[Zumbrennen-Bullough, Kimberly B.] Harvard Univ, Massachusetts Gen Hosp, Sch Med,Program Membrane Biol,Ctr Syst Biol, Program Anemia Signaling Res,Div Nephrol, Boston, MA USA; [Becker, Lore; Garrett, Lillian; Hoelter, Sabine M.; Calzada-Wack, Julia; Mossbrugger, Ilona; Quintanilla-Fend, Leticia; Racz, Ildiko; Rathkolb, Birgit; Fuchs, Helmut; Gailus-Durner, Valerie; de Angelis, Martin Hrabe] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, German Mouse Clin, Neuherberg, Germany; [Becker, Lore; Fuchs, Helmut; Gailus-Durner, Valerie; de Angelis, Martin Hrabe] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Expt Genet, Neuherberg, Germany; [Garrett, Lillian; Hoelter, Sabine M.; Wurst, Wolfgang] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany; [Calzada-Wack, Julia; Mossbrugger, Ilona; Quintanilla-Fend, Leticia] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Pathol, Neuherberg, Germany; [Racz, Ildiko; Zimmer, Andreas] Univ Bonn, Inst Mol Psychiat, Life & Brain Ctr, Bonn, Germany; [Rathkolb, Birgit; Wolf, Eckhard] Univ Munich, Inst Mol Anim Breeding & Biotechnol, Gene Ctr, Munich, Germany; [Klopstock, Thomas] Klinikum Ludwig Maximilians Univ, Friedrich Baur Inst, Dept Neurol, Munich, Germany; [de Angelis, Martin Hrabe] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, Chair Expt Genet, Freising Weihenstephan, Germany; [de Angelis, Martin Hrabe] German Ctr Diabet Res, Neuherberg, Germany; [Wurst, Wolfgang] Tech Univ Munich, Chair Dev Genet, Freising Weihenstephan, Germany; [Wurst, Wolfgang] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Klopstock, Thomas; Wurst, Wolfgang] Deutsch Zentrum Neurodegenerat Erkrankungen, Munich, Germany; [Klopstock, Thomas; Wurst, Wolfgang] Munich Cluster Syst Neurol, Munich, Germany; [Romney, Steven J.; Leibold, Elizabeth A.] Univ Utah, Dept Med, Div Hematol & Hematol Malignancies, Salt Lake City, UT 84112 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Bonn; University of Munich; University of Munich; Technical University of Munich; Technical University of Munich; Max Planck Society; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Utah System of Higher Education; University of Utah	Leibold, EA (corresponding author), Univ Utah, Dept Med, Div Hematol & Hematol Malignancies, Salt Lake City, UT 84112 USA.	betty.leibold@genetics.utah.edu	Becker, Lore/AAJ-1203-2020; Becker, Lore/E-3717-2010; Zimmer, Andreas/B-8357-2009; Gailus-Durner, Valerie/M-7337-2014; Racz, I./C-3074-2009; de Angelis, Martin Hrabe/F-5531-2012; Fuchs, Helmut/M-7347-2014; Hölter, Sabine M./N-5868-2014	Becker, Lore/0000-0002-6890-4984; Racz, I./0000-0002-1549-3616; de Angelis, Martin Hrabe/0000-0002-7898-2353; Fuchs, Helmut/0000-0002-5143-2677; Hölter, Sabine M./0000-0003-4878-5241; Wurst, Wolfgang/0000-0003-4422-7410; Calzada, Julia/0000-0003-0816-9305; Garrett, Lillian/0000-0003-4880-7076; Wolf, Eckhard/0000-0002-0430-9510	NIH [R01GM45201, T32DK007115]; German Federal Ministry of Education and Research [01KX1012]; German Center for Vertigo and Balance Disorders [01EO 0901]; Helmholtz Alliance HelMA-Helmholtz Alliance for Mental Health in an Ageing Society, through the Initiative and Network Fund of the Helmholtz Association; Helmholtz Portfolio Theme 'Metabolic Dysfunction and disease'; DFG [WU 164/5-1]; Seventh Framework Programme of the European Commission (FP7) [HEALTH-F2-2011];  [277984]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045201] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Center for Vertigo and Balance Disorders; Helmholtz Alliance HelMA-Helmholtz Alliance for Mental Health in an Ageing Society, through the Initiative and Network Fund of the Helmholtz Association; Helmholtz Portfolio Theme 'Metabolic Dysfunction and disease'; DFG(German Research Foundation (DFG)); Seventh Framework Programme of the European Commission (FP7); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH grant R01GM45201 to EAL and the NIH Hematology training grant T32DK007115 to KZB. German Mouse Clinic researchers (SMH, WW, BR, EW, LG, LB, IM, JCW, LQF, IR and AZ) were supported by the German Federal Ministry of Education and Research (Infrafrontier grant 01KX1012); the German Center for Vertigo and Balance Disorders (grant 01EO 0901); by the Helmholtz Alliance HelMA-Helmholtz Alliance for Mental Health in an Ageing Society, through the Initiative and Network Fund of the Helmholtz Association; by the Helmholtz Portfolio Theme 'Metabolic Dysfunction and disease', by the DFG grant 'DJ-1 Linked Neurodegeneration Pathways in New Mouse Models of Parkinson's Disease'(WU 164/5-1). TK was supported by the Seventh Framework Programme of the European Commission (FP7/2007-2013, HEALTH-F2-2011), grant agreement no. 277984 to TIRCON (Treat Iron-Related Childhood-Onset Neurodegeneration). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CP, 2012, BBA-MOL CELL RES, V1823, P1468, DOI 10.1016/j.bbamcr.2012.05.010; Anderson SA, 2013, CELL METAB, V17, P282, DOI 10.1016/j.cmet.2013.01.007; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Burn John, 2006, Semin Pediatr Neurol, V13, P176; Connor JR, 1996, GLIA, V17, P83, DOI 10.1002/(SICI)1098-1136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7; Cooperman SS, 2005, BLOOD, V106, P1084, DOI 10.1182/blood-2004-12-4703; Crusio WE, 2004, BIOL PSYCHIAT, V56, P381, DOI 10.1016/j.biopsych.2003.12.026; Dickinson TK, 1998, BRAIN RES, V801, P171, DOI 10.1016/S0006-8993(98)00575-7; Dusek P, 2012, NEUROBIOL DIS, V46, P1, DOI 10.1016/j.nbd.2011.12.054; Fretham SJB, 2012, HIPPOCAMPUS, V22, P1691, DOI 10.1002/hipo.22004; Galy B, 2005, GENESIS, V43, P181, DOI 10.1002/gene.20169; Galy B, 2005, BLOOD, V106, P2580, DOI 10.1182/blood-2005-04-1365; Galy B, 2006, NAT GENET, V38, P967, DOI 10.1038/ng0906-967; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Ghosh MC, 2008, P NATL ACAD SCI USA, V105, P12028, DOI 10.1073/pnas.0805361105; Ghosh MC, 2013, CELL METAB, V17, P271, DOI 10.1016/j.cmet.2012.12.016; Grabill C, 2003, BRAIN RES, V971, P95, DOI 10.1016/S0006-8993(03)02366-7; GUO B, 1994, J BIOL CHEM, V269, P24252; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Jeong SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025404; Kallnik M, 2007, MAMM GENOME, V18, P173, DOI 10.1007/s00335-007-9002-z; Kono S, 2006, BIOL RES, V39, P15, DOI 10.4067/S0716-97602006000100003; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; LEBOEUF RC, 1995, J LAB CLIN MED, V126, P128; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; Leitner DF, 2012, BBA-GEN SUBJECTS, V1820, P393, DOI 10.1016/j.bbagen.2011.10.016; Lozoff Betsy, 2006, Semin Pediatr Neurol, V13, P158, DOI 10.1016/j.spen.2006.08.004; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Mogil JS, 1999, P NATL ACAD SCI USA, V96, P7744, DOI 10.1073/pnas.96.14.7744; Moroishi T, 2011, CELL METAB, V14, P339, DOI 10.1016/j.cmet.2011.07.011; Neff F, 2013, J CLIN INVEST, V123, P3272, DOI 10.1172/JCI67674; Ohl F, 2001, BEHAV RES METH INS C, V33, P392, DOI 10.3758/BF03195393; Pham CTN, 1996, P NATL ACAD SCI USA, V93, P13090, DOI 10.1073/pnas.93.23.13090; Phillips JD, 2007, P NATL ACAD SCI USA, V104, P5079, DOI 10.1073/pnas.0700547104; Rao R, 2007, SEMIN FETAL NEONAT M, V12, P54, DOI 10.1016/j.siny.2006.10.007; Rouault TA, 2013, NAT REV NEUROSCI; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Sanchez M, 2011, BLOOD, V118, pE168, DOI 10.1182/blood-2011-04-343541; Simcox JA, 2013, CELL METAB, V17, P329, DOI 10.1016/j.cmet.2013.02.007; Smith SR, 2004, ANN NY ACAD SCI, V1012, P65, DOI 10.1196/annals.1306.006; Todorich B, 2009, GLIA, V57, P467, DOI 10.1002/glia.20784; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Watase K, 2003, NAT REV GENET, V4, P296, DOI 10.1038/nrg1045; Wilkinson N, 2013, BLOOD, V122, P1658, DOI 10.1182/blood-2013-03-492454; Yoshiki A, 2006, ILAR J, V47, P94, DOI 10.1093/ilar.47.2.94; Youdim MBH, 2008, NEUROTOX RES, V14, P45, DOI 10.1007/BF03033574; YU Y, 1992, J BIOL CHEM, V267, P19005	48	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98072	10.1371/journal.pone.0098072	http://dx.doi.org/10.1371/journal.pone.0098072			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896637	Green Published, gold, Green Submitted			2022-12-27	WOS:000338430700024
J	Buesser, P; Tomassini, M				Buesser, Pierre; Tomassini, Marco			The Role of Opportunistic Migration in Cyclic Games	PLOS ONE			English	Article							EVOLUTION; BIODIVERSITY; COOPERATION; PROMOTES	We study cyclic evolutionary games in a spatial diluted grid environment in which agents strategically interact locally but can also opportunistically move to other positions within a given migration radius. We find that opportunistic migration can inverse the cyclic prevalence between the strategies when the frequency of random imitation is large enough compared to the payoff-driven imitation. At the transition the average size of the patterns diverges and this threatens diversity of strategies.	[Buesser, Pierre; Tomassini, Marco] Univ Lausanne, Fac Business & Econ, Lausanne, Switzerland	University of Lausanne	Buesser, P (corresponding author), Univ Lausanne, Fac Business & Econ, Lausanne, Switzerland.	pierre.buesser@unil.ch			Swiss National Foundation [200021-146616]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	P. Buesser received Swiss National Foundation grant n. 200021-146616; M. Tomassini is self-supported. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktipis CA, 2004, J THEOR BIOL, V231, P249, DOI 10.1016/j.jtbi.2004.06.020; Buesser P, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042806; Chen Z, 2011, PHYSICA A, V390, P1615, DOI 10.1016/j.physa.2011.01.004; Cong R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035776; deForest R, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062138; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Helbing D, 2009, P NATL ACAD SCI USA, V106, P3680, DOI 10.1073/pnas.0811503106; Hofbauer J, 1998, EVOLUTIONARY GAMES P; JACKSON JBC, 1975, P NATL ACAD SCI USA, V72, P5160, DOI 10.1073/pnas.72.12.5160; Jiang LL, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.036108; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Ni XA, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.066211; Reichenbach T, 2007, NATURE, V448, P1046, DOI 10.1038/nature06095; Sandholm WH., 2010, POPULATION GAMES EVO; Semmann D, 2003, NATURE, V425, P390, DOI 10.1038/nature01986; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Szabo G, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.036107; Szabo G, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.062903; Szabo G, 2004, J PHYS A-MATH GEN, V37, P2599, DOI 10.1088/0305-4470/37/7/006; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2010, PHYS REV E, V80; Szolnoki A, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036110; TAINAKA K, 1991, EUROPHYS LETT, V15, P399, DOI 10.1209/0295-5075/15/4/006; Vukov J, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022123; Wang Z, 2012, SCI REP-UK, V2, DOI 10.1038/srep00369; Wang Z, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.037101	26	0	0	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98190	10.1371/journal.pone.0098190	http://dx.doi.org/10.1371/journal.pone.0098190			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892660	Green Submitted, Green Published, gold			2022-12-27	WOS:000336911400038
J	Buono, L; Lopez-Villavicencio, M; Shykoff, JA; Snirc, A; Giraud, T				Buono, Lorenza; Lopez-Villavicencio, Manuela; Shykoff, Jacqui A.; Snirc, Alodie; Giraud, Tatiana			Influence of Multiple Infection and Relatedness on Virulence: Disease Dynamics in an Experimental Plant Population and Its Castrating Parasite	PLOS ONE			English	Article							FUNGUS MICROBOTRYUM-VIOLACEUM; POLYMORPHIC MICROSATELLITE LOCI; WITHIN-HOST COMPETITION; ANTHER-SMUT DISEASE; USTILAGO-VIOLACEA; SPORE PRODUCTION; LIFE-HISTORY; SILENE-ALBA; EVOLUTION; REPRODUCTION	The level of parasite virulence, i.e., the decrease in host's fitness due to a pathogen, is expected to depend on several parameters, such as the type of the disease (e.g., castrating or host-killing) and the prevalence of multiple infections. Although these parameters have been extensively studied theoretically, few empirical data are available to validate theoretical predictions. Using the anther smut castrating disease on Silene latifolia caused by Microbotryum lychnidis-dioicae, we studied the dynamics of multiple infections and of different components of virulence (host death, non-recovery and percentage of castrated stems) during the entire lifespan of the host in an experimental population. We monitored the number of fungal genotypes within plants and their relatedness across five years, using microsatellite markers, as well as the rates of recovery and host death in the population. The mean relatedness among genotypes within plants remained at a high level throughout the entire host lifespan despite the dynamics of the disease, with recurrent new infections. Recovery was lower for plants with multiple infections compared to plants infected by a single genotype. As expected for castrating parasites, M. lychnidis-dioicae did not increase host mortality. Mortality varied across years but was generally lower for plants that had been diseased the preceding year. This is one of the few studies to have empirically verified theoretical expectations for castrating parasites, and to show particularly i) that castrated hosts live longer, suggesting that parasites can redirect resources normally used in reproduction to increase host lifespan, lengthening their transmission phase, and ii) that multiple infections increase virulence, here in terms of non-recovery and host castration.	[Buono, Lorenza; Shykoff, Jacqui A.; Snirc, Alodie; Giraud, Tatiana] Univ Paris 11, Orsay, France; [Buono, Lorenza; Shykoff, Jacqui A.; Snirc, Alodie; Giraud, Tatiana] CNRS, F-91405 Orsay, France; [Lopez-Villavicencio, Manuela] Museum Natl Hist Nat, CNRS, UMR 7205, Dept Systemat & Evolut, Paris, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Giraud, T (corresponding author), Univ Paris 11, Orsay, France.	tatiana.giraud@u-psud.fr		Giraud, Tatiana/0000-0002-2685-6478	 [ANR-13-BSV7-0008]		ANR-13-BSV7-0008 (http://www.agence-nationale-recherche.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER HM, 1995, J ECOL, V83, P783, DOI 10.2307/2261415; ALEXANDER HM, 1988, J ECOL, V76, P91, DOI 10.2307/2260456; Alizon S, 2009, J EVOLUTION BIOL, V22, P245, DOI 10.1111/j.1420-9101.2008.01658.x; Antonovics J, 2005, NEW PHYTOL, V165, P71, DOI 10.1111/j.1469-8137.2004.01215.x; Bashey F, 2012, J EVOLUTION BIOL, V25, P431, DOI 10.1111/j.1420-9101.2011.02441.x; BAUDOIN M, 1975, EVOLUTION, V29, P335, DOI [10.2307/2407221, 10.1111/j.1558-5646.1975.tb00213.x]; Best A, 2010, EVOLUTION, V64, P348, DOI 10.1111/j.1558-5646.2009.00819.x; Biere A, 1996, OECOLOGIA, V107, P307, DOI 10.1007/BF00328447; Bonds MH, 2006, AM NAT, V168, P281, DOI 10.1086/506922; Brown SP, 2002, TRENDS MICROBIOL, V10, P401, DOI 10.1016/S0966-842X(02)02413-7; Bucheli E, 1998, MOL ECOL, V7, P665; Buckling A, 2008, HEREDITY, V100, P484, DOI 10.1038/sj.hdy.6801093; Burns CE, 2005, ECOLOGY, V86, P753, DOI 10.1890/03-0735; Cafuir L, 2007, INT J PLANT SCI, V168, P415, DOI 10.1086/511754; Chung E, 2012, ECOL EVOL, V2, P2304, DOI 10.1002/ece3.346; Dawkins R., 1999, THE EXTENDED PHENOTY; DAY AW, 1980, BOT GAZ, V141, P313, DOI 10.1086/337162; de Roode JC, 2005, P NATL ACAD SCI USA, V102, P7624, DOI 10.1073/pnas.0500078102; de Roode JC, 2005, AM NAT, V166, P531, DOI 10.1086/491659; Delmotte F, 1999, HEREDITY, V82, P300, DOI 10.1038/sj.hdy.6884850; Ebert D, 2004, AM NAT, V164, pS19, DOI 10.1086/424606; Ebert D, 1997, P ROY SOC B-BIOL SCI, V264, P985, DOI 10.1098/rspb.1997.0136; Edwards DP, 2008, BEHAV ECOL SOCIOBIOL, V63, P95, DOI 10.1007/s00265-008-0639-8; Flor HH, 1942, PHYTOPATHOLOGY, V32, P653; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Gardner A, 2004, P ROY SOC B-BIOL SCI, V271, P1529, DOI 10.1098/rspb.2004.2756; Giraud T, 2008, MOL ECOL RESOUR, V8, P387, DOI 10.1111/j.1471-8286.2007.01967.x; Giraud T, 2004, HEREDITY, V93, P559, DOI 10.1038/sj.hdy.6800554; Giraud T, 2002, MOL ECOL NOTES, V2, P142, DOI 10.1046/j.1471-8286.2002.00172.x; Gladieux P, 2011, MOL BIOL EVOL, V28, P459, DOI 10.1093/molbev/msq235; Gold Alexander, 2009, BMC Ecology, V9, P11, DOI 10.1186/1472-6785-9-11; Hechinger RF, 2008, P ROY SOC B-BIOL SCI, V275, P2707, DOI 10.1098/rspb.2008.0875; Hechinger RF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-136; Hood ME, 2003, AM NAT, V162, P122, DOI 10.1086/375539; Jaenike J, 1996, EVOLUTION, V50, P2241, DOI [10.1111/j.1558-5646.1996.tb03613.x, 10.2307/2410694]; Jensen KH, 2006, PLOS BIOL, V4, P1265, DOI 10.1371/journal.pbio.0040197; Kaltz O, 1999, EVOLUTION, V53, P395, DOI [10.1111/j.1558-5646.1999.tb03775.x, 10.2307/2640776]; Kaltz O, 2002, J EVOLUTION BIOL, V15, P850, DOI 10.1046/j.1420-9101.2002.00433.x; Keeney DB, 2007, MOL ECOL, V16, P431, DOI 10.1111/j.1365-294X.2006.03143.x; Koskella B, 2006, AM NAT, V168, P121, DOI 10.1086/505770; KURIS AM, 1994, ANNU REV ECOL SYST, V25, P189, DOI 10.1146/annurev.es.25.110194.001201; Lafferty KD, 2009, TRENDS PARASITOL, V25, P564, DOI 10.1016/j.pt.2009.09.003; Lefevre T, 2008, TRENDS PARASITOL, V24, P435, DOI 10.1016/j.pt.2008.06.006; Lopez-Villavicencio M, 2007, PLOS PATHOG, V3, P1710, DOI 10.1371/journal.ppat.0030176; Lopez-Villavicencio M, 2011, EVOLUTION, V65, P1357, DOI 10.1111/j.1558-5646.2010.01207.x; Mageroy JH, 2011, PARASITOLOGY, V138, P1910, DOI 10.1017/S0031182011001302; Massey RC, 2004, P ROY SOC B-BIOL SCI, V271, P785, DOI 10.1098/rspb.2004.2676; Min KJ, 2012, CURR BIOL, V22, pR792, DOI 10.1016/j.cub.2012.06.036; Morris WF, 1998, AM J BOT, V85, P784, DOI 10.2307/2446413; Neuhaus P, 2001, CAN J ZOOL, V79, P465, DOI 10.1139/cjz-79-3-465; O'Keefe KJ, 2002, AM NAT, V159, P597, DOI 10.1086/339990; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; Obreski S, 2005, SCIENCE, V188, P1314; Ojosnegros S, 2010, P NATL ACAD SCI USA, V107, P2108, DOI 10.1073/pnas.0909787107; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Read AF, 2001, SCIENCE, V292, P1099, DOI 10.1126/science.1059410; Schafer AM, 2010, BOTANY, V88, P875, DOI 10.1139/B10-061; Shykoff JA, 1998, INT J PLANT SCI, V159, P236, DOI 10.1086/297544; Thomas A, 2003, INT J PLANT SCI, V164, P641, DOI 10.1086/375374; Thomas F, 2000, J EVOLUTION BIOL, V13, P409, DOI 10.1046/j.1420-9101.2000.00190.x; THRALL PH, 1994, J ECOL, V82, P549, DOI 10.2307/2261263; vanBaalen M, 1995, AM NAT, V146, P881, DOI 10.1086/285830; Vercken E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001229; West SA, 2003, P ROY SOC B-BIOL SCI, V270, P37, DOI 10.1098/rspb.2002.2209	65	12	13	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98526	10.1371/journal.pone.0098526	http://dx.doi.org/10.1371/journal.pone.0098526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892951	Green Published, gold, Green Submitted			2022-12-27	WOS:000336911400062
J	Little, JP; Bleedorn, JA; Sutherland, BJ; Sullivan, R; Kalscheur, VL; Ramaker, MA; Schaefer, SL; Hao, ZL; Muir, P				Little, Jeffrey P.; Bleedorn, Jason A.; Sutherland, Brian J.; Sullivan, Ruth; Kalscheur, Vicki L.; Ramaker, Megan A.; Schaefer, Susan L.; Hao, Zhengling; Muir, Peter			Arthroscopic Assessment of Stifle Synovitis in Dogs with Cranial Cruciate Ligament Rupture	PLOS ONE			English	Article							RESISTANT ACID-PHOSPHATASE; PLATEAU LEVELING OSTEOTOMY; CATHEPSIN-K; JOINT; OSTEOARTHRITIS; PATHOGENESIS; POPULATIONS; PROGRESSION; SUBLUXATION; EXPRESSION	Cranial cruciate ligament rupture (CR) is a degenerative condition in dogs that typically has a non-contact mechanism. Subsequent contralateral rupture often develops in dogs with unilateral CR. Synovitis severity is an important factor that promotes ligament degradation. Consequently, we wished to evaluate the utility of arthroscopy for assessment of stifle synovitis in dogs with CR. Herein, we report results of a prospective study of 27 dogs with unilateral CR and bilateral radiographic osteoarthritis. Arthroscopic images and synovial biopsies from the lateral and medial joint pouches were obtained bilaterally and graded for synovial hypertrophy, vascularity, and synovitis. Synovial tartrate-resistant acid phosphatase-positive (TRAP(+)) macrophages, CD3(+) T lymphocytes, Factor VIII+ blood vessels, and synovial intima thickness were quantified histologically and related to arthroscopic observations. Risk of subsequent contralateral CR was examined using survival analysis. We found that arthroscopic scores were increased in the index stifle, compared with the contralateral stifle (p < 0.05). Numbers of CD3(+) T lymphocytes (S-R = 0.50, p < 0.05) and TRAP(+) cells in joint pouches (S-R = 0.59, p < 0.01) were correlated between joint pairs. Arthroscopic grading of vascularity and synovitis was correlated with number density of Factor VIII+ vessels (S-R > 0.34, p < 0.05). Arthroscopic grading of villus hypertrophy correlated with numbers of CD3(+) T lymphocytes (SR = 0.34, p, 0.05). Synovial intima thickness was correlated with arthroscopic hypertrophy, vascularity, and synovitis (S-R > 0.31, p < 0.05). Strong intra-observer and moderate inter-observer agreement for arthroscopic scoring was found. Dog age and arthroscopic vascularity significantly influenced risk of contralateral CR over time. We conclude that arthroscopic grading of synovitis is a precise tool that correlates with histologic synovitis. Arthroscopy is useful for assessment of stifle synovitis in client-owned dogs, and could be used in longitudinal clinical trials to monitor synovial responses to disease-modifying therapy.	[Little, Jeffrey P.; Bleedorn, Jason A.; Sutherland, Brian J.; Kalscheur, Vicki L.; Ramaker, Megan A.; Schaefer, Susan L.; Hao, Zhengling; Muir, Peter] Univ Wisconsin, Sch Vet Med, Comparat Orthopaed Res Lab, Madison, WI 53706 USA; [Sullivan, Ruth] Univ Wisconsin, Comparat Pathol Lab, Res Anim Resources Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Muir, P (corresponding author), Univ Wisconsin, Sch Vet Med, Comparat Orthopaed Res Lab, Madison, WI 53706 USA.	muirp@vetmed.wisc.edu	Muir, Peter/AAH-8057-2021; Bleedorn, Jason A/AAE-2115-2019; Mickelson, Megan/AAB-4563-2020	Muir, Peter/0000-0003-0028-6005; Bleedorn, Jason A/0000-0003-2987-7722; Mickelson, Megan/0000-0002-8197-9315	Companion Animal Fund, School of Veterinary Medicine, University of Wisconsin-Madison; Clinical and Translational Science Award (CTSA) program, through the NIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000427]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER	Companion Animal Fund, School of Veterinary Medicine, University of Wisconsin-Madison; Clinical and Translational Science Award (CTSA) program, through the NIH National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by a grant from the Companion Animal Fund, School of Veterinary Medicine, University of Wisconsin-Madison. The project described was also supported by the Clinical and Translational Science Award (CTSA) program, through the NIH National Center for Advancing Translational Sciences (NCATS), grant UL1TR000427. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Af Klint E, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2714; Ayral X, 1996, BAILLIERE CLIN RHEUM, V10, P477, DOI 10.1016/S1521-6942(96)80009-X; Bleedorn JA, 2011, VET SURG, V40, P531, DOI 10.1111/j.1532-950X.2011.00841.x; Bondeson J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2099; Bresnihan B, 1998, BRIT J RHEUMATOL, V37, P636; Buote N, 2009, VET SURG, V38, P481, DOI 10.1111/j.1532-950X.2009.00532.x; Cabrera SY, 2008, JAVMA-J AM VET MED A, V232, P889, DOI 10.2460/javma.232.6.889; Chu PG, 2001, APPL IMMUNOHISTO M M, V9, P97, DOI 10.1097/00022744-200106000-00001; Comerford EJ, 2011, VET COMP ORTHOPAED, V24, P91, DOI 10.3415/VCOT-10-04-0055; Conzemius MG, 2005, JAVMA-J AM VET MED A, V226, P232, DOI 10.2460/javma.2005.226.232; Cook JL, 2010, VET SURG, V39, P270, DOI 10.1111/j.1532-950X.2010.00653.x; Danielsson F, 2004, VET COMP ORTHOPAED, V17, P237; de Bruin T, 2007, VET REC, V161, P745, DOI 10.1136/vr.161.22.745; Doom M, 2008, VET IMMUNOL IMMUNOP, V125, P143, DOI 10.1016/j.vetimm.2008.05.023; DOVERSPIKE M, 1993, J AM ANIM HOSP ASSOC, V29, P167; Erne JB, 2009, JAVMA-J AM VET MED A, V235, P386, DOI 10.2460/javma.235.4.386; Faldyna M, 2004, ACTA VET BRNO, V73, P79, DOI 10.2754/avb200473010079; Fuller MC, 2014, JAVMA-J AM VET MED A, V244, P328, DOI 10.2460/javma.244.3.328; GALLOWAY RH, 1995, J AM ANIM HOSP ASSOC, V31, P289, DOI 10.5326/15473317-31-4-289; GOLDBERG VM, 1982, J BONE JOINT SURG AM, V64, P900, DOI 10.2106/00004623-198264060-00014; Hayashi K, 2011, VET SURG, V40, P192, DOI 10.1111/j.1532-950X.2010.00777.x; Hulse D, 2010, VET SURG, V39, P350, DOI 10.1111/j.1532-950X.2010.00676.x; Innes JF, 2004, VET RADIOL ULTRASOUN, V45, P143, DOI 10.1111/j.1740-8261.2004.04024.x; Kent MS, 2002, AM J VET RES, V63, P363, DOI 10.2460/ajvr.2002.63.363; Kim SE, 2011, AM J VET RES, V72, P410, DOI 10.2460/ajvr.72.3.410; Kjelgaard-Hansen M, 2004, THESIS ROYAL VET AGR; Lemburg AK, 2004, VET IMMUNOL IMMUNOP, V97, P231, DOI 10.1016/j.vetimm.2003.09.007; LINDBLAD S, 1985, ARTHRITIS RHEUM, V28, P977, DOI 10.1002/art.1780280904; Martano M, 2004, VET RES COMMUN, V28, P299, DOI 10.1023/B:VERC.0000045431.82158.4e; Might KR, 2013, VET SURG, V42, P392, DOI 10.1111/j.1532-950X.2012.01064.x; MOORE KW, 1995, AUST VET J, V72, P281, DOI 10.1111/j.1751-0813.1995.tb03555.x; Muir P, 2005, VET SURG, V34, P239, DOI 10.1111/j.1532-950X.2005.00036.x; Muir P, 2002, AM J VET RES, V63, P1279, DOI 10.2460/ajvr.2002.63.1279; Muir P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025331; Muir P, 2011, VET SURG, V40, P753, DOI 10.1111/j.1532-950X.2011.00867.x; Ohno K, 2006, J VET MED SCI, V68, P1275, DOI 10.1292/jvms.68.1275; PAUS AC, 1990, SCAND J RHEUMATOL, V19, P202, DOI 10.3109/03009749009095044; Preziosi R, 2004, J COMP PATHOL, V130, P143, DOI 10.1016/j.jcpa.2003.10.003; REINKE JD, 1982, J AM ANIM HOSP ASSOC, V18, P257; Sakkas LI, 2007, ARTHRITIS RHEUM-US, V56, P409, DOI 10.1002/art.22369; Seed SM, 2009, GERIATRICS-US, V64, P20; STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0; Sumner JP, 2010, VET SURG, V39, P936, DOI 10.1111/j.1532-950X.2010.00738.x; Sutton S, 2009, VET J, V179, P10, DOI 10.1016/j.tvjl.2007.08.013; Wilke VL, 2005, JAVMA-J AM VET MED A, V227, P1604, DOI 10.2460/javma.2005.227.1604; Wilkerson MJ, 2005, VET IMMUNOL IMMUNOP, V106, P179, DOI 10.1016/j.vetimm.2005.02.020	46	22	22	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e97329	10.1371/journal.pone.0097329	http://dx.doi.org/10.1371/journal.pone.0097329			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892866	Green Published, gold, Green Submitted			2022-12-27	WOS:000336911400011
J	Liu, Y; Liu, YY; Sun, C; Gan, L; Zhang, LW; Mao, AH; Du, YT; Zhou, R; Zhang, H				Liu, Yang; Liu, Yuanyuan; Sun, Chao; Gan, Lu; Zhang, Luwei; Mao, Aihong; Du, Yuting; Zhou, Rong; Zhang, Hong			Carbon Ion Radiation Inhibits Glioma and Endothelial Cell Migration Induced by Secreted VEGF	PLOS ONE			English	Article							FOCAL ADHESION KINASE; MALIGNANT GLIOMA; GENE; ANGIOGENESIS; RADIOTHERAPY; EXPRESSION; SURVIVAL; INVASION; BIOLOGY; FAK	This study evaluated the effects of carbon ion and X-ray radiation and the tumor microenvironment on the migration of glioma and endothelial cells, a key process in tumorigenesis and angiogenesis during cancer progression. C6 glioma and human microvascular endothelial cells were treated with conditioned medium from cultures of glioma cells irradiated at a range of doses and the migration of both cell types, tube formation by endothelial cells, as well as the expression and secretion of migration-related proteins were evaluated. Exposure to X-ray radiation-conditioned medium induced dose-dependent increases in cell migration and tube formation, which were accompanied by an upregulation of vascular endothelial growth factor (VEGF) and matrix metalloproteinase (MMP)-2 and -9 expression. However, glioma cells treated with conditioned medium of cells irradiated at a carbon ion dose of 4.0 Gy showed a marked decrease in migratory potential and VEGF secretion relative to non-irradiated cells. The application of recombinant VEGF165 stimulated migration in glioma and endothelial cells, which was associated with increased FAK phosphorylation at Tyr861, suggesting that the suppression of cell migration by carbon ion radiation could be via VEGF-activated FAK signaling. Taken together, these findings indicate that carbon ion may be superior to X-ray radiation for inhibiting tumorigenesis and angiogenesis through modulation of VEGF level in the glioma microenvironment.	[Liu, Yang; Liu, Yuanyuan; Sun, Chao; Gan, Lu; Zhang, Luwei; Mao, Aihong; Zhou, Rong; Zhang, Hong] Chinese Acad Sci, Inst Modern Phys, Dept Radiat Med, Lanzhou, Peoples R China; [Liu, Yang; Liu, Yuanyuan; Sun, Chao; Gan, Lu; Zhang, Luwei; Mao, Aihong; Zhou, Rong; Zhang, Hong] Chinese Acad Sci, Key Lab Heavy Ion Radiat Biol & Med, Lanzhou, Peoples R China; [Liu, Yang; Liu, Yuanyuan; Sun, Chao; Gan, Lu; Zhang, Luwei; Mao, Aihong; Zhou, Rong; Zhang, Hong] Key Lab Heavy Ion Radiat Med Gansu Prov, Lanzhou, Peoples R China; [Mao, Aihong] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Du, Yuting] Lanzhou Univ, Hosp Stomatol, Lanzhou 730000, Peoples R China	Chinese Academy of Sciences; Institute of Modern Physics, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Lanzhou University	Zhang, H (corresponding author), Chinese Acad Sci, Inst Modern Phys, Dept Radiat Med, Lanzhou, Peoples R China.	zhangh@impcas.ac.cn			National Basic Research Program of China [2010CB834202]; National Natural Science Foundation of China [11205214, 11305224]; Scientific Technology Research Projects of Gansu Province [0702NKDA045, 0806RJYA020]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Technology Research Projects of Gansu Province	This work was supported by grants from the National Basic Research Program of China (2010CB834202), The National Natural Science Foundation of China (11205214 and 11305224), the Scientific Technology Research Projects of Gansu Province (0702NKDA045, 0806RJYA020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen G, 2010, ONCOL REP, V23, P997, DOI 10.3892/or_00000725; Chen XL, 2012, DEV CELL, V22, P146, DOI 10.1016/j.devcel.2011.11.002; Chu SH, 2007, SURG NEUROL, V68, P610, DOI [10.1016/j.sumeu.2006.12.050, 10.1016/j.surneu.2006.12.050]; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Desai S, 2013, CYTOKINE, V61, P54, DOI 10.1016/j.cyto.2012.08.022; Durante M, 2000, INT J RADIAT ONCOL, V47, P793, DOI 10.1016/S0360-3016(00)00455-7; Gorski DH, 1999, CANCER RES, V59, P3374; Hamada N, 2010, J RADIAT RES, V51, P365, DOI 10.1269/jrr.09137; Hauck CR, 2002, IUBMB LIFE, V53, P115, DOI 10.1080/15216540211470; Holland EC, 2000, P NATL ACAD SCI USA, V97, P6242, DOI 10.1073/pnas.97.12.6242; Jensen AD, 2011, BRIT J RADIOL, V84, pS35, DOI 10.1259/bjr/71511359; Joy AM, 2003, J CELL SCI, V116, P4409, DOI 10.1242/jcs.00712; Kargiotis O, 2010, J NEURO-ONCOL, V100, P323, DOI 10.1007/s11060-010-0199-4; Kil WJ, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-25; Kim SY, 2013, BIOCHEM BIOPH RES CO, V433, P260, DOI 10.1016/j.bbrc.2013.02.093; Le Boeuf F, 2004, J BIOL CHEM, V279, P39175, DOI 10.1074/jbc.M405493200; Liu Y, 2012, J PINEAL RES, V52, P47, DOI 10.1111/j.1600-079X.2011.00917.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Malik MT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-61; Marie M, 2012, INT J RADIAT BIOL, V88, P688, DOI 10.3109/09553002.2012.706358; Nakagawa Y, 2012, BIOCHEM BIOPH RES CO, V423, P654, DOI 10.1016/j.bbrc.2012.06.004; Nakajima NI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070107; Nakamura K, 2001, ONCOGENE, V20, P2626, DOI 10.1038/sj.onc.1204359; Park CM, 2006, CANCER RES, V66, P8511, DOI 10.1158/0008-5472.CAN-05-4340; Parthymou A, 2004, INT J CANCER, V110, P807, DOI 10.1002/ijc.20188; Ruegg C, 2011, B CANCER, V98, pE47, DOI 10.1684/bdc.2011.1372; Sieg DJ, 1999, J CELL SCI, V112, P2677; Takahashi Y, 2003, CANCER RES, V63, P4253; Wild-Bode C, 2001, CANCER RES, V61, P2744; Yoshimura M, 2013, BIOMED RES IN PRESS; Zhang H, 2012, BRIT J DERMATOL, V166, P1100, DOI 10.1111/j.1365-2133.2011.10764.x	32	8	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98448	10.1371/journal.pone.0098448	http://dx.doi.org/10.1371/journal.pone.0098448			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893038	gold, Green Submitted, Green Published			2022-12-27	WOS:000336911400052
J	Tagliafico, A; Bignotti, B; Tagliafico, G; Astengo, D; Martino, L; Airaldi, S; Signori, A; Sormani, MP; Houssami, N; Calabrese, M				Tagliafico, Alberto; Bignotti, Bianca; Tagliafico, Giulio; Astengo, Davide; Martino, Lucia; Airaldi, Sonia; Signori, Alessio; Sormani, Maria Pia; Houssami, Nehmat; Calabrese, Massimo			Breast Density Assessment Using a 3T MRI System: Comparison among Different Sequences	PLOS ONE			English	Article							CANCER RISK PREDICTION; X-RAY MAMMOGRAPHY; MAGNETIC-RESONANCE; DIGITAL MAMMOGRAPHY; PARENCHYMAL PATTERNS; TISSUE DENSITY; WOMEN; WATER; FAT; CLASSIFICATION	Purpose: To compare MRI sequences for breast density measurements on a 3T MRI system using IDEAL (Iterative Decomposition of water and fat with Echo Asymmetry and Least squares estimation) as possible physiology-like reference. Materials and Methods: MRI examination was performed in 48 consecutive patients (mean age 41, years; range, 35-67 years) on a 3.0T scanner and 46 were included. All (fertile) women, were examined between days 5 and 15 of their menstrual cycle. MRI protocol included: T1-turbo spin-echo (T1-tSE), T2-turbo spin-echo (T2-tSE), VIBRANT (Volume Imaging for Breast Assessment) before and after injection of contrast media and IDEAL. Breast density was calculated with semi-automated software. Statistical analysis was performed with non-parametric tests. Results: Mean percentage of breast density calculated in each sequence was: T1-tSE = 56%; T2-tSE = 52%; IDEAL FatOnly = 55%; IDEAL WaterOnly = 53%, VIBRANT = 55%. Significant differences were observed between T2-tSE and both T1-tSE (p<0.001), VIBRANT sequences (p = 0.009), T1-tSE and both IDEAL WaterOnly (p = 0.007) and IDEAL FatOnly (p = 0.047). Breast density percentage showed a positive linear correlation among different sequences: r >= 0.93. Conclusions: Differences exist between MRI sequences used to assess breast density percentage. T1-weighted sequences values were similar to IDEAL sequences.	[Tagliafico, Alberto] Univ Genoa, Dept Expt Med, Inst Anat, Genoa, Italy; [Bignotti, Bianca; Astengo, Davide; Martino, Lucia; Airaldi, Sonia] Univ Genoa, Dept Radiol, Genoa, Italy; [Tagliafico, Giulio] CNR, IMATI, Ist Matemat Applicata & Tecnol Informat, Genoa, Italy; [Signori, Alessio; Sormani, Maria Pia] Univ Genoa, Dept Hlth Sci, Inst Stat, Genoa, Italy; [Houssami, Nehmat] Univ Sydney, Sydney Med Sch, Sch Publ Hlth, STEP, Sydney, NSW 2006, Australia; [Calabrese, Massimo] IRCCS Azienda Osped Univ San Martino, Ist Ist Nazl Ric Canc, Dept Diagnost Senol, Genoa, Italy	University of Genoa; University of Genoa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Matematica Applicata e Tecnologie Informatiche "Enrico Magenes" (IMATI-CNR); University of Genoa; University of Sydney; University of Genoa; IRCCS AOU San Martino IST	Tagliafico, A (corresponding author), Univ Genoa, Dept Expt Med, Inst Anat, Genoa, Italy.	alberto.tagliafico@unige.it	Houssami, Nehmat/ABC-1103-2020; Signori, Alessio/L-3081-2016; Tagliafico, Alberto/Y-5729-2019; Calabrese, Massimo/Y-6985-2019; Sormani, Maria Pia/ABH-8756-2020	Houssami, Nehmat/0000-0002-3641-952X; Signori, Alessio/0000-0001-6289-9144; Tagliafico, Alberto/0000-0003-1736-0697; Calabrese, Massimo/0000-0001-7281-5573; SORMANI, MARIA PIA/0000-0001-6892-104X				BOYD NF, 1995, J NATL CANCER I, V87, P670, DOI 10.1093/jnci/87.9.670; Byng JW, 1998, RADIOGRAPHICS, V18, P1587, DOI 10.1148/radiographics.18.6.9821201; Darabi H, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3110; Diorio C, 2005, CANCER EPIDEM BIOMAR, V14, P1065, DOI 10.1158/1055-9965.EPI-04-0706; DIXON WT, 1984, RADIOLOGY, V153, P189, DOI 10.1148/radiology.153.1.6089263; Eng-Wong J, 2008, CANCER EPIDEM BIOMAR, V17, P1696, DOI 10.1158/1055-9965.EPI-07-2752; GLOVER GH, 1991, JMRI-J MAGN RESON IM, V1, P521, DOI 10.1002/jmri.1880010504; Graham SJ, 1996, BRIT J CANCER, V73, P162, DOI 10.1038/bjc.1996.30; Gram IT, 1997, EUR J RADIOL, V24, P131, DOI 10.1016/S0720-048X(96)01138-2; Gram IT, 2005, BREAST CANCER RES, V7, pR854, DOI 10.1186/bcr1308; Harvey JA, 2004, RADIOLOGY, V230, P29, DOI 10.1148/radiol.2301020870; Highnam R, 2007, PHYS MED BIOL, V52, P5881, DOI 10.1088/0031-9155/52/19/010; Houssami N, 2012, CURR BREAST CANC REP, DOI [10.1007/s12609-012-0070-z, DOI 10.1007/S12609-012-0070-Z.]; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Jordan CD, 2013, J MAGN RESON IMAGING, V37, P227, DOI 10.1002/jmri.23762; Khazen M, 2008, CANCER EPIDEM BIOMAR, V17, P2268, DOI 10.1158/1055-9965.EPI-07-2547; Klifa C, 2004, P ANN INT IEEE EMBS, V26, P1667; Klifa C, 2010, MAGN RESON IMAGING, V28, P8, DOI 10.1016/j.mri.2009.05.040; Kopans DB, 2008, RADIOLOGY, V246, P348, DOI 10.1148/radiol.2461070309; Krishnamurthy R, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-68; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee NA, 1997, AM J ROENTGENOL, V168, P501, DOI 10.2214/ajr.168.2.9016235; Lobbes MBI, 2012, INSIGHTS IMAGING, V3, P91, DOI 10.1007/s13244-011-0139-7; Lu LJW, 2012, PHYS MED BIOL, V57, P6903, DOI 10.1088/0031-9155/57/21/6903; Martin LJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1831; McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965.EPI-06-0034; Pineda AR, 2005, MAGNET RESON MED, V54, P625, DOI 10.1002/mrm.20623; POON CS, 1992, J NATL CANCER I, V84, P777, DOI 10.1093/jnci/84.10.777; Reeder SB, 2004, MAGNET RESON MED, V51, P35, DOI 10.1002/mrm.10675; Reeder SB, 2007, J MAGN RESON IMAGING, V25, P644, DOI 10.1002/jmri.20831; Sardanelli F, 2010, EUR J CANCER, V46, P1296, DOI 10.1016/j.ejca.2010.02.015; Tagliafico A, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20130528; Tagliafico A, 2012, RADIOL MED, V117, P992, DOI 10.1007/s11547-012-0831-9; Tagliafico A, 2013, BREAST CANCER RES TR, V138, P311, DOI 10.1007/s10549-013-2419-z; Tagliafico A, 2012, EUR RADIOL, V22, P1265, DOI 10.1007/s00330-012-2380-y; Tagliafico A, 2011, EUR J ENDOCRINOL, V164, P335, DOI 10.1530/EJE-10-0896; Tagliafico A, 2009, BREAST, V18, P35, DOI 10.1016/j.breast.2008.09.005; Thompson DJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2447; Tice JA, 2005, BREAST CANCER RES TR, V94, P115, DOI 10.1007/s10549-005-5152-4; Wang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081653; Wei J, 2004, MED PHYS, V31, P933, DOI 10.1118/1.1668512	41	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e99027	10.1371/journal.pone.0099027	http://dx.doi.org/10.1371/journal.pone.0099027			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892933	gold, Green Published, Green Submitted			2022-12-27	WOS:000336911400121
J	Tegtmeyer, N; Lind, J; Schmid, B; Backert, S				Tegtmeyer, Nicole; Lind, Judith; Schmid, Benedikt; Backert, Steffen			Helicobacter pylori CagL Y58/E59 Mutation Turns-Off Type IV Secretion-Dependent Delivery of CagA into Host Cells	PLOS ONE			English	Editorial Material							PATHOGENICITY ISLAND; ADHESION; PROTEIN; PHOSPHORYLATION; EXPRESSION; INDUCTION; SYSTEM; GENES	The type IV secretion system (T4SS) is a major virulence determinant of the gastric pathogen Helicobacter pylori. The CagL protein is a specialized adhesin of the corresponding T4SS pilus, which establishes initial contact with the integrin beta 1 receptor on host target cells. Recent studies proposed that Y58 and E59 amino acid polymorphisms in CagL increase the virulence of H. pylori strains by enhanced translocation and phosphorylation of the CagA effector protein. These polymorphisms were therefore correlated with an increased risk of gastric cancer development. Here we show that the Y58/E59 motif, which is located in a loop connecting two a-helices, and corresponding polymorphisms could influence the function of CagL. However, expression of isogenic CagL Y58/E59 variants in H. pylori strain 26695 significantly blocked the translocation and phosphorylation of CagA as compared to complemented wild-type CagL. These results suggest that the function of the T4SS for delivery of CagA is turned-off by the Y58/E59 mutation in CagL. This activity appears to be similar to the one recently described for another T4SS pilus protein, CagY, which is also sufficient to cause gain or loss of T4SS function. These data support the hypothesis that certain mutations in CagL or recombination events in CagY may serve as a sort of molecular switch or perhaps rheostat in the T4SS, which could alter the function of the pilus and "tunes" injection of CagA and host pro-inflammatory responses, respectively.	[Tegtmeyer, Nicole; Lind, Judith; Backert, Steffen] Univ Erlangen Nurnberg, Dept Biol, Div Microbiol, D-91054 Erlangen, Germany; [Schmid, Benedikt] Univ Erlangen Nurnberg, Dept Biol, Div Biotech, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Backert, S (corresponding author), Univ Erlangen Nurnberg, Dept Biol, Div Microbiol, D-91054 Erlangen, Germany.	Steffen.Backert@fau.de						Barden S, 2014, ACTA CRYSTALLOGR D, V70, P1391, DOI 10.1107/S1399004714003150; Barden S, 2013, STRUCTURE, V21, P1931, DOI 10.1016/j.str.2013.08.018; Barrozo RM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003189; Bijlsma JJE, 1999, INFECT IMMUN, V67, P2433, DOI 10.1128/IAI.67.5.2433-2440.1999; Boehm M, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00017; Conradi J, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00070; Conradi J, 2012, AMINO ACIDS, V43, P219, DOI 10.1007/s00726-011-1066-0; Fischer W, 2001, MOL MICROBIOL, V42, P1337, DOI 10.1046/j.1365-2958.2001.02714.x; Gorrell RJ, 2013, CELL MICROBIOL, V15, P554, DOI 10.1111/cmi.12055; Hirsch C, 2012, J GASTROENTEROL, V47, P936, DOI 10.1007/s00535-012-0618-8; Hofreuter D, 2001, MOL MICROBIOL, V41, P379, DOI 10.1046/j.1365-2958.2001.02502.x; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Moese S, 2007, CELL MICROBIOL, V9, P1148, DOI 10.1111/j.1462-5822.2006.00856.x; Mueller D, 2012, J CLIN INVEST, V122, P1553, DOI 10.1172/JCI61143; Pachathundikandi SK, 2013, GUT MICROBES, V4, P454, DOI 10.4161/gmic.27001; Patel SR, 2013, CELL MICROBIOL, V15, P2080, DOI 10.1111/cmi.12174; Saha A, 2010, GASTROENTEROLOGY, V139, P239, DOI 10.1053/j.gastro.2010.03.036; Salama NR, 2013, NAT REV MICROBIOL, V11, P385, DOI 10.1038/nrmicro3016; Shaffer CL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002237; Smolka AJ, 2012, J GASTROENTEROL, V47, P609, DOI 10.1007/s00535-012-0592-1; Tegtmeyer N, 2011, CELL HOST MICROBE, V9, P520, DOI 10.1016/j.chom.2011.05.007; Tegtmeyer N, 2011, FEBS J, V278, P1190, DOI 10.1111/j.1742-4658.2011.08035.x; Tegtmeyer N, 2010, J BIOL CHEM, V285, P23513, DOI 10.1074/jbc.M109.096214; Wiedemann T, 2012, GUT, V61, P986, DOI 10.1136/gutjnl-2011-300525; Yeh YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072735; Yeh YC, 2011, MOL CARCINOGEN, V50, P751, DOI 10.1002/mc.20753	26	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e97782	10.1371/journal.pone.0097782	http://dx.doi.org/10.1371/journal.pone.0097782			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893039	Green Published, gold, Green Submitted			2022-12-27	WOS:000336911400022
J	Xia, WT; Bai, J; Wu, XM; Wei, Y; Feng, SY; Li, L; Zhang, J; Xiong, GX; Fan, YP; Shi, JB; Li, HB				Xia, Wentong; Bai, Jing; Wu, Xingmei; Wei, Yi; Feng, Shaoyan; Li, Lei; Zhang, Jia; Xiong, Guanxia; Fan, Yunping; Shi, Jianbo; Li, Huabin			Interleukin-17A Promotes MUC5AC Expression and Goblet Cell Hyperplasia in Nasal Polyps via the Act1-Mediated Pathway	PLOS ONE			English	Article							MUCIN GENE-EXPRESSION; HUMAN AIRWAY CELLS; CHRONIC RHINOSINUSITIS; MESSENGER-RNA; EPITHELIAL-CELLS; INFLAMMATION; ACT1; FEATURES; DISEASE; STIMULATION	Background: Recent studies demonstrated that nasal polyps (NP) patients in China and other Asian regions possessed distinct Th17-dominant inflammation and enhanced tissue remodeling. However, the mechanism underlying these observations is not fully understood. This study sought to evaluate the association of interleukin (IL)-17A with MUC5AC expression and goblet cell hyperplasia in Chinese NP patients and to characterize the signaling pathway underlying IL-17A-induced MUC5AC expression in vitro. Method: We enrolled 25 NP patients and 22 normal controls and examined the expression of IL-17A, MUC5AC and act1 in polyp tissues by immunohistochemical (IHC) staining, quantitative polymerase chain reaction (qPCR) and western blot. Moreover, by using an in vitro culture system of polyp epithelial cells (PECs), IL-17A-induced gene expression was screened in cultured PECs by DNA microarray. The expression of IL-17RA, IL-17RC, act1 and MUC5AC and the activation of the MAPK pathway (ERK, p38 and JNK), were further examined in cultured PECs and NCI-H292 cells by qPCR and western blotting, respectively. Results: We found that increased IL-17A production was significantly correlated with MUC5AC and act1 expression and goblet cell hyperplasia in polyp tissues (p<0.05). IL-17A significantly stimulated the expression of IL-17RA, IL-17RC, act1 and MUC5AC, and the activation of the MAPK pathway in cultured PECs and NCI-H292 cells (p<0.05). In addition, IL-17RA, IL-17RC and act1 siRNA significantly blocked IL-17A-induced MUC5AC production in vitro (p<0.05). Conclusion: Our results suggest that IL-17A plays a crucial role in stimulating the production of MUC5AC and goblet cell hyperplasia through the act1-mediated signaling pathway and may suggest a promising strategy for the management of Th17-dominant NP patients.	[Xia, Wentong; Bai, Jing; Wu, Xingmei; Wei, Yi; Zhang, Jia; Xiong, Guanxia; Shi, Jianbo; Li, Huabin] Sun Yat Sen Univ, Affiliated Hosp 1, Otorhinolarygol Hosp, Allergy & Canc Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Xia, Wentong; Li, Lei; Li, Huabin] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai 200030, Peoples R China; [Feng, Shaoyan; Fan, Yunping] Sun Yat Sen Univ, Affiliated Hosp 5, Dept Otolaryngol, Zhuhai, Peoples R China	Sun Yat Sen University; Shanghai Jiao Tong University; Sun Yat Sen University	Li, HB (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Otorhinolarygol Hosp, Allergy & Canc Ctr, Guangzhou 510275, Guangdong, Peoples R China.	allergyli@163.com			National Nature and Science Grant of China [81070772, 81271054]; Program for New Century Excellent Talents in University [NCET-10-0851]	National Nature and Science Grant of China; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This study is supported by National Nature and Science Grant of China (No. 81070772, 81271054) and Program for New Century Excellent Talents in University (No. NCET-10-0851). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alevy YG, 2012, J CLIN INVEST, V122, P4555, DOI 10.1172/JCI64896; Ali MS, 2005, ACTA OTO-LARYNGOL, V125, P618, DOI 10.1080/00016480510027538; Burgel PR, 2004, EUR RESPIR J, V24, P594, DOI 10.1183/09031936.04.00014404; Cao PP, 2009, J ALLERGY CLIN IMMUN, V124, P478, DOI 10.1016/j.jaci.2009.05.017; Chen Y, 2003, J BIOL CHEM, V278, P17036, DOI 10.1074/jbc.M210429200; Curran DR, 2010, AM J RESP CELL MOL, V42, P268, DOI 10.1165/rcmb.2009-0151TR; Datta S, 2010, J IMMUNOL, V184, P1484, DOI 10.4049/jimmunol.0902423; Derycke L, 2012, J CYST FIBROS, V11, P193, DOI 10.1016/j.jcf.2011.11.007; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Fouser LA, 2008, IMMUNOL REV, V226, P87, DOI 10.1111/j.1600-065X.2008.00712.x; Fujisawa T, 2009, J IMMUNOL, V183, P6236, DOI 10.4049/jimmunol.0900614; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Halwani R, 2013, CHEST, V143, P494, DOI 10.1378/chest.12-0598; Hartupee J, 2007, J IMMUNOL, V179, P4135, DOI 10.4049/jimmunol.179.6.4135; Hsu J, 2011, AM J RHINOL ALLERGY, V25, P285, DOI 10.2500/ajra.2011.25.3680; Hu XD, 2013, J INT MED RES, V41, P777, DOI 10.1177/0300060513478089; Kanoh S, 2011, CLIN EXP ALLERGY, V41, P1747, DOI 10.1111/j.1365-2222.2011.03852.x; Kim CH, 2000, LARYNGOSCOPE, V110, P2110, DOI 10.1097/00005537-200012000-00026; Kim JW, 2007, OTOLARYNG HEAD NECK, V137, P925, DOI 10.1016/j.otohns.2007.07.036; Liu CN, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000382; Martinez-Anton A, 2008, ALLERGY, V63, P1368, DOI 10.1111/j.1398-9995.2008.01678.x; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Molet SM, 2003, LARYNGOSCOPE, V113, P1803, DOI 10.1097/00005537-200310000-00027; Peters AT, 2010, J ALLERGY CLIN IMMUN, V125, P397, DOI 10.1016/j.jaci.2009.10.072; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Shi LL, 2013, ALLERGY, V68, P101, DOI 10.1111/all.12064; Shi PQ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001653; Swaidani S, 2009, J IMMUNOL, V182, P1631, DOI 10.4049/jimmunol.182.3.1631; Tanabe T, 2011, AM J RESP CELL MOL, V45, P1075, DOI 10.1165/rcmb.2010-0327OC; Turner J, 2009, BIOCHEM SOC T, V37, P877, DOI 10.1042/BST0370877; Van Crombruggen K, 2011, J ALLERGY CLIN IMMUN, V128, P728, DOI 10.1016/j.jaci.2011.07.049; Vazquez-Tello A, 2010, CLIN EXP ALLERGY, V40, P1312, DOI 10.1111/j.1365-2222.2010.03544.x; Wang HT, 2013, EUR ARCH OTO-RHINO-L, V270, P1867, DOI 10.1007/s00405-012-2295-x; Zijlstra GJ, 2012, EUR RESPIR J, V39, P439, DOI 10.1183/09031936.00017911	34	30	31	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98915	10.1371/journal.pone.0098915	http://dx.doi.org/10.1371/journal.pone.0098915			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892823	Green Published, Green Submitted, gold			2022-12-27	WOS:000336911400110
J	Wang, F; Chang, GM; Geng, X				Wang, Fei; Chang, Guangming; Geng, Xin			NGF and TERT Co-Transfected BMSCs Improve the Restoration of Cognitive Impairment in Vascular Dementia Rats	PLOS ONE			English	Article							MARROW STROMAL CELLS; NERVE GROWTH-FACTOR; STEM-CELLS; IN-VITRO; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; TELOMERE LENGTH; EXPRESSION; MEMORY; DYSFUNCTION	Vascular dementia (VaD) is a mental disorder caused by brain damage due to cerebrovascular disease, and incidence of VaD is rising. To date, there is no known effective cure for VaD, so effort in developing an effective treatment for VaD is of great importance. The differentiation plasticity of BMSCs, in conjunction with its weak immunogenicity, makes manipulated BMSCs an attractive strategy for disease treatment. However, BMSCs often display disabled differentiation, premature aging, and unstable proliferation, reducing their neuroprotective function. These problems may be caused by the lack of telomerase activity in BMSCs. Our results show that NGF-TERT co-transfected BMSCs have a better therapeutic effect than BMSCs lacking NGF and TERT expression, demonstrated by significant improvements in learning and memory in VaD rats. The underlying mechanism might be increased expression of NGF, TrkA and SYN in the hippocampal CA1 area, which has potential implication in advancing therapeutics for VaD.	[Wang, Fei] Tianjin Med Univ, Gen Hosp, Dept Neurol, Tianjin, Peoples R China; [Chang, Guangming] Tianjin Med Univ, Gen Hosp, Dept Clin Lab, Tianjin, Peoples R China; [Geng, Xin] Tianjin Med Univ, Dept Biochem & Mol Biol, Tianjin, Peoples R China; [Geng, Xin] Tianjin Key Lab Cellular & Mol Immunol, Tianjin, Peoples R China; [Geng, Xin] Minist China, Key Lab Educ, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Geng, X (corresponding author), Tianjin Med Univ, Dept Biochem & Mol Biol, Tianjin, Peoples R China.	gengx@tmu.edu.cn			Chinese National Natural Science Foundation [81100805]; Tianjin Education Committee Technology Development Grant [20080107]; Foundation of Key Laboratory of Genetic Engineering of the Ministry of Education [201302]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Tianjin Education Committee Technology Development Grant; Foundation of Key Laboratory of Genetic Engineering of the Ministry of Education	This work was supported by Chinese National Natural Science Foundation Grant (No. 81100805), Tianjin Education Committee Technology Development Grant (No. 20080107), and the Foundation of Key Laboratory of Genetic Engineering of the Ministry of Education (201302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinyemi RO, 2013, CURR ALZHEIMER RES, V10, P642; Banfi A, 2002, TISSUE ENG, V8, P901, DOI 10.1089/107632702320934001; Baskys A, 2012, EXP GERONTOL, V47, P887, DOI 10.1016/j.exger.2012.07.002; Baxter MA, 2004, STEM CELLS, V22, P675, DOI 10.1634/stemcells.22-5-675; de Jesus BB, 2012, EMBO MOL MED, V4, P691, DOI 10.1002/emmm.201200245; Bianchi G, 2003, EXP CELL RES, V287, P98, DOI 10.1016/S0014-4827(03)00138-1; Birch AM, 2013, NEUROPHARMACOLOGY, V75, P255, DOI 10.1016/j.neuropharm.2013.07.023; Birch AM, 2013, HIPPOCAMPUS, V23, P437, DOI 10.1002/hipo.22103; Boccardi V, 2012, EMBO MOL MED, V4, P685, DOI 10.1002/emmm.201200246; Bokara KK, 2011, STEM CELLS DEV, V20, P527, DOI 10.1089/scd.2010.0312; Ding J, 2011, J NEUROSCI RES, V89, P222, DOI 10.1002/jnr.22535; Dong Y, 2013, CURR MOL MED, V13, P488; Fontanet P, 2013, J NEUROSCI, V33, P15940, DOI 10.1523/JNEUROSCI.0928-13.2013; Garcia-Gutierrez MS, 2013, NEUROPHARMACOLOGY, V73, P388, DOI 10.1016/j.neuropharm.2013.05.034; GAROFALO L, 1992, P NATL ACAD SCI USA, V89, P2639, DOI 10.1073/pnas.89.7.2639; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Ikejima C, 2009, STROKE, V40, P2709, DOI 10.1161/STROKEAHA.108.542308; Li HY, 2013, CHEMOSPHERE, V92, P52, DOI 10.1016/j.chemosphere.2013.02.061; Li MD, 2014, REGEN MED, V9, P27, DOI [10.2217/RME.13.80, 10.2217/rme.13.80]; Li S, 2013, EXP GERONTOL, V48, P778, DOI 10.1016/j.exger.2013.04.014; Liu XF, 2014, PROG NEUROBIOL, V115, P92, DOI 10.1016/j.pneurobio.2013.11.007; NI JW, 1994, BRAIN RES, V653, P231, DOI 10.1016/0006-8993(94)90394-8; O'Callaghan RM, 2009, HIPPOCAMPUS, V19, P1019, DOI 10.1002/hipo.20591; Ogura F, 2014, STEM CELLS DEV, V23, P717, DOI 10.1089/scd.2013.0473; Ojeda D, 2014, J NEUROSCI RES, V92, P267, DOI 10.1002/jnr.23294; Pantoni L, 2005, STROKE, V36, P619, DOI 10.1161/01.STR.0000155686.73908.3e; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Pham TM, 2002, PHARMACOL BIOCHEM BE, V73, P167, DOI 10.1016/S0091-3057(02)00783-9; Razavi S, 2013, BIOCHEM BIOPH RES CO, V440, P381, DOI 10.1016/j.bbrc.2013.09.069; Sanchez-Ortiz E, 2012, J NEUROSCI, V32, P4065, DOI 10.1523/JNEUROSCI.6314-11.2012; Sun S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083523; Tanaka N, 2013, PSYCHOGERIATRICS, V13, P199, DOI 10.1111/psyg.12012; Tang H, 2013, BIOCHEM BIOPH RES CO, V440, P502, DOI 10.1016/j.bbrc.2013.09.053; van Gorp S, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt209; Wagner W, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt145; Wang F, 2010, J MOL NEUROSCI, V41, P145, DOI 10.1007/s12031-009-9311-7; Wang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075477; Wang ZT, 2009, J MOL NEUROSCI, V38, P265, DOI 10.1007/s12031-009-9208-5; Willyard C, 2013, NATURE, V503, pS4, DOI 10.1038/503S4a; Yoon JK, 2010, NUCL MED BIOL, V37, P381, DOI 10.1016/j.nucmedbio.2009.12.001; Zhang H, 2014, NEUROCHEM RES, V39, P276, DOI 10.1007/s11064-013-1219-5; Zhang N, 2013, NEUROSCI B	42	17	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98774	10.1371/journal.pone.0098774	http://dx.doi.org/10.1371/journal.pone.0098774			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887495	Green Published, gold, Green Submitted			2022-12-27	WOS:000336956300107
J	Feng, JY; Liu, KT; Abraham, E; Chen, CY; Tsai, PY; Chen, YC; Lee, YC; Yang, KY				Feng, Jia-Yih; Liu, Kuan-Ting; Abraham, Edward; Chen, Cheng-Yu; Tsai, Po-Yi; Chen, Yu-Chun; Lee, Yu-Chin; Yang, Kuang-Yao			Serum Estradiol Levels Predict Survival and Acute Kidney Injury in Patients with Septic Shock- A Prospective Study	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; INTERNATIONAL GUIDELINES; SEPSIS CAMPAIGN; NITRIC-OXIDE; ESTROGEN; 17-BETA-ESTRADIOL; MANAGEMENT; CELLS; SEX; TESTOSTERONE	Sex hormones have diverse immunomodulatory effects that may be involved in the pathogenesis of sepsis. However, the roles of serum sex hormones in predicting outcomes and the severity of organ dysfunction, especially acute kidney injury (AKI), in septic shock patients remains controversial. We prospectively enrolled 107 clinically diagnosed pneumonia-related septic shock patients and serum sex hormone levels were measured on the day of shock onset. The aim of the present study was to investigate the predictive values of serum sex hormones levels for 28-day mortality and organs dysfunction, especially AKI. Compared with survivors, serum levels of progesterone (p<0.001) and estradiol (p<0.001) were significantly elevated in non-survivors. In multivariate Cox regression analysis, serum level of estradiol >40 pg/mL (p = 0.047) and APACHE II score >= 25 (p = <0.001) were found to be independent predictors of day 28 mortality. Inclusion of estradiol levels further enhanced the ability of APACHE II scores to predict survival in patients with high mortality risk. A serum level of estradiol >40 pg/mL was also an independent predictor of concomitant AKI (p = 0.002) and correlated well with severity of renal dysfunction using RIFLE classification. Elevated serum estradiol levels also predicted the development of new AKI within 28 days of shock onset (p = 0.013). In conclusion, serum estradiol levels appear to have value in predicting 28-day mortality in septic shock patients. Increased serum estradiol levels are associated with higher severity of concomitant AKI and predict development of new AKI.	[Feng, Jia-Yih; Lee, Yu-Chin] Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan; [Feng, Jia-Yih] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Liu, Kuan-Ting] Taipei City Hosp, Zhongxiao Branch, Taipei, Taiwan; [Liu, Kuan-Ting; Chen, Cheng-Yu; Tsai, Po-Yi; Chen, Yu-Chun; Lee, Yu-Chin] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Abraham, Edward] Wake Forest Sch Med, Winston Salem, NC USA; [Chen, Cheng-Yu] Natl Yang Ming Univ Hosp, Sect Chest Med, Dept Internal Med, Ilan, Taiwan; Cardinal Tien Coll Healthcare & Management, Taipei, Taiwan; [Tsai, Po-Yi] Taipei Vet Gen Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Chen, Yu-Chun] Natl Yang Ming Univ Hosp, Dept Med Res & Educ, Ilan, Taiwan; [Yang, Kuang-Yao] Taipei Vet Gen Hosp, Dept Chest Med, Ctr Immunol, Taipei, Taiwan; [Yang, Kuang-Yao] Natl Yang Ming Univ, Sch Med, Immun & Inflammat Res Ctr, Taipei 112, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei City Hospital; National Yang Ming Chiao Tung University; Wake Forest University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Yang, KY (corresponding author), Taipei Vet Gen Hosp, Dept Chest Med, Ctr Immunol, Shipai Rd, Taipei, Taiwan.	kyyang@vghtpe.gov.tw	Chen, Yu Chun/K-6635-2019; Chen, YuChun/L-1052-2019; liu, kt/AFU-9413-2022	Chen, YuChun/0000-0002-4124-1949; 	Taiwan National Science Council [NSC 100-2314-B-075-047-MY3]; Taipei Veterans General Hospital [V99A-024, V99C1-167, V99A-023, V100A-002, V100C-159, V101B-027, V101C-065, V102C-025, V103C-078]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This work was supported by Taiwan National Science Council Research Grant NSC 100-2314-B-075-047-MY3 and Taipei Veterans General Hospital Grants V99A-024, V99C1-167, V99A-023, V100A-002, V100C-159, V101B-027, V101C-065, V102C-025, and V103C-078. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLERCREUTZ H, 1976, J CLIN ENDOCR METAB, V43, P497, DOI 10.1210/jcem-43-3-497; Angstwurm MWA, 2005, CRIT CARE MED, V33, P2786, DOI 10.1097/01.CCM.0000190242.24410.17; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Asai K, 2001, SHOCK, V16, P340, DOI 10.1097/00024382-200116050-00003; Bagshaw SM, 2009, INTENS CARE MED, V35, P871, DOI 10.1007/s00134-008-1367-2; BELEH MA, 1995, J STEROID BIOCHEM, V52, P479, DOI 10.1016/0960-0760(95)00003-I; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bengtsson AK, 2004, BLOOD, V104, P1404, DOI 10.1182/blood-2003-10-3380; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Chen YC, 2009, SHOCK, V31, P139, DOI 10.1097/SHK.0b013e31817d419e; CHRISTEFF N, 1992, CIRC SHOCK, V36, P249; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; FOURRIER F, 1994, CIRC SHOCK, V43, P171; George RL, 2003, SHOCK, V19, P28, DOI 10.1097/00024382-200301000-00006; Hattori Y, 2004, CARDIOVASC RES, V63, P31, DOI 10.1016/j.cardiores.2004.03.014; Hughes GC, 2012, AUTOIMMUN REV, V11, pA502, DOI 10.1016/j.autrev.2011.12.003; Hutchens MP, 2012, AM J PHYSIOL-RENAL, V303, pF377, DOI 10.1152/ajprenal.00354.2011; Hutchens MP, 2010, ANESTHESIOLOGY, V112, P395, DOI 10.1097/ALN.0b013e3181c98da9; Joannidis M, 2006, INTENS CARE MED, V32, P18, DOI 10.1007/s00134-005-2866-z; Kim WY, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.04.005; Liarte S, 2011, DEV COMP IMMUNOL, V35, P19, DOI 10.1016/j.dci.2010.07.007; Liu LM, 2005, STEROIDS, V70, P604, DOI 10.1016/j.steroids.2005.02.020; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; May AK, 2008, CRIT CARE MED, V36, P62, DOI 10.1097/01.CCM.0000292015.16171.6D; Moss M, 2005, CLIN INFECT DIS, V41, pS490, DOI 10.1086/432003; Ohlsson C, 2013, J CLIN ENDOCR METAB, V98, pE1097, DOI 10.1210/jc.2012-3861; PETROS A, 1994, CARDIOVASC RES, V28, P34, DOI 10.1093/cvr/28.1.34; Plataki M, 2011, CLIN J AM SOC NEPHRO, V6, P1744, DOI 10.2215/CJN.05480610; Potier M, 2001, J AM SOC NEPHROL, V12, P241, DOI 10.1681/ASN.V122241; Rahman F, 2007, TRENDS ENDOCRIN MET, V18, P371, DOI 10.1016/j.tem.2007.09.004; Rudkowski JC, 2004, AM J PHYSIOL-LUNG C, V286, pL793, DOI 10.1152/ajplung.00266.2003; Satake A, 2008, KIDNEY INT, V73, P308, DOI 10.1038/sj.ki.5002690; Shibata Y, 2004, J CARDIOVASC PHARM, V44, pS459, DOI 10.1097/01.fjc.0000166315.38258.e1; Spratt DI, 2006, AM J PHYSIOL-ENDOC M, V291, pE631, DOI 10.1152/ajpendo.00467.2005; Tanaka R, 2012, EUR J PHARMACOL, V683, P270, DOI 10.1016/j.ejphar.2012.02.044; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Xu YD, 2010, RESP RES, V11, DOI [10.1186/1465-9921-11-166, 10.1186/1465-9921-11-107]; ZHAO Y, 1995, MOL ENDOCRINOL, V9, P340, DOI 10.1210/me.9.3.340	40	22	23	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e97967	10.1371/journal.pone.0097967	http://dx.doi.org/10.1371/journal.pone.0097967			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24904990	Green Submitted, Green Published, gold			2022-12-27	WOS:000341869000017
J	Hackradt, CW; Garcia-Charton, JA; Harmelin-Vivien, M; Perez-Ruzafa, A; Le Direach, L; Bayle-Sempere, J; Charbonnel, E; Ody, D; Renones, O; Sanchez-Jerez, P; Valle, C				Werner Hackradt, Carlos; Antonio Garcia-Charton, Jose; Harmelin-Vivien, Mireille; Perez-Ruzafa, Angel; Le Direach, Laurence; Bayle-Sempere, Just; Charbonnel, Eric; Ody, Denis; Renones, Olga; Sanchez-Jerez, Pablo; Valle, Carlos			Response of Rocky Reef Top Predators (Serranidae: Epinephelinae) in and Around Marine Protected Areas in the Western Mediterranean Sea	PLOS ONE			English	Article							HABITAT STRUCTURE; MARGINATUS LOWE; DUSKY GROUPERS; FISH ASSEMBLAGE; RESERVES; SPILLOVER; FISHERIES; BIOMASS; SIZE; DEGRADATION	Groupers species are extremely vulnerable to overfishing and many species are threatened worldwide. In recent decades, Mediterranean groupers experienced dramatic population declines. Marine protected areas (MPAs) can protect populations inside their boundaries and provide individuals to adjacent fishing areas through the process of spillover and larval export. This study aims to evaluate the effectiveness of six marine reserves in the Western Mediterranean Sea to protect the populations of three species of grouper, Epinephelus marginatus, Epinephelus costae and Mycteroperca rubra, and to understand in which circumstances MPAs are able to export biomass to neighbouring areas. All the studied MPAs, except one where no grouper was observed, were able to maintain high abundance, biomass and mean weight of groupers. Size classes were more evenly distributed inside than outside MPAs. In two reserves, biomass gradients could be detected through the boundaries of the reserve as an indication of spillover. In some cases, habitat structure appeared to exert a great influence on grouper abundance, biomass and mean individual weight, influencing the gradient shape. Because groupers are generally sedentary animals with a small home range, we suggest that biomass gradients could only occur where groupers attain sufficient abundance inside MPA limits, indicating a strongly density-dependent process.	[Werner Hackradt, Carlos; Antonio Garcia-Charton, Jose; Perez-Ruzafa, Angel] Univ Murcia, Dept Ecol & Hidrol, Murcia, Spain; [Harmelin-Vivien, Mireille] Univ Sud Toulon Var, Aix Marseille Univ, CNRS INSU IRD, Inst Mediterraneen Oceanol MIO, Marseille, France; [Le Direach, Laurence] Inst Mediterraneen Oceanol MIO, GIS Posidonie, Marseille, France; [Bayle-Sempere, Just; Sanchez-Jerez, Pablo; Valle, Carlos] Univ Alicante, Dept Ciencias Mar & Biol Aplicada, E-03080 Alicante, Spain; [Charbonnel, Eric] Parc Marin Cote Bleue, Carry Le Rouet, France; [Ody, Denis] WWF France, Marseille, France; [Renones, Olga] Ctr Oceanog Baleares, Inst Espanol Oceanog, Palma De Mallorca, Spain	University of Murcia; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Universitat d'Alacant; World Wildlife Fund; Spanish Institute of Oceanography	Hackradt, CW (corresponding author), Univ Murcia, Dept Ecol & Hidrol, Murcia, Spain.	hackradtcw@gmail.com	Pérez-Ruzafa, Angel/A-3406-2009; Bayle-Sempere, Just Tomàs/J-1574-2012; Hackradt, Carlos Werner/B-2037-2013; Sanchez-Jerez, Pablo/L-4750-2014; García-Charton, José Antonio/E-2793-2010; Pérez, Carlos Valle/H-8426-2015	Pérez-Ruzafa, Angel/0000-0003-4769-8912; Bayle-Sempere, Just Tomàs/0000-0001-6841-1824; Hackradt, Carlos Werner/0000-0002-8326-6503; Sanchez-Jerez, Pablo/0000-0003-4047-238X; García-Charton, José Antonio/0000-0002-5973-9913; Pérez, Carlos Valle/0000-0001-7270-5841; Renones, Olga/0000-0003-2217-5576	EC Project BIOMEX [QLRT-2001-0891]; National Council for Technology and Science Development (CNPq-MCT, Brazil, for Brazilian acronym) from the Ministry of Science of Brazil [Proc: 200630/2008-3]; Fundacion BBVA (Foundation of Bilbao-Viscaya Bank, Spain)	EC Project BIOMEX; National Council for Technology and Science Development (CNPq-MCT, Brazil, for Brazilian acronym) from the Ministry of Science of Brazil; Fundacion BBVA (Foundation of Bilbao-Viscaya Bank, Spain)	This work was developed in the framework of the EC Project BIOMEX (QLRT-2001-0891). The authors express thanks to the National Council for Technology and Science Development (CNPq-MCT, Brazil, for Brazilian acronym) from the Ministry of Science of Brazil for giving personal financial support to CWH (Proc: 200630/2008-3), and to the Fundacion BBVA (Foundation of Bilbao-Viscaya Bank, Spain) for additional support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], MODERN APPL STAT S; Bodilis P, 2003, J FISH BIOL, V62, P242, DOI 10.1046/j.1095-8649.2003.00028.x; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Chapman MR, 1999, MAR ECOL PROG SER, V181, P81, DOI 10.3354/meps181081; Chiappone M, 2000, MAR ECOL PROG SER, V198, P261, DOI 10.3354/meps198261; Claudet J, 2010, ECOL APPL, V20, P830, DOI 10.1890/08-2131.1; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Coll J, 2004, FISH RES, V70, P97, DOI 10.1016/j.fishres.2004.05.004; Crec'hriou R, 2010, FISH OCEANOGR, V19, P135, DOI 10.1111/j.1365-2419.2010.00533.x; Di Franco A, 2009, MAR ECOL PROG SER, V387, P275, DOI 10.3354/meps08051; Felix-Hackradt FC, 2014, J SEA RES, V88, P67, DOI 10.1016/j.seares.2013.12.018; Fenberg PB, 2012, MAR POLICY, V36, P1012, DOI 10.1016/j.marpol.2012.02.021; Forcada A, 2009, MAR ECOL PROG SER, V379, P197, DOI 10.3354/meps07892; Garcia-Charton JA, 2008, J NAT CONSERV, V16, P193, DOI 10.1016/j.jnc.2008.09.007; Garcia-Charton JA, 1998, MAR ECOL-P S Z N I, V19, P111; Garcia-Charton JA, 2004, MAR BIOL, V144, P161, DOI 10.1007/s00227-003-1170-0; Garcia-Charton JA, 2001, MAR BIOL, V138, P917, DOI 10.1007/s002270000524; Goni R, 2008, MAR ECOL PROG SER, V366, P159, DOI 10.3354/meps07532; Guidetti P, 2008, BIOL CONSERV, V141, P699, DOI 10.1016/j.biocon.2007.12.013; Guidetti P, 2006, ECOL APPL, V16, P963, DOI 10.1890/1051-0761(2006)016[0963:MRRLPI]2.0.CO;2; Guidetti P, 2010, CONSERV BIOL, V24, P312, DOI 10.1111/j.1523-1739.2009.01358.x; Harmelin JG, 1995, MAR ECOL-P S Z N I, V16, P233, DOI 10.1111/j.1439-0485.1995.tb00408.x; Harmelin-Vivien M, 2008, BIOL CONSERV, V141, P1829, DOI 10.1016/j.biocon.2008.04.029; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hereu B, 2006, MAR ECOL PROG SER, V325, P187, DOI 10.3354/meps325187; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Kramer DL, 1999, ENVIRON BIOL FISH, V55, P65, DOI 10.1023/A:1007481206399; La Mesa G, 2002, MAR BIOL, V140, P175, DOI 10.1007/s002270100682; Lembo G, 2002, HYDROBIOLOGIA, V483, P249, DOI 10.1023/A:1021360419150; Lenfant P, 2003, CYBIUM, V27, P27; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Lizaso JLS, 2000, ENVIRON CONSERV, V27, P144, DOI 10.1017/S0376892900000187; Lloret J, 2008, FISH RES, V91, P252, DOI 10.1016/j.fishres.2007.12.002; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; McCullagh P, 1989, GEN LINEAR MODELS; de Mitcheson YS, 2013, FISH FISH, V14, P119, DOI 10.1111/j.1467-2979.2011.00455.x; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Pastor J, 2009, CR BIOL, V332, P732, DOI 10.1016/j.crvi.2009.03.010; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pelc RA, 2010, P NATL ACAD SCI USA, V107, P18266, DOI 10.1073/pnas.0907368107; Perez-Ruzafa A, 2008, J NAT CONSERV, V16, P234, DOI 10.1016/j.jnc.2008.09.003; Amargos FP, 2010, ENVIRON BIOL FISH, V87, P363, DOI 10.1007/s10641-010-9612-2; Planes S, 2000, ENVIRON CONSERV, V27, P126, DOI 10.1017/S0376892900000175; Renones Olga, 2002, Marine Life, V9, P45; Renones O, 2010, SCI MAR, V74, P523, DOI 10.3989/scimar.2010.74n3523; ROWLEY RJ, 1994, AQUAT CONSERV, V4, P233, DOI 10.1002/aqc.3270040305; Russ GR, 2010, OECOLOGIA, V163, P1103, DOI 10.1007/s00442-010-1692-3; Russ GR, 2003, MAR ECOL PROG SER, V264, P15, DOI 10.3354/meps264015; Sala E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032742; Samoilys MA, 2007, BIOL CONSERV, V136, P584, DOI 10.1016/j.biocon.2007.01.003; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Stallings CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005333; Stelzenmuller V, 2008, MAR POLLUT BULL, V56, P2018, DOI 10.1016/j.marpolbul.2008.08.006; Stobart B, 2009, MAR ECOL PROG SER, V384, P47, DOI 10.3354/meps08007; Unsworth RKF, 2007, MAR BIOL, V152, P243, DOI 10.1007/s00227-007-0675-3; Hackradt CW, 2011, MAR ENVIRON RES, V72, P235, DOI 10.1016/j.marenvres.2011.09.006; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Zabala M, 1997, SCI MAR, V61, P65	60	46	47	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98206	10.1371/journal.pone.0098206	http://dx.doi.org/10.1371/journal.pone.0098206			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905331	Green Published, gold, Green Submitted			2022-12-27	WOS:000341869000020
J	Liu, C; Han, Y; Chen, X; Zhang, W				Liu, Cheng; Han, Yue; Chen, Xi; Zhang, Wei			Structure-Function Relationship of SW-AT-1, a Serpin-Type Protease Inhibitor in Silkworm	PLOS ONE			English	Article							CONFORMATIONAL-CHANGE; CHROMATIN-STRUCTURE; BOMBYX-MORI; PROTEINS; COMPLEX	Although SW-AT-1, a serpin-type trypsin inhibitor from silkworm (Bombyx mori), was identified in previous study, its structure-function relationship has not been studied. In this study, SW-AT-1 was cloned from the body wall of silkworm and expressed in E. coli. rSW-AT-1 inhibited both trypsin and chymotrypsin in a concentration-dependent manner. The association rate constant for rSW-AT-1 and trypsin is 1.31610(-5) M-1 s(-1), for rSW-AT-1 and chymotrpsin is 2.85610(-6) M-1 s(-1). Circular dichroism (CD) assay showed 33% alpha-helices, 16% beta-sheets, 17% turns, and 31% random coils in the secondary structure of the protein. Enzymatic and CD analysis indicated that rSW-AT-1 was stable at wide pH range between 4-10, and exhibited the highest activity at weakly acidic or alkaline condition. The predicted three-dimensional structure of SW-AT-1 by PyMOL (v1.4) revealed a deductive reactive centre loop (RCL) near the C-terminus, which was extended from the body of the molecule. In addition to trypsin cleavage site in RCL, matrix-assisted laser desorption ionization time of flight mass spectrometry indicated that the chymotrypsin cleavage site of SW-AT-1 was between F336 and T337 in RCL. Directed mutagenesis indicated that both the N- and C-terminal sides of RCL have effects on the activity, and G327 and E329 played an important role in the proper folding of RCL. The physiological role of SW-AT-1 in the defense responses of silkworm were also discussed.	[Liu, Cheng; Han, Yue; Chen, Xi; Zhang, Wei] Nanjing Agr Univ, Dept Biochem & Mol Biol, Coll Life Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Zhang, W (corresponding author), Nanjing Agr Univ, Dept Biochem & Mol Biol, Coll Life Sci, Nanjing, Jiangsu, Peoples R China.	wzhang@njau.edu.cn			National Natural Science Foundation of China [31171326]; Jiangsu Sci-Tech Support Project-Agriculture, Jiangsu, China [BE2013428]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Sci-Tech Support Project-Agriculture, Jiangsu, China	This work was partially supported by the National Natural Science Foundation of China (31171326), and Jiangsu Sci-Tech Support Project-Agriculture (BE2013428), Jiangsu, China. The funders had no role in study design, data collection and analysis, decision to publish, or prepareation of the manuscript.	ASHIDA M, 1994, INSECT BIOCHEM MOLEC, V24, P1037, DOI 10.1016/0965-1748(94)90141-4; ATKINSON AH, 1993, PLANT CELL, V5, P203, DOI 10.1105/tpc.5.2.203; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRYANT J, 1976, BIOCHEMISTRY-US, V15, P3418, DOI 10.1021/bi00661a004; CARRELL RW, 1987, COLD SPRING HARB SYM, V52, P527, DOI 10.1101/SQB.1987.052.01.060; Charnley AK, 2003, ADV BOT RES, V40, P241, DOI 10.1016/S0065-2296(05)40006-3; Clemente A, 2011, CURR PROTEIN PEPT SC, V12, P358, DOI 10.2174/138920311796391133; De Gregorio E, 2002, DEV CELL, V3, P581, DOI 10.1016/S1534-5807(02)00267-8; Dementiev A, 2003, J BIOL CHEM, V278, P37881, DOI 10.1074/jbc.M305195200; Dunstone MA, 2000, PROTEIN SCI, V9, P417; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Grigoryev SA, 1998, J BIOL CHEM, V273, P3082, DOI 10.1074/jbc.273.5.3082; Huang LL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008098; Huntington JA, 2011, J THROMB HAEMOST, V9, P26, DOI 10.1111/j.1538-7836.2011.04360.x; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Huntington JA, 2006, TRENDS BIOCHEM SCI, V31, P427, DOI 10.1016/j.tibs.2006.06.005; Irving JA, 2003, STRUCTURE, V11, P387, DOI 10.1016/S0969-2126(03)00057-1; Irving JA, 2002, J BIOL CHEM, V277, P13192, DOI 10.1074/jbc.M108460200; KANOST MR, 1990, INSECT BIOCHEM, V20, P141, DOI 10.1016/0020-1790(90)90006-G; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Ligoxygakis P, 2003, CURR BIOL, V13, P2097, DOI 10.1016/j.cub.2003.10.062; Liu HF, 2011, MOL BIOL REP, V38, P2793, DOI 10.1007/s11033-010-0424-4; NARUMI H, 1993, EUR J BIOCHEM, V214, P181, DOI 10.1111/j.1432-1033.1993.tb17911.x; Olson ST, 2001, BIOCHEMISTRY-US, V40, P11742, DOI 10.1021/bi0107290; Pak SC, 2004, J BIOL CHEM, V279, P15448, DOI 10.1074/jbc.M400261200; Patston PA, 1996, FEBS LETT, V383, P87, DOI 10.1016/0014-5793(96)00231-1; PLUNKETT G, 1982, ARCH BIOCHEM BIOPHYS, V213, P463, DOI 10.1016/0003-9861(82)90572-0; Rau JC, 2007, J THROMB HAEMOST, V5, P102, DOI 10.1111/j.1538-7836.2007.02516.x; RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y; Ricagno S, 2009, J MOL BIOL, V388, P109, DOI 10.1016/j.jmb.2009.02.056; SASAKI T, 1987, J BIOCHEM-TOKYO, V102, P433, DOI 10.1093/oxfordjournals.jbchem.a122071; SASAKI T, 1985, BIOCHEM BIOPH RES CO, V132, P320, DOI 10.1016/0006-291X(85)91025-3; Shirai K, 2000, INSECT BIOCHEM MOLEC, V30, P363, DOI 10.1016/S0965-1748(00)00003-5; Steinert S, 2011, IMMUNOL REV, V240, P129, DOI 10.1111/j.1600-065X.2010.00985.x; TAKAGI H, 1990, J BIOCHEM, V108, P372, DOI 10.1093/oxfordjournals.jbchem.a123208; Takuji S, 1991, EUR J BIOCHEM, V202, P255; Whisstock JC, 2010, J BIOL CHEM, V285, P24307, DOI 10.1074/jbc.R110.141408; Zhou Y, 2013, GENOMICS, V101, P256, DOI 10.1016/j.ygeno.2013.02.004; Zou Z, 2009, GENOMICS, V93, P367, DOI 10.1016/j.ygeno.2008.12.010	41	3	6	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99013	10.1371/journal.pone.0099013	http://dx.doi.org/10.1371/journal.pone.0099013			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901510	Green Published, Green Submitted, gold			2022-12-27	WOS:000336841400086
J	Kleppa, E; Ramsuran, V; Zulu, S; Karlsen, GH; Bere, A; Passmore, JAS; Ndhlovu, P; Lillebo, K; Holmen, SD; Onsrud, M; Gundersen, SG; Taylor, M; Kjetland, EF; Ndung'u, T				Kleppa, Elisabeth; Ramsuran, Veron; Zulu, Siphosenkosi; Karlsen, Gunn Hege; Bere, Alfred; Passmore, Jo-Ann S.; Ndhlovu, Patricia; Lillebo, Kristine; Holmen, Sigve D.; Onsrud, Mathias; Gundersen, Svein Gunnar; Taylor, Myra; Kjetland, Eyrun F.; Ndung'u, Thumbi			Effect of Female Genital Schistosomiasis and Anti-Schistosomal Treatment on Monocytes, CD4(+) T-Cells and CCR5 Expression in the Female Genital Tract	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HIV-1 CORECEPTOR EXPRESSION; RURAL ZIMBABWEAN WOMEN; TARGET-CELLS; UROGENITAL SCHISTOSOMIASIS; HAEMATOBIUM INFECTION; IMMUNE ACTIVATION; MANSONI INFECTION; PERIPHERAL-BLOOD; CERVICAL TISSUE	Background: Schistosoma haematobium is a waterborne parasite that may cause female genital schistosomiasis (FGS), characterized by genital mucosal lesions. There is clinical and epidemiological evidence for a relationship between FGS and HIV. We investigated the impact of FGS on HIV target cell density and expression of the HIV co-receptor CCR5 in blood and cervical cytobrush samples. Furthermore we evaluated the effect of anti-schistosomal treatment on these cell populations. Design: The study followed a case-control design with post treatment follow-up, nested in an on-going field study on FGS. Methods: Blood and cervical cytobrush samples were collected from FGS negative and positive women for flow cytometry analyses. Urine samples were investigated for schistosome ova by microscopy and polymerase chain reaction (PCR). Results: FGS was associated with a higher frequency of CD14(+) cells (monocytes) in blood (11.5% in FGS+ vs. 2.2% in FGS-, p = 0.042). Frequencies of CD4(+) cells expressing CCR5 were higher in blood samples from FGS+ than from FGS-women (4.7% vs. 1.5%, p = 0.018). The CD14(+) cell population decreased significantly in both compartments after anti-schistosomal treatment (p = 0.043). Although the frequency of CD4+ cells did not change after treatment, frequencies of CCR5 expression by CD4+ cells decreased significantly in both compartments (from 3.4% to 0.5% in blood, p = 0.036; and from 42.4% to 5.6% in genital samples, p = 0.025). Conclusions: The results support the hypothesis that FGS may increase the risk of HIV acquisition, not only through damage of the mucosal epithelial barrier, but also by affecting HIV target cell populations, and that anti-schistosomal treatment can modify this.	[Kleppa, Elisabeth; Lillebo, Kristine; Holmen, Sigve D.; Kjetland, Eyrun F.] Oslo Univ Hosp OUH, Dept Infect Dis, Norwegian Ctr Imported & Trop Dis, Oslo, Norway; [Kleppa, Elisabeth; Lillebo, Kristine; Holmen, Sigve D.] Univ Oslo, Fac Med, Oslo, Norway; [Ramsuran, Veron; Ndung'u, Thumbi] Univ KwaZulu Natal UKZN, HIV Pathogenesis Programme, Nelson R Mandela Sch Med, Durban, South Africa; [Zulu, Siphosenkosi; Taylor, Myra; Kjetland, Eyrun F.] UKZN, Sch Publ Hlth Med, Nelson R Mandela Sch Med, Durban, South Africa; [Karlsen, Gunn Hege] Aarhus Univ, Aarhus, Denmark; [Bere, Alfred] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Passmore, Jo-Ann S.] Univ Cape Town, Div Med Virol, IDM, ZA-7925 Cape Town, South Africa; [Ndhlovu, Patricia] Univ London Imperial Coll Sci Technol & Med, London, England; [Onsrud, Mathias] OUH, Dept Gynaecol, Oslo, Norway; [Gundersen, Svein Gunnar] Sorlandet Hosp, Res Unit, Kristiansand, Norway; [Gundersen, Svein Gunnar] Univ Agder, Ctr Dev Studies, Kristiansand, Norway	University of Oslo; University of Kwazulu Natal; University of Kwazulu Natal; Aarhus University; Emory University; University of Cape Town; Imperial College London; University of Agder	Kleppa, E (corresponding author), Oslo Univ Hosp OUH, Dept Infect Dis, Norwegian Ctr Imported & Trop Dis, Oslo, Norway.	elisabeth.kleppa@medisin.uio.no		Holmen, Sigve/0000-0001-9698-6625; Kjetland, Eyrun Floerecke/0000-0002-5552-1095; Ndung'u, Thumbi/0000-0003-2962-3992; Ramsuran, Veron/0000-0003-1590-9893; Taylor, Myra/0000-0003-3087-2240	South-Eastern Norway Regional Health Authority; Norwegian Research Council	South-Eastern Norway Regional Health Authority; Norwegian Research Council(Research Council of NorwayEuropean Commission)	The study was funded by the South-Eastern Norway Regional Health Authority (http://www.helse-sorost.no/omoss/english/Sider/page.aspx) and the Norwegian Research Council (http://www.forskningsradet.no/en/Home_page/1177315753906). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barron L, 2011, EUR J IMMUNOL, V41, P2509, DOI 10.1002/eji.201141869; Bentwich Z, 2000, AIDS, V14, P2071, DOI 10.1097/00002030-200009290-00002; Bere A, 2013, IMMUNOLOGY, V139, P342, DOI 10.1111/imm.12084; Bere A, 2010, J IMMUNOL METHODS, V354, P68, DOI 10.1016/j.jim.2010.02.002; Bigley V, 2010, BLOOD, V116, P2859, DOI 10.1182/blood-2010-05-285676; Bol SM, 2011, FUTURE VIROL, V6, P187, DOI 10.2217/FVL.10.93; Chenine AL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000265; Clerici M, 2000, AIDS, V14, P2083, DOI 10.1097/00002030-200009290-00003; Cohen CR, 2010, AIDS, V24, P2069, DOI 10.1097/QAD.0b013e32833c323b; Department of Health: South Africa, 2008, STAND TREATM GUID ES; Doenhoff MJ, 2004, TRENDS PARASITOL, V20, P35, DOI 10.1016/j.pt.2003.10.019; Downs JA, 2012, AM J TROP MED HYG, V87, P868, DOI 10.4269/ajtmh.2012.12-0395; Downs JA, 2011, AM J TROP MED HYG, V84, P364, DOI 10.4269/ajtmh.2011.10-0585; Fox J, 2010, ANTIVIR RES, V85, P276, DOI 10.1016/j.antiviral.2009.10.012; Gopinath R, 2000, J INFECT DIS, V182, P1804, DOI 10.1086/317623; Greenhead P, 2000, J VIROL, V74, P5577, DOI 10.1128/JVI.74.12.5577-5586.2000; Gumbi PP, 2008, J VIROL, V82, P8529, DOI 10.1128/JVI.00183-08; Hegertun IEA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002104; HellingGiese G, 1996, ACTA TROP, V62, P257, DOI 10.1016/S0001-706X(96)00027-7; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Horsnell WGC, 2010, IMMUNOBIOLOGY, V215, P704, DOI 10.1016/j.imbio.2010.05.011; Iqbal SM, 2008, AM J REPROD IMMUNOL, V59, P44; Jourdan PM, 2011, AM J TROP MED HYG, V85, P1060, DOI 10.4269/ajtmh.2011.11-0135; Jourdan PM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001170; Kaul R, 2008, J REPROD IMMUNOL, V77, P32, DOI 10.1016/j.jri.2007.02.002; Kaul R, 2011, AM J REPROD IMMUNOL, V65, P317, DOI 10.1111/j.1600-0897.2010.00962.x; Kjetland EF, 2006, AIDS, V20, P593, DOI 10.1097/01.aids.0000210614.45212.0a; Kjetland EF, 2005, AM J TROP MED HYG, V72, P311, DOI 10.4269/ajtmh.2005.72.311; Kjetland EF, 2006, T ROY SOC TROP MED H, V100, P740, DOI 10.1016/j.trstmh.2005.09.010; Kjetland EF, 2012, TRENDS PARASITOL, V28, P58, DOI 10.1016/j.pt.2011.10.008; Levine WC, 1998, J INFECT DIS, V177, P167, DOI 10.1086/513820; Mbabazi PS, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001396; McClure CP, 2013, HIV MED, V14, P108, DOI 10.1111/hiv.12002; McKinnon LR, 2012, CURR OPIN HIV AIDS, V7, P195, DOI 10.1097/COH.0b013e3283504941; Meditz AL, 2011, J VIROL, V85, P10189, DOI 10.1128/JVI.02529-10; Miller CJ, 2003, MICROBES INFECT, V5, P59, DOI 10.1016/S1286-4579(02)00056-4; Morgas D. E. T., 2010, Southern African Journal of Epidemiology & Infection, V25, P30; Obeng BB, 2008, ANN TROP MED PARASIT, V102, P625, DOI 10.1179/136485908X337490; Oppermann M, 2004, CELL SIGNAL, V16, P1201, DOI 10.1016/j.cellsig.2004.04.007; Passmore JAS, 2006, IMMUNOLOGY, V119, P507, DOI 10.1111/j.1365-2567.2006.02465.x; Patterson BK, 2002, AM J PATHOL, V161, P867, DOI 10.1016/S0002-9440(10)64247-2; Picton ACP, 2012, IMMUNOLOGY, V136, P397, DOI 10.1111/j.1365-2567.2012.03592.x; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Prakash M, 2003, AM J OBSTET GYNECOL, V188, P376, DOI 10.1067/mob.2003.16; Rebbapragada A, 2007, AIDS, V21, P589, DOI 10.1097/QAD.0b013e328012b896; Reynes J, 2000, J INFECT DIS, V181, P927, DOI 10.1086/315315; Secor WE, 2003, INFECT IMMUN, V71, P6668, DOI 10.1128/IAI.71.11.6668-6671.2003; Shacklett BL, 2010, CURR OPIN HIV AIDS, V5, P128, DOI 10.1097/COH.0b013e328335c178; Sheffield JS, 2007, J INFECT DIS, V196, P1509, DOI 10.1086/522518; Shen RZ, 2011, AM J REPROD IMMUNOL, V65, P261, DOI 10.1111/j.1600-0897.2010.00939.x; Shen R, 2009, J VIROL, V83, P3258, DOI 10.1128/JVI.01796-08; Siddappa NB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001270; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Taylor MD, 2012, TRENDS IMMUNOL, V33, P181, DOI 10.1016/j.it.2012.01.001; The Joint United Nations Programme on HIV and AIDS, 2010, UNAIDS REP GLOB AIDS	55	37	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98593	10.1371/journal.pone.0098593	http://dx.doi.org/10.1371/journal.pone.0098593			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896815	Green Published, Green Accepted, gold			2022-12-27	WOS:000338430700052
J	Smirnova, L; Block, K; Sittka, A; Oelgeschlager, M; Seiler, AEM; Luch, A				Smirnova, Lena; Block, Katharina; Sittka, Alexandra; Oelgeschlaeger, Michael; Seiler, Andrea E. M.; Luch, Andreas			MicroRNA Profiling as Tool for In Vitro Developmental Neurotoxicity Testing: The Case of Sodium Valproate	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HISTONE DEACETYLASE; SKELETAL-MUSCLE; CAENORHABDITIS-ELEGANS; NEURAL DIFFERENTIATION; EPIGENETIC REGULATION; RESPONSE EVALUATION; MIRNA EXPRESSION; GENE-EXPRESSION; MOOD STABILIZER	Studying chemical disturbances during neural differentiation of murine embryonic stem cells (mESCs) has been established as an alternative in vitro testing approach for the identification of developmental neurotoxicants. miRNAs represent a class of small non-coding RNA molecules involved in the regulation of neural development and ESC differentiation and specification. Thus, neural differentiation of mESCs in vitro allows investigating the role of miRNAs in chemical-mediated developmental toxicity. We analyzed changes in miRNome and transcriptome during neural differentiation of mESCs exposed to the developmental neurotoxicant sodium valproate (VPA). A total of 110 miRNAs and 377 mRNAs were identified differently expressed in neurally differentiating mESCs upon VPA treatment. Based on miRNA profiling we observed that VPA shifts the lineage specification from neural to myogenic differentiation (upregulation of muscleabundant miRNAs, mir-206, mir-133a and mir-10a, and downregulation of neural-specific mir-124a, mir-128 and mir-137). These findings were confirmed on the mRNA level and via immunochemistry. Particularly, the expression of myogenic regulatory factors (MRFs) as well as muscle-specific genes (Actc1, calponin, myosin light chain, asporin, decorin) were found elevated, while genes involved in neurogenesis (e.g. Otx1, 2, and Zic3, 4, 5) were repressed. These results were specific for valproate treatment and_based on the following two observations_most likely due to the inhibition of histone deacetylase (HDAC) activity: (i) we did not observe any induction of muscle-specific miRNAs in neurally differentiating mESCs exposed to the unrelated developmental neurotoxicant sodium arsenite; and (ii) the expression of muscle-abundant mir-206 and mir-10a was similarly increased in cells exposed to the structurally different HDAC inhibitor trichostatin A (TSA). Based on our results we conclude that miRNA expression profiling is a suitable molecular endpoint for developmental neurotoxicity. The observed lineage shift into myogenesis, where miRNAs may play an important role, could be one of the developmental neurotoxic mechanisms of VPA.	[Smirnova, Lena; Block, Katharina; Sittka, Alexandra; Oelgeschlaeger, Michael; Seiler, Andrea E. M.; Luch, Andreas] BfR Fed Inst Risk Assessment, Berlin, Germany	Federal Institute for Risk Assessment	Smirnova, L (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Johns Hopkins Ctr Alternat Anim Testing CAAT, Baltimore, MD 21218 USA.	lsmirov@jhsph.edu		Block, Katharina/0000-0002-2752-5232	German Federal Institute for Risk Assessment (BfR), SFP [1322-458]	German Federal Institute for Risk Assessment (BfR), SFP	This study was financially supported by intramural funding of the German Federal Institute for Risk Assessment (BfR), SFP grant # 1322-458. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2010, MOL CELL BIOL, V30, P4197, DOI 10.1128/MCB.00316-10; Ambros V, 2000, CURR OPIN GENET DEV, V10, P428, DOI 10.1016/S0959-437X(00)00108-8; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Andersen HR, 2000, TOXICOLOGY, V144, P121, DOI 10.1016/S0300-483X(99)00198-5; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Auerbach W, 2000, BIOTECHNIQUES, V29, P1024, DOI 10.2144/00295st04; Balmer N. V., 2014, BASIC CLIN PHARM TOX, DOI 10.1111/bcpt.12203; Balmer NV, 2012, HUM MOL GENET, V21, P4104, DOI 10.1093/hmg/dds239; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Batty N, 2009, CANCER LETT, V280, P192, DOI 10.1016/j.canlet.2009.03.013; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boeckeler K, 2006, EUR J CELL BIOL, V85, P1047, DOI 10.1016/j.ejcb.2006.04.013; Bowden CL, 2009, BIPOLAR DISORD, V11, P20, DOI 10.1111/j.1399-5618.2009.00708.x; Boyes WK, 1997, FUND APPL TOXICOL, V40, P175, DOI 10.1006/faat.1997.2388; BOYLE CA, 1994, PEDIATRICS, V93, P399; Briner W, 2000, NEUROTOXICOL TERATOL, V22, P761, DOI 10.1016/S0892-0362(00)00086-6; Bruno IG, 2011, MOL CELL, V42, P500, DOI 10.1016/j.molcel.2011.04.018; Buschmann Jochen, 2013, Methods Mol Biol, V947, P37, DOI 10.1007/978-1-62703-131-8_4; Calabresi P, 2007, TRENDS PHARMACOL SCI, V28, P188, DOI 10.1016/j.tips.2007.02.005; Castanon I, 2002, GENE, V287, P11, DOI 10.1016/S0378-1119(01)00893-9; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; De Ferrari GV, 2006, ONCOGENE, V25, P7545, DOI 10.1038/sj.onc.1210064; Delcuve GP, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-5; Dey BK, 2011, MOL CELL BIOL, V31, P203, DOI 10.1128/MCB.01009-10; Feng Y, 2011, CELL BIOCHEM FUNCT, V29, P378, DOI 10.1002/cbf.1760; Flynt AS, 2007, NAT GENET, V39, P259, DOI 10.1038/ng1953; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Ge YJ, 2011, CELL CYCLE, V10, P441, DOI 10.4161/cc.10.3.14710; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Grandjean P, 2006, LANCET, V368, P2167, DOI 10.1016/S0140-6736(06)69665-7; Grandjean P, 2007, EPIDEMIOLOGY, V18, P25, DOI 10.1097/01.ede.0000249533.77900.74; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grinberg I, 2005, ZIC GENE FAMILY DEV; Gurvich N, 2005, FASEB J, V19, P1166, DOI 10.1096/fj.04-3425fje; Hagiwara H, 2011, BIOCHEM BIOPH RES CO, V414, P826, DOI 10.1016/j.bbrc.2011.10.036; Hao YL, 2004, J NEUROSCI, V24, P6590, DOI 10.1523/JNEUROSCI.5747-03.2004; Huang HR, 2010, J BIOL CHEM, V285, P9383, DOI [10.1074/jbc.M110.101543, 10.1074/jbc.M109.095612]; Huang TW, 2010, J MOL CELL BIOL, V2, P152, DOI 10.1093/jmcb/mjq008; Iezzi S, 2002, P NATL ACAD SCI USA, V99, P7757, DOI 10.1073/pnas.112218599; Jergil M, 2011, TOXICOL SCI, V121, P328, DOI 10.1093/toxsci/kfr070; Jergil M, 2009, TOXICOL SCI, V108, P132, DOI 10.1093/toxsci/kfp002; Johannessen CU, 2000, NEUROCHEM INT, V37, P103, DOI 10.1016/S0197-0186(00)00013-9; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Kaul D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037767; Kaur P, 2012, J TOXICOLOGY, V2012, P1, DOI [10.2353/ajpath.2010.091202, DOI 10.2353/AJPATH.2010.091202]; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Krug AK, 2013, ARCH TOXICOL, V87, P123, DOI 10.1007/s00204-012-0967-3; Kuehn BM, 2010, JAMA-J AM MED ASSOC, V304, P27, DOI 10.1001/jama.2010.860; Kultima K, 2004, ENVIRON HEALTH PERSP, V112, P1225, DOI 10.1289/txg.7034; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Landrigan PJ, 2010, CURR OPIN PEDIATR, V22, P219, DOI 10.1097/MOP.0b013e328336eb9a; Larsen KB, 2010, J HISTOCHEM CYTOCHEM, V58, P669, DOI 10.1369/jhc.2010.955757; Lee CT, 2007, DNA CELL BIOL, V26, P209, DOI 10.1089/dna.2006.0545; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lee YB, 2009, NUCLEIC ACIDS RES, V37, P123, DOI 10.1093/nar/gkn920; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Lein P, 2005, ENVIRON TOXICOL PHAR, V19, P735, DOI 10.1016/j.etap.2004.12.035; Li XK, 2010, NAT REV NEUROSCI, V11, P329, DOI 10.1038/nrn2739; Liu J, 2010, J BIOL CHEM, V285, P26599, DOI 10.1074/jbc.M110.115824; McCarthy JJ, 2008, BBA-GENE REGUL MECH, V1779, P682, DOI 10.1016/j.bbagrm.2008.03.001; Meseguer S, 2011, J BIOL CHEM, V286, P4150, DOI 10.1074/jbc.M110.167817; Nimmo RA, 2009, CHROMOSOMA, V118, P405, DOI 10.1007/s00412-009-0210-z; Noorbakhsh F, 2011, BRAIN, V134, P2703, DOI 10.1093/brain/awr200; O'Carroll D, 2013, NEUROPSYCHOPHARMACOL, V38, P39, DOI 10.1038/npp.2012.87; Ornoy A, 2009, REPROD TOXICOL, V28, P1, DOI 10.1016/j.reprotox.2009.02.014; Pallocca G, 2013, CELL BIOL TOXICOL, V29, P239, DOI 10.1007/s10565-013-9250-5; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; REDLINE RW, 1992, LAB INVEST, V66, P659; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Sagiv SK, 2010, AM J EPIDEMIOL, V171, P593, DOI 10.1093/aje/kwp427; Schettler T, 2001, ENVIRON HEALTH PERSP, V109, P813, DOI 10.2307/3454643; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seiler AEM, 2011, NAT PROTOC, V6, P961, DOI 10.1038/nprot.2011.348; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shi YH, 2010, J NEUROSCI, V30, P14931, DOI 10.1523/JNEUROSCI.4280-10.2010; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Smirnova Lena, 2012, Exp Suppl, V101, P499, DOI 10.1007/978-3-7643-8340-4_18; Sweetman D, 2008, DEV BIOL, V321, P491, DOI 10.1016/j.ydbio.2008.06.019; Szulwach KE, 2010, J CELL BIOL, V189, P127, DOI 10.1083/jcb.200908151; Tal TL, 2012, NEUROTOXICOLOGY, V33, P530, DOI 10.1016/j.neuro.2012.02.013; Tarantino C, 2010, FASEB J, V24, P3255, DOI 10.1096/fj.09-152207; Theunissen PT, 2012, TOXICOL SCI, V125, P430, DOI 10.1093/toxsci/kfr293; Theunissen PT, 2011, TOXICOL SCI, V122, P437, DOI 10.1093/toxsci/kfr134; Visan A, 2012, NEUROTOXICOLOGY, V33, P1135, DOI 10.1016/j.neuro.2012.06.006; Waldmann T, 2014, CHEM RES TOXICOL, V27, P408, DOI 10.1021/tx400402j; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Winbanks CE, 2011, J BIOL CHEM, V286, P13805, DOI 10.1074/jbc.M110.192625; Wu XD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-244; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Yablonka-Reuveni Z, 2008, J Anim Sci, V86, pE207; Yin G, 2010, ONCOGENE, V29, P3545, DOI 10.1038/onc.2010.111; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	94	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98892	10.1371/journal.pone.0098892	http://dx.doi.org/10.1371/journal.pone.0098892			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896083	Green Published, gold, Green Submitted			2022-12-27	WOS:000338430700091
J	Xiang, Y; Liu, W; Chen, Y; Zhang, CT; Su, WH; Zhang, Y; Sun, JX; Gao, F; Jiang, CL				Xiang, Yue; Liu, Wei; Chen, Yue; Zhang, Chuntao; Su, Weiheng; Zhang, Yan; Sun, Jiaxi; Gao, Feng; Jiang, Chunlai			The Variable Loop 3 in the Envelope Glycoprotein Is Critical for the Atypical Coreceptor Usage of an HIV-1 Strain	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; V3 LOOP; TYPE-1; CCR5; RECEPTORS; INFECTION; ENTRY; TROPISM; CLONING; 7-TRANSMEMBRANE	The majority of HIV-1 strains enter CD4(+) T cells using the CCR5 and/or CXCR4 co-receptor. However, we recently identified a transmitted/founder (T/F) virus (ZP6248) that efficiently used an alternative coreceptor GPR15, rather than commonly used CXCR4 and CCR5, to establish clinical infection. To understand which regions in the env gene were critical for the atypical coreceptor usage, we generated a set of V3 mutants and determined their infectivity in GHOST cells that expressed different coreceptors. When the variable loop 3 (V3) in YU2 was replaced with the ZP6248 V3 (YU2.6248V3), the chimera YU2.6248V3 infected GPR15(+) cells but not CCR5(+) cells. To determine which amino acids in V3 was responsible for this phenotype change, each of the eight amino acids that differed from the subtype B consensus V3 was substituted with alanine. The G306A and S322A mutations significantly reduced the replication capacity of YU2.6248V3 in GPR15(+) cells, while all other alanine substitutions at positions 307, 314, 315, 316, 317 and 318 completely abrogated the infectivity of YU2.6248V3 in GPR15(+) cells. The E314A mutation, as the E314G mutation reported before, also rendered the YU2.6248V3 infectious in CCR5(+) cells, while none of other alanine mutants could infect CCR5+ cells. These results demonstrated that amino acids in ZP6248 V3 might form a unique conformation that was critical for the interaction with GPR15 while the amino acids at position 314 in the V3 crown of ZP6248 played a key role in interaction with both CCR5 and GPR15. The unique phenotypes of ZP6248 can serve as a model to understand how HIV-1 explores the diverse coreceptor reservoir through novel genetic variants to establish clinical infection.	[Xiang, Yue; Liu, Wei; Su, Weiheng; Zhang, Yan; Sun, Jiaxi; Gao, Feng; Jiang, Chunlai] Jilin Univ, Coll Life Sci, Natl Engn Lab AIDS Vaccine, Changchun 130023, Jilin, Peoples R China; [Chen, Yue; Gao, Feng] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC USA; [Zhang, Chuntao] Natl Inst Food & Drug Control, Div Vitro Diagnost 2, Beijing, Peoples R China	Jilin University; Duke University; National Institute of Food & Drug Control - China	Gao, F (corresponding author), Jilin Univ, Coll Life Sci, Natl Engn Lab AIDS Vaccine, Changchun 130023, Jilin, Peoples R China.	fgao@duke.edu; jiangcl@jlu.edu.cn			National Science and Technology Major Project [2012ZX10001009]; National Institute of Allergy and Infectious Diseases, National Institutes of Health [R21-AI016443]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI106443] Funding Source: NIH RePORTER	National Science and Technology Major Project; National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grants from the National Science and Technology Major Project (2012ZX10001009) and the National Institute of Allergy and Infectious Diseases, National Institutes of Health (R21-AI016443). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Alkhatib G, 1997, NATURE, V388, P238, DOI 10.1038/40789; Almond D, 2010, AIDS RES HUM RETROV, V26, P717, DOI 10.1089/aid.2009.0254; Beer BE, 2001, J VIROL, V75, P12014, DOI 10.1128/JVI.75.24.12014-12027.2001; Begaud E, 2003, AIDS RES HUM RETROV, V19, P551, DOI 10.1089/088922203322230914; Blaak H, 2005, J VIROL, V79, P1686, DOI 10.1128/JVI.79.3.1686-1700.2005; BOYD MT, 1993, J VIROL, V67, P3649, DOI 10.1128/JVI.67.6.3649-3652.1993; Cardozo T, 2007, AIDS RES HUM RETROV, V23, P415, DOI 10.1089/aid.2006.0130; Cashin K, 2011, J VIROL, V85, P10699, DOI 10.1128/JVI.05510-11; Cecilia D, 1998, J VIROL, V72, P6988, DOI 10.1128/JVI.72.9.6988-6996.1998; Chen ZW, 1998, J EXP MED, V188, P2057, DOI 10.1084/jem.188.11.2057; Cilliers T, 2003, J VIROL, V77, P4449, DOI 10.1128/JVI.77.7.4449-4456.2003; Clayton F, 2001, AM J PATHOL, V159, P1933, DOI 10.1016/S0002-9440(10)63040-4; Deng HK, 1997, NATURE, V388, P296, DOI 10.1038/40894; Edinger AL, 1999, VIROLOGY, V260, P211, DOI 10.1006/viro.1999.9819; Edinger AL, 1998, VIROLOGY, V249, P367, DOI 10.1006/viro.1998.9306; Elliott STC, 2012, J VIROL, V86, P898, DOI 10.1128/JVI.06415-11; Farzan M, 1997, J EXP MED, V186, P405, DOI 10.1084/jem.186.3.405; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; FOUCHIER RAM, 1992, J VIROL, V66, P3183, DOI 10.1128/JVI.66.5.3183-3187.1992; Hoffman NG, 2002, J VIROL, V76, P3852, DOI 10.1128/JVI.76.8.3852-3864.2002; Jiang CL, 2011, J VIROL, V85, P10669, DOI 10.1128/JVI.05249-11; Kim SV, 2013, SCIENCE, V340, P1456, DOI 10.1126/science.1237013; Maresca M, 2003, J BIOMED SCI, V10, P156, DOI 10.1159/000068089; Nabatov AA, 2004, J VIROL, V78, P524, DOI 10.1128/JVI.78.1.524-530.2004; Owen SM, 1998, J VIROL, V72, P5425, DOI 10.1128/JVI.72.7.5425-5432.1998; Pohlmann S, 1999, J GEN VIROL, V80, P1241, DOI 10.1099/0022-1317-80-5-1241; Riddick NE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001064; Shimizu N, 2009, AIDS, V23, P761, DOI 10.1097/QAD.0b013e328326cc0d; Simmons G, 1998, J VIROL, V72, P8453, DOI 10.1128/JVI.72.10.8453-8457.1998; Zhang LQ, 1998, J VIROL, V72, P9307, DOI 10.1128/JVI.72.11.9307-9312.1998; Zhang YJ, 1998, J VIROL, V72, P9337, DOI 10.1128/JVI.72.11.9337-9344.1998; Zhang YJ, 2000, J VIROL, V74, P6893, DOI 10.1128/JVI.74.15.6893-6910.2000	33	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98058	10.1371/journal.pone.0098058	http://dx.doi.org/10.1371/journal.pone.0098058			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897520	Green Submitted, gold, Green Published			2022-12-27	WOS:000338430700021
J	Chandhok, G; Schmitt, N; Sauer, V; Aggarwal, A; Bhatt, M; Schmidt, HHJ				Chandhok, Gursimran; Schmitt, Nadine; Sauer, Vanessa; Aggarwal, Annu; Bhatt, Mohit; Schmidt, Hartmut H. J.			The Effect of Zinc and D-Penicillamine in a Stable Human Hepatoma ATP7B Knockout Cell Line	PLOS ONE			English	Article							WILSON-DISEASE GENE; COPPER-TRANSPORTING ATPASE; EVANS-CINNAMON RATS; HEPG2 CELLS; LEC RATS; FUNCTIONAL-PROPERTIES; METALLOTHIONEIN; EXPRESSION; INDUCTION; HEPATITIS	Mutations in the copper (Cu) transporter gene ATP7B, the primary cause of Wilson disease (WD), result in high liver Cu and death of hepatocytes. Cu chelators and zinc salts are the two most important drugs used in the treatment of WD patients; however, the molecular mechanisms of the drugs with regard to ATP7B expression have not been determined. A targeted knockout of ATP7B (KO) was established in the most widely used human hepatoma cell line, HepG2 for molecular studies of the pathogenesis and treatment of the disease. KO cells showed similar growth, Cu uptake, release, and gene expression as compared to parental cells. However, in the presence of Cu, morphological changes, oxidative stress, apoptosis, and loss of viability were observed. Induction of metallothionein (MT1X) after Cu exposure was significantly reduced in KO cells. Following zinc treatment, MT1X expression was strongly induced and a high percentage of KO cells could be rescued from Cu induced toxicity. D-penicillamine treatment had a minor effect on the viability of KO cells whereas the parental cell line showed a pronounced improvement. Combined treatment displayed a highly synergistic effect in KO cells. The data suggest that zinc has a previously unrecognized effect on the viability of hepatocytes that lack ATP7B due to a high induction of MT1X expression that compensates low gene expression after Cu exposure. A combination therapy that simultaneously targets at MT1X induction and Cu chelation improves the overall survival of hepatocytes for most efficient therapy of patients having WD.	[Chandhok, Gursimran; Schmitt, Nadine; Sauer, Vanessa; Schmidt, Hartmut H. J.] Munster Univ Hosp, Clin Transplantat Med, Munster, Germany; [Chandhok, Gursimran; Aggarwal, Annu; Bhatt, Mohit] Kokilaben Dhirubhai Ambani Hosp & Med Res Inst, Wilson Dis Clin, Mumbai, Maharashtra, India	University of Munster	Schmidt, HHJ (corresponding author), Munster Univ Hosp, Clin Transplantat Med, Munster, Germany.	hepar@ukmuenster.de		Bhatt, Mohit/0000-0002-5233-3371	European Commission [247506]	European Commission(European CommissionEuropean Commission Joint Research Centre)	GC was partly funded by European Commission (WilsonIndia project 247506). All the other funding was from internal sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A, INT REV NEU IN PRESS, V110, P313; Aggarwal A, 2013, ANN HUM GENET, V77, P299, DOI 10.1111/ahg.12024; Brewer GJ, 2005, J HEPATOL, V42, pS13, DOI 10.1016/j.jhep.2004.11.013; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; Cater MA, 2006, GASTROENTEROLOGY, V130, P493, DOI 10.1053/j.gastro.2005.10.054; Delangle P, 2012, DALTON T, V41, P6359, DOI 10.1039/c2dt12188c; Ferenci P, 2003, LIVER INT, V23, P139, DOI 10.1034/j.1600-0676.2003.00824.x; Ferenci P, 2006, HUM GENET, V120, P151, DOI 10.1007/s00439-006-0202-5; Forbes JR, 1998, AM J HUM GENET, V63, P1663, DOI 10.1086/302163; Gaetke LM, 2003, TOXICOLOGY, V189, P147, DOI 10.1016/S0300-483X(03)00159-8; Graham John M, 2002, ScientificWorldJournal, V2, P1638; Gupte A, 2007, FREE RADICAL BIO MED, V43, P1271, DOI 10.1016/j.freeradbiomed.2007.07.003; HEILMAIER HE, 1986, TOXICOLOGY, V42, P23, DOI 10.1016/0300-483X(86)90089-2; HOOGENRAAD TU, 1979, EUR NEUROL, V18, P205, DOI 10.1159/000115077; Huster D, 2006, AM J PATHOL, V168, P423, DOI 10.2353/ajpath.2006.050312; Huster D, 2003, GASTROENTEROLOGY, V124, P335, DOI 10.1053/gast.2003.50066; Huster D, 2012, GASTROENTEROLOGY, V142, P947, DOI 10.1053/j.gastro.2011.12.048; Jimenez I, 2002, TOXICOL IN VITRO, V16, P167, DOI 10.1016/S0887-2333(01)00117-5; Klein D, 2003, ARCH TOXICOL, V77, P568, DOI 10.1007/s00204-003-0493-4; Lang PA, 2007, NAT MED, V13, P164, DOI 10.1038/nm1539; LODEMANN E, 1981, BIOCHEM BIOPH RES CO, V102, P775, DOI 10.1016/S0006-291X(81)80199-4; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Matsumoto A, 1998, FREE RADICAL RES, V28, P383, DOI 10.3109/10715769809070807; MCQUAID A, 1992, J LAB CLIN MED, V119, P744; Medici V, 2005, LIVER INT, V25, P888, DOI 10.1111/j.1478-3231.2005.01108.x; Nair J, 2005, CARCINOGENESIS, V26, P1307, DOI 10.1093/carcin/bgi073; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; Roelofsen H, 2000, GASTROENTEROLOGY, V119, P782, DOI 10.1053/gast.2000.17834; Santon A, 2003, BBA-MOL BASIS DIS, V1637, P91, DOI 10.1016/S0925-4439(02)00218-1; Sauer V, 2010, BIOCHEM BIOPH RES CO, V395, P307, DOI 10.1016/j.bbrc.2010.03.158; SCHEINBERG IH, 1987, LANCET, V2, P95, DOI 10.1016/S0140-6736(87)92753-X; Schilsky M L, 2001, Curr Gastroenterol Rep, V3, P54, DOI 10.1007/s11894-001-0041-4; Schilsky ML, 1998, HEPATOLOGY, V28, P1347, DOI 10.1002/hep.510280525; SCHILSKY ML, 1989, J CLIN INVEST, V84, P1562, DOI 10.1172/JCI114333; Siaj R, 2012, WORLD J GASTROENTERO, V18, P5542, DOI 10.3748/wjg.v18.i39.5542; SOKOL RJ, 1994, GASTROENTEROLOGY, V107, P1788, DOI 10.1016/0016-5085(94)90822-2; Song MO, 2005, MOL CELL BIOCHEM, V279, P141, DOI 10.1007/s11010-005-8286-0; Stapelbroek JM, 2004, J HEPATOL, V41, P758, DOI 10.1016/j.jhep.2004.07.017; STOCKERT RJ, 1986, HEPATOLOGY, V6, P60, DOI 10.1002/hep.1840060112; TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344; Tsivkovskii R, 2002, J BIOL CHEM, V277, P976, DOI 10.1074/jbc.M109368200; Vadasz Z, 2005, J HEPATOL, V43, P499, DOI 10.1016/j.jhep.2005.02.052; Yeh CT, 2005, CARCINOGENESIS, V26, P2138, DOI 10.1093/carcin/bgi185	43	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98809	10.1371/journal.pone.0098809	http://dx.doi.org/10.1371/journal.pone.0098809			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892424	Green Published, gold, Green Submitted			2022-12-27	WOS:000336911400096
J	Stahli, BE; Yonekawa, K; Altwegg, LA; Wyss, C; Hof, D; Fischbacher, P; Brauchlin, A; Schulthess, G; Krayenbuhl, PA; von Eckardstein, A; Hersberger, M; Neidhart, M; Gay, S; Novopashenny, I; Wolters, R; Frank, M; Wischnewsky, MB; Luscher, TF; Maier, W				Staehli, Barbara Elisabeth; Yonekawa, Keiko; Altwegg, Lukas Andreas; Wyss, Christophe; Hof, Danielle; Fischbacher, Philipp; Brauchlin, Andreas; Schulthess, Georg; Krayenbuehl, Pierre-Alexandre; von Eckardstein, Arnold; Hersberger, Martin; Neidhart, Michel; Gay, Steffen; Novopashenny, Igor; Wolters, Regine; Frank, Michelle; Wischnewsky, Manfred Bernd; Luescher, Thomas Felix; Maier, Willibald			Clinical Criteria Replenish High-Sensitive Troponin and Inflammatory Markers in the Stratification of Patients with Suspected Acute Coronary Syndrome	PLOS ONE			English	Article							NATRIURETIC PEPTIDE LEVELS; ACID-BINDING PROTEIN; TIMI RISK SCORE; MYOCARDIAL-INFARCTION; PROGNOSTIC VALUE; EARLY-DIAGNOSIS; MULTIMARKER APPROACH; PLASMA-PROTEIN; HEART-FAILURE; CHEST-PAIN	Objectives: In patients with suspected acute coronary syndrome (ACS), rapid triage is essential. The aim of this study was to establish a tool for risk prediction of 30-day cardiac events (CE) on admission. 30-day cardiac events (CE) were defined as early coronary revascularization, subsequent myocardial infarction, or cardiovascular death within 30 days. Methods and Results: This single-centre, prospective cohort study included 377 consecutive patients presenting to the emergency department with suspected ACS and for whom troponin T measurements were requested on clinical grounds. Fifteen biomarkers were analyzed in the admission sample, and clinical parameters were assessed by the TIMI risk score for unstable angina/Non-ST myocardial infarction and the GRACE risk score. Sixty-nine (18%) patients presented with and 308 (82%) without ST-elevations, respectively. Coronary angiography was performed in 165 (44%) patients with subsequent percutaneous coronary intervention - accounting for the majority of CE - in 123 (33%) patients, respectively. Eleven out of 15 biomarkers were elevated in patients with CE compared to those without. High-sensitive troponin T (hs-cTnT) was the best univariate biomarker to predict CE in Non-ST-elevation patients (AUC 0.80), but did not yield incremental information above clinical TIMI risk score (AUC 0.80 vs 0.82, p = 0.69). Equivalence testing of AUCs of risk models and non-inferiority testing demonstrated that the clinical TIMI risk score alone was non-inferior to its combination with hs-cTnT in predicting CE. Conclusions: In patients presenting without ST-elevations, identification of those prone to CE is best based on clinical assessment based on TIMI risk score criteria and hs-cTnT.	[Staehli, Barbara Elisabeth; Yonekawa, Keiko; Altwegg, Lukas Andreas; Wyss, Christophe; Brauchlin, Andreas; Frank, Michelle; Luescher, Thomas Felix; Maier, Willibald] Univ Zurich Hosp, Cardiovasc Ctr, Dept Cardiol, CH-8091 Zurich, Switzerland; [Yonekawa, Keiko; Krayenbuehl, Pierre-Alexandre] Univ Zurich Hosp, Div Internal Med, CH-8091 Zurich, Switzerland; [Hof, Danielle; von Eckardstein, Arnold] Univ Zurich Hosp, Inst Clin Chem, CH-8091 Zurich, Switzerland; [Fischbacher, Philipp; Schulthess, Georg] Hosp Mannedorf, Dept Internal Med, Mannedorf, Switzerland; [Hersberger, Martin] Univ Zurich, Childrens Hosp, Inst Clin Chem & Biochem, Zurich, Switzerland; [Neidhart, Michel; Gay, Steffen] Univ Zurich Hosp, Ctr Expt Rheumatol, Dept Rheumatol, CH-8091 Zurich, Switzerland; [Novopashenny, Igor; Wolters, Regine; Wischnewsky, Manfred Bernd] Univ Bremen, FB Math & Comp Sci, D-28359 Bremen, Germany	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University Children's Hospital Zurich; University of Zurich; University of Zurich; University Zurich Hospital; University of Bremen	Maier, W (corresponding author), Univ Zurich Hosp, Cardiovasc Ctr, Dept Cardiol, CH-8091 Zurich, Switzerland.	karmaiew@usz.uzh.ch		Hersberger, Martin/0000-0002-4472-329X; Neidhart, Michel/0000-0002-9656-5967	Swiss National Research Foundation [3200B0-112661, 33CM30-1241112/1, 3100-068118.02/1]; Roche Diagnostics GmbH	Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); Roche Diagnostics GmbH	This study has partially been supported by grants of the Swiss National Research Foundation (http://www.snf.ch/E/Pages/default.aspx; no. 3200B0-112661, Special Programme University Medicine: Grant Nr 33CM30-1241112/1 and 3100-068118.02/1) and Roche Diagnostics GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Altwegg LA, 2007, EUR HEART J, V28, P941, DOI 10.1093/eurheartj/ehm078; Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Antman EM, 1996, NEW ENGL J MED, V335, P1342, DOI 10.1056/NEJM199610313351802; Bayes-Genis A, 2001, NEW ENGL J MED, V345, P1022, DOI 10.1056/NEJMoa003147; Bijsterveld NR, 2003, J AM COLL CARDIOL, V42, P2083, DOI 10.1016/j.jacc.2003.05.014; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; de Lemos JA, 2010, JAMA-J AM MED ASSOC, V304, P2503, DOI 10.1001/jama.2010.1768; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Goodacre S, 2005, HEART, V91, P229, DOI 10.1136/hrt.2003.027599; Granger CB, 2003, ARCH INTERN MED, V163, P2345, DOI 10.1001/archinte.163.19.2345; HAMM CW, 1992, NEW ENGL J MED, V327, P146, DOI 10.1056/NEJM199207163270302; Healy AM, 2006, CIRCULATION, V113, P2278, DOI 10.1161/CIRCULATIONAHA.105.607333; Hochholzer W, 2011, CLIN CHEM, V57, P1318, DOI 10.1373/clinchem.2011.162073; James SK, 2006, J AM COLL CARDIOL, V48, P1146, DOI 10.1016/j.jacc.2006.05.056; Khan DA, 2011, KOREAN J LAB MED, V31, P172, DOI 10.3343/kjlm.2011.31.3.172; Krauser DG, 2005, AM HEART J, V149, P744, DOI 10.1016/j.ahj.2004.07.010; Mantenti ERF, 2006, CLIN CARDIOL, V29, P405, DOI 10.1002/clc.4960290907; McCann CJ, 2009, AM J CARDIOL, V103, P22, DOI 10.1016/j.amjcard.2008.08.026; Morris AC, 2006, HEART, V92, P1333, DOI 10.1136/hrt.2005.080226; Morrow DA, 2007, CLIN CHEM, V53, P552, DOI 10.1373/clinchem.2006.084194; Oemrawsingh RM, 2011, HEART, V97, P1061, DOI 10.1136/hrt.2010.197392; Ohman EM, 1996, NEW ENGL J MED, V335, P1333, DOI 10.1056/NEJM199610313351801; Reichlin T, 2011, CIRCULATION, V124, P136, DOI 10.1161/CIRCULATIONAHA.111.023937; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Sabatine MS, 2002, CIRCULATION, V105, P1760, DOI 10.1161/01.CIR.0000015464.18023.0A; Saunders JT, 2011, CIRCULATION, V123, P1367, DOI 10.1161/CIRCULATIONAHA.110.005264; Schaub N, 2011, CLIN CHEM; Scirica BM, 2002, AM J CARDIOL, V90, P303, DOI 10.1016/S0002-9149(02)02468-2; Seino Y, 2003, AM J MED, V115, P185, DOI 10.1016/S0002-9343(03)00325-5; Shand JA, 2011, HEART, V97, P605, DOI 10.1136/hrt.2011.223404; Tello-Montoliu A, 2007, J INTERN MED, V262, P651, DOI 10.1111/j.1365-2796.2007.01871.x; Thygesen K, 2010, EUR HEART J, V31, P2197, DOI 10.1093/eurheartj/ehq251; Vora Amit N, 2012, J Thromb Thrombolysis, V34, P229, DOI 10.1007/s11239-012-0705-y; Wang LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065539; Wang TJ, 2002, AM J CARDIOL, V90, P254, DOI 10.1016/S0002-9149(02)02464-5	36	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98626	10.1371/journal.pone.0098626	http://dx.doi.org/10.1371/journal.pone.0098626			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892556	Green Accepted, Green Published, gold			2022-12-27	WOS:000336911400077
J	Stein, JH; Asthana, A; Smith, SS; Piper, ME; Loh, WY; Fiore, MC; Baker, TB				Stein, James H.; Asthana, Asha; Smith, Stevens S.; Piper, Megan E.; Loh, Wei-Yin; Fiore, Michael C.; Baker, Timothy B.			Smoking Cessation and the Risk of Diabetes Mellitus and Impaired Fasting Glucose: Three-Year Outcomes after a Quit Attempt	PLOS ONE			English	Article							SUSTAINED-RELEASE BUPROPION; RECEPTOR PARTIAL AGONIST; BETA-CELL FUNCTION; WEIGHT-GAIN; METABOLIC SYNDROME; CIGARETTE-SMOKING; ASSOCIATION; PLACEBO; VARENICLINE; PREVENTION	Weight gain after smoking cessation may increase diabetes mellitus and impaired fasting glucose (IFG) risk. This study evaluated associations between smoking cessation and continued smoking with incident diabetes and IFG three years after a quit attempt. The 1504 smokers (58% female) were mean (standard deviation) 44.7 (11.1) years old and smoked 21.4 (8.9) cigarettes/ day. Of 914 participants with year 3 data, the 238 abstainers had greater weight gain, increase in waist circumference, and increase in fasting glucose levels than the 676 continuing smokers (p <= 0.008). In univariate analyses, Year 3 abstinence was associated with incident diabetes (OR = 2.60, 95% CI 1.44-4.67, p = .002; 4.3% absolute excess) and IFG (OR = 2.43, 95% CI 1.74-3.41, p<0.0001; 15.6% absolute excess). In multivariate analyses, incident diabetes was associated independently with older age (p = 0.0002), higher baseline body weight (p = 0.021), weight gain (p = 0.023), baseline smoking rate (p = 0.008), baseline IFG (p<0.0001), and baseline hemoglobin A1C (all p<0.0001). Smoking more at baseline predicted incident diabetes among eventual abstainers (p<0.0001); weighing more at baseline predicted incident diabetes among continuing smokers (p = 0.0004). Quitting smoking is associated with increased diabetes and IFG risk. Independent risk factors include older age, baseline body weight, baseline glycemic status, and heavier pre-quit smoking. These findings may help target smokers for interventions to prevent dysglycemia.	[Stein, James H.; Asthana, Asha; Smith, Stevens S.; Piper, Megan E.; Loh, Wei-Yin; Fiore, Michael C.; Baker, Timothy B.] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Stein, JH (corresponding author), Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI 53706 USA.	jhs@medicine.wisc.edu	Loh, Wei-Yin/ABA-8456-2020	Loh, Wei-Yin/0000-0001-6983-2495; Stein, James/0000-0002-2770-8223; Smith, Stevens/0000-0002-6824-2829	NIH [P50 DA019706, K05CA139871, UL1RR025011]; U.S. Army Research Office [W911NF-09-1-0205]; NATIONAL CANCER INSTITUTE [R35CA197573, P01CA180945, K05CA139871] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA019706] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Army Research Office; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by NIH grants P50 DA019706, K05CA139871, and UL1RR025011 and by U.S. Army Research Office Grant W911NF-09-1-0205. The authors are solely responsible for the design and conduct of this study, all analyses, drafting and editing of the paper, and its final contents.	Aubin HJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4439; Baker TB, 2011, ANN BEHAV MED, V41, P192, DOI 10.1007/s12160-010-9252-y; Balkau B, 2006, EUR J CARDIOV PREV R, V13, P334, DOI 10.1097/00149831-200606000-00007; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Broderick P, 2009, CANCER RES, V69, P6633, DOI 10.1158/0008-5472.CAN-09-0680; Campbell SC, 2008, ATHEROSCLEROSIS, V201, P225, DOI 10.1016/j.atherosclerosis.2008.04.046; CDC Services U. S. D. o. H. a. H, 2004, HLTH CONS SMOK REP S; Clair C, 2013, JAMA-J AM MED ASSOC, V309, P1014, DOI 10.1001/jama.2013.1644; Clark MM, 2004, ADDICT BEHAV, V29, P1637, DOI 10.1016/j.addbeh.2004.02.034; Daniel M, 2004, DIABETIC MED, V21, P188, DOI 10.1046/j.1464-5491.2003.01064.x; Farley AC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006219.pub3; Fiore MC, 2013, JAMA-J AM MED ASSOC, V309, P1032, DOI 10.1001/jama.2013.1793; Fishman PA, 2006, NICOTINE TOB RES, V8, P393, DOI 10.1080/14622200600670314; Galuska D. A., 2008, Morbidity and Mortality Weekly Report, V57, P765; Gepner AD, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.09.023; Gonzales D, 2006, JAMA-J AM MED ASSOC, V296, P47, DOI 10.1001/jama.296.1.47; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Hur NW, 2007, EUR J CARDIOV PREV R, V14, P244, DOI 10.1097/01.hjr.0000239474.41379.79; Jeffery RW, 2000, HEALTH PSYCHOL, V19, P242, DOI 10.1037/0278-6133.19.3.242; Johnson HM, 2010, J AM COLL CARDIOL, V55, P1988, DOI 10.1016/j.jacc.2010.03.002; Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P56, DOI 10.1001/jama.296.1.56; Lindstrom J, 2003, DIABETES CARE, V26, P3230, DOI 10.2337/diacare.26.12.3230; Loh WY, 2009, ANN APPL STAT, V3, P1710, DOI 10.1214/09-AOAS260; Luo JH, 2013, JAMA-J AM MED ASSOC, V310, P94, DOI 10.1001/jama.2013.6871; Mcbride PE, 2008, J NUTR HEALTH AGING, V12, p745S; Nakanishi N, 2000, ANN INTERN MED, V133, P183, DOI 10.7326/0003-4819-133-3-200008010-00009; O'Hara P, 1998, AM J EPIDEMIOL, V148, P821, DOI 10.1093/oxfordjournals.aje.a009706; Oba S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0017061; Ostgren CJ, 2000, DIABETIC MED, V17, P445, DOI 10.1046/j.1464-5491.2000.00294.x; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Piper ME, 2009, ARCH GEN PSYCHIAT, V66, P1253, DOI 10.1001/archgenpsychiatry.2009.142; Saccone NL, 2010, GENES BRAIN BEHAV, V9, P741, DOI 10.1111/j.1601-183X.2010.00608.x; Siapush M, 2013, TOBACCO CONTROL, V10; Wannamethee SG, 2001, DIABETES CARE, V24, P1590, DOI 10.2337/diacare.24.9.1590; Weiss RB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000125; Will JC, 2001, INT J EPIDEMIOL, V30, P540, DOI 10.1093/ije/30.3.540; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Yang M, 2013, ADDICT BEHAV, V38, P1865, DOI 10.1016/j.addbeh.2012.11.007; Yeh HC, 2010, ANN INTERN MED, V152, P10, DOI 10.7326/0003-4819-152-1-201001050-00005	40	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98278	10.1371/journal.pone.0098278	http://dx.doi.org/10.1371/journal.pone.0098278			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5ML	24893290	Green Submitted, gold, Green Published			2022-12-27	WOS:000336911400044
J	Tian, JG; Li, X; Si, M; Liu, T; Li, JM				Tian, Jiguang; Li, Xin; Si, Meng; Liu, Ting; Li, Jianmin			CD271(+) Osteosarcoma Cells Display Stem-Like Properties	PLOS ONE			English	Article							MURAMYL TRIPEPTIDE; BONE-MARROW; CANCER; IDENTIFICATION; PLURIPOTENCY; POPULATIONS; CISPLATIN; LEUKEMIA; SARCOMA; TUMORS	Cancer stem cell (CSC) theory has been proposed and verified in many cancers. The existence of osteosarcoma CSCs has been confirmed for many years and multiple surface markers have been employed to identify them. In this study, we identified CD271(+) subpopulation of osteosarcoma displaying stem-like properties. CD271, known as the neural crest nerve growth factor receptor, is the marker of bone marrow mesenchymal stem cells (MSCs) and human melanoma-initiating cells. We discovered that CD271 was expressed differentially in diverse types of human osteosarcoma and stabilized cell lines. CD271(+) osteosarcoma cells displayed most of the properties of CSC, such as self-renewal, differentiation, drug resistance and tumorigenicity in vivo. Nanog, Oct3/4, STAT3, DNA-PKcs, Bcl-2 and ABCG2 were more expressed in CD271(+) cells compared with CD271(-) cells. Our study supported the osteosarcoma CSC hypothesis and, to a certain extent, revealed one of the possible mechanisms involved in maintaining CSCs properties.	[Tian, Jiguang; Li, Xin; Si, Meng; Li, Jianmin] Shandong Univ, Qilu Hosp, Dept Orthoped, Jinan, Shandong, Peoples R China; [Liu, Ting] Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan, Shandong, Peoples R China	Shandong University; Shandong University	Li, JM (corresponding author), Shandong Univ, Qilu Hosp, Dept Orthoped, Jinan, Shandong, Peoples R China.	gkljmin@outlook.com			National Natural Science Foundation of China [81172551]; Shandong Technological Development Project [ZR2011HM037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Technological Development Project	This study was supported by a National Natural Science Foundation of China (81172551), and a Shandong Technological Development Project (ZR2011HM037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari AS, 2010, CANCER RES, V70, P4602, DOI 10.1158/0008-5472.CAN-09-3463; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Basu-Roy U, 2013, CANCER LETT, V338, P158, DOI 10.1016/j.canlet.2012.05.028; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Clarke MF, 2005, BIOL BLOOD MARROW TR, V11, P14, DOI 10.1016/j.bbmt.2004.11.011; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Fujii H, 2009, INT J ONCOL, V34, P1381, DOI 10.3892/ijo_00000265; Gibbs CP, 2005, NEOPLASIA, V7, P967, DOI 10.1593/neo.05394; Gonzalez VM, 2001, MOL PHARMACOL, V59, P657, DOI 10.1124/mol.59.4.657; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Hadnagy A, 2006, EXP CELL RES, V312, P3701, DOI 10.1016/j.yexcr.2006.08.030; La Porta Caterina Am, 2012, World J Stem Cells, V4, P17, DOI 10.4252/wjsc.v4.i3.17; Lieber MR, 2010, NAT STRUCT MOL BIOL, V17, P393, DOI 10.1038/nsmb0410-393; MANOHARAN A, 1979, BRIT J HAEMATOL, V43, P185, DOI 10.1111/j.1365-2141.1979.tb03740.x; Meyers PA, 2005, J CLIN ONCOL, V23, P2004, DOI 10.1200/JCO.2005.06.031; Meyers PA, 2009, EXPERT REV ANTICANC, V9, P1035, DOI [10.1586/era.09.69, 10.1586/ERA.09.69]; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mohseny AB, 2009, J PATHOL, V219, P294, DOI 10.1002/path.2603; Pontikoglou C, 2011, STEM CELL REV REP, V7, P569, DOI 10.1007/s12015-011-9228-8; Rasini V, 2013, CYTOTHERAPY, V15, P292, DOI 10.1016/j.jcyt.2012.11.009; Saini V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041401; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Singh SK, 2003, CANCER RES, V63, P5821; Tang DG, 2007, MOL CARCINOGEN, V46, P1, DOI 10.1002/mc.20255; Tirino V, 2011, FASEB J, V25, P2022, DOI 10.1096/fj.10-179036; Tirino V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003469; Wang BX, 2013, J INTERF CYTOK RES, V33, P181, DOI 10.1089/jir.2012.0154; Wu PK, 2009, JPN J CLIN ONCOL, V39, P514, DOI 10.1093/jjco/hyp057	30	43	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98549	10.1371/journal.pone.0098549	http://dx.doi.org/10.1371/journal.pone.0098549			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893164	gold, Green Published, Green Submitted			2022-12-27	WOS:000336911400064
J	Yao, TC; Tu, YL; Chang, SW; Tsai, HJ; Gu, PW; Ning, HC; Hua, MC; Liao, SL; Tsai, MH; Chiu, CY; Lai, SH; Yeh, KW; Huang, JL				Yao, Tsung-Chieh; Tu, Yu-Ling; Chang, Su-Wei; Tsai, Hui-Ju; Gu, Po-Wen; Ning, Hsian-Chen; Hua, Man-Chin; Liao, Sui-Ling; Tsai, Ming-Han; Chiu, Chih-Yung; Lai, Shen-Hao; Yeh, Kuo-Wei; Huang, Jing-Long		PATCH Study Grp	Suboptimal Vitamin D Status in a Population-Based Study of Asian Children: Prevalence and Relation to Allergic Diseases and Atopy	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; EXHALED NITRIC-OXIDE; D DEFICIENCY; RISK-FACTORS; ADOLESCENTS; ASTHMA; SENSITIZATION; IGE	Background: New evidence shows high prevalence of vitamin D deficiency in many countries and some studies suggest a possible link between vitamin D status and allergic diseases. The objectives of this study were to determine the prevalence of suboptimal vitamin D status in a population sample of Asian children and to investigate the relationship of vitamin D status with allergic diseases and atopy. Methods: Children aged 5-18 years (N = 1315) in the Prediction of Allergies in Taiwanese CHildren (PATCH) study were evaluated using questionnaires, anthropometric measurements, and serum levels of 25-hydroxyvitamin D [25(OH) D] and total and specific immunoglobulin E (IgE). Results: The mean concentration of serum 25(OH) D was 20.4 ng/mL (SD: 7.1 ng/mL). Vitamin D deficiency (defined as serum 25(OH) D < 20 ng/mL) was present in 670 subjects (51.0%), while vitamin D insufficiency (defined as serum 25(OH) D, 30 ng/mL) was observed in 1187 subjects (90.3%). Older age (P < 0.001), female gender (P < 0.001), higher body mass index (P = 0.001), winter and spring seasons (compared to summer; P both < 0.001), and passive smoking (P = 0.011) were independently associated with low serum 25(OH) D levels. After adjusting for potential confounders, serum 25(OH) D status had no association with asthma, rhinitis, eczema, atopy, or total serum IgE (all P > 0.05). Conclusions: Low serum 25(OH) D levels are remarkably common in this population sample of Asian children, suggesting that millions of children living in Taiwan may have suboptimal levels of vitamin D, which should be a matter of public health concern. Our results provides epidemiological evidence against the association of vitamin D status with various allergic diseases and atopy in Asian children.	[Yao, Tsung-Chieh; Tu, Yu-Ling; Yeh, Kuo-Wei; Huang, Jing-Long] Chang Gung Mem Hosp, Dept Pediat, Div Allergy Asthma & Rheumatol, Taoyuan, Taiwan; [Yao, Tsung-Chieh; Tu, Yu-Ling; Yeh, Kuo-Wei; Huang, Jing-Long] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Yao, Tsung-Chieh; Tu, Yu-Ling; Hua, Man-Chin; Liao, Sui-Ling; Tsai, Ming-Han; Chiu, Chih-Yung; Lai, Shen-Hao; Yeh, Kuo-Wei; Huang, Jing-Long] Chang Gung Mem Hosp, Community Med Res Ctr, Keelung, Taiwan; [Tu, Yu-Ling] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Chang, Su-Wei] Chang Gung Univ, Coll Med, Clin Informat & Med Stat Res Ctr, Taoyuan, Taiwan; [Tsai, Hui-Ju] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Miaoli, Taiwan; [Tsai, Hui-Ju] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Tsai, Hui-Ju] Kaohsiung Univ, Dept Genome Med, Kaohsiung, Taiwan; [Gu, Po-Wen; Ning, Hsian-Chen] Chang Gung Mem Hosp, Dept Lab Med, Taoyuan, Taiwan; [Hua, Man-Chin; Liao, Sui-Ling; Tsai, Ming-Han; Chiu, Chih-Yung] Chang Gung Mem Hosp, Dept Pediat, Keelung, Taiwan; [Lai, Shen-Hao] Chang Gung Mem Hosp, Dept Pediat, Div Pediat Pulmonol, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; National Health Research Institutes - Taiwan; Northwestern University; Feinberg School of Medicine; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Yao, TC (corresponding author), Chang Gung Mem Hosp, Dept Pediat, Div Allergy Asthma & Rheumatol, Taoyuan, Taiwan.	yao@adm.cgmh.org.tw; long@adm.cgmh.org.tw	Yeh, Kuo-Wei/V-3725-2019; Chiu, CY/Q-4238-2019; Tsai, Hui-Ju/E-3937-2010	Huang, Jing-Long/0000-0001-9280-920X; Huang, Jing-Long/0000-0002-3530-7753	National Science Council of Taiwan [NSC 101-2314-B-182A-044, NSC 102-2314-B-182A-048, NSC 101-2314-B-400-009-MY2]; Chang Gung Memorial Hospital [CMRPG260291similar to260293, CMRPG2B0071similar to2B0073, CMRPG4B0031similar to4B0033]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was funded by the National Science Council of Taiwan (grants NSC 101-2314-B-182A-044, NSC 102-2314-B-182A-048, and NSC 101-2314-B-400-009-MY2) and by Chang Gung Memorial Hospital (grants CMRPG260291 similar to 260293, CMRPG2B0071 similar to 2B0073, and CMRPG4B0031 similar to 4B0033). The funders only provided financial support for conducting this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absoud M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022179; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Ballardini N, 2006, ALLERGY, V61, P337, DOI 10.1111/j.1398-9995.2005.00936.x; Bener A, 2012, INT ARCH ALLERGY IMM, V157, P168, DOI 10.1159/000323941; Carpenter TO, 2012, AM J CLIN NUTR, V95, P137, DOI 10.3945/ajcn.111.018721; El Taieb MA, 2013, DERMATITIS, V24, P296, DOI 10.1097/DER.0000000000000010; El-Hajj Fuleihan G, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.4.e53; Emmen JMA, 2012, CLIN CHEM LAB MED, V50, P1969, DOI 10.1515/cclm-2011-0085; Freishtat RJ, 2010, J PEDIATR-US, V156, P948, DOI 10.1016/j.jpeds.2009.12.033; Gonzalez-Gross M, 2012, BRIT J NUTR, V107, P755, DOI 10.1017/S0007114511003527; Gordon CM, 2004, ARCH PEDIAT ADOL MED, V158, P531, DOI 10.1001/archpedi.158.6.531; Henry HL, 2010, J STEROID BIOCHEM, V121, P4, DOI 10.1016/j.jsbmb.2010.05.008; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hollams EM, 2011, EUR RESPIR J, V38, P1320, DOI 10.1183/09031936.00029011; Hypponen E, 2009, ALLERGY, V64, P613, DOI 10.1111/j.1398-9995.2008.01865.x; Looker AC, 2002, BONE, V30, P771, DOI 10.1016/S8756-3282(02)00692-0; Mansbach JM, 2009, PEDIATRICS, V124, P1404, DOI 10.1542/peds.2008-2041; Marwaha RK, 2005, AM J CLIN NUTR, V82, P477, DOI 10.1093/ajcn/82.2.477; McGrath JJ, 2001, MED J AUSTRALIA, V174, P150, DOI 10.5694/j.1326-5377.2001.tb143195.x; Ovesen L, 2003, P NUTR SOC, V62, P813, DOI 10.1079/PNS2003297; Rockell JE, 2005, J NUTR, V135, P2602, DOI 10.1093/jn/135.11.2602; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; SALLIS JF, 1993, CRIT REV FOOD SCI, V33, P403, DOI 10.1080/10408399309527639; SEDRANI SH, 1984, ANN NUTR METAB, V28, P181, DOI 10.1159/000176801; Sharief S, 2011, J ALLERGY CLIN IMMUN, V127, P1195, DOI 10.1016/j.jaci.2011.01.017; Tolppanen AM, 2012, J CLIN ENDOCR METAB, V97, P1202, DOI 10.1210/jc.2011-2516; Tu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080996; Valtuena J, 2013, J NUTR SCI VITAMINOL, V59, P161; Weng FL, 2007, AM J CLIN NUTR, V86, P150, DOI 10.1093/ajcn/86.1.150; Wjst M, 2007, ALLERGY, V62, P1085, DOI 10.1111/j.1398-9995.2007.01437.x; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Yao TC, 2014, ALLERGY, V69, P678, DOI 10.1111/all.12378; Yao TC, 2012, EUR RESPIR J, V39, P378, DOI 10.1183/09031936.00013911; Yao TC, 2011, CLIN EXP ALLERGY, V41, P556, DOI 10.1111/j.1365-2222.2010.03687.x; Yao TC, 2011, J ASTHMA, V48, P503, DOI 10.3109/02770903.2011.576743	36	48	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e99105	10.1371/journal.pone.0099105	http://dx.doi.org/10.1371/journal.pone.0099105			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892430	Green Submitted, Green Published, gold			2022-12-27	WOS:000336911400126
J	Lee, GQ; Dong, W; Mo, T; Knapp, DJHF; Brumme, CJ; Woods, CK; Kanters, S; Yip, B; Harrigan, PR				Lee, Guinevere Q.; Dong, Winnie; Mo, Theresa; Knapp, David J. H. F.; Brumme, Chanson J.; Woods, Conan K.; Kanters, Steve; Yip, Benita; Harrigan, P. Richard			Limited Evolution of Inferred HIV-1 Tropism while Viremia Is Undetectable during Standard HAART Therapy	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; TREATMENT-NAIVE PATIENTS; VIRUS TYPE-1 TROPISM; CORECEPTOR USAGE; TREATED PATIENTS; PROVIRAL DNA; VIRAL LOAD; INFECTED PATIENTS; MERIT TRIAL; MARAVIROC	Background: HIV patients on suppressive antiretroviral therapy have undetectable viremia making it impossible to screen plasma HIV tropism if regimen change is required during suppression. We investigated the prevalence and predictors of tropism switch from CCR5-using ("R5'') to non-CCR5-using ("non-R5'') before and after viral suppression in the initially therapy-naive HOMER cohort from British Columbia, Canada. Methods: We compared pre-therapy and post-suppression viral genotypic tropism in patients who initiated on PI/NNRTI-based antiretroviral regimens between 1996-1999 (n=462). Virologic suppression was defined as having two consecutive viral loads of,500 copies/mL, which was the sensitivity limit of most viral load assays at the time. Viral tropism was inferred by V3-loop-population-sequencing and geno2pheno([coreceptor]) with cutoff at 5.75% false positive rate (FPR). Results: When virologic suppression was defined as two-consecutive viral loads <500 copies/mL, 34 (9%) of the 397 patients with pre-therapy R5-virus switched to non-R5 at viral load rebound after a median of 19 months (IQR 8-41 months) of undetectable viremia. Duration of viral load suppression was not a predictor of switch, but lower CD4 count during suppression (median 400 versus 250 cells/mL) and an increased prevalence of pre-therapy non-R5 HIV by "deep'' sequencing (median 0.2% versus 3.2%) were independently associated with switch (p=0.03 and p<0.0001, respectively). Conclusion: R5-to-non-R5 tropism switches in plasma virus after undetectable viremia were relatively rare events especially among patients with higher CD4 counts during virologic suppression. Our study supports the use of pre-suppression tropism results if maraviroc is being considered during virologic suppression in this subgroup of patients.	[Lee, Guinevere Q.; Dong, Winnie; Mo, Theresa; Knapp, David J. H. F.; Brumme, Chanson J.; Woods, Conan K.; Kanters, Steve; Yip, Benita; Harrigan, P. Richard] BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Lee, Guinevere Q.; Knapp, David J. H. F.; Brumme, Chanson J.; Harrigan, P. Richard] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia	Harrigan, PR (corresponding author), BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada.	prharrigan@cfenet.ubc.ca	Lee, Guinevere Q./D-4436-2017	Lee, Guinevere Q./0000-0002-9412-886X; Brumme, Chanson/0000-0003-2722-5288; Knapp, David JHF/0000-0002-2161-9959	ViiV Healthcare; Vanier Graduate Scholarship from the Canadian Institutes of Health Research (CIHR); CIHR/GSK Research Chair in Clinical Virology	ViiV Healthcare; Vanier Graduate Scholarship from the Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR/GSK Research Chair in Clinical Virology(Canadian Institutes of Health Research (CIHR))	This study was supported by ViiV Healthcare. CJB is supported by a Vanier Graduate Scholarship from the Canadian Institutes of Health Research (CIHR). PRH is supported by CIHR/GSK Research Chair in Clinical Virology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asboe D, 2012, HIV MED, V13, P1, DOI 10.1111/j.1468-1293.2011.00971.x; Banoo S, 2006, NAT REV MICROBIOL, pS20, DOI 10.1038/nrmicro1570; Baroncelli S, 2012, J ANTIMICROB CHEMOTH, V67, P1479, DOI 10.1093/jac/dks055; Bello G, 2007, AIDS RES HUM RETROV, V23, P1242, DOI 10.1089/aid.2007.0074; Bonjoch A, 2013, J ANTIMICROB CHEMOTH, V68, P1382, DOI 10.1093/jac/dks539; Briz V, 2008, J ANTIMICROB CHEMOTH, V61, P405, DOI 10.1093/jac/dkm469; Brumme CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043882; Brumme ZL, 2005, J INFECT DIS, V192, P466, DOI 10.1086/431519; Brumme ZL, 2004, AIDS, V18, pF1, DOI 10.1097/00002030-200403050-00001; Clinicaltrials.gov, 2014, MAR SWITCH COLL STUD; Cooper DA, 2010, J INFECT DIS, V201, P803, DOI 10.1086/650697; Delaugerre C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036673; Delobel P, 2005, JAIDS-J ACQ IMM DEF, V38, P382, DOI 10.1097/01.qai.0000152835.17747.47; DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents, 2013, GUID US ANT AG HIV I, P5; Doyle T, 2012, CLIN INFECT DIS, V54, P724, DOI 10.1093/cid/cir936; Durand CM, 2010, AIDS, V24, P2405, DOI 10.1097/QAD.0b013e32833d8a38; Fatkenheuer G, 2008, NEW ENGL J MED, V359, P1442, DOI 10.1056/NEJMoa0803154; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Harrigan P.R., 2013, CLIN INFECT DIS; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Karlsson AC, 2004, AIDS, V18, P981, DOI 10.1097/00002030-200404300-00005; Knapp DJHF, 2013, J CLIN MICROBIOL, V51, P444, DOI 10.1128/JCM.00739-12; Knapp DJHF, 2012, CLIN INFECT DIS, V54, P1652, DOI 10.1093/cid/cis253; Lee GQ, 2012, HOT TOP HIV OTHER RE, P7, DOI [10.4147/HTHR-120307, DOI 10.4147/HTHR-120307]; McGovern RA, 2009, 12 EUR AIDS C COL GE; McGovern RA, 2012, JAIDS-J ACQ IMM DEF, V61, P279, DOI 10.1097/QAI.0b013e31826249cf; McGovern RA, 2010, AIDS, V24, P2512, DOI 10.1097/QAD.0b013e32833e6cfb; Mens H, 2010, J VIROL, V84, P12971, DOI 10.1128/JVI.00387-10; Monogram Biosciences Inc, 2014, TROF DNA COR TROP AS; Paar C, 2011, J CLIN MICROBIOL, V49, P2697, DOI 10.1128/JCM.00336-11; Parisi SG, 2011, J CLIN MICROBIOL, V49, P1441, DOI 10.1128/JCM.02564-10; Prosperi MCF, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-56; Reeves JD, 2009, J VIRAL ENTRY, V3, P94; Saracino A, 2007, VIRUS RES, V130, P34, DOI 10.1016/j.virusres.2007.05.011; Saracino A, 2009, J MED VIROL, V81, P2036, DOI 10.1002/jmv.21598; Seclen E, 2010, J ANTIMICROB CHEMOTH, V65, P1493, DOI 10.1093/jac/dkq156; Shiu C, 2009, J VIROL, V83, P9731, DOI 10.1128/JVI.00570-09; Sing T, 2007, ANTIVIR THER, V12, P1097; Skrabal K, 2003, AIDS, V17, P809, DOI 10.1097/00002030-200304110-00005; Soriano V, 2009, AIDS, V23, P2377, DOI 10.1097/QAD.0b013e328332d32d; Soulie C, 2007, AIDS, V21, P2243, DOI 10.1097/QAD.0b013e3282f0e3d0; Soulie C, 2011, AIDS, V25, P537, DOI 10.1097/QAD.0b013e32834345d3; Soulie C, 2010, J ANTIMICROB CHEMOTH, V65, P749, DOI 10.1093/jac/dkq029; Strizki JM, 2010, ANTIVIR THER, V15, pA18; Swenson LC, 2009, 12 EUR AIDS C COL GE, V80; Swenson LC, 2011, CLIN INFECT DIS, V53, P732, DOI 10.1093/cid/cir493; Swenson LC, 2011, J INFECT DIS, V203, P237, DOI 10.1093/infdis/jiq030; Swenson LC, 2010, JAIDS-J ACQ IMM DEF, V54, P506, DOI 10.1097/QAI.0b013e3181d0558f; Tobin NH, 2005, J VIROL, V79, P9625, DOI 10.1128/JVI.79.15.9625-9634.2005; Toma J, 2010, 17 C RETR OPP INF CR; Vandekerckhove LPR, 2011, LANCET INFECT DIS, V11, P394, DOI 10.1016/S1473-3099(10)70319-4; Verhofstede C, 2011, HIV MED, V12, P544, DOI 10.1111/j.1468-1293.2011.00922.x; Vitiello P, 2012, INTERVIROLOGY, V55, P172, DOI 10.1159/000332023; Wasmuth JC, 2012, EXPERT OPIN DRUG SAF, V11, P161, DOI 10.1517/14740338.2012.640670; Waters L, 2009, 16 C RETR OPP INF CR, p439a; Wilkin TJ, 2011, CLIN INFECT DIS, V52, P925, DOI 10.1093/cid/cir072; Woods CK, 2012, J CLIN MICROBIOL, V50, P1936, DOI 10.1128/JCM.06689-11	57	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99000	10.1371/journal.pone.0099000	http://dx.doi.org/10.1371/journal.pone.0099000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905411	gold, Green Published, Green Submitted			2022-12-27	WOS:000341869000087
J	Corson, TW; Samuels, BC; Wenzel, AA; Geary, AJ; Riley, AA; McCarthy, BP; Hanenberg, H; Bailey, BJ; Rogers, PI; Pollok, KE; Rajashekhar, G; Territo, PR				Corson, Timothy W.; Samuels, Brian C.; Wenzel, Andrea A.; Geary, Anna J.; Riley, Amanda A.; McCarthy, Brian P.; Hanenberg, Helmut; Bailey, Barbara J.; Rogers, Pamela I.; Pollok, Karen E.; Rajashekhar, Gangaraju; Territo, Paul R.			Multimodality Imaging Methods for Assessing Retinoblastoma Orthotopic Xenograft Growth and Development	PLOS ONE			English	Article							FIREFLY LUCIFERASE; MOUSE MODEL; PRECLINICAL MODELS; INTRACELLULAR PH; GENE-EXPRESSION; REPORTER GENE; QUANTUM YIELD; GENOMIC GAIN; CELL-LINE; IN-VITRO	Genomic studies of the pediatric ocular tumor retinoblastoma are paving the way for development of targeted therapies. Robust model systems such as orthotopic xenografts are necessary for testing such therapeutics. One system involves bioluminescence imaging of luciferase-expressing human retinoblastoma cells injected into the vitreous of newborn rat eyes. Although used for several drug studies, the spatial and temporal development of tumors in this model has not been documented. Here, we present a new model to allow analysis of average luciferin flux ((F) over bar) through the tumor, a more biologically relevant parameter than peak bioluminescence as traditionally measured. Moreover, we monitored the spatial development of xenografts in the living eye. We engineered Y79 retinoblastoma cells to express a lentivirally-delivered enhanced green fluorescent protein-luciferase fusion protein. In intravitreal xenografts, we assayed bioluminescence and computed (F) over bar, as well as documented tumor growth by intraocular optical coherence tomography (OCT), brightfield, and fluorescence imaging. In vivo bioluminescence, ex vivo tumor size, and ex vivo fluorescent signal were all highly correlated in orthotopic xenografts. By OCT, xenografts were dense and highly vascularized, with well-defined edges. Small tumors preferentially sat atop the optic nerve head; this morphology was confirmed on histological examination. In vivo, F in xenografts showed a plateau effect as tumors became bounded by the dimensions of the eye. The combination of (F) over bar modeling and in vivo intraocular imaging allows both quantitative and high-resolution, non-invasive spatial analysis of this retinoblastoma model. This technique will be applied to other cell lines and experimental therapeutic trials in the future.	[Corson, Timothy W.; Samuels, Brian C.; Wenzel, Andrea A.; Geary, Anna J.; Rajashekhar, Gangaraju] Indiana Univ Sch Med, Dept Ophthalmol, Eugene & Marilyn Glick Eye Inst, Indianapolis, IN 46202 USA; [Corson, Timothy W.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Corson, Timothy W.; Pollok, Karen E.] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Corson, Timothy W.; Hanenberg, Helmut; Pollok, Karen E.] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA; [Samuels, Brian C.] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Samuels, Brian C.; Rajashekhar, Gangaraju] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Geary, Anna J.] Eastern Univ, St Davids, PA USA; [Riley, Amanda A.; McCarthy, Brian P.; Territo, Paul R.] Indiana Univ Sch Med, Dept Radiol & Imaging Sci, Indianapolis, IN 46202 USA; [Hanenberg, Helmut] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Hanenberg, Helmut; Bailey, Barbara J.; Pollok, Karen E.] Indiana Univ Hlth, Riley Hosp Children, Sect Pediat Hematol Oncol, Herman B Wells Ctr Pediat Res,Dept Pediat, Indianapolis, IN USA; [Rogers, Pamela I.; Rajashekhar, Gangaraju] Indiana Univ Sch Med, Indiana Ctr Vasc Biol & Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; James Whitcomb Riley Hospital Children; Indiana University System; Indiana University Bloomington	Corson, TW (corresponding author), Indiana Univ Sch Med, Dept Ophthalmol, Eugene & Marilyn Glick Eye Inst, Indianapolis, IN 46202 USA.	tcorson@iupui.edu	Gangaraju, Rajashekhar/I-7852-2019; Corson, Timothy W./B-6851-2009	Gangaraju, Rajashekhar/0000-0002-6664-8286; Corson, Timothy W./0000-0002-1402-7875; Samuels, Brian/0000-0003-3860-6879	Indiana Clinical and Translational Sciences Institute; National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award [TR000006, TR000163]; Alcon Research Institute Young Investigator Award;  [R01 CA138798]; NATIONAL CANCER INSTITUTE [P30CA082709, R01CA138798] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, UL1TR001108] Funding Source: NIH RePORTER	Indiana Clinical and Translational Sciences Institute; National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award; Alcon Research Institute Young Investigator Award; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by the Indiana Clinical and Translational Sciences Institute funded, in part by the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award (TR000006 and TR000163; TWC, BCS and GR), by R01 CA138798 (BJB and KEP) and by an Alcon Research Institute Young Investigator Award (TWC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando Y, 2008, NAT PHOTONICS, V2, P44, DOI 10.1038/nphoton.2007.251; Badr CE, 2011, TRENDS BIOTECHNOL, V29, P624, DOI 10.1016/j.tibtech.2011.06.010; Benavente CA, 2013, ONCOTARGET, V4, P844, DOI 10.18632/oncotarget.1051; Bhaumik S, 2002, P NATL ACAD SCI USA, V99, P377, DOI 10.1073/pnas.012611099; Conkrite K, 2011, GENE DEV, V25, P1734, DOI 10.1101/gad.17027411; Corson TW, 2005, ONCOGENE, V24, P4741, DOI 10.1038/sj.onc.1208641; Dalgard CL, 2008, CLIN CANCER RES, V14, P3113, DOI 10.1158/1078-0432.CCR-07-4836; DELUCA M, 1984, BIOCHEM BIOPH RES CO, V123, P764, DOI 10.1016/0006-291X(84)90295-X; Dimaras H, 2012, LANCET, V379, P1436, DOI 10.1016/S0140-6736(11)61137-9; Dyer MA, 2005, PLOS MED, V2, P971, DOI 10.1371/journal.pmed.0020332; Farnsworth RH, 2014, ONCOGENE, V33, P3496, DOI 10.1038/onc.2013.304; Fraga H, 2006, CHEMBIOCHEM, V7, P929, DOI 10.1002/cbic.200500443; GALLIE BL, 1977, INVEST OPHTH VIS SCI, V16, P256; Hirokawa K, 2002, BBA-PROTEIN STRUCT M, V1597, P271, DOI 10.1016/S0167-4838(02)00302-3; Ignowski JM, 2004, BIOTECHNOL BIOENG, V86, P827, DOI 10.1002/bit.20059; Inoue Y, 2010, INT J BIOMED IMAGING, V2010, DOI 10.1155/2010/471408; Ji XD, 2009, INVEST OPHTH VIS SCI, V50, P5544, DOI 10.1167/iovs.08-3258; Ji XD, 2009, EXP EYE RES, V89, P193, DOI 10.1016/j.exer.2009.03.007; Jo DH, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-71; Kulkarni AD, 2009, BRIT J OPHTHALMOL, V93, P1105, DOI 10.1136/bjo.2008.152843; Laurie NA, 2005, CLIN CANCER RES, V11, P7569, DOI 10.1158/1078-0432.CCR-05-0849; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; Lembert N, 1996, BIOCHEM J, V317, P273, DOI 10.1042/bj3170273; LEMBERT N, 1995, BIOCHEM J, V305, P929, DOI 10.1042/bj3050929; Leurs C, 2003, HUM GENE THER, V14, P509, DOI 10.1089/104303403764539305; Li JH, 1997, RADIOTHER ONCOL, V42, P69, DOI 10.1016/S0167-8140(96)01868-3; Marchong MN, 2004, MOL CANCER RES, V2, P495; MASSOF RW, 1972, VISION RES, V12, P793, DOI 10.1016/0042-6989(72)90005-3; MCELROY WD, 1969, PHOTOCHEM PHOTOBIOL, V10, P153, DOI 10.1111/j.1751-1097.1969.tb05676.x; Mohr PJ, 2012, CODATA RECOMMENDED V; Moriyama EH, 2008, PHOTOCH PHOTOBIO SCI, V7, P675, DOI 10.1039/b719231b; Nassr M, 2010, INVEST OPHTH VIS SCI, V51, P3813, DOI 10.1167/iovs.09-5042; Nemeth KM, 2011, CANCER-AM CANCER SOC, V117, P421, DOI 10.1002/cncr.25574; Orlic M, 2006, GENE CHROMOSOME CANC, V45, P72, DOI 10.1002/gcc.20263; Pacal M, 2006, CURR MOL MED, V6, P759; Paroo Z, 2004, MOL IMAGING, V3, P117, DOI 10.1162/1535350041464865; PLANT PJ, 1968, BIOCHEM BIOPH RES CO, V31, P98, DOI 10.1016/0006-291X(68)90036-3; REID TW, 1974, J NATL CANCER I, V53, P347, DOI 10.1093/jnci/53.2.347; Ruggeri M, 2007, INVEST OPHTH VIS SCI, V48, P1808, DOI 10.1167/iovs.06-0815; Ruggeri M, 2008, J INNOV OPT HEAL SCI, V1, P17, DOI 10.1142/S1793545808000066; Ruggeri M, 2009, OPT EXPRESS, V17, P4074, DOI 10.1364/OE.17.004074; Rushlow DE, 2013, LANCET ONCOL, V14, P327, DOI 10.1016/S1470-2045(13)70045-7; SELIGER HH, 1960, ARCH BIOCHEM BIOPHYS, V88, P136, DOI 10.1016/0003-9861(60)90208-3; SELIGER HH, 1961, P NATL ACAD SCI USA, V47, P1129, DOI 10.1073/pnas.47.8.1129; Shih CS, 2009, NEUROMOL MED, V11, P43, DOI 10.1007/s12017-009-8059-0; Sin CF, 2001, PROCEEDINGS OF 2001 INTERNATIONAL SYMPOSIUM ON INTELLIGENT MULTIMEDIA, VIDEO AND SPEECH PROCESSING, P283, DOI 10.1109/ISIMP.2001.925389; Theriault BL, 2014, CLIN EXP OPHTHALMOL, V42, P33, DOI 10.1111/ceo.12132; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Urbanchek MG, 2001, J GERONTOL A-BIOL, V56, pB191, DOI 10.1093/gerona/56.5.B191; Vooijs M, 2002, CANCER RES, V62, P1862; Wetterwald A, 2002, AM J PATHOL, V160, P1143, DOI 10.1016/S0002-9440(10)64934-6; Xin GH, 2012, INT J OPHTHALMOL-CHI, V5, P440, DOI 10.3980/j.issn.2222-3959.2012.04.07; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733	53	15	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99036	10.1371/journal.pone.0099036	http://dx.doi.org/10.1371/journal.pone.0099036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901248	Green Submitted, Green Published, gold			2022-12-27	WOS:000336841400090
J	Fiori, M; Antonietti, JP; Mikolajczak, M; Luminet, O; Hansenne, M; Rossier, J				Fiori, Marina; Antonietti, Jean-Philippe; Mikolajczak, Moira; Luminet, Olivier; Hansenne, Michel; Rossier, Jerome			What Is the Ability Emotional Intelligence Test (MSCEIT) Good for? An Evaluation Using Item Response Theory	PLOS ONE			English	Article							VALIDITY	The ability approach has been indicated as promising for advancing research in emotional intelligence (EI). However, there is scarcity of tests measuring EI as a form of intelligence. The Mayer Salovey Caruso Emotional Intelligence Test, or MSCEIT, is among the few available and the most widespread measure of EI as an ability. This implies that conclusions about the value of EI as a meaningful construct and about its utility in predicting various outcomes mainly rely on the properties of this test. We tested whether individuals who have the highest probability of choosing the most correct response on any item of the test are also those who have the strongest EI ability. Results showed that this is not the case for most items: The answer indicated by experts as the most correct in several cases was not associated with the highest ability; furthermore, items appeared too easy to challenge individuals high in EI. Overall results suggest that the MSCEIT is best suited to discriminate persons at the low end of the trait. Results are discussed in light of applied and theoretical considerations.	[Fiori, Marina] Univ Lausanne, Fac Business & Econ, Dept Org Behav, Lausanne, Switzerland; [Antonietti, Jean-Philippe; Rossier, Jerome] Univ Lausanne, Fac Social & Polit Sci, Inst Psychol, Lausanne, Switzerland; [Mikolajczak, Moira; Luminet, Olivier] Catholic Univ Louvain, Dept Psychol, B-3000 Louvain, Belgium; [Hansenne, Michel] Univ Liege, Dept Psychol, Liege, Belgium	University of Lausanne; University of Lausanne; Universite Catholique Louvain; University of Liege	Fiori, M (corresponding author), Univ Lausanne, Fac Business & Econ, Dept Org Behav, Lausanne, Switzerland.	Marina.Fiori@unil.ch	Rossier, Jérôme/A-3494-2009; Hansenne, Michel/D-2138-2015; Fiori, Marina/J-6238-2012; Fiori, Marina/K-9563-2019	Rossier, Jérôme/0000-0002-9924-3672; Hansenne, Michel/0000-0002-3478-4953; Fiori, Marina/0000-0003-2004-7458; Mikolajczak, Moira/0000-0002-7333-1578				Antonakis J, 2010, IND ORGAN PSYCHOL-US, V3, P165, DOI 10.1111/j.1754-9434.2010.01219.x; BOCK RD, 1982, APPL PSYCH MEAS, V6, P431, DOI 10.1177/014662168200600405; Cooper A, 2010, J PERS ASSESS, V92, P449, DOI 10.1080/00223891.2010.497426; Farrelly D, 2007, COGNITION EMOTION, V21, P1043, DOI 10.1080/02699930601069404; Fiori M, 2012, INTELLIGENCE, V40, P245, DOI 10.1016/j.intell.2012.02.004; Fiori M, 2011, PERS INDIV DIFFER, V50, P329, DOI 10.1016/j.paid.2010.10.010; Larsen JT, 2009, COGNITION EMOTION, V23, P453, DOI 10.1080/02699930801994054; MacCann C., 2003, INT J ORG ANAL, V11, P247, DOI DOI 10.1108/EB028975; Matthews G, 2004, PSYCHOL INQ, V15, P179, DOI 10.1207/s15327965pli1503_01; Maul A, 2012, EMOT REV, V4, P394, DOI 10.1177/1754073912445811; Maul A, 2012, COGNITION EMOTION, V26, P503, DOI 10.1080/02699931.2011.588690; Mayer J., 2002, MAYER SALOVEY CARUSO; Mayer J. D., 1997, EMOTIONAL DEV EMOTIO, P3, DOI DOI 10.1177/1066480710387486; Mayer JD, 1999, INTELLIGENCE, V27, P267, DOI 10.1016/S0160-2896(99)00016-1; Mayer JD, 2004, PSYCHOL INQ, V15, P197, DOI 10.1207/s15327965pli1503_02; Mayer JD, 2008, AM PSYCHOL, V63, P503, DOI 10.1037/0003-066X.63.6.503; Mayer JD, 2001, EMOTION, V1, P232, DOI 10.1037//1528-3542.1.3.232; Mayer JD, 2012, EMOT REV, V4, P403, DOI 10.1177/1754073912445815; Mayer JD, 2003, EMOTION, V3, P97, DOI 10.1037/1528-3542.3.1.97; Petrides K. V., 2011, WILEY BLACKWELL HDB, P656, DOI [DOI 10.1002/9781444343120.CH25, 10.1002/9781444343120.ch25]; Petrides KV, 2001, EUR J PERSONALITY, V15, P425, DOI 10.1002/per.416; Petrides KV, 2009, TECHNICAL MANUAL TRA; Rizopoulos D., 2006, J STAT SOFTW, V17, P1, DOI DOI 10.18637/JSS.V017.I05; Roberts RD, 2006, EMOTION, V6, P663, DOI 10.1037/1528-3542.6.4.663; Roberts RD, 2010, SOC PERSONAL PSYCHOL, V4, P821, DOI 10.1111/j.1751-9004.2010.00277.x; Roberts RJ, 2001, J FISH DIS, V24, P1; Salovey P., 1990, IMAG COGN PERS, P185, DOI [10.2190/dugg-p24--52wk-6cdg, DOI 10.2190/DUGG-P24E-52WK-6CDG, 10.2190/DUGG-P24E-52WK-6CDG]; Schulte MJ, 2004, PERS INDIV DIFFER, V37, P1059, DOI 10.1016/j.paid.2003.11.014; Wu M.L., 1997, THESIS U MELBOURNE; Wu M. L., 1997, CONQUEST MULTIASPECT; Zinbarg RE, 2006, APPL PSYCH MEAS, V30, P121, DOI 10.1177/0146621605278814	31	53	54	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98827	10.1371/journal.pone.0098827	http://dx.doi.org/10.1371/journal.pone.0098827			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4NF	24901541	Green Published, gold			2022-12-27	WOS:000336841400058
J	Jung, KS; Kim, BK; Kim, SU; Chon, YE; Cheon, KH; Kim, SB; Lee, SH; Ahn, SS; Park, JY; Kim, DY; Ahn, SH; Park, YN; Han, KH				Jung, Kyu Sik; Kim, Beom Kyung; Kim, Seung Up; Chon, Young Eun; Cheon, Kyung Hyun; Kim, Sung Bae; Lee, Sang Hoon; Ahn, Sung Soo; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Park, Young Nyun; Han, Kwang-Hyub			Factors Affecting the Accuracy of Controlled Attenuation Parameter (CAP) in Assessing Hepatic Steatosis in Patients with Chronic Liver Disease	PLOS ONE			English	Article							TRANSIENT ELASTOGRAPHY; NONINVASIVE ASSESSMENT; STIFFNESS; DIAGNOSIS; FIBROSIS; METAANALYSIS; VALIDATION; BIOPSY	Background & Aims: Controlled attenuation parameter (CAP) can measure hepatic steatosis. However, factors affecting its accuracy have not been described yet. This study investigated predictors of discordance between liver biopsy (LB) and CAP. Methods: A total of 161 consecutive patients with chronic liver disease who underwent LB and CAP were enrolled prospectively. Histological steatosis was graded as S0 (<5%), S1 (5-33%), S2 (34-66%), and S3 (>66% of hepatocytes). Cutoff CAP values were calculated from our cohort (250, 301, and 325 dB/m for >= S1, >= S2, and S3). Discordance was defined as a discrepancy of at least two steatosis stages between LB and CAP. Results: The median age (102 males and 59 females) was 49 years. Repartition of histological steatosis was as follows; S0 26.1% (n = 42), S1 49.7% (n = 80), S2 20.5% (n = 33), and S3 3.7% (n = 6). In multivariate linear regression analysis, CAP value was independently associated with steatosis grade along with body mass index (BMI) and interquartile range/median of CAP value (IQR/MCAP) (all P<0.05). Discordance was identified in 13 (8.1%) patients. In multivariate analysis, histological S3 (odd ratio [OR], 9.573; 95% confidence interval [CI], 1.207-75.931; P = 0.033) and CAP value (OR, 1.020; 95% CI, 1.006-1.034; P = 0.006) were significantly associated with discordance, when adjusting for BMI, IQR/MCAP, and necroinflammation, reflected by histological activity or ALT level. Conclusions: Patients with high grade steatosis or high CAP values have a higher risk of discordance between LB and CAP. Further studies are needed to improve the accuracy of CAP interpretation, especially in patients with higher CAP values.	[Jung, Kyu Sik; Kim, Beom Kyung; Kim, Seung Up; Chon, Young Eun; Cheon, Kyung Hyun; Kim, Sung Bae; Lee, Sang Hoon; Ahn, Sung Soo; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Beom Kyung; Kim, Seung Up; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub] Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea; [Park, Young Nyun] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Kim, Beom Kyung; Kim, Seung Up; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub] Liver Cirrhosis Clin Res Ctr, Seoul, South Korea; [Ahn, Sang Hoon; Han, Kwang-Hyub] Brain Korea 21 Project Med Sci, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, BK (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	beomkkim@yuhs.ac; ksukorea@yuhs.ac	Ahn, Sung Soo/AAB-4945-2021; Park, Jun Yong/H-7127-2019	Ahn, Sung Soo/0000-0002-9002-9880; Park, Young Nyun/0000-0003-0357-7967; CHUN, KYEONG-HYEON/0000-0002-7798-658X; Han, Kwang-Hyub/0000-0003-3960-6539; Ahn, Sang Hoon/0000-0002-3629-4624; Park, Jun Yong/0000-0001-6324-2224; Kim, Beom Kyung/0000-0002-5363-2496; Lee, Sang Hoon/0000-0002-3619-4340; Kim, Seung Up/0000-0002-9658-8050	Liver Cirrhosis Clinical Research Center; Korea Healthcare technology R & D project, Ministry of Health and Welfare, Republic of Korea [A102065]; Yonsei Liver Blood Bank (YLBB); sanofi-aventis Korea	Liver Cirrhosis Clinical Research Center; Korea Healthcare technology R & D project, Ministry of Health and Welfare, Republic of Korea; Yonsei Liver Blood Bank (YLBB); sanofi-aventis Korea(Sanofi-Aventis)	This study was supported by the Liver Cirrhosis Clinical Research Center, in part by a grant from the Korea Healthcare technology R & D project, Ministry of Health and Welfare, Republic of Korea (no. A102065), and by the Yonsei Liver Blood Bank (YLBB), in part by a grant from sanofi-aventis Korea. BioPredictive kindly provided the complimentary service for calculation of FT score. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Arena U, 2008, HEPATOLOGY, V47, P380, DOI 10.1002/hep.22007; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Boursier J, 2012, LIVER INT, V32, P875, DOI 10.1111/j.1478-3231.2012.02824.x; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Chon YE, 2014, LIVER INT, V34, P102, DOI 10.1111/liv.12282; Chon YE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044930; de Ledinghen V, 2012, LIVER INT, V32, P911, DOI 10.1111/j.1478-3231.2012.02820.x; de Meijer VE, 2010, BRIT J SURG, V97, P1331, DOI 10.1002/bjs.7194; Dowman JK, 2011, ALIMENT PHARM THER, V33, P525, DOI 10.1111/j.1365-2036.2010.04556.x; El-Badry AM, 2009, ANN SURG, V250, P691, DOI 10.1097/SLA.0b013e3181bcd6dd; Kim SU, 2010, ALIMENT PHARM THER, V32, P498, DOI 10.1111/j.1365-2036.2010.04353.x; Kim SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032233; Kim SU, 2010, J CLIN GASTROENTEROL, V44, P66, DOI 10.1097/MCG.0b013e3181a95c7f; Kim SU, 2009, LIVER INT, V29, P810, DOI 10.1111/j.1478-3231.2008.01894.x; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kumar M, 2013, J GASTROEN HEPATOL, V21, P12134; Leandro G, 2006, GASTROENTEROLOGY, V130, P1636, DOI 10.1053/j.gastro.2006.03.014; Lucidarme D, 2009, HEPATOLOGY, V49, P1083, DOI 10.1002/hep.22748; Mederacke I, 2009, LIVER INT, V29, P1500, DOI 10.1111/j.1478-3231.2009.02100.x; Myers RP, 2012, LIVER INT, V32, P902, DOI 10.1111/j.1478-3231.2012.02781.x; Myers RP, 2010, LIVER INT, V30, P1471, DOI 10.1111/j.1478-3231.2010.02331.x; Oh MK, 2008, ALIMENT PHARM THER, V28, P503, DOI 10.1111/j.1365-2036.2008.03752.x; Ong JP, 2008, J HEPATOL, V49, P608, DOI 10.1016/j.jhep.2008.06.018; Poynard T, 2003, HEPATOLOGY, V38, P75, DOI 10.1053/jhep.2003.50267; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Ratziu V, 2002, HEPATOLOGY, V35, P1485, DOI 10.1053/jhep.2002.33324; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Sasso M, 2012, J VIRAL HEPATITIS, V19, P244, DOI 10.1111/j.1365-2893.2011.01534.x; Sasso M, 2010, ULTRASOUND MED BIOL, V36, P1825, DOI 10.1016/j.ultrasmedbio.2010.07.005; Schwenzer NF, 2009, J HEPATOL, V51, P433, DOI 10.1016/j.jhep.2009.05.023; Spitzer AL, 2010, LIVER TRANSPLANT, V16, P874, DOI 10.1002/lt.22085; Wong GLH, 2009, CLIN GASTROENTEROL H, V7, P227, DOI 10.1016/j.cgh.2008.10.023; Yilmaz Y, 2012, ALIMENT PHARM THER, V36, P815, DOI 10.1111/apt.12046	34	32	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98689	10.1371/journal.pone.0098689	http://dx.doi.org/10.1371/journal.pone.0098689			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901649	Green Published, Green Submitted, gold			2022-12-27	WOS:000336841400045
J	Kim, SH; Oh, SJ				Kim, Sung Han; Oh, Seung-June			Nonspecific Genitourinary Pain Improves after Prostatectomy Using Holmium Laser Enucleation of Prostate in Patients with Benign Prostatic Hyperplasia: A Prospective Study	PLOS ONE			English	Article							URINARY-TRACT SYMPTOMS; BLADDER OUTLET OBSTRUCTION; TRANSURETHRAL RESECTION; DETRUSOR OVERACTIVITY; MEN; NOCTURIA; BPH; ASSOCIATION; INDEX; SCORE	Objective: To investigate changes in nonspecific genitourinary discomfort or pain (GUDP) before and after holmium laser enucleation of prostate (HoLEP). GUDP associated with lower urinary tract symptoms (LUTS) is a common complaint among benign prostatic hyperplasia (BPH) patients, but very little is known about this clinical entity. Methods: From February 2010 to August 2011, 100 HoLEP patients with complete clinical data at a single institution were enrolled in the study to analyze the degree of GUDP with a visual analog scale (VAS) from 0 to 10 points at baseline and at 3 and 6 months postoperatively, and to investigate any relationships between GUDP and urodynamics, uroflowmetry, and scores from the International Prostate Symptom Score (IPSS) questionnaire. Results: Fifty-six patients had LUTS only, while the remaining 44 had both LUTS and GUDP. Pain was located in the suprapubic (42.0%), perineal/penile (33.0%), back (17.0%), and perianal (8.0%) regions. During the post-operative period, at six months, the VAS, IPSS, peak flow rate and post-void residual volume had improved significantly in 44 GUDP patients (p, 0.010). GUDP had completely resolved in 40 (90.9%) patients and had decreased in four (9.1%) patients, while seven (12.5%) patients developed GUDP with voiding in the urethral and perineal areas by the third month postoperatively. When compared to patients with complete resolution, those with persistent GUDP were found to have a significantly higher preoperative presence of bladder outlet obstruction (BOO) as an independent risk factor (OR 6.173, 95% CI 1.132-1.323). Conclusion: Both GUDP and LUTS improved significantly after HoLEP. Patients with significant preoperative BOO tended to have persistent GUDP after surgery.	[Kim, Sung Han] Natl Canc Ctr, Prostate Canc Ctr, Dept Urol, Goyang, South Korea; [Oh, Seung-June] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Urol, Seoul, South Korea	National Cancer Center - Korea (NCC); Seoul National University (SNU); Seoul National University Hospital	Oh, SJ (corresponding author), Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Urol, Seoul, South Korea.	sjo@snu.ac.kr	Oh, Seung-June/D-6015-2012	Oh, Seung-June/0000-0002-0322-3539; KIM, Sung Han/0000-0002-1689-5203				Badia X, 2001, UROLOGY, V57, P71, DOI 10.1016/S0090-4295(00)00894-3; Cho MC, 2011, NEUROUROL URODYNAM, V30, P1343, DOI 10.1002/nau.21050; Fall M, 2010, EUR UROL, V57, P35, DOI 10.1016/j.eururo.2009.08.020; Fujimura T, 2012, BJU INT, V109, P1512, DOI 10.1111/j.1464-410X.2011.10445.x; Gourova LW, 2006, BJU INT, V97, P528, DOI 10.1111/j.1464-410X.2006.06029.x; Hanno P, 2012, NEUROUROL URODYNAM, V31, P375, DOI 10.1002/nau.22202; Jeong HJ, 2012, INT NEUROUROL J, V16, P175, DOI 10.5213/inj.2012.16.4.175; KAPLAN SA, 1994, J UROLOGY, V152, P2063, DOI 10.1016/S0022-5347(17)32309-1; Kim DS, 2013, ARCH PHYS MED REHAB, V94, P930, DOI 10.1016/j.apmr.2012.12.011; Kingery L, 2012, INT J CLIN PRACT, V66, P883, DOI 10.1111/j.1742-1241.2012.02960.x; Matthiesen TB, 2003, APMIS, V111, P59; Metcalfe Charles, 2011, Curr Urol Rep, V12, P265, DOI 10.1007/s11934-011-0193-1; Nakamura M, 2012, AGING MALE, V15, P111, DOI 10.3109/13685538.2011.646342; Oh MM, 2011, UROLOGY, V77, P167, DOI 10.1016/j.urology.2010.05.034; Peters KM, 2008, UROLOGY, V71, P634, DOI 10.1016/j.urology.2007.11.013; Pinto R, 2013, J UROLOGY, V189, P548, DOI 10.1016/j.juro.2012.09.027; Porru D, 2002, EUR UROL, V41, P246, DOI 10.1016/S0302-2838(02)00021-0; Roehrborn CG, 2011, MED CLIN N AM, V95, P87, DOI 10.1016/j.mcna.2010.08.013; Shin JH, 2011, CURR PAIN HEADACHE R, V15, P377, DOI 10.1007/s11916-011-0204-4; Tanaka Y, 2006, INT J UROL, V13, P1398, DOI 10.1111/j.1442-2042.2006.01589.x; van Doorn B, 2012, MATURITAS, V71, P8, DOI 10.1016/j.maturitas.2011.10.007; van Melick HHE, 2003, J UROLOGY, V169, P1411, DOI 10.1097/01.ju.0000054657.59200.97; Yoshimura K, 2004, INT J UROL, V11, P282, DOI 10.1111/j.1442-2042.2004.00791.x	23	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98979	10.1371/journal.pone.0098979	http://dx.doi.org/10.1371/journal.pone.0098979			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901224	Green Published, Green Submitted, gold			2022-12-27	WOS:000336841400083
J	Merino, AM; Dugast, AS; Wilson, CM; Goepfert, PA; Alter, G; Kaslow, RA; Tang, JM				Merino, Aimee M.; Dugast, Anne-Sophie; Wilson, Craig M.; Goepfert, Paul A.; Alter, Galit; Kaslow, Richard A.; Tang, Jianming			KIR2DS4 Promotes HIV-1 Pathogenesis: New Evidence from Analyses of Immunogenetic Data and Natural Killer Cell Function	PLOS ONE			English	Article							VIRUS TYPE-1 INFECTION; KIR3DL1(+) NK CELLS; DISEASE PROGRESSION; RECEPTOR; ACTIVATION; INNATE; REPLICATION; RECOGNITION; INHIBITION; IMMUNITY	Background: KIR2DS4 gene variants encode full-length and truncated protein products, with only the former serving as membrane-bound receptors to activate natural killer (NK) cells. We have previously shown that full-length KIR2DS4 was associated with relatively high viral load and accelerated heterosexual HIV-1 transmission. Our objective here was to provide confirmatory data and to offer new insights about the potential mechanisms. Methodology/Principal Findings: Mixed models for repeated (longitudinal) outcome measurements on 207 HIV-1 seropositive American youth revealed an association of full-length KIR2DS4 with relatively high viral load and low CD4(+) T-cell count (p < 0.01 for both). Depending on KIR2DS4 expression (presence or absence) on cell surface, NK cells from 43 individuals with untreated, chronic HIV-1 infection often differed in functional properties, including degranulation and secretion of IFN-gamma and MIP-1 beta. In particular, polyfunctional NK cells were enriched in the KIR2DS4-positive subset. Conclusions/Significance: Full-length KIR2DS4 promotes HIV-1 pathogenesis during chronic infection, probably through the maintenance of an excessively pro-inflammatory state.	[Merino, Aimee M.; Goepfert, Paul A.; Kaslow, Richard A.; Tang, Jianming] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Merino, Aimee M.; Goepfert, Paul A.; Tang, Jianming] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Dugast, Anne-Sophie; Alter, Galit] Ragon Inst MGH MIT & Harvard, Boston, MA USA; [Wilson, Craig M.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Alabama System; University of Alabama Birmingham	Tang, JM (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.	jtang@uab.edu	Tang, Jianming "James"/O-4980-2019; Dugast, AnneSophie/L-9541-2015; Merino, Aimee/GSD-7651-2022	Tang, Jianming "James"/0000-0003-0137-7486; Merino, Aimee/0000-0003-4433-0127; Wilson, Craig/0000-0001-6869-1053	National Institute of Allergy and Infectious Diseases (NIAID) [AI071906]; National Institute of Child Health and Human Development [U01-HD32830]; NIAID; National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD032830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071906, R01AI064060] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research summarized in this paper was funded by an R01 grant (AI071906) from the National Institute of Allergy and Infectious Diseases (NIAID) to RAK and JT. The Reaching for Excellence in Adolescent Care and Health (REACH) cohort was supported primarily by the National Institute of Child Health and Human Development (U01-HD32830), with supplemental funding from the NIAID, the National Institute on Drug Abuse (NIDA), and the National Institute of Mental Health (NIMH). The funders have no role in study design, data collection, data analysis, decision to publish, or preparation of the manuscript.	Alter G, 2007, J EXP MED, V204, P3027, DOI 10.1084/jem.20070695; Alter G, 2011, NATURE, V476, P96, DOI 10.1038/nature10237; Alter G, 2009, J VIROL, V83, P6798, DOI 10.1128/JVI.00256-09; Biassoni R, 1996, J EXP MED, V183, P645, DOI 10.1084/jem.183.2.645; Christensen MD, 2000, SCAND J IMMUNOL, V51, P557; Chwae YJ, 2002, J IMMUNOL, V169, P3726, DOI 10.4049/jimmunol.169.7.3726; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Cooper MA, 2009, EMBO REP, V10, P1103, DOI 10.1038/embor.2009.203; Eller MA, 2011, J VIROL, V85, P4802, DOI 10.1128/JVI.00111-11; Graef T, 2009, J EXP MED, V206, P2557, DOI 10.1084/jem.20091010; Holland CA, 2000, AIDS RES HUM RETROV, V16, P959, DOI 10.1089/08892220050058371; Horowitz A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006702; Jiang YJ, 2013, J CLIN IMMUNOL, V33, P1376, DOI 10.1007/s10875-013-9930-1; Kamya P, 2011, J VIROL, V85, P5949, DOI 10.1128/JVI.02652-10; Katz G, 2004, J IMMUNOL, V173, P1819, DOI 10.4049/jimmunol.173.3.1819; Katz G, 2001, J IMMUNOL, V166, P7260, DOI 10.4049/jimmunol.166.12.7260; Liovat AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046143; Liu Hong, 2004, In Silico Biology, V4, P489; Long BR, 2008, J VIROL, V82, P4785, DOI 10.1128/JVI.02449-07; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Maxwell LD, 2002, TISSUE ANTIGENS, V60, P254, DOI 10.1034/j.1399-0039.2002.600307.x; McErlean C, 2010, IMMUNOGENETICS, V62, P431, DOI 10.1007/s00251-010-0449-9; McGowan I, 2004, JAIDS-J ACQ IMM DEF, V37, P1228, DOI 10.1097/01.qai.0000131846.12453.29; Merino A, 2011, J INFECT DIS, V203, P487, DOI 10.1093/infdis/jiq075; Milush JM, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-158; Naranbhai V, 2012, J INFECT DIS, V206, P993, DOI 10.1093/infdis/jis465; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Schellekens J, 2008, MOL IMMUNOL, V45, P981, DOI 10.1016/j.molimm.2007.07.040; Shao WS, 2006, AIDS, V20, P1583, DOI 10.1097/01.aids.0000238403.08497.3f; Wilson CM, 2001, J ADOLESCENT HEALTH, V29, P8, DOI 10.1016/S1054-139X(01)00291-9; Yao HH, 2010, J NEUROIMMUNE PHARM, V5, P489, DOI 10.1007/s11481-010-9211-1	32	19	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99353	10.1371/journal.pone.0099353	http://dx.doi.org/10.1371/journal.pone.0099353			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901871	Green Published, gold, Green Submitted			2022-12-27	WOS:000336841400123
J	Zhao, XY; Yang, S; Chen, YR; Li, PC; Dou, MM; Zhang, J				Zhao, Xiao-Yan; Yang, Shen; Chen, You-Ran; Li, Pei-Chun; Dou, Meng-Meng; Zhang, Jie			Resveratrol and Arsenic Trioxide Act Synergistically to Kill Tumor Cells In Vitro and In Vivo	PLOS ONE			English	Article							CANCER-CELLS; APOPTOSIS; VEGF; CHEMOPREVENTION; TRANSCRIPTION; MECHANISMS; PREVENTION; EFFICACY; AS2O3; MODEL	Background and Aims: Arsenic trioxide (As2O3), which used as an effective agent in the treatment of leukaemia and other solid tumors, is largely limited by its toxicity. QT prolongation, torsades de pointes and sudden heart death have been implicated in the cardiotoxicity of As2O3. The present study was designed to explore whether the combination of As2O3 and resveratrol could generate a more powerful anti-cancer effect both in vitro and in vivo. Materials and Methods: MTT assay was performed to assess the proliferation of Hela, MCF-7 and NB4 cells. Isobolographic analysis was used to evaluate combination index values from cell viability data. The apoptosis and the cellular reactive oxygen species (ROS) level were assessed by fluorescent microscopy and flow cytometry separately in vitro. The effect of As2O3, alone and in combination with resveratrol on Hela tumor growth in an orthotopic nude mouse model was also investigated. The tumor volume and the immunohistochemical analysis of CD31, CD34 and VEGF were determined. Results: Resveratrol dramatically enhanced the anti-cancer effect induced by As2O3 in vitro. In addition, isobolographic analysis further demonstrated that As2O3 and resveratrol generated a synergistic action. More apoptosis and ROS generation were observed in the combination treatment group. Similar synergistic effects were found in nude mice in vivo. The combination of As2O3 and resveratrol dramatically suppressed both tumor growth and angiogenesis in nude mice. Conclusions: Combining As2O3 with resveratrol would be a novel strategy to treat cancer in clinical practice.	[Zhao, Xiao-Yan; Yang, Shen; Chen, You-Ran; Li, Pei-Chun; Dou, Meng-Meng] Southwest Univ, Coll Pharmaceut Sci, Chongqing, Peoples R China; [Zhang, Jie] Ninth Peoples Hosp Chongqing, Dept Neurol, Chongqing, Peoples R China	Southwest University - China	Zhao, XY (corresponding author), Southwest Univ, Coll Pharmaceut Sci, Chongqing, Peoples R China.	Zhaoxiaoyan67@163.com; Zhjzhj121@163.com		Yang, Sen/0000-0001-5902-7177	National Natural Science Foundation of China [81001454]; fundamental Research Funds for the Central Universities [XDJK2014B024]; Fund for Construction of Scientific and Technical Innovation of Chongqing (CSTC) [2009CB1010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Fund for Construction of Scientific and Technical Innovation of Chongqing (CSTC)	This study was supported by the National Natural Science Foundation of China (81001454), the fundamental Research Funds for the Central Universities (XDJK2014B024), and the Fund for Construction of Scientific and Technical Innovation of Chongqing (CSTC, 2009CB1010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Aggarwal BB, 2004, ANTICANCER RES, V24, P2783; Aziz MH, 2003, INT J ONCOL, V23, P17; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Bianchini F, 2003, EUR J CANCER PREV, V12, P417, DOI 10.1097/00008469-200310000-00011; Borriello A, 2014, CANCER TREAT RES, V159, P167, DOI 10.1007/978-3-642-38007-5_10; Corpet DE, 2003, CANCER EPIDEM BIOMAR, V12, P391; Cyranoski D, 2007, NAT MED, V13, P1005, DOI 10.1038/nm0907-1005; Ding WQ, 2006, MOL CANCER THER, V5, P1864, DOI 10.1158/1535-7163.MCT-06-0067; Dobrydneva Y, 1999, BRIT J PHARMACOL, V128, P149, DOI 10.1038/sj.bjp.0702749; Fremont L, 2000, LIFE SCI, V66, P663, DOI 10.1016/S0024-3205(99)00410-5; Fukui M, 2010, EUR J CANCER, V46, P1882, DOI 10.1016/j.ejca.2010.02.004; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Kamiya H, 2012, CELL PHYSIOL BIOCHEM, V29, P687, DOI 10.1159/000312589; Lee YK, 2004, BLOOD, V104, P788, DOI 10.1182/blood-2003-08-2763; Leite M, 1999, ANAL CELL PATHOL, V19, P139, DOI 10.1155/1999/176515; Ma Y, 2011, CANCER LETT, V301, P75, DOI 10.1016/j.canlet.2010.10.022; Mancuso MR, 2006, J CLIN INVEST, V116, P2610, DOI 10.1172/JCI24612; Mandal BK, 2002, TALANTA, V58, P201, DOI 10.1016/S0039-9140(02)00268-0; Ohta Y, 1999, BRIT J CANCER, V81, P54, DOI 10.1038/sj.bjc.6690650; Pettersson HM, 2009, MOL CANCER THER, V8, P160, DOI 10.1158/1535-7163.MCT-08-0595; Piao FY, 2005, J OCCUP HEALTH, V47, P445, DOI 10.1539/joh.47.445; Rezk Youssef A, 2006, Am J Obstet Gynecol, V194, pe23, DOI 10.1016/j.ajog.2005.11.030; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; Tong NN, 2012, ONCOL LETT, V3, P1263, DOI 10.3892/ol.2012.644; Wang G, 2004, TRENDS PHARMACOL SCI, V25, P120, DOI 10.1016/j.tips.2004.01.009; Wu EJ, 2014, CANCER BIOL THER, V15, P473, DOI 10.4161/cbt.27824; Xin P, 2010, EUR J PHARMACOL, V649, P293, DOI 10.1016/j.ejphar.2010.09.036; Yang J, 2004, FREE RADICAL BIO MED, V37, P2027, DOI 10.1016/j.freeradbiomed.2004.09.016; Yu J, 2007, GYNECOL ONCOL, V106, P400, DOI 10.1016/j.ygyno.2007.04.016; Zhang WQ, 2013, FOOD CHEM TOXICOL, V51, P87, DOI 10.1016/j.fct.2012.09.023; Zhang Y, 2013, BIOCHEM PHARMACOL, V85, P59, DOI 10.1016/j.bcp.2012.09.002; Zhao XY, 2008, BRIT J PHARMACOL, V154, P105, DOI 10.1038/bjp.2008.81; Zhao XY, 2008, BASIC CLIN PHARMACOL, V102, P419, DOI 10.1111/j.1742-7843.2007.00150.x	34	23	26	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98925	10.1371/journal.pone.0098925	http://dx.doi.org/10.1371/journal.pone.0098925			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901647	gold, Green Submitted, Green Published			2022-12-27	WOS:000336841400073
J	Arora, R; Yates, C; Gary, BD; McClellan, S; Tan, M; Xi, YG; Reed, E; Piazza, GA; Owen, LB; Dean-Colomb, W				Arora, Ritu; Yates, Clayton; Gary, Bernard D.; McClellan, Steven; Tan, Ming; Xi, Yaguang; Reed, Eddie; Piazza, Gary A.; Owen, Laurie B.; Dean-Colomb, Windy			Panepoxydone Targets NF-kB and FOXM1 to Inhibit Proliferation, Induce Apoptosis and Reverse Epithelial to Mesenchymal Transition in Breast Cancer	PLOS ONE			English	Article							FACTOR-KAPPA-B; PATHOLOGICAL COMPLETE RESPONSE; TRANSCRIPTION FACTOR; TUMOR-CELLS; GENE-EXPRESSION; CYCLE ARREST; SURVIVIN; ACTIVATION; ANTITUMOR; PROGRESSION	Background: Triple-negative breast cancer (TNBC) is a highly diverse group that is associated with an aggressive phenotype. Its treatment has been challenging due to its heterogeneity and absence of well-defined molecular targets. Thus, there is an urgent need to identify novel agents with therapeutic application. NF-kappa B is over-expressed in many breast cancers; thus, inactivation of the NF-kappa B pathway could serve as a therapeutic target. Here we report for the first time the anti-tumor activity of panepoxydone (PP), a NF-kappa B inhibitor isolated from an edible mushroom, in several breast cancer cell lines. Methods: We investigated the effects of PP on cell growth, migration-invasion, apoptosis and EMT-related proteins expression in MCF-7 and TNBC cell lines MDA-MB-231, MDA-MB-468 and MDA-MB-453. Results: Significant antitumor activity was seen in all cell lines, with differential responses noted in cell-line specific manner. Treatment with PP resulted in significant cytotoxicity, decreased invasion, migration and increased apoptosis in all cell lines tested. Up-regulation of Bax and cleaved PARP and down-regulation of Bcl-2, survivin, cyclin D1 and caspase 3 were noted in PP-treated breast cancer cells. The antitumor effect of PP appeared related to its ability to inhibit the phosphorylation of inhibitor of NF-kappa B (I kappa B alpha) with cytoplasmic accumulation. PP treatment also down-regulated FOXM1 which resulted in a reversal of EMT. Similar results were obtained after silencing of NF-kB and FOXM1. Conclusion: Altogether, these studies show, for the first time the antitumor activity of PP against breast cancer cells, in particular TNBC cells. Furthermore, it highlights the concept that optimal treatment of TNBC warrants attention to the differential sensitivity of various TNBC subtypes to therapeutic agents. These results suggest that the PP may be a potentially effective chemopreventive or therapeutic agent against breast cancer. However, additional studies are required to more fully elucidate the mechanism of antitumor effect of PP.	[Arora, Ritu; Gary, Bernard D.; McClellan, Steven; Tan, Ming; Xi, Yaguang; Reed, Eddie; Piazza, Gary A.; Owen, Laurie B.; Dean-Colomb, Windy] Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, Mobile, AL 36688 USA; [Yates, Clayton] Tuskegee Univ, Dept Biol, Tuskegee, AL 36088 USA; [Yates, Clayton] Tuskegee Univ, Ctr Canc Res, Tuskegee, AL 36088 USA	University of South Alabama; Tuskegee University; Tuskegee University	Dean-Colomb, W (corresponding author), Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, Mobile, AL 36688 USA.	windydean@usouthal.edu	Tan, Ming/ABD-5847-2021	Tan, Ming/0000-0003-2007-9898; Piazza, Gary/0000-0003-4418-887X; Xi, Yaguang/0000-0003-3681-9352	University of South Alabama Mitchell Cancer Institute Research Award;  [U54706CA118948]; NATIONAL CANCER INSTITUTE [U54CA118948, R01CA149646, U54CA118623] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003059] Funding Source: NIH RePORTER	University of South Alabama Mitchell Cancer Institute Research Award; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by the University of South Alabama Mitchell Cancer Institute Research Award to Dr. Windy Dean-Colomb and U54706CA118948 (NIH/NCI) [CY]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Agrawal G, 2007, J CLIN ONCOL, V25, P2618, DOI 10.1200/JCO.2007.11.3084; Ahmad A, 2008, BREAST CANC RES TREA, V122, P337; Ahmad A, 2008, J CELL BIOCHEM, V105, P1461, DOI 10.1002/jcb.21966; Altieri D, 2001, CELL DEATH DIFFER, V8, P4, DOI 10.1038/sj.cdd.4400795; Bao B, 2011, J CELL BIOCHEM, V112, P2296, DOI 10.1002/jcb.23150; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Blackwell TS, 1997, AM J RESP CELL MOL, V17, P3, DOI 10.1165/ajrcmb.17.1.f132; Blanc-Brude OP, 2003, CLIN CANCER RES, V9, P2683; Buchholz TA, 2005, CLIN CANCER RES, V11, P8398, DOI 10.1158/1078-0432.CCR-05-0885; Caldas-Lopes E, 2009, P NATL ACAD SCI USA, V106, P8368, DOI 10.1073/pnas.0903392106; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Chen F, 2001, AM J PATHOL, V159, P387, DOI 10.1016/S0002-9440(10)61708-7; de la Mare JA, 2012, INVEST NEW DRUG, V30, P2187, DOI 10.1007/s10637-011-9788-0; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Duangmano S, 2012, J ONCOL, V2012, DOI 10.1155/2012/601682; Erkel G, 2007, INT IMMUNOPHARMACOL, V7, P612, DOI 10.1016/j.intimp.2007.01.001; Erkel G, 1996, BIOCHEM BIOPH RES CO, V226, P214, DOI 10.1006/bbrc.1996.1335; GILLETT C, 1994, CANCER RES, V54, P1812; Gong Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033656; Guarino M, 2007, INT J BIOCHEM CELL B, V39, P2153, DOI 10.1016/j.biocel.2007.07.011; Helbig G, 2003, J BIOL CHEM, V278, P21631, DOI 10.1074/jbc.M300609200; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Janicke RU, 2009, BREAST CANCER RES TR, V117, P219, DOI 10.1007/s10549-008-0217-9; Jeong H, 2012, HISTOPATHOLOGY, V60, pE87, DOI 10.1111/j.1365-2559.2012.04195.x; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kallergi G, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2896; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003; Kostanova-Poliakova D, 2005, NEOPLASMA, V52, P441; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li FZ, 2006, J CELL PHYSIOL, V208, P476, DOI 10.1002/jcp.20634; Li X, 2012, ONCOGENE, V31, P4979, DOI 10.1038/onc.2011.655; Liu H, 2008, EUR J PHARMACOL, V591, P43, DOI 10.1016/j.ejphar.2008.06.026; Mehta PP, 2011, CLIN CANCER RES, V17, P5432, DOI 10.1158/1078-0432.CCR-11-0592; MIZUNO T, 1995, FOOD REV INT, V11, P23, DOI 10.1080/87559129509541018; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Podo F, 2010, MOL ONCOL, V4, P209, DOI 10.1016/j.molonc.2010.04.006; Ramachandran PV, 2009, FUTURE MED CHEM, V1, P179, DOI 10.4155/FMC.09.15; Ramasamy S, 2013, EXP TOXICOL PATHOL, V65, P341, DOI 10.1016/j.etp.2011.11.005; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; Rhee JY, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-307; Romieu-Mourez R, 2001, CANCER RES, V61, P3810; Schneider BP, 2008, CLIN CANCER RES, V14, P8010, DOI 10.1158/1078-0432.CCR-08-1208; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Span PN, 2004, CLIN CHEM, V50, P1986, DOI 10.1373/clinchem.2004.039149; Stan SD, 2008, NUTR CANCER, V60, P51, DOI 10.1080/01635580802381477; Sun SH, 2012, EUR J PHARMACOL, V690, P22, DOI 10.1016/j.ejphar.2012.05.036; Tanaka K, 2000, CLIN CANCER RES, V6, P127; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wang XH, 2002, P NATL ACAD SCI USA, V99, P16881, DOI 10.1073/pnas.252570299; Wang XB, 2007, NAT CELL BIOL, V9, P470, DOI 10.1038/ncb1559; Wang Yifan, 2011, Chin J Cancer, V30, P603, DOI 10.5732/cjc.011.10226; Wasser SP, 1999, CRIT REV IMMUNOL, V19, P65; Wasser SP, 2002, APPL MICROBIOL BIOT, V60, P258, DOI 10.1007/s00253-002-1076-7; Wu K, 2009, CRIT REV IMMUNOL, V29, P241, DOI 10.1615/CritRevImmunol.v29.i3.40; Yang C, 2013, CANCER GENE THER, V20, P117, DOI 10.1038/cgt.2012.94; Yang C, 2013, CANCER LETT, V340, P104, DOI 10.1016/j.canlet.2013.07.004; Ye HG, 1999, MOL CELL BIOL, V19, P8570; Zhen C, 2013, ONCOGENE, V32, P3452, DOI 10.1038/onc.2012.356	65	44	47	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98370	10.1371/journal.pone.0098370	http://dx.doi.org/10.1371/journal.pone.0098370			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896091	Green Submitted, Green Published, gold			2022-12-27	WOS:000338430700036
J	Kaizu, S; Kishimoto, H; Iwase, M; Fujii, H; Ohkuma, T; Ide, H; Jodai, T; Kikuchi, Y; Idewaki, Y; Hirakawa, Y; Nakamura, U; Kitazono, T				Kaizu, Shinako; Kishimoto, Hiro; Iwase, Masanori; Fujii, Hiroki; Ohkuma, Toshiaki; Ide, Hitoshi; Jodai, Tamaki; Kikuchi, Yohei; Idewaki, Yasuhiro; Hirakawa, Yoichiro; Nakamura, Udai; Kitazono, Takanari			Impact of Leisure-Time Physical Activity on Glycemic Control and Cardiovascular Risk Factors in Japanese Patients with Type 2 Diabetes Mellitus: The Fukuoka Diabetes Registry	PLOS ONE			English	Article							QUALITY-OF-LIFE; SUPERVISED EXERCISE; METAANALYSIS; MORTALITY; ASSOCIATION; PREDICTOR; PEOPLE; MUSCLE; DIET	Aims/hypothesis: The effects of leisure-time physical activity (LTPA) on glycemia and cardiovascular risk factors are not fully understood in Asian type 2 diabetic patients, who are typically non-obese. We studied associations between LTPA and glycemia and cardiovascular risk factors in Japanese type 2 diabetic patients. Methods: A total of 4,870 Japanese type 2 diabetic patients aged >= 20 years were divided into eight groups according to their LTPA. We investigated associations between the amount and intensity levels of physical activity (PA) and glycemic control, insulin sensitivity, cardiovascular risk factors, and low-grade systemic inflammation in a cross-sectional study. Results: LTPA was dose-dependently associated with body mass index (BMI), waist circumference, hemoglobin A(1c) (HbA(1c)), fasting plasma glucose, homeostasis model assessment of insulin resistance, triglyceride, high density lipoprotein cholesterol, high sensitivity C-reactive protein, and prevalence of metabolic syndrome, but not with blood pressure, low density lipoprotein cholesterol or adiponectin. The amount of PA required to lower HbA(1c) was greater than that required to improve cardiovascular risk factors. LTPA was inversely associated with HbA(1c) in non-obese participants but not in obese participants after multivariate adjustments for age, sex, duration of diabetes, current smoking, current drinking, energy intake, cardiovascular diseases, depressive symptoms, and treatment of diabetes. Higher-intensity LTPA, not lower-intensity LTPA was associated with HbA(1c) after multivariate adjustments with further adjustment including BMI. Conclusions/interpretation: LTPA was dose-dependently associated with better glycemic control and amelioration of some cardiovascular risk factors in Japanese type 2 diabetic patients. In addition, increased higher-intensity LTPA may be appropriate for glycemic control.	[Kaizu, Shinako; Iwase, Masanori; Ohkuma, Toshiaki; Ide, Hitoshi; Jodai, Tamaki; Nakamura, Udai; Kitazono, Takanari] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan; [Kishimoto, Hiro; Hirakawa, Yoichiro] Kyushu Univ, Grad Sch Med Sci, Dept Environm Med, Fukuoka 812, Japan; [Iwase, Masanori; Kikuchi, Yohei; Idewaki, Yasuhiro] Hakujyuji Hosp, Ctr Diabet, Fukuoka, Japan; [Fujii, Hiroki] Kyushu Dent Univ, Div Gen Internal Med, Sch Oral Hlth Sci, Kitakyushu, Fukuoka, Japan	Kyushu University; Kyushu University; Kyushu Dental University	Iwase, M (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan.	iwase@intmed2.med.kyushu-u.ac.jp		Kishimoto, Hiro/0000-0001-8944-1539	JSPS KAKENHI [23249037, 23659353]; Grants-in-Aid for Scientific Research [26350895] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI (grant number 23249037, 23659353) for MI. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Balducci S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049297; Balducci S, 2010, ARCH INTERN MED, V170, P1794, DOI 10.1001/archinternmed.2010.380; Beavers KM, 2010, CLIN CHIM ACTA, V411, P785, DOI 10.1016/j.cca.2010.02.069; Boule NG, 2003, DIABETOLOGIA, V46, P1071, DOI 10.1007/s00125-003-1160-2; Chae JS, 2012, DIABETES CARE, V35, P1680, DOI 10.2337/dc11-2074; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chudyk A, 2011, DIABETES CARE, V34, P1228, DOI 10.2337/dc10-1881; Colberg SR, 2010, DIABETES CARE, V33, pe147; Di Loreto C, 2005, DIABETES CARE, V28, P1295, DOI 10.2337/diacare.28.6.1295; Coello S, 2010, EUR J NUTR, V49, P505, DOI 10.1007/s00394-010-0110-2; Hayashino Y, 2012, DIABETES RES CLIN PR, V98, P349, DOI 10.1016/j.diabres.2012.10.004; Iijima K, 2012, GERIATR GERONTOL INT, V12, P77, DOI 10.1111/j.1447-0594.2011.00815.x; Ishikawa-Takata K, 2011, J EPIDEMIOL, V21, P114, DOI 10.2188/jea.JE20100079; Jeon CY, 2007, DIABETES CARE, V30, P744, DOI 10.2337/dc06-1842; Kobayashi S, 2011, PUBLIC HEALTH NUTR, V14, P1200, DOI 10.1017/S1368980011000504; Kodama S, 2013, DIABETES CARE, V36, P471, DOI 10.2337/dc12-0783; Li CL, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-67; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; Nakamura Y, 2009, OBESITY, V17, P1269, DOI 10.1038/oby.2009.3; O'Hagan C, 2013, SPORTS MED, V43, P39, DOI 10.1007/s40279-012-0004-y; O'Leary VB, 2007, AM J PHYSIOL-ENDOC M, V293, pE421, DOI 10.1152/ajpendo.00123.2007; Ohkuma T, 2013, DIABETOLOGIA, V56, P70, DOI 10.1007/s00125-012-2746-3; Pattyn N, 2013, SPORTS MED, V43, P121, DOI 10.1007/s40279-012-0003-z; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ridker PM, 2001, CIRCULATION, V103, P1813, DOI 10.1161/01.CIR.103.13.1813; Sone H, 2013, DIABETOLOGIA, V56, P1021, DOI 10.1007/s00125-012-2810-z; Sukala WR, 2012, DIABETES RES CLIN PR, V97, P206, DOI 10.1016/j.diabres.2012.02.001; Umpierre D, 2013, DIABETOLOGIA, V56, P242, DOI 10.1007/s00125-012-2774-z; Umpierre D, 2011, JAMA-J AM MED ASSOC, V305, P1790, DOI 10.1001/jama.2011.576; US Department of Health and Human Services, 2008, PHYS ACT GUID AM; van der Heijden MMP, 2013, DIABETOLOGIA, V56, P1210, DOI 10.1007/s00125-013-2871-7; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487	35	29	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98768	10.1371/journal.pone.0098768	http://dx.doi.org/10.1371/journal.pone.0098768			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897110	Green Published, Green Submitted, gold			2022-12-27	WOS:000338430700074
J	Betran, AP; Vindevoghel, N; Souza, JP; Gulmezoglu, AM; Torloni, MR				Betran, Ana Pilar; Vindevoghel, Nadia; Souza, Joao Paulo; Guelmezoglu, A. Metin; Torloni, Maria Regina			A Systematic Review of the Robson Classification for Caesarean Section: What Works, Doesn't Work and How to Improve It	PLOS ONE			English	Review							PREGNANCY OUTCOMES; PERINATAL HEALTH; DELIVERY RATES; GLOBAL SURVEY; TRENDS; BIRTHS; DETERMINANTS; POPULATION; SINGLETON; WOMEN	Background: Caesarean sections (CS) rates continue to increase worldwide without a clear understanding of the main drivers and consequences. The lack of a standardized internationally-accepted classification system to monitor and compare CS rates is one of the barriers to a better understanding of this trend. The Robson's 10-group classification is based on simple obstetrical parameters (parity, previous CS, gestational age, onset of labour, fetal presentation and number of fetuses) and does not involve the indication for CS. This classification has become very popular over the last years in many countries. We conducted a systematic review to synthesize the experience of users on the implementation of this classification and proposed adaptations. Methods: Four electronic databases were searched. A three-step thematic synthesis approach and a qualitative metasummary method were used. Results: 232 unique reports were identified, 97 were selected for full-text evaluation and 73 were included. These publications reported on the use of Robson's classification in over 33 million women from 31 countries. According to users, the main strengths of the classification are its simplicity, robustness, reliability and flexibility. However, missing data, misclassification of women and lack of definition or consensus on core variables of the classification are challenges. To improve the classification for local use and to decrease heterogeneity within groups, several subdivisions in each of the 10 groups have been proposed. Group 5 (women with previous CS) received the largest number of suggestions. Conclusions: The use of the Robson classification is increasing rapidly and spontaneously worldwide. Despite some limitations, this classification is easy to implement and interpret. Several suggested modifications could be useful to help facilities and countries as they work towards its implementation.	[Betran, Ana Pilar; Guelmezoglu, A. Metin] WHO, UNDP UNFPA UNICEF WHO World Bank Special Programm, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland; [Vindevoghel, Nadia] Maternal Child Clin, Calgary, AB, Canada; [Souza, Joao Paulo] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Social Med, Ribeirao Preto, SP, Brazil; [Torloni, Maria Regina] Brazilian Cochrane Ctr, Sao Paulo, Brazil; [Torloni, Maria Regina] Univ Fed Sao Paulo, Dept Internal Med, Sao Paulo, Brazil	The World Bank; United Nations Population Fund; World Health Organization; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Betran, AP (corresponding author), WHO, UNDP UNFPA UNICEF WHO World Bank Special Programm, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland.	betrana@who.int	Souza, João Paulo/G-1982-2010	Souza, João Paulo/0000-0002-2288-4244	UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction at the Department of Reproductive Health and Research of the World Health Organization	UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction at the Department of Reproductive Health and Research of the World Health Organization	This systematic review has been supported by the UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction at the Department of Reproductive Health and Research of the World Health Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abha S, 2009, J OBSTET GYN INDIA, V59, P547; Allen VM, 2012, J OBSTET GYNAECOL CA, V34, P1132; Allen VM, 2010, J OBSTET GYNAECOL CA, V32, P633, DOI 10.1016/S1701-2163(16)34566-2; ANDERSON GM, 1984, NEW ENGL J MED, V311, P887, DOI 10.1056/NEJM198410043111405; Barcaite E, 2012, LLIETUVOS AKUSERIJA, V15, P222; BC PS, 2011, EXAM CES DEL RAT BRI; Betran AP, 2007, PAEDIATR PERINAT EP, V21, P98, DOI 10.1111/j.1365-3016.2007.00786.x; Betran Ana P, 2009, Reprod Health, V6, P18, DOI 10.1186/1742-4755-6-18; Betran AP, 2014, PLOS ONE; Bjarnadottir R, 2013, ICELAND REPORT BIRTH; Bjarnadottir R, 2012, ACTA OBSTET GYN SCAN, V91, P70; Brennan DJ, 2011, OBSTET GYNECOL, V117, P273, DOI 10.1097/AOG.0b013e318204521a; Brennan DJ, 2009, AM J OBSTET GYNECOL, V200, pE8, DOI 10.1016/j.ajog.2008.09.004; Budhwa T, 2010, BIRTHING REV PROJECT; Burke G, 2006, AM J OBSTET GYNECOL, V10, P307; Cabeza Vengoechea PJ, PROG OBSTET GINECOL, V53, P385, DOI [DOI 10.1016/j.pog.2010.05.003, 10.1016/j.pog.2010.05, DOI 10.1016/J.POG.2010.05]; Chan JCY, 2010, ARCH DIS CHILD FETAL; Chong C, 2012, ACTA OBSTET GYN SCAN, V91, P1422, DOI 10.1111/j.1600-0412.2012.01529.x; Ciriello E, 2012, J MATERN-FETAL NEO M, V25, P2717, DOI 10.3109/14767058.2012.712567; COHN J, 1985, LANCET, V2, P437; Colais P, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-54; Costa ML, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-13; Delbaere I, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-3; Farine D, 2012, J OBSTET GYNAECOL CA, V34, P976, DOI 10.1016/S1701-2163(16)35412-3; Fell D, 2011, BETTER OUTCOMES REGI; Fischer A, 2005, OBSTET GYNECOL, V105, P816, DOI 10.1097/01.AOG.0000156299.52668.e2; Flood K, 2013, AM J OBSTET GYNECO S; Florica M, 2006, INT J GYNECOL OBSTET, V92, P181, DOI 10.1016/j.ijgo.2005.10.016; Gonzales Rengifo G, 2013, TENDENCIAS DETERMINA; Gonzalez R, 2006, PEDIATRICS, V117, pE949, DOI 10.1542/peds.2005-2354; Goonewardene M., 2012, SRI LANKA J OBSTET G, V34, P11; Grunebaum A, 2012, AM J OBSTET GYNECOL, V206, pS287, DOI 10.1016/j.ajog.2011.10.660; Gu Y, 2011, J PAEDIAT CHILD HL S, V47, P79; Homer CSE, 2010, MIDWIFERY, V26, P532, DOI 10.1016/j.midw.2010.03.010; Howell S, 2009, AUST NZ J OBSTET GYN, V49, P606, DOI 10.1111/j.1479-828X.2009.01100.x; Kazmi Tahira, 2012, Oman Med J, V27, P415, DOI 10.5001/omj.2012.102; Keane D, 2000, INT J GYNECOL OBSTET, V70, pA19; Kelly S, 2013, J OBSTET GYNAECOL CA; Knight M, 2010, BMJ, V341; Kraulaidyte V, 2011, LIETUVOS AKUSERIJA G, V14, P114; Litorp H, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-107; Lumbiganon P, 2010, LANCET, V375, P490, DOI 10.1016/S0140-6736(09)61870-5; Maneschi F, 2011, RIFLESSIONI TASSO GL, P4; Maneschi F, 2009, RIV IT OST GIN, V21, P13; McCarthy FP, 2007, AUST NZ J OBSTET GYN, V47, P316, DOI 10.1111/j.1479-828X.2007.00753.x; Meloni A, 2012, J PEDIATR NEONATAL I, V1, P53, DOI 10.7363/010109; Minsart AF, 2013, ACTA OBSTET GYN SCAN, V92, P204, DOI 10.1111/aogs.12003; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Noyes J., 2008, COCHRANE HDB SYSTEMA, P571, DOI DOI 10.1002/9780470712184.CH20; Paleari Leonardo, 2012, Ginecol Obstet Mex, V80, P263; Pot M, 2009, NATL WOMENS ANN CLIN, P74; Program BCPH, 2009, CAESAREAN BIRTH TAS; Program PEIRC, 2011, PERINATAL DATABASE R; Rasmussen OB, 2000, ACTA OBSTET GYN SCAN, V79, P227, DOI 10.1080/j.1600-0412.2000.079003227.x; Reti L, 2007, CLIN PRACTICE REV; Robson M, 2013, BEST PRACT RES CL OB, V27, P297, DOI 10.1016/j.bpobgyn.2012.09.004; Robson MS, 2001, BEST PRACT RES CL OB, V15, P179, DOI 10.1053/beog.2000.0156; Robson MS, 2001, FETAL MATERN MED REV, V12, P23, DOI [DOI 10.1017/S0965539501000122, 10.1017/S0965539501000122]; Robson MS, 2012, CLIN REPORT YEAR 200; Salinas P Hugo, 2004, Rev. chil. obstet. ginecol., V69, P8; Sandelowski M, 2007, RES NURS HEALTH, V30, P99, DOI 10.1002/nur.20176; Scarella A, 2011, EUR J OBSTET GYN R B, V154, P136, DOI 10.1016/j.ejogrb.2010.09.005; Services AH, 2009, CAESAREAN BIRTH ALBE, P12; Services DoCaFH, 2004, TRENDS CESAREAN BIRT; Slavin V, 2012, INT J CHILDBIRTH, V2, P85, DOI 10.1891/2156-5287.2.2.85; Sorbye IK, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-55; Stavrou EP, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-8; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sudarsan S, 2012, J OBSTET GYN INDIA, V62, P391, DOI 10.1007/s13224-012-0288-8; Suliman S, 2010, FACTORS ASS CAESAREA; Teguete I, 2012, CESAREAN DELIVERY IN; Thaens A, 2011, FACTS VIEWS VIS OBGY, V3, P286; Thomas J, 2001, NATL SENTINEL CAESAR; Thomas J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-45; Torloni MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014566; Torloni MR, 2009, WHY ARE CESAREAN SEC; Vera P.G Claudio, 2004, Rev. chil. obstet. ginecol., V69, P219; Villar J, 2007, BRIT MED J, V335, P1025, DOI 10.1136/bmj.39363.706956.55; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7; Watson M, 2009, EFFECT BODY MASS IND; WHO, 2010, WOR HEALT REP, P1; Zamarian A, 2009, INT J GYNAECOL OBS S, V107S, pS451; Zhang J, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.058	83	120	130	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e97769	10.1371/journal.pone.0097769	http://dx.doi.org/10.1371/journal.pone.0097769			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892928	Green Submitted, gold, Green Published			2022-12-27	WOS:000336911400021
J	Liu, M; Xu, YY; Hu, YM; Li, CL; Sun, FY; Chen, T				Liu, Miao; Xu, Yanyan; Hu, Yuanman; Li, Chunlin; Sun, Fengyun; Chen, Tan			A Century of the Evolution of the Urban Area in Shenyang, China	PLOS ONE			English	Article							LAND-USE CHANGE; QUANTIFYING SPATIOTEMPORAL PATTERNS; DRIVING FORCES; METROPOLITAN REGION; LANDSCAPE PATTERN; CELLULAR-AUTOMATA; GRADIENT ANALYSIS; HISTORICAL MAPS; COVER CHANGE; DYNAMICS	Analyzing spatiotemporal characteristics of the historical urbanization process is essential in understanding the dynamics of urbanization and scientifically planned urban development. Based on historical urban area maps and remote sensing images, this study examined the urban expansion of Shenyang from 1910 to 2010 using area statistics, typology identification, and landscape metrics approaches. The population and gross domestic product were analyzed as driving factors. The results showed that the urban area of Shenyang increased 43.39-fold during the study period and that the growth rate has accelerated since the 1980s. Three urban growth types were distinguished: infilling, edge-expansion, and spontaneous growth. Edge-expansion was the primary growth type. Infilling growth became the main growth type in the periods 1946-70, 1988-97, and 2004-10. Spontaneous growth was concentrated in the period of 1997 to 2000. The results of landscape metrics indicate that the urban landscape of Shenyang originally was highly aggregated, but has become increasingly fragmented. The urban fringe area was the traditional hot zone of urbanization. Shenyang was mainly located north of the Hun River before 1980; however, the south side of the river has been the hot zone of urbanization since the 1980s. The increase of urban area strongly correlated with the growth of GDP and population. Over a long time scale, the urbanization process has been affected by major historical events.	[Liu, Miao; Xu, Yanyan; Hu, Yuanman; Li, Chunlin; Sun, Fengyun; Chen, Tan] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [Xu, Yanyan; Li, Chunlin; Sun, Fengyun; Chen, Tan] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Hu, YM (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	lium79@163.com	Liu, Miao/AAH-9655-2021; Li, Chunlin/AAH-7341-2019	Li, Chunlin/0000-0002-1987-7174; Sun, Fengyun/0000-0002-4101-5255	National Natural Science Foundation of China [41171155, 40801069]; national science and technology major project: water pollution control and governance [2012ZX07505-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); national science and technology major project: water pollution control and governance	This project was supported by the National Natural Science Foundation of China (No. 41171155 and 40801069) and national science and technology major project: water pollution control and governance (No. 2012ZX07505-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN PM, 1979, J SOC BIOL STRUCT, V2, P269; [Anonymous], 1998, POPULATION; [Anonymous], 2010, WORLD URB PROSP 2009; Antrop M, 2000, LANDSCAPE ECOL, V15, P257, DOI 10.1023/A:1008151109252; Batty M, 2005, ENVIRON PLANN A, V37, P1373, DOI 10.1068/a3784; Batty M, 1997, J AM PLANN ASSOC, V63, P266, DOI 10.1080/01944369708975918; Berling-Wolff Sheryl, 2004, Urban Ecosystems, V7, P215, DOI 10.1023/B:UECO.0000044037.23965.45; BROWN LR, 2001, ECOECONOMY BUILDING, P330; Burgess E. W., 1925, CITY SUGGESTIONS INV, P47, DOI DOI 10.1007/978-0-387-73412-5_5; Burgi M, 2004, LANDSCAPE ECOL, V19, P857, DOI 10.1007/s10980-004-0245-8; CHANG Y, 1997, CHIN J APPL ECOL, V8, P421; Chen YG, 2013, CHAOS SOLITON FRACT, V49, P47, DOI 10.1016/j.chaos.2013.02.006; Cousins SAO, 2007, LANDSCAPE ECOL, V22, P723, DOI 10.1007/s10980-006-9067-1; Dale VH, 2000, ECOL APPL, V10, P639; Dietzel C, 2005, INT J GEOGR INF SCI, V19, P175, DOI 10.1080/13658810410001713407; ENGELEN G, 1995, ENVIRON MONIT ASSESS, V34, P203, DOI 10.1007/BF00546036; Foster DR, 1998, ECOSYSTEMS, V1, P96, DOI 10.1007/s100219900008; Franceschetti G, 2000, PHYS REV E, V61, pR2228, DOI 10.1103/PhysRevE.61.R2228; Grimm NB, 2000, BIOSCIENCE, V50, P571, DOI 10.1641/0006-3568(2000)050[0571:IATLTO]2.0.CO;2; Haase D, 2007, LAND USE POLICY, V24, P248, DOI 10.1016/j.landusepol.2005.09.003; Herold M, 2003, REMOTE SENS ENVIRON, V86, P286, DOI 10.1016/S0034-4257(03)00075-0; Hoyt H., 1939, STRUCTURE GROWTH RES; Iverson LR, 2007, CAM STU LAN, P11, DOI 10.1017/CBO9780511618581.003; Jenerette GD, 2001, LANDSCAPE ECOL, V16, P611, DOI 10.1023/A:1013170528551; Kayhko N, 2006, LANDSCAPE URBAN PLAN, V75, P300, DOI 10.1016/j.landurbplan.2005.02.011; Krausmann F, 2003, LAND USE POLICY, V20, P1, DOI 10.1016/S0264-8377(02)00048-0; Li XZ, 2005, PATTERN RECOGN, V38, P2626, DOI 10.1016/j.patcog.2005.05.009; Long HL, 2007, J ENVIRON MANAGE, V83, P351, DOI 10.1016/j.jenvman.2006.04.003; Longley PA, 2002, PROG HUM GEOG, V26, P231, DOI 10.1191/0309132502ph366pr; Luck M, 2002, LANDSCAPE ECOL, V17, P327, DOI 10.1023/A:1020512723753; Makse HA, 1998, PHYS REV E, V58, P7054, DOI 10.1103/PhysRevE.58.7054; Masek JG, 2000, INT J REMOTE SENS, V21, P3473, DOI 10.1080/014311600750037507; McGarigal K., 1995, FRAGSTATS SPATIAL PA, DOI [10.2737/PNW-GTR-351, DOI 10.2737/PNW-GTR-351]; Montgomery MR, 2008, SCIENCE, V319, P761, DOI 10.1126/science.1153012; Parker DC, 2003, ANN ASSOC AM GEOGR, V93, P314, DOI 10.1111/1467-8306.9302004; Partel M, 1999, LANDSCAPE ECOL, V14, P187, DOI 10.1023/A:1008040114832; Petit CC, 2002, LANDSCAPE ECOL, V17, P117, DOI 10.1023/A:1016599627798; Pickett S.T.A., 2008, URBAN ECOLOGY INT PE, P99, DOI 10.1007/978-0-387-73412-5_7; Portugali J., 1999, SELF ORG CITY; Rhemtulla JM, 2007, LANDSCAPE ECOL, V22, P1, DOI 10.1007/s10980-007-9163-x; Seto KC, 2010, ANNU REV ENV RESOUR, V35, P167, DOI 10.1146/annurev-environ-100809-125336; Seto KC, 2005, LANDSCAPE ECOL, V20, P871, DOI 10.1007/s10980-005-5238-8; Seto KC, 2003, PHOTOGRAMM ENG REM S, V69, P981, DOI 10.14358/PERS.69.9.981; Skalos J, 2011, APPL GEOGR, V31, P426, DOI 10.1016/j.apgeog.2010.10.004; Stephenne N., 2004, GeoJournal, V61, P365, DOI 10.1007/s10708-004-5053-9; ULLMAN CDH, 1945, ANN AM ACAD POLITICA; UNFPA, 2007, STAT WORLD POP 2007; Uuemaa E, 2013, ECOL INDIC, V28, P100, DOI 10.1016/j.ecolind.2012.07.018; Wang Hou-jun, 2008, Ying Yong Sheng Tai Xue Bao, V19, P2673; WILSON AG, 1976, ENVIRON PLANN A, V8, P351, DOI 10.1068/a080351; Wong D.W.S., 1990, GEOGR ANN B, V72, P89; Wu J., 2000, ANN GIS, V6, P6, DOI DOI 10.1080/10824000009480529; Wu JG, 2002, LANDSCAPE ECOL, V17, P355, DOI 10.1023/A:1020561630963; Wu JG, 2011, ECOL COMPLEX, V8, P1, DOI 10.1016/j.ecocom.2010.03.002; [吴晓青 WU Xiao-qing], 2009, [地理研究, Geographical Research], V28, P1264; Xu C, 2007, LANDSCAPE ECOL, V22, P925, DOI 10.1007/s10980-007-9079-5; YEH AGO, 2001, MEASUREMENT MONITORI; [周锐 ZHOU Rui], 2009, [资源科学, Resources Science], V31, P1947; Zhu M, 2006, LANDSCAPE ECOL, V21, P723, DOI 10.1007/s10980-005-5323-z	59	11	12	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98847	10.1371/journal.pone.0098847	http://dx.doi.org/10.1371/journal.pone.0098847			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5ML	24893167	Green Submitted, Green Published, gold			2022-12-27	WOS:000336911400103
J	Loras, H; Sigmundsson, H; Stensdotter, AK; Talcott, JB				Loras, Havard; Sigmundsson, Hermundur; Stensdotter, Ann-Katrin; Talcott, Joel B.			Postural Control Is Not Systematically Related to Reading Skills: Implications for the Assessment of Balance as a Risk Factor for Developmental Dyslexia	PLOS ONE			English	Article							DEFICIT HYPOTHESIS; STATIC BALANCE; MOTOR COORDINATION; CHILDREN; DIFFICULTIES; ABNORMALITIES; HYPERACTIVITY; ORGANIZATION; ATTENTION; SAMPLE	Impaired postural control has been associated with poor reading skills, as well as with lower performance on measures of attention and motor control variables that frequently co-occur with reading difficulties. Measures of balance and motor control have been incorporated into several screening batteries for developmental dyslexia, but it is unclear whether the relationship between such skills and reading manifests as a behavioural continuum across the range of abilities or is restricted to groups of individuals with specific disorder phenotypes. Here were obtained measures of postural control alongside measures of reading, attention and general cognitive skills in a large sample of young adults (n = 100). Postural control was assessed using centre of pressure (CoP) measurements, obtained over 5 different task conditions. Our results indicate an absence of strong statistical relationships between balance measures with either reading, cognitive or attention measures across the sample as a whole.	[Loras, Havard; Sigmundsson, Hermundur] Sor Trondelag Univ Coll, Trondheim, Norway; [Sigmundsson, Hermundur; Stensdotter, Ann-Katrin] Norwegian Univ Sci & Technol, N-7034 Trondheim, Norway; [Talcott, Joel B.] Aston Univ, Sch Life & Hlth Sci, Aston Brain Ctr, Birmingham B4 7ET, W Midlands, England	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Aston University	Talcott, JB (corresponding author), Aston Univ, Sch Life & Hlth Sci, Aston Brain Ctr, Birmingham B4 7ET, W Midlands, England.	j.b.talcott@aston.ac.uk	Sigmundsson, Hermundur/R-7796-2019		Faculty of Health Education and Social Work at Sor-Trondelag University College	Faculty of Health Education and Social Work at Sor-Trondelag University College	Ths study was supported by a studentship grant from the Faculty of Health Education and Social Work at Sor-Trondelag University College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Barela JA, 2011, RES DEV DISABIL, V32, P1814, DOI 10.1016/j.ridd.2011.03.011; Bishop DVM, 2002, CORTEX, V38, P491, DOI 10.1016/S0010-9452(08)70018-2; BRADLEY L, 1978, NATURE, V271, P746, DOI 10.1038/271746a0; Brookes RL, 2010, DYSLEXIA, V16, P358, DOI 10.1002/dys.420; Brookes RL, 2005, DYSLEXIA, V11, P174, DOI 10.1002/dys.293; Cramer AOJ, 2010, BEHAV BRAIN SCI, V33, P137, DOI 10.1017/S0140525X09991567; Duarte M, 2010, REV BRAS FISIOTER, V14, P183, DOI 10.1590/S1413-35552010000300003; Era P, 2006, GERONTOLOGY, V52, P204, DOI 10.1159/000093652; Fawcett A., 1998, DYSLEXIA ADULT SCREE; Fawcett & Nicolson, 2004, DYSL SCREEN TEST JUN; Forseth AK, 2003, CHILD CARE HLTH DEV, V29, P569, DOI 10.1046/j.1365-2214.2003.00378.x; Geuze RH, 2003, HUM MOVEMENT SCI, V22, P527, DOI 10.1016/j.humov.2003.09.008; Guron LM, 2004, DYSLEXIA, V10, P44, DOI 10.1002/dys.260; Haslum MN, 2007, DYSLEXIA, V13, P257, DOI 10.1002/dys.350; Hoien T., 1997, ORDKJEDETESTEN; Iversen S, 2005, DYSLEXIA, V11, P217, DOI 10.1002/dys.297; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Lonnemann J, 2011, J NEUROLINGUIST, V24, P592, DOI 10.1016/j.jneuroling.2011.02.005; Maki BE, 1996, J VESTIBUL RES-EQUIL, V6, P53, DOI 10.1016/0957-4271(95)00014-3; Menghini D, 2010, NEUROPSYCHOLOGIA, V48, P863, DOI 10.1016/j.neuropsychologia.2009.11.003; Miller-Guron L., 1999, WORDCHAINS WORD READ; Moe-Nilssen R, 2003, EXP BRAIN RES, V150, P237, DOI 10.1007/s00221-003-1450-4; Nicolson RI, 2001, TRENDS NEUROSCI, V24, P508, DOI 10.1016/S0166-2236(00)01896-8; NICOLSON RI, 1995, DYSLEXIA, V1, P37; NICOLSON RI, 1997, J RES READ, V20, P77, DOI DOI 10.1111/1467-9817.00022; Olson Richard K, 2002, Dyslexia, V8, P143, DOI 10.1002/dys.228; Paracchini S, 2008, AM J PSYCHIAT, V165, P1576, DOI 10.1176/appi.ajp.2008.07121872; Paracchini S, 2007, ANNU REV GENOM HUM G, V8, P57, DOI 10.1146/annurev.genom.8.080706.092312; Patel M, 2010, DYSLEXIA, V16, P162, DOI 10.1002/dys.398; PENNINGTON BF, 1990, CHILD DEV, V61, P1753, DOI 10.1111/j.1467-8624.1990.tb03564.x; Pennington BF, 2006, COGNITION, V101, P385, DOI 10.1016/j.cognition.2006.04.008; Piek JP, 1999, DEV MED CHILD NEUROL, V41, P159, DOI 10.1017/S0012162299000341; Plomin R, 2005, PSYCHOL BULL, V131, P592, DOI 10.1037/0033-2909.131.4.592; Raberger T, 2003, NEUROPSYCHOLOGIA, V41, P1493, DOI 10.1016/S0028-3932(03)00078-2; RACK JP, 1992, READ RES QUART, V27, P28, DOI 10.2307/747832; Rae C, 1998, LANCET, V351, P1849, DOI 10.1016/S0140-6736(97)99001-2; Rae C, 2002, NEUROPSYCHOLOGIA, V40, P1285, DOI 10.1016/S0028-3932(01)00216-0; Ramus F, 2003, BRAIN, V126, P841, DOI 10.1093/brain/awg076; Raven J., 2000, MANUAL RAVENS STANDA; Rochelle KSH, 2006, J CHILD PSYCHOL PSYC, V47, P1159, DOI 10.1111/j.1469-7610.2006.01641.x; Rochelle KSH, 2009, EXP BRAIN RES, V192, P627, DOI 10.1007/s00221-008-1568-5; Snowling MJ, 2008, Q J EXP PSYCHOL, V61, P142, DOI 10.1080/17470210701508830; Stoodley CJ, 2005, EXP BRAIN RES, V167, P370, DOI 10.1007/s00221-005-0042-x; Sugden D, 2008, INT J DISABIL DEV ED, V55, P93, DOI 10.1080/10349120802033360; Talcott JB, 2013, NEUROPSYCHOLOGIA, V51, P472, DOI 10.1016/j.neuropsychologia.2012.11.016; Tsai CL, 2008, HUM MOVEMENT SCI, V27, P142, DOI 10.1016/j.humov.2007.08.002; VAN IJZENDOORN MH, 1994, READ RES QUART, V29, P267; Vieira S, 2009, NEUROSCI LETT, V462, P125, DOI 10.1016/j.neulet.2009.06.093; Viholainen H, 2011, DEV MED CHILD NEUROL, V53, P350, DOI 10.1111/j.1469-8749.2010.03856.x; Wechsler D, 1999, MANUAL WECHSLER ADUL; Williams J, 2006, EUR J HUM GENET, V14, P681, DOI 10.1038/sj.ejhg.5201575; Wimmer H, 1999, J LEARN DISABIL, V32, P473, DOI 10.1177/002221949903200513; YAP RL, 1994, J LEARN DISABIL, V27, P660, DOI 10.1177/002221949402701006	54	10	10	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98224	10.1371/journal.pone.0098224	http://dx.doi.org/10.1371/journal.pone.0098224			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5ML	24892925	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000336911400041
J	Soliman, A; Ayele, BT; Daayf, F				Soliman, Atta; Ayele, Belay T.; Daayf, Fouad			Biochemical and Molecular Characterization of Barley Plastidial ADP-Glucose Transporter (HvBT1)	PLOS ONE			English	Article							CYTOSOLIC SMALL-SUBUNIT; ESCHERICHIA-COLI; STARCH SYNTHESIS; GENE; PYROPHOSPHORYLASE; EXPRESSION; ENDOSPERM; PROTEIN; BIOSYNTHESIS; SYSTEM	In cereals, ADP-glucose transporter protein plays an important role in starch biosynthesis. It acts as a main gate for the transport of ADP-glucose, the main precursor for starch biosynthesis during grain filling, from the cytosol into the amyloplasts of endospermic cells. In this study, we have shed some light on the molecular and biochemical characteristics of barley plastidial ADP-glucose transporter, HvBT1. Phylogenetic analysis of several BT1 homologues revealed that BT1 homologues are divided into two distinct groups. The HvBT1 is assigned to the group that represents BT homologues from monocotyledonous species. Some members of this group mainly work as nucleotide sugar transporters. Southern blot analysis showed the presence of a single copy of HvBT1 in barley genome. Gene expression analysis indicated that HvBT1 is mainly expressed in endospermic cells during grain filling; however, low level of its expression was detected in the autotrophic tissues, suggesting the possible role of HvBT1 in autotrophic tissues. The cellular and subcellular localization of HvBT1 provided additional evidence that HvBT1 targets the amyloplast membrane of the endospermic cells. Biochemical characterization of HvBT1 using E. coli system revealed that HvBT1 is able to transport ADP-glucose into E. coli cells with an affinity of 614.5 mu M and in counter exchange of ADP with an affinity of 334.7 mu M. The study also showed that AMP is another possible exchange substrate. The effect of non-labeled ADP-glucose and ADP on the uptake rate of [alpha-P-32] ADP-glucose indicated the substrate specificity of HvBT1 for ADP-glucose and ADP.	[Soliman, Atta; Ayele, Belay T.; Daayf, Fouad] Univ Manitoba, Dept Plant Sci, Fac Agr & Food Sci, Winnipeg, MB R3T 2N2, Canada; [Soliman, Atta] Tanta Univ, Fac Agr, Dept Genet, Tanta, El Gharbia, Egypt	University of Manitoba; Egyptian Knowledge Bank (EKB); Tanta University	Daayf, F (corresponding author), Univ Manitoba, Dept Plant Sci, Fac Agr & Food Sci, Winnipeg, MB R3T 2N2, Canada.	Fouad.Daayf@umanitoba.ca	Daayf, Fouad/P-3901-2019	Daayf, Fouad/0000-0001-8912-0460	ministry of Higher Education, Egypt; Agri-Food Research and Development Initiative, Manitoba, Canada [ARDI-10-1042]	ministry of Higher Education, Egypt(Ministry of Higher Education & Scientific Research (MHESR)); Agri-Food Research and Development Initiative, Manitoba, Canada	AS was financially supported by a Ph.D. scholarship from the ministry of Higher Education, Egypt. BTA and FD received grant #ARDI-10-1042 from Agri-Food Research and Development Initiative, Manitoba, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bahaji A, 2014, BIOTECHNOL ADV, V32, P87, DOI 10.1016/j.biotechadv.2013.06.006; Bahaji A, 2011, PLANT CELL PHYSIOL, V52, P597, DOI 10.1093/pcp/pcr019; Belmonte M, 2006, J EXP BOT, V56, P23; Bernaudat F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029191; Bowsher CG, 2007, J EXP BOT, V58, P1321, DOI 10.1093/jxb/erl297; Brown W, 2008, NATURE ED, V1, P202; Canton FR, 1999, PLANT MOL BIOL, V40, P623, DOI 10.1023/A:1006219205062; CAO HP, 1995, PHYSIOL PLANTARUM, V95, P176, DOI 10.1111/j.1399-3054.1995.tb00825.x; Cao HP, 1996, PHYSIOL PLANTARUM, V97, P665, DOI 10.1111/j.1399-3054.1996.tb00530.x; Chen DQ, 2006, GENE THER MOL BIOL, V10A, P1; Denyer K, 1996, PLANT J, V10, P1135, DOI 10.1046/j.1365-313X.1996.10061135.x; GHOSH HP, 1966, J BIOL CHEM, V241, P4491; GIROUX MJ, 1994, MOL GEN GENET, V243, P400, DOI 10.1007/BF00280470; James MG, 2003, CURR OPIN PLANT BIOL, V6, P215, DOI 10.1016/S1369-5266(03)00042-6; Johnson PE, 2003, PLANT PHYSIOL, V131, P684, DOI 10.1104/pp.013094; Kirchberger S, 2008, PLANT J, V56, P51, DOI 10.1111/j.1365-313X.2008.03583.x; Kirchberger S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702484200; LAEMMLI UK, 1970, J MOL BIOL, V49, P99, DOI 10.1016/0022-2836(70)90379-7; Lee DW, 2011, METHODS MOL BIOL, V774, P59, DOI 10.1007/978-1-61779-234-2_4; Leroch M, 2005, J BIOL CHEM, V280, P17992, DOI 10.1074/jbc.M412462200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Millar AH, 2003, PLANT PHYSIOL, V131, P443, DOI 10.1104/pp.009985; Narayanan A, 2011, PROTEIN SCI, V20, P51, DOI 10.1002/pro.535; Patron NJ, 2004, PLANT PHYSIOL, V135, P2088, DOI 10.1104/pp.104.045203; Picault N, 2004, TRENDS PLANT SCI, V9, P138, DOI 10.1016/j.tplants.2004.01.007; Rosti S, 2006, J EXP BOT, V57, P3619, DOI 10.1093/jxb/erl110; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shannon JC, 1996, PLANT PHYSIOL, V110, P835, DOI 10.1104/pp.110.3.835; Tahir M, 2006, TREE PHYSIOL, V26, P1257, DOI 10.1093/treephys/26.10.1257; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tetlow IJ, 2003, J EXP BOT, V54, P715, DOI 10.1093/jxb/erg088; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tjaden J, 1998, J BIOL CHEM, V273, P9630, DOI 10.1074/jbc.273.16.9630; Wagner S, 2008, P NATL ACAD SCI USA, V105, P14371, DOI 10.1073/pnas.0804090105; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	36	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98524	10.1371/journal.pone.0098524	http://dx.doi.org/10.1371/journal.pone.0098524			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892865	Green Published, Green Submitted, gold			2022-12-27	WOS:000336911400061
J	Sun, LH; Zhuo, K; Lin, BR; Wang, HH; Liao, JL				Sun, Longhua; Zhuo, Kan; Lin, Borong; Wang, Honghong; Liao, Jinling			The Complete Mitochondrial Genome of Meloidogyne graminicola (Tylenchina): A Unique Gene Arrangement and Its Phylogenetic Implications	PLOS ONE			English	Article							PLANT-PARASITIC NEMATODES; AMINO-ACID REPLACEMENT; CONTROL REGION; RNA GENES; EVOLUTION; DNA; MODEL; IDENTIFICATION; SEQUENCES; SELECTION	Meloidogyne graminicola is one of the most economically important plant parasitic-nematodes (PPNs). In the present study, we determined the complete mitochondrial (mt) DNA genome sequence of this plant pathogen. Compared with other PPNs genera, this genome (19,589 bp) is only slightly smaller than that of Pratylenchus vulnus (21,656 bp). The nucleotide composition of the whole mtDNA sequence of M. graminicola is significantly biased toward A and T, with T being the most favored nucleotide and C being the least favored. The A+T content of the entire genome is 83.51%. The mt genome of M. graminicola contains 36 genes (lacking atp8) that are transcribed in the same direction. The gene arrangement of the mt genome of M. graminicola is unique. A total of 21 out of 22 tRNAs possess a DHU loop only, while tRNA(Ser(AGN)) lacks a DHU loop. The two large noncoding regions (2,031 bp and 5,063 bp) are disrupted by tRNA(Ser(UCN)). Phylogenetic analysis based on concatenated amino acid sequences of 12 protein-coding genes support the monophylies of the three orders Rhabditida, Mermithida and Trichinellida, the suborder Rhabditina and the three infraorders Spiruromorpha, Oxyuridomorpha and Ascaridomorpha, but do not support the monophylies of the two suborders Spirurina and Tylenchina, and the three infraorders Rhabditomorpha, Panagrolaimomorpha and Tylenchomorpha. The four Tylenchomorpha species including M. graminicola, P. vulnus, H. glycines and R. similis from the superfamily Tylenchoidea are placed within a well-supported monophyletic clade, but far from the other two Tylenchomorpha species B. xylophilus and B. mucronatus of Aphelenchoidea. In the clade of Tylenchoidea, M. graminicola is sister to P. vulnus, and H. glycines is sister to R. similis, which suggests root-knot nematodes has a closer relationship to Pratylenchidae nematodes than to cyst nematodes.	[Sun, Longhua; Zhuo, Kan; Lin, Borong; Wang, Honghong; Liao, Jinling] South China Agr Univ, Lab Plant Nematol, Guangzhou, Guangdong, Peoples R China; [Sun, Longhua; Zhuo, Kan; Lin, Borong; Wang, Honghong; Liao, Jinling] South China Agr Univ, Guangdong Prov Key Lab Microbial Signals & Dis Co, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; South China Agricultural University	Zhuo, K (corresponding author), South China Agr Univ, Lab Plant Nematol, Guangzhou, Guangdong, Peoples R China.	zhuokan@scau.edu.cn; jlliao@scau.edu.cn			National Key Basic Research Program of China (973 Program) [2013CB127501]; special fund for agro-scientific research in the public interest of China [201103018]; National Natural Science Foundation of China [31171824]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); special fund for agro-scientific research in the public interest of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Key Basic Research Program of China (973 Program) (No. 2013CB127501), the special fund for agro-scientific research in the public interest of China (number 201103018) and the National Natural Science Foundation of China (No. 31171824). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Abascal F, 2007, MOL BIOL EVOL, V24, P1; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bert W, 2008, MOL PHYLOGENET EVOL, V48, P728, DOI 10.1016/j.ympev.2008.04.011; Besnard G, 2014, CR BIOL, V337, P295, DOI 10.1016/j.crvi.2014.03.003; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; De Ley Paul, 2002, P1; Decraemer W, 2006, PLANT NEMATOLOGY, P3, DOI [10.1079/9781845930561.0003, 10.1079/9781780641515.0003]; Geraert E, 1997, NEMATOLOGICA, V43, P283, DOI 10.1163/005025997X00049; Gibson T, 2007, J MOL EVOL, V65, P308, DOI 10.1007/s00239-007-9007-y; Gibson T, 2007, J MOL EVOL, V64, P463, DOI 10.1007/s00239-006-0187-7; Gibson T, 2011, GENOME, V54, P565, DOI [10.1139/G11-024, 10.1139/g11-024]; Gross SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024534; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HARRIS TS, 1990, J NEMATOL, V22, P518; Hassanin A, 2005, SYST BIOL, V54, P277, DOI 10.1080/10635150590947843; He Y, 2005, J MOL EVOL, V61, P819, DOI 10.1007/s00239-005-0102-7; Holterman M, 2009, PHYTOPATHOLOGY, V99, P227, DOI 10.1094/PHYTO-99-3-0227; Holterman M, 2006, MOL BIOL EVOL, V23, P1792, DOI 10.1093/molbev/msl044; Hu M, 2006, TRENDS PARASITOL, V22, P78, DOI 10.1016/j.pt.2005.12.003; HUGALL A, 1994, GENETICS, V136, P903; Hugall A, 1997, MOL BIOL EVOL, V14, P40, DOI 10.1093/oxfordjournals.molbev.a025700; Humphreys-Pereira DA, 2014, MOL BIOCHEM PARASIT, V194, P20, DOI 10.1016/j.molbiopara.2014.04.003; Humphreys-Pereira DA, 2013, NEMATOLOGY, V15, P315, DOI 10.1163/15685411-00002684; Jacob Joachim E M, 2009, BMC Res Notes, V2, P192, DOI 10.1186/1756-0500-2-192; Jex AR, 2010, NUCLEIC ACIDS RES, V38, P522, DOI 10.1093/nar/gkp883; Jones JT, 2013, MOL PLANT PATHOL, V14, P946, DOI 10.1111/mpp.12057; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Lavrov DV, 2007, INTEGR COMP BIOL, V47, P734, DOI 10.1093/icb/icm045; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Liu GH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-414; Liu GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042172; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lunt DH, 1998, MOL ECOL, V7, P1441, DOI 10.1046/j.1365-294x.1998.00495.x; MAGGENTI A R, 1987, Revue de Nematologie, V10, P135; Mancini E, 2008, GENOME, V51, P196, DOI 10.1139/G07-116; Moreira C, 2014, MITOCHONDR DNA, V25, P420, DOI 10.3109/19401736.2013.809438; Morrison D. A., 2010, ARXIV10013813V1; Nicol JM, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P21, DOI 10.1007/978-94-007-0434-3_2; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; OKIMOTO R, 1994, J MOL EVOL, V39, P598, DOI 10.1007/BF00160405; OKIMOTO R, 1991, NUCLEIC ACIDS RES, V19, P1619, DOI 10.1093/nar/19.7.1619; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; POWERS TO, 1993, J NEMATOL, V25, P1; Powers TO, 2005, J NEMATOL, V37, P226; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rybarczyk-Mydlowska K, 2014, NEMATOLOGY, V16, P125, DOI 10.1163/15685411-00002750; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Siddiqi M. R., 2000, TYLENCHIDA PARASITES; Subbotin SA, 2006, NEMATOLOGY, V8, P455, DOI 10.1163/156854106778493420; Sultana T, 2013, GENE, V520, P39, DOI 10.1016/j.gene.2013.02.006; Sultana T, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-12; Tan HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023008; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Whipple LE, 1998, FUND APPL NEMATOL, V21, P265; WOLSTENHOLME DR, 1987, P NATL ACAD SCI USA, V84, P1324, DOI 10.1073/pnas.84.5.1324; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; ZHANG DX, 1995, J MOL EVOL, V40, P382, DOI 10.1007/BF00164024	62	31	31	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98558	10.1371/journal.pone.0098558	http://dx.doi.org/10.1371/journal.pone.0098558			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892428	gold, Green Published, Green Submitted			2022-12-27	WOS:000336911400066
J	Jamsheer, KM; Laxmi, A				Jamsheer, Muhammed K.; Laxmi, Ashverya			DUF581 Is Plant Specific FCS-Like Zinc Finger Involved in Protein-Protein Interaction	PLOS ONE			English	Article							DUF283 DOMAIN; ARABIDOPSIS; GENE; SEQUENCE; RECOGNITION; EVOLUTION; METHYLATION; FAMILY; FOLD; LOCALIZATION	Zinc fingers are a ubiquitous class of protein domain with considerable variation in structure and function. Zf-FCS is a highly diverged group of C-2-C-2 zinc finger which is present in animals, prokaryotes and viruses, but not in plants. In this study we identified that a plant specific domain of unknown function, DUF581 is a zf-FCS type zinc finger. Based on HMM-HMM comparison and signature motif similarity we named this domain as (F) under bar CS-(L) under bar ike (Z) under bar inc finger (FLZ) domain. A genome wide survey identified that FLZ domain containing genes are bryophytic in origin and this gene family is expanded in spermatophytes. Expression analysis of selected FLZ gene family members of A. thaliana identified an overlapping expression pattern suggesting a possible redundancy in their function. Unlike the zf-FCS domain, the FLZ domain found to be highly conserved in sequence and structure. Using a combination of bioinformatic and protein-protein interaction tools, we identified that FLZ domain is involved in protein-protein interaction.	[Jamsheer, Muhammed K.; Laxmi, Ashverya] Natl Inst Plant Genome Res, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Laxmi, A (corresponding author), Natl Inst Plant Genome Res, New Delhi, India.	ashverya_laxmi@nipgr.ac.in		Jamsheer K, Muhammed/0000-0002-2135-8760	National Institute of Plant Genome Research (NIPGR); University Grants Commission, Government of India	National Institute of Plant Genome Research (NIPGR)(Department of Biotechnology (DBT) India); University Grants Commission, Government of India(University Grants Commission, India)	This work was financially supported by the National Institute of Plant Genome Research (NIPGR) core grant and University Grants Commission, Government of India (research fellowship to MJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beuchle D, 2001, DEVELOPMENT, V128, P993; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Brown NP, 1998, BIOINFORMATICS, V14, P380, DOI 10.1093/bioinformatics/14.4.380; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Citovsky V, 2006, J MOL BIOL, V362, P1120, DOI 10.1016/j.jmb.2006.08.017; Coggill P, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-265; Crocco CD, 2010, PLANT J, V64, P551, DOI 10.1111/j.1365-313X.2010.04360.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Datta S, 2007, PLANT CELL, V19, P3242, DOI 10.1105/tpc.107.054791; Dlakic M, 2006, BIOINFORMATICS, V22, P2711, DOI 10.1093/bioinformatics/btl468; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Ettema TJG, 2003, TRENDS BIOCHEM SCI, V28, P170, DOI 10.1016/S0968-0004(03)00037-9; FarzadFard F, 2008, J STRUCT BIOL, V161, P101, DOI 10.1016/j.jsb.2007.09.024; Goldstein RA, 2008, CURR OPIN STRUC BIOL, V18, P170, DOI 10.1016/j.sbi.2008.01.006; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Grimm C, 2009, EMBO J, V28, P1965, DOI 10.1038/emboj.2009.147; He YH, 2004, PLANT MOL BIOL, V54, P1, DOI 10.1023/B:PLAN.0000028730.10834.e3; He YH, 2001, PLANT PHYSIOL, V126, P707, DOI 10.1104/pp.126.2.707; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Jaroszewski L, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000205; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; JONES DT, 1992, NATURE, V358, P86, DOI 10.1038/358086a0; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kohler C, 2008, TRENDS CELL BIOL, V18, P236, DOI 10.1016/j.tcb.2008.02.005; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Kubo K, 1998, NUCLEIC ACIDS RES, V26, P608, DOI 10.1093/nar/26.2.608; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lechtenberg BC, 2009, PROTEIN SCI, V18, P657, DOI 10.1002/pro.51; Perez-Perez JM, 2013, PLANT PHYSIOL, V162, P589, DOI 10.1104/pp.113.217323; Miller RT, 1996, FASEB J, V10, P171, DOI 10.1096/fasebj.10.1.8566539; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Overvoorde PJ, 2005, PLANT CELL, V17, P3282, DOI 10.1105/tpc.105.036723; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Prakash A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025570; Proost S, 2009, PLANT CELL, V21, P3718, DOI 10.1105/tpc.109.071506; Qin HN, 2010, RNA, V16, P474, DOI 10.1261/rna.1965310; Reiter A, 1998, BLOOD, V92, P1735, DOI 10.1182/blood.V92.5.1735.417k11_1735_1742; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Schuster-Bockler B, 2005, BIOINFORMATICS, V21, P2912, DOI 10.1093/bioinformatics/bti434; Sigrist CJA, 2009, NUCLEIC ACIDS RES, V41, pD344; Takatsuji H, 1996, J BIOL CHEM, V271, P23368, DOI 10.1074/jbc.271.38.23368; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tzfira T, 2005, PLANT MOL BIOL, V57, P503, DOI 10.1007/s11103-005-0340-5; van Koningsbruggen S, 2004, J MED GENET, V41, DOI 10.1136/jmg 2003.012781; Wang RJ, 2011, BIOCHEMISTRY-US, V50, P4998, DOI 10.1021/bi101487s; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Wu R, 2005, MOL BIOL CELL, V16, P2872, DOI 10.1091/mbc.e04-11-0997; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang H, 2004, MOL CELL, V14, P841, DOI 10.1016/j.molcel.2004.06.001	57	21	39	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99074	10.1371/journal.pone.0099074	http://dx.doi.org/10.1371/journal.pone.0099074			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901469	gold, Green Published, Green Submitted			2022-12-27	WOS:000336841400092
J	Jurado-Tarifa, E; Napp, S; Gomez-Pacheco, JM; Fernandez-Morente, M; Jaen-Tellez, JA; Arenas, A; Garcia-Bocanegra, I				Jurado-Tarifa, Estefania; Napp, Sebastian; Manuel Gomez-Pacheco, Juan; Fernandez-Morente, Manuel; Antonio Jaen-Tellez, Juan; Arenas, Antonio; Garcia-Bocanegra, Ignacio			Surveillance of Influenza Viruses in Waterfowl Used As Decoys in Andalusia, Spain	PLOS ONE			English	Article							PATHOGENIC AVIAN INFLUENZA; WILD BIRDS; A-VIRUS; EXPERIMENTAL-INFECTION; ACTIVE SURVEILLANCE; SEROLOGICAL SURVEY; DUCKS; H5N1; CIRCULATION; SUBTYPES	A longitudinal study was carried out to determine the seroprevalence of avian influenza viruses (AIVs) in waterfowl used as decoys in Andalusia, southern Spain. A total of 2319 aquatic birds from 193 flocks were analyzed before and after the hunting season 2011-2012. In the first sampling, 403 out of 2319 (18.0%, CI95%: 15.8-19.0) decoys showed antibodies against AIVs by ELISA. The AI seroprevalence was significantly higher in geese (21.0%) than in ducks (11.7%) (P<0.001). Besides, the spatial distribution of AIVs was not homogeneous as significant differences among regions were observed. The prevalence of antibodies against AIVs subtypes H5 and H7 were 1.1% and 0.3%, respectively, using hemagglutination inhibition test (HI). The overall and H5 seroprevalences slightly increased after the hunting period (to 19.2% and 1.4%, respectively), while the H7 seroprevalence remained at the same level (0.3%). The proportion of flocks infected by AIVs was 65.3%, while 11.2% and 4.9% of flocks were positive for H5 and H7, respectively. Viral shedding was not detected in any of the 47 samples positive by both ELISA and HI, tested by RRT-PCR. The individual incidence after the hunting season was 3.4%. The fact that 57 animals seroconverted, 15 of which were confirmed by HI (12 H5 and 3 H7), was indication of contact with AIVs during the hunting period. The results indicate that waterfowl used as decoys are frequently exposed to AIVs and may be potentially useful as sentinels for AIVs monitoring. The seroprevalence detected and the seropositivity against AIVs H5 and H7, suggest that decoys can act as reservoirs of AIVs, which may be of animal and public health concern.	[Jurado-Tarifa, Estefania; Arenas, Antonio; Garcia-Bocanegra, Ignacio] Univ Cordoba, Fac Vet, Dept Sanidad Anim, Cordoba, Spain; [Napp, Sebastian] UAB, IRTA, Ctr Recerca Sanitat Anim CReSA, Barcelona, Spain; [Manuel Gomez-Pacheco, Juan] Consejeria Agr Pesca & Desarrollo Rural Junta And, Lab Sanidad & Prod Anim, Cordoba, Spain; [Fernandez-Morente, Manuel] Consejeria Agr Pesca & Desarrollo Rural Junta And, Serv Sanidad Anim, Seville, Spain; [Antonio Jaen-Tellez, Juan] Consejeria Agr Pesca & Desarrollo Rural Junta And, Agencia Gest Agr & Pesquera Andalucia, Seville, Spain	Universidad de Cordoba; Autonomous University of Barcelona; IRTA	Garcia-Bocanegra, I (corresponding author), Univ Cordoba, Fac Vet, Dept Sanidad Anim, Agrifood Excellence Int Campus, Cordoba, Spain.	nacho.garcia@uco.es	Bocanegra, Ignacio Garcia/G-1443-2016; ARENAS, Antonio J/I-3997-2017; Napp, Sebastian/F-3331-2016	Bocanegra, Ignacio Garcia/0000-0003-3388-2604; ARENAS, Antonio J/0000-0001-5334-2440; Napp, Sebastian/0000-0001-5813-7286; Jaen Tellez, Juan Antonio/0000-0002-7570-6687	Regional Ministry of Agriculture and Fisheries of the Government of Andalusia, Spain	Regional Ministry of Agriculture and Fisheries of the Government of Andalusia, Spain	The following funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was partially supported by Regional Ministry of Agriculture and Fisheries of the Government of Andalusia, Spain. No additional external funding received for this study.	Alba A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044354; Albayrak H, 2010, ZOONOSES PUBLIC HLTH, V57, pE71, DOI 10.1111/j.1863-2378.2010.01327.x; Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; ARENAS A, 1990, AVIAN PATHOL, V19, P539, DOI 10.1080/03079459008418706; ASTORGA RJ, 1994, AVIAN PATHOL, V23, P339, DOI 10.1080/03079459408419001; Barral M, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-50; Baumer A, 2010, AVIAN DIS, V54, P875, DOI 10.1637/9119-110209-Reg.1; Bragstad K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-43; Brown JD, 2008, EMERG INFECT DIS, V14, P136, DOI 10.3201/eid1401.070740; Busquets N, 2010, VIRUS RES, V149, P10, DOI 10.1016/j.virusres.2009.12.005; Cattoli G, 2007, AVIAN DIS, V51, P414, DOI 10.1637/7562-033106R.1; De Marco MA, 2005, AVIAN PATHOL, V34, P480, DOI 10.1080/03079450500368185; De Marco MA, 2004, VET MICROBIOL, V98, P197, DOI 10.1016/j.vetmic.2003.10.018; Delogu M, 2012, AVIAN DIS, V56, P1034, DOI 10.1637/10174-041012-ResNote.1; Fereidouni SR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-43; Fink M, 2010, J VIROL, V84, P5815, DOI 10.1128/JVI.01642-09; Fouchier RAM, 2003, AVIAN DIS, V47, P857, DOI 10.1637/0005-2086-47.s3.857; Germundsson A, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-28; Gilbert M, 2008, P NATL ACAD SCI USA, V105, P4769, DOI 10.1073/pnas.0710581105; Henriques AM, 2011, AVIAN PATHOL, V40, P597, DOI 10.1080/03079457.2011.618943; Iglesias I, 2010, TRANSBOUND EMERG DIS, V57, P282, DOI 10.1111/j.1865-1682.2010.01145.x; Iqbal M, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-100; Jonassen CM, 2007, AVIAN DIS, V51, P425, DOI 10.1637/7555-033106R1.1; Jourdain E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008935; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; Kelvin AA, 2012, J INFECT DEV COUNTR, V6, P786, DOI 10.3855/jidc.2793; Kim JK, 2009, INFLUENZA OTHER RESP, V3, P121, DOI 10.1111/j.1750-2659.2009.00084.x; Lang V, 2010, ZOONOSES PUBLIC HLTH, V57, pE184, DOI 10.1111/j.1863-2378.2010.01326.x; Latorre-Margalef N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003443; Lebarbenchon C, 2012, J VET DIAGN INVEST, V24, P161, DOI 10.1177/1040638711416626; Lebarbenchon C, 2010, AVIAN DIS, V54, P446, DOI 10.1637/8665-022509-ResNote.1; Lebarbenchon C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007289; Lewis NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058534; Lindh E, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-35; Marche S, 2014, TRANSBOUND EMERG DIS, V61, P526, DOI 10.1111/tbed.12056; Martinez M, 2009, TRANSBOUND EMERG DIS, V56, P86, DOI 10.1111/j.1865-1682.2008.01062.x; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Nicoll A, 2013, EUROSURVEILLANCE, V18, P2; Nielsen AA, 2013, VET MICROBIOL, V166, P419, DOI 10.1016/j.vetmic.2013.06.024; OIE website, 2008, MAN DIAGN TESTS VACC, V1; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Pannwitz G, 2009, J WILDLIFE DIS, V45, P512, DOI 10.7589/0090-3558-45.2.512; Perez-Ramirez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046418; Perez-Ramirez E, 2010, VET MICROBIOL, V146, P200, DOI 10.1016/j.vetmic.2010.05.008; Rabl S, 2009, BERL MUNCH TIERARZTL, V122, P486, DOI 10.2376/0005-9366-122-486; Schenk C, 2013, EURO SURVEILL, V18; Siembieda JL, 2010, VECTOR-BORNE ZOONOT, V10, P793, DOI 10.1089/vbz.2009.0095; Slavec B, 2012, AVIAN DIS, V56, P999, DOI 10.1637/10175-041012-ResNote.1; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Spackman E, 2009, POULTRY SCI, V88, P847, DOI 10.3382/ps.2008-00336; Spackman E, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-331; Sturm-Ramirez KM, 2005, J VIROL, V79, P11269, DOI 10.1128/JVI.79.17.11269-11279.2005; Terregino C, 2007, AVIAN PATHOL, V36, P337, DOI 10.1080/03079450701488345; Thrusfield M, 1997, VET EPIDEMIOLOGY, V2nd, P182; Tolf C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049002; Tonnessen R, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-112; Tsiodras S, 2008, J INFECTION, V56, P83, DOI 10.1016/j.jinf.2007.11.001; Vergara-Alert J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058692; Verhagen JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038256; Vittecoq M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043974; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; Webster RG, 2004, REV SCI TECH OIE, V23, P453, DOI 10.20506/rst.23.2.1493; Wilson HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058308; Wunderwald C, 2002, AVIAN PATHOL, V31, P157, DOI 10.1080/03079450120118649; Yang P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050770	66	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98890	10.1371/journal.pone.0098890	http://dx.doi.org/10.1371/journal.pone.0098890			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901946	Green Published, gold, Green Submitted			2022-12-27	WOS:000336841400067
J	Sequeira, IR; Lentle, RG; Kruger, MC; Hurst, RD				Sequeira, Ivana R.; Lentle, Roger G.; Kruger, Marlena C.; Hurst, Roger D.			Standardising the Lactulose Mannitol Test of Gut Permeability to Minimise Error and Promote Comparability	PLOS ONE			English	Article							INTESTINAL PERMEABILITY; CROHNS-DISEASE; CELIAC-DISEASE; GASTROINTESTINAL TRANSIT; GLUCOSE-TOLERANCE; INSULIN-SECRETION; SUGAR ABSORPTION; DEGREE RELATIVES; CAPSULE; LENGTH	Background: Lactulose mannitol ratio tests are clinically useful for assessing disorders characterised by changes in gut permeability and for assessing mixing in the intestinal lumen. Variations between currently used test protocols preclude meaningful comparisons between studies. We determined the optimal sampling period and related this to intestinal residence. Methods: Half-hourly lactulose and mannitol urinary excretions were determined over 6 hours in 40 healthy female volunteers after administration of either 600 mg aspirin or placebo, in randomised order at weekly intervals. Gastric and small intestinal transit times were assessed by the SmartPill in 6 subjects from the same population. Half-hourly percentage recoveries of lactulose and mannitol were grouped on a basis of compartment transit time. The rate of increase or decrease of each sugar within each group was explored by simple linear regression to assess the optimal period of sampling. Key Results: The between subject standard errors for each half-hourly lactulose and mannitol excretion were lowest, the correlation of the quantity of each sugar excreted with time was optimal and the difference between the two sugars in this temporal relationship maximal during the period from 2K-4 h after ingestion. Half-hourly lactulose excretions were generally increased after dosage with aspirin whilst those of mannitol were unchanged as was the temporal pattern and period of lowest between subject standard error for both sugars. Conclusion: The results indicate that between subject variation in the percentage excretion of the two sugars would be minimised and the differences in the temporal patterns of excretion would be maximised if the period of collection of urine used in clinical tests of small intestinal permeability were restricted to 2K-4 h post dosage. This period corresponds to a period when the column of digesta column containing the probes is passing from the small to the large intestine.	[Sequeira, Ivana R.; Lentle, Roger G.; Kruger, Marlena C.] Massey Univ, Inst Food Nutr & Human Hlth, Palmerston North, New Zealand; [Hurst, Roger D.] New Zealand Inst Plant & Food Res Ltd, Palmerston North, New Zealand	Massey University; New Zealand Institute for Plant & Food Research Ltd	Lentle, RG (corresponding author), Massey Univ, Inst Food Nutr & Human Hlth, Palmerston North, New Zealand.	R.G.Lentle@massey.ac.nz	Sequeira, Ivana/AAG-3501-2020; Hurst, Roger D/B-9460-2014	Sequeira, Ivana/0000-0001-5414-9925; Hurst, Roger D/0000-0002-4097-1368	Ministry of Business Innovation and Employment, New Zealand [C06X0807]	Ministry of Business Innovation and Employment, New Zealand(New Zealand Ministry of Business, Innovation and Employment (MBIE))	This work was funded by the Ministry of Business Innovation and Employment (formerly Science and Innovation), New Zealand, contract number C06X0807, awarded to The New Zealand Institute for Plant and Food Research Limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRE F, 1988, GUT, V29, P511, DOI 10.1136/gut.29.4.511; Arrieta MC, 2006, GUT, V55, DOI 10.1136/gut.2005.085373; BJARNASON I, 1995, GASTROENTEROLOGY, V108, P1566, DOI 10.1016/0016-5085(95)90708-4; BRADEN B, 1995, GASTROENTEROLOGY, V108, P1048, DOI 10.1016/0016-5085(95)90202-3; Cassilly D, 2008, NEUROGASTROENT MOTIL, V20, P311, DOI 10.1111/j.1365-2982.2007.01061.x; Dastych M, 2008, DIGEST DIS SCI, V53, P2789, DOI 10.1007/s10620-007-0184-8; DATZ FL, 1987, J NUCL MED, V28, P1204; DeMeo MT, 2002, J CLIN GASTROENTEROL, V34, P385, DOI 10.1097/00004836-200204000-00003; Ehrmann DA, 1999, DIABETES CARE, V22, P141, DOI 10.2337/diacare.22.1.141; Farhadi A, 2003, J GASTROEN HEPATOL, V18, P479, DOI 10.1046/j.1440-1746.2003.03032.x; Farhadi A, 2010, ALCOHOL, V44, P447, DOI 10.1016/j.alcohol.2010.05.004; FINK AS, 1983, AM J PHYSIOL, V245, pG85, DOI 10.1152/ajpgi.1983.245.1.G85; Fleming SC, 1996, CLIN CHEM, V42, P445; Halme L, 2000, SCAND J CLIN LAB INV, V60, P695, DOI 10.1080/00365510050216420; Hilsden RJ, 1996, GASTROENTEROLOGY, V110, P1395, DOI 10.1053/gast.1996.v110.pm8613043; HOLLANDER D, 1992, SCAND J GASTROENTERO, V27, P721, DOI 10.3109/00365529209011172; Hollander D, 1999, Curr Gastroenterol Rep, V1, P410, DOI 10.1007/s11894-999-0023-5; Holst JJ, 2004, AM J PHYSIOL-ENDOC M, V287, pE199, DOI 10.1152/ajpendo.00545.2003; HOROWITZ M, 1985, BRIT J OBSTET GYNAEC, V92, P743, DOI 10.1111/j.1471-0528.1985.tb01458.x; HUNT JN, 1954, J PHYSIOL-LONDON, V126, P459, DOI 10.1113/jphysiol.1954.sp005222; Kloetzer L, 2010, NEUROGASTROENT MOTIL, V22, P527, DOI 10.1111/j.1365-2982.2010.01468.x; KRUGLIAK P, 1994, DIGEST DIS SCI, V39, P796, DOI 10.1007/BF02087426; Kwiatek MA, 2009, AM J PHYSIOL-GASTR L, V297, pG894, DOI 10.1152/ajpgi.00117.2009; Lambert GP, 2007, INT J SPORTS MED, V28, P722, DOI 10.1055/s-2007-964891; Lambert GP, 2012, INT J SPORTS MED, V33, P421, DOI 10.1055/s-0032-1301892; Lentle RG, 2010, CRIT REV FOOD SCI, V50, P130, DOI 10.1080/10408390802248726; Lichtenberger LM, 2012, BBA-MOL CELL BIOL L, V1821, P994, DOI 10.1016/j.bbalip.2012.04.002; LIN HC, 1989, AM J PHYSIOL, V256, pG404, DOI 10.1152/ajpgi.1989.256.2.G404; LIN HC, 1990, AM J PHYSIOL, V259, pG1025, DOI 10.1152/ajpgi.1990.259.6.G1025; LIN HC, 1990, AM J PHYSIOL, V259, pG1031, DOI 10.1152/ajpgi.1990.259.6.G1031; Ma TY, 1997, P SOC EXP BIOL MED, V214, P318; Mahmud T, 1996, ANN RHEUM DIS, V55, P211, DOI 10.1136/ard.55.4.211; Maqbool S, 2009, DIGEST DIS SCI, V54, P2167, DOI 10.1007/s10620-009-0899-9; MENZIES IS, 1979, LANCET, V2, P1107; Meyer JH, 1998, AM J PHYSIOL-REG I, V275, pR1308, DOI 10.1152/ajpregu.1998.275.4.R1308; MOJAVERIAN P, 1991, PHARM RES-DORDR, V8, P97, DOI 10.1023/A:1015894626403; MOJAVERIAN P, 1989, PHARMACEUT RES, V6, P719, DOI 10.1023/A:1015998708560; MUNKHOLM P, 1994, GUT, V35, P68, DOI 10.1136/gut.35.1.68; Parkman Henry P, 2009, Gastrointest Endosc Clin N Am, V19, P49, DOI 10.1016/j.giec.2008.12.003; PRYTZ H, 1989, SCAND J GASTROENTERO, V24, P1084, DOI 10.3109/00365528909089259; Rao AS, 2011, AM J PHYSIOL-GASTR L, V301, pG919, DOI 10.1152/ajpgi.00168.2011; Rao SSC, 2011, NEUROGASTROENT MOTIL, V23, P8, DOI 10.1111/j.1365-2982.2010.01612.x; Sequeira IR, 2012, NEUROGASTROENT MOTIL, V24, pe401, DOI 10.1111/j.1365-2982.2012.01969.x; Sequeira IR, 2013, CLIN EXPT PHARM PHYS; Smecuol E, 2009, CLIN GASTROENTEROL H, V7, P524, DOI 10.1016/j.cgh.2008.12.019; Soderholm JD, 1999, GUT, V44, P96, DOI 10.1136/gut.44.1.96; TAI MM, 1994, DIABETES CARE, V17, P152, DOI 10.2337/diacare.17.2.152; Timm D, 2011, BRIT J NUTR, V105, P1337, DOI 10.1017/S0007114510004988; Uil JJ, 2000, DIGEST LIVER DIS, V32, P195, DOI 10.1016/S1590-8658(00)80820-8; van Nieuwenhoven MA, 1999, EUR J CLIN INVEST, V29, P160, DOI 10.1046/j.1365-2362.1999.00421.x; van Wijck K, 2012, CLIN NUTR; VANELBURG RM, 1995, J PEDIATR GASTR NUTR, V20, P184, DOI 10.1097/00005176-199502000-00008; VANELBURG RM, 1993, GUT, V34, P354, DOI 10.1136/gut.34.3.354; Vilsboll T, 2004, DIABETOLOGIA, V47, P357, DOI 10.1007/s00125-004-1342-6; VOGELSANG H, 1995, AM J GASTROENTEROL, V90, P1838; Wilkinson L, 2010, WIRES COMPUT STAT, V2, P256, DOI 10.1002/wics.66	56	63	64	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99256	10.1371/journal.pone.0099256	http://dx.doi.org/10.1371/journal.pone.0099256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901524	Green Published, gold, Green Submitted			2022-12-27	WOS:000336841400114
J	Yang, TT; Goodkin, NF				Yang, Teng Teng; Goodkin, Nathalie Fairbank			Wet Season Upwelling and Dry Season Chlorophyll-a Describe Interannual Growth Rates of Porites in Southern China	PLOS ONE			English	Article							DENSITY BAND FORMATION; SKELETAL GROWTH; CORAL SKELETONS; REEF; COASTAL; PHOTOSYNTHESIS; COMMUNITIES; RESILIENCE; SALINITY; PATTERNS	Southern China hosts coral communities in marginal environments that are characterized by low linear extension rates, low coral cover and/or no reef formation, thus providing natural laboratories to study coral communities with below average growth rates. Here we compare the annual linear extension rates over 10 years (range 1.2 to 11.4 mm yr(-1)) of six Porites sp. coral cores collected from Hong Kong with monthly hydrographic data from the Hong Kong Environmental Protection Department. At all sites, low-density, dry season extension were more variable than high-density, wet season extension and on average, was lower at two of the three sites. We applied multi-variate linear regressions that revealed high-density, wet season band extension to inversely correlate most significantly to temperature (r = -0.39, p<0.01). In contrast, low-density, dry season band extension was more variable and correlated most significantly with dry season chlorophyll-a (Chl-a) (r = 0.64, p<0.001). Additionally, we find that corals at the site with highest dry season Chl-a have the highest dry season extension lengths. Our findings indicate that relative mixing of fresh and salt water in the wet season and primary productivity in the dry season, and their influences on aragonite saturation, are likely to impact interannual coral extension variability in marginal environments.	[Yang, Teng Teng] Univ Hong Kong, Dept Earth Sci, Hong Kong, Hong Kong, Peoples R China; [Goodkin, Nathalie Fairbank] Univ Hong Kong, Swire Inst Marine Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Goodkin, NF (corresponding author), Univ Hong Kong, Swire Inst Marine Sci, Hong Kong, Hong Kong, Peoples R China.	nathalie@ntu.edu.sg		Goodkin, Nathalie/0000-0001-9697-5520	General Research Fund of HK [GRF-HKU702509P]; Ocean Park Conservation Foundation; National Research Foundation Singapore under its Singapore NRF Fellowship scheme (National Research Fellow Award) [NRFF-2012-03]; National Research Foundation Singapore; Singapore Ministry of Education under the Research Centres of Excellence initiative	General Research Fund of HK; Ocean Park Conservation Foundation; National Research Foundation Singapore under its Singapore NRF Fellowship scheme (National Research Fellow Award)(National Research Foundation, Singapore); National Research Foundation Singapore(National Research Foundation, Singapore); Singapore Ministry of Education under the Research Centres of Excellence initiative(Ministry of Education, Singapore)	The General Research Fund of HK (GRF-HKU702509P) and Ocean Park Conservation Foundation provided funding. This research is also supported by the National Research Foundation Singapore under its Singapore NRF Fellowship scheme (National Research Fellow Award No. NRFF-2012-03) and administered by Earth Observatory of Singapore, the National Research Foundation Singapore and the Singapore Ministry of Education under the Research Centres of Excellence initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. (http://www.ugc.edu.hk/eng/rgc/grf/grf.htm; http://www.opcf.org.hk/en/; http://www.nrf.gov.sg; http://www.moe.gov.sg).	Al-Horani FA, 2005, CORAL REEFS, V24, P173, DOI 10.1007/s00338-004-0461-3; Ang P, 2010, STATUS CORAL REEFS E, P65; Anthony KRN, 2006, MAR ECOL PROG SER, V319, P111, DOI 10.3354/meps319111; Anthony KRN, 2000, CORAL REEFS, V19, P59, DOI 10.1007/s003380050227; Anthony KRN, 2000, J EXP MAR BIOL ECOL, V252, P221, DOI 10.1016/S0022-0981(00)00237-9; BARNES DJ, 1993, J EXP MAR BIOL ECOL, V167, P91, DOI 10.1016/0022-0981(93)90186-R; Buddemeier RW, 1999, AM ZOOL, V39, P1; Cantin NE, 2010, SCIENCE, V329, P322, DOI 10.1126/science.1190182; Cooper TF, 2007, ESTUAR COAST SHELF S, V74, P458, DOI 10.1016/j.ecss.2007.05.020; Cooper TF, 2012, SCIENCE, V335, P593, DOI 10.1126/science.1214570; Dai MH, 2008, CONT SHELF RES, V28, P1416, DOI 10.1016/j.csr.2007.04.018; DeLong KL, 2013, PALAEOGEOGR PALAEOCL, V373, P6, DOI 10.1016/j.palaeo.2012.08.019; DEVANTIER L, 2003, CORALS CORAL COMMUNI; DODGE RE, 1974, EARTH PLANET SC LETT, V23, P313, DOI 10.1016/0012-821X(74)90121-6; Doney S C, 2013, INT GEOPHYS SERIES, P817, DOI [10.1016/B978-0-12-391851-2.00031-3, DOI 10.1016/B978-0-12-391851-2.00031-3]; Edinger EN, 2000, MAR POLLUT BULL, V40, P404, DOI 10.1016/S0025-326X(99)00237-4; Emerson S, 2008, CHEMICAL OCEANOGRAPHY AND THE MARINE CARBON CYCLE, P1, DOI 10.1017/CBO9780511793202; EPD, 2010, MAR WAT QUAL HONG KO; Fabricius KE, 2006, MAR POLLUT BULL, V52, P22, DOI 10.1016/j.marpolbul.2005.08.004; Glover D. M., 2011, MODELING METHODS MAR; Goodkin NF, 2011, MAR ECOL PROG SER, V426, P185, DOI 10.3354/meps09019; Goodkin NF, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001140; Guinotte JM, 2003, CORAL REEFS, V22, P551, DOI 10.1007/s00338-003-0331-4; Haapkyla J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016893; Harrison PJ, 2008, CONT SHELF RES, V28, P1405, DOI 10.1016/j.csr.2007.02.011; Helmle KP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1222; Hennige SJ, 2010, J EXP MAR BIOL ECOL, V391, P143, DOI 10.1016/j.jembe.2010.06.019; HOAGLIN DC, 1987, J AM STAT ASSOC, V82, P1147, DOI 10.1080/01621459.1987.10478551; Houlbreque F, 2003, J EXP MAR BIOL ECOL, V296, P145, DOI 10.1016/S0022-0981(03)00259-4; Inoue M, 2006, ENVIRON POLLUT, V144, P1045, DOI 10.1016/j.envpol.2005.11.048; KLEIN R, 1991, MAR ECOL PROG SER, V77, P253, DOI 10.3354/meps077253; Lam K, 2007, MARINE POLLUTION B, V54, P97; LAPOINTE BE, 1992, ESTUARIES, V15, P465, DOI 10.2307/1352391; Lee JHW, 2006, ENVIRONMENT IN ASIA PACIFIC HARBOURS, P187, DOI 10.1007/1-4020-3655-8_13; Libes S.M., 1992, INTRO MARINE BIOGEOC; Lirman D, 2009, J EXP MAR BIOL ECOL, V369, P72, DOI 10.1016/j.jembe.2008.10.024; Lough JM, 2011, EARTH-SCI REV, V108, P170, DOI 10.1016/j.earscirev.2011.07.001; Lough JM, 2000, J EXP MAR BIOL ECOL, V245, P225, DOI 10.1016/S0022-0981(99)00168-9; LOUGH JM, 1990, J EXP MAR BIOL ECOL, V135, P35, DOI 10.1016/0022-0981(90)90197-K; Manzello D, 2003, CORAL REEFS, V22, P537, DOI 10.1007/s00338-003-0327-0; McCorry D, 1999, CORAL REEFS, V18, P408, DOI 10.1007/s003380050219; MUCCI A, 1983, AM J SCI, V283, P780, DOI 10.2475/ajs.283.7.780; Perry CT, 2003, CORAL REEFS, V22, P485, DOI 10.1007/s00338-003-0339-9; Perry CT, 2003, CORAL REEFS, V22, P427, DOI 10.1007/s00338-003-0330-5; Porter JW, 1999, LIMNOL OCEANOGR, V44, P941, DOI 10.4319/lo.1999.44.3_part_2.0941; Reynaud S, 2003, GLOBAL CHANGE BIOL, V9, P1660, DOI 10.1046/j.1365-2486.2003.00678.x; Riegl B, 1999, CORAL REEFS, V18, P63, DOI 10.1007/s003380050156; Roberts LG, 2003, CORAL REEFS, V22, P517, DOI 10.1007/s00338-003-0337-y; Schleyer M.H., 2003, Zoologische Verhandelingen (Leiden), V345, P387; SCOTT PJB, 1990, J EXP MAR BIOL ECOL, V139, P51, DOI 10.1016/0022-0981(90)90038-E; Szmant AM, 2002, ESTUARIES, V25, P743, DOI 10.1007/BF02804903; Tanzil JTI, 2009, CORAL REEFS, V28, P519, DOI 10.1007/s00338-008-0457-5; TAYLOR RB, 1993, J EXP MAR BIOL ECOL, V167, P109, DOI 10.1016/0022-0981(93)90187-S; Wicks LC, 2010, MAR ECOL PROG SER, V400, P101, DOI 10.3354/meps08398; Yuan XC, 2011, BIOGEOSCIENCES, V8, P289, DOI 10.5194/bg-8-289-2011; Zeebe R. E., 2001, CO2 SEAWATER EQUILIB	56	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99088	10.1371/journal.pone.0099088	http://dx.doi.org/10.1371/journal.pone.0099088			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901939	Green Published, gold			2022-12-27	WOS:000336841400095
J	Yu, YY; Jin, J; Liu, F; Crozier, S				Yu, Yeyang; Jin, Jin; Liu, Feng; Crozier, Stuart			Multidimensional Compressed Sensing MRI Using Tensor Decomposition-Based Sparsifying Transform	PLOS ONE			English	Article							LOW-RANK STRUCTURE; K-T BLAST; SIGNAL RECONSTRUCTION; MATRIX COMPLETION; SPARSITY; FOCUSS; REGULARIZATION	Compressed Sensing (CS) has been applied in dynamic Magnetic Resonance Imaging (MRI) to accelerate the data acquisition without noticeably degrading the spatial-temporal resolution. A suitable sparsity basis is one of the key components to successful CS applications. Conventionally, a multidimensional dataset in dynamic MRI is treated as a series of two-dimensional matrices, and then various matrix/vector transforms are used to explore the image sparsity. Traditional methods typically sparsify the spatial and temporal information independently. In this work, we propose a novel concept of tensor sparsity for the application of CS in dynamic MRI, and present the Higher-order Singular Value Decomposition (HOSVD) as a practical example. Applications presented in the three-and four-dimensional MRI data demonstrate that HOSVD simultaneously exploited the correlations within spatial and temporal dimensions. Validations based on cardiac datasets indicate that the proposed method achieved comparable reconstruction accuracy with the low-rank matrix recovery methods and, outperformed the conventional sparse recovery methods.	[Yu, Yeyang; Jin, Jin; Liu, Feng; Crozier, Stuart] Univ Queensland, Sch Informat Technol & Elect Engn, St Lucia, Qld, Australia	University of Queensland	Yu, YY (corresponding author), Univ Queensland, Sch Informat Technol & Elect Engn, St Lucia, Qld, Australia.	yeyang.yu@uqconnect.edu.au	; liu, feng/B-3050-2019	Crozier, Stuart/0000-0003-4036-2930; liu, feng/0000-0002-1074-2601				Akcakaya M, 2011, MAGN RESON MED, V66, P756, DOI 10.1002/mrm.22841; Brinegar C, 2009, IEEE ENG MED BIO, P4383, DOI 10.1109/IEMBS.2009.5333482; Brinegar C, 2008, IEEE ENG MED BIO, P3381, DOI 10.1109/IEMBS.2008.4649931; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Candes E, 2007, INVERSE PROBL, V23, P969, DOI 10.1088/0266-5611/23/3/008; Candes EJ, 2006, COMMUN PUR APPL MATH, V59, P1207, DOI 10.1002/cpa.20124; Candes EJ, 2010, P IEEE, V98, P925, DOI 10.1109/JPROC.2009.2035722; Candes EJ, 2009, FOUND COMPUT MATH, V9, P717, DOI 10.1007/s10208-009-9045-5; Chartrand R, 2008, INT CONF ACOUST SPEE, P3869, DOI 10.1109/ICASSP.2008.4518498; Chartrand R, 2007, IEEE SIGNAL PROC LET, V14, P707, DOI 10.1109/LSP.2007.898300; Chartrand R, 2008, INVERSE PROBL, V24, DOI 10.1088/0266-5611/24/3/035020; Chartrand R, 2009, I S BIOMED IMAGING, P262, DOI 10.1109/ISBI.2009.5193034; Comon P, 2002, INST MATH C, P1; Dai W, 2010, INT CONF ACOUST SPEE, P3646, DOI 10.1109/ICASSP.2010.5495899; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; ElShahaby FEA, 2011, PROC SPIE, V7962, DOI 10.1117/12.878382; Fischer A, 2008, P 16 ANN M ISMRM TOR; GORODNITSKY IF, 1995, ELECTROEN CLIN NEURO, V95, P231, DOI 10.1016/0013-4694(95)00107-A; Gorodnitsky IF, 1997, IEEE T SIGNAL PROCES, V45, P600, DOI 10.1109/78.558475; HAASE A, 1990, MAGN RESON MED, V13, P77, DOI 10.1002/mrm.1910130109; Haldar JP, 2011, I S BIOMED IMAGING, P1052, DOI 10.1109/ISBI.2011.5872582; Haldar JP, 2010, I S BIOMED IMAGING, P716, DOI 10.1109/ISBI.2010.5490076; Hitchcock F. L., 1927, J MATH PHYS, V6, P164, DOI 10.1002/sapm192761164; Hitchcock FL., 1927, J MATH PHYS, V7, P39, DOI [DOI 10.1002/SAPML9287139, DOI 10.1002/SAPM19287139]; Hong MJ, 2011, PHYS MED BIOL, V56, P6311, DOI 10.1088/0031-9155/56/19/010; Jung H, 2007, PHYS MED BIOL, V52, P3201, DOI 10.1088/0031-9155/52/11/018; Jung H, 2009, MAGN RESON MED, V61, P103, DOI 10.1002/mrm.21757; Kolda TG, 2009, SIAM REV, V51, P455, DOI 10.1137/07070111X; Lee K, 2010, IEEE T INFORM THEORY, V56, P4402, DOI 10.1109/TIT.2010.2054251; Liang D, 2011, I S BIOMED IMAGING, P1264, DOI 10.1109/ISBI.2011.5872631; Lingala SG, 2011, IEEE T MED IMAGING, V30, P1042, DOI 10.1109/TMI.2010.2100850; Lustig M, 2008, IEEE SIGNAL PROC MAG, V25, P72, DOI 10.1109/MSP.2007.914728; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; Ma S., 2008, P IEEE C COMP VIS PA, P1, DOI DOI 10.1109/CVPR.2008.4587391; Majumdar A, 2012, MAGN RESON IMAGING, V30, P1483, DOI 10.1016/j.mri.2012.04.012; Majumdar A, 2010, LECT NOTES COMPUT SC, V6363, P513; Majumdar A, 2011, MAGN RESON IMAGING, V29, P408, DOI 10.1016/j.mri.2010.09.001; Meka R., 2009, ARXIV09095457; Miao J, 2011, P 19 ANN M ISMRM MON; Osher S, 2005, MULTISCALE MODEL SIM, V4, P460, DOI 10.1137/040605412; Pauly, 2006, P 13 ANN M ISMRM SEA; Prieto C, 2013, MAGN RESON MED, V69, P1169, DOI 10.1002/mrm.24333; Ramirez-Giraldo JC, 2011, MED PHYS, V38, P2157, DOI 10.1118/1.3560878; Recht B, 2010, SIAM REV, V52, P471, DOI 10.1137/070697835; RUDIN LI, 1992, PHYSICA D, V60, P259, DOI 10.1016/0167-2789(92)90242-F; Saab R, 2008, INT CONF ACOUST SPEE, P3885, DOI 10.1109/ICASSP.2008.4518502; STEHLING MK, 1991, SCIENCE, V254, P43, DOI 10.1126/science.1925560; Trzasko J., 2011, P 19 ANN M ISMRM, V19, P4371; Trzasko J, 2013, UNIFIED TENSOR REGRE; Trzasko J, 2009, I S BIOMED IMAGING, P274, DOI 10.1109/ISBI.2009.5193037; Trzasko JD, 2013, PROC SPIE, V8858, DOI 10.1117/12.2027059; Trzasko JD, 2011, MAGN RESON MED, V66, P1019, DOI 10.1002/mrm.22892; TUCKER LR, 1966, PSYCHOMETRIKA, V31, P279, DOI 10.1007/BF02289464; Wang SJ, 2012, INT C PATT RECOG, P2278; Wang SJ, 2012, IEEE T NEUR NET LEAR, V23, P876, DOI 10.1109/TNNLS.2012.2191620; Yu YY, 2011, IEEE ENG MED BIO, P5734, DOI 10.1109/IEMBS.2011.6091419; Zhi-Pei Liang, 2007, 2007 Joint Meeting of the 6th International Symposium on Noninvasive Functional Source Imaging of the Brain and Heart and the International Conference on Functional Biomedical Imaging, P181	61	28	32	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98441	10.1371/journal.pone.0098441	http://dx.doi.org/10.1371/journal.pone.0098441			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901331	Green Submitted, gold, Green Published			2022-12-27	WOS:000336841400028
J	Zhao, L; Li, Y				Zhao, Lei; Li, Yan			The C-TERMINUS of AtGRIP Is Crucial for Its Self-Association and for Targeting to Golgi Stacks in Arabidopsis	PLOS ONE			English	Article							GRIP-DOMAIN PROTEINS; TRANS-GOLGI; STRUCTURAL BASIS; NETWORK; LOCALIZATION; GTPASE; RECRUITMENT; TRAFFICKING; DYNAMICS; SYSTEM	Background: In animals and fungi, dimerization is crucial for targeting GRIP domain proteins to one gene in the Arabidopsis genome, AtGRIP, codes for a GRIP domain protein. It remains unclear properties similar to those of GRIP domain proteins the Golgi apparatus Only ar whether AtGRIP has Results: In this study, western blot and yea two-hybrid analyses indicated that AtGRIPs could form a parallel homodlmer In addition, yeas h two-hybrid analysis indicated a AtGRIR(aa71-75), AtGRIP(aa711-766) and AtGRIP(aa711-776) did no interact with themselves, but h intact GRIP domain with he AtGRIP C-terminus did. Confocal microscopy that only an intact GRIP domain with the AtGRIP C-terminus could localize to the Golgi a P in Arabidopsis leaf protoplasts. A BLAST analysis showed that C-terminus of GRIP proteins was conserved in the plant kingdom. Mutagenesis and yeast two hybrid analyses showed that the L742 of AtGRIP contributed to dimerization and was crucial for Golgi localization. Conclusions:These results indicate that h C-terminus Go in plan cell suggest that several of GRIP proteins is e self-association and or targeting properties of GRIP proteins differ between plant and animal cells.	[Zhao, Lei; Li, Yan] China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China	China Agricultural University	Li, Y (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China.	liyan@cau.edu.cn			National Natural Science Foundation of China [30971435, 31270230]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (grant nos. 30971435 and 31270230 to YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr FA, 2003, CURR OPIN CELL BIOL, V15, P405, DOI 10.1016/S0955-0674(03)00054-1; Barr FA, 2002, CURR BIOL, V9, P381; Chen Y, 2008, CHINESE SCI BULL, V53, P3191, DOI 10.1007/s11434-008-0420-4; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gilson PR, 2004, PLANTA, V219, P1050, DOI 10.1007/s00425-004-1311-9; Hawes C, 2005, NEW PHYTOL, V165, P29, DOI 10.1111/j.1469-8137.2004.01218.x; Kjer-Nielsen L, 1999, CURR BIOL, V9, P385, DOI 10.1016/S0960-9822(99)80168-7; Ladinsky MS, 2002, MOL BIOL CELL, V13, P2810, DOI 10.1091/mbc.01-12-0593; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Latijnhouwers M, 2005, PLANT J, V44, P459, DOI 10.1111/j.1365-313X.2005.02542.x; Latijnhouwers M, 2007, J EXP BOT, V58, P4373, DOI 10.1093/jxb/erm304; Lippincott-Schwartz J, 2000, ANNU REV CELL DEV BI, V16, P557, DOI 10.1146/annurev.cellbio.16.1.557; Lippincott-Schwartz J, 1998, TRENDS CELL BIOL, V8, P16, DOI 10.1016/S0962-8924(97)01199-9; Lu L, 2003, MOL BIOL CELL, V14, P3767, DOI 10.1091/mbc.E03-01-0864; Lu L, 2004, MOL BIOL CELL, V15, P4426, DOI 10.1091/mbc.E03-12-0872; Lu L, 2006, TRAFFIC, V7, P1399, DOI 10.1111/j.1600-0854.2006.00473.x; Luke MR, 2005, BIOCHEM J, V388, P835, DOI 10.1042/BJ20041810; Luke MR, 2003, J BIOL CHEM, V278, P4216, DOI 10.1074/jbc.M210387200; McConville MJ, 2002, EUR J CELL BIOL, V81, P485, DOI 10.1078/0171-9335-00268; Munro S, 1999, CURR BIOL, V9, P377, DOI 10.1016/S0960-9822(99)80166-3; Panic B, 2003, MOL CELL, V12, P863, DOI 10.1016/S1097-2765(03)00356-3; Setty SRG, 2003, CURR BIOL, V13, P401, DOI 10.1016/S0960-9822(03)00089-7; Stefano G, 2006, PLANT MOL BIOL, V61, P431, DOI 10.1007/s11103-006-0022-y; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Worden N, 2012, J INTEGR PLANT BIOL, V54, P875, DOI 10.1111/j.1744-7909.2012.01179.x; Wu MS, 2004, NAT STRUCT MOL BIOL, V11, P86, DOI 10.1038/nsmb714; Wylie FG, 2003, TRAFFIC, V4, P175, DOI 10.1034/j.1600-0854.2003.00106.x; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yoshino A, 2003, J CELL SCI, V116, P4441, DOI 10.1242/jcs.00746	30	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98963	10.1371/journal.pone.0098963	http://dx.doi.org/10.1371/journal.pone.0098963			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901770	Green Published, Green Submitted, gold			2022-12-27	WOS:000336841400080
J	Cleasby, A; Yon, J; Day, PJ; Richardson, C; Tickle, IJ; Williams, PA; Callahan, JF; Carr, R; Concha, N; Kerns, JK; Qi, HW; Sweitzer, T; Ward, P; Davies, TG				Cleasby, Anne; Yon, Jeff; Day, Philip J.; Richardson, Caroline; Tickle, Ian J.; Williams, Pamela A.; Callahan, James F.; Carr, Robin; Concha, Nestor; Kerns, Jeffrey K.; Qi, Hongwei; Sweitzer, Thomas; Ward, Paris; Davies, Thomas G.			Structure of the BTB Domain of Keap1 and Its Interaction with the Triterpenoid Antagonist CDDO	PLOS ONE			English	Article							SMOKE-INDUCED EMPHYSEMA; NRF2 ENHANCES SUSCEPTIBILITY; NITRIC-OXIDE PRODUCTION; OXIDATIVE STRESS; UBIQUITIN LIGASE; KEAP1-NRF2-ARE PATHWAY; CYSTEINE RESIDUES; RECOGNITION MODEL; MOUSE MACROPHAGES; PHASE-2 RESPONSE	The protein Keap1 is central to the regulation of the Nrf2-mediated cytoprotective response, and is increasingly recognized as an important target for therapeutic intervention in a range of diseases involving excessive oxidative stress and inflammation. The BTB domain of Keap1 plays key roles in sensing environmental electrophiles and in mediating interactions with the Cul3/Rbx1 E3 ubiquitin ligase system, and is believed to be the target for several small molecule covalent activators of the Nrf2 pathway. However, despite structural information being available for several BTB domains from related proteins, there have been no reported crystal structures of Keap1 BTB, and this has precluded a detailed understanding of its mechanism of action and interaction with antagonists. We report here the first structure of the BTB domain of Keap1, which is thought to contain the key cysteine residue responsible for interaction with electrophiles, as well as structures of the covalent complex with the antagonist CDDO/bardoxolone, and of the constitutively inactive C151W BTB mutant. In addition to providing the first structural confirmation of antagonist binding to Keap1 BTB, we also present biochemical evidence that adduction of Cys 151 by CDDO is capable of inhibiting the binding of Cul3 to Keap1, and discuss how this class of compound might exert Nrf2 activation through disruption of the BTB-Cul3 interface.	[Cleasby, Anne; Yon, Jeff; Day, Philip J.; Richardson, Caroline; Tickle, Ian J.; Williams, Pamela A.; Davies, Thomas G.] Astex Pharmaceut, Cambridge, England; [Callahan, James F.; Sweitzer, Thomas] GlaxoSmithKline, King Of Prussia, PA USA; [Carr, Robin] GlaxoSmithKline, Stevenage, Herts, England; [Concha, Nestor; Qi, Hongwei; Ward, Paris] GlaxoSmithKline, Collegeville, PA USA	Astex Pharmaceuticals; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Davies, TG (corresponding author), Astex Pharmaceut, Cambridge, England.	tom.davies@astx.com		Tickle, Ian/0000-0003-2977-0650; Williams, Pamela/0000-0002-1257-2351	GlaxoSmithKline; Astex Pharmaceuticals	GlaxoSmithKline(GlaxoSmithKline); Astex Pharmaceuticals	The research described in this article was funded by GlaxoSmithKline and Astex Pharmaceuticals. The funders played a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Baird L, 2013, BIOCHEM BIOPH RES CO, V433, P58, DOI 10.1016/j.bbrc.2013.02.065; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bricogne G., 2011, BUSTER; Calkins MJ, 2009, ANTIOXID REDOX SIGN, V11, P497, DOI [10.1089/ars.2008.2242, 10.1089/ARS.2008.2242]; Canning P, 2013, J BIOL CHEM, V288, P7803, DOI 10.1074/jbc.M112.437996; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Davies TG, 2012, TOP CURR CHEM, V317, P33, DOI 10.1007/128_2011_179; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Dinkova-Kostova AT, 2005, P NATL ACAD SCI USA, V102, P4584, DOI 10.1073/pnas.0500815102; Eggler AL, 2007, CHEM RES TOXICOL, V20, P1878, DOI 10.1021/tx700217c; Eggler AL, 2009, BIOCHEM J, V422, P171, DOI 10.1042/BJ20090471; Eggler AL, 2005, P NATL ACAD SCI USA, V102, P10070, DOI 10.1073/pnas.0502402102; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Errington WJ, 2012, STRUCTURE, V20, P1141, DOI 10.1016/j.str.2012.04.009; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gao L, 2007, J BIOL CHEM, V282, P2529, DOI 10.1074/jbc.M607622200; Giudice A, 2006, BIOESSAYS, V28, P169, DOI 10.1002/bies.20359; Hartshorn MJ, 2002, J COMPUT AID MOL DES, V16, P871, DOI 10.1023/A:1023813504011; Hayes JD, 2008, EUR J NUTR, V47, P73, DOI 10.1007/s00394-008-2009-8; Holland R, 2008, CHEM RES TOXICOL, V21, P2051, DOI 10.1021/tx800226m; Honda T, 2004, J MED CHEM, V47, P4923, DOI 10.1021/jm049727e; Honda T, 1998, BIOORG MED CHEM LETT, V8, P2711, DOI 10.1016/S0960-894X(98)00479-X; Honda T, 2000, J MED CHEM, V43, P4233, DOI 10.1021/jm0002230; Hong F, 2005, J BIOL CHEM, V280, P31768, DOI 10.1074/jbc.M503346200; Hong F, 2005, CHEM RES TOXICOL, V18, P1917, DOI 10.1021/tx0502138; Hu CQ, 2011, CHEM RES TOXICOL, V24, P515, DOI 10.1021/tx100389r; Ichikawa T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008391; Iizuka T, 2005, GENES CELLS, V10, P1113, DOI 10.1111/j.1365-2443.2005.00905.x; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Ji AX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060445; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levonen AL, 2004, BIOCHEM J, V378, P373, DOI 10.1042/BJ20031049; Li JQ, 2009, EXPERT OPIN THER TAR, V13, P785, DOI 10.1517/14728220903025762; Linker RA, 2011, BRAIN, V134, P678, DOI 10.1093/brain/awq386; Luo Y, 2007, J AM SOC MASS SPECTR, V18, P2226, DOI 10.1016/j.jasms.2007.09.015; Magesh S, 2012, MED RES REV, V32, P687, DOI 10.1002/med.21257; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McMahon M, 2010, P NATL ACAD SCI USA, V107, P18838, DOI 10.1073/pnas.1007387107; Mooij WTM, 2006, CHEMMEDCHEM, V1, P827, DOI 10.1002/cmdc.200600074; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niture SK, 2009, J CELL SCI, V122, P4452, DOI 10.1242/jcs.058537; Ogura T, 2010, P NATL ACAD SCI USA, V107, P2842, DOI 10.1073/pnas.0914036107; Pergola PE, 2011, NEW ENGL J MED, V365, P327, DOI 10.1056/NEJMoa1105351; Rachakonda G, 2008, CHEM RES TOXICOL, V21, P705, DOI 10.1021/tx700302s; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Saalau-Bethell SM, 2012, NAT CHEM BIOL, V8, P920, DOI [10.1038/NCHEMBIO.1081, 10.1038/nchembio.1081]; Stogios PJ, 2010, J MOL BIOL, V400, P983, DOI 10.1016/j.jmb.2010.05.028; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Sussan TE, 2009, P NATL ACAD SCI USA, V106, P250, DOI 10.1073/pnas.0804333106; Takaya K, 2012, FREE RADICAL BIO MED, V53, P817, DOI 10.1016/j.freeradbiomed.2012.06.023; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Tong KI, 2007, MOL CELL BIOL, V27, P7511, DOI 10.1128/MCB.00753-07; Tong KI, 2006, BIOL CHEM, V387, P1311, DOI 10.1515/BC.2006.164; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; Wilson AJ, 2013, J MED CHEM, V56, P7463, DOI 10.1021/jm400224q; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamamoto T, 2008, MOL CELL BIOL, V28, P2758, DOI 10.1128/MCB.01704-07; Yang HJ, 2006, J NAT PROD, V69, P1531, DOI 10.1021/np060159a; Yates MS, 2007, DRUG NEWS PERSPECT, V20, P109, DOI 10.1358/dnp.2007.20.2.1083437; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang MJ, 2013, PROG NEUROBIOL, V100, P30, DOI 10.1016/j.pneurobio.2012.09.003; Zhuang M, 2009, MOL CELL, V36, P39, DOI 10.1016/j.molcel.2009.09.022; Zipper LM, 2002, J BIOL CHEM, V277, P36544, DOI 10.1074/jbc.M206530200	71	151	157	5	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98896	10.1371/journal.pone.0098896	http://dx.doi.org/10.1371/journal.pone.0098896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896564	Green Submitted, Green Published, gold			2022-12-27	WOS:000338430700093
J	Grimm, A; Gruber, B; Henle, K				Grimm, Annegret; Gruber, Bernd; Henle, Klaus			Reliability of Different Mark-Recapture Methods for Population Size Estimation Tested against Reference Population Sizes Constructed from Field Data	PLOS ONE			English	Article							CAPTURE PROBABILITIES VARY; ESTIMATING ANIMAL ABUNDANCE; CLOSED-POPULATION; ROBUST ESTIMATION; LIVETRAPPING DATA; SPECIES RICHNESS; GEHYRA-VARIEGATA; MODEL SELECTION; HETEROGENEITY; SQUIRREL	Reliable estimates of population size are fundamental in many ecological studies and biodiversity conservation. Selecting appropriate methods to estimate abundance is often very difficult, especially if data are scarce. Most studies concerning the reliability of different estimators used simulation data based on assumptions about capture variability that do not necessarily reflect conditions in natural populations. Here, we used data from an intensively studied closed population of the arboreal gecko Gehyra variegata to construct reference population sizes for assessing twelve different population size estimators in terms of bias, precision, accuracy, and their 95%-confidence intervals. Two of the reference populations reflect natural biological entities, whereas the other reference populations reflect artificial subsets of the population. Since individual heterogeneity was assumed, we tested modifications of the Lincoln-Petersen estimator, a set of models in programs MARK and CARE-2, and a truncated geometric distribution. Ranking of methods was similar across criteria. Models accounting for individual heterogeneity performed best in all assessment criteria. For populations from heterogeneous habitats without obvious covariates explaining individual heterogeneity, we recommend using the moment estimator or the interpolated jackknife estimator (both implemented in CAPTURE/MARK). If data for capture frequencies are substantial, we recommend the sample coverage or the estimating equation (both models implemented in CARE-2). Depending on the distribution of catchabilities, our proposed multiple Lincoln-Petersen and a truncated geometric distribution obtained comparably good results. The former usually resulted in a minimum population size and the latter can be recommended when there is a long tail of low capture probabilities. Models with covariates and mixture models performed poorly. Our approach identified suitable methods and extended options to evaluate the performance of mark-recapture population size estimators under field conditions, which is essential for selecting an appropriate method and obtaining reliable results in ecology and conservation biology, and thus for sound management.	[Grimm, Annegret; Gruber, Bernd; Henle, Klaus] UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, Leipzig, Germany; [Grimm, Annegret] Univ Leipzig, Inst Biol, Fac Biosci Pharm & Psychol, D-04109 Leipzig, Germany; [Gruber, Bernd] Univ Canberra, Fac Sci Appl, Inst Appl Ecol, Canberra, ACT 2601, Australia	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leipzig University; University of Canberra	Grimm, A (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, Leipzig, Germany.	annegret.grimm@ufz.de	Henle, Klaus/I-6837-2013; Grimm-Seyfarth, Annegret/I-9243-2019	Henle, Klaus/0000-0002-6647-5362; Grimm-Seyfarth, Annegret/0000-0003-0577-7508; Gruber, Bernd/0000-0003-0078-8179	German National Academic Foundation	German National Academic Foundation	The research of Annegret Grimm was funded by the German National Academic Foundation. (http://www.studienstiftung.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amstrup SC, 2005, HANDBOOK OF CAPTURE-RECAPTURE ANALYSIS, P1; ANDERSON DR, 1994, ECOLOGY, V75, P1780, DOI 10.2307/1939637; [Anonymous], 1982, ESTIMATION ANIMAL AB; Boulinier T, 1998, ECOLOGY, V79, P1018, DOI 10.2307/176597; BURNHAM KP, 1978, BIOMETRIKA, V65, P625, DOI 10.2307/2335915; BURNHAM KP, 1979, ECOLOGY, V60, P927, DOI 10.2307/1936861; CAROTHERS AD, 1973, J ANIM ECOL, V42, P125, DOI 10.2307/3408; CHAO A, 1992, BIOMETRICS, V48, P201, DOI 10.2307/2532750; CHAO A, 1989, BIOMETRICS, V45, P427, DOI 10.2307/2531487; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; CHAO A, 1988, J WILDLIFE MANAGE, V52, P295, DOI 10.2307/3801237; Chao A, 2001, J STAT PLAN INFER, V92, P213, DOI 10.1016/S0378-3758(00)00151-8; Chao A., 2003, PROGRAM CARE 2; Chao A, 2006, USER GUIDE PROGRAM C; Chen YH, 2013, INSECT SOC, V60, P351, DOI 10.1007/s00040-013-0300-z; Cooch E., 2010, PROGRAM MARK GENTLE, V9th; DON BAC, 1984, ACTA THERIOL, V29, P187, DOI 10.4098/AT.arch.84-20; Dorazio RM, 2005, J AM STAT ASSOC, V100, P389, DOI 10.1198/016214505000000015; Eberhardt L, 1963, WILDLIFE MONOGR, V10, P3; EBERHARDT LL, 1969, J WILDLIFE MANAGE, V33, P28, DOI 10.2307/3799647; EDWARDS WR, 1967, J WILDLIFE MANAGE, V31, P87, DOI 10.2307/3798362; Efford MG, 2013, OIKOS, V122, P918, DOI 10.1111/j.1600-0706.2012.20440.x; Efford MG, 2009, ECOLOGY, V90, P2676, DOI 10.1890/08-1735.1; Grimm A, 2013, FREQ ESTIMATE POPULA; Gruber B, 2004, OIKOS, V107, P406, DOI 10.1111/j.0030-1299.2004.12901.x; Gruber B, 2008, OECOLOGIA, V154, P679, DOI 10.1007/s00442-007-0866-0; Hellmann JJ, 1999, ECOL APPL, V9, P824, DOI 10.1890/1051-0761(1999)009[0824:BPAAOF]2.0.CO;2; HENLE K, 1990, HERPETOL MONOGR, V4, P30, DOI DOI 10.2307/1466967; HORVITZ DG, 1952, J AM STAT ASSOC, V47, P663, DOI 10.2307/2280784; HUGGINS RM, 1991, BIOMETRICS, V47, P725, DOI 10.2307/2532158; HUGGINS RM, 1989, BIOMETRIKA, V76, P133, DOI 10.1093/biomet/76.1.133; Jung RE, 2002, J HERPETOL, V36, P465, DOI 10.1670/0022-1511(2002)036[0465:AEOPIA]2.0.CO;2; LEE SM, 1994, BIOMETRICS, V50, P88, DOI 10.2307/2533199; Link WA, 2003, BIOMETRICS, V59, P1123, DOI 10.1111/j.0006-341X.2003.00129.x; MENKENS GE, 1988, ECOLOGY, V69, P1952, DOI 10.2307/1941172; Nitwitpong S, 2013, METRIKA, V76, P495; NIXON CM, 1967, J WILDLIFE MANAGE, V31, P96, DOI 10.2307/3798363; Norris JL, 1996, BIOMETRICS, V52, P639, DOI 10.2307/2532902; OTIS DL, 1978, WILDLIFE MONOGR, P1; Peterson N.P., 1984, North American Journal of Fisheries Management, V4, P99, DOI 10.1577/1548-8659(1984)4<99:ACOTRA>2.0.CO;2; Pine WE, 2003, FISHERIES, V28, P10, DOI 10.1577/1548-8446(2003)28[10:AROTMF]2.0.CO;2; Pledger S, 2005, BIOMETRICS, V61, P868, DOI 10.1111/j.1541-020X.2005.00411_1.x; POLLOCK KH, 1982, J WILDLIFE MANAGE, V46, P752, DOI 10.2307/3808568; POLLOCK KH, 1983, BIOMETRICS, V39, P1035, DOI 10.2307/2531337; Pollock KH, 1990, WILDLIFE MONOGR, V107, P3; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rodda GH, 2001, J TROP ECOL, V17, P331, DOI 10.1017/S0266467401001225; RODGERS J D, 1992, North American Journal of Fisheries Management, V12, P79, DOI 10.1577/1548-8675(1992)012<0079:COTTTE>2.3.CO;2; Schwarz CJ, 1999, STAT SCI, V14, P427; Stanley TR, 1998, BIOMETRICAL J, V40, P475, DOI 10.1002/(SICI)1521-4036(199808)40:4<475::AID-BIMJ475>3.3.CO;2-R; Vincent JP, 1996, J WILDLIFE MANAGE, V60, P18, DOI 10.2307/3802035; Wagner TC, 2009, ECOL RES, V24, P345; White G. C., 2010, PROGRAM MARK; White GC, 2008, ENVIRON ECOL STAT, V15, P89, DOI 10.1007/s10651-007-0030-3; Williams B. K., 2002, ANAL MANAGEMENT ANIM	56	28	29	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98840	10.1371/journal.pone.0098840	http://dx.doi.org/10.1371/journal.pone.0098840			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896260	Green Submitted, Green Published, gold			2022-12-27	WOS:000338430700085
J	Maghuly, F; Ramkat, RC; Laimer, M				Maghuly, Fatemeh; Ramkat, Rose C.; Laimer, Margit			Virus versus Host Plant MicroRNAs: Who Determines the Outcome of the Interaction?	PLOS ONE			English	Article							RNA-SILENCING SUPPRESSORS; TIME QUANTITATIVE PCR; CASSAVA MOSAIC-VIRUS; JATROPHA-CURCAS; COMPUTATIONAL IDENTIFICATION; GENE-EXPRESSION; RT-PCR; PROTEIN; REAL; DNA	Considering the importance of microRNAs (miRNAs) in the regulation of essential processes in plant pathogen interactions, it is not surprising that, while plant miRNA sequences counteract viral attack via antiviral RNA silencing, viruses in turn have developed antihost defense mechanisms blocking these RNA silencing pathways and establish a counter-defense. In the current study, computational and stem-loop Reverse Transcription - Polymerase Chain Reaction (RT-PCR) approaches were employed to a) predict and validate virus encoded mature miRNAs (miRs) in 39 DNA-A sequences of the bipartite genomes of African cassava mosaic virus (ACMV) and East African cassava mosaic virus-Uganda (EACMV-UG) isolates, b) determine whether virus encoded miRs/miRs* generated from the 5'/3' harpin arms have the capacity to bind to genomic sequences of the host plants Jatropha or cassava and c) investigate whether plant encoded miR/miR* sequences have the potential to bind to the viral genomes. Different viral pre-miRNA hairpin sequences and viral miR/miR* length variants occurring as isomiRs were predicted in both viruses. These miRNAs were located in three Open Reading Frames (ORFs) and in the Intergenic Region (IR). Moreover, various target genes for miRNAs from both viruses were predicted and annotated in the host plant genomes indicating that they are involved in biotic response, metabolic pathways and transcription factors. Plant miRs/miRs* from conserved and highly expressed families were identified, which were shown to have potential targets in the genome of both begomoviruses, representing potential plant miRNAs mediating antiviral defense. This is the first assessment of predicted viral miRs/miRs* of ACMV and EACMV-UG and host plant miRNAs, providing a reference point for miRNA identification in pathogens and their hosts. These findings will improve the understanding of host-pathogen interaction pathways and the function of viral miRNAs in Euphorbiaceous crop plants.	[Maghuly, Fatemeh; Ramkat, Rose C.; Laimer, Margit] Univ Nat Resources & Life Sci, BOKU VIBT, Dept Biotechnol, PBU, Vienna, Austria; [Ramkat, Rose C.] Egerton Univ, Dept Biol Sci, Nakuru, Kenya	University of Natural Resources & Life Sciences, Vienna; Egerton University	Laimer, M (corresponding author), Univ Nat Resources & Life Sci, BOKU VIBT, Dept Biotechnol, PBU, Vienna, Austria.	margit.laimer@boku.ac.at	Maghuly, Fatemeh/D-2640-2014; Laimer, Margit/C-3524-2019; Margit, Laimer/P-7096-2019	Margit, Laimer/0000-0002-6796-8126; Maghuly, Fatemeh/0000-0001-5433-0070	Austrian Science Fund (FWF) [P23836-B16]; Austrian Partnership Program in Higher Education & Research for Development (APPEAR) scholarship; Austrian Research Promotion Agency (FFG); Bioplant RD; Austrian Science Fund (FWF) [P 23836] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Partnership Program in Higher Education & Research for Development (APPEAR) scholarship; Austrian Research Promotion Agency (FFG); Bioplant RD; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The Austrian Science Fund (FWF) -P23836-B16, The Austrian Partnership Program in Higher Education & Research for Development (APPEAR) scholarship for RCR, Austrian Research Promotion Agency (FFG), and Bioplant R&D provided funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon S, 2011, GENOME RES, V21, P1506, DOI 10.1101/gr.121715.111; Alves L, 2009, NUCLEIC ACIDS RES, V37, P4010, DOI 10.1093/nar/gkp272; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Amin I, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-143; Amiteye S, 2011, AFR J BIOTECHNOL, V10, P2562; Anselmo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017374; Bartel B, 2003, PLANT PHYSIOL, V132, P709, DOI 10.1104/pp.103.023630; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Benes V, 2010, METHODS, V50, P244, DOI 10.1016/j.ymeth.2010.01.026; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Chapman EJ, 2004, GENE DEV, V18, P1179, DOI 10.1101/gad.1201204; Chellappan P, 2005, P NATL ACAD SCI USA, V102, P10381, DOI 10.1073/pnas.0504439102; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen X, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r78; Cloonan N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r126; Colaiacovo M, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00165; Cullen BR, 2009, NATURE, V457, P421, DOI 10.1038/nature07757; Czimmerer Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055168; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; de Sant'Anna Q, 2013, GENETIC IMPROVEMENT; Dijkstra JR, 2012, J CELL MOL MED, V16, P683, DOI 10.1111/j.1582-4934.2011.01467.x; Dunoyer P, 2005, CURR OPIN PLANT BIOL, V8, P415, DOI 10.1016/j.pbi.2005.05.012; ETESSAMI P, 1991, J GEN VIROL, V72, P1005, DOI 10.1099/0022-1317-72-5-1005; Fairless D, 2007, NATURE, V449, P652, DOI 10.1038/449652a; FONTES EPB, 1994, J BIOL CHEM, V269, P8459; Gao RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048736; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106; Grundhoff A, 2011, METHODS MOL BIOL, V721, P143, DOI 10.1007/978-1-61779-037-9_8; Grundhoff A, 2011, VIROLOGY, V411, P325, DOI 10.1016/j.virol.2011.01.002; Gubitz GM, 1999, BIORESOURCE TECHNOL, V67, P73, DOI 10.1016/S0960-8524(99)00069-3; Guo L, 2014, GENE, V533, P149, DOI 10.1016/j.gene.2013.09.102; Guo L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021072; Haas W, 2000, IND CROP PROD, V12, P111, DOI 10.1016/S0926-6690(00)00043-1; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hofer P, 1997, VIROLOGY, V236, P288, DOI 10.1006/viro.1997.8751; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW339, DOI 10.1093/nar/gkm368; Jin WB, 2008, J PLANT RES, V121, P351, DOI 10.1007/s10265-007-0139-3; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Kozlowska E, 2013, INT J MOL SCI, V14, P16999, DOI 10.3390/ijms140816999; Kumar A, 2008, IND CROP PROD, V28, P1, DOI 10.1016/j.indcrop.2008.01.001; Lekprasert P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020622; Li SC, 2008, NUCLEIC ACIDS RES, V36, pD184, DOI 10.1093/nar/gkm610; Maghuly F, 2013, GENETIC IMPROVEMENT; Mao WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033040; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Naqvi AR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-281; Naqvi AR, 2011, PLANT PHYSIOL BIOCH, V49, P13, DOI 10.1016/j.plaphy.2010.09.013; Narayana D. S. A., 2007, International Journal of Virology, V3, P1; Nikovics K, 2006, PLANT CELL, V18, P2929, DOI 10.1105/tpc.106.045617; Openshaw K, 2000, BIOMASS BIOENERG, V19, P1, DOI 10.1016/S0961-9534(00)00019-2; Padmanabhan M, 2009, CELL MICROBIOL, V11, P191, DOI 10.1111/j.1462-5822.2008.01260.x; PASZKOWSKI U, 1993, J GEN VIROL, V74, P2725, DOI 10.1099/0022-1317-74-12-2725; Patanun O, 2013, MOL BIOTECHNOL, V53, P257, DOI 10.1007/s12033-012-9521-z; Patil BL, 2009, MOL PLANT PATHOL, V10, P685, DOI [10.1111/j.1364-3703.2009.00559.x, 10.1111/J.1364-3703.2009.00559.X]; Perez-Quintero AL, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-29; Perez-Quintero AL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-138; Ramkat RC, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-386; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rouha H, 2010, NUCLEIC ACIDS RES, V38, P8328, DOI 10.1093/nar/gkq681; Sabandar CW, 2013, PHYTOCHEMISTRY, V85, P7, DOI 10.1016/j.phytochem.2012.10.009; Sablok G, 2013, FEBS LETT, V587, P2629, DOI 10.1016/j.febslet.2013.06.047; Sanan-Mishra N, 2009, MOL GENET GENOMICS, V282, P463, DOI 10.1007/s00438-009-0478-y; Santoro MG, 2000, BIOCHEM PHARMACOL, V59, P55, DOI 10.1016/S0006-2952(99)00299-3; Scaria V, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-68; Sharma P, 2008, J GEN PLANT PATHOL, V74, P189, DOI 10.1007/s10327-008-0085-5; Shen W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048236; Soitamo AJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-204; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Steffen P, 2006, BIOINFORMATICS, V22, P500, DOI 10.1093/bioinformatics/btk010; Sullivan CS, 2007, METHOD ENZYMOL, V427, P3, DOI 10.1016/S0076-6879(07)27001-6; Sullivan CS, 2005, MOL CELL, V20, P3, DOI 10.1016/j.molcel.2005.09.012; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Taylor N, 2004, PLANT MOL BIOL, V56, P671, DOI 10.1007/s11103-004-4872-x; Trinks D, 2005, J VIROL, V79, P2517, DOI 10.1128/JVI.79.4.2517-2527.2005; van Wezel R, 2003, J VIROL, V77, P696, DOI 10.1128/JVI.77.1.696-700.2003; Vanitharani R, 2004, J VIROL, V78, P9487, DOI 10.1128/JVI.78.17.9487-9498.2004; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Vaucheret H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006442; Vishwakarma NP, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23152; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Vollmann J, 2013, BIOPROCESSING TECHNOLOGIES IN BIOREFINERY FOR SUSTAINABLE PRODUCTION OF FUELS, CHEMICALS, AND POLYMERS, P47; Wang CM, 2012, INT J BIOL SCI, V8, P418, DOI 10.7150/ijbs.3676; Wang H, 2003, PLANT CELL, V15, P3020, DOI 10.1105/tpc.015180; Wang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033696; Wang XW, 2005, BIOINFORMATICS, V21, P3610, DOI 10.1093/bioinformatics/bti562; Wang YQ, 2011, GENOMICS, V98, P73, DOI 10.1016/j.ygeno.2011.04.011; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xu RH, 2011, BIOMASS BIOENERG, V35, P1683, DOI 10.1016/j.biombioe.2011.01.001; Xu W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069995; Xuan P, 2011, BIOINFORMATICS, V27, P1368, DOI 10.1093/bioinformatics/btr153; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310; Yu Guangchuang, 2011, J Clin Bioinforma, V1, P15, DOI 10.1186/2043-9113-1-15; Zeng CY, 2010, NUCLEIC ACIDS RES, V38, P981, DOI 10.1093/nar/gkp1035; Zhang BH, 2006, COMPUT BIOL CHEM, V30, P395, DOI 10.1016/j.compbiolchem.2006.08.006; Zhou M, 2009, GENOMICS, V94, P125, DOI 10.1016/j.ygeno.2009.04.006	100	9	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98263	10.1371/journal.pone.0098263	http://dx.doi.org/10.1371/journal.pone.0098263			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896088	Green Published, gold			2022-12-27	WOS:000338430700029
J	Abdallah, HM; Al-Abd, AM; Asaad, GF; Abdel-Naim, AB; El-Halawany, AM				Abdallah, Hossam M.; Al-Abd, Ahmed M.; Asaad, Gihan F.; Abdel-Naim, Ashraf B.; El-Halawany, Ali M.			Isolation of Antiosteoporotic Compounds from Seeds of Sophora japonica	PLOS ONE			English	Article							ASSAY; VIABILITY	Chemical investigation of Sophora japonica seeds resulted in the isolation of seven metabolites identified as: genistin (1), sophoricoside (2), sophorabioside (3), sophoraflavonoloside (4), genistein 7,4'-di-O-beta-D-glucopyransoide (5), kaempferol 3-O-alpha-L-rhamnopyranosyl(1 -> 6)beta-D-glucopyranosyl(1 -> 2)beta-D-glucopyranoside (6) and rutin (7). Compounds 1, 2 and 5 showed significant estrogenic proliferative effect in MCF-7 cell in sub-cytotoxic concentration range. Compounds 1 and 2 showed minimal cell membrane damaging effect using LDH leakage assay. Accordingly, compound 2 (sophoricoside, (SPH)) was selected for further in-vivo studies as a potential anti-osteoporosis agent. The anti-osteoporotic effect of SPH was assessed in ovarectomized (OVX) rats after oral administration (15 mg/kg and 30 mg/kg) for 45 days compared to estradiol (10 mu g/kg) as a positive control. Only in a dose of 30 mg/kg, SPH regained the original mechanical bone hardness compared to normal non-osteoporotic group. However, SPH (15 mg/kg) significantly increased the level of alkaline phosphatase (ALP) to normal level. Treatment with SPH (30 mg/kg) increased the level of ALP to be higher than normal group. SPH (15 mg/kg) did not significantly increase the serum level of osteocalcin (OC) compared to OVX group. On the other hand, treatment with SPH (30 mg/kg) significantly increased the level of OC to 78% higher than normal non-ovarectomized animals group. In addition, SPH (15 mg/kg) decreased the bone resorption marker, acid phosphatase (ACP) to normal level and SPH (30 mg/kg) further diminished the level of serum ACP. Histopathologically, sophoricoside ameliorated the ovarectomy induced osteoporosis in a dose dependent manner. The drug showed thicker bony trabeculae, more osteoid, and more osteoblastic rimming compared to OVX group.	[Abdallah, Hossam M.; El-Halawany, Ali M.] King Abdulaziz Univ, Fac Pharm, Dept Nat Prod, Jeddah 21413, Saudi Arabia; [Abdallah, Hossam M.; El-Halawany, Ali M.] Cairo Univ, Fac Pharm, Dept Pharmacognosy, Cairo, Egypt; [Al-Abd, Ahmed M.; Asaad, Gihan F.] Natl Res Ctr, Dept Pharmacol, Div Med, Giza, Egypt; [Al-Abd, Ahmed M.; Abdel-Naim, Ashraf B.] King Abdulaziz Univ, Fac Pharm, Dept Pharmacol & Toxicol, Jeddah 21413, Saudi Arabia; [Asaad, Gihan F.] Jazan Univ, Dept Pharmacol, Fac Pharm, Jazan, Saudi Arabia	King Abdulaziz University; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); King Abdulaziz University; Jazan University	El-Halawany, AM (corresponding author), King Abdulaziz Univ, Fac Pharm, Dept Nat Prod, Jeddah 21413, Saudi Arabia.	ali.elhalawany@pharma.cu.edu.eg	El-Halawany, Ali M./ABE-2550-2021; Al-Abd, Ahmed/J-2826-2012; Asaad, Gihan/AAB-8649-2022; Abdel-Naim, Ashraf B/J-3199-2012; El-Halawany, Ali M/K-8120-2012; Afifi, Hossam Mohamed/B-7711-2016; Abdallah, Hossam/H-9654-2012	Al-Abd, Ahmed/0000-0001-7872-4867; Asaad, Gihan/0000-0002-7679-5968; Abdel-Naim, Ashraf B/0000-0002-0400-9075; El-Halawany, Ali M/0000-0002-5864-1674; Afifi, Hossam Mohamed/0000-0002-0234-7492; Abdallah, Hossam/0000-0002-0234-7492; , Gihan/0000-0002-8017-6668	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [208/166/1433]; DSR	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	This project was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant no. 208/166/1433. The authors, therefore, acknowledge with thanks DSR technical and financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addar M, 2004, CLIN EXP OBSTET GYN, V32, P135; Brzezinski A, 1999, EUR J OBSTET GYN R B, V85, P47, DOI 10.1016/S0301-2115(98)00281-4; COWAN JD, 1984, CANC DRUG DEL, V1, P95, DOI 10.1089/cdd.1984.1.95; Du Ning, 2003, Zhong Xi Yi Jie He Xue Bao, V1, P44; El-Halawany AM, 2010, PHARM BIOL, V48, P177, DOI 10.3109/13880200903062663; Fu JY, 1999, CALCIFIED TISSUE INT, V64, P229, DOI 10.1007/s002239900608; GERHARDT W, 1974, CLIN CHIM ACTA, V53, P291, DOI 10.1016/0009-8981(74)90267-8; Grishkovets V. I., 1995, Chemistry of Natural Compounds, V31, P596, DOI 10.1007/BF01164887; GRUBER HE, 1984, METABOLISM, V33, P295, DOI 10.1016/0026-0495(84)90187-2; ISHIDA H, 1989, YAKUGAKU ZASSHI, V109, P179, DOI 10.1248/yakushi1947.109.3_179; Jia TL, 2003, BIOCHEM PHARMACOL, V65, P709, DOI 10.1016/S0006-2952(02)01585-X; Ko YJ, 2012, J ETHNOPHARMACOL, V139, P558, DOI 10.1016/j.jep.2011.11.050; Mahmoud AM, 2012, J ENZYM INHIB MED CH, V27, P673, DOI 10.3109/14756366.2011.607446; Min B, 1999, PLANTA MED, V65, P408, DOI 10.1055/s-1999-14016; Mosli HA, 2013, TOXICOL LETT, V220, P247, DOI 10.1016/j.toxlet.2013.05.002; Mostafa K, 2003, B FAC PHARM, V41, P253; Mukhamedova Kh. S., 1997, Chemistry of Natural Compounds, V33, P445, DOI 10.1007/BF02282362; Nagareddy Prabhakara Reddy, 2005, Journal of Pharmacological and Toxicological Methods, V52, P350; OBRANT KJ, 1989, CALCIFIED TISSUE INT, V44, P157, DOI 10.1007/BF02556558; Phillips CA, 2009, ACTA HISTOCHEM, V111, P166, DOI 10.1016/j.acthis.2008.03.003; Sadat-Ali M, 2004, SAUDI MED J, V25, P1623; Shim JG, 2005, ARCH PHARM RES, V28, P106, DOI 10.1007/BF02975144; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Tang YP, 2002, J ASIAN NAT PROD RES, V4, P123, DOI 10.1080/10286020290027407; Tang YP, 2001, J NAT PROD, V64, P1107, DOI 10.1021/np010081s; Wang ZL, 2006, PHYTOMEDICINE, V13, P718, DOI 10.1016/j.phymed.2005.09.005; WATANABE K, 1993, CHEM PHARM BULL, V41, P394, DOI 10.1248/cpb.41.394; Yoon HJ, 2013, NUTR RES, V33, P1053, DOI 10.1016/j.nutres.2013.08.004	28	35	38	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98559	10.1371/journal.pone.0098559	http://dx.doi.org/10.1371/journal.pone.0098559			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892557	Green Submitted, gold, Green Published			2022-12-27	WOS:000336911400067
J	Baker, LL; Jonsen, ID; Flemming, JEM; Lidgard, DC; Bowen, WD; Iverson, SJ; Webber, DM				Baker, Laurie L.; Jonsen, Ian D.; Flemming, Joanna E. Mills; Lidgard, Damian C.; Bowen, William D.; Iverson, Sara J.; Webber, Dale M.			Probability of Detecting Marine Predator-Prey and Species Interactions Using Novel Hybrid Acoustic Transmitter-Receiver Tags	PLOS ONE			English	Article							PERFORMANCE; TRACKING; DESIGN; BIOTELEMETRY; CIRCULATION; MOVEMENT; HABITAT; SEALS	Understanding the nature of inter-specific and conspecific interactions in the ocean is challenging because direct observation is usually impossible. The development of dual transmitter/receivers, Vemco Mobile Transceivers (VMT), and satellite-linked (e. g. GPS) tags provides a unique opportunity to better understand between and within species interactions in space and time. Quantifying the uncertainty associated with detecting a tagged animal, particularly under varying field conditions, is vital for making accurate biological inferences when using VMTs. We evaluated the detection efficiency of VMTs deployed on grey seals, Halichoerus grypus, off Sable Island (NS, Canada) in relation to environmental characteristics and seal behaviour using generalized linear models (GLM) to explore both post-processed detection data and summarized raw VMT data. When considering only post-processed detection data, only about half of expected detections were recorded at best even when two VMT-tagged seals were estimated to be within 50-200 m of one another. At a separation of 400 m, only about 15% of expected detections were recorded. In contrast, when incomplete transmissions from the summarized raw data were also considered, the ratio of complete transmission to complete and incomplete transmissions was about 70% for distances ranging from 50-1000 m, with a minimum of around 40% at 600 m and a maximum of about 85% at 50 m. Distance between seals, wind stress, and depth were the most important predictors of detection efficiency. Access to the raw VMT data allowed us to focus on the physical and environmental factors that limit a transceiver's ability to resolve a transmitter's identity.	[Baker, Laurie L.; Jonsen, Ian D.; Lidgard, Damian C.; Iverson, Sara J.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Flemming, Joanna E. Mills] Dalhousie Univ, Dept Math & Stat, Halifax, NS, Canada; [Bowen, William D.] Fisheries & Oceans Canada, Bedford Inst Oceanog, Populat Ecol Div, Dartmouth, NS B2Y 4A2, Canada; [Webber, Dale M.] VEMCO Ltd, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Bedford Institute of Oceanography; Fisheries & Oceans Canada	Baker, LL (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	Laurie.Baker@dal.ca	Bowen, William/AAE-7204-2022	Bowen, William/0000-0001-8334-5677; Iverson, Sara/0000-0003-2842-4094; Jonsen, Ian/0000-0001-5423-6076; Mills Flemming, Joanna/0000-0002-3517-3089	Natural Sciences and Engineering Research Council of Canada (NSERC) [NETGP 375118 - 08]; Dalhousie Graduate Fellowship; NSERC; Department of Fisheries and Oceans Canada	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Dalhousie Graduate Fellowship; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Department of Fisheries and Oceans Canada	This study and a graduate student stipend to L. Baker were supported by a research network grant (NETGP 375118 - 08) from the Natural Sciences and Engineering Research Council of Canada (NSERC) for the Ocean Tracking Network; L. Baker was additionally supported by a Dalhousie Graduate Fellowship. Additional support was provided by NSERC Discovery Grants to J. Mills Flemming, D. Bowen and S. Iverson, and by the Department of Fisheries and Oceans Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Animal Behaviour Society, 2006, ANIM BEHAV, V71, P245, DOI DOI 10.1016/J.ANBEHAV.2005.10.001; Austin D, 2006, ECOLOGY, V87, P3095, DOI 10.1890/0012-9658(2006)87[3095:LMDAHT]2.0.CO;2; Barnett A, 2012, OIKOS, V121, P882, DOI 10.1111/j.1600-0706.2011.20000.x; Barnett A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015464; Beck CA, 2007, J ANIM ECOL, V76, P490, DOI 10.1111/j.1365-2656.2007.01215.x; Bowles AE, 2010, J ACOUST SOC AM, V128, P3223, DOI 10.1121/1.3493438; Breed GA, 2006, P R SOC B, V273, P2319, DOI 10.1098/rspb.2006.3581; Bryant E, 2007, TR01 WILDTR TEL SYST; Cantor M, 2013, PHILOS T R SOC B, P368; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; Cooke SJ, 2012, AFS 142 ANN M AFS; Finstad B, 2005, J FISH BIOL, V66, P86, DOI 10.1111/j.0022-1112.2005.00581.x; Gjelland KO, 2013, METHODS ECOL EVOL, V4, P665, DOI 10.1111/2041-210X.12057; Gorini L, 2012, MAMMAL REV, V42, P55, DOI 10.1111/j.1365-2907.2011.00189.x; Hazel J, 2009, J EXP MAR BIOL ECOL, V374, P58, DOI 10.1016/j.jembe.2009.04.009; Heupel MR, 2006, MAR FRESHWATER RES, V57, P1, DOI 10.1071/MF05091; How JR, 2012, MAR FRESHWATER RES, V63, P312, DOI 10.1071/MF11194; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Kastelein RA, 2009, J ACOUST SOC AM, V125, P1222, DOI 10.1121/1.3050283; Kessel ST, 2013, REV FISH BIOL FISHER, P1; Kuperman WA, 2004, PHYS TODAY, V57, P55, DOI 10.1063/1.1825269; LARGE WG, 1981, J PHYS OCEANOGR, V11, P324, DOI 10.1175/1520-0485(1981)011<0324:OOMFMI>2.0.CO;2; Lidgard DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048962; Lidgard DC, 2005, BEHAV ECOL, V16, P541, DOI 10.1093/beheco/ari023; Lindegren M, 2010, P ROY SOC B-BIOL SCI, V277, P2121, DOI 10.1098/rspb.2010.0353; Medwin H., 1997, FUNDAMENTALS ACOUSTI, DOI [10.1016/B978-0-12-487570-8.X5000-4, DOI 10.1016/B978-0-12-487570-8.X5000-4]; Mellish JAE, 1999, PHYSIOL BIOCHEM ZOOL, V72, P677, DOI 10.1086/316708; O'Dor RK, 2007, AUSTR SOC FISH BIOL, P6; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Simpfendorfer CA, 2008, CAN J FISH AQUAT SCI, V65, P482, DOI 10.1139/F07-180; Singh L, 2009, AFR J MAR SCI, V31, P355, DOI 10.2989/AJMS.2009.31.3.8.996; SMITH PC, 1991, CONT SHELF RES, V11, P977, DOI 10.1016/0278-4343(91)90088-N; SUTCLIFFE WH, 1976, J FISH RES BOARD CAN, V33, P98, DOI 10.1139/f76-012; Thorstad EB, 2000, J FISH BIOL, V57, P531, DOI 10.1006/jfbi.2000.1315; Voegeli FA, 1996, OVERVIEW UNDERWATER, V50, P277; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y; Winship AJ, 2012, METHODS ECOL EVOL, V3, P291, DOI 10.1111/j.2041-210X.2011.00161.x; Worm B, 2003, ECOLOGY, V84, P162, DOI 10.1890/0012-9658(2003)084[0162:MAOCSI]2.0.CO;2; Zuur Alain F., 2009, P1	39	5	5	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98117	10.1371/journal.pone.0098117	http://dx.doi.org/10.1371/journal.pone.0098117			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892286	Green Published, gold, Green Submitted			2022-12-27	WOS:000336911400035
J	Christensen, LL; Holm, A; Rantala, J; Kallioniemi, O; Rasmussen, MH; Ostenfeld, MS; Dagnaes-Hansen, F; Oster, B; Schepeler, T; Tobiasen, H; Thorsen, K; Sieber, OM; Gibbs, P; Lamy, P; Hansen, TF; Jakobsen, A; Riising, EM; Helin, K; Lubinski, J; Hagemann-Madsen, R; Laurberg, S; Orntoft, TF; Andersen, CL				Christensen, Lise Lotte; Holm, Anja; Rantala, Juha; Kallioniemi, Olli; Rasmussen, Mads H.; Ostenfeld, Marie S.; Dagnaes-Hansen, Frederik; Oster, Bodil; Schepeler, Troels; Tobiasen, Heidi; Thorsen, Kasper; Sieber, Oliver M.; Gibbs, Peter; Lamy, Philippe; Hansen, Torben F.; Jakobsen, Anders; Riising, Eva M.; Helin, Kristian; Lubinski, Jan; Hagemann-Madsen, Rikke; Laurberg, Soren; Orntoft, Torben F.; Andersen, Claus L.			Functional Screening Identifies miRNAs Influencing Apoptosis and Proliferation in Colorectal Cancer	PLOS ONE			English	Article							CELL-PROLIFERATION; EXPRESSION PROFILES; MICRORNA; MICROARRAY; SURVIVAL; TRANSCRIPTION; VALIDATION; CARCINOMA; ONCOGENES; ENHANCER	MicroRNAs (miRNAs) play a critical role in many biological processes and are aberrantly expressed in human cancers. Particular miRNAs function either as tumor suppressors or oncogenes and appear to have diagnostic and prognostic significance. Although numerous miRNAs are dys-regulated in colorectal cancer (CRC) only a small fraction has been characterized functionally. Using high-throughput functional screening and miRNA profiling of clinical samples the present study aims at identifying miRNAs important for the control of cellular growth and/or apoptosis in CRC. The high-throughput functional screening was carried out in six CRC cell lines transfected with a pre-miR library including 319 synthetic human pre-miRs. Phenotypic alterations were evaluated by immunostaining of cleaved cPARP (apoptosis) or MKI67 (proliferation). Additionally, TaqMan Human MicroRNA Array Set v2.0 was used to profile the expression of 667 miRNAs in 14 normal colon mucosa and 46 microsatellite stable stage II CRC patients. Among the miRNAs that induced growth arrest and apoptosis in the CRC cell lines, and at same time were dys-regulated in the clinical samples, miR-375 was selected for further analysis. Independent in vitro analysis of transient and stable transfected CRC cell lines confirmed that miR-375 reduces cell viability through the induction of apoptotic death. We identified YAP1 as a direct miR-375 target in CRC and show that HELLS and NOLC1 are down-stream targets. Knock-down of YAP1 mimicked the phenotype induced by miR-375 over-expression indicating that miR-375 most likely exerts its pro-apoptotic role through YAP1 and its anti-apoptotic down-stream targets BIRC5 and BCL2L1. Finally, in vivo analysis of mouse xenograft tumors showed that miR-375 expression significantly reduced tumor growth. We conclude that the high-throughput screening successfully identified miRNAs that induce apoptosis and/or inhibit proliferation in CRC cells. Finally, combining the functional screening with profiling of CRC tissue samples we identified clinically relevant miRNAs and miRNA targets in CRC.	[Christensen, Lise Lotte; Rasmussen, Mads H.; Oster, Bodil; Schepeler, Troels; Tobiasen, Heidi; Thorsen, Kasper; Lamy, Philippe; Orntoft, Torben F.; Andersen, Claus L.] Univ Aarhus, Colorectal Canc Res Grp, Dept Mol Med MOMA, Aarhus Univ Hosp, Aarhus, Denmark; [Holm, Anja] Glostrup Cty Hosp, Glostrup Res Inst, Glostrup, Denmark; [Holm, Anja] Univ Copenhagen, Glostrup Hosp, Mol Sleep Lab, Dept Diagnost, Glostrup, Denmark; [Holm, Anja] Univ Copenhagen, Glostrup Hosp, Danish Ctr Sleep Med, Dept Clin Neurophysiol, Glostrup, Denmark; [Rantala, Juha; Kallioniemi, Olli] VTT Tech Res Ctr Finland, Turku, Finland; [Ostenfeld, Marie S.] Univ Aarhus, Bladder Canc Res Grp, Dept Mol Med MOMA, Aarhus Univ Hosp, Aarhus, Denmark; [Dagnaes-Hansen, Frederik] Univ Aarhus, Dept Biomed, Aarhus, Denmark; [Sieber, Oliver M.; Gibbs, Peter] Ludwig Inst Canc Res, Ludwig Colon Canc Initiat Lab, Melbourne, Vic 3050, Australia; [Sieber, Oliver M.; Gibbs, Peter] Univ Melbourne, Fac Med, Fac Med Dent & Hlth Sci, Dept Surg, Melbourne, Vic, Australia; [Gibbs, Peter] Royal Melbourne & Western Hosp, Dept Med Oncol, Melbourne, Vic, Australia; [Hansen, Torben F.; Jakobsen, Anders] Univ Southern Denmark, Dept Oncol, Vejle Hosp, Vejle, Denmark; [Riising, Eva M.; Helin, Kristian] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Lubinski, Jan] Pomeranian Med Univ, Dept Pathol & Genet, Szczecin, Poland; [Hagemann-Madsen, Rikke] Univ Aarhus, Aarhus Univ Hosp, Dept Pathol, Aarhus, Denmark; [Laurberg, Soren] Univ Aarhus, Aarhus Univ Hosp, Dept Surg, Aarhus, Denmark	Aarhus University; University of Copenhagen; University of Copenhagen; University of Copenhagen; VTT Technical Research Center Finland; Aarhus University; Aarhus University; Ludwig Institute for Cancer Research; University of Melbourne; University of Southern Denmark; Lillebaelt Hospital; University of Copenhagen; Pomeranian Medical University; Aarhus University; Aarhus University	Christensen, LL (corresponding author), Univ Aarhus, Colorectal Canc Res Grp, Dept Mol Med MOMA, Aarhus Univ Hosp, Aarhus, Denmark.	liselotte.christensen@ki.au.dk; cla@ki.au.dk	Helin, Kristian/K-2526-2019; Helin, Kristian/HDM-8306-2022; Sieber, Oliver/M-9473-2015; Sieber, Oliver/ABA-9211-2021; Hansen, Torben F/J-8065-2012; Holm, Anja/AAN-7702-2020; Kallioniemi, Olli P/H-5111-2011; Andersen, Claus L/C-1477-2017; Andersen, Claus Lindbjerg/A-9217-2012	Helin, Kristian/0000-0003-1975-6097; Sieber, Oliver/0000-0001-9480-0786; Sieber, Oliver/0000-0001-9480-0786; Kallioniemi, Olli P/0000-0002-3231-0332; Gibbs, Peter/0000-0003-1423-4484; Madi Riising, Eva/0000-0003-3152-5769; Rasmussen, Mads Heilskov/0000-0001-5723-6303; Jakobsen, Anders/0000-0003-2110-2615; Andersen, Claus Lindbjerg/0000-0002-7406-2103; Rantala, Juha/0000-0002-4999-5585; Hansen, Torben/0000-0001-8748-3831; Hansen, Torben/0000-0001-7476-671X; Lubinski, Jan/0000-0003-2931-3003; Holm, Anja/0000-0001-8796-1872; Dagnaes-Hansen, Frederik/0000-0002-6622-0853	Danish National Advanced Technology Foundation; John and Birthe Meyer Foundation; Danish Council for Independent Research (Medical Sciences); Danish Council for Strategic Research; Lundbeck Foundation; The European Union [SYSCOL HEALTH-F5-2010-258236]	Danish National Advanced Technology Foundation; John and Birthe Meyer Foundation; Danish Council for Independent Research (Medical Sciences)(Det Frie Forskningsrad (DFF)); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Lundbeck Foundation(Lundbeckfonden); The European Union(European Commission)	This work was supported by the Danish National Advanced Technology Foundation, the John and Birthe Meyer Foundation, the Danish Council for Independent Research (Medical Sciences), the Danish Council for Strategic Research, the Lundbeck Foundation and The European Union's Seventh Framework Program (SYSCOL HEALTH-F5-2010-258236). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2010, MOL CELL BIOL, V30, P4197, DOI 10.1128/MCB.00316-10; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arndt GM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-374; Avnit-Sagi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005033; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boyle P, 2000, BRIT MED J, V321, P805, DOI 10.1136/bmj.321.7264.805; Cekaite L, 2012, NEOPLASIA, V14, P868, DOI 10.1593/neo.121094; Chang KH, 2011, INT J COLORECTAL DIS, V26, P1415, DOI 10.1007/s00384-011-1279-4; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Ding L, 2010, CELL RES, V20, P784, DOI 10.1038/cr.2010.79; Faltejskova P, 2012, J CELL MOL MED, V16, P2655, DOI 10.1111/j.1582-4934.2012.01579.x; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Hwang YC, 2009, AM J PATHOL, V175, P342, DOI 10.2353/ajpath.2009.080931; Izumiya M, 2011, CANCER SCI, V102, P1615, DOI 10.1111/j.1349-7006.2011.02007.x; Izumiya M, 2010, CARCINOGENESIS, V31, P1354, DOI 10.1093/carcin/bgq112; Bueno MJ, 2008, CELL CYCLE, V7, P3143, DOI 10.4161/cc.7.20.6833; Kong KL, 2012, GUT, V61, P33, DOI 10.1136/gutjnl-2011-300178; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Li XL, 2011, DIGEST DIS SCI, V56, P2849, DOI 10.1007/s10620-011-1711-1; Liu AM, 2010, BIOCHEM BIOPH RES CO, V394, P623, DOI 10.1016/j.bbrc.2010.03.036; Mazar J, 2011, FEBS LETT, V585, P2467, DOI 10.1016/j.febslet.2011.06.025; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Motoyama K, 2009, INT J ONCOL, V34, P1069, DOI 10.3892/ijo_00000233; Nakano H, 2010, INT J CANCER, V127, P1072, DOI 10.1002/ijc.25143; Nishimura Y, 2013, BRIT J CANCER, V108, P1324, DOI 10.1038/bjc.2013.65; Ostenfeld MS, 2005, CANCER RES, V65, P8975, DOI 10.1158/0008-5472.CAN-05-0269; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rantala JK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-162; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Sarver AL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-401; Schepeler T, 2012, ONCOGENE, V31, P2750, DOI 10.1038/onc.2011.453; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schetter AJ, 2009, CLIN CANCER RES, V15, P5878, DOI 10.1158/1078-0432.CCR-09-0627; Simonini PDR, 2010, CANCER RES, V70, P9175, DOI 10.1158/0008-5472.CAN-10-1318; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Suarez Y, 2009, CIRC RES, V104, P442, DOI 10.1161/CIRCRESAHA.108.191270; Subramanian S, 2010, J CELL PHYSIOL, V223, P289, DOI 10.1002/jcp.22066; Tsukamoto Y, 2010, CANCER RES, V70, P2339, DOI 10.1158/0008-5472.CAN-09-2777; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; von Eyss B, 2012, EMBO J, V31, P972, DOI 10.1038/emboj.2011.451; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang SY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-163; Xi YG, 2006, BIOMARK INSIGHTS, V1, P113; Yan HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020628; Yochum GS, 2008, MOL CELL BIOL, V28, P7368, DOI 10.1128/MCB.00744-08; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang S, 2008, JOVE-J VIS EXP, V19, pe920	60	46	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e96767	10.1371/journal.pone.0096767	http://dx.doi.org/10.1371/journal.pone.0096767			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892549	gold, Green Published, Green Submitted			2022-12-27	WOS:000336911400007
J	Doktor, TK; Schroder, LD; Andersen, HS; Broner, S; Kitewska, A; Sorensen, CB; Andresen, BS				Doktor, Thomas Koed; Schroder, Lisbeth Dahl; Andersen, Henriette Skovgaard; Broner, Sabrina; Kitewska, Anna; Sorensen, Charlotte Brandt; Andresen, Brage Storstein			Absence of an Intron Splicing Silencer in Porcine Smn1 Intron 7 Confers Immunity to the Exon Skipping Mutation in Human SMN2	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; SURVIVAL-MOTOR-NEURON; MOUSE MODEL; DETERMINING GENE; ANIMAL-MODEL; IN-VIVO; ENHANCERS; IDENTIFICATION; MICE; INCLUSION	Spinal Muscular Atrophy is caused by homozygous loss of SMN1. All patients retain at least one copy of SMN2 which produces an identical protein but at lower levels due to a silent mutation in exon 7 which results in predominant exclusion of the exon. Therapies targeting the splicing of SMN2 exon 7 have been in development for several years, and their efficacy has been measured using either in vitro cellular assays or in vivo small animal models such as mice. In this study we evaluated the potential for constructing a mini-pig animal model by introducing minimal changes in the endogenous porcine Smn1 gene to maintain the native genomic structure and regulation. We found that while a Smn2-like mutation can be introduced in the porcine Smn1 gene and can diminish the function of the ESE, it would not recapitulate the splicing pattern seen in human SMN2 due to absence of a functional ISS immediately downstream of exon 7. We investigated the ISS region and show here that the porcine ISS is inactive due to disruption of a proximal hnRNP A1 binding site, while a distal hnRNP A1 binding site remains functional but is unable to maintain the functionality of the ISS as a whole.	[Doktor, Thomas Koed; Andersen, Henriette Skovgaard; Broner, Sabrina; Andresen, Brage Storstein] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense M, Denmark; [Schroder, Lisbeth Dahl; Sorensen, Charlotte Brandt] Aarhus Univ, Dept Biomed, Aarhus C, Denmark; [Kitewska, Anna] Polish Acad Sci, Inst Anim Reprod & Food Res, Olsztyn, Poland	University of Southern Denmark; Aarhus University; Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences	Andresen, BS (corresponding author), Univ Southern Denmark, Dept Biochem & Mol Biol, Odense M, Denmark.	bragea@bmb.sdu.dk	Doktor, Thomas K/G-9923-2014; Andresen, Brage/D-2515-2012; Doktor, Thomas/AAB-2216-2020	Doktor, Thomas K/0000-0002-5315-8325; Andresen, Brage/0000-0001-7488-3035; Doktor, Thomas/0000-0002-5315-8325; Sorensen, Charlotte Brandt/0000-0002-4469-8696; Wieckowska, Anna/0000-0001-6103-3875; Broner, Sabrina/0000-0002-0508-2434	Riisfort Foundation; Lundbeck foundation; Danish Medical Research Council (FSS) [271-07-342, 11-107174]; Villum Fonden [00007292] Funding Source: researchfish	Riisfort Foundation; Lundbeck foundation(Lundbeckfonden); Danish Medical Research Council (FSS)(Danish Medical Research Council); Villum Fonden(Villum Fonden)	This work was supported by a grant from The Riisfort Foundation (BSA), the Lundbeck foundation ( BSA) and The Danish Medical Research Council (FSS grants no. 271-07-342 and no. 11-107174) to BSA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Cartegni L, 2006, AM J HUM GENET, V78, P63, DOI 10.1086/498853; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Cooper TA, 1997, AM J HUM GENET, V61, P259, DOI 10.1086/514856; Coulter LR, 1997, MOL CELL BIOL, V17, P2143, DOI 10.1128/MCB.17.4.2143; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dickson A, 2008, HUM GENE THER, V19, P1307, DOI 10.1089/hgt.2008.067; Doktor TK, 2011, HUM MUTAT, V32, P220, DOI 10.1002/humu.21419; Fairbrother WG, 2004, NUCLEIC ACIDS RES, V32, pW187, DOI 10.1093/nar/gkh393; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Geib T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008204; Gladman JT, 2010, HUM MOL GENET, V19, P4239, DOI 10.1093/hmg/ddq343; Gogliotti RG, 2011, NEUROBIOL DIS, V43, P142, DOI 10.1016/j.nbd.2011.03.002; Heier CR, 2010, HUM MOL GENET, V19, P3906, DOI 10.1093/hmg/ddq330; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; Hua YM, 2007, PLOS BIOL, V5, P729, DOI 10.1371/journal.pbio.0050073; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Hua YM, 2010, GENE DEV, V24, P1634, DOI 10.1101/gad.1941310; Jablonka S, 2000, HUM MOL GENET, V9, P341, DOI 10.1093/hmg/9.3.341; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; Lorson MA, 2008, DEV DYNAM, V237, P2268, DOI 10.1002/dvdy.21642; Luo YL, 2012, TRANSGENIC RES, V21, P671, DOI 10.1007/s11248-011-9563-1; Madocsai C, 2005, MOL THER, V12, P1013, DOI 10.1016/j.ymthe.2005.08.022; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Nielsen KB, 2007, AM J HUM GENET, V80, P416, DOI 10.1086/511992; Park GH, 2010, CURR NEUROL NEUROSCI, V10, P108, DOI 10.1007/s11910-010-0095-5; Porensky PN, 2012, HUM MOL GENET, V21, P1625, DOI 10.1093/hmg/ddr600; Rigo F, 2012, J CELL BIOL, V199, P21, DOI 10.1083/jcb.201207087; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schweingruber C, 2013, BBA-GENE REGUL MECH, V1829, P612, DOI 10.1016/j.bbagrm.2013.02.005; Sironi M, 2004, NUCLEIC ACIDS RES, V32, P1783, DOI 10.1093/nar/gkh341; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Velasco E, 1996, HUM MOL GENET, V5, P257, DOI 10.1093/hmg/5.2.257; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Wernersson R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-70; Wolstencroft EC, 2005, HUM MOL GENET, V14, P1199, DOI 10.1093/hmg/ddi131; Zatkova A, 2004, HUM MUTAT, V24, P491, DOI 10.1002/humu.20103; Zhang CL, 2008, P NATL ACAD SCI USA, V105, P5797, DOI 10.1073/pnas.0801692105; Zhang XHF, 2005, MOL CELL BIOL, V25, P7323, DOI 10.1128/MCB.25.16.7323-7332.2005; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304	47	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98841	10.1371/journal.pone.0098841	http://dx.doi.org/10.1371/journal.pone.0098841			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892836	Green Published, Green Submitted, gold			2022-12-27	WOS:000336911400100
J	Dolev, Y; Nelson, XJ				Dolev, Yinnon; Nelson, Ximena J.			Innate Pattern Recognition and Categorization in a Jumping Spider	PLOS ONE			English	Article							ANTERIOR-LATERAL EYES; PRINCIPAL EYES; PHIDIPPUS-AUDAX; VISUAL-STIMULI; PERCEPTION; ORIENTATION; BEHAVIOR; VISION; DENDRYPHANTINAE; DISCRIMINATION	The East African jumping spider Evarcha culicivora feeds indirectly on vertebrate blood by preferentially preying upon blood-fed Anopheles mosquitoes, the vectors of human malaria 1, using the distinct resting posture and engorged abdomen characteristic of these specific prey as key elements for their recognition. To understand perceptual categorization of objects by these spiders, we investigated their predatory behavior toward different digital stimuli - abstract 'stick figure' representations of Anopheles constructed solely by known key identification elements, disarranged versions of these, as well as non-prey items and detailed images of alternative prey. We hypothesized that the abstract images representing Anopheles would be perceived as potential prey, and would be preferred to those of non-preferred prey. Spiders perceived the abstract stick figures of Anopheles specifically as their preferred prey, attacking them significantly more often than non-preferred prey, even when the comprising elements of the Anopheles stick figures were disarranged and disconnected from each other. However, if the relative angles between the elements of the disconnected stick figures of Anopheles were altered, the otherwise identical set of elements was no longer perceived as prey. These data show that E. culicivora is capable of making discriminations based on abstract concepts, such as the hypothetical angle formed by discontinuous elements. It is this inter-element angle rather than resting posture that is important for correct identification of Anopheles. Our results provide a glimpse of the underlying processes of object recognition in animals with minute brains, and suggest that these spiders use a local processing approach for object recognition, rather than a holistic or global approach. This study provides an excellent basis for a comparative analysis on feature extraction and detection by animals as diverse as bees and mammals.	[Dolev, Yinnon; Nelson, Ximena J.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand	University of Canterbury	Dolev, Y (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand.	yinnond@gmail.com			Royal Society of New Zealand Marsden Fund [M1149]; University of Canterbury	Royal Society of New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); University of Canterbury	This research was supported by the Royal Society of New Zealand Marsden Fund to XJN (M1149). YD was supported by an International Doctoral Scholarship from the University of Canterbury. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPELLE S, 1972, PSYCHOL BULL, V78, P266, DOI 10.1037/h0033117; Avargues-Weber A, 2012, P NATL ACAD SCI USA, V109, P7481, DOI 10.1073/pnas.1202576109; Avargues-Weber A, 2011, P ROY SOC B-BIOL SCI, V278, P898, DOI 10.1098/rspb.2010.1891; Bar M, 2003, J COGNITIVE NEUROSCI, V15, P600, DOI 10.1162/089892903321662976; BARLOW HB, 1953, J PHYSIOL-LONDON, V119, P58, DOI 10.1113/jphysiol.1953.sp004828; Bednarski JV, 2012, ANIM BEHAV, V84, P1221, DOI 10.1016/j.anbehav.2012.08.032; BLEST AD, 1990, CELL TISSUE RES, V262, P445, DOI 10.1007/BF00305241; Chen S, 1996, VISION RES, V36, P1721, DOI 10.1016/0042-6989(95)00245-6; Douglas R.H., 1990, P373; DREES OSKAR, 1952, ZEITSCHR TIERPSYCHOL, V9, P169; Edward Bradford Titchener, 1909, LECT EXPT PSYCHOL TH; Enns JT., 2004, THINKING EYE SEEING; Ewert Joerg-Peter, 2004, P117; Ewert JP, 1997, TRENDS NEUROSCI, V20, P332; Forster J, 2005, PSYCHOL SCI, V16, P631, DOI 10.1111/j.1467-9280.2005.01586.x; Forster L., 1985, P249; Harel A, 2011, J VISION, V11, DOI 10.1167/11.8.18; Heinze HJ, 1998, J COGNITIVE NEUROSCI, V10, P485, DOI 10.1162/089892998562898; Horridge A, 2000, J COMP PHYSIOL A, V186, P521, DOI 10.1007/s003590000103; Horridge A, 2009, J EXP BIOL, V212, P2721, DOI 10.1242/jeb.030916; Horridge A, 2009, J INSECT PHYSIOL, V55, P499, DOI 10.1016/j.jinsphys.2009.03.006; Ingle DJ., 1983, ADV VERTEBRATE NEURO, P177; Ito M, 2004, J NEUROSCI, V24, P3313, DOI 10.1523/JNEUROSCI.4364-03.2004; Jackson RR, 2012, ANIM COGN, V15, P461, DOI 10.1007/s10071-012-0469-y; Jackson RR, 2005, P NATL ACAD SCI USA, V102, P15155, DOI 10.1073/pnas.0507398102; Jackson RR, 1996, ANNU REV ENTOMOL, V41, P287, DOI 10.1146/annurev.en.41.010196.001443; Kennedy GJ, 2006, VISION RES, V46, P1530, DOI 10.1016/j.visres.2005.06.003; KIMCHI R, 1992, PSYCHOL BULL, V112, P24, DOI 10.1037/0033-2909.112.1.24; King WV, 1943, J ECON ENTOMOL, V36, P573, DOI 10.1093/jee/36.4.573; Land M.F., 1985, P53; LAND MF, 1969, J EXP BIOL, V51, P443; LAND MF, 1969, J EXP BIOL, V51, P471; LAND MF, 1971, J EXP BIOL, V54, P119; Land MF., 1972, INFORM PROCESSING VI, P231, DOI [10.1007/978-3-642-65477-0%5F34, DOI 10.1007/978-3-642-65477-0%5F34]; LETTVIN JY, 1959, P IRE, V47, P1940, DOI 10.1109/JRPROC.1959.287207; Lillywhite K, 2013, PATTERN RECOGN, V46, P3300, DOI 10.1016/j.patcog.2013.06.002; MARR D, 1978, PROC R SOC SER B-BIO, V200, P269, DOI 10.1098/rspb.1978.0020; MASKE R, 1986, PROC R SOC SER B-BIO, V229, P257, DOI 10.1098/rspb.1986.0085; McKone E, 2007, TRENDS COGN SCI, V11, P8, DOI 10.1016/j.tics.2006.11.002; Nelson XJ, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000132; Nelson XJ, 2012, J EXP BIOL, V215, P2255, DOI 10.1242/jeb.069609; Nelson XJ, 2005, J ARACHNOL, V33, P541, DOI 10.1636/05-3.1; Piepers DW, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00559; Prete FR, 2002, ANIM BEHAV, V63, P503, DOI 10.1006/anbe.2001.1955; Prete FR, 2011, J COMP PHYSIOL A, V197, P877, DOI 10.1007/s00359-011-0649-2; Regan D, 1996, VISION RES, V36, P323, DOI 10.1016/0042-6989(95)00113-E; Richler JJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00553; ROCK I, 1990, SCI AM, V263, P84, DOI 10.1038/scientificamerican1290-84; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Shashar N, 1996, J EXP BIOL, V199, P999; Shevelev IA, 1998, BIOSYSTEMS, V48, P195, DOI 10.1016/S0303-2647(98)00066-5; Spano L, 2012, BIOL LETTERS, V8, P949, DOI 10.1098/rsbl.2012.0716; Srinivasan MV, 2010, ANNU REV ENTOMOL, V55, P267, DOI 10.1146/annurev.ento.010908.164537; VANHATEREN JH, 1990, VISION RES, V30, P603, DOI 10.1016/0042-6989(90)90071-R; Wagemans J, 2012, PSYCHOL BULL, V138, P1172, DOI 10.1037/a0029333; WILLIAMS DS, 1980, NATURE, V288, P578, DOI 10.1038/288578a0; Won YG, 2000, LECT NOTES COMPUT SC, V1876, P806; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; Zurek DB, 2012, J COMP PHYSIOL A, V198, P411, DOI 10.1007/s00359-012-0719-0; Zurek DB, 2010, J EXP BIOL, V213, P2372, DOI 10.1242/jeb.042382	60	26	26	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e97819	10.1371/journal.pone.0097819	http://dx.doi.org/10.1371/journal.pone.0097819			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5ML	24893306	gold, Green Published			2022-12-27	WOS:000336911400024
J	Martinez-Clemente, J; Lopez-Arnau, R; Abad, S; Pubill, D; Escubedo, E; Camarasa, J				Martinez-Clemente, Jose; Lopez-Arnau, Raul; Abad, Sonia; Pubill, David; Escubedo, Elena; Camarasa, Jorge			Dose and Time-Dependent Selective Neurotoxicity Induced by Mephedrone in Mice	PLOS ONE			English	Article							MDMA-INDUCED NEUROTOXICITY; SELF-INJURIOUS-BEHAVIOR; BATH SALTS; 3,4-METHYLENEDIOXYPYROVALERONE MDPV; DESIGNER STIMULANT; DOPAMINE; DRUG; SEROTONIN; RATS; ECSTASY	Mephedrone is a drug of abuse marketed as 'bath salts". There are discrepancies concerning its long-term effects. We have investigated the neurotoxicity of mephedrone in mice following different exposition schedules. Schedule 1: four doses of 50 mg/kg. Schedule 2: four doses of 25 mg/kg. Schedule 3: three daily doses of 25 mg/kg, for two consecutive days. All schedules induced, in some animals, an aggressive behavior and hyperthermia as well as a decrease in weight gain. Mephedrone (schedule 1) induced dopaminergic and serotoninergic neurotoxicity that persisted 7 days after exposition. At a lower dose (schedule 2) only a transient dopaminergic injury was found. In the weekend consumption pattern (schedule 3), mephedrone induced dopamine and serotonin transporter loss that was accompanied by a decrease in tyrosine hydroxylase and tryptophan hydroxylase 2 expression one week after exposition. Also, mephedrone induced a depressive-like behavior, as well as a reduction in striatal D2 density, suggesting higher susceptibility to addictive drugs. In cultured cortical neurons, mephedrone induced a concentration-dependent cytotoxic effect. Using repeated doses for 2 days in an elevated ambient temperature we evidenced a loss of frontal cortex dopaminergic and hippocampal serotoninergic neuronal markers that suggest injuries at nerve endings.	[Escubedo, Elena] Univ Barcelona, Fac Pharm, Dept Pharmacol & Therapeut Chem, Pharmacol Sect, Barcelona, Spain; Univ Barcelona, Fac Pharm, Inst Biomed IBUB, Barcelona, Spain	University of Barcelona; University of Barcelona	Escubedo, E (corresponding author), Univ Barcelona, Fac Pharm, Dept Pharmacol & Therapeut Chem, Pharmacol Sect, Barcelona, Spain.	eescubedo@ub.edu	López-Arnau, Raúl/Q-5896-2018; Escubedo, Elena/K-5295-2014; Sanchez, David Pubill/H-3013-2016	López-Arnau, Raúl/0000-0001-8904-7398; Escubedo, Elena/0000-0002-5078-366X; Sanchez, David Pubill/0000-0002-6627-4501; Sonia, ABAD/0000-0001-8238-0016	Generalitat de Catalunya [SGR977]; Plan Nacional sobre Drogas [2010/005, 2012/102]; Ministerio de Ciencia e Innovacion [SAF2010-15948]; Plan Nacional sobre Drogas; Generalitat de Catalunya	Generalitat de Catalunya(Generalitat de Catalunya); Plan Nacional sobre Drogas; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Plan Nacional sobre Drogas; Generalitat de Catalunya(Generalitat de Catalunya)	Funding for this study was provided by grants from Generalitat de Catalunya (SGR977), Plan Nacional sobre Drogas (2010/005; 2012/102) and Ministerio de Ciencia e Innovacion (SAF2010-15948). Martinez-Clemente is a recipient of a fellowship from the Plan Nacional sobre Drogas and Lopez-Arnau is a recipient of a fellowship from Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angoa-Perez M, 2012, J NEUROCHEM, V120, P1097, DOI 10.1111/j.1471-4159.2011.07632.x; BATTAGLIA G, 1988, PHARMACOL BIOCHEM BE, V29, P269, DOI 10.1016/0091-3057(88)90155-4; Baumann MH, 2013, NEUROPSYCHOPHARMACOL, V38, P552, DOI 10.1038/npp.2012.204; Baumann MH, 2012, NEUROPSYCHOPHARMACOL, V37, P1192, DOI 10.1038/npp.2011.304; Biezonski DK, 2011, CURR NEUROPHARMACOL, V9, P84, DOI 10.2174/157015911795017146; Borek HA, 2012, ANN EMERG MED, V60, P103, DOI 10.1016/j.annemergmed.2012.01.005; Brunt TM, 2011, J PSYCHOPHARMACOL, V25, P1543, DOI 10.1177/0269881110378370; Calapai G, 2001, PHARMACOPSYCHIATRY, V34, P45, DOI 10.1055/s-2001-15180; Cameron K, 2013, PSYCHOPHARMACOLOGY, V227, P493, DOI 10.1007/s00213-013-2967-2; Capela JP, 2013, NEUROTOXICOLOGY, V34, P254, DOI 10.1016/j.neuro.2012.09.005; Clark RA, 2012, J PSYCHOPHARMACOL, V26, P1136, DOI 10.1177/0269881111420313; de la Torre R, 2004, THER DRUG MONIT, V26, P137, DOI 10.1097/00007691-200404000-00009; den Hollander B, 2013, PHARMACOL BIOCHEM BE, V103, P501, DOI 10.1016/j.pbb.2012.10.006; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Escubedo E, 2005, J PHARMACOL EXP THER, V315, P658, DOI 10.1124/jpet.105.089748; Fantegrossi WE, 2013, NEUROPSYCHOPHARMACOL, V38, P563, DOI 10.1038/npp.2012.233; Groman SM, 2012, J NEUROSCI, V32, P5843, DOI 10.1523/JNEUROSCI.0029-12.2012; Gunderson EW, 2013, J ADDICT MED, V7, P153, DOI 10.1097/ADM.0b013e31829084b7; Hadlock GC, 2011, J PHARMACOL EXP THER, V339, P530, DOI 10.1124/jpet.111.184119; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Kasick DP, 2012, AM J DRUG ALCOHOL AB, V38, P176, DOI 10.3109/00952990.2011.643999; Kehr J, 2011, BRIT J PHARMACOL, V164, P1949, DOI 10.1111/j.1476-5381.2011.01499.x; Kuhn DM, 2007, J NEUROCHEM, V103, P1567, DOI 10.1111/j.1471-4159.2007.04855.x; LOGAN BJ, 1988, EUR J PHARMACOL, V152, P227, DOI 10.1016/0014-2999(88)90717-0; Lopez-Arnau R, 2012, BRIT J PHARMACOL, V167, P407, DOI 10.1111/j.1476-5381.2012.01998.x; Martinez-Clemente J, 2013, PSYCHOPHARMACOLOGY, V229, P295, DOI 10.1007/s00213-013-3108-7; Martinez-Clemente J, 2012, EUR NEUROPSYCHOPHARM, V22, P231, DOI 10.1016/j.euroneuro.2011.07.009; Maskell PD, 2011, J ANAL TOXICOL, V35, P188, DOI 10.1093/anatox/35.3.188; McElrath K, 2011, INT J DRUG POLICY, V22, P120, DOI 10.1016/j.drugpo.2010.11.001; McGregor IS, 2003, PSYCHOPHARMACOLOGY, V168, P465, DOI 10.1007/s00213-003-1452-8; Measham F, 2010, DRUGS ALCOHOL TODAY, V10, P14, DOI 10.5042/daat.2010.0123; Meng H, 2012, TOXICOL LETT, V208, P62, DOI 10.1016/j.toxlet.2011.10.010; Motbey CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045473; O'Shea E, 2006, BRIT J PHARMACOL, V148, P778, DOI 10.1038/sj.bjp.0706783; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Prosser JM, 2012, J MED TOXICOL, V8, P33, DOI 10.1007/s13181-011-0193-z; PU CF, 1993, DEV BRAIN RES, V72, P325; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rockhold RW, 1997, ANN EMERG MED, V29, P383, DOI 10.1016/S0196-0644(97)70351-2; Sanchez V, 2004, J PSYCHOPHARMACOL, V18, P412, DOI 10.1177/026988110401800312; SCHEFFEL U, 1992, NEUROPHARMACOLOGY, V31, P881, DOI 10.1016/0028-3908(92)90126-A; Schifano F, 2011, PSYCHOPHARMACOLOGY, V214, P593, DOI 10.1007/s00213-010-2070-x; Schroter CJ, 1999, J IMMUNOL METHODS, V227, P161, DOI 10.1016/S0022-1759(99)00079-4; Shishido T, 2000, PHARMACOL BIOCHEM BE, V66, P579, DOI 10.1016/S0091-3057(00)00219-7; Simmler LD, 2013, BRIT J PHARMACOL, V168, P458, DOI 10.1111/j.1476-5381.2012.02145.x; Vardakou I, 2011, TOXICOL LETT, V201, P191, DOI 10.1016/j.toxlet.2010.12.014; Varner KJ, 2013, PSYCHOPHARMACOLOGY, V225, P675, DOI 10.1007/s00213-012-2855-1; Verdaguer E, 2002, NEUROREPORT, V13, P413, DOI 10.1097/00001756-200203250-00010; Vidal-Infer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043107; Volkow ND, 2004, MOL PSYCHIATR, V9, P557, DOI 10.1038/sj.mp.4001507; Wagner GC, 2004, NEUROPHARMACOLOGY, V46, P700, DOI 10.1016/j.neuropharm.2003.11.009; Wikstrom M, 2010, J ANAL TOXICOL, V34, P594, DOI 10.1093/jat/34.9.594; Winstock A, 2011, ADDICTION, V106, P1991, DOI 10.1111/j.1360-0443.2011.03502.x; Winstock A, 2010, LANCET, V376, P1537, DOI 10.1016/S0140-6736(10)62021-1; Wood DM, 2011, EMERG MED J, V28, P280, DOI 10.1136/emj.2010.092288; Wright MJ, 2012, BRIT J PHARMACOL, V167, P1342, DOI 10.1111/j.1476-5381.2012.02091.x; Wright MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044652	57	44	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e99002	10.1371/journal.pone.0099002	http://dx.doi.org/10.1371/journal.pone.0099002			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892744	Green Published, gold, Green Submitted			2022-12-27	WOS:000336911400119
J	Yu, LJ; Zhou, LL; Tan, L; Jiang, HB; Wang, Y; Wei, S; Nie, SF				Yu, Lijing; Zhou, Lingling; Tan, Li; Jiang, Hongbo; Wang, Ying; Wei, Sheng; Nie, Shaofa			Application of a New Hybrid Model with Seasonal Auto-Regressive Integrated Moving Average (ARIMA) and Nonlinear Auto-Regressive Neural Network (NARNN) in Forecasting Incidence Cases of HFMD in Shenzhen, China	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; HUMAN ENTEROVIRUS 71; FOOT-MOUTH DISEASE; DENGUE INFECTION; HAND; OUTBREAK; HERPANGINA; PREDICTION; EPIDEMIC; CHILDREN	Background: Outbreaks of hand-foot-mouth disease (HFMD) have been reported for many times in Asia during the last decades. This emerging disease has drawn worldwide attention and vigilance. Nowadays, the prevention and control of HFMD has become an imperative issue in China. Early detection and response will be helpful before it happening, using modern information technology during the epidemic. Method: In this paper, a hybrid model combining seasonal auto-regressive integrated moving average (ARIMA) model and nonlinear auto-regressive neural network (NARNN) is proposed to predict the expected incidence cases from December 2012 to May 2013, using the retrospective observations obtained from China Information System for Disease Control and Prevention from January 2008 to November 2012. Results: The best-fitted hybrid model was combined with seasonal ARIMA ((2,3)1,0)(12) and NARNN with 15 hidden units and 5 delays. The hybrid model makes the good forecasting performance and estimates the expected incidence cases from December 2012 to May 2013, which are respectively -965.03, -1879.58, 4138.26, 1858.17, 4061.86 and 6163.16 with an obviously increasing trend. Conclusion: The model proposed in this paper can predict the incidence trend of HFMD effectively, which could be helpful to policy makers. The usefulness of expected cases of HFMD perform not only in detecting outbreaks or providing probability statements, but also in providing decision makers with a probable trend of the variability of future observations that contains both historical and recent information.	[Yu, Lijing; Zhou, Lingling; Tan, Li; Jiang, Hongbo; Wang, Ying; Wei, Sheng; Nie, Shaofa] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Nie, SF (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Wuhan 430074, Peoples R China.	sf_nie@mails.tjmu.edu.cn		Jiang, Hongbo/0000-0002-0631-4460	Biotechnology and Biological Sciences Research Council [BB/G010579/1] Funding Source: Medline; BBSRC [BB/G010579/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		AbuBakar S, 1999, VIRUS RES, V61, P1, DOI 10.1016/S0168-1702(99)00019-2; Aladag CH, 2009, APPL MATH LETT, V22, P1467, DOI 10.1016/j.aml.2009.02.006; Allard R, 1998, B WORLD HEALTH ORGAN, V76, P327; Bendig J W, 1996, Commun Dis Rep CDR Rev, V6, pR81; Benschop J, 2008, EPIDEMIOL INFECT, V136, P1511, DOI 10.1017/S0950268807000234; Box G.E., 2013, TIME SERIES ANAL FOR; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chen KT, 2007, PEDIATRICS, V120, pE244, DOI 10.1542/peds.2006-3331; Chen KY, 2007, EXPERT SYST APPL, V32, P254, DOI 10.1016/j.eswa.2005.11.027; CLARKE SKR, 1964, BRIT MED J, V1, P58, DOI 10.1136/bmj.1.5374.58-a; CONNOR JT, 1994, IEEE T NEURAL NETWOR, V5, P240, DOI 10.1109/72.279188; Frydenberg Alexis, 2003, Aust Fam Physician, V32, P594; GILBERT GL, 1988, PEDIATR INFECT DIS J, V7, P484, DOI 10.1097/00006454-198807000-00007; Guan P, 2004, WORLD J GASTROENTERO, V10, P3579, DOI 10.3748/wjg.v10.i24.3579; HAYWARD JC, 1989, PEDIATR INFECT DIS J, V8, P611, DOI 10.1097/00006454-198909000-00009; Hii YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016796; Hongyuan Z, 1985, J JILIN U MED EDITIO, V5; HORNIK K, 1989, NEURAL NETWORKS, V2, P359, DOI 10.1016/0893-6080(89)90020-8; Huang Y, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-134; Huibin L, 1986, BEIJING MED J, V4; Jianchi S, 1986, BEIJING MED J, V4; Lee HS, 2013, PREV VET MED, V110, P190, DOI 10.1016/j.prevetmed.2012.12.003; Liehua CXD, 1990, J JINAN U, V4; Liu CC, 2000, J CLIN VIROL, V17, P23, DOI 10.1016/S1386-6532(00)00068-8; Ma E, 2010, EPIDEMIOL INFECT, V138, P1779, DOI 10.1017/S0950268810002256; Martinez EZ, 2011, CAD SAUDE PUBLICA, V27, P1809, DOI 10.1590/S0102-311X2011000900014; NAGY G, 1982, ARCH VIROL, V71, P217, DOI 10.1007/BF01314873; Onozuka D, 2011, SCI TOTAL ENVIRON, V410, P119, DOI 10.1016/j.scitotenv.2011.09.055; Roman J., 1996, Proceedings of the Twenty-Ninth Hawaii International Conference on System Sciences, P454, DOI 10.1109/HICSS.1996.495431; Shafie-khah M, 2011, ENERG CONVERS MANAGE, V52, P2165, DOI 10.1016/j.enconman.2010.10.047; Teheng L, 1983, TIANJIN MED J, V12; Urashima M, 2003, JPN J INFECT DIS, V56, P48; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wang LD, 2008, LANCET, V372, P1598, DOI 10.1016/S0140-6736(08)61365-3; Wang LP, 2007, DIS SURVEILLANCE, V22, P412; Wong SSY, 2010, EPIDEMIOL INFECT, V138, P1071, DOI 10.1017/S0950268809991555; Wongkoon S, 2012, ASIAN PAC J TROP MED, V5, P249, DOI 10.1016/S1995-7645(12)60034-0; Xu W, 2011, ASIA-PAC J PUBLIC HE, P1; Yan WR, 2010, JPN J INFECT DIS, V63, P264; Zeng M, 2012, EPIDEMIOL INFECT, V140, P1122, DOI 10.1017/S0950268811001622; Zhang GP, 2003, NEUROCOMPUTING, V50, P159, DOI 10.1016/S0925-2312(01)00702-0; Zhang J, 2011, BIOMED ENVIRON SCI, V24, P214, DOI 10.3967/0895-3988.2011.03.002; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; ZHENG ZM, 1995, J MED VIROL, V47, P161, DOI 10.1002/jmv.1890470209; Zhilun Z, 1987, TIANJIN MED J, V11; Zhu Q, 2011, BIOMED ENVIRON SCI, V24, P349, DOI 10.3967/0895-3988.2011.04.005	46	50	63	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98241	10.1371/journal.pone.0098241	http://dx.doi.org/10.1371/journal.pone.0098241			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893000	Green Published, Green Submitted, gold			2022-12-27	WOS:000336911400042
J	Zhou, KK; Jiang, MS; Liu, YL; Qu, YL; Shi, GJ; Yang, XG; Qin, XF; Wang, XH				Zhou, Kangkang; Jiang, Mingshan; Liu, Yuanli; Qu, Yilin; Shi, Guojing; Yang, Xinguang; Qin, Xiaofa; Wang, Xiuhong			Effect of Bile Pigments on the Compromised Gut Barrier Function in a Rat Model of Bile Duct Ligation	PLOS ONE			English	Article							BACTERIAL TRANSLOCATION; OBSTRUCTIVE-JAUNDICE; BILIRUBIN; SALTS; BILIVERDIN; MORPHOLOGY; DIAGNOSIS; SYSTEMS; INJURY	Background: Studies have shown that the absence of bile in the gut lumen, either by bile duct ligation or bile diversion, induces mucosal injury. However, the mechanism remains elusive. In this study, the role of bile pigments in gut barrier function was investigated in a rat model of bile duct ligation. Methods: Male Sprague Dawley (SD) rats were used in this study. After ligation of bile duct, the animals were administrated with free bilirubin, bilirubin ditaurate, or biliverdin by intragastric gavage. 1, 2, or 3 days later, the animals were sacrificed and the damage of mucosa was assessed by histological staining as well as biochemical parameters such as changes of diamine oxidase (DAO) and D-lactate (D-Lac) in the blood. Trypsin and chymotrypsin of the gut were also measured to determine how these digestive proteases may relate to the observed effects of bile pigments. Results: Bile duct ligation (BDL) caused significant increases in gut trypsin and chymotrypsin along with damage of the mucosa as demonstrated by the histological findings under microscope, the reduced expression of tight junction molecules like occludin, and significant changes in DAO and D-lac in the blood. Free bilirubin but not bilirubin ditaurate or biliverdin showed significant inhibitions on trypsin and chymotrypsin as well as alleviated changes of histological and biochemical parameters related to gut barrier disruption. Conclusion: Bile may protect the gut from damage through inhibiting digestive proteases like trypsin and chymotrypsin by free bilirubin.	[Zhou, Kangkang; Liu, Yuanli; Qu, Yilin; Shi, Guojing; Yang, Xinguang; Wang, Xiuhong] Harbin Med Univ, Dept Biochem & Mol Biol, Heilongjiang Prov Sci & Technol Innovat Team, Higher Educ Inst Infect, Harbin, Peoples R China; [Zhou, Kangkang; Liu, Yuanli; Qu, Yilin; Shi, Guojing; Yang, Xinguang; Wang, Xiuhong] Harbin Med Univ, Dept Biochem & Mol Biol, Heilongjiang Prov Sci & Technol Innovat Team, Higher Educ Inst Immun, Harbin, Peoples R China; [Jiang, Mingshan] Harbin Med Univ, Affiliated Hosp 2, Dept Gen Surg, Harbin, Peoples R China; [Qin, Xiaofa] Rutgers New Jersey Med Sch, Dept Surg, Newark, NJ USA	Harbin Medical University; Harbin Medical University; Harbin Medical University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Wang, XH (corresponding author), Harbin Med Univ, Dept Biochem & Mol Biol, Heilongjiang Prov Sci & Technol Innovat Team, Higher Educ Inst Infect, Harbin, Peoples R China.	wangxh700417@yahoo.com.cn			National Natural Science Foundation of China [30973596]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by The National Natural Science Foundation of China (No. 30973596). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basinska A, 2003, BETA GLUCORONIDASE P, P386; Biancheri P, 2013, CELL TISSUE RES, V351, P269, DOI 10.1007/s00441-012-1390-z; BRANDT RB, 1980, ANAL BIOCHEM, V102, P39, DOI 10.1016/0003-2697(80)90314-0; Bulmer AC, 2011, BRIT J PHARMACOL, V164, P1857, DOI 10.1111/j.1476-5381.2011.01413.x; Bulmer AC, 2008, ATHEROSCLEROSIS, V199, P390, DOI 10.1016/j.atherosclerosis.2007.11.022; Cakmakci M, 1996, EUR J SURG, V162, P567; DELANEY JP, 1992, SURGERY, V112, P587; FALLON MB, 1995, AM J PHYSIOL-CELL PH, V269, pC1057, DOI 10.1152/ajpcell.1995.269.4.C1057; Gencay C, 2008, WORLD J GASTROENTERO, V14, P3410, DOI 10.3748/wjg.14.3410; Gruber L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071661; Gurleyik E, 2006, J INVEST SURG, V19, P283, DOI 10.1080/08941930600889391; GUSLANDI M, 1983, GUT, V24, P594, DOI 10.1136/gut.24.6.594; HENRIKSON CK, 1989, LAB INVEST, V60, P72; KEELING JW, 1976, J PATHOL, V118, P157, DOI 10.1002/path.1711180305; LOWBEER TS, 1970, GUT, V11, P486, DOI 10.1136/gut.11.6.486; LUK GD, 1983, J CLIN INVEST, V71, P1308, DOI 10.1172/JCI110881; MCDONAGH AF, 1972, BIOCHEM J, V129, P797, DOI 10.1042/bj1290797; Mowat AP, 1987, GUT, V28, P365; NAKAGAMI T, 1993, BIOCHIM BIOPHYS ACTA, V1158, P189, DOI 10.1016/0304-4165(93)90013-X; Ogata Y, 2003, J SURG RES, V115, P18, DOI 10.1016/S0022-4804(03)00308-1; Qin XF, 2007, GUT, V56, P1641, DOI 10.1136/gut.2007.132076; ROD TO, 1977, ACTA PATH MICRO IM B, V85, P271; SALO JA, 1983, SURGERY, V93, P525; SLOCUM MM, 1992, AM SURGEON, V58, P305; SMITH SM, 1986, J INFECT DIS, V154, P658, DOI 10.1093/infdis/154.4.658; SPIVAK W, 1986, BIOCHEM J, V234, P101, DOI 10.1042/bj2340101; Vitek L, 2003, EUR J CLIN INVEST, V33, P799, DOI 10.1046/j.1365-2362.2003.01214.x; Vos TA, 1999, HEPATOLOGY, V29, P1833, DOI 10.1002/hep.510290638; Whitson BA, 2006, TURNING GREEN GOLD; Zsila F, 2011, BIOMACROMOLECULES, V12, P221, DOI 10.1021/bm1012103	30	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98905	10.1371/journal.pone.0098905	http://dx.doi.org/10.1371/journal.pone.0098905			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892651	Green Published, gold, Green Submitted			2022-12-27	WOS:000336911400108
J	Meng, KX; Xu, J; Zhang, CW; Zhang, R; Yang, H; Liao, C; Jiao, JD				Meng, Kexin; Xu, Jia; Zhang, Chengwei; Zhang, Rui; Yang, He; Liao, Chang; Jiao, Jundong			Calcium Sensing Receptor Modulates Extracellular Calcium Entry and Proliferation via TRPC3/6 Channels in Cultured Human Mesangial Cells	PLOS ONE			English	Article							OPERATED CA2+ ENTRY; CA2+-SENSING RECEPTOR; EPITHELIAL-CELLS; CONTRIBUTES; EXPRESSION; LOCALIZATION; STIMULATION; PROTEINS	Calcium-sensing receptor (CaSR) has been demonstrated to be present in several tissues and cells unrelated to systemic calcium homeostasis, where it regulates a series of diverse cellular functions. A previous study indicated that CaSR is expressed in mouse glomerular mesangial cells (MCs), and stimulation of CaSR induces cell proliferation. However, the signaling cascades initiated by CaSR activation in MCs are currently unknown. In this study, our data demonstrate that CaSR mRNA and protein are expressed in a human mesangial cell line. Activating CaSR with high extracellular Ca2+ concentration ([Ca2+](o)) or spermine induces a phospholipase C (PLC)-dependent increase in intracellular Ca2+ concentration ([Ca2+](i)). Interestingly, the CaSR activation-induced increase in [Ca2+](i) results not only from intracellular Ca2+ release from internal stores but also from canonical transient receptor potential (TRPC)-dependent Ca2+ influx. This increase in Ca2+ was attenuated by treatment with a nonselective TRPC channel blocker but not by treatment with a voltage-gated calcium blocker or Na+/Ca2+ exchanger inhibitor. Furthermore, stimulation of CaSR by high [Ca2+](o) enhanced the expression of TRPC3 and TRPC6 but not TRPC1 and TRPC4, and siRNA targeting TRPC3 and TRPC6 attenuated the CaSR activation-induced [Ca2+](i) increase. Further experiments indicate that 1-oleoyl-2-acetyl-sn-glycerol (OAG), a known activator of receptor-operated calcium channels, significantly enhances the CaSR activation-induced [Ca2+](i) increase. Moreover, under conditions in which intracellular stores were already depleted with thapsigargin (TG), CaSR agonists also induced an increase in [Ca2+](i), suggesting that calcium influx stimulated by CaSR agonists does not require the release of calcium stores. Finally, our data indicate that pharmacological inhibition and knock down of TRPC3 and TRPC6 attenuates the CaSR activation-induced cell proliferation in human MCs. With these data, we conclude that CaSR activation mediates Ca2+ influx and cell proliferation via TRPC3 and TRPC6 in human MCs.	[Meng, Kexin; Zhang, Chengwei; Zhang, Rui; Yang, He; Liao, Chang; Jiao, Jundong] Harbin Med Univ, Affiliated Hosp 2, Dept Nephrol, Harbin, Peoples R China; [Jiao, Jundong] Harbin Med Univ, Inst Nephrol, Harbin, Peoples R China; [Xu, Jia] Harbin Med Univ, Affiliated Hosp 4, Dept Nephrol, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Jiao, JD (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Nephrol, Harbin, Peoples R China.	jiaojundong@163.com			National Nature Science Foundation of China [31071016]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China (31071016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai M, 1996, J BIOL CHEM, V271, P19537, DOI 10.1074/jbc.271.32.19537; Bandyopadhyay BC, 2005, J BIOL CHEM, V280, P12908, DOI 10.1074/jbc.M410013200; Bandyopadhyay BC, 2012, J BIOL CHEM, V287, P30305, DOI 10.1074/jbc.M112.394122; Bennett BD, 2001, ENDOCRINOLOGY, V142, P1968, DOI 10.1210/en.142.5.1968; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; BROWN EM, 1995, CELL, V83, P679, DOI 10.1016/0092-8674(95)90180-9; Cai SW, 2006, PFLUG ARCH EUR J PHY, V452, P43, DOI 10.1007/s00424-005-0001-1; Chow JYC, 2011, AM J PHYSIOL-CELL PH, V301, pC461, DOI 10.1152/ajpcell.00389.2010; Diez-Fraile A, 2013, CURR MOL MED, V13, P282, DOI 10.2174/156652413804810763; Eder P, 2008, CHANNELS, V2, P94, DOI 10.4161/chan.2.2.6015; El Hiani Y, 2006, J MEMBRANE BIOL, V211, P127, DOI 10.1007/s00232-006-0017-2; Hiani YEL, 2009, CELL PHYSIOL BIOCHEM, V23, P335, DOI 10.1159/000218179; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Kwak JO, 2005, EXP MOL MED, V37, P457, DOI 10.1038/emm.2005.56; Lembrechts R, 2013, J CELL SCI, V126, P4490, DOI 10.1242/jcs.131656; Liao C, 2012, BIOCHEM BIOPH RES CO, V421, P750, DOI 10.1016/j.bbrc.2012.04.075; Ma R, 2005, PHYSIOLOGY, V20, P102, DOI 10.1152/physiol.00050.2004; Oh J, 2011, KIDNEY INT, V80, P483, DOI 10.1038/ki.2011.105; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Piecha G, 2008, AM J PHYSIOL-RENAL, V294, pF748, DOI 10.1152/ajprenal.00220.2007; RADTKE HW, 1981, J CLIN INVEST, V67, P1623, DOI 10.1172/JCI110197; Rey O, 2010, J CELL PHYSIOL, V225, P73, DOI 10.1002/jcp.22198; Riccardi D, 1996, AM J PHYSIOL-RENAL, V271, pF951, DOI 10.1152/ajprenal.1996.271.4.F951; Sours S, 2006, AM J PHYSIOL-RENAL, V290, pF1507, DOI 10.1152/ajprenal.00268.2005; Sours-Brorhers S, 2009, EXP BIOL MED, V234, P673, DOI 10.3181/0809-RM-279; Sraer JD, 1996, KIDNEY INT, V49, P267, DOI 10.1038/ki.1996.38; Sun YH, 2010, BIOCHEM BIOPH RES CO, V394, P955, DOI 10.1016/j.bbrc.2010.03.096; Thebault S, 2005, J CELL PHYSIOL, V204, P320, DOI 10.1002/jcp.20301; Torres PAU, 2012, KIDNEY INT, V82, P19, DOI 10.1038/ki.2012.69; Tu CL, 2007, J INVEST DERMATOL, V127, P1074, DOI 10.1038/sj.jid.5700633; Ye CP, 1996, BIOCHEM BIOPH RES CO, V226, P572, DOI 10.1006/bbrc.1996.1396	31	36	37	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98777	10.1371/journal.pone.0098777	http://dx.doi.org/10.1371/journal.pone.0098777			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905090	gold, Green Published, Green Submitted			2022-12-27	WOS:000341869000062
J	Woyda-Ploszczyca, AM; Jarmuszkiewicz, W				Woyda-Ploszczyca, Andrzej M.; Jarmuszkiewicz, Wieslawa			Different Effects of Guanine Nucleotides (GDP and GTP) on Protein-Mediated Mitochondrial Proton Leak	PLOS ONE			English	Article							RAT-LIVER MITOCHONDRIA; NUCLEOSIDE-DIPHOSPHATE-KINASE; SKELETAL-MUSCLE MITOCHONDRIA; ISOLATED HEART-MITOCHONDRIA; OXYGEN SPECIES PRODUCTION; BROWN ADIPOSE-TISSUE; UNCOUPLING PROTEIN; OXIDATIVE-PHOSPHORYLATION; SUBMITOCHONDRIAL PARTICLES; PURINE NUCLEOTIDES	In this study, we compared the influence of GDP and GTP on isolated mitochondria respiring under conditions favoring oxidative phosphorylation (OXPHOS) and under conditions excluding this process, i.e., in the presence of carboxyatractyloside, an adenine nucleotide translocase inhibitor, and/or oligomycin, an FOF1-ATP synthase inhibitor. Using mitochondria isolated from rat kidney and human endothelial cells, we found that the action of GDP and GTP can differ diametrically depending on the conditions. Namely, under conditions favoring OXPHOS, both in the absence and presence of linoleic acid, an activator of uncoupling proteins (UCPs), the addition of 1 mM GDP resulted in the state 4 (non-phosphorylating respiration)-state 3 (phosphorylating respiration) transition, which is characteristic of ADP oxidative phosphorylation. In contrast, the addition of 1 mM GTP resulted in a decrease in the respiratory rate and an increase in the membrane potential, which is characteristic of UCP inhibition. The stimulatory effect of GDP, but not GTP, was also observed in inside-out submitochondrial particles prepared from rat kidney mitochondria. However, the effects of GDP and GTP were more similar in the presence of OXPHOS inhibitors. The importance of these observations in connection with the action of UCPs, adenine nucleotide translocase (or other carboxyatractyloside-sensitive carriers), carboxyatractyloside-and purine nucleotide-insensitive carriers, as well as nucleoside-diphosphate kinase (NDPK) are considered. Because the measurements favoring oxidative phosphorylation better reflect in vivo conditions, our study strongly supports the idea that GDP cannot be considered a significant physiological inhibitor of UCP. Moreover, it appears that, under native conditions, GTP functions as a more efficient UCP inhibitor than GDP and ATP.	[Woyda-Ploszczyca, Andrzej M.; Jarmuszkiewicz, Wieslawa] Adam Mickiewicz Univ, Dept Bioenerget, Poznan, Poland	Adam Mickiewicz University	Jarmuszkiewicz, W (corresponding author), Adam Mickiewicz Univ, Dept Bioenerget, Poznan, Poland.	wiesiaj@amu.edu.pl	Woyda-Ploszczyca, Andrzej Marek/D-6195-2019	Jarmuszkiewicz, Wieslawa/0000-0001-8550-8337; Woyda-Ploszczyca, Andrzej Marek/0000-0002-3324-3397	Polish Ministry of Science and Higher Education [NN 301 636440, 2013 2015 IP2012 059172]; European Union; European Regional Development Fund under the Innovative Economy Programme [POIG.01.01.02-00-069/09]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); European Union(European Commission); European Regional Development Fund under the Innovative Economy Programme	This work was supported by grants of the Polish Ministry of Science and Higher Education (NN 301 636440 and Iuventus Plus program 2013 2015 IP2012 059172) and partially by European Union with resources from the European Regional Development Fund under the Innovative Economy Programme (POIG.01.01.02-00-069/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre E, 2010, BBA-BIOENERGETICS, V1797, P1716, DOI 10.1016/j.bbabio.2010.06.009; ANDREYEV AY, 1988, FEBS LETT, V226, P265, DOI 10.1016/0014-5793(88)81436-4; ANDREYEV AY, 1989, EUR J BIOCHEM, V182, P585, DOI 10.1111/j.1432-1033.1989.tb14867.x; Azzu V, 2008, BIOCHEM J, V413, P323, DOI 10.1042/BJ20080321; Barile M, 1997, BIOCHEM PHARMACOL, V53, P913, DOI 10.1016/S0006-2952(96)00831-3; Bevilacqua L, 2010, BBA-BIOENERGETICS, V1797, P1389, DOI 10.1016/j.bbabio.2010.02.018; Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890; BRIERLEY G, 1965, J BIOL CHEM, V240, P4532; Cadenas S, 2000, BIOCHEM J, V348, P209, DOI 10.1042/0264-6021:3480209; Cannon B, 2006, BBA-BIOENERGETICS, V1757, P449, DOI 10.1016/j.bbabio.2006.05.016; COLE RJ, 1980, J AGR FOOD CHEM, V28, P1330, DOI 10.1021/jf60232a043; Czarna M, 2005, FEBS LETT, V579, P3136, DOI 10.1016/j.febslet.2005.04.081; Dlaskova A, 2010, BBA-BIOENERGETICS, V1797, P1470, DOI 10.1016/j.bbabio.2010.04.008; Dolce V, 2001, P NATL ACAD SCI USA, V98, P2284, DOI 10.1073/pnas.031430998; DUEE ED, 1969, J BIOL CHEM, V244, P3920; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Fiermonte G, 2004, J BIOL CHEM, V279, P30722, DOI 10.1074/jbc.M400445200; Friederich-Persson M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039635; GOFFEAU A, 1967, J BIOL CHEM, V242, P1845; Gordon DM, 2006, BIOCHEM J, V400, P163, DOI 10.1042/BJ20060904; GRUBMEYER C, 1979, PLANT PHYSIOL, V64, P757, DOI 10.1104/pp.64.5.757; Itoh K, 2013, TRENDS CELL BIOL, V23, P64, DOI 10.1016/j.tcb.2012.10.006; JACOBUS WE, 1977, J BIOL CHEM, V252, P4232; Jarmuszkiewicz W, 2010, BBA-BIOENERGETICS, V1797, P792, DOI 10.1016/j.bbabio.2009.12.005; KAY CJ, 1985, FEBS LETT, V193, P169, DOI 10.1016/0014-5793(85)80144-7; Khailova LS, 2006, BBA-BIOENERGETICS, V1757, P1324, DOI 10.1016/j.bbabio.2006.04.024; Klingenberg M, 1999, BBA-BIOMEMBRANES, V1415, P271, DOI 10.1016/S0005-2736(98)00232-6; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Komelina NP, 2010, ACTA BIOCHIM POL, V57, P413; Kowluru A, 2002, ARCH BIOCHEM BIOPHYS, V398, P160, DOI 10.1006/abbi.2001.2710; Koziel A, 2012, PFLUG ARCH EUR J PHY, V464, P657, DOI 10.1007/s00424-012-1156-1; Lacombe ML, 2009, BIOCHIMIE, V91, P779, DOI 10.1016/j.biochi.2009.02.006; Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022; MATSUNOYAGI A, 1990, J BIOL CHEM, V265, P20308; MATSUNOYAGI A, 1990, J BIOL CHEM, V265, P82; McKee EE, 1999, BIOCHEM BIOPH RES CO, V257, P466, DOI 10.1006/bbrc.1999.0489; McKee EE, 2000, AM J PHYSIOL-CELL PH, V279, pC1870, DOI 10.1152/ajpcell.2000.279.6.C1870; MOREL F, 1974, FEBS LETT, V39, P133, DOI 10.1016/0014-5793(74)80035-9; Murphy MP, 2003, J BIOL CHEM, V278, P48534, DOI 10.1074/jbc.M308529200; Parker N, 2008, BIOCHEM J, V412, P131, DOI 10.1042/BJ20080006; PEDERSEN PL, 1973, J BIOL CHEM, V248, P3956; PERLIN DS, 1984, BIOCHEMISTRY-US, V23, P4998, DOI 10.1021/bi00316a026; PFAFF E, 1968, EUR J BIOCHEM, V6, P66, DOI 10.1111/j.1432-1033.1968.tb00420.x; Popov VN, 2002, BBA-BIOENERGETICS, V1553, P232, DOI 10.1016/S0005-2728(01)00244-4; ROTTENBERG H, 1977, BIOCHEMISTRY-US, V16, P3220, DOI 10.1021/bi00633a028; Shabalina IG, 2006, BIOCHEM J, V399, P405, DOI 10.1042/BJ20060706; Simonyan RA, 1998, FEBS LETT, V436, P81, DOI 10.1016/S0014-5793(98)01106-5; Sluse FE, 2006, BBA-BIOENERGETICS, V1757, P480, DOI 10.1016/j.bbabio.2006.02.004; Smith AMO, 2004, J BIOL CHEM, V279, P51944, DOI 10.1074/jbc.M408920200; Swida A, 2008, BIOCHEM J, V413, P359, DOI 10.1042/BJ20080333; Swida-Barteczka A, 2009, BIOCHEM J, V424, P297, DOI 10.1042/BJ20091158; Toime LJ, 2010, FREE RADICAL BIO MED, V49, P606, DOI 10.1016/j.freeradbiomed.2010.05.010; Tokarska-Schlattner M, 2008, J BIOL CHEM, V283, P26198, DOI 10.1074/jbc.M803132200; Valenti D, 1999, FEBS LETT, V444, P291, DOI 10.1016/S0014-5793(99)00071-X; Vozza A, 2004, J BIOL CHEM, V279, P20850, DOI 10.1074/jbc.M313610200; Vozza A, 2014, P NATL ACAD SCI USA, V111, P960, DOI 10.1073/pnas.1317400111; WEIDEMAN.MJ, 1970, EUR J BIOCHEM, V16, P313, DOI 10.1111/j.1432-1033.1970.tb01086.x; WINKLER HH, 1968, J BIOL CHEM, V243, P20; Woriax VL, 1996, BBA-GENE STRUCT EXPR, V1307, P66, DOI 10.1016/0167-4781(95)00240-5; Woyda-Ploszczyca A, 2011, BBA-BIOENERGETICS, V1807, P42, DOI 10.1016/j.bbabio.2010.08.012	60	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98969	10.1371/journal.pone.0098969	http://dx.doi.org/10.1371/journal.pone.0098969			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24904988	Green Submitted, Green Published, gold			2022-12-27	WOS:000341869000083
J	Bielecki, J; Zaharoff, AK; Leung, NY; Garm, A; Oakley, TH				Bielecki, Jan; Zaharoff, Alexander K.; Leung, Nicole Y.; Garm, Anders; Oakley, Todd H.			Ocular and Extraocular Expression of Opsins in the Rhopalium of Tripedalia cystophora (Cnidaria: Cubozoa)	PLOS ONE			English	Article							BOX JELLYFISH; NERVOUS-SYSTEM; LENS EYES; EVOLUTION; LIGHT; PHOTOTRANSDUCTION; VISION; COLOR	A growing body of work on the neuroethology of cubozoans is based largely on the capabilities of the photoreceptive tissues, and it is important to determine the molecular basis of their light sensitivity. The cubozoans rely on 24 special purpose eyes to extract specific information from a complex visual scene to guide their behavior in the habitat. The lens eyes are the most studied photoreceptive structures, and the phototransduction in the photoreceptor cells is based on light sensitive opsin molecules. Opsins are photosensitive transmembrane proteins associated with photoreceptors in eyes, and the amino acid sequence of the opsins determines the spectral properties of the photoreceptors. Here we show that two distinct opsins (Tripedalia cystophora-lens eye expressed opsin and Tripedalia cystophora-neuropil expressed opsin, or Tc-leo and Tc-neo) are expressed in the Tripedalia cystophora rhopalium. Quantitative PCR determined the level of expression of the two opsins, and we found Tc-leo to have a higher amount of expression than Tc-neo. In situ hybridization located Tc-leo expression in the retinal photoreceptors of the lens eyes where the opsin is involved in image formation. Tc-neo is expressed in a confined part of the neuropil and is probably involved in extraocular light sensation, presumably in relation to diurnal activity.	[Bielecki, Jan; Zaharoff, Alexander K.; Leung, Nicole Y.; Oakley, Todd H.] Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA; [Garm, Anders] Univ Copenhagen, Marine Biol Sect, Copenhagen, Denmark	University of California System; University of California Santa Barbara; University of Copenhagen	Bielecki, J (corresponding author), Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA.	jan@bielecki.dk	Garm, Anders/K-4362-2014	Garm, Anders/0000-0002-2080-735X; Leung, Nicole/0000-0001-8823-1783; Oakley, Todd/0000-0002-4478-915X	Journal of Experimental Biology; Danish Independent Research Council [DFF132500146]; Villum-Kahn Rasmussen grant [VKR022166]; National Science Foundation [ISO-1045257]; Direct For Biological Sciences [1146337] Funding Source: National Science Foundation	Journal of Experimental Biology; Danish Independent Research Council(Det Frie Forskningsrad (DFF)); Villum-Kahn Rasmussen grant; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The study was funded by a travel grant from Journal of Experimental Biology and Danish Independent Research Council grant DFF132500146 awarded to JB, Villum-Kahn Rasmussen grant VKR022166 to AG and National Science Foundation grant ISO-1045257 to THO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Buskey EJ, 2003, MAR BIOL, V142, P225, DOI 10.1007/s00227-002-0938-y; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Coates MM, 2006, J EXP BIOL, V209, P3758, DOI 10.1242/jeb.02431; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Feuda R, 2012, P NATL ACAD SCI USA, V109, P18868, DOI 10.1073/pnas.1204609109; Garm A, 2008, J COMP PHYSIOL A, V194, P641, DOI 10.1007/s00359-008-0336-0; Garm A, 2007, J EXP BIOL, V210, P3616, DOI 10.1242/jeb.004044; Garm A, 2007, J COMP PHYSIOL A, V193, P547, DOI 10.1007/s00359-007-0211-4; Garm A, 2006, CELL TISSUE RES, V325, P333, DOI 10.1007/s00441-005-0134-8; Garm A, 2012, BIOL BULL-US, V222, P35, DOI 10.1086/BBLv222n1p35; Garm A, 2009, J EXP BIOL, V212, P3951, DOI 10.1242/jeb.031559; Garm A, 2011, CURR BIOL, V21, P798, DOI 10.1016/j.cub.2011.03.054; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gray GC, 2009, BIOL BULL-US, V217, P35, DOI 10.1086/BBLv217n1p35; Grens A, 1995, DEVELOPMENT, V121, P4027; Hamner WM, 1995, MAR FRESHWATER RES, V46, P985, DOI 10.1071/MF9950985; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Koyanagi M, 2008, P NATL ACAD SCI USA, V105, P15576, DOI 10.1073/pnas.0806215105; Koyanagi M, 2013, P NATL ACAD SCI USA, V110, P4998, DOI 10.1073/pnas.1219416110; Kozmik Z, 2008, P NATL ACAD SCI USA, V105, P8989, DOI 10.1073/pnas.0800388105; Levy O, 2007, SCIENCE, V318, P467, DOI 10.1126/science.1145432; Matsumoto GI, 1995, MAR FRESHW BEHAV PHY, V26, P139, DOI 10.1080/10236249509378935; Nilsson DE, 2013, VISUAL NEUROSCI, V30, P5, DOI 10.1017/S0952523813000035; O'Connor M, 2009, J COMP PHYSIOL A, V195, P557, DOI 10.1007/s00359-009-0431-x; Oakley TH, BMC BIOINFO IN PRESS; Petie R, 2011, J EXP BIOL, V214, P2809, DOI 10.1242/jeb.057190; Piatigorsky J, 2004, INT J DEV BIOL, V48, P719, DOI 10.1387/ijdb.041851jp; Plachetzki DC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001054; Plachetzki DC, 2007, INTEGR COMP BIOL, V47, P759, DOI 10.1093/icb/icm050; Plachetzki DC, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-17; Plachetzki DC, 2010, P ROY SOC B-BIOL SCI, V277, P1963, DOI 10.1098/rspb.2009.1797; Porter ML, 2012, P ROY SOC B-BIOL SCI, V279, P3, DOI 10.1098/rspb.2011.1819; Ramirez MD, 2011, VISUAL NEUROSCI, V28, P265, DOI 10.1017/S0952523811000150; Rivera AS, 2012, J EXP BIOL, V215, P1278, DOI 10.1242/jeb.067140; Skogh C, 2006, J MORPHOL, V267, P1391, DOI 10.1002/jmor.10472; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suga H, 2008, CURR BIOL, V18, P51, DOI 10.1016/j.cub.2007.11.059; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Yatsu Naohide, 1917, Tokyo Journal of the College of Science, V40	41	18	19	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98870	10.1371/journal.pone.0098870	http://dx.doi.org/10.1371/journal.pone.0098870			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901369	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000336841400063
J	Scribbans, TD; Edgett, BA; Vorobej, K; Mitchell, AS; Joanisse, SD; Matusiak, JBL; Parise, G; Quadrilatero, J; Gurd, BJ				Scribbans, Trisha D.; Edgett, Brittany A.; Vorobej, Kira; Mitchell, Andrew S.; Joanisse, Sophie D.; Matusiak, Jennifer B. L.; Parise, Gianni; Quadrilatero, Joe; Gurd, Brendon J.			Fibre-Specific Responses to Endurance and Low Volume High Intensity Interval Training: Striking Similarities in Acute and Chronic Adaptation	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; SPRINT-INTERVAL; GLYCOGEN DEPLETION; MITOCHONDRIAL BIOGENESIS; METABOLIC ADAPTATIONS; CONTINUOUS EXERCISE; NUCLEAR ABUNDANCE; AEROBIC FITNESS; AMPK ACTIVATION; MESSENGER-RNA	The current study involved the completion of two distinct experiments. Experiment 1 compared fibre specific and whole muscle responses to acute bouts of either low-volume high-intensity interval training (LV-HIT) or moderate-intensity continuous endurance exercise (END) in a randomized crossover design. Experiment 2 examined the impact of a six-week training intervention (END or LV-HIT; 4 days/week), on whole body and skeletal muscle fibre specific markers of aerobic and anaerobic capacity. Six recreationally active men (Age: 20.7 +/- 3.8 yrs; VO(2)peak: 51.9 +/- 5.1 mL/kg/min) reported to the lab on two separate occasions for experiment 1. Following a muscle biopsy taken in a fasted state, participants completed an acute bout of each exercise protocol (LV-HIT: 8, 20-second intervals at,170% of VO(2)peak separated by 10 seconds of rest; END: 30 minutes at similar to 65% of VO(2)peak), immediately followed by a muscle biopsy. Glycogen content of type I and IIA fibres was significantly (p<0.05) reduced, while p-ACC was significantly increased (p<0.05) following both protocols. Nineteen recreationally active males (n = 16) and females (n = 3) were VO(2)peak-matched and assigned to either the LV-HIT (n = 10; 21 +/- 2 yrs) or END (n = 9; 20.7 +/- 3.8 yrs) group for experiment 2. After 6 weeks, both training protocols induced comparable increases in aerobic capacity (END: Pre: 48.3 +/- 6.0, Mid: 51.8 +/- 6.0, Post: 55.0 +/- 6.3 mL/kg/min LV-HIT: Pre: 47.9 +/- 8.1, Mid: 50.4 +/- 7.4, Post: 54.7 +/- 7.6 mL/kg/min), fibre-type specific oxidative and glycolytic capacity, glycogen and IMTG stores, and whole-muscle capillary density. Interestingly, only LV-HIT induced greater improvements in anaerobic performance and estimated whole-muscle glycolytic capacity. These results suggest that 30 minutes of END exercise at similar to 65% VO(2)peak or 4 minutes of LV-HIT at,170% VO(2)peak induce comparable changes in the intra-myocellular environment (glycogen content and signaling activation); correspondingly, training-induced adaptations resulting for these protocols, and other HIT and END protocols are strikingly similar.	[Scribbans, Trisha D.; Edgett, Brittany A.; Matusiak, Jennifer B. L.; Gurd, Brendon J.] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada; [Vorobej, Kira; Mitchell, Andrew S.; Quadrilatero, Joe] Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada; [Joanisse, Sophie D.; Parise, Gianni] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada	Queens University - Canada; University of Waterloo; McMaster University	Gurd, BJ (corresponding author), Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada.	gurdb@queensu.ca		Joanisse, Sophie/0000-0001-9983-9401; Edgett, Brittany/0000-0002-8232-0432	Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Foundation for Innovation (CFI)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation)	Funding was provided by the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canada Foundation for Innovation (CFI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEMEIER CA, 1994, J APPL PHYSIOL, V77, P2385, DOI 10.1152/jappl.1994.77.5.2385; [Anonymous], 2013, OPEN J MOL INTEGR PH, V03, P202, DOI [10.4236/ojmip.2013.34027, DOI 10.4236/OJMIP.2013.34027]; Bartlett JD, 2012, J APPL PHYSIOL, V112, P1135, DOI 10.1152/japplphysiol.01040.2011; BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787; Birk JB, 2006, J PHYSIOL-LONDON, V577, P1021, DOI 10.1113/jphysiol.2006.120972; Bishop D, 2008, AM J PHYSIOL-REG I, V295, pR1991, DOI 10.1152/ajpregu.00863.2007; BLANCO CE, 1988, HISTOCHEM J, V20, P230, DOI 10.1007/BF01747468; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Boyd JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068091; Burgomaster KA, 2005, J APPL PHYSIOL, V98, P1985, DOI 10.1152/japplphysiol.01095.2004; Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109; Cebasek V, 2004, EUR J HISTOCHEM, V48, P151; Cocks M, 2013, J PHYSIOL-LONDON, V591, P641, DOI 10.1113/jphysiol.2012.239566; Creer AR, 2004, INT J SPORTS MED, V25, P92; Daussin FN, 2008, AM J PHYSIOL-REG I, V295, pR264, DOI 10.1152/ajpregu.00875.2007; Dawson B, 1998, EUR J APPL PHYSIOL O, V78, P163, DOI 10.1007/s004210050402; EDDY DO, 1977, EUR J APPL PHYSIOL O, V37, P83, DOI 10.1007/BF00421694; Edgett BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071623; Egan B, 2010, J PHYSIOL-LONDON, V588, P1779, DOI 10.1113/jphysiol.2010.188011; ESBJORNSSON M, 1993, ACTA PHYSIOL SCAND, V149, P245, DOI 10.1111/j.1748-1716.1993.tb09618.x; ESSEN B, 1978, ACTA PHYSIOL SCAND, V103, P446, DOI 10.1111/j.1748-1716.1978.tb06239.x; FOURNIER M, 1982, MED SCI SPORT EXER, V14, P453, DOI 10.1249/00005768-198206000-00008; Gibala MJ, 2006, J PHYSIOL-LONDON, V575, P901, DOI 10.1113/jphysiol.2006.112094; Gibala MJ, 2009, J APPL PHYSIOL, V106, P929, DOI 10.1152/japplphysiol.90880.2008; GOLLNICK PD, 1974, J PHYSIOL-LONDON, V241, P45, DOI 10.1113/jphysiol.1974.sp010639; GREENHAFF PL, 1994, J PHYSIOL-LONDON, V478, P149, DOI 10.1113/jphysiol.1994.sp020238; HALKJAERKRISTENSEN J, 1979, HISTOCHEM J, V11, P127, DOI 10.1007/BF01002990; Hazell TJ, 2010, EUR J APPL PHYSIOL, V110, P153, DOI 10.1007/s00421-010-1474-y; Jacobs RA, 2013, J APPL PHYSIOL, V114, P344, DOI 10.1152/japplphysiol.01081.2012; JANSSON E, 1990, ACTA PHYSIOL SCAND, V140, P359, DOI 10.1111/j.1748-1716.1990.tb09010.x; Jeukendrup A, 1996, MED SCI SPORT EXER, V28, P266, DOI 10.1097/00005768-199602000-00017; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Lee-Young RS, 2009, J APPL PHYSIOL, V107, P283, DOI 10.1152/japplphysiol.91208.2008; Little JP, 2011, AM J PHYSIOL-REG I, V300, pR1303, DOI 10.1152/ajpregu.00538.2010; Little JP, 2010, AM J PHYSIOL-REG I, V298, pR912, DOI 10.1152/ajpregu.00409.2009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacDougall JD, 1998, J APPL PHYSIOL, V84, P2138, DOI 10.1152/jappl.1998.84.6.2138; Macpherson REK, 2011, MED SCI SPORT EXER, V43, P115, DOI 10.1249/MSS.0b013e3181e5eacd; McRae G, 2012, APPL PHYSIOL NUTR ME, V37, P1124, DOI [10.1139/h2012-093, 10.1139/H2012-093]; PETTE D, 1985, MUSCLE NERVE, V8, P676, DOI 10.1002/mus.880080810; Phillips SM, 1996, AM J PHYSIOL-ENDOC M, V270, pE265, DOI 10.1152/ajpendo.1996.270.2.E265; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Quadrilatero J, 2010, AM J PHYSIOL-ENDOC M, V298, pE534, DOI 10.1152/ajpendo.00678.2009; Rodas G, 2000, EUR J APPL PHYSIOL, V82, P480, DOI 10.1007/s004210000223; Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874; SALTIN B, 1976, ACTA PHYSIOL SCAND, V96, P289, DOI 10.1111/j.1748-1716.1976.tb10200.x; Shepherd SO, 2013, J PHYSIOL-LONDON, V591, P657, DOI 10.1113/jphysiol.2012.240952; SIMONEAU JA, 1985, EUR J APPL PHYSIOL O, V54, P250, DOI 10.1007/BF00426141; Tabata I, 1996, MED SCI SPORT EXER, V28, P1327, DOI 10.1097/00005768-199610000-00018; Terada S, 2004, JPN J PHYSIOL, V54, P47, DOI 10.2170/jjphysiol.54.47; Tjonna AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065382; Treebak JT, 2007, AM J PHYSIOL-ENDOC M, V292, pE715, DOI 10.1152/ajpendo.00380.2006; Vogiatzis I, 2005, CHEST, V128, P3838, DOI 10.1378/chest.128.6.3838; VOLLESTAD NK, 1984, ACTA PHYSIOL SCAND, V122, P433; VOLLESTAD NK, 1985, ACTA PHYSIOL SCAND, V125, P395, DOI 10.1111/j.1748-1716.1985.tb07735.x; VOLLESTAD NK, 1992, ACTA PHYSIOL SCAND, V144, P135; Wang L, 2012, ACTA PHYSIOL, V204, P525, DOI 10.1111/j.1748-1716.2011.02354.x; Wang L, 2009, MED SCI SPORT EXER, V41, P2136, DOI 10.1249/MSS.0b013e3181abc1ec; Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200	60	80	82	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98119	10.1371/journal.pone.0098119	http://dx.doi.org/10.1371/journal.pone.0098119			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901767	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000336841400017
J	Bar-Haim, E; Erez, N; Malloy, AMW; Graham, BS; Ruckwardt, TJ				Bar-Haim, Erez; Erez, Noam; Malloy, Allison M. W.; Graham, Barney S.; Ruckwardt, Tracy J.			CD8+TCR Transgenic Strains Expressing Public versus Private TCR Targeting the Respiratory Syncytial Virus K(d)M2(82-90) Epitope Demonstrate Similar Functional Profiles	PLOS ONE			English	Article							REGULATORY T-CELLS; AIRWAY HYPERRESPONSIVENESS; SENSITIZED MICE; MOUSE MODEL; INFECTION; IMMUNOPATHOLOGY; RESPONSES; IMMUNITY; LYMPHOCYTES; ALPHA	Our previous work has characterized the functional and clonotypic features of two respiratory syncytial virus (RSV) epitope-specific T cell responses in mice. Following single-cell sequencing, we selected T cell receptor sequences to represent both a public and a private clone specific for the dominant K(d)M2(82-90) epitope for the generation of T cell receptor transgenic (TCR Tg) mice. We evaluated cells from these TCR Tg strains for three major functions of CD8+ T cells: proliferation, cytokine production and cytolytic activity. In vitro comparisons of the functional characteristics of T cells from the newly-generated mice demonstrated many similarities in their responsiveness to cognate antigen stimulation. Cells from both TRBV13-1 (private) and TRBV13-2 (public) TCR Tg mice had similar affinity, and proliferated similarly in vitro in response to cognate antigen stimulation. When transferred to BALB/c mice, cells from both strains demonstrated extensive proliferation in mediastinal lymph nodes following RSV infection, with TRBV13-2 demonstrating better in vivo proliferation. Both strains similarly expressed cytokines and chemokines following stimulation, and had similar Granzyme B and perforin expression, however cells expressing TRBV13-1 demonstrated better cytolytic activity than TRBV13-2 cells. These new, well-characterized mouse strains provide new opportunities to study molecular mechanisms that control the phenotype and function of CD8+ T cell responses.	[Bar-Haim, Erez; Erez, Noam; Malloy, Allison M. W.; Graham, Barney S.; Ruckwardt, Tracy J.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Bar-Haim, Erez] Israel Inst Biol Res, Dept Biochem & Mol Genet, IL-70450 Ness Ziona, Israel; [Erez, Noam] Israel Inst Biol Res, Dept Infect Dis, IL-70450 Ness Ziona, Israel	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Ruckwardt, TJ (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	truckwardt@mail.nih.gov	Erez, Noam/AAW-4953-2021; Graham, Barney S./AAC-5898-2019; Bar-Haim, Erez/AAA-6444-2020	Graham, Barney S./0000-0001-8112-0853; Bar-Haim, Erez/0000-0003-3435-8599; Malloy, Allison Marie Wahl/0000-0003-2962-0302; Erez, Noam/0000-0001-5241-8028	National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005027] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by intramural funding from the National Institute of Allergy and Infectious Diseases. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Billam P, 2011, J BIOL CHEM, V286, P4829, DOI 10.1074/jbc.M110.191437; Brehm MA, 2005, J IMMUNOL, V175, P5043, DOI 10.4049/jimmunol.175.8.5043; Candon S, 2004, J IMMUNOL, V172, P2917, DOI 10.4049/jimmunol.172.5.2917; CANNON MJ, 1988, J EXP MED, V168, P1163, DOI 10.1084/jem.168.3.1163; Dash P, 2011, J CLIN INVEST, V121, P288, DOI 10.1172/JCI44752; Fulton RB, 2010, J IMMUNOL, V185, P2382, DOI 10.4049/jimmunol.1000423; GRAHAM BS, 1988, J MED VIROL, V26, P153, DOI 10.1002/jmv.1890260207; GRAHAM BS, 1991, J CLIN INVEST, V88, P1026, DOI 10.1172/JCI115362; Han Q, 2012, P NATL ACAD SCI USA, V109, P1607, DOI 10.1073/pnas.1117194109; Hashimoto K, 2004, J VIROL, V78, P10303, DOI 10.1128/JVI.78.19.10303-10309.2004; Hwang LN, 2006, CANCER RES, V66, P1132, DOI 10.1158/0008-5472.CAN-05-1679; Itoh Y, 1997, J EXP MED, V186, P757, DOI 10.1084/jem.186.5.757; Krishnamoorthy N, 2012, NAT MED, V18, P1525, DOI 10.1038/nm.2896; KULKARNI AB, 1993, J VIROL, V67, P4086, DOI 10.1128/JVI.67.7.4086-4092.1993; KULKARNI AB, 1993, J VIROL, V67, P1044, DOI 10.1128/JVI.67.2.1044-1049.1993; Lee DCP, 2010, J VIROL, V84, P8790, DOI 10.1128/JVI.00796-10; Newell Evan W, 2012, IMMUNITY, V36, P142; Obar JJ, 2010, INT IMMUNOL, V22, P619, DOI 10.1093/intimm/dxq053; OPENSHAW PJM, 1995, AM J RESP CRIT CARE, V152, pS59, DOI 10.1164/ajrccm/152.4_Pt_2.S59; Ostler T, 2002, EUR J IMMUNOL, V32, P2117, DOI 10.1002/1521-4141(200208)32:8<2117::AID-IMMU2117>3.0.CO;2-C; Peebles R Stokes Jr, 2005, Proc Am Thorac Soc, V2, P110, DOI 10.1513/pats.200501-002AW; Peebles RS, 2000, J INFECT DIS, V182, P671; Peebles RS, 1999, J MED VIROL, V57, P186, DOI 10.1002/(SICI)1096-9071(199902)57:2<186::AID-JMV17>3.0.CO;2-Q; Peebles RS, 2001, J INFECT DIS, V184, P1374; Ruckwardt TJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003934; Ruckwardt TJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002377; Ruckwardt TJ, 2010, J IMMUNOL, V185, P4673, DOI 10.4049/jimmunol.1001606; Ruckwardt TJ, 2009, J VIROL, V83, P3019, DOI 10.1128/JVI.00036-09; Rutigliano JA, 2007, VIROLOGY, V362, P314, DOI 10.1016/j.virol.2006.12.023; Slifka MK, 2001, NAT IMMUNOL, V2, P711, DOI 10.1038/90650; Srikiatkhachorn A, 1997, J EXP MED, V186, P421, DOI 10.1084/jem.186.3.421; Welten SPM, 2013, CURR OPIN VIROL, V3, P475, DOI 10.1016/j.coviro.2013.06.012; Yoon H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015423	34	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99249	10.1371/journal.pone.0099249	http://dx.doi.org/10.1371/journal.pone.0099249			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897427	Green Published, Green Submitted, gold			2022-12-27	WOS:000338430700125
J	Bolet, A; Delfino, M; Fortuny, J; Almecija, S; Robles, JM; Alba, DM				Bolet, Arnau; Delfino, Massimo; Fortuny, Josep; Almecija, Sergio; Robles, Josep M.; Alba, David M.			An Amphisbaenian Skull from the European Miocene and the Evolution of Mediterranean Worm Lizards	PLOS ONE			English	Article							SQUAMATE REPTILES; MIDDLE MIOCENE; BURROWING REPTILES; CRANIAL ANATOMY; LOWER EOCENE; RESOLUTION; PHYLOGENY; OLIGOCENE; SNAKES; PLEISTOCENE	The evolution of blanid amphisbaenians (Mediterranean worm lizards) is mainly inferred based on molecular studies, despite their fossils are common in Cenozoic European localities. This is because the fossil record exclusively consists in isolated elements of limited taxonomic value. We describe the only known fossil amphisbaenian skull from Europe - attributed to Blanus mendezi sp. nov. (Amphisbaenia, Blanidae) - which represents the most informative fossil blanid material ever described. This specimen, from the Middle Miocene of Abocador de Can Mata (11.6 Ma, MN7+8) in the Valles-Penedes Basin (Catalonia, NE Iberian Peninsula), unambiguously asserts the presence of Blanus in the Miocene of Europe. This reinforces the referral to this genus of the previously-known, much more incomplete and poorly-diagnostic material from other localities of the European Neogene. Our analysis - integrating the available molecular, paleontological and biogeographic data - suggests that the new species postdates the divergence between the two main (Eastern and Western Mediterranean) extant clades of blanids, and probably precedes the split between the Iberian and North-Western African subclades. This supports previous paleobiogeographic scenarios for blanid evolution and provides a significant minimum divergence time for calibrating molecular analyses of blanid phylogeny.	[Bolet, Arnau; Delfino, Massimo; Fortuny, Josep; Almecija, Sergio; Robles, Josep M.; Alba, David M.] Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont, E-08193 Barcelona, Spain; [Delfino, Massimo; Alba, David M.] Univ Turin, Dipartimento Sci Terra, Turin, Italy; [Almecija, Sergio] SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; [Robles, Josep M.] FOSSILIA Serv Paleontol & Geol SL, Barcelona, Spain	Autonomous University of Barcelona; Institut Catala de Paleontologia Miquel Crusafont (ICP); University of Turin; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Bolet, A (corresponding author), Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont, E-08193 Barcelona, Spain.	arnau.bolet@icp.cat	Bolet, Arnau/N-1059-2016; Fortuny, Josep/L-2523-2014; Alba, David/G-9716-2015; Almécija, Sergio/ABG-8129-2020	Bolet, Arnau/0000-0003-4416-4560; Fortuny, Josep/0000-0003-4282-1619; Alba, David/0000-0002-8886-5580; Almécija, Sergio/0000-0003-1373-1497; Robles Gimenez, Josep Maria/0000-0002-5410-3529	Spanish Ministerio de Economia y Competitividad [CGL0211-28681, CGL2011-30069-C02-01, CGL2011-27343, RYC-2009-04533, BES-2009-026731]; Generalitat de Catalunya [2009 SGR 754 GRC]	Spanish Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	This work has been supported by the Spanish Ministerio de Economia y Competitividad (CGL0211-28681, CGL2011-30069-C02-01, CGL2011-27343, RYC-2009-04533 to DMA, and BES-2009-026731 associated to CGL2008-06533-C03-01/BTE to AB) and the Generalitat de Catalunya (2009 SGR 754 GRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti J., 1985, PALEONTOLOGIA EVOLUC, V18, P57, DOI DOI 10.1016/J.GEOBIOS.2003.11.011; Alba D.M., 2006, Estudios Geologicos (Madrid), V62, P295; Alba D.M., 2011, PALEONTOL EVOL MEM E, V6, P95; Alba David M., 2009, Paleolusitana, V1, P59; Albert EM, 2007, MOL ECOL, V16, P1519, DOI 10.1111/j.1365-294X.2007.03248.x; Albert EM, 2009, ZOOTAXA, P56, DOI 10.11646/zootaxa.2234.1.4; ALEXANDER AA, 1966, COPEIA, P205; [Anonymous], 2006, DEEP SCALY PROJECT; Auge M, 2003, GEODIVERSITAS, V25, P539; Auge M, 2000, MEMOIR MUS NATL HIST, V183, P263; AUGE M, 1992, CR ACAD SCI II, V315, P885; Auge M.L., 2005, MEMOIRES MUSEUM NATL, V192, P1; Auge Marc Louis, 2012, Palaeobiodiversity Palaeoenvironments, V92, P425, DOI 10.1007/s12549-012-0104-6; BAILON S., 1991, THESIS; Bailon Salvador, 2000, Geodiversitas, V22, P539; Barbadillo LJ, 1989, TRAB NEOGENO CUATERN, V11, P151; BARTRINA MT, 1992, TECTONOPHYSICS, V203, P219, DOI 10.1016/0040-1951(92)90225-U; BEDRIAGA J. V., 1884, ARCH NATURGESCH, V50, P23; BERMAN DS, 1976, J PALEONTOL, V50, P165; BERMAN DS, 1977, J PALEONTOL, V51, P986; BERMAN DS, 1973, COPEIA, P704; Blain HA, 2007, GEODIVERSITAS, V29, P269; Blain Hugues-Alexandre, 2009, Treballs del Museu de Geologia de Barcelona, V16, P39; Bohme M, 2010, PALAEONTOL Z, V84, P3, DOI 10.1007/s12542-010-0050-4; Bohme Madelaine, 1999, Mitteilungen der Bayerischen Staatssammlung fuer Palaeontologie und Historische Geologie, V39, P85; Bolet A, 2013, LIZARDS AMPHISBAENIA; Bolet A, 2014, ANAT REC, V297, P505, DOI 10.1002/ar.22855; BUSACK SD, 1988, COPEIA, P101; Cabrera L, 1991, LIBRO GUIA EXCURSION, V4, P1; Cabrera L, 2004, GEOLOGIA ESPANA, P569; Casanovas-Vilar I., 2011, PALEONTOL EVOL MEM E, V6, P55; Casanovas-Vilar I, 2011, P NATL ACAD SCI USA, V108, P5554, DOI 10.1073/pnas.1018562108; Charig A.J., 1990, Bulletin of the British Museum (Natural History) Geology, V46, P19; Colombero S, 2013, GEOBIOS-LYON, V46, P111, DOI 10.1016/j.geobios.2012.10.007; Crusafont Pairo M., 1952, Estudios Geologicos Instituto Lucas Mallada, V8, P213; Delfino M, 2003, AMPHIBIA-REPTILIA, V24, P407, DOI 10.1163/156853803322763873; Delfino M., 2002, THESIS U MODENA REGG; Delfino M, 2004, 5 C SOC HERP IT, P24; Delfino Massimo, 1997, P89; desRochebrune AT, 1884, MEM SOC SCI NAT SAON, V5, P149; Daza JD, 2011, ANAT REC, V294, P1765, DOI 10.1002/ar.21467; Folie A, 2013, GEOL BELG, V16, P227; Gans C., 1967, Bulletin of the American Museum of Natural History, V135, P61; Gans C, 2005, B AM MUS NAT HIST, P7; GANS C, 1978, Transactions of the Zoological Society of London, V34, P347; Gans C., 2008, BIOL REPTILIA MORPHO, P621; GANS CARL, 1957, BREVIORA MUS COMP ZOOL [HARVARD], V70, P1; GANS CARL, 1960, BULL AMER MUS NAT HIST, V119, P129; Garcia-Porta J, 2001, BUTLL SOC CAT HERP, V15, P91; Garcia-Porta Joan, 2002, Revista Espanola de Herpetologia, V16, P19; Gervais P, 1853, ANN SCI NAT, V19-20, P293; Hembree DI, 2006, PALAEOGEOGR PALAEOCL, V235, P340, DOI 10.1016/j.palaeo.2005.11.006; Herrel A, 2007, INTEGR COMP BIOL, V47, P107, DOI 10.1093/icb/icm014; Kearney M, 2005, J MORPHOL, V264, P1, DOI 10.1002/jmor.10210; Kearney M, 2003, HERPETOL MONOGR, V17, P1, DOI 10.1655/0733-1347(2003)017[0001:SOTALB]2.0.CO;2; Lee MSY, 2009, J EVOLUTION BIOL, V22, P1308, DOI 10.1111/j.1420-9101.2009.01751.x; Lee MSY, 1998, BIOL J LINN SOC, V65, P369, DOI 10.1111/j.1095-8312.1998.tb01148.x; Lopez Martinez N, 1981, TRABAJOS PREHIST, V38, P134; Maisano JA, 2006, J MORPHOL, V267, P70, DOI 10.1002/jmor.10388; Milner A.C., 1982, Tertiary Research, V4, P149; Montero R, 1999, ANN CARNEGIE MUS, V68, P15; Montero R, 1999, J MORPHOL, V239, P1, DOI 10.1002/(SICI)1097-4687(199901)239:1<1::AID-JMOR1>3.0.CO;2-A; Moya-Sola S, 2009, AM J PHYS ANTHROPOL, V139, P126, DOI 10.1002/ajpa.20891; Muller J, 2011, NATURE, V473, P364, DOI 10.1038/nature09919; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; Rage J.C., 2003, Universidade Nova de Lisboa Ciencias da Terra, V15, P103; Rage J-C, 1976, GEOL MEDITERR, V3, P47; RAGE JC, 1984, B SOC GEOL FR, V26, P1251; ROCA E, 1992, TECTONOPHYSICS, V203, P203, DOI 10.1016/0040-1951(92)90224-T; Rocek Z., 1984, Rozpravy Ceskoslovenske Akademie Ved Rada Matematickych a Prirodnich Ved, V94, P1; Schleich H.H., 1985, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V4, P1; SCHLEICH H H, 1988, Palaeontologische Zeitschrift, V62, P95; Sindaco R, 2008, REPTILES W PALEARCTI, V1; Speybroeck J, 2010, ZOOTAXA, P1; Taylor E. H., 1951, University of Kansas Science Bulletin, V34, P521; Townsend TM, 2004, SYST BIOL, V53, P735, DOI 10.1080/10635150490522340; Vaconcelos R, 2006, AMPHIBIA-REPTILIA, V27, P339, DOI 10.1163/156853806778190033; Vandelli D., 1797, ACAD REAL SCI LISBOA, V1, P37; VANZOLINI P. E., 1951, HERPETOLOGICA, V7, P113; Venczel Marton, 2006, Hantkeniana, V5, P72; Venczel M, 2008, GEODIVERSITAS, V30, P731; Vidal N, 2005, CR BIOL, V328, P1000, DOI 10.1016/j.crvi.2005.10.001; Vidal N, 2008, BIOL LETTERS, V4, P115, DOI 10.1098/rsbl.2007.0531; Vidal N, 2009, CR BIOL, V332, P129, DOI 10.1016/j.crvi.2008.07.010; Wellnhofer P., 1983, HDB PALAOHERPETOLOGI, P1; Wiens JJ, 2010, SYST BIOL, V59, P674, DOI 10.1093/sysbio/syq048; ZANGERL R, 1945, AM MIDL NAT, V33, P764, DOI 10.2307/2421188	87	14	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98082	10.1371/journal.pone.0098082	http://dx.doi.org/10.1371/journal.pone.0098082			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896828	Green Published, gold			2022-12-27	WOS:000338430700025
J	Grebely, J; Lima, VD; Marshall, BDL; Milloy, MJ; DeBeck, K; Montaner, J; Simo, A; Krajden, M; Dore, GJ; Kerr, T; Wood, E				Grebely, Jason; Lima, Viviane Dias; Marshall, Brandon D. L.; Milloy, M-J; DeBeck, Kora; Montaner, Julio; Simo, Annick; Krajden, Mel; Dore, Gregory J.; Kerr, Thomas; Wood, Evan			Declining Incidence of Hepatitis C Virus Infection among People Who Inject Drugs in a Canadian Setting, 1996-2012	PLOS ONE			English	Article							RISK-FACTORS; USERS; HIV; COHORT; SEROCONVERSION; PREVALENCE; HCV; PREVENTION; PROGRAMS; ACCESS	Background: People who inject drugs (PWID) are at high risk of hepatitis C virus (HCV) infection. Trends in HCV incidence and associated risk factors among PWID recruited between 1996 and 2012 in Vancouver, Canada were evaluated. Methods: Data were derived from a long-term cohort of PWID in Vancouver. Trends in HCV incidence were evaluated. Factors associated with time to HCV infection were assessed using Cox proportional hazards regression. Results: Among 2,589, 82% (n = 2,121) were HCV antibody-positive at enrollment. Among 364 HCV antibody-negative participants with recent (last 30 days) injecting at enrollment, 126 HCV seroconversions were observed [Overall HCV incidence density: 8.6 cases/100 person-years (py); 95% confidence interval (95% CI): 7.2, 10.1; HCV incidence density among those with injecting during follow-up: 11.5 cases/100 py; 95% CI 9.7, 13.6]. The overall HCV incidence density declined significantly from 25.0/100 py (95% CI: 20.2, 30.3) in 1996-99, as compared to 6.0/100 py (95% CI: 4.1, 8.5) in 2000-2005, and 3.1/100 py (95% CI: 2.0, 4.8) in 2006-2012. Among those with injecting during follow-up, the overall HCV incidence density declined significantly from 27.9/100 py (95% CI: 22.6, 33.6) in 1996-99, as compared to 7.5/100 py (95% CI: 5.1, 10.6) in 2000-2005, and 4.9/100 py (95% CI: 3.1, 7.4) in 2006-2012. Unstable housing, HIV infection, and injecting of cocaine, heroin and methamphetamine were independently associated with HCV seroconversion. Conclusions: HCV incidence has dramatically declined among PWID in this setting. However, improved public health strategies to prevent and treat HCV are urgently required to reduce HCV-associated morbidity and mortality.	[Grebely, Jason; Dore, Gregory J.] UNSW Australia, Kirby Inst, Sydney, NSW, Australia; [Lima, Viviane Dias; Milloy, M-J; DeBeck, Kora; Montaner, Julio; Simo, Annick; Kerr, Thomas; Wood, Evan] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Lima, Viviane Dias; Montaner, Julio; Simo, Annick; Kerr, Thomas; Wood, Evan] Univ British Columbia, Fac Med, Dept Med, Div Aids, Vancouver, BC, Canada; [Marshall, Brandon D. L.] Brown Univ, Dept Epidemiol, Providence, RI 02912 USA; [Milloy, M-J] Univ British Columbia, Fac Med, Dept Family Practice, Vancouver, BC, Canada; [DeBeck, Kora] Simon Fraser Univ, Sch Publ Policy, Vancouver, BC, Canada; [Krajden, Mel] British Columbia Ctr Dis Control, Vancouver, BC, Canada	University of New South Wales Sydney; Kirby Institute; B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; Brown University; University of British Columbia; Simon Fraser University	Grebely, J (corresponding author), UNSW Australia, Kirby Inst, Sydney, NSW, Australia.	jgrebely@kirby.unsw.edu.au	Dore, Gregory John/ABD-5665-2021; Marshall, Brandon/B-4895-2010; Milloy, M-J/AAY-3618-2020	Dore, Gregory John/0000-0002-4741-2622; Marshall, Brandon/0000-0002-0134-7052; DeBeck, Kora/0000-0003-2045-1653	National Institutes of Health (NIH) [R01DA011591]; Canadian Institutes of Health (CIHR) [HHP-67262, RAA-79918, HES-115697, MOP-125948]; Australian Government Department of Health and Ageing; National Health andMedical Research Council (NHMRC) Career Development Fellowship; Michael Institute for Health Research; CIHR; Michael Smith Foundation for Health Research and the Canadian Institutes of Health Research; Michael Smith Foundation for Health Research/St. Paul's Hospital Foundation Providence Health Care CareerScholar Award; British Columbia Ministry of Health; National Institute of Drug Abuse (NIDA), at the United States National Institutes of Health (NIH) [1DP1DA026182]; International AIDS Society; United Nations AIDS Program; World Health Organization; National Institutes of Health Research-Office of AIDS Research; National Institute of Allergy & Infectious Diseases; United States President's Emergency Plan for AIDS Relief (PEPfAR); UNICEF; University of British Columbia; Simon Fraser University; Providence Health Care; Vancouver Coastal Health Authority; NHMRC Practitioner Research Fellowship; Canada Research Chairs program through a Tier 1 Canada Research Chair in Inner City Medicine; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA026182, R01DA011591, R03DA033851] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health (CIHR)(Canadian Institutes of Health Research (CIHR)); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); National Health andMedical Research Council (NHMRC) Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Michael Institute for Health Research; CIHR(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research and the Canadian Institutes of Health Research; Michael Smith Foundation for Health Research/St. Paul's Hospital Foundation Providence Health Care CareerScholar Award; British Columbia Ministry of Health; National Institute of Drug Abuse (NIDA), at the United States National Institutes of Health (NIH); International AIDS Society; United Nations AIDS Program; World Health Organization(World Health Organization); National Institutes of Health Research-Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy & Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States President's Emergency Plan for AIDS Relief (PEPfAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); UNICEF; University of British Columbia; Simon Fraser University; Providence Health Care; Vancouver Coastal Health Authority; NHMRC Practitioner Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Canada Research Chairs program through a Tier 1 Canada Research Chair in Inner City Medicine(Canada Research Chairs); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for this study was provided by the National Institutes of Health (NIH) (R01DA011591) and the Canadian Institutes of Health (CIHR) (HHP-67262, RAA-79918, HES-115697; MOP-125948). NIH and CIHR had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication. The Kirby Institute is funded by the Australian Government Department of Health and Ageing. The views expressed in this publication do not necessarily represent the position of the Australian Government. JG is supported by a National Health andMedical Research Council (NHMRC) Career Development Fellowship. VDL is supported by a Scholar Award from the Michael Institute for Health Research and a New Investigator Award from CIHR. M-JM is supported by fellowships from the Michael Smith Foundation for Health Research and the Canadian Institutes of Health Research. KD is supported by a Michael Smith Foundation for Health Research/St. Paul's Hospital Foundation Providence Health Care CareerScholar Award. JM is supported by the British Columbia Ministry of Health and through an Avant-Garde Award (No. 1DP1DA026182) from the National Institute of Drug Abuse (NIDA), at the United States National Institutes of Health (NIH). JM has also received financial support from the International AIDS Society, United Nations AIDS Program, World Health Organization, National Institutes of Health Research-Office of AIDS Research, National Institute of Allergy & Infectious Diseases, The United States President's Emergency Plan for AIDS Relief (PEPfAR), UNICEF, the University of British Columbia, Simon Fraser University, Providence Health Care and Vancouver Coastal Health Authority. GD is supported by an NHMRC Practitioner Research Fellowship. This research was undertaken, in part, thanks to funding from the Canada Research Chairs program through a Tier 1 Canada Research Chair in Inner City Medicine which supports EW.	BCCDC, 2010, TRENDS HCV INC BRIT; Brenner BG, 2013, JAIDS-J ACQ IMM DEF, V63, pS248, DOI 10.1097/QAI.0b013e3182986f96; Bruneau J, 2012, ADDICTION, V107, P1318, DOI 10.1111/j.1360-0443.2012.03803.x; Bruneau J, 2010, INT J DRUG POLICY, V21, P477, DOI 10.1016/j.drugpo.2010.05.001; Cox AL, 2005, CLIN INFECT DIS, V40, P951, DOI 10.1086/428578; de Vos AS, 2013, ADDICTION, V108, P1070, DOI 10.1111/add.12125; Grebely J, 2014, ANTIVIR RES; Grebely J, 2011, J INFECT DIS, V203, P571, DOI 10.1093/infdis/jiq111; Hadland SE, 2012, AM J ADDICTION, V21, P488, DOI 10.1111/j.1521-0391.2012.00257.x; Hagan H, 2004, EPIDEMIOLOGY, V15, P543, DOI 10.1097/01.ede.0000135170.54913.9d; Hagan H, 2001, AM J PUBLIC HEALTH, V91, P42, DOI 10.2105/AJPH.91.1.42; Hagan H, 2010, J INFECT DIS, V201, P378, DOI 10.1086/649783; Hyshka E, 2012, INT J DRUG POLICY, V23, P261, DOI 10.1016/j.drugpo.2012.03.006; Iversen Jenny, 2013, Am J Public Health, V103, P1436, DOI 10.2105/AJPH.2012.301206; Kerr T, 2010, AM J PUBLIC HEALTH, V100, P1449, DOI 10.2105/AJPH.2009.178467; Kim C, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-270; Kwon JA, 2009, JAIDS-J ACQ IMM DEF, V51, P462, DOI 10.1097/QAI.0b013e3181a2539a; Li XH, 2003, AM STAT, V57, P193, DOI 10.1198/0003130031883; Lima VD, 2010, JAIDS-J ACQ IMM DEF, V55, P460, DOI 10.1097/QAI.0b013e3181f2ac87; Lima VD, 2012, AIDS, V26, P1491, DOI 10.1097/QAD.0b013e3283550b68; Lucidarme D, 2004, EPIDEMIOL INFECT, V132, P699, DOI 10.1017/S095026880400247X; Maher L, 2007, AUST NZ J PUBL HEAL, V31, P30, DOI 10.1111/j.1753-6405.2007.00007.x; Maher L, 2006, ADDICTION, V101, P1499, DOI 10.1111/j.1360-0443.2006.01543.x; Martin NK, 2013, HEPATOLOGY, V58, P1598, DOI 10.1002/hep.26431; Mehta SH, 2011, J INFECT DIS, V203, P587, DOI 10.1093/infdis/jiq112; Miller CL, 2002, HEPATOLOGY, V36, P737, DOI 10.1053/jhep.2002.35065; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Page K, 2009, J INFECT DIS, V200, P1216, DOI 10.1086/605947; Patrick DM, 2001, CAN MED ASSOC J, V165, P889; Pouget ER, 2012, ADDICTION, V107, P1057, DOI 10.1111/j.1360-0443.2011.03765.x; Roy E, 2007, INT J STD AIDS, V18, P23, DOI 10.1258/095646207779949880; Roy E, 2012, DRUG ALCOHOL DEPEN, V126, P246, DOI 10.1016/j.drugalcdep.2012.05.018; Roy E, 2009, DRUG ALCOHOL DEPEN, V102, P158, DOI 10.1016/j.drugalcdep.2009.01.006; Ruan YH, 2013, SEX TRANSM DIS, V40, P323, DOI 10.1097/OLQ.0b013e31827fd4d4; Tyndall MW, 2001, J ACQ IMMUN DEF SYND, V28, P351, DOI 10.1097/00126334-200112010-00008; van den Berg CHSB, 2007, EUR J EPIDEMIOL, V22, P183, DOI 10.1007/s10654-006-9089-7; Werb D, 2013, DRUG ALCOHOL DEPEN, V132, P535, DOI 10.1016/j.drugalcdep.2013.03.024; Werb D, 2010, DRUG ALCOHOL REV, V29, P271, DOI 10.1111/j.1465-3362.2009.00145.x	38	29	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e97726	10.1371/journal.pone.0097726	http://dx.doi.org/10.1371/journal.pone.0097726			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK4YO	24897109	Green Published, gold, Green Submitted			2022-12-27	WOS:000338430700012
J	Jankovics, F; Henn, L; Bujna, A; Vilmos, P; Spirohn, K; Boutros, M; Erdelyi, M				Jankovics, Ferenc; Henn, Laszlo; Bujna, Agnes; Vilmos, Peter; Spirohn, Kerstin; Boutros, Michael; Erdelyi, Miklos			Functional Analysis of the Drosophila Embryonic Germ Cell Transcriptome by RNA Interference	PLOS ONE			English	Article							MESSENGER-RNA; STEM-CELLS; TRANSEPITHELIAL MIGRATION; TRANSLATIONAL CONTROL; BRAIN-TUMOR; MELANOGASTER; GENES; NANOS; PEBBLE; GROWTH	In Drosophila melanogaster, primordial germ cells are specified at the posterior pole of the very early embryo. This process is regulated by the posterior localized germ plasm that contains a large number of RNAs of maternal origin. Transcription in the primordial germ cells is actively down-regulated until germ cell fate is established. Bulk expression of the zygotic genes commences concomitantly with the degradation of the maternal transcripts. Thus, during embryogenesis, maternally provided and zygotically transcribed mRNAs determine germ cell development collectively. In an effort to identify novel genes involved in the regulation of germ cell behavior, we carried out a large-scale RNAi screen targeting both maternal and zygotic components of the embryonic germ line transcriptome. We identified 48 genes necessary for distinct stages in germ cell development. We found pebble and fascetto to be essential for germ cell migration and germ cell division, respectively. Our data uncover a previously unanticipated role of mei-P26 in maintenance of embryonic germ cell fate. We also performed systematic co-RNAi experiments, through which we found a low rate of functional redundancy among homologous gene pairs. As our data indicate a high degree of evolutionary conservation in genetic regulation of germ cell development, they are likely to provide valuable insights into the biology of the germ line in general.	[Jankovics, Ferenc; Henn, Laszlo; Bujna, Agnes; Vilmos, Peter; Erdelyi, Miklos] Hungarian Acad Sci, Biol Res Ctr, Inst Genet, H-6701 Szeged, Hungary; [Spirohn, Kerstin; Boutros, Michael] German Canc Res Ctr, Heidelberg, Germany; [Spirohn, Kerstin; Boutros, Michael] Heidelberg Univ, Div Signaling & Funct Genom, Heidelberg, Germany	Hungarian Academy of Sciences; Hungarian Biological Research Center; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Jankovics, F (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Genet, H-6701 Szeged, Hungary.	jankovics.ferenc@brc.mta.hu; erdelyi.miklos@brc.mta.hu	Boutros, Michael/C-3566-2008	Boutros, Michael/0000-0002-9458-817X; Jankovics, Ferenc/0000-0001-9697-4472; Vilmos, Peter/0000-0001-5692-8818; Henn, Laszlo/0000-0002-4071-5719	Howard Hughes Medical Institutes (HHMI) [55005606]; Hungarian National Science Foundation [OTKA-NK84121, OTKA-K108538]; Janos Bolyai Research Fellowship of the Hungarian Academy of Sciences; European Union; State of Hungary [TAMOP 4.2.4.A/2-11-1-20120001]; German Research Foundation (DFG.)	Howard Hughes Medical Institutes (HHMI)(Howard Hughes Medical Institute); Hungarian National Science Foundation; Janos Bolyai Research Fellowship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); European Union(European Commission); State of Hungary; German Research Foundation (DFG.)(German Research Foundation (DFG))	This work was supported by grants from the Howard Hughes Medical Institutes (HHMI, 55005606 to M.E.) and from the Hungarian National Science Foundation (OTKA-NK84121 to M.E. and OTKA-K108538 to P.V.). P.V. and F.J. is supported by the Janos Bolyai Research Fellowship of the Hungarian Academy of Sciences, L.H. was supported by the European Union and the State of Hungary (TAMOP 4.2.4.A/2-11-1-20120001). Work in the group of M.B. was supported by the German Research Foundation (DFG.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asaoka M, 2004, DEVELOPMENT, V131, P5079, DOI 10.1242/dev.01391; Asaoka-Taguchi M, 1999, NAT CELL BIOL, V1, P431, DOI 10.1038/15666; Axelsson E, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-342; Bai JW, 2008, DEVELOPMENT, V135, P1439, DOI 10.1242/dev.012849; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Caussinus E, 2012, NAT STRUCT MOL BIOL, V19, P117, DOI 10.1038/nsmb.2180; Chanet S, 2012, NAT CELL BIOL, V14, P467, DOI 10.1038/ncb2481; Coffman CR, 2002, GENETICS, V162, P273; DeGennaro M, 2011, DEV CELL, V20, P233, DOI 10.1016/j.devcel.2010.12.007; Dorfman R, 2001, DEVELOPMENT, V128, P965; Duellberg C, 2013, TRENDS CELL BIOL, V23, P54, DOI 10.1016/j.tcb.2012.10.003; Eun SH, 2010, CURR OPIN CELL BIOL, V22, P737, DOI 10.1016/j.ceb.2010.09.004; Forbes A, 1998, DEVELOPMENT, V125, P679; Gilboa L, 2004, CURR BIOL, V14, P981, DOI 10.1016/j.cub.2004.05.049; Gilboa L, 2006, NATURE, V443, P97, DOI 10.1038/nature05068; Hanyu-Nakamura K, 2004, DEVELOPMENT, V131, P4545, DOI 10.1242/dev.01321; Hayashi Y, 2004, P NATL ACAD SCI USA, V101, P10338, DOI 10.1073/pnas.0401647101; Holland AJ, 2012, P NATL ACAD SCI USA, V109, pE3350, DOI 10.1073/pnas.1216880109; Horn T, 2011, NAT METHODS, V8, P341, DOI 10.1038/NMETH.1581; Horn T, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r61; Insco ML, 2012, CELL STEM CELL, V11, P689, DOI 10.1016/j.stem.2012.08.012; Janic A, 2010, SCIENCE, V330, P1824, DOI 10.1126/science.1195481; Jankovics F, 2001, GENETICS, V158, P1177; Jankovics F, 2006, DEV CELL, V11, P375, DOI 10.1016/j.devcel.2006.07.014; Jankovics F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022229; Juliano C, 2010, SCIENCE, V329, P640, DOI 10.1126/science.1194037; Juliano CE, 2010, DEVELOPMENT, V137, P4113, DOI 10.1242/dev.047969; Kadyrova LY, 2007, DEVELOPMENT, V134, P1519, DOI 10.1242/dev.002212; Kai TS, 2003, P NATL ACAD SCI USA, V100, P4633, DOI 10.1073/pnas.0830856100; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kugler JM, 2013, G3-GENES GENOM GENET, V3, P1573, DOI 10.1534/g3.113.007591; Kunwar PS, 2008, J CELL BIOL, V183, P157, DOI 10.1083/jcb.200807049; Kunwar PS, 2006, ANNU REV CELL DEV BI, V22, P237, DOI 10.1146/annurev.cellbio.22.010305.103337; Kunwar PS, 2003, PLOS BIOL, V1, P372, DOI 10.1371/journal.pbio.0000080; Le Bras S, 2006, DEV BIOL, V294, P92, DOI 10.1016/j.ydbio.2006.02.030; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; LEHNER CF, 1992, J CELL SCI, V103, P1021; Lesch BJ, 2012, NAT REV GENET, V13, P781, DOI 10.1038/nrg3294; Li JH, 2003, DEV CELL, V5, P787, DOI 10.1016/S1534-5807(03)00328-9; Li MA, 2003, NAT CELL BIOL, V5, P994, DOI 10.1038/ncb1058; Li Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058301; Li Y, 2012, DEVELOPMENT, V139, P1547, DOI 10.1242/dev.077412; Moore LA, 1998, DEVELOPMENT, V125, P667; Mukai M, 2006, GENE EXPR PATTERNS, V6, P256, DOI 10.1016/j.modgep.2005.08.002; Muraro NI, 2008, J NEUROSCI, V28, P2099, DOI 10.1523/JNEUROSCI.5092-07.2008; Murray SM, 2010, CURR OPIN CELL BIOL, V22, P722, DOI 10.1016/j.ceb.2010.09.006; Neumuller RA, 2008, NATURE, V454, P241, DOI 10.1038/nature07014; Niki Y, 2003, P NATL ACAD SCI USA, V100, P14042, DOI 10.1073/pnas.2235591100; Olesnicky EC, 2012, DEV BIOL, V365, P208, DOI 10.1016/j.ydbio.2012.02.028; Parrish JZ, 2006, GENE DEV, V20, P820, DOI 10.1101/gad.1391006; Prokopenko SN, 2000, MECH DEVELOP, V90, P269, DOI 10.1016/S0925-4773(99)00233-6; Sano H, 2005, J CELL BIOL, V171, P675, DOI 10.1083/jcb.200506038; Shigenobu S, 2006, P NATL ACAD SCI USA, V103, P13728, DOI 10.1073/pnas.0603767103; Siddiqui NU, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r11; Smallhorn M, 2004, DEVELOPMENT, V131, P2641, DOI 10.1242/dev.01150; Solana J, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-2; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; Staton AA, 2011, NAT GENET, V43, P204, DOI 10.1038/ng.758; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; van Impel A, 2009, DEVELOPMENT, V136, P813, DOI 10.1242/dev.026203; Verni F, 2004, CURR BIOL, V14, P1569, DOI 10.1016/j.cub.2004.08.054; Vilmos P, 2007, ACTA BIOL HUNG, V58, P81, DOI 10.1556/ABiol.58.2007.Suppl.7; Wang YY, 2010, GENE DEV, V24, P2081, DOI 10.1101/gad.1951010; Weyers JJ, 2011, DEV BIOL, V353, P217, DOI 10.1016/j.ydbio.2011.02.023; Yohn CB, 2003, GENETICS, V165, P1889; Yuan HB, 2010, CURR OPIN CELL BIOL, V22, P730, DOI 10.1016/j.ceb.2010.08.013	66	7	7	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98579	10.1371/journal.pone.0098579	http://dx.doi.org/10.1371/journal.pone.0098579			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896584	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000338430700051
J	Silberman, DM; Ross, K; Sande, PH; Kubota, S; Ramaswamy, S; Apte, RS; Mostoslavsky, R				Silberman, Dafne M.; Ross, Kenneth; Sande, Pablo H.; Kubota, Shunsuke; Ramaswamy, Sridhar; Apte, Rajendra S.; Mostoslavsky, Raul			SIRT6 Is Required for Normal Retinal Function	PLOS ONE			English	Article							ACUTE HYPOGLYCEMIA; HOMEOSTASIS; EXPRESSION; LONGEVITY	The retina is one of the major energy consuming tissues within the body. In this context, synaptic transmission between light-excited rod and cone photoreceptors and downstream ON-bipolar neurons is a highly demanding energy consuming process. Sirtuin 6 (SIRT6), a NAD-dependent deacylase, plays a key role in regulating glucose metabolism. In this study, we demonstrate that SIRT6 is highly expressed in the retina, controlling levels of histone H3K9 and H3K56 acetylation. Notably, despite apparent normal histology, SIRT6 deficiency caused major retinal transmission defects concomitant to changes in expression of glycolytic genes and glutamate receptors, as well as elevated levels of apoptosis in inner retina cells. Our results identify SIRT6 as a critical modulator of retinal function, likely through its effects on chromatin.	[Silberman, Dafne M.; Sande, Pablo H.] CEFyBO CONICET UBA, Lab Retinal Neurochem & Expt Ophthalmol, Dept Human Biochem, Sch Med, Buenos Aires, DF, Argentina; [Silberman, Dafne M.; Ross, Kenneth; Ramaswamy, Sridhar; Mostoslavsky, Raul] Harvard Univ, Massachusetts Gen Hosp, Ctr Canc, Sch Med, Boston, MA 02114 USA; [Kubota, Shunsuke; Apte, Rajendra S.] Washington Univ, Dept Ophthalmol & Visual Sci, St Louis, MO 63130 USA; [Kubota, Shunsuke; Apte, Rajendra S.] Washington Univ, St Louis, MO USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Harvard University; Harvard Medical School; Massachusetts General Hospital; Washington University (WUSTL); Washington University (WUSTL)	Silberman, DM (corresponding author), CEFyBO CONICET UBA, Lab Retinal Neurochem & Expt Ophthalmol, Dept Human Biochem, Sch Med, Buenos Aires, DF, Argentina.	dsilberman@fmed.uba.ar			CONICET [PIP 0030]; National Institutes of Health [GM093072-01]; NIH [R01EY019287, P30EY02687]; Carl Marshall and Mildred Almen Reeves Foundation Inc.; Lacy Foundation; Research to Prevent Blindness Inc. Unrestrict University; NATIONAL EYE INSTITUTE [P30EY002687, R01EY019287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093072] Funding Source: NIH RePORTER	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carl Marshall and Mildred Almen Reeves Foundation Inc.; Lacy Foundation; Research to Prevent Blindness Inc. Unrestrict University(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by PIP 0030 CONICET (D.M.S.), National Institutes of Health grant GM093072-01 (R.M.), NIH grant R01EY019287, NIH Vision Core Grant P30EY02687, the Carl Marshall and Mildred Almen Reeves Foundation Inc. Award, the Lacy Foundation research Award, and a Research to Prevent Blindness Inc. Unrestrict University (R.S.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban N, 2013, EXP GERONTOL, V48, P1212, DOI 10.1016/j.exger.2013.04.010; Barlow RB, 2003, ADV EXP MED BIOL, V533, P259; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Dhingra A, 2000, J NEUROSCI, V20, P9053; Dryja TP, 2005, P NATL ACAD SCI USA, V102, P4884, DOI 10.1073/pnas.0501233102; Ewing FME, 1998, PHYSIOL BEHAV, V64, P653, DOI 10.1016/S0031-9384(98)00120-6; Fernandez DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051966; Graymore C. N., 1970, BIOCH EYE, P645; Hennig AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069721; Howarth C, 2012, J CEREBR BLOOD F MET, V32, P1222, DOI 10.1038/jcbfm.2012.35; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Izumi Y, 2002, GLIA, V39, P58, DOI 10.1002/glia.10082; Jolivet Renaud, 2009, Front Neuroenergetics, V1, P4, DOI 10.3389/neuro.14.004.2009; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Khan MI, 2011, VISION RES, V51, P1623, DOI 10.1016/j.visres.2011.05.003; Khatri N, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00199; KUMAGAI AK, 1994, INVEST OPHTH VIS SCI, V35, P2887; MANTYCH GJ, 1993, ENDOCRINOLOGY, V133, P600, DOI 10.1210/en.133.2.600; McCrimmon RJ, 1996, BRAIN, V119, P1277, DOI 10.1093/brain/119.4.1277; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; Pelzel HR, 2012, INVEST OPHTH VIS SCI, V53, P1428, DOI 10.1167/iovs.11-8872; Sebastian C, 2012, J BIOL CHEM, V287, P42444, DOI 10.1074/jbc.R112.402768; SKRANDIES W, 1992, NEUROSCI LETT, V134, P165, DOI 10.1016/0304-3940(92)90507-4; Umino Y, 2006, P NATL ACAD SCI USA, V103, P19541, DOI 10.1073/pnas.0604478104; Wei L, 2012, CELL REP, V2, P1151, DOI 10.1016/j.celrep.2012.10.013; WINKLER BS, 1981, J GEN PHYSIOL, V77, P667, DOI 10.1085/jgp.77.6.667; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041; Zhong Q, 2011, DIABETES, V60, P1304, DOI 10.2337/db10-0133	32	35	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98831	10.1371/journal.pone.0098831	http://dx.doi.org/10.1371/journal.pone.0098831			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896097	Green Published, gold, Green Submitted			2022-12-27	WOS:000338430700084
J	Simon-Szabo, L; Kokas, M; Mandl, J; Keri, G; Csala, M				Simon-Szabo, Laura; Kokas, Marton; Mandl, Jozsef; Keri, Gyoergy; Csala, Miklos			Metformin Attenuates Palmitate-Induced Endoplasmic Reticulum Stress, Serine Phosphorylation of IRS-1 and Apoptosis in Rat Insulinoma Cells	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; INDUCED ER STRESS; FREE FATTY-ACIDS; RESISTANCE; LIPOTOXICITY; ACTIVATION; PROTECTION; SECRETION; OBESITY	Lipotoxicity refers to cellular dysfunctions caused by elevated free fatty acid levels playing a central role in the development and progression of obesity related diseases. Saturated fatty acids cause insulin resistance and reduce insulin production in the pancreatic islets, thereby generating a vicious cycle, which potentially culminates in type 2 diabetes. The underlying endoplasmic reticulum (ER) stress response can lead to even beta-cell death (lipoapoptosis). Since improvement of beta-cell viability is a promising anti-diabetic strategy, the protective effect of metformin, a known insulin sensitizer was studied in rat insulinoma cells. Assessment of palmitate-induced lipoapoptosis by fluorescent microscopy and by detection of caspase-3 showed a significant decrease in metformin treated cells. Attenuation of beta-cell lipotoxicity was also revealed by lower induction/activation of various ER stress markers, e.g. phosphorylation of eukaryotic initiation factor 2 alpha (eIF2 alpha), c-Jun N-terminal kinase (JNK), insulin receptor substrate-1 (IRS-1) and induction of CCAAT/enhancer binding protein homologous protein (CHOP). Our results indicate that the beta-cell protective activity of metformin in lipotoxicity can be at least partly attributed to suppression of ER stress.	[Simon-Szabo, Laura; Mandl, Jozsef; Csala, Miklos] Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, H-1085 Budapest, Hungary; [Simon-Szabo, Laura; Kokas, Marton; Keri, Gyoergy] Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, MTA SE Pathobiochem Res Grp, H-1085 Budapest, Hungary; [Keri, Gyoergy] Vichem Chem Res Ltd, Budapest, Hungary	Semmelweis University; Semmelweis University; Vichem Chemie Research Ltd.	Keri, G (corresponding author), Vichem Chem Res Ltd, Budapest, Hungary.	keri.gyorgy@med.semmelweis-univ.hu	Csala, Miklos/H-5369-2011	Csala, Miklos/0000-0002-3829-4361	Hungarian Scientific Research Fund [OTKA 104113, 106060]; Hungarian Research and Technological Innovation Fund [KMR_12-1-2012-0074]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Research and Technological Innovation Fund	This work was supported by the Hungarian Scientific Research Fund (OTKA 104113 and 106060) and by the Hungarian Research and Technological Innovation Fund (KMR_12-1-2012-0074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Baldwin AC, 2012, AM J PHYSIOL-ENDOC M, V302, pE1390, DOI 10.1152/ajpendo.00519.2011; Beeharry N, 2004, APOPTOSIS, V9, P599, DOI 10.1023/B:APPT.0000038039.82506.0c; Bonora E, 2008, NUTR METAB CARDIOVAS, V18, P74, DOI 10.1016/j.numecd.2007.05.004; Cho H, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-9; Cnop M, 2008, BIOCHEM SOC T, V36, P909, DOI 10.1042/BST0360909; Combettes-Souverain M, 1998, DIABETES METAB, V24, P477; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Frohnert BI, 2013, DIABETES; Fu Z, 2013, CURR DIABETES REV, V9, P25, DOI 10.2174/157339913804143225; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jung TW, 2012, BIOCHEM BIOPH RES CO, V417, P147, DOI 10.1016/j.bbrc.2011.11.073; Kim DS, 2010, IMMUNOPHARM IMMUNOT, V32, P251, DOI 10.3109/08923970903252220; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Lupi R, 2002, DIABETES, V51, pS134, DOI 10.2337/diabetes.51.2007.S134; Mandl J, 2009, TRENDS ENDOCRIN MET, V20, P194, DOI 10.1016/j.tem.2009.01.003; Marchetti P, 2013, ADV EXP MED BIOL, V771, P288; Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074; OBRIEN R, 1970, J HISTOCHEM CYTOCHEM, V18, P581, DOI 10.1177/18.8.581; Oh YS, 2013, J ENDOCRINOL, V216, P343, DOI 10.1530/JOE-12-0311; Olsen GS, 2002, AM J PHYSIOL-ENDOC M, V283, pE965, DOI 10.1152/ajpendo.00118.2002; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Sommerweiss D, 2013, BIOCHEM BIOPH RES CO, V441, P770, DOI 10.1016/j.bbrc.2013.10.130; Tao JL, 2012, CHINESE MED J-PEKING, V125, P3137, DOI 10.3760/cma.j.issn.0366-6999.2012.17.031; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; Welters HJ, 2004, FEBS LETT, V560, P103, DOI 10.1016/S0014-5793(04)00079-1; Williams BL, 2006, J VIROL, V80, P8613, DOI 10.1128/JVI.00836-06; Ye JP, 2013, FRONT MED-PRC, V7, P14, DOI 10.1007/s11684-013-0262-6	29	67	69	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e97868	10.1371/journal.pone.0097868	http://dx.doi.org/10.1371/journal.pone.0097868			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896641	Green Published, gold			2022-12-27	WOS:000338430700017
J	Ferguson, MK; Thompson, K; Huisingh-Scheetz, M; Farnan, J; Hemmerich, JA; Slawinski, K; Acevedo, J; Lee, SM; Rojnica, M; Small, S				Ferguson, Mark K.; Thompson, Katherine; Huisingh-Scheetz, Megan; Farnan, Jeanne; Hemmerich, Josh A.; Slawinski, Kris; Acevedo, Julissa; Lee, Sang Mee; Rojnica, Marko; Small, Stephen			Thoracic Surgeons' Perception of Frail Behavior in Videos of Standardized Patients	PLOS ONE			English	Article							OLDER-ADULTS; SURGICAL OUTCOMES; POSTOPERATIVE COMPLICATIONS; GERIATRIC ASSESSMENT; PREDICTION; MORBIDITY; MORTALITY; INDEX; COST; RISK	Background: Frailty is a predictor of poor outcomes following many types of operations. We measured thoracic surgeons' accuracy in assessing patient frailty using videos of standarized patients demonstrating signs of physical frailty. We compared their performance to that of geriatrics specialists. Methods: We developed an anchored scale for rating degree of frailty. Reference categories were assigned to 31 videos of standarized patients trained to exhibit five levels of activity ranging from "vigorous" to "frail." Following an explanation of frailty, thoracic surgeons and geriatrics specialists rated the videos. We evaluated inter-rater agreement and tested differences between ratings and reference categories. The influences of clinical specialty, clinical experience, and self-rated expertise were examined. Results: Inter-rater rank correlation among all participants was high (Kendall's W 0.85) whereas exact agreement (Fleiss' kappa) was only moderate (0.47). Better inter-rater agreement was demonstrated for videos exhibiting extremes of behavior. Exact agreement was better for thoracic surgeons (n = 32) than geriatrics specialists (n = 9; p = 0.045), whereas rank correlation was similar for both groups. More clinical years of experience and self-reported expertise were not associated with better inter-rater agreement. Conclusions: Videos of standarized patients exhibiting varying degrees of frailty are rated with internal consistency by thoracic surgeons as accurately as geriatrics specialists when referenced to an anchored scale. Ratings were less consistent for moderate degrees of frailty, suggesting that physicians require training to recognize early frailty. Such videos may be useful in assessing and teaching frailty recognition.	[Ferguson, Mark K.; Rojnica, Marko] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Thompson, Katherine; Huisingh-Scheetz, Megan; Farnan, Jeanne; Hemmerich, Josh A.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Slawinski, Kris] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; [Acevedo, Julissa] Univ Chicago, Ctr Res Informat, Chicago, IL 60637 USA; [Lee, Sang Mee] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Small, Stephen] Univ Chicago, Dept Anesthesiol & Crit Care, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago	Ferguson, MK (corresponding author), Univ Chicago, Dept Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA.	mferguso@surgery.bsd.uchicago.edu			NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000430] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Ber R, 2001, ACAD MED, V76, P656, DOI 10.1097/00001888-200106000-00022; Birkmeyer JD, 2012, ANN SURG, V255, P1, DOI 10.1097/SLA.0b013e3182402c17; Carey K, 2011, MED CARE RES REV, V68, P490, DOI 10.1177/1077558710396378; Dale W, 2014, ANN SURG, V259, P960, DOI 10.1097/SLA.0000000000000226; Dasgupta M, 2009, ARCH GERONTOL GERIAT, V48, P78, DOI 10.1016/j.archger.2007.10.007; Ferguson MK, 2010, ANN THORAC SURG, V89, P1037, DOI 10.1016/j.athoracsur.2009.12.068; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Hamaker ME, 2012, LANCET ONCOL, V13, pE437, DOI 10.1016/S1470-2045(12)70259-0; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hodari A, 2013, ANN THORAC SURG, V96, P1240, DOI 10.1016/j.athoracsur.2013.05.051; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Maan ZN, 2012, BRIT J SURG, V99, P1610, DOI 10.1002/bjs.8893; Makary MA, 2010, J AM COLL SURGEONS, V210, P901, DOI 10.1016/j.jamcollsurg.2010.01.028; Pol RA, 2011, EUR J VASC ENDOVASC, V42, P824, DOI 10.1016/j.ejvs.2011.07.006; Revenig LM, 2013, J AM COLL SURGEONS, V217, P665, DOI 10.1016/j.jamcollsurg.2013.06.012; Robinson TN, 2011, AM J SURG, V202, P511, DOI 10.1016/j.amjsurg.2011.06.017; Robinson TN, 2011, J AM COLL SURGEONS, V213, P37, DOI 10.1016/j.jamcollsurg.2011.01.056; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Sundermann S, 2011, EUR J CARDIO-THORAC, V39, P33, DOI 10.1016/j.ejcts.2010.04.013; Tsiouris A, 2013, J SURG RES, V183, P40, DOI 10.1016/j.jss.2012.11.059; Woodfield JC, 2007, WORLD J SURG, V31, P1912, DOI 10.1007/s00268-007-9178-0	21	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98654	10.1371/journal.pone.0098654	http://dx.doi.org/10.1371/journal.pone.0098654			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892734	Green Submitted, Green Published, gold			2022-12-27	WOS:000336911400079
J	Grist, H; Daunt, F; Wanless, S; Nelson, EJ; Harris, MP; Newell, M; Burthe, S; Reid, JM				Grist, Hannah; Daunt, Francis; Wanless, Sarah; Nelson, Emily J.; Harris, Mike P.; Newell, Mark; Burthe, Sarah; Reid, Jane M.			Site Fidelity and Individual Variation in Winter Location in Partially Migratory European Shags	PLOS ONE			English	Article							PHALACROCORAX-ARISTOTELIS; POPULATION-DYNAMICS; BREEDING-SUCCESS; HABITAT QUALITY; SURVIVAL; HISTORY; CONSERVATION; CONSEQUENCES; SEGREGATION; CORMORANTS	In partially migratory populations, individuals from a single breeding area experience a range of environments during the non-breeding season. If individuals show high within-and among-year fidelity to specific locations, any annual environmental effect on individual life histories could be reinforced, causing substantial demographic heterogeneity. Quantifying within-and among-individual variation and repeatability in non-breeding season location is therefore key to predicting broad-scale environmental impacts on the dynamics of partially migratory populations. We used field resightings of colour-ringed adult European shags known to have bred on the Isle of May, Scotland, to quantify individual variation and repeatability in winter location within and among three consecutive winters. In total, 3797 resightings of 882 individuals were recorded over 622 km of coastline, including the Isle of May. These individuals comprised over 50% of the known breeding population, and encompassed representative distributions of ages and sexes. The distances from the Isle of May at which individuals were resighted during winter varied substantially, up to 486 km and 136 km north and south respectively and including the breeding colony on the Isle of May. However, resighting distances were highly repeatable within individuals; within-and among-winter repeatabilities were >0.72 and >0.59 respectively across the full September-March observation period, and >0.95 and >0.79 respectively across more restricted mid-winter periods. Repeatability did not differ significantly between males and females or among different age classes, either within or among winters. These data demonstrate that the focal shag population is partially migratory, and moreover that individuals show highly repeatable variation in winter location and hence migration strategy across consecutive winters. Such high among-individual variation and within-individual repeatability, both within and among winters, could lead to substantial life history variation, and therefore influence population dynamics and future conservation management strategies.	[Grist, Hannah; Reid, Jane M.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Grist, Hannah; Daunt, Francis; Wanless, Sarah; Nelson, Emily J.; Harris, Mike P.; Newell, Mark; Burthe, Sarah] Ctr Ecol & Hydrol, Penicuik, Midlothian, Scotland; [Grist, Hannah] Scottish Ornithologists Club, Aberlady, East Lothian, Scotland	University of Aberdeen; UK Centre for Ecology & Hydrology (UKCEH)	Daunt, F (corresponding author), Ctr Ecol & Hydrol, Penicuik, Midlothian, Scotland.	frada@ceh.ac.uk; jane.reid@abdn.ac.uk	Burthe, Sarah J/Q-9505-2016; Daunt, Francis/K-6688-2012	Burthe, Sarah J/0000-0001-8871-3432; Daunt, Francis/0000-0003-4638-3388; Grist, Hannah/0000-0001-7299-1868	Natural Environment Research Council CASE studentship; Centre for Ecology and Hydrology, Edinburgh; Scottish Ornithologists' Club; Natural Environment Research Council; Royal Society; Natural Environment Research Council [ceh010010] Funding Source: researchfish	Natural Environment Research Council CASE studentship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Centre for Ecology and Hydrology, Edinburgh; Scottish Ornithologists' Club; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society(Royal Society of London); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	HG is funded by a Natural Environment Research Council CASE studentship, in partnership with the Centre for Ecology and Hydrology, Edinburgh (www.ceh.ac.uk), and the Scottish Ornithologists' Club (www.the-soc.org.uk). FD, SW, EN, MPH and MN are funded by the Natural Environment Research Council (www.nerc.ac.uk). JR is funded by the Royal Society (royalsociety.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1995, IBIS, V137, P11, DOI 10.1111/j.1474-919X.1995.tb03214.x; AEBISCHER NJ, 1986, J ANIM ECOL, V55, P613, DOI 10.2307/4743; AEBISCHER NJ, 1995, IBIS, V137, P19, DOI 10.1111/j.1474-919X.1995.tb03215.x; Alves JA, 2010, BIRD STUDY, V57, P381, DOI 10.1080/00063651003678475; [Anonymous], 2012, ISL MAY NAT NA UNPUB; Baird RW, 2008, MAR MAMMAL SCI, V24, P591, DOI 10.1111/j.1748-7692.2008.00200.x; Bakken V, 2003, NORWEGIAN BIRD RINGI, P431; Barlow EJ, 2013, IBIS, V155, P762, DOI 10.1111/ibi.12060; Bates D, 2012, LME4 LINEAR MIXED EF; Bearhop S, 2004, P ROY SOC B-BIOL SCI, V271, pS215, DOI 10.1098/rsbl.2003.0129; Belda EJ, 2007, IBIS, V149, P396, DOI 10.1111/j.1474-919X.2007.00657.x; Benton TG, 2006, P R SOC B, V273, P1173, DOI 10.1098/rspb.2006.3495; BIRKHEAD TR, 1977, J ANIM ECOL, V46, P751, DOI 10.2307/3638; Boyle WA, 2008, J ANIM ECOL, V77, P1122, DOI 10.1111/j.1365-2656.2008.01451.x; Brodersen J, 2008, ECOLOGY, V89, P1195, DOI 10.1890/07-1318.1; Brown DR, 2007, CONDOR, V109, P548, DOI 10.1650/8351.1; Chapman BB, 2011, OIKOS, V120, P1764, DOI 10.1111/j.1600-0706.2011.20131.x; Cherel Y, 2006, BIOL LETTERS, V2, P301, DOI 10.1098/rsbl.2006.0445; Clark Nigel A., 2010, Wader Study Group Bulletin, V117, P173; Clutton-Brock T, 2010, TRENDS ECOL EVOL, V25, P562, DOI 10.1016/j.tree.2010.08.002; Dalling JW, 2002, J ECOL, V90, P557, DOI 10.1046/j.1365-2745.2002.00695.x; Daunt F, 2007, FUNCT ECOL, V21, P561, DOI 10.1111/j.1365-2435.2007.01260.x; Daunt F, 2006, BEHAV ECOL SOCIOBIOL, V59, P381, DOI 10.1007/s00265-005-0061-4; Dias MP, 2011, P ROY SOC B-BIOL SCI, V278, P1786, DOI 10.1098/rspb.2010.2114; Dingemanse NJ, 2013, J ANIM ECOL, V82, P39, DOI 10.1111/1365-2656.12013; Dochtermann NA, 2012, CURR ZOOL, V58, P358, DOI 10.1093/czoolo/58.2.358; Eaton Mark A., 2009, British Birds, V102, P296; Edwards MA, 2009, ANIM BEHAV, V77, P23, DOI 10.1016/j.anbehav.2008.09.025; EEC, 2009, OFF J, VL20, P7; Einoder LD, 2009, FISH RES, V95, P6, DOI 10.1016/j.fishres.2008.09.024; Environmental Systems Research Institute (ESRI), 2011, ARCGIS DESKT; Esler D, 2000, J WILDLIFE MANAGE, V64, P839, DOI 10.2307/3802754; Fiedler Wolfgang, 2009, Ringing & Migration, V24, P175; Forero MG, 2002, MAR ECOL PROG SER, V234, P289, DOI 10.3354/meps234289; Frederiksen M, 2008, J ANIM ECOL, V77, P1020, DOI 10.1111/j.1365-2656.2008.01422.x; Frederiksen M, 2002, WILDLIFE BIOL, V8, P241, DOI 10.2981/wlb.2002.021; Frederiksen M, 2012, DIVERS DISTRIB, V18, P530, DOI 10.1111/j.1472-4642.2011.00864.x; GALBRAITH H, 1986, ORNIS SCAND, V17, P68, DOI 10.2307/3676754; Gill JA, 2001, NATURE, V412, P436, DOI 10.1038/35086568; Gonzalez-Solis J, 2007, FRONT ECOL ENVIRON, V5, P297, DOI 10.1890/1540-9295(2007)5[297:TMAMIT]2.0.CO;2; Gremillet D, 1998, FUNCT ECOL, V12, P386, DOI 10.1046/j.1365-2435.1998.00199.x; Gunnarsson TG, 2005, P ROY SOC B-BIOL SCI, V272, P2319, DOI 10.1098/rspb.2005.3214; Gunnarsson TG, 2006, J ANIM ECOL, V75, P1119, DOI 10.1111/j.1365-2656.2006.01131.x; Harris MP, 2010, MAR BIOL, V157, P827, DOI 10.1007/s00227-009-1365-0; HARRIS MP, 1994, CONDOR, V96, P600, DOI 10.2307/1369462; Harris MP, 2002, MIGRATION ATLAS MOVE, P139; Harrison XA, 2011, J ANIM ECOL, V80, P4, DOI 10.1111/j.1365-2656.2010.01740.x; Hatch SA, 2011, J FIELD ORNITHOL, V82, P269, DOI 10.1111/j.1557-9263.2011.00330.x; Hobson KA, 1986, MURRELET, P65; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Iverson SA, 2006, J AVIAN BIOL, V37, P219; Lehikoinen E, 2004, ADV ECOL RES, V35, P1, DOI 10.1016/S0065-2504(04)35001-4; Lescroel A, 2009, J ANIM ECOL, V78, P798, DOI 10.1111/j.1365-2656.2009.01542.x; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Marra PP, 2001, AUK, V118, P92, DOI 10.1642/0004-8038(2001)118[0092:CODMHS]2.0.CO;2; Martin JGA, 2011, METHODS ECOL EVOL, V2, P362, DOI 10.1111/j.2041-210X.2010.00084.x; McKnight A, 2011, MAR ECOL PROG SER, V442, P241, DOI 10.3354/meps09373; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Norris DR, 2007, CONDOR, V109, P535; Norris DR, 2006, BIOL LETTERS, V2, P148, DOI 10.1098/rsbl.2005.0397; Oppel S, 2008, MAR ECOL PROG SER, V373, P149, DOI 10.3354/meps07744; OSBORNE P, 1980, IBIS, V122, P512, DOI 10.1111/j.1474-919X.1980.tb00908.x; PIPER WH, 1990, ETHOLOGY, V85, P114; POTTS GR, 1980, J ANIM ECOL, V49, P465, DOI 10.2307/4258; Pulido F, 1996, P NATL ACAD SCI USA, V93, P14642, DOI 10.1073/pnas.93.25.14642; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reid JM, 2003, J ANIM ECOL, V72, P36, DOI 10.1046/j.1365-2656.2003.00673.x; Reynolds TJ, 2011, IBIS, V153, P818, DOI 10.1111/j.1474-919X.2011.01149.x; Rodenhouse NL, 1997, ECOLOGY, V78, P2025, DOI 10.2307/2265942; Saether BE, 1997, TRENDS ECOL EVOL, V12, P143, DOI 10.1016/S0169-5347(96)10068-9; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Sherry TW, 1996, ECOLOGY, V77, P36, DOI 10.2307/2265652; SNOW BARBARA K., 1963, BRIT BIRDS, V56-56, P77; Sponza S, 2013, ITAL J ZOOL, V80, P380, DOI 10.1080/11250003.2013.775365; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Velando A, 2003, WATERBIRDS, V26, P473, DOI 10.1675/1524-4695(2003)026[0000:NSCOAB]2.0.CO;2; Velando A, 2001, J ETHOL, V19, P121, DOI 10.1007/s101640170008; Vindenes Y, 2008, AM NAT, V171, P455, DOI 10.1086/528965; Wanless Sarah, 2004, P146; Warkentin IG, 1996, BIOL CONSERV, V77, P143, DOI 10.1016/0006-3207(95)00146-8; White PJ, 2007, BIOL CONSERV, V135, P502, DOI 10.1016/j.biocon.2006.10.041	81	34	35	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98562	10.1371/journal.pone.0098562	http://dx.doi.org/10.1371/journal.pone.0098562			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892676	Green Published, Green Accepted, gold			2022-12-27	WOS:000336911400068
J	Lavery, SD; Farhadi, A; Farahmand, H; Chan, TY; Azhdehakoshpour, A; Thakur, V; Jeffs, AG				Lavery, Shane D.; Farhadi, Ahmad; Farahmand, Hamid; Chan, Tin-Yam; Azhdehakoshpour, Ashkan; Thakur, Vibhavari; Jeffs, Andrew G.			Evolutionary Divergence of Geographic Subspecies within the Scalloped Spiny Lobster Panulirus homarus (Linnaeus 1758)	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; MOLECULAR PHYLOGENY; GENUS PANULIRUS; RIBOSOMAL DNA; DECAPODA; SPECIATION; PALINURIDAE; JMODELTEST; CRUSTACEA; ATLANTIC	Panulirus homarus is an economically important spiny lobster that is widespread through the Indo-West Pacific Region, but has an uncertain taxonomic status, with three or four geographic subspecies having been described. This study used mitochondrial (16S, COI and control region) and nuclear (18S, ITS-1) DNA sequences to examine specimens of all putative subspecies and forms from throughout their range, in order to determine their genetic validity, and understand the evolutionary history of this species. Despite the range of diversity present in the loci examined, the results were consistent across genes. P. h. rubellus from the SW Indian Ocean comprised the most divergent lineage that was reciprocally monophyletic with respect to all other P. homarus (approx. 9% divergence in COI), and has likely evolved reproductive barriers. The putative P. h. "Brown'' subspecies from the Marquesas Is in the central Pacific also comprised a somewhat divergent monophyletic lineage (approx. 3% in COI), but may simply be an allopatric population. The widespread P. h. homarus was not diverged at all from the described P. h. megasculpta from the NW Indian Ocean. The degree of evolutionary divergence of populations at the extremes distribution of the species is somewhat surprising, given the long pelagic larval stage, but suggests that allopatric speciation has been an important driver in the evolution of the genus.	[Lavery, Shane D.; Thakur, Vibhavari] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Lavery, Shane D.; Jeffs, Andrew G.] Univ Auckland, Inst Marine Sci, Auckland 1, New Zealand; [Farhadi, Ahmad; Farahmand, Hamid] Univ Tehran, Dept Fisheries, Karaj, Iran; [Chan, Tin-Yam] Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung 202, Taiwan; [Chan, Tin-Yam] Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung 202, Taiwan; [Azhdehakoshpour, Ashkan] IFRO Chabahar Branch, Chabahr, Iran	University of Auckland; University of Auckland; University of Tehran; National Taiwan Ocean University; National Taiwan Ocean University	Farhadi, A (corresponding author), Univ Tehran, Dept Fisheries, Karaj, Iran.	farhadia63@yahoo.com	Jeffs, Andrew G/D-9474-2012; Ajdari, Ashkan/AAB-6517-2019; Lavery, Shane/AFX-7929-2022	Lavery, Shane/0000-0003-3038-292X; Jeffs, Andrew/0000-0002-8504-1949; Farhadi, Ahmad/0000-0002-8282-4825	Australian Research Council [IH 120100032]; Worldwide Universities Network; University of Auckland; National Science Council, Taiwan, R.O.C.; University of Tehran	Australian Research Council(Australian Research Council); Worldwide Universities Network; University of Auckland; National Science Council, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan); University of Tehran(University of Tehran)	The study was conducted with the financial support of the Australian Research Council's Industrial Transformation Research Hub funding scheme (project number IH 120100032) and the Worldwide Universities Network (AJ), the University of Auckland (SL), grants from the National Science Council, Taiwan, R.O.C. (TYC) and the University of Tehran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Marzouqi A., 2007, Western Indian Ocean Journal of Marine Science, V6, P159; [Anonymous], 1953, ZOOGEOGRAPHY SEA; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; BAKER CS, 1994, MOL ECOL, V3, P313, DOI 10.1111/j.1365-294X.1994.tb00071.x; BERRY P F, 1974, Crustaceana (Leiden), V27, P31, DOI 10.1163/156854074X00208; Berry PF, 1971, 28 OC RES I, P75; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Chan TY, 2009, MOL PHYLOGENET EVOL, V50, P411, DOI 10.1016/j.ympev.2008.11.020; Chan TY, 2001, CRUSTACEANA, V74, P123, DOI 10.1163/156854001505307; Chan TY, PERSONAL OBSERVATION; Chow S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029280; Chu KH, 2001, MAR BIOTECHNOL, V3, P355, DOI 10.1007/s10126001-0014-5; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Diniz FM, 2005, MAR BIOTECHNOL, V7, P462, DOI 10.1007/s10126-004-4062-5; Drummond AJ, 2011, GENEIOUS AUCKLAND BI; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FAO, 2010, FAO YB FISH ACQ STAT, P100; Farhadi A, 2013, ICES J MAR SCI, V70, P1491, DOI 10.1093/icesjms/fst097; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gaither MR, 2010, J BIOGEOGR, V37, P133, DOI 10.1111/j.1365-2699.2009.02188.x; George RW, 2006, CRUSTACEANA, V79, P397, DOI 10.1163/156854006777554848; George RW, 2005, CRUSTACEANA, V78, P1281, DOI 10.1163/156854005776759780; George RW, 2005, NEW ZEAL J MAR FRESH, V39, P493, DOI 10.1080/00288330.2005.9517328; Gopal K, 2006, MAR ECOL PROG SER, V319, P191, DOI 10.3354/meps319191; Groeneveld JC, 2007, MOL PHYLOGENET EVOL, V45, P102, DOI 10.1016/j.ympev.2007.06.002; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HALANYCH KM, 1995, SCIENCE, V267, P1641, DOI 10.1126/science.7886451; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; Holthuis L, 1991, FAO FISHERIES SYNOPS, V13; Huxley VAJ, 2011, J THEOR EXP BIOL, V8, P58; Jeffs AG, 2005, NEW ZEAL J MAR FRESH, V39, P605, DOI 10.1080/00288330.2005.9517339; Jimoh AA, 2013, AQUACULTURE, V410, P25, DOI 10.1016/j.aquaculture.2013.06.013; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; Li CP, 2011, ZOOL ANZ, V250, P270, DOI 10.1016/j.jcz.2011.04.003; LUTJEHARMS JRE, 1988, S AFR J SCI, V84, P236; Palero F, 2008, MOL PHYLOGENET EVOL, V48, P708, DOI 10.1016/j.ympev.2008.04.022; Palero F, 2009, MOL PHYLOGENET EVOL, V50, P152, DOI 10.1016/j.ympev.2008.10.003; Palumbi Stephen R., 1996, P205; Patek SN, 2007, LOBSTERS BIOL MANAGE, P113; Phillips BF, 2006, LOBSTERS BIOL MANAGE, P30; Phillips B, 2011, RECENT ADVANCES AND NEW SPECIES IN AQUACULTURE, P22; Phillips Bruce F., 2006, P231, DOI 10.1002/9780470995969.ch7; POLLOCK DE, 1992, B MAR SCI, V51, P135; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ptacek MB, 2001, MAR FRESHWATER RES, V52, P1037, DOI 10.1071/MF01070; Quenouille B, 2011, MOL PHYLOGENET EVOL, V58, P546, DOI 10.1016/j.ympev.2010.12.009; Ravago RG, 2002, CRUSTACEANA, V75, P1047, DOI 10.1163/156854002763270455; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; RYDER OA, 1986, TRENDS ECOL EVOL, V1, P9, DOI 10.1016/0169-5347(86)90059-5; Sarver SK, 1998, J CRUSTACEAN BIOL, V18, P177, DOI 10.2307/1549532; SPRINGER VG, 1982, SMITHSONIAN CONTR ZO, V367, P1, DOI DOI 10.5479/SI.00810282.367; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tourinho JL, 2012, MAR BIOL, V159, P1897, DOI 10.1007/s00227-012-1977-7; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; Yang CH, 2012, MOL PHYLOGENET EVOL, V62, P237, DOI 10.1016/j.ympev.2011.09.019; Yeung C, 2001, MAR FRESHWATER RES, V52, P1217, DOI 10.1071/MF01110	56	39	40	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e97247	10.1371/journal.pone.0097247	http://dx.doi.org/10.1371/journal.pone.0097247			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892781	gold, Green Published, Green Submitted			2022-12-27	WOS:000336911400010
J	Martin, CR; Zaman, MM; Gilkey, C; Salguero, MV; Hasturk, H; Kantarci, A; Van Dyke, TE; Freedman, SD				Martin, Camilia R.; Zaman, Munir M.; Gilkey, Calvin; Salguero, Maria V.; Hasturk, Hatice; Kantarci, Alpdogan; Van Dyke, Thomas E.; Freedman, Steven D.			Resolvin D1 and Lipoxin A(4) Improve Alveolarization and Normalize Septal Wall Thickness in a Neonatal Murine Model of Hyperoxia-Induced Lung Injury	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BIRTH-WEIGHT INFANTS; BRONCHOPULMONARY DYSPLASIA; PRETERM INFANTS; TGF-BETA; LIPID MEDIATORS; COUNT METHOD; MOUSE LUNG; MICE; INTRAUTERINE	Background: The critical fatty acids Docosahexaenoic Acid (DHA) and Arachidonic Acid (AA) decline in preterm infants within the first postnatal week and are associated with neonatal morbidities, including bronchopulmonary dysplasia (BPD). DHA and AA are precursors to downstream metabolites that terminate the inflammatory response. We hypothesized that treatment with Resolvin D1 and/or Lipoxin A(4) would prevent lung injury in a murine model of BPD. Objective: To determine the effect of Resolvin D1 and/or Lipoxin A(4) on hyperoxia-induced lung injury. Methods: C57/BL6 pups were randomized at birth to Room Air, Hyperoxia (>90% oxygen), Hyperoxia + Resolvin D1, Hyperoxia + Lipoxin A(4), or Hyperoxia + Resolvin D1/Lipoxin A(4). Resolvin D1 and/or Lipoxin A(4) (2 ng/g) were given IP on days 0, 3, 6, and 9. On day 10, mice were sacrificed and lungs collected for morphometric analyses including Mean Linear Intercept (MLI), Radial Alveolar Count (RAC), and Septal Thickness (ST); RT-PCR analyses of biomarkers of lung development and inflammation; and ELISA for TGF beta(1) and TGF beta(2). Result: The increased ST observed with hyperoxia exposure was normalized by both Resolvin D1 and Lipoxin A(4); while, hyperoxia-induced alveolar simplification was attenuated by Lipoxin A(4). Relative to hyperoxia, Resolvin D1 reduced the gene expression of CXCL2 (2.9 fold), TIMP1 (6.7 fold), and PPAR gamma (4.8 fold). Treatment with Lipoxin A(4) also led to a reduction of CXCL2 (2.4 fold) while selectively increasing TGF beta(2) (2.1 fold) and Smad3 (1.58 fold). Conclusion: The histologic and biochemical changes seen in hyperoxia-induced lung injury in this murine model can be reversed by the addition of DHA and AA fatty acid downstream metabolites that terminate the inflammatory pathways and modulate growth factors. These fatty acids or their metabolites may be novel therapies to prevent or treat lung injury in preterm infants.	[Martin, Camilia R.] Beth Israel Deaconess Med Ctr, Dept Neonatol, Boston, MA 02215 USA; [Martin, Camilia R.; Freedman, Steven D.] Beth Israel Deaconess Med Ctr, Div Translat Res, Boston, MA 02215 USA; [Zaman, Munir M.; Gilkey, Calvin; Salguero, Maria V.; Freedman, Steven D.] Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA 02215 USA; [Hasturk, Hatice; Kantarci, Alpdogan; Van Dyke, Thomas E.] Forsyth Inst, Ctr Periodontol, Dept Appl Oral Sci, Cambridge, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Forsyth Institute	Martin, CR (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neonatol, Boston, MA 02215 USA.	cmartin1@bidmc.harvard.edu			Program for Faculty Development and Diversity; Harvard Catalyst; Harvard Clinical and Translational Science Center; National Center for Research Resources [UL1 RR 025758]; Harvard University; Charles H. Hood Foundation; National Institute of Dental and Craniofacial Research [s R01 DE15566, R01 DE19938, R21 DE20906, K23 DE18917]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K23DE018917, R21DE020906, R01DE015566, R01DE019938] Funding Source: NIH RePORTER	Program for Faculty Development and Diversity; Harvard Catalyst; Harvard Clinical and Translational Science Center; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Harvard University; Charles H. Hood Foundation; National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The work of CRM was supported by the Program for Faculty Development and Diversity supported by Harvard Catalyst, and the Harvard Clinical and Translational Science Center, from the National Center for Research Resources (award #UL1 RR 025758 and financial contributions from Harvard University and its affiliated academic health care centers). The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, the National Center for Research Resources or the National Institutes of Health. This study was also funded by the Charles H. Hood Foundation (CRM; www.hria.org/tmfservices/tmfgrants/hood.html), generous philanthropic donors to the Infant Health Research Program at Beth Israel Deaconess Medical Center, and the National Institute of Dental and Craniofacial Research (Award #s R01 DE15566, R01 DE19938, R21 DE20906, and K23 DE18917. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejandre-Alcazar MA, 2007, AM J PHYSIOL-LUNG C, V292, pL537, DOI 10.1152/ajplung.00050.2006; Bannenberg G, 2010, BBA-MOL CELL BIOL L, V1801, P1260, DOI 10.1016/j.bbalip.2010.08.002; Bhandari V, 2010, SEMIN FETAL NEONAT M, V15, P223, DOI 10.1016/j.siny.2010.03.009; Bourbon J, 2005, PEDIATR RES, V57, p38R, DOI 10.1203/01.PDR.0000159630.35883.BE; Carraro S, 2013, EARLY HUM DEV, V89, pS3, DOI 10.1016/j.earlhumdev.2013.07.015; Chen H, 2005, AM J PHYSIOL-LUNG C, V288, pL683, DOI 10.1152/ajplung.00298.2004; COONEY TP, 1982, THORAX, V37, P572, DOI 10.1136/thx.37.8.572; COONEY TP, 1982, THORAX, V37, P580, DOI 10.1136/thx.37.8.580; Dasgupta C, 2009, AM J PHYSIOL-LUNG C, V296, pL1031, DOI 10.1152/ajplung.90392.2008; Dong J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-204; Eickmeier O, 2013, MUCOSAL IMMUNOL, V6, P256, DOI 10.1038/mi.2012.66; EMERY JL, 1960, ARCH DIS CHILD, V35, P544, DOI 10.1136/adc.35.184.544; Hilgendorff A., 2013, AM J RESP CELL MOL B; Hillman NH, 2011, AM J PHYSIOL-LUNG C, V300, pL232, DOI 10.1152/ajplung.00294.2010; Husain AN, 1998, HUM PATHOL, V29, P710, DOI 10.1016/S0046-8177(98)90280-5; Jeng SF, 2008, DEV MED CHILD NEUROL, V50, P51, DOI 10.1111/j.1469-8749.2007.02011.x; Jin SW, 2007, ANESTH ANALG, V104, P369, DOI 10.1213/01.ane.0000252414.00363.c4; Kumarasamy A, 2009, AM J RESP CRIT CARE, V180, P1239, DOI 10.1164/rccm.200902-0215OC; Landry JS, 2012, CAN RESPIR J, V19, P255, DOI 10.1155/2012/606507; Lapillonne A, 2010, NEONATOLOGY, V98, P397, DOI 10.1159/000320159; Levy BD, 2013, ANN REV PHYSL; Ma LY, 2012, NUTRITION, V28, P1186, DOI 10.1016/j.nut.2012.04.001; Martin CR, 2011, J PEDIATR-US, V159, P743, DOI 10.1016/j.jpeds.2011.04.039; Merritt TA, 2009, SEMIN FETAL NEONAT M, V14, P345, DOI 10.1016/j.siny.2009.08.009; Nakanishi H, 2007, AM J PHYSIOL-LUNG C, V293, pL151, DOI 10.1152/ajplung.00389.2006; Natarajan G, 2012, EARLY HUM DEV, V88, P509, DOI 10.1016/j.earlhumdev.2011.12.013; Recchiuti A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00298; Rogers LK, 2013, PHARMACOL RES, V70, P13, DOI 10.1016/j.phrs.2012.12.003; Rogers LK, 2011, J NUTR, V141, P214, DOI 10.3945/jn.110.129882; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Thebaud B, 2005, CIRCULATION, V112, P2477, DOI 10.1161/CIRCULATIONAHA.105.541524; Thebaud B, 2007, NEONATOLOGY, V91, P291, DOI 10.1159/000101344; Vicencio AG, 2004, AM J RESP CELL MOL, V31, P650, DOI 10.1165/rcmb.2004-0092OC; Vicencio AG, 2002, J APPL PHYSIOL, V93, P1123, DOI 10.1152/japplphysiol.00031.2002; Voelkel NF, 2006, AM J PHYSIOL-LUNG C, V290, pL209, DOI 10.1152/ajplung.00185.2005; Vom Hove M, 2014, J PEDIAT, V164, p[40, e44]; Wagenaar GTA, 2004, FREE RADICAL BIO MED, V36, P782, DOI 10.1016/j.freeradbiomed.2003.12.007; Wang B, 2011, PULM PHARMACOL THER, V24, P434, DOI 10.1016/j.pupt.2011.04.001; Wang Q, 2014, J IMMUNOL; Warner BB, 1998, AM J PHYSIOL-LUNG C, V275, pL110, DOI 10.1152/ajplung.1998.275.1.L110; Wendel DP, 2000, AM J RESP CELL MOL, V23, P320, DOI 10.1165/ajrcmb.23.3.3906; Yaxin W, 2013, J SURG RES; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85	43	44	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98773	10.1371/journal.pone.0098773	http://dx.doi.org/10.1371/journal.pone.0098773			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892762	Green Published, Green Submitted, gold			2022-12-27	WOS:000336911400090
J	Tulloch, O; Theobald, S; Ananworanich, J; Chasombat, S; Kosalaraksa, P; Jirawattanapisal, T; Lakonphon, S; Lumbiganon, P; Taegtmeyer, M				Tulloch, Olivia; Theobald, Sally; Ananworanich, Jintanat; Chasombat, Sanchai; Kosalaraksa, Pope; Jirawattanapisal, Thidaporn; Lakonphon, Sudrak; Lumbiganon, Pagakrong; Taegtmeyer, Miriam			From Transmission to Transition: Lessons Learnt from the Thai Paediatric Antiretroviral Programme	PLOS ONE			English	Article							HIV-INFECTED CHILDREN; QUALITATIVE RESEARCH; NATIONAL PROGRAM; ADULT CARE; OUTCOMES; ADOLESCENTS; MODEL	Background: The Thai HIV programme is a leader in the public health approach to HIV treatment. Starting at transmission of HIV and ending with transition to adult services this paper assesses the paediatric HIV treatment continuum from three perspectives: service-user, provider and policy maker, to understand what works well and why. Methods: A qualitative research design was used to assess and triangulate the stakeholder perspectives. Semi-structured interviews were conducted with ART service-users (n = 35), policy actors (n = 20); telephone interviews with prior caregivers of orphans (n = 10); and three focus group discussions with service-providers (hospital staff and volunteers) from a district, provincial and a university hospital. Findings: Children accessing HIV care were often orphaned, cared for by elderly relatives and experiencing multiple vulnerabilities. Services were divided into three stages, 1. Diagnosis and linkage: Despite strong policies there were supply and demand-side gaps in the prevention of mother-to-child transmission 'cascade' preventing early diagnosis and/or treatment. 2. Maintenance on ART - Children did well on treatment; caregivers took adherence seriously and valued the quality of services. Drug resistance, adherence and psychosocial issues were important concerns from all perspectives. 3. Adolescents and transition: Adolescent service-users faced greater complexity in their physical and emotional lives for which providers lacked skills; transition from the security of paediatric clinic was a daunting prospect. Dedicated healthcare providers felt they struggled to deliver services that met service-users' diverse needs at all stages. Child-and adolescent-specific elements of HIV policy were considered low priority. Conclusions: Using the notion of the continuum of care a number of strengths and weaknesses were identified. Features of paediatric services need to evolve alongside the changing needs of service users. Peer-support volunteers have potential to add continuity and support at all stages. It is critical that adolescents receive targeted support, particularly during transition to adult services.	[Tulloch, Olivia; Theobald, Sally; Taegtmeyer, Miriam] Univ Liverpool, Liverpool Sch Trop Med, Dept Int Publ Hlth, Liverpool L3 5QA, Merseyside, England; [Ananworanich, Jintanat; Lakonphon, Sudrak] Thai Red Cross AIDS Res Ctr, SEARCH & HIV NAT, Bangkok, Thailand; [Ananworanich, Jintanat] Chulalongkorn Univ, Fac Med, Bangkok 10330, Thailand; [Chasombat, Sanchai; Jirawattanapisal, Thidaporn] Minist Publ Hlth, Dept Dis Control, Bur AIDS TB & Sexually Transmitted Infect, Nonthaburi, Thailand; [Kosalaraksa, Pope; Lumbiganon, Pagakrong] Khon Kaen Univ, Fac Med, Dept Pediat, Khon Kaen, Thailand	Liverpool School of Tropical Medicine; University of Liverpool; Thai Red Cross Society; Chulalongkorn University; Ministry of Public Health - Thailand; Khon Kaen University	Tulloch, O (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Dept Int Publ Hlth, Liverpool L3 5QA, Merseyside, England.	oht@liv.ac.uk	Ananworanich, Jintanat/AAC-6348-2021	Ananworanich, Jintanat/0000-0003-1369-3224; Taegtmeyer, Miriam/0000-0002-5377-2536; Theobald, Sally/0000-0002-9053-211X	Global Fund to Fight AIDS TB and Malaria	Global Fund to Fight AIDS TB and Malaria(United States Agency for International Development (USAID))	Data collection was funded by the Global Fund to Fight AIDS TB and Malaria, allocated by the Thai Ministry of Public Health. Ministry of Public Health co-authors were involved in the study design, analysis and preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boon-Yasidhi V, 2013, AIDS CARE, V25, P756, DOI 10.1080/09540121.2012.749331; BRITTEN N, 1995, BRIT MED J, V311, P251, DOI 10.1136/bmj.311.6999.251; Castro H, 2011, LANCET, V377, P1580, DOI 10.1016/S0140-6736(11)60208-0; Cervia JS, 2013, AIDS PATIENT CARE ST, V27, P692, DOI 10.1089/apc.2013.0253; Chokephaibulkit K, 2013, PEDIAT INFECT DIS J; Department of Disease Control, COMM BAS PED HIV TRE; Department of Disease Control, 2011, THAIL NAT ANT TREATM; Doherty K, 2013, CURR OPIN HIV AIDS, V8, P457, DOI 10.1097/COH.0b013e328362db0d; Epidemiological Information Section Bureau of Epidemiology Department of Disease Control Thai Ministry of Public Health, 2010, 2545 TOT SENT SURV; Family Health International Bureau of AIDS TB and STIs Department of Disease Control MOPH Thailand, 2008, AS EP MOD AEM PROJ H, P2008; Hansudewechakul R, 2012, JIAS, V15; Hansudewechakul R, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17358; Johnson JA, 2005, J INFECT DIS, V192, P16, DOI 10.1086/430741; Jongudomkarn Darunee, 2006, Nurs Health Sci, V8, P156, DOI 10.1111/j.1442-2018.2006.00273.x; Kanshana S, 2002, AIDS, V16, P953, DOI 10.1097/00002030-200205030-00001; King E, 2009, INTERVENTIONS IMPROV; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Kuntawee C, 2010, SE ASIAN J TROP MED, V41, P1136; Lee SJ, 2013, AIDS CARE, V25, P1536, DOI 10.1080/09540121.2013.793264; Lolekha R, 2010, JT COMM J QUAL PATIE, V36, P541, DOI 10.1016/S1553-7250(10)36082-X; Louthrenoo O, 2013, J INT ASS AIDS CARE; Lumbiganon D, 2009, ASIAN BIOMED, V3, P143; Maturo D, 2011, J PEDIATR HEALTH CAR, V25, P16, DOI 10.1016/j.pedhc.2009.12.005; Mays N, 2000, BRIT MED J, V320, P320, DOI DOI 10.1136/BMJ.320.7226.50.PUBMED:10617534; McConnell MS, 2010, JAIDS-J ACQ IMM DEF, V54, P423, DOI 10.1097/QAI.0b013e3181dc5eb0; National AIDS Prevention and Alleviation Committee UNGASS Country, 2009, NAT AIDS PREV ALL CO; National Statistical Office: Ministry of Information and Communication Technology, 2008, THAIL MULT IND CLUST; Press B, 2009, MIGRANTS HLTH VULNER; Punpanich W, 2011, J PAEDIATR CHILD H, V47, P27, DOI 10.1111/j.1440-1754.2010.01886.x; Puthanakit T, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-20; RITCHIE J, 1996, ANAL QUALITATIVE DAT; Sankar A, 2006, JAIDS-J ACQ IMM DEF, V43, pS54, DOI 10.1097/01.qai.0000248341.28309.79; Sharma N, 2013, J ASS NURSES AIDS CA; Sibanda EL, 2013, AIDS, V27, P2787, DOI 10.1097/QAD.0000000000000027; Sirinirund P, 2010, COMPREHENSIVE HIV AI; Torpey K, 2010, BMC HEALTH SERV RES, V10, P1472, DOI [10.1186/1472-6963-10-29, DOI 10.1186/1472-6963-10-29]; Voramongkol N, 2013, SE ASIAN J TROP MED, V44, P997; Weigel R, 2009, BMC PEDIATR, V9; Wolf F, 2010, J MIX METHOD RES, V4, P144, DOI 10.1177/1558689810364987; World Health Organisation, 2008, TASK SHIFT GLOB REC; World Health Organization SEARO Ministry of Public Health Thai MOPH-US CDC Collaboration Thai AIDS Society Pediatric Infectious Disease Society, 2007, SCAL ANT TREATM LESS	41	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e99061	10.1371/journal.pone.0099061	http://dx.doi.org/10.1371/journal.pone.0099061			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5ML	24893160	gold, Green Published, Green Accepted			2022-12-27	WOS:000336911400123
J	Yang, X; Yang, YM; Gan, R; Zhao, LX; Li, W; Zhou, HB; Wang, XJ; Lu, JX; Meng, QH				Yang, Xiao; Yang, Yingmei; Gan, Rong; Zhao, Lingxu; Li, Wei; Zhou, Huaibin; Wang, Xiaojuan; Lu, Jianxin; Meng, Qing H.			Down-Regulation of miR-221 and miR-222 Restrain Prostate Cancer Cell Proliferation and Migration That Is Partly Mediated by Activation of SIRT1	PLOS ONE			English	Article							COLON-CANCER; EXPRESSION; TUMORIGENESIS; MICRORNAS; CARCINOMA; GROWTH; XENOGRAFTS; INHIBITION; LINES; MICE	Studies have shown that miR-221 and miR-222 are deregulated in many cancers, including prostate cancer. Nevertheless, the biological role and the underlying mechanisms of miR-221 and miR-222 in the pathogenesis of androgen-independent prostate cancer are still not clear. The proliferation, apoptosis, cell cycle distinction, and migration capacity of prostate cells were determined following transfection of miR-221 or miR-222 inhibitor. The biological impact and regulation of SIRT1 on prostate cancer cells were investigated. MiR-221 and miR-222 were highly expressed in PC-3 cells compared with in LNCap cells. After miR-221 or miR-222 expression was inhibited, the proliferation and migration rates of PC-3 cells decreased and the apoptosis rate increased. Moreover, SIRT1 protein was up-regulated in cells after they were transfected with miR-221 or miR-222 inhibitor. Cells transfected with siSIRT1 showed increased migration and a decreased apoptosis rate, but there was no significant effect on cell proliferation compared with the controls. There was a negative correlation between miR-221 or miR-222 and SIRT1, but no direct target relationship was identified. These data demonstrate that miR-221 and miR-222 are highly expressed in PC-3 cells. Their inhibition leads to reduced cell proliferation and migration and increased apoptosis in prostate cancer cells. These effects are potentially mediated by up-regulation of SIRT1.	[Yang, Xiao; Yang, Yingmei; Gan, Rong; Zhao, Lingxu; Li, Wei; Zhou, Huaibin; Wang, Xiaojuan; Lu, Jianxin] Wenzhou Med Univ, Sch Lab Med & Life Sci, Wenzhou, Zhejiang, Peoples R China; [Li, Wei; Zhou, Huaibin; Lu, Jianxin] Minist Educ, Key Lab Lab Med, Wenzhou, Zhejiang, Peoples R China; [Li, Wei; Zhou, Huaibin; Lu, Jianxin] Zhejiang Prov Key Lab Med Genet, Wenzhou, Zhejiang, Peoples R China; [Wang, Xiaojuan] Jinhua Peoples Hosp, Dept Clin Lab Med, Jinhua, Zhejiang, Peoples R China; [Meng, Qing H.] Univ Texas MD Anderson Canc Ctr, Dept Lab Med, Houston, TX 77030 USA	Wenzhou Medical University; University of Texas System; UTMD Anderson Cancer Center	Lu, JX (corresponding author), Wenzhou Med Univ, Sch Lab Med & Life Sci, Wenzhou, Zhejiang, Peoples R China.	jxlu313@163.com; qhmeng@mdanderson.org	Lu, Jianxin/E-4485-2015; Meng, Q./GSI-6185-2022		National Natural Science Foundation of China; Zhejiang Provincial Natural Science Foundation [81170257, Y2110513]; MD Anderson Cancer Center Startup Fund	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); MD Anderson Cancer Center Startup Fund	This study was supported by grants from the National Natural Science Foundation of China and Zhejiang Provincial Natural Science Foundation (81170257 and Y2110513). This study was also partially supported by the MD Anderson Cancer Center Startup Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078023; Chen WX, 2013, TUMOR BIOL, V34, P1361, DOI 10.1007/s13277-013-0750-y; Chen Y, 2011, CANCER PREV RES, V4, P76, DOI 10.1158/1940-6207.CAPR-10-0167; Deng CX, 2009, INT J BIOL SCI, V5, P147, DOI 10.7150/ijbs.5.147; Farazi TA, 2013, ADV EXP MED BIOL, V774, P1, DOI 10.1007/978-94-007-5590-1_1; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Fu MF, 2006, MOL CELL BIOL, V26, P8122, DOI 10.1128/MCB.00289-06; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Hao JW, 2012, ONCOL REP, V27, P1504, DOI 10.3892/or.2012.1652; Jikuzono T, 2013, INT J ONCOL, V42, P1858, DOI 10.3892/ijo.2013.1879; Jung W, 2013, KOREAN J PATHOL, V47, P332, DOI 10.4132/KoreanJPathol.2013.47.4.332; Jung-Hynes B, 2009, CELL CYCLE, V8, P1478, DOI 10.4161/cc.8.10.8408; Kabra N, 2009, J BIOL CHEM, V284, P18210, DOI 10.1074/jbc.M109.000034; KIM J, 2013, NATL GEOGR, V224, P8; Kim WT, 2013, PROSTATE INT, V1, P3, DOI 10.12954/PI.12011; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lhee Sang Jae, 2012, Int J Stem Cells, V5, P125; Li Kai, 2011, N Am J Med Sci (Boston), V4, P104; Lin Zhenghong, 2013, Genes Cancer, V4, P97, DOI 10.1177/1947601912475079; Lovaas JD, 2013, PROSTATE, V73, P522, DOI 10.1002/pros.22592; Lu YZ, 2011, J BIOL CHEM, V286, P42292, DOI 10.1074/jbc.M111.270926; Lupini Laura, 2013, Frontiers in Genetics, V4, P64, DOI 10.3389/fgene.2013.00064; Mercatelli N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004029; Munker R, 2011, CLIN SCI, V121, P141, DOI 10.1042/CS20110005; Shah MY, 2011, GENOME MED, V3, DOI 10.1186/gm272; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Singh Prashant Kumar, 2013, Cancers (Basel), V5, P998, DOI 10.3390/cancers5030998; Siva AC, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-17; Srivastava A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076994; Sun T., 2013, ONCOGENE; Sun T, 2009, CANCER RES, V69, P3356, DOI 10.1158/0008-5472.CAN-08-4112; Sun T, 2009, CELL CYCLE, V8, P2315, DOI 10.4161/cc.8.15.9221; Wang RH, 2008, MOL CELL, V32, P11, DOI 10.1016/j.molcel.2008.09.011; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wozney JL, 2014, CANC METASTASIS REV; Yuan HF, 2013, ONCOTARGETS THER, V6, P1399, DOI 10.2147/OTT.S37750; Zhang CZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-367	38	35	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98833	10.1371/journal.pone.0098833	http://dx.doi.org/10.1371/journal.pone.0098833			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892674	Green Submitted, gold, Green Published			2022-12-27	WOS:000336911400098
J	Abram, NK; Xofis, P; Tzanopoulos, J; MacMillan, DC; Ancrenaz, M; Chung, R; Peter, L; Ong, R; Lackman, I; Goossens, B; Ambu, L; Knight, AT				Abram, Nicola K.; Xofis, Panteleimon; Tzanopoulos, Joseph; MacMillan, Douglas C.; Ancrenaz, Marc; Chung, Robin; Peter, Lucy; Ong, Robert; Lackman, Isabelle; Goossens, Benoit; Ambu, Laurentius; Knight, Andrew T.			Synergies for Improving Oil Palm Production and Forest Conservation in Floodplain Landscapes	PLOS ONE			English	Article							CLASSIFICATION; EXPANSION; SABAH; DEFORESTATION; CORRIDORS; EMISSIONS; STATE; CODE	Lowland tropical forests are increasingly threatened with conversion to oil palm as global demand and high profit drives crop expansion throughout the world's tropical regions. Yet, landscapes are not homogeneous and regional constraints dictate land suitability for this crop. We conducted a regional study to investigate spatial and economic components of forest conversion to oil palm within a tropical floodplain in the Lower Kinabatangan, Sabah, Malaysian Borneo. The Kinabatangan ecosystem harbours significant biodiversity with globally threatened species but has suffered forest loss and fragmentation. We mapped the oil palm and forested landscapes (using object-based-image analysis, classification and regression tree analysis and on-screen digitising of high-resolution imagery) and undertook economic modelling. Within the study region (520,269 ha), 250,617 ha is cultivated with oil palm with 77% having high Net-Present-Value (NPV) estimates ($413/ha(-yr)-$637/ha(-yr)); but 20.5% is under-producing. In fact 6.3% (15,810 ha) of oil palm is commercially redundant (with negative NPV of $-299/ha(-yr)-$-65/ha(-yr)) due to palm mortality from flood inundation. These areas would have been important riparian or flooded forest types. Moreover, 30,173 ha of unprotected forest remain and despite its value for connectivity and biodiversity 64% is allocated for future oil palm. However, we estimate that at minimum 54% of these forests are unsuitable for this crop due to inundation events. If conversion to oil palm occurs, we predict a further 16,207 ha will become commercially redundant. This means that over 32,000 ha of forest within the floodplain would have been converted for little or no financial gain yet with significant cost to the ecosystem. Our findings have globally relevant implications for similar floodplain landscapes undergoing forest transformation to agriculture such as oil palm. Understanding landscape level constraints to this crop, and transferring these into policy and practice, may provide conservation and economic opportunities within these seemingly high opportunity cost landscapes.	[Abram, Nicola K.; Tzanopoulos, Joseph; MacMillan, Douglas C.] Univ Kent, Sch Anthropol & Conservat, Durrell Inst Conservat & Ecol, Canterbury, Kent, England; [Abram, Nicola K.; Ancrenaz, Marc; Lackman, Isabelle] HUTAN Kinabatangan Orang Utan Conservat Programme, Kota Kinabalu, Sabah, Malaysia; [Abram, Nicola K.] Living Landscape Alliance, Reading, Berks, England; [Abram, Nicola K.; Ancrenaz, Marc] People & Nat Consulting Int, Borneo Futures initiat, Jakarta, Indonesia; [Xofis, Panteleimon] Technol Educ Inst Kavala, Dept Forestry & Management Nat Environm, Drama, Greece; [Ancrenaz, Marc] North England Zool Soc, Chester, Cheshire, England; [Chung, Robin] CH Williams Talhar & Wong Sabah Sdn Bhd, Sandakan, Sabah, Malaysia; [Peter, Lucy; Goossens, Benoit] Sabah Wildlife Dept, Danau Girang Field Ctr, Kota Kinabalu, Sabah, Malaysia; [Ong, Robert] Sabah Wildlife Dept, Forest Res Ctr, Sandakan, Sabah, Malaysia; [Goossens, Benoit] Cardiff Univ, Sch Biosci, Organisms & Environm Div, Cardiff CF10 3AX, S Glam, Wales; [Goossens, Benoit; Ambu, Laurentius] Sabah Wildlife Dept, Kota Kinabalu, Sabah, Malaysia; [Knight, Andrew T.] Imperial Coll London, Dept Life Sci, Ascot, Berks, England; [Knight, Andrew T.] Nelson Mandela Metrropolitan Univ, Dept Bot, Port Elizabeth, Eastern Cape, South Africa	University of Kent; People & Nature Consulting International; Pusat Penyelidikan Hutan; Cardiff University; Imperial College London; Nelson Mandela University	Abram, NK (corresponding author), Univ Kent, Sch Anthropol & Conservat, Durrell Inst Conservat & Ecol, Canterbury, Kent, England.	nicola_abram@hotmail.com	Knight, Andrew Thomas/C-8394-2009; Xofis, Panteleimon/AAG-9513-2019; MA, Lei/I-4597-2014; Abram, Nicola/K-2060-2014	Knight, Andrew Thomas/0000-0002-6563-0500; Xofis, Panteleimon/0000-0003-0528-3073; Abram, Nicola/0000-0003-1886-7297	RICS Research Trust; U.S. Fish and Wildlife Service's Great Ape Fund; Arcus Foundation; Department of Life Sciences at Imperial College London, UK; ARC Centre of Excellence in Environmental Decisions, University of Queensland, Australia	RICS Research Trust; U.S. Fish and Wildlife Service's Great Ape Fund; Arcus Foundation; Department of Life Sciences at Imperial College London, UK; ARC Centre of Excellence in Environmental Decisions, University of Queensland, Australia	NKA thanks RICS Research Trust, U.S. Fish and Wildlife Service's Great Ape Fund and the Arcus Foundation for financial support; Planet Action and Trimble for providing satellite imagery and the Definiens eCognition License. ATK acknowledges support from the Department of Life Sciences at Imperial College London, UK, and ARC Centre of Excellence in Environmental Decisions, University of Queensland, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram NK, 2013, SPATIAL PLANNING CON; Abram NK, 2013, ECOSYSTEM SERVICES; Alexander S, 2011, OPPORTUNITIES CHALLE; Ancrenaz M, 2004, ANIM CONSERV, V7, P375, DOI 10.1017/S136794300400157X; Ancrenaz M, ORYX IN PRESS; [Anonymous], SOIL SUIT MAP AGR; Benz UC, 2004, ISPRS J PHOTOGRAMM, V58, P239, DOI 10.1016/j.isprsjprs.2003.10.002; Broadbent EN, 2008, BIOL CONSERV, V141, P1745, DOI 10.1016/j.biocon.2008.04.024; Brown KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024107; Butchart SHM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032529; Butler RA, 2009, TROP CONSERV SCI, V2, P1, DOI 10.1177/194008290900200102; Carlson KM, 2012, P NATL ACAD SCI USA, V109, P7559, DOI 10.1073/pnas.1200452109; CGONY, 2019, NYERI COUNTY GOVT NY; Cowling RM, 2003, BIOL CONSERV, V112, P1, DOI 10.1016/S0006-3207(02)00418-4; CRIST EP, 1984, PHOTOGRAMM ENG REM S, V50, P343; den Besten JW, 2013, EVOLUTION REDD ANAL; Estes JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044601; FAO, 2009, FAOSTAT ONL STAT SER; Feintrenie L, 2010, SMALL-SCALE FOR, V9, P379, DOI 10.1007/s11842-010-9122-2; Fitzherbert EB, 2008, TRENDS ECOL EVOL, V23, P538, DOI 10.1016/j.tree.2008.06.012; Foody GM, 2006, REMOTE SENS ENVIRON, V103, P179, DOI 10.1016/j.rse.2006.04.001; Garcia-Ulloa J, 2012, CONSERV LETT, V5, P366, DOI 10.1111/j.1755-263X.2012.00254.x; Gilbert N., 2012, NATURE NEWS; Gillies CS, 2008, P NATL ACAD SCI USA, V105, P19774, DOI 10.1073/pnas.0803530105; Goossens B, 2005, MOL ECOL, V14, P441, DOI 10.1111/j.1365-294X.02421.x; Hai TC, 2001, BALANCING NEED SUSTA; Heumann BW, 2011, REMOTE SENS-BASEL, V3, P2440, DOI 10.3390/rs3112440; Hoh C, 2001, OIL PALM CULTIVATION; IDS, 2007, SAB DEV CORR SOC BLU; Junk W.J., 1990, P491; Knight AT, 2007, CONSERV BIOL, V21, P1124, DOI 10.1111/j.1523-1739.2007.00690.x; Knight AT, 2010, CONSERV BIOL, V24, P1348, DOI 10.1111/j.1523-1739.2010.01494.x; Koh LP, 2009, TRENDS ECOL EVOL, V24, P67, DOI 10.1016/j.tree.2008.09.006; Lackman-Ancrenaz I, 2008, KINABATANGAN BIOSPHE; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Levin J., 2012, ANAL INCREMENTAL FIN; Li HT, 2010, INT J REMOTE SENS, V31, P1453, DOI 10.1080/01431160903475266; Lindermayer DB, 2006, HABITAT FRAGMENTATIO; Malaysian Palm Oil Board (MPOB), 2012, MAL OIL PALM STAT 20; Mantel S, 2007, BIOPHYSICAL LAND SUI; McMorrow J, 2001, GLOBAL ENVIRON CHANG, V11, P217, DOI 10.1016/S0959-3780(00)00059-5; Monserud RA, 1990, METHOD COMP GLOBAL V, P90; MPOB, 2010, PALM OIL COST PROD M; MPOB, 2010, OIL PALM IND LAB ISS; Nazeeb ATM, 2008, J OIL PALM RES, P61; Ng P. H. C., 2013, Planter, V89, P409; Paterson RRM, 2009, J PHYTOPATHOL, V157, P649, DOI 10.1111/j.1439-0434.2009.01553.x; Roever CL, 2013, BIOL CONSERV, V157, P128, DOI 10.1016/j.biocon.2012.06.025; RSPO, 2013, ROUNDT SUST PALM OIL; Sabah Forestry Department, 2007, VEG ASS CLASS LOW KI; Sabah Land Ordinance, 2010, STAT SAB LAND ORD SA; Sabah State Government, 1998, SAB WAT RES EN; Sabah Wildlife Department, 2012, SABAH WILDLIFE DEP M; Sha John C.M., 2008, Primate Conservation, V23, P107, DOI 10.1896/052.023.0112; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Stark DJ, 2009, PROBOSCIS MONKEY NAS; Teoh CH, 2000, LAND USE OIL PALM IN; Tockner K, 2002, ENVIRON CONSERV, V29, P308, DOI 10.1017/S037689290200022X; United Nations Environment Programme (UNEP), 2011, OIL PALM PLANT THREA; van der Werf GR, 2009, NAT GEOSCI, V2, P737, DOI 10.1038/ngeo671; Vermeulen S., 2006, BETTER PRACTICE SMAL, V5; Wilcove DS, 2010, BIODIVERS CONSERV, V19, P999, DOI 10.1007/s10531-009-9760-x; Zavaleta ES, 2010, P NATL ACAD SCI USA, V107, P1443, DOI 10.1073/pnas.0906829107	63	55	58	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e95388	10.1371/journal.pone.0095388	http://dx.doi.org/10.1371/journal.pone.0095388			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887555	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000336956300006
J	Weitkamp, JH; Rosen, MJ; Zhao, Z; Koyama, T; Geem, D				Weitkamp, J-H; Rosen, M. J.; Zhao, Z.; Koyama, T.; Geem, D.			Small Intestinal Intraepithelial TCR gamma delta(+) T Lymphocytes Are Present in the Premature Intestine but Selectively Reduced in Surgical Necrotizing Enterocolitis (vol 9, e99042, 2014)	PLOS ONE			English	Correction													Weitkamp, Joern-Hendrik/AAZ-8272-2020; Moore, Daniel J/A-4924-2008; Denning, Patricia W/G-4485-2011; Moore, Daniel/V-6145-2019	Weitkamp, Joern-Hendrik/0000-0002-6654-4823; Moore, Daniel J/0000-0002-6889-9345; Moore, Daniel/0000-0002-6889-9345; Denning, Timothy/0000-0002-1072-7444; Rosen, Michael/0000-0002-5149-718X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059122, K08HD061607] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK090146, P30DK058404, P30DK020593, R24DK064399, K23DK094832, R21DK102058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER; NCATS NIH HHS [2 UL1 TR000445-06, UL1 TR000445] Funding Source: Medline; NCRR NIH HHS [UL1 RR024975, UL1 RR024975-01] Funding Source: Medline; NICHD NIH HHS [R01 HD059122, R01HD05922, K08HD061607, K08 HD061607] Funding Source: Medline; NIDDK NIH HHS [P30DK058404, K08 DK090146, 5K08DK090146-03, P30DK20593, R24 DK064399, R21 DK102058, P30 DK058404, K23DK094832, K23 DK094832, DK 063399, P30 DK020593] Funding Source: Medline; NIGMS NIH HHS [T32 GM008169] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Weitkamp JH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0099042, 10.1371/journal.pone.0105487]	1	31	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e105487	10.1371/journal.pone.0105487	http://dx.doi.org/10.1371/journal.pone.0105487			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	24905458	Green Submitted, gold, Green Published			2022-12-27	WOS:000339995100097
J	Endo, H; Okuyama, H; Ohue, M; Inoue, M				Endo, Hiroko; Okuyama, Hiroaki; Ohue, Masayuki; Inoue, Masahiro			Dormancy of Cancer Cells with Suppression of AKT Activity Contributes to Survival in Chronic Hypoxia	PLOS ONE			English	Article							ACTIVATION; CULTURE; OXYGEN; MECHANISMS; PHYSIOLOGY; MODELS; SYSTEM; KINASE; TARGET; GROWTH	A hypoxic microenvironment in tumors has been recognized as a cause of malignancy or resistance to various cancer therapies. In contrast to recent progress in understanding the acute response of cancer cells to hypoxia, the characteristics of tumor cells in chronic hypoxia remain elusive. We have identified a pancreatic cancer cell line, AsPC-1, that is exceptionally able to survive for weeks under 1% oxygen conditions while most tested cancer cell lines die after only some days under these conditions. In chronic hypoxia, AsPC-1 cells entered a state of dormancy characterized by no proliferation, no death, and metabolic suppression. They reversibly switched to active status after being placed again in optimal culture conditions. ATP turnover, an indicator of energy demand, was markedly decreased and accompanied by reduced AKT phosphorylation. Forced activation of AKT resulted in increased ATP turnover and massive cell death in vitro and a decreased number of dormant cells in vivo. In contrast to most cancer cell lines, primary-cultured colorectal cancer cells easily entered the dormant status with AKT suppression under hypoxia combined with growth factor-depleted conditions. Primary colorectal cancer cells in dormancy were resistant to chemotherapy. Thus, the ability to survive in a deteriorated microenvironment by entering into dormancy under chronic hypoxia might be a common property among cancer cells. Targeting the regulatory mechanism inducing this dormant status could provide a new strategy for treating cancer.	[Endo, Hiroko; Inoue, Masahiro] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Biochem, Osaka, Japan; [Okuyama, Hiroaki] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Pathol, Osaka, Japan; [Ohue, Masayuki] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Osaka, Japan	Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka Medical Center for Cancer & Cardiovascular Diseases	Inoue, M (corresponding author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Biochem, Osaka, Japan.	inoue-ma2@mc.pref.osaka.jp			KAKENHI [25461937]; Charitable Trust Osaka Cancer Researcher-Found; Japan Foundation for Applied Enzymology; Takeda Science Foundation; Naito Foundation; Grants-in-Aid for Scientific Research [25461937] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Charitable Trust Osaka Cancer Researcher-Found; Japan Foundation for Applied Enzymology; Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by KAKENHI (25461937) (www.jsps.go.jp/j-grantsinaid/, H.E., M.I.), the Charitable Trust Osaka Cancer Researcher-Found (H.E.), Japan Foundation for Applied Enzymology (www.mt-pharma.co.jp/jfae/, H.E., H.O., M.I.), Takeda Science Foundation (www.takeda-sci.or.jp/, M.I.), and The Naito Foundation (www.naito-f.or.jp/, M.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Ghiso JA, 2004, CANCER RES, V64, P7336, DOI 10.1158/0008-5472.CAN-04-0113; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Almog N, 2010, CANCER LETT, V294, P139, DOI 10.1016/j.canlet.2010.03.004; Arsham AM, 2003, J BIOL CHEM, V278, P29655, DOI 10.1074/jbc.M212770200; Berg S, 2003, CRIT CARE MED, V31, P1203, DOI 10.1097/01.CCM.0000059647.92390.92; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Dekervel J, 2014, CLIN CANCER RES, V20, P2159, DOI 10.1158/1078-0432.CCR-13-2958; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; El Touny LH, 2014, J CLIN INVEST, V124, P156, DOI 10.1172/JCI70259; Endo H, 2007, CANCER RES, V67, P8095, DOI 10.1158/0008-5472.CAN-06-3389; Endo H, 2013, J THORAC ONCOL, V8, P131, DOI 10.1097/JTO.0b013e3182779ccf; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Ghiso JAA, 1999, J CELL BIOL, V147, P89, DOI 10.1083/jcb.147.1.89; Guppy M, 1997, J CELL PHYSIOL, V170, P1, DOI 10.1002/(SICI)1097-4652(199701)170:1<1::AID-JCP1>3.0.CO;2-S; Harada H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1786; Hochachka P. W., 2002, BIOCH ADAPTATION; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jiao M, 2012, INT J ONCOL, V40, P461, DOI 10.3892/ijo.2011.1197; Kondo J, 2011, P NATL ACAD SCI USA, V108, P6235, DOI 10.1073/pnas.1015938108; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Kyle AH, 2012, CANCER RES, V72, P801, DOI 10.1158/0008-5472.CAN-11-3059; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Mardilovich K, 2009, CANCER RES, V69, P8894, DOI 10.1158/0008-5472.CAN-09-1152; Masuyama N, 2001, J BIOL CHEM, V276, P32799, DOI 10.1074/jbc.M105431200; Okuyama H, 2013, J UROLOGY, V190, P302, DOI 10.1016/j.juro.2012.12.106; Okuyama H, 2010, CANCER RES, V70, P10213, DOI 10.1158/0008-5472.CAN-10-2720; Polytarchou C, 2011, CANCER RES, V71, P4720, DOI 10.1158/0008-5472.CAN-11-0365; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Saggar JK, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00154; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Stegeman H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-463; Storey KB, 2001, MOL MECH METABOLIC; Tannock IF, 2001, CANCER METAST REV, V20, P123, DOI 10.1023/A:1013125027697; TANNOCK IF, 1968, BRIT J CANCER, V22, P258, DOI 10.1038/bjc.1968.34; Wouters BG, 2005, SEMIN CELL DEV BIOL, V16, P487, DOI 10.1016/j.semcdb.2005.03.009; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Yoshimura M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/685308	41	41	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98858	10.1371/journal.pone.0098858	http://dx.doi.org/10.1371/journal.pone.0098858			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905002	gold, Green Published, Green Submitted			2022-12-27	WOS:000341869000072
J	Gu, YH; Tao, X; Lai, XJ; Wang, HY; Zhang, YZ				Gu, Ying-Hong; Tao, Xiang; Lai, Xian-Jun; Wang, Hai-Yan; Zhang, Yi-Zheng			Exploring the Polyadenylated RNA Virome of Sweet Potato through High-Throughput Sequencing	PLOS ONE			English	Article							FEATHERY-MOTTLE-VIRUS; GENOME SEQUENCE; COAT PROTEIN; IDENTIFICATION; DISEASE; GENUS; SWEET-POTATO-VIRUS-2; DIFFERENTIATION; POTYVIRUSES; SYMPTOMS	Background: Viral diseases are the second most significant biotic stress for sweet potato, with yield losses reaching 20% to 40%. Over 30 viruses have been reported to infect sweet potato around the world, and 11 of these have been detected in China. Most of these viruses were detected by traditional detection approaches that show disadvantages in detection throughput. Next-generation sequencing technology provides a novel, high sensitive method for virus detection and diagnosis. Methodology/Principal Findings: We report the polyadenylated RNA virome of three sweet potato cultivars using a high throughput RNA sequencing approach. Transcripts of 15 different viruses were detected, 11 of which were detected in cultivar Xushu18, whilst 11 and 4 viruses were detected in Guangshu 87 and Jingshu 6, respectively. Four were detected in sweet potato for the first time, and 4 were found for the first time in China. The most prevalent virus was SPFMV, which constituted 88% of the total viral sequence reads. Virus transcripts with extremely low expression levels were also detected, such as transcripts of SPLCV, CMV and CymMV. Digital gene expression (DGE) and reverse transcription polymerase chain reaction (RT-PCR) analyses showed that the highest viral transcript expression levels were found in fibrous and tuberous roots, which suggest that these tissues should be optimum samples for virus detection. Conclusions/Significance: A total of 15 viruses were presumed to present in three sweet potato cultivars growing in China. This is the first insight into the sweet potato polyadenylated RNA virome. These results can serve as a basis for further work to investigate whether some of the 'new' viruses infecting sweet potato are pathogenic.	[Gu, Ying-Hong; Lai, Xian-Jun; Wang, Hai-Yan; Zhang, Yi-Zheng] Sichuan Univ, Key Lab Bioresources & Ecoenvironm, Sichuan Key Lab Mol Biol & Biotechnol, Coll Life Sci,Minist Educ,Ctr Funct Genom & Bioin, Chengdu 610064, Sichuan, Peoples R China; [Tao, Xiang] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China	Sichuan University; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS	Zhang, YZ (corresponding author), Sichuan Univ, Key Lab Bioresources & Ecoenvironm, Sichuan Key Lab Mol Biol & Biotechnol, Coll Life Sci,Minist Educ,Ctr Funct Genom & Bioin, Chengdu 610064, Sichuan, Peoples R China.	yizzhang@scu.edu.cn	GU, Yinghong/D-2433-2010	GU, Yinghong/0000-0002-9364-1389	National Science & Technology Pillar Program of China [2007BAD78B03]; "Eleven-Five" Key Project of Sichuan Province [07SG111-003-1]	National Science & Technology Pillar Program of China; "Eleven-Five" Key Project of Sichuan Province	This work was financially supported by the National Science & Technology Pillar Program of China (No. 2007BAD78B03) and the "Eleven-Five" Key Project of Sichuan Province (No. 07SG111-003-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Rwahnih M, 2009, VIROLOGY, V387, P395, DOI 10.1016/j.virol.2009.02.028; Aritua V, 1998, ANN APPL BIOL, V132, P387, DOI 10.1111/j.1744-7348.1998.tb05216.x; Ateka EM, 2007, ARCH VIROL, V152, P479, DOI 10.1007/s00705-006-0879-8; Ateka EM, 2004, ANN APPL BIOL, V144, P371, DOI 10.1111/j.1744-7348.2004.tb00353.x; Ateka EM, 2004, ARCH VIROL, V149, P225, DOI 10.1007/s00705-003-0233-3; Chen XuanYang, 2001, Journal of Fujian Agricultural University, V30, P449; Chiba S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002146; Clark CA, 2012, PLANT DIS, V96, P168, DOI 10.1094/PDIS-07-11-0550; Clark CA, 2010, HORTTECHNOLOGY, V20, P977, DOI 10.21273/HORTSCI.20.6.977; Coetzee B, 2010, VIROLOGY, V400, P157, DOI 10.1016/j.virol.2010.01.023; COLINET D, 1993, J VIROL METHODS, V45, P149, DOI 10.1016/0166-0934(93)90099-D; Colinet D, 1996, AGRO FOOD IND HI TEC, V7, P33; Colinet D, 1997, VIRUS RES, V49, P91, DOI 10.1016/S0168-1702(97)01456-1; Colinet D, 1998, PLANT DIS, V82, P223, DOI 10.1094/PDIS.1998.82.2.223; de VRIES C. A., 1967, NETH J AGR SCI, V15, P241; Du XiHua, 1999, Plant Physiology Communications, V35, P185; Firon N., 2009, P13, DOI 10.1007/978-1-4020-9475-0_3; Gao F, 2000, CROP PROT, V19, P105, DOI 10.1016/S0261-2194(99)00085-X; GEDDES AMW, 1990, RELATIVE IMPORTANCE; Gibbs A, 1997, J VIROL METHODS, V63, P9, DOI 10.1016/S0166-0934(96)02103-9; Gibson RW, 1998, PLANT PATHOL, V47, P95, DOI 10.1046/j.1365-3059.1998.00196.x; Karyeija RF, 1998, PLANT DIS, V82, P4, DOI 10.1094/PDIS.1998.82.1.4; Khan MB, 2012, J ANIM PLANT SCI, V22, P309; Kokkinos CD, 2006, PLANT DIS, V90, P783, DOI 10.1094/PD-90-0783; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; Kreuze JF, 2000, ARCH VIROL, V145, P567, DOI 10.1007/s007050050047; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li F, 2012, J VIROL METHODS, V186, P161, DOI 10.1016/j.jviromet.2012.07.021; Li F, 2012, VIRUS GENES, V45, P118, DOI 10.1007/s11262-012-0749-2; Loebenstein G., 2009, P105, DOI 10.1007/978-1-4020-9475-0_8; Luan YS, 2006, PLANT DIS, V90, P1111, DOI 10.1094/PD-90-1111C; Ma CJ, 2012, BIODEGRADATION, V23, P907, DOI 10.1007/s10532-012-9583-4; Mbanzibwa DR, 2012, PLANT DIS, V96, P1430; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NIE F, 2000, CHINESE AGR SCI B, V16, P13; OBRIEN PJ, 1972, AM ANTHROPOL, V74, P342, DOI 10.1525/aa.1972.74.3.02a00070; Perez-Egusquiza Z, 2009, PLANT DIS, V93, P427, DOI 10.1094/PDIS-93-4-0427B; Qiao Q, 2011, PLANT DIS, V95, P356, DOI 10.1094/PDIS-09-10-0675; SCHAEFERS GA, 1976, PHYTOPATHOLOGY, V66, P642, DOI 10.1094/Phyto-66-642; Srinivas T., 2009, P235, DOI 10.1007/978-1-4020-9475-0_12; Stathers T., 2005, MANUAL SWEETPOTATO I, P168; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tao X, 2013, BIOSCI BIOTECH BIOCH, V77, P2169, DOI 10.1271/bbb.130218; Tao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036234; Trenado HP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027329; Valverde RA., 2007, PLANT VIRUSES, V1, P116; Varshney RK, 2010, TRENDS BIOTECHNOL, V28, P452, DOI 10.1016/j.tibtech.2010.06.007; Wang QM, 2010, CROP PROT, V29, P110, DOI 10.1016/j.cropro.2009.11.002; Wang RL, 2008, ARCH VIROL, V153, P1765, DOI 10.1007/s00705-008-0180-0; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Xie FL, 2012, PLANTA, V236, P101, DOI 10.1007/s00425-012-1591-4; Yang ChongLiang, 1998, Acta Phytophylacica Sinica, V25, P51; Zhang L., 2009, P325, DOI 10.1007/978-1-4020-9475-0_15; Zhang LM, 2006, ACTA HORTIC, P71; Zhang LiMing, 2005, Acta Botanica Boreali-Occidentalia Sinica, V25, P316; Zhang Yu-qi, 2005, Chinese Journal of Medical Imaging Technology, V21, P74	57	19	27	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98884	10.1371/journal.pone.0098884	http://dx.doi.org/10.1371/journal.pone.0098884			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901789	Green Published, Green Submitted, gold			2022-12-27	WOS:000336841400066
J	Olivares, MJ; Gonzalez-Jamett, AM; Guerra, MJ; Baez-Matus, X; Haro-Acuna, V; Martinez-Quiles, N; Cardenas, AM				Jose Olivares, Maria; Gonzalez-Jamett, Arlek M.; Jose Guerra, Maria; Baez-Matus, Ximena; Haro-Acuna, Valentina; Martinez-Quiles, Narcisa; Cardenas, Ana M.			Src Kinases Regulate De Novo Actin Polymerization during Exocytosis in Neuroendocrine Chromaffin Cells	PLOS ONE			English	Article							PROTEIN-TYROSINE KINASE; FUSION PORE EXPANSION; N-WASP; FAMILY KINASES; CORTICAL ACTIN; F-ACTIN; C-SRC; CORTACTIN; PHOSPHORYLATION; DYNAMICS	The cortical actin network is dynamically rearranged during secretory processes. Nevertheless, it is unclear how de novo actin polymerization and the disruption of the preexisting actin network control transmitter release. Here we show that in bovine adrenal chromaffin cells, both formation of new actin filaments and disruption of the preexisting cortical actin network are induced by Ca2+ concentrations that trigger exocytosis. These two processes appear to regulate different stages of exocytosis; whereas the inhibition of actin polymerization with the N-WASP inhibitor wiskostatin restricts fusion pore expansion, thus limiting the release of transmitters, the disruption of the cortical actin network with cytochalasin D increases the amount of transmitter released per event. Further, the Src kinase inhibitor PP2, and cSrc SH2 and SH3 domains also suppress Ca2+-dependent actin polymerization, and slow down fusion pore expansion without disturbing the cortical Factin organization. Finally, the isolated SH3 domain of c-Src prevents both the disruption of the actin network and the increase in the quantal release induced by cytochalasin D. These findings support a model where a rise in the cytosolic Ca2+ triggers actin polymerization through a mechanism that involves Src kinases. The newly formed actin filaments would speed up the expansion of the initial fusion pore, whereas the preexisting actin network might control a different step of the exocytosis process.	[Jose Olivares, Maria; Gonzalez-Jamett, Arlek M.; Jose Guerra, Maria; Baez-Matus, Ximena; Haro-Acuna, Valentina; Cardenas, Ana M.] Univ Valparaiso, Fac Ciencias, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso, Chile; [Martinez-Quiles, Narcisa] Univ Complutense Madrid, Fac Med, Dept Microbiol Inmunol, Madrid, Spain	Universidad de Valparaiso; Complutense University of Madrid	Cardenas, AM (corresponding author), Univ Valparaiso, Fac Ciencias, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso, Chile.	ana.cardenas@uv.cl	Martinez-Quiles, Narcisa/G-8514-2013	Martinez Quiles, Narcisa/0000-0002-0366-6591; Baez-Matus, Ximena/0000-0002-4176-0239	ICM-ECONOMIA, Chile [FONDECYT 1110552, P09-022-F]	ICM-ECONOMIA, Chile	This work has been supported by grants FONDECYT 1110552 and P09-022-F from ICM-ECONOMIA, Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; Allen CM, 1996, J NEUROSCI RES, V44, P421, DOI 10.1002/(SICI)1097-4547(19960601)44:5<421::AID-JNR2>3.0.CO;2-H; Ardiles AO, 2007, J NEUROCHEM, V103, P1574, DOI 10.1111/j.1471-4159.2007.04871.x; Ardiles AO, 2006, J NEUROCHEM, V99, P29, DOI 10.1111/j.1471-4159.2006.04080.x; Berberian K, 2009, J NEUROSCI, V29, P863, DOI 10.1523/JNEUROSCI.2818-08.2009; Cao H, 2010, MOL CELL BIOL, V30, P781, DOI 10.1128/MCB.00330-09; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; De Corte V, 1999, PROTEIN SCI, V8, P234; Doreian BW, 2008, J NEUROSCI, V28, P4470, DOI 10.1523/JNEUROSCI.0008-08.2008; Egea G, 2006, CURR OPIN CELL BIOL, V18, P168, DOI 10.1016/j.ceb.2006.02.007; Elhamdani A, 2001, NEURON, V31, P819, DOI 10.1016/S0896-6273(01)00418-4; Engen JR, 2008, CELL MOL LIFE SCI, V65, P3058, DOI 10.1007/s00018-008-8122-2; Finkelstein M, 2010, J BIOL CHEM, V285, P39702, DOI 10.1074/jbc.M110.170951; Garcia-Palomero E, 2000, J NEUROCHEM, V74, P1049, DOI 10.1046/j.1471-4159.2000.0741049.x; Gasman S, 2004, MOL BIOL CELL, V15, P520, DOI 10.1091/mbc.E03-06-0402; Giner D, 2005, J CELL SCI, V118, P2871, DOI 10.1242/jcs.02419; Gonzalez-Jamett Arlek M, 2013, Front Endocrinol (Lausanne), V4, P126, DOI 10.3389/fendo.2013.00126; Gonzalez-Jamett AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070638; Guerriero CJ, 2007, AM J PHYSIOL-CELL PH, V292, pC1562, DOI 10.1152/ajpcell.00426.2006; Helgeson LA, 2013, ELIFE, V2, DOI 10.7554/eLife.00884; Lindau M, 2003, BBA-MOL CELL RES, V1641, P167, DOI 10.1016/S0167-4889(03)00085-5; Malacombe M, 2006, BBA-MOL CELL RES, V1763, P1175, DOI 10.1016/j.bbamcr.2006.09.004; Martinez-Quiles N, 2004, MOL CELL BIOL, V24, P5269, DOI 10.1128/MCB.24.12.5269-5280.2004; Monteiro ANA, 2006, BIOCHIMIE, V88, P905, DOI 10.1016/j.biochi.2006.01.013; Neco P, 2008, J BIOL CHEM, V283, P10949, DOI 10.1074/jbc.M709058200; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; PARSONS SJ, 1986, BIOCHEM BIOPH RES CO, V134, P736, DOI 10.1016/S0006-291X(86)80482-X; Pene TD, 2005, J NEUROCHEM, V92, P780, DOI 10.1111/j.1471-4159.2004.02907.x; Peterson JR, 2004, NAT STRUCT MOL BIOL, V11, P747, DOI 10.1038/nsmb796; Rusanescu G, 1995, NEURON, V15, P1415, DOI 10.1016/0896-6273(95)90019-5; Samasilp P, 2012, J NEUROSCI, V32, P10438, DOI 10.1523/JNEUROSCI.1299-12.2012; Schroeder TJ, 1996, BIOPHYS J, V70, P1061, DOI 10.1016/S0006-3495(96)79652-2; Sever S, 2013, TRAFFIC, V14, P1194, DOI 10.1111/tra.12116; Singh VP, 2008, MOL BIOL CELL, V19, P2339, DOI 10.1091/mbc.E07-11-1130; Siton O, 2011, CURR BIOL, V21, P2092, DOI 10.1016/j.cub.2011.11.010; Tatosyan AG, 2000, BIOCHEMISTRY-MOSCOW+, V65, P49; Tehrani S, 2007, P NATL ACAD SCI USA, V104, P11933, DOI 10.1073/pnas.0701077104; Tomatis VM, 2013, J CELL BIOL, V200, P301, DOI 10.1083/jcb.201204092; Torres E, 2006, J BIOL CHEM, V281, P3513, DOI 10.1074/jbc.M509416200; Trifaro JM, 2000, NEUROCHEM RES, V25, P133, DOI 10.1023/A:1007503919265; VITALE N, 1993, J BIOL CHEM, V268, P14715; Wang K, 2004, J BIOL CHEM, V279, P8779, DOI 10.1074/jbc.M309652200; Wang SJ, 2003, NEUROREPORT, V14, P1519, DOI 10.1097/00001756-200308060-00024; Weaver AM, 2002, CURR BIOL, V12, P1270, DOI 10.1016/S0960-9822(02)01035-7; Wijetunge S, 2000, BRIT J PHARMACOL, V129, P1347, DOI 10.1038/sj.bjp.0703186; Wollman R, 2012, NAT CELL BIOL, V14, P1261, DOI 10.1038/ncb2614; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417; Yamada H, 2013, J NEUROSCI, V33, P4514, DOI 10.1523/JNEUROSCI.2762-12.2013; Yoo Y, 2010, ONCOGENE, V29, P263, DOI 10.1038/onc.2009.319; Zhang ZT, 2013, J CELL BIOCHEM, V114, P144, DOI 10.1002/jcb.24311; ZHAO YH, 1992, P NATL ACAD SCI USA, V89, P8298, DOI 10.1073/pnas.89.17.8298; Zhou Z, 1996, BIOPHYS J, V70, P1543, DOI 10.1016/S0006-3495(96)79718-7	53	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99001	10.1371/journal.pone.0099001	http://dx.doi.org/10.1371/journal.pone.0099001			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901433	gold, Green Submitted, Green Published			2022-12-27	WOS:000336841400085
J	Marshall, SM; Gromovsky, AD; Kelley, KL; Davis, MA; Wilson, MD; Lee, RG; Crooke, RM; Graham, MJ; Rudel, LL; Brown, JM; Temel, RE				Marshall, Stephanie M.; Gromovsky, Anthony D.; Kelley, Kathryn L.; Davis, Matthew A.; Wilson, Martha D.; Lee, Richard G.; Crooke, Rosanne M.; Graham, Mark J.; Rudel, Lawrence L.; Brown, J. Mark; Temel, Ryan E.			Acute Sterol O-Acyltransferase 2 (SOAT2) Knockdown Rapidly Mobilizes Hepatic Cholesterol for Fecal Excretion	PLOS ONE			English	Article							APOLIPOPROTEIN-E; ACYL-COENZYME; DENSITY-LIPOPROTEIN; HEART-DISEASE; ACAT2; BILIARY; ESTER; LIVER; LDL; ATHEROSCLEROSIS	The primary risk factor for atherosclerotic cardiovascular disease is LDL cholesterol, which can be reduced by increasing cholesterol excretion from the body. Fecal cholesterol excretion can be driven by a hepatobiliary as well as a non-biliary pathway known as transintestinal cholesterol efflux (TICE). We previously showed that chronic knockdown of the hepatic cholesterol esterifying enzyme sterol O-acyltransferase 2 (SOAT2) increased fecal cholesterol loss via TICE. To elucidate the initial events that stimulate TICE, C57Bl/6 mice were fed a high cholesterol diet to induce hepatic cholesterol accumulation and were then treated for 1 or 2 weeks with an antisense oligonucleotide targeting SOAT2. Within 2 weeks of hepatic SOAT2 knockdown (SOAT2(HKD)), the concentration of cholesteryl ester in the liver was reduced by 70% without a reciprocal increase in hepatic free cholesterol. The rapid mobilization of hepatic cholesterol stores resulted in a similar to 2-fold increase in fecal neutral sterol loss but no change in biliary cholesterol concentration. Acute SOAT2(HKD) increased plasma cholesterol carried primarily in lipoproteins enriched in apoB and apoE. Collectively, our data suggest that acutely reducing SOAT2 causes hepatic cholesterol to be swiftly mobilized and packaged onto nascent lipoproteins that feed cholesterol into the TICE pathway for fecal excretion.	[Marshall, Stephanie M.; Kelley, Kathryn L.; Davis, Matthew A.; Wilson, Martha D.; Rudel, Lawrence L.; Brown, J. Mark; Temel, Ryan E.] Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, Sect Lipid Sci, Winston Salem, NC 27103 USA; [Lee, Richard G.; Crooke, Rosanne M.; Graham, Mark J.] ISIS Pharmaceut, Cardiovasc Grp, Antisense Drug Discovery, Carlsbad, CA 92008 USA; [Gromovsky, Anthony D.; Brown, J. Mark] Cleveland Clin Fdn, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Temel, Ryan E.] Univ Kentucky, Saha Cardiovasc Res Ctr, Lexington, KY USA	Wake Forest University; Wake Forest Baptist Medical Center; Isis Pharmaceuticals Inc; Cleveland Clinic Foundation; University of Kentucky	Brown, JM (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, Sect Lipid Sci, Winston Salem, NC 27103 USA.	brownm5@ccf.org; ryan.temel@uky.edu			National Heart, Lung, and Blood Institute of the National Institutes of Health [P01-HL049373, K99/R00-HL096166, K99/R00-HL088528]; Isis Pharmaceuticals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL096166, P01HL049373, K99HL088528] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Isis Pharmaceuticals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Heart, Lung, and Blood Institute of the National Institutes of Health (http://www.nhlbi.nih.gov/) funded this work through the following awards: P01-HL049373 to LLR, K99/R00-HL096166 to JMB, and K99/R00-HL088528 to RET. Co authors RMC, RGL, and MJG are employees of and have ownership interest in Isis Pharmaceuticals. Isis Pharmaceuticals provided support in the form of salaries for authors RMC, RGL, and MJG, but did not have any additional role in the study design, data collection and analysis, or decision to publish. The specific roles of these authors are articulated in the 'author contributions' section.	Alger HM, 2010, J BIOL CHEM, V285, P14267, DOI 10.1074/jbc.M110.118422; Bell TA, 2007, ARTERIOSCL THROM VAS, V27, P1396, DOI 10.1161/ATVBAHA.107.142802; Bell TA, 2006, ARTERIOSCL THROM VAS, V26, P1814, DOI 10.1161/01.ATV.0000225289.30767.06; Besseling J, 2013, DRUGS, V73, P293, DOI 10.1007/s40265-013-0028-0; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown JM, 2008, J BIOL CHEM, V283, P10522, DOI 10.1074/jbc.M707659200; Brufau G, 2011, ARTERIOSCL THROM VAS, V31, P1726, DOI 10.1161/ATVBAHA.108.181206; Buhman KK, 2000, NAT MED, V6, P1341, DOI 10.1038/82153; CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; Furbee JW, 2002, J LIPID RES, V43, P428; Gilham D, 2004, REV ENDOCR METAB DIS, V5, P303, DOI 10.1023/B:REMD.0000045101.42431.c7; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; GOODMAN DS, 1965, PHYSIOL REV, V45, P747, DOI 10.1152/physrev.1965.45.4.747; Jiang XC, 2003, J BIOL CHEM, V278, P49072, DOI 10.1074/jbc.M304274200; Le May Cedric, 2013, Arterioscler Thromb Vasc Biol, V33, P1484, DOI 10.1161/ATVBAHA.112.300263; Lee RG, 2005, J LIPID RES, V46, P1205, DOI 10.1194/jlr.M500018-JLR200; Lee RG, 2004, CIRC RES, V95, P998, DOI 10.1161/01.RES.0000147558.15554.67; Melchior JT, 2013, J LIPID RES, V54, P2495, DOI 10.1194/jlr.M039644; Nguyen TM, 2012, J LIPID RES, V53, P95, DOI 10.1194/jlr.M018820; Ohshiro T, 2011, ARTERIOSCL THROM VAS, V31, P1108, DOI 10.1161/ATVBAHA.111.223552; Ouimet M, 2011, CELL METAB, V13, P655, DOI 10.1016/j.cmet.2011.03.023; Parini P, 2004, CIRCULATION, V110, P2017, DOI 10.1161/01.CIR.0000143163.76212.0B; Rayner KJ, 2011, NATURE, V478, P404, DOI 10.1038/nature10486; Repa JJ, 2004, HEPATOLOGY, V40, P1088, DOI 10.1002/hep.20439; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Robinet P, 2013, ARTERIOSCL THROM VAS, V33, P903, DOI 10.1161/ATVBAHA.112.301041; Rudel LL, 2005, ARTERIOSCL THROM VAS, V25, P1112, DOI 10.1161/01.ATV.0000166548.65753.1e; Temel RE, 2005, J LIPID RES, V46, P2423, DOI 10.1194/jlr.M500232-JLR200; Temel RE, 2007, J CLIN INVEST, V117, P1968, DOI 10.1172/JCI30060; Temel RE, 2007, J LIPID RES, V48, P1618, DOI 10.1194/jlr.M700109-JLR200; Temel RE, 2012, CURR OPIN LIPIDOL, V23, P85, DOI 10.1097/MOL.0b013e3283508c21; Temel RE, 2010, CELL METAB, V12, P96, DOI 10.1016/j.cmet.2010.05.011; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; van der Veen JN, 2009, J BIOL CHEM, V284, P19211, DOI 10.1074/jbc.M109.014860; Vrins CLJ, 2012, J LIPID RES, V53, P2017, DOI 10.1194/jlr.M022194; Wei EH, 2010, CELL METAB, V11, P183, DOI 10.1016/j.cmet.2010.02.005; Willner EL, 2003, P NATL ACAD SCI USA, V100, P1262, DOI 10.1073/pnas.0336398100; Zhang J, 2012, J LIPID RES, V53, P1144, DOI 10.1194/jlr.M024356	39	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98953	10.1371/journal.pone.0098953	http://dx.doi.org/10.1371/journal.pone.0098953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901470	Green Published, gold, Green Submitted			2022-12-27	WOS:000336841400078
J	Park, SK; Tao, YB; Meeker, JD; Harlow, SD; Mukherjee, B				Park, Sung Kyun; Tao, Yebin; Meeker, John D.; Harlow, Sioban D.; Mukherjee, Bhramar			Environmental Risk Score as a New Tool to Examine Multi-Pollutants in Epidemiologic Research: An Example from the NHANES Study Using Serum Lipid Levels	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; PARTICULATE AIR-POLLUTION; DAILY MORTALITY; BLOOD-PRESSURE; SYSTEMATIC EVALUATION; ATHEROSCLEROSIS RISK; EXPOSURE MEASUREMENT; WIDE ASSOCIATION; ODDS RATIO; PREDICTION	Objective: A growing body of evidence suggests that environmental pollutants, such as heavy metals, persistent organic pollutants and plasticizers play an important role in the development of chronic diseases. Most epidemiologic studies have examined environmental pollutants individually, but in real life, we are exposed to multi-pollutants and pollution mixtures, not single pollutants. Although multi-pollutant approaches have been recognized recently, challenges exist such as how to estimate the risk of adverse health responses from multi-pollutants. We propose an "Environmental Risk Score (ERS)" as a new simple tool to examine the risk of exposure to multi-pollutants in epidemiologic research. Methods and Results: We examined 134 environmental pollutants in relation to serum lipids (total cholesterol, high-density lipoprotein cholesterol (HDL), low-density lipoprotein cholesterol (LDL) and triglycerides) using data from the National Health and Nutrition Examination Survey between 1999 and 2006. Using a two-stage approach, stage-1 for discovery (n = 10818) and stage-2 for validation (n = 4615), we identified 13 associated pollutants for total cholesterol, 9 for HDL, 5 for LDL and 27 for triglycerides with adjustment for sociodemographic factors, body mass index and serum nutrient levels. Using the regression coefficients (weights) from joint analyses of the combined data and exposure concentrations, ERS were computed as a weighted sum of the pollutant levels. We computed ERS for multiple lipid outcomes examined individually (single-phenotype approach) or together (multi-phenotype approach). Although the contributions of ERS to overall risk predictions for lipid outcomes were modest, we found relatively stronger associations between ERS and lipid outcomes than with individual pollutants. The magnitudes of the observed associations for ERS were comparable to or stronger than those for socio-demographic factors or BMI. Conclusions: This study suggests ERS is a promising tool for characterizing disease risk from multi-pollutant exposures. This new approach supports the need for moving from a single-pollutant to a multi-pollutant framework.	[Park, Sung Kyun; Harlow, Sioban D.] Univ Michigan, Dept Epidemiol, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Park, Sung Kyun; Meeker, John D.] Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA; [Tao, Yebin; Mukherjee, Bhramar] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Park, SK (corresponding author), Univ Michigan, Dept Epidemiol, Sch Publ Hlth, Ann Arbor, MI 48109 USA.	sungkyun@umich.edu		Park, Sung Kyun/0000-0001-9981-6250; Meeker, John/0000-0001-8357-5085	NIEHS (National Institute of Environmental Health Sciences) [ES20811, K01-ES016587, R01-ES021465, P01-ES022844]; NIEHS [P30-ES017885, P42-ES017198]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092926, P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES020811, P01ES022844, P42ES017198, R01ES021465, P30ES017885, K01ES016587] Funding Source: NIH RePORTER	NIEHS (National Institute of Environmental Health Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The research was supported by NIEHS (National Institute of Environmental Health Sciences) grant ES20811 (BM), and K01-ES016587 (SKP), and R01-ES021465 and P01-ES022844 (JDM). Additional support was provided by NIEHS Grant P30-ES017885 entitled "Lifestage Exposure and Adult Disease'' and NIEHS Grant P42-ES017198. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bair E, 2006, J AM STAT ASSOC, V101, P119, DOI 10.1198/016214505000000628; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Billionnet C, 2012, ANN EPIDEMIOL, V22, P126, DOI 10.1016/j.annepidem.2011.11.004; Billionnet C, 2011, ENVIRON RES, V111, P425, DOI 10.1016/j.envres.2011.02.008; Bobb JF, 2013, APPL STAT, V62; Boonstra PS, 2013, BIOSTATISTICS, V14, P259, DOI 10.1093/biostatistics/kxs036; Brautbar A, 2012, ATHEROSCLEROSIS, V223, P421, DOI 10.1016/j.atherosclerosis.2012.05.035; Brunekreef B, 2013, ENVIRON MOL MUTAGEN, V54, P596, DOI 10.1002/em.21767; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Chatterjee N, 2013, NAT GENET, V45, P400, DOI 10.1038/ng.2579; Clougherty JE, 2010, ENVIRON HEALTH PERSP, V118, P167, DOI 10.1289/ehp.0900994; Cole SR, 2009, INT J EPIDEMIOL, V38, P1674, DOI 10.1093/ije/dyp269; Derks EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037852; Dominici F, 2010, EPIDEMIOLOGY, V21, P187, DOI 10.1097/EDE.0b013e3181cc86e8; Garcia-Closas M, 2013, CANCER RES, V73, P2211, DOI 10.1158/0008-5472.CAN-12-2388; Gibson G, 2010, NAT GENET, V42, P558, DOI 10.1038/ng0710-558; Guallar E, 2002, NEW ENGL J MED, V347, P1747, DOI 10.1056/NEJMoa020157; Hammond E C, 1979, Ann N Y Acad Sci, V330, P473, DOI 10.1111/j.1749-6632.1979.tb18749.x; Hicken MT, 2013, ENVIRON HEALTH PERSP, V121, P205, DOI 10.1289/ehp.1104517; Hong YC, 1999, ENVIRON HEALTH PERSP, V107, P873, DOI 10.2307/3454474; Janssens ACJW, 2011, EUR J HUM GENET, V19, DOI 10.1038/ejhg.2011.27; Janssens ACJW, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000420; Johns DO, 2012, ENVIRON HEALTH PERSP, V120, P1238, DOI 10.1289/ehp.1204939; Kim S, 2009, BIOINFORMATICS, V25, pI204, DOI 10.1093/bioinformatics/btp218; Laden F, 2000, ENVIRON HEALTH PERSP, V108, P941, DOI 10.2307/3435052; Lind PM, 2013, ENVIRON INT, V55, P1, DOI 10.1016/j.envint.2013.01.017; Louis GMB, 2012, STAT MED, V31, P2569, DOI 10.1002/sim.5496; MADIGAN D, 1994, J AM STAT ASSOC, V89, P1535, DOI 10.2307/2291017; Mauderly JL, 2009, ENVIRON HEALTH PERSP, V117, P1, DOI 10.1289/ehp.11654; Mondul AM, 2013, CANCER EPIDEM BIOMAR, V22, P688, DOI 10.1158/1055-9965.EPI-13-0007-T; Morrison AC, 2007, AM J EPIDEMIOL, V166, P28, DOI 10.1093/aje/kwm060; National Institutes of Health National Heart Lung and Blood Institute, 2001, 3 NCEP NIH US DEP HL; Nie L, 2010, EPIDEMIOLOGY, V21, pS17, DOI 10.1097/EDE.0b013e3181ce97d8; O'Reilly PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034861; Ostro B, 2011, ENVIRON HEALTH PERSP, V119, P1781, DOI 10.1289/ehp.1103618; Park SK, 2008, AM J RESP CRIT CARE, V178, P283, DOI 10.1164/rccm.200708-1286OC; Park SK, 2007, J EXPO SCI ENV EPID, V17, P488, DOI 10.1038/sj.jes.7500552; Patel CJ, 2013, INT J EPIDEMIOL, V42, P1795, DOI 10.1093/ije/dyt208; Patel CJ, 2012, INT J EPIDEMIOL, V41, P828, DOI 10.1093/ije/dys003; Patel CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010746; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Porta M, 2012, ENVIRON INT, V44, P106, DOI 10.1016/j.envint.2012.02.005; Qian ZM, 2004, INT J EPIDEMIOL, V33, P582, DOI 10.1093/ije/dyg278; Raghunathan T. E., 2002, IVEWARE IMPUTATION V; Raghunathan TE, 2001, SURV METHODOL, V27, P85; Rappaport SM, 2011, J EXPO SCI ENV EPID, V21, P5, DOI 10.1038/jes.2010.50; Rappaport SM, 2010, SCIENCE, V330, P460, DOI 10.1126/science.1192603; Rhomberg LR, 2012, REGUL TOXICOL PHARM, V64, P130, DOI 10.1016/j.yrtph.2012.06.015; Roberts S, 2005, ATMOS ENVIRON, V39, P6223, DOI 10.1016/j.atmosenv.2005.07.004; Roberts S, 2006, ENVIRON HEALTH PERSP, V114, P1877, DOI 10.1289/ehp.9226; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Samet JM, 2001, AM J RESP CRIT CARE, V164, P819, DOI 10.1164/ajrccm.164.5.2008003; SARACCI R, 1977, INT J CANCER, V20, P323, DOI 10.1002/ijc.2910200302; Sarnat SE, 2006, OCCUP ENVIRON MED, V63, P700, DOI 10.1136/oem.2006.027292; Satagopan JM, 2002, BIOMETRICS, V58, P163, DOI 10.1111/j.0006-341X.2002.00163.x; Scinicariello F, 2011, ENVIRON RES, V111, P1249, DOI 10.1016/j.envres.2011.08.011; Silver MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026868; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Stephens M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065245; Stern AH, 2011, ENVIRON HEALTH PERSP, V119, P1043, DOI 10.1289/ehp.1002824; Sun ZC, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-85; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tong HY, 2012, ENVIRON HEALTH PERSP, V120, P952, DOI 10.1289/ehp.1104472; Tzoulaki I, 2012, CIRCULATION, V126, P2456, DOI 10.1161/CIRCULATIONAHA.112.114058; Vahter M, 2007, ENVIRON RES, V104, P85, DOI 10.1016/j.envres.2006.08.003; van Meurs JBJ, 2013, AM J CLIN NUTR, V98, P668, DOI 10.3945/ajcn.112.044545; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Vupputuri S, 2003, HYPERTENSION, V41, P463, DOI 10.1161/01.HYP.0000055015.39788.29; Wild CP, 2012, INT J EPIDEMIOL, V41, P24, DOI 10.1093/ije/dyr236; Wild CP, 2005, CANCER EPIDEM BIOMAR, V14, P1847, DOI 10.1158/1055-9965.EPI-05-0456; Willems SM, 2011, CURR DIABETES REP, V11, P511, DOI 10.1007/s11892-011-0235-6; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Zeger SL, 2000, ENVIRON HEALTH PERSP, V108, P419, DOI 10.2307/3454382; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735; Zou H, 2009, ANN STAT, V37, P1733, DOI 10.1214/08-AOS625	77	38	39	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98632	10.1371/journal.pone.0098632	http://dx.doi.org/10.1371/journal.pone.0098632			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901996	Green Submitted, Green Published, gold			2022-12-27	WOS:000336841400040
J	Coeur d'acier, A; Cruaud, A; Artige, E; Genson, G; Clamens, AL; Pierre, E; Hudaverdian, S; Simon, JC; Jousselin, E; Rasplus, JY				Coeur d'acier, Armelle; Cruaud, Astrid; Artige, Emmanuelle; Genson, Gwenaelle; Clamens, Anne-Laure; Pierre, Eric; Hudaverdian, Sylvie; Simon, Jean-Christophe; Jousselin, Emmanuelle; Rasplus, Jean-Yves			DNA Barcoding and the Associated PhylAphidB@se Website for the Identification of European Aphids (Insecta: Hemiptera: Aphididae)	PLOS ONE			English	Article							SYMPATRIC HOST RACES; REPRODUCTIVE ISOLATION; PEA APHIDS; COMPLEX; BRACHYCAUDUS; HOMOPTERA; BUCHNERA; DIFFERENTIATION; PHYLOGENETICS; AMPLIFICATION	Aphids constitute a diverse group of plant-feeding insects and are among the most important crop pests in temperate regions. Their morphological identification is time-consuming and requires specific knowledge, training and skills that may take years to acquire. We assessed the advantages and limits of DNA barcoding with the standard COI barcode fragment for the identification of European aphids. We constructed a large reference dataset of barcodes from 1020 specimens belonging to 274 species and 87 genera sampled throughout Europe and set up a database-driven website allowing species identification from query sequences. Results: In this unbiased sampling of the taxonomic diversity of European aphids, intraspecific divergence ranged from 0.0% to 3.9%, with a mean value of 0.29%, whereas mean congeneric divergence was 6.4%, ranging from 0.0% to 15%. Neighbor-joining analysis generated a tree in which most species clustered in distinct genetic units. Most of the species with undifferentiated or overlapping barcodes belonged to the genus Aphis or, to a lesser extent, the genera Brachycaudus, Dysaphis and Macrosiphum. The taxa involved were always morphologically similar or closely related and belonged to species groups known to present taxonomic difficulties. Conclusions: These data confirm that COI barcoding is a useful identification tool for aphids. Barcode identification is straightforward and reliable for 80% of species, including some difficult to distinguish on the basis of morphological characters alone. Unsurprisingly, barcodes often failed to distinguish between species from groups for which classical taxonomy has also reached its limits, leading to endless revisions and discussions about species and subspecies definitions. In such cases, the development of an effective procedure for the accurate identification of aphid specimens continues to pose a difficult challenge.	[Coeur d'acier, Armelle; Cruaud, Astrid; Artige, Emmanuelle; Genson, Gwenaelle; Clamens, Anne-Laure; Pierre, Eric; Jousselin, Emmanuelle; Rasplus, Jean-Yves] INRA, CBGP, UMR 1062, Montferrier Sur Lez, France; [Hudaverdian, Sylvie; Simon, Jean-Christophe] INRA, UMR, IGEPP, Le Rheu, France	INRAE; Institut de Recherche pour le Developpement (IRD); INRAE	Coeur d'acier, A (corresponding author), INRA, CBGP, UMR 1062, Montferrier Sur Lez, France.	coeur@supagro.inra.fr	Simon, Jean-Christophe/I-2700-2014; Rasplus, Jean-Yves/O-2873-2017; Coeur d'acier, Armelle/N-6916-2014	Rasplus, Jean-Yves/0000-0001-8614-6665; Coeur d'acier, Armelle/0000-0002-8915-1395	BIOFIS project [1001-001]; project @-Speed-ID included in the network "Bibliotheque du Vivant'' - CNRS; Museum National d'Histoire Naturelle; INRA; CEA (Genoscope); SDIPS project; ANR JCJC-05 (Brachycaudus) grant	BIOFIS project; project @-Speed-ID included in the network "Bibliotheque du Vivant'' - CNRS; Museum National d'Histoire Naturelle; INRA; CEA (Genoscope); SDIPS project; ANR JCJC-05 (Brachycaudus) grant(French National Research Agency (ANR))	This work was based on financial supports received from the BIOFIS project (number 1001-001) allocated by the French Agropolis Fondation (RTRA - Montpellier) to JYR, the project @-Speed-ID included in the network "Bibliotheque du Vivant'' funded by the CNRS, the Museum National d'Histoire Naturelle, the INRA and the CEA (Genoscope), the SDIPS project allocated by INRA to EJ and the ANR JCJC-05 (Brachycaudus) grant awarded to EJ and ACDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBAGALLO S, 1995, HOMOPTERA STERNORRHY; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; BLACKMAN R.L., 2006, APHIDS WORLDS HERBAC; Blackman R.L., 1994, APHIDS WORLDS TREES; Blackman R.L., 2000, APHIDS WORLDS CROPS, V2nd; BLACKMAN RL, 2013, APHIDS WORLDS PLANTS; BORNER C., 1949, NACHRICHTENBL DEUTSCH PFLANZENSCHUTZDIENST, V3, P121; Borner C., 1950, NEUE EUROPAISCHE BLA; BORNER C, 1952, MITTEILUNGEN THURING, V3, P1; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Caillaud MC, 2000, AM NAT, V156, P606, DOI 10.1086/316991; Carletto J, 2009, SYST ENTOMOL, V34, P307, DOI 10.1111/j.1365-3113.2008.00458.x; CHAN CK, 1991, AGR CANADA TECHNIC B; Chen R, 2013, SYST ENTOMOL, V38, P615, DOI 10.1111/syen.12018; Chen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046190; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Cocuzza Giuseppe, 2007, Redia, V90, P33; Coeur d'Acier A, 2007, MOL PHYLOGENET EVOL, V42, P598, DOI 10.1016/j.ympev.2006.10.006; Coeur d'Acier A, 2008, ZOOL SCR, V37, P175, DOI 10.1111/j.1463-6409.2007.00317.x; Cruaud A, 2010, CLADISTICS, V26, P359, DOI 10.1111/j.1096-0031.2009.00291.x; DACIER AC, 2010, ALIEN TERRESTRIAL AR, P435; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Dixon AF G, 1998, APHID ECOLOGY; DRUMMOND AJ, 2010, GENEIOUS V5 5; Eastop VF, 2005, ZOOTAXA, P1; EASTOP VF, 1973, APHIDS VIRUS VECTORS, P4; Favret C., 2013, APHID SPECIES FILE V; Ferrari J, 2006, EVOLUTION, V60, P1574, DOI 10.1111/j.0014-3820.2006.tb00502.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foottit RG, 2008, MOL ECOL RESOUR, V8, P1189, DOI 10.1111/j.1755-0998.2008.02297.x; Foottit RG, 2009, CAN ENTOMOL, V141, P478, DOI 10.4039/n09-037; Foottit RG, 2006, P ENTOMOL SOC WASH, V108, P583; Foottit Robert G., 2009, Redia, V92, P87; Gauffre B, 2006, MOL ECOL NOTES, V6, P440, DOI 10.1111/j.1471-8286.2006.01264.x; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heie O. E., 1967, Spolia Zoologica Musei Hauniensis, V26, P1; Heie O. E., 1986, APHIDOIDEA HEMIPTERA; Huang XL, 2013, NATURE, V497, P40, DOI 10.1038/497040b; IGLISCH I, 1968, MITTEILUNGEN BIOLOGI, V131, P5; Janisch R., 1926, Arb biol Reichsanst Berlin, V14, P291; Jorg E., 1995, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V68, P387; Jousselin E, 2009, P ROY SOC B-BIOL SCI, V276, P187, DOI 10.1098/rspb.2008.0679; Jousselin E, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-295; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Kim H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011608; Kim H, 2010, ANN ENTOMOL SOC AM, V103, P532, DOI 10.1603/AN09166; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; LAMBERS DHR, 1947, ZOOLOGISCHE MEDEDEEL, V28, P291; LAMBERS DHR, 1956, Z ANGEW ENTOMOL, V39, P467; Lee W, 2011, MOL ECOL RESOUR, V11, P32, DOI 10.1111/j.1755-0998.2010.02877.x; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miller Gary L., 2009, P463, DOI 10.1002/9781444308211.ch20; MINKS AK, 1987, APHIDS THEIR BIOL NA; Moller F.W., 1972, Archiv Pflanzenschutz, V8, P305; Moller F. W., 1970, Zool. Anz., V184, P107; Moller F. W., 1971, Dt ent Z, V18, P207; MORDWILKO AK, 1907, BIOL ZBL, V27, P769; Muller F. P., 1968, Faun Abh St Mus Tierk Dresden, V2, P101; MULLER FP, 1982, Z ANGEW ENTOMOL, V94, P432; MULLER FP, 1985, ENTOMOL GEN, V10, P161; Naaum AM, 2012, J APPL ENTOMOL, V136, P704, DOI 10.1111/j.1439-0418.2012.01706.x; NAFRIA JMN, 1998, REV FRANCAISE ENTOMO, V19, P77; NAFRIA JMN, 2013, FAUNA EUROPAEA APHID; Nieto Nafria JM, 2005, HEMIPTERA APHIDIDAE; Novakova E, 2013, MOL PHYLOGENET EVOL, V68, P42, DOI 10.1016/j.ympev.2013.03.016; Ortiz-Rivas B, 2010, MOL PHYLOGENET EVOL, V55, P305, DOI 10.1016/j.ympev.2009.12.005; Peccoud J, 2010, CR BIOL, V333, P474, DOI 10.1016/j.crvi.2010.03.004; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P7495, DOI 10.1073/pnas.0811117106; Piffaretti J, 2013, APPL ENTOMOL ZOOL, V48, P155, DOI 10.1007/s13355-013-0165-7; Piffaretti J, 2012, ZOOL SCR, V41, P266, DOI 10.1111/j.1463-6409.2012.00531.x; Popescu AA, 2012, BIOINFORMATICS, V28, P1536, DOI 10.1093/bioinformatics/bts184; Prieto F. Garcia, 2004, Graellsia, V60, P197; Rakauskas R., 1998, P451; Raymond B, 2001, BIOL J LINN SOC, V74, P205, DOI 10.1111/j.1095-8312.2001.tb01387.x; Remaudiere G., 1997, CATALOGUE APHIDIDAE; Robert V, 2011, OPEN APPL INFORM J, V5, P87, DOI DOI 10.2174/1874136301005010087; Roques Alain, 2010, BioRisk, V4, P11; Shaposhnikov G.C., 1985, P19; Shaposhnikov G.Kh., 1986, Entomologicheskoe Obozrenie, V65, P535; SHAPOSHNIKOV G. Kh, 1965, ENTOMOL OBOZRENIE, V44, P3; Shaposhnikov G. Kh., 1961, Entomologicheskoe Obozrenie, V40, P739; SHAPOSHNIKOV GC, 1981, POPULATIONS SPECIES; Shaposhnikov GC., 1987, APHIDS THEIR BIOL NA, V2A, P415; SHAPOSHNIKOV GC, 1985, DEFINING NOTION SPEC, P167; Shen YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057125; Shufran KA, 2011, ANN ENTOMOL SOC AM, V104, P39, DOI 10.1603/AN10129; Stekolshchikov AV, 2004, SCI UPDATE, P183; STROYAN HLG, 1963, REVISION BRIT SPEC 2; STROYAN HLG, 1984, APHIDS PTEROCOMMATIN; STROYAN HLG, 1958, J LINN SOC LOND, V43, P643; STROYAN HLG, 1985, RECENT DEV TAXONOMIC, P347; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thieme T., 1987, P314; THOMAS K. H., 1962, Wissenschaftliche Zeitschrift der Universitat Rostock, V11, P325; Thomas K. H., 1968, Ent. Abh. Mus. Tierk. Dresden, V35, P337; Tosh CR, 2004, ENVIRON ENTOMOL, V33, P1081, DOI 10.1603/0046-225X-33.4.1081; Via S, 2000, EVOLUTION, V54, P1626, DOI 10.1111/j.0014-3820.2000.tb00707.x; Via S, 1999, EVOLUTION, V53, P1446, DOI 10.1111/j.1558-5646.1999.tb05409.x; Virgilio M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-206; Wang Jian-Feng, 2011, ZooKeys, V122, P1; Wang JF, 2009, INSECT SCI, V16, P475, DOI 10.1111/j.1744-7917.2009.01270.x; Wiens JJ, 2002, SYST BIOL, V51, P69, DOI 10.1080/106351502753475880; Zhang AB, 2010, MOL PHYLOGENET EVOL, V54, P1035, DOI 10.1016/j.ympev.2009.09.014	105	38	42	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e97620	10.1371/journal.pone.0097620	http://dx.doi.org/10.1371/journal.pone.0097620			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896814	Green Published, Green Submitted, gold			2022-12-27	WOS:000338430700011
J	Heo, J; Oh, J; Subramanian, SV; Kawachi, I				Heo, Jongho; Oh, Juhwan; Subramanian, S. V.; Kawachi, Ichiro			Household and School-Level Influences on Smoking Behavior among Korean Adolescents: A Multilevel Analysis	PLOS ONE			English	Article							HEALTH-RISK BEHAVIORS; POWER-CONTROL THEORY; CIGARETTE-SMOKING; SOCIOECONOMIC-STATUS; UNITED-STATES; SUBSTANCE USE; DEPRESSIVE SYMPTOMS; YOUNG ADOLESCENTS; SOCIAL INFLUENCES; PARENTAL SMOKING	Background: Trends in adolescent smoking rates in South Korea have not shown substantial progress due to a lack of effective anti-smoking interventions and policies in school settings. Methods and Findings: We examined individual- and school-level determinants of adolescent smoking behavior (ever smoking, current smoking, and daily smoking) using the nationally representative fifth Korean Youth Risk Behavior Web-based Survey conducted in 2009. We found that students in coeducation schools or vocational high schools had greater risks of smoking for each type of smoking behavior than those in single-sex schools or general high schools, respectively even after controlling for individual-level factors. Higher family affluence and higher weekly allowances were associated with greater risks of ever smoking, current smoking and daily smoking even after controlling for parental education and other confounders. Conclusions: Whilst caution is required in interpreting results given the cross-sectional nature of the study, our findings suggest that in addition to raising the price of cigarettes, youth anti-smoking interventions in South Korea may benefit from focusing on coeducation schools and vocational high schools.	[Heo, Jongho] San Diego State Univ, Publ Hlth Joint Doctoral Program, La Jolla, CA USA; [Heo, Jongho] Univ Calif San Diego, La Jolla, CA 92093 USA; [Oh, Juhwan] Seoul Natl Univ, Coll Med, JW LEE Ctr Global Med, Seoul, South Korea; [Subramanian, S. V.; Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA	California State University System; San Diego State University; University of California System; University of California San Diego; Seoul National University (SNU); Harvard University; Harvard T.H. Chan School of Public Health	Oh, J (corresponding author), Seoul Natl Univ, Coll Med, JW LEE Ctr Global Med, Seoul, South Korea.	oh328@snu.ac.kr	Oh, Juhwan/O-6517-2019	Oh, Juhwan/0000-0003-0983-4872; Heo, Jongho/0000-0002-6405-3860				Alexander C, 2001, J ADOLESCENT HEALTH, V29, P22, DOI 10.1016/S1054-139X(01)00210-5; Amos A, 1997, SOC SCI MED, V45, P847, DOI 10.1016/S0277-9536(96)00425-X; [Anonymous], 2011, MULTILEVEL ANAL; Bergman MM, 2001, J ADOLESCENCE, V24, P183, DOI 10.1006/jado.2001.0378; Bethel JW, 2005, AM J PREV MED, V29, P143, DOI 10.1016/j.amepre.2005.04.014; Blecher EH, 2004, TOB CONTROL, V13, P339, DOI 10.1136/tc.2003.006726; Bourdieu P., 1990, REPROD ED SOC CULTUR; Boyce W, 2006, SOC INDIC RES, V78, P473, DOI 10.1007/s11205-005-1607-6; Chen C-Y, 2013, J ADOLESCENT HLTH; Chen CY, 2006, DRUG ALCOHOL DEPEN, V84, P273, DOI 10.1016/j.drugalcdep.2006.03.003; Chen Y, 1992, HLTH VALUES J HLTH B; Cho HJ, 2010, J PUBLIC HEALTH-HEID, V18, P169, DOI 10.1007/s10389-009-0299-9; Choi I, 2010, KOREAN SURVEY CAREER; Choi WS, 1997, ANN BEHAV MED, V19, P42, DOI 10.1007/BF02883426; Choi WS, 1997, ADOLESCENT EXPT PROG; COVEY LS, 1990, AM J PUBLIC HEALTH, V80, P1330, DOI 10.2105/AJPH.80.11.1330; Cubbin C, 2011, AM J HEALTH BEHAV, V35, P28; Distefan JM, 1998, J ADOLESCENT HEALTH, V22, P466, DOI 10.1016/S1054-139X(98)00013-5; Do YK, 2012, J ADOLESCENT HEALTH, V51, P226, DOI 10.1016/j.jadohealth.2012.01.012; ECKHARDT L, 1994, J SCHOOL HEALTH, V64, P67, DOI 10.1111/j.1746-1561.1994.tb06181.x; Epstein JA, 1998, J ADOLESCENT HEALTH, V23, P160, DOI 10.1016/S1054-139X(98)00027-5; Farkas AJ, 1999, PREV MED, V28, P213, DOI 10.1006/pmed.1998.0451; FAWZY FI, 1983, ADDICT BEHAV, V8, P109, DOI 10.1016/0306-4603(83)90003-5; Flay BR, 1998, PREV MED, V27, pA9, DOI 10.1006/pmed.1998.0380; FLAY BR, 1994, J HEALTH SOC BEHAV, V35, P248, DOI 10.2307/2137279; Flay BR, 1993, NICOTINE ADDICTION P, P365; Friestad C, 2003, J ADOLESCENT HEALTH, V33, P275, DOI 10.1016/S1054-139X(03)00214-3; Goodman E, 2000, PEDIATRICS, V106, P748, DOI 10.1542/peds.106.4.748; HAGAN J, 1987, AM J SOCIOL, V92, P788, DOI 10.1086/228583; HAGAN J, 1985, AM J SOCIOL, V90, P1151, DOI 10.1086/228206; Hanson MD, 2007, J BEHAV MED, V30, P263, DOI 10.1007/s10865-007-9098-3; Hanson MD, 2007, J HEALTH PSYCHOL, V12, P32, DOI 10.1177/1359105306069073; Harrell JS, 1998, J ADOLESCENT HEALTH, V23, P271, DOI 10.1016/S1054-139X(98)00078-0; Heo J, 2010, VALIDITY ANAL IMPLIC; Hu MC, 2006, AM J PUBLIC HEALTH, V96, P299, DOI 10.2105/AJPH.2004.057232; Huurre T, 2003, SOC PSYCH PSYCH EPID, V38, P249, DOI 10.1007/s00127-003-0630-7; Johnson RA, 2000, J HEALTH SOC BEHAV, V41, P392, DOI 10.2307/2676293; Kandel DB, 2004, AM J PUBLIC HEALTH, V94, P128, DOI 10.2105/AJPH.94.1.128; Kandel DB, 2004, J INFORM, V94; Kassel JD, 2003, PSYCHOL BULL, V129, P270, DOI 10.1037/0033-2909.129.2.270; KELLY DH, 1973, CRIMINOLOGY, V0010; Kepler K, 1999, ESTONIAN SCH CHILDRE; Kim H., 2007, INT C SOC AD; Kim SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030501, 10.1371/journal.pone.0045068]; Kim SH, 2003, J HEALTH COMMUN, V8, P343, DOI 10.1080/10810730305723; KOKKEVI A, 1991, AM J PUBLIC HEALTH, V81, P48, DOI 10.2105/AJPH.81.1.48; Korea Ministry of Health and Welfare, 2010, STAT REP KOR YOUTH R; Larson RW, 1999, PSYCHOL BULL, V125, P701, DOI 10.1037/0033-2909.125.6.701; Leatherdale ST, 2005, AM J HEALTH BEHAV, V29, P520, DOI 10.5993/AJHB.29.6.7; Leatherdale ST, 2005, PREV MED, V40, P853, DOI 10.1016/j.ypmed.2004.09.033; Lee Jeong-Kyu, 2006, REDIE, V8, P1; Lee M, 2000, J YOUTH ADOLESCENCE, V29, P249, DOI 10.1023/A:1005160717081; Lee M, 2003, NEW DIR CHILD ADOLES, V99, P9, DOI 10.1002/cd.63; LEVENTHAL H, 1980, PSYCHOL BULL, V88, P370, DOI 10.1037/0033-2909.88.2.370; Lloyd-Richardson EE, 2002, J CONSULT CLIN PSYCH, V70, P998, DOI 10.1037/0022-006X.70.4.998; Lowry R, 1996, JAMA-J AM MED ASSOC, V276, P792, DOI 10.1001/jama.276.10.792; Maes L, 2003, SOC SCI MED, V56, P517, DOI 10.1016/S0277-9536(02)00052-7; Mayhew Kathryn P., 2000, Drug and Alcohol Dependence, V59, pS61; MCNEILL AD, 1989, J EPIDEMIOL COMMUN H, V43, P72, DOI 10.1136/jech.43.1.72; Miranda JJ, 2008, TROP MED INT HEALTH, V13, P1225, DOI 10.1111/j.1365-3156.2008.02116.x; Morrow M, 2002, SOC SCI MED, V55, P681, DOI 10.1016/S0277-9536(01)00310-0; Mott JA, 1999, J BEHAV MED, V22, P35, DOI 10.1023/A:1018747602026; Murnaghan DA, 2008, HEALTH EDUC RES, V23, P1016, DOI 10.1093/her/cyn034; OECD, 2009, HLTH GLANC 2009 OECD; Parna K, 2003, SCAND J PUBLIC HEALT, V31, P350, DOI 10.1080/14034940210165091; Pascoe EA, 2009, PSYCHOL BULL, V135, P531, DOI 10.1037/a0016059; Pierce JP, 1996, HEALTH PSYCHOL, V15, P355, DOI 10.1037/0278-6133.15.5.355; Pinilla J, 2002, J EPIDEMIOL COMMUN H, V56, P227, DOI 10.1136/jech.56.3.227; Rugkasa J, 2003, HEALTH PROMOT INT, V18, P307, DOI 10.1093/heapro/dag404; Soteriades ES, 2003, AM J PUBLIC HEALTH, V93, P1155, DOI 10.2105/AJPH.93.7.1155; Soteriades ES, 2003, J INFORM, V93; Spijkerman R, 2005, PREV MED, V40, P785, DOI 10.1016/j.ypmed.2004.09.025; Sugathan TN, 1998, SOC SCI MED, V47, P1855, DOI 10.1016/S0277-9536(98)00204-4; TOWNSEND J, 1994, BMJ-BRIT MED J, V309, P923, DOI 10.1136/bmj.309.6959.923; Tyas SL, 1998, TOB CONTROL, V7, P409, DOI 10.1136/tc.7.4.409; US Department of Health and Human Services (USDHHS), 1994, PREV TOB US YOUNG PE; Vettcnburg Nicole, 2011, Int J Adolesc Med Health, V10, P193, DOI 10.1515/IJAMH.1998.10.3.193; Wang MQ, 1996, J ALCOHOL DRUG EDUC, V41, P1; Warren Charles W, 2009, Glob Health Promot, V16, P38, DOI 10.1177/1757975909342192; West P, 1999, ADDICTION, V94, P1397, DOI 10.1046/j.1360-0443.1999.949139711.x; West P, 2007, TOB CONTROL, V16, P329, DOI 10.1136/tc.2006.018721; WHO Western Pacific Region, 2002, FACT SHEETS SMOK STA; Williams DR, 2009, J BEHAV MED, V32, P20, DOI 10.1007/s10865-008-9185-0; Wright BRE, 1999, CRIMINOLOGY, V37, P22	84	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98683	10.1371/journal.pone.0098683	http://dx.doi.org/10.1371/journal.pone.0098683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK4YO	24896251	Green Published, gold, Green Submitted			2022-12-27	WOS:000338430700064
J	Roggia, MF; Imai, H; Shiraya, T; Noda, Y; Ueta, T				Roggia, Murilo Felix; Imai, Hirotaka; Shiraya, Tomoyasu; Noda, Yasuo; Ueta, Takashi			Protective Role of Glutathione Peroxidase 4 in Laser-Induced Choroidal Neovascularization in Mice	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; INCREASED EXPRESSION; MODEL; SUPPRESSION; PREVALENCE; CELLS	Purpose: To evaluate the influence of glutathione peroxidase 4 (GPx4) expression in retinal pigment epithelium (RPE)/choroid tissue using a mouse model of laser-induced choroidal neovascularization (CNV). Methods: In this study, GPx4(+/-), GPx4(+/+), and GPx4-overexpressing transgenic mice were created for comparison. The mRNA and protein expression of vascular endothelial growth factor (VEGF)-A in RPE/choroid tissue were evaluated before and after CNV induction by laser. Moreover, we investigated the changes in the VEGF-A mRNA level in RPE/choroid tissue in the CNV model that have not been clearly shown previously. Lipid peroxidation in RPE/choroid tissue was evaluated by immunohistochemistry using antibody against 4-hydroxy-2-nonenal. To investigate the protective role of GPx4, the size of laser-induced CNV was compared on day 7 among the mice expressing different levels of GPx4. Results: In the laser-induced CNV mouse model, laser treatment reduced the VEGF-A mRNA level in RPE/choroid tissue, while it increased the VEGF-A protein level. Evaluation of VEGF-A expression in RPE/choroid tissue of the GPx4(+/-), GPx4(+/+), and GPx4 transgenic mice revealed that GPx4 increased the VEGF-A protein level under physiological conditions (i.e., without laser treatment), while GPx4 suppressed the increase in the VEGF-A protein level under pathological conditions (i.e., after CNV induction by laser). In addition, GPx4 reduced the CNV size in a dose-dependent manner in vivo. Conclusions: GPx4 suppresses the increase in the VEGF-A protein level, which occurs during the development of pathological CNV, thus partly explaining the protective effect of GPx4 against CNV.	[Roggia, Murilo Felix; Shiraya, Tomoyasu; Noda, Yasuo; Ueta, Takashi] Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan; [Roggia, Murilo Felix; Shiraya, Tomoyasu; Noda, Yasuo; Ueta, Takashi] Univ Tokyo, Fac Med, Tokyo 113, Japan; [Imai, Hirotaka] Kitasato Univ, Sch Pharmaceut Sci, Tokyo 108, Japan	University of Tokyo; University of Tokyo; Kitasato University	Ueta, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan.	ueta-tky@umin.ac.jp			 [40323547]		Funding provided by Grants-in-Aid for Scientific Research (40323547). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chew EY, 2013, OPHTHALMOLOGY, V120, P1604, DOI 10.1016/j.ophtha.2013.01.021; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Dong A, 2009, J CELL PHYSIOL, V219, P544, DOI 10.1002/jcp.21698; Ebrahem Q, 2006, P NATL ACAD SCI USA, V103, P13480, DOI 10.1073/pnas.0601552103; Giani A, 2011, INVEST OPHTH VIS SCI, V52, P3880, DOI 10.1167/iovs.10-6266; Hara R, 2010, CURR EYE RES, V35, P1012, DOI 10.3109/02713683.2010.500112; Hu WZ, 2009, EXP EYE RES, V88, P79, DOI 10.1016/j.exer.2008.10.014; Imai H, 2003, BIOCHEM BIOPH RES CO, V305, P278, DOI 10.1016/S0006-291X(03)00734-4; Imai H, 2001, BIOL REPROD, V64, P674, DOI 10.1095/biolreprod64.2.674; Imai H, 2009, J BIOL CHEM, V284, P32522, DOI 10.1074/jbc.M109.016139; Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103; Inomata Y, 2008, INVEST OPHTH VIS SCI, V49, P5118, DOI 10.1167/iovs.07-1659; KAHN HA, 1977, AM J EPIDEMIOL, V106, P17, DOI 10.1093/oxfordjournals.aje.a112428; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P653, DOI 10.1001/archopht.116.5.653; Kurihara T, 2012, J CLIN INVEST, V122, P4213, DOI 10.1172/JCI65157; Lambert V, 2013, NAT PROTOC, V8, P2197, DOI 10.1038/nprot.2013.135; Liu J, 2011, J BIOL CHEM, V286, P20991, DOI 10.1074/jbc.M111.226266; Lu LL, 2009, ANTIOXID REDOX SIGN, V11, P715, DOI [10.1089/ars.2008.2171, 10.1089/ARS.2008.2171]; Mizutani T, 2009, INVEST OPHTH VIS SCI, V54, P1564; Oshima Y, 2004, J CELL PHYSIOL, V201, P393, DOI 10.1002/jcp.20110; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; THOMAS JP, 1990, BIOCHIM BIOPHYS ACTA, V1045, P252, DOI 10.1016/0005-2760(90)90128-K; Ueta T, 2012, ARTERIOSCL THROM VAS, V32, P1366, DOI 10.1161/ATVBAHA.112.248021; Ueta T, 2012, J BIOL CHEM, V287, P7675, DOI 10.1074/jbc.M111.335174; Wirth EK, 2010, FASEB J, V24, P844, DOI 10.1096/fj.09-143974; Wortmann M, 2013, CIRC RES, V113, P408, DOI 10.1161/CIRCRESAHA.113.279984; Xie P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028933	27	16	16	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98864	10.1371/journal.pone.0098864	http://dx.doi.org/10.1371/journal.pone.0098864			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897344	gold, Green Published, Green Submitted			2022-12-27	WOS:000338430700089
J	Goudjil, S; Imestouren, F; Armougon, A; Razafimanantsoa, L; Mahmoudzadeh, M; Wallois, F; Leke, A; Kongolo, G				Goudjil, Sabrina; Imestouren, Fatiha; Armougon, Aurelie; Razafimanantsoa, Lucie; Mahmoudzadeh, Mahdi; Wallois, Fabrice; Leke, Andre; Kongolo, Guy			Noninvasive Technique for the Diagnosis of Patent Ductus Arteriosus in Premature Infants by Analyzing Pulse Wave Phases on Photoplethysmography Signals Measured in the Right Hand and the Left Foot	PLOS ONE			English	Article							LEFT-VENTRICULAR OUTPUT; PRETERM INFANTS; PERIPHERAL-CIRCULATION; INTENSIVE-CARE; TRANSIT-TIME; PRESSURE; OXIMETRY; SHUNT	Objective: To evaluate the impact of patent ductus arteriosus (PDA) on the pulse phase difference (PPD) between the left foot (postductal region) and the right hand (preductal region). Materials and Methods: PPD was determined from arterial photoplethysmography signals (pulse waves) measured by infrared sensors routinely used for pulse oximetry in 56 premature infants less than 32 weeks gestation. Only infants with significant PDA (sPDA) diagnosed by echocardiography were treated with ibuprofen (for 3 days). Patients were classified according to whether or not they responded (Success/Failure) to this treatment. The Control group was composed of infants in whom ductus had already closed spontaneously at the time of the first echocardiography. The 3 groups were compared in terms of PPD at the beginning (T1) and at the end (T2) of the study. For patients in the Failure (n = 17) and Success groups (n = 18), T1 corresponded to the first day of treatment and T2 to the day after completion of the course of ibuprofen. In the Control group (n = 21), T1 corresponded to 1 to 3 days of life (DOL), and T2 to 4-6 DOL. Results: Compared to the Control group, PPD was higher in the Failure (at T1 and T2) and Success (at T1) groups characterized by sPDA. After ibuprofen therapy, PPD in the Success group decreased to about the level observed in the Control group. The area under the ROC curve of PPD for the diagnosis of sPDA was 0.98 (95% CI 0.96-1); for an optimal cutoff of PPD >= 1.65 deg/cm, the sensitivity was 94.2% and the specificity was 98.3%. Conclusion: In this study, PPD was correlated with ductus arteriosus status evaluated by echocardiography, indicating involvement of the ductal shunt in the mechanism of redistribution in systemic vascular territories. PPD can be considered for the diagnosis of hemodynamically significant PDA.	[Goudjil, Sabrina; Imestouren, Fatiha; Armougon, Aurelie; Leke, Andre; Kongolo, Guy] Amiens Univ Hosp, Neonatal Intens Care Unit, Amiens, France; [Razafimanantsoa, Lucie] Amiens Univ Hosp, Amiens, France; [Goudjil, Sabrina; Mahmoudzadeh, Mahdi; Wallois, Fabrice; Kongolo, Guy] Jules Verne Univ Picardie, GRAMFC, INSERM U1105, Amiens, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV)	Goudjil, S (corresponding author), Amiens Univ Hosp, Neonatal Intens Care Unit, Amiens, France.	goudsab2002@yahoo.fr						AGATA Y, 1994, PEDIATR RES, V36, P805, DOI 10.1203/00006450-199412000-00022; Ahn JH, 2011, KOREAN J FAM MED, V32, P406, DOI 10.4082/kjfm.2011.32.7.406; Allen J, 2007, PHYSIOL MEAS, V28, pR1, DOI 10.1088/0967-3334/28/3/R01; Armitage P, 2002, STAT METHODS MED RES, P43; Beuchee A, 2003, PFLUG ARCH EUR J PHY, V446, P154, DOI 10.1007/s00424-002-0961-3; Caro C, 2012, MECH CIRCULATION, P268; Cheung YF, 2004, ARCH DIS CHILD, V89, P217, DOI 10.1136/adc.2003.025999; Chowienczyk PJ, 1999, J AM COLL CARDIOL, V34, P2007, DOI 10.1016/S0735-1097(99)00441-6; Cohen J.E., 1988, STAT POWER ANAL BEHA; De Felice C, 2004, EARLY HUM DEV, V78, P45, DOI 10.1016/j.earlhumdev.2004.03.003; de-Wahl Granelli Anne, 2009, BMJ, V338, pa3037, DOI 10.1136/bmj.a3037; El Hajjar M, 2005, ARCH DIS CHILD-FETAL, V90, pF419, DOI 10.1136/adc.2003.027698; Evans N, 1996, ARCH DIS CHILD-FETAL, V75, pF183, DOI 10.1136/fn.75.3.F183; EVANS N, 1994, J PEDIATR-US, V125, P778, DOI 10.1016/S0022-3476(94)70078-8; Evans N, 2008, HEMODYNAMICS CARDIOL, P83; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FREYSCHUSS U, 1986, CLIN SCI, V70, P199, DOI 10.1042/cs0700199; Fung Y, 1981, BIOMECHANICS MECH PR, P282; Hiedl S, 2010, J PEDIATR-US, V156, P191, DOI 10.1016/j.jpeds.2009.08.034; Hoodbhoy SA, 2009, J PEDIATR-US, V154, P196, DOI 10.1016/j.jpeds.2008.07.051; Huang NE, 1999, ANNU REV FLUID MECH, V31, P417, DOI 10.1146/annurev.fluid.31.1.417; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Kelly RP, 2001, HYPERTENSION, V37, P1429, DOI 10.1161/01.HYP.37.6.1429; Landsverk SA, 2008, ANESTHESIOLOGY, V109, P849, DOI 10.1097/ALN.0b013e3181895f9f; Lo MT, 2008, EURASIP J ADV SIG PR, DOI 10.1155/2008/785243; Millasseau SC, 2000, HYPERTENSION, V36, P952, DOI 10.1161/01.HYP.36.6.952; OISHI M, 1993, PEDIATR RES, V33, P653, DOI 10.1203/00006450-199306000-00024; Oppenheimer A, 1989, DISCRETE TIME SIGNAL; Pagani J, 2003, CHEST, V124, P1487, DOI 10.1378/chest.124.4.1487; Peters J, 2001, INTENS CARE MED, V27, P1446, DOI 10.1007/s001340101034; Philips, 2007, MAN UT MON PAT INTEL; POLOGE JA, 1987, INT ANESTHESIOL CLIN, V25, P137, DOI 10.1097/00004311-198702530-00009; SHEREBRIN MH, 1990, IEEE T BIO-MED ENG, V37, P313, DOI 10.1109/10.52332; SHIMADA S, 1994, J PEDIATR-US, V125, P270, DOI 10.1016/S0022-3476(94)70210-1; Skinner J, 2000, ECHOCARDIOGRAPHY NEO, P151; Smith RP, 1999, THORAX, V54, P452, DOI 10.1136/thx.54.5.452; Stoica P, 2005, SPECTRAL ANAL SIGNAL, P4; Szpinda M, 2007, ANN ANAT, V189, P465, DOI 10.1016/j.aanat.2007.01.007; Teixeira LS, 2006, ACTA PAEDIATR, V95, P394, DOI 10.1080/08035250500482271; Wang JJ, 2004, J BIOMECH, V37, P457, DOI 10.1016/j.jbiomech.2003.09.007; Yasmin, 1999, QJM-INT J MED, V92, P595, DOI 10.1093/qjmed/92.10.595; Zuppa AA, 2014, J MATERN-FETAL NEO M, V0, P1	42	6	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98763	10.1371/journal.pone.0098763	http://dx.doi.org/10.1371/journal.pone.0098763			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892695	Green Published, gold, Green Submitted			2022-12-27	WOS:000336911400089
J	Guan, T; Fan, Y; Duan, LY; Yu, JQ				Guan, Tao; Fan, Yin; Duan, Liya; Yu, Junqing			On-Device Mobile Visual Location Recognition by Using Panoramic Images and Compressed Sensing Based Visual Descriptors	PLOS ONE			English	Article							SEARCH; RETRIEVAL	Mobile Visual Location Recognition (MVLR) has attracted a lot of researchers' attention in the past few years. Existing MVLR applications commonly use Query-by-Example (QBE) based image retrieval principle to fulfill the location recognition task. However, the QBE framework is not reliable enough due to the variations in the capture conditions and viewpoint changes between the query image and the database images. To solve the above problem, we make following contributions to the design of a panorama based on-device MVLR system. Firstly, we design a heading (from digital compass) aware BOF (Bag-of-features) model to generate the descriptors of panoramic images. Our approach fully considers the characteristics of the panoramic images and can facilitate the panorama based on-device MVLR to a large degree. Secondly, to search high dimensional visual descriptors directly on mobile devices, we propose an effective bilinear compressed sensing based encoding method. While being fast and accurate enough for on-device implementation, our algorithm can also reduce the memory usage of projection matrix significantly. Thirdly, we also release a panoramas database as well as a set of test panoramic quires which can be used as a new benchmark to facilitate further research in the area. Experimental results prove the effectiveness of the proposed methods for on-device MVLR applications.	[Guan, Tao; Fan, Yin; Duan, Liya; Yu, Junqing] Huazhong Univ Sci & Technol, Sch Comp Sci & Technol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Guan, T (corresponding author), Huazhong Univ Sci & Technol, Sch Comp Sci & Technol, Wuhan 430074, Peoples R China.	qd_gt@126.com						Bay H, 2006, LECT NOTES COMPUT SC, V3951, P404, DOI 10.1007/11744023_32; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P5406, DOI 10.1109/TIT.2006.885507; Cao Y, 2010, PROC CVPR IEEE, P3352, DOI 10.1109/CVPR.2010.5540021; Chen DM, 2011, PROC CVPR IEEE, P737, DOI 10.1109/CVPR.2011.5995610; Chen T, 2013, IEEE T CIRC SYST VID, V23, P1611, DOI 10.1109/TCSVT.2013.2254978; Chen T, 2009, MDM: 2009 10TH INTERNATIONAL CONFERENCE ON MOBILE DATA MANAGEMENT, P625, DOI 10.1109/MDM.2009.107; Chen YJ, 2010, SENSORS-BASEL, V10, P11259, DOI 10.3390/s101211259; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; Davenport MA, 2010, IEEE J-STSP, V4, P445, DOI 10.1109/JSTSP.2009.2039178; David P, 2011, IEEE INT C INT ROBOT, P494, DOI 10.1109/IROS.2011.6048164; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Donoho DL, 2003, P NATL ACAD SCI USA, V100, P2197, DOI 10.1073/pnas.0437847100; Duarte MF, 2007, IEEE IMAGE PROC, P2957; Duarte MF, 2006, P IEEE INT C AC SPEE, P3; Gao Y, 2013, IEEE T IMAGE PROCESS, V22, P363, DOI 10.1109/TIP.2012.2202676; Gao Y, 2012, IEEE T IMAGE PROCESS, V21, P4290, DOI 10.1109/TIP.2012.2199502; Girod B, 2011, IEEE MULTIMEDIA, V18, P86, DOI 10.1109/MMUL.2011.48; Gong YC, 2013, PROC CVPR IEEE, P484, DOI 10.1109/CVPR.2013.69; Guan T, 2013, IEEE T MULTIMEDIA, V15, P1688, DOI 10.1109/TMM.2013.2265674; Haupt J, 2006, CONF REC ASILOMAR C, P1430; Jegou H, 2010, PROC CVPR IEEE, P3304, DOI 10.1109/CVPR.2010.5540039; Ji R., 2011, IJCAI P INT JOINT C, V22, P2456; Ji R., 2009, P 17 ACM INT C MULT, P105, DOI DOI 10.1145/1631272.1631289; Ji R., 2014, IEEE T IMAG IN PRESS; Ji RR, 2012, INT J COMPUT VISION, V96, P290, DOI 10.1007/s11263-011-0472-9; Ji RR, 2014, IEEE T GEOSCI REMOTE, V52, P1811, DOI 10.1109/TGRS.2013.2255297; Ji RR, 2013, IEEE T MULTIMEDIA, V15, P153, DOI 10.1109/TMM.2012.2225035; Ji RR, 2012, IEEE T IMAGE PROCESS, V21, P2282, DOI 10.1109/TIP.2011.2176950; Ji RR, 2011, ACM T MULTIM COMPUT, V7, DOI 10.1145/2037676.2037688; Kim D, 2012, 2012 THIRD FTRA INTERNATIONAL CONFERENCE ON MOBILE, UBIQUITOUS, AND INTELLIGENT COMPUTING (MUSIC), P47, DOI 10.1109/MUSIC.2012.16; Lazebnik S, 2006, COMPUTER VISION PATT, P810; Lin Y, 2013, PROC CVPR IEEE, P446, DOI 10.1109/CVPR.2013.64; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Min WQ, 2014, IEEE T MULTIMEDIA, V16, P623, DOI 10.1109/TMM.2014.2302744; Nister D., 2006, IEEE COMP SOC C COMP, P2161, DOI DOI 10.1109/CVPR.2006.264; Nowak E, 2006, LECT NOTES COMPUT SC, V3954, P490; Schroth G, 2011, IEEE SIGNAL PROC MAG, V28, P77, DOI 10.1109/MSP.2011.940882; Sivic J, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P1470, DOI 10.1109/iccv.2003.1238663; Weiss Y, 2013, ADV NEURAL INFORM PR; Xiao X, 2012, IEEE T MULTIMEDIA, V14, P1246, DOI 10.1109/TMM.2012.2190384; Zhang S., 2009, ACM INT C MULT, DOI DOI 10.1145/1631272.1631285; Zhang SG, 2010, PROCEEDINGS OF THE ASME JOINT RAIL CONFERENCE, VOL 2, P501, DOI 10.1145/1873951.1874018; Zhang YM, 2011, PROC CVPR IEEE, P809, DOI 10.1109/CVPR.2011.5995528; Zhou W., 2010, P ACM INT C MULT, P511	45	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98806	10.1371/journal.pone.0098806	http://dx.doi.org/10.1371/journal.pone.0098806			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892288	gold, Green Published, Green Submitted			2022-12-27	WOS:000336911400095
J	Ndiath, MO; Mazenot, C; Sokhna, C; Trape, JF				Ndiath, Mamadou Ousmane; Mazenot, Catherine; Sokhna, Cheikh; Trape, Jean-Francois			RETRACTED: How the Malaria Vector Anopheles gambiae Adapts to the Use of Insecticide-Treated Nets by African Populations (Retracted article. See vol. 11, e0156196, 2016)	PLOS ONE			English	Article; Retracted Publication							IMPREGNATED BEDNETS; HOLOENDEMIC AREA; BED NETS; RESISTANCE; IDENTIFICATION; TRANSMISSION; BEHAVIOR; IMPACT; CULICIDAE; MOSQUITOS	Background: Insecticide treated bed nets have been recommended and proven efficient as a measure to protect African populations from malaria mosquito vector Anopheles spp. This study evaluates the consequences of bed nets use on vectors resistance to insecticides, their feeding behavior and malaria transmission in Dielmo village, Senegal, were LLINs were offered to all villagers in July 2008. Methods: Adult mosquitoes were collected monthly from January 2006 to December 2011 by human landing catches (HLC) and by pyrethroid spray catches (PCS). A randomly selected sub-sample of 15-20% of An. gambiae s.l. collected each month was used to investigate the molecular forms of the An. gambiae complex, kdr mutations, and Plasmodium falciparum circumsporozoite (CSP) rate. Malaria prevalence and gametocytaemia in Dielmo villagers were measured quarterly. Results: Insecticide susceptible mosquitoes (wild kdr genotype) presented a reduced lifespan after LLINs implementation but they rapidly adapted their feeding behavior, becoming more exophageous and zoophilic, and biting earlier during the night. In the meantime, insecticide-resistant specimens (kdr L1014F genotype) increased in frequency in the population, with an unchanged lifespan and feeding behaviour. P. falciparum prevalence and gametocyte rate in villagers decreased dramatically after LLINs deployment. Malaria infection rate tended to zero in susceptible mosquitoes whereas the infection rate increased markedly in the kdr homozygote mosquitoes. Conclusion: Dramatic changes in vector populations and their behavior occurred after the deployment of LLINs due to the extraordinary adaptative skills of An. gambiae s.l. mosquitoes. However, despite the increasing proportion of insecticide resistant mosquitoes and their almost exclusive responsibility in malaria transmission, the P. falciparum gametocyte reservoir continued to decrease three years after the deployment of LLINs.	[Ndiath, Mamadou Ousmane] Inst Pasteur, Grp G4, Inst Pasteur Int Network, Entomol Unit, Bangui, Cent Afr Republ; [Mazenot, Catherine; Trape, Jean-Francois] Inst Rech Dev, Lab Paludol & Zool Med, Dakar, Senegal; [Sokhna, Cheikh] Univ Aix Marseille, Unite Rech Malad Infect & Trop Emergentes, IRD198, UM63,CNRS7278,INSERMU1095, Dakar, Senegal	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite	Ndiath, MO (corresponding author), Inst Pasteur, Grp G4, Inst Pasteur Int Network, Entomol Unit, Bangui, Cent Afr Republ.	Ousmane.ndiath@gmail.com			French Ministry of Research; Department Support and Formation of the south communities of the Research Institute for the Development (IRD); G4 Bangui (CAR) fellowship, Institut Pasteur International Network	French Ministry of Research(Ministry of Research, FranceEuropean Commission); Department Support and Formation of the south communities of the Research Institute for the Development (IRD); G4 Bangui (CAR) fellowship, Institut Pasteur International Network	This work was supported by the French Ministry of Research and the Department Support and Formation of the south communities of the Research Institute for the Development (IRD). M. O. Ndiath was supported by a G4 Bangui (CAR) fellowship provided by Institut Pasteur International Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, COCHRANE DB SYST REV; BEIER JC, 1988, J MED ENTOMOL, V25, P9, DOI 10.1093/jmedent/25.1.9; BURKOT TR, 1984, AM J TROP MED HYG, V33, P227, DOI 10.4269/ajtmh.1984.33.227; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; Corbel V, 2012, LANCET INFECT DIS, V12, P617, DOI 10.1016/S1473-3099(12)70081-6; Curtis C. F., 2003, Journal of Vector Borne Diseases, V40, P1; Czeher C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-189; Diabate A, 2002, AM J TROP MED HYG, V67, P617, DOI 10.4269/ajtmh.2002.67.617; Donnelly MJ, 2009, TRENDS PARASITOL, V25, P213, DOI 10.1016/j.pt.2009.02.007; Enayati A, 2010, ANNU REV ENTOMOL, V55, P569, DOI 10.1146/annurev-ento-112408-085423; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Fegan GW, 2007, LANCET, V370, P1035, DOI 10.1016/S0140-6736(07)61477-9; Fontenille D, 1997, AM J TROP MED HYG, V56, P247, DOI 10.4269/ajtmh.1997.56.247; Fornadel CM, 2010, AM J TROP MED HYG, V83, P848, DOI 10.4269/ajtmh.2010.10-0242; Gillies M. T., 1968, PUBL S AFR I MED RES, V54, P343; Hemingway J, 2002, SCIENCE, V298, P96, DOI 10.1126/science.1078052; Lemasson JJ, 1997, J MED ENTOMOL, V34, P396, DOI 10.1093/jmedent/34.4.396; MAGESA SM, 1991, ACTA TROP, V49, P97, DOI 10.1016/0001-706X(91)90057-Q; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Mutuku FM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-356; Ndiath MO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031943; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Reddy MR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-184; Russell TL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-80; Russell TL, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-187; Shaukat AM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-122; Sougoufara S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-125; Trape JF, 2014, LANCET INFECT DIS, V14, P476, DOI 10.1016/S1473-3099(14)70712-1; Trape JF, 2012, J INFECT DIS, V205, P672, DOI 10.1093/infdis/jir805; Trape JF, 2011, LANCET INFECT DIS, V11, P925, DOI 10.1016/S1473-3099(11)70194-3; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; VULULE JM, 1994, MED VET ENTOMOL, V8, P71, DOI 10.1111/j.1365-2915.1994.tb00389.x; WHO, 2011, WORLD MALARIA REPORT 2011, P1	35	25	25	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e97700	10.1371/journal.pone.0097700	http://dx.doi.org/10.1371/journal.pone.0097700			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892677	Green Published, gold			2022-12-27	WOS:000336911400018
J	Stewart, DR; Pemov, A; Johnston, JJ; Sapp, JC; Yeager, M; He, J; Boland, JF; Burdett, L; Brown, C; Gatti, RA; Alter, BP; Biesecker, LG; Savage, SA				Stewart, Douglas R.; Pemov, Alexander; Johnston, Jennifer J.; Sapp, Julie C.; Yeager, Meredith; He, Ji; Boland, Joseph F.; Burdett, Laurie; Brown, Christina; Gatti, Richard A.; Alter, Blanche P.; Biesecker, Leslie G.; Savage, Sharon A.			Dubowitz Syndrome Is a Complex Comprised of Multiple, Genetically Distinct and Phenotypically Overlapping Disorders	PLOS ONE			English	Article							DNA-LIGASE-IV; SEVERE COMBINED IMMUNODEFICIENCY; TELOMERE BIOLOGY DISORDERS; NIJMEGEN BREAKAGE SYNDROME; NEUTRAL COMET ASSAY; DYSKERATOSIS-CONGENITA; ATAXIA-TELANGIECTASIA; HUMAN-PAPILLOMAVIRUS; CARNEY COMPLEX; ANAL CANCER	Dubowitz syndrome is a rare disorder characterized by multiple congenital anomalies, cognitive delay, growth failure, an immune defect, and an increased risk of blood dyscrasia and malignancy. There is considerable phenotypic variability, suggesting genetic heterogeneity. We clinically characterized and performed exome sequencing and high-density array SNP genotyping on three individuals with Dubowitz syndrome, including a pair of previously-described siblings (Patients 1 and 2, brother and sister) and an unpublished patient (Patient 3). Given the siblings' history of bone marrow abnormalities, we also evaluated telomere length and performed radiosensitivity assays. In the siblings, exome sequencing identified compound heterozygosity for a known rare nonsense substitution in the nuclear ligase gene LIG4 (rs104894419, NM_002312.3:c.2440C>T) that predicts p.Arg814X (MAF:0.0002) and an NM_002312.3:c.613delT variant that predicts a p.Ser205Leufs*29 frameshift. The frameshift mutation has not been reported in 1000 Genomes, ESP, or ClinSeq. These LIG4 mutations were previously reported in the sibling sister; her brother had not been previously tested. Western blotting showed an absence of a ligase IV band in both siblings. In the third patient, array SNP genotyping revealed a de novo similar to 3.89 Mb interstitial deletion at chromosome 17q24.2 (chr 17:62,068,463-65,963,102, hg18), which spanned the known Carney complex gene PRKAR1A. In all three patients, a median lymphocyte telomere length of <= 1st centile was observed and radiosensitivity assays showed increased sensitivity to ionizing radiation. Our work suggests that, in addition to dyskeratosis congenita, LIG4 and 17q24.2 syndromes also feature shortened telomeres; to confirm this, telomere length testing should be considered in both disorders. Taken together, our work and other reports on Dubowitz syndrome, as currently recognized, suggest that it is not a unitary entity but instead a collection of phenotypically similar disorders. As a clinical entity, Dubowitz syndrome will need continual re-evaluation and re-definition as its constituent phenotypes are determined.	[Stewart, Douglas R.; Pemov, Alexander; Alter, Blanche P.; Savage, Sharon A.] NCI, Clin Genet Branch, Div Canc Epidemiol & Genet, NIH, Rockville, MD 20892 USA; [Johnston, Jennifer J.; Sapp, Julie C.; Biesecker, Leslie G.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; [Yeager, Meredith; He, Ji; Boland, Joseph F.; Burdett, Laurie] NCI, Canc Genom Res Lab, Div Canc Epidemiol & Genet, NIH, Rockville, MD USA; [Brown, Christina; Gatti, Richard A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Gatti, Richard A.] David Geffen UCLA Sch Med, Dept Human Genet, Los Angeles, CA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Stewart, DR (corresponding author), NCI, Clin Genet Branch, Div Canc Epidemiol & Genet, NIH, Rockville, MD 20892 USA.	drstewart@mail.nih.gov	Yeager, Meredith/AAA-5322-2020; Savage, Sharon/AAB-5160-2019; Savage, Sharon A/B-9747-2015	Savage, Sharon/0000-0001-6006-0740; Savage, Sharon A/0000-0001-6006-0740; Sapp, Julie/0000-0002-4003-258X	Division of Intramural Research of the National Human Genome Research Institute (NHGRI); Division of Cancer Epidemiology and Genetics (DCEG) of the National Cancer Institute's Intramural Research Program; NATIONAL CANCER INSTITUTE [ZIACP010144] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200388, ZIAHG200328] Funding Source: NIH RePORTER	Division of Intramural Research of the National Human Genome Research Institute (NHGRI); Division of Cancer Epidemiology and Genetics (DCEG) of the National Cancer Institute's Intramural Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the Division of Intramural Research of the National Human Genome Research Institute (NHGRI) and the Division of Cancer Epidemiology and Genetics (DCEG) of the National Cancer Institute's Intramural Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 1999, AM J MED GENET, V86, P503, DOI 10.1002/(SICI)1096-8628(19991029)86:5<503::AID-AJMG21>3.0.CO;2-Y; Alter BP, 2007, BLOOD, V110, P1439, DOI 10.1182/blood-2007-02-075598; Alter BP, 2012, HAEMATOL-HEMATOL J, V97, P353, DOI 10.3324/haematol.2011.055269; Baerlocher GM, 2006, NAT PROTOC, V1, P2365, DOI 10.1038/nprot.2006.263; Ballew BJ, 2013, EXPERT REV HEMATOL, V6, P327, DOI [10.1586/EHM.13.23, 10.1586/ehm.13.23]; Ballew BJ, 2013, HUM GENET, V132, P473, DOI 10.1007/s00439-013-1265-8; Ben-Omran TI, 2005, AM J MED GENET A, V137A, P283, DOI 10.1002/ajmg.a.30869; Blyth M, 2008, EUR J MED GENET, V51, P672, DOI 10.1016/j.ejmg.2008.09.002; Buck D, 2006, EUR J IMMUNOL, V36, P224, DOI 10.1002/eji.200535401; Cabuy E, 2005, RADIAT RES, V164, P53, DOI 10.1667/RR3376; Chistiakov DA, 2010, ADV EXP MED BIOL, V685, P175; Christiansen A, 2013, CANCER LETT, V331, P18, DOI 10.1016/j.canlet.2012.12.013; Chun HH, 2003, MOL GENET METAB, V80, P437, DOI 10.1016/j.ymgme.2003.09.008; Daling JR, 2004, CANCER-AM CANCER SOC, V101, P270, DOI 10.1002/cncr.20365; Darcy DC, 2011, CASE REP GENET, V2011; di Fagagna FD, 2001, CURR BIOL, V11, P1192, DOI 10.1016/S0960-9822(01)00328-1; DUBOWITZ V, 1965, J Med Genet, V2, P12, DOI 10.1136/jmg.2.1.12; Enders A, 2006, J IMMUNOL, V176, P5060, DOI 10.4049/jimmunol.176.8.5060; Gruhn B, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-5; Grunebaum E, 2008, J ALLERGY CLIN IMMUN, V122, P1219, DOI 10.1016/j.jaci.2008.08.031; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Hasgall PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022107; Hennekam RCM, 2010, GORLINS SYNDROMES HE, P434; Jayakumar S, 2012, MUTAT RES-GEN TOX EN, V748, P52, DOI 10.1016/j.mrgentox.2012.06.008; Johnson LG, 2004, CANCER-AM CANCER SOC, V101, P281, DOI 10.1002/cncr.20364; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; Lestner JM, 2012, EUR J MED GENET, V55, P700, DOI 10.1016/j.ejmg.2012.08.003; Maas N, 2006, GENET COUNSEL, V17, P477; Martinez FJ, 2012, J MED GENET, V49, P380, DOI 10.1136/jmedgenet-2011-100686; Nahas SA, 2012, RADIAT RES, V177, P176, DOI 10.1667/RR2580.1; O'Driscoll M, 2001, MOL CELL, V8, P1175, DOI 10.1016/S1097-2765(01)00408-7; Oh S, 2013, NUCLEIC ACIDS RES, V41, P1734, DOI 10.1093/nar/gks1326; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; OPITZ JM, 1973, Z KINDERHEILKD, V116, P1, DOI 10.1007/BF00438824; Pardo B, 2005, EMBO J, V24, P3117, DOI 10.1038/sj.emboj.7600778; PLOWMAN PN, 1990, BRIT J RADIOL, V63, P624, DOI 10.1259/0007-1285-63-752-624; Priori SG, 2005, CIRC RES, V96, P800, DOI 10.1161/01.RES.0000162101.76263.8c; Riballo E, 1999, CURR BIOL, V9, P699, DOI 10.1016/S0960-9822(99)80311-X; Savage SA, 2010, GENET MED, V12, P753, DOI 10.1097/GIM.0b013e3181f415b5; Sun M, 2009, AM J HUM GENET, V84, P807, DOI 10.1016/j.ajhg.2009.04.018; Sun X, 2002, J PEDIATR-US, V140, P724, DOI 10.1067/mpd.2002.123879; Teer JK, 2010, GENOME RES, V20, P1420, DOI 10.1101/gr.106716.110; Teo SH, 1997, EMBO J, V16, P4788, DOI 10.1093/emboj/16.15.4788; Toita N, 2007, AM J MED GENET A, V143A, P742, DOI 10.1002/ajmg.a.31644; Tseng SF, 2005, J BIOL CHEM, V280, P39594, DOI 10.1074/jbc.M508425200; Tsukahara M, 1996, AM J MED GENET, V63, P277; Unal S, 2009, PEDIATR BLOOD CANCER, V53, P482, DOI 10.1002/pbc.22031; van der Burg M, 2006, J CLIN INVEST, V116, P137, DOI 10.1172/JCI26121; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Vergult S, 2012, EUR J HUM GENET, V20, P534, DOI 10.1038/ejhg.2011.239; WALTERS TR, 1985, J PEDIATR-US, V106, P622, DOI 10.1016/S0022-3476(85)80089-5; Yamada M, 2001, AM J MED GENET, V100, P9, DOI 10.1002/1096-8628(20010415)100:1<9::AID-AJMG1200>3.0.CO;2-0; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551; Yue JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054389; Zandberg DP, 2013, CA-CANCER J CLIN, V63, P57, DOI 10.3322/caac.21167	55	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98686	10.1371/journal.pone.0098686	http://dx.doi.org/10.1371/journal.pone.0098686			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892279	Green Submitted, Green Published, gold			2022-12-27	WOS:000336911400085
J	Ali, H; Ries, MI; Lankhorst, PP; van der Hoeven, RAM; Schouten, OL; Noga, M; Hankemeier, T; van Peij, NNME; Bovenberg, RAL; Vreeken, RJ; Driessen, AJM				Ali, Hazrat; Ries, Marco I.; Lankhorst, Peter P.; van der Hoeven, Rob A. M.; Schouten, Olaf L.; Noga, Marek; Hankemeier, Thomas; van Peij, Noel N. M. E.; Bovenberg, Roel A. L.; Vreeken, Rob J.; Driessen, Arnold J. M.			A Non-Canonical NRPS Is Involved in the Synthesis of Fungisporin and Related Hydrophobic Cyclic Tetrapeptides in Penicillium chrysogenum	PLOS ONE			English	Article							ASSEMBLY-LINE ENZYMOLOGY; ADENYLATION DOMAIN; SYNTHETASE; YERSINIABACTIN; BIOSYNTHESIS; EXPRESSION; PURIFICATION; BIOGENESIS; POLYKETIDE; GENES	The filamentous fungus Penicillium chrysogenum harbors an astonishing variety of nonribosomal peptide synthetase genes, which encode proteins known to produce complex bioactive metabolites from simple building blocks. Here we report a novel non-canonical tetra-modular nonribosomal peptide synthetase (NRPS) with microheterogenicity of all involved adenylation domains towards their respective substrates. By deleting the putative gene in combination with comparative metabolite profiling various unique cyclic and derived linear tetrapeptides were identified which were associated with this NRPS, including fungisporin. In combination with substrate predictions for each module, we propose a mechanism for a 'trans-acting' adenylation domain.	[Ali, Hazrat; Driessen, Arnold J. M.] Univ Groningen, Zernike Inst Adv Mat, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands; [Ali, Hazrat; Driessen, Arnold J. M.] Kluyver Ctr Genom Ind Fermentat, Delft, Netherlands; [Ries, Marco I.; Noga, Marek; Hankemeier, Thomas; Vreeken, Rob J.] Leiden Univ, Leiden Acad Ctr Drug Res, Div Analyt Biosci, Leiden, Netherlands; [Lankhorst, Peter P.; van der Hoeven, Rob A. M.; Schouten, Olaf L.; van Peij, Noel N. M. E.; Bovenberg, Roel A. L.] DSM Biotechnol Ctr, Delft, Netherlands; [Noga, Marek; Hankemeier, Thomas; Vreeken, Rob J.] Leiden Univ, Netherlands Metabol Ctr, Leiden, Netherlands; [Bovenberg, Roel A. L.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands	University of Groningen; Leiden University; Leiden University - Excl LUMC; DSM NV; Leiden University; Leiden University - Excl LUMC; University of Groningen	Driessen, AJM (corresponding author), Univ Groningen, Zernike Inst Adv Mat, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands.	a.j.m.driessen@rug.nl	Vreeken, Rob/AAA-4563-2021; Noga, Marek/O-4983-2016; Institute, Zernike/W-7033-2019; Hankemeier, Thomas/V-5407-2019; Driessen, Arnold J.M./D-1876-2012	Noga, Marek/0000-0001-8352-611X; Hankemeier, Thomas/0000-0001-7871-2073; Vreeken, Rob/0000-0003-3568-1371; Driessen, Arnold J.M./0000-0001-9258-9104; Lankhorst, Peter/0000-0002-0373-5673	STW (Stichting Technische Wetenschappen) in the framework of the Genbiotics Perspectief Programme; Higher education commission Pakistan (HEC)	STW (Stichting Technische Wetenschappen) in the framework of the Genbiotics Perspectief Programme; Higher education commission Pakistan (HEC)(Higher Education Commission of Pakistan)	HA and MR were supported by STW (Stichting Technische Wetenschappen) in the framework of the Genbiotics Perspectief Programme. HA was also supported by Higher education commission Pakistan (HEC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065328; ALVAREZ E, 1987, ANTIMICROB AGENTS CH, V31, P1675, DOI 10.1128/AAC.31.11.1675; Baltz RH, 2011, J IND MICROBIOL BIOT, V38, P1747, DOI 10.1007/s10295-011-1022-8; Bleiholder C, 2008, J AM CHEM SOC, V130, P17774, DOI 10.1021/ja805074d; COHEN SA, 1993, ANAL BIOCHEM, V211, P279, DOI 10.1006/abio.1993.1270; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Doekel S, 2008, MICROBIOL-SGM, V154, P2872, DOI 10.1099/mic.0.2008/020685-0; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Frisvad JC, 2004, STUD MYCOL, P201; Gao X, 2012, NAT CHEM BIOL, V8, P823, DOI 10.1038/NCHEMBIO.1047; Garcia-Estrada C, 2011, CHEM BIOL, V18, P1499, DOI 10.1016/j.chembiol.2011.08.012; Gehring AM, 1998, BIOCHEMISTRY-US, V37, P11637, DOI 10.1021/bi9812571; Gehring AM, 1998, CHEM BIOL, V5, P573, DOI 10.1016/S1074-5521(98)90115-6; Grunewald J, 2006, MICROBIOL MOL BIOL R, V70, P121, DOI 10.1128/MMBR.70.1.121-146.2006; Harju S, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-8; Keating TA, 2001, CHEMBIOCHEM, V2, P99, DOI 10.1002/1439-7633(20010202)2:2<99::AID-CBIC99>3.0.CO;2-3; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; KOLAR M, 1988, GENE, V62, P127, DOI 10.1016/0378-1119(88)90586-0; Kovalchuk A, 2012, METHODS MOL BIOL, V835, P1, DOI 10.1007/978-1-61779-501-5_1; MIYAO K, 1960, B AGR CHEM SOC JAPAN, V24, P23, DOI 10.1080/03758397.1960.10857626; Mootz HD, 2002, CHEMBIOCHEM, V3, P490, DOI 10.1002/1439-7633(20020603)3:6<490::AID-CBIC490>3.0.CO;2-N; Nijland JG, 2008, FUNGAL GENET BIOL, V45, P1415, DOI 10.1016/j.fgb.2008.07.008; Noga MJ, 2012, METABOLOMICS, V8, P253, DOI 10.1007/s11306-011-0306-3; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Perez-Victoria I, 2012, J NAT PROD, V75, P1210, DOI 10.1021/np3000987; Rottig M, 2011, NUCLEIC ACIDS RES, V39, pW362, DOI 10.1093/nar/gkr323; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schwarzer D, 2003, NAT PROD REP, V20, P275, DOI 10.1039/b111145k; Shaw-Reid CA, 1999, CHEM BIOL, V6, P385, DOI 10.1016/S1074-5521(99)80050-7; Stevens BW, 2006, BIOCHEMISTRY-US, V45, P15495, DOI 10.1021/bi061788m; STUDER RO, 1969, EXPERIENTIA, V25, P899, DOI 10.1007/BF01898048; Sussmuth R, 2011, NAT PROD REP, V28, P99, DOI 10.1039/c001463j; Suo ZC, 2001, P NATL ACAD SCI USA, V98, P99, DOI 10.1073/pnas.021537498; van den Berg MA, 2008, NAT BIOTECHNOL, V26, P1161, DOI 10.1038/nbt.1498; Wyatt MA, 2012, CHEMBIOCHEM, V13, P2408, DOI 10.1002/cbic.201200340; Zhang K, 2013, CHEM BIOL, V20, P92, DOI 10.1016/j.chembiol.2012.10.020	36	28	29	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98212	10.1371/journal.pone.0098212	http://dx.doi.org/10.1371/journal.pone.0098212			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887561	Green Published, gold, Green Submitted			2022-12-27	WOS:000336956300047
J	Kosiorek, M; Podszywalow-Bartnicka, P; Zylinska, L; Pikula, S				Kosiorek, Michalina; Podszywalow-Bartnicka, Paulina; Zylinska, Ludmila; Pikula, Slawomir			NFAT1 and NFAT3 Cooperate with HDAC4 during Regulation of Alternative Splicing of PMCA Isoforms in PC12 Cells	PLOS ONE			English	Article							PLASMA-MEMBRANE CA2+-ATPASE; ACTIVATED T-CELLS; GATED CALCIUM-CHANNELS; NONCODING RNAS; FUNCTIONAL DIVERSITY; NERVOUS-SYSTEM; TRANSCRIPTION; EXPRESSION; GENE; MECHANISMS	Background: The bulk of human genes undergo alternative splicing (AS) upon response to physiological stimuli. AS is a great source of protein diversity and biological processes and is associated with the development of many diseases. Pheochromocytoma is a neuroendocrine tumor, characterized by an excessive Ca2+-dependent secretion of catecholamines. This underlines the importance of balanced control of calcium transport via regulation of gene expression pattern, including different calcium transport systems, such as plasma membrane Ca2+-ATPases (PMCAs), abundantly expressed in pheochromocytoma chromaffin cells (PC12 cells). PMCAs are encoded by four genes (Atp2b1, Atp2b2, Atp2b3, Atp2b4), whose transcript products undergo alternative splicing giving almost 30 variants. Results: In this scientific report, we propose a novel mechanism of regulation of PMCA alternative splicing in PC12 cells through cooperation of the nuclear factor of activated T-cells (NFAT) and histone deacetylases (HDACs). Luciferase assays showed increased activity of NFAT in PC12 cells, which was associated with altered expression of PMCA. RT-PCR experiments suggested that inhibition of the transcriptional activity of NFAT might result in the rearrangement of PMCA splicing variants in PC12 cells. NFAT inhibition led to dominant expression of 2x/c, 3x/a and 4x/a PMCA variants, while in untreated cells the 2w, z/b, 3z, x/b, c, e, f, and 4x/b variants were found as well. Furthermore, chromatin immunoprecipitation experiments showed that NFAT1-HDAC4 or NFAT3-HDAC4 complexes might be involved in regulation of PMCA2x splicing variant generation. Conclusions: We suggest that the influence of NFAT/HDAC on PMCA isoform composition might be important for altered dopamine secretion by PC12 cells.	[Kosiorek, Michalina; Pikula, Slawomir] M Nencki Inst Expt Biol, Dept Biochem, PL-02093 Warsaw, Poland; [Kosiorek, Michalina] Mossakowski Med Res Ctr PAS, Dept Neurodegenerat Disorders, Neurogenet Lab, Warsaw, Poland; [Podszywalow-Bartnicka, Paulina] M Nencki Inst Expt Biol, Lab Cytometry, PL-02093 Warsaw, Poland; [Zylinska, Ludmila] Med Univ Lodz, Dept Mol Neurochem, Lodz, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Medical University Lodz	Pikula, S (corresponding author), M Nencki Inst Expt Biol, Dept Biochem, PL-02093 Warsaw, Poland.	s.pikula@nencki.gov.pl	Wężyk, Michalina Maria/R-2208-2018; Zylinska, Ludmila/ABE-9113-2020	Wężyk, Michalina Maria/0000-0001-7498-4610; Zylinska, Ludmila/0000-0002-3876-8942; Podszywalow-Bartnicka, Paulina/0000-0002-4965-828X; Pikula, Slawomir/0000-0003-4640-3094				Abraham F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037750; Abramowitz J, 2000, J MOL CELL CARDIOL, V32, P777, DOI 10.1006/jmcc.2000.1120; Allen SE, 2010, CHANNELS, V4, P483, DOI 10.4161/chan.4.6.12868; Asadi S, 2009, J MOL NEUROSCI, V39, P40, DOI 10.1007/s12031-008-9159-2; Auboeuf D, 2004, MOL CELL BIOL, V24, P442, DOI 10.1128/MCB.24.1.442-453.2004; Badran BM, 2002, J BIOL CHEM, V277, P47136, DOI 10.1074/jbc.M206330200; Barrandon C, 2008, BIOL CELL, V100, P83, DOI 10.1042/BC20070090; Berglund L, 1996, BIOCHEM BIOPH RES CO, V264, P777; Bonnal S, 2012, NAT REV DRUG DISCOV, V11, P847, DOI 10.1038/nrd3823; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Calarco JA, 2009, CELL, V138, P898, DOI 10.1016/j.cell.2009.06.012; Cano E, 2005, J BIOL CHEM, V280, P29435, DOI 10.1074/jbc.M506205200; Carafoli E, 2000, CURR OPIN CHEM BIOL, V4, P152, DOI 10.1016/S1367-5931(99)00069-1; Chasin LA, 2007, ADV EXP MED BIOL, V623, P85, DOI 10.1007/978-0-387-77374-2_6; Chen Lu, 2012, Int J Evol Biol, V2012, P596274, DOI 10.1155/2012/596274; Chiang CS, 2009, CIRC RES, V104, P522, DOI 10.1161/CIRCRESAHA.108.184051; Choo MK, 2009, BONE, V45, P579, DOI 10.1016/j.bone.2009.05.009; Cramer P, 1999, MOL CELL, V4, P251, DOI 10.1016/S1097-2765(00)80372-X; Cramer P, 1997, P NATL ACAD SCI USA, V94, P11456, DOI 10.1073/pnas.94.21.11456; Delcuve GP, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-5; Desai-Shah M, 2009, SYNAPSE, V63, P1100, DOI 10.1002/syn.20695; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; Domi T, 2007, ANN NY ACAD SCI, V1099, P237, DOI 10.1196/annals.1387.043; Duman JG, 2008, J GEN PHYSIOL, V131, P307, DOI 10.1085/jgp.200709915; Enyedi Agnes, 2011, Commun Integr Biol, V4, P340, DOI 10.4161/cib.4.3.15040; Garcia AG, 2006, PHYSIOL REV, V86, P1093, DOI 10.1152/physrev.00039.2005; Garg K, 2007, GENOME RES, V17, P1015, DOI 10.1101/gr.6347907; Girard C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1998; Grabowski P, 2011, CURR OPIN GENET DEV, V21, P388, DOI 10.1016/j.gde.2011.03.005; Grabowski PJ, 2001, PROG NEUROBIOL, V65, P289, DOI 10.1016/S0301-0082(01)00007-7; Gunderson FQ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000682; Habib T, 2007, J CELL BIOL, V179, P717, DOI 10.1083/jcb.200704173; Han SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Holton Mary Louisa, 2010, World J Biol Chem, V1, P201, DOI 10.4331/wjbc.v1.i6.201; Isenmann S, 1998, MOL BIOL CELL, V9, P1649, DOI 10.1091/mbc.9.7.1649; Jonas JC, 2001, J BIOL CHEM, V276, P35375, DOI 10.1074/jbc.M105020200; Kamagate A, 2000, CELL CALCIUM, V27, P231, DOI 10.1054/ceca.2000.0116; Kee HJ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/928326; Kelemen O, 2013, GENE, V514, P1, DOI 10.1016/j.gene.2012.07.083; Kim E, 2008, BIOESSAYS, V30, P38, DOI 10.1002/bies.20692; Kim HJ, 2012, J CELL BIOL, V199, P1145, DOI 10.1083/jcb.201204067; Kornblihtt AR, 2005, CURR OPIN CELL BIOL, V17, P262, DOI 10.1016/j.ceb.2005.04.014; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; Kosiorek M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092176; Kosiorek M, 2011, BIOCHEM BIOPH RES CO, V411, P235, DOI 10.1016/j.bbrc.2011.06.098; Langland JO, 1999, BIOCHEMISTRY-US, V38, P6361, DOI 10.1021/bi982410u; Lee CJ, 2003, BIOL PSYCHIAT, V54, P771, DOI 10.1016/S0006-3223(03)00375-5; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Liao P, 2009, PFLUG ARCH EUR J PHY, V458, P481, DOI 10.1007/s00424-009-0635-5; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Ling JQ, 2007, PEDIATR RES, V61, p11R, DOI 10.1203/pdr.0b013e31804575db; Lipscombe D, 2013, BBA-BIOMEMBRANES, V1828, P1522, DOI 10.1016/j.bbamem.2012.09.018; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Loomis RJ, 2009, MOL CELL, V33, P450, DOI 10.1016/j.molcel.2009.02.003; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Mammucari C, 2005, DEV CELL, V8, P665, DOI 10.1016/j.devcel.2005.02.016; Mascarell L, 2006, MOL IMMUNOL, V43, P1846, DOI 10.1016/j.molimm.2005.10.019; Mercer TR, 2013, NAT STRUCT MOL BIOL, V20, P300, DOI 10.1038/nsmb.2480; Misteli T, 1999, MOL CELL, V3, P697, DOI 10.1016/S1097-2765(01)80002-2; Nagy G, 2005, MOL BIOL CELL, V16, P5675, DOI 10.1091/mbc.E05-07-0595; Nakayama T, 2012, J CELL SCI, V125, P817, DOI 10.1242/jcs.081943; Nilsson LM, 2008, FASEB J S, V22, P49; Nogues G, 2002, J BIOL CHEM, V277, P43110, DOI 10.1074/jbc.M208418200; Oceandy D, 2007, BIOCHEM SOC T, V35, P927, DOI 10.1042/BST0350927; Pagani F, 2003, J BIOL CHEM, V278, P1511, DOI 10.1074/jbc.M209676200; Pandya-Jones A, 2009, RNA, V15, P1896, DOI 10.1261/rna.1714509; Quednau BD, 1997, AM J PHYSIOL-CELL PH, V272, pC1250, DOI 10.1152/ajpcell.1997.272.4.C1250; Ranger AM, 2000, J EXP MED, V191, P9, DOI 10.1084/jem.191.1.9; Reddy ASN, 2007, ANNU REV PLANT BIOL, V58, P267, DOI 10.1146/annurev.arplant.58.032806.103754; Santoro M, 2013, NEUROPATHOL APPL NEU, V29, DOI [10.1111/nap.12076, DOI 10.1111/NAP.12076]; Santoro M, 2013, MOL CELL BIOCHEM, V380, P259, DOI 10.1007/s11010-013-1681-z; Shen TS, 2006, J MUSCLE RES CELL M, V27, P405, DOI 10.1007/s10974-006-9080-7; Shubair M, 2012, MOL CELL BIOCHEM, V370, P15, DOI 10.1007/s11010-012-1393-9; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Sudhof T. C., 2011, CSH PERSPECT BIOL, V3, P3, DOI DOI 10.1101/CSHPERSPECT.A005637; Talarico EF, 2007, EXP EYE RES, V85, P869, DOI 10.1016/j.exer.2007.08.023; UNSICKER K, 1993, J ANAT, V183, P207; Van Eylen F, 2001, CELL CALCIUM, V30, P191, DOI 10.1054/ceca.2001.0223; Venables JP, 2012, NUCLEIC ACIDS RES, V40, P1, DOI 10.1093/nar/gkr648; Waguespack SG, 2010, J CLIN ENDOCR METAB, V95, P2023, DOI 10.1210/jc.2009-2830; Waks Z, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.32; Walters RD, 2013, MOL IMMUNOL, V56, P48, DOI 10.1016/j.molimm.2013.03.022; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Xie JY, 2008, BBA-GENE REGUL MECH, V1779, P438, DOI 10.1016/j.bbagrm.2008.01.003; Ximenes HM, 2003, J BIOL CHEM, V278, P22956, DOI 10.1074/jbc.M212339200; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zaidi A, 2010, WORLD J BIOL CHEM, V1, P271, DOI DOI 10.4331/WJBC.V1.I9.271; Zylinska L, 2007, ANN NY ACAD SCI, V1099, P254, DOI 10.1196/annals.1387.008	91	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99118	10.1371/journal.pone.0099118	http://dx.doi.org/10.1371/journal.pone.0099118			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905014	Green Published, gold, Green Submitted			2022-12-27	WOS:000341869000105
J	Midorikawa, K; Kuroda, M; Terauchi, K; Hoshi, M; Ikenaga, S; Ishimaru, Y; Abe, K; Asakura, T				Midorikawa, Keiko; Kuroda, Masaharu; Terauchi, Kaede; Hoshi, Masako; Ikenaga, Sachiko; Ishimaru, Yoshiro; Abe, Keiko; Asakura, Tomiko			Additional Nitrogen Fertilization at Heading Time of Rice Down-Regulates Cellulose Synthesis in Seed Endosperm	PLOS ONE			English	Article							SUCROSE SYNTHASE; ALPHA-AMYLASE; GENE-EXPRESSION; PROTEIN BODIES; CULTURED-CELLS; ARABIDOPSIS; METABOLISM; PLANTS; WALL; MICROARRAY	The balance between carbon and nitrogen is a key determinant of seed storage components, and thus, is of great importance to rice and other seed-based food crops. To clarify the influence of the rhizosphere carbon/nitrogen balance during the maturation stage of several seed components, transcriptome analysis was performed on the seeds from rice plants that were provided additional nitrogen fertilization at heading time. As a result, it was assessed that genes associated with molecular processes such as photosynthesis, trehalose metabolism, carbon fixation, amino acid metabolism, and cell wall metabolism were differentially expressed. Moreover, cellulose and sucrose synthases, which are involved in cellulose synthesis, were down-regulated. Therefore, we compared cellulose content of mature seeds that were treated with additional nitrogen fertilization with those from control plants using calcofluor staining. In these experiments, cellulose content in endosperm from plants receiving additional nitrogen fertilization was less than that in control endosperm. Other starch synthesis-related genes such as starch synthase 1, starch phosphorylase 2, and branching enzyme 3 were also down-regulated, whereas some alpha-amylase and beta-amylase genes were up-regulated. On the other hand, mRNA expression of amino acid biosynthesis-related molecules was up-regulated. Moreover, additional nitrogen fertilization caused accumulation of storage proteins and up-regulated Cys-poor prolamin mRNA expression. These data suggest that additional nitrogen fertilization at heading time changes the expression of some storage substance-related genes and reduces cellulose levels in endosperm.	[Midorikawa, Keiko; Terauchi, Kaede; Hoshi, Masako; Ishimaru, Yoshiro; Abe, Keiko; Asakura, Tomiko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo, Japan; [Kuroda, Masaharu] NARO Agr Res Ctr, Crop Dev Div, Niigata, Japan; [Ikenaga, Sachiko] NARO Tohoku Agr Res Ctr, Field Crop & Hort Res Div, Morioka, Iwate, Japan; [Abe, Keiko] Kanagawa Acad Sci & Technol, Food Safety & Reliabil Project, Takatsu Ku, Kawasaki, Kanagawa, Japan	University of Tokyo; National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan; Kanagawa Academy Science & Technology	Kuroda, M (corresponding author), NARO Agr Res Ctr, Crop Dev Div, Niigata, Japan.	kurodama@affrc.go.jp; asakura@mail.ecc.u-tokyo.ac.jp	Ishimaru, Yoshiro/AAI-3049-2020	Midorikawa, Keiko/0000-0003-2297-1564	Nissin Food Holdings Co., LTD; Tojuro Iijima Foundation for Food Science and Technology; Grants-in-Aid for Scientific Research [26242007] Funding Source: KAKEN	Nissin Food Holdings Co., LTD; Tojuro Iijima Foundation for Food Science and Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Nissin Food Holdings Co., LTD (http://www.nissinfoods-holdings.co.jp/). It was supported by grant in aid for food science research to T. A. and M. K. from the Tojuro Iijima Foundation for Food Science and Technology (http://www.iijima-kinenzaidan.or.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akihiro T, 2005, PLANT CELL PHYSIOL, V46, P937, DOI 10.1093/pcp/pci101; AMOR Y, 1995, P NATL ACAD SCI USA, V92, P9353, DOI 10.1073/pnas.92.20.9353; Atanassov II, 2009, J BIOL CHEM, V284, P3833, DOI 10.1074/jbc.M807456200; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Brown DM, 2005, PLANT CELL, V17, P2281, DOI 10.1105/tpc.105.031542; Burton RA, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00130; Chen ZX, 2007, BIOINFORMATICS, V23, P321, DOI 10.1093/bioinformatics/btl609; Fabian C, 2011, CRIT REV FOOD SCI, V51, P816, DOI 10.1080/10408398.2010.482678; Foyer CH, 2003, J EXP BOT, V54, P585, DOI 10.1093/jxb/erg053; Fujii S, 2010, PLANT CELL PHYSIOL, V51, P294, DOI 10.1093/pcp/pcp190; Hirose T, 2008, PLANT SCI, V174, P534, DOI 10.1016/j.plantsci.2008.02.009; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang JW, 1996, BIOSCI BIOTECH BIOCH, V60, P233, DOI 10.1271/bbb.60.233; KARRER EE, 1992, PLANT J, V2, P517; Ken'ichi O, 1993, JAPAN AGR RES Q, P95; King SP, 1997, PLANT PHYSIOL, V114, P153, DOI 10.1104/pp.114.1.153; Kuroda M, 2010, BIOSCI BIOTECH BIOCH, V74, P2348, DOI 10.1271/bbb.100465; Lian XM, 2006, PLANT MOL BIOL, V60, P617, DOI 10.1007/s11103-005-5441-7; Matsushima S, 1995, SCI RICE PLANT, P753; OGAWA M, 1987, PLANT CELL PHYSIOL, V28, P1517; Okadome H, 2005, JARQ-JPN AGR RES Q, V39, P261, DOI 10.6090/jarq.39.261; Price J, 2004, PLANT CELL, V16, P2128, DOI 10.1105/tpc.104.022616; Rolland F, 2002, PLANT CELL, V14, pS185, DOI 10.1105/tpc.010455; Saito Y, 2008, BIOSCI BIOTECH BIOCH, V72, P2779, DOI 10.1271/bbb.80337; Saito Y, 2012, PLANT J, V70, P1043, DOI 10.1111/j.1365-313X.2012.04947.x; Scheible WR, 1997, PLANT CELL, V9, P783, DOI 10.1105/tpc.9.5.783; SHIBUYA N, 1985, CEREAL CHEM, V62, P252; Shigemitsu T, 2012, BIOSCI BIOTECH BIOCH, V76, P594, DOI 10.1271/bbb.110791; Stitt M, 2002, J EXP BOT, V53, P959, DOI 10.1093/jexbot/53.370.959; Suzuki Kiyoshi, 2005, Functional & Integrative Genomics, V5, P117, DOI 10.1007/s10142-004-0125-y; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Taira H, 1995, SCI RICE PLANT, P1064; Tanaka K, 2003, PLANT PHYSIOL, V133, P73, DOI 10.1104/pp.103.022442; TANAKA Y, 1975, AGR BIOL CHEM TOKYO, V39, P515, DOI 10.1080/00021369.1975.10861629; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Thum KE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r10; Umemura T, 1998, PLANTA, V204, P420, DOI 10.1007/s004250050275; Usuda H, 1999, PLANT CELL PHYSIOL, V40, P369, DOI 10.1093/oxfordjournals.pcp.a029552; Wang RC, 2000, PLANT CELL, V12, P1491, DOI 10.1105/tpc.12.8.1491; Wang RC, 2003, PLANT PHYSIOL, V132, P556, DOI 10.1104/pp.103.021253; Yamakawa H, 2010, PLANT CELL PHYSIOL, V51, P795, DOI 10.1093/pcp/pcq034; YU SM, 1991, J BIOL CHEM, V266, P21131; Zhou ZK, 2002, INT J FOOD SCI TECH, V37, P849, DOI 10.1046/j.1365-2621.2002.00625.x	45	18	18	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98738	10.1371/journal.pone.0098738	http://dx.doi.org/10.1371/journal.pone.0098738			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905454	gold, Green Published, Green Submitted			2022-12-27	WOS:000341869000054
J	Cuadra, VMB; Gonzalez-Huerta, NC; Romero-Cordoba, S; Hidalgo-Miranda, A; Miranda-Duarte, A				Borgonio Cuadra, Veronica M.; Celia Gonzalez-Huerta, Norma; Romero-Cordoba, Sandra; Hidalgo-Miranda, Alfredo; Miranda-Duarte, Antonio			Altered Expression of Circulating MicroRNA in Plasma of Patients with Primary Osteoarthritis and In Silico Analysis of Their Pathways	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CHONDROCYTE APOPTOSIS; RHEUMATOID-ARTHRITIS; INHIBITION; BIOMARKERS; MECHANISM; MIRNA; PCR; DIAGNOSIS; CARTILAGE	Objective: To analyze a set of circulating microRNA (miRNA) in plasma from patients with primary Osteoarthritis (OA) and describe the biological significance of altered miRNA in OA based on an in silico analysis of their target genes. Methods: miRNA expression was analyzed using TaqMan Low Density Arrays and independent assays. The search for potential messenger RNA (mRNA) targets of the differentially expressed miRNA was performed by means of the miRWalk and miRecords database; we conducted the biological relevance of the predicted miRNA targets by pathway analysis with the Reactome and DAVID databases. Results: We measured the expression of 380 miRNA in OA; 12 miRNA were overexpressed under the OA condition (p value, <= 0.05; fold change, >2). These results were validated by the detection of some selected miRNA by quantitative PCR (qPCR). In silico analysis showed that target messenger RNA (mRNA) were potentially regulated by these miRNA, including genes such as SMAD1, IL-1B, COL3A, VEGFA, and FGFR1, important in chondrocyte maintenance and differentiation. Some metabolic pathways affected by the miRNA: mRNA ratio are signaling Bone morphogenetic proteins (BMP), Platelet-derived growth factor (PDGF), and Nerve growth factor (NGF), these latter two involved in the process of pain. Conclusions: We identified 12 miRNA in the plasma of patients with primary OA. Specific miRNA that are altered in the disease could be released into plasma, either due to cartilage damage or to an inherent cellular mechanism. Several miRNA could regulate genes and pathways related with development of the disease; eight of these circulating miRNA are described, to our knowledge, for first time in OA.	[Borgonio Cuadra, Veronica M.; Celia Gonzalez-Huerta, Norma; Miranda-Duarte, Antonio] INR, Dept Genet, Mexico City, DF, Mexico; [Romero-Cordoba, Sandra; Hidalgo-Miranda, Alfredo] Inst Nacl Med Genom INMEGEN, Lab Genom Canc, Mexico City, DF, Mexico	Instituto Nacional de Medicina Genomica	Cuadra, VMB (corresponding author), INR, Dept Genet, Mexico City, DF, Mexico.	vborgoni@yahoo.com.mx	Romero, Sandra/A-2246-2014; Hidalgo-Miranda, Alfredo/B-2123-2010; Romero-Cordoba, Sandra/AAY-2625-2020	Romero, Sandra/0000-0002-5591-696X; Hidalgo-Miranda, Alfredo/0000-0003-2315-3977; Miranda-Duarte, Antonio/0000-0001-6530-4636	National Council for Science and Technology (CONACyT-Mexico) [114945]	National Council for Science and Technology (CONACyT-Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was financially supported by grant No. 114945 of the National Council for Science and Technology (CONACyT-Mexico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar N, 2010, ARTHRITIS RHEUM-US, V62, P1361, DOI 10.1002/art.27329; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Caporali A, 2011, TRENDS CARDIOVAS MED, V21, P162, DOI 10.1016/j.tcm.2012.05.003; Chamorro-Jorganes A, 2011, ARTERIOSCL THROM VAS, V31, P2595, DOI 10.1161/ATVBAHA.111.236521; Chapman K, 2012, BONE, V51, P258, DOI 10.1016/j.bone.2011.11.026; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Diaz-Prado S, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-144; Felson DT, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2531; Gilbert AM, 2008, BIOORG MED CHEM LETT, V18, P6454, DOI 10.1016/j.bmcl.2008.10.065; Goldring MB, 2010, ANN NY ACAD SCI, V1192, P230, DOI 10.1111/j.1749-6632.2009.05240.x; Gooljarsingh LT, 2008, PROTEIN SCI, V17, P66, DOI 10.1110/ps.073130208; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; Iuliano R, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/591931; Jones SW, 2009, OSTEOARTHR CARTILAGE, V17, P464, DOI 10.1016/j.joca.2008.09.012; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Li J, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3798; Li X, 2010, RECENT PAT ANTI-CANC, V5, P109, DOI 10.2174/157489210790936234; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Little CB, 2009, ARTHRITIS RHEUM-US, V60, P3723, DOI 10.1002/art.25002; Liu G, 2010, EXP NEUROL, V226, P200, DOI 10.1016/j.expneurol.2010.08.032; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Michael JWP, 2010, DTSCH ARZTEBL INT, V107, P152, DOI 10.3238/arztebl.2010.0152; Miyaki S, 2012, NAT REV RHEUMATOL, V8, P543, DOI 10.1038/nrrheum.2012.128; Miyaki S, 2010, GENE DEV, V24, P1173, DOI 10.1101/gad.1915510; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Murata K, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3013; Nakasa T, 2008, ARTHRITIS RHEUM-US, V58, P1284, DOI 10.1002/art.23429; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Sapre N, 2013, PROSTATE CANCER, V2013, DOI 10.1155/2013/539680; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Tang D, 2013, EUR J CANC PREV; Tomaselli S, 2012, BIOMARK MED, V6, P729, DOI [10.2217/bmm.12.91, 10.2217/BMM.12.91]; Tortorella MD, 2009, J BIOL CHEM, V284, P24185, DOI 10.1074/jbc.M109.029116; Wang B, 2012, J AM SOC NEPHROL, V23, P252, DOI 10.1681/ASN.2011010055; Wittwer AJ, 2007, BIOCHEMISTRY-US, V46, P6393, DOI 10.1021/bi7000642; Yamasaki K, 2009, ARTHRITIS RHEUM-US, V60, P1035, DOI 10.1002/art.24404; Yang N, 2008, INT J CANCER, V122, P963, DOI 10.1002/ijc.23325; Zamli Z, 2011, INT J RHEUM DIS, V14, P159, DOI 10.1111/j.1756-185X.2011.01618.x; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	45	72	74	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e97690	10.1371/journal.pone.0097690	http://dx.doi.org/10.1371/journal.pone.0097690			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901787	Green Published, Green Submitted, gold			2022-12-27	WOS:000336841400010
J	Raz, O; Lev, DL; Battler, A; Lev, EI				Raz, Oshrat; Lev, Dorit L.; Battler, Alexander; Lev, Eli I.			Pathways Mediating the Interaction between Endothelial Progenitor Cells (EPCs) and Platelets	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; INDUCE DIFFERENTIATION; ACTIVATED PLATELETS; CARDIOVASCULAR RISK; VASCULAR INJURY; ANGIOGENESIS; NEOVASCULARIZATION; MICROPARTICLES; MOBILIZATION; VEGF	Introduction: Endothelial progenitor cells (EPCs) have an important role in the process of vascular injury repair. Platelets have been shown to mediate EPC recruitment, maturation and differentiation. Yet, the mechanism underlying this interaction is unclear. We, therefore, aimed to examine whether direct contact between platelets and EPCs is essential for the positive platelets-EPC effect, and to investigate the main mediators responsible for the improvement in EPCs function. Methods: Human EPCs were isolated from donated buffy coats and cultured in either: 1. EPCs co-incubated with platelets placed in a 1 mu m-Boyden chamber. 2. EPCs incubated with or without platelets in the presence or absence of bFGF/PDGF Receptor inhibitor (PDGFRI). After 7 days culture, EPCs ability to form colonies, proliferate and differentiate was examined. Culture supernatants were collected and growth factors levels were evaluated using ELISA. Growth factors mRNA levels in EPCs were evaluated using RT-PCR. Results and Conclusions: After 7 days culture, EPCs functional properties were higher following co-incubation with platelets (directly or indirectly), implying that direct contact is not essential for the platelet's positive effect on EPCs. This effect was reduced by PDGFRI inhibition. Additionally, higher levels of PDGFB in EPCs-platelets supernatant and higher levels of PDGFC mRNA in EPCs co-incubated with platelets were found. In contrast, FGF and other potential mediators that were examined and inhibited did not significantly affect the interaction between platelets and EPCs. Thus, we conclude that PDGF has a central role in the interaction between platelets and EPCs. Further study is required to examine additional aspects of EPC-platelets interaction.	[Lev, Dorit L.; Lev, Eli I.] Felsenstein Med Res Inst, Petah Tiqwa, Israel; [Raz, Oshrat; Lev, Dorit L.; Lev, Eli I.] Rabin Med Ctr, Dept Cardiol, Petah Tiqwa, Israel; [Raz, Oshrat; Battler, Alexander; Lev, Eli I.] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Raz, O (corresponding author), Rabin Med Ctr, Dept Cardiol, Jabotinsky St, Petah Tiqwa, Israel.	oshratra@clalit.org.il			Leo Mintz Foundation; David Halperne Chair in Cellular and Molecular Cardiology, Sackler Faculty of Medicine, Tel Aviv University	Leo Mintz Foundation; David Halperne Chair in Cellular and Molecular Cardiology, Sackler Faculty of Medicine, Tel Aviv University	This work was supported by the Leo Mintz Foundation and the David Halperne Chair in Cellular and Molecular Cardiology, Sackler Faculty of Medicine, Tel Aviv University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Banerjee S, 2006, ATHEROSCLEROSIS, V189, P70, DOI 10.1016/j.atherosclerosis.2006.04.026; Brill A, 2005, CARDIOVASC RES, V67, P30, DOI 10.1016/j.cardiores.2005.04.007; Brill A, 2004, CARDIOVASC RES, V63, P226, DOI 10.1016/j.cardiores.2004.04.012; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Daub K, 2006, FASEB J, V20, P2559, DOI 10.1096/fj.06-6265fje; de Boer HC, 2006, ARTERIOSCL THROM VAS, V26, P1653, DOI 10.1161/01.ATV.0000222982.55731.f1; Dernbach E, 2008, BASIC RES CARDIOL, V103, P572, DOI 10.1007/s00395-008-0734-z; Dimmeler S, 2005, NEW ENGL J MED, V352, P1815, DOI 10.1056/NEJMcibr050670; Dimmeler S, 2004, J MOL MED, V82, P671, DOI 10.1007/s00109-004-0580-x; Garg R, 2008, CATHETER CARDIO INTE, V72, P205, DOI 10.1002/ccd.21611; Gill M, 2001, CIRC RES, V88, P167; Guo SF, 2012, CELL BIOL INT, V36, P945, DOI 10.1042/CBI20110657; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Hristov M, 2004, J CELL MOL MED, V8, P498, DOI 10.1111/j.1582-4934.2004.tb00474.x; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Langer H, 2006, CIRC RES, V98, pE2, DOI 10.1161/01.RES.0000201285.87524.9e; Leshem-Lev D, 2010, J THROMB THROMBOLYS, V30, P398, DOI 10.1007/s11239-010-0514-0; Lev EI, 2013, EUR J PREV CARDIOL; Lev EI, 2006, THROMB HAEMOSTASIS, V96, P498, DOI 10.1160/TH06-05-0250; Lev EI, 2010, EUR HEART J, V31, P2625, DOI 10.1093/eurheartj/ehq184; Li XR, 2005, J CLIN INVEST, V115, P118, DOI 10.1172/JCI200519189; Massberg S, 2006, J EXP MED, V203, P1221, DOI 10.1084/jem.20051772; Mause SF, 2010, CIRCULATION, V122, P495, DOI 10.1161/CIRCULATIONAHA.109.909473; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Pintucci G, 2002, THROMB HAEMOSTASIS, V88, P834, DOI 10.1055/s-0037-1613311; Prokopi M, 2009, BLOOD, V114, P723, DOI 10.1182/blood-2009-02-205930; Sieveking DP, 2008, J AM COLL CARDIOL, V51, P660, DOI 10.1016/j.jacc.2007.09.059; Solomon A, 2012, AM J MED, V125, P604, DOI 10.1016/j.amjmed.2011.10.025; Sufen G, 2010, CELL BIOL INT, V35, P545; Vaturi M, 2011, AM J CARDIOL, V108, P272, DOI 10.1016/j.amjcard.2011.03.039; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; Wara AK, 2011, BLOOD, V118, P6450, DOI 10.1182/blood-2011-06-363713; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Werner N, 2002, ARTERIOSCL THROM VAS, V22, P1567, DOI 10.1161/01.ATV.0000036417.43987.D8	38	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e95156	10.1371/journal.pone.0095156	http://dx.doi.org/10.1371/journal.pone.0095156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901498	gold, Green Published, Green Submitted			2022-12-27	WOS:000336841400002
J	Bouabid, S; Delaville, C; De Deurwaerdere, P; Lakhdar-Ghazal, N; Benazzouz, A				Bouabid, Safa; Delaville, Claire; De Deurwaerdere, Philippe; Lakhdar-Ghazal, Nouria; Benazzouz, Abdelhamid			Manganese-Induced Atypical Parkinsonism Is Associated with Altered Basal Ganglia Activity and Changes in Tissue Levels of Monoamines in the Rat	PLOS ONE			English	Article							GLOBUS-PALLIDUS NEURONS; SUBTHALAMIC NUCLEUS; NIGROSTRIATAL PATHWAY; FIRING PATTERN; SUBSTANTIA-NIGRA; MOTOR DEFICITS; DOPAMINE; BRAIN; EXPOSURE; NORADRENALINE	Manganese neurotoxicity is associated with motor and cognitive disturbances known as Manganism. However, the mechanisms underlying these deficits remain unknown. Here we investigated the effects of manganese intoxication on motor and non-motor parkinsonian-like deficits such as locomotor activity, motor coordination, anxiety and "depressive-like'' behaviors. Then, we studied the impact of this intoxication on the neuronal activity, the globus pallidus (GP) and subthalamic nucleus (STN). At the end of experiments, post-mortem tissue level of the three monoamines (dopamine, norepinephrine and serotonin) has been determined. The experiments were carried out in adult Sprague-Dawley rats, daily treated with MnCl2 (10 mg/kg/, i.p.) for 5 weeks. We show that manganese progressively reduced locomotor activity as well as motor coordination in parallel with the manifestation of anxiety and "depressive-like'' behaviors. Electrophysiological results show that, while majority of GP and STN neurons discharged regularly in controls, manganese increased the number of GP and STN neurons discharging irregularly and/or with bursts. Biochemical results show that manganese significantly decreased tissue levels of norepinephrine and serotonin with increased metabolism of dopamine in the striatum. Our data provide evidence that manganese intoxication is associated with impaired neurotransmission of monoaminergic systems, which is at the origin of changes in basal ganglia neuronal activity and the manifestation of motor and non-motor deficits similar to those observed in atypical Parkinsonism.	[Bouabid, Safa; Delaville, Claire; De Deurwaerdere, Philippe; Benazzouz, Abdelhamid] Univ Bordeaux, Inst Malad Neurodegenerat, UMR 5293, Bordeaux, France; [Bouabid, Safa; Delaville, Claire; De Deurwaerdere, Philippe; Benazzouz, Abdelhamid] CNRS, Inst Malad Neurodegenerat, UMR 5293, Bordeaux, France; [Bouabid, Safa; Lakhdar-Ghazal, Nouria] Univ Mohamed V Agdal, Fac Sci, Equipe Rythmes Biol Neurosci & Environm, Rabat, Morocco	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Mohammed V University in Rabat	Benazzouz, A (corresponding author), Univ Bordeaux, Inst Malad Neurodegenerat, UMR 5293, Bordeaux, France.	Abdelhamid.Benazzouz@u-bordeaux.fr	Benazzouz, Abdelhamid/E-5050-2016; De Deurwaerdère, Philippe/I-5834-2019	De Deurwaerdère, Philippe/0000-0002-1226-3516; Bouabid, Safa/0000-0003-4184-3795	Universite Bordeaux Segalen; "Groupement de Recherche International" [GDRI N198]; "Groupement de Recherche International'' (CNRS INSERM France); "Groupement de Recherche International'' (CNRST Morocco); Egide-Volubilis [20565ZM]	Universite Bordeaux Segalen; "Groupement de Recherche International"; "Groupement de Recherche International'' (CNRS INSERM France); "Groupement de Recherche International'' (CNRST Morocco); Egide-Volubilis	This study was supported by the "Universite Bordeaux Segalen'' and exchange grants of the "Groupement de Recherche International'' (GDRI N198, CNRS & INSERM France, and CNRST Morocco), Egide-Volubilis No 20565ZM, CNRS-CNRST Convention Adivmar 22614 and NEUROMED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamy M, 2012, NEUROSCI BIOBEHAV R, V36, P1463, DOI 10.1016/j.neubiorev.2012.03.009; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Aschner M, 2005, CRIT REV TOXICOL, V35, P1, DOI 10.1080/10408440590905920; Aschner M, 2007, TOXICOL APPL PHARM, V221, P131, DOI 10.1016/j.taap.2007.03.001; ASTONJONES G, 1991, J NEUROSCI, V11, P760; AUTISSIER N, 1982, TOXICOLOGY, V24, P175, DOI 10.1016/0300-483X(82)90055-5; Avila DS, 2010, TOXICOL SCI, V115, P194, DOI 10.1093/toxsci/kfq036; Belujon P, 2007, J NEUROSCI, V27, P9595, DOI 10.1523/JNEUROSCI.2583-07.2007; Betharia S, 2012, NEUROTOXICOLOGY, V33, P1117, DOI 10.1016/j.neuro.2012.06.002; Bouchard M, 2007, NEUROTOXICOLOGY, V28, P290, DOI 10.1016/j.neuro.2006.08.002; Bowler RM, 2006, NEUROTOXICOLOGY, V27, P315, DOI 10.1016/j.neuro.2005.10.007; Breit S, 2007, EXP NEUROL, V205, P36, DOI 10.1016/j.expneurol.2006.12.016; Butterworth RF, 2010, NEUROTOX RES, V18, P100, DOI 10.1007/s12640-010-9185-z; Calabresi P, 2001, NEUROBIOL DIS, V8, P419, DOI 10.1006/nbdi.2000.0379; CHANDRA SV, 1981, J NEUROCHEM, V36, P683, DOI 10.1111/j.1471-4159.1981.tb01642.x; Chetrit J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006208; Cordova FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033057; Crossgrove J, 2004, NMR BIOMED, V17, P544, DOI 10.1002/nbm.931; DEDEURWAERDERE P, 1995, J NEUROCHEM, V65, P1100; Delaville C, 2012, NEUROSCIENCE, V202, P424, DOI 10.1016/j.neuroscience.2011.11.024; Delaville C, 2012, NEUROBIOL DIS, V45, P763, DOI 10.1016/j.nbd.2011.10.023; Delaville C, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00031; DESOLE MS, 1995, NEUROPHARMACOLOGY, V34, P289, DOI 10.1016/0028-3908(94)00140-N; DETKE MJ, 1995, PSYCHOPHARMACOLOGY, V121, P66, DOI 10.1007/BF02245592; Diaz-Veliz G, 2004, PHARMACOL BIOCHEM BE, V77, P245, DOI 10.1016/j.pbb.2003.10.016; Dietz MC, 2001, ENVIRON RES, V85, P37, DOI 10.1006/enrs.2000.4068; Dobson AW, 2004, ANN NY ACAD SCI, V1012, P115, DOI 10.1196/annals.1306.009; ERIKSSON H, 1987, ARCH TOXICOL, V59, P426, DOI 10.1007/BF00316209; EXON JH, 1975, B ENVIRON CONTAM TOX, V14, P370, DOI 10.1007/BF01685652; Fitoussi A, 2013, NEUROSCIENCE, V255, P233, DOI 10.1016/j.neuroscience.2013.09.059; Golub MS, 2005, NEUROTOXICOL TERATOL, V27, P615, DOI 10.1016/j.ntt.2005.04.003; Guiard BP, 2008, INT J NEUROPSYCHOPH, V11, P625, DOI 10.1017/S1461145707008383; Guilarte TR, 2006, EXP NEUROL, V202, P381, DOI 10.1016/j.expneurol.2006.06.015; Guilarte TR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00023; Gwiazda RH, 2002, NEUROTOXICOLOGY, V23, P69, DOI 10.1016/S0161-813X(02)00002-5; Gwiazda R, 2007, J TOXICOL ENV HEAL A, V70, P594, DOI 10.1080/10937400600882897; INGERSOLL RT, 1995, FUND APPL TOXICOL, V27, P106, DOI 10.1006/faat.1995.1113; Jackson SJ, 2011, BEHAV BRAIN RES, V216, P293, DOI 10.1016/j.bbr.2010.08.007; Josephs KA, 2005, NEUROLOGY, V64, P2033, DOI 10.1212/01.WNL.0000167411.93483.A1; Kaneoke Y, 1996, J NEUROSCI METH, V68, P211, DOI 10.1016/0165-0270(96)00081-7; Klos KJ, 2006, EUR J NEUROL, V13, P1139, DOI 10.1111/j.1468-1331.2006.01407.x; Labarre D, 2008, INT CONF ACOUST SPEE, P489, DOI 10.1109/ICASSP.2008.4517653; Mallet N, 2008, J NEUROSCI, V28, P4795, DOI 10.1523/JNEUROSCI.0123-08.2008; dos Santos APM, 2011, BRAIN RES, V1382, P282, DOI 10.1016/j.brainres.2011.01.047; Nam J, 2008, BIOL PHARM BULL, V31, P1894, DOI 10.1248/bpb.31.1894; Ni ZG, 2001, SYNAPSE, V40, P145, DOI 10.1002/syn.1036.abs; Ni ZG, 2000, EUR J NEUROSCI, V12, P4338, DOI 10.1111/j.1460-9568.2000.01346.x; Normandin Louise, 2002, Rev Environ Health, V17, P189; PAN HS, 1988, SYNAPSE, V2, P650, DOI 10.1002/syn.890020612; PAPP M, 1987, BEHAV BRAIN RES, V23, P221, DOI 10.1016/0166-4328(87)90022-2; Paxinos G., 1996, RAT BRAIN STEREOTATI; Perl DP, 2007, J NEUROPATH EXP NEUR, V66, P675, DOI 10.1097/nen.0b013e31812503cf; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Roels H, 1997, ARCH TOXICOL, V71, P223, DOI 10.1007/s002040050380; Rommelfanger KS, 2007, P NATL ACAD SCI USA, V104, P13804, DOI 10.1073/pnas.0702753104; Sabbar M, 2012, NEUROSCIENCE, V210, P375, DOI 10.1016/j.neuroscience.2012.02.026; SALLER CF, 1990, J PHARMACOL EXP THER, V253, P1162; Sanchez-Betancourt J, 2012, NEUROTOXICOLOGY, V33, P1346, DOI 10.1016/j.neuro.2012.08.012; Sclafani A, 2003, PHYSIOL BEHAV, V79, P663, DOI 10.1016/S0031-9384(03)00143-4; SETH PK, 1981, TOXICOL LETT, V9, P247, DOI 10.1016/0378-4274(81)90157-0; Sistrunk SC, 2007, ENVIRON TOXICOL PHAR, V23, P286, DOI 10.1016/j.etap.2006.11.004; Struve MF, 2007, AM J IND MED, V50, P772, DOI 10.1002/ajim.20489; Takeda A, 2003, BRAIN RES REV, V41, P79, DOI 10.1016/S0165-0173(02)00234-5; Temel Y, 2005, PROG NEUROBIOL, V76, P393, DOI 10.1016/j.pneurobio.2005.09.005; Temel Y, 2007, P NATL ACAD SCI USA, V104, P17087, DOI 10.1073/pnas.0704144104; Tomas-Camardiel M, 2002, MOL BRAIN RES, V103, P116, DOI 10.1016/S0169-328X(02)00192-4; Tordoff MG, 2003, CHEM SENSES, V28, P315, DOI 10.1093/chemse/28.4.315; Torrente M, 2005, TOXICOLOGY, V211, P59, DOI 10.1016/j.tox.2005.02.010; Uchino A, 2007, NEURORADIOLOGY, V49, P715, DOI 10.1007/s00234-007-0243-z; UNGERSTEDT U, 1968, EUR J PHARMACOL, V5, P107, DOI 10.1016/0014-2999(68)90164-7; Vezer T, 2007, AM J IND MED, V50, P841, DOI 10.1002/ajim.20485; Zheng W, 2003, TOXICOL APPL PHARM, V192, P1, DOI 10.1016/S0041-008X(03)00251-5	72	31	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98952	10.1371/journal.pone.0098952	http://dx.doi.org/10.1371/journal.pone.0098952			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896650	Green Submitted, Green Published, gold			2022-12-27	WOS:000338430700100
J	Choi, SL; Lee, SJ; Yeom, SJ; Kim, HJ; Rhee, YH; Jung, HC; Lee, SG				Choi, Su-Lim; Lee, Sang Jun; Yeom, Soo-Jin; Kim, Hyun Ju; Rhee, Young Ha; Jung, Heung-Chae; Lee, Seung-Goo			Controlled Localization of Functionally Active Proteins to Inclusion Bodies Using Leucine Zippers	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; RECOMBINANT BACTERIA; CELLULOMONAS-FIMI; ESCHERICHIA-COLI; AGGREGATION; MICROSCOPY; BINDING; FUSION; DOMAIN; CELLS	Inclusion bodies (IBs) are typically non-functional particles of aggregated proteins. However, some proteins in fusion with amyloid-like peptides, viral coat proteins, and cellulose binding domains (CBDs) generate IB particles retaining the original functions in cells. Here, we attempted to generate CBD IBs displaying functional leucine zipper proteins (LZs) as bait for localizing cytosolic proteins in E. coli. When a red fluorescent protein was tested as a target protein, microscopic observations showed that the IBs red-fluoresced strongly. When different LZ pairs with K(D)s of 8-1,000 mu M were tested as the bait and prey, the localization of the red fluorescence appeared to change following the affinities between the LZs, as observed by fluorescence imaging and flow cytometry. This result proposed that LZ-tagged CBD IBs can be applied as an in vivo matrix to entrap cytosolic proteins in E. coli while maintaining their original activities. In addition, easy detection of localization to IBs provides a unique platform for the engineering and analyses of protein-protein interactions in E. coli.	[Choi, Su-Lim; Yeom, Soo-Jin; Jung, Heung-Chae; Lee, Seung-Goo] KRIBB, Biochem & Synthet Biol Res Ctr, Taejon, South Korea; [Choi, Su-Lim; Rhee, Young Ha] Chungnam Natl Univ, Dept Biosci & Biotechnol, Taejon, South Korea; [Lee, Sang Jun; Kim, Hyun Ju] KRIBB, Infect & Immun Biol Res Ctr, Taejon, South Korea; [Lee, Sang Jun; Kim, Hyun Ju; Lee, Seung-Goo] Korea Univ Sci & Technol, Taejon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungnam National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Lee, SG (corresponding author), KRIBB, Biochem & Synthet Biol Res Ctr, Taejon, South Korea.	sglee@kribb.re.kr	Lee, Seung-Goo/AAS-1613-2021; Lee, Seung-Goo/AAR-9823-2021; Yeom, Soojin/AAE-3558-2022	Lee, Seung-Goo/0000-0003-4539-9812; Lee, Sang Jun/0000-0002-2803-753X; Yeom, Soo-Jin/0000-0001-7307-237X; JUNG, Heungchae/0000-0003-4226-8235	Intelligent Synthetic Biology Center of Global Frontier Project [2011-0031944]; Pioneer Research Program for Converging Technology [20110001745]; Bio-industry Technology Development Program [310006-5]; New & Renewable Energy Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning [20133030000300]; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program	Intelligent Synthetic Biology Center of Global Frontier Project; Pioneer Research Program for Converging Technology; Bio-industry Technology Development Program; New & Renewable Energy Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program	This research was supported by grants from the Intelligent Synthetic Biology Center of Global Frontier Project (2011-0031944), the Pioneer Research Program for Converging Technology (20110001745), Bio-industry Technology Development Program (No. 310006-5), the New & Renewable Energy Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (20133030000300), and the Korea Research Institute of Bioscience and Biotechnology Research Initiative Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENTLEY WE, 1990, BIOTECHNOL BIOENG, V35, P668, DOI 10.1002/bit.260350704; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Carrio MM, 1998, FEMS MICROBIOL LETT, V169, P9, DOI 10.1111/j.1574-6968.1998.tb13292.x; Chen AH, 2012, TRENDS CELL BIOL, V22, P662, DOI 10.1016/j.tcb.2012.07.002; Choi SL, 2011, BIOTECHNOL BIOPROC E, V16, P1173, DOI 10.1007/s12257-011-0336-8; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Garcia-Fruitos E, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-27; Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w; Hanaor D, 2012, J EUR CERAM SOC, V32, P235, DOI 10.1016/j.jeurceramsoc.2011.08.015; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Koyama-Honda I, 2005, BIOPHYS J, V88, P2126, DOI 10.1529/biophysj.104.048967; Lalonde S, 2008, PLANT J, V53, P610, DOI 10.1111/j.1365-313X.2007.03332.x; Magliery TJ, 2005, J AM CHEM SOC, V127, P146, DOI 10.1021/ja046699g; McLean BW, 2000, PROTEIN ENG, V13, P801, DOI 10.1093/protein/13.11.801; Nahalka J, 2007, BIOTECHNOL BIOENG, V97, P454, DOI 10.1002/bit.21244; Palmer Ira, 2004, Curr Protoc Protein Sci, VChapter 6, DOI [10.1002/0471140864.ps0603s70, 10.1002/0471140864.ps0603s38]; PHIZICKY EM, 1995, MICROBIOL REV, V59, P94, DOI 10.1128/MMBR.59.1.94-123.1995; Sabate R, 2010, CELL MOL LIFE SCI, V67, P2695, DOI 10.1007/s00018-010-0344-4; Singh SM, 2005, J BIOSCI BIOENG, V99, P303, DOI 10.1263/jbb.99.303; Steinmann B, 2010, APPL ENVIRON MICROB, V76, P5563, DOI 10.1128/AEM.00612-10; Suhling K, 2002, BIOPHYS J, V83, P3589, DOI 10.1016/S0006-3495(02)75359-9; Theer P, 2006, J OPT SOC AM A, V23, P3139, DOI 10.1364/JOSAA.23.003139; Ventura S, 2006, TRENDS BIOTECHNOL, V24, P179, DOI 10.1016/j.tibtech.2006.02.007; Villaverde A, 2003, BIOTECHNOL LETT, V25, P1385, DOI 10.1023/A:1025024104862; Wu W, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-9; You C, 2013, ACS SYNTH BIOL, V2, P102, DOI 10.1021/sb300068g; Young PA, 2011, J MICROSC-OXFORD, V242, P148, DOI 10.1111/j.1365-2818.2010.03448.x	27	81	81	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e97093	10.1371/journal.pone.0097093	http://dx.doi.org/10.1371/journal.pone.0097093			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897378	Green Published, gold, Green Submitted			2022-12-27	WOS:000338430700006
J	Kawakami, Y; Nomura, K; Tanaka, H				Kawakami, Yutaka; Nomura, Kazuharu; Tanaka, Hideki			Growth Promoting Effect of Hyaluronan Synthesis Promoting Substances on Japanese Eel Leptocephali	PLOS ONE			English	Article							HORMONE-RECEPTOR-BETA; MOLECULAR-CLONING; ANGUILLA-JAPONICA; 17,20 BETA-DIHYDROXY-4-PREGNEN-3-ONE; NORTHERN KYUSHU; GLASS-EELS; CONGER EEL; CDNA; IDENTIFICATION; OVULATION	Hyaluronans (HAs) are glycosaminoglycans produced in the bodies of Anguilliform and Elopiform leptocephali, and play a role in metabolic energy. In mammals, HA synthesis-promoting substances (HASPS) up-regulate the expression of HA synthase (HAS) and increase the amount of HA in the body. In this study, Japanese eel leptocephali were fed a HASPS containing diet. We analyzed HAS1s and HAS2 expression, HA content, and their influence on growth. HASPS extracted from Grifola frondosa promoted HAS1s and HAS2 mRNA and HA content. Other than mammals, these results are first reported in vertebrate. Moreover, HASPS extracted from G. frondosa promoted leptocephalus growth. The relationship between growth and HA in the leptocephali is not yet clear. However, based on our results we hypothesize that HA is involved in the storage of energy, which is metabolized to sugars when needed for metabolic energy.	[Kawakami, Yutaka; Nomura, Kazuharu; Tanaka, Hideki] Fisheries Res Agcy, Nansei Stn, Natl Res Inst Aquaculture, Minamiise, Japan	Japan Fisheries Research & Education Agency (FRA)	Kawakami, Y (corresponding author), Fisheries Res Agcy, Nansei Stn, Natl Res Inst Aquaculture, Minamiise, Japan.	yutakakjp@yahoo.co.jp			Ministry of Agriculture Forestry and Fisheries, Government of Japan	Ministry of Agriculture Forestry and Fisheries, Government of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This study was supported by a grant-in-aid for "Development of Sustainable Aquaculture Technology Independent of Wild Fishery Resources'' from the Ministry of Agriculture Forestry and Fisheries, Government of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender DA, 2006, HARPERS ILLUSTRATED, P177; Brecht M, 1986, J IMMUNOL, V148, P3912; CHEN WYJ, 1989, J CELL SCI, V94, P577; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Itano N, 1996, J BIOL CHEM, V271, P9875, DOI 10.1074/jbc.271.17.9875; Itano N, 1996, BIOCHEM BIOPH RES CO, V222, P816, DOI 10.1006/bbrc.1996.0827; Kagawa H, 1997, FISHERIES SCI, V63, P365, DOI 10.2331/fishsci.63.365; Kagawa H, 2005, FISH PHYSIOL BIOCHEM, V31, P193, DOI 10.1007/s10695-006-0024-3; Kawakami Y, 2003, GEN COMP ENDOCR, V132, P321, DOI 10.1016/S0016-6480(03)00087-X; Kawakami Y, 2003, GEN COMP ENDOCR, V131, P232, DOI 10.1016/S0016-6480(02)00638-X; Kawakami Y, 1999, J EXP MAR BIOL ECOL, V238, P1, DOI 10.1016/S0022-0981(98)00166-X; Kawakami Y, 1999, B MAR SCI, V64, P315; Kawakami Y, 2009, RES LETT BIOCH; Kawakami Y, 2006, COMP BIOCHEM PHYS B, V144, P503, DOI 10.1016/j.cbpb.2006.05.003; KOJIMA M, 1991, Journal of the Japan Oil Chemists' Society, V40, P53; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Masuda Yoshitsugu, 2012, Bulletin of Fisheries Research Agency, P111; Miller MJ, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0826; Miyahara Y, 1995, Japan patent Kokai H, Patent No. [7-101871, 7101871]; Ohta H, 1996, AQUACULTURE, V139, P291, DOI 10.1016/0044-8486(95)01167-6; Okamura A, 2009, AQUAC RES, V40, P509, DOI 10.1111/j.1365-2109.2008.02127.x; Pfeiler E, 2002, COMP BIOCHEM PHYS B, V132, P443, DOI 10.1016/S1096-4959(02)00060-X; Pfeiler E, 1996, FISH PHYSIOL BIOCHEM, V15, P359, DOI 10.1007/BF02112363; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shiojiri M, 2010, European Patent, Patent No. [2010-09717725.7, 2010097177257]; Shyjan AM, 1996, J BIOL CHEM, V271, P23395, DOI 10.1074/jbc.271.38.23395; Spicer AP, 1996, J BIOL CHEM, V271, P23400, DOI 10.1074/jbc.271.38.23400; Spicer AP, 1997, J BIOL CHEM, V272, P8957; Takahashi M, 2009, WO Patent, Patent No. [2,009,063,885, 2009063885]; Tanaka H, 2003, FISH PHYSIOL BIOCHEM, V28, P493, DOI 10.1023/B:FISH.0000030638.56031.ed; Tanaka H, 2011, NIPPON SUISAN GAKK, V77, P345, DOI 10.2331/suisan.77.345; Toole BP, 1990, CURR OPIN CELL BIOL, V2, P839, DOI 10.1016/0955-0674(90)90081-O; Watanabe K, 1996, J BIOL CHEM, V271, P22945, DOI 10.1074/jbc.271.38.22945	33	7	7	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98688	10.1371/journal.pone.0098688	http://dx.doi.org/10.1371/journal.pone.0098688			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896609	Green Submitted, Green Published, gold			2022-12-27	WOS:000338430700065
J	Zhu, FH; Wang, WX; Di, ZR; Fan, Y				Zhu, Fenghui; Wang, Wenxu; Di, Zengru; Fan, Ying			Identifying and Characterizing Key Nodes among Communities Based on Electrical-Circuit Networks	PLOS ONE			English	Article							COMPLEX NETWORKS; CENTRALITY	Complex networks with community structures are ubiquitous in the real world. Despite many approaches developed for detecting communities, we continue to lack tools for identifying overlapping and bridging nodes that play crucial roles in the interactions and communications among communities in complex networks. Here we develop an algorithm based on the local flow conservation to effectively and efficiently identify and distinguish the two types of nodes. Our method is applicable in both undirected and directed networks without a priori knowledge of the community structure. Our method bypasses the extremely challenging problem of partitioning communities in the presence of overlapping nodes that may belong to multiple communities. Due to the fact that overlapping and bridging nodes are of paramount importance in maintaining the function of many social and biological networks, our tools open new avenues towards understanding and controlling real complex networks with communities accompanied with the key nodes.	[Zhu, Fenghui; Wang, Wenxu; Di, Zengru; Fan, Ying] Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China	Beijing Normal University	Wang, WX (corresponding author), Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China.	wenxuwang@bnu.edu.cn; yfan@bnu.edu.cn			National Natural Science Foundation of China [61174150, NCET-09-0228]; Ministry of Education [20110003110027]; National Social Science Fund [12ZD217]; MOE (Ministry of Education in China) [11YJC840006]; NSFC [11105011]; CNNSF [61074116]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education; National Social Science Fund; MOE (Ministry of Education in China)(Ministry of Education, China); NSFC(National Natural Science Foundation of China (NSFC)); CNNSF(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Funded by the National Natural Science Foundation of China under Grant No. 61174150, NCET-09-0228 and the Doctoral Fund of the Ministry of Education (20110003110027); the major project of National Social Science Fund (12 & ZD217); MOE (Ministry of Education in China) Youth Fund Project of Humanities and Social Sciences (Project No. 11YJC840006) and NSFC under Grant No. 11105011, CNNSF under Grant No. 61074116 and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Almendral JA, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.016115; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Borgatti SP, 2005, SOC NETWORKS, V27, P55, DOI 10.1016/j.socnet.2004.11.008; Duch J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.027104; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Kaul R, 2009, COMMUN ACM, V52, P132, DOI 10.1145/1536616.1536649; Kim YA, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035012; Lancichinetti A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011976; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Li D, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.168701; Li G, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.018701; Missiuro PV, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000350; Nepusz T, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016107; Newman ME., 2005, SOC NETWORKS, V27, P39, DOI [DOI 10.1016/j.socnet.2004.11.009, 10.1016/j.socnet.2004.11.009, DOI 10.1016/J.SOCNET.2004.11.009]; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027418; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wu F, 2004, EUR PHYS J B, V38, P331, DOI 10.1140/epjb/e2004-00125-x; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752	24	4	4	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e97021	10.1371/journal.pone.0097021	http://dx.doi.org/10.1371/journal.pone.0097021			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK4YO	24897125	Green Submitted, gold, Green Published			2022-12-27	WOS:000338430700005
J	Arostegui, I; Esteban, C; Garcia-Gutierrez, S; Bare, M; Fernandez-de-Larrea, N; Briones, E; Quintana, JM				Arostegui, Inmaculada; Esteban, Cristobal; Garcia-Gutierrez, Susana; Bare, Marisa; Fernandez-de-Larrea, Nerea; Briones, Eduardo; Quintana, Jose M.		IRYSS-COPD Grp	Subtypes of Patients Experiencing Exacerbations of COPD and Associations with Outcomes	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CLUSTER-ANALYSIS; PHENOTYPES; BIOMARKERS	Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous condition characterized by occasional exacerbations. Identifying clinical subtypes among patients experiencing COPD exacerbations (ECOPD) could help better understand the pathophysiologic mechanisms involved in exacerbations, establish different strategies of treatment, and improve the process of care and patient prognosis. The objective of this study was to identify subtypes of ECOPD patients attending emergency departments using clinical variables and to validate the results using several outcomes. We evaluated data collected as part of the IRYSS-COPD prospective cohort study conducted in 16 hospitals in Spain. Variables collected from ECOPD patients attending one of the emergency departments included arterial blood gases, presence of comorbidities, previous COPD treatment, baseline severity of COPD, and previous hospitalizations for ECOPD. Patient subtypes were identified by combining results from multiple correspondence analysis and cluster analysis. Results were validated using key outcomes of ECOPD evolution. Four ECOPD subtypes were identified based on the severity of the current exacerbation and general health status (largely a function of comorbidities): subtype A (n = 934), neither high comorbidity nor severe exacerbation; subtype B (n = 682), moderate comorbidities; subtype C (n = 562), severe comorbidities related to mortality; and subtype D (n = 309), very severe process of exacerbation, significantly related to mortality and admission to an intensive care unit. Subtype D experienced the highest rate of mortality, admission to an intensive care unit and need for noninvasive mechanical ventilation, followed by subtype C. Subtypes A and B were primarily related to other serious complications. Hospitalization rate was more than 50% for all the subtypes, although significantly higher for subtypes C and D than for subtypes A and B. These results could help identify characteristics to categorize ECOPD patients for more appropriate care, and help test interventions and treatments in subgroups with poor evolution and outcomes.	[Arostegui, Inmaculada] Univ Pais Vasco UPV EHU, Dept Matemat Aplicada & Estadist, Leioa, Bizkaia, Spain; [Arostegui, Inmaculada] Univ Pais Vasco UPV EHU, IO, Leioa, Bizkaia, Spain; [Esteban, Cristobal] Hosp Galdakao Usansolo, Serv Neumol, Galdakao, Bizkaia, Spain; [Garcia-Gutierrez, Susana; Quintana, Jose M.] Hosp Galdakao Usansolo, Serv Epidemiol Clin, Galdakao, Bizkaia, Spain; [Arostegui, Inmaculada; Esteban, Cristobal; Garcia-Gutierrez, Susana; Bare, Marisa; Fernandez-de-Larrea, Nerea; Quintana, Jose M.] Red Invest Serv Salud Enfermedades Cron REDISSEC, Galdakao, Bizkaia, Spain; [Bare, Marisa] Unidad Epidemiol Clin, Barcelona, Spain; [Fernandez-de-Larrea, Nerea] Consejeri Sanidad Comunidad Madrid, Subdirecc Gen Tecnol & Innovac Sanitarias, Madrid, Spain; [Briones, Eduardo] Dist Sanitario Atenc Primaria, Seville, Spain	University of Basque Country; University of Basque Country; Galdakao Hospital; Galdakao Hospital	Arostegui, I (corresponding author), Univ Pais Vasco UPV EHU, Dept Matemat Aplicada & Estadist, Leioa, Bizkaia, Spain.	inmaculada.arostegui@ehu.es	González, Nerea/L-5979-2017; , 0000-0001-8085-2833/ABI-7466-2020; Bare, Marisa/H-4806-2011; Rivas-Ruiz, Francisco/I-2814-2017; AROSTEGUI, INMACULADA/G-5941-2014	González, Nerea/0000-0003-3928-3274; , 0000-0001-8085-2833/0000-0001-8085-2833; Bare, Marisa/0000-0001-8085-2833; ESTEBAN, CRISTOBAL/0000-0001-9878-7806; Rivas-Ruiz, Francisco/0000-0002-8894-0501; Orive Calzada, Miren/0000-0003-1848-6638; Quintana, Jose M./0000-0003-2170-7876; AROSTEGUI, INMACULADA/0000-0002-6848-2240; Aguirre Larracoechea, Urko/0000-0002-8049-3030	Ministerio de Economia y Competitividad del Gobierno Espanol [MTM2010-14913]; Universidad del Pais Vasco UPV/EHU [GIU10/21, UFI11/52]; Departamento de Educacion, Politica Linguistica y Cultura del Gobierno Vasco [IT620-13]; Departamento de Sanidad del Gobierno Vasco [2012111008]; Fondo de Investigacion Sanitaria [PI06\1010, PI06\1017, PI06\714, PI06\0326, PI06\00664]	Ministerio de Economia y Competitividad del Gobierno Espanol; Universidad del Pais Vasco UPV/EHU; Departamento de Educacion, Politica Linguistica y Cultura del Gobierno Vasco; Departamento de Sanidad del Gobierno Vasco; Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III)	This research was supported by Ministerio de Economia y Competitividad del Gobierno Espanol (MTM2010-14913), Universidad del Pais Vasco UPV/EHU (GIU10/21, UFI11/52), Departamento de Educacion, Politica Linguistica y Cultura del Gobierno Vasco (IT620-13), Departamento de Sanidad del Gobierno Vasco (2012111008) and Fondo de Investigacion Sanitaria (PI06\1010, PI06\1017, PI06\714, PI06\0326, PI06\00664). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Anzueto A, 2009, Int J Chron Obstruct Pulmon Dis, V4, P245; Arostegui I, 2006, METHOD INFORM MED, V45, P622; Bafadhel M, 2011, AM J RESP CRIT CARE, V184, P662, DOI 10.1164/rccm.201104-0597OC; Benzecri J. P., 1969, Proceedings of the international conference on methodologies of pattern recognition, P35; Burgel PR, 2010, EUR RESPIR J, V36, P531, DOI 10.1183/09031936.00175109; Burgel PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051048; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; DORNHORST AC, 1955, LANCET, V1, P1185; Esteban C, 2011, EUR RESPIR J, V38, P1294, DOI 10.1183/09031936.00189010; Esteban C, 2009, RESP MED, V103, P1201, DOI 10.1016/j.rmed.2009.02.002; Gao P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057678; Garcia-Aymerich J, 2011, THORAX, V66, P430, DOI 10.1136/thx.2010.154484; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2011, GLOBAL STRATEGY FOR; Greenacre M, 1992, Stat Methods Med Res, V1, P97, DOI 10.1177/096228029200100106; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Jambu M, 1978, METHODES ET ALGORITM, V1; Lange P, 2012, AM J RESP CRIT CARE, V186, P975, DOI 10.1164/rccm.201207-1299OC; Varela MVL, 2013, ARCH BRONCONEUMOL, V49, P468, DOI 10.1016/j.arbres.2013.05.003; Mannino DM, 2008, EUR RESPIR J, V32, P962, DOI 10.1183/09031936.00012408; Miravitlles M, 2014, ARCH BRONCONEUMOL, V50, P155, DOI 10.1016/j.arbres.2013.09.001; Perera PN, 2012, COPD, V9, P131, DOI 10.3109/15412555.2011.650239; Pozo-Rodriguez F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042156; Quintana JM, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-322; TEASDALE G, 1974, LANCET, V2, P81; Turino GM, 2008, THORAX, V63, P1032, DOI 10.1136/thx.2008.105957; Vanfleteren LEGW, 2013, AM J RESP CRIT CARE, V187, P728, DOI 10.1164/rccm.201209-1665OC; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Weatherall M, 2009, EUR RESPIR J, V34, P812, DOI 10.1183/09031936.00174408	30	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98580	10.1371/journal.pone.0098580	http://dx.doi.org/10.1371/journal.pone.0098580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892936	Green Published, Green Submitted, gold			2022-12-27	WOS:000336911400071
J	Forget, MA; Voorhees, JL; Cole, SL; Dakhlallah, D; Patterson, IL; Gross, AC; Moldovan, L; Mo, XK; Evans, R; Marsh, CB; Eubank, TD				Forget, Mary A.; Voorhees, Jeffrey L.; Cole, Sara L.; Dakhlallah, Duaa; Patterson, Ivory L.; Gross, Amy C.; Moldovan, Leni; Mo, Xiaokui; Evans, Randall; Marsh, Clay B.; Eubank, Tim D.			Macrophage Colony-Stimulating Factor Augments Tie2-Expressing Monocyte Differentiation, Angiogenic Function, and Recruitment in a Mouse Model of Breast Cancer	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; THYMIDINE PHOSPHORYLASE EXPRESSION; MAMMARY-TUMORS; HEPATOCELLULAR-CARCINOMA; MATRIX METALLOPROTEASE-2; ALTERNATIVE ACTIVATION; GENE-EXPRESSION; CELL MIGRATION; FACTOR CSF-1; ANGIOPOIETIN-2	Reports demonstrate the role of M-CSF (CSF1) in tumor progression in mouse models as well as the prognostic value of macrophage numbers in breast cancer patients. Recently, a subset of CD14+ monocytes expressing the Tie2 receptor, once thought to be predominantly expressed on endothelial cells, has been characterized. We hypothesized that increased levels of CSF1 in breast tumors can regulate differentiation of Tie2- monocytes to a Tie2+ phenotype. We treated CD14+ human monocytes with CSF1 and found a significant increase in CD14+/Tie2+ positivity. To understand if CSF1-induced Tie2 expression on these cells improved their migratory ability, we pre-treated CD14+ monocytes with CSF1 and used Boyden chemotaxis chambers to observe enhanced response to angiopoietin-2 (ANG2), the chemotactic ligand for the Tie2 receptor. We found that CSF1 pre-treatment significantly augmented chemotaxis and that Tie2 receptor upregulation was responsible as siRNA targeting Tie2 receptor abrogated this effect. To understand any augmented angiogenic effect produced by treating these cells with CSF1, we cultured human umbilical vein endothelial cells (HUVECs) with conditioned supernatants from CSF1-pre-treated CD14+ monocytes for a tube formation assay. While supernatants from CSF1-pretreated TEMs increased HUVEC branching, a neutralizing antibody against the CSF1R abrogated this activity, as did siRNA against the Tie2 receptor. To test our hypothesis in vivo, we treated PyMT tumor-bearing mice with CSF1 and observed an expansion in the TEM population relative to total F4/80+ cells, which resulted in increased angiogenesis. Investigation into the mechanism of Tie2 receptor upregulation on CD14+ monocytes by CSF1 revealed a synergistic contribution from the PI3 kinase and HIF pathways as the PI3 kinase inhibitor LY294002, as well as HIF-1 alpha-deficient macrophages differentiated from the bone marrow of HIF-1 alpha(fl/fl)/LysMcre mice, diminished CSF1-stimulated Tie2 receptor expression.	[Forget, Mary A.; Voorhees, Jeffrey L.; Dakhlallah, Duaa; Patterson, Ivory L.; Gross, Amy C.; Moldovan, Leni; Evans, Randall; Marsh, Clay B.; Eubank, Tim D.] Ohio State Univ, Dept Internal Med, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA; [Forget, Mary A.; Marsh, Clay B.] Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA; [Cole, Sara L.] Ohio State Univ, Campus Microscopy & Imaging Facil, Columbus, OH 43210 USA; [Mo, Xiaokui] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Marsh, Clay B.; Eubank, Tim D.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Marsh, CB (corresponding author), Ohio State Univ, Dept Internal Med, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA.	clay.marsh@osumc.edu; tim.eubank@osumc.edu	Cole, Sara L/GYQ-5700-2022	Dakhlallah, Duaa A/0000-0002-6288-4927; Moldovan, Leni/0000-0003-1967-2408	National Cancer Institute [R00 CA131552, R01 HL067167]; NATIONAL CANCER INSTITUTE [R00CA131552, P30CA016058] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109481] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Cancer Institute grant R00 CA131552 (to T. D. E.), start-up funds (to T. D. E.), and R01 HL067167 (to C. B. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; BOTTAZZI B, 1983, SCIENCE, V220, P210, DOI 10.1126/science.6828888; Coffelt SB, 2011, J IMMUNOL, V186, P4183, DOI 10.4049/jimmunol.1002802; Coffelt SB, 2010, CANCER RES, V70, P5270, DOI 10.1158/0008-5472.CAN-10-0012; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Curry JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003405; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; De Palma M, 2008, CANCER CELL, V14, P299, DOI 10.1016/j.ccr.2008.09.004; De Palma M, 2011, CLIN CANCER RES, V17, P5226, DOI 10.1158/1078-0432.CCR-10-0171; DeNardo D, 2010, CANCER METAST REV, V29, P309, DOI 10.1007/s10555-010-9223-6; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Dube A, 1999, CIRC RES, V84, P1177, DOI 10.1161/01.RES.84.10.1177; Elgert KD, 1998, J LEUKOCYTE BIOL, V64, P275, DOI 10.1002/jlb.64.3.275; Engels K, 1997, J PATHOL, V182, P414, DOI 10.1002/(SICI)1096-9896(199708)182:4<414::AID-PATH897>3.0.CO;2-Q; Eubank TD, 2003, J IMMUNOL, V171, P2637, DOI 10.4049/jimmunol.171.5.2637; Felcht M, 2012, J CLIN INVEST, V122, P1991, DOI 10.1172/JCI58832; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245; Fleetwood AJ, 2009, J LEUKOCYTE BIOL, V86, P411, DOI 10.1189/jlb.1108702; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gort EH, 2006, ONCOGENE, V25, P6123, DOI 10.1038/sj.onc.1209643; He HH, 2012, BLOOD, V120, P3152, DOI 10.1182/blood-2012-04-422758; Hu B, 2006, CANCER RES, V66, P775, DOI 10.1158/0008-5472.CAN-05-1149; Hu B, 2003, P NATL ACAD SCI USA, V100, P8904, DOI 10.1073/pnas.1533394100; Ichihara E, 2011, BIOCHEM BIOPH RES CO, V416, P239, DOI 10.1016/j.bbrc.2011.10.061; ICHIKAWA Y, 1966, P NATL ACAD SCI USA, V56, P488, DOI 10.1073/pnas.56.2.488; Jacquel A, 2009, BLOOD, V114, P3633, DOI 10.1182/blood-2009-03-208843; Jiao M, 2012, INT J ONCOL, V40, P461, DOI 10.3892/ijo.2011.1197; Kelley TW, 1999, J BIOL CHEM, V274, P26393, DOI 10.1074/jbc.274.37.26393; Kitaura H, 2008, J DENT RES, V87, P396, DOI 10.1177/154405910808700405; Kubota Y, 2009, J EXP MED, V206, P1089, DOI 10.1084/jem.20081605; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Leek RD, 1998, BRIT J CANCER, V77, P2246, DOI 10.1038/bjc.1998.373; LEWIS CE, 1995, J LEUKOCYTE BIOL, V57, P747, DOI 10.1002/jlb.57.5.747; Lin EY, 2007, CANCER RES, V67, P5064, DOI 10.1158/0008-5472.CAN-07-0912; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lin EY, 2002, J MAMMARY GLAND BIOL, V7, P147, DOI 10.1023/A:1020399802795; Mantovani A, 2004, EUR J CANCER, V40, P1660, DOI 10.1016/j.ejca.2004.03.016; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mazzieri R, 2011, CANCER CELL, V19, P512, DOI 10.1016/j.ccr.2011.02.005; Murdoch C, 2007, J IMMUNOL, V178, P7405, DOI 10.4049/jimmunol.178.11.7405; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pucci F, 2009, BLOOD, V114, P901, DOI 10.1182/blood-2009-01-200931; REEDIJK M, 1992, EMBO J, V11, P1365, DOI 10.1002/j.1460-2075.1992.tb05181.x; Sanchez-Martin L, 2011, BLOOD, V117, P88, DOI 10.1182/blood-2009-12-258186; Scholl SM, 1996, BREAST CANCER RES TR, V39, P275, DOI 10.1007/BF01806155; SCHOLL SM, 1994, JNCI-J NATL CANCER I, V86, P120, DOI 10.1093/jnci/86.2.120; SHURTLEFF SA, 1990, EMBO J, V9, P2415, DOI 10.1002/j.1460-2075.1990.tb07417.x; Song HH, 2009, J BIOL CHEM, V284, P29109, DOI 10.1074/jbc.M109.041145; STANLEY ER, 1986, CIBA F SYMP, V118, P29, DOI 10.1002/9780470720998.ch3; Tsutsui S, 2006, BREAST CANCER RES TR, V98, P261, DOI 10.1007/s10549-005-9157-9; Varney ML, 2005, J INTERF CYTOK RES, V25, P674, DOI 10.1089/jir.2005.25.674; Venneri MA, 2007, BLOOD, V109, P5276, DOI 10.1182/blood-2006-10-053504; WANG JM, 1988, J IMMUNOL, V141, P575; Wang YJ, 2007, AM J RESP CELL MOL, V36, P68, DOI 10.1165/rcmb.2006-0165OC; Wang YJ, 2004, J IMMUNOL, V173, P6820, DOI 10.4049/jimmunol.173.11.6820; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Yeung YG, 2003, MOL CELL PROTEOMICS, V2, P1143, DOI 10.1074/mcp.R300009-MCP200; Zhu XD, 2008, J CLIN ONCOL, V26, P2707, DOI 10.1200/JCO.2007.15.6521	63	62	63	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98623	10.1371/journal.pone.0098623	http://dx.doi.org/10.1371/journal.pone.0098623			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892425	gold, Green Published, Green Submitted			2022-12-27	WOS:000336911400076
J	Kim, HJ; Ryu, J; Woo, HM; Cho, SS; Sung, MK; Kim, SC; Park, MH; Park, T; Koo, SK				Kim, Hyung Jin; Ryu, Jihee; Woo, Hae-Mi; Cho, Samuel Sunghwan; Sung, Min Kyung; Kim, Sang Cheol; Park, Mi-Hyun; Park, Taesung; Koo, Soo Kyung			Patterns of Gene Expression Associated with Pten Deficiency in the Developing Inner Ear	PLOS ONE			English	Article							SPIRAL GANGLION NEURONS; TRANSCRIPTION FACTORS; PARKINSONS-DISEASE; TECTORIAL MEMBRANE; DEAFNESS DFNB22; AXON GUIDANCE; CANCER-CELLS; MUTANT MICE; HAIR-CELLS; OSTEOPONTIN	In inner ear development, phosphatase and tensin homolog (PTEN) is necessary for neuronal maintenance, such as neuronal survival and accurate nerve innervations of hair cells. We previously reported that Pten conditional knockout (cKO) mice exhibited disorganized fasciculus with neuronal apoptosis in spiral ganglion neurons (SGNs). To better understand the genes and signaling networks related to auditory neuron maintenance, we compared the profiles of differentially expressed genes (DEGs) using microarray analysis of the inner ear in E14.5 Pten cKO and wild-type mice. We identified 46 statistically significant transcripts using significance analysis of microarrays, with the false-discovery rate set at 0%. Among the DEGs, expression levels of candidate genes and expression domains were validated by quantitative real-time RT-PCR and in situ hybridization, respectively. Ingenuity pathway analysis using DEGs identified significant signaling networks associated with apoptosis, cellular movement, and axon guidance (i.e., secreted phosphoprotein 1 (Spp1)-mediated cellular movement and regulator of G-protein signaling 4 (Rgs4)-mediated axon guidance). This result was consistent with the phenotypic defects of SGNs in Pten cKO mice (e. g., neuronal apoptosis, abnormal migration, and irregular nerve fiber patterns of SGNs). From this study, we suggest two key regulatory signaling networks mediated by Spp1 and Rgs4, which may play potential roles in neuronal differentiation of developing auditory neurons.	[Kim, Hyung Jin; Ryu, Jihee; Woo, Hae-Mi; Park, Mi-Hyun; Koo, Soo Kyung] Natl Inst Hlth, Div Intractable Dis, Ctr Biomed Sci, Chungcheongbuk Do, South Korea; [Cho, Samuel Sunghwan; Park, Taesung] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea; [Park, Taesung] Seoul Natl Univ, Dept Stat, Seoul, South Korea; [Sung, Min Kyung; Kim, Sang Cheol] Korea Res Inst Biosci & Biotechnol, Korean BioInformat Ctr KOBIC, Taejon, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science; Seoul National University (SNU); Seoul National University (SNU); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Koo, SK (corresponding author), Natl Inst Hlth, Div Intractable Dis, Ctr Biomed Sci, Chungcheongbuk Do, South Korea.	skkoo@nih.go.kr		Sung, Minkyung/0000-0001-6573-2622	Korea National Institute of Health [4800-4845-302-210 (2012-N61001-00), 4861-307-210-13]	Korea National Institute of Health	This work was supported by Korea National Institute of Health intramural research grant 4800-4845-302-210 (no. 2012-N61001-00) and 4861-307-210-13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030790; Appler JM, 2013, J NEUROSCI, V33, P3679, DOI 10.1523/JNEUROSCI.4703-12.2013; Appler JM, 2011, PROG NEUROBIOL, V93, P488, DOI 10.1016/j.pneurobio.2011.01.004; Aviles EC, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00086; Bell D, 2008, DEV BIOL, V322, P109, DOI 10.1016/j.ydbio.2008.07.011; Ben Said M, 2011, EUR J MED GENET, V54, pE535, DOI 10.1016/j.ejmg.2011.06.008; Camarero G, 2002, HEARING RES, V170, P2, DOI 10.1016/S0378-5955(02)00447-1; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Charron F, 2007, ADV EXP MED BIOL, V621, P116, DOI 10.1007/978-0-387-76715-4_9; Cheng YC, 2013, CELL MOL LIFE SCI, V70, P935, DOI 10.1007/s00018-012-1178-z; Coate TM, 2013, SEMIN CELL DEV BIOL, V24, P460, DOI 10.1016/j.semcdb.2013.04.003; Comi C, 2010, J ALZHEIMERS DIS, V19, P1143, DOI 10.3233/JAD-2010-1309; Das R, 2005, IUBMB LIFE, V57, P441, DOI 10.1080/15216540500159424; DAVIS RL, 1995, ANN NY ACAD SCI, V760, P279, DOI 10.1111/j.1749-6632.1995.tb44638.x; Ding J, 2006, NAT NEUROSCI, V9, P832, DOI 10.1038/nn1700; Dudoit S, 2003, BIOTECHNIQUES, P45; Fong YC, 2009, LUNG CANCER, V64, P263, DOI 10.1016/j.lungcan.2008.09.003; Ghaffari R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1094; Grillet N, 2005, MOL CELL BIOL, V25, P4221, DOI 10.1128/MCB.25.10.4221-4228.2005; Grillet N, 2003, J NEUROSCI, V23, P10613; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Hains MD, 2004, METHOD ENZYMOL, V389, P71; Huang EJ, 2001, DEVELOPMENT, V128, P2421; Iczkiewicz J, 2006, BRAIN RES, V1118, P239, DOI 10.1016/j.brainres.2006.08.036; Katoh H, 1998, J BIOL CHEM, V273, P28700, DOI 10.1074/jbc.273.44.28700; Kazdoba TM, 2012, DEV NEUROSCI-BASEL, V34, P198, DOI 10.1159/000337229; Kim HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055609; Kury P, 2004, FASEB J, V18, P398, DOI 10.1096/fj.04-1777fje; Lee K, 2012, CLIN GENET; Li L, 2002, MOL CELL NEUROSCI, V20, P21, DOI 10.1006/mcne.2002.1115; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu CC, 2011, J NEUROSCI, V31, P10903, DOI 10.1523/JNEUROSCI.2358-11.2011; Lukashkin AN, 2012, P NATL ACAD SCI USA, V109, P19351, DOI 10.1073/pnas.1210159109; Maetzler W, 2007, NEUROBIOL DIS, V25, P473, DOI 10.1016/j.nbd.2006.10.020; Marino S, 2002, DEVELOPMENT, V129, P3513; Mi ZY, 2006, CARCINOGENESIS, V27, P1134, DOI 10.1093/carcin/bgi352; Milo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007144; Morsli H, 1998, J NEUROSCI, V18, P3327; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Ratnaparkhi A, 2002, J NEUROSCI, V22, P4499, DOI 10.1523/JNEUROSCI.22-11-04499.2002; Richardson GP, 2011, ANNU REV PHYSIOL, V73, P311, DOI 10.1146/annurev-physiol-012110-142228; Russell IJ, 2007, NAT NEUROSCI, V10, P215, DOI 10.1038/nn1828; Sakagami Masafumi, 2000, Medical Electron Microscopy, V33, P3, DOI 10.1007/s007950000001; Salinas PC, 2012, COLD SPRING HARB PER, V4; Sanchez-Calderon H, 2007, INT J DEV BIOL, V51, P557, DOI 10.1387/ijdb.072373hs; Sanchez-Calderon H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008699; Shah SM, 2009, NEUROSCIENCE, V164, P478, DOI 10.1016/j.neuroscience.2009.08.049; Stuebner S, 2010, DEV DYNAM, V239, P246, DOI 10.1002/dvdy.22127; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wai PY, 2004, J SURG RES, V121, P228, DOI 10.1016/j.jss.2004.03.028; Yan YP, 2009, NEUROCHEM INT, V55, P826, DOI 10.1016/j.neuint.2009.08.007; Yang T, 2011, HEARING RES, V278, P21, DOI 10.1016/j.heares.2011.03.002; Zwaenepoel I, 2002, P NATL ACAD SCI USA, V99, P6240, DOI 10.1073/pnas.082515999	53	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e97544	10.1371/journal.pone.0097544	http://dx.doi.org/10.1371/journal.pone.0097544			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893171	Green Published, gold, Green Submitted			2022-12-27	WOS:000336911400014
J	Loebel, DAF; Hor, ACC; Bildsoe, HK; Tam, PPL				Loebel, David A. F.; Hor, Angelyn C. C.; Bildsoe, Heidi K.; Tam, Patrick P. L.			Timed Deletion of Twist1 in the Limb Bud Reveals Age-Specific Impacts on Autopod and Zeugopod Patterning	PLOS ONE			English	Article							SAETHRE-CHOTZEN-SYNDROME; DNA-BINDING; HOX GENES; MOUSE; SHH; EXPRESSION; FGF; ABSENCE	Twist1 encodes a transcription factor that plays a vital role in limb development. We have used a tamoxifen-inducible Cre transgene, Ubc-CreERT2, to generate time-specific deletions of Twist1 by inducing Cre activity in mouse embryos at different ages from embryonic (E) day 9.5 onwards. A novel forelimb phenotype of supernumerary pre-axial digits and enlargement or partial duplication of the distal radius was observed when Cre activity was induced at E9.5. Gene expression analysis revealed significant upregulation of Hoxd10, Hoxd11 and Grem1 in the anterior half of the forelimb bud at E11.5. There is also localized upregulation of Ptch1, Hand2 and Hoxd13 at the site of ectopic digit formation, indicating a posterior molecular identity for the supernumerary digits. The specific skeletal phenotypes, which include duplication of digits and distal zeugopods but no overt posteriorization, differ from those of other Twist1 conditional knockout mutants. This outcome may be attributed to the deferment of Twist1 ablation to a later time frame of limb morphogenesis, which leads to the ectopic activation of posterior genes in the anterior tissues after the establishment of anterior-posterior anatomical identities in the forelimb bud.	[Loebel, David A. F.; Hor, Angelyn C. C.; Bildsoe, Heidi K.; Tam, Patrick P. L.] Childrens Med Res Inst, Embryol Unit, Westmead, NSW, Australia; [Loebel, David A. F.; Bildsoe, Heidi K.; Tam, Patrick P. L.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	Children's Medical Research Institute - Australia; University of Sydney	Loebel, DAF (corresponding author), Childrens Med Res Inst, Embryol Unit, Westmead, NSW, Australia.	dloebel@cmri.org.au		Bildsoe, Heidi/0000-0003-4504-9476	Australian Research Council [DP1094008]; University of Sydney [2013-00050]	Australian Research Council(Australian Research Council); University of Sydney(University of Sydney)	This research was funded by a Discovery Project Grant from the Australian Research Council (www.arc.gov.au), grant number DP1094008 and a Bridging Grant from The University of Sydney ID 2013-00050. David Loebel was CMRI Kimberly Clark-Research Fellow, Heidi Bildsoe is a postgraduate scholar of the National Health and Medical Reserch Council (www.nhmrc.gov.au), and Patrick Tam is a NHMRC Senior Principal Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastida MF, 2009, DEVELOPMENT, V136, P3779, DOI 10.1242/dev.036418; Bildsoe H, 2013, DEV BIOL, V374, P295, DOI 10.1016/j.ydbio.2012.12.004; Bildsoe H, 2009, DEV BIOL, V331, P176, DOI 10.1016/j.ydbio.2009.04.034; Bourgeois P, 1998, HUM MOL GENET, V7, P945, DOI 10.1093/hmg/7.6.945; Charite J, 2000, DEVELOPMENT, V127, P2461; Chen YT, 2007, GENESIS, V45, P588, DOI 10.1002/dvg.20332; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Connerney J, 2008, DEV BIOL, V318, P323, DOI 10.1016/j.ydbio.2008.03.037; Firulli BA, 2005, NAT GENET, V37, P373, DOI 10.1038/ng1525; Firulli BA, 2007, J BIOL CHEM, V282, P27536, DOI 10.1074/jbc.M702613200; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; Galli A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000901; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Hogan B, 1994, MANIPULATING MOUSE E; Khokha MK, 2003, NAT GENET, V34, P303, DOI 10.1038/ng1178; Krawchuk D, 2010, DEV BIOL, V347, P133, DOI 10.1016/j.ydbio.2010.08.015; Lewandoski M, 2000, NAT GENET, V26, P460, DOI 10.1038/82609; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038403; Loebel DAF, 2004, GENE EXPR PATTERNS, V4, P467, DOI 10.1016/j.modgep.2003.12.003; Loebel DAF, 2012, DEV BIOL, V362, P132, DOI 10.1016/j.ydbio.2011.11.020; McFadden DG, 2002, DEVELOPMENT, V129, P3077; O'Rourke MP, 2002, DEV BIOL, V248, P143, DOI 10.1006/dbio.2002.0730; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Shen XK, 2011, J BIOL CHEM, V286, P26616, DOI 10.1074/jbc.M111.224212; Sheth R, 2013, DEVELOPMENT, V140, P2130, DOI 10.1242/dev.089409; Verheyden JM, 2008, NATURE, V454, P638, DOI 10.1038/nature07085; Yang Y, 1997, DEVELOPMENT, V124, P4393; Zakany J, 2004, SCIENCE, V304, P1669, DOI 10.1126/science.1096049; Zhang Z, 2010, DEVELOPMENT, V137, P3417, DOI 10.1242/dev.051789; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008	30	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98945	10.1371/journal.pone.0098945	http://dx.doi.org/10.1371/journal.pone.0098945			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893291	Green Published, gold, Green Submitted			2022-12-27	WOS:000336911400114
J	Manda, KM; Yedlapudi, D; Korukonda, S; Bojja, S; Kalivendi, SV				Manda, Krishna Madhuri; Yedlapudi, Deepthi; Korukonda, Srikanth; Bojja, Sreedhar; Kalivendi, Shasi V.			The Chaperone-Like Activity of alpha-Synuclein Attenuates Aggregation of Its Alternatively Spliced Isoform, 112-Synuclein In Vitro: Plausible Cross-Talk between Isoforms in Protein Aggregation	PLOS ONE			English	Article							PARKINSONS-DISEASE; POSTTRANSLATIONAL MODIFICATION; CARBOXY-TERMINUS; MESSENGER-RNA; BRAIN-REGIONS; LEWY BODIES; PATHOGENESIS; NEURODEGENERATION; OLIGOMERIZATION; FIBRILLIZATION	Abnormal oligomerization and aggregation of alpha-synuclein (alpha-syn/WT-syn) has been shown to be a precipitating factor in the pathophysiology of Parkinson's disease (PD). Earlier observations on the induced-alternative splicing of alpha-syn by Parkinsonism mimetics as well as identification of region specific abnormalities in the transcript levels of 112-synclein (112-syn) in diseased subjects underscores the role of 112-syn in the pathophysiology of PD. In the present study, we sought to identify the aggregation potential of 112-syn in the presence or absence of WT-syn to predict its plausible role in protein aggregation events. Results demonstrate that unlike WT-syn, lack of 28 aa in the C-terminus results in the loss of chaperone-like activity with a concomitant gain in vulnerability to heat-induced aggregation and time-dependent fibrillation. The effects were dose and time-dependent and a significant aggregation of 112-syn was evident at as low as 45 degrees C following 10 min of incubation. The heat-induced aggregates were found to be ill-defined structures and weakly positive towards Thioflavin-T (ThT) staining as compared to clearly distinguishable ThT positive extended fibrils resulting upon 24 h of incubation at 37 degrees C. Further, the chaperone-like activity of WT-syn significantly attenuated heat-induced aggregation of 112-syn in a dose and time-dependent manner. On contrary, WT-syn synergistically enhanced fibrillation of 112-syn. Overall, the present findings highlight a plausible cross-talk between isoforms of alpha-syn and the relative abundance of these isoforms may dictate the nature and fate of protein aggregates.	[Manda, Krishna Madhuri; Kalivendi, Shasi V.] CSIR IICT, Ctr Acad Sci & Innovat Res, Hyderabad, Andhra Pradesh, India; [Manda, Krishna Madhuri; Yedlapudi, Deepthi; Korukonda, Srikanth; Kalivendi, Shasi V.] CSIR IICT, Ctr Chem Biol, Hyderabad, Andhra Pradesh, India; [Bojja, Sreedhar] CSIR IICT, Inorgan & Phys Chem Div, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT)	Kalivendi, SV (corresponding author), CSIR IICT, Ctr Acad Sci & Innovat Res, Hyderabad, Andhra Pradesh, India.	kalivendi@iict.res.in		Yedlapudi, Deepthi/0000-0002-9811-8976	Department of Biotechnology (DBT), India; miND project from CSIR, India [BSC-115]; Council of Scientific and Industrial Research (CSIR), India; DENOVA project by CSIR, INDIA	Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India); miND project from CSIR, India; Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); DENOVA project by CSIR, INDIA	S.V.K. acknowledges funding from the Department of Biotechnology (DBT), India and miND project (BSC-115) from CSIR, India. The senior research fellowship from Council of Scientific and Industrial Research (CSIR), India, is gratefully acknowledged by K. M. M. D.Y. acknowledges financial support from DENOVA project by CSIR, INDIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrekopoulos C, 2004, BIOCHEM J, V378, P435, DOI 10.1042/BJ20031466; Antony T, 2003, J BIOL CHEM, V278, P3235, DOI 10.1074/jbc.M208249200; Beitz Janice M, 2014, Front Biosci (Schol Ed), V6, P65; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Beyer K, 2008, NEUROGENETICS, V9, P163, DOI 10.1007/s10048-008-0124-6; Beyer K, 2008, NEUROGENETICS, V9, P15, DOI 10.1007/s10048-007-0106-0; Beyer K, 2006, ACTA NEUROPATHOL, V112, P237, DOI 10.1007/s00401-006-0104-6; Beyer K, 2006, NEUROREPORT, V17, P1327, DOI 10.1097/01.wnr.0000224773.66904.e7; Beyer K, 2013, MOL NEUROBIOL, V47, P509, DOI 10.1007/s12035-012-8330-5; CAMPION D, 1995, GENOMICS, V26, P254, DOI 10.1016/0888-7543(95)80208-4; Cardo LF, 2014, NEUROSCI LETT, V562, P45, DOI 10.1016/j.neulet.2014.01.009; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; HAN HY, 1995, CHEM BIOL, V2, P163, DOI 10.1016/1074-5521(95)90071-3; Hong DP, 2011, FEBS LETT, V585, P561, DOI 10.1016/j.febslet.2011.01.009; Hoyer W, 2004, BIOCHEMISTRY-US, V43, P16233, DOI 10.1021/bi048453u; Ischiropoulos H, 2003, ANN NY ACAD SCI, V991, P93; Kalivendi SV, 2010, FREE RADICAL BIO MED, V48, P377, DOI 10.1016/j.freeradbiomed.2009.10.045; Kim TD, 2002, BIOCHEMISTRY-US, V41, P13782, DOI 10.1021/bi026284c; Kim TD, 2000, PROTEIN SCI, V9, P2489, DOI 10.1110/ps.9.12.2489; Lee FJS, 2001, FASEB J, V15, P916, DOI 10.1096/fj.00-0334com; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Levitan K, 2011, J MOL BIOL, V411, P329, DOI 10.1016/j.jmb.2011.05.046; Liu CW, 2005, J BIOL CHEM, V280, P22670, DOI 10.1074/jbc.M501508200; McCarthy JJ, 2011, NEUROGENETICS, V12, P59, DOI 10.1007/s10048-010-0263-4; McLean JR, 2012, MOL CELL NEUROSCI, V49, P230, DOI 10.1016/j.mcn.2011.11.006; McLean PJ, 2002, NEUROSCI LETT, V323, P219, DOI 10.1016/S0304-3940(02)00154-4; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Recchia A, 2004, FASEB J, V18, P617, DOI 10.1096/fj.03-0338rev; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Shults CW, 2006, P NATL ACAD SCI USA, V103, P1661, DOI 10.1073/pnas.0509567103; Souza JM, 2000, J BIOL CHEM, V275, P18344, DOI 10.1074/jbc.M000206200; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Surguchov A, 2013, J NEUROSCI RES, V91, P161, DOI 10.1002/jnr.23149; Takeda A, 1998, AM J PATHOL, V152, P367; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; UEDA K, 1994, BIOCHEM BIOPH RES CO, V205, P1366, DOI 10.1006/bbrc.1994.2816; Ulusoy A, 2010, EUR J NEUROSCI, V32, P409, DOI 10.1111/j.1460-9568.2010.07284.x; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Volles MJ, 2003, BIOCHEMISTRY-US, V42, P7871, DOI 10.1021/bi030086j; Xia Y, 2001, J ALZHEIMERS DIS, V3, P485, DOI 10.3233/JAD-2001-3508	50	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98657	10.1371/journal.pone.0098657	http://dx.doi.org/10.1371/journal.pone.0098657			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892822	Green Published, Green Submitted, gold			2022-12-27	WOS:000336911400080
J	Melnik, TN; Majorina, MA; Larina, DS; Kashparov, IA; Samatova, EN; Glukhov, AS; Melnik, BS				Melnik, Tatiana N.; Majorina, Maria A.; Larina, Daria S.; Kashparov, Ivan A.; Samatova, Ekaterina N.; Glukhov, Anatoly S.; Melnik, Bogdan S.			Independent of Their Localization in Protein the Hydrophobic Amino Acid Residues Have No Effect on the Molten Globule State of Apomyoglobin and the Disulfide Bond on the Surface of Apomyoglobin Stabilizes This Intermediate State	PLOS ONE			English	Article							PHI-VALUE ANALYSIS; SIDE-CHAIN INTERACTIONS; FOLDING INTERMEDIATE; ALPHA-LACTALBUMIN; TRANSITION-STATES; STRUCTURAL HETEROGENEITY; THERMODYNAMIC ANALYSIS; MUTATIONAL ANALYSIS; COLD DENATURATION; SINGLE-PATHWAY	At present it is unclear which interactions in proteins reveal the presence of intermediate states, their stability and formation rate. In this study, we have investigated the effect of substitutions of hydrophobic amino acid residues in the hydrophobic core of protein and on its surface on a molten globule type intermediate state of apomyoglobin. It has been found that independent of their localization in protein, substitutions of hydrophobic amino acid residues do not affect the stability of the molten globule state of apomyoglobin. It has been shown also that introduction of a disulfide bond on the protein surface can stabilize the molten globule state. However in the case of apomyoglobin, stabilization of the intermediate state leads to relative destabilization of the native state of apomyoglobin. The result obtained allows us not only to conclude which mutations can have an effect on the intermediate state of the molten globule type, but also explains why the introduction of a disulfide bond (which seems to "strengthen" the protein) can result in destabilization of the protein native state of apomyoglobin.	[Melnik, Tatiana N.; Majorina, Maria A.; Larina, Daria S.; Kashparov, Ivan A.; Samatova, Ekaterina N.; Glukhov, Anatoly S.; Melnik, Bogdan S.] RAS, Inst Prot Res, Pushchino, Moscow Region, Russia; [Samatova, Ekaterina N.] Max Planck Inst Biophys Chem, Dept Phys Biochem, D-37077 Gottingen, Germany	Russian Academy of Sciences; Max Planck Society	Melnik, BS (corresponding author), RAS, Inst Prot Res, Pushchino, Moscow Region, Russia.	bmelnik@phys.protres.ru	Melnik, Bogdan/U-1988-2017	Melnik, Bogdan/0000-0002-9176-6452; Melnik, Tatiana/0000-0002-9081-4678	MCB program of the Russian Academy of Sciences [01201280919]; Russian Foundation for Basic Research [13-04-00923, 14-04-01729]	MCB program of the Russian Academy of Sciences; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported in part by the MCB program of the Russian Academy of Sciences (01201280919), by the Russian Foundation for Basic Research (13-04-00923 and 14-04-01729). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGASHE VR, 1995, NATURE, V377, P754, DOI 10.1038/377754a0; Arai M, 2000, ADV PROTEIN CHEM, V53, P209; Bai P, 2001, PROTEIN SCI, V10, P55, DOI 10.1110/ps.34101; Baldwin RL, 1996, FOLD DES, V1, pR1, DOI 10.1016/S1359-0278(96)00003-X; Baldwin RL, 2013, CURR OPIN STRUC BIOL, V23, P4, DOI 10.1016/j.sbi.2012.11.004; Baryshnikova E N, 2009, Mol Biol (Mosk), V43, P136; Baryshnikova E N, 2005, Mol Biol (Mosk), V39, P330; Baryshnikova E N, 2007, Mol Biol (Mosk), V41, P674; Baryshnikova EN, 2005, PROTEIN SCI, V14, P2658, DOI 10.1110/ps.051402705; BETZ SF, 1993, PROTEIN SCI, V2, P1551, DOI 10.1002/pro.5560021002; Bhat V, 2012, ARCH BIOCHEM BIOPHYS, V528, P32, DOI 10.1016/j.abb.2012.08.009; Boehm K, 2008, BIOCHEMISTRY-US, V47, P7116, DOI 10.1021/bi800554v; Brylinski M, 2006, COMPUT BIOL CHEM, V30, P255, DOI 10.1016/j.compbiolchem.2006.04.007; Bushmarina NA, 2006, PROTEIN SCI, V15, P659, DOI 10.1110/ps.051904206; Carra JH, 2003, CLIN IMMUNOL, V108, P60, DOI 10.1016/S1521-6616(03)00058-5; Cavagnero S, 1999, J MOL BIOL, V285, P269, DOI 10.1006/jmbi.1998.2273; Chiti F, 1999, NAT STRUCT BIOL, V6, P1005; Dadlez M, 1997, BIOCHEMISTRY-US, V36, P2788, DOI 10.1021/bi962407f; Dombkowski AA, 2014, FEBS LETT, V588, P206, DOI 10.1016/j.febslet.2013.11.024; Dyuysekina AE, 2008, BIOCHEMISTRY-MOSCOW+, V73, P693, DOI 10.1134/S0006297908060102; Eijsink VGH, 2004, J BIOTECHNOL, V113, P105, DOI 10.1016/j.jbiotec.2004.03.026; ELIEZER D, 1995, SCIENCE, V270, P487, DOI 10.1126/science.270.5235.487; Faudry E, 2007, FEBS J, V274, P3601, DOI 10.1111/j.1742-4658.2007.05893.x; Fersht AR, 2004, P NATL ACAD SCI USA, V101, P7976, DOI 10.1073/pnas.0402684101; Fersht AR, 2000, P NATL ACAD SCI USA, V97, P1525, DOI 10.1073/pnas.97.4.1525; FERSHT AR, 1993, FEBS LETT, V325, P5, DOI 10.1016/0014-5793(93)81405-O; FERSHT AR, 1995, P NATL ACAD SCI USA, V92, P10869, DOI 10.1073/pnas.92.24.10869; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; Fersht AR, 2000, P NATL ACAD SCI USA, V97, P14121, DOI 10.1073/pnas.260502597; Fersht AR, 1997, CURR OPIN STRUC BIOL, V7, P3, DOI 10.1016/S0959-440X(97)80002-4; FERSHT AR, 1995, PHILOS T ROY SOC B, V348, P11, DOI 10.1098/rstb.1995.0040; Garcia C, 2000, BIOCHEMISTRY-US, V39, P11227, DOI 10.1021/bi0010266; GAST K, 1994, EUR BIOPHYS J BIOPHY, V23, P297, DOI 10.1007/BF00213579; Gilmanshin R, 1997, PROTEIN SCI, V6, P2134; GOLDENBERG DP, 1989, NATURE, V338, P127, DOI 10.1038/338127a0; GOLDENBERG DP, 1985, J CELL BIOCHEM, V29, P321, DOI 10.1002/jcb.240290406; GRIKO IV, 1986, DOKL AKAD NAUK SSSR+, V291, P709; Halskau O, 2009, CURR PROTEIN PEPT SC, V10, P339, DOI 10.2174/138920309788922199; HARRISON SC, 1985, P NATL ACAD SCI USA, V82, P4028, DOI 10.1073/pnas.82.12.4028; HUGHSON FM, 1989, BIOCHEMISTRY-US, V28, P4415, DOI 10.1021/bi00436a044; Indu S, 2011, PROTEINS, V79, P244, DOI 10.1002/prot.22878; Inobe T, 2004, J MOL BIOL, V339, P199, DOI 10.1016/j.jmb.2004.03.026; JAENICKE L, 1974, ANAL BIOCHEM, V61, P623, DOI 10.1016/0003-2697(74)90429-1; Jamin M, 1998, J MOL BIOL, V276, P491, DOI 10.1006/jmbi.1997.1543; Jamin M, 2005, PROTEIN PEPTIDE LETT, V12, P229, DOI 10.2174/0929866053587174; JENNINGS PA, 1995, J BIOMOL NMR, V6, P271; JENNINGS PA, 1991, METHOD ENZYMOL, V202, P113; JENNINGS PA, 1993, SCIENCE, V262, P892, DOI 10.1126/science.8235610; King J, 1986, Methods Enzymol, V131, P250; MATOUSCHEK A, 1989, NATURE, V340, P122, DOI 10.1038/340122a0; MATOUSCHEK A, 1990, NATURE, V346, P440, DOI 10.1038/346440a0; MATSUMURA M, 1989, P NATL ACAD SCI USA, V86, P6562, DOI 10.1073/pnas.86.17.6562; Matsumura Y, 1996, BBA-PROTEIN STRUCT M, V1292, P69, DOI 10.1016/0167-4838(95)00197-2; Melnik BS, 2008, BIOCHEM BIOPH RES CO, V369, P701, DOI 10.1016/j.bbrc.2008.02.096; Nawrocki JP, 1999, J MOL BIOL, V293, P991, DOI 10.1006/jmbi.1999.3226; Nishimura C, 2002, J MOL BIOL, V322, P483, DOI 10.1016/S0022-2836(02)00810-0; Pan T, 1997, NAT STRUCT BIOL, V4, P931, DOI 10.1038/nsb1197-931; PARKER MJ, 1995, J MOL BIOL, V253, P771, DOI 10.1006/jmbi.1995.0590; Petrovich M, 2006, J MOL BIOL, V360, P865, DOI 10.1016/j.jmb.2006.05.050; PRIVALOV PL, 1986, J MOL BIOL, V190, P487, DOI 10.1016/0022-2836(86)90017-3; PRIVALOV PL, 1971, BIOPOLYMERS, V10, P1865, DOI 10.1002/bip.360101009; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Rabbani G, 2012, CELL BIOCHEM BIOPHYS, V62, P487, DOI 10.1007/s12013-011-9335-9; Rezaei H, 2002, J MOL BIOL, V322, P799, DOI 10.1016/S0022-2836(02)00856-2; Samatova EN, 2010, BIOPHYS J, V98, P1694, DOI 10.1016/j.bpj.2009.12.4326; Samatova EN, 2009, PROTEIN SCI, V18, P2152, DOI 10.1002/pro.229; Settanni G, 2005, P NATL ACAD SCI USA, V102, P628, DOI 10.1073/pnas.0406754102; Shimanouchi T, 2013, COLLOID SURFACE B, V103, P75, DOI 10.1016/j.colsurfb.2012.10.011; Siadat Omid Ranaei, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-12; Soldi G, 2005, BIOPHYS J; Tsui V, 1999, PROTEIN SCI, V8, P45, DOI 10.1110/ps.8.1.45; Van Mierlo CPM, 1998, PROTEIN SCI, V7, P2331, DOI 10.1002/pro.5560071110; VOGL T, 1995, J MOL BIOL, V254, P481, DOI 10.1006/jmbi.1995.0632; ZAHLER WL, 1968, J BIOL CHEM, V243, P716; Zhou RH, 2004, SCIENCE, V305, P1605, DOI 10.1126/science.1101176	75	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98645	10.1371/journal.pone.0098645	http://dx.doi.org/10.1371/journal.pone.0098645			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892675	gold, Green Submitted, Green Published			2022-12-27	WOS:000336911400078
J	Shakoor, S; Kabir, F; Khowaja, AR; Qureshi, SM; Jehan, F; Qamar, F; Whitney, CG; Zaidi, AKM				Shakoor, Sadia; Kabir, Furqan; Khowaja, Asif R.; Qureshi, Shahida M.; Jehan, Fyezah; Qamar, Farah; Whitney, Cynthia G.; Zaidi, Anita K. M.			Pneumococcal Serotypes and Serogroups Causing Invasive Disease in Pakistan, 2005-2013	PLOS ONE			English	Article							DETERMINING CAPSULAR SEROTYPES; SEQUENTIAL MULTIPLEX PCR; STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; CHILDREN; SURVEILLANCE; MENINGITIS	While pneumococcal conjugate vaccines have been implemented in most countries worldwide, use in Asia has lagged in part because of a lack of data on the amount of disease that is vaccine preventable in the region. We describe pneumococcal serotypes elicited from 111 episodes of invasive pneumococcal disease (IPD) from 2005 to 2013 among children and adults in Pakistan. Seventy-three percent (n = 81) of 111 IPD episodes were cases of meningitis (n = 76 in children 0-15 years and n = 5 among adults). Serotypes were determined by target amplification of DNA extracted from pneumococcal isolates (n = 52) or CSF specimens (n = 59). Serogroup 18 was the most common serogroup causing meningitis in children <5 years, accounting for 21% of cases (n = 13). The 10-valent pneumococcal conjugate vaccine (PCV 10) or PCV10- related serotypes were found in 61% (n = 47) of childhood (age 0-15 years) meningitis episodes. PCV-13 increased this coverage to 63% (one additional serotype 19A; n = 48). Our data indicate that use of PCVs would prevent a large proportion of serious pneumococcal disease.	[Shakoor, Sadia; Kabir, Furqan; Khowaja, Asif R.; Qureshi, Shahida M.; Jehan, Fyezah; Qamar, Farah; Zaidi, Anita K. M.] Aga Khan Univ Hosp, Dept Pediat & Child Hlth, Karachi, Pakistan; [Shakoor, Sadia] Aga Khan Univ Hosp, Dept Pathol & Microbiol, Karachi, Pakistan; [Whitney, Cynthia G.] CDC, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA	Aga Khan University; Aga Khan University; Centers for Disease Control & Prevention - USA	Zaidi, AKM (corresponding author), Aga Khan Univ Hosp, Dept Pediat & Child Hlth, Karachi, Pakistan.	anita.zaidi@aku.edu	Furqan Kabir/AAY-7400-2020		Johns Hopkins University [PO2000273560]; National Institute of Health's Fogarty International Center [1 D43 TW007585-01]; FOGARTY INTERNATIONAL CENTER [D43TW007585] Funding Source: NIH RePORTER	Johns Hopkins University(Johns Hopkins University); National Institute of Health's Fogarty International Center; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Collection of CSF samples used in the study was done through the Johns-Hopkins and GAVI collaboration for the study: Impact of Introduction of HiB Vaccine in selected districts of Pakistan. Grant No. PO2000273560 Johns Hopkins University. Dr. Sadia Shakoor received research training support from the National Institute of Health's Fogarty International Center (1 D43 TW007585-01). The funders of this primary study had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Carvalho MD, 2010, J CLIN MICROBIOL, V48, P1611, DOI 10.1128/JCM.02243-09; Dias CA, 2007, J MED MICROBIOL, V56, P1185, DOI 10.1099/jmm.0.47347-0; Feikin DR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001517; Hausdorff WP, 2005, LANCET INFECT DIS, V5, P83, DOI 10.1016/S1473-3099(05)01280-6; Hsu KK, 2010, PEDIATR INFECT DIS J, V29, P289, DOI 10.1097/INF.0b013e3181c15471; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Khowaja AR, 2013, J PEDIATR-US, V163, pS86, DOI 10.1016/j.jpeds.2013.03.035; Khowaja AR, 2013, J PEDIATR-US, V163, pS79, DOI 10.1016/j.jpeds.2013.03.034; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; MASTRO TD, 1991, LANCET, V337, P156, DOI 10.1016/0140-6736(91)90813-5; McIntosh EDG, 2011, EXPERT REV VACCINES, V10, P109, DOI 10.1586/ERV.10.145; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Pai R, 2005, J INFECT DIS, V192, P1988, DOI 10.1086/498043; Pimenta FC, 2009, J CLIN MICROBIOL, V47, P2353, DOI 10.1128/JCM.00704-09; Pneumococcal vaccines WHO position paper, 2012, WKLY EPIDEMIOL REC, V14, P129; Popovic T, 1998, LAB METHODS DIAGNOSI; Sacchi CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020675; Saha SK, 2009, CLIN INFECT DIS, V48, pS75, DOI 10.1086/596544; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2; WHO/IVB, 2012, EST HIB PNEUM DEATHS; Zaidi AKM, 2009, CLIN INFECT DIS, V48, pS129, DOI 10.1086/596491	23	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98796	10.1371/journal.pone.0098796	http://dx.doi.org/10.1371/journal.pone.0098796			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892937	Green Submitted, Green Published, gold			2022-12-27	WOS:000336911400092
J	Cafazzo, S; Bonanni, R; Valsecchi, P; Natoli, E				Cafazzo, Simona; Bonanni, Roberto; Valsecchi, Paola; Natoli, Eugenia			Social Variables Affecting Mate Preferences, Copulation and Reproductive Outcome in a Pack of Free-Ranging Dogs	PLOS ONE			English	Article							MALE MATING SUCCESS; JAPANESE MACAQUES; DOMINANCE RANK; CANIS-FAMILIARIS; BREEDING SUCCESS; SEXUAL COERCION; FECUND FEMALES; SPOTTED HYENAS; STRAY DOGS; BODY-SIZE	Mating and reproductive outcome is often determined by the simultaneous operation of different mechanisms like intra-sexual competition, mating preferences and sexual coercion. The present study investigated how social variables affected mating outcome in a pack of free-ranging dogs, a species supposed to have lost most features of the social system of wolves during domestication. We found that, although the pack comprised multiple breeding individuals, both male copulation success and female reproductive success were positively influenced by a linear combination of dominance rank, age and leadership. Our results also suggest that mate preferences affect mating outcome by reinforcing the success of most dominant individuals. In particular, during their oestrous period bitches clearly searched for the proximity of high-ranking males who displayed affiliative behaviour towards them, while they were more likely to reject the males who intimidated them. At the same time, male courting effort and male-male competition for receptive females appeared to be stronger in the presence of higher-ranking females, suggesting a male preference for dominant females. To our knowledge, these results provide the first clear evidence of social regulation of reproductive activities in domestic dogs, and suggest that some common organizing mechanisms may contribute to shape the social organization of both dogs and wolves.	[Cafazzo, Simona; Bonanni, Roberto; Valsecchi, Paola] Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy; [Cafazzo, Simona] Wolf Sci Ctr, Ernstbrunn, Austria; [Natoli, Eugenia] Azienda USL Roma D, Area Dipartimentale Sanita Pubbl Vet, Rome, Italy	University of Parma	Cafazzo, S (corresponding author), Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy.	simona.cafazzo@inwind.it	Natoli, Eugenia/AAE-2156-2020	, Eugenia/0000-0002-9232-7048; Valsecchi, Paola/0000-0002-0491-9845	Department of Education, University and Research of Italian Government (PRIN); University of Parma; FIL; Austrian Science Fund (FWF) [M 1400-B19]	Department of Education, University and Research of Italian Government (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); University of Parma; FIL; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research was partially funded by the Department of Education, University and Research of Italian Government (PRIN 2004), and by University of Parma with FIL 2005 to Paola Valsecchi; it also complies with all laws of the country (Italy) in which it was performed. Manuscript preparation was funded by the Austrian Science Fund (FWF): [M 1400-B19] to Simona Cafazzo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Amundsen T, 2000, TRENDS ECOL EVOL, V15, P149, DOI 10.1016/S0169-5347(99)01800-5; [Anonymous], ADAPTATION NATURAL S; [Anonymous], 1994, SEXUAL SELECTION; [Anonymous], 2014, THE SOCIAL DOG; BEACH FA, 1967, ANIM BEHAV, V15, P546, DOI 10.1016/0003-3472(67)90057-7; Beck A.M., 1973, ECOLOGY STRAY DOGS S; BERCOVITCH FB, 1995, ANIM BEHAV, V50, P137, DOI 10.1006/anbe.1995.0227; BERENSTAIN L, 1983, INT J PRIMATOL, V4, P201, DOI 10.1007/BF02743758; BERGLUND A, 1993, BEHAV ECOL SOCIOBIOL, V32, P331; BOITANI L, 1995, ETHOL ECOL EVOL, V7, P49, DOI 10.1080/08927014.1995.9522969; Boitani L, 2007, BEHAVIOURAL BIOLOGY OF DOGS, P147, DOI 10.1079/9781845931872.0147; Bonanni R, 2011, ANIM COGN, V14, P103, DOI 10.1007/s10071-010-0348-3; Bonanni R, 2010, ANIM BEHAV, V79, P981, DOI 10.1016/j.anbehav.2010.02.021; Bonanni R, 2010, ANIM BEHAV, V79, P957, DOI 10.1016/j.anbehav.2010.01.016; Bradshaw JWS, 2009, J VET BEHAV, V4, P135, DOI 10.1016/j.jveb.2008.08.004; BURLEY N, 1979, ANIM BEHAV, V27, P686, DOI 10.1016/0003-3472(79)90005-8; Cafazzo S, 2012, ETHOLOGY, V118, P955, DOI 10.1111/j.1439-0310.2012.02088.x; Cafazzo S, 2010, BEHAV ECOL, V21, P443, DOI 10.1093/beheco/arq001; Camenzind FJ, 1978, COYOTES BIOL BEHAV M; Cassinello J, 1996, J ZOOL, V239, P141, DOI 10.1111/j.1469-7998.1996.tb05442.x; CHAPAIS B, 1983, BEHAV ECOL SOCIOBIOL, V12, P215, DOI 10.1007/BF00290774; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; CLUTTONBROCK TH, 1986, ANIM BEHAV, V34, P460, DOI 10.1016/S0003-3472(86)80115-4; CLUTTONBROCK TH, 1995, ANIM BEHAV, V49, P1345, DOI 10.1006/anbe.1995.0166; CLUTTONBROCK TH, 1984, NATURE, V308, P358, DOI 10.1038/308358a0; CLUTTONBROCK TH, 1991, NATURE, V351, P58; Coppinger R., 2001, DOGS NEW UNDERSTANDI; CORBETT LK, 1988, ETHOLOGY, V78, P177, DOI 10.1111/j.1439-0310.1988.tb00229.x; Cote SD, 2001, ANIM BEHAV, V62, P173, DOI 10.1006/anbe.2001.1719; COWLISHAW G, 1991, ANIM BEHAV, V41, P1045, DOI 10.1016/S0003-3472(05)80642-6; COX CR, 1977, AM NAT, V111, P317, DOI 10.1086/283163; Cunningham EJA, 1998, ANIM BEHAV, V56, P1311, DOI 10.1006/anbe.1998.0953; DANIELS TJ, 1989, J MAMMAL, V70, P754, DOI 10.2307/1381709; DANIELS TJ, 1983, APPL ANIM ETHOL, V10, P365, DOI 10.1016/0304-3762(83)90185-2; DANIELS TJ, 1989, ETHOLOGY, V81, P300; Davies N. B., 1992, DUNNOCK BEHAV SOCIAL; DERIX R, 1993, BEHAVIOUR, V127, P141, DOI 10.1163/156853993X00461; DERIX RRWM, 1995, BEHAVIOUR, V132, P127, DOI 10.1163/156853995X00333; DEWSBURY DA, 1982, AM NAT, V119, P601, DOI 10.1086/283938; Dixson AF, 1998, PRIMATE SEXUALITY; DUNBAR RIM, 1977, NATURE, V266, P351, DOI 10.1038/266351a0; East ML, 2003, P ROY SOC B-BIOL SCI, V270, P1247, DOI 10.1098/rspb.2003.2363; ELLIS L, 1995, ETHOL SOCIOBIOL, V16, P257, DOI 10.1016/0162-3095(95)00050-U; EMLEN ST, 1986, ETHOLOGY, V71, P2; FEDIGAN LM, 1983, YEARB PHYS ANTHROPOL, V26, P91; FESTABIANCHET M, 1988, J MAMMAL, V69, P157, DOI 10.2307/1381764; FONT E, 1987, APPL ANIM BEHAV SCI, V17, P319, DOI 10.1016/0168-1591(87)90155-9; GHOSH B, 1984, APPL ANIM BEHAV SCI, V13, P113, DOI 10.1016/0168-1591(84)90057-1; Gier HT., 1968, KAN STATE COLL AG EX, V939, P1; Gipson PS, 1983, VERTEBRATE PEST CONT, V4, P285; Girman DJ, 1997, BEHAV ECOL SOCIOBIOL, V40, P187, DOI 10.1007/s002650050332; GWYNNE DT, 1981, SCIENCE, V213, P779, DOI 10.1126/science.213.4509.779; HALEY MP, 1994, ANIM BEHAV, V48, P1249, DOI 10.1006/anbe.1994.1361; Harrington F.H., 1982, P81; Hayakawa S, 2007, INT J PRIMATOL, V28, P73, DOI 10.1007/s10764-006-9109-1; Honer OP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1059; Hoffman CL, 2008, BEHAV ECOL SOCIOBIOL, V62, P1711, DOI 10.1007/s00265-008-0599-z; Horne TJ, 1996, BEHAV ECOL SOCIOBIOL, V38, P401, DOI 10.1007/s002650050257; Hrdy SB, 1984, INFANTICIDE COMP EVO; Jenks SM, 2011, BEHAV GENET, V41, P810, DOI 10.1007/s10519-011-9453-6; Johnstone RA, 1996, EVOLUTION, V50, P1382, DOI [10.2307/2410876, 10.1111/j.1558-5646.1996.tb03912.x]; Kirk RW, 1977, CURRENT VET THERAPY, VVI; KLEIMAN DG, 1977, Q REV BIOL, V52, P39, DOI 10.1086/409721; Klinkova E, 2005, INT J PRIMATOL, V26, P357, DOI 10.1007/s10764-005-2929-6; Kraak SBM, 1998, ANIM BEHAV, V56, P859, DOI 10.1006/anbe.1998.0822; Le Boeuf BJ, 1967, PSYCHON SCI, V7, P313; Longpre KM, 2011, HORM BEHAV, V60, P505, DOI 10.1016/j.yhbeh.2011.07.019; Lord K, 2013, BEHAV PROCESS, V92, P131, DOI 10.1016/j.beproc.2012.10.009; MacDonald D. W., 1995, P199; MacNulty DR, 2012, BEHAV ECOL, V23, P75, DOI 10.1093/beheco/arr159; MacNulty DR, 2009, ECOL LETT, V12, P1347, DOI 10.1111/j.1461-0248.2009.01385.x; MCLEOD PJ, 1990, CAN J ZOOL, V68, P402, DOI 10.1139/z90-058; Mech L. David, 2003, P1; MECH LD, 1989, J MAMMAL, V70, P675, DOI 10.2307/1381450; Mech LD, 1999, CAN J ZOOL, V77, P1196, DOI 10.1139/cjz-77-8-1196; Mech LD, 2000, CAN FIELD NAT, V114, P259; Mech LD., 1970, WOLF ECOLOGY BEHAV E; Medina Martin, 2007, WORLDS SCAVENGERS SA; Moehlman P.D., 1983, AM SOC MAMMAL SPEC P, V7, P423; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Nichols HJ, 2010, ANIM BEHAV, V80, P649, DOI 10.1016/j.anbehav.2010.06.025; Nolan PM, 2010, ETHOLOGY, V116, P635, DOI 10.1111/j.1439-0310.2010.01775.x; Ognev SI, 1931, MAMMALS E EUROPE NO; OZOGA JJ, 1986, J WILDLIFE MANAGE, V50, P480, DOI 10.2307/3801110; Packard J.M., 1980, BIOSOCIAL MECH POPUL, P135; Packard Jane M., 2003, P35; PACKARD JM, 1985, Z TIERPSYCHOL, V68, P24; Packard JM, 1983, REPORT SERIES CANADI, V45, P78; Packard JM, 2011, ENCY BEHAV; Pal S.K., 2011, International Journal of Zoology, V2011, P1, DOI 10.1155/2011/314216; Pal SK, 1998, APPL ANIM BEHAV SCI, V61, P123, DOI 10.1016/S0168-1591(98)00185-3; Pal SK, 2005, APPL ANIM BEHAV SCI, V90, P31, DOI 10.1016/j.applanim.2004.08.002; Pal SK, 2003, ACTA THERIOL, V48, P271, DOI 10.1007/BF03194167; Pal SK, 1999, APPL ANIM BEHAV SCI, V62, P267, DOI 10.1016/S0168-1591(98)00220-2; Pal SK, 1998, APPL ANIM BEHAV SCI, V59, P331, DOI 10.1016/S0168-1591(98)00108-7; Parker GA, 1983, MATE CHOICE; PEMBERTON JM, 1992, BEHAV ECOL, V3, P66, DOI 10.1093/beheco/3.1.66; PEREIRA ME, 1991, BEHAV ECOL SOCIOBIOL, V28, P141; Peterson RO, 2002, CAN J ZOOL, V80, P1405, DOI 10.1139/Z02-124; PETERSON RO, 1984, J WILDLIFE MANAGE, P1; Pusey A, 1997, SCIENCE, V277, P828, DOI 10.1126/science.277.5327.828; RASA OAE, 1977, Z TIERPSYCHOL, V43, P337; RAUSCH RA, 1967, AM ZOOL, V7, P253; REITER J, 1981, ANIM BEHAV, V29, P670, DOI 10.1016/S0003-3472(81)80002-4; REYNOLDS JD, 1990, AM NAT, V136, P230, DOI 10.1086/285093; ROBINSON JG, 1982, AM J PRIMATOL, V2, P131; Rubenstein DI, 1986, ECOLOGICAL ASPECTS S, P463; Sand H, 1996, OECOLOGIA, V106, P212, DOI 10.1007/BF00328601; Sands J, 2004, ANIM BEHAV, V67, P387, DOI 10.1016/j.anbehav.2003.03.019; SARGENT RC, 1986, ANIM BEHAV, V34, P545, DOI 10.1016/S0003-3472(86)80123-3; Savolainen P, 2004, P NATL ACAD SCI USA, V101, P12387, DOI 10.1073/pnas.0401814101; Say L, 1999, P ROY SOC B-BIOL SCI, V266, P2071, DOI 10.1098/rspb.1999.0889; Schmidt K, 2008, J ETHOL, V26, P69, DOI 10.1007/s10164-006-0031-y; SMALL MF, 1982, ANIM BEHAV, V30, P626, DOI 10.1016/S0003-3472(82)80076-6; Smuts B.B., 1985, SEX FRIENDSHIP BABOO; SMUTS BB, 1993, ADV STUD BEHAV, V22, P1, DOI 10.1016/S0065-3454(08)60404-0; Smuts BB, 1983, PRIMATE SOCIAL RELAT; SOLOMON NG, 1993, ANIM BEHAV, V45, P1031, DOI 10.1006/anbe.1993.1122; Soltis J, 2001, ANIM BEHAV, V62, P485, DOI 10.1006/anbe.2001.1774; Soltis J, 1997, ANIM BEHAV, V54, P737, DOI 10.1006/anbe.1997.0568; Spritzer MD, 2006, ETHOLOGY, V112, P1027, DOI 10.1111/j.1439-0310.2006.01260.x; Stumpf RM, 2006, BEHAV ECOL SOCIOBIOL, V60, P749, DOI 10.1007/s00265-006-0219-8; Stumpf RM, 2010, ANIM BEHAV, V79, P333, DOI 10.1016/j.anbehav.2009.11.008; Stumpf RM, 2005, BEHAV ECOL SOCIOBIOL, V57, P511, DOI 10.1007/s00265-004-0868-4; Szykman M, 2001, BEHAV ECOL SOCIOBIOL, V50, P231, DOI 10.1007/s002650100356; Takahata Y, 1999, PRIMATES, V40, P143, DOI 10.1007/BF02557707; THORNHILL R, 1980, ANIM BEHAV, V28, P52, DOI 10.1016/S0003-3472(80)80007-8; Trivers RL, 1972, SELECTION DESCENT MA; VERRELL PA, 1995, ETHOLOGY, V99, P162; VERRELL PA, 1989, ANIM BEHAV, V38, P1086, DOI 10.1016/S0003-3472(89)80150-2; VERRELL PA, 1985, HERPETOLOGICA, V41, P382; Vonholdt BM, 2008, MOL ECOL, V17, P252, DOI 10.1111/j.1365-294X.2007.03468.x; WOOLPY JH, 1967, AM ZOOL, V7, P305; Wroblewski EE, 2009, ANIM BEHAV, V77, P873, DOI 10.1016/j.anbehav.2008.12.014; Young S. P., 1964, WOLVES N AM; ZIMEN E, 1976, Z TIERPSYCHOL, V40, P300; [No title captured]	138	31	31	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98594	10.1371/journal.pone.0098594	http://dx.doi.org/10.1371/journal.pone.0098594			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905360	Green Submitted, Green Published, gold			2022-12-27	WOS:000341869000042
J	Chisholm, V; Gonzalez, A; Atkinson, L				Chisholm, Vivienne; Gonzalez, Andrea; Atkinson, Leslie			Interpersonal Engagement Mediates the Relation between Maternal Affect and Externalising Behaviour in Young Children with Type 1 Diabetes	PLOS ONE			English	Article							CROSS-SECTIONAL ANALYSES; MOTHER-CHILD; METABOLIC-CONTROL; GLYCEMIC CONTROL; PSYCHOSOCIAL ADJUSTMENT; MEALTIME INTERACTIONS; DEPRESSIVE SYMPTOMS; ADHERENCE; PREDICTORS; OUTCOMES	Mother-child interactions around a shared activity have been shown to play a key role in the development of young children's capacity to interact cooperatively with others. This evidence is particularly germane to type 1 diabetes (T1D) management in younger children where cooperation with parental treatment efforts is crucial for treatment success and where maternal distress and child behavioural problems are risk factors for treatment management, biomedical and psychological outcomes. In 49 4-to-8 year old children with T1D, we investigated whether the association between maternal affect and child problematic behaviour is mediated by mother-child interactions in the context of a T1D-relevant collaborative problem-solving activity. Mothers completed standardised measures of maternal and child psychological adjustment and interacted with their children in the problem-solving activity, analysed for quality of interpersonal engagement based on evaluations of maternal (sensitivity and cognitive stimulation) and dyadic (joint attention and warmth) behaviours. Mediation analyses confirmed the hypothesis that interpersonal engagement mediates the relation between maternal affective state and child behavioural problems. Specifically, more negative maternal affect is associated with lower levels of interpersonal engagement; these less engaged interactions in turn are associated with more behavioural problems in children. These findings are consistent with research involving typically developing children. The implications of our findings are twofold. First, in the context of psychological adjustment to T1D, maternal affect and mother-child interactions are 2 potential targets for interventions which promote cooperative interactions. Second, understanding and caring for children at biological risk requires attention to developmental psychology theory and method; in particular, research addressing parent-child cooperation carries both conceptual and clinical relevance.	[Chisholm, Vivienne] Queen Margaret Univ, Div Psychol & Sociol, Musselburgh, Scotland; [Gonzalez, Andrea] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Atkinson, Leslie] Ryerson Univ, Dept Psychol, Toronto, ON, Canada	Queen Margaret University; McMaster University; Toronto Metropolitan University	Chisholm, V (corresponding author), Queen Margaret Univ, Div Psychol & Sociol, Musselburgh, Scotland.	vchisholm@qmu.ac.uk	González Ríos, Andrea/HGU-7618-2022; Gonzalez, Andrea/HDM-9987-2022; Gonzalez, Andrea/G-4302-2017	Atkinson, Leslie/0000-0003-1265-3298; Gonzalez, Andrea/0000-0003-0087-830X	Chief Scientist Office, NHS, Scotland; Queen Margaret University	Chief Scientist Office, NHS, Scotland; Queen Margaret University	This research was supported by the Chief Scientist Office, NHS, Scotland and Queen Margaret University Research Theme funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allhusen V, 2003, CHILD DEV, V74, P1639; [Anonymous], 1991, MANUAL CHILD BEHAV C; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Berg CA, 2011, J PEDIATR PSYCHOL, V36, P329, DOI 10.1093/jpepsy/jsq088; Borge AIH, 2004, EUR J DEV PSYCHOL, V1, P19, DOI 10.1080/17405620344000004; Borus JS, 2010, CURR OPIN PEDIATR, V22, P405, DOI 10.1097/MOP.0b013e32833a46a7; Bryden KS, 2001, DIABETES CARE, V24, P1536, DOI 10.2337/diacare.24.9.1536; Cameron FJ, 2007, DIABETES CARE, V30, P2716, DOI 10.2337/dc07-0603; Campbell SB, 2009, J ABNORM PSYCHOL, V118, P479, DOI 10.1037/a0015923; Cardoso C, 2012, EXP CLIN PSYCHOPHARM, V20, P84, DOI 10.1037/a0025763; Chisholm V, 2014, CHILD CARE HLTH DEV, V40, P85, DOI 10.1111/cch.12004; Chisholm V, 2010, CLIN CHILD PSYCHOL P, V16, P443, DOI DOI 10.1177/1359104510373312; Chisholm V, 2007, J ADV NURS, V57, P482, DOI 10.1111/j.1365-2648.2006.04137.x; Cohen DM, 2004, J PEDIATR PSYCHOL, V29, P171, DOI 10.1093/jpepsy/jsh019; Combs-Ronto LA, 2009, J ABNORM CHILD PSYCH, V37, P1151, DOI 10.1007/s10802-009-9332-2; Cummings EM, 2005, J CHILD PSYCHOL PSYC, V46, P479, DOI 10.1111/j.1469-7610.2004.00368.x; Dabelea D, 2009, LANCET, V373, P1999, DOI 10.1016/S0140-6736(09)60874-6; Deater-Deckard K, 2004, J ABNORM CHILD PSYCH, V32, P609, DOI 10.1023/B:JACP.0000047210.81880.14; DENHAM SA, 1991, CHILD DEV, V62, P242, DOI 10.1111/j.1467-8624.1991.tb01528.x; Devendra D, 2004, BMJ-BRIT MED J, V328, P750, DOI 10.1136/bmj.328.7442.750; Duke DC, 2008, J PEDIATR PSYCHOL, V33, P719, DOI 10.1093/jpepsy/jsn012; Fivush R, 2006, CHILD DEV, V77, P1568, DOI 10.1111/j.1467-8624.2006.00960.x; Foster CJE, 2008, J ABNORM CHILD PSYCH, V36, P527, DOI 10.1007/s10802-007-9197-1; Galboda-Liyanage KC, 2003, J CHILD PSYCHOL PSYC, V44, P1037, DOI 10.1111/1469-7610.00188; Gartstein MA, 2003, J APPL DEV PSYCHOL, V24, P143, DOI 10.1016/S0193-3973(03)00043-1; Gauvain M, 2008, CHILD DEV, V79, P761, DOI 10.1111/j.1467-8624.2008.01156.x; Gelman SA, 2011, WIRES COGN SCI, V2, P95, DOI 10.1002/wcs.96; Glasgow RE, 1999, DIABETES CARE, V22, P832, DOI 10.2337/diacare.22.5.832; GOLDSMITH DF, 1995, DEV PSYCHOL, V31, P388, DOI 10.1037/0012-1649.31.3.388; Goldsmith DF, 1997, DEV PSYCHOL, V33, P113; Goodman SH, 2007, ANNU REV CLIN PSYCHO, V3, P107, DOI 10.1146/annurev.clinpsy.3.022806.091401; Harris JA, 2003, PERS INDIV DIFFER, V35, P1903, DOI 10.1016/S0191-8869(03)00039-4; Harvey JN, 2004, DIABETIC MED, V21, P26, DOI 10.1046/j.1464-5491.2003.01062.x; Hayes AF, 2011, SPSS INDIRECT MACROS; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Hill-Briggs F, 2001, DIABETES CARE, V24, P959, DOI 10.2337/diacare.24.5.959; Hilliard ME, 2011, CHILD CARE HLTH DEV, V37, P224, DOI 10.1111/j.1365-2214.2010.01162.x; Hirsh-Pasek K, 2006, MERRILL PALMER QUART, V52, P449, DOI 10.1353/mpq.2006.0027; Holmbeck GN, 2008, J PEDIATR PSYCHOL, V33, P958, DOI 10.1093/jpepsy/jsm059; Horton D, 2009, J PEDIATR PSYCHOL, V34, P1008, DOI 10.1093/jpepsy/jsp022; Huebner CE, 2002, PUBLIC HEALTH NURS, V19, P377, DOI 10.1046/j.1525-1446.2002.19507.x; JACOBSON AM, 1990, J PEDIATR PSYCHOL, V15, P511; Jaser SS, 2009, CHILD HEALTH CARE, V38, P91, DOI 10.1080/02739610902813229; KOVACS M, 1995, DIABETIC MED, V12, P142, DOI 10.1111/j.1464-5491.1995.tb00445.x; Landolt MA, 2005, J AM ACAD CHILD PSY, V44, P682, DOI 10.1097/01.chi.0000161645.98022.35; Lorr M., 1988, MANUAL PROFILE MOOD; Lunkenheimer ES, 2011, DEV PSYCHOPATHOL, V23, P577, DOI 10.1017/S095457941100006X; Ma RCW, 2009, NAT REV ENDOCRINOL, V5, P529, DOI 10.1038/nrendo.2009.180; MACCOBY EE, 1992, DEV PSYCHOL, V28, P1006, DOI 10.1037/0012-1649.28.6.1006; Maxwell SE, 2007, PSYCHOL METHODS, V12, P23, DOI 10.1037/1082-989X.12.1.23; Maxwell SE, 2011, MULTIVAR BEHAV RES, V46, P816, DOI 10.1080/00273171.2011.606716; McNair D., 2005, PROFILE MOOD STATES; Miller VA, 2011, J PEDIATR PSYCHOL, V36, P1102, DOI 10.1093/jpepsy/jsr033; Moss E, 2011, DEV PSYCHOPATHOL, V23, P195, DOI 10.1017/S0954579410000738; Naar-King S, 2006, J PEDIATR PSYCHOL, V31, P793, DOI 10.1093/jpepsy/jsj090; Nguyen SP, 2008, INFANT CHILD DEV, V17, P285, DOI 10.1002/icd.553; Nguyen SP, 2012, CHILD DEV, V83, P1748, DOI 10.1111/j.1467-8624.2012.01812.x; Nguyen SP, 2012, INFANT CHILD DEV, V21, DOI 10.1002/icd.745; Nguyen SP, 2003, CHILD DEV, V74, P1783, DOI 10.1046/j.1467-8624.2003.00638.x; Northam EA, 2006, DIABETIC MED, V23, P113, DOI 10.1111/j.1464-5491.2005.01678.x; Northam EA, 2005, DIABETIC MED, V22, P152, DOI 10.1111/j.1464-5491.2004.01370.x; Northam EA, 2010, DIABETES CARE, V33, P1430, DOI 10.2337/dc09-2232; O'Halloran PD, 2004, PSYCHOL REP, V95, P459, DOI 10.2466/pr0.95.2.459-463; Ohr PS, 2010, J FAM PSYCHOL, V24, P625, DOI 10.1037/a0021007; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Patton SR, 2006, DIABETES CARE, V29, P1002, DOI 10.2337/dc05-2354; Patton SR, 2008, J PEDIATR PSYCHOL, V33, P885, DOI 10.1093/jpepsy/jsn026; Poole K, 1999, BREAST, V8, P334, DOI 10.1054/brst.1999.0085; Powers SW, 2002, DIABETES CARE, V25, P313, DOI 10.2337/diacare.25.2.313; Rayman M, 2006, BIOL PSYCHIAT, V59, P147, DOI 10.1016/j.biopsych.2005.06.019; Reising MM, 2013, J CHILD FAM STUD, V22, P335, DOI 10.1007/s10826-012-9582-4; Sullivan-Bolyai S, 2003, J Pediatr Nurs, V18, P21, DOI 10.1053/jpdn.2003.4; Weinfield NS, 2002, CHILD DEV, V73, P528, DOI 10.1111/1467-8624.00422; Wilson AC, 2009, J CLIN PSYCHOL MED S, V16, P216, DOI 10.1007/s10880-009-9163-x; Xinshu Z, 2010, J CONSUM RES, V37, P97	76	15	15	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e97672	10.1371/journal.pone.0097672	http://dx.doi.org/10.1371/journal.pone.0097672			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP1YS	24905358	Green Published, Green Submitted, gold			2022-12-27	WOS:000341869000009
J	Ge, D; Jing, QC; Zhao, WB; Yue, HW; Su, L; Zhang, SL; Zhao, J				Ge, Di; Jing, Qingchuan; Zhao, Wenbo; Yue, Hongwei; Su, Le; Zhang, ShangLi; Zhao, Jing			Finding ATF4/p75NTR/IL-8 Signal Pathway in Endothelial-Mesenchymal Transition by Safrole Oxide	PLOS ONE			English	Article							PRECURSOR CELLS; SMALL-MOLECULE; APOPTOSIS; GROWTH; 1-ETHOXY-3-(3,4-METHYLENEDIOXYPHENYL)-2-PROPANOL; TRANSDIFFERENTIATION; DIFFERENTIATION; ANGIOGENESIS; DEPRIVATION; INDUCTION	Targeting the endothelial-to-mesenchymal transition Endo T) may be a novel therapeutic strategy for cancer and various diseases induced by fibrosis. We aimed to den small chemical molecule as an inducer of EndoMT and find a new signal pathway by using the inducer. Safrole oxide (SFO) 50 mu g/ml, could most effectively induce EndoMT within 12 h. To understand the underlying molecular mechanism, we performed microarray, quantitative real-time PCR and western blot analysis to find key factors involved in SFO-induced EndoMT and demonstrated the involvement of the factors by RNAi. The expression of activating transcription factor 4 (ATF4), p75 neurotrophin receptor (p75NTR), and interleukin 8 (IL-8) was greatly increased in SFO-induced EndoMT. Knockdown of ATF4 inhibited the SFO-induced EndoMT completely, and knockdown of p75NTR or 1L-8 partially inhibited the EnoMT, which suggests that all three factors were involved in the process. Furthermore knockdown of p75NTR inhibited the SFO-increased IL-8 expression and secretion and knockdown of ATF4 inhibited SFO-increased p75NTR level significantly. The ATF4/p75NTR/1L-8 signal pathway may have an important role in EndoMT induced by SFO. Our findings support potential novel targets for the therapeutics of cancer and fibrosis disease.	[Ge, Di; Zhao, Wenbo; Yue, Hongwei; Su, Le; Zhang, ShangLi; Zhao, Jing] Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cells & Dev Biol, Jinan 250100, Peoples R China; [Jing, Qingchuan] Shandong Acad Agr Sci, Inst Poultry Sci, Jinan, Peoples R China	Shandong University; Shandong Academy of Agricultural Sciences	Zhao, J (corresponding author), Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cells & Dev Biol, Jinan 250100, Peoples R China.	jingzhao@sdu.edu.cn	zhao, jing/B-3868-2019		National Natural Science Foundation of China [30800398, 81021001]; Science Foundation for the Excellent Youth Scholars of Ministry of Education of China [200804221004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation for the Excellent Youth Scholars of Ministry of Education of China	This work was supported by National Natural Science Foundation of China (No. 30800398 and 81021001 http://isisn.nsfc.gov.cn/egrantweb/); Science Foundation for the Excellent Youth Scholars of Ministry of Education of China (No. 200804221004 http://www.moe.edu.cn/publicfiles/business/htmlfiles/moe/moe_257/index.html) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CS, 2002, CRIT REV ORAL BIOL M, V13, P465, DOI 10.1177/154411130201300604; Caporali A, 2008, CIRC RES, V103, pE15, DOI 10.1161/CIRCRESAHA.108.177386; Chen SB, 2006, P NATL ACAD SCI USA, V103, P17266, DOI 10.1073/pnas.0608156103; Choi M, 2013, INT J BIOCHEM CELL B, V45, P560, DOI 10.1016/j.biocel.2012.12.001; Colombo E, 2011, J NEUROPATH EXP NEUR, V70, P133, DOI 10.1097/NEN.0b013e3182084391; Du AY, 2005, BIOORGAN MED CHEM, V13, P4176, DOI 10.1016/j.bmc.2005.04.031; Emmanuel C, 2013, CYTOKINE, V61, P38, DOI 10.1016/j.cyto.2012.09.017; Firestone AJ, 2010, ACS CHEM BIOL, V5, P15, DOI 10.1021/cb900249y; Gargalovic PS, 2006, ARTERIOSCL THROM VAS, V26, P2490, DOI 10.1161/01.ATV.0000242903.41158.a1; Ge D, 2012, ACTA PHARMACOL SIN, V33, P57, DOI 10.1038/aps.2011.142; Ge D, 2011, J CELL PHYSIOL, V226, P2827, DOI 10.1002/jcp.22632; Goumans MJ, 2008, TRENDS CARDIOVAS MED, V18, P293, DOI 10.1016/j.tcm.2009.01.001; Hashmi AZ, 2007, AM J PHYSIOL-GASTR L, V292, pG395, DOI 10.1152/ajpgi.00208.2006; Hertig A, 2010, J MOL CELL CARDIOL, V48, P497, DOI 10.1016/j.yjmcc.2009.07.022; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Malabanan KP, 2010, J MOL MED, V88, P545, DOI 10.1007/s00109-010-0615-4; Miao JY, 2002, ACTA PHARMACOL SIN, V23, P323; Mitra RS, 1997, LAB INVEST, V76, P99; Mungrue IN, 2009, J IMMUNOL, V182, P466, DOI 10.4049/jimmunol.182.1.466; Nakajima Y, 2000, ANAT RECORD, V258, P119, DOI 10.1002/(SICI)1097-0185(20000201)258:2<119::AID-AR1>3.0.CO;2-U; Piera-Velazquez S, 2011, AM J PATHOL, V179, P1074, DOI 10.1016/j.ajpath.2011.06.001; Potenta S, 2008, BRIT J CANCER, V99, P1375, DOI 10.1038/sj.bjc.6604662; Sakao S, 2007, FASEB J, V21, P3640, DOI 10.1096/fj.07-8432com; Su L, 2006, BBA-MOL CELL RES, V1763, P247, DOI 10.1016/j.bbamcr.2006.01.002; Sun CH, 2010, J CELL PHYSIOL, V225, P673, DOI 10.1002/jcp.22262; Talavera D, 2004, J GEN VIROL, V85, P1801, DOI 10.1099/vir.0.19652-0; Tennakoon AH, 2013, EXP TOXICOL PATHOL; Weiss N, 2010, J NEUROIMMUNOL, V223, P131, DOI 10.1016/j.jneuroim.2010.03.009; Zhang Q, 2009, TOXICOL IN VITRO, V23, P797, DOI 10.1016/j.tiv.2009.04.007; Zhao BX, 2003, VASC PHARMACOL, V40, P183, DOI 10.1016/S1537-1891(03)00050-8; Zhao J, 2006, INT J BIOCHEM CELL B, V38, P1603, DOI 10.1016/j.biocel.2006.03.018	32	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99378	10.1371/journal.pone.0099378	http://dx.doi.org/10.1371/journal.pone.0099378			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905361	Green Published, Green Submitted, gold			2022-12-27	WOS:000341869000119
J	Banszegi, O; Kosztolanyi, A; Bakonyi, G; Szabo, B; Dombos, M				Banszegi, Oxana; Kosztolanyi, Andras; Bakonyi, Gabor; Szabo, Borbala; Dombos, Miklos			New Method for Automatic Body Length Measurement of the Collembolan, Folsomia candida Willem 1902 (Insecta: Collembola)	PLOS ONE			English	Article							NATURAL SOILS; GROWTH; REPRODUCTION; TOXICITY; CADMIUM; SPRINGTAIL; POPULATION; INDICATORS; ZINC	The collembolan, Folsomia candida, is widely used in soil ecotoxicology. In recent years, growth rate of collembolans has become as frequently used endpoint as reproduction rate in ecotoxicological studies. However, measuring collembolan body sizes to estimate growth rate is a complicated and time-consuming task. Here we present a new image analysis method, which facilitates and accelerates the body length measurement of the collembolan Folsomia candida. The new software package, called CollScope, consists of three elements: 1) an imaging device; 2) photographing software; 3) an ImageJ macro for image processing, measurement and data analysis. We give a complete description of the operation of the software, the image analyzing process and describe its accuracy and reliability. The software with a detailed usage manual is attached as Supplementary Material. We report a case study to demonstrate that the automated measurement of collembolan body sizes is highly correlated with the traditional manual measurements (estimated measuring accuracy 0.05 mm). Furthermore, we performed a dose-response ecotoxicity test using cadmium-sulfate by using CollScope as well as classical methods for size measurement. Size data measured by CollScope or manually did not differ significantly. Furthermore the new software package decreased time consumption of the measurements to 42% when tested on 35 animals. Consequently, methodological investigations performed in this study should be regarded as a recommendation for any other routine dose-response study where body growth is an endpoint.	[Banszegi, Oxana; Dombos, Miklos] Hungarian Acad Sci, Agr Res Ctr, Inst Soil Sci & Agr Chem, Budapest, Hungary; [Kosztolanyi, Andras] Univ Debrecen, Dept Evolutionary Zool & Human Biol, MTA DE Lendulet Behav Ecol Res Grp, H-4012 Debrecen, Hungary; [Bakonyi, Gabor] Szent Istvan Univ, Fac Agr & Environm Sci, Godollo, Hungary; [Szabo, Borbala] Szent Istvan Univ, Fac Vet Sci, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; University of Debrecen; Hungarian University of Agriculture & Life Sciences; Hungarian University of Agriculture & Life Sciences	Dombos, M (corresponding author), Hungarian Acad Sci, Agr Res Ctr, Inst Soil Sci & Agr Chem, Budapest, Hungary.	dombos.miklos@gmail.com	Bánszegi, Oxána/ABF-7208-2020; Szabó, Borbála/ABA-2223-2020; Kosztolanyi, Andras/B-8008-2016; Bakonyi, Gabor/AAD-4298-2019	Bánszegi, Oxána/0000-0002-1704-3539; Kosztolanyi, Andras/0000-0002-9109-5871; Szabo, Borbala/0000-0001-7587-1597	MEDAPHON LIFE+ project [LIFE 08ENV/H/000292]	MEDAPHON LIFE+ project	This study was supported financially by MEDAPHON LIFE+ project (LIFE 08ENV/H/000292). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENGTSSON G, 1983, OIKOS, V40, P216, DOI 10.2307/3544585; Bur T, 2012, SCI TOTAL ENVIRON, V414, P187, DOI 10.1016/j.scitotenv.2011.10.029; Bur T, 2010, ECOTOX ENVIRON SAFE, V73, P415, DOI 10.1016/j.ecoenv.2009.10.010; Caridade CMR, 2011, 4 INT C IM SIGN PROC, P1837; Crommentuijn T, 1997, CH ECOTOXIC, V5, P275; CROMMENTUIJN T, 1993, ECOTOX ENVIRON SAFE, V26, P216, DOI 10.1006/eesa.1993.1051; Crouau Y, 2006, ECOTOX ENVIRON SAFE, V64, P115, DOI 10.1016/j.ecoenv.2005.06.002; Filser J, 2013, APPL SOIL ECOL; FolkerHansen P, 1996, ECOTOX ENVIRON SAFE, V33, P207, DOI 10.1006/eesa.1996.0027; Fountain MT, 2001, ECOTOX ENVIRON SAFE, V48, P275, DOI 10.1006/eesa.2000.2007; Hopkin S.P., 1997, BIOL SPRINGTAILS INS; ISO, 2011, 1751222011 ISO; ISO, 2006, 2361122006 ISO; ISO, 1999, 11267 ISO; Krogh PH, 1998, APPL SOIL ECOL, V7, P201, DOI 10.1016/S0929-1393(97)00043-7; Mallard F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064387; Marcal ARS, 2006, LECT NOTES COMPUT SC, V4142, P814; Nursita AI, 2005, ECOTOX ENVIRON SAFE, V60, P306, DOI 10.1016/j.ecoenv.2004.05.001; OECD, 2009, OECD GUID TEST CHEM; Scheu S, 2004, OECOLOGIA, V139, P347, DOI 10.1007/s00442-004-1513-7; Scott-Fordsmand JJ, 1999, ECOTOX ENVIRON SAFE, V43, P57, DOI 10.1006/eesa.1998.1758; Smit CE, 1997, ECOTOX ENVIRON SAFE, V37, P213, DOI 10.1006/eesa.1997.1558; Staempfli C, 2007, ECOTOX ENVIRON SAFE, V68, P263, DOI 10.1016/j.ecoenv.2006.11.007; TRANVIK L, 1993, J APPL ECOL, V30, P43, DOI 10.2307/2404269; van Gestel CAM, 2012, ZOOKEYS, P275, DOI 10.3897/zookeys.176.2275; VANSTRAALEN NM, 1989, ECOTOX ENVIRON SAFE, V17, P190, DOI 10.1016/0147-6513(89)90038-9; Xu J, 2009, INSECT SCI, V16, P57, DOI 10.1111/j.1744-7917.2009.00254.x	27	11	12	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98230	10.1371/journal.pone.0098230	http://dx.doi.org/10.1371/journal.pone.0098230			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901322	Green Submitted, Green Published, gold			2022-12-27	WOS:000336841400021
J	Hernandez-Ruedas, MA; Arroyo-Rodriguez, V; Meave, JA; Martinez-Ramos, M; Ibarra-Manriquez, G; Martinez, E; Jamangape, G; Melo, FPL; Santos, BA				Hernandez-Ruedas, Manuel A.; Arroyo-Rodriguez, Victor; Meave, Jorge A.; Martinez-Ramos, Miguel; Ibarra-Manriquez, Guillermo; Martinez, Esteban; Jamangape, Gilberto; Melo, Felipe P. L.; Santos, Braulio A.			Conserving Tropical Tree Diversity and Forest Structure: The Value of Small Rainforest Patches in Moderately-Managed Landscapes	PLOS ONE			English	Article							HABITAT FRAGMENTATION; ATLANTIC FOREST; CONSERVATION; BIODIVERSITY; ATTRIBUTES; PROSPECTS; MAMMALS; BIRDS	Rainforests are undergoing severe deforestation and fragmentation worldwide. A huge amount of small forest patches are being created, but their value in conserving biodiversity and forest structure is still controversial. Here, we demonstrate that in a species-rich and moderately-managed Mexican tropical landscape small rainforest patches (<100 ha) can be highly valuable for the conservation of tree diversity and forest structure. These patches showed diverse communities of native plants, including endangered species, and a new record for the country. Although the number of logged trees increased in smaller patches, patch size was a poor indicator of basal area, stem density, number of species, genera and families, and community evenness. Cumulative species-area curves indicated that all patches had a similar contribution to the regional species diversity. This idea also was supported by the fact that patches strongly differed in floristic composition (high beta-diversity), independently of patch size. Thus, in agreement with the land-sharing approach, our findings support that small forest patches in moderately-managed landscapes should be included in conservation initiatives to maintain landscape heterogeneity, species diversity, and ecosystem services.	[Hernandez-Ruedas, Manuel A.; Arroyo-Rodriguez, Victor; Martinez-Ramos, Miguel; Ibarra-Manriquez, Guillermo] Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Morelia, Michoacan, Mexico; [Meave, Jorge A.] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Ecol & Recursos Nat, Mexico City 04510, DF, Mexico; [Martinez, Esteban] Univ Nacl Autonoma Mexico, Inst Biol, Dept Bot, Mexico City 04510, DF, Mexico; [Jamangape, Gilberto] Ejido Loma Bonita, Ocosingo, Chiapas, Mexico; [Melo, Felipe P. L.] Univ Fed Pernambuco, Dept Bot, Recife, PE, Brazil; [Santos, Braulio A.] Univ Fed Paraiba, Dept Sistemat & Ecol, BR-58059900 Joao Pessoa, Paraiba, Brazil	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidade Federal de Pernambuco; Universidade Federal da Paraiba	Arroyo-Rodriguez, V (corresponding author), Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Morelia, Michoacan, Mexico.	victorarroyo_rodriguez@hotmail.com	Martínez-Ramos, Miguel/G-8451-2019; Santos, Bráulio A./M-2582-2013; Melo, Felipe P.L./B-7720-2008; Arroyo-Rodríguez, Víctor/C-9255-2009; Meave, Jorge/B-3673-2008	Martínez-Ramos, Miguel/0000-0002-7785-1917; Santos, Bráulio A./0000-0001-6046-4024; Melo, Felipe P.L./0000-0002-1271-3214; Arroyo-Rodríguez, Víctor/0000-0002-0858-0324; Meave, Jorge/0000-0002-6241-8803; Hernandez-Ruedas, Manuel A./0000-0003-1471-7603	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT), DGAPA-UNAM [IA-203111, IB-200812, RR-280812]; CONACyT, Mexico; Programa de Apoyo a los Estudios de Posgrado (PAEP), UNAM; Programa de Becas Mixtas para Becarios CONACyT nacionales, CONACyT; Direct For Biological Sciences [1147429] Funding Source: National Science Foundation	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT), DGAPA-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); CONACyT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a los Estudios de Posgrado (PAEP), UNAM; Programa de Becas Mixtas para Becarios CONACyT nacionales, CONACyT; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded by the Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT), DGAPA-UNAM (Projects IA-203111, IB-200812 and RR-280812). MAHR obtained a scholarship from the CONACyT, Mexico. The Centro de Investigaciones en Ecosistemas (UNAM) provided logical support. H. Ferreira and A. Palencia provided technical support, and A. Navarrete provided the SPOT images. C. Dobler digitized the maps and S. Nicasio-Arzeta elaborated the Figure 1. A. Garmendia, M. San-Jose and M. Sola assisted the field work. MAHR is grateful to M. G. F. Mendes, K. M. Demetrio, U. Gonzalez-Gordillo, and their families for their support. The authors are indebted to the local people of the Marques de Comillas region. Part of this paper was written while MAHR was on a research stay at the Departamento de Botanica, Universidade Federal de Pernambuco, and Departamento de Sistematica e Ecologia, Universidade Federal da Paraiba funded by the Programa de Apoyo a los Estudios de Posgrado (PAEP), UNAM, and the Programa de Becas Mixtas para Becarios CONACyT nacionales, CONACyT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar LF, 1992, REV GEOGR, V116, P67; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Arroyo-Rodriguez V, 2012, J ECOL, V100, P702, DOI 10.1111/j.1365-2745.2011.01952.x; Arroyo-Rodriguez V, 2009, CONSERV BIOL, V23, P729, DOI 10.1111/j.1523-1739.2008.01120.x; Chao A, 2014, ECOL MONOGR, V84, P45, DOI 10.1890/13-0133.1; Chao A, 2012, ECOLOGY, V93, P2533, DOI 10.1890/11-1952.1; Chazdon RL, 2009, BIOTROPICA, V41, P142, DOI 10.1111/j.1744-7429.2008.00471.x; CONAFOR, 2013, PROGR ESP SELV LAC 2; CONAFOR, 2010, COORD GEN PROD PROD; COOK RR, 1995, OECOLOGIA, V101, P204, DOI 10.1007/BF00317285; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fahrig L, 1998, ECOL MODEL, V105, P273, DOI 10.1016/S0304-3800(97)00163-4; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Fischer J, 2002, BIOL CONSERV, V106, P129, DOI 10.1016/S0006-3207(01)00241-5; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Garmendia A, 2013, J TROP ECOL, V29, P331, DOI 10.1017/S0266467413000370; Gentry A. H., 1982, FLORA VENEZUELA, V8, P1; Hsieh T. C., 2013, INEXT ONLINE INTERPO; Ibarra-Manriquez G, 2002, PLANT ECOL, V160, P91, DOI 10.1023/A:1015839400578; Ibarra-Manriquez G, 2012, BOT SCI, V90, P389, DOI 10.17129/botsci.472; JOST L, 2010, DIVERSITY-BASEL, V2, P207, DOI [DOI 10.3390/d2020207, 10.3390/d2020207]; Laurance WF, 2000, NATURE, V404, P836, DOI 10.1038/35009032; Laurance WF, 2006, P NATL ACAD SCI USA, V103, P19010, DOI 10.1073/pnas.0609048103; Laurance WF, 2014, TRENDS ECOL EVOL, V29, P107, DOI 10.1016/j.tree.2013.12.001; Lindenmayer D, 2008, ECOL LETT, V11, P78, DOI 10.1111/j.1461-0248.2007.01114.x; Lobo D, 2011, DIVERS DISTRIB, V17, P287, DOI 10.1111/j.1472-4642.2010.00739.x; Martinez E, 1994, B SOC BOT MEX, V54, P99, DOI DOI 10.17129/BOTSCI.1430; Martinez E, 2003, DEFORESTACION 24 REG, P124; Martinez-Ramos M, 1998, TRENDS PLANT SCI, V3, P400, DOI 10.1016/S1360-1385(98)01313-2; Melo FPL, 2013, TRENDS ECOL EVOL, V28, P462, DOI 10.1016/j.tree.2013.01.001; Mesquita RCG, 1999, BIOL CONSERV, V91, P129, DOI 10.1016/S0006-3207(99)00086-5; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pardini R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013666; Perfecto I., 2009, NATURES MATRIX LINKI; Pinto SRR, 2010, TROP CONSERV SCI, V3, P389, DOI 10.1177/194008291000300404; QUINN JF, 1988, OECOLOGIA, V75, P132, DOI 10.1007/BF00378826; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Santos BA, 2008, BIOL CONSERV, V141, P249, DOI 10.1016/j.biocon.2007.09.018; Santos BA, 2009, REV MEX BIODIVERS, V80, P857; Santos GGA, 2012, BIOTROPICA, V44, P771, DOI 10.1111/j.1744-7429.2012.00882.x; Schutzman B, 1998, NOVON, V8, P441, DOI 10.2307/3391871; Tabarelli M, 2012, BIOL CONSERV, V155, P136, DOI 10.1016/j.biocon.2012.06.020; Turner IM, 1996, TRENDS ECOL EVOL, V11, P330, DOI 10.1016/0169-5347(96)10046-X; van Breugel M, 2006, J TROP ECOL, V22, P663, DOI 10.1017/S0266467406003452	46	63	63	0	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98931	10.1371/journal.pone.0098931	http://dx.doi.org/10.1371/journal.pone.0098931			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901954	Green Published, gold, Green Submitted			2022-12-27	WOS:000336841400075
J	Kimpler, LA; Glosson, NL; Downs, D; Gonyo, P; May, NA; Hudson, AW				Kimpler, Lisa A.; Glosson, Nicole L.; Downs, Deanna; Gonyo, Patrick; May, Nathan A.; Hudson, Amy W.			Adaptor Protein Complexes AP-1 and AP-3 Are Required by the HHV-7 Immunoevasin U21 for Rerouting of Class I MHC Molecules to the Lysosomal Compartment	PLOS ONE			English	Article							POLARIZED EPITHELIAL-CELLS; MEMBRANE-PROTEINS; ANTIGEN PRESENTATION; DOWN-REGULATION; HEAVY-CHAINS; TRAFFICKING; CLATHRIN; GLYCOPROTEIN; TRANSPORT; DEGRADATION	The human herpesvirus-7 (HHV-7) U21 gene product binds to class I major histocompatibility complex (MHC) molecules and reroutes them to a lysosomal compartment. Trafficking of integral membrane proteins to lysosomes is mediated through cytoplasmic sorting signals that recruit heterotetrameric clathrin adaptor protein (AP) complexes, which in turn mediate protein sorting in post-Golgi vesicular transport. Since U21 can mediate rerouting of class I molecules to lysosomes even when lacking its cytoplasmic tail, we hypothesize the existence of a cellular protein that contains the lysosomal sorting information required to escort class I molecules to the lysosomal compartment. If such a protein exists, we expect that it might recruit clathrin adaptor protein complexes as a means of lysosomal sorting. Here we describe experiments demonstrating that the m adaptins from AP-1 and AP-3 are involved in U21-mediated trafficking of class I molecules to lysosomes. These experiments support the idea that a cellular protein(s) is necessary for U21-mediated lysosomal sorting of class I molecules. We also examine the impact of transient versus chronic knockdown of these adaptor protein complexes, and show that the few remaining m subunits in the cells are eventually able to reroute class I molecules to lysosomes.	[Kimpler, Lisa A.; Glosson, Nicole L.; Downs, Deanna; Gonyo, Patrick; May, Nathan A.; Hudson, Amy W.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Hudson, AW (corresponding author), Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA.	ahudson@mcw.edu			National Instititues of Health/National Institute of Allergy and Infectious Disease [1R01AI069099-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069099] Funding Source: NIH RePORTER	National Instititues of Health/National Institute of Allergy and Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the National Instititues of Health/National Institute of Allergy and Infectious Disease Grant # 1R01AI069099-01 to AWH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 1996, EMBO J, V15, P3247, DOI 10.1002/j.1460-2075.1996.tb00689.x; Ahn KS, 1996, P NATL ACAD SCI USA, V93, P10990, DOI 10.1073/pnas.93.20.10990; Boname JM, 2004, IMMUNITY, V20, P305, DOI 10.1016/S1074-7613(04)00047-0; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Burgos PV, 2010, DEV CELL, V18, P425, DOI 10.1016/j.devcel.2010.01.015; Chapuy B, 2008, TRAFFIC, V9, P1157, DOI 10.1111/j.1600-0854.2008.00745.x; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; Glosson NL, 2007, VIROLOGY, V365, P125, DOI 10.1016/j.virol.2007.03.048; Glosson NL, 2010, J BIOL CHEM, V285, P37016, DOI 10.1074/jbc.M110.125849; Hansen TH, 2009, NAT REV IMMUNOL, V9, P503, DOI 10.1038/nri2575; HARTER C, 1992, J CELL BIOL, V117, P311, DOI 10.1083/jcb.117.2.311; Hengel H, 1997, IMMUNITY, V6, P623, DOI 10.1016/S1074-7613(00)80350-7; Hirst J, 2003, MOL BIOL CELL, V14, P625, DOI 10.1091/mbc.E02-09-0552; Hudson AW, 2003, TRAFFIC, V4, P824, DOI 10.1046/j.1398-9219.2003.0137.x; Hudson AW, 2001, J VIROL, V75, P12347, DOI 10.1128/JVI.75.24.12347-12358.2001; Hunziker W, 1996, BIOESSAYS, V18, P379, DOI 10.1002/bies.950180508; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; Janvier K, 2005, MOL BIOL CELL, V16, P4231, DOI 10.1091/mbc.E05-03-0213; Jones TR, 1996, P NATL ACAD SCI USA, V93, P11327, DOI 10.1073/pnas.93.21.11327; Kim SH, 2009, J NEUROSCI, V29, P3865, DOI 10.1523/JNEUROSCI.5639-08.2009; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; Le Borgne R, 1998, J BIOL CHEM, V273, P29451, DOI 10.1074/jbc.273.45.29451; Lubben NB, 2007, MOL BIOL CELL, V18, P3351, DOI 10.1091/mbc.E07-03-0218; MANE SM, 1989, ARCH BIOCHEM BIOPHYS, V268, P360, DOI 10.1016/0003-9861(89)90597-3; May NA, 2010, J VIROL, V84, P3738, DOI 10.1128/JVI.01782-09; McCormick PJ, 2005, P NATL ACAD SCI USA, V102, P7910, DOI 10.1073/pnas.0502206102; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Mostoslavsky G, 2006, P NATL ACAD SCI USA, V103, P16406, DOI 10.1073/pnas.0608130103; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Ohno H, 1999, FEBS LETT, V449, P215, DOI 10.1016/S0014-5793(99)00432-9; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; Peden AA, 2002, J CELL BIOL, V156, P327, DOI 10.1083/jcb.200107140; Reusch U, 2002, TRAFFIC, V3, P752, DOI 10.1034/j.1600-0854.2002.31007.x; Roeth JF, 2004, J CELL BIOL, V167, P903, DOI 10.1083/jcb.200407031; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Schneider CL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002362; Stevenson PG, 2000, P NATL ACAD SCI USA, V97, P8455, DOI 10.1073/pnas.150240097; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; TRAUB LM, 1995, J BIOL CHEM, V270, P4933, DOI 10.1074/jbc.270.9.4933; Wagner M, 1999, J VIROL, V73, P7056, DOI 10.1128/JVI.73.8.7056-7060.1999; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Yang W, 2000, J CELL SCI, V113, P4077	46	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99139	10.1371/journal.pone.0099139	http://dx.doi.org/10.1371/journal.pone.0099139			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901711	Green Published, gold, Green Submitted			2022-12-27	WOS:000336841400101
J	Pan, ZH; Ganjawala, TH; Lu, Q; Ivanova, E; Zhang, ZF				Pan, Zhuo-Hua; Ganjawala, Tushar H.; Lu, Qi; Ivanova, Elena; Zhang, Zhifei			ChR2 Mutants at L132 and T159 with Improved Operational Light Sensitivity for Vision Restoration	PLOS ONE			English	Article							RESTORES VISUAL RESPONSES; ECTOPIC EXPRESSION; PHOTORECEPTOR DEGENERATION; OPTOGENETIC EXCITATION; RETINAL DEGENERATION; CHANNELRHODOPSIN-2; CHANNEL; MICE; STIMULATION; ACTIVATION	The ectopic expression of microbial opsin-based optogenetic sensors, such as channelrhodopsin-2 (ChR2) in surviving inner retinal neurons, is a promising approach to restoring vision after retinal degeneration. However, a major limitation in using native ChR2 as a light sensor for vision restoration is the low light sensitivity of its expressing cells. Recently, two ChR2 mutations, T159C and L132C, were reported to produce higher photocurrents or have ultra light sensitivity. In this study, we created additional ChR2 mutants at these two sites to search for more light responsive ChR2 forms and evaluate their suitability for vision restoration by examining their light responsive properties in HEK cells and mouse retinal ganglion cells. We found additional ChR2 mutants at these two sites that showed a further increase in current amplitude at low light levels in the cells expressing these mutants, or operational light sensitivity. However, the increase in the operational light sensitivity was correlated with a decrease in temporal kinetics. Therefore, there is a trade-off between operational light sensitivity and temporal resolution for these more light responsive ChR2 mutants. Our results showed that for the two most light responsive mutants, L132C/T159C and L132C/T159S, the required light intensities for generating the threshold spiking activity in retinal ganglion cells were 1.5 and nearly 2 log units lower than wild-type ChR2 (wt-ChR2), respectively. Additionally, their ChR2-mediated spiking activities could follow flicker frequencies up to 20 and 10 Hz, respectively, at light intensities up to 1.5 log units above their threshold levels. Thus, the use of these more light responsive ChR2 mutants could make the optogenetic approach to restoring vision more feasible.	[Pan, Zhuo-Hua; Ganjawala, Tushar H.; Lu, Qi; Ivanova, Elena; Zhang, Zhifei] Wayne State Univ, Dept Anat Cell Biol, Sch Med, Detroit, MI 48202 USA; [Pan, Zhuo-Hua] Wayne State Univ Sch Med, Kresge Eye Inst, Dept Ophthalmol, Detroit, MI USA	Wayne State University; Wayne State University	Pan, ZH (corresponding author), Wayne State Univ, Dept Anat Cell Biol, Sch Med, Detroit, MI 48202 USA.	zhpan@med.wayne.edu	LU, QI/K-5684-2015; Lu, Qi/Y-6568-2019	LU, QI/0000-0002-8353-765X; Lu, Qi/0000-0002-8353-765X; Ganjawala, Tushar/0000-0002-5070-1572	National Institutes of Health (NIH) [EY04068, EY17130]; Dryer Foundation; Ligon Research Center of Vision; Research to Prevent Blindness	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dryer Foundation; Ligon Research Center of Vision; Research to Prevent Blindness(Research to Prevent Blindness (RPB))	This work was supported by National Institutes of Health (NIH) grant EY17130, core grant EY04068 to Department of Anatomy and Cell Biology at Wayne State University, Dryer Foundation, the Ligon Research Center of Vision, and Research to Prevent Blindness to Department of Ophthalmology at Wayne State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; Caporale N, 2011, MOL THER, V19, P1212, DOI 10.1038/mt.2011.103; Doroudchi MM, 2011, MOL THER, V19, P1220, DOI 10.1038/mt.2011.69; Greenberg KP, 2011, NEURON, V69, P713, DOI 10.1016/j.neuron.2011.01.024; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Hart Jr W M, 1987, ADLERS PHYSL EYE CLI; Ivanova E, 2009, MOL VIS, V15, P1680; Kleinlogel S, 2011, NAT NEUROSCI, V14, P513, DOI 10.1038/nn.2776; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; Lin B, 2008, P NATL ACAD SCI USA, V105, P16009, DOI 10.1073/pnas.0806114105; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Polosukhina A, 2012, NEURON, V75, P271, DOI 10.1016/j.neuron.2012.05.022; Prigge M, 2012, J BIOL CHEM, V287, P31804, DOI 10.1074/jbc.M112.391185; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Tomita H, 2007, INVEST OPHTH VIS SCI, V48, P3821, DOI 10.1167/iovs.06-1501; Tomita H, 2010, EXP EYE RES, V90, P429, DOI 10.1016/j.exer.2009.12.006; Wang H., J BIOL CHEM, V284, P5685; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Wu CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066332; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang Y, 2009, J NEUROSCI, V29, P9186, DOI 10.1523/JNEUROSCI.0184-09.2009	32	27	35	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98924	10.1371/journal.pone.0098924	http://dx.doi.org/10.1371/journal.pone.0098924			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901492	gold, Green Submitted, Green Published			2022-12-27	WOS:000336841400072
J	Tichy, H; Kallina, W				Tichy, Harald; Kallina, Wolfgang			Sensitivity of Honeybee Hygroreceptors to Slow Humidity Changes and Temporal Humidity Variation Detected in High Resolution by Mobile Measurements	PLOS ONE			English	Article							STICK INSECT; COCKROACH; ANTENNA; MOIST	The moist cell and the dry cell on the antenna of the male honeybee were exposed to humidities slowly rising and falling at rates between -1.5%/s and + 1.5%/s and at varying amplitudes in the 10 to 90% humidity range. The two cells respond to these slow humidity oscillations with oscillations in impulse frequency which depend not only on instantaneous humidity but also on the rate with which humidity changes. The impulse frequency of each cell was plotted as a function of these two parameters and regression planes were fitted to the data points of single oscillation periods. The regression slopes, which estimate sensitivity, rose with the amplitude of humidity oscillations. During large-amplitude oscillations, moist and dry cell sensitivity for instantaneous humidity and its rate of change was high. During small-amplitude oscillations, their sensitivity for both parameters was low, less exactly reflecting humidity fluctuations. Nothing is known about the spatial and temporal humidity variations a honeybee may encounter when flying through natural environments. Microclimatic parameters (absolute humidity, temperature, wind speed) were measured from an automobile traveling through different landscapes of Lower Austria. Landscape type affected extremes and mean values of humidity. Differences between peaks and troughs of humidity fluctuations were generally smaller in open grassy fields or deciduous forests than in edge habitats or forest openings. Overall, fluctuation amplitudes were small. In this part of the stimulus range, hygroreceptor sensitivity is not optimal for encoding instantaneous humidity and the rate of humidity change. It seems that honeybee's hygroreceptors are specialized for detecting large-amplitude fluctuations that are relevant for a specific behavior, namely, maintaining a sufficiently stable state of water balance. The results suggest that optimal sensitivity of both hygroreceptors is shaped not only by humidity oscillation amplitudes but also according to their impact on behavior.	[Tichy, Harald; Kallina, Wolfgang] Univ Vienna, Fac Life Sci, Dept Neurobiol, Vienna, Austria	University of Vienna	Tichy, H (corresponding author), Univ Vienna, Fac Life Sci, Dept Neurobiol, Vienna, Austria.	harald.tichy@univie.ac.at		Harald, Tichy/0000-0003-1582-5139	Austrian Science Fund [P20.197-B17]; Austrian Science Fund (FWF) [P 20196] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by a grant from the Austrian Science Fund (Project P20.197-B17)(www.fwf.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ITOH T, 1984, ZOOL SCI, V1, P533; LACHER V, 1964, Z VERGL PHYSIOL, V48, P587, DOI 10.1007/BF00333743; Resch R, 1998, APPL PHYS A-MATER, V66, pS607, DOI 10.1007/s003390051209; TICHY H, 1987, J COMP PHYSIOL A, V160, P43, DOI 10.1007/BF00613440; Tichy H, 2003, J COMP PHYSIOL A, V189, P175, DOI 10.1007/s00359-003-0397-z; Tichy H, 2010, J NEUROPHYSIOL, V103, P3274, DOI 10.1152/jn.01043.2009; TICHY H, 1990, J COMP PHYSIOL A, V166, P507, DOI 10.1007/BF00192021; Tichy H, 1996, NATURWISSENSCHAFTEN, V83, P255; Tichy H., 2001, ECOLOGY SENSING, P271, DOI [10.1007/978-3-662-22644-5_14, DOI 10.1007/978-3-662-22644-5_14]; Tichy H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053998; von Frisch K, 1955, NATURWISSENSCHAFTEN, V13, P376; YOKOHARI F, 1976, J COMP PHYSIOL, V106, P137, DOI 10.1007/BF00620495; YOKOHARI F, 1978, J COMP PHYSIOL, V124, P53, DOI 10.1007/BF00656391; YOKOHARI F, 1983, CELL TISSUE RES, V233, P355, DOI 10.1007/BF00238302	14	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99032	10.1371/journal.pone.0099032	http://dx.doi.org/10.1371/journal.pone.0099032			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901985	Green Published, gold, Green Submitted			2022-12-27	WOS:000336841400089
J	Kawamura, K; Takahashi, T; Kanazawa, M; Igarashi, H; Nakada, T; Nishizawa, M; Shimohata, T				Kawamura, Kunio; Takahashi, Tetsuya; Kanazawa, Masato; Igarashi, Hironaka; Nakada, Tsutomu; Nishizawa, Masatoyo; Shimohata, Takayoshi			Effects of Angiopoietin-1 on Hemorrhagic Transformation and Cerebral Edema after Tissue Plasminogen Activator Treatment for Ischemic Stroke in Rats	PLOS ONE			English	Article							ARTERY OCCLUSION; TIE2 RECEPTOR; EXPRESSION; BRAIN; ANGIOGENESIS; THROMBOLYSIS; LIGAND	An angiogenesis factor, angiopoietin-1 (Ang1), is associated with the blood-brain barrier (BBB) disruption after focal cerebral ischemia. However, whether hemorrhagic transformation and cerebral edema after tissue plasminogen activator (tPA) treatment are related to the decrease in Ang1 expression in the BBB remains unknown. We hypothesized that administering Ang1 might attenuate hemorrhagic transformation and cerebral edema after tPA treatment by stabilizing blood vessels and inhibiting hyperpermeability. Sprague-Dawley rats subjected to thromboembolic focal cerebral ischemia were assigned to a permanent ischemia group (permanent middle cerebral artery occlusion; PMCAO) and groups treated with tPA at 1 h or 4 h after ischemia. Endogenous Ang1 expression was observed in pericytes, astrocytes, and neuronal cells. Western blot analyses revealed that Ang1 expression levels on the ischemic side of the cerebral cortex were decreased in the tPA-1h, tPA-4h, and PMCAO groups as compared to those in the control group (P = 0.014, 0.003, and 0.014, respectively). Ang1-positive vessel densities in the tPA-4h and PMCAO groups were less than that in the control group (p = 0.002 and <0.001, respectively) as well as that in the tPA-1h group (p = 0.047 and 0.005, respectively). These results suggest that Ang1-positive vessel density was maintained when tPA was administered within the therapeutic time window (1 h), while it was decreased when tPA treatment was given after the therapeutic time window (4 h). Administering Ang1 fused with cartilage oligomeric protein (COMP) to supplement this decrease has the potential to suppress hemorrhagic transformation as measured by hemoglobin content in a whole cerebral homogenate (p = 0.007) and cerebral edema due to BBB damage (p = 0.038), as compared to administering COMP protein alone. In conclusion, Ang1 might be a promising target molecule for developing vasoprotective therapies for controlling hemorrhagic transformation and cerebral edema after tPA treatment.	[Kawamura, Kunio; Takahashi, Tetsuya; Kanazawa, Masato; Nishizawa, Masatoyo; Shimohata, Takayoshi] Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 951, Japan; [Igarashi, Hironaka; Nakada, Tsutomu] Niigata Univ, Brain Res Inst, Dept Ctr Integrated Human Brain Sci, Niigata, Japan	Niigata University; Niigata University	Shimohata, T (corresponding author), Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 951, Japan.	t-shimo@bri.niigata-u.ac.jp	Kanazawa, Masato/J-3267-2017; Kanazawa, Masato/AAK-1982-2020	Kanazawa, Masato/0000-0001-6337-8156; 	Yujin Memorial Grant; JSPS KAKENHI [25430063]; Tsubaki Memorial Neuroscience Research Foundation; Grants-in-Aid for Scientific Research [25430063] Funding Source: KAKEN	Yujin Memorial Grant; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Tsubaki Memorial Neuroscience Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Yujin Memorial Grant (TS), JSPS KAKENHI Grant Number 25430063 (TT), and the Tsubaki Memorial Neuroscience Research Foundation (MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahi M, 2000, J CEREBR BLOOD F MET, V20, P452, DOI 10.1097/00004647-200003000-00002; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Baffert F, 2006, AM J PHYSIOL-HEART C, V290, pH107, DOI 10.1152/ajpheart.00542.2005; Beck H, 2000, AM J PATHOL, V157, P1473, DOI 10.1016/S0002-9440(10)64786-4; Cho CH, 2004, P NATL ACAD SCI USA, V101, P5553, DOI 10.1073/pnas.0307575101; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Fuxe J, 2011, AM J PATHOL, V178, P2897, DOI 10.1016/j.ajpath.2011.02.008; Gamble JR, 2000, CIRC RES, V87, P603, DOI 10.1161/01.RES.87.7.603; Hacke W, 2004, LANCET, V363, P768; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hang Y, 2012, J MOL NEUROSCI, V46, P236, DOI 10.1007/s12031-011-9584-5; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P166, DOI 10.1097/00004647-200302000-00004; Kanazawa M, 2011, J CEREBR BLOOD F MET, V31, P1461, DOI 10.1038/jcbfm.2011.9; Kanazawa M, 2011, J NEUROCHEM, V116, P957, DOI 10.1111/j.1471-4159.2010.06860.x; Kilkenny C, 2011, J CEREBR BLOOD F MET, V31, P991, DOI 10.1038/jcbfm.2010.220; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; Makinde T, 2008, J CELL MOL MED, V12, P810, DOI 10.1111/j.1582-4934.2008.00254.x; Nourhaghighi N, 2003, LAB INVEST, V83, P1211, DOI 10.1097/01.LAB.0000082383.40635.FE; Okubo S, 2007, BRAIN RES, V1143, P221, DOI 10.1016/j.brainres.2007.01.050; Salmon AHJ, 2009, CARDIOVASC RES, V83, P24, DOI 10.1093/cvr/cvp093; Shimohata T, 2007, J CEREBR BLOOD F MET, V27, P1463, DOI 10.1038/sj.jcbfm.9600450; Shin HY, 2010, J NEUROSCI RES, V88, P1052, DOI 10.1002/jnr.22274; Su EJ, 2008, NAT MED, V14, P731, DOI 10.1038/nm1787; Sundberg C, 2002, LAB INVEST, V82, P387, DOI 10.1038/labinvest.3780433; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Zacharek A, 2007, J CEREBR BLOOD F MET, V27, P1684, DOI 10.1038/sj.jcbfm.9600475; Zausinger S, 2000, BRAIN RES, V863, P94, DOI 10.1016/S0006-8993(00)02100-4; Zhang ZG, 2002, NEUROSCIENCE, V113, P683, DOI 10.1016/S0306-4522(02)00175-6	29	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98639	10.1371/journal.pone.0098639	http://dx.doi.org/10.1371/journal.pone.0098639			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896569	gold, Green Published, Green Submitted			2022-12-27	WOS:000338430700058
J	Olson, DD; Bissonette, JA; Cramer, PC; Green, AD; Davis, ST; Jackson, PJ; Coster, DC				Olson, Daniel D.; Bissonette, John A.; Cramer, Patricia C.; Green, Ashley D.; Davis, Scott T.; Jackson, Patrick J.; Coster, Daniel C.			Monitoring Wildlife-Vehicle Collisions in the Information Age: How Smartphones Can Improve Data Collection	PLOS ONE			English	Article							NATIONAL-PARK; UNITED-STATES; UNDERPASSES; ROADS; HIGHWAY; IMPACTS	Background: Currently there is a critical need for accurate and standardized wildlife-vehicle collision data, because it is the underpinning of mitigation projects that protect both drivers and wildlife. Gathering data can be challenging because wildlife-vehicle collisions occur over broad areas, during all seasons of the year, and in large numbers. Collecting data of this magnitude requires an efficient data collection system. Presently there is no widely adopted system that is both efficient and accurate. Methodology/Principal Findings: Our objective was to develop and test an integrated smartphone-based system for reporting wildlife-vehicle collision data. The WVC Reporter system we developed consisted of a mobile web application for data collection, a database for centralized storage of data, and a desktop web application for viewing data. The smartphones that we tested for use with the application produced accurate locations (median error = 4.6-5.2 m), and reduced location error 99% versus reporting only the highway/marker. Additionally, mean times for data entry using the mobile web application (22.0-26.5 s) were substantially shorter than using the pen/paper method (52 s). We also found the pen/paper method had a data entry error rate of 10% and those errors were virtually eliminated using the mobile web application. During the first year of use, 6,822 animal carcasses were reported using WVC Reporter. The desktop web application improved access to WVC data and allowed users to easily visualize wildlife-vehicle collision patterns at multiple scales. Conclusions/Significance: The WVC Reporter integrated several modern technologies into a seamless method for collecting, managing, and using WVC data. As a result, the system increased efficiency in reporting, improved accuracy, and enhanced visualization of data. The development costs for the system were minor relative to the potential benefits of having spatially accurate and temporally current wildlife-vehicle collision data.	[Olson, Daniel D.; Bissonette, John A.; Cramer, Patricia C.; Jackson, Patrick J.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Green, Ashley D.] Utah Div Wildlife Resources, Salt Lake City, UT USA; [Davis, Scott T.] Automated Geog Reference Ctr, Salt Lake City, UT USA; [Coster, Daniel C.] Utah State Univ, Dept Math & Stat, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Olson, DD (corresponding author), Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA.	dolson22@gmail.com	Bissonette, John A./J-7494-2019		Utah Department of Transportation; Utah Division of Wildlife Resources	Utah Department of Transportation; Utah Division of Wildlife Resources	This project was funded by the Utah Department of Transportation and the Utah Division of Wildlife Resources. The funding agencies provided input on the initial design of the WVC Reporter system and assisted in testing and collecting data. They did not participate in data analysis or the decision to publish the results.	Al-Ghamdi AS, 2004, ACCIDENT ANAL PREV, V36, P749, DOI 10.1016/j.aap.2003.05.006; Ament R, 2007, ROADKILL OBSERVATION; Bernales H. H., 2011, UTAH BIG GAME ANN RE; Bissonette JA, 2008, BIOL CONSERV, V141, P482, DOI 10.1016/j.biocon.2007.10.019; Bissonette JA, 2008, 615 NAT RES COUNC NA; Bissonette JA, 2012, WILDLIFE BIOL, V18, P414, DOI 10.2981/11-122; Bissonette John A., 2008, Human-Wildlife Conflicts, V2, P17; Bruinderink GWTAG, 1996, CONSERV BIOL, V10, P1059, DOI 10.1046/j.1523-1739.1996.10041059.x; Clevenger AP, 2000, CONSERV BIOL, V14, P47, DOI 10.1046/j.1523-1739.2000.00099-085.x; Clevenger AP, 2001, WILDLIFE SOC B, V29, P646; CONOVER MR, 1995, WILDLIFE SOC B, V23, P407; Cramer P, 2012, UT1207 UT STAT U; Donaldson BM, 2010, TRANSP RES RECORD, P18, DOI 10.3141/2147-03; Economic Research Service, 2013, STAT FACT SHEETS; Ford AT, 2009, J WILDLIFE MANAGE, V73, P1213, DOI 10.2193/2008-387; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Gagnon JW, 2011, J WILDLIFE MANAGE, V75, P1477, DOI 10.1002/jwmg.160; GILLIES R. R., 2009, RANGELAND RESOURCES, P39; GRIFFITH G, 2009, ENCY EARTH; Gunson KE, 2009, ENVIRON MANAGE, V44, P268, DOI 10.1007/s00267-009-9303-y; Gura Trisha, 2013, Nature, V496, P259; Hesse, 2010, WILDLIFE BIOL PRACTI, V6, P1, DOI DOI 10.2461/WBP.2010.6.1; Hubbard MW, 2000, J WILDLIFE MANAGE, V64, P707, DOI 10.2307/3802740; Huijser MP, 2009, ECOL SOC, V14; Huijser MP, 2008, FHWAHRT08034; Langley RL, 2006, WILD ENVIRON MED, V17, P229, DOI 10.1580/06-WEME-OR-001R1.1; Lee T, 2006, ECOL SOC, V11; Lefler N., 2011, BACKGROUND REPORT GU; Leydsman McGinty EI, 2009, RANGELANDS RESOURCES, P153; Leydsman-McGinty E.I., 2009, RANGELAND RESOURCES, P9; Mkande FX, 2011, S AFR J WILDL RES, V41, P68, DOI 10.3957/056.041.0114; Noro M, 2010, ANAL DEER ECOLOGY LA; Pope C, 2012, 2012 UDOT ANN STAT S; Ramp D, 2006, BIOL CONSERV, V129, P348, DOI 10.1016/j.biocon.2005.11.002; Sawyer H, 2012, WILDLIFE SOC B, V36, P492, DOI 10.1002/wsb.166; Sawyer H, 2009, ECOL APPL, V19, P2016, DOI 10.1890/08-2034.1; Seiler A, 2004, WILDLIFE BIOL, V10, P301, DOI 10.2981/wlb.2004.036; Sinha P, 2010, REGULATORY IMPACT AN; Stoner D, 1925, Science, V61, P56, DOI 10.1126/science.61.1568.56; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; U. S. Census Bureau, 2010, RES POP DAI; UDOT, 2010, VEH MIL TRAV; Van Der Grift E, 2006, ENVIRONM POLLUT SER, V10, P205, DOI 10.1007/1-4020-4504-2_10; Wagner M.E., 2007, ANIMAL VEHICLE COLLI; Welsh S.L., 1993, A UTAH FLORA, V2; West P. W., 2008, UDOT WILDLIFE DOMEST	46	36	38	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98613	10.1371/journal.pone.0098613	http://dx.doi.org/10.1371/journal.pone.0098613			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897502	Green Submitted, gold, Green Published			2022-12-27	WOS:000338430700055
J	Rivalin, R; Lepinoux-Chambaud, C; Eyer, J; Savagner, F				Rivalin, Romain; Lepinoux-Chambaud, Claire; Eyer, Joel; Savagner, Frederique			The NFL-TBS.40-63 Anti-Glioblastoma Peptide Disrupts Microtubule and Mitochondrial Networks in the T98G Glioma Cell Line	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; CARDIORESPIRATORY FITNESS; DIABETES PREVENTION; RISK; EXERCISE; OBESITY; ADULTS; A1C	Despite aggressive therapies, including combinations of surgery, radiotherapy and chemotherapy, glioblastoma remains a highly aggressive brain cancer with the worst prognosis of any central nervous system disease. We have previously identified a neurofilament-derived cell-penetrating peptide, NFL-TBS.40-63, that specifically enters by endocytosis in glioblastoma cells, where it induces microtubule destruction and inhibits cell proliferation. Here, we explore the impact of NFL-TBS.40-63 peptide on the mitochondrial network and its functions by using global cell respiration, quantitative PCR analysis of the main actors directing mitochondrial biogenesis, western blot analysis of the oxidative phosphorylation (OXPHOS) subunits and confocal microscopy. We show that the internalized peptide disturbs mitochondrial and microtubule networks, interferes with mitochondrial dynamics and induces a rapid depletion of global cell respiration. This effect may be related to reduced expression of the NRF-1 transcription factor and of specific miRNAs, which may impact mitochondrial biogenesis, in regard to default mitochondrial mobility.	[Rivalin, Romain; Lepinoux-Chambaud, Claire; Eyer, Joel; Savagner, Frederique] Univ Angers, Angers, France; [Rivalin, Romain; Lepinoux-Chambaud, Claire; Eyer, Joel; Savagner, Frederique] Univ Angers, UPRES EA 3143, LNBT, Lab Neurobiol & Transgenese, Angers, France; [Savagner, Frederique] CHU Angers, Biochim Lab, Angers, France	Universite d'Angers; Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Savagner, F (corresponding author), Univ Angers, Angers, France.	Frederique.savagner@univ-angers.fr	Eyer, Joel/K-4265-2015; Eyer, Joel/V-8679-2019	Eyer, Joel/0000-0001-6301-7465; Eyer, Joel/0000-0001-6301-7465	CIMATH-2 (ciblage moleculaire et applications therapeutiques) Region Pays de la Loire; L'INSERM; Ligue Contre le Cancer	CIMATH-2 (ciblage moleculaire et applications therapeutiques) Region Pays de la Loire(Region Pays de la Loire); L'INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ligue Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by grants from CIMATH-2 (ciblage moleculaire et applications therapeutiques) Region Pays de la Loire, Ligue Contre le Cancer and L'INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah A, 2010, DIABETES RES CLIN PR, V89, P309, DOI 10.1016/j.diabres.2010.04.012; American College of Sports Medicine, 2010, ACSMS GUID EX TEST P; Blair SN, 2004, JAMA-J AM MED ASSOC, V292, P1232, DOI 10.1001/jama.292.10.1232; Burr JF, 2010, PHYSICIAN SPORTSMED, V38, P72, DOI 10.3810/psm.2010.04.1764; Carnethon MR, 2003, JAMA-J AM MED ASSOC, V290, P3092, DOI 10.1001/jama.290.23.3092; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Demakakos P, 2010, DIABETOLOGIA, V53, P1877, DOI 10.1007/s00125-010-1785-x; Fogelholm M, 2010, OBES REV, V11, P202, DOI 10.1111/j.1467-789X.2009.00653.x; Haskell WL, 2000, AM J CLIN NUTR, V72, p541S, DOI 10.1093/ajcn/72.2.541S; Hu G, 2007, APPL PHYSIOL NUTR ME, V32, P583, DOI 10.1139/H07-030; Jeon CY, 2007, DIABETES CARE, V30, P744, DOI 10.2337/dc06-1842; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kashiwagi A, 2012, DIABETOL INT, V3, P8, DOI 10.1007/s13340-012-0069-8; Katzmarzyk PT, 2007, DIABETOLOGIA, V50, P538, DOI 10.1007/s00125-006-0554-3; Klein S, 2004, DIABETES CARE, V27, P2067, DOI 10.2337/diacare.27.8.2067; Lee DC, 2009, DIABETES CARE, V32, P257, DOI 10.2337/dc08-1377; Ma RCW, 2013, ANN NY ACAD SCI, V1281, P64, DOI 10.1111/nyas.12098; Malin SK, 2013, AM J PHYSIOL-ENDOC M, V305, pE1248, DOI 10.1152/ajpendo.00260.2013; Ministry of Education Culture Sports Science and Technology Ministry of Health Labour and Welfare of Japan, 2002, ETH GUID EP RES; Miyashita M, 1984, JPN J SPORTS SCI, V3, P559; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; PATE RR, 1984, SPORTS MED, V1, P87, DOI 10.2165/00007256-198401020-00001; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Sato KK, 2009, DIABETES CARE, V32, P644, DOI 10.2337/dc08-1631; Sawada SS, 2003, DIABETES CARE, V26, P2918, DOI 10.2337/diacare.26.10.2918; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Sigal RJ, 2010, DIABETES CARE, V33, P147, DOI DOI 10.2337/DC10-9990; Slentz CA, 2009, DIABETES CARE, V32, P1807, DOI 10.2337/dc09-0032; Sui X, 2008, DIABETES CARE, V31, P550, DOI 10.2337/dc07-1870; Williams PT, 2013, ARTERIOSCL THROM VAS, V33, P1085, DOI 10.1161/ATVBAHA.112.300878	31	7	7	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98473	10.1371/journal.pone.0098473	http://dx.doi.org/10.1371/journal.pone.0098473			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896268	Green Published, Green Submitted, gold			2022-12-27	WOS:000338430700044
J	Simmons, GE; Pandey, S; Nedeljkovic-Kurepa, A; Saxena, M; Wang, A; Pruitt, K				Simmons, Glenn E., Jr.; Pandey, Somnath; Nedeljkovic-Kurepa, Ana; Saxena, Madhurima; Wang, Allison; Pruitt, Kevin			Frizzled 7 Expression Is Positively Regulated by SIRT1 and beta-Catenin in Breast Cancer Cells	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA CELLS; POTENTIAL THERAPEUTIC TARGET; WNT SIGNAL-TRANSDUCTION; TRANSCRIPTION FACTORS; COLORECTAL-CANCER; POOR-PROGNOSIS; INHIBITION; PATHWAY; FZD7; GROWTH	The Wnt signaling pathway is often chronically activated in diverse human tumors, and the Frizzled (FZD) family of receptors for Wnt ligands, are central to propagating oncogenic signals in a beta-catenin-dependent and independent manner. SIRT1 is a class III histone deacetylase (HDAC) that deacetylates histone and non-histone proteins to regulate gene transcription and protein function. We previously demonstrated that SIRT1 loss of function led to a significant decrease in the levels of Dishevelled (DvI) proteins. To further explore this connection between the sirtuins and components of the Wnt pathway, we analyzed sirtuin-mediated regulation of FZD proteins. Here we explore the contribution of sirtuin deacetylases in promoting constitutive Wnt pathway activation in breast cancer cells. We demonstrate that the use of small molecule inhibitors of SIRT1 and SIRT2, and siRNA specific to SIRT1, all reduce the levels of FZD7 mRNA. We further demonstrate that pharmacologic inhibition of SIRT1/2 causes a marked reduction in FZD7 protein levels. Additionally, we show that beta-catenin and c-Jun occupy the 7 kb region upstream of the transcription start site of the FZD7 gene, and SIRT1 inhibition leads to a reduction in the occupancy of both b-catenin and c-Jun at points along this region. This work uncovers a new mechanism for the regulation of FZD7 and provides a critical new link between the sirtuins and FZD7, one of the earliest nodal points from which oncogenic Wnt signaling emanates. This study shows that inhibition of specific sirtuins may provide a unique strategy for inhibiting the constitutively active Wnt pathway at the level of the receptor.	[Simmons, Glenn E., Jr.; Pandey, Somnath; Nedeljkovic-Kurepa, Ana; Saxena, Madhurima; Wang, Allison; Pruitt, Kevin] LSU Hlth Sci Ctr Sch Med Shreveport, Dept Mol & Cellular Physiol, Shreveport, LA 71103 USA; [Pruitt, Kevin] LSU Hlth Sci Ctr Sch Med Shreveport, Feist Weiller Canc Ctr, Shreveport, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Pruitt, K (corresponding author), LSU Hlth Sci Ctr Sch Med Shreveport, Dept Mol & Cellular Physiol, Shreveport, LA 71103 USA.	kpruit@lsuhsc.edu	Simmons, Glenn/AAT-6135-2020; Pandey, Somnath/GRX-5166-2022; Simmons, Glenn/A-1777-2015	Simmons, Glenn/0000-0003-2081-5672; Simmons, Glenn/0000-0003-2081-5672; Pandey, Somnath/0000-0002-4544-8939	NIH [R01 CA155223]; NATIONAL CANCER INSTITUTE [R01CA155223] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by an NIH R01 grant CA155223. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Byles V, 2012, ONCOGENE, V31, P4619, DOI 10.1038/onc.2011.612; Cha EJ, 2009, CLIN CANCER RES, V15, P4453, DOI 10.1158/1078-0432.CCR-08-3329; Chen ZL, 2013, CELL SIGNAL, V25, P2693, DOI 10.1016/j.cellsig.2013.08.032; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Gurney A, 2012, P NATL ACAD SCI USA, V109, P11717, DOI 10.1073/pnas.1120068109; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Holloway KR, 2013, MOL ENDOCRINOL, V27, P480, DOI 10.1210/me.2012-1347; Holloway KR, 2010, P NATL ACAD SCI USA, V107, P9216, DOI 10.1073/pnas.0911325107; Hu J, 2009, CANCER RES, V69, P6951, DOI 10.1158/0008-5472.CAN-09-0541; Hussain M, 2009, CANCER RES, V69, P3570, DOI 10.1158/0008-5472.CAN-08-2807; Jang KY, 2008, AM J SURG PATHOL, V32, P1523, DOI 10.1097/PAS.0b013e31816b6478; Kaler P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045462; Katoh M, 2007, INT J MOL MED, V19, P529; King TD, 2012, CELL SIGNAL, V24, P846, DOI 10.1016/j.cellsig.2011.12.009; King TD, 2012, J CELL BIOCHEM, V113, P13, DOI 10.1002/jcb.23350; Kirikoshi H, 2001, INT J ONCOL, V19, P111; Kojima K, 2008, BIOCHEM BIOPH RES CO, V373, P423, DOI 10.1016/j.bbrc.2008.06.045; Leal LF, 2011, J CLIN ENDOCR METAB, V96, P3106, DOI 10.1210/jc.2011-0363; Lee H, 2011, HUM PATHOL, V42, P204, DOI 10.1016/j.humpath.2010.05.023; Leko V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066283; Liang XJ, 2008, MOL CANCER RES, V6, P1499, DOI 10.1158/1541-7786.MCR-07-2130; Lindvall C, 2007, STEM CELL REV, V3, P157, DOI 10.1007/s12015-007-0025-3; Mei H, 2014, STEM CELLS, V32, P938, DOI 10.1002/stem.1582; Nosho K, 2009, MODERN PATHOL, V22, P922, DOI 10.1038/modpathol.2009.49; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; Roth M., 2013, ONCOGENE, DOI 10. 1038/onc. 2013. 120; Saxena M, 2013, ONCOGENE; Ueno K, 2009, BRIT J CANCER, V101, P1374, DOI 10.1038/sj.bjc.6605307; Ueno K, 2008, NEOPLASIA, V10, P697, DOI 10.1593/neo.08320; Vincan E, 2010, DEV DYNAM, V239, P311, DOI 10.1002/dvdy.22045; Voloshanenko O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3610; Wang Q, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.202; Wei W, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-16; Wharton KA, 2003, DEV BIOL, V253, P1, DOI 10.1006/dbio.2002.0869; Yang L, 2011, ONCOGENE, V30, P4437, DOI 10.1038/onc.2011.145; Yao Y, 2010, CARCINOGENESIS, V31, P382, DOI 10.1093/carcin/bgp308; Zhang Y, 2009, ONCOGENE, V28, P445, DOI 10.1038/onc.2008.388	38	37	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98861	10.1371/journal.pone.0098861	http://dx.doi.org/10.1371/journal.pone.0098861			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897117	Green Published, Green Submitted, gold			2022-12-27	WOS:000338430700088
J	Solis, AD				Solis, Armando D.			Deriving High-Resolution Protein Backbone Structure Propensities from All Crystal Data Using the Information Maximization Device	PLOS ONE			English	Article							STATISTICAL POTENTIALS; VALIDATION	The most informative probability distribution functions (PDFs) describing the Ramachandran phi-psi dihedral angle pair, a fundamental descriptor of backbone conformation of protein molecules, are derived from high-resolution X-ray crystal structures using an information-theoretic approach. The Information Maximization Device (IMD) is established, based on fundamental information-theoretic concepts, and then applied specifically to derive highly resolved phi-psi maps for all 20 single amino acid and all 8000 triplet sequences at an optimal resolution determined by the volume of current data. The paper shows that utilizing the latent information contained in all viable high-resolution crystal structures found in the Protein Data Bank (PDB), totaling more than 77,000 chains, permits the derivation of a large number of optimized sequence-dependent PDFs. This work demonstrates the effectiveness of the IMD and the superiority of the resulting PDFs by extensive fold recognition experiments and rigorous comparisons with previously published triplet PDFs. Because it automatically optimizes PDFs, IMD results in improved performance of knowledge-based potentials, which rely on such PDFs. Furthermore, it provides an easy computational recipe for empirically deriving other kinds of sequence-dependent structural PDFs with greater detail and precision. The high-resolution phi-psi maps derived in this work are available for download.	CUNY, Dept Biol Sci, New York City Coll Technol, Brooklyn, NY 11210 USA	City University of New York (CUNY) System	Solis, AD (corresponding author), CUNY, Dept Biol Sci, New York City Coll Technol, Brooklyn, NY 11210 USA.	asolis@citytech.cuny.edu	Solis, Armando/AAF-2853-2019		PSC-CUNY Grant Award [60081-4041]	PSC-CUNY Grant Award	PSC-CUNY Grant Award # 60081-4041; https://www.rfcuny.org/rfwebsite/research/content.aspx?catID=1190. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Beck DAC, 2008, P NATL ACAD SCI USA, V105, P12259, DOI 10.1073/pnas.0706527105; Bertinia I, 2003, J BIOMOL NMR, V26, P355, DOI 10.1023/A:1024092421649; Betancourt MR, 2008, J PHYS CHEM B, V112, P5058, DOI 10.1021/jp076906+; Dahl DB, 2008, J MOL BIOL, V378, P749, DOI 10.1016/j.jmb.2008.02.043; Eyal E, 2005, J MOL BIOL, V351, P431, DOI 10.1016/j.jmb.2005.05.066; Haddadian EJ, 2011, BIOPHYS J, V101, P899, DOI 10.1016/j.bpj.2011.06.063; HOBOHM U, 1992, PROTEIN SCI, V1, P409; Hollingsworth Scott A, 2010, Biomol Concepts, V1, P271, DOI 10.1515/BMC.2010.022; Jiang F, 2010, J PHYS CHEM B, V114, P5840, DOI 10.1021/jp909088e; Kleinman CL, 2010, MOL BIOL EVOL, V27, P1546, DOI 10.1093/molbev/msq047; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; Kleywegt GJ, 2000, ACTA CRYSTALLOGR D, V56, P249, DOI 10.1107/S0907444999016364; Lakshmi B, 2013, BIOMOLECULAR FORMS AND FUNCTIONS: A CELEBRATION OF 50 YEARS OF THE RAMACHANDRAN MAP, P128; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Melo F, 2002, PROTEIN SCI, V11, P430, DOI 10.1002/pro.110430; Moult J, 2014, PROTEINS, V82, P1, DOI 10.1002/prot.24452; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Rata IA, 2010, J PHYS CHEM B, V114, P1859, DOI 10.1021/jp909874g; Richardson JS, 2013, BIOMOLECULAR FORMS AND FUNCTIONS: A CELEBRATION OF 50 YEARS OF THE RAMACHANDRAN MAP, P46; Shelar A, 2013, BIOMOLECULAR FORMS AND FUNCTIONS: A CELEBRATION OF 50 YEARS OF THE RAMACHANDRAN MAP, P116; Shortle D, 2002, PROTEIN SCI, V11, P18, DOI 10.1110/ps.ps.31002; SIPPL MJ, 1990, J MOL BIOL, V213, P859, DOI 10.1016/S0022-2836(05)80269-4; SIPPL MJ, 1995, CURR OPIN STRUC BIOL, V5, P229, DOI 10.1016/0959-440X(95)80081-6; Solis AD, 2006, PROTEINS, V62, P892, DOI 10.1002/prot.20501; Solis AD, 2002, PROTEINS, V48, P463, DOI 10.1002/prot.10126; Solis AD, 2008, PROTEINS, V71, P1071, DOI 10.1002/prot.21733; Thomas MC, 2006, ELEMENTS INFORM THEO; Ting D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000763; Walther D, 1999, ACTA CRYSTALLOGR D, V55, P506, DOI 10.1107/S0907444998013353; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224	32	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e94334	10.1371/journal.pone.0094334	http://dx.doi.org/10.1371/journal.pone.0094334			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896099	gold, Green Published			2022-12-27	WOS:000338430700001
J	Yoneda, S; Loeser, B; Feng, J; Dmytryk, J; Qi, FX; Merritt, J				Yoneda, Saori; Loeser, Brandon; Feng, Joseph; Dmytryk, John; Qi, Fengxia; Merritt, Justin			Ubiquitous Sialometabolism Present among Oral Fusobacteria	PLOS ONE			English	Article							GROUP-B STREPTOCOCCUS; CAMPYLOBACTER-JEJUNI LIPOOLIGOSACCHARIDES; SIALYLATED NEISSERIA-GONORRHOEAE; OUTER-MEMBRANE PROTEIN; ACID O-ACETYLATION; SIALIC-ACID; SERUM RESISTANCE; MULTISPECIES BIOFILM; ACUTE APPENDICITIS; FACTOR-H	Fusobacterium nucleatum is a ubiquitous member of the human oral flora and is associated with the development of periodontitis and a variety of other types of polymicrobial infections of the mucosa. In the oral cavity, this species is one of the few that is prevalent in both healthy and diseased subgingival plaque. Using microarray analysis, we examined the transcriptional response of F. nucleatum subspecies nucleatum to whole blood in order to identify some of the genetic responses that might occur during the transition from health to disease. From these studies, we identified a sialic acid catabolism operon that was induced by the presence of blood. We subsequently confirmed that this operon was inducible by the presence of synthetic sialic acid, but we found no evidence suggesting sialic acid was used as a major carbon source. However, this organism was found to possess a de novo synthesized surface sialylation ability that is widely conserved among the various F. nucleatum subspecies as well as in F. periodonticum. We provide evidence that fusobacterial sialylation does occur in the oral cavity irrespective of health status. Interestingly, only a minority of fusobacterial cells exhibit surface sialylation within dental plaque, whereas most cells are uniformly sialylated when grown in pure culture. The implications of these results are discussed.	[Yoneda, Saori] Ohu Univ, Dept Oral Med Sci, Fukushima, Japan; [Loeser, Brandon; Feng, Joseph; Dmytryk, John] Univ Oklahoma, Hlth Sci Ctr, Dept Periodontol, Oklahoma City, OK USA; [Qi, Fengxia; Merritt, Justin] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA; [Qi, Fengxia; Merritt, Justin] Univ Oklahoma, Hlth Sci Ctr, Div Oral Biol, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Merritt, J (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA.	justin-merritt@ouhsc.edu			National Institute of Dental and Craniofacial Research grant [DE018893]; J. Dean Robertson Society; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018893] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research grant; J. Dean Robertson Society; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by a National Institute of Dental and Craniofacial Research grant DE018893 to JM (https://www.nidcr.nih.gov/). BL was supported by funds provided by the J. Dean Robertson Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Vercoe E, 2011, GUT MICROBES, V2, P294, DOI 10.4161/gmic.2.5.18603; Avril T, 2006, INFECT IMMUN, V74, P4133, DOI 10.1128/IAI.02094-05; Bolstad AI, 1996, CLIN MICROBIOL REV, V9, P55, DOI 10.1128/CMR.9.1.55; Carlin AF, 2009, J EXP MED, V206, P1691, DOI 10.1084/jem.20090691; Carlin AF, 2009, BLOOD, V113, P3333, DOI 10.1182/blood-2008-11-187302; Cohen M, 2010, OMICS, V14, P455, DOI 10.1089/omi.2009.0148; Dharmani P, 2011, INFECT IMMUN, V79, P2597, DOI 10.1128/IAI.05118-11; Edwards AM, 2007, ORAL MICROBIOL IMMUN, V22, P217, DOI 10.1111/j.1399-302X.2006.00343.x; Engstler M, 1997, ANAL BIOCHEM, V250, P176, DOI 10.1006/abio.1997.2205; Fujita T, 1999, J CLIN LAB ANAL, V13, P173, DOI 10.1002/(SICI)1098-2825(1999)13:4<173::AID-JCLA6>3.3.CO;2-L; Gmur R, 2004, EUR J ORAL SCI, V112, P33, DOI 10.1111/j.0909-8836.2004.00103.x; Guerry P, 2000, INFECT IMMUN, V68, P6656, DOI 10.1128/IAI.68.12.6656-6662.2000; Han YPW, 2010, OBSTET GYNECOL, V115, P442, DOI 10.1097/AOG.0b013e3181cb9955; Han YW, 2009, J CLIN MICROBIOL, V47, P38, DOI 10.1128/JCM.01206-08; Han YW, 2000, INFECT IMMUN, V68, P3140, DOI 10.1128/IAI.68.6.3140-3146.2000; Heikema AP, 2010, INFECT IMMUN, V78, P3237, DOI 10.1128/IAI.01273-09; Hofbauer J, 1998, UROL RES, V26, P49, DOI 10.1007/s002400050023; Hood DW, 1999, MOL MICROBIOL, V33, P679, DOI 10.1046/j.1365-2958.1999.01509.x; Ikegami A, 2009, INFECT IMMUN, V77, P3075, DOI 10.1128/IAI.00209-09; Jones C, 2003, MOL MICROBIOL, V49, P1213, DOI 10.1046/j.1365-2958.2003.03634.x; Kapatral V, 2003, GENOME RES, V13, P1180, DOI 10.1101/gr.566003; Kaplan CW, 2009, MOL MICROBIOL, V71, P35, DOI 10.1111/j.1365-2958.2008.06503.x; Kaplan CW, 2005, J DENT RES, V84, P700, DOI 10.1177/154405910508400803; Kim HS, 2010, J CLIN MICROBIOL, V48, P545, DOI 10.1128/JCM.01631-09; Kim S, 2011, APPL MICROBIOL BIOT, V91, P1, DOI 10.1007/s00253-011-3307-2; Kinder Haake S, 1997, J PERIODONTOL, V68, P39; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Lewis AL, 2006, J BIOL CHEM, V281, P11186, DOI 10.1074/jbc.M513772200; Lewis AL, 2004, P NATL ACAD SCI USA, V101, P11123, DOI 10.1073/pnas.0403010101; MANGAN DF, 1989, INFECT IMMUN, V57, P3601, DOI 10.1128/IAI.57.11.3601-3611.1989; MARQUES MB, 1992, INFECT IMMUN, V60, P3986, DOI 10.1128/IAI.60.10.3986-3993.1992; Merritt J, 2009, APPL ENVIRON MICROB, V75, P7725, DOI 10.1128/AEM.00916-09; Nistico Laura, 2009, V493, P191, DOI 10.1007/978-1-59745-523-7_12; Ram S, 1998, J EXP MED, V187, P743, DOI 10.1084/jem.187.5.743; Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012; Severi E, 2008, J BIOL CHEM, V283, P4841, DOI 10.1074/jbc.M707822200; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; Shaughnessy J, 2011, J BIOL CHEM, V286, P22235, DOI 10.1074/jbc.M111.225516; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Stafford G, 2012, MOL ORAL MICROBIOL, V27, P11, DOI 10.1111/j.2041-1014.2011.00630.x; Strauss J, 2011, INFLAMM BOWEL DIS, V17, P1971, DOI 10.1002/ibd.21606; Swidsinski A, 2012, SAUDI J GASTROENTERO, V18, P55, DOI 10.4103/1319-3767.91734; Swidsinski A, 2011, GUT, V60, P34, DOI 10.1136/gut.2009.191320; Varki A, 1997, FASEB J, V11, P248, DOI 10.1096/fasebj.11.4.9068613; Vimr E, 2002, TRENDS MICROBIOL, V10, P254, DOI 10.1016/S0966-842X(02)02361-2; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; von Gunten S, 2008, ANN NY ACAD SCI, V1143, P61, DOI 10.1196/annals.1443.011; Weiman S, 2009, GLYCOBIOLOGY, V19, P1204, DOI 10.1093/glycob/cwp111; Zeleny R, 2006, PLANTA, V224, P222, DOI 10.1007/s00425-005-0206-8; Zeng Y, 2009, NAT METHODS, V6, P207, DOI [10.1038/NMETH.1305, 10.1038/nmeth.1305]	51	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99263	10.1371/journal.pone.0099263	http://dx.doi.org/10.1371/journal.pone.0099263			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896093	Green Published, Green Submitted, gold			2022-12-27	WOS:000338430700126
J	Zinkevich, V; Sapojnikova, N; Mitchell, J; Kartvelishvili, T; Asatiani, N; Alkhalil, S; Bogdarina, I; Al-Humam, AA				Zinkevich, Vitaly; Sapojnikova, Nelly; Mitchell, Julian; Kartvelishvili, Tamar; Asatiani, Nino; Alkhalil, Samia; Bogdarina, Irina; Al-Humam, Abdulmohsen A.			A Novel Cassette Method for Probe Evaluation in the Designed Biochips	PLOS ONE			English	Article							OLIGONUCLEOTIDE; DNA; MICROARRAYS; PLATFORM	A critical step in biochip design is the selection of probes with identical hybridisation characteristics. In this article we describe a novel method for evaluating DNA hybridisation probes, allowing the fine-tuning of biochips, that uses cassettes with multiple probes. Each cassette contains probes in equimolar proportions so that their hybridisation performance can be assessed in a single reaction. The model used to demonstrate this method was a series of probes developed to detect TORCH pathogens. DNA probes were designed for Toxoplasma gondii, Chlamidia trachomatis, Rubella, Cytomegalovirus, and Herpes virus and these were used to construct the DNA cassettes. Five cassettes were constructed to detect TORCH pathogens using a variety of genes coding for membrane proteins, viral matrix protein, an early expressed viral protein, viral DNA polymerase and the repetitive gene B1 of Toxoplasma gondii. All of these probes, except that for the B1 gene, exhibited similar profiles under the same hybridisation conditions. The failure of the B1 gene probe to hybridise was not due to a position effect, and this indicated that the probe was unsuitable for inclusion in the biochip. The redesigned probe for the B1 gene exhibited identical hybridisation properties to the other probes, suitable for inclusion in a biochip.	[Zinkevich, Vitaly; Alkhalil, Samia; Bogdarina, Irina] Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth, Hants, England; [Sapojnikova, Nelly; Kartvelishvili, Tamar; Asatiani, Nino] I Javakhishvili Tbilisi State Univ, Andronikashvili Inst Phys, Tbilisi, Georgia; [Mitchell, Julian] Univ Portsmouth, Sch Biol Sci, Portsmouth, Hants, England; [Al-Humam, Abdulmohsen A.] Saudi Aramcos Res & Dev Ctr, Dhahran, Saudi Arabia	University of Portsmouth; Ivane Javakhishvili Tbilisi State University; University of Portsmouth	Zinkevich, V (corresponding author), Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth, Hants, England.	vitaly.zinkevich@port.ac.uk	Sapojnikova, Nelly/H-4340-2017	Sapojnikova, Nelly/0000-0001-6126-6185	International Science and Technology Center [G-1761p]	International Science and Technology Center	This work was supported by International Science and Technology Center (G-1761p) http://www.istc.ru/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen D, 2009, EXPERT REV MOL DIAGN, V9, P645, DOI 10.1586/ERM.09.46; Arron ST, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/756905; Chandler Darrell P, 2012, Microarrays (Basel), V1, P107, DOI 10.3390/microarrays1030107; Craw P, 2012, LAB CHIP, V12, P2469, DOI [10.1039/c2lc40100b, 10.1039/c21c40100b]; Dalma-Weiszhausz DD, 2006, METHOD ENZYMOL, V410, P3, DOI 10.1016/S0076-6879(06)10001-4; Dugat-Bony E, 2012, ENVIRON MICROBIOL, V14, P356, DOI 10.1111/j.1462-2920.2011.02559.x; Fang XE, 2011, ANAL CHEM, V83, P690, DOI 10.1021/ac102858j; Guschin D, 1997, ANAL BIOCHEM, V250, P203, DOI 10.1006/abio.1997.2209; Hager J, 2006, METHOD ENZYMOL, V410, P135, DOI 10.1016/S0076-6879(06)10007-5; He ZL, 2005, APPL ENVIRON MICROB, V71, P3753, DOI 10.1128/AEM.71.7.3753-3760.2005; Huang SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060059; Kamal SAA, 2013, J BIOL AGR HEALTHCAR, V3, P49; Kim MJ, 2011, BIOCHIP J, V5, P39, DOI 10.1007/s13206-011-5107-2; Kimura Y, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr041; Livshits MA, 1996, BIOPHYS J, V71, P2795, DOI 10.1016/S0006-3495(96)79473-0; Miller MB, 2009, CLIN MICROBIOL REV, V22, P611, DOI 10.1128/CMR.00019-09; Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9; Rohrman BA, 2012, LAB CHIP, V12, P3082, DOI 10.1039/c2lc40423k; Safavieh M, 2014, ANALYST, V139, P482, DOI 10.1039/c3an01859h; Timofeev EN, 1996, NUCLEIC ACIDS RES, V24, P3142, DOI 10.1093/nar/24.16.3142; Yoon HK, 2010, BIOCHIP J, V4, P105, DOI 10.1007/s13206-010-4203-z; Zanoli LM, 2013, BIOSENSORS-BASEL, V3, P18, DOI 10.3390/bios3010018; Zhao YA, 2009, J CLIN MICROBIOL, V47, P2067, DOI 10.1128/JCM.02230-08; Zhou WM, 2004, J CLIN MICROBIOL, V42, P5819, DOI 10.1128/JCM.42.12.5819-5824.2004	24	2	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98596	10.1371/journal.pone.0098596	http://dx.doi.org/10.1371/journal.pone.0098596			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897111	Green Published, Green Submitted, gold			2022-12-27	WOS:000338430700053
J	Dufresnes, C; Stock, M; Brelsford, A; Perrin, N				Dufresnes, Christophe; Stoeck, Matthias; Brelsford, Alan; Perrin, Nicolas			Range-Wide Sex-Chromosome Sequence Similarity Supports Occasional XY Recombination in European Tree Frogs (Hyla arborea)	PLOS ONE			English	Article							EVOLUTION	In contrast with mammals and birds, most poikilothermic vertebrates feature structurally undifferentiated sex chromosomes, which may result either from frequent turnovers, or from occasional events of XY recombination. The latter mechanism was recently suggested to be responsible for sex-chromosome homomorphy in European tree frogs (Hyla arborea). However, no single case of male recombination has been identified in large-scale laboratory crosses, and populations from NW Europe consistently display sex-specific allelic frequencies with male-diagnostic alleles, suggesting the absence of recombination in their recent history. To address this apparent paradox, we extended the phylogeographic scope of investigations, by analyzing the sequences of three sex-linked markers throughout the whole species distribution. Refugial populations (southern Balkans and Adriatic coast) show a mix of X and Y alleles in haplotypic networks, and no more within-individual pairwise nucleotide differences in males than in females, testifying to recurrent XY recombination. In contrast, populations of NW Europe, which originated from a recent postglacial expansion, show a clear pattern of XY differentiation; the X and Y gametologs of the sex-linked gene Med15 present different alleles, likely fixed by drift on the front wave of expansions, and kept differentiated since. Our results support the view that sex-chromosome homomorphy in H. arborea is maintained by occasional or historical events of recombination; whether the frequency of these events indeed differs between populations remains to be clarified.	[Dufresnes, Christophe; Brelsford, Alan; Perrin, Nicolas] Univ Lausanne, Dept Ecol & Evolut Biophore Bldg, Lausanne, Switzerland; [Stoeck, Matthias] Leibniz Inst Freshwater Ecol & Inland Fisheries I, Berlin, Germany	University of Lausanne; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB)	Stock, M (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries I, Berlin, Germany.	matthias.stoeck@igb-berlin.de	Stöck, Matthias/E-7245-2014; Perrin, Nicolas/AAA-3150-2020; Dufresnes, Christophe/U-1387-2019	Stöck, Matthias/0000-0003-4888-8371; Perrin, Nicolas/0000-0002-7756-6323	Swiss National Science Foundation [31003A_129894]; Faculty of Biology and Medicine; Fondation Agassiz; Fondation du 450e; Deutsche Forschungsgemeinschaft (DFG) [Sto 493/2-1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Faculty of Biology and Medicine; Fondation Agassiz; Fondation du 450e; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was founded in part by the Swiss National Science Foundation (grant 31003A_129894 to NP), by the University of Lausanne (PhD fellowship from the Faculty of Biology and Medicine, grants from the Fondation Agassiz and the Fondation du 450e to CD), and by a Heisenberg-Fellowship (Sto 493/2-1) of the Deutsche Forschungsgemeinschaft (DFG) to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berset-Brandli L, 2008, P ROY SOC B-BIOL SCI, V275, P1577, DOI 10.1098/rspb.2008.0298; Brelsford A, 2013, EVOLUTION, V67, P2434, DOI 10.1111/evo.12151; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dufresnes C, 2013, MOL ECOL, V22, P5669, DOI 10.1111/mec.12513; Dufresnes C, 2011, EVOL BIOL, V38, P208, DOI 10.1007/s11692-011-9114-y; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grossen C, 2012, EVOLUTION, V66, P3155, DOI 10.1111/j.1558-5646.2012.01661.x; Guerrero RF, 2012, J EVOLUTION BIOL, V25, P1947, DOI 10.1111/j.1420-9101.2012.02591.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Perrin N, 2009, EVOLUTION, V63, P3043, DOI 10.1111/j.1558-5646.2009.00837.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Schartl M, 2004, CURR OPIN GENET DEV, V14, P634, DOI 10.1016/j.gde.2004.09.005; Stock M, 2013, SEX DEV, V7, P261, DOI 10.1159/000351089; Stock M, 2012, MOL PHYLOGENET EVOL, V65, P1, DOI 10.1016/j.ympev.2012.05.014; Stock M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001062; Volff JN, 2007, SEX DEV, V1, P85, DOI 10.1159/000100030	16	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e97959	10.1371/journal.pone.0097959	http://dx.doi.org/10.1371/journal.pone.0097959			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892652	gold, Green Published, Green Submitted			2022-12-27	WOS:000336911400028
J	Genc, Y; Taylor, J; Rongala, J; Oldach, K				Genc, Yusuf; Taylor, Julian; Rongala, Jay; Oldach, Klaus			A Major Locus for Chloride Accumulation on Chromosome 5A in Bread Wheat	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; SALT TOLERANCE; PHYSIOLOGICAL TRAITS; SALINITY TOLERANCE; NA+ TRANSPORT; SPRING WHEAT; BARLEY; GENOTYPES; SODIUM; RICE	Chloride (CL-) is an essential micronutrient for plant growth, but can be toxic at high concentrations resulting in reduced growth and yield. Although saline soils are generally dominated by both sodium (Na+ and Cl- ions, compared to Na+ toxicity very little is known about physiological and genetic control mechanisms of tolerance to Cl- toxicity. In hydroponics and field studies, a bread wheat mapping population was tested to examine the relationships between physiological traits [Na+, potassium (K+) and Cl- ucidate the genetic control mechanism of plantconcentration] involved in salinity tolerance (ST) and seedling growth or grain yield, and to Cl- accumulation differed entirely between hydroponics and field locations and few were detected in two or more environments, demonstrating substantial QTL-by-environment interactions. The presence of several QTL for Cl- concentration indicated that uptake and accumulation was a polygenic trait. A major Cl- concentration QTL (5A; barc56/gwm 7 86) was identified in three field environments, and accounted for 27-32% he total genetic variance. Alignment between the 5A QTL interval and its corresponding physical genome regions in wheat heat and other grasses has enabled the search for candidate genes involved in Cl- transport, which is discussed.	[Genc, Yusuf; Taylor, Julian; Oldach, Klaus] Univ Adelaide, Sch Agr Food & Wine, Glen Osmond, SA, Australia; [Genc, Yusuf; Rongala, Jay; Oldach, Klaus] Plant Genom Ctr, South Australian Res & Dev Inst, Glen Osmond, SA, Australia	University of Adelaide; South Australian Research & Development Institute (SARDI)	Oldach, K (corresponding author), Univ Adelaide, Sch Agr Food & Wine, Waite Campus, Glen Osmond, SA, Australia.	klaus.oldach@sa.gov.au	Taylor, Julian/AAO-6302-2020	Taylor, Julian/0000-0002-9145-052X	Molecular Plant Breeding Cooperative Research Centre; South Australian Research and Development Institute; Grains Research and Development Corporation; University of Adelaide, Australia	Molecular Plant Breeding Cooperative Research Centre; South Australian Research and Development Institute; Grains Research and Development Corporation(Grains R&D Corp); University of Adelaide, Australia	This work was supported by the Molecular Plant Breeding Cooperative Research Centre, the South Australian Research and Development Institute, the Grains Research and Development Corporation and the University of Adelaide, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock KG, 2001, J PLANT NUTR, V24, P1217, DOI 10.1081/PLN-100106977; Ammar MHM, 2009, J PLANT BIOCHEM BIOT, V18, P139, DOI 10.1007/BF03263312; Ashraf M, 1996, J AGRON CROP SCI, V176, P91, DOI 10.1111/j.1439-037X.1996.tb00451.x; ASHRAF M, 1988, J AGRON CROP SCI, V160, P14, DOI 10.1111/j.1439-037X.1988.tb01160.x; Bagci SA, 2007, TURK J AGRIC FOR, V31, P363; Bergmann W., 1992, NUTR DISORDERS PLANT; Bonneau J, 2013, THEOR APPL GENET, V126, P747, DOI 10.1007/s00122-012-2015-3; Byrt CS, 2007, PLANT PHYSIOL, V143, P1918, DOI 10.1104/pp.106.093476; CHEESEMAN JM, 1982, J MEMBRANE BIOL, V70, P157, DOI 10.1007/BF01870225; Colmenero-Flores JM, 2007, PLANT J, V50, P278, DOI 10.1111/j.1365-313X.2007.03048.x; Cramer GR, 2002, SALINITY: ENVIRONMENT - PLANTS - MOLECULES, P205; Cullis BR, 2006, J AGR BIOL ENVIR ST, V11, P381, DOI 10.1198/108571106X154443; EHRET DL, 1990, PLANT SOIL, V128, P143, DOI 10.1007/BF00011103; El-Hendawy SE, 2005, AUST J AGR RES, V56, P123, DOI 10.1071/AR04019; Garcia A, 1997, PLANT CELL ENVIRON, V20, P1167, DOI 10.1046/j.1365-3040.1997.d01-146.x; Genc Y, 2010, THEOR APPL GENET, V121, P877, DOI 10.1007/s00122-010-1357-y; Genc Y, 2010, PLANT SOIL, V327, P331, DOI 10.1007/s11104-009-0057-3; Genc Y, 2007, PLANT CELL ENVIRON, V30, P1486, DOI 10.1111/j.1365-3040.2007.01726.x; Hechenberger M, 1996, J BIOL CHEM, V271, P33632, DOI 10.1074/jbc.271.52.33632; Hollington PA, 2000, P NAT C SAL MAN AGR, P273; Horie T, 2011, PLANT PHYSIOL, V156, P1493, DOI 10.1104/pp.110.168047; Huang YZ, 2006, COMMUN SOIL SCI PLAN, V37, P557, DOI 10.1080/00103620500449419; Isla R, 1997, PLANT SOIL, V197, P105, DOI 10.1023/A:1004240622652; Khan MA, 2009, PAK J BOT, V41, P633; KINGSBURY RW, 1986, PLANT PHYSIOL, V80, P651, DOI 10.1104/pp.80.3.651; Kong XQ, 2011, PLANT MOL BIOL, V75, P567, DOI 10.1007/s11103-011-9744-6; Koyama ML, 2001, PLANT PHYSIOL, V125, P406, DOI 10.1104/pp.125.1.406; Lin HX, 2004, THEOR APPL GENET, V108, P253, DOI 10.1007/s00122-003-1421-y; Lurin C, 1996, PLANT CELL, V8, P701, DOI 10.1105/tpc.8.4.701; Maathuis FJM, 1999, ANN BOT-LONDON, V84, P123, DOI 10.1006/anbo.1999.0912; MART PK, 1995, BIOL PLANTARUM, V37, P265, DOI 10.1007/BF02913224; Martinez Beltran J., 2005, International salinity forum - managing saline soils and water: science, technology and social issues. Oral Presentation Abstracts, Riverside Convention Center, Riverside, California, USA, 25-28 April 2005, P311; MARTINEZ O, 1992, THEOR APPL GENET, V85, P480, DOI 10.1007/BF00222330; Mian A. A., 2011, PLANT STRESS, V5, P64; Munns R, 2003, PLANT SOIL, V253, P201, DOI 10.1023/A:1024553303144; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Long NV, 2013, THEOR APPL GENET, V126, P2335, DOI 10.1007/s00122-013-2139-0; PANDIT A, 2010, MOL GENET GENOMICS, V284, P121, DOI DOI 10.1007/s00438-010-0551-6; Peng S, 2004, PHYSL BIOTECHNOLOGY, P72; Poustini K, 2004, FIELD CROP RES, V85, P125, DOI 10.1016/S0378-4290(03)00157-6; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RAWSON HM, 1988, AUST J AGR RES, V39, P759, DOI 10.1071/AR9880759; Royo A, 1999, PLANT SOIL, V209, P9, DOI 10.1023/A:1004549927123; Salam A, 1999, J AGRON CROP SCI, V183, P145, DOI 10.1046/j.1439-037x.1999.00361.x; SCHACHTMAN DP, 1991, CROP SCI, V31, P992, DOI 10.2135/cropsci1991.0011183X003100040030x; Smith A, 2001, BIOMETRICS, V57, P1138, DOI 10.1111/j.0006-341X.2001.01138.x; Tavakkoli E, 2010, FUNCT PLANT BIOL, V37, P621, DOI 10.1071/FP09202; Taylor JD, 2013, WGAIM WHOLE GENOME A; Teakle NL, 2010, PLANT CELL ENVIRON, V33, P566, DOI 10.1111/j.1365-3040.2009.02060.x; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; Verbyla AP, 2007, THEOR APPL GENET, V116, P95, DOI 10.1007/s00122-007-0650-x; Verbyla AP, 2012, GENET RES, V94, P291, DOI 10.1017/S0016672312000493; Nguyen VL, 2013, MOL BREEDING, V31, P137, DOI 10.1007/s11032-012-9777-9; Wheal MS, 2011, ANAL METHODS-UK, V3, P2854, DOI 10.1039/c1ay05430a; Wheal MS, 2010, J ANAL ATOM SPECTROM, V25, P1946, DOI 10.1039/c0ja00059k; White PJ, 2001, ANN BOT-LONDON, V88, P967, DOI 10.1006/anbo.2001.1540; Wong TH, 2013, J PLANT PHYSIOL, V170, P101, DOI 10.1016/j.jplph.2012.08.003; Xu G., 2000, ADV AGRON, V68, P96	60	21	21	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98845	10.1371/journal.pone.0098845	http://dx.doi.org/10.1371/journal.pone.0098845			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893005	Green Published, Green Submitted, gold			2022-12-27	WOS:000336911400102
J	Murad, AM; Molinari, HBC; Magalhaes, BS; Franco, AC; Takahashi, FSC; de Oliveira, NG; Franco, OL; Quirino, BF				Murad, Aline Melro; Correa Molinari, Hugo Bruno; Magalhaes, Beatriz Simas; Franco, Augusto Cesar; Caldeira Takahashi, Frederico Scherr; de Oliveira-Junior, Nelson Gomes; Franco, Octavio Luiz; Quirino, Betania Ferraz			Physiological and Proteomic Analyses of Saccharum spp. Grown under Salt Stress	PLOS ONE			English	Article							GERMIN-LIKE PROTEINS; HEAT-SHOCK PROTEINS; CHLOROPHYLL FLUORESCENCE; RESPONSIVE PROTEINS; OSMOTIC ADJUSTMENT; OXALATE OXIDASE; NACL STRESS; PLANT; SUGARCANE; TOLERANCE	Sugarcane (Saccharum spp.) is the world most productive sugar producing crop, making an understanding of its stress physiology key to increasing both sugar and ethanol production. To understand the behavior and salt tolerance mechanisms of sugarcane, two cultivars commonly used in Brazilian agriculture, RB867515 and RB855536, were submitted to salt stress for 48 days. Physiological parameters including net photosynthesis, water potential, dry root and shoot mass and malondialdehyde (MDA) content of leaves were determined. Control plants of the two cultivars showed similar values for most traits apart from higher root dry mass in RB867515. Both cultivars behaved similarly during salt stress, except for MDA levels for which there was a delay in the response for cultivar RB867515. Analysis of leaf macro-and micronutrients concentrations was performed and the concentration of Mn2+ increased on day 48 for both cultivars. In parallel, to observe the effects of salt stress on protein levels in leaves of the RB867515 cultivar, two-dimensional gel electrophoresis followed by MS analysis was performed. Four proteins were differentially expressed between control and salt-treated plants. Fructose 1,6-bisphosphate aldolase was down-regulated, a germin-like protein and glyceraldehyde 3-phosphate dehydrogenase showed increased expression levels under salt stress, and heat-shock protein 70 was expressed only in salt-treated plants. These proteins are involved in energy metabolism and defense-related responses and we suggest that they may be involved in protection mechanisms against salt stress in sugarcane.	[Murad, Aline Melro; Magalhaes, Beatriz Simas; Franco, Octavio Luiz; Quirino, Betania Ferraz] Univ Catolica Brasilia, Genome Sci & Biotechnol Program, Brasilia, DF, Brazil; [Murad, Aline Melro; de Oliveira-Junior, Nelson Gomes; Franco, Octavio Luiz] Univ Catolica Brasilia, Ctr Anal Prote & Bioquim, Brasilia, DF, Brazil; [Correa Molinari, Hugo Bruno; Quirino, Betania Ferraz] Embrapa Agroenergy, Brasilia, DF, Brazil; [Franco, Augusto Cesar] Univ Brasilia, Dept Bot, Brasilia, DF, Brazil; [Caldeira Takahashi, Frederico Scherr] Univ Brasilia, Dept Ecol, Brasilia, DF, Brazil	Universidade Catolica de Brasilia; Universidade Catolica de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Brasilia; Universidade de Brasilia	Franco, OL (corresponding author), Univ Catolica Brasilia, Genome Sci & Biotechnol Program, Brasilia, DF, Brazil.	ocfranco@gmail.com; betania.quirino@embrapa.br	Quirino, Betania F/H-8835-2013; Franco, Octavio L/T-3020-2017; Franco, Augusto C/B-1615-2008; Oliveira-Júnior, Nelson/M-5794-2014	Franco, Augusto C/0000-0003-0869-5989; Oliveira-Júnior, Nelson/0000-0001-9437-6778; Franco, Octavio/0000-0001-9546-0525; Quirino, Betania/0000-0002-7578-6314	Conselho Nacional de PEsquisa e Desenvolvimento; Fundacao de Amparo a Pesquisa do Distrito Federal	Conselho Nacional de PEsquisa e Desenvolvimento(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Distrito Federal(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	Authors are also grateful to Conselho Nacional de PEsquisa e Desenvolvimento and Fundacao de Amparo a Pesquisa do Distrito Federal for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi FM, 2004, PROTEOMICS, V4, P2072, DOI 10.1002/pmic.200300741; Aghaei K, 2008, J PROTEOME RES, V7, P4858, DOI 10.1021/pr800460y; Amorim JRAd, 2009, SALINIDADE AREAS IRR; Barkla BJ, 2009, PLANT CELL, V21, P4044, DOI 10.1105/tpc.109.069211; Bernier F, 2001, PLANT PHYSIOL BIOCH, V39, P545, DOI 10.1016/S0981-9428(01)01285-2; Borba MMZ, 2009, ESTUDO EC CICLO PROD; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Cheavegatti-Gianotto Adriana, 2011, Trop Plant Biol, V4, P62, DOI 10.1007/s12042-011-9068-3; Chopart J-L, 2009, INT S ROOT RES APPL, P1; Molinari HBC, 2007, PHYSIOL PLANTARUM, V130, P218, DOI 10.1111/j.1399-3054.2007.00909.x; Davidson RM, 2009, PLANT SCI, V177, P499, DOI 10.1016/j.plantsci.2009.08.012; Deytieux C, 2007, J EXP BOT, V58, P1851, DOI 10.1093/jxb/erm049; Du CX, 2010, PHYTOCHEMISTRY, V71, P1450, DOI 10.1016/j.phytochem.2010.05.020; DUMAS B, 1993, CR ACAD SCI III-VIE, V316, P793; Esteves BS, 2008, OECOL BRAS, V4, P662, DOI DOI 10.4257/0EC0.2008.1204.06; EVANS H., 1936, EMPIRE JOUR EXP AGRIC, V4, P208; FAO, 2011, STAT WORLDS LAND WAT; [FAO] Food and Agriculture Organization of the United Nations, 2009, FAOSTAT; Gava GJD, 2011, REV BRAS ENG AGR AMB, V15, P250, DOI 10.1590/S1415-43662011000300005; Ghaffari A, 2014, J PLANT PHYSIOL, V171, P31, DOI 10.1016/j.jplph.2013.07.014; Ghassemi F., 1995, SALINISATION LAND WA; Grimplet J, 2009, PROTEOMICS, V9, P2503, DOI 10.1002/pmic.200800158; Grover A, 2013, PLANT SCI, V205, P38, DOI 10.1016/j.plantsci.2013.01.005; Gunes A, 2007, J PLANT PHYSIOL, V164, P728, DOI 10.1016/j.jplph.2005.12.009; Hakeem KR, 2012, APPL BIOCHEM BIOTECH, V168, P2309, DOI 10.1007/s12010-012-9939-6; Hara MR, 2006, BBA-MOL BASIS DIS, V1762, P502, DOI 10.1016/j.bbadis.2006.01.012; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; HOFFMANN H.P., 2008, VARIEDADES RB CANA D; Jangpromma Nisachon, 2010, American Journal of Biochemistry and Biotechnology, V6, P89, DOI 10.3844/ajbbsp.2010.89.102; Kang DH, 2002, B KOREAN CHEM SOC, V23, P1511; Kosova K, 2013, INT J MOL SCI, V14, P6757, DOI 10.3390/ijms14046757; Kosova K, 2011, J PROTEOMICS, V74, P1301, DOI 10.1016/j.jprot.2011.02.006; Laclau PB, 2009, FIELD CROP RES, V114, P351, DOI 10.1016/j.fcr.2009.09.004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANE BG, 1993, J BIOL CHEM, V268, P12239; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lv DW, 2014, MOL CELL PROTEOMICS, V13, P632, DOI 10.1074/mcp.M113.030171; Miranda JR, 2008, HIST CANA DE ACUCAR; Molinari HBC, 2004, PLANT SCI, V167, P1375, DOI 10.1016/j.plantsci.2004.07.007; Moons A, 1997, PLANTA, V202, P443, DOI 10.1007/s004250050148; Moradi F, 2007, ANN BOT-LONDON, V99, P1161, DOI 10.1093/aob/mcm052; Morris D. R., 2004, Journal - American Society of Sugar Cane Technologists, V24, P41; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Ngamhui NO, 2012, PLANT OMICS, V5, P365; Nogueira ARA., 2005, MANUAL LAB SOLO AGUA; Ohmiya A, 1998, PLANT CELL PHYSIOL, V39, P492, DOI 10.1093/oxfordjournals.pcp.a029396; Ono M, 1996, PLANT CELL PHYSIOL, V37, P855, DOI 10.1093/oxfordjournals.pcp.a029022; Pacheco CM, 2013, J PROTEOME RES, V12, P5681, DOI 10.1021/pr400654a; Parry MAJ, 2013, J EXP BOT, V64, P717, DOI 10.1093/jxb/ers336; Quirino BF, 2010, PHYTOCHEMISTRY, V71, P351, DOI 10.1016/j.phytochem.2009.11.005; Rodrigues FA, 2009, PLANT SCI, V176, P286, DOI 10.1016/j.plantsci.2008.11.007; Saciloto RFZ, 2003, FISIOLOGIA BIOQUIMIC, P74; Sahi C, 2006, PHYSIOL PLANTARUM, V127, P1, DOI 10.1111/j.1399-3054.2005.00610.x; Sairam RK, 2004, CURR SCI INDIA, V86, P407; Salekdeh GH, 2002, FIELD CROP RES, V76, P199, DOI 10.1016/S0378-4290(02)00040-0; Sarkar D., 2019, NLME LINEAR NONLINEA; SCHOLANDER PF, 1964, P NATL ACAD SCI USA, V52, P119, DOI 10.1073/pnas.52.1.119; Shao HB, 2007, COLLOID SURFACE B, V54, P143, DOI 10.1016/j.colsurfb.2006.09.004; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Silva MD, 2008, SCI AGR, V65, P620, DOI 10.1590/S0103-90162008000600008; Smith DM, 2005, FIELD CROP RES, V92, P169, DOI 10.1016/j.fcr.2005.01.017; Sobhanian H, 2011, J PROTEOMICS, V74, P1323, DOI 10.1016/j.jprot.2011.03.018; Sobhanian H, 2010, J PROTEOME RES, V9, P2882, DOI 10.1021/pr900974k; Solari LI, 2006, TREE PHYSIOL, V26, P1333, DOI 10.1093/treephys/26.10.1333; Song AP, 2014, INT J MOL SCI, V15, P5063, DOI 10.3390/ijms15035063; Song Y, 2011, J PROTEOMICS, V74, P1045, DOI 10.1016/j.jprot.2011.03.009; Stepien P, 2006, BIOL PLANTARUM, V50, P610, DOI 10.1007/s10535-006-0096-z; Tada Y, 2009, PLANT CELL PHYSIOL, V50, P439, DOI 10.1093/pcp/pcp002; Takahashi S, 2008, TRENDS PLANT SCI, V13, P178, DOI 10.1016/j.tplants.2008.01.005; Team RC, 2012, R LANG ENV STAT COMP; Thammasirirak, 2007, KMITL STJ, V7, P44; Thomson EW, 1980, J BIOL CHEM, V255, P5964; Tiroli AO, 2007, INT J BIOCHEM CELL B, V39, P818, DOI 10.1016/j.biocel.2007.01.014; Tiroli-Cepeda AO, 2010, PLANT PHYSIOL BIOCH, V48, P108, DOI 10.1016/j.plaphy.2010.01.001; Tuncturk M, 2008, AFR J BIOTECHNOL, V7, P1650; van den Berg M, 2000, AGR ECOSYST ENVIRON, V81, P43, DOI 10.1016/S0167-8809(00)00167-5; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; Wang W, 2003, ELECTROPHORESIS, V24, P2369, DOI 10.1002/elps.200305500; Woo EJ, 2000, NAT STRUCT BIOL, V7, P1036; Yang F, 2009, PLANT SCI, V176, P669, DOI 10.1016/j.plantsci.2009.02.008; Zamboni A, 2008, J EXP BOT, V59, P4145, DOI 10.1093/jxb/ern256; Zhou G, 2011, PLANT MOL BIOL REP, DOI [10.1007/s11105-011-0343-0: 1-11, DOI 10.1007/S11105-011-0343-0:1-11]; Zimmermann G, 2006, PLANT PHYSIOL, V142, P181, DOI 10.1104/pp.106.083824	87	29	30	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98463	10.1371/journal.pone.0098463	http://dx.doi.org/10.1371/journal.pone.0098463			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893295	Green Published, Green Submitted, gold			2022-12-27	WOS:000336911400054
J	Zeyhle, P; Bauer, JS; Kalinowski, J; Shin-ya, K; Gross, H; Heide, L				Zeyhle, Philipp; Bauer, Judith S.; Kalinowski, Joern; Shin-ya, Kazuo; Gross, Harald; Heide, Lutz			Genome-Based Discovery of a Novel Membrane-Bound 1,6-Dihydroxyphenazine Prenyltransferase from a Marine Actinomycete	PLOS ONE			English	Article							BIOSYNTHETIC GENE-CLUSTER; PHENAZINE BIOSYNTHESIS; MEVALONATE PATHWAY; HETEROLOGOUS EXPRESSION; ISOPRENOID PRODUCTION; ESCHERICHIA-COLI; NATURAL-PRODUCTS; PSEUDOMONAS; PRENYLATION; SYNTHASE	Recently, novel prenylated derivatives of 1,6-dihydroxyphenazine have been isolated from the marine sponge-associated Streptomyces sp. SpC080624SC-11. Genome sequencing of this strain now revealed a gene cluster containing all genes necessary for the synthesis of the phenazine and the isoprenoid moieties. Unexpectedly, however, the cluster did not contain a gene with similarity to previously investigated phenazine prenyltransferases, but instead a gene with modest similarity to the membrane-bound prenyltransferases of ubiquinone and menaquinone biosynthesis. Expression of this gene in E. coli and isolation of the membrane fraction proved that the encoded enzyme, Mpz10, catalyzes two successive prenylations of 1,6-dihydroxyphenazine. Mpz10 is the first example of a membrane-bound enzyme catalyzing the prenylation of a phenazine substrate, and one of few examples of membrane-bound enzymes involved in the prenylation of aromatic secondary metabolites in microorganisms.	[Zeyhle, Philipp; Bauer, Judith S.; Gross, Harald; Heide, Lutz] Univ Tubingen, Inst Pharmazeut, Tubingen, Germany; [Kalinowski, Joern] Univ Bielefeld, Ctr Biotechnol, D-33615 Bielefeld, Germany; [Shin-ya, Kazuo] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tokyo, Japan	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Bielefeld; National Institute of Advanced Industrial Science & Technology (AIST)	Heide, L (corresponding author), Univ Tubingen, Inst Pharmazeut, Tubingen, Germany.	heide@uni-tuebingen.de	Shin-ya, Kazuo/L-9613-2018	Shin-ya, Kazuo/0000-0002-4702-0661; Heide, Lutz/0000-0001-7809-7453	German Federal Ministry of Education and Research (GenBioCom)	German Federal Ministry of Education and Research (GenBioCom)	This work has been supported by a grant from the German Federal Ministry of Education and Research (GenBioCom) to LH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja EG, 2008, J AM CHEM SOC, V130, P17053, DOI 10.1021/ja806325k; Awakawa T, 2011, CHEMBIOCHEM, V12, P439, DOI 10.1002/cbic.201000628; Bonitz T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027336; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brauer L, 2008, CHEMBIOCHEM, V9, P982, DOI 10.1002/cbic.200700575; BREITMAIER E, 1976, J ORG CHEM, V41, P2104, DOI 10.1021/jo00874a008; Bringmann G, 2007, J ORG CHEM, V72, P4198, DOI 10.1021/jo0703404; Brzostowicz PC, 2005, ENVIRON MICROBIOL, V7, P179, DOI 10.1111/j.1462-2920.2004.00681.x; Greenhagen BT, 2008, BIOCHEMISTRY-US, V47, P5281, DOI 10.1021/bi702480t; Gross F, 2006, ARCH MICROBIOL, V185, P28, DOI 10.1007/s00203-005-0059-3; Heide L, 2009, CURR OPIN CHEM BIOL, V13, P171, DOI 10.1016/j.cbpa.2009.02.020; Hu J, 2011, J ANTIBIOT, V64, P221, DOI 10.1038/ja.2010.162; Itoh T, 2012, CHEMBIOCHEM, V13, P1132, DOI 10.1002/cbic.201200124; Itoh T, 2010, NAT CHEM, V2, P858, DOI [10.1038/NCHEM.764, 10.1038/nchem.764]; Izumikawa M, 2010, J NAT PROD, V73, P208, DOI 10.1021/np900747t; Kawasaki T, 2003, J ANTIBIOT, V56, P957, DOI 10.7164/antibiotics.56.957; Khan ST, 2010, FEMS MICROBIOL LETT, V304, P89, DOI 10.1111/j.1574-6968.2009.01886.x; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kitagawa W, 2013, CHEMBIOCHEM, V14, P1085, DOI 10.1002/cbic.201300167; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuzuyama T, 2005, NATURE, V435, P983, DOI 10.1038/nature03668; Laursen JB, 2004, CHEM REV, V104, P1663, DOI 10.1021/cr020473j; Lo HC, 2012, J AM CHEM SOC, V134, P4709, DOI 10.1021/ja209809t; Mavrodi DV, 2013, ENVIRON MICROBIOL, V15, P675, DOI 10.1111/j.1462-2920.2012.02846.x; Mavrodi DV, 2010, APPL ENVIRON MICROB, V76, P866, DOI 10.1128/AEM.02009-09; Mavrodi DV, 1998, J BACTERIOL, V180, P2541, DOI 10.1128/JB.180.9.2541-2548.1998; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; Meganathan R, 2001, FEMS MICROBIOL LETT, V203, P131, DOI 10.1016/S0378-1097(01)00330-5; MELZER M, 1994, BBA-LIPID LIPID MET, V1212, P93, DOI 10.1016/0005-2760(94)90193-7; Mentel M, 2009, CHEMBIOCHEM, V10, P2295, DOI 10.1002/cbic.200900323; Metzger U, 2009, P NATL ACAD SCI USA, V106, P14309, DOI 10.1073/pnas.0904897106; Nowicka B, 2010, BBA-BIOENERGETICS, V1797, P1587, DOI 10.1016/j.bbabio.2010.06.007; Ohara K, 2009, BIOCHEM J, V421, P231, DOI 10.1042/BJ20081968; Okamura E, 2010, P NATL ACAD SCI USA, V107, P11265, DOI 10.1073/pnas.1000532107; Pierson LS, 2010, APPL MICROBIOL BIOT, V86, P1659, DOI 10.1007/s00253-010-2509-3; Poulter C. Dale, 2006, Phytochemistry Reviews, V5, P17, DOI 10.1007/s11101-005-4887-1; Romer A, 1982, ORG MAGN RESONANCE, V19, P66; Saleh O, 2012, MEDCHEMCOMM, V3, P1009, DOI 10.1039/c2md20045g; Saleh O, 2012, BEILSTEIN J ORG CHEM, V8, DOI 10.3762/bjoc.8.57; Saleh O, 2009, J BIOL CHEM, V284, P14439, DOI 10.1074/jbc.M901312200; Sambrook J., 2001, MOL CLONING LAB MANU; Sasaki K, 2008, PLANT PHYSIOL, V146, P1075, DOI 10.1104/pp.107.110544; Seeger K, 2011, MICROB BIOTECHNOL, V4, P252, DOI 10.1111/j.1751-7915.2010.00234.x; SHEN B, 1993, BIOCHEMISTRY-US, V32, P6656, DOI 10.1021/bi00077a019; SHIRLING E. B., 1966, INT J SYST BACTERIOL, V16, P313; Stec E, 2011, CHEMBIOCHEM, V12, P1724, DOI 10.1002/cbic.201100188; Suvarna K, 1998, J BACTERIOL, V180, P2782, DOI 10.1128/JB.180.10.2782-2787.1998; WOODSIDE AB, 1988, ORG SYNTH, V66, P211; Yu X, 2012, METHOD ENZYMOL, V516, P259, DOI 10.1016/B978-0-12-394291-3.00005-8; Zendah I, 2012, J NAT PROD, V75, P2, DOI 10.1021/np100818d	50	20	20	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e99122	10.1371/journal.pone.0099122	http://dx.doi.org/10.1371/journal.pone.0099122			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892559	Green Published, Green Submitted, gold			2022-12-27	WOS:000336911400127
J	Lin, Y; Fang, ZF; Che, LQ; Xu, SY; Wu, D; Wu, CM; Wu, XQ				Lin, Yan; Fang, Zheng-feng; Che, Lian-qiang; Xu, Sheng-yu; Wu, De; Wu, Cai-mei; Wu, Xiu-qun			Use of Sodium Butyrate as an Alternative to Dietary Fiber: Effects on the Embryonic Development and Anti-Oxidative Capacity of Rats	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; SUBSTRATE-INDUCED REGULATION; OXIDATIVE STRESS; MONOCARBOXYLATE TRANSPORTER; CELL PROLIFERATION; GENE-EXPRESSION; IMPROVES; SUPPLEMENTATION; MECHANISMS; PLACENTA	In this study, we evaluated the effect of replacing dietary fiber with sodium butyrate on reproductive performance and antioxidant defense in a high fat diet during pregnancy by using a rat model. Eighty virgin female Sprague Dawley rats were fed one of four diets-(1) control diet (C group), (2) high fat + high fiber diet (HF group), (3) high-fat + 5% sodium butyrate diet (SB group), and (4) HF diet + alpha-cyano-4-hydroxy cinnamic acid (CHC group)-intraperitoneally on days 8, 10, 12, 14, and 16 of gestation. SB and dietary fiber had similar effects on improving fetal number and reducing the abortion rate; however, the anti-oxidant capacity of maternal serum, placenta, and fetus was superior in the HF group than in the SB group. In comparison, CHC injection decreased reproductive performance and antioxidant defense. Both dietary fiber (DF) and SB supplementation had a major but different effect on the expression of anti-oxidant related genes and nutrient transporters genes. In summary, our data indicate that SB and DF showed similar effect on reproductive performance, but SB cannot completely replace the DF towards with respect to redox regulation in high-fat diet; and SB might influence offspring metabolism and health differently to DF.	[Wu, De] Sichuan Agr Univ, Key Lab Anim Dis Resistance Nutr, Minist Educ, Yaan, Sichuan, Peoples R China; Sichuan Agr Univ, Inst Anim Nutr, Yaan, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Wu, D (corresponding author), Sichuan Agr Univ, Key Lab Anim Dis Resistance Nutr, Minist Educ, Yaan, Sichuan, Peoples R China.	pig2pig@sina.com		Lin, Yu-Hsuan/0000-0001-9393-3886; Chen, Sue-Huie/0000-0001-6737-2966; CHANG, LI-REN/0000-0003-0853-3904				Abrahamse SL, 1999, CARCINOGENESIS, V20, P629, DOI 10.1093/carcin/20.4.629; Anderson JW, 2009, NUTR REV, V67, P188, DOI 10.1111/j.1753-4887.2009.00189.x; Andoh A, 1999, JPEN-PARENTER ENTER, V23, pS70, DOI 10.1177/014860719902300518; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; BOERNER P, 1988, J CELL PHYSIOL, V137, P117, DOI 10.1002/jcp.1041370114; Borthakur A, 2012, AM J PHYSIOL-GASTR L, V303, pG1126, DOI 10.1152/ajpgi.00308.2012; Buege J A, 1978, Methods Enzymol, V52, P302; Che L, 2011, REPROD DOMEST ANIM, V46, P1061, DOI 10.1111/j.1439-0531.2011.01787.x; Chung HW, 2012, NEPHROL DIAL TRANSPL, V27, P2213, DOI 10.1093/ndt/gfr613; CLAUSEN MR, 1994, GASTROENTEROLOGY, V106, P423, DOI 10.1016/0016-5085(94)90601-7; Clemens R, 2012, J NUTR, V142, p1390S, DOI 10.3945/jn.112.160176; Cuff MA, 2002, J PHYSIOL-LONDON, V539, P361, DOI 10.1113/jphysiol.2001.014241; da Silva CS, 2013, PHYSIOL BEHAV, V110, P148, DOI 10.1016/j.physbeh.2013.01.006; Dalmasso G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002476; Daly K, 2006, DNA CELL BIOL, V25, P49, DOI 10.1089/dna.2006.25.49; Das ZC, 2010, CELL REPROGRAM, V12, P95, DOI 10.1089/cell.2009.0068; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; Dgen L, 2009, ACTA AGR SCAND, V59, P150; Lopez-Oliva ME, 2013, BRIT J NUTR, V109, P4, DOI 10.1017/S0007114512000517; FERNANDEZMEJIA C, 1993, PANCREAS, V8, P589, DOI 10.1097/00006676-199309000-00010; Fung KYC, 2012, BRIT J NUTR, V108, P820, DOI 10.1017/S0007114512001948; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Gill RK, 2005, AM J PHYSIOL-CELL PH, V289, pC846, DOI 10.1152/ajpcell.00112.2005; Goicoa S, 2006, CLONING STEM CELLS, V8, P140, DOI 10.1089/clo.2006.8.140; GOODGER AM, 1993, J REPROD FERTIL, V99, P451, DOI 10.1530/jrf.0.0990451; Halestrap AP, 2012, IUBMB LIFE, V64, P109, DOI 10.1002/iub.572; Hamer HM, 2009, CLIN NUTR, V28, P88, DOI 10.1016/j.clnu.2008.11.002; Hara H, 1999, J NUTR, V129, P942, DOI 10.1093/jn/129.5.942; Hashimoto T, 2007, FASEB J, V21, P2602, DOI 10.1096/fj.07-8174com; Ichikawa H, 2002, DIGEST DIS SCI, V47, P1141, DOI 10.1023/A:1015014829605; Kirat D, 2010, J COMP PHYSIOL B, V180, P57, DOI 10.1007/s00360-009-0382-0; Kumar AP, 2010, J FOOD BIOCHEM, V34, P15, DOI 10.1111/j.1745-4514.2009.00284.x; Kuo Dar-Chih, 2009, J Biomed Sci, V16, P15, DOI 10.1186/1423-0127-16-15; Le Gall M, 2009, BRIT J NUTR, V102, P1285, DOI 10.1017/S0007114509990213; Lecumberri E, 2007, NUTRITION, V23, P332, DOI 10.1016/j.nut.2007.01.013; Lee SH, 2002, J ANIM SCI, V80, P2840; Li N, 2010, J PEDIATR GASTR NUTR, V51, P414, DOI 10.1097/MPG.0b013e3181dd913a; Lin Y, 2012, NUTRITION, V28, P1037, DOI 10.1016/j.nut.2012.01.002; Lin Y, 2011, BRIT J NUTR, V106, P510, DOI 10.1017/S0007114511000614; Liu LM, 2012, J EXP ZOOL PART B, V318B, P224, DOI 10.1002/jez.b.22440; Lu H, 2012, J ANIM SCI, V90, P430, DOI 10.2527/jas.53817; Mangian HF, 2009, JPEN-PARENTER ENTER, V33, P607, DOI 10.1177/0148607109336599; Marzioni D, 1998, HUM REPROD, V13, P1717, DOI 10.1093/humrep/13.6.1717; Moslehi M, 2013, CELL BIOCHEM BIOPHYS, V66, P817, DOI 10.1007/s12013-013-9526-7; MURASE M, 1995, J CHROMATOGR B, V664, P415, DOI 10.1016/0378-4347(94)00491-M; Nagai A, 2010, PLACENTA, V31, P126, DOI 10.1016/j.placenta.2009.11.013; REMESY C, 1992, NUTR RES, V12, P1235, DOI 10.1016/S0271-5317(05)80780-8; Russo I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032841; Salminen S, 1998, BRIT J NUTR, V80, pS147, DOI 10.1079/BJN19980108; Sauer J, 2007, J NUTR BIOCHEM, V18, P736, DOI 10.1016/j.jnutbio.2006.12.012; Scharlau D, 2009, MUTAT RES-REV MUTAT, V682, P39, DOI 10.1016/j.mrrev.2009.04.001; Sharma B, 2011, PSYCHOPHARMACOLOGY, V215, P677, DOI 10.1007/s00213-011-2164-0; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Shin JH, 2013, GENE REGUL SYST BIO, V7, P57, DOI 10.4137/GRSB.S11243; Tappenden KA, 1998, AM J CLIN NUTR, V68, P118, DOI 10.1093/ajcn/68.1.118; Tzanetakou IP, 2011, OPEN CARDIOVASC MED, V5, P103, DOI 10.2174/1874192401105010103; Zimmermann AK, 2007, J BIOL CHEM, V282, P29296, DOI 10.1074/jbc.M702853200; Zubova S G, 2008, Tsitologiia, V50, P964	58	163	166	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2014	9	5							e97838	10.1371/journal.pone.0097838	http://dx.doi.org/10.1371/journal.pone.0097838			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK3KS	24896252	Green Published, gold, Green Submitted			2022-12-27	WOS:000338323200031
J	Luo, Y; He, FL; Hu, L; Hai, L; Huang, MF; Xu, ZP; Zhang, JJ; Zhou, ZG; Liu, F; Dai, YS				Luo, Yan; He, Fengli; Hu, Li; Hai, Luo; Huang, Meifeng; Xu, Zhipeng; Zhang, Jingjing; Zhou, Zhiguang; Liu, Feng; Dai, Yan-Shan			Transcription Factor Ets1 Regulates Expression of Thioredoxin-Interacting Protein and Inhibits Insulin Secretion in Pancreatic beta-Cells	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; GENE-EXPRESSION; OXIDATIVE STRESS; GLUCOSE; INFLAMMASOME; ACTIVATION; KINASE; TXNIP; LINK; PHOSPHORYLATION	Long-term activation of extracellular-regulated kinase (ERK1/2) pathway has been shown to cause glucotoxicity and inhibit insulin gene expression in beta-cells. Transcription factor Ets1 is activated by ERK1/2-mediated phosphorylation at the Thr38 residue. We hypothesize that Ets1 plays an important role in mediating ERK1/2 induced glucotoxicity in beta-cells. We determined the role of Ets1 in Min6 cells and isolated mouse islets using overexpression and siRNA mediated knockdown of Ets1. The results show that Ets1 was localized in insulin-staining positive cells but not in glucagon-staining positive cells. Overexpression of Ets1 reduced glucose-stimulated insulin secretion in primary mouse islets. Overexpression of Ets1 in Min6 beta-cells and mouse islets increased expression of thioredoxin-interacting protein (TXNIP). Conversely, knockdown of Ets1 by siRNA reduced expression of TXNIP in Min6 cells. Ets1 was associated with the txnip promoter in min6 cells and transfection of 293 cells with Ets1 and p300 synergistically increased txnip promoter reporter activity. Moreover, overexpression of Ets1 inhibited Min6 cell proliferation. Our results suggest that Ets1, by promoting TXNIP expression, negatively regulates beta-cell function. Thus, over-activation of Ets1 may contribute to diet-induced beta-cell dysfunction.	[Luo, Yan; He, Fengli; Hu, Li; Hai, Luo; Huang, Meifeng; Xu, Zhipeng; Zhang, Jingjing; Zhou, Zhiguang; Liu, Feng; Dai, Yan-Shan] Cent S Univ, Xiangya Hosp 2, Minist Educ, Metab Syndrome Res Ctr,Key Lab Diabet Immunol, Changsha, Hunan, Peoples R China; [Liu, Feng] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA	Central South University; University of Texas System; University of Texas Health San Antonio	Dai, YS (corresponding author), Cent S Univ, Xiangya Hosp 2, Minist Educ, Metab Syndrome Res Ctr,Key Lab Diabet Immunol, Changsha, Hunan, Peoples R China.	ydai88@csu.edu.cn	Hai, Luo/ABE-5483-2020; Dai, Yanshan/B-8577-2009; Chen, Huai/AAI-1024-2020; Chen, Huai/A-7418-2015; Zhang, Yao/P-2009-2015	Chen, Huai/0000-0001-7650-289X; Zhou, Zhiguang/0000-0002-0374-1838; Dai, Yanshan/0000-0001-5048-7417; Yang, Yanzheng/0000-0002-3299-0403; Chen, Huai/0000-0001-6208-1481; Zhang, Yao/0000-0002-7468-2409	Natural Science Foundation of China [81270905, 81130015]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by Natural Science Foundation of China grant no. 81270905 (Y.-S. Dai) and 81130015 (F. Liu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MQ, 2011, HUM MOL GENET, V20, P165, DOI 10.1093/hmg/ddq455; Bensellam M, 2012, MOL CELL ENDOCRINOL, V364, P1, DOI 10.1016/j.mce.2012.08.003; Cha-Molstad H, 2009, J BIOL CHEM, V284, P16898, DOI 10.1074/jbc.M109.010504; Chen JQ, 2008, FASEB J, V22, P3581, DOI 10.1096/fj.08-111690; Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; Chen JQ, 2014, MOL ENDOCRINOL, V28, P674, DOI 10.1210/me.2014-1041; Chen JQ, 2010, DIABETES, V59, P440, DOI 10.2337/db09-0949; Choy WW, 2014, ACTA CRYSTALLOGR F, V70, P44, DOI 10.1107/S2053230X13024795; Dai YS, 2002, J BIOL CHEM, V277, P24390, DOI 10.1074/jbc.M202490200; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Fang SH, 2011, MOL CELL BIOCHEM, V347, P175, DOI 10.1007/s11010-010-0626-z; Fontes G, 2009, DIABETES, V58, P2048, DOI 10.2337/db08-0579; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; Goehring I, 2011, DIABETOLOGIA, V54, P2584, DOI 10.1007/s00125-011-2249-7; Hamzaoui H, 2007, MOL CELL ENDOCRINOL, V268, P75, DOI 10.1016/j.mce.2007.01.014; Harmon JS, 2005, J BIOL CHEM, V280, P11107, DOI 10.1074/jbc.M410345200; Hashiguchi K, 2010, BIOCHEM BIOPH RES CO, V391, P621, DOI 10.1016/j.bbrc.2009.11.109; He XQ, 2012, MOL PHARMACOL, V82, P887, DOI 10.1124/mol.112.081133; Jayaraman G, 1999, J BIOL CHEM, V274, P17342, DOI 10.1074/jbc.274.24.17342; Jin CC, 2010, IMMUNOL CELL BIOL, V88, P510, DOI 10.1038/icb.2010.56; Jing G, 2014, J BIOL CHEM, V289, P11807, DOI 10.1074/jbc.M113.525022; Kanari Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059026; Kibbe C, 2013, J BIOL CHEM, V288, P23194, DOI 10.1074/jbc.M113.473082; Kumar P, 2009, HYPERTENSION, V54, P172, DOI 10.1161/HYPERTENSIONAHA.109.133033; Lawrence M, 2008, ACTA PHYSIOL, V192, P11, DOI 10.1111/j.1748-1716.2007.01785.x; Lawrence MC, 2005, J BIOL CHEM, V280, P26751, DOI 10.1074/jbc.M503158200; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Lombardi A, 2012, DIABETOLOGIA, V55, P141, DOI 10.1007/s00125-011-2315-1; Luo Y, 2013, DIABETES, V62, pA582; Nelson ML, 2010, P NATL ACAD SCI USA, V107, P10026, DOI 10.1073/pnas.0915137107; Oka S, 2009, ENDOCRINOLOGY, V150, P1225, DOI 10.1210/en.2008-0646; Oslowski CM, 2012, CELL METAB, V16, P265, DOI 10.1016/j.cmet.2012.07.005; Peterson CW, 2010, MOL CELL BIOL, V30, P2887, DOI 10.1128/MCB.01613-09; Poitout V, 2010, BBA-MOL CELL BIOL L, V1801, P289, DOI 10.1016/j.bbalip.2009.08.006; Poungvarin N, 2012, DIABETOLOGIA, V55, P1783, DOI 10.1007/s00125-012-2506-4; Rani S, 2010, CELL PHYSIOL BIOCHEM, V25, P667, DOI 10.1159/000315086; Sarkar A, 2011, FASEB J, V25, P2592, DOI 10.1096/fj.10-173757; Tsao HW, 2013, P NATL ACAD SCI USA, V110, P15776, DOI 10.1073/pnas.1304343110; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Xu GL, 2013, NAT MED, V19, P1141, DOI 10.1038/nm.3287; Yang BS, 1996, MOL CELL BIOL, V16, P538; Yang C, 1998, MOL CELL BIOL, V18, P2218, DOI 10.1128/MCB.18.4.2218; Yoshihara E, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1127; Zhan YM, 2005, J CLIN INVEST, V115, P2508, DOI 10.1172/JCI24403; Zhang JJ, 2012, DIABETES, V61, P3189, DOI 10.2337/db12-0249; Zhang XF, 2014, ENDOCRINE, V46, P470, DOI 10.1007/s12020-013-0114-9; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	47	30	32	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99049	10.1371/journal.pone.0099049	http://dx.doi.org/10.1371/journal.pone.0099049			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897113	Green Submitted, gold, Green Published			2022-12-27	WOS:000338430700109
